4,703 Matching Annotations
  1. Nov 2024
    1. https://stationeryfestival.com/exhibitors

      Elite Accessories<br /> 3428 Hauck Rd, Ste K<br /> Cincinnati, OH 45241<br /> (630) 945-2710

      Represents the following stationery manufacturers in the US:<br /> - Kaweco (Germany) fountain pens - Kyo No Oto (Tag Stationery) inks - Oeda Letterpress (Osaka Japan) letterpress stationery - Onishi Seisakusho (fountain pens) - Diamine Inks (Liverpool, UK)

    1. Reviewer #2 (Public review):

      Summary:

      The authors tried to determine how PA28g functions in oral squamous cell carcinoma (OSCC) cells. They hypothesized it may act through metabolic reprogramming in the mitochondria.

      Strengths:

      They found that the genes of PA28g and C1QBP are in an overlapping interaction network after an analysis of a genome database. They also found that the two proteins interact in coimmunoprecipitation and pull-down assays using the lysate from OSCC cells with or without expression of the exogenous genes. They used truncated C1QBP proteins to map the interaction site to the N-terminal 167 residues of C1QBP protein. They observed the levels of the two proteins are positively correlated in the cells. They provided evidence for the colocalization of the two proteins in the mitochondria and the effect on mitochondrial form and function in vitro and in vivo OSCC models, and the correlation of the protein expression with the prognosis of cancer patients.

      Weaknesses:

      Many data sets are shown in figures that cannot be understood without more descriptions either in the text or the legend, e.g., Fig. 1A. Similarly, many abbreviations are not defined.

      The revision addressed these issues.

      Some of the pull-down and coimmunoprecipitation data do not support the conclusion about the PA28g-C1QBP interaction. For example, in Appendix Fig. 1B the Flag-C1QBP was detected in the Myc beads pull-down when the protein was expressed in the 293T cells without the Myc-PA28g, suggesting that the pull-down was not due to the interaction of the C1QBP and PA28g proteins. In Appendix Fig. 1C, assume the SFB stands for a biotin tag, then the SFB-PA28g should be detected in the cells expressing this protein after pull-down by streptavidin; however, it was not. The Western blot data in Fig. 1E and many other figures must be quantified before any conclusions about the levels of proteins can be drawn.

      The revision addressed these problems.

      The immunoprecipitation method is flawed as it is described. The antigen (PA28g or C1QBP) should bind to the respective antibody that in turn should binds to Protein G beads. The resulting immunocomplex should end up in the pellet fraction after centrifugation, and analyzed further by Western blot for coprecipitates. However, the method in the Appendix states that the supernatant was used for the Western blot.

      The revision corrected this method.

      To conclude that PA28g stabilizes C1QBP through their physical interaction in the cells, one must show whether a protease inhibitor can substitute PA28q and prevent C1QBP degradation, and also show whether a mutation that disrupt the PA28g-C1QBP interaction can reduce the stability of C1QBP. In Fig. 1F, all cells expressed Myc-PA28g. Therefore, the conclusion that PA28g prevented C1QBP degradation cannot be reached. Instead, since more Myc-PA28g was detected in the cells expressing Flag-C1QBP compared to the cells not expressing this protein, a conclusion would be that the C1QBP stabilized the PA28g. Fig. 1G is a quantification of a Western blot data that should be shown.

      The binding site for PA28g in C1QBP was mapped to the N-terminal 167 residues using truncated proteins. One caveat would be that some truncated proteins did not fold correctly in the absence of the sequence that was removed. Thus, the C-terminal region of the C1QBP with residues 168-283 may still bind to the PA29g in the context of full-length protein. In Fig. 1I, more Flag-C1QBP 1-167 was pull-down by Myc-PA28g than the full-length protein or the Flag-C1QBP 1-213. Why?

      The interaction site in PA28g for C1QBP was not mapped, which prevents further analysis of the interaction. Also, if the interaction domain can be determined, structural modeling of the complex would be feasible using AlphaFold2 or other programs. Then, it is possible to test point mutations that may disrupt the interaction and if so, the functional effect.

      The revision added AlphaFold models for the protein interaction. However, the models were not analyzed and potential mutations that would disrupt the interact were not predicted, made and tested. The revision did not addressed the request for the protease inhibitor.

    2. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, the authors have tried to dissect the functions of Proteasome activator 28γ (PA28γ) which is known to activate proteasomal function in an ATP-independent manner. Although there are multiple works that have highlighted the role of this protein in tumours, this study specifically tried to develop a correlation with Complement C1q binding protein (C1QBp) that is associated with immune response and energy homeostasis.

      Strengths:

      The observations of the authors hint that beyond PA28y's association with the proteasome, it might also stabilize certain proteins such as C1QBP which influences energy metabolism.

      Weaknesses:

      The strength of the work also becomes its main drawback. That is, how PA28y stabilizes C1QBP or how C1QBP elicits its pro-tumourigenic role under PA28y OE.<br /> In most of the experiments, the authors have been dependent on the parallel changes in the expression of both the proteins to justify their stabilizing interaction. However, this approach is indirect at best and does not confirm the direct stabilizing effect of this interaction. IP experiments do not indicate direct interaction and have some quality issues. The upregulation of C1QBP might be indirect at best. It is quite possible that PA28y might be degrading some secondary protein/complex that is responsible for C1QBP expression. Since the core idea of the work is PA28y direct interaction with C1QBP stabilizing it, the same should be demonstrated in a more convincing manner.

      Thank you very much for the important comments. Using AlphaFold 3, we found that interaction between PA28γ and C1QBP may depend on amino acids 1-167 and 1-213 (Revised Appendix Figure 1D-H), which was confirmed by our immunoprecipitation (Revised Figure 1I). In the future, we will use nuclear magnetic resonance spectroscopy to analyze protein-protein interaction between PA28γ and C1QBP and demonstrate it by GST pull down in vitro experiments.

      In all of the assays, C1QBP has been detected as doublet. However, the expression pattern of the two bands varies depending on the experiment. In some cases, the upper band is intensely stained and in some the lower bands. Do C1QBP isoforms exist and are they differentially regulated depending on experiment conditions/tissue types?

      Thank you very much for the important comments. We have rechecked the experimental results with two bands, which may have been caused by using polyclonal antibody of C1QBP (Abcam: ab101267). Therefore, we conducted the experiment with monoclonal antibody of C1QBP (Cell Signaling Technology: #6502) and replaced the corresponding images in revised figure (Revised Figure 1E and Revised Appendix Figure 3D).

      Problems with the background of the work: Line 76. This statement is far-fetched. There are presently a number of works of literature that have dealt with the metabolic programming of OSCC including identification of specific metabolites. Moreover, beyond the estimation of OCR, the authors have not conducted any experiments related to metabolism. In the Introduction, the significance of this study and how it will extend our understanding of OSCC needs to be elaborated.

      Thank you very much for the important comments. Based on your suggestion, we have revised the content and updated the references (“Introduction”, Paragraph 2, Line 13-17 and Paragraph 4, Line 5-8). In addition, we plan to conduct experiments to investigate the regulation of metabolism by PA28γ and C1QBP and update our data in the future.

      The modified content is as follows:

      “Current research on metabolic reprogramming in OSCC primarily focused on mechanism of glycolytic metabolism and metabolic shift from glycolysis to oxidative phosphorylation (OXPHOS) of oral squamous cell carcinoma, which lays the groundwork for novel therapeutic interventions to counteract OSCC (Chen et al., 2024; Zhang et al., 2020).”

      “It is the first study to describe the undiscovered role of PA28γ in promoting the malignant progression of OSCC by elevating mitochondrial function, providing new clinical insights for the treatment of OSCC.”

      Reviewer #2 (Public review):

      Summary:

      The authors tried to determine how PA28g functions in oral squamous cell carcinoma (OSCC) cells. They hypothesized it may act through metabolic reprogramming in the mitochondria.

      Strengths:

      They found that the genes of PA28g and C1QBP are in an overlapping interaction network after an analysis of a genome database. They also found that the two proteins interact in coimmunoprecipitation and pull-down assays using the lysate from OSCC cells with or without expression of the exogenous genes. They used truncated C1QBP proteins to map the interaction site to the N-terminal 167 residues of C1QBP protein. They observed the levels of the two proteins are positively correlated in the cells. They provided evidence for the colocalization of the two proteins in the mitochondria, the effect on mitochondrial form and function in vitro and in vivo OSCC models, and the correlation of the protein expression with the prognosis of cancer patients.

      Weaknesses:

      Many data sets are shown in figures that cannot be understood without more descriptions, either in the text or the legend, e.g., Figure 1A. Similarly, many abbreviations are not defined.

      Thank you very much for the important comments. We have revised the descriptions in the legend to make it easier to understand.

      Some of the pull-down and coimmunoprecipitation data do not support the conclusion about the PA28g-C1QBP interaction. For example, in Appendix Figure 1B the Flag-C1QBP was detected in the Myc beads pull-down when the protein was expressed in the 293T cells without the Myc-PA28g, suggesting that the pull-down was not due to the interaction of the C1QBP and PA28g proteins. In Appendix Figure 1C, assume the SFB stands for a biotin tag, then the SFB-PA28g should be detected in the cells expressing this protein after pull-down by streptavidin; however, it was not. The Western blot data in Figure 1E and many other figures must be quantified before any conclusions about the levels of proteins can be drawn.

      Thank you very much for the meticulous review. We have rechecked the experimental results, and we made a mistake in the labeling of the image. Therefore, we have corrected it in the revised figure (Revised Appendix Figure 1B, C). In addition, we have conducted a quantitative analysis of gray values to confirm the results of western blot data are accurate by Image J software.

      The immunoprecipitation method is flawed as it is described. The antigen (PA28g or C1QBP) should bind to the respective antibody that in turn should binds to Protein G beads. The resulting immunocomplex should end up in the pellet fraction after centrifugation and be analyzed further by Western blot for coprecipitates. However, the method in the Appendix states that the supernatant was used for the Western blot.

      Thank you very much for the careful review. We have corrected it in the revised appendix file (“Supplemental Materials and Methods”, Part“Immunoprecipitation assay”, Line 4-6).

      The modified content is as follows:

      The sample was shaken on a horizontal shaker for 4 h, after which the deposit was collected for western blotting.

      To conclude that PA28g stabilizes C1QBP through their physical interaction in the cells, one must show whether a protease inhibitor can substitute PA28q and prevent C1QBP degradation, and show whether a mutation that disrupts the PA28g-C1QBP interaction can reduce the stability of C1QBP. In Figure 1F, all cells expressed Myc-PA28g. Therefore, the conclusion that PA28g prevented C1QBP degradation cannot be reached. Instead, since more Myc-PA28g was detected in the cells expressing Flag-C1QBP compared to the cells not expressing this protein, a conclusion would be that the C1QBP stabilized the PA28g. Figure 1G is a quantification of Western blot data that should be shown.

      Thank you very much for the meticulous review. We have rechecked the experimental results, and we made a mistake in the labeling of the image. Therefore, we have corrected it in the revised figure. Compared with the control group, the presence of Myc-PA28γ significantly increased the expression level of Flag-C1QBP (Revised Figure 1F). Gray value analysis showed that in cells transfected with Myc-PA28γ, the decay rate of Flag-C1QBP was significantly slower than that of the control group (Revised Figure 1G), suggesting that PA28γ can delay the protein degradation of C1QBP and stabilize its protein level. This indicates that an increase in the level of PA28γ protein can significantly enhance the expression level of C1QBP protein, while PA28γ can slow down the degradation rate of C1QBP and improve its stability. In addition, we plan to conduct experiments to investigate the effects of protease inhibitors and PA28γ mutants on the stability of C1QBP and update our data in the future.

      The binding site for PA28g in C1QBP was mapped to the N-terminal 167 residues using truncated proteins. One caveat would be that some truncated proteins did not fold correctly in the absence of the sequence that was removed. Thus, the C-terminal region of the C1QBP with residues 168-283 may still bind to the PA29g in the context of full-length protein. In Figure 1I, more Flag-C1QBP 1-167 was pulled down by Myc-PA28g than the full-length protein or the Flag-C1QBP 1-213. Why?

      Thank you very much for the important comments. Immunoprecipitation is a qualitative experiment. Using AlphaFold 3, we found that interaction between PA28γ and C1QBP may depend on amino acids 1-167 and 1-213 (Revised Appendix Figure 1D-H), which was confirmed by our immunoprecipitation (Revised Figure 1I).

      The interaction site in PA28g for C1QBP was not mapped, which prevents further analysis of the interaction. Also, if the interaction domain can be determined, structural modeling of the complex would be feasible using AlphaFold2 or other programs. Then, it is possible to test point mutations that may disrupt the interaction and if so, the functional effect.

      Thank you very much for the important comments. Based on your suggestion, we have added relevant content to the revised appendix figure. (Revised Appendix Figure 1D-H).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) There are a lot of typos in the figure and manuscript that need to be addressed.

      Thank you very much for the important comments. We have corrected the typos in the revised figure and manuscript.

      (2) Figure 1A: The amount of protein that has been immunoprecipitated is more than the actual amount present in the lysate. The authors should calculate the efficiency of the precipitation to support their results.

      Thank you very much for the important comments. Immunoprecipitation is a qualitative experiment. Moreover, it can enrich specific proteins and their binding partners, increase their concentration in the sample, and thus improve the sensitivity of detection.

      (3) Figure 1D: The relative expression levels of C1QBP look similar in almost all cell lines except for HN12. It seems that the relation of PA28y with C1QBP is more of a cell type-specific effect. It would be better if the blots were quantified, and the differences were statistically determined.

      Thank you very much for the important comments. We have conducted a quantitative analysis of gray values to confirm the results of western blot data are accurate by Image J software.

      (4) Figure 1E: How do the authors quantify the expression of the protein in absolute terms? From the methods, it is understood that the flag-tagged construct is stably expressed. Under such conditions, how the authors observed the variable expression of the protein should be elaborated.

      Thank you very much for the important comments. We transfected Flag-PA28γ plasmids at 0ug, 0.5ug, 1ug, and 2ug in 293T cells. After collecting the protein for Western Blot, we found that the protein expression of Flag-PA28γ gradually increased. Moreover, the increased protein expression of C1QBP is consistent with the expression of Flag-PA28γ, which indicated a dose-dependent relationship between the two proteins.

      (5) Figures 1F, G: The data does not correlate with the arguments presented in the text. The authors propose that interaction with PA28y increases the stability of C1QBP. However, the experiment lacks appropriate controls. Ideally, the expression of C1QBP should be tested in the presence and absence of PA28y. Moreover, the observed difference in expression between lanes 1-4 and 5-8 for myc-PA28y needs to be explained. Are the samples from different sources with variable PA28y expression? Figure 1G quantification for C1QBP does not correlate with the figure presented in F since the expression of the protein in the first four lanes is undetectable.

      Thank you very much for the meticulous review. We have rechecked the experimental results, and we made a mistake in the labeling of the image. Therefore, we have corrected it in the revised figure. Compared with the control group, the presence of Myc-PA28γ significantly increased the expression level of Flag-C1QBP (Revised Figure 1F). Gray value analysis showed that in cells transfected with Myc-PA28γ, the decay rate of Flag-C1QBP was significantly slower than that of the control group (Revised Figure 1G), suggesting that PA28γ can delay the protein degradation of C1QBP and stabilize its protein level. This indicates that an increase in the level of PA28γ protein can significantly enhance the expression level of C1QBP protein, while PA28γ can slow down the degradation rate of C1QBP and improve its stability. In addition, we plan to conduct experiments to investigate the effects of protease inhibitors and PA28γ mutants on the stability of C1QBP and update our data in the future.

      (6) Appendix Figure 1B: Lane 1 does not express Myc-tagged protein but pull-down has been performed using Myc beads. Then how come flag-C1qbp is getting pulled down in lane 1 if there is no PA28y? This indicates a non-specific interaction of C1qbp with the substrata under the experimental conditions used. Similarly, in Figure 1C SFB-PA28y is expressed in both lanes but is reflected only in lane 2 and not in lane 1 even when pull-down is being performed using SFB beads, again reflecting the non-specificity of the interactions shown through immunoprecipitated.

      Thank you very much for the meticulous review. We have rechecked the experimental results, and we made a mistake in the labeling of the image. Therefore, we have corrected it in the revised figure (Revised Appendix Figure 1B, C).

      (7) Figure 2A: Figure 2A the co-localization of P28y with C1QBP in mitochondria is not very convincing. The authors are urged to provide high-resolution images for the same along with quantification of co-localization coefficients.

      Thank you very much for the important comments. We plan to obtain high-resolution images of co-localization of PA28γ with C1QBP in mitochondria and add the quantification analysis. We will update our data in the future.

      (8) Figure 2C: Mitochondria dynamics is an interplay of multiple factors. From the images, it seems that PA28y OE elevates mitochondria biogenesis in general which is having an umbrella effect on mitochondria fusion/fission and OCR. Images also do not convincingly indicate changes in mitochondrial length. The role of PA28y on mitochondria dynamics requires further justification. However, the presented data does not underline whether the changes in mitochondria behaviour are a consequence of PA28y and C1QBP interaction. Correlating higher mitochondria respiration with ROS generation is a far-fetched conclusion since, at present, there are multiple reports that suggest otherwise.

      Thank you very much for the important comments. We plan to knock out the interaction regions between PA28γ and C1QBP (like amino acids 1-167 and 1-213) to confirm whether PA28γ affects mitochondrial function through C1QBP and update our data in the future.

      (9) Line 157: The presented data does not substantiate the claims made that Pa28y regulates mitochondrial function through C1QBP.

      Thank you very much for the important comments. Based on your suggestion, we have made some modifications to make it more accurate (“Results”, Part “PA28γ and C1QBP colocalize in mitochondria and affect mitochondrial functions”, Paragraph 3, Line 1-2).

      The modified content is as follows:

      “Collectively, these data suggest that PA28γ, which co-localizes with C1QBP in mitochondria, may involve in regulating mitochondrial morphology and function.”

      (10) Line 159: From the past data it is not very clear how PA28y upregulates C1QBP, hence the statement is not well supported. The presented data indicates the presence of a functional association between the two proteins.

      Thank you very much for the important comments. We detected the expression of C1QBP in two PA28γ-overexpressing OSCC cells (UM1 and 4MOSC2) and found an increase in C1QBP expression (Revised Figure 4B). Based on the results of the protein levels of the mitochondrial respiratory chain complex and other mitochondrial functional proteins, we believe that PA28γ regulates mitochondrial function by upregulating C1QBP.

      (11) Figure 4A, B: Given the mitochondrial role of C1QBP, the lesser levels of mitochondrial proteins upon C1QBP silencing are expected. Does it get phenocopied upon PA28y silencing? Similarly, all the subsequent mitochondrial phenotypes in D should be seen in a PA28y-depleted background.

      Thank you very much for the important comments. We plan to detect the mitochondrial protein expressions and OCRs of PA28γ-silenced OSCC cells. We will update our data in the future.

      (12) Line 198: The presented data do indicate a functional association between these two proteins but it does not provide a solid evidence for the same.

      Thank you very much for the important comments. Based on your suggestion, we have made some modifications to make it more accurate (“Discussion”, Paragraph 1, Line 9-10).

      The modified content is as follows:

      “Excitingly, we found the evidence that PA28γ interacts with and stabilizes C1QBP.”

      (13) Line 218-220: In this work, the authors highlight the non-degradome role of PA28y and hence, this fact should be treated appropriately in discussion in line with the presented data.

      Thank you very much for the important comments. Based on your suggestion, we have added relevant content to the revised manuscript (“Discussion”, Paragraph 2, Line 16-19).

      The modified content is as follows:

      “In addition, PA28γ can also play as a non-degradome role on tumor angiogenesis. For example, PA28γ can regulate the activation of NF-κB to promote the secretion of IL-6 and CCL2 in OSCC cells, thus promoting the angiogenesis of endothelial cells ( S. Liu et al., 2018).”

      (14) Line 236-240: Although the authors' statement on organ heterogeneity being the cause for getting the contrasting result is justifiable but here there is no direct evidence of PA28y involvement in regulation of OXPHOS and its impact on cellular metabolism (glycolysis, metabolic signalling, etc).

      Thank you very much for the important comments. Based on your suggestion, we have made some modifications to make it more accurate (“Discussion”, Paragraph 3, Line 7-9).

      The modified content is as follows:

      “Therefore, PA28γ's regulation of OXPHOS may impact cellular energy metabolism.”

      (15) Line 249: No conclusive data supporting this statement.

      Thank you very much for the important comments. Based on your suggestion, we have made some modifications to make it more accurate (“Discussion”, Paragraph 5, Line 1-3).

      The modified content is as follows:

      “Furthermore, our study reveals that PA28γ can regulate C1QBP and influence mitochondrial morphology and function by enhancing the expression of OPA1, MFN1, MFN2 and the mitochondrial respiratory complex.”

      Reviewer #2 (Recommendations for the authors):

      (1) The images shown in Figure 2A need to be quantified before the conclusion about the mitochondrial colocalization of the two proteins can be drawn. In Figure 2B and Appendix Figure 2A, the mitochondrial vacuoles and ridge should be indicated for general readers, and quantification should be performed before the conclusion is drawn.

      Thank you very much for the important comments. We will update our data in the future.

      (2) The OCR data from two cell lines are shown in Figure 2E and F. Which is which? The sentence, "The results indicated ... compared to control cells" in lines 130-132, was confusing; perhaps, it would be clear if "were significantly greater" could be deleted.

      Thank you very much for the important comments. We have re-labeled the Figure 2E and F to make it clearly (Revised Figure 2E, F). Based on your suggestion, we have deleted the words in revised manuscript. (“Results”, Part “PA28γ and C1QBP colocalize in mitochondria and affect mitochondrial functions”, Paragraph 1, Line 9-11).

      The modified content is as follows:

      “The results indicated significantly higher basal respiration, maximal OCRs and ATP production in PA28γ-overexpressing cells compared to control cells (Fig. 2G-I and Appendix Fig. 2B-D).”

      (3) Figures 4E-H show the migration, invasive, and proliferation capabilities of the cells. Which for which?

      Thank you very much for the important comments. We have re-labeled the Figure 4F-H to make it clearly (Revised Figure 4F-H).

      (4) In the Discussion, lines 198-201, it states that "C1QBP enhances ... function of OPA1, MNF1, MFN2..." What is the evidence? In lines 222-224, it says that "the binding sites ... may mask the specific ... modification sites". Please justify. In lines 253-254, "fuse" and fuses" are misleading, Did the authors mean "localize" and "localizes"?

      Thank you very much for the important comments. Based on your suggestion, we have made some modifications to make it more accurate (“Discussion”, Paragraph 1, Line 9-13, Paragraph 2, Line 20-23, and Paragraph 5, Line 3-6).

      The modified content is as follows:

      “Excitingly, we found the evidence that PA28γ interacts with and stabilizes C1QBP. We speculate that aberrantly accumulated C1QBP enhances the function of mitochondrial OXPHOS and leads to the production of additional ATP and ROS by activating the expression and function of OPA1, MNF1, MFN2 and mitochondrial respiratory chain complex proteins.”

      “Our study reveals that PA28γ interacts with C1QBP and stabilizes C1QBP at the protein level. Therefore, we speculate that the binding sites of PA28γ and C1QBP may mask the specific post-translational modification sites of C1QBP and inhibit its degradation.”

      “Mitochondrial fusion, crucial for oxidative metabolism and cell proliferation, is regulated by MFN1, MFN2, and OPA1. The first two fuse with the outer mitochondrial membrane, while the last fuses with the inner mitochondrial membrane (Westermann, 2010).”

      (5) Figure 6 was not referred to in the text. In this figure, PA28g and C1QBP are located in the inner membrane and matrix. Has this been determined? What is the blue ovals that are intermediaries of PA28g/C1QBP and OPA1/MFN1/MFN2?

      Thank you very much for the important comments. According to our immunofluorescence assay (Figure 2A), PA28γ is in both the nucleus and cytoplasm. A recent study has demonstrated that PA28γ can shuttle between the nucleus and cytoplasm, participating in various cellular processes. Furthermore, GeneCard information indicates that the subcellular localization of PA28γ includes the nucleus, cytoplasm and mitochondria (Author response image 1). In this article, we mainly focus on the functions of PA28γ and C1QBP located in the cytoplasm. Therefore, figure 6 mainly displays PA28γ and C1QBP in the cytoplasm. Based on your suggestion, we have made some modifications to make it more accurate in revised figure (Revised Figure 6).

      Author response image 1.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This useful manuscript shows a set of interesting data including the first cryo-EM structures of human PIEZO1 as well as structures of disease-related mutants in complex with the regulatory subunit MDFIC, which generate different inactivation phenotypes. The molecular basis of PIEZO channel inactivation is of great interest due to its association with several pathologies. This manuscript provides some structural insights that may help to ultimately build a molecular picture of PIEZO channel inactivation. While the structures are of use and clear conformational differences can be seen in the presence of the auxiliary subunit MDFIC, the strength of the evidence supporting the conclusions of the paper, especially the proposed role for pore lipids in inactivation, is incomplete and there is a lack of data to support them.

      We thank the editors and reviewers for taking the time and effort to review our manuscript.  The evidence supporting the key role of pore lipids in hPIEZO1 activation is as follows. i. Compared with wild-type hPIEZO1, the hydrophobic acyl chain tails of the pore lipids retracted from the hydrophobic pore region in slower inactivating mutant hPIEZO1-A1988V (Fig. 7a-b). ii. Previous electrophysiological functional studies revealed that substituting this hydrophobic pore formed by I2447, V2450, and F2454 with a hydrophilic pore prolongs the inactivation time for both PIEZO1 and PIEZO2 channels (PMID: 30628892). iii. In the structure of the HX channelopathy mutant R2456H, the interaction between the hydrophilic phosphate group head of pore lipids and R2456 is disrupted, remodeling the blade and pore module and resulting in a significantly slow-inactivating rate. iv. The interaction between pore lipids and lipidated-MDFIC stabilizes the pore lipids to reseal the pore upon activation of the hPIEZO1-MDFIC complex.

      According to previously proposed models for the role of pore lipids in mechanosensitive ion channels, such as MscS (PMID: 33568813), MS K2P (PMID: 25500157) and OSCA channels (PMID: 37402734), the pore lipids seal the channel pores in closed state and could be removed in open state by mechanical force induced membrane deformation, which obeys the force-from-lipids principle. Therefore, in our putative model, the pore lipids seal the hydrophobic pore of hPIEZO1 in the closed state. Upon activation of hPIEZO1, the pore lipids retract from the hydrophobic pore and interact with multi-lipidated MDFIC, stabilizing in the inactivation state. The mild channelopathy mutants make the pore lipids retract from the hydrophobic pore and harder to close upon activation. For the severe channelopathy mutant, the interaction between the pore lipids and R2456 is disrupted, resulting in the missing of pore lipids and significantly slow-inactivating. We fully understand the concern of the role of pore lipids in our proposed model. Therefore, we have toned down our putative model.

      Public Reviews:  

      Reviewer #1 (Public review):  

      Summary:  

      This manuscript by Shan, Guo, Zhang, Chen et al., shows a raft of interesting data including the first cryo-EM structures of human PIEZO1. Clearly, the molecular basis of PIEZO channel inactivation is of great interest and as such this manuscript provides some valuable extra information that may help to ultimately build a molecular picture of PIEZO channel inactivation. However, the current manuscript though does not provide any compelling evidence for a detailed mechanism of PIEZO inactivation.

      Strengths:

      This manuscript documents the first cryo-EM structures of human PIEZO1 and the gain of function mutants associated with hereditary anaemia. It is also the first evidence showing that PIEZO1 gain of function mutants are also regulated by the auxiliary subunit MDFIC.

      We thank reviewer #1 for the encouragement.

      Weaknesses:

      While the structures are interesting and clear differences can be seen in the presence of the auxiliary subunit MDFIC the major conclusions and central tenets of the paper, especially a role for pore lipids in inactivation, lack data to support them. The post-translational modification of PIEZOser# auxiliary subunit MDFIC is not modelled as a covalent interaction.

      We fully understand the concern of the role of pore lipids in our proposed model. Therefore, we have toned down our putative model.

      The lipids densities of the post-transcriptional modification of PIEZO1 auxiliary subunit MDFIC are shown below. As the lipids densities are not confident, we only use the single-chain lipids to represent them. And the lipidated MDFIC is proven by the MDFIC identification paper.

      Author response image 1.

      Reviewer #2 (Public review):

      Summary:

      Mechanically activated ion channels PIEZOs have been widely studied for their role in mechanosensory processes like touch sensation and red blood cell volume regulation. PIEZO in vivo roles are further exemplified by the presence of gain-of-function (GOF) or loss-of-function (LOF) mutations in humans that lead to disease pathologies. Hereditary xerocytosis (HX) is one such disease caused due to GOF mutation in Human PIEZO1, which are characterized by their slow inactivation kinetics, the ability of a channel to close in the presence of stimulus. But how these mutations alter PIEZO1 inactivation or even the underlying mechanisms of channel inactivation remains unknown. Recently, MDFIC (myoblast determination family inhibitor proteins) was shown to directly interact with mouse PIEZO1 as an auxiliary subunit to prolong inactivation and alter gating kinetics. Furthermore, while lipids are known to play a role in the inactivation and gating of other mechanosensitive channels, whether this mechanism is conserved in PIEZO1 is unknown. Thus, the structural basis for PIEZO1 inactivation mechanism, and whether lipids play a role in these mechanisms represent important outstanding questions in the field and have strong implications for human health and disease.

      To get at these questions, Shan et al. use cryogenic electron microscopy (Cryo-EM) to investigate the molecular basis underlying differences in inactivation and gating kinetics of PIEZO1 and human disease-causing PIEZO1 mutations. Notably, the authors provide the first structure of human PIEZO1 (hPIEZO1), which will facilitate future studies in the field. They reveal that hPIEZO1 has a more flattened shape than mouse PIEZO1 (mPIEZO1) and has lipids that insert into the hydrophobic pore region. To understand how PIEZO1 GOF mutations might affect this structure and the underlying mechanistic changes, they solve structures of hPIEZO1 as well as two HXcausing mild GOF mutations (A1988V and E756del) and a severe GOF mutation (R2456H). Unable to glean too much information due to poor resolution of the mutant channels, the authors also attempt to resolve MCFIC-bound structures of the mutants. These structures show that MDFIC inserts into the pore region of hPIEZO1, similar to its interaction with mPIEZO1, and results in a more curved and contracted state than hPIEZO1 on its own. The authors use these structures to hypothesize that differences in curvature and pore lipid position underlie the differences in inactivation kinetics between wild-type hPIEZO1, hPIEZO1 GOF mutations, and hPIEZO1 in complex with MDFIC.

      Strengths:

      This is the first human PIEZO1 structure. Thus, these studies become the stepping stone for future investigations to better understand how disease-causing mutations affect channel gating kinetics.

      We thank reviewer #2 for the positive comments.

      Weaknesses:

      Many of the hypotheses made in this manuscript are not substantiated with data and are extrapolated from mid-resolution structures.

      We fully understand the concern of the role of pore lipids in our proposed model. Therefore, we have toned down our putative model.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript, the authors used structural biology approaches to determine the molecular mechanism underlying the inactivation of the PIEZO1 ion channel. To this end, the authors presented structures of human PIEZO1 and its slow-inactivating mutants. The authors also determined the structures of these PIEZO1 constructs in complexes with the auxiliary subunit MDFIC, which substantially slows down PIEZO1 inactivation. From these structures, the authors suggested an anti-correlation between the inactivation kinetics and the resting curvature of PIEZO1 in detergent. The authors also observed a unique feature of human PIEZO1 in which the lipid molecules plugged the channel pore. The authors proposed that these lipid molecules could stabilize human PIEZO1 in a prolonged inactivated state.

      We thank reviewer #3 for the summary.

      Strengths:

      Notedly, this manuscript reported the first structures of a human PIEZO1 channel, its channelopathy mutants, and their complexes with MDFIC. The evidence that lipid molecules could occupy the channel pore of human PIEZO1 is solid. The authors' proposals to correlate PIEZO1 resting curvature and pore-resident lipid molecules with the inactivation kinetics are novel and interesting.

      Thanks for the positive comments.

      Weaknesses:

      However, in my opinion, additional evidence is needed to support the authors' proposals.

      (1) The authors determined the apo structure of human PIEZO1, which showed a more flattened architecture than that of the mouse PIEZO1. Functionally, the inactivation kinetics of human PIEZO1 is faster than its mouse counterpart. From this observation (and some subsequent observations such as the complex with MDFIC), the authors proposed the anti-correlation between curvature and inactivation kinetics. However, the comparison between human and mouse PIEZO1 structure might not be justified. For example, the human and mouse structures were determined in different detergent environments, and the choice of detergent could influence the resting curvature of the PIEZO structures.

      We apologize for the misleading statement about the anti-correlation between curvature and inactivation kinetics of PIEZOs. We cannot conclude that the observation of curvature variation of mPIEZO1 and hPIEZO1 is related to their inactivation kinetics based on structural studies and electrophysiological assay. The difference in structural basis between mPIEZO1 and hPIEZO1 is what we want to state. To avoid this misleading, we have revised the manuscript. 

      For the concern about detergent, we cannot fully exclude its influence on the curvature of PIEZOs. However, previously reported structures of mPiezo1 (PDB: 7WLT, 5Z10, 6B3R) were in the different detergent environments or in lipid bilayer, but the curvature of mPiezo1 is similar as shown below. Considering the high sequence similarity between mPiezo1 and hPiezo1, we hypothesize that the curvature of both hPiezo1 and mPiezo1 may be unaffected by the detergent.

      Author response image 2.

      Overall structural comparison of curved mPIEZO1 in the lipid bilayer (PDB: 7WLT), mPiezo1 in CHAPS (PDB: 6B3R) and mPiezo1 in Digitonin (PDB: 5Z10).

      (2) Related to point 1), the 3.7 Å structure of the A1988V mutant presented by the authors showed a similar curvature as the WT but has a slower inactivating kinetics.

      Based on the structural comparison between hPIEZO1 and its A1998V mutant, the retraction of pore lipids from the hydrophobic center pore in hPIEZO1-A1998V is mainly responsible for its slower inactivating kinetics.

      (3) Related to point 1), the authors stated that human PIEZO1 might not share the same mechanism as mouse PIEZO1 due to its unique properties. For example, MDFIC only modifies the curvature of human PIEZO1, and lipid molecules were only observed in the pore of the human PIEZO1. Therefore, it may not be justified to draw any conclusions by comparing the structures of PIEZO1 from humans and mice.

      Thanks for the constructive suggestion. To avoid this misleading, we have revised the manuscript.

      (4) Related to point 1), it is well established that PIEZO1 opening is associated with a flattened structure. If the authors' proposal were true, in which a more flattened structure led to faster inactivation, we would have the following prediction: more opening is associated with faster inactivation. In this case, we would expect a pressure-dependent increase in the inactivation kinetics.

      Could the authors provide such evidence, or provide other evidence along this direction?

      We appreciate the reviewer’s comment. We are not claiming a relationship between the flattened structure and activation/inactivation. We only present the results of the structure of wild-type/mutant PIEZO1.

      (5) In Figure S2, the authors showed representative experiments of the inactivation kinetics of PIEZO1 using whole-cell poking. However, poking experiments have high cell-to-cell variability.

      The authors should also show statics of experiments obtained from multiple cells.

      We have shown the statics of representative electrophysiology experiments obtained from multiple cells in Figure S2.

      (6) In Figure 2 and Figure 5, when the authors show the pore diameter, it could be helpful to also show the side chain densities of the pore lining residues.

      We appreciate the reviewer’s suggestion. The side chain of the pore lining restricted residues have been shown in Figure 2 and Figure 5 and the densities of pore domain have been shown in Figure S4 and S14. Interestingly, the pore lining restricted residues in mPIEZO1 and hPIEZO1 is highly conserved.

      (7) The authors observed pore-plugging lipids in slow inactivating conditions such as channelopathy mutations or in complex with MDFIC. The authors propose that these lipid molecules stabilize a "deep resting state" of PIEZO1, making it harder to open and harder to inactivate once opened. This will lead to the prediction that the slow-inactivating conditions will lead to a higher activation threshold, such as the mid-point pressure in the activation curve. Is this true?

      Yes, it is true. In Figure S2, the MDFIC-induced slow-inactivation conditions in hPIEZO1-MDFIC, hPIEZO1-A1988V-MDFIC, hPIEZO1-E756del-MDFIC and hPIEZO1-R2456H-MDFIC result in larger half-activation thresholds than hPIEZO1, hPIEZO1-A1988V, hPIEZO1-E756del and hPIEZO1-R2456H, respectively.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      I document the major issues below:

      (1) Mouse vs Human inactivation

      Line 21- "than the slower inactivating curved mouse PIEZO1 (mPIEZO1)."

      Where is the data in this paper or any other paper that human PIEZO1 inactivates faster than mouse PIEZO1? This is central to the way the authors present the paper. In fact, the tau quoted for the hPIEZO1 of ~10 ms is similar to that often measured for mPIEZO1. The reference in the discussion for mouse vs human inactivation times is a review of mechanotransduction. Either the authors need to directly compare the tau of mP1 vs hP1 or quote the relevant primary literature if it exists.

      As measured in HEK-PIKO cells transfected with mPiezo1, the inactivation time of mPiezo1 is 13 ± 1 ms (PMID: 29261642) at -80 mV. 

      The tau is also voltage-dependent. The tau is beyond 20 ms at -60 mV for mPIEZO1 (PMID:

      20813920) and for hPIEZO1 is still around 10 ms.

      (2) MDFIC-lipidation

      Without seeing the PDB or EMDB I can't guarantee this but from Figure 6d it seems like the Sacylation in the distal C-terminus of MDFIC is not modelled as a covalent interaction, these lipids are covalently added to the Cys residues in S-acylation via zDHHC enzymes. This should be modelled correctly.

      Thanks for this suggestion. As the lipid densities of the post-transcriptional modification of PIEZOs auxiliary subunit MDFIC are not confident, we only use the single-chain lipids to represent them.

      And the lipidated MDFIC is proven by the MDFIC identification paper (PMID: 37590348).

      (3) Pore lipids and inactivation

      The lipids close to the pore are interesting and the density for a lipid is also seen in the mouse MDFIC-PIEZO1 complex from Zhou, Ma et al, 2023. However, there is no data provided by the authors that the lipid is functionally relevant to anything. There is not even a correlation with inactivation in Figure 7. P1+MDFIC inactivates slowest yet the lipids are present within the pore. Second, there is no evidence for what these structures are: closed, or inactivated? In fact, the Xiao lab is now interpreting the 7WLU structure as inactivated.

      The evidence supporting the key role of pore lipids in hPIEZO1 activation is as follows. i. Compared with wild-type hPIEZO1, the hydrophobic acyl chain tails of the pore lipids retracted from the hydrophobic pore region in slower inactivating mutant hPIEZO1-A1988V (Fig. 7a-b). ii. Previous electrophysiological functional studies revealed that substituting this hydrophobic pore formed by I2447, V2450, and F2454 with a hydrophilic pore prolongs the inactivation time for both PIEZO1 and PIEZO2 channels (PMID: 30628892). iii. In the structure of the HX channelopathy mutant R2456H, the interaction between the hydrophilic phosphate group head of pore lipids and R2456 is disrupted, remodeling the blade and pore module and resulting in a significantly slow-inactivating rate. iv. The interaction between pore lipids and lipidated-MDFIC stabilizes the pore lipids to reseal the pore upon activation of the hPIEZO1-MDFIC complex. Overall, the pore lipid is involved in inactivation, and we have toned down the statement.

      (4) Cytosolic plug

      There is additional cytosolic density for the human PIEZO1 that the authors intimate could be from a different binding partner. IS it possible to refine this density? Is it from the PIEZO1-tag? At the very least a little more information about this density should be given if it is going to be mentioned like this.

      Our purification result shows that the protein is tag-free. We are also curious about the extra cytosolic density, but we do not know what it is.

      (5) Reduced sensitivity of PIEZO1 in the presence of MDFIC and its regulatory mechanism

      This was reported in the first article however no data is presented by the authors to support MDFIC increasing the mechanical energy required to open PIEZO1. The sentence in the discussion; "MDFIC enables hPIEZO1 to respond to different forces by modifying the pore module through lipid interactions." is not supported by any functional data and seems to be an over-interpretation of the structures.

      We appreciate this suggestion. The half-activation threshold of hPEIZO1 and hPEIZO1-MDFIC is measured to be 7 μm and 9 μm, respectively (Fig.S2). In addition, the mechanical currents amplitude of hPIEZO1-MDFIC is extremely small compared to that of WT reaching the nA level (Fig.S2). Therefore, the less mechanosensitive hPIEZO1-MDFIC may require more mechanical energy to open than PIEZO1 WT.

      6) Both referencing of the PIEZO1 literature and prose could be improved.

      Thanks for the suggestion. We have improved the referencing and prose.

      Reviewer #2 (Recommendations for the authors):

      (1) The authors speculate that the difference in curvature between human and mouse PIEZO1 results in its fast inactivation but do not provide experimental evidence to support this idea. This claim would have been bolstered by showing that the GOF human mutations have a more curved structure, but these proved too structurally unstable to be solved at high resolution. However, the authors state that the 3.7 angstrom map solved for hPIEZO1-A1988V does have an overall similar architecture as wild-type hPIEZO1; thus, contradicting their hypothesis.

      We apologize for the misleading statement. In our revised manuscript, we do not claim a relationship between the flattened structure and activation/inactivation. We only present the results of the structure of wild-type/mutant PIEZO1.

      The structure comparison between the A1988V mutant and WT shows a similar architecture but a different occupancy pattern of pore lipids. Therefore, we suggested that the A1988V mutant has slightly slower inactivation kinetics, mainly due to the exit of pore lipids from the pore.

      (2) The authors show that interaction with MDFIC alters hPIEZO1 structure to be more curved and use this to support their idea that changing the curvature of the protein underlies the prolonged inactivation kinetics. It has been previously shown that MDFIC does not change the structure of mPIEZO1 but does alter its inactivation and gating kinetics. How does this discrepancy fit into the inactivation model proposed by the authors? Similarly, their claim that MDFIC slows hPIEZO1 inactivation and weakens mechanosensitivity just by affecting the pore module and changing blade curvature is made based on observation and no experimental data to test it.

      We have revised the manuscript to avoid misleading the relationship between the curvature and the inaction kinetics of hPIEZO1. The evidence reported previously that substitution of the hydrophobic pore, formed by I2447, V2450, and F2454, with a hydrophilic pore prolongs the inactivation time for both PIEZO1 and PIEZO2 channels (PMID: 30628892). In addition, the severe HX channelopathy mutant R2456H, wherein the interaction between the hydrophilic phosphate group head and R2456 is disrupted, leads to remodeling of the blade and pore module. Indeed, our observation is limited and further experiments will be performed to support our model.

      (3) How does their model fit in cell types that have PIEZO1 (or GOF mutant PIEZO1) but not MDFIC?

      In cell types that have PIEZO1 or GOF mutant PIEZO1 but not MDFIC, PIEZO1 or GOF mutant PIEZO1 may have a faster inactivation rate than those that bind to MDFIC. It can be proved that overexpressed PIEZOs exhibit faster inactivation kinetics than those in some native cell types with MDFIC expression (PMID: 20813920, 30132757).

      (4) Figure S2 is missing quantification of the electrophysiology data. The authors should show summary data in addition to their representative traces including the Imax for all conditions, tau for data shown in b, and sample size for all conditions, and related statistics. The text claims that MDFIC decreases mechanosensitivity (line 156) but there is no data to support this.

      For the electrophysiological assay in Figure S2, we referred to previously reported mPIEZO1 mutants (PMID: 23487776, 28716860). We confirmed that the slower inactivation phenotypes of these mutations of hPIEZO1 are similar to those of mPIEZO1.

      The half-activation threshold of hPEIZO1 and hPEIZO1-MDFIC is measured to be 7 μm and 9 μm, respectively. This tendency of increased half-activation threshold of hPIEZO1 upon binding with MDFIC is also shown in the electrophysiological result of hPIEZO1 channelopathy mutants.

      (5) In line 144, the authors mention that they were able to validate the MDFIC density with multilipidated cysteines on the C-terminal amphipathic helix, but they do not show the density with fitted lipids. While individual densities for some of the lipids are shown in extended Figure 12, it would be helpful to include a figure where they show the map for MDFIC with fitted lipids in it.

      Thanks for the valuable suggestion. As the lipid densities of the post-transcriptional modification of PIEZOs auxiliary subunit MDFIC are not confident, we only use the single-chain lipids to represent them. And the lipidated MDFIC is proven by the MDFIC identification paper.

      (6) The authors show that R2456 interacts with a lipid at the pore module and hypothesize that this underlies the fast inactivation of hPIEZO1. While they did not obtain a high-resolution structure of this mutant, this hypothesis could be tested by substituting R for side chains with different charges and performing electrophysiology to determine the effects on inactivation.

      Thanks for the constructive suggestion. We will perform the electrophysiology assay for R2456 mutants with different side chains.

      7) Figure 4 shows overall structure of hPIEZO1 GOF mutations A1988V and E756del in complex with MDFIC. Other than showing an overall similar structure to wildtype hPIEZO1, the authors do not show how the human mutations A1988V alter the structure of the protein at the site of change. Understanding how these mutations affect the local architecture of the protein has important relevance for human physiology.

      As the GOF channelopathy mutant hPIEZO1-A1988V is structurally unstable, the density at the site of A1988V is too weak to figure out the related interaction in the structure of the hPIEZO1-A1988V mutant. 

      Minor comment:

      In general, the manuscript will benefit from heavy copy editing. For example, the word cartoon is misspelled in many of the figure legends.

      We apologize for the mistake. The manuscript has been checked and revised.

      Reviewer #3 (Recommendations for the authors):

      Some portions of this manuscript were not well written. For example, at the end of the 3rd paragraph in the introduction, the authors talked about HX mutations and their correlation with malaria infection and plasma iron. This is irrelevant information and will only distract the readers. It would be ideal if the authors could go through the entire manuscript and improve its clarity.

      Thanks for the suggestion. We have revised the sentences about HX mutations as suggested and improved the entire manuscript.

    1. Décryptage du porno mainstream et exploration du porno alternatif : L'industrie, les normes et l'impact sur la perception de la sexualité

      I. Datagueule #85 : "Datagaule et clitodonnées : le plaisir à la chaîne"

      A. L'industrie du porno en ligne : Une domination par les "tubes"

      Présentation des données clés de l'industrie du porno en ligne: Trafic, téléchargements, évolution depuis l'arrivée de l'internet haut débit.

      Focus sur Pornhub, un des géants du secteur, illustrant l'ampleur du phénomène et la rapidité de consommation.

      Ascension de la société MGeek, qui a racheté des studios historiques du X fragilisés par la crise de 2008.

      Fonctionnement des "tubes" qui offrent un accès gratuit aux vidéos, impactant les revenus des studios.

      B. Le porno mainstream : Des normes et des dérives

      Le porno mainstream, majoritairement produit pour un public masculin hétérosexuel et blanc, impose ses normes.

      Illustration de ces normes à travers la popularité du tag "lesbien" et la stigmatisation des scènes gays pour les acteurs.

      L'émergence du "pro-am" (productions professionnelles d'amateurs) et ses conditions de tournage précaires et parfois dangereuses.

      Problèmes liés aux contrats, au consentement et à la difficulté de faire retirer des contenus des plateformes.

      Conditions de travail des acteurs masculins : Salaires faibles, recours à des médicaments pour la performance sexuelle et risques associés.

      C. Addictivité et tabou : Des idées reçues à déconstruire

      L'argument de l'addictivité du porno, souvent utilisé pour la censure, est démenti scientifiquement.

      L'Organisation Mondiale de la Santé a rejeté l'ajout du visionnage de pornographie dans sa liste des troubles addictifs.

      Le porno, érigé en tabou, échappe aux questionnements légitimes qui entourent les autres productions culturelles.

      II. Interview de Camille Emmanuel, journaliste et auteur de "Sex Power"

      A. Le regard masculin dominant dans le porno mainstream

      L'industrie du porno traditionnellement dominée par une vision masculine, centrée sur le plaisir masculin et la pénétration.

      Le porno mainstream reproduit les schémas traditionnels de la sexualité, ignorant le plaisir féminin et la diversité des pratiques.

      Le discours dominant sur la sexualité féminine est déconstruit par des études scientifiques sur le clitoris et l'orgasme féminin.

      B. L'émergence du porno alternatif : Un contre-pouvoir nécessaire

      Le mouvement du porno alternatif initié par des femmes dans les années 80, pour proposer une vision différente de la sexualité.

      Ce mouvement, encore niche, met en avant la diversité des pratiques, des corps et des sexualités.

      Le porno alternatif se distingue par ses modes de production éthiques, respectueux du consentement et du droit du travail.

      C. L'impact du porno sur la perception de la sexualité

      Le porno mainstream véhicule une vision normée et limitée de la sexualité, pouvant influencer négativement la perception du public.

      Le porno alternatif, en proposant une vision plus diverse et inclusive, permet de questionner les normes et de s'ouvrir à d'autres possibilités.

      L'importance de se questionner sur sa propre consommation de porno et de réfléchir à l'imaginaire pornographique proposé aux générations futures.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      It is evident that studying leukocyte extravasation in vitro is a challenge. One needs to include physiological flow, culture cells and isolate primary immune cells. Timing is of utmost Importance and a reproducible setup essential. Extra challenges are met when extravasation kinetics in different vascular beds is required, e.g., across the blood-brain barrier. In this study, the authors describe a reliable and reproducible method to analyze leukocyte TEM under physiological flow conditions, including this analysis. That the software can also detect reverse TEM is a plus.

      Strengths:

      It is quite a challenge to get this assay reproducible and stable, in particular as there is flow included. Also for the analysis, there is currently no clear software analysis program, and many labs have their own methods. This paper gives the opportunity to unify the data and results obtained with this assay under label-free conditions. This should eventually lead to more solid and reproducible results.

      Also, the comparison between manual and software analysis is appreciated.

      We thank the Reviewer for their positive evaluation of our manuscript and highlighting the value of obtaining more reproducible and unbiases results, as well as detection of forward and reverse transmigration with UFMTrack.

      Weaknesses:

      The authors stress that it can be done in BBB models, but I would argue that it is much more broadly applicable. This is not necessarily a weakness of the study but more an opportunity to strengthen the method. So I would encourage the authors to rewrite some parts and make it more broadly applicable.

      We thank the Reviewer for this suggestion. In the revised version of our manuscript, we have now emphasized the broader applicability of UFMTrack to analyze the interaction of immune cells with 2dimensional endothelial monolayers in various contexts in the abstract, introduction, and discussion sections.

      Reviewer #2 (Public Review):

      Summary:

      This paper develops an under-flow migration tracker to evaluate all the steps of the extravasation cascade of immune cells across the BBB. The algorithm is useful and has important applications.

      Strengths:

      Algorithm is almost as accurate as manual tracking and importantly saves time for researchers.

      We thank the Reviewer for this positive evaluation of our work.

      Weaknesses:

      Applicability can be questioned because the device used is 2D and physiological biology is in 3D. Comparisons to other automated tools was not performed by the authors.

      We thank the Reviewer for pointing our attention to these weaknesses in our manuscript.

      We have clarified in the revised manuscript that using 2D endothelial monolayer models in parallel laminar flow chambers is still a state-of-the-art methodology for studying the multi-step extravasation process of immune cells across endothelial monolayers under physiological flow by in vitro live cell imaging. These models provide excellent optical quality that is not yet achieved in 3D models. We have extended the introduction to emphasize the limitations of existing tools that motivated us to establish UFMTrack. We have furthermore extended the discussion section to highlight the features unique to our UFMTrack framework.

      Reviewer #3 (Public Review):

      Summary:

      The authors aimed to establish a faster and more efficient method of tracking steps of T-cell extravasation across the blood brain barrier. The authors developed a framework to visualize, recognize and track the movement of different immune cells across primary human and mouse brain microvascular endothelial cells without the need for fluorescence-based imaging. The authors succinctly describe the basic requirements for tracking in the introduction followed by an in-depth account of the execution.

      We thank the Reviewer for their positive evaluation of our manuscript and highlighting the value of label-free analysis of the multistep immune cell extravasation cascade with UFMTrack.

      Weaknesses and Strengths:

      Materials & methods and results:

      (1) The methods section also lacks details of the microfluidic device that the authors talk about in the paper. Under physiological sheer stress, the T-cells detach from the pMBMEC monolayer, and are hence unable to be detected; however, this observation requires an explanation pertaining to the reason of occurrence and potential solutions to circumvent it to ensure physiologically relevant experimental parameters.

      We thank the Reviewer for pointing out this oversight. We have used a custom-made microfluidic device that has been published and described in detail before. This information has now been included in the Methods Section under Point 7, and the two references describing the flow chamber in depth are mentioned below and have been included in the manuscript.  

      Coisne Caroline, Ruth Lyck and Britta Engelhardt. 2013. Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo. Fluids and Barriers of the CNS 10:7 doi:10.1186/20458118-10-7; 21 January 2013

      Lyck R, Hideaki Nishihara, Sidar Aydin, Sasha Soldati and Britta Engelhardt. 2022. Modeling brain vasculature immune interactions in vitro. Angogenesis, 2nd edition. Editors PatriciaD’Amore and Diane Bielenberg Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a041185

      T cell detachment is a physiologically relevant parameter besides T cell arrest, polarization, crawling, probing, and transmigration during the interaction with an endothelial monolayer. T cell detachment means that post-arrest, the T cell cannot engage adhesion molecules required for subsequent polarization and, eventually, transmigration. 

      (2) The author describes a method for debris exclusion using UFMTrack that eliminates objects of <30 pixels in size from analysis based on a mean pixel size of 400 for T lymphocytes. However, this mean pixel size appears to stem from in-vitro activated CD8 T cells, which rapidly grow and proliferate upon stimulation. In line with this, activated lymphocytes exhibit increased cytoplasmic area, making them appear less dense or “brighter” by phase microscopy compared to naïve lymphocytes, which are relatively compact and subsequently appear dimmer. Given this, it is not clear whether UFMTrack is sufficiently trained to identify naïve human lymphocytes in circulating blood, nor smaller, murine lymphocytes. Analysis of each lymphocyte subtype in terms of pixel size and intensity would be beneficial to strengthen the claim that UFMTrack can identify each of these populations. Additionally, demonstrating that UFMTrack can correctly characterize the behavior of naïve versus activated lymphocytes isolated from murine and human sources would strengthen the claim that UFMTrack can be broadly applied to study lymphocyte dynamics in diverse models without additional training

      We thank the Reviewer for the suggestion to more precisely evaluate the range of cell sizes that can be analyzed by our framework. We have included a visualization of crawling cell sizes successfully analyzed by the UFMTrack in Supplementary Figure 7. It demonstrates that the human peripheral blood mononuclear cells, that are almost twice as small as the activated mouse CD4 T cells used in these assays, can be successfully segmented, tracked, and analyzed with the UFMTrack framework. Thus, our UFMTrack framework is suitable for a broad application to differentially sized immune cells during their interaction with the endothelial cell monolayer under flow. 

      (3) Average precision was compared to the analysis of UFMTrack but it is unclear how average precision was calculated. This information should have been included in the methods section

      We thank the Reviewer for pointing our attention to the missing information. We have added a subsection, “Performance Analysis”, to the Materials and Methods section, where we describe the statistical methods and the performance metrics used to evaluate the UFMTrack framework.

      (4) CD4 and CD8 T cells exhibit distinct biology and interaction kinetics driven in part by their MHC molecule affinity and distinct receptor expression profiles. Thus, it is unclear why two distinct mechanisms of endothelial cell activation are needed to see differences between the populations.

      We thank the Reviewer for pointing out that different cytokine stimulations of endothelial cells were used in the assays used here to test our UFMTrack to analyze CD4 and CD8 T cell interactions with the endothelial monolayer. While the Reviewer is correct that CD4 and CD8 T cells use different mechanism to cross the pMBMEC monolayer as show by us (doi: 10.1002/eji.201546251.) and others and that recognition of cognate antigen on MHC class I on pMBMECs will arrest CD8 T cells and lead to CD8 T-cell mediated apoptosis ( doi: 10.1038/s41467-023-38703-2.) the focus of the present study was not on comparing CD4 and CD8 T cell interactions with the pMBMEC monolayer but rather to test suitability of UFMTrack to study the different multi-step transmigration of these T cell subsets across the endothelial monolayer. 

      (5) The BMECs are barrier tissues but were cultured on µdishes in this study. To study the transmigration of T-cells across the endothelium, the model would have been more relevant on a semi-permeable membrane instead of a closed surface.

      We understand the critique of the Reviewer, but laminar flow chambers with endothelial monolayers still provide a state-of-the-art and established methodology to study immune cell migration across endothelial monolayers by in vitro live cell imaging including endothelial cells forming the blood-brain barrier.  

      (6) Methods are provided for the isolation and expansion of human effector and memory CD4+ T cells. However, there is no mention of specific CD4+ T cell populations used for analysis with UFMTrack, nor a clear breakdown of tracking efficiency for each subpopulation. Further, there is no similar method for the isolation of CD8+ T cell compartments. A clear breakdown of the performance efficiency of UFMTrack with each cell population investigated in this study would provide greater insight into the software’s performance with regard to tracking the behavior and movement of distinct immune populations.

      We thank the Reviewer for this comment. Since a fair performance evaluation requires collecting reliable and consistent manual annotations, in this work we have performed such analysis only for the mouse CD8 T-cell population migrating on the pMBMEC monolayer. We have chosen this as a reference since it is a different cell population than the one the segmentation model was trained on. This provides an insight into how high performance is expected when other immune cell types are studied than the ones used for model development.

      (7) The results section is quite extensive and discusses details of establishment of the framework while highlighting both the pros and cons of the different aspects of the process, for example the limitation of the two models, 2D and 2D+T were highlighted well. However, the results section includes details which may be more fitting in the methods section.

      We thank the Reviewer for highlighting the extensive work carried out in the development of our UFMTrack framework. We decided to include in the results section only the description of key elements and design decisions taken when developing the framework, such as the need to include a time series of images for successful segmentation of the transmigrated cells. At the same time, the majority of implementational details can be found in the Supplementary Material.

      (8) A few statements in the results section lacked literary support, which was not provided in the discussion either, such as support for increased variance of T-cell instantaneous speed on stimulated vs non-stimulated pMBMECs. Another example is the enhancement of cytokine stimulation directed T-cell movement on the pMBMECs that the authors observed but failed to relay the physiological relevance of it. The authors don’t provide enough references for developments in the field prior to their work which form the basis and need for this technology.

      We thank the Reviewer for this comment and for asking for literature references. However, we cannot provide such references as these are original observations we made by employing the UFMTrack framework.  This shows that UFMTrack observes T-cell behaviors that have previously been overlooked. Their physiological relevance will have to be explored in separate studies. We have extended the introduction section to include the details on the existing methods developed in the field, as well as their weaknesses that motivated the development of the UFMTrack framework.

      (9) The rationale for use of OT-1 and 2D2-derived murine lymphocytes is unclear here. The OT-1 model has been generated to study antigen-specific CD8+ T cell responses, while the 2D2 model has been generated to recapitulate CD4 T cell-specific myelin oligodendrocyte glycoprotein (MOG) responses.

      To establish and test the UFMTrack framework, we have made use of the specific T-cell subsets and endothelial cell models we generally use within our research context. Especially for animal work, this is according to the 3R rules requesting to reduce animal experimentation.  

      Figures and text:

      (1) There are certain discrepancies and misarrangement of figures and text. For example, discussion of the effect of sheer flow on T cell attachment as part of the introduction in figure 1 and then mentioning it in the text again in the results section as part of figure 4 is repetitive.

      We thank the Reviewer for pointing our attention to this misarrangement. We have adjusted the label of Figure 4 to emphasize that this effect is correctly captured by the UFMTrack.

      (2) Section IV, subsection 1 of the results section, refers to ‘data acquisition section above’ in line 279, however the said section is part of materials and methods which is provided towards the end of the manuscript.

      We thank the Reviewer for pointing our attention to this misarrangement. We have adjusted the text to reflect the correct chapter order.

      (3) There are figures in the manuscript that have not been referenced in the results section, for example, figure 3A and B. Figure 1 hasn’t been addressed until subsection 7 of materials and methods

      We thank the Reviewer for pointing our attention to this misarrangement. We have adjusted the text to refer to all figure panels and the clarification of the cell multiplicity estimation in the supplementary information section. References to Figure 1 were added in the introduction section to illustrate the in vitro under flow imaging setup as well as the typical T cell behaviors in such experiments.

      (4) A lack of significance but an observed trend of increased variance of T cell instantaneous speed is reported in line 296-298; however, the graph (figure 4G) shows a significant change in instantaneous speed between non-stimulated and TNFα-stimulated systems. This is misleading to the readers.

      We thank the Reviewer for pointing our attention to this discrepancy. We have expanded the text to indicate a low statistical significance for the TNF and no significance but just a trend for the IL1-beta conditions.

      (5) The authors talk about three beginner experimentors testing the manual T cell tracking process but figure 5 only showcases data from two experimentors without stating the reason for excluding experimentor 1.

      We thank the Reviewer for pointing our attention to this ambiguity. While both the migration analysis and the manual cell tracking were performed by all three beginner experimenters, the cell tracking data for the first one was unfortunately lost due to a hardware failure.

      Discussion:

      (1) While the discussion captures the major takeaways from the paper, it lacks relevant supporting references to relate the observation to physiological conditions and applicability.

      This study is not about the physiological relevance of the microfluidic devices and immune cells used but rather about advancing methodology to analyze dynamic immune cell behavior on endothelial monolayers under physiological flow. Therefore, the discussion does not extend to comparing the physiological relevance of the specific in vitro models employed in this study.   

      (2) The discussion lacks connection to the results since the figures were not referenced while discussing an observed trend

      We thank the Reviewer for pointing our attention to this misarrangement. We have included the references to the relevant figures as well as supporting references.

      (3) The authors briefly looked into mouse and human BMECs and their individual interaction with Tcells, but don’t discuss the differences between the two, if any, that challenged their framework.

      We thank the Reviewer for pointing our attention to this weakness. We have added to the discussion section clarifications on the challenges of analyzing the T cell interactions with the HBMEC and the BMDM interactions with the pMBMEC monolayer.

      (4) Even though though the imaging tool relies on difference in appearance for detection, the authors talk about lack of feasibility in detecting transmigration of BMDMs due to their significantly different appearance. The statement lacks a problem solving approach to discuss how and why this was the case.

      We thank the Reviewer for pointing our attention to this weakness and apologize for the misleading explanation of the problem of analyzing the BMDM sample. Since the transmigrated part of the macrophages differs in appearance from a transmigrated part of a T cell, its detection by a Deep Neural Network trained on the T cell data is worse than that for the T cells. At the same time, the detection performance before the transmigration is sufficient for the BMDM migration analysis. The potential approaches to alleviate this are added to the discussion section.

      Relevance to the field:

      Utilizing the framework provided by the authors, the application can be adapted and/or utilized for visualizing a range of different cell types, provided they are different in appearance. However, this would require extensive changes to the script and won’t be adaptable in its current form.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      The authors should announce in the abstract that the software analysis Track is downloadable and free to use for all researchers. They may consider providing some sort of helpdesk, although I realize that that may run into too much time.

      As said above, they stress that it can be done in BBB models, but I would argue that it is much more broadly applicable.

      We thank the Reviewer for these suggestions. We have emphasized the broader applicability of UFMTrack in the abstract and pointed out the public availability of the code and data.

      Can they add an experiment that shows that it also works for neutrophils for example? I understand that on paper yes it should work, but the neutrophils are of course faster etc.

      This is an excellent suggestion, but we tested UFMTrack within the current framework of ongoing research, which does not include the investigation of neutrophil transmigration across endothelial monolayers.  

      Also, the combination of different leukocytes in one TEM assay would really be a step forward. If the software can detect different-sized leukocytes, then this should be possible.

      We thank the Reviewer for this suggestion. We have added Supplementary Figure 7, demonstrating the range of cell sizes that were successfully analyzed by the UFMTrack framework throughout our manuscript. We also added a statement to the discussion that according to this data, “simply by discriminating cells by size, it is possible to extend UFMTrack to study the interaction of several types of immune cells migrating on top of a cellular monolayer under flow.”

      Extra challenges: can the method also discriminate between paracellular and transcellular migration modes? In particular for T-cells this is known to happen.

      We thank the Reviewer for this suggestion. We have added this to the potential applications of UFMTrack in the discussion section. While this differentiation is not feasible relying solely on the phasecontrast imaging data, UFMTrack can simplify this analysis by providing automatically the predictions of the transmigration locations, for analysis of the fluorescent data of the junctional labels.

      Reviewer #2 (Recommendations For The Authors):

      This paper develops an under-flow migration tracker to evaluate all the steps of the extravasation cascade of immune cells across the BBB. The algorithm is useful and has important applications. There are several points that need to be addressed, particularly about the claims made by the authors.

      Please see the comments below for more details:

      • Lines 88-92: Add a citation for the characteristics of the BBB as a barrier

      We have added two references accordingly.  

      • Lines 94-95: Can the authors indicate what models were used for these studies and how those compare to their in vitro model? In addition, can the authors say whether T cells were manually tracked in this study to translate results to the clinic and whether the results were successful when translated to the clinic? This may enhance the argument that automatic trackers are needed if the translation was not 100% successful

      This introductory paragraph summarizes in vivo and in vitro observations from several laboratories. Although these studies include manual tracking of T cells, they do not necessarily distinguish all sequential steps of the multi-step T cell transmigration cascade. Thus, automated tracking may provide additional insights, allowing for increased translation of findings to the clinic.  

      • Lines 96-98: Citing the work of Roger Kamm and Noo Li Jeon would be helpful here as they pioneered these BBB microfluidic models and have protocol papers on how to build them and how to use them for cancer cell extravasation studies. Roger Kamm has also worked on several extravasation studies with neutrophils, monocytes, and PBMCs from 3D vasculatures in microfluidic devices, under flow using pressurized fluid or recirculating pumps. Mentioning those would be helpful as they are directly related to what the authors are presenting in their paper.

      We thank the Reviewer for this comment, and we consider the work of Roger Kamm and Noo Li Jeon as very valuable for the field. However, these authors have focused on developing functional 3D microfluidic devices, including, e.g., all cells of the neurovascular unit which is not the focus of this present study that solely employed parallel flow chamber devices and endothelial monolayers.  

      • Lines 110-116: Can the authors comment on the use of ImageJ or similar automatic tracking tools and how these compare to the under-flow migration tracker developed in this paper? Several groups use ImageJ to track cellular migration successfully and in an automatic manner with short intervals between each frame. One paper that comes to mind is Chen et al: DOI: 10.1073/pnas.1715932115 where neutrophil migration in 3D was assessed with ImageJ in microfluidic devices of the vasculature. If the authors can highlight differences between their tool and what is currently available and used for automatic tracking (e.g. ImageJ), this would help in understanding the advantages of the migration tracker developed in this paper.

      • Lines 118-121: Add citations for the current state of the art for T cell extravasation tracking

      We thank the Reviewer for these suggestions. We have extended the introduction to add more details on the available tools for tracking migrating immune cells and their limitations, as well as the discussion section to emphasize the features unique to the developed UFMTrack framework.

      • Figure 1: The device used by the authors is considered to be a 2D microfluidic device with a monolayer of mouse brain endothelial cells. I would recommend the authors to carefully revise the claims made in the paper to mention that this is a 2D device as opposed to a 3D device, in order to not mislead readers who may be expecting these analyses to be performed in 3D vasculatures.

      We thank the Reviewer for this suggestion. We have included in the summary the mention of the 2dimensional nature of the employed BBB model.

      • Figure 1: The T cells used in this study are not fluorescently-labeled but the authors mention that this is an issue from current state-of-the-art tools. I would recommend that the authors remove this point as being an issue because it is not addressed in their paper. The T cells are also not labeled in this study so this limitation of other systems is not addressed in this paper.

      We apologize to the Reviewer as we do not understand this question. There will be many experimental conditions not allowing to study fluorescently tagged T cells. Therefore, UFMTrack is tailored to follow and analyze T cells and other immune cells during their interaction with endothelial monolayers independent of a fluorescence tag.  

      • Figure 1: Was the shear stress controlled manually with a syringe? Or with the use of a pressure controller? I would clarify this aspect and discuss human errors that can be introduced from manually controlling the pressure applied to the monolayer.

      We thank the Reviewer for pointing our attention to this ambiguity. We have added a mention of the automated syringe pump used to control the shear stress in the text where the values of shear stress applied to the sample are first mentioned.

      • Figure 1: Does T cell attachment occur within the first 5 minutes? Can the authors comment on how they chose this timeline and the percentage of T cells that are washed off at the second step at 1.5 dynes/cm^2? Is 30 seconds enough to ensure all the non-adhered T cells are washed off with 1.5 dyns/cm^2?

      Superfusion of the T cells over the endothelial monolayer is performed under 0.5 dynes/cm2 to allow the T cells to settle on the endothelial cell monolayer under flow. After increasing to physiological, flow non adherent T cells detach within 30 seconds, as described by the Reviewer. We have included in the Methods Section Point 7 the references describing in depth the design of the flow chamber device and methods used here.  

      • Line 154: How many images were used in the training vs. testing dataset for T cell migrations?

      We thank the Reviewer for pointing our attention to this missing information. We have added the sizes of the training and validation datasets. Specifically, the 226MPix of available imaging data was split into 154Mpix training and 37 MPix validation sets. The gap in between was introduced to avoid a correlation between validation and training set that would compromise the performance evaluation.

      • Are the supplementary videos at real speed or accelerated?

      We thank the Reviewer for pointing our attention to this missing information. The videos are sped up by a factor of 96. We have added this information to the Supplementary video descriptions.  

      • Lines 208 216: Can the authors comment on how their initial adhesion timeframe of 30sec before starting the recording at 5.5min affects the number of T cells with rapid displacement? 30 seconds may not be enough to ensure T cells have adhered to the endothelium

      Please see our comment above. The methodology used in the present assays has been set up and validated in numerous publications. We have included in the Methods Section under Point 7 the references describing in depth the design of the flow chamber device and the methods used here.  

      • Lines 275-277: Was the number of testing images 18? Can the authors comment on how this compares to training dataset size and whether these numbers are enough to achieve robust results?

      We apologize for this ambiguity in our manuscript. The framework was evaluated on 18 imaging datasets, each corresponding to 32 minutes of recording, not 18 images. We have added this clarification to the “CD4+ T cell analysis” subsection. The total size of these datasets is 18 datasets * 191 timeframe/dataset * 9.9MPix/frame = 34MPix

      • Figure 4B: Can the authors add statistics here? Individual datapoints on the error bars would be helpful too. 

      We thank the Reviewer for pointing our attention to this weakness. The data corresponds to the statistical errors as evaluated based on all cells in the 18 datasets. We have added the total number of cells in each of the endothelium stimulation conditions to the text.

      • Figure 4C-J: Can the authors put individual datapoints here as well and explain whether they considered each T cell to be one datapoint or each endothelium (averaging all T cells) to be one datapoint? 

      We thank the Reviewer for this suggestion. However, adding about one thousand points corresponding to each cell would be impractical. We thus present the distributions of the evaluated from the data metrics as a histogram on the violin plot instead of the swarm plot.

      • Figure 4: Did the authors wash the monolayers before introducing T cells? Soluble unbound cytokines may still be present and there are two different questions that would be studied here: “Is the inflamed endothelium affecting T cell migration?” (if washing was performed) or “Is T cell and microenvironmental inflammation affecting T cell migration?” (if no washing was performed)

      The endothelial monolayers are “washed” by starting the flow in the flow chamber device and this is before superfusing the T cells over the endothelial monolayer. We agree that our flow chamber device combined with UFMTrack will allow to address all these questions.

      • Figure 4I: Are all the T cells decelerating? (negative AM speed)

      We thank the Reviewer for this question. The cells are moving along the flow, which, in our experiments, is from left to right. The vector of speed is thus pointing against the x-axis, and thus the AM speed is negative.

      • Lines 302 306: Please explain how this compares to ImageJ or similar trackers that can achieve similar outputs. 

      We thank the Reviewer for this question. We have added a statement in the “T-cell tracking” section emphasizing that standard trackers are incapable of correctly capturing large displacements.

      • Lines 306-309: It is not lower for TNF stimulation though. How do the authors address this? TNF is also a pro-inflammatory cytokine.

      We have previously shown that stimulation of pMBMECs with IL-1 and TNF-a induces different cell surface levels of ICAM-1 and VCAM-1, which will influence T cell behavior on the pMBMEC monolayer.  

      • Lines 313-315: Could this be because the monolayer was not washed and soluble cytokines affected T cell response directly?

      Please see our answer to lines 306-309.  

      • Lines 319: Please cite Roger Kamm and Noo Li Jeon’s papers on BBB models with human BMECs, pericytes and astrocytes in 3D microfluidic devices.

      We thank the Reviewer again for pointing out these studies. As mentioned above, as our present study does not explore 3D models of the BBB, we think it does not fit into the framework of our study to elaborate on 3D models of the BBB. In addition, this would require the inclusion of a discussion of the work of others like, e.g., Peter Searson and others.  

      • Figure 5: Several statistics are missing from parts of the figure. Please add those.

      We apologize – but we do not understand which statistical analysis the Reviewer is missing from this Figure.  

      • Can the authors comment on the number of T cells perfused over the monolayer and if this ratio of T cells to endothelial cells makes physiological sense? Too many T cells may result in endothelium inflammation and increased diapedesis.

      The number of T cells used to suprerfuse over the endothelial monolayer is tested to avoid aggregation of T cells in suspension and thus artificial interactions with the endothelial monolayer. T cell behavior on the pMBMEC monolayer remains the same over the dilution of factor 10.  

      • Lines 381 383: How does this compare to analyses that look at the cross-section of the endothelium? It is difficult to assess transmigration looking at the top view of the endothelium. Perhaps, cross-section assessments will identify differences in manual vs. automatic tracking.

      There is, to the best of our knowledge, no microscopic device that would allow for in vitro live cell imaging of a live endothelial monolayer – this is in the presence of tissue culture medium – from the side at a resolution that would allow to define transmigration. Our current study rather shows the UFMTrack can distinguish cells moving above or below the endothelial monolayer.  

      • Figure 5J: This is probably the most important argument of the paper. If the authors can show statistical differences in their graph, this would greatly help convince readers that this tool is necessary and actually computationally efficient compared to manual work by researchers.

      We thank the Reviewer for this suggestion. However, comparing a single data point for automated measurement with four manual experimenter analysts is not a statistically sound comparison. We believe that Figure 5K is clearly showing the factor 5 difference in analysis speed as compared to manual analysis. More importantly, though, the automated analysis is taking the machine time, lifting the need for the experimenter to invest even 1/5th of the original analysis time.

      • Figure 6: Did the authors use autologous immune cells and endothelial cells? This is particularly relevant with the use of human-derived T cells (line 436) on the BMEC monolayer. Can the authors comment on non-self reactivity by the T cells encountering BMEC from another human subject?

      Autologous T cell interaction with BMECs would only be possible when using hiPSC-derived EECM-BMECs and the T cells from the same individual. All other experimental frameworks will not include autologous interactions. This is the experimental framework used by most authors studying immune cell interactions with commercially available donors. We have not studied alloreactive interactions in our assays and thus cannot further comment.  

      • Figure 6M,N,O: How does this compare to ImageJ for tracking of fluorescent cells? I recommend the authors to try that, at least for this section, as this may enhance their argument for their tool vs. standard tools like ImageJ if success rates are higher for their tool.

      We thank the Reviewer for this suggestion. We included a note on the analysis of the fluorescent datasets using the  TrackMate plugin for imageJ performed previously in our lab in the “Human T cells on immobilized recombinant BBB adhesion molecules” subsection.

      • Figure 6: Please put individual datapoints on the bar or violin plots where they are missing.

      We thank the Reviewer for this suggestion. However, adding about one thousand points corresponding to each cell would be impractical. We thus present the distributions of the evaluated from the data metrics as a histogram on the violin plot instead of the swarm plot.

      • Lines 467-471: This argument is important and should be mentioned earlier in the introduction.

      Another point that can be mentioned is the application of this platform to imaging modalities in vivo (mouse or human) given that there is no fluorescent staining in these cases. This review may be relevant: https://doi.org/10.1002/jcb.10454

      We thank the Reviewer for this suggestion. We have clarified in the introduction that UFMTrack does not require fluorescent labels of the imaged migrating cells and relies solely on the phase contrast imaging data.

      • Discussion: Please address a few more potential applications to this study. One can be cancer and immune infiltration.

      We thank the Reviewer for this suggestion. We have elaborated on additional potential applications to the discussion section.

      Reviewer #3 (Recommendations For The Authors):

      (1) Line 327-328: The authors talk about ‘As we have previously shown…pMBMEC monolayers differs between CD4+ and CD8+ cells…’. Where was this shown? If it was in a previously published article, please provide a reference.

      We have added these missing references.  

      (2) Line 353: Please provide clear location on where to find the associated information instead of stating ‘see below’.

      We thank the Reviewer for pointing our attention to this ambiguity. We have corrected the phrase to “see next paragraph”

      (3) Line 439: Please correct the acronym to BMECs

      We thank the Reviewer for pointing our attention to this typo. We have corrected it.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Summary of revisions

      Title

      We have changed the title of the manuscript to “Chromatin endogenous cleavage provides a global view of yeast RNA polymerase II transcription kinetics”.

      Text

      Additional discussion of the patterns for elongation factors added (detailed below).

      Small text changes throughout, as mentioned in the detailed response below.

      Figures

      Updated legend-image in Figure 2F to reflect correct colors

      Added Figure 2 – supplement 1F – RNAPII enrichment with shorter promoter dwell times

      Added Figure 2 - supplement 2 with ChIP-seq outcomes (and text legend)

      Removed gene numbers in Figure 5C and put them in the legend.

      Substituted Med1 and Med8 ChEC over Rap1 sites in Figure 5F.

      Moved kin28-is growth inhibition to Figure 5 – Supplement 1.

      Substituted a new panel overlaying the RNAPII enrichment over UASs or promoters for all three strains in Figure 7D.

      Improved the labeling and legend of Figure 7E

      Methods

      Added ChIP-seq performed to confirm that the MNase fusion proteins are able to produce the expected pattern for ChIP.

      Point-by-point response to reviewers’ comments

      Reviewer 1:

      (1) Extending this work to elongation factors Ctk1 and Spt5 unexpectedly give strong signals near the PIC location and little signals over the coding region. This, and mapping CTD S2 and S5 phosphorylation by ChEC suggests to me that, for some reason, ChEC isn't optimal for detecting components of the elongation complex over coding regions. 

      (3) mapping the elongation factors Spt5 and Ctk1 by ChEC gives unexpected results as the signals over the coding sequences appear weak but unexpectedly strong at promoters and terminators. It would be helpful if the authors could comment on reasons why ChEC may not work well with elongation factors. For example, could this be something to do with the speed of Pol elongation and/or the chromatin structure of coding sequences such that coding sequence DNA is less accessible to MNase cleavage? 

      (7) The mintbodys are an interesting attempt to measure Pol II CTD modifications during elongation but give unexpected results as the signals in the coding region are lower than at promoters and terminators. It seems like ChIP is still a much better option for elongation factors unless I'm missing something. 

      We agree with the reviewer that this is a point that could confuse the reader.  Therefore, we have devoted two additional paragraphs to possible interpretations of our data in the Discussion:

      ChEC with factors involved in elongation (Ctk1, Spt5, Ser2p-RNAPII), when normalized to total RNAPII, showed greater enrichment over the CDS (Figure 3G), as expected. However, it is surprising that we also observed clear enrichment of these factors at promoters (e.g. Figure 3A, E & F). The association of elongation factors with the promoter seems to be biologically relevant. Changes in transcription correlate with changes in ChEC enrichment for these factors and modifications (Figure 4C). Blocking initiation by inhibiting TFIIH kinase led to a reduction of Ser5p RNAPII and Ser2p RNAPII over both the promoter and the transcribed region (Figure 5G). This suggests either that the true signal of these factors over transcribed regions is less evident by ChEC than by ChIP or that ChEC can reveal interactions of elongation factors at early stages of transcription that are missed by ChIP. The expectations for enrichment of elongation factors and phosphorylated CTD are largely based on ChIP data. Because ChIP fails to capture RNAPII enrichment at UASs and promoters, it is possible that ChIP also fails to capture promoter interaction of factors involved in elongation as well.

      Factors important for elongation can also function at the promoter. For example, Ctk1 is required for the dissociation of basal transcription factors from RNAPII at the promoter (Ahn et al., 2009). Transcriptional induction leads to increases in Ctk1 ChEC enrichment both over the promoter and over the 3’ end of the transcribed region (Figure 4C). Dynamics of Spt4/5 association with RNAPII from in vitro imaging (Rosen et al., 2020) indicate that the majority of Spt4/5 binding to RNAPII does not lead to elongation; Spt4/5 frequently dissociates from DNA-bound RNAPII. Association of Spt4/5 with RNAPII may represent a slow, inefficient step in the transition to productive elongation. If so, then ChEC-seq2 may capture transient Spt4/5 interactions that occur prior to productive elongation, producing enrichment of Spt5 at the promoter.

      (2) Finally, the role of nuclear pore binding by Gcn4 is explored, although the results do not seem convincing (10) In Figure 7, it's not convincing to me that ChEC is revealing the reason for the transcriptional defect in the Gcn4 PD mutant. The plots in panel D look nearly the same and I don't follow the authors' description of the differences stated in the text. In panel A, replotting the data in some other way might make the transcriptional differences between WT and Gcn4 PD mutants more obvious. 

      The phenotype of the gcn4-pd mutant is a quantitative decrease in transcription and this leads to a quantitative decrease, rather than qualitative loss, of RNA polymerase II over the promoter, without impacting the association of RNA polymerase II over the UAS region. This effect is small but statistically significant (p = 4e5). We have changed the title of this section of the manuscript to “ChEC-seq2 suggests a role for the NPC in stabilizing promoter association of RNAPII”. Also, to make comparison clearer, we have plotted the data together in the revised figure (Figure 7D).

      The magnitude of the decrease is not large, but we would highlight that is almost as large as that produced by inhibiting the Kin28 kinase (Figure 5H). Because the promoter-bound RNAPII is poorly captured by ChIP, this effect might be difficult to observe by techniques other than ChEC. Obviously, more mechanistic studies will need to be performed to fully understand this phenotype, but this result supports a role for the interaction with the nuclear pore complex in either enhancing the transfer of RNA polymerase II from the enhancer to the promoter or in preventing its dissociation from the promoter.

      I think that the related methods cut&run/cut&tag have been used to map elongating pol II. The authors should summarize what is known from this approach in the introduction and/or discussion. 

      CUT&RUN has been used to map RNAPII in mammals, but we are not aware of reports in S. cerevisiae.  Work from the Henikoff Lab in yeast mapped transcription factors and histone modifications (PMIDs 28079019 and 31232687).  A report using CUT&RUN in a human cell line reported a promoter-5’ bias of RNAPII that appeared to be dependent on fragment length (PMID 33070289). Regardless, the report highlights a key distinction between yeast and other eukaryotes: paused RNAPII. Indeed, paused RNAPII dominates ChIP-seq tracks in metazoans, and so we are hesitant to speculate between CUT&RUN in other species vs. ChEC-seq2 in S. cerevisiae

      Are the Rpb1, Rpb3, TFIIA, and TFIIE cleavage patterns expected based on the known structure of the PIC (Figures 2C, E)? 

      Rpb1 and 3 show peaks at approximately -17 and +34 with respect to TATA. TFIIA (Toa2) shows peaks at -12 and + 12.  And TFIIE (Tfa1) shows a peak around +34 (Figure 2C & E):

      As shown in the supplementary movie (based on the cMed-PIC structure; PDB #5OQM; Schilbach et al., 2017), upon binding to TBP/TFIID, TFIIA would be expected to cleave slightly upstream and downstream of the protected TATA (-12 and +12), while TFIIE binds downstream after the +12 site is protected and would be closest to the +34 unprotected site (to the right in the image below). RNAPII, which binds the fully assembled PIC, should be able to access either the upstream site (-12) or the downstream site (+34). Rpb1’s unstructured carboxy terminal domain, to which MNase is fused, would give it maximum flexibility, which likely explains why Rpb1 cleaves both at -12 and +34, with a preference for -12. Rpb3 also cleaves both sites, but without an obvious preference. 

      Author response image 1.

      Author response image 2.

      cleavage at -12, +12 and +34

      Author response image 3.

      Highlighted sites corresponding to the peaks in TFIIA assembled with TBP:

      Author response image 4.

      The complete PIC, protecting the +12 site, but leaving the +34 site exposed: 

      (6) Figure 2 S1: Pol II ChIP in the coding region gives a better correlation with transcription vs ChEC in promoters. Also, Pol II ChIP at terminators is almost as good as ChEC at promoters for estimating transcription. This latter point seems at odds with the text. The authors should comment on this and modify the text as needed. 

      Thank you for this comment.  We have clarified the text.

      In Figures 4 and 5, it's hard to tell how well changes in transcription correlate with changes in Pol II ChEC signals. It might be helpful to have a scatterplot or some other type of plot so that this relationship can be better evaluated. 

      While we find corresponding increase/decrease in ChEC-seq2 signal in genes identified as up/downregulated by SLAM-seq, the magnitude in change is not well correlated between the two techniques.  This was not surprising, because neither ChIP nor ChEC correlate especially well with SLAM-seq (Figure 2 – supplement 1E).

      In Figure 5, it's unclear why Pol association with Rap1 is being measured. Buratowski/Gelles showed that Pol associates with strong acidic activators - presumably through Mediator. Rap1 supposedly does not bind Mediator - so how is Pol associating here? Perhaps it would be better to measure Pol binding at STM genes that show Mediator-UAS binding. 

      Thank you; this is a good point.  We chose Rap1 because we had generated high-confidence binding sites in our strains under these conditions by ChEC-seq2. The results suggest that RNAPII is recruited well to these sites and that this recruitment does not require TFIIB. However, in disagreement with the notion that Mediator does not interact with Rap1, ChEC with Mediator subunits Med1 and Med8 also show peaks at these sites (new Figure 5F; the old Figure 5F is now Figure 5 – Supplement 1).  Therefore, either these sites are co-occupied by other transcription factors that mind Mediator, or Mediator is recruited by Rap1.  In either case, this correlates with binding of RNAPII. 

      Reviewer 2:

      (1) The term "nascent transcription" is all too often used interchangeably for NET-seq, PRO-seq, 4sUseq, and other assays that often provide different types of information. The authors should make it clear their use of the term refers to SLAM-seq data. 

      We have clarified throughout the manuscript that nascent transcription measured by SLAM-seq.

      The authors should explicitly state that experiments were performed in S. cerevisiae in the Results section. 

      We have made it clear in the title and the text that these experiments were performed in S. cerevisiae.

      Lines 216-218 state that "None of the 24 predicted the strong signal over the transcribed region with promoter depletion characteristic of ChIP-seq". I understand the authors' point, but there are parameter combinations that produce a flat profile with slightly less signal over the promoter (e.g., 5 sec dwell times and 3000 bp/ min elongation rate). If flanking windows were included, this profile would look something like ChIP-seq. I'd encourage the authors to be more precise with their language. 

      Thank you for highlighting this over-statement.

      We have now clarified the text and added another supplementary panel as follows:

      “While some combinations predicted a relatively flat distribution across the gene with lower levels in the promoter, none of the 24 predicted the strong signal over the transcribed region with promoter depletion characteristic of ChIP-seq. Only very short promoter dwell times (i.e., < 1s), produced the low promoter occupancy seen in ChIP-seq (Figure 2 – supplement 1F).”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The manuscript by Choi and co-authors presents "P3 editing", which leverages dual-component guide RNAs (gRNA) to induce protein-protein proximity. They explore three strategies for leveraging prime-editing gRNA (pegRNA) as a dimerization module to create a molecular proximity sensor that drives genome editing, splitting a pegRNA into two parts (sgRNA and petRNA), inserting self-splicing ribozymes within pegRNA, and dividing pegRNA at the crRNA junction. Among these, splitting at the crRNA junction proved the most promising, achieving significant editing efficiency. They further demonstrated the ability to control genome editing via protein-protein interactions and small molecule inducers by designing RNA-based systems that form active gRNA complexes. This approach was also adaptable to other genome editing methods like base editing and ADAR-based RNA editing.

      Strengths:

      The study demonstrates significant advancements in leveraging guide RNA (gRNA) as a dimerization module for genome editing, showcasing its high specificity and versatility. By investigating three distinct strategies-splitting pegRNA into sgRNA and petRNA, inserting self-splicing ribozymes within the pegRNA, and dividing the pegRNA at the repeat junction-the researchers present a comprehensive approach to achieving molecular proximity and reconstituting function. Among these methods, splitting the pegRNA at the repeat junction emerged as the most promising, achieving editing efficiencies up to 76% of the control, highlighting its potential for further development in CRISPR-Cas9 systems. Additionally, the study extends genome editing control by linking protein-protein interactions to RNA-mediated editing, using specific protein-RNA interaction pairs to regulate editing through engineered protein proximity. This innovative approach expands the toolkit for precision genome editing, demonstrating the feasibility of controlling genome editing with enhanced specificity and efficiency.

      Weaknesses:

      The initial experiments with splitting the pegRNA into sgRNA and petRNA showed low editing efficiency, less than 2%. Similarly, inserting self-splicing ribozymes within pegRNA was inefficient, achieving under 2% editing efficiency in all constructs tested, possibly hindered by the prime editing enzyme. The editing efficiency of the crRNA and petracrRNA split at the repeat junction varied, with the most promising configurations only reaching 76% of the control efficiency. The RNA-RNA duplex formation's inefficiency might be due to the lack of additional protein binding, leading to potential degradation outside the Cas9-gRNA complex. Extending the approach to control genome editing via protein-protein interactions introduced complexity, with a significant trade-off between efficiency and specificity, necessitating further optimization. The strategy combining RADARS and P3 editing to control genome editing with specific RNA expression events exhibited high background levels of non-specific editing, indicating the need for improved specificity and reduced leaky expression. Moreover, P3 editing efficiencies are exclusively quantified after transfecting DNA into HEK cells, a strategy that has resulted in past reproducibility concerns for other technologies. Overall, the various methods and combinations require further optimization to enhance efficiency and specificity, especially when integrating multiple synthetic modules.

      Thank you for this accurate summary and assessment of the strengths and weaknesses of the P3 editing as it stands. Looking ahead, we agree that further optimizations will be important, as will characterizing the performance of P3 editing in additional cellular contexts. The revised Discussion (see below) now makes these points more clearly.

      Reviewer #2 (Public Review):

      Choi et al. describe a new approach for enabling input-specific CRISPR-based genome editing in cultured cells. While CRISPR-Cas9 is a broadly applied system across all of biology, one limitation is the difficulty in inducing genome editing based on cellular events. A prior study, from the same group, developed ENGRAM - which relies on activity-dependent transcription of a prime editing guide RNA, which records a specific cellular event as a given edit in a target DNA "tape". However, this approach is limited to the detection of induced transcription and does not enable the detection of broader molecular events including protein-protein interactions or exposure to small molecules. As an alternative, this study envisioned engineering the reconstitution of a split prime editing guide RNA (pegRNA) in a protein-protein interaction (PPI)-dependent manner. This would enable location- and content-specific genome editing in a controlled setting.

      The authors explored three different design possibilities for engineering a PPI-dependent split pegRNA. First, they tried splitting pegRNA into a functional sgRNA and corresponding prime editing transRNA, incorporating reverse-complementary dimerization sequences on each guide half. This approach, however, resulted in low editing efficiency across 7 different designs with various complementary annealing template lengths (<2% efficiency). They also tried inserting a self-splicing ribozyme within the pegRNA, which produces a functional pegRNA post-transcriptionally. The incorporation of a split-ribozyme, dependent on a PPI, could have been used to reconstitute the split pegRNA in an event-controlled manner. However again, only modest levels of editing were observed with the self-splicing ribozyme design (<2%). Finally, they tried splitting the pegRNA at the repeat:anti-repeat junction that was used to join the original dual-guide system comprised of a crRNA and tracrRNA, into a single-guide RNA. They incorporated the prime editing features into the tracrRNA half, to create petracrRNA. Dimerization was initially induced by different complementary RNA annealing sequences. Using this design, they were able to induce an editing efficiency of ~28% (compared to 37% efficiency using a positive control epegRNA guide).

      Having identified a suitable split pegRNA system, they next sought to induce the reconstitution of the two halves in a PPI-dependent manner. They replaced the complementary RNA annealing sequences with two different RNA aptamers (MS2 and BoxB). MS2 detects the MCP protein, while BoxB detects the LambdaN protein. Close proximity between MCP and LambdaN would thus bring together the two split pegRNA halves, creating a functional pegRNA that would enable prime editing at a specific target site. They demonstrated that they could induce MCP-BoxB proximity by fusing them to different dimerizing protein partners: 1) constitutive epitope-nanobody/antibody pairs such as scFv/GCN4 or NbALFA/ALFA-Tag; 2) split-GFP; or 3) chemically-induced protein pairs such as FKBP/FRB or ABI/PYL. For all of these approaches, they could achieve between ~20-60% normalized editing efficiency (relative to positive control editing levels with epegRNA). Additional mutation of the linkers between the RNA and aptamers could increase editing efficiency but also increase non-specific background editing even in the absence of an induced PPI.

      Additional applications of this overall strategy included incorporating the design with different DNA base editors, with the most promising examples shown with the base editors CBE4max and ABE8. It should be noted that these specific examples used a non-physiological LambdaN-MCP direct fusion protein as the "bait" that induced reconstitution of the two halves of the guideRNA, rather than relying on a true induced PPI. They also demonstrated that the recently reported RADARS strategy could be incorporated into their system. In this example, they used an ADAR-guide-RNA to drive the expression of a LambdaN-PCP fusion protein in the presence of a specific target RNA molecule, IL6. This induced LambdaN-PCP protein could then reconstitute the split peg-RNAs to drive prime editing. To enable this last application, they replaced the MS2 aptamer in their pegRNA with the PP7 aptamer that binds the PCP protein (this was to avoid crosstalk with RADARS, which also uses MS2/MCP interaction). Using this strategy, they observed a normalized editing efficiency of around 12% (but observed non-specific editing of around 8% in the absence of the target RNA).

      Strengths:

      The strengths of this paper include an interesting concept for engineering guide RNAs to enable activity-dependent genome editing in living cells in the future, based on discreet protein-protein interactions (either constitutively, spatially, or chemically induced). Important groundwork is laid down to engineer and improve these guide RNAs in the future (especially the work describing altering the linkers in Supplementary Figure 3 - which provides a path forward).

      Weaknesses:

      In its current state, the editing efficiency appears too low to be applied in physiological settings. Much of the latter work in the paper relies on a LambdaN-MCP direction fusion protein, rather than two interacting protein pairs. Further characterizations in the future, especially varying the transfection amounts/durations/etc of the various components of the system, would be beneficial to improve the system. It will also be important to demonstrate editing at additional sites; to characterize how long the PPI must be active to enable efficient prime editing; and how reversible the reconstitution of the split pegRNA is.

      Thank you for this assessment of the strengths and weaknesses of the P3 editing as it stands. Looking ahead, we agree that further optimizations will be important, including along the lines suggested by the reviewer, as will further characterization of the system with respect to dependencies, reversibility, etc. The revised Discussion (see below) now makes these points more clearly.

      Recommendations for the authors:

      Reviewing Editor comments:

      It would be helpful to better describe the nature of improvements (on-targeting and/or off-targeting) that would be needed to effectively use this approach in vitro and in vivo applications.

      We agree, and have accordingly revised the last paragraph of our discussion to better describe what improvements are needed for in vitro and in vivo applications:

      “In our view, there are four outstanding challenges for P3 editing to be broadly useful: evaluating additional cellular contexts, the method’s efficiency and specificity, understanding the limit of detectable protein-protein interactions, and the development of sensors compatible with multiplex P3 editing within the same cell. First, we have thus far only conducted P3 editing in HEK293T cells, and obviously needs to be tested in additional cell types. Second, both the efficiency and specificity of the P3 editing need to be improved before it can be used as a selective editing tool in model systems. We have explored how modifying the crRNA and petracrRNA pair sequences can tune the efficiency-vs-specificity tradeoff, but alternative avenues to improvement (e.g., better docking of RNA-aptamers such as MS2, BoxB, or PP7 by testing more linker sequences that place crRNA and petracrRNA for duplex formation) may be more fruitful in terms of achieving high efficiency and specificity at once (e.g., >50% editing in the setting of a specific protein-protein interaction, and <1% editing without it). Second, it is not clear whether weak and transient interactions among proteins can be used to trigger P3 editing. Assuming the genome editing complex formation is reversible, improving P3 editing efficiency may be able to capture different strengths of protein-protein interactions, although some interactions may be too transient to promote functional guide RNA formation. Finally, the current P3 editing design uses a pair of RNA aptamers and their corresponding protein binders, limiting the multiplex detection of protein-protein pairs. More orthogonal protein-RNA pairs need to be identified (e.g., using a massively parallel platform (Buenrostro et al., 2014) and/or computational prediction (Baek et al., 2023)) to allow for large numbers of P3 sensors for different protein-protein interactions to be deployed within the same cell. Overcoming these four challenges is necessary for P3 editing to be broadly useful for gating genome editing on physiological levels of specific protein-protein interactions in a multiplex fashion.”

      Reviewer #2 (Recommendations For The Authors):

      It does not appear that all plasmids necessary to reproduce the results of this paper have been deposited to addgene, but only a small subset. The authors might include that these plasmids are available upon request, if not uploaded to a public repository.

      We have added a statement that additional plasmids are available upon request. Our Data Availability Statement reads (with the added sentence underlined):

      “Raw sequencing data have been uploaded to Sequencing Read Archive (SRA) with the associated BioProject ID PRJNA1004865. The following plasmids have been deposited to Addgene: pU6-crRNA-MS2, pU6-BoxB-petracrRNA, pCMV-LambdaN-MCP, pCMV-LambdaN-NbALFA,  and pCMV-ALFA-MCP (Addgene ID 207624 - 207628). The rest of the plasmids used in this study are available upon request.”

      It could be useful to include somewhere why, specifically, editing the guide RNAs as opposed to the Cas9 itself is advantageous. Light-inducible split Cas9s have been engineered, and I imagine other PPI-inducible split Cas9s have also been engineered. A specific mention of the advantages of using engineered split pegRNAs could put the significance of this work in a better context.

      Thanks for raising this, and we agree. We have revised the first paragraph of the Results section to highlight why we think splitting the guide RNAs as opposed to Cas9 might be advantageous:

      “In the split architecture, the “dimerization module” is a key sensor component. Although strategies that split the protein component of the genome editing complex have been described (e.g., split-Cas9 (Yu et al., 2020)), we reasoned that having the guide RNA serve as the dimerization module rather than the protein, i.e. by splitting it into two parts, and making the restoration of its function dependent on a molecular proximity event, would afford even more control. For example, if multiple split gRNAs were present within the same cell, they could be independently controlled, whereas a split Cas9 would only allow a single control point.  In our initial experiments, we focused on splitting the pegRNA used in prime editing.”

    1. Welcome back.

      This is part two of this lesson.

      We're going to continue immediately from the end of part one.

      So let's get started.

      Okay, so the instance is now in an available state.

      Let's just close down this informational dialogue at the top.

      And let's just minimize this menu on the left.

      Let's maximize the amount of screen space that we have for this specific purpose.

      So I just want us to go inside this database instance and explore together the information that we have available.

      So I talked in the theory lesson how every RDS instance is given an endpoint name and an endpoint port.

      So this is the information that we'll use to connect to this RDS instance.

      Networking wise, this instance has been provisioned in US-EAST-1A.

      It's in the Animals for Life VPC and it's used our A4L subnet group that we created at the start of this demo.

      And that means that it's currently utilizing all three database subnets in the Animals for Life VPC.

      But it's chosen because we only deployed one instance to use US-EAST-1A.

      Now this is the VPC security group that we're going to need to configure.

      So right click on this and open it in a new tab and move to that tab.

      This is the security group which controls access to this RDS instance.

      So let's expand this at the bottom.

      So currently it has my IP address being the only source allowed to connect into this RDS instance.

      So the only inbound rule on the security group protecting this RDS instance is allowing my IP address.

      So we're going to click on Edit and then click on Add Rule.

      And we're going to add a rule which allows our other instances to connect to this RDS instance.

      So first in the type drop down click and then type mySQL to get the same option as the line above and then click to select.

      Next go ahead and type instance into the source box and then select the migrate to RDS-instance security group.

      Now this is the security group that's used by any instances deployed by our one click deployment.

      And this allows those instances to connect to our RDS instance and that's what we want.

      So go ahead and select that and then click on Save Rules.

      And this means now that our WordPress instance can communicate with RDS.

      So now let's move back to the RDS tab and then make sure we're inside the A4L WordPress database instance.

      So that's the connectivity and the security tab.

      We also have the monitoring tab and it's here where you can see various CloudWatch provided metrics about the database instance.

      You also have logs and events related to this instance.

      So if we go and have a look at recent events we can see all of the events such as when the database instance was created, when its first backup was created.

      And you can explore those because they might be different in your environment.

      You can click on the Configuration tab and see the current configuration of the RDS instance.

      The Maintenance and Backups tab is where you can configure the maintenance and backup processes and then of course you can tag the RDS instance.

      Now in other lessons in this section of the course and depending on what course you're taking I will be talking about many of these options, what you can modify and which actions you can perform on RDS instances.

      But for now we're just going to move on with this demo.

      So the next step is that we need to migrate our existing data into this RDS instance.

      So what we're going to do is to click on the Connectivity and Security tab and we're going to leave this open.

      We're going to need this endpoint name and port very shortly.

      You should still have a tab open to the EC2 console.

      If you don't you can reach that by going on Services and then opening EC2 in a new tab.

      But I want you to select the A4L-WordPress instance and then right click and connect to it using Instance Connect.

      So go ahead and do that.

      Once you've done that we're going to start referring to the lesson commands document.

      So make sure you've got that open.

      We're going to use this command to take a backup of the existing MariaDB database.

      So we need to replace a placeholder.

      What we need to do is delete this and replace it with the private IP address of the MariaDB EC2 instance.

      So go back to the EC2 console, select the DB-WordPress instance and copy the private IP version 4 address into your clipboard.

      And then let's move back to the WordPress instance and paste that in.

      Go ahead and press Enter and it will prompt you for the password.

      And the password is the same Animals for Life strong password that we've been using everywhere.

      Copy that into your clipboard.

      So this is the password for the A4L WordPress user on the MariaDB EC2 instance.

      So paste that in and press Enter and then LS-LA to confirm that we now have this A4L WordPress.SQL database backup file.

      And we do, so that's good.

      So as we did in the previous demo lesson, we're going to take this backup file and we're going to import it into the new destination database, which is going to be the RDS instance.

      To do that, we'll use this command, but we're going to need to replace the placeholder hostname with the CNAME of the RDS instance.

      So go ahead and delete this placeholder, then go back to the RDS console and I'll want you to copy the endpoint name into your clipboard.

      So select it, right click and then copy.

      We won't need the port number because this is the standard MySQL port and if you don't specify it, most applications will assume this default.

      So just make sure that you have the endpoint DNS name or endpoint CNAME in your clipboard.

      And then back on the WordPress EC2 instance, go ahead and paste this database name into this command and press Enter.

      And again, you'll be asked for the password and that's the same Animals for Life strong password.

      So copy that into your clipboard, paste that in and press Enter.

      And that's imported this A4LWordPress.SQL file into the RDS instance.

      So now we need to follow the same process and change WordPress so that it points at the RDS instance.

      And we do that by moving to where the WordPress configuration file is.

      So cd space forward slash var forward slash ww w forward slash html and press Enter.

      And then shudu.

      So we have admin privileges, nano, which is a text editor and then wp-config.php and press Enter.

      Then we need to scroll down and we're looking for where it says DB host and currently it has a host name here.

      Now if you go back to the EC2 console and you look at the A4L-DB-WordPress instance, you'll see that its private IP version for DNS name is what's listed inside this configuration item.

      So it's currently pointing at this dedicated database instance.

      What we need to do is replace that and we're going to replace it with the RDS database DNS name or the CNAME of this RDS instance.

      So copy that into your clipboard and then go ahead and delete this private DNS name for the MariaDB EC2 instance and then paste in the RDS endpoint name, also known as the RDS CNAME.

      Once you've done that, control O and Enter to save and control X to exit.

      And now our WordPress instance is pointing at the RDS instance for its database.

      Now we can verify that by checking WordPress, move back to instances, select the WordPress instance, copy the public IP version for addressing to your clipboard.

      Don't use this open address link.

      Open that in a new tab.

      Go ahead and just click on the best cats ever to verify the functionality and it does look as though it's working.

      And to verify that, if we go back to the EC2 console, select the A4L-DB-WordPress instance and right click and then stop that instance.

      Now the original database that was providing database services to WordPress is going to move into a stopped state.

      And if our WordPress blog continues functioning, we know that it's using the RDS instance.

      So let's keep refreshing and wait for this to change into a stopped state.

      There we go.

      It's stopped.

      And if we go back to our WordPress page and refresh, it still loads.

      And so we know that it's now using RDS for its database services.

      So at this point, that's everything that I wanted you to do in this demo lesson.

      You've stepped through the process of provisioning an RDS instance.

      So you've created a subnet group, provisioned the instance itself, explored the functionality of the instance, including how to provide access to it by selecting a security group.

      And then editing that security group to allow access.

      You've performed a database migration and you've explored how the RDS instance is presented in the console.

      So that's everything that you need to do within this demo lesson.

      And don't worry, we're going to be exploring much more of the advanced functionality of RDS as we move through this section of the course.

      For now, though, I want us to clear up the infrastructure that we've created as part of this demo lesson.

      Now, because we've provisioned RDS manually outside of CloudFormation, unfortunately, there is a little bit more manual work involved in the cleanup.

      So I want you to go to the RDS console, move to databases, select this database, click on actions, and then select delete.

      Now it will prompt you to create a final snapshot and we're not going to do that.

      We're not going to retain automated backups and so you'll need to acknowledge that upon instance deletion, automated backups including any system snapshots and pointing time recoveries will no longer be available.

      And don't worry, I'll be talking about backups and recovery in another lesson in this section of the course.

      For now, just acknowledge that and then type delete me into this box and confirm the deletion.

      Now this deletion is going to take a few minutes.

      It's not an immediate process.

      It will start in a deleting state and we need to wait for this process to be completed before we continue the cleanup.

      So go ahead and pause this video and wait for this instance to fully delete before continuing.

      Now that the instance has been deleted, it vanishes from this list.

      Next, we need to delete the subnet group that we created earlier.

      So click on subnet groups, select the subnet group and then delete it.

      You'll need to confirm that deletion.

      Once done, it too should vanish from that list.

      Next, go to the tab you've got open to the VPC console, scroll down and select security groups.

      Now look through this list and locate the security group that you created as part of provisioning the RDS instance.

      It should be called a4LVPC-RDS-SG.

      Select that, click on actions and then delete security group and you'll need to confirm that process as well.

      Once that's deleted, the final step is to go to the cloud formation console and then you'll need to delete the cloud formation stack that was created using the one-click deployment at the start of the demo.

      It should be called migrate to RDS.

      Select it, click on delete and confirm that deletion.

      And once deleted, the account will be returned into the same state as it was at the start of the demo lesson.

      So all of the infrastructure that we've used will be removed from the account and the account will be in the same state as at the start of the demo.

      Now I hope you've enjoyed this demo and that we're repeating the same WordPress installation and then the creation of the blog post over and over again.

      But I want you to get used to different parts of this process over and over again.

      You need to know why not to use a database on EC2.

      You need to know why not to perform a lot of these processes manually.

      From this point onward in the course, we're going to be using RDS to evolve our WordPress design into something that is truly elastic.

      And so all of these processes, the things I'm having you repeat are really useful to aid in your understanding of all of these different components.

      So from this point onward, we're going to be automating the creation of RDS and focusing on the specific pieces of functionality that you need to understand.

      But at this point, that's everything that you need to do in this demo.

      So go ahead, complete the video and when you're ready, I look forward to you joining me in the next.

    1. Author response:

      eLife Assessment 

      This valuable study investigates how the neural representation of individual finger movements changes during the early period of sequence learning. By combining a new method for extracting features from human magnetoencephalography data and decoding analyses, the authors provide incomplete evidence of an early, swift change in the brain regions correlated with sequence learning, including a set of previously unreported frontal cortical regions. The addition of more control analyses to rule out that head movement artefacts influence the findings, and to further explain the proposal of offline contextualization during short rest periods as the basis for improvement performance would strengthen the manuscript. 

      We appreciate the Editorial assessment on our paper’s strengths and novelty.  We have implemented additional control analyses to show that neither task-related eye movements nor increasing overlap of finger movements during learning account for our findings, which are that contextualized neural representations in a network of bilateral frontoparietal brain regions actively contribute to skill learning.  Importantly, we carried out additional analyses showing that contextualization develops predominantly during rest intervals.

      Public Reviews:

      We thank the Reviewers for their comments and suggestions, prompting new analyses and additions that strengthened our report.

      Reviewer #1 (Public review): 

      Summary: 

      This study addresses the issue of rapid skill learning and whether individual sequence elements (here: finger presses) are differentially represented in human MEG data. The authors use a decoding approach to classify individual finger elements and accomplish an accuracy of around 94%. A relevant finding is that the neural representations of individual finger elements dynamically change over the course of learning. This would be highly relevant for any attempts to develop better brain machine interfaces - one now can decode individual elements within a sequence with high precision, but these representations are not static but develop over the course of learning. 

      Strengths: The work follows a large body of work from the same group on the behavioural and neural foundations of sequence learning. The behavioural task is well established and neatly designed to allow for tracking learning and how individual sequence elements contribute. The inclusion of short offline rest periods between learning epochs has been influential because it has revealed that a lot, if not most of the gains in behaviour (ie speed of finger movements) occur in these so-called micro-offline rest periods. The authors use a range of new decoding techniques, and exhaustively interrogate their data in different ways, using different decoding approaches. Regardless of the approach, impressively high decoding accuracies are observed, but when using a hybrid approach that combines the MEG data in different ways, the authors observe decoding accuracies of individual sequence elements from the MEG data of up to 94%. 

      We have previously showed that neural replay of MEG activity representing the practiced skill correlated with micro-offline gains during rest intervals of early learning, 1 consistent with the recent report that hippocampal ripples during these offline periods predict human motor sequence learning2.  However, decoding accuracy in our earlier work1 needed improvement.  Here, we reported a strategy to improve decoding accuracy that could benefit future studies of neural replay or BCI using MEG.

      Weaknesses: 

      There are a few concerns which the authors may well be able to resolve. These are not weaknesses as such, but factors that would be helpful to address as these concern potential contributions to the results that one would like to rule out. Regarding the decoding results shown in Figure 2 etc, a concern is that within individual frequency bands, the highest accuracy seems to be within frequencies that match the rate of keypresses. This is a general concern when relating movement to brain activity, so is not specific to decoding as done here. As far as reported, there was no specific restraint to the arm or shoulder, and even then it is conceivable that small head movements would correlate highly with the vigor of individual finger movements. This concern is supported by the highest contribution in decoding accuracy being in middle frontal regions - midline structures that would be specifically sensitive to movement artefacts and don't seem to come to mind as key structures for very simple sequential keypress tasks such as this - and the overall pattern is remarkably symmetrical (despite being a unimanual finger task) and spatially broad. This issue may well be matching the time course of learning, as the vigor and speed of finger presses will also influence the degree to which the arm/shoulder and head move. This is not to say that useful information is contained within either of the frequencies or broadband data. But it raises the question of whether a lot is dominated by movement "artefacts" and one may get a more specific answer if removing any such contributions. 

      Reviewer #1 expresses concern that the combination of the low-frequency narrow-band decoder results, and the bilateral middle frontal regions displaying the highest average intra-parcel decoding performance across subjects is suggestive that the decoding results could be driven by head movement or other artefacts.

      Head movement artefacts are highly unlikely to contribute meaningfully to our results for the following reasons. First, in addition to ICA denoising, all “recordings were visually inspected and marked to denoise segments containing other large amplitude artifacts due to movements” (see Methods). Second, the response pad was positioned in a manner that minimized wrist, arm or more proximal body movements during the task. Third, while head position was not monitored online for this study, the head was restrained using an inflatable air bladder, and head position was assessed at the beginning and at the end of each recording. Head movement did not exceed 5mm between the beginning and end of each scan for all participants included in the study. Fourth, we agree that despite the steps taken above, it is possible that minor head movements could still contribute to some remaining variance in the MEG data in our study. The Reviewer states a concern that “it is conceivable that small head movements would correlate highly with the vigor of individual finger movements”. However, in order for any such correlations to meaningfully impact decoding performance, such head movements would need to: (A) be consistent and pervasive throughout the recording (which might not be the case if the head movements were related to movement vigor and vigor changed over time); and (B) systematically vary between different finger movements, and also between the same finger movement performed at different sequence locations (see 5-class decoding performance in Figure 4B). The possibility of any head movement artefacts meeting all these conditions is extremely unlikely.

      Given the task design, a much more likely confound in our estimation would be the contribution of eye movement artefacts to the decoder performance (an issue appropriately raised by Reviewer #3 in the comments below). Remember from Figure 1A in the manuscript that an asterisk marks the current position in the sequence and is updated at each keypress. Since participants make very few performance errors, the position of the asterisk on the display is highly correlated with the keypress being made in the sequence. Thus, it is possible that if participants are attending to the visual feedback provided on the display, they may move their eyes in a way that is systematically related to the task.  Since we did record eye movements simultaneously with the MEG recordings (EyeLink 1000 Plus; Fs = 600 Hz), we were able to perform a control analysis to address this question. For each keypress event during trials in which no errors occurred (which is the same time-point that the asterisk position is updated), we extracted three features related to eye movements: 1) the gaze position at the time of asterisk position update (or keyDown event), 2) the gaze position 150ms later, and 3) the peak velocity of the eye movement between the two positions. We then constructed a classifier from these features with the aim of predicting the location of the asterisk (ordinal positions 1-5) on the display. As shown in the confusion matrix below (Author response image 1), the classifier failed to perform above chance levels (Overall cross-validated accuracy = 0.21817):

      Author response image 1.

      Confusion matrix showing that three eye movement features fail to predict asterisk position on the task display above chance levels (Fold 1 test accuracy = 0.21718; Fold 2 test accuracy = 0.22023; Fold 3 test accuracy = 0.21859; Fold 4 test accuracy = 0.22113; Fold 5 test accuracy = 0.21373; Overall cross-validated accuracy = 0.2181). Since the ordinal position of the asterisk on the display is highly correlated with the ordinal position of individual keypresses in the sequence, this analysis provides strong evidence that keypress decoding performance from MEG features is not explained by systematic relationships between finger movement behavior and eye movements (i.e. – behavioral artefacts).

      In fact, inspection of the eye position data revealed that a majority of participants on most trials displayed random walk gaze patterns around a center fixation point, indicating that participants did not attend to the asterisk position on the display. This is consistent with intrinsic generation of the action sequence, and congruent with the fact that the display does not provide explicit feedback related to performance. A similar real-world example would be manually inputting a long password into a secure online application. In this case, one intrinsically generates the sequence from memory and receives similar feedback about the password sequence position (also provided as asterisks), which is typically ignored by the user. The minimal participant engagement with the visual task display observed in this study highlights another important point – that the behavior in explicit sequence learning motor tasks is highly generative in nature rather than reactive to stimulus cues as in the serial reaction time task (SRTT).  This is a crucial difference that must be carefully considered when designing investigations and comparing findings across studies.

      We observed that initial keypress decoding accuracy was predominantly driven by contralateral primary sensorimotor cortex in the initial practice trials before transitioning to bilateral frontoparietal regions by trials 11 or 12 as performance gains plateaued.  The contribution of contralateral primary sensorimotor areas to early skill learning has been extensively reported in humans and non-human animals. 1,3-5  Similarly, the increased involvement of bilateral frontal and parietal regions to decoding during early skill learning in the non-dominant hand is well known.  Enhanced bilateral activation in both frontal and parietal cortex during skill learning has been extensively reported6-11, and appears to be even more prominent during early fine motor skill learning in the non-dominant hand12,13.  The frontal regions identified in these studies are known to play crucial roles in executive control14, motor planning15, and working memory6,8,16-18 processes, while the same parietal regions are known to integrate multimodal sensory feedback and support visuomotor transformations6,8,16-18, in addition to working memory19. Thus, it is not surprising that these regions increasingly contribute to decoding as subjects internalize the sequential task.  We now include a statement reflecting these considerations in the revised Discussion.

      A somewhat related point is this: when combining voxel and parcel space, a concern is whether a degree of circularity may have contributed to the improved accuracy of the combined data, because it seems to use the same MEG signals twice - the voxels most contributing are also those contributing most to a parcel being identified as relevant, as parcels reflect the average of voxels within a boundary. In this context, I struggled to understand the explanation given, ie that the improved accuracy of the hybrid model may be due to "lower spatially resolved whole-brain and higher spatially resolved regional activity patterns".

      We strongly disagree with the Reviewer’s assertion that the construction of the hybrid-space decoder is circular. To clarify, the base feature set for the hybrid-space decoder constructed for all participants includes whole-brain spatial patterns of MEG source activity averaged within parcels. As stated in the manuscript, these 148 inter-parcel features reflect “lower spatially resolved whole-brain activity patterns” or global brain dynamics. We then independently test how well spatial patterns of MEG source activity for all voxels distributed within individual parcels can decode keypress actions. Again, the testing of these intra-parcel spatial patterns, intended to capture “higher spatially resolved regional brain activity patterns”, is completely independent from one another and independent from the weighting of individual inter-parcel features. These intra-parcel features could, for example, provide additional information about muscle activation patterns or the task environment. These approximately 1150 intra-parcel voxels (on average, within the total number varying between subjects) are then combined with the 148 inter-parcel features to construct the final hybrid-space decoder. In fact, this varied spatial filter approach shares some similarities to the construction of convolutional neural networks (CNNs) used to perform object recognition in image classification applications. One could also view this hybrid-space decoding approach as a spatial analogue to common time-frequency based analyses such as theta-gamma phase amplitude coupling (PAC), which combine information from two or more narrow-band spectral features derived from the same time-series data.

      We directly tested this hypothesis – that spatially overlapping intra- and inter-parcel features portray different information – by constructing an alternative hybrid-space decoder (HybridAlt) that excluded average inter-parcel features which spatially overlapped with intra-parcel voxel features, and comparing the performance to the decoder used in the manuscript (HybridOrig). The prediction was that if the overlapping parcel contained similar information to the more spatially resolved voxel patterns, then removing the parcel features (n=8) from the decoding analysis should not impact performance. In fact, despite making up less than 1% of the overall input feature space, removing those parcels resulted in a significant drop in overall performance greater than 2% (78.15% ± SD 7.03% for HybridOrig vs. 75.49% ± SD 7.17% for HybridAlt; Wilcoxon signed rank test, z = 3.7410, p = 1.8326e-04) (Author response image 2).

      Author response image 2.

      Comparison of decoding performances with two different hybrid approaches. HybridAlt: Intra-parcel voxel-space features of top ranked parcels and inter-parcel features of remaining parcels. HybridOrig:  Voxel-space features of top ranked parcels and whole-brain parcel-space features (i.e. – the version used in the manuscript). Dots represent decoding accuracy for individual subjects. Dashed lines indicate the trend in performance change across participants. Note, that HybridOrig (the approach used in our manuscript) significantly outperforms the HybridAlt approach, indicating that the excluded parcel features provide unique information compared to the spatially overlapping intra-parcel voxel patterns.

      Firstly, there will be a relatively high degree of spatial contiguity among voxels because of the nature of the signal measured, i.e. nearby individual voxels are unlikely to be independent. Secondly, the voxel data gives a somewhat misleading sense of precision; the inversion can be set up to give an estimate for each voxel, but there will not just be dependence among adjacent voxels, but also substantial variation in the sensitivity and confidence with which activity can be projected to different parts of the brain. Midline and deeper structures come to mind, where the inversion will be more problematic than for regions along the dorsal convexity of the brain, and a concern is that in those midline structures, the highest decoding accuracy is seen. 

      We definitely agree with the Reviewer that some inter-parcel features representing neighboring (or spatially contiguous) voxels are likely to be correlated. This has been well documented in the MEG literature20,21 and is a particularly important confound to address in functional or effective connectivity analyses (not performed in the present study). In the present analysis, any correlation between adjacent voxels presents a multi-collinearity problem, which effectively reduces the dimensionality of the input feature space. However, as long as there are multiple groups of correlated voxels within each parcel (i.e. - the effective dimensionality is still greater than 1), the intra-parcel spatial patterns could still meaningfully contribute to the decoder performance. Two specific results support this assertion.

      First, we obtained higher decoding accuracy with voxel-space features [74.51% (± SD 7.34%)] compared to parcel space features [68.77% (± SD 7.6%)] (Figure 3B), indicating individual voxels carry more information in decoding the keypresses than the averaged voxel-space features or parcel-space features.  Second, Individual voxels within a parcel showed varying feature importance scores in decoding keypresses (Author response image 3). This finding supports the Reviewer’s assertion that neighboring voxels express similar information, but also shows that the correlated voxels form mini subclusters that are much smaller spatially than the parcel they reside in.

      Author response image 3.

      Feature importance score of individual voxels in decoding keypresses: MRMR was used to rank the individual voxel space features in decoding keypresses and the min-max normalized MRMR score was mapped to a structural brain surface. Note that individual voxels within a parcel showed different contribution to decoding.

       

      Some of these concerns could be addressed by recording head movement (with enough precision) to regress out these contributions. The authors state that head movement was monitored with 3 fiducials, and their time courses ought to provide a way to deal with this issue. The ICA procedure may not have sufficiently dealt with removing movement-related problems, but one could eg relate individual components that were identified to the keypresses as another means for checking. An alternative could be to focus on frequency ranges above the movement frequencies. The accuracy for those still seems impressive and may provide a slightly more biologically plausible assessment. 

      We have already addressed the issue of movement related artefacts in the first response above. With respect to a focus on frequency ranges above movement frequencies, the Reviewer states the “accuracy for those still seems impressive and may provide a slightly more biologically plausible assessment”. First, it is important to note that cortical delta-band oscillations measured with local field potentials (LFPs) in macaques is known to contain important information related to end-effector kinematics22,23 muscle activation patterns24 and temporal sequencing25 during skilled reaching and grasping actions. Thus, there is a substantial body of evidence that low-frequency neural oscillatory activity in this range contains important information about the skill learning behavior investigated in the present study. Second, our own data shows (which the Reviewer also points out) that significant information related to the skill learning behavior is also present in higher frequency bands (see Figure 2A and Figure 3—figure supplement 1). As we pointed out in our earlier response to questions about the hybrid space decoder architecture (see above), it is likely that different, yet complimentary, information is encoded across different temporal frequencies (just as it is encoded across different spatial frequencies). Again, this interpretation is supported by our data as the highest performing classifiers in all cases (when holding all parameters constant) were always constructed from broadband input MEG data (Figure 2A and Figure 3—figure supplement 1).  

      One question concerns the interpretation of the results shown in Figure 4. They imply that during the course of learning, entirely different brain networks underpin the behaviour. Not only that, but they also include regions that would seem rather unexpected to be key nodes for learning and expressing relatively simple finger sequences, such as here. What then is the biological plausibility of these results? The authors seem to circumnavigate this issue by moving into a distance metric that captures the (neural network) changes over the course of learning, but the discussion seems detached from which regions are actually involved; or they offer a rather broad discussion of the anatomical regions identified here, eg in the context of LFOs, where they merely refer to "frontoparietal regions". 

      The Reviewer notes the shift in brain networks driving keypress decoding performance between trials 1, 11 and 36 as shown in Figure 4A. The Reviewer questions whether these substantial shifts in brain network states underpinning the skill are biologically plausible, as well as the likelihood that bilateral superior and middle frontal and parietal cortex are important nodes within these networks.

      First, previous fMRI work in humans performing a similar sequence learning task showed that flexibility in brain network composition (i.e. – changes in brain region members displaying coordinated activity) is up-regulated in novel learning environments and explains differences in learning rates across individuals26.  This work supports our interpretation of the present study data, that brain networks engaged in sequential motor skills rapidly reconfigure during early learning.

      Second, frontoparietal network activity is known to support motor memory encoding during early learning27,28. For example, reactivation events in the posterior parietal29 and medial prefrontal30,31 cortex (MPFC) have been temporally linked to hippocampal replay, and are posited to support memory consolidation across several memory domains32, including motor sequence learning1,33,34.  Further, synchronized interactions between MPFC and hippocampus are more prominent during early learning as opposed to later stages27,35,36, perhaps reflecting “redistribution of hippocampal memories to MPFC” 27.  MPFC contributes to very early memory formation by learning association between contexts, locations, events and adaptive responses during rapid learning37. Consistently, coupling between hippocampus and MPFC has been shown during, and importantly immediately following (rest) initial memory encoding38,39.  Importantly, MPFC activity during initial memory encoding predicts subsequent recall40. Thus, the spatial map required to encode a motor sequence memory may be “built under the supervision of the prefrontal cortex” 28, also engaged in the development of an abstract representation of the sequence41.  In more abstract terms, the prefrontal, premotor and parietal cortices support novice performance “by deploying attentional and control processes” 42-44 required during early learning42-44. The dorsolateral prefrontal cortex DLPFC specifically is thought to engage in goal selection and sequence monitoring during early skill practice45, all consistent with the schema model of declarative memory in which prefrontal cortices play an important role in encoding46,47.  Thus, several prefrontal and frontoparietal regions contributing to long term learning 48 are also engaged in early stages of encoding. Altogether, there is strong biological support for the involvement of bilateral prefrontal and frontoparietal regions to decoding during early skill learning.  We now address this issue in the revised manuscript.

      If I understand correctly, the offline neural representation analysis is in essence the comparison of the last keypress vs the first keypress of the next sequence. In that sense, the activity during offline rest periods is actually not considered. This makes the nomenclature somewhat confusing. While it matches the behavioural analysis, having only key presses one can't do it in any other way, but here the authors actually do have recordings of brain activity during offline rest. So at the very least calling it offline neural representation is misleading to this reviewer because what is compared is activity during the last and during the next keypress, not activity during offline periods. But it also seems a missed opportunity - the authors argue that most of the relevant learning occurs during offline rest periods, yet there is no attempt to actually test whether activity during this period can be useful for the questions at hand here. 

      We agree with the Reviewer that our previous “offline neural representation” nomenclature could be misinterpreted. In the revised manuscript we refer to this difference as the “offline neural representational change”. Please, note that our previous work did link offline neural activity (i.e. – 16-22 Hz beta power and neural replay density during inter-practice rest periods) to observed micro-offline gains49.

      Reviewer #2 (Public review): 

      Summary 

      Dash et al. asked whether and how the neural representation of individual finger movements is "contextualized" within a trained sequence during the very early period of sequential skill learning by using decoding of MEG signal. Specifically, they assessed whether/how the same finger presses (pressing index finger) embedded in the different ordinal positions of a practiced sequence (4-1-3-2-4; here, the numbers 1 through 4 correspond to the little through the index fingers of the non-dominant left hand) change their representation (MEG feature). They did this by computing either the decoding accuracy of the index finger at the ordinal positions 1 vs. 5 (index_OP1 vs index_OP5) or pattern distance between index_OP1 vs. index_OP5 at each training trial and found that both the decoding accuracy and the pattern distance progressively increase over the course of learning trials. More interestingly, they also computed the pattern distance for index_OP5 for the last execution of a practice trial vs. index_OP1 for the first execution in the next practice trial (i.e., across the rest period). This "off-line" distance was significantly larger than the "on-line" distance, which was computed within practice trials and predicted micro-offline skill gain. Based on these results, the authors conclude that the differentiation of representation for the identical movement embedded in different positions of a sequential skill ("contextualization") primarily occurs during early skill learning, especially during rest, consistent with the recent theory of the "micro-offline learning" proposed by the authors' group. I think this is an important and timely topic for the field of motor learning and beyond. <br /> Strengths 

      The specific strengths of the current work are as follows. First, the use of temporally rich neural information (MEG signal) has a large advantage over previous studies testing sequential representations using fMRI. This allowed the authors to examine the earliest period (= the first few minutes of training) of skill learning with finer temporal resolution. Second, through the optimization of MEG feature extraction, the current study achieved extremely high decoding accuracy (approx. 94%) compared to previous works. As claimed by the authors, this is one of the strengths of the paper (but see my comments). Third, although some potential refinement might be needed, comparing "online" and "offline" pattern distance is a neat idea. 

      Weaknesses 

      Along with the strengths I raised above, the paper has some weaknesses. First, the pursuit of high decoding accuracy, especially the choice of time points and window length (i.e., 200 msec window starting from 0 msec from key press onset), casts a shadow on the interpretation of the main result. Currently, it is unclear whether the decoding results simply reflect behavioral change or true underlying neural change. As shown in the behavioral data, the key press speed reached 3~4 presses per second already at around the end of the early learning period (11th trial), which means inter-press intervals become as short as 250-330 msec. Thus, in almost more than 60% of training period data, the time window for MEG feature extraction (200 msec) spans around 60% of the inter-press intervals. Considering that the preparation/cueing of subsequent presses starts ahead of the actual press (e.g., Kornysheva et al., 2019) and/or potential online planning (e.g., Ariani and Diedrichsen, 2019), the decoder likely has captured these future press information as well as the signal related to the current key press, independent of the formation of genuine sequential representation (e.g., "contextualization" of individual press). This may also explain the gradual increase in decoding accuracy or pattern distance between index_OP1 vs. index_OP5 (Figure 4C and 5A), which co-occurred with performance improvement, as shorter inter-press intervals are more favorable for the dissociating the two index finger presses followed by different finger presses. The compromised decoding accuracies for the control sequences can be explained in similar logic. Therefore, more careful consideration and elaborated discussion seem necessary when trying to both achieve high-performance decoding and assess early skill learning, as it can impact all the subsequent analyses.

      The Reviewer raises the possibility that (given the windowing parameters used in the present study) an increase in “contextualization” with learning could simply reflect faster typing speeds as opposed to an actual change in the underlying neural representation. The issue can essentially be framed as a mixing problem. As correct sequences are generated at higher and higher speeds over training, MEG activity patterns related to the planning, execution, evaluation and memory of individual keypresses overlap more in time. Thus, increased overlap between the “4” and “1” keypresses (at the start of the sequence) and “2” and “4” keypresses (at the end of the sequence) could artefactually increase contextualization distances even if the underlying neural representations for the individual keypresses remain unchanged (assuming this mixing of representations is used by the classifier to differentially tag each index finger press). If this were the case, it follows that such mixing effects reflecting the ordinal sequence structure would also be observable in the distribution of decoder misclassifications. For example, “4” keypresses would be more likely to be misclassified as “1” or “2” keypresses (or vice versa) than as “3” keypresses. The confusion matrices presented in Figures 3C and 4B and Figure 3—figure supplement 3A in the previously submitted manuscript do not show this trend in the distribution of misclassifications across the four fingers.

      Moreover, if the representation distance is largely driven by this mixing effect, it’s also possible that the increased overlap between consecutive index finger keypresses during the 4-4 transition marking the end of one sequence and the beginning of the next one could actually mask contextualization-related changes to the underlying neural representations and make them harder to detect. In this case, a decoder tasked with separating individual index finger keypresses into two distinct classes based upon sequence position might show decreased performance with learning as adjacent keypresses overlapped in time with each other to an increasing extent. However, Figure 4C in our previously submitted manuscript does not support this possibility, as the 2-class hybrid classifier displays improved classification performance over early practice trials despite greater temporal overlap.

      We also conducted a new multivariate regression analysis to directly assess whether the neural representation distance score could be predicted by the 4-1, 2-4 and 4-4 keypress transition times observed for each complete correct sequence (both predictor and response variables were z-score normalized within-subject). The results of this analysis affirmed that the possible alternative explanation put forward by the Reviewer is not supported by our data (Adjusted R2 = 0.00431; F = 5.62). We now include this new negative control analysis result in the revised manuscript.

      Overall, we do strongly agree with the Reviewer that the naturalistic, self-paced, generative task employed in the present study results in overlapping brain processes related to planning, execution, evaluation and memory of the action sequence. We also agree that there are several tradeoffs to consider in the construction of the classifiers depending on the study aim. Given our aim of optimizing keypress decoder accuracy in the present study, the set of trade-offs resulted in representations reflecting more the latter three processes, and less so the planning component. Whether separate decoders can be constructed to tease apart the representations or networks supporting these overlapping processes is an important future direction of research in this area. For example, work presently underway in our lab constrains the selection of windowing parameters in a manner that allows individual classifiers to be temporally linked to specific planning, execution, evaluation or memory-related processes to discern which brain networks are involved and how they adaptively reorganize with learning. Results from the present study (Figure 4—figure supplement 2) showing hybrid-space decoder prediction accuracies exceeding 74% for temporal windows spanning as little as 25ms and located up to 100ms prior to the keyDown event strongly support the feasibility of such an approach.

      Related to the above point, testing only one particular sequence (4-1-3-2-4), aside from the control ones, limits the generalizability of the finding. This also may have contributed to the extremely high decoding accuracy reported in the current study. 

      The Reviewer raises a question about the generalizability of the decoder accuracy reported in our study. Fortunately, a comparison between decoder performances on Day 1 and Day 2 datasets does provide some insight into this issue. As the Reviewer points out, the classifiers in this study were trained and tested on keypresses performed while practicing a specific sequence (4-1-3-2-4). The study was designed this way as to avoid the impact of interference effects on learning dynamics. The cross-validated performance of classifiers on MEG data collected within the same session was 90.47% overall accuracy (4-class; Figure 3C). We then tested classifier performance on data collected during a separate MEG session conducted approximately 24 hours later (Day 2; see Figure 3—supplement 3). We observed a reduction in overall accuracy rate to 87.11% when tested on MEG data recorded while participants performed the same learned sequence, and 79.44% when they performed several previously unpracticed sequences. Both changes in accuracy are important with regards to the generalizability of our findings. First, 87.11% performance accuracy for the trained sequence data on Day 2 (a reduction of only 3.36%) indicates that the hybrid-space decoder performance is robust over multiple MEG sessions, and thus, robust to variations in SNR across the MEG sensor array caused by small differences in head position between scans.  This indicates a substantial advantage over sensor-space decoding approaches. Furthermore, when tested on data from unpracticed sequences, overall performance dropped an additional 7.67%. This difference reflects the performance bias of the classifier for the trained sequence, possibly caused by high-order sequence structure being incorporated into the feature weights. In the future, it will be important to understand in more detail how random or repeated keypress sequence training data impacts overall decoder performance and generalization. We strongly agree with the Reviewer that the issue of generalizability is extremely important and have added a new paragraph to the Discussion in the revised manuscript highlighting the strengths and weaknesses of our study with respect to this issue.

      In terms of clinical BCI, one of the potential relevance of the study, as claimed by the authors, it is not clear that the specific time window chosen in the current study (up to 200 msec since key press onset) is really useful. In most cases, clinical BCI would target neural signals with no overt movement execution due to patients' inability to move (e.g., Hochberg et al., 2012). Given the time window, the surprisingly high performance of the current decoder may result from sensory feedback and/or planning of subsequent movement, which may not always be available in the clinical BCI context. Of course, the decoding accuracy is still much higher than chance even when using signal before the key press (as shown in Figure 4 Supplement 2), but it is not immediately clear to me that the authors relate their high decoding accuracy based on post-movement signal to clinical BCI settings.

      The Reviewer questions the relevance of the specific window parameters used in the present study for clinical BCI applications, particularly for paretic patients who are unable to produce finger movements or for whom afferent sensory feedback is no longer intact. We strongly agree with the Reviewer that any intended clinical application must carefully consider these specific input feature constraints dictated by the clinical cohort, and in turn impose appropriate and complimentary constraints on classifier parameters that may differ from the ones used in the present study.  We now highlight this issue in the Discussion of the revised manuscript and relate our present findings to published clinical BCI work within this context.

      One of the important and fascinating claims of the current study is that the "contextualization" of individual finger movements in a trained sequence specifically occurs during short rest periods in very early skill learning, echoing the recent theory of micro-offline learning proposed by the authors' group. Here, I think two points need to be clarified. First, the concept of "contextualization" is kept somewhat blurry throughout the text. It is only at the later part of the Discussion (around line #330 on page 13) that some potential mechanism for the "contextualization" is provided as "what-and-where" binding. Still, it is unclear what "contextualization" actually is in the current data, as the MEG signal analyzed is extracted from 0-200 msec after the keypress. If one thinks something is contextualizing an action, that contextualization should come earlier than the action itself. 

      The Reviewer requests that we: 1) more clearly define our use of the term “contextualization” and 2) provide the rationale for assessing it over a 200ms window aligned to the keyDown event. This choice of window parameters means that the MEG activity used in our analysis was coincident with, rather than preceding, the actual keypresses.  We define contextualization as the differentiation of representation for the identical movement embedded in different positions of a sequential skill. That is, representations of individual action elements progressively incorporate information about their relationship to the overall sequence structure as the skill is learned. We agree with the Reviewer that this can be appropriately interpreted as “what-and-where” binding. We now incorporate this definition in the Introduction of the revised manuscript as requested.

      The window parameters for optimizing accurate decoding individual finger movements were determined using a grid search of the parameter space (a sliding window of variable width between 25-350 ms with 25 ms increments variably aligned from 0 to +100ms with 10ms increments relative to the keyDown event). This approach generated 140 different temporal windows for each keypress for each participant, with the final parameter selection determined through comparison of the resulting performance between each decoder.  Importantly, the decision to optimize for decoding accuracy placed an emphasis on keypress representations characterized by the most consistent and robust features shared across subjects, which in turn maximize statistical power in detecting common learning-related changes. In this case, the optimal window encompassed a 200ms epoch aligned to the keyDown event (t0 = 0 ms).  We then asked if the representations (i.e. – spatial patterns of combined parcel- and voxel-space activity) of the same digit at two different sequence positions changed with practice within this optimal decoding window.  Of course, our findings do not rule out the possibility that contextualization can also be found before or even after this time window, as we did not directly address this issue in the present study.  Ongoing work in our lab, as pointed out above, is investigating contextualization within different time windows tailored specifically for assessing sequence skill action planning, execution, evaluation and memory processes.

      The second point is that the result provided by the authors is not yet convincing enough to support the claim that "contextualization" occurs during rest. In the original analysis, the authors presented the statistical significance regarding the correlation between the "offline" pattern differentiation and micro-offline skill gain (Figure 5. Supplement 1), as well as the larger "offline" distance than "online" distance (Figure 5B). However, this analysis looks like regressing two variables (monotonically) increasing as a function of the trial. Although some information in this analysis, such as what the independent/dependent variables were or how individual subjects were treated, was missing in the Methods, getting a statistically significant slope seems unsurprising in such a situation. Also, curiously, the same quantitative evidence was not provided for its "online" counterpart, and the authors only briefly mentioned in the text that there was no significant correlation between them. It may be true looking at the data in Figure 5A as the online representation distance looks less monotonically changing, but the classification accuracy presented in Figure 4C, which should reflect similar representational distance, shows a more monotonic increase up to the 11th trial. Further, the ways the "online" and "offline" representation distance was estimated seem to make them not directly comparable. While the "online" distance was computed using all the correct press data within each 10 sec of execution, the "offline" distance is basically computed by only two presses (i.e., the last index_OP5 vs. the first index_OP1 separated by 10 sec of rest). Theoretically, the distance between the neural activity patterns for temporally closer events tends to be closer than that between the patterns for temporally far-apart events. It would be fairer to use the distance between the first index_OP1 vs. the last index_OP5 within an execution period for "online" distance, as well. 

      The Reviewer suggests that the current data is not convincing enough to show that contextualization occurs during rest and raises two important concerns: 1) the relationship between online contextualization and micro-online gains is not shown, and 2) the online distance was calculated differently from its offline counterpart (i.e. - instead of calculating the distance between last IndexOP5 and first IndexOP1 from a single trial, the distance was calculated for each sequence within a trial and then averaged).

      We addressed the first concern by performing individual subject correlations between 1) contextualization changes during rest intervals and micro-offline gains; 2) contextualization changes during practice trials and micro-online gains, and 3) contextualization changes during practice trials and micro-offline gains (Author response image 4). We then statistically compared the resulting correlation coefficient distributions and found that within-subject correlations for contextualization changes during rest intervals and micro-offline gains were significantly higher than online contextualization and micro-online gains (t = 3.2827, p = 0.0015) and online contextualization and micro-offline gains (t = 3.7021, p = 5.3013e-04). These results are consistent with our interpretation that micro-offline gains are supported by contextualization changes during the inter-practice rest period.

      Author response image 4.

      Distribution of individual subject correlation coefficients between contextualization changes occurring during practice or rest with  micro-online and micro-offline performance gains. Note that, the correlation distributions were significantly higher for the relationship between contextualization changes during rest and micro-offline gains than for contextualization changes during practice and either micro-online or offline gain.

      With respect to the second concern highlighted above, we agree with the Reviewer that one limitation of the analysis comparing online versus offline changes in contextualization as presented in the reviewed manuscript, is that it does not eliminate the possibility that any differences could simply be explained by the passage of time (which is smaller for the online analysis compared to the offline analysis). The Reviewer suggests an approach that addresses this issue, which we have now carried out.   When quantifying online changes in contextualization from the first IndexOP1 the last IndexOP5 keypress in the same trial we observed no learning-related trend (Author response image 5, right panel). Importantly, offline distances were significantly larger than online distances regardless of the measurement approach and neither predicted online learning (Author response image 6).

      Author response image 5.

      Trial by trial trend of offline (left panel) and online (middle and right panels) changes in contextualization. Offline changes in contextualization were assessed by calculating the distance between neural representations for the last IndexOP5 keypress in the previous trial and the first IndexOP1 keypress in the present trial. Two different approaches were used to characterize online contextualization changes. The analysis included in the reviewed manuscript (middle panel) calculated the distance between IndexOP1 and IndexOP5 for each correct sequence, which was then averaged across the trial. This approach is limited by the lack of control for the passage of time when making online versus offline comparisons. Thus, the second approach controlled for the passage of time by calculating distance between the representations associated with the first IndexOP1 keypress and the last IndexOP5 keypress within the same trial. Note that while the first approach showed an increase online contextualization trend with practice, the second approach did not.

      Author response image 6.

      Relationship between online contextualization and online learning is shown for both within-sequence (left; note that this is the online contextualization measure used in the reviewd manuscript) and across-sequence (right) distance calculation. There was no significant relationship between online learning and online contextualization regardless of the measurement approach.

      A related concern regarding the control analysis, where individual values for max speed and the degree of online contextualization were compared (Figure 5 Supplement 3), is whether the individual difference is meaningful. If I understood correctly, the optimization of the decoding process (temporal window, feature inclusion/reduction, decoder, etc.) was performed for individual participants, and the same feature extraction was also employed for the analysis of representation distance (i.e., contextualization). If this is the case, the distances are individually differently calculated and they may need to be normalized relative to some stable reference (e.g., 1 vs. 4 or average distance within the control sequence presses) before comparison across the individuals. 

      The Reviewer makes a good point here. We have now implemented the suggested normalization procedure in the analysis provided in the revised manuscript.

      Reviewer #3 (Public review): 

      Summary: 

      One goal of this paper is to introduce a new approach for highly accurate decoding of finger movements from human magnetoencephalography data via dimension reduction of a "multi-scale, hybrid" feature space. Following this decoding approach, the authors aim to show that early skill learning involves "contextualization" of the neural coding of individual movements, relative to their position in a sequence of consecutive movements. Furthermore, they aim to show that this "contextualization" develops primarily during short rest periods interspersed with skill training and correlates with a performance metric which the authors interpret as an indicator of offline learning. <br /> Strengths: 

      A clear strength of the paper is the innovative decoding approach, which achieves impressive decoding accuracies via dimension reduction of a "multi-scale, hybrid space". This hybrid-space approach follows the neurobiologically plausible idea of the concurrent distribution of neural coding across local circuits as well as large-scale networks. A further strength of the study is the large number of tested dimension reduction techniques and classifiers (though the manuscript reveals little about the comparison of the latter). 

      We appreciate the Reviewer’s comments regarding the paper’s strengths.

      A simple control analysis based on shuffled class labels could lend further support to this complex decoding approach. As a control analysis that completely rules out any source of overfitting, the authors could test the decoder after shuffling class labels. Following such shuffling, decoding accuracies should drop to chance level for all decoding approaches, including the optimized decoder. This would also provide an estimate of actual chance-level performance (which is informative over and beyond the theoretical chance level). Furthermore, currently, the manuscript does not explain the huge drop in decoding accuracies for the voxel-space decoding (Figure 3B). Finally, the authors' approach to cortical parcellation raises questions regarding the information carried by varying dipole orientations within a parcel (which currently seems to be ignored?) and the implementation of the mean-flipping method (given that there are two dimensions - space and time - what do the authors refer to when they talk about the sign of the "average source", line 477?). 

      The Reviewer recommends that we: 1) conduct an additional control analysis on classifier performance using shuffled class labels, 2) provide a more detailed explanation regarding the drop in decoding accuracies for the voxel-space decoding following LDA dimensionality reduction (see Fig 3B), and 3) provide additional details on how problems related to dipole solution orientations were addressed in the present study.  

      In relation to the first point, we have now implemented a random shuffling approach as a control for the classification analyses. The results of this analysis indicated that the chance level accuracy was 22.12% (± SD 9.1%) for individual keypress decoding (4-class classification), and 18.41% (± SD 7.4%) for individual sequence item decoding (5-class classification), irrespective of the input feature set or the type of decoder used. Thus, the decoding accuracy observed with the final model was substantially higher than these chance levels.  

      Second, please note that the dimensionality of the voxel-space feature set is very high (i.e. – 15684). LDA attempts to map the input features onto a much smaller dimensional space (number of classes-1; e.g. –  3 dimensions, for 4-class keypress decoding). Given the very high dimension of the voxel-space input features in this case, the resulting mapping exhibits reduced accuracy. Despite this general consideration, please refer to Figure 3—figure supplement 3, where we observe improvement in voxel-space decoder performance when utilizing alternative dimensionality reduction techniques.

      The decoders constructed in the present study assess the average spatial patterns across time (as defined by the windowing procedure) in the input feature space.  We now provide additional details in the Methods of the revised manuscript pertaining to the parcellation procedure and how the sign ambiguity problem was addressed in our analysis.

      Weaknesses: 

      A clear weakness of the paper lies in the authors' conclusions regarding "contextualization". Several potential confounds, described below, question the neurobiological implications proposed by the authors and provide a simpler explanation of the results. Furthermore, the paper follows the assumption that short breaks result in offline skill learning, while recent evidence, described below, casts doubt on this assumption. 

      We thank the Reviewer for giving us the opportunity to address these issues in detail (see below).

      The authors interpret the ordinal position information captured by their decoding approach as a reflection of neural coding dedicated to the local context of a movement (Figure 4). One way to dissociate ordinal position information from information about the moving effectors is to train a classifier on one sequence and test the classifier on other sequences that require the same movements, but in different positions50. In the present study, however, participants trained to repeat a single sequence (4-1-3-2-4). As a result, ordinal position information is potentially confounded by the fixed finger transitions around each of the two critical positions (first and fifth press). Across consecutive correct sequences, the first keypress in a given sequence was always preceded by a movement of the index finger (=last movement of the preceding sequence), and followed by a little finger movement. The last keypress, on the other hand, was always preceded by a ring finger movement, and followed by an index finger movement (=first movement of the next sequence). Figure 4 - Supplement 2 shows that finger identity can be decoded with high accuracy (>70%) across a large time window around the time of the key press, up to at least +/-100 ms (and likely beyond, given that decoding accuracy is still high at the boundaries of the window depicted in that figure). This time window approaches the keypress transition times in this study. Given that distinct finger transitions characterized the first and fifth keypress, the classifier could thus rely on persistent (or "lingering") information from the preceding finger movement, and/or "preparatory" information about the subsequent finger movement, in order to dissociate the first and fifth keypress. Currently, the manuscript provides no evidence that the context information captured by the decoding approach is more than a by-product of temporally extended, and therefore overlapping, but independent neural representations of consecutive keypresses that are executed in close temporal proximity - rather than a neural representation dedicated to context. 

      Such temporal overlap of consecutive, independent finger representations may also account for the dynamics of "ordinal coding"/"contextualization", i.e., the increase in 2-class decoding accuracy, across Day 1 (Figure 4C). As learning progresses, both tapping speed and the consistency of keypress transition times increase (Figure 1), i.e., consecutive keypresses are closer in time, and more consistently so. As a result, information related to a given keypress is increasingly overlapping in time with information related to the preceding and subsequent keypresses. The authors seem to argue that their regression analysis in Figure 5 - Figure Supplement 3 speaks against any influence of tapping speed on "ordinal coding" (even though that argument is not made explicitly in the manuscript). However, Figure 5 - Figure Supplement 3 shows inter-individual differences in a between-subject analysis (across trials, as in panel A, or separately for each trial, as in panel B), and, therefore, says little about the within-subject dynamics of "ordinal coding" across the experiment. A regression of trial-by-trial "ordinal coding" on trial-by-trial tapping speed (either within-subject or at a group-level, after averaging across subjects) could address this issue. Given the highly similar dynamics of "ordinal coding" on the one hand (Figure 4C), and tapping speed on the other hand (Figure 1B), I would expect a strong relationship between the two in the suggested within-subject (or group-level) regression. Furthermore, learning should increase the number of (consecutively) correct sequences, and, thus, the consistency of finger transitions. Therefore, the increase in 2-class decoding accuracy may simply reflect an increasing overlap in time of increasingly consistent information from consecutive keypresses, which allows the classifier to dissociate the first and fifth keypress more reliably as learning progresses, simply based on the characteristic finger transitions associated with each. In other words, given that the physical context of a given keypress changes as learning progresses - keypresses move closer together in time and are more consistently correct - it seems problematic to conclude that the mental representation of that context changes. To draw that conclusion, the physical context should remain stable (or any changes to the physical context should be controlled for). 

      The issues raised by Reviewer #3 here are similar to two issues raised by Reviewer #2 above and agree they must both be carefully considered in any evaluation of our findings.

      As both Reviewers pointed out, the classifiers in this study were trained and tested on keypresses performed while practicing a specific sequence (4-1-3-2-4). The study was designed this way as to avoid the impact of interference effects on learning dynamics. The cross-validated performance of classifiers on MEG data collected within the same session was 90.47% overall accuracy (4-class; Figure 3C). We then tested classifier performance on data collected during a separate MEG session conducted approximately 24 hours later (Day 2; see Figure 3—supplement 3). We observed a reduction in overall accuracy rate to 87.11% when tested on MEG data recorded while participants performed the same learned sequence, and 79.44% when they performed several previously unpracticed sequences. This classification performance difference of 7.67% when tested on the Day 2 data could reflect the performance bias of the classifier for the trained sequence, possibly caused by mixed information from temporally close keypresses being incorporated into the feature weights.

      Along these same lines, both Reviewers also raise the possibility that an increase in “ordinal coding/contextualization” with learning could simply reflect an increase in this mixing effect caused by faster typing speeds as opposed to an actual change in the underlying neural representation. The basic idea is that as correct sequences are generated at higher and higher speeds over training, MEG activity patterns related to the planning, execution, evaluation and memory of individual keypresses overlap more in time. Thus, increased overlap between the “4” and “1” keypresses (at the start of the sequence) and “2” and “4” keypresses (at the end of the sequence) could artefactually increase contextualization distances even if the underlying neural representations for the individual keypresses remain unchanged (assuming this mixing of representations is used by the classifier to differentially tag each index finger press). If this were the case, it follows that such mixing effects reflecting the ordinal sequence structure would also be observable in the distribution of decoder misclassifications. For example, “4” keypresses would be more likely to be misclassified as “1” or “2” keypresses (or vice versa) than as “3” keypresses. The confusion matrices presented in Figures 3C and 4B and Figure 3—figure supplement 3A in the previously submitted manuscript do not show this trend in the distribution of misclassifications across the four fingers.

      Following this logic, it’s also possible that if the ordinal coding is largely driven by this mixing effect, the increased overlap between consecutive index finger keypresses during the 4-4 transition marking the end of one sequence and the beginning of the next one could actually mask contextualization-related changes to the underlying neural representations and make them harder to detect. In this case, a decoder tasked with separating individual index finger keypresses into two distinct classes based upon sequence position might show decreased performance with learning as adjacent keypresses overlapped in time with each other to an increasing extent. However, Figure 4C in our previously submitted manuscript does not support this possibility, as the 2-class hybrid classifier displays improved classification performance over early practice trials despite greater temporal overlap.

      As noted in the above replay to Reviewer #2, we also conducted a new multivariate regression analysis to directly assess whether the neural representation distance score could be predicted by the 4-1, 2-4 and 4-4 keypress transition times observed for each complete correct sequence (both predictor and response variables were z-score normalized within-subject). The results of this analysis affirmed that the possible alternative explanation put forward by the Reviewer is not supported by our data (Adjusted R2 = 0.00431; F = 5.62). We now include this new negative control analysis result in the revised manuscript.

      Finally, the Reviewer hints that one way to address this issue would be to compare MEG responses before and after learning for sequences typed at a fixed speed. However, given that the speed-accuracy trade-off should improve with learning, a comparison between unlearned and learned skill states would dictate that the skill be evaluated at a very low fixed speed. Essentially, such a design presents the problem that the post-training test is evaluating the representation in the unlearned behavioral state that is not representative of the acquired skill. Thus, this approach would not address our experimental question: “do neural representations of the same action performed at different locations within a skill sequence contextually differentiate or remain stable as learning evolves”.

      A similar difference in physical context may explain why neural representation distances ("differentiation") differ between rest and practice (Figure 5). The authors define "offline differentiation" by comparing the hybrid space features of the last index finger movement of a trial (ordinal position 5) and the first index finger movement of the next trial (ordinal position 1). However, the latter is not only the first movement in the sequence but also the very first movement in that trial (at least in trials that started with a correct sequence), i.e., not preceded by any recent movement. In contrast, the last index finger of the last correct sequence in the preceding trial includes the characteristic finger transition from the fourth to the fifth movement. Thus, there is more overlapping information arising from the consistent, neighbouring keypresses for the last index finger movement, compared to the first index finger movement of the next trial. A strong difference (larger neural representation distance) between these two movements is, therefore, not surprising, given the task design, and this difference is also expected to increase with learning, given the increase in tapping speed, and the consequent stronger overlap in representations for consecutive keypresses. Furthermore, initiating a new sequence involves pre-planning, while ongoing practice relies on online planning (Ariani et al., eNeuro 2021), i.e., two mental operations that are dissociable at the level of neural representation (Ariani et al., bioRxiv 2023). 

      The Reviewer argues that the comparison of last finger movement of a trial and the first in the next trial are performed in different circumstances and contexts. This is an important point and one we tend to agree with. For this task, the first sequence in a practice trial (which is pre-planned offline) is performed in a somewhat different context from the sequence iterations that follow, which involve temporally overlapping planning, execution and evaluation processes.  The Reviewer is particularly concerned about a difference in the temporal mixing effect issue raised above between the first and last keypresses performed in a trial. However, in contrast to the Reviewers stated argument above, findings from Korneysheva et. al (2019) showed that neural representations of individual actions are competitively queued during the pre-planning period in a manner that reflects the ordinal structure of the learned sequence.  Thus, mixing effects are likely still present for the first keypress in a trial. Also note that we now present new control analyses in multiple responses above confirming that hypothetical mixing effects between adjacent keypresses do not explain our reported contextualization finding. A statement addressing these possibilities raised by the Reviewer has been added to the Discussion in the revised manuscript.

      In relation to pre-planning, ongoing MEG work in our lab is investigating contextualization within different time windows tailored specifically for assessing how sequence skill action planning evolves with learning.

      Given these differences in the physical context and associated mental processes, it is not surprising that "offline differentiation", as defined here, is more pronounced than "online differentiation". For the latter, the authors compared movements that were better matched regarding the presence of consistent preceding and subsequent keypresses (online differentiation was defined as the mean difference between all first vs. last index finger movements during practice).  It is unclear why the authors did not follow a similar definition for "online differentiation" as for "micro-online gains" (and, indeed, a definition that is more consistent with their definition of "offline differentiation"), i.e., the difference between the first index finger movement of the first correct sequence during practice, and the last index finger of the last correct sequence. While these two movements are, again, not matched for the presence of neighbouring keypresses (see the argument above), this mismatch would at least be the same across "offline differentiation" and "online differentiation", so they would be more comparable. 

      This is the same point made earlier by Reviewer #2, and we agree with this assessment. As stated in the response to Reviewer #2 above, we have now carried out quantification of online contextualization using this approach and included it in the revised manuscript. We thank the Reviewer for this suggestion.

      A further complication in interpreting the results regarding "contextualization" stems from the visual feedback that participants received during the task. Each keypress generated an asterisk shown above the string on the screen, irrespective of whether the keypress was correct or incorrect. As a result, incorrect (e.g., additional, or missing) keypresses could shift the phase of the visual feedback string (of asterisks) relative to the ordinal position of the current movement in the sequence (e.g., the fifth movement in the sequence could coincide with the presentation of any asterisk in the string, from the first to the fifth). Given that more incorrect keypresses are expected at the start of the experiment, compared to later stages, the consistency in visual feedback position, relative to the ordinal position of the movement in the sequence, increased across the experiment. A better differentiation between the first and the fifth movement with learning could, therefore, simply reflect better decoding of the more consistent visual feedback, based either on the feedback-induced brain response, or feedback-induced eye movements (the study did not include eye tracking). It is not clear why the authors introduced this complicated visual feedback in their task, besides consistency with their previous studies.

      We strongly agree with the Reviewer that eye movements related to task engagement are important to rule out as a potential driver of the decoding accuracy or contextualization effect. We address this issue above in response to a question raised by Reviewer #1 about the impact of movement related artefacts in general on our findings.

      First, the assumption the Reviewer makes here about the distribution of errors in this task is incorrect. On average across subjects, 2.32% ± 1.48% (mean ± SD) of all keypresses performed were errors, which were evenly distributed across the four possible keypress responses. While errors increased progressively over practice trials, they did so in proportion to the increase in correct keypresses, so that the overall ratio of correct-to-incorrect keypresses remained stable over the training session. Thus, the Reviewer’s assumptions that there is a higher relative frequency of errors in early trials, and a resulting systematic trend phase shift differences between the visual display updates (i.e. – a change in asterisk position above the displayed sequence) and the keypress performed is not substantiated by the data. To the contrary, the asterisk position on the display and the keypress being executed remained highly correlated over the entire training session. We now include a statement about the frequency and distribution of errors in the revised manuscript.

      Given this high correlation, we firmly agree with the Reviewer that the issue of eye movement-related artefacts is still an important one to address. Fortunately, we did collect eye movement data during the MEG recordings so were able to investigate this. As detailed in the response to Reviewer #1 above, we found that gaze positions and eye-movement velocity time-locked to visual display updates (i.e. – a change in asterisk position above the displayed sequence) did not reflect the asterisk location above chance levels (Overall cross-validated accuracy = 0.21817; see Author response image 1). Furthermore, an inspection of the eye position data revealed that a majority of participants on most trials displayed random walk gaze patterns around a center fixation point, indicating that participants did not attend to the asterisk position on the display. This is consistent with intrinsic generation of the action sequence, and congruent with the fact that the display does not provide explicit feedback related to performance. As pointed out above, a similar real-world example would be manually inputting a long password into a secure online application. In this case, one intrinsically generates the sequence from memory and receives similar feedback about the password sequence position (also provided as asterisks), which is typically ignored by the user. Notably, the minimal participant engagement with the visual task display observed in this study highlights an important difference between behavior observed during explicit sequence learning motor tasks (which is highly generative in nature) with reactive responses to stimulus cues in a serial reaction time task (SRTT).  This is a crucial difference that must be carefully considered when comparing findings across studies. All elements pertaining to this new control analysis are now included in the revised manuscript.

      The authors report a significant correlation between "offline differentiation" and cumulative micro-offline gains. However, it would be more informative to correlate trial-by-trial changes in each of the two variables. This would address the question of whether there is a trial-by-trial relation between the degree of "contextualization" and the amount of micro-offline gains - are performance changes (micro-offline gains) less pronounced across rest periods for which the change in "contextualization" is relatively low? Furthermore, is the relationship between micro-offline gains and "offline differentiation" significantly stronger than the relationship between micro-offline gains and "online differentiation"? 

      In response to a similar issue raised above by Reviewer #2, we now include new analyses comparing correlation magnitudes between (1) “online differention” vs micro-online gains, (2) “online differention” vs micro-offline gains and (3) “offline differentiation” and micro-offline gains (see Author response images 4, 5 and 6 above). These new analyses and results have been added to the revised manuscript. Once again, we thank both Reviewers for this suggestion.

      The authors follow the assumption that micro-offline gains reflect offline learning.

      This statement is incorrect. The original Bonstrup et al (2019) 49 paper clearly states that micro-offline gains must be carefully interpreted based upon the behavioral context within which they are observed, and lays out the conditions under which one can have confidence that micro-offline gains reflect offline learning.  In fact, the excellent meta-analysis of Pan & Rickard (2015) 51, which re-interprets the benefits of sleep in overnight skill consolidation from a “reactive inhibition” perspective, was a crucial resource in the experimental design of our initial study49, as well as in all our subsequent work. Pan & Rickard stated:

      “Empirically, reactive inhibition refers to performance worsening that can accumulate during a period of continuous training (Hull, 1943). It tends to dissipate, at least in part, when brief breaks are inserted between blocks of training. If there are multiple performance-break cycles over a training session, as in the motor sequence literature, performance can exhibit a scalloped effect, worsening during each uninterrupted performance block but improving across blocks52,53. Rickard, Cai, Rieth, Jones, and Ard (2008) and Brawn, Fenn, Nusbaum, and Margoliash (2010) 52,53 demonstrated highly robust scalloped reactive inhibition effects using the commonly employed 30 s–30 s performance break cycle, as shown for Rickard et al.’s (2008) massed practice sleep group in Figure 2. The scalloped effect is evident for that group after the first few 30 s blocks of each session. The absence of the scalloped effect during the first few blocks of training in the massed group suggests that rapid learning during that period masks any reactive inhibition effect.”

      Crucially, Pan & Rickard51 made several concrete recommendations for reducing the impact of the reactive inhibition confound on offline learning studies. One of these recommendations was to reduce practice times to 10s (most prior sequence learning studies up until that point had employed 30s long practice trials). They stated:

      “The traditional design involving 30 s-30 s performance break cycles should be abandoned given the evidence that it results in a reactive inhibition confound, and alternative designs with reduced performance duration per block used instead 51. One promising possibility is to switch to 10 s performance durations for each performance-break cycle Instead 51. That design appears sufficient to eliminate at least the majority of the reactive inhibition effect 52,53.”

      We mindfully incorporated recommendations from Pan and Rickard51  into our own study designs including 1) utilizing 10s practice trials and 2) constraining our analysis of micro-offline gains to early learning trials (where performance monotonically increases and 95% of overall performance gains occur), which are prior to the emergence of the “scalloped” performance dynamics that are strongly linked to reactive inhibition effects. 

      However, there is no direct evidence in the literature that micro-offline gains really result from offline learning, i.e., an improvement in skill level.

      We strongly disagree with the Reviewer’s assertion that “there is no direct evidence in the literature that micro-offline gains really result from offline learning, i.e., an improvement in skill level.”  The initial Bönstrup et al. (2019) 49 report was followed up by a large online crowd-sourcing study (Bönstrup et al., 2020) 54. This second (and much larger) study provided several additional important findings supporting our interpretation of micro-offline gains in cases where the important behavioral conditions clarified above were met (see Author response image 7 below for further details on these conditions).

      Author response image 7.

      Micro-offline gains observed in learning and non-learning contexts are attributed to different underlying causes. (A) Micro-offline and online changes relative to overall trial-by-trial learning. This figure is based on data from Bönstrup et al. (2019) 49. During early learning, micro-offline gains (red bars) closely track trial-by-trial performance gains (green line with open circle markers), with minimal contribution from micro-online gains (blue bars). The stated conclusion in Bönstrup et al. (2019) is that micro-offline gains only during this Early Learning stage reflect rapid memory consolidation (see also 54). After early learning, about practice trial 11, skill plateaus. This plateau skill period is characterized by a striking emergence of coupled (and relatively stable) micro-online drops and micro-offline increases. Bönstrup et al. (2019) as well as others in the literature 55-57, argue that micro-offline gains during the plateau period likely reflect recovery from inhibitory performance factors such as reactive inhibition or fatigue, and thus must be excluded from analyses relating micro-offline gains to skill learning.  The Non-repeating groups in Experiments 3 and 4 from Das et al. (2024) suffer from a lack of consideration of these known confounds.

      Evidence documented in that paper54 showed that micro-offline gains during early skill learning were: 1) replicable and generalized to subjects learning the task in their daily living environment (n=389); 2) equivalent when significantly shortening practice period duration, thus confirming that they are not a result of recovery from performance fatigue (n=118);  3) reduced (along with learning rates) by retroactive interference applied immediately after each practice period relative to interference applied after passage of time (n=373), indicating stabilization of the motor memory at a microscale of several seconds consistent with rapid consolidation; and 4) not modified by random termination of the practice periods, ruling out a contribution of predictive motor slowing (N = 71) 54.  Altogether, our findings were strongly consistent with the interpretation that micro-offline gains reflect memory consolidation supporting early skill learning. This is precisely the portion of the learning curve Pan and Rickard51 refer to when they state “…rapid learning during that period masks any reactive inhibition effect”.

      This interpretation is further supported by brain imaging evidence linking known memory-related networks and consolidation mechanisms to micro-offline gains. First, we reported that the density of fast hippocampo-neocortical skill memory replay events increases approximately three-fold during early learning inter-practice rest periods with the density explaining differences in the magnitude of micro-offline gains across subjects1. Second, Jacobacci et al. (2020) independently reproduced our original behavioral findings and reported BOLD fMRI changes in the hippocampus and precuneus (regions also identified in our MEG study1) linked to micro-offline gains during early skill learning. 33 These functional changes were coupled with rapid alterations in brain microstructure in the order of minutes, suggesting that the same network that operates during rest periods of early learning undergoes structural plasticity over several minutes following practice58. Third, even more recently, Chen et al. (2024) provided direct evidence from intracranial EEG in humans linking sharp-wave ripple events (which are known markers for neural replay59) in the hippocampus (80-120 Hz in humans) with micro-offline gains during early skill learning. The authors report that the strong increase in ripple rates tracked learning behavior, both across blocks and across participants. The authors conclude that hippocampal ripples during resting offline periods contribute to motor sequence learning. 2

      Thus, there is actually now substantial evidence in the literature directly supporting the assertion “that micro-offline gains really result from offline learning”.  On the contrary, according to Gupta & Rickard (2024) “…the mechanism underlying RI [reactive inhibition] is not well established” after over 80 years of investigation60, possibly due to the fact that “reactive inhibition” is a categorical description of behavioral effects that likely result from several heterogenous processes with very different underlying mechanisms.

      On the contrary, recent evidence questions this interpretation (Gupta & Rickard, npj Sci Learn 2022; Gupta & Rickard, Sci Rep 2024; Das et al., bioRxiv 2024). Instead, there is evidence that micro-offline gains are transient performance benefits that emerge when participants train with breaks, compared to participants who train without breaks, however, these benefits vanish within seconds after training if both groups of participants perform under comparable conditions (Das et al., bioRxiv 2024). 

      It is important to point out that the recent work of Gupta & Rickard (2022,2024) 55 does not present any data that directly opposes our finding that early skill learning49 is expressed as micro-offline gains during rest breaks. These studies are essentially an extension of the Rickard et al (2008) paper that employed a massed (30s practice followed by 30s breaks) vs spaced (10s practice followed by 10s breaks) to assess if recovery from reactive inhibition effects could account for performance gains measured after several minutes or hours. Gupta & Rickard (2022) added two additional groups (30s practice/10s break and 10s practice/10s break as used in the work from our group). The primary aim of the study was to assess whether it was more likely that changes in performance when retested 5 minutes after skill training (consisting of 12 practice trials for the massed groups and 36 practice trials for the spaced groups) had ended reflected memory consolidation effects or recovery from reactive inhibition effects. The Gupta & Rickard (2024) follow-up paper employed a similar design with the primary difference being that participants performed a fixed number of sequences on each trial as opposed to trials lasting a fixed duration. This was done to facilitate the fitting of a quantitative statistical model to the data.  To reiterate, neither study included any analysis of micro-online or micro-offline gains and did not include any comparison focused on skill gains during early learning. Instead, Gupta & Rickard (2022), reported evidence for reactive inhibition effects for all groups over much longer training periods. Again, we reported the same finding for trials following the early learning period in our original Bönstrup et al. (2019) paper49 (Author response image 7). Also, please note that we reported in this paper that cumulative micro-offline gains over early learning did not correlate with overnight offline consolidation measured 24 hours later49 (see the Results section and further elaboration in the Discussion). Thus, while the composition of our data is supportive of a short-term memory consolidation process operating over several seconds during early learning, it likely differs from those involved over longer training times and offline periods, as assessed by Gupta & Rickard (2022).

      In the recent preprint from Das et al (2024) 61,  the authors make the strong claim that “micro-offline gains during early learning do not reflect offline learning” which is not supported by their own data.   The authors hypothesize that if “micro-offline gains represent offline learning, participants should reach higher skill levels when training with breaks, compared to training without breaks”.  The study utilizes a spaced vs. massed practice group between-subjects design inspired by the reactive inhibition work from Rickard and others to test this hypothesis. Crucially, the design incorporates only a small fraction of the training used in other investigations to evaluate early skill learning1,33,49,54,57,58,62.  A direct comparison between the practice schedule designs for the spaced and massed groups in Das et al., and the training schedule all participants experienced in the original Bönstrup et al. (2019) paper highlights this issue as well as several others (Author response image 8):

      Author response image 8.

      (A) Comparison of Das et al. Spaced & Massed group training session designs, and the training session design from the original Bönstrup et al. (2019) 49 paper. Similar to the approach taken by Das et al., all practice is visualized as 10-second practice trials with a variable number (either 0, 1 or 30) of 10-second-long inter-practice rest intervals to allow for direct comparisons between designs. The two key takeaways from this comparison are that (1) the intervention differences (i.e. – practice schedules) between the Massed and Spaced groups from the Das et al. report are extremely small (less than 12% of the overall session schedule) and (2) the overall amount of practice is much less than compared to the design from the original Bönstrup report 49  (which has been utilized in several subsequent studies). (B) Group-level learning curve data from Bönstrup et al. (2019) 49 is used to estimate the performance range accounted for by the equivalent periods covering Test 1, Training 1 and Test 2 from Das et al (2024). Note that the intervention in the Das et al. study is limited to a period covering less than 50% of the overall learning range.

      First, participants in the original Bönstrup et al. study 49 experienced 157.14% more practice time and 46.97% less inter-practice rest time than the Spaced group in the Das et al. study (Author response image 8).  Thus, the overall amount of practice and rest differ substantially between studies, with much more limited training occurring for participants in Das et al.  

      Second, and perhaps most importantly, the actual intervention (i.e. – the difference in practice schedule between the Spaced and Massed groups) employed by Das et al. covers a very small fraction of the overall training session. Identical practice schedule segments for both the Spaced & Massed groups are indicated by the red shaded area in Author response image 8. Please note that these identical segments cover 94.84% of the Massed group training schedule and 88.01% of the Spaced group training schedule (since it has 60 seconds of additional rest). This means that the actual interventions cover less than 5% (for Massed) and 12% (for Spaced) of the total training session, which minimizes any chance of observing a difference between groups.

      Also note that the very beginning of the practice schedule (during which Figure R9 shows substantial learning is known to occur) is labeled in the Das et al. study as Test 1.  Test 1 encompasses the first 20 seconds of practice (alternatively viewed as the first two 10-second-long practice trials with no inter-practice rest). This is immediately followed by the Training 1 intervention, which is composed of only three 10-second-long practice trials (with 10-second inter-practice rest for the Spaced group and no inter-practice rest for the Massed group). Author response image 8 also shows that since there is no inter-practice rest after the third Training practice trial for the Spaced group, this third trial (for both Training 1 and 2) is actually a part of an identical practice schedule segment shared by both groups (Massed and Spaced), reducing the magnitude of the intervention even further.

      Moreover, we know from the original Bönstrup et al. (2019) paper49 that 46.57% of all overall group-level performance gains occurred between trials 2 and 5 for that study. Thus, Das et al. are limiting their designed intervention to a period covering less than half of the early learning range discussed in the literature, which again, minimizes any chance of observing an effect.

      This issue is amplified even further at Training 2 since skill learning prior to the long 5-minute break is retained, further constraining the performance range over these three trials. A related issue pertains to the trials labeled as Test 1 (trials 1-2) and Test 2 (trials 6-7) by Das et al. Again, we know from the original Bönstrup et al. paper 49 that 18.06% and 14.43% (32.49% total) of all overall group-level performance gains occurred during trials corresponding to Das et al Test 1 and Test 2, respectively. In other words, Das et al averaged skill performance over 20 seconds of practice at two time-points where dramatic skill improvements occur. Pan & Rickard (1995) previously showed that such averaging is known to inject artefacts into analyses of performance gains.

      Furthermore, the structure of the Test in Das et. al study appears to have an interference effect on the Spaced group performance after the training intervention.  This makes sense if you consider that the Spaced group is required to now perform the task in a Massed practice environment (i.e., two 10-second-long practice trials merged into one long trial), further blurring the true intervention effects. This effect is observable in Figure 1C,E of their pre-print. Specifically, while the Massed group continues to show an increase in performance during test relative to the last 10 seconds of practice during training, the Spaced group displays a marked decrease. This decrease is in stark contrast to the monotonic increases observed for both groups at all other time-points.

      Interestingly, when statistical comparisons between the groups are made at the time-points when the intervention is present (as opposed to after it has been removed) then the stated hypothesis, “If micro-offline gains represent offline learning, participants should reach higher skill levels when training with breaks, compared to training without breaks”, is confirmed.

      The data presented by Gupta and Rickard (2022, 2024) and Das et al. (2024) is in many ways more confirmatory of the constraints employed by our group and others with respect to experimental design, analysis and interpretation of study findings, rather than contradictory. Still, it does highlight a limitation of the current micro-online/offline framework, which was originally only intended to be applied to early skill learning over spaced practice schedules when reactive inhibition effects are minimized49. Extrapolation of this current framework to post-plateau performance periods, longer timespans, or non-learning situations (e.g. – the Non-repeating groups from Experiments 3 & 4 in Das et al. (2024)), when reactive inhibition plays a more substantive role, is not warranted. Ultimately, it will be important to develop new paradigms allowing one to independently estimate the different coincident or antagonistic features (e.g. - memory consolidation, planning, working memory and reactive inhibition) contributing to micro-online and micro-offline gains during and after early skill learning within a unifying framework.

      References

      (1) Buch, E. R., Claudino, L., Quentin, R., Bonstrup, M. & Cohen, L. G. Consolidation of human skill linked to waking hippocampo-neocortical replay. Cell Rep 35, 109193 (2021). https://doi.org:10.1016/j.celrep.2021.109193

      (2) Chen, P.-C., Stritzelberger, J., Walther, K., Hamer, H. & Staresina, B. P. Hippocampal ripples during offline periods predict human motor sequence learning. bioRxiv, 2024.2010.2006.614680 (2024). https://doi.org:10.1101/2024.10.06.614680

      (3) Classen, J., Liepert, J., Wise, S. P., Hallett, M. & Cohen, L. G. Rapid plasticity of human cortical movement representation induced by practice. J Neurophysiol 79, 1117-1123 (1998).

      (4) Karni, A. et al. Functional MRI evidence for adult motor cortex plasticity during motor skill learning. Nature 377, 155-158 (1995). https://doi.org:10.1038/377155a0

      (5) Kleim, J. A., Barbay, S. & Nudo, R. J. Functional reorganization of the rat motor cortex following motor skill learning. J Neurophysiol 80, 3321-3325 (1998).

      (6) Shadmehr, R. & Holcomb, H. H. Neural correlates of motor memory consolidation. Science 277, 821-824 (1997).

      (7) Doyon, J. et al. Experience-dependent changes in cerebellar contributions to motor sequence learning. Proc Natl Acad Sci U S A 99, 1017-1022 (2002).

      (8) Toni, I., Ramnani, N., Josephs, O., Ashburner, J. & Passingham, R. E. Learning arbitrary visuomotor associations: temporal dynamic of brain activity. Neuroimage 14, 1048-1057 (2001).

      (9) Grafton, S. T. et al. Functional anatomy of human procedural learning determined with regional cerebral blood flow and PET. J Neurosci 12, 2542-2548 (1992).

      (10) Kennerley, S. W., Sakai, K. & Rushworth, M. F. Organization of action sequences and the role of the pre-SMA. J Neurophysiol 91, 978-993 (2004). https://doi.org:10.1152/jn.00651.2003 00651.2003 [pii]

      (11) Hardwick, R. M., Rottschy, C., Miall, R. C. & Eickhoff, S. B. A quantitative meta-analysis and review of motor learning in the human brain. Neuroimage 67, 283-297 (2013). https://doi.org:10.1016/j.neuroimage.2012.11.020

      (12) Sawamura, D. et al. Acquisition of chopstick-operation skills with the non-dominant hand and concomitant changes in brain activity. Sci Rep 9, 20397 (2019). https://doi.org:10.1038/s41598-019-56956-0

      (13) Lee, S. H., Jin, S. H. & An, J. The difference in cortical activation pattern for complex motor skills: A functional near- infrared spectroscopy study. Sci Rep 9, 14066 (2019). https://doi.org:10.1038/s41598-019-50644-9

      (14) Battaglia-Mayer, A. & Caminiti, R. Corticocortical Systems Underlying High-Order Motor Control. J Neurosci 39, 4404-4421 (2019). https://doi.org:10.1523/JNEUROSCI.2094-18.2019

      (15) Toni, I., Thoenissen, D. & Zilles, K. Movement preparation and motor intention. Neuroimage 14, S110-117 (2001). https://doi.org:10.1006/nimg.2001.0841

      (16) Wolpert, D. M., Goodbody, S. J. & Husain, M. Maintaining internal representations: the role of the human superior parietal lobe. Nat Neurosci 1, 529-533 (1998). https://doi.org:10.1038/2245

      (17) Andersen, R. A. & Buneo, C. A. Intentional maps in posterior parietal cortex. Annu Rev Neurosci 25, 189-220 (2002). https://doi.org:10.1146/annurev.neuro.25.112701.142922 112701.142922 [pii]

      (18) Buneo, C. A. & Andersen, R. A. The posterior parietal cortex: sensorimotor interface for the planning and online control of visually guided movements. Neuropsychologia 44, 2594-2606 (2006). https://doi.org:S0028-3932(05)00333-7 [pii] 10.1016/j.neuropsychologia.2005.10.011

      (19) Grover, S., Wen, W., Viswanathan, V., Gill, C. T. & Reinhart, R. M. G. Long-lasting, dissociable improvements in working memory and long-term memory in older adults with repetitive neuromodulation. Nat Neurosci 25, 1237-1246 (2022). https://doi.org:10.1038/s41593-022-01132-3

      (20) Colclough, G. L. et al. How reliable are MEG resting-state connectivity metrics? Neuroimage 138, 284-293 (2016). https://doi.org:10.1016/j.neuroimage.2016.05.070

      (21) Colclough, G. L., Brookes, M. J., Smith, S. M. & Woolrich, M. W. A symmetric multivariate leakage correction for MEG connectomes. NeuroImage 117, 439-448 (2015). https://doi.org:10.1016/j.neuroimage.2015.03.071

      (22) Mollazadeh, M. et al. Spatiotemporal variation of multiple neurophysiological signals in the primary motor cortex during dexterous reach-to-grasp movements. J Neurosci 31, 15531-15543 (2011). https://doi.org:10.1523/JNEUROSCI.2999-11.2011

      (23) Bansal, A. K., Vargas-Irwin, C. E., Truccolo, W. & Donoghue, J. P. Relationships among low-frequency local field potentials, spiking activity, and three-dimensional reach and grasp kinematics in primary motor and ventral premotor cortices. J Neurophysiol 105, 1603-1619 (2011). https://doi.org:10.1152/jn.00532.2010

      (24) Flint, R. D., Ethier, C., Oby, E. R., Miller, L. E. & Slutzky, M. W. Local field potentials allow accurate decoding of muscle activity. J Neurophysiol 108, 18-24 (2012). https://doi.org:10.1152/jn.00832.2011

      (25) Churchland, M. M. et al. Neural population dynamics during reaching. Nature 487, 51-56 (2012). https://doi.org:10.1038/nature11129

      (26) Bassett, D. S. et al. Dynamic reconfiguration of human brain networks during learning. Proc Natl Acad Sci U S A 108, 7641-7646 (2011). https://doi.org:10.1073/pnas.1018985108

      (27) Albouy, G., King, B. R., Maquet, P. & Doyon, J. Hippocampus and striatum: dynamics and interaction during acquisition and sleep-related motor sequence memory consolidation. Hippocampus 23, 985-1004 (2013). https://doi.org:10.1002/hipo.22183

      (28) Albouy, G. et al. Neural correlates of performance variability during motor sequence acquisition. Neuroimage 60, 324-331 (2012). https://doi.org:10.1016/j.neuroimage.2011.12.049

      (29) Qin, Y. L., McNaughton, B. L., Skaggs, W. E. & Barnes, C. A. Memory reprocessing in corticocortical and hippocampocortical neuronal ensembles. Philos Trans R Soc Lond B Biol Sci 352, 1525-1533 (1997). https://doi.org:10.1098/rstb.1997.0139

      (30) Euston, D. R., Tatsuno, M. & McNaughton, B. L. Fast-forward playback of recent memory sequences in prefrontal cortex during sleep. Science 318, 1147-1150 (2007). https://doi.org:10.1126/science.1148979

      (31) Molle, M. & Born, J. Hippocampus whispering in deep sleep to prefrontal cortex--for good memories? Neuron 61, 496-498 (2009). https://doi.org:S0896-6273(09)00122-6 [pii] 10.1016/j.neuron.2009.02.002

      (32) Frankland, P. W. & Bontempi, B. The organization of recent and remote memories. Nat Rev Neurosci 6, 119-130 (2005). https://doi.org:10.1038/nrn1607

      (33) Jacobacci, F. et al. Rapid hippocampal plasticity supports motor sequence learning. Proc Natl Acad Sci U S A 117, 23898-23903 (2020). https://doi.org:10.1073/pnas.2009576117

      (34) Albouy, G. et al. Maintaining vs. enhancing motor sequence memories: respective roles of striatal and hippocampal systems. Neuroimage 108, 423-434 (2015). https://doi.org:10.1016/j.neuroimage.2014.12.049

      (35) Gais, S. et al. Sleep transforms the cerebral trace of declarative memories. Proc Natl Acad Sci U S A 104, 18778-18783 (2007). https://doi.org:0705454104 [pii] 10.1073/pnas.0705454104

      (36) Sterpenich, V. et al. Sleep promotes the neural reorganization of remote emotional memory. J Neurosci 29, 5143-5152 (2009). https://doi.org:10.1523/JNEUROSCI.0561-09.2009

      (37) Euston, D. R., Gruber, A. J. & McNaughton, B. L. The role of medial prefrontal cortex in memory and decision making. Neuron 76, 1057-1070 (2012). https://doi.org:10.1016/j.neuron.2012.12.002

      (38) van Kesteren, M. T., Fernandez, G., Norris, D. G. & Hermans, E. J. Persistent schema-dependent hippocampal-neocortical connectivity during memory encoding and postencoding rest in humans. Proc Natl Acad Sci U S A 107, 7550-7555 (2010). https://doi.org:10.1073/pnas.0914892107

      (39) van Kesteren, M. T., Ruiter, D. J., Fernandez, G. & Henson, R. N. How schema and novelty augment memory formation. Trends Neurosci 35, 211-219 (2012). https://doi.org:10.1016/j.tins.2012.02.001

      (40) Wagner, A. D. et al. Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science (New York, N.Y.) 281, 1188-1191 (1998).

      (41) Ashe, J., Lungu, O. V., Basford, A. T. & Lu, X. Cortical control of motor sequences. Curr Opin Neurobiol 16, 213-221 (2006).

      (42) Hikosaka, O., Nakamura, K., Sakai, K. & Nakahara, H. Central mechanisms of motor skill learning. Curr Opin Neurobiol 12, 217-222 (2002).

      (43) Penhune, V. B. & Steele, C. J. Parallel contributions of cerebellar, striatal and M1 mechanisms to motor sequence learning. Behav. Brain Res. 226, 579-591 (2012). https://doi.org:10.1016/j.bbr.2011.09.044

      (44) Doyon, J. et al. Contributions of the basal ganglia and functionally related brain structures to motor learning. Behavioural brain research 199, 61-75 (2009). https://doi.org:10.1016/j.bbr.2008.11.012

      (45) Schendan, H. E., Searl, M. M., Melrose, R. J. & Stern, C. E. An FMRI study of the role of the medial temporal lobe in implicit and explicit sequence learning. Neuron 37, 1013-1025 (2003). https://doi.org:10.1016/s0896-6273(03)00123-5

      (46) Morris, R. G. M. Elements of a neurobiological theory of hippocampal function: the role of synaptic plasticity, synaptic tagging and schemas. The European journal of neuroscience 23, 2829-2846 (2006). https://doi.org:10.1111/j.1460-9568.2006.04888.x

      (47) Tse, D. et al. Schemas and memory consolidation. Science 316, 76-82 (2007). https://doi.org:10.1126/science.1135935

      (48) Berlot, E., Popp, N. J. & Diedrichsen, J. A critical re-evaluation of fMRI signatures of motor sequence learning. Elife 9 (2020). https://doi.org:10.7554/eLife.55241

      (49) Bonstrup, M. et al. A Rapid Form of Offline Consolidation in Skill Learning. Curr Biol 29, 1346-1351 e1344 (2019). https://doi.org:10.1016/j.cub.2019.02.049

      (50) Kornysheva, K. et al. Neural Competitive Queuing of Ordinal Structure Underlies Skilled Sequential Action. Neuron 101, 1166-1180 e1163 (2019). https://doi.org:10.1016/j.neuron.2019.01.018

      (51) Pan, S. C. & Rickard, T. C. Sleep and motor learning: Is there room for consolidation? Psychol Bull 141, 812-834 (2015). https://doi.org:10.1037/bul0000009

      (52) Rickard, T. C., Cai, D. J., Rieth, C. A., Jones, J. & Ard, M. C. Sleep does not enhance motor sequence learning. J Exp Psychol Learn Mem Cogn 34, 834-842 (2008). https://doi.org:10.1037/0278-7393.34.4.834

      53) Brawn, T. P., Fenn, K. M., Nusbaum, H. C. & Margoliash, D. Consolidating the effects of waking and sleep on motor-sequence learning. J Neurosci 30, 13977-13982 (2010). https://doi.org:10.1523/JNEUROSCI.3295-10.2010

      (54) Bonstrup, M., Iturrate, I., Hebart, M. N., Censor, N. & Cohen, L. G. Mechanisms of offline motor learning at a microscale of seconds in large-scale crowdsourced data. NPJ Sci Learn 5, 7 (2020). https://doi.org:10.1038/s41539-020-0066-9

      (55) Gupta, M. W. & Rickard, T. C. Dissipation of reactive inhibition is sufficient to explain post-rest improvements in motor sequence learning. NPJ Sci Learn 7, 25 (2022). https://doi.org:10.1038/s41539-022-00140-z

      (56) Jacobacci, F. et al. Rapid hippocampal plasticity supports motor sequence learning. Proceedings of the National Academy of Sciences 117, 23898-23903 (2020).

      (57) Brooks, E., Wallis, S., Hendrikse, J. & Coxon, J. Micro-consolidation occurs when learning an implicit motor sequence, but is not influenced by HIIT exercise. NPJ Sci Learn 9, 23 (2024). https://doi.org:10.1038/s41539-024-00238-6

      (58) Deleglise, A. et al. Human motor sequence learning drives transient changes in network topology and hippocampal connectivity early during memory consolidation. Cereb Cortex 33, 6120-6131 (2023). https://doi.org:10.1093/cercor/bhac489

      (59) Buzsaki, G. Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning. Hippocampus 25, 1073-1188 (2015). https://doi.org:10.1002/hipo.22488

      (60) Gupta, M. W. & Rickard, T. C. Comparison of online, offline, and hybrid hypotheses of motor sequence learning using a quantitative model that incorporate reactive inhibition. Sci Rep 14, 4661 (2024). https://doi.org:10.1038/s41598-024-52726-9

      (61) Das, A., Karagiorgis, A., Diedrichsen, J., Stenner, M.-P. & Azanon, E. “Micro-offline gains” convey no benefit for motor skill learning. bioRxiv, 2024.2007.2011.602795 (2024). https://doi.org:10.1101/2024.07.11.602795

      (62) Mylonas, D. et al. Maintenance of Procedural Motor Memory across Brief Rest Periods Requires the Hippocampus. J Neurosci 44 (2024). https://doi.org:10.1523/JNEUROSCI.1839-23.2024

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #4

      We sincerely appreciate the time and effort you have taken to review our manuscript. We followed your recommendations to polish the text and make it easier to understand.

      Regarding terms and terminology, we changed “non-breeding” everywhere in the text to “over- wintering.”

      Regarding the title, as it was suggested by reviewer #1 as his recommendation, we tried to find a compromise and make the changes you suggested but left part of the suggestion from reviewer #1. So, now it’s “Foxtrot migration and dynamic over-wintering range of an arctic raptor”

      Thank you for highlighting the importance of snow cover and changes in snow cover as a possible factor of over-wintering movements. We appreciate your feedback and have explored several approaches to address this issue. Specifically, we examined how both snow cover extent and changes in snow cover influenced movement distance. However, we found no effect of either factor on movement distance.

      Our data show that birds leave their sites in October and move southwest, even though snow cover is minimal at that time. They also leave their sites in November and in subsequent months, regardless of the snow cover levels. Thus, we observed no pattern of birds leaving sites when snow cover reaches a specific threshold (e.g., 75-80%). Similarly, we found no evidence of birds staying in areas with a certain snow cover extent (e.g., 30%), nor did they leave sites when snow cover increased by a specific amount (e.g., by 10 or 20%).

      It is possible that more experienced birds anticipate that October plots will become inaccessible later in the winter and, therefore, leave early without waiting for significant snow accumulation. Alternatively, other factors, such as brief heavy snowfalls, may trigger movement, even if these do not lead to sustained increases in snow cover. Multiple factors, possibly acting asynchronously, could also play a role. This complexity adds an interesting dimension to the study of ecological patterns. However, in this study, we chose to focus on describing the migration pattern itself and its impact on aspects like over-winter range determination and population dynamics. While we have prioritized this approach, we remain committed to further analyzing the data to uncover additional details about this behavior.

      In response to your suggestion, we have expanded the Methods sections to clarify that we tested the effects of snow cover and changes in snow cover on distance (Lines 241-246); the Results section (Lines 348-349). We have also included the relevant plots in the Supplementary Materials. In the Discussion, we noted that this approach did not reveal any significant dependence and acknowledged that this issue requires further investigation (Lines 422-459).

      ---------

      The following is the authors’ response to the previous reviews.

      Reviewer #2:

      We sincerely appreciate the time and effort you have taken to review our manuscript. 

      First of all, we apologize for publishing the preprint without incorporating certain adjustments outlined in our earlier response, particularly in the Methods section. This was due to an oversight regarding the different versions of the manuscript. We have corrected this mistake. Our response to the feedback on this section (Methods), with line numbers of the changes made, is immediately below this response. In addition, we have included the units of measurement (mean and standard deviation) in both the results and figure captions for clarity.

      To focus on the main point regarding wintering strategies, we acknowledge that in the previous versions, this aspect was inadequately addressed and caused some confusion. In the revised edition, both the Introduction and the Discussion have been thoroughly reworked.

      As you suggested, we have removed the long introductory paragraph and all references to foxtrot migrations from the Introduction. As a result, the Introduction is now short and to the point. In the second paragraph, we explain why we propose the wintering strategies outlined (L74-81).

      In the Discussion, we've added a substantial new section at the beginning that discusses different wintering strategies. We have also updated Figure 4 accordingly. Previously, we erroneously suggested that Montagu's harrier and other African-Palaearctic migrants might adopt wintering strategies similar to those we describe. Upon further investigation, however, we found that almost all African-Palaearctic migrants exhibit an itinerant wintering strategy. Conversely, the strategy we describe is primarily observed in mid-latitude wintering species.

      We have shown that, unlike itinerancy, the birds in our study don't pause for 1-2 months at multiple non-breeding sites, but instead migrate significant distances, up to 1000 km, throughout the winter. Furthermore, unlike itinerancy, the sites they reach are consistently snow-free throughout the year. Following the logic of publications on Montagu's harriers (Schlaich et al. 2023), our birds do not wait for favorable conditions at the next site, as is typical of itinerancy. Moreover, this behavior is influenced by external factors such as snow cover dynamics and occurs primarily in mid-latitudes. Researchers studying a species similar to our subject, the Common buzzard, observed a similar pattern and termed it "prolonged autumn migration" rather than itinerancy. Although their transmitters stopped working in mid-winter, precluding a full observation of the annual cycle, they captured the essence of continued migration at a slower pace, distinct from itinerancy. We've detailed all of these findings in a new section.

      In addition, we acknowledge the mischaracterization of the implications of our research as ‘Conservation implications’ and have corrected this to ‘Mapping ranges and assessing population trends’, as you suggested.

      Finally, we've rewritten the Conclusion, removing overly grandiose statements and simply summarizing the main findings.

      We appreciate your time and effort in reviewing our manuscript. With your invaluable input, it has become clearer, more concise, and easier to understand.

      Dataset: unclear what is the frequency of GPS transmissions. Furthermore, information on relative tag mass for the tracked individuals should be reported.

      We have included this information in our manuscript (L 115-122). We also refer to the study in which this dataset was first used and described in detail (L 123).

      Data pre-processing: more details are needed here. What data have been removed if the bird died? The entire track of the individual? Only the data classified in the last section of the track? The section also reports on an 'iterative procedure' for annotating tracks, which is only vaguely described. A piecewise regression is mentioned, but no details are provided, not even on what is the dependent variable (I assume it should be latitude?).

      Regarding the deaths, we only removed the data when the bird was already dead. We estimated the date of death and excluded tracking data corresponding to the period after the bird's death. We have corrected the text to make this clear (L 130-131).

      Regarding the piecewise regression. We have added a detailed description on lines 136-148.

      Data analysis: several potential issues here:

      (1) Unclear why sex was not included in all mixed models. I think it should be included.

      Our dataset contains 35 females and eight males (L116). This ratio does not allow us to include sex in all models and adequately assess the influence of this factor. At the same time, because adult females disperse farther than males in some raptor species, we conducted a separate analysis of the dependence of migration distance on sex (Table S8) and found no evidence for this in our species. We have written about that in the Methods (L177-181) and after in the Results (L277-278).

      (2) Unclear what is the rationale of describing habitat use during migration; is it only to show that it is a largely unsuitable habitat for the species? But is a formal analysis required then? Wouldn't be enough to simply describe this?

      Habitat use and snow cover determine the two main phases (quick and slow) of the pattern we describe. We believe that habitat analysis is appropriate in this case, and a simple description would be uninformative and not support our conclusions.

      (3) Analysis of snow cover: such a 'what if' analysis is fine but it seems to be a rather indirect assessment of the effect of snow cover on movement patterns. Can a more direct test be envisaged relating e.g. daily movement patterns to concomitant snow cover? This should be rather straightforward. The effectiveness of this method rests on among-year differences in snow cover and timing of snowfall. A further possibility would be to demonstrate habitat selection within the entire non-breeding home range of an individual in relation snow cover. Such an analysis would imply associating presenceabsence of snow to every location within the non-breeding range and testing whether the proportion of locations with snow is lower than the proportion of snow of random locations within the entire nonbreeding home range (95% KDE) for every individual (e.g. by setting a 1/10 ratio presence to random locations).

      The proposed analysis will provide an opportunity to assess whether the Rough-legged buzzard selects areas with the lowest snow cover, but will not provide an opportunity to follow the dynamics and will therefore give a misleading overall picture. This is especially true in the spring months. In March-April, Rough-legged buzzards move northeast and are in an area that is not the most open to snow. At this time, areas to the southwest are more open to snow (this can be seen in Figure 3b). If we perform the proposed analysis, the control points for this period would be both to the north (where there is more snow) and to the south (where there is less snow) from the real locations, and the result would be that there is no difference in snow cover. 

      A step-selection analysis could be used, as we did in our previous work (Curk et al 2020 Sci Rep) with the same Rough-legged buzzards (but during migration, not winter). But this would only give us a qualitative idea, not a quantitative one - that Rough-legged Buzzards move from snow (in the fall) and follow snowmelt progression (in the spring). 

      At the same time, our analysis gives a complete picture of snow cover dynamics in different parts of the non-breeding range. This allows us to see that if Rough-legged buzzards remained at their fall migration endpoint without moving southwest, they would encounter 14.4% more snow cover (99.5% vs. 85.1%). Although this difference may seem small (14.4%), it holds significance for rodent-hunting birds, distinguishing between complete and patchy snow cover.

      Simultaneously, if Rough-legged buzzards immediately flew to the southwest and stayed there throughout winter, they would experience 25.7% less snow cover (57.3% vs. 31.6%). Despite a greater difference than in the first case, it doesn't compel them to adopt this strategy, as it represents the difference between various degrees of landscape openness from snow cover.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this work by Wang et al., the authors use single-molecule super-resolution microscopy together with biochemical assays to quantify the organization of Nipah virus fusion protein F (NiV-F) on cell and viral membranes. They find that these proteins form nanoscale clusters which favors membrane fusion activation, and that the physical parameters of these clusters are unaffected by protein expression level and endosomal cleavage. Furthermore, they find that the cluster organization is affected by mutations in the trimer interface on the NiV-F ectodomain and the putative oligomerization motif on the transmembrane domain, and that the clusters are stabilized by interactions among NiV-F, the AP2-complex, and the clathrin coat assembly. This work improves our understanding of the NiV fusion machinery, which may have implications also for our understanding of the function of other viruses.

      Strengths:

      The conclusions of this paper are well-supported by the presented data. This study sheds light on the activation mechanisms underlying the NiV fusion machinery.

      Weaknesses:

      The authors provide limited details of the convolutional neural network they developed in this work. Even though custom-codes are made available, a description of the network and specifications of how it was used in this work would aid the readers in assessing its performance and applicability. The same holds for the custom-written OPTICS algorithm. Furthermore, limited details are provided for the imaging setup, oxygen scavenging buffer, and analysis for the single-molecule data, which limits reproducibility in other laboratories. The claim of 10 nm resolution is not backed up by data and seems low given the imaging conditions and fluorophores used. Fourier Ring Correlation analysis would have validated this claim. If the authors refer to localization precision rather than resolution, then this should be specified and appropriate data provided to support this claim.

      We thank reviewer 1 for these suggestions. We described key steps in imaging setup, singlemolecule data reconstruction, the OPTICS algorithm in cluster identification, and 1D CNN in

      classification of the OPTICS data in the Materials and Methods section. We also provided a recipe for the imaging buffer. We refer to 10 nm localization precision rather than resolution. The localization precision achieved by our SMLM system is shown in the Author response image 1.

      Author response image 1.

      The localization precision of the custom-built SMLM. Shows the distribution of localization error at the x (dX), y (dY), and z (dZ) direction in nanometer of blinks generated from Alexa Flour 647 labeled to NiV-F expressed on the plasma membrane of PK13 cells. The lateral precision is <10 nm and the axial precision is < 20 nm. 

      Reviewer #2 (Public Review): 

      Summary:

      In this manuscript, Wang and co-workers employ single molecule light microscopy (SMLM) to detect NiV fusion protein (NiV-F) in the surface of cells. They corroborate that these glycoproteins form microclusters (previously seen and characterized together with the NiVG and Nipah Matrix protein by Liu and co-workers (2018) also with super-resolution light microscopy). Also seen by Liu and coworkers the authors show that the level of expression of NiV-F does not alter the identity of these microclusters nor endosomal cleavage. Moreover, mutations and the transmembrane domain or the hexamer-of-trimer interface seem to have a mild effect on the size of the clusters that the authors quantified.

      Importantly, it has also been shown that these particles tend to cluster in Nipah VLPs.

      We thank reviewer #2 for the comments and suggestions. This paper is built on Liu et al 1 to further characterize the nanoclusters formed by NiV-F and their role in membrane fusion activation. While Liu et al. studied the NiV glycoprotein distribution at the NiV assembly sites to inform mechanisms in NiV assembly and release, Wang et al. analyzed the nanoorganization and distribution of NiV-F at the prefusion conformation, providing insights into the membrane fusion activation mechanisms.  

      Strengths:

      The authors have tried to perform SMLM in single VLPs and have shown partially the importance of NiV-F clustering.

      Weaknesses:

      The labelling strategy for the NiV-F is not sufficiently explained. The use of a FLAG tag in the extracellular domain should be validated and compared with the unlabelled WT NiV-F when expressed in functional pseudoviruses (for example HIV-1 based particles decorated with NiV-F). This experiment should also be carried out for both infection and fusion (including BlaM-Vpr as a readout for fusion). I would also suggest to run a time-of-addition BlaM experiment to understand how this particular labelling strategy affects single virion fusion as compared to the the WT.  

      We thank reviewer #2 for this suggestion. We have made various efforts to validate the expression and function of FLAG-tagged NiV-F. The NiV-F-FLAG shows comparable cell surface expression levels and induces similar cell-cell fusion levels in 293T cells as that of untagged NiV-F 1. The NiV-F-FLAG also showed similar levels of virus entry as untagged NiV-F when both were pseudotyped on a recombinant Vesicular Stomatitis Virus (VSV) with the VSV glycoprotein replaced by a Renilla luciferase reporter gene (VSV-ΔG-rLuc; Fig. S1D). We also performed a virus entry kinetics assay using NiV VLPs expressing NiV-M-βlactamase (NiV-M-Bla), NiV-G-HA, and NiV-F-FLAG, NiV-F-AU1 or untagged NiV-F. The intracellular AU1 tag is located at the C-terminus of NiV-F (Genbank accession no. AY816748.1). However, we detected different levels of NiV-M-Bla in equal volume of VLPs, suggesting that the tags in NiV-F affect the budding of the VLPs (Author response image 2A). Therefore, we performed fusion kinetics assay by using VLPs expressing the same levels of NiV-M-Bla. Among them, the NiV-F-FLAG on VLPs shows the most efficient fusion between VLP and HEK293T cell membranes (Author response image 2B), significantly more efficient than that of untagged NiV-F and NiV-FAU1. However, we cannot attribute the enhanced fusion activity to the FLAG tag, because the readout of this assay relies on both the levels of β-lactamase (introduced by NiV-M-Bla in VLPs) and the NiV-F constructs. The tags in NiV-F could affect both the budding of VLPs and the stoichiometry of F and M in individual VLPs. We did not use the HIV-based pseudovirus system because the incorporation of NiV-F into HIV pseudoviruses requires a C-terminal deletion 2,3.

      In summary, the FLAG tag does not affect cell-cell fusion 1 and virus entry when pseudotyped to the recombinant VSV-ΔG-rLuc viruses (Fig. S1D). Given that we do not observe any difference in clustering between an HA- and FLAG-tagged NiV-F constructs on PK13 cell surface (Fig. S1A-C), we conclude that the FLAG tag has minimal effect on both the fusion activity and the nanoscale distribution of NiV-F. 

      Author response image 2.

      Viral entry is not affected by labeling of NiV-F. A) Western blot analysis of NiV-M-Bla in NiV-VLPs generated by HEK293T cells expressing NiV-M-Bla, NiV-G-HA and NiV-F-FLAG, untagged NiV-F, or NiV-F-AU1. Equal volume of VLPs were separated by a denaturing 10% SDS–PAGE and probed against β-lactamase (SANTA CRUZ, sc-66062). B) NiV-VLPs expressing NiV-M-BLa, NiV-G-HA, and NiV-F-FLAG, untagged NiV-F or NiV-F-AU1 expression plasmids were bond to the target HEK293T cells loaded with CCF2-AM dye at 4°C. The Blue/Green (B/G) ratio was measured at 37°C for 4 hrs at a 3-min interval. Results were normalized to the maximal B/G ratio of NiV-F-FLAG-NiV VLPs. Results from one representative experiment out of three independent experiments are shown. 

      It would also be very important to compare the FLAG labelling approach with recent advances in the field (for instance incorporating noncanonical amino acids (ncAAs) into NiVF by amber stop-codon suppression, followed by click chemistry). 

      We are greatly thankful for this comment from reviewer #2. Labeling noncanonical amino acids (ncAAs) with biorthogonal click chemistry is indeed a more precise labeling strategy compared to the traditional epitope labeling approach used in this paper. We will explore the applications of ncAAs labeling in single-molecule localization imaging and virus-host interactions in future projects. 

      In this paper, the FLAG tag inserted in NiV-F protein seems to have minimal effect on the NiV-F-induced virus entry and cell-cell fusion 1 (Fig. S1). Although the FLAG tag labeling approach may increase the detectable size of NiV-F nanoclusters due to the use of the antibody complex, it should not affect our conclusions drawn from the relative comparisons between wt and mutant NiV-F or control and drug-treated cells. 

      The correlation between the existence of microclusters of a particular size and their functionality is missing. Only cell-cell fusion assays are shown in supplementary figures and clearly, single virus entry and fusion cannot be compared with the biophysics of cell-cell fusion. Not only the environment is completely different, membrane curvature and the number of NiV-F drastically varies also. Therefore, specific fusion assays (either single virus tracking and/or time-of-addition BlaM kinetics with functional pseudoviruses) are needed to substantiate this claim.  

      We thank Reviewer 2 for the suggestion. To support the link between F clustering and viruscell membrane fusion, we conducted pseudotyped virus entry and VLP fusion kinetics assays, as shown in revised Figure S4. The viral entry results (Fig. S4 E and F) corroborate that of the cell-cell fusion assay (Fig. S4A and B) and previously published data 4. The fusion kinetics confirmed that the real-time fusion kinetics was affected by mutations at the hexameric interface, with the hypo-fusogenic mutants L53D and V108D exhibited reduced entry efficiency while the hyper-fusogenic mutant Q393L showed increased efficiency (Fig. S4G and H). The results were described in detail in the revised manuscript. 

      Additionally, we performed a pseudotyped virus entry assay on the LI4A (Fig. S6F and G) and YA (Fig. S7F and G) mutants to verify the function of these mutants on viruses in revised Supplemental Figures. Neither LI4A nor YA incorporated into the VSV/NiV pseudotyped viruses as shown by the Western blot analyses of the pseudovirions (Fig. S6F and S7F), and thus did not induce virus entry, consisting with the cell-cell fusion results (Fig. S6C, D and Fig. S7C, D). We did not perform the entry kinetic assay of these two mutants as they do not incorporate into VLPs or pseudovirions. 

      The authors also claim they could not characterize the number of NiV-F particles per cluster. Another technique such as number and brightness (Digman et al., 2008) could support current SMLM data and identify the number of single molecules per cluster. Also, this technology does not require complex microscopy apparatus. I suggest they perform either confocal fluorescence fluctuation spectroscopy or TIRF-based nandb to validate the clusters and identify how many molecule are present in these clusters.  

      We thank reviewer 2 for this suggestion. Determining the true copy number of NiV-F in individual clusters could verify whether the F clusters on the plasma membrane are hexamer-of-trimer assemblies. Regardless, it does not affect our conclusion that the organization of NiV-F into nanoclusters affects the membrane fusion triggering ability. The confocal fluorescence fluctuation spectroscopy (FFS) and TIRF-based analyses are accessible tools for quantifying fluorophore copy numbers and/or stoichiometry based on fluorescence fluctuation or photobleaching. However, these methods are unable to quantify the number of proteins in individual clusters because they analyze fluorophores either in the entire cell (as in wide-field epifluorescence microscopy coupled with FFS and TIRF-coupled photobleaching) 5–7 or within a large excitation volume (confocal laser scanning microscopycoupled FFS) 8. Both of these volumes are significantly larger than a single NiV-F cluster, which has an average diameter of 24-26 nm (Fig. 1F). 

      The current SMLM setup is useful for characterizing the protein distribution and organization. However, quantifying the true protein copy number within a nanocluster is challenging because of the stochasticity of fluorophore blinking and the unknown labeling stoichiometry 9–11. To address the challenge in fluorophore blinking, quantitative DNA-PAINT (qDNA-PAINT) may be used because the on-off frequency of the fluorophores is tied to the well-defined kinetic constants of DNA binding and the influx rate of the imager strands, rather than the stochasticity of fluorophore blinking. Thus, the frequency of blinks can be translated to protein counting 12. To address the challenge in unknown labeling stoichiometry, DNA origami can be used as a calibration standard 11. DNA origami supports handles at a regular space with several to tens of nanometers apart, and the handles can be conjugated with a certain number of proteins of interest. The copy number of protein interest in the experimental group can be determined by comparing the SMLM localization distribution of the sample to that of the DNA origami calibration standard. Given the requirement of a more sophisticated SMLM setup and a high-precision calibration tool, we will explore the quantification of NiV-F copy numbers in nanoclusters in a future project. 

      Also, it is not clear how many cells the authors employ for their statistics (at least 30-50 cells should be employed and not consider the number of events blinking events. I hope the authors are not considering only a single cell to run their stats... The differences between the mutants and the NiV-F is minor even if their statistical analyses give a difference (they should average the number and size of the clusters per cell for a total of 30-50 cells with experiments performed at least in three different cells following the same protocol). Overall, it seems that the authors have only evaluated a very low number of cells.

      We disagree with this comment from Reviewer #2. The sample size for cluster analysis in SMLM images was chosen by considering the target of the study (cells and VLPs) and the data acquisition and analysis standards in the SMLM imaging field. We also noted the sample size (# of ROI and cells) in the figure legend. 

      Below, we compared the sample sizes in our study to those in similar studies that used comparable imaging and cluster analysis methods from 2015 to 2024. The classical clustering analysis methods are categorized into global clustering (e.g. nearest neighbor analysis, Ripley’s K function, and pair correlation function) and complete clustering, such as density-based analysis (e.g. DBSCAN, Superstructure, FOCAL, ToMATo) and Tessellationbased analysis (e.g. Delaunay triangulation, Voronoii Tessellation). The global clustering analysis method provides spatial statistics for global protein clustering or organization (e.g. clustering extent), while the complete clustering approach extracts information from a single-cluster level, such as the morphology and localization density of individual clusters. We used the density-based analyses, DBSCAN and OPTICS, for cluster analysis on cell plasma membranes and VLP membranes. 

      Author response table 1.

      The comparison of imaging methods, analysis methods, and sample size in the current study to other studies conducted from 2015 to 2024.

      They should also compare the level of expression (with the number of molecules per cell provided by number and brightness) with the total number of clusters. 

      We thank reviewer 2 for this suggestion. We compared the level of expression with the total number of clusters for F-WT in Figure 1I in the main text.  

      The same applies to the VLP assay. I assume the authors have only taken VLPs expressing both NiV-M and NiV-F (and NiV-G). But even if this is not clearly stated I would urge the authors to show how many viruses were compared per condition (normally I would expect 300 particles per condition coming from three independent experiments. As a negative control to evaluate the cluster effect I would mix the different conditions. Clearly you have clusters with all conditions and the differences in clustering depending on each condition are minimal. Therefore you need to increase the n for all experiments.

      We thank reviewer 2 for this comment. We acquired and analyzed more images of NiV VLPs bearing F-WT, Q393L, L53D, and V108D. Results are shown in the revised Figure 4 and the number of VLPs (>300) used for analysis is specified in the figure legend. An increased number of VLP images does not affect the classification result in Figure 4C. 

      As for the suggestion on “evaluating the cluster effect at different mixed conditions”, I assume that reviewer 2 would like to see how the presence of different viral structural proteins (F, M, and G) on VLPs could affect F clustering.  We showed that the organization of NiV envelope proteins on the VLP membrane is similar in the presence or absence of NiV-M by direct visualization 27, suggesting that the effect of NiV-M on F-WT clustering on VLPs is minimal. We also show comparable incorporation of NiV-F among the NiV-F hexamer-oftrimer mutants (Fig. 4A). Therefore, we did not test the F clustering at different F, M, and G combinations in this paper. However, this could be an interesting question to pursue in a paper focusing on NiV VLP production. 

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Wang and colleagues describes single molecule localization microscopy to quantify the distribution and organization of Nipah virus F expressed on cells and on virus-like particles. Notably the crystal structure of F indicated hexameric assemblies of F trimers. The authors propose that F clustering favors membrane fusion.

      Strengths:

      The manuscript provides solid data on imaging of F clustering with the main findings of:

      -  F clusters are independent of expression levels

      -  Proteolytic cleavage does not affect F clustering

      -  Mutations that have been reported to affect the hexamer interface reduce clustering on cells and its distribution on VLPs - - F nanoclusters are stabilized by AP

      Weaknesses:

      The relationship between F clustering and fusion is per se interesting, but looking at F clusters on the plasma membrane does not exclude that F clustering occurs for budding. Many viral glycoproteins cluster at the plasma membrane to generate micro domains for budding. 

      This does not exclude that these clusters include hexamer assemblies or clustering requires hexamer assemblies. 

      We thank reviewer #3 for this question. We did not focus on the role of NiV-F clusters for budding in the current manuscript, although this is an interesting topic to pursue. In this manuscript, we observed that NiV VLP budding is decreased for some cluster-disrupting mutants, such as F-YA, and F-LI4A. however, F-V108D showed increased budding compared to F-WT (Fig. 4A). We also observed that VLPs and VSV/NiV pseudoviruses expressing L53D have little NiV-G (Fig. 4A, Fig. S4F and S4H), although the incorporation level of L53D is comparable to that of wt F in both VLPs and pseudovirions (Fig. 4A and Fig. S4F). L53D is a hypofusogenic mutant with decreased clustering ability. Therefore, our current data do not show a clear link between F clustering and NiV VLP budding or glycoprotein incorporation. 

      We reported that both NiV-F and -M form clusters at the plasma membrane although NiV-F clusters are not enriched at the NiV-M positive membrane domains 1. This result indicates that NiV-M is the major driving force for assembly and budding, while NiV-F is passively incorporated into the assembly sites. The central role of NiV-M in budding is also supported by a recent study showing that NiV-M induces membrane curvature by binding to PI(4,5)P2 in the inner leaflet of the plasma membrane 28. However, the expression of NiV-F alone induces the production of vesicles bearing NiV-F 29 and NiV-F recruits vesicular trafficking and actin cytoskeleton factors to VLPs either alone or in combination with NiV-G and -M, indicating a potential autonomous role in budding 30. Additionally, several electron microscopy studies show that the paramyxovirus F forms 2D lattice interspersed above the M lattice, suggesting the participation of F in virus assembly and budding. Nonetheless, the evidence above suggests that NiV-F may play a role in budding, but our data cannot correlate NiV-F clustering to budding. 

      Assuming that the clusters are important for entry, hexameric clusters are not unique to Nipah virus F. Similar hexameric clusters have been described for the HEF on influenza virus C particles (Halldorsson et al 2021) and env organization on Foamy virus particles (Effantin et al 2016), both with specific interactions between trimers. What is the organization of F on Nipah virus particles? If F requires to be hexameric for entry, this should be easily imaged by EM on infectious or inactivated virus particles. 

      We thank reviewer #3 for this suggestion. The hexamer-of-trimer NiV-F is observed on the VLP surface by electron tomography 4. The NiV-F hexamer-of-trimers are arranged into a soccer ball-like structure, with one trimer being part of multiple hexamer-of-trimers. The implication of NiV-F clusters in virus entry and the potential mechanism for NiV-F higherorder structure formation are discussed in the revised manuscripts. 

      AP stabilization of the F clusters is curious if the clusters are solely required for entry? Virus entry does not recruit the clathrin machinery. Is it possible that F clusters are endocytosed in the absence of budding? 

      We thank reviewer #3 for this question. The evidence from the current study does not exclude the role of NiV-F clustering in virus budding. NiV-F is known to be endocytosed in the virus-producing cells for cleavage by Cathepsin B or L at endocytic compartments at a pH-dependent manner31–33 in the absence of budding. However, given that all cleaved and uncleaved NiV-F have an endocytosis signal sequence at the cytoplasmic tail and are able to interact with AP-2 for endosome assembly and the cleaved and uncleaved F may have similar clustering patterns (Fig. 2), we do not think NiV-F clustering is specifically regulated for the cleavage of NiV-F. A plausible hypothesis is that NiV-F clusters are stabilized by multiple intrinsic factors (e.g. trimer interface) and host factors (e.g. AP-2) on cell membrane for cell-cell fusion and virus budding. We linked the clustering to the fusion ability of NiV-F in this study, but the NiV-F clustering may also be important in facilitating virus budding. Once in the viruses, the higher-order assembly of the clusters (e.g. lattice) may form due to protein enrichment, and the cell factors may not be the major maintenance force. 

      Clusters are required for budding. 

      Other points:

      Fig. 3: Some of the V108D and L53D clusters look similar in size than wt clusters. It seems that the interaction is important but not absolutely essential. Would a double mutant abrogate clustering completely?

      We thank Reviewer #3 for the suggestion. We generated a double mutant of NIV-F with L53D and V108D (NiV-F-LV) and assessed its expression and processing. Although the mutant retained processing capability, it exhibited minimal surface expression, making it unfeasible to analyze its nano-organization on the cell or viral membrane.

      Author response image 4.

      The expression and fusion activity of Flag-tagged NiV-F and NiV-F L53D-V108D (LV). (A) Representative western blot analysis of NiV-F-WT, LV in the cell lysate of 293T cells. 293T cells were transfected by NiV-F-WT or the LV mutant. The empty vector was used as a negative control. The cell lysates were analyzed on SDS-PAGE followed by western blotting after 28hrs post-transfection. F0 and F2 were probed by the M2 monoclonal mouse antiFLAG antibody. GAPDH was probed by monoclonal mouse anti-GAPDH. (B) Representative images of 293T cell-cell fusion induced by NiV-G and NiV-F-WT or NiV-F-LV. 293T cells were co-transfected with plasmids coding for NiV-G and empty vector (NC) or NiV-F constructs. Cells were fixed at 18 hrs post-transfection. Arrows point to syncytia. Scale bar: 10um. (C) Relative cell-cell fusion levels in 293T cells in (B). Five fields per experiment were counted from three independent experiments. Data are presented as mean ± SEM. (D) The cell surface expression levels of NiV-F-WT, NiV-F-LV in 293T cells measured by flow cytometry. Mean fluorescence Intensity (MFI) values were calculated by FlowJo and normalized to that of F-WT. Data are presented as mean ± SEM of three independent experiments. Statistical significance was determined by the unpaired t-test with Welch’s correction (*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001). Values were compared to that of the NiV-F-WT.

      Fig. 4: The distribution of F on VLPs should be confirmed by cryoEM analyses. This would also confirm the symmetry of the clusters. The manuscript by Chernomordik et al. JBC 2004 showed that influenza HA outside the direct contact zone affects fusion, which could be further elaborated in the context of F clusters and the fusion mechanism.

      We thank reviewer 3 for this suggestion. The distribution of F on VLPs was resolved by electron tomogram which showed that the NiV-F hexamer-of-trimers are arranged into a soccer ball-like structure 4. The role of influenza HA outside of the contact zone in fusion activation is an interesting phenomenon. It may address the energy transmission within and among clusters. We will pursue this topic in a future project.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      •  Please define all used abbreviations throughout the manuscript and in the SI.

      We defined the abbreviations at their first usage. 

      •  The sentence starting with "Additionally, ..." on line 155 appears to be incomplete.

      We corrected this sentence.  

      •  The statement starting with "As reported, ..." on line 181 should be supported by a reference.

      We added a reference. 

      •  In Fig. 4C, it is unclear what the x and y axes represent.  

      Fig. 4C is a t-SNE plot for visualizing high-dimensional data in a low-dimensional space. It maintains the local data structure but does not represent exact quantitative relationships. In other words, points that are close together in Fig. 4C are also close in the high-dimensional space, meaning the OPTICS plots, which reflect the clustering patterns, are similar for two points that are positioned near each other in Fig. 4C. Therefore, the x and y axes do not represent the original, quantitative data, and thus the axis titles are meaningless.  

      •  The reference on line 306 appears to be unformatted.

      We reformatted the reference.  

      Reviewer #2 (Recommendations For The Authors):

      The authors need to include the overall statistics for each experiment (at least 30 to 50 cells with three independent experiments are needed). 

      We highlighted the sample size (number of ROI and number of cells) used for analysis in the figure legend. The determination of the sample size is justified in Table 1 in the response letter. 

      The authors need to generate a functional pseudovirus system (for example HIVpp/NiV F) to run both infectivity and fusion experiments (including Apr-BlaM assay). 

      We tested viral entry using a VSV/NiV pseudovirus system and the viral entry kinetics using VLPs expressing NiV-M-β-lactamase. The results are presented in Fig. S1, S4, S6, and S7.  

      Reviewer #3 (Recommendations For The Authors):

      Even low resolution EM data on VLPs or viruses would strengthen the conclusions.

      We thank this reviewer for the suggestion. We cited the NiV VLP images acquired by electron tomography 4, but we currently have limited resources to perform cryoEM on NiV VLPs.  

      References.

      (1) Liu, Q., Chen, L., Aguilar, H. C. & Chou, K. C. A stochastic assembly model for Nipah virus revealed by super-resolution microscopy. Nature Communications 9, 3050 (2018).

      (2) Khetawat, D. & Broder, C. C. A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System. Virology Journal 7, 312 (2010).

      (3) Palomares, K. et al. Nipah Virus Envelope-Pseudotyped Lentiviruses Efficiently Target ephrinB2Positive Stem Cell Populations In Vitro and Bypass the Liver Sink When Administered In Vivo. J Virol 87, 2094–2108 (2013).

      (4) Xu, K. et al. Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly. PLoS Pathog 11, e1005322 (2015).

      (5)    Bakker, E. & Swain, P. S. Estimating numbers of intracellular molecules through analysing fluctuations in photobleaching. Sci Rep 9, 15238 (2019).

      (6) Nayak, C. R. & Rutenberg, A. D. Quantification of Fluorophore Copy Number from Intrinsic

      Fluctuations during Fluorescence Photobleaching. Biophys J 101, 2284–2293 (2011).

      (7) Salavessa, L. & Sauvonnet, N. Stoichiometry of ReceptorsReceptors at the Plasma MembranePlasma membrane During Their EndocytosisEndocytosis Using Total Internal Reflection Fluorescent (TIRF) MicroscopyMicroscopy Live Imaging and Single-Molecule Tracking. in Exocytosis and Endocytosis: Methods and Protocols (eds. Niedergang, F., Vitale, N. & Gasman, S.) 3–17 (Springer US, New York, NY, 2021). doi:10.1007/978-1-0716-1044-2_1.

      (8) Slenders, E. et al. Confocal-based fluorescence fluctuation spectroscopy with a SPAD array detector. Light Sci Appl 10, 31 (2021).

      (9) Annibale, P., Vanni, S., Scarselli, M., Rothlisberger, U. & Radenovic, A. Identification of clustering artifacts in photoactivated localization microscopy. Nat Methods 8, 527–528 (2011).

      (10) Baumgart, F. et al. Varying label density allows artifact-free analysis of membrane-protein nanoclusters. Nat Methods 13, 661–664 (2016).

      (11) Zanacchi, F. C. et al. A DNA origami platform for quantifying protein copy number in super-resolution. Nat Methods 14, 789–792 (2017).

      (12) Jungmann, R. et al. Multiplexed 3D cellular super-resolution imaging with DNA-PAINT and Exchange-PAINT. Nature Methods 11, 313–318 (2014).

      (13) Rubin-Delanchy, P. et al. Bayesian cluster identification in single-molecule localization microscopy data. Nat Methods 12, 1072–1076 (2015).

      (14) Griffié, J. et al. 3D Bayesian cluster analysis of super-resolution data reveals LAT recruitment to the T cell synapse. Sci Rep 7, 4077 (2017).

      (15) Dynamic Bayesian Cluster Analysis of Live-Cell Single Molecule Localization Microscopy Datasets - Griffié - 2018 - Small Methods - Wiley Online Library. https://onlinelibrary.wiley.com/doi/full/10.1002/smtd.201800008.

      (16) Caetano, F. A. et al. MIiSR: Molecular Interactions in Super-Resolution Imaging Enables the Analysis of Protein Interactions, Dynamics and Formation of Multi-protein Structures. PLOS Computational Biology 11, e1004634 (2015).

      (17) Malkusch, S. & Heilemann, M. Extracting quantitative information from single-molecule superresolution imaging data with LAMA – LocAlization Microscopy Analyzer. Sci Rep 6, 34486 (2016).

      (18) Zhang, Y., Lara-Tejero, M., Bewersdorf, J. & Galán, J. E. Visualization and characterization of individual type III protein secretion machines in live bacteria. Proceedings of the National Academy of Sciences 114, 6098–6103 (2017).

      (19) Tobin, S. J. et al. Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2. Sci Rep 8, 15154 (2018).

      (20) Levet, F. et al. SR-Tesseler: a method to segment and quantify localization-based super-resolution microscopy data. Nature Methods 12, 1065–1071 (2015).

      (21) Peters, R., Griffié, J., Burn, G. L., Williamson, D. J. & Owen, D. M. Quantitative fibre analysis of singlemolecule localization microscopy data. Sci Rep 8, 10418 (2018).

      (22) Levet, F. et al. A tessellation-based colocalization analysis approach for single-molecule localization microscopy. Nat Commun 10, (2019).

      (23) Banerjee, C. et al. ULK1 forms distinct oligomeric states and nanoscopic structures during autophagy initiation. Science Advances 9, eadh4094 (2023).

      (24) Pageon, S. V. et al. Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination. Proceedings of the National Academy of Sciences 113, E5454–E5463 (2016).

      (25) Cresens, C. et al. Flat clathrin lattices are linked to metastatic potential in colorectal cancer. iScience 26, 107327 (2023).

      (26) Seeling, M. et al. Immunoglobulin G-dependent inhibition of inflammatory bone remodeling requires pattern recognition receptor Dectin-1. Immunity 56, 1046-1063.e7 (2023).

      (27) Liu, Q. T. et al. The nanoscale organization of Nipah virus matrix protein revealed by super-resolution microscopy. Biophysical Journal 121, 2290–2296 (2022).

      (28) Norris, M. J. et al. Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization. Science Advances 8, eabn1440 (2022).

      (29) Patch, J. R. et al. The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol. J. 5, 137 (2008).

      (30) Johnston, G. P. et al. Nipah Virus-Like Particle Egress Is Modulated by Cytoskeletal and Vesicular Trafficking Pathways: a Validated Particle Proteomics Analysis. mSystems 4, e00194-19 (2019).

      (31) Diederich, S. et al. Activation of the Nipah Virus Fusion Protein in MDCK Cells Is Mediated by Cathepsin B within the Endosome-Recycling Compartment. J Virol 86, 3736–3745 (2012).

      (32) Diederich, S., Thiel, L. & Maisner, A. Role of endocytosis and cathepsin-mediated activation in Nipah virus entry. Virology 375, 391–400 (2008).

      (33) Pager, C. T., Craft, W. W., Patch, J. & Dutch, R. E. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 346, 251–257 (2006).

    1. node* Address

      kalo di notal "pointer to node"

      ok intinya ini pake tag node biar bisa memberi instruksi ke preprocessor membuat struct baru node dengan Address yang beda-beda.

      pada umumnya itu typedef Node (cara aksesnya)

      cuman karna ini pake tag, instead of mengubah, kita membuat baru dengan address yang bisa beda beda

      ini typedef struct node* Address (perhatikan bahwa struct di tulis juga)

    2. node

      ini tag

      tag dan type nya dibedakan (node dan Node) untuk mengatasi strictnya bahasa C dimana tipe tidak bisa di declare setelah operasi lain. dibuatlah jadi tag, im not to sure so ask again ke GPT

    Annotators

    1. Author response:

      The following is the authors’ response to the current reviews.

      We are grateful to the reviewers for their positive assessment of the revised version of the article.

      Please find below our answers to the last, minor comments of the reviewers.

      We thank the reviewer for this important comment. In our live imaging experiments, we actually tracked the dorsal and ventral borders of the omp:yfp positive clusters in control and sly mutant embryos. These measurements showed that the omp:yfp positive clusters are more elongated along the DV axis in mutants as compared with control siblings, as seen on fixed samples (data not shown), suggesting that this difference in tissue shape is not due to fixation.

      Reviewer #4 (Public review):

      Summary:

      In this elegant study XX and colleagues use a combination of fixed tissue analyses and live imaging to characterise the role of Laminin in olfactory placode development and neuronal pathfinding in the zebrafish embryo. They describe Laminin dynamics in the developing olfactory placode and adjacent brain structures and identify potential roles for Laminin in facilitating neuronal pathfinding from the olfactory placode to the brain. To test whether Laminin is required for olfactory placode neuronal pathfinding they analyse olfactory system development in a well-established laminin-gamma-1 mutant, in which the laminin-rich basement membrane is disrupted. They show that while the OP still coalesces in the absence of Laminin, Laminin is required to contain OP cells during forebrain flexure during development and maintain separation of the OP and adjacent brain region. They further demonstrate that Laminin is required for growth of OP neurons from the OP-brain interface towards the olfactory bulb. The authors also present data describing that while the Laminin mutant has partial defects in neural crest cell migration towards the developing OP, these NCC defects are unlikely to be the cause of the neuronal pathfinding defects upon loss of Laminin. Altogether the study is extremely well carried out, with careful analysis of high-quality data. Their findings are likely to be of interest to those working on olfactory system development, or with an interest in extracellular matrix in organ morphogenesis, cell migration, and axonal pathfinding.

      Strengths:

      The authors describe for the first time Laminin dynamics during the early development of the olfactory placode and olfactory axon extension. They use an appropriate model to perturb the system (lamc1 zebrafish mutant), and demonstrate novel requirements for Laminin in pathfinding of OP neurons towards the olfactory bulb.

      The study utilises careful and impressive live imaging to draw most of its conclusions, really drawing upon the strengths of the zebrafish model to investigate the role of laminin in OP pathfinding. This imaging is combined with deep learning methodology to characterise and describe phenotypes in their Laminin-perturbed models, along with detailed quantifications of cell behaviours, together providing a relatively complete picture of the impact of loss of Laminin on OP development.

      Weaknesses:

      Some of the statistical tests are performed on experiments where n=2 for each condition (for example the measurements in Figure S2) - in places the data is non-significant, but clear trends are observed, and one wonders whether some experiments are under-powered.

      We initially planned the electron microscopy experiments in order to analyse 3 embryos per genotype per stage. However, because of technical issues we could not perform the measurements in all the cases, explaining why we have n = 2 in some of the graphs. The trends were quite clear, so we chose to keep these data in the article. We believe they nicely complement the immunostaining data assessing basement membrane integrity in control and mutant embryos.


      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      The authors describe the dynamic distribution of laminin in the olfactory system and forebrain. Using immunohistochemistry and transgenic lines, they found that the olfactory system and adjacent brain tissues are enveloped by BMs from the earliest stages of olfactory system assembly. They also found that laminin deposits follow the axonal trajectory of axons. They performed a functional analysis of the sly mutant to analyse the function of laminin γ1 in the development of the zebrafish olfactory system. Their study revealed that laminin enables the shape and position of placodes to be maintained late in the face of major morphogenetic movements in the brain, and its absence promotes the local entry of sensory axons into the brain and their navigation towards the olfactory bulb. 

      Strengths: 

      - They showed that in the sly mutants, no BM staining of laminin and Nidogen could be detected around the OP and the brain. The authors then elegantly used electron microscopy to analyse the ultrastructure of the border between the OP and the brain in control and sly mutant conditions. 

      - To analyse the role of laminin γ1-dependent BMs in OP coalescence, the authors used the cluster size of Tg(neurog1:GFP)+ OP cells at 22 hpf as a marker. They found that the mediolateral dimension increased specifically in the mutants. However, proliferation did not seem to be affected, although apoptosis appeared to increase slightly at a later stage. This increase could therefore be due to a dispersal of cells in the OP. To test this hypothesis, the authors then analysed the cell trajectories and extracted 3D mean square displacements (MSD), a measure of the volume explored by a cell in a given period of time. Their conclusion indicates that although brain cell movements are increased in the absence of BM during coalescence phases, overall OP cell movements occur within normal parameters and allow OPs to condense into compact neuronal clusters in sly mutants. The authors also analysed the dimensions of the clusters composed of OMP+ neurons. Their results show an increase in cluster size along the dorso-ventral axis. These results were to be expected since, compared with BM, early neurog1+ neurons should compact along the medio-lateral axis, and those that are OMP+ essentially along the dorso-ventral axis. In addition to the DV elongation of OP tissue, the authors show the existence of isolated and ectopic (misplaced) YFP+ cells in sly mutants. 

      - To understand the origin of these phenotypes, the authors analysed the dynamic behaviour of brain cells and OPs during forebrain flexion. The authors then quantitatively measured brain versus OPs in the sly mutant and found that the OP-brain boundary was poorly defined in the sly mutant compared with the control. Once again, the methods (cell tracks, brain size, and proliferation/apoptosis, and the shape of the brain/OP boundary) are elegant but the results were expected. 

      - They then analysed the dynamic behaviour of the axon using live imaging. Thus, olfactory axon migration is drastically impaired in sly mutants, demonstrating that Laminin γ1dependent BMs are essential for the growth and navigation of axons from the OP to the olfactory bulb. 

      - The authors therefore performed a quantitative analysis of the loss of function of Laminin γ1. They propose that the BM of the OP prevents its deformation in response to mechanical forces generated by morphogenetic movements of the neighbouring brain. 

      Weaknesses: 

      - The authors did not analyse neurog1 + axonal migration at the level of the single cell and instead made a global analysis. An analysis at the cell level would strengthen their hypotheses.  

      - Rescue experiments by locally inducing Laminin expression would have strengthened the paper. 

      - The paper lacks clarity between the two neuronal populations described (early EONs and late OSNs).  

      - The authors quantitatively measured brain versus OPs in the sly mutant and found that the OP-brain boundary was poorly defined in the sly mutant compared with the control. Once again, the methods (cell tracks, brain size, proliferation/apoptosis, and the shape of the brain/OP boundary) are elegant but the results were expected. 

      - A missing point in the paper is the effect of Laminin γ1 on the migration of cranial NCCs that interact with OP cells. The authors could have analysed the dynamic distribution of neural crest cells in the sly mutant. 

      We thank the reviewer for the overall positive assessment of our work, and we carefully responded to all her/his insightful comments below. Live imaging experiments to (1) visualise exit and entry point formation with only a few axons labelled, (2) characterise the behaviour of single neurog1:GFP-positive neurons/axons during OP coalescence and to (3) analyse the migration of cranial NCC are now included in the revised manuscript to address the reviewer’s questions, and reinforce our initial conclusions.

      Reviewer #2 (Public Review): 

      Summary: 

      This manuscript addresses the role of the extracellular matrix in olfactory development. Despite the importance of these extracellular structures, the specific roles and activities of matrix molecules are still poorly understood. Here, the authors combine live imaging and genetics to examine the role of laminin gamma 1 in multiple steps of olfactory development. The work comprises a descriptive but carefully executed, quantitative assessment of the olfactory phenotypes resulting from loss of laminin gamma. Overall, this is a constructive advance in our understanding of extracellular matrix contributions to olfactory development, with a well-written Discussion with relevance to many other systems. 

      Strengths: 

      The strengths of the manuscript are in the approaches: the authors have combined live imaging, careful quantitative analyses, and molecular genetics. The work presented takes advantage of many zebrafish tools including mutants and transgenics to directly visualize the laminin extracellular matrix in living embryos during the developmental process. 

      Weaknesses: 

      The weaknesses are primarily in the presentation of some of the imaging data. In certain cases, it was not straightforward to evaluate the authors' interpretations and conclusions based on the single confocal sections included in the manuscript. For example, it was difficult to assess the authors' interpretation of when and how laminin openings arise around the olfactory placode and brain during olfactory axon guidance. 

      We thank the reviewer for the overall positive assessment of our work, and we carefully responded to all her/his insightful comments below. To address these comments, live imaging data to visualise exit and entry point formation with a sparse labelling of axons, and z-stacks showing how exit and entry points are organised in 3D, have been added to the revised manuscript.

      Reviewer #3 (Public Review): 

      This is a beautifully presented paper combining live imaging and analysis of mutant phenotypes to elucidate the role of laminin γ1-dependent basement membranes in the development of the zebrafish olfactory placode. The work is clearly illustrated and carefully quantified throughout. There are some very interesting observations based on the analysis of wild-type, laminin γ1, and foxd3 mutant embryos. The authors demonstrate the importance of a Laminin γ1-dependent basement membrane in olfactory placode morphogenesis, and in establishing and maintaining both boundaries and neuronal connections between the brain and the olfactory system. There are some very interesting observations, including the identification of different mechanisms for axons to cross basement membranes, either by taking advantage of incompletely formed membranes at early stages, or by actively perforating the membrane at later ones. 

      This is a valuable and important study but remains quite descriptive. In some cases, hypotheses for mechanisms are stated but are not tested further. For example, the authors propose that olfactory axons must actively disrupt a basement membrane to enter the brain and suggest alternative putative mechanisms for this, but these are not tested experimentally. In addition, the authors propose that the basement membrane of the olfactory placode acts to resist mechanical forces generated by the morphogenetic movement of the developing brain, and thus to prevent passive deformation of the placode, but this is not tested anywhere, for example by preventing or altering the brain movements in the laminin γ1 mutant. 

      We thank the reviewer for the overall positive assessment of our work and for suggesting interesting experiments to attempt in the future, and we carefully responded to all her/his constructive comments below.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      In general, it would be easier to draw conclusions and compare data if the authors used similar stages throughout the article. 

      Throughout the article we tried to focus on a series of stages that cover both the coalescence of the OP (up to 24 hpf) and later stages of olfactory system development spanning the brain flexure process (28, 32, 36 hpf). However, for technical reasons it was not always possible to stick to these precise stages in some of our experiments. Also, in Fig. 1E-J, we picked in the movies some images illustrating specific cell or axonal behaviours, and thus the corresponding stages could not match exactly the stage series used in Fig. 1A-D and elsewhere in the article. Nevertheless, this stage heterogeneity does not affect our main conclusions.

      It would be useful to schematise the olfactory placode and the brain in an insert to clearly visualise the system in each figure. 

      We hope that the schematic which was initially presented in Fig. 1K already helps the reader to understand how the system is organised. Although we have not added more schematic views to represent the system in each figure (we think this would make the figures overcrowded), we have added additional legends to point to the OP and the brain in the pictures in order to clarify the localisation of each tissue.

      In the Summary, the authors refer to the integrity of the basement membrane. I don't think there is any attempt to affect basement membrane integrity in the article. It would be important to do so to look at the effect on CNS-PNS separation and axonal elongation. 

      In the Summary, we use the term « integrity of the basement membrane » to mention that we have analysed this integrity in the sly mutant. Given the results of our immunostainings against three main components of the basement membrane (Laminin, Collagen IV and Nidogen), as well as our EM observations, we see the sly mutant as a condition in which the integrity of the basement membrane is strongly affected.

      Rescue experiments by locally inducing Laminin expression would have strengthened the paper. 

      We have attempted to rescue the sly mutant phenotypes by introducing the mutation in the transgenic TgBAC(lamC1:lamC1-sfGFP) background, in which Laminin γ1 tagged with sfGFP is expressed under the control of its own regulatory sequences (Yamaguchi et al., 2022). To do so, we crossed sly+/-;Tg(omp:yfp) fish with sly+/-; Tg(lamC1:LamC1-sfGFP) fish. Surprisingly, while a rescue of the global embryo morphology was observed, no clear rescue of the olfactory system defects could be detected at 36 hpf. This could be due to the fact that the expression level of LamC1-sfGFP obtained with one copy of the transgene is not sufficient to rescue the olfactory system phenotypes, or that the sfGFP tag specifically affects the function of the Laminin 𝛾1 chain during the development of the olfactory system, making it unable to rescue the defects. Given the results of our first attemps, we decided not to continue in this direction.

      (1) Developing OP & brain are surrounded by laminin-containing BM (already described by Torrez-Pas & Whitlock in 2014). 

      "we first noticed the appearance of a continuous Laminin-rich BM surrounding the brain from 14-18 hpf, while around the OP, only discrete Laminin spots were detected at this stage (Fig. 1A, A'). " 

      Around 8ss for Torrez-Pas & Whitlock (before 14 hpf). Can you modify the text, or show an 8ss stage embryo? As far as I know, the authors do not show images at 14hpf. Please correct this sentence or show a 14 hpf picture. 

      The reviewer is right, we do not show any 14 hpf stage in the images and thus have removed this stage in the text and replaced it by 17 hpf.

      In Figure 1A, the labelling of laminin 111 does not appear to be homogeneous along the brain.

      Is this true? 

      At this stage the brain’s BM revealed by the Laminin immunostaining appears fairly continuous (while the OP’s one is clearly dotty and less defined), but indeed very tiny/local interruptions of the signal can been seen along the structure as detected by the reviewer. We thus modified the text to mention these tiny interruptions.

      How is the Laminin antibody used by the authors specific to laminin 111?  

      We thank the reviewer for raising this important point. The immunogen used to produce this rabbit polyclonal antibody is the Laminin protein isolated from the basement membrane of a mouse Engelbreth Holm-Swarm sarcoma (EHS). It is thus likely to recognise several Laminin isoforms and not only Laminin 111. We thus replaced Laminin 111 by Laminin when mentioning this antibody in the text and Figures.

      Please schematise in Figure 1K the stages you have tested and shown here in the article i.e. stages 18 - 22 - 28 -36 hpf using immunohistochemistry and 17-26-27-29-33 and 38 hpf using transgenics for laminin 111 and LamC1 respectively.  

      As suggested by the reviewer, we changed the stages in the schematics for stages we have presented in Figure 1 (analysed either with immunostaining or in live imaging experiments). We chose to represent 17 - 22 - 26 - 33 hpf (and thus adapted some of the schematics for them to match these stages).  

      Please specify in the Figure 1 legend for panels A to D whether this is a 3D projection or a zsection.

      We indicated in the Figure 1 legend that all these images are single z-sections (as well as for panels E-J).

      Furthermore, the schematisation in Fig. 1K does not reflect what the authors show: at 22 hpf laminin 111 labelling appears to be present only near the brain, and no labelling lateral to the olfactory placode and anteriorly and posteriorly. Thus, the schematisation in Figure 1K needs to be modified to reflect what the authors show.

      We agree with the reviewer that the Laminin staining at this stage is observed around the medial region of the OP, but not more laterally. We modified the schematic view accordingly in Figure 1K. Anterior and posterior sides of the OP are not represented in this schematic because we chose to represent a frontal view rather than a dorsal view.

      The authors suggest that" the laminin-rich BM of OP assembles between 18 and 22 hpf, during the late phase of OP coalescence". However, their data indicate that this BM assembles around 28hpf (Figure 1C). Can they clarify this point?

      What we meant with this sentence is that we cleary see two distinct BMs from 22 hpf. However, as noticed by the reviewer, the OP’s BM is only present around the medial/basal regions of the OP and does not surround the whole OP tissue at this stage. We modified the text to clarify this point (in particular by mentioning that the OP’s BM starts to assemble between 18 and 22 hpf), and replaced the image shown in Figure 1B, B’ with a more representative picture (the previous z-section was taken in very dorsal regions of the OP).

      It would be useful to disrupt these cells that have a cytoplasmic expression of Laminin-sfGFP, to analyse their contribution to BM and OP coalescence.

      Indeed it will be interesting in the future to test specifically the role of the cells expressing cytoplasmic Laminin-sfGFP around and within the OP, as proposed by the reviewer. Laser ablation of these cells could be attempted, but due to their very superficial localisation, close to the skin, we believe these ablations (with the protocol/set-up we currently use in the lab) would impair the skin integrity, preventing us to conclude. We consider that the optimisation of this experiment is out of the scope of the present work.

      Tg(-2.0ompb:gapYFP)rw032 marks ciliated olfactory sensory neurons (OSNs) (Sato et al., 2005). The authors should mention this. 

      Please see our detailed response to the next point below.

      Points to be clarified: 

      -Tg(-2.0ompb:gapYFP)rw032 marks ciliated olfactory sensory neurons (OSNs) (Sato et al., 2005). The authors should mention this here. Moreover, the authors refer to "OP neurons" throughout the article. In the development of the olfactory organ, two types of neurons have been described in the literature: early EONs (12hpf-26hpf) and later OSNs. Each could have a specific role in the establishment and maintenance of the BM described by the authors. The authors need to clarify this point as, in Figure 1 for example, they use a marker for Tg(neurog1:GFP) EONs and a marker for ciliated OSNs without distinction. The distinction between EONs and OSNs comes a little late in the text and should be placed higher up. 

      As mentioned by the reviewer, according to the initial view of neurogenesis in the OP, OP neurons are born in two waves. A transient population of unipolar, dendrite-less pioneer neurons would differentiate first, in the ventro-medial region of the OP and elongate their axons dorsally out of the placode, along the brain wall. These pioneer axons would then be used as a scaffold by later born OSNs located in the dorso-lateral rosette to outgrow their axons towards the olfactory bulb (Whitlock and Westerfield, 1998). 

      Another study further characterised OP neurogenesis and showed that the first neurons to differentiate in the OP (the early olfactory neurons or EONs) express the Tg(neurog1:GFP) transgene (Madelaine et al., 2011). As mentioned by the authors in the discussion of this article, neurog1:GFP+ neurons appear much more numerous than the previously described pioneer neurons, and may thus include pioneers but also other neuronal subtypes.

      We would like here to share additional, unpublished observations from our lab that further suggest that the situation is more complex than the pioneer/OSN and EON/OSN nomenclatures. First, in many of our live imaging experiments, we can clearly visualise some neurog1:GFP+ unipolar neurons, initially located in a medial position in the OP, which intercalate and contribute to the dorsolateral rosette (where OSNs are proposed to be located) at the end of OP coalescence, from 22-24 hpf. Second, in fixed tissues, we observed that most neurog1:GFP+ neurons located in the rosette at 32 hpf co-express the Tg(omp:meRFP) transgene (Sato et al., 2005). These observations suggest that at least a subpopulation of neurog1:GFP+ neurons could incorporate in the dorsolateral rosette and become ciliated OSNs during development. We can share these results with the reviewer upon request. Further studies are thus needed to clarify and describe the neuronal subpopulations and lineage relationships in the OP, but this detailed investigation is out of the scope and focus of the present study. 

      An additional complication comes from the fact that, as shown and acknowledged by the authors in Miyasaka et al., 2005, the Tg(omp:meYFP) line (6kb promoter) labels ciliated OSNs in the rosette but also some unipolar, ventral neurons (around 10 neurons at 1 dpf, Miyasaka et al. 2005, Figure 3A, white arrowheads). This was also observed using the 2 kb promoter Tg(omp:meYFP) line (see for instance Miyasaka et al., 2007) and in our study, we can indeed detect these ventro-medial neurons labelled in the Tg(omp:meYFP) line (2 kb promoter), see for instance Figure 1C’, D’ or Movie 6. It is unclear whether these unipolar omp:meYFPpositive cells are pioneer neurons or EONs expressing the omp:meYFP transgene, or OSN progenitors that would be located basally/ventrally in the OP at these stages.

      For all these reasons, we decided to present in the text the current view of neurogenesis in the OP but instead of attributing a definitive identity to the neurons we visualise with the transgenic lines, we prefer to mention them in the manuscript (and in the rest of the response to the reviewers) as neurons expressing neurog1:GFP or omp:meYFP transgenes (or cells/axons/neurons expressing RFP in the Tg(cldnb:Gal4; UAS:RFP) background).

      What we also changed in the text to be more clear on this point:

      - we moved higher up in the text, as suggested by reviewer 1, the description of the current model of neurogenesis in the OP,

      - we mentioned that neurog1:GFP+ neurons are more numerous than the initially described pioneer neurons, as discussed in Madelaine et al., 2011,

      - we wrote more clearly that the Tg(omp:meYFP) line labels ciliated OSNs but also a subset of unipolar, ventral neurons (Miyasaka et al., 2005), and pointed to these ventral neurons in Figure 1C’, D’,

      - in the initial presentation of the current view of OP neurogenesis we renamed neurog1:GFP+ into EONs to be coherent with Madelaine et al., 2011.

      - To visualise pioneer axons, the authors should use an EONS marker such as neurog1 because, to my knowledge, OMP only marks OSN axons and not pioneer axons.  

      To visualise neurog1:GFP+ axons during OP coalescence, we performed live imaging upon injection of the neurog1:GFP plasmid (Blader et al., 2003) in the Tg(cldnb:Gal4; UAS:RFP) background (n = 4 mutants and n = 4 controls from 2 independent experiments). We observed some GFP+ placodal neurons exhibiting retrograde axon extension in both controls and sly mutants. In such experiments it is very difficult to quantify and compare the number of neurons/axons showing specific behaviours between different experimental conditions/genetic background. Indeed, due to the cytoplasmic localisation of GFP, the axons can only be seen in neurons expressing high levels of GFP, and due to the injection the number of such neurons varies a lot in between embryos, even in a given condition. Nevertheless, our qualitative observations reinforce the idea that the basement membrane is not absolutely required for mediolateral movements and retrograde axon extension of neurog1:GFP+ neurons in the OP. We added examples of images extracted from these new live imaging experiments in the revised Fig. S5A, B.

      - The authors should analyse the presence of laminin in the OP and forebrain in conjunction with neural crest cell dynamics (using a Sox10 transgenic line for example) to refine their entry and exit point hypotheses. 

      As described in the answer to the next point, we performed new experiments in which we visualised NCC migration in the Tg(neurog1:GFP) background, which allowed us to analyse the localisation of NCC at the forebrain/OP boundary, in ventral and dorsal positions, both in sly mutant embryos and control siblings.

      - A dynamic analysis of the distribution of neural crest cells in the sly mutant over time and during OP coalescence would be important. 

      The dynamics of zebrafish cranial NCC migration in the vicinity of the OP has been previously analysed using sox10 reporter lines (Harden et al., 2012, Torres-Paz and Whitlock, 2014, Bryan et al., 2020). To address the point raised by the reviewer, we performed live imaging from 16 to 32 hpf on sly mutants and control siblings carrying the Tg(neurog1:GFP) and Tg(UAS:RFP) transgenes and injected with a sox10(7.2):KalTA4 plasmid (Almeida et al., 2015). This allows the mosaic labelling of cells that express or have expressed sox10 during their development which, in the head region at these stages, represents mostly NCC and their derivatives. 3 independent experiments were carried out (n = 4 mutant embryos in which 8 placodes could be analysed; n = 6 control siblings in which 10 placodes could be analysed). A new movie (Movie 9) has been added to the revised article to show representative examples of control and mutant embryos.

      From these new data, we could make the following observations:

      - As expected from previous studies (Harden et al., 2012, Torres-Paz and Whitlock, 2014, Bryan et al., 2020), in control embryos a lot of NCC had already migrated to reach the vicinity of the OP when the movies begin at 16 hpf, and were then seen invading mainly the interface between the eye and the OP (10/10 placodes). Surprisingly, in sly mutants, a lot of motile NCC had also reached the OP region at 16 hpf in all the analysed placodes (8/8), and populated the eye/OP interface in 7/8 placodes (10/10 in controls). Counting NCC or tracking individual NCC during the whole duration of the movies was unfortunately too difficult to achieve in these movies, because of the low level of mosaicism (a high number of cells were labelled) and of the high speed of NCC movements (as compared with the 10 min delta t we chose for the movies). 

      - in some of the control placodes we could detect a few NCC that populated the forebrain/OP interface, either ventrally, close to the exit point of the axons (4/10 placodes), or more dorsally (8/10 placodes). By contrast, in sly mutants, NCC were observed in the dorsal region of the brain/OP boundary in only 2/8 placodes, and in the ventral brain/OP frontier in only 2/8 placodes as well. Interestingly, in these 2 last samples, NCC that had initially populated the ventral region of the brain/OP interface were then expelled from the boundary at later stages.

      We reported these observations in a new Table that is presented in revised Fig. S6B. In addition, instances of NCC migrating at the eye/OP or forebain/OP interfaces are indicated with arrowheads on Movie 9. Previous Figure S6 was splitted into two parts presenting NCC defects in sly mutants (revised Figure S6) and in foxd3 mutants (revised Figure S7).

      Altogether, these new data suggest that the first postero-anterior phase of NCC migration towards the OP, as well as their migration in between the eye and OP tissues, is not fully perturbed in sly mutants. The subset of NCC that populate the OP/forebrain seem to be more specifically affected, as these NCC show defects in their migration to the interface or the maintenance of their position at the interface. Since the crestin marker labels mostly NCC at the OP/forebrain interface at 32 hpf (revised Fig. S6A), this could explain why the crestin ISH signal is almost lost in sly mutants at this stage.

      (2) Laminin distribution suggests a role in olfactory axon development 

      "Laminin 111 immunostaining revealed local disruptions in the membrane enveloping the OP and brain, precisely where YFP+ axons exit the OP (exit point) and enter the brain (entry point) (Fig. 1C-D')." Can the authors quantify this situation? It would be important to analyse this behaviour on the scale of a neuron and thus axonal migration to strengthen the hypotheses. 

      As suggested by the reviewer, to better visualise individual axons at the exit and entry point, we used mosaic red labelling of OP axons. To achieve this sparse labelling, we took advantage of the mosaic expression of a red fluorescent membrane protein observed in the Tg(cldnb:Gal4; UAS:lyn-TagRFP) background. The unpublished Tg(UAS:lyn-TagRFP) line was kindly provided by Marion Rosello and Shahad Albadri from the lab of Filippo Del Bene. We crossed the Tg(cldnb:Gal4; UAS:lyn-TagRFP) line with the TgBAC(lamC1:lamC1-sfGFP) reporter and performed live imaging on 2 embryos/4 placodes, in a frontal view. A new movie (Movie 3 in the revised article) shows examples of exit and entry point formation in this context.This allowed us to visualise the formation of the exit and entry points in more samples (6 embryos and 12 placodes in total when we pool the two strategies for labelling OP axons) and through the visualisation of a small number of axons, and reinforce our initial conclusions. 

      (3) The integrity of BMs around the brain and the OP is affected in the sly mutant 

      Why do the authors analyse the distribution of collagen IV and Nidogen and not proteoglycans and heparan sulphate? 

      We attempted to label more ECM components such as proteoglycans and heparan sulfate, but whole-mount immunostainings did not work in our hands.

      A dynamic analysis of the distribution of neural crest cells in the sly mutant over time and during OP coalescence would be important. 

      See our detailed response to this point above.  

      (4) Role of Laminin γ1-dependent BMs in OP coalescence 

      The authors use the size of the Tg(neurog1:GFP)+ OP cell cluster at 22 hpf as a marker.  The authors should count the number of cells in the OP at the indicated time using a nuclear dye to check that in the sly mutant the number of cells is the same over time. Two time points as analysed in Figure S2 may not be sufficient to quantify proliferation which at these stages should be almost zero according to Whitlock & Westerfield and Madelaine et al.

      Counting the neurog1:GFP+ cell numbers in our existing data was unfortunately impossible, due to the poor quality of the DAPI staining. We are nevertheless confident that the number of cells within neurog1:GFP+ clusters is fairly similar between controls and sly mutants at 22 hpf, since the OP dimensions are the same for AP and DV dimensions, and only slightly different for the ML dimension. In addition, we analysed proliferation and apoptosis within the neurog1:GFP+ cluster at 16 and 21 hpf and observed no difference between controls and mutants.

      (5) Role of Laminin γ1-dependent BMs during the forebrain flexure 

      In Figure 4F at 32hpf, the presence of 77% ectopic OMP+ cells medially should result in an increase in dimensions along the M-L? This is not the case in the article. The authors should clarify this point. 

      As we explained in the Material and Methods, ectopic fluorescent cells (cells that are physically separated from the main cluster) were not taken into account for the measurement of the OP dimensions. This is now also also mentioned in the legends of the Figures (4 and S3) showing the quantifications of OP dimensions.

      Cell distribution also seems to be affected within the OMP+ cluster at 36hpf, with fewer cells laterally and more medially. The authors should analyse the distribution of OMP+ cells in the clusters. in sly mutants and controls to understand whether the modification corresponds to the absence of BM function. 

      On the pictures shown in Figure 4F,G, we agree that omp:meYFP+ cells appear to be more medially distributed in the mutant, however this is not the case in other sections or samples, and is rather specific to the z-section chosen for the Figure. We found that the ML dimension is unchanged in mutants as compared with controls, except for the 28 hpf stage where it is smaller, but this appears to be a transient phenomenon, since no change is detected at earlier or later stages (Figure 4A-D and Figure S3A-L). The difference we observe at 28 hpf is now mentioned in the revised manuscript.

      The conclusions of Figures 4 and S3 would rather be that laminin allows OMP+ cells to be oriented along the medio-lateral axis whereas it would control their position along the dorsoventral axis. The authors should modify the text. It would be useful to map the distribution of OMP+ cells along the dorsoventral and mediolateral axes. The same applies to Neurog1+ cells. An analysis of skin cell movements, for example, would be useful to determine whether the effects are specific.  

      We are confident that the measurements of OP dimensions in AP, DV and ML are sufficient to describe the OP shape defects observed in the sly mutants. Analysing cell distribution along the 3 axes as well as skin cell movements will be interesting to perform in the future but we consider these quantifications as being out of the scope of the present work.

      (6) Laminin γ1-dependent BMs are required to define a robust boundary between the OP and the brain 

      The authors must weigh this conclusion "Laminin γ1-dependent BMs serve to establish a straight boundary between the brain and OP, preventing local mixing and late convergence of the two OPs towards each other during flexion movement." Indeed, they don't really show any local mixing between the brain and OP cells. They would need to quantify in their images (Figure 5A-A' and Figure S4 A-A') the percentage of cells co-labelled by HuC and Tg(cldnb:GFP). 

      We agree with the reviewer and thus replaced « reveal » by « suggest » in the conclusion of this section. 

      (7) Role of Laminin γ1-dependent BMs in olfactory axon development 

      An analysis of the retrograde extension movement in the axons of OMP+ ectopic neurons in the sly1 mutant condition would be useful to validate that the loss of laminin function does not play a role in this event. 

      Indeed, even though we can visualise instances of retrograde extension occurring normally in sly mutants, we can not rule out that this process is affected in a subset of OP neurons, for instance in ectopic cells, which often show no axon or a misoriented axon. We added a sentence to mention this in the revised manuscript.

      Minor comments and typos: 

      Please check and mention the D-V/L-M or A-P/L-M orientation of the images in all figures. 

      This has been checked.

      Legend Figure 1: "distalmost" is missing a space "distal most". 

      We checked and this word can be written without a space.

      Figure 1 panel C: check the orientation (I am not sure that Dorsal is up). 

      We double-checked and confirm that dorsal is up in this panel.

      Movie 1 Legend: "aroung "the OP should be around the OP. 

      Thanks to the reviewer for noticing the typo, we corrected it.

      Reviewer #2 (Recommendations For The Authors):

      The comments below are relatively minor and mostly raise questions regarding images and their presentation in the manuscript. 

      • Figure 1, visualization of exit and entry points: It is a bit difficult to visualize the axon exit and entry points in these images, and in particular, to understand how the exit and entry points in C and D correspond to what is seen in F, F', H, and H'. There appears to be one resolvable break in the staining in C and D, whereas there are two distinct breaks in F-H'. Are these single optical sections? Is it possible to visualize these via 3-dimensional rendering? 

      All the images presented in Figure 1 are single z-sections, which is now indicated in the Figure legend. As noticed by the reviewer, Laminin immunostainings on fixed embryos at 28 and 36 hpf suggested that the exit and entry points are facing each other, as shown in Figure 1C-D’. However, in our live imaging experiments we always observed that the exit point is slightly more ventral than the entry point (of about 10 to 20 µm). This discrepancy could be due to the fixation that precedes the immunostaining procedure, which could modify slightly the size and shape of cells/tissues. We added a sentence on this point in the text. In addition, we added new movies of the LamC1-sfGFP reporter with sparse red axonal labelling (Movie 3, see response to reviewer 1), as well as z-stacks presenting the organisation of exit and entry points in 3D (Movie 4), which should help to better illustrate the mechanisms of exit and entry point formation.

      • Movie 2, p. 6, "small interruptions of the BM were already present near the axon tips, along the ventro-medial wall of the OP." This is a bit difficult to assess since the movie seems to show at least one other small interruption in the BM in addition to the exit point, in particular, one slightly dorsal to the exit point. Was this seen in other samples, or in different optical sections? 

      Indeed the exit and entry points often appear as regions with several, small BM interruptions, rather than single holes in the BM. We now show in revised Movie 4 the two z-stacks (the merge and the single channel for green fluorescence) corresponding to the last time points of the movies showing exit and entry point formation in Movie 2, where several BM interruptions can be seen for both the exit and entry points. We had already mentioned this observation in the legend of Movie 2, and we added a sentence on this point in the main text of the revised manuscript. This is also represented for both exit and entry points in the new schematics in revised Fig. 1K and its legend. 

      • Movie 2, p. 6, "The opening of the entry point through the brain BM was concomitant with the arrival of the RFP+ axons, suggesting that the axons degrade or displace BM components to enter the brain." Similar to the questions regarding the exit point, it was a bit difficult to evaluate this statement. There appears to be a broader region of BM discontinuity more dorsal to the arrowhead in Movie 2. A single-channel movie of just the laminin fluorescence might help to convey the extent of the discontinuity. As with above, was this seen in other samples, or in different optical sections?  

      See our response to the previous comment.

      • Figure 1H, I, "the distal tip of the RFP+ axons migrated in close proximity with the brain's BM." This is again a bit difficult to see, and quite different than what is seen in Figure 4A, in which the axons do not seem close to the BM in this section. Is it possible to visualize this via 3-dimensional rendering? 

      In fixed embryos or in live imaging experiments, we observed that, once entered in the brain, the distal tips (the growth cones) of the axons are located close to the BM of the brain. However, this is not the case of the axon shafts which, as development proceeds, are located further away from the BM. This can clearly be seen at 36 hpf in Figure 1D’ and Figure 4A, as spotted by the reviewer. We modified the text to clarify this point.

      • Figure 2J, J', p. 7, the gap between the OP and brain cells of sly mutants "was most often devoid of electron-dense material." It is difficult to see this loss of electron-dense material in 2J'. The thickness of the space is quantified well and is clearly smaller, but the change in electron-dense material is more difficult to see.  

      We looked at Figure 2 again and it seems clear to us that there is electron-dense material between the plasma membranes in controls, which is practically not seen (rare spots) in the mutants. We added a sentence mentioning that we rarely see electron-dense spots in sly mutants.

      • Figure 5E-F': There are concerns about evaluating the shape of a tissue based on nuclear position. Is there a way to co-stain for cell boundaries (maybe actin?), and then quantify distortion of the dlx+ cell population using the cell boundaries, rather than nuclear staining? 

      We agree with the reviewer that it is not ideal to evaluate the shape of the OP/brain boundary based on a nuclear staining. As explained in the text, we could not use the Tg(eltC:GFP) or Tg(cldnb:Gal4; UAS:RFP) reporter lines for this analysis, due to ectopic or mosaic expression. However we are confident that the segmentation of the Dlx3b immunostaining reflects the organisation of the cells at the OP/brain tissue boundary: in other data sets in which we performed Dlx3b staining with membrane labelling independently of the present study and in the wild type context, we clearly see that cell membranes are juxtaposed to the Dlx3b nuclear staining (in other words, the cytoplasm volume of OP cells is very small). 

      • Figure S5E: It would be helpful to see representative images for each of the categories (Proper axon bundle; Ventral projections; Medial projections) or a schematic to understand how the phenotypes were assessed. 

      To address this point we added a schematic view to illustrate the phenotypes assessed in each column of the table in revised Figure S5G.

      • Figure 6, p. 12, "Laminin gamma 1-dependent BMs are essential for growth and navigation of the axons...": What fraction of the tracked axons managed to exit the OP? Given the quantitative analyses in Figure 6, one might interpret this to mean that laminin gamma 1 is not essential for axon growth (speed and persistence are largely unchanged), but rather, primarily for navigation. 

      As noticed by the reviewer, the speed and persistence of axonal growth cones are largely unchanged in the sly mutants (except for the reduced persistence in the 200-400 min window, and an increased speed in the 800-1000 min window), showing that the growth cones are still motile. However, as shown by the tracks, they tend to wander around within the OP, close to the cell bodies, which results in the end in a perturbed growth of the axons. The navigation issues are rather revealed by the analysis of fixed Tg(omp:meYFP) embryos presented in the table of Figure S5G. We modified the text to separate more clearly the conclusions of the two types of experiments (fixed, transgenic embryos versus live, mosaically labelled embryos).

      Reviewer #3 (Recommendations For The Authors):

      Testing the hypotheses mentioned in the public review will be interesting experiments for a follow-up study, but are not essential revisions for this manuscript. 

      I have only a few minor suggestions for revisions: 

      P8 subheading 'Role of Laminin γ1-dependent BMs in OP coalescence' - since no major role was demonstrated here, this heading should be reworded.  

      We agree with the reviewer and replaced the previous title by « OP coalescence still occurs in the sly mutant ».

      P11, line 3 - the authors conclude that the forebrain is smaller 'due to' the inward convergence of the OPs. I do not think it is possible to assign causation to this when the mutant disrupts Laminin γ1 systemically - it is equally possible that the OPs move inward due to a failure of the brain to form in the normal shape. Thus, the wording should be changed here. (In the Discussion on p15, the authors mention the 'apparent distortion' of the brain, and say that it is 'possibly due' to the inward migration of the placodes', but again this could be toned down.) 

      We agree with the reviewer’s comment and changed the wording of our conclusions in the Results section.

      P11 and Fig. S5 - The table and text seem to be saying opposite things here. The text on p11 (3rd paragraph) indicates that the normal exit point is ventral and that this is disrupted in the mutant, with axons exiting dorsally. However, in the table, at each time point there is a higher % of axons exiting ventrally in the mutant. Please clarify. The table does not provide a % value for axons exiting dorsally - it might help to add a column to show this value. 

      We are grateful to the reviewer for pointing this out, and we apologize for the lack of clarity in the first version of the manuscript. We have modified the text and Figure S5 in order to clarify the different points raised by the reviewer in this comment. The Table in Fig. S5G does not represent the % of axons showing defects, but the % of embryos showing the phenotypes. In addition, an embryo is counted in the ventral or medial projection category if it shows at least one ventral or medial projection (even if its shows a proper bundle). This is now clearly indicated in the title of the columns in the table itself and in the legend. The embryos in which the axons exit dorsally in sly mutants are actually those counted in the left column of the Table (they exit dorsally and form a bundle), as shown by the new schematics added below the table. We also added this information in the title of the left column, and mention in the legend the pictures in which this dorsal exit can be observed in the article (Figures 4B and S3E’). Having more sly mutant embryos with axons exiting dorsally is thus compatible with more embryos showing at least one ventral projection.

      Fig. S6, shows the lack of neural crest cells between the olfactory placode and the brain in both laminin γ1 mutants (without a basement membrane) and foxd3 mutants (which retain the membrane). Comparison of the two mutants here is a neat experiment and the result is striking, demonstrating that it is the basement membrane, and not the neural crest, that is required for correct morphology of the olfactory placode. I think this figure should be presented as a main figure, rather than supplementary.  

      Our new live imaging characterisation of NCC migration in sly mutants and control siblings (Movie 9) revealed that at 32 hpf, in the vicinity of the OP, NCC (or their derivatives) are much more numerous than the subset of NCC showing crestin expression by in situ hybridisation (compare the end of our control movie – 32 hfp, with crestin ISH shown in Figure S6A for instance). 

      Thus, the extent of the NCC migration defects should be analysed in more detail in the foxd3 mutant in the future (using live imaging or other NCC markers), and for this reason we chose to keep this dataset in the supplementary Figures.

      One of the first topics covered in the Discussion section is the potential role of Collagen. I was surprised to see the description on P15 'the dramatic disorganization of the Collagen IV pattern observed by immunofluorescence in the sly mutant', as I hadn't picked this up from the Results section of the paper. I went back to the relevant figure (Fig. 2) and description on p7, which does not give the same impression: 'in sly mutants, Collagen IV immunoreactivity was not totally abolished'. This suggested to me that there was only minor (not dramatic) disorganisation of the Collagen IV. This needs clarification.  

      The linear, BM-like Collagen IV staining was lost in sly mutants, but not the fibrous staining which remained in the form of discrete patches surrounding the OP. We modified the text in the Results section as well as in the Figure 2 legend to clarify our observations made on embryos immunostained for Collagen IV.

      Typos etc 

      P5 - '(ii) above of the neuronal rosette' - delete the word 'of'. 

      P5 two lines below this - ensheathed. 

      P10 - '3 distinct AP levels' (delete s from distincts). 

      P10 - distortion (not distorsion) . 

      P12 - 'From 14 hpf, they' should read 'From 14 hpf, neural crest cells'. 

      P15, line 1 - 'is a consequence of' rather than 'is consecutive of'? 

      P22 'When the data were not normal,' should read 'When the data were not normally distributed,'. 

      We thank the reviewer for noticing these typos and have corrected them.

      General 

      Please number lines in future manuscripts for ease of reference. 

      This has been done.

    1. In all this time, our men being all or the most part well recovered, and not willing to trifle away more time then necessitie enforced us into: we thought good, for the better content of the adventurers, in some reasonable sort of fraight home Maister Nelson, with Cedar wood. About which, our men going with willing minds, was in very good time effected, and the ship sent for England. Wee now remaining being in good health, all our men wel contented, free from mutinies, in love one with another, and as we hope in a continuall peace with the Indians: where we doubt not but by Gods gracious assistance, and the adventurers willing minds and speedie furtherance to so honorable an action, in after times to see our Nation to enjoy a Country, not onely exceeding pleasant habitation, but also very profitable for comerce in generall; no doubt pleasing to almightie God, honourable to our gracious Soveraigne, and commodious generally to the whole Kingdome.

      Most of the second half of John Smith account talks about trade relations and exploratory missions between various indigenous tribes in the area. (Smith, John “A True Relation of Such Occurrences) Because of this, there wasn't too much to compare to the movie. For one, the movie is short and I can understand why a lot of the mundane time that is spent setting up a colony wasn't included. ("Goldberg, Eric, and Mike Gabriel. 1995. Pocahontas") The movie also deviates so far from this, and other scholarly sources, that there isn't much to compare. Overall, this source is heavily biased with a fair bit of exaggeration, that modern day historians know not to be true. At the same time, half of what John Smith talks about is a gateway into what life was like in the early days of Jamestown. It talks about disease, conditions of the settlement, various indigenous tribes (which the rest of the world knew relatively little about), the land and new sources of food which was an important source at the time it was published. (Smith, John “A True Relation of Such Occurrences) While Disney's Pocahontas isn't that close to this primary source, nor is it to other sources detailing this part of history, it does a good job in respecting Native American culture. There weren't a lot of films depicting Native Americans in a positive or appropriate light before this movie was made. While there is still shockingly low number of films that tell Native American stories, Pocahontas I think was a small catalyst for future indigenous movies due to its commercial success.

      Bibliography: “A True Relation of Such Occurrences and Accidents of Note as Hath Hapned in Virginia Since the First Planting of That Colony, Which Is Now Resident in the South Part Thereof, till the Last Returne from Thence. Written by Captaine Smith One of the Said Collony, to a Worshipfull Friend of His in England.,” April 13, 2005. http://web.archive.org/web/20050413081941/http://etext.lib.virginia.edu/etcbin/toccer-new2?id=J1007.xml&images=images/modeng&data=/texts/english/modeng/parsed&tag=public&part=all.

      Goldberg, Eric, and Mike Gabriel. 1995. Pocahontas. United States: Buena Vista Pictures.

    1. I’m always negotiating the relationship between micro.blog and my big blog, but I’m getting closer to a system in which micro.blog is a box of delights and the big blog is a Memex. Gonna try to stick with that model.

      reply to @ayjay @annie at https://micro.blog/ayjay/48571448

      @ayjay I've long presumed you were digitally commonplacing by means of your websites, so thanks for laying out some of your specific current thoughts on the process.

      ​@Annie I've been collecting examples of bloggers who are using their personal websites as commonplaces, zettelkasten, and "thought spaces" at https://indieweb.org/commonplace_book. If you're interested, you'll also find examples and details to explore in my own digital commonplace. "Thought spaces" is an interesting entry point.

      Doctorow goes through more of his process in which he's saving both his "box of delights" and the refashioning of them into longer pieces in "20 years a blogger". In his case it's (now) all done on Pluralistic and syndicated out from there, in much the same way @dave has done for years.

  2. Oct 2024
    1. Using the same microscopy setup as above, in vegetative cells, PHAkt-Achilles and PHAkt-mNeonGreen fluorescence appeared localized in the pinocytic cups (Fig. 2A),

      Was the cytoplasmic background also brighter here (not just the localized signal)? I'm just naively wondering if the achilles tag is causing some stress that is increasing background autofluorescence in the cell (given the onset of uniform cytoplasmic fluorescence in Fig 1).

    1. Reviewer #1 (Public review):

      Summary:

      The authors describe a method to probe both the proteins associated with genomic elements in cells, as well as 3D contacts between sites in chromatin. The approach is interesting and promising, and it is great to see a proximity labeling method like this that can make both proteins and 3D contacts. It utilizes DNA oligomers, which will likely make it a widely adopted method. However, the manuscript over-interprets its successes, which are likely due to the limited appropriate controls, and of any validation experiments. I think the study requires better proteomic controls, and some validation experiments of the "new" proteins and 3D contacts described. In addition, toning down the claims made in the paper would assist those looking to implement one of the various available proximity labeling methods and would make this manuscript more reliable to non-experts.

      Strengths:

      (1) The mapping of 3D contacts for 20 kb regions using proximity labeling is beautiful.

      (2) The use of in situ hybridization will probably improve background and specificity.

      (3) The use of fixed cells should prove enabling and is a strong alternative to similar, living cell methods.

      Weaknesses:

      (1) A major drawback to the experimental approach of this study is the "multiplexed comparisons". Using the mtDNA as a comparator is not a great comparison - there is no reason to think the telomeres/centrosomes would look like mtDNA as a whole. The mito proteome is much less complex. It is going to provide a large number of false positives. The centromere/telomere comparison is ok, if one is interested in what's different between those two repetitive elements. But the more realistic use case of this method would be "what is at a specific genomic element"? A purely nuclear-localized control would be needed for that. Or a genomic element that has nothing interesting at it (I do not know of one). You can see this in the label-free work: non-specific, nuclear GO terms are enriched likely due to the random plus non-random labeling in the nucleus. What would a Telo vs general nucleus GSEA look like? (GSEA should be used for quantitative data, no GO). That would provide some specificity. Figures 2G and S4A are encouraging, but a) these proteins are largely sequestered in their respective locations, and b) no validation by an orthogonal method like ChIP or Cut and Run/Tag is used.

      You can also see this in the enormous number of "enriched" proteins in the supplemental volcano plots. The hypothesis-supporting ones are labeled, but do the authors really believe all of those proteins are specific to the loci being looked at? Maybe compared to mitochondria, but it's hard to believe there are not a lot of false positives in those blue clouds. I believe the authors are more seeing mito vs nucleus + Telo than the stated comparison. For example, if you have no labeling in the nucleus in the control (Figures 1C and 2C) you cannot separate background labeling from specific labeling. Same with mito vs. nuc+Telo. It is not the proper control to say what is specifically at the Telo.

      I would like to see a Telo vs nuclear control and a Centromere vs nuc control. One could then subtract the background from both experiments, then contrast Telo vs Cent for a proper, rigorous comparison. However, I realize that is a lot of work, so rewriting the manuscript to better and more accurately reflect what was accomplished here, and its limitations, would suffice.

      (2) A second major drawback is the lack of validation experiments. References to literature are helpful but do not make up for the lack of validation of a new method claiming new protein-DNA or DNA-DNA interactions. At least a handful of newly described proximal proteins need to be validated by an orthogonal method, like ChIP qPCR, other genomic methods, or gel shifts if they are likely to directly bind DNA. It is ok to have false positives in a challenging assay like this. But it needs to be well and clearly estimated and communicated.

      (3) The mapping of 3D contacts for 20 kb regions is beautiful. Some added discussion on this method's benefits over HiC-variants would be welcomed.

      (4) The study claims this method circumvents the need for transfectable cells. However, the authors go on to describe how they needed tons of cells, now in solution, to get it to work. The intro should be more in line with what was actually accomplished.

      (5) Comments like "Compared to other repetitive elements in the human genome...." appear to circumvent the fact that this method is still (apparently) largely limited to repetitive elements. Other than Glopro, which did analyze non-repetitive promoter elements, most comparable methods looked at telomeres. So, this isn't quite the advancement you are implying. Plus, the overlap with telomeric proteins and other studies should be addressed. However, that will be challenging due to the controls used here, discussed above.

    2. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors describe a method to probe both the proteins associated with genomic elements in cells, as well as 3D contacts between sites in chromatin. The approach is interesting and promising, and it is great to see a proximity labeling method like this that can make both proteins and 3D contacts. It utilizes DNA oligomers, which will likely make it a widely adopted method. However, the manuscript over-interprets its successes, which are likely due to the limited appropriate controls, and of any validation experiments. I think the study requires better proteomic controls, and some validation experiments of the "new" proteins and 3D contacts described. In addition, toning down the claims made in the paper would assist those looking to implement one of the various available proximity labeling methods and would make this manuscript more reliable to non-experts.

      Strengths:

      (1) The mapping of 3D contacts for 20 kb regions using proximity labeling is beautiful.

      (2) The use of in situ hybridization will probably improve background and specificity.

      (3) The use of fixed cells should prove enabling and is a strong alternative to similar, living cell methods.

      Weaknesses:

      (1) A major drawback to the experimental approach of this study is the "multiplexed comparisons". Using the mtDNA as a comparator is not a great comparison - there is no reason to think the telomeres/centrosomes would look like mtDNA as a whole. The mito proteome is much less complex. It is going to provide a large number of false positives. The centromere/telomere comparison is ok, if one is interested in what's different between those two repetitive elements. But the more realistic use case of this method would be "what is at a specific genomic element"? A purely nuclear-localized control would be needed for that. Or a genomic element that has nothing interesting at it (I do not know of one). You can see this in the label-free work: non-specific, nuclear GO terms are enriched likely due to the random plus non-random labeling in the nucleus. What would a Telo vs general nucleus GSEA look like? (GSEA should be used for quantitative data, no GO). That would provide some specificity. Figures 2G and S4A are encouraging, but a) these proteins are largely sequestered in their respective locations, and b) no validation by an orthogonal method like ChIP or Cut and Run/Tag is used.

      You can also see this in the enormous number of "enriched" proteins in the supplemental volcano plots. The hypothesis-supporting ones are labeled, but do the authors really believe all of those proteins are specific to the loci being looked at? Maybe compared to mitochondria, but it's hard to believe there are not a lot of false positives in those blue clouds. I believe the authors are more seeing mito vs nucleus + Telo than the stated comparison. For example, if you have no labeling in the nucleus in the control (Figures 1C and 2C) you cannot separate background labeling from specific labeling. Same with mito vs. nuc+Telo. It is not the proper control to say what is specifically at the Telo.

      I would like to see a Telo vs nuclear control and a Centromere vs nuc control. One could then subtract the background from both experiments, then contrast Telo vs Cent for a proper, rigorous comparison. However, I realize that is a lot of work, so rewriting the manuscript to better and more accurately reflect what was accomplished here, and its limitations, would suffice.

      (2) A second major drawback is the lack of validation experiments. References to literature are helpful but do not make up for the lack of validation of a new method claiming new protein-DNA or DNA-DNA interactions. At least a handful of newly described proximal proteins need to be validated by an orthogonal method, like ChIP qPCR, other genomic methods, or gel shifts if they are likely to directly bind DNA. It is ok to have false positives in a challenging assay like this. But it needs to be well and clearly estimated and communicated.

      (3) The mapping of 3D contacts for 20 kb regions is beautiful. Some added discussion on this method's benefits over HiC-variants would be welcomed.

      (4) The study claims this method circumvents the need for transfectable cells. However, the authors go on to describe how they needed tons of cells, now in solution, to get it to work. The intro should be more in line with what was actually accomplished.

      (5) Comments like "Compared to other repetitive elements in the human genome...." appear to circumvent the fact that this method is still (apparently) largely limited to repetitive elements. Other than Glopro, which did analyze non-repetitive promoter elements, most comparable methods looked at telomeres. So, this isn't quite the advancement you are implying. Plus, the overlap with telomeric proteins and other studies should be addressed. However, that will be challenging due to the controls used here, discussed above.

      We thank the Reviewer for their careful reading of manuscript and constructive suggestions. We plan to substantially revise the framing and presentation of manuscript to address the concerns raised by all three reviewers.

      Reviewer #2 (Public review):

      Summary

      Liu and MacGann et al. introduce the method DNA O-MAP that uses oligo-based ISH probes to recruit horseradish peroxidase for targeted proximity biotinylation at specific DNA loci. The method's specificity was tested by profiling the proteomic composition at repetitive DNA loci such as telomeres and pericentromeric alpha satellite repeats. In addition, the authors provide proof-of-principle for the capture and mapping of contact frequencies between individual DNA loop anchors.

      Strengths

      Identifying locus-specific proteomes still represents a major technical challenge and remains an outstanding issue (1). Theoretically, this method could benefit from the specificity of ISH probes and be applied to identify proteomes at non-repetitive DNA loci. This method also requires significantly fewer cells than other ISH- or dCas9-based locus-enrichment methods. Another potential advantage to be tested is the lack of cell line engineering that allows its application to primary cell lines or tissue.

      Weaknesses

      The authors indicate that DNA O-MAP is superior to other methods for identifying locus-specific proteomes. Still, no proof exists that this method could uncover proteomes at non-repetitive DNA loci. Also, there is very little validation of novel factors to confirm the superiority of the technique regarding specificity.

      The authors first tested their method's specificity at repetitive telomeric regions, and like other approaches, expected low-abundant telomere-specific proteins were absent (for example, all subunits of the telomerase holoenzyme complex). Detecting known proteins while identifying noncanonical and unexpected protein factors with high confidence could indicate that DNA O-MAP does not fully capture biologically crucial proteins due to insufficient enrichment of locus-specific factors. The newly identified proteins in Figure 1E might still be relevant, but independent validation is missing entirely. In my opinion, the current data cannot be interpreted as successfully describing local protein composition.

      Finally, the authors could have discussed the limitations of DNA O-MAP and made a fair comparison to other existing methods (2-5). Unlike targeted proximity biotinylation methods, DNA O-MAP requires paraformaldehyde crosslinking, which has several disadvantages. For instance, transient protein-protein interactions may not be efficiently retained on crosslinked chromatin. Similarly, some proteins may not be crosslinked by formaldehyde and thus will be lost during preparation (6).

      (1) Gauchier M, van Mierlo G, Vermeulen M, Dejardin J. Purification and enrichment of specific chromatin loci. Nat Methods. 2020;17(4):380-9.

      (2) Dejardin J, Kingston RE. Purification of proteins associated with specific genomic Loci. Cell. 2009;136(1):175-86.

      (3) Liu X, Zhang Y, Chen Y, Li M, Zhou F, Li K, et al. In Situ Capture of Chromatin Interactions by Biotinylated dCas9. Cell. 2017;170(5):1028-43 e19.

      (4) Villasenor R, Pfaendler R, Ambrosi C, Butz S, Giuliani S, Bryan E, et al. ChromID identifies the protein interactome at chromatin marks. Nat Biotechnol. 2020;38(6):728-36.

      (5) Santos-Barriopedro I, van Mierlo G, Vermeulen M. Off-the-shelf proximity biotinylation for interaction proteomics. Nat Commun. 2021;12(1):5015.

      (6) Schmiedeberg L, Skene P, Deaton A, Bird A. A temporal threshold for formaldehyde crosslinking and fixation. PLoS One. 2009;4(2):e4636.

      We thank the Reviewer for their constructive feedback on our work. As noted above, we plan to substantially revise the framing and presentation of manuscript to address the concerns raised by all three reviewers.

      Reviewer #3 (Public review):

      Significance of the Findings:

      The study by Liu et al. presents a novel method, DNA-O-MAP, which combines locus-specific hybridisation with proximity biotinylation to isolate specific genomic regions and their associated proteins. The potential significance of this approach lies in its purported ability to target genomic loci with heightened specificity by enabling extensive washing prior to the biotinylation reaction, theoretically improving the signal-to-noise ratio when compared with other methods such as dCas9-based techniques. Should the method prove successful, it could represent a notable advancement in the field of chromatin biology, particularly in establishing the proteomes of individual chromatin regions - an extremely challenging objective that has not yet been comprehensively addressed by existing methodologies.

      Strength of the Evidence:

      The evidence presented by the authors is somewhat mixed, and the robustness of the findings appears to be preliminary at this stage. While certain data indicate that DNA-O-MAP may function effectively for repetitive DNA regions, a number of the claims made in the manuscript are either unsupported or require further substantiation. There are significant concerns about the resolution of the method, with substantial biotinylation signals extending well beyond the intended target regions (megabases around the target), suggesting a lack of specificity and poor resolution, particularly for smaller loci. Furthermore, comparisons with previous techniques are unfounded since the authors have not provided direct comparisons with the same mass spectrometry (MS) equipment and protocols. Additionally, although the authors assert an advantage in multiplexing, this claim appears overstated, as previous methods could achieve similar outcomes through TMT multiplexing. Therefore, while the method has potential, the evidence requires more rigorous support, comprehensive benchmarking, and further experimental validation to demonstrate the claimed improvements in specificity and practical applicability.

      We thank the Reviewer for providing detailed critiques of our manuscript. As noted above, we plan to substantially revise the framing and presentation of manuscript to address the concerns raised by all three reviewers.

    1. Reviewer #3 (Public review):

      Summary:

      The study explores the cellular and circuit features that distinguish dentate gyrus semilunar granule cells and granule cells activated during contextual memory formation. The authors tag memory and enriched environment-activated dentate granule cells and semilunar granule cells and show their reactivation in an appropriate context a week later. They perform patch clamp recordings from activated and surrounding neurons to understand cellular driving the selective activation of semilunar granule cells and granule cells. Authors perform dual patch clamp recordings from various pairs of labeled semilunar granule cells, labeled granule cells, unlabeled granule cells, and unlabeled semilunar granule cells. The sustained firing of semilunar granule cells explained their preferential activation. In addition, activated neurons received correlated inputs.

      Strengths:

      The authors confirmed engram cell properties of activated semilunar granule cells and granule cells in two different paradigms, validated using an enriched environment paradigm.

      The authors carefully separate semilunar granule cells from granule cells, using electrophysiology and morphology. Cell filling to confirm morphology further strengthens confidence.

      The dual patch recordings, which are technically challenging, are carefully performed, and the presence of synaptic activity is confirmed.

      Finally, the correlation analysis of EPSCs on labeled neurons is rigorous.

      Weaknesses:

      (1) Engram cells are (i) activated by a learning experience, (ii) physically or chemically modified by the learning experience, and (iii) reactivated by subsequent presentation of the stimuli present at the learning experience (or some portion thereof), resulting in memory retrieval. The authors show that exposure to Barnes Maze and the enriched environment-activated semilunar granule cells and granule cells preferentially in the superior blade of the dentate gyrus, and a significant fraction were reactivated on re-exposure. However, physical or chemical modification by experience was not tested. Experience modifies engram cells, and a common modification is the Hebbian, i.e., potentiation of excitatory synapses. The authors recorded EPSCs from labeled and unlabeled GCs and SGCs. Was there a difference in the amplitude or frequency of EPSCs recorded from labeled and unlabeled cells?

      (2) The authors studied five sequential sections, each 250 μm apart across the septotemporal axis, which were immunostained for c-Fos and analyzed for quantification. Is this an adequate sample? Also, it would help to report the dorso-ventral gradient since more engram cells are in the dorsal hippocampus. Slices shown in the figures appear to be from the dorsal hippocampus.

      (3) The authors investigated the role of surround inhibition in establishing memory engram SGCS and GCs. Surprisingly, they found no evidence of lateral inhibition in the slice preparation. Interneurons, e.g., PV interneurons, have large axonal arbors that may be cut during slicing. Similarly, the authors point out that some excitatory connections may be lost in slices. This is a limitation of slice electrophysiology.

    1. Reviewer #1 (Public review):

      In this manuscript, Sun et al report the development of a POST-IT (Pup-On-target for Small molecule Target Identification Technology) approach for drug target identification. Generally, this new technology applies a non-diffusive proximity tagging system by utilizing an engineered fusion of proteasomal accessory factor A (PafA) and HaloTag to transfer prokaryotic ubiquitin-like protein (Pup) to proximal proteins upon directly binding to the small molecule. After the pupylated targets are captured, they are able to be detected by mass spectrometry. Significant optimization (Lys-Arg and other mutations) was conducted to eliminate the interference of self-pupylation, polypupylation, and depupylation, POST-IT was successfully applied for the target identification of 2 well-known drugs: dasatinib and hydroxychloroquine, which yielded SEPHS2 and VPS37C as their new potential targets, respectively. Furthermore, POST-IT was also applied in live zebrafish embryos, highlighting its potential for broad biological research and drug development.

      This work was well designed and the experiments were logically conducted. The solid results support POST-IT as a promising technology for new drug target identification.

      Weakness and limitations:

      (1) The technology requires a halo-tagged derivation of the active compound, and the linked position will have a huge impact on the potential "target hits" of the molecules. Given the fact that most of the active molecules lack of structure-activity relationship information, it is very challenging to identify the optimal position of the halo tag linkage.

      (2) Although POST-IT works in zebrafish embryos, there is still a long way to go for the broad application of the technology in other animal models.

      (3) The authors identified SEPHS2 as a new potential target of dasatinib and further validated the direct binding of dasatinib with this protein. However, considering the super strong activity of dasatinib against c-Src (sub nanomolar IC50 value), it is hard to conclude the contribution of SEPHS2 binding (micromolar potency) to its antitumor activity.

    1. Technical Feedback (8/20)

      HTML Structure (3/5)

      • ✓ Good heading variety (h1-h4)
      • ✗ Structural issues:
      • <h3> nested inside <h3>
      • Invalid custom tags (<p1>, <p2>)
      • ✓ Links properly embedded
      • ⚠ Image implementation:
      • Alt attributes present
      • Some invalid URLs (\ddd)
      • Inconsistent sources

      CSS Implementation (4/10)

      • ✗ Missing IDs completely
      • ✗ No class usage
      • ✗ Style issues:
      • Invalid selectors (p1, p2)
      • Redundant background declarations
      • Overuse of inline styles
      • ⚠ Limited styling scope:
      • Basic font sizing
      • Simple background images
      • Needs more detailed styling

      Code Quality (1/5)

      • ✗ Organization problems:
      • Excessive <br> tags
      • Missing closing tags
      • Poor indentation
      • ✗ Invalid elements:
      • Custom paragraph tags
      • Broken image sources
      • Improper tag nesting

      Priority Fixes:

      1. Fix HTML structure:
      2. Replace <p1>, <p2> with <p>
      3. Correct heading hierarchy
      4. Add proper closing tags
      5. Fix image URLs

      6. Improve CSS:

      7. Add 5+ unique IDs
      8. Create reusable classes
      9. Remove redundant styles
      10. Replace inline styling

      11. Clean up code:

      12. Replace <br> with margins/padding
      13. Improve indentation
      14. Fix tag nesting

      Your content structure shows promise, but needs technical cleanup. Focus first on using valid HTML elements and building a proper CSS structure with IDs and classes.

    1. Technical Feedback (18/20)

      HTML Structure (5/5)

      • ✓ Excellent heading hierarchy (h1-h3)
      • ✓ Well-organized paragraphs
      • ✓ Links properly implemented:
      • Correct <a> tag usage
      • Good use of target="_blank"
      • ✓ Images:
      • Properly embedded
      • Well-styled

      CSS Implementation (9/10)

      • ✓ Strong ID usage:
      • #intro
      • #ind
      • #iow
      • #pel
      • ✓ Effective class reuse:
      • .div1 across sections
      • .div2 across sections
      • ✓ Comprehensive tag styling:
      • Headers
      • Paragraphs
      • Images
      • ⚠ Minor optimization needed:
      • Redundant properties in .div1 and .div2
      • Could combine common styles

      Code Quality (4/5)

      • ✓ Clean, readable structure
      • ✓ Proper indentation
      • ✓ Good element nesting
      • ✗ Missing </head> closing tag

      Suggestions for Perfect Score:

      1. Optimize CSS:
      2. Create shared class for common div styles
      3. Combine repeated properties
      4. Add missing </head> tag

      Excellent work overall! Your code is clean and well-structured. Making these minor improvements would make it perfect. Your use of classes and IDs is particularly strong, showing good understanding of CSS organization.

    1. Technical Feedback (8/20)

      HTML Structure (2/5)

      • ✗ Critical structure issues:
      • <div> inside <h1> (invalid)
      • Multiple <body> tags
      • Missing closing tags for <a> and <ol>
      • ✗ Invalid <frame> usage (should be <iframe>)
      • ⚠ Heading issues:
      • Uses <h1> and <h3>
      • Improper nesting
      • ⚠ Custom paragraph ID used instead of <p> tag
      • ✓ Images have alt attributes

      CSS Implementation (5/10)

      • ⚠ Problematic ID usage:
      • #heading
      • #heading2
      • #p (should be tag selector)
      • Split styles that should be unified
      • ✗ Class issues:
      • Invalid .container: syntax
      • Missing second reusable class
      • ✗ Style problems:
      • Redundant h1/h3 styles
      • Inline styles in <body>
      • Misplaced colons
      • Missing semicolons

      Code Quality (1/5)

      • ✗ Major structural issues:
      • Multiple body tags
      • Broken closing tags
      • Improper element nesting
      • ✗ Redundant styling
      • ✗ Invalid HTML/CSS syntax
      • ✗ Disorganized code structure

      Critical Fixes:

      1. Fix HTML structure:
      2. Remove extra <body> tag
      3. Fix tag nesting
      4. Close all tags properly
      5. Correct element usage:
      6. Replace <frame> with <iframe>
      7. Use proper <p> tags
      8. Fix CSS:
      9. Remove .container: syntax error
      10. Consolidate heading styles
      11. Move inline styles to CSS file
      12. Clean up redundant code
      13. Fix all closing tags

      Hi Collin, I really enjoyed your projects concept; however, your project needs significant technical improvements to function properly. Focus first on fixing the HTML structure and closing tags, then work on organizing your CSS more efficiently.

    1. Technical Feedback (19/20)

      HTML Structure (5/5)

      • ✓ Excellent heading hierarchy (h1-h5)
      • ✓ Proper paragraph structure
      • ✓ Media well-implemented (YouTube, Giphy iframes)
      • ✓ Images correctly formatted
      • ⚠ Minor note: Redundant <a> tag after Giphy embed

      CSS Implementation (10/10)

      • ✓ Strong ID usage:
      • #containerOne
      • #leftnote
      • #rightnote
      • #color
      • #define
      • #bold
      • #big
      • ✓ Effective class reuse:
      • .notes
      • .small
      • ✓ Comprehensive tag styling:
      • Tables (table, th, td)
      • Headings
      • Paragraphs

      Code Quality (4/5)

      • ✓ Clean, readable structure
      • ✓ Good separation of concerns
      • ✓ Proper indentation
      • ⚠ Some inline styles could move to CSS file

      Suggestions for Perfect Score:

      1. Remove redundant <a> tag after Giphy
      2. Move inline styles to CSS file
      3. Review table styling for consistency

      Outstanding work on HTML structure and CSS implementation. Your code is clean, semantic, and well-organized. Minor tweaks to styling organization, but overall nice job.

    1. Technical Feedback (8/20)

      HTML Structure (3/5)

      • ✓ Main heading (<h1>) used correctly
      • ✗ Custom tags used instead of standard <p> tags (<p1>, <p2>, <p4>)
      • ⚠ Links present but have syntax errors (missing >)
      • ✓ Image (elio2.jpeg) implemented correctly
      • ✗ Needs more section headings

      CSS Implementation (4/10)

      • ⚠ IDs implemented:
      • #containerone
      • #containertwo
      • #floatingpup
      • Need 2 more to meet requirements
      • ⚠ Classes:
      • .container used well
      • Need another reusable class (3+ instances)
      • ✗ Style issues:
      • Invalid syntax (opacity: .7.5)
      • Missing semicolons
      • Broken custom tag selectors

      Code Quality (1/5)

      • ✗ Invalid HTML elements (<div1>, <p1>, <p2>, <p4>)
      • ✗ Improper CSS formatting
      • ✗ Missing closing brackets
      • ✗ Invalid font-family declarations
      • ✗ Misused quotes in div1 styling

      Priority Fixes:

      1. Replace custom tags (<p1>, <p2>, <p4>) with standard <p> tags
      2. Add 2 more unique IDs
      3. Create another reusable class
      4. Fix link syntax
      5. Clean up CSS syntax (semicolons, opacity values)

      Enjoyed this project overall! Address the technical issues listed here and this will be a solid submission.

    1. Technical Feedback (14/20)

      HTML Structure (4/5)

      • ✓ Good use of heading hierarchy (h1-h6)
      • ✓ Paragraphs properly tagged
      • ✗ Two empty <p> tags need content
      • ✗ Missing navigation links
      • ⚠ Images work but need better organization

      CSS Implementation (7/10)

      • ✓ Multiple IDs used effectively
      • ✓ Good reuse of .container class
      • #rain1 ID exists in CSS but not in HTML
      • .container class missing style definitions
      • ✗ Layout issues due to undefined container styles

      Code Quality (3/5)

      • ✗ HTML syntax errors:
      • Missing > in <link> tag
      • Unclosed final <div>
      • ✗ Unused CSS selectors (p2, h2, #rain1)
      • ✗ Inconsistent margin spacing
      • ✗ Div structure needs optimization

      Key Improvements:

      1. Add navigation links
      2. Define .container styles
      3. Fix HTML syntax errors
      4. Clean up unused CSS
      5. Improve div organization

      Overall I really enjoyed your concept and visuals that reinforced the theme of the page. Focus on cleaning up the technical details and completing the missing style definitions to take this to the next level.

    1. Existing facilities that can filter carbon dioxide out of the air only have the capacity to capture 0.01 million metric tons of CO2 globally today, costing companies like Microsoft as much as $600 per ton of CO2. That’s very little capacity with a very high price tag.

      Calma, Justine. “Trying to Reverse Climate Change Won’t Save Us, Scientists Warn.” Msn.Com, 1729, https://www.msn.com/en-us/news/technology/trying-to-reverse-climate-change-won-t-save-us-scientists-warn/ar-AA1sN6OC?ocid=msedgntp&cvid=20987699b6484dd5c9aad7c390f9e4cd&ei=4.

    1. Reviewer #3 (Public review):

      Summary:

      This work investigated the immune response in the murine retina after focal laser lesions. These lesions are made with close to 2 orders of magnitude lower laser power than the more prevalent choroidal neovascularization model of laser ablation. Histology and OCT together show that the laser insult is localized to the photoreceptors and spares the inner retina, the vasculature, and the pigment epithelium. As early as 1-day after injury, a loss of cell bodies in the outer nuclear layer is observed. This is accompanied by strong microglial proliferation at the site of injury in the outer retina where microglia do not typically reside. The injury did not seem to result in the extravasation of neutrophils from the capillary network constituting one of the main findings of the paper. The demonstrated paradigm of studying the immune response and potentially retinal remodeling in the future in vivo is valuable and would appeal to a broad audience in visual neuroscience. However, there are some issues with the conclusions drawn from the data and analysis that can be addressed to further bolster the manuscript.

      Strengths:

      Adaptive optics imaging of the murine retina is cutting edge and enables non-destructive visualization of fluorescently labeled cells in the milieu of retinal injury. As may be obvious, this in vivo approach is beneficial for studying fast and dynamic immune processes on a local time scale - minutes and hours, and also for the longer days-to-months follow-up of retinal remodeling as demonstrated in the article. In certain cases, the in vivo findings are corroborated with histology.

      The analysis is sound and accompanied by stunning video and static imagery. A few different sets of mouse models are used, (a) two different mouse lines, each with a fluorescent tag for neutrophils and microglia, (b) two different models of inflammation - endotoxin-induced uveitis (EAU) and laser ablation are used to study differences in the immune interaction.

      One of the major advances in this article is the development of the laser ablation model for 'mild' retinal damage as an alternative to the more severe neovascularization models. While not directly shown in the article, this model would potentially allow for controlling the size, depth, and severity of the laser injury opening interesting avenues for future study.

      Weaknesses:

      (1) It is unclear based on the current data/study to what extent the mild laser damage phenotype is generalizable to disease phenotypes. The outer nuclear cell loss of 28% and a complete recovery in 2 months would seem quite mild, thus the generalizability in terms of immune-mediated response in the face of retinal remodeling is not certain, specifically whether the key finding regarding the lack of neutrophil recruitment will be maintained with a stronger laser ablation.

      (2) Mice numbers and associated statistics are insufficient to draw strong conclusions in the paper on the activity of neutrophils, some examples are below :

      a) 2 catchup mice and 2 positive control EAU mice are used to draw inferences about immune-mediated activity in response to injury. If the goal was to show 'feasibility' of imaging these mouse models for the purposes of tracking specific cell type behavior, the case is sufficiently made and already published by the authors earlier. It is possible that a larger sample size would alter the conclusion.

      b) There are only 2 examples of extravasated neutrophils in the entire article, shown in the positive control EAU model. With the rare extravasation events of these cells and their high-speed motility, the chance of observing their exit from the vasculature is likely low overall, therefore the general conclusions made about their recruitment or lack thereof are not justified by these limited examples shown.

      c) In Figure 3, the 3-day time point post laser injury shows an 18% reduction in the density of ONL nuclei (p-value of 0.17 compared to baseline). In the case of neutrophils, it is noted that "Control locations (n = 2 mice, 4 z-stacks) had 15 {plus minus} 8 neutrophils per sq.mm of retina whereas lesioned locations (n = 2 mice, 4 z-stacks) had 23 {plus minus} 5 neutrophils per sq.mm of retina (Figure 10b). The difference between control and lesioned groups was not statistically significant (p = 0.19)." These data both come from histology. While the p-values - 0.17 and 0.19 - are similar, in the first case a reduction in ONL cell density is concluded while in the latter, no difference in neutrophil density is inferred in the lesioned case compared to control. Why is there a difference in the interpretation where the same statistical test and methodology are used in both cases? Besides this statistical nuance, is there an alternate possibility that there is an increased, albeit statistically insignificant, concentration of circulating neutrophils in the lesioned model? The increase is nearly 50% (15 {plus minus} 8 vs. 23 {plus minus} 5 neutrophils per sq.mm) and the reader may wonder if a larger animal number might skew the statistic towards significance.

      (2) The conclusions on the relative activity of neutrophils and microglia come from separate animals. The reader may wonder why simultaneous imaging of microglia and neutrophils is not shown in either the EAU mice or the fluorescently labeled catchup mice where the non-labeled cell type could possibly be imaged with phase-contrast as has been shown by the authors previously. One might suspect that the microglia dynamics are not substantially altered in these mice compared to the CX3CR1-GFP mice subjected to laser lesions, but for future applicability of this paradigm of in vivo imaging assessment of the laser damage model, including documenting the repeatability of the laser damage model and the immune cell behavior, acquiring these data in the same animals would be critical.

      (3) Along the same lines as above, the phase contrast ONL images at time points from 3-day to 2-month post laser injury are not shown and the absence of this data is not addressed. This missing data pertains only to the in vivo imaging mice model but are conducted in histology that adequately conveys the time-course of cell loss in the ONL. It is suggested that the reason be elaborated for the exclusion of this data and the simultaneous imaging of microglia and neutrophils mentioned above. Also, it would be valuable to further qualify and check the claims in the Discussion that "ex vivo analysis confirms in vivo findings" and "Microglial/neutrophil discrimination using label-free phase contrast"

    1. During this period of reggae’s development, a connection grew between the music and the Rastafarian movement, which encourages the relocation of the African diaspora to Africa, deifies the Ethiopian emperor Haile Selassie I (whose precoronation name was Ras [Prince] Tafari), and endorses the sacramental use of ganja (marijuana). Rastafari (Rastafarianism) advocates equal rights and justice and draws on the mystical consciousness of kumina, an earlier Jamaican religious tradition that ritualized communication with ancestors.

      Diaspora: the jews living outside Israel (https://www.merriam-webster.com/dictionary/diaspora)

      Interesting musical roots for Reggae... Wonder if this is still present?

      Mystical roots.

      (Note, I give this the fiction tag because I might want to look into this mystical religion for fiction writing as inspiration)

      Logical that marijuana (a drug) is correlated with the mystical concept of communicating with diseased spirits for marijuana makes you hallucinate (or perhaps it's demonic in nature?)

    1. Chris M. recommends to use a layered system for music categorization:

      • Layer 1) Genres / Subgenres
      • Layer 2) Energy
      • Layer 3) Vibe

      Genre itself is the main overall (and broad) genre. Subgenres are tag-like and related to when you want to play it more granularly.

      Energy is a measurement of the average energy of the song.

      Vibes refer to the emotions and memories it brings up to you and potentially others you play it for. Some questions he asks: - 1) How does it make me feel? - 2) What does it remind me of? - 3) Where would I play it? - 4) When would I play it? - 5) Why would I play it? - 6) Who would I play it for?

    1. Author response:

      Reviewer #1 (Public Review):

      Summary

      The authors asked if parabrachial CGRP neurons were only necessary for a threat alarm to promote freezing or were necessary for a threat alarm to promote a wider range of defensive behaviors, most prominently flight.

      Major Strengths of Methods and Results

      The authors performed careful single-unit recording and applied rigorous methodologies to optogenetically tag CGRP neurons within the PBN. Careful analyses show that single-units and the wider CGRP neuron population increases firing to a range of unconditioned stimuli. The optogenetic stimulation of experiment 2 was comparatively simpler but achieved its aim of determining the consequence of activating CGRP neurons in the absence of other stimuli. Experiment 3 used a very clever behavioral approach to reveal a setting in which both cue-evoked freezing and flight could be observed. This was done by having the unconditioned stimulus be a "robot" traveling along a circular path at a given speed. Subsequent cue presentation elicited mild flight in controls and optogenetic activation of CGRP neurons significantly boosted this flight response. This demonstrated for the first time that CGRP neuron activation does more than promote freezing. The authors conclude by demonstrating that bidirectional modulation of CGRP neuron activity bidirectionally aTects freezing in a traditional fear conditioning setting and aTects both freezing and flight in a setting in which the robot served as the unconditioned stimulus. Altogether, this is a very strong set of experiments that greatly expand the role of parabrachial CGRP neurons in threat alarm.

      We would like to sincerely thank the reviewer for the positive and insightful comments on our work. We greatly appreciate the acknowledgment of our new behavioral approach, which allowed us to observe a dynamic spectrum of defensive behaviors in animals. Our use of the robot-based paradigm, which enables the observation of both freezing and flight, has been instrumental in expanding our understanding of how parabrachial CGRP neurons modulate diverse threat responses. We are pleased that the reviewer found this methodological innovation to be a valuable contribution to the field.

      Weaknesses

      In all of their conditioning studies the authors did not include a control cue. For example, a sound presented the same number of times but unrelated to US (shock or robot) presentation. This does not detract from their behavioral findings. However, it means the authors do not know if the observed behavior is a consequence of pairing. Or is a behavior that would be observed to any cue played in the setting? This is particularly important for the experiments using the robot US.

      We appreciate the reviewer’s insightful comment regarding the absence of a control cue in our conditioning studies. First, we would like to mention that, in response to the Reviewer 3, we have updated how we present our flight data by following methods from previously published papers (Fadok et al., 2017; Borkar et al., 2024). Instead of counting flight responses, we calculated flight scores as the ratio of the velocity during the CS to the average velocity in the 7 s before the CS on the conditioning day (or 10 s for the retention test). This method better captures both the speed and duration of fleeing during CS. With this updated approach, we observed a significant difference in flight scores between the ChR2 and control groups, even during conditioning, which may partly address the reviewer’s concern about whether the observed behavior is a consequence of CS-US pairing.

      However, we agree with the reviewer that including an unpaired group would provide stronger evidence, and in response, we conducted an additional experiment with an unpaired group. In this unpaired group, the CS was presented the same number of times, but the robot US was delivered randomly within the inter-trial interval. The unpaired group did not exhibit any notable conditioned freezing or flight responses. We believe that this additional experiment, now reflected in Figure 3, further strengthens our conclusion that the fleeing behavior is driven by associative learning between the CS and US, rather than a reaction to the cue itself.

      The authors make claims about the contribution of CGRP neurons to freezing and fleeing behavior, however, all of the optogenetic manipulations are centered on the US presentation period. Presently, the experiments show a role for these neurons in processing aversive outcomes but show little role for these neurons in cue responding or behavior organizing. Claims of contributions to behavior should be substantiated by manipulations targeting the cue period.

      We appreciate the reviewer’s constructive comments. We would like to emphasize that our primary objective in this study was to investigate whether activating parabrachial CGRP neurons—thereby increasing the general alarm signal—would elicit different defensive behaviors beyond passive freezing. To this end, we focused on manipulating CGRP neurons during the US period rather than the cue period.

      Previous studies have shown that CGRP neurons relay US signals, and direct activation of CGRP neurons has been used as the US to successfully induce conditioned freezing responses to the CS during retention tests (Han et al., 2015; Bowen et al., 2020). In our experiments, we also observed that CGRP neurons responded exclusively to the US during conditioning with the robot (Figure 1F), and stimulating these neurons in the absence of any external stimuli elicited strong freezing responses (Figure 2B). These findings, collectively, suggest that activation of CGRP neurons during the CS period would predominantly result in freezing behavior.

      Therefore, we manipulated the activity of CGRP neurons during the US period to examine whether adjusting the perceived threat level through these neurons would result in diverse dfensive behaivors when paired with chasing robot. We observed that enhancing CGRP neuron activity while animals were chased by the robot at 70 cm/s made them react as if chased at a higher speed (90 cm/s), leading to increased fleeing behaviors. While this may not fully address the role of these neurons in cue responding or behavior organizing, we found that silencing CGRP neurons with tetanus toxin (TetTox) abolished fleeing behavior even when animals were chased at high speeds (90 cm/s), which usually elicits fleeing without CGRP manipulation (Figure 5). This supports the conclusion that CGRP neurons are necessary for processing fleeing responses.

      In summary, manipulating CGRP neurons during the US period was essential for effectively investigating their role in adjusting defensive responses, thereby expanding our understanding of their function within the general alarm system. We hope this clarifies our experimental design and addresses the concern the reviewer has raised.

      Appraisal

      The authors achieved their aims and have revealed a much greater role for parabrachial CGRP neurons in threat alarm.

      Discussion

      Understanding neural circuits for threat requires us (as a field) to examine diverse threat settings and behavioral outcomes. A commendable and rigorous aspect of this manuscript was the authors decision to use a new behavioral paradigm and measure multiple behavioral outcomes. Indeed, this manuscript would not have been nearly as impactful had they not done that. This novel behavior was combined with excellent recording and optogenetic manipulations - a standard the field should aspire to. Studies like this are the only way that we as a field will map complete neural circuits for threat.

      We sincerely thank the reviewer for their positive and encouraging comments. We are grateful for the acknowledgment of our efforts in employing a novel behavioral paradigm to study diverse defensive behaviors. We are pleased that our work contributes to advancing the understanding of neural circuits involved in threat responses.

      Reviewer #3 (Public Review):

      Strengths:

      The study used optogenetics together with in vivo electrophysiology to monitor CGRP neuron activity in response to various aversive stimuli including robot chasing to determine whether they encode noxious stimuli diTerentially. The study used an interesting conditioning paradigm to investigate the role of CGRP neurons in the PBN in both freezing and flight behaviors.

      Weakness:

      The major weakness of this study is that the chasing robot threat conditioning model elicits weak unconditioned and conditioned flight responses, making it diTicult to interpret the robustness of the findings. Furthermore, the conclusion that the CGRP neurons are capable of inducing flight is not substantiated by the data. No manipulations are made to influence the flight behavior of the mouse. Instead, the manipulations are designed to alter the intensity of the unconditioned stimulus.

      We sincerely thank the reviewer for the thoughtful and constructive comments on our manuscript. In response to this feedback, we revisited our analysis of the flight responses and compared our methods with those used in previous literatures examining similar behaviors.

      We reviewed a study investigating sex differences in defensive behavior using rats (Gruene et al., 2015). In that study, the CS was presented for 30 s, and active defensive behvaior – referred to as ‘darting’ – was quantified as ‘Dart rate (dart/min)’. This was calculated by doubling the number of darts counted during the 30-s CS presentation to extrapolate to a per-min rate. The highest average dart rate observed was approximatley 1.5. Another relevant studies using mice quantified active defensive behavior by calculating a flight score—the ratio of the average speed during each CS to the average speed during the 10 s pre-CS period (Fadok et al., 2017; Borkar et al., 2024). This method captures multiple aspects of flight behavior during CS presentation, including overall velocity, number of bouts, and duration of fleeing. Moreover, it accounts for each animal’s individual velocity prior to the CS, reflecting how fast the animals were fleeing relative to their baseline activity.

      In our original analysis, we quantified flight responses by counting rapid fleeing movements, defined as movements exceeding 8 cm/s. This approach was consistent with our previous study using the same robot paradigm to observe unique patterns of defensive behavior related to sex differences (Pyeon et al., 2023). Based on our earlier findings, where this approach effectively identified significant differences in defensive behaviors, we believed that this method was appropriate for capturing conditioned flight behavior within our specific experimental context. However, prompted by the reviewer's insightful comments, we recognized that our initial method might not fully capture the robustness of the flight responses. Therefore, we re-analyzed our data using the flight score method described by Fadok and colleagues, which provides a more sensitive measure of fleeing during the CS.

      Re-analyzing our data revealed a more robust flight response than previously reported, demonstrating that additional CGRP neuron stimulation promoted flight behavior in animals during conditioning, addressing the concern that the data did not substantiate the role of CGRP neurons in inducing flight. In addition, we would like to emphasize the findings from our final experiment, where silencing CGRP neurons, even under high-threat conditions (90 cm/s), prevented animals from exhibiting flight responses. This demonstrates that CGRP neurons are necessary in influencing flight responses.

      We have updated all flight data in the manuscript and revised the relevant figures and text accordingly. We appreciate the opportunity to enhance our analysis. The reviewer's insightful observation led us to adopt a better method for quantifying flight behavior, which substantiates our conclusion about the role of CGRP neurons in modulating defensive responses.

      Borkar, C.D., Stelly, C.E., Fu, X., Dorofeikova, M., Le, Q.-S.E., Vutukuri, R., et al. (2024). Top- down control of flight by a non-canonical cortico-amygdala pathway. Nature 625(7996), 743-749.

      Bowen, A.J., Chen, J.Y., Huang, Y.W., Baertsch, N.A., Park, S., and Palmiter, R.D. (2020). Dissociable control of unconditioned responses and associative fear learning by parabrachial CGRP neurons. Elife 9, e59799.

      Fadok, J.P., Krabbe, S., Markovic, M., Courtin, J., Xu, C., Massi, L., et al. (2017). A competitive inhibitory circuit for selection of active and passive fear responses. Nature 542(7639), 96-100.

      Gruene, T.M., Flick, K., Stefano, A., Shea, S.D., and Shansky, R.M. (2015). Sexually divergent expression of active and passive conditioned fear responses in rats. Elife 4, e11352.

      Han, S., Soleiman, M.T., Soden, M.E., Zweifel, L.S., and Palmiter, R.D. (2015). Elucidating an a_ective pain circuit that creates a threat memory. Cell 162(2), 363-374.

      Pyeon, G.H., Lee, J., Jo, Y.S., and Choi, J.-S. (2023). Conditioned flight response in female rats to naturalistic threat is estrous-cycle dependent. Scientific Reports 13(1), 20988.

    1. Résumé de la vidéo [00:00:00][^1^][1] - [00:10:23][^2^][2]:

      Cette vidéo explore comment les adolescentes YouTubeuses mettent en scène leur féminité en ligne. Elle présente les recherches de Claire Balle, sociologue, sur les pratiques numériques des jeunes filles sur YouTube.

      Points forts : + [00:00:00][^3^][3] Développement de l'identité féminine * Affirmation identitaire en ligne * Étude des vidéos de filles et garçons * Importance des vidéos "je suis bizarre" et "anti-boyfriend tag" + [00:02:47][^4^][4] Proximité et sociabilité * Partage d'expériences personnelles * Attente de soutien des abonnés * Mention fréquente d'autres YouTubeuses + [00:04:46][^5^][5] Utilisation de l'intimité * Validation de l'identité par les pairs * Différences de genre dans l'expression de l'intimité * Sexualité et honte corporelle chez les filles + [00:06:30][^6^][6] Caractéristiques féminines involontaires * Manies et habitudes perçues comme féminines * Exigences dans le domaine amoureux * Perfectionnisme et propreté + [00:07:52][^7^][7] Dramatisation et standardisation * Effets de dramatisation pour représenter la féminité * Standardisation des modes de présentation * Influence des médias et réseaux sociaux

    1. Welcome back and in this demo lesson you're going to learn how to install the Docker engine inside an EC2 instance and then use that to create a Docker image.

      Now this Docker image is going to be running a simple application and we'll be using this Docker image later in this section of the course to demonstrate the Elastic Container service.

      So this is going to be a really useful demo where you're going to gain the experience of how to create a Docker image.

      Now there are a few things that you need to do before we get started.

      First as always make sure that you're logged in to the I am admin user of the general AWS account and you'll also need the Northern Virginia region selected.

      Now attached to this lesson is a one-click deployment link so go ahead and click that now.

      This is going to deploy an EC2 instance with some files pre downloaded that you'll use during the demo lesson.

      Now everything's pre-configured you just need to check this box at the bottom and click on create stack.

      Now that's going to take a few minutes to create and we need this to be in a create complete state.

      So go ahead and pause the video wait for your stack to move into create complete and then we're good to continue.

      So now this stack is in a create complete state and we're good to continue.

      Now if you're following along with this demo within your own environment there's another link attached to this lesson called the lesson commands document and that will include all of the commands that you'll need to type as you move through the demo.

      Now I'm a fan of typing all commands in manually because I personally think that it helps you learn but if you are the type of person who has a habit of making mistakes when typing along commands out then you can copy and paste from this document to avoid any typos.

      Now one final thing before we finish at the end of this demo lesson you'll have the opportunity to upload the Docker image that you create to Docker Hub.

      If you're going to do that then you should pre sign up for a Docker Hub account if you don't already have one and the link for this is included attached to this lesson.

      If you already have a Docker Hub account then you're good to continue.

      Now at this point what we need to do is to click on the resources tab of this stack and locate the public EC2 resource.

      Now this is a normal EC2 instance that's been provisioned on your behalf and it has some files which have been pre downloaded to it.

      So just go ahead and click on the physical ID next to public EC2 and that will move you to the EC2 console.

      Now this machine is set up and ready to connect to and I've configured it so that we can connect to it using Session Manager and this avoids the need to use SSH keys.

      So to do that just right-click and then select connect.

      You need to pick Session Manager from the tabs across the top here and then just click on connect.

      Now that will take a few minutes but once connected you should see this prompt.

      So it should say SH- and then a version number and then dollar.

      Now the first thing that we need to do as part of this demo lesson is to install the Docker engine.

      The Docker engine is the thing that allows Docker containers to run on this EC2 instance.

      So we need to install the Docker engine package and we'll do that using this command.

      So we're using shudu to get admin permissions then the package manager DNF then install then Docker.

      So go ahead and run that and that will begin the installation of Docker.

      It might take a few moments to complete it might have to download some prerequisites and you might have to answer that you're okay with the install.

      So press Y for yes and then press enter.

      Now we need to wait a few moments for this install process to complete and once it has completed then we need to start the Docker service and we do that using this command.

      So shudu again to get admin permissions and then service and then the Docker service and then start.

      So type that and press enter and that starts the Docker service.

      Now I'm going to type clear and then press enter to make this easier to see and now we need to test that we can interact with the Docker engine.

      So the most simple way to do that is to type Docker space and then PS and press enter.

      Now you're going to get an error.

      This error is because not every user of this EC2 instance has the permissions to interact with the Docker engine.

      We need to grant permissions for this user or any other users of this EC2 instance to be able to interact with the Docker engine and we're going to do that by adding these users to a group and we do that using this command.

      So shudu for admin permissions and then user mod -a -g for group and then the Docker group and then EC2 -user.

      Now that will allow a local user of this system, specifically EC2 -user, to be able to interact with the Docker engine.

      Okay so I've cleared the screen to make it slightly easier to see now that we've added EC2 -user the ability to interact with Docker.

      So the next thing is we need to log out and log back in of this instance.

      So I'm going to go ahead and type exit just to disconnect from session manager and then click on close and then I'm going to reconnect to this instance and you need to do the same.

      So connect back in to this EC2 instance.

      Now once you're connected back into this EC2 instance we need to run another command which moves us into EC2 user so it basically logs us in as EC2 -user.

      So that's this command and the result of this would be the same as if you directly logged in to EC2 -user.

      Now the reason we're doing it this way is because we're using session manager so that we don't need a local SSH client or to worry about SSH keys.

      We can directly log in via the console UI we just then need to switch to EC2 -user.

      So run this command and press enter and we're now logged into the instance using EC2 -user and to test everything's okay we need to use a command with the Docker engine and that command is Docker space ps and if everything's okay you shouldn't see any output beyond this list of headers.

      What we've essentially done is told the Docker engine to give us a list of any running containers and even though we don't have any it's not erred it's simply displayed this empty list and that means everything's okay.

      So good job.

      Now what I've done to speed things up if you just run an LS and press enter the instance has been configured to download the sample application that we're going to be using and that's what the file container.zip is within this folder.

      I've configured the instance to automatically extract that zip file which has created the folder container.

      So at this point I want you to go ahead and type cd space container and press enter and that's going to move you inside this container folder.

      Then I want you to clear the screen by typing clear and press enter and then type ls space -l and press enter.

      Now this is the web application which I've configured to be automatically downloaded to the EC2 instance.

      It's a simple web page we've got index.html which is the index we have a number of images which this index.html contains and then we have a docker file.

      Now this docker file is the thing that the docker engine will use to create our docker image.

      I want to spend a couple of moments just stepping you through exactly what's within this docker file.

      So I'm going to move across to my text editor and this is the docker file that's been automatically downloaded to your EC2 instance.

      Each of these lines is a directive to the docker engine to perform a specific task and remember we're using this to create a docker image.

      This first line tells the docker engine that we want to use version 8 of the Red Hat Universal base image as the base component for our docker image.

      This next line sets the maintainer label it's essentially a brief description of what the image is and who's maintaining it in this case it's just a placeholder of animals for life.

      This next line runs a command specifically the yum command to install some software specifically the Apache web server.

      This next command copy copies files from the local directory when you use the docker command to create an image so it's copying that index.html file from this local folder that I've just been talking about and it's going to put it inside the docker image in this path so it's going to copy index.html to /var/www/html and this is where an Apache web server expects this index.html to be located.

      This next command is going to do the same process for all of the jpegs in this folder so we've got a total of six jpegs and they're going to be copied into this folder inside the docker image.

      This line sets the entry point and this essentially determines what is first run when this docker image is used to create a docker container.

      In this example it's going to run the Apache web server and finally this expose command can be used for a docker image to tell the docker engine which services should be exposed.

      Now this doesn't actually perform any configuration it simply tells the docker engine what port is exposed in this case port 80 which is HTTP.

      Now this docker file is going to be used when we run the next command which is to create a docker image.

      So essentially this file is the same docker file that's been downloaded to your EC2 instance and that's what we're going to run next.

      So this is the next command within the lesson commands document and this command builds a container image.

      What we're essentially doing is giving it the location of the docker file.

      This dot at the end contains the working directory so it's here where we're going to find the docker file and any associated files that that docker file uses.

      So we're going to run this command and this is going to create our docker image.

      So let's go ahead and run this command.

      It's going to download version 8 of UBI which it will use as a starting point and then it's going to run through every line in the docker file performing each of the directives and each of those directives is going to create another layer within the docker image.

      Remember from the theory lesson each line within the docker file generally creates a new file system layer so a new layer of a docker image and that's how docker images are efficient because you can reuse those layers.

      Now in this case this has been successful.

      We've successfully built a docker image with this ID so it's giving it a unique ID and it's tagged this docker image with this tag colon latest.

      So this means that we have a docker image that's now stored on this EC2 instance.

      Now I'll go ahead and clear the screen to make it easier to see and let's go ahead and run the next command which is within the lesson commands document and this is going to show us a list of images that are on this EC2 instance but we're going to filter based on the name container of cats and this will show us the docker image which we've just created.

      So the next thing that we need to do is to use the docker run command which is going to take the image that we've just created and use it to create a running container and it's that container that we're going to be able to interact with.

      So this is the command that we're going to use it's the next one within the lesson commands document.

      It's docker run and then it's telling it to map port 80 on the container with port 80 on the EC2 instance and it's telling it to use the container of cats image and if we run that command docker is going to take the docker image that we've got on this EC2 instance run it to create a running container and we should be able to interact with that container.

      So if you go back to the AWS console if we click on instances so look for a4l-public EC2 that's in the running state.

      I'm just going to go ahead and select this instance so that we can see the information and we need the public IP address of this instance.

      Go ahead and click on this icon to copy the public IP address into your clipboard and then open that in a new tab.

      Now be sure not to use this link to the right because that's got a tendency to open the HTTPS version.

      We just need to use the IP address directly.

      So copy that into your clipboard open a new tab and then open that IP address and now we can see the amazing application if it fits i sits in a container in a container and this amazing looking enterprise application is what's contained in the docker image that you just created and it's now running inside a container based off that image.

      So that's great everything's working as expected and that's running locally on the EC2 instance.

      Now in the demo lesson for the elastic container service that's coming up later in this section of the course you have two options.

      You can either use my docker image which is this image that I've just created or you can use your own docker image.

      If you're going to use my docker image then you can skip this next step.

      You don't need a docker hub account and you don't need to upload your image.

      If you want to use your own image then you do need to follow these next few steps and I need to follow them anyway because I need to upload this image to docker hub so that you can potentially use it rather than your own image.

      So I'm going to move back to the session manager tab and I'm going to control C to exit out of this running container and I'm going to type clear to clear the screen and make it easier to see.

      Now to upload this to docker hub first you need to log in to docker hub using your credentials and you can do that using this command.

      So it's docker space login space double hyphen username equals and then your username.

      So if you're doing this in your own environment you need to delete this placeholder and type your username.

      I'm going to type my username because I'll be uploading this image to my docker hub.

      So this is my docker hub username and then press enter and it's going to ask for the corresponding password to this username.

      So I'm going to paste in my password if you're logging into your docker hub you should use your password.

      Once you've pasted in the password go ahead and press enter and that will log you in to docker hub.

      Now you don't have to worry about the security message because whilst your docker hub password is going to be stored on the EC2 instance shortly we're going to terminate this instance which will remove all traces of this password from this machine.

      Okay so again we're going to upload our docker image to docker hub so let's run this command again and you'll see because we're just using the docker images command we can see the base image as well as our image.

      So we can see red hat UBI 8.

      We want the container of cats latest though so what you need to do is copy down the image ID of the container of cats image.

      So this is the top line in my case container of cats latest and then the image ID.

      So then we need to run this command so docker space tag and then the image ID that you've just copied into your clipboard and then a space and then your docker hub username.

      In my case it's actrl with 1L if you're following along you need to use your own username and then forward slash and then the name of the image that you want this to be stored as on docker hub so I'm going to use container of cats.

      So that's the command you need to use so docker tag and then your image ID for container of cats and then your username forward slash container of cats and press enter and that's everything we need to do to prepare to upload this image to docker hub.

      So the last command that we need to run is the command to actually upload the image to docker hub and that command is docker space push so we're going to push the image to docker hub then we need to specify the docker hub username so again this is my username but if you're doing this in your environment it needs to be your username and then forward slash and then the image name in my case container of cats and then colon latest and once you've got all that go ahead and press enter and that's going to push the docker image that you've just created up to your docker hub account and once it's up there it means that we can deploy from that docker image to other EC2 instances and even ECS and we're going to do that in a later demo in this section of the course.

      Now that's everything that you need to do in this demo lesson you've essentially installed and configured the docker engine you've used a docker file to create a docker image from some local assets you've tested that docker image by running a container using that image and then you've uploaded that image to docker hub and as I mentioned before we're going to use that in a future demo lesson in this section of the course.

      Now the only thing that remains to do is to clear up the infrastructure that we've used in this demo lesson so go ahead and close down all of these extra tabs and go back to the cloud formation console this is the stack that's been created by the one click deployment link so all you need to do is select this stack it should be called EC2 docker and then click on delete and confirm that deletion and that will return the account into the same state as it was at the start of this demo lesson.

      Now that is everything you need to do in this demo lesson I hope it's been useful and I hope you've enjoyed it so go ahead and complete the video and when you're ready I look forward to you joining me in the next.

    1. Welcome back and we're going to use this demo lesson to get some experience of working with EBS and Instant Store volumes.

      Now before we get started, this series of demo videos will be split into two main components.

      The first component will be based around EBS and EBS snapshots and all of this will come under the free tier.

      The second component will be based on Instant Store volumes and will be using larger instances which are not included within the free tier.

      So I'm going to make you aware of when we move on to a part which could incur some costs and you can either do that within your own environment or watch me do it in the video.

      If you do decide to do it in your own environment, just be aware that there will be a 13 cents per hour cost for the second component of this demo series and I'll make it very clear when we move into that component.

      The second component is entirely optional but I just wanted to warn you of the potential cost in advance.

      Now to get started with this demo, you're going to need to deploy some infrastructure.

      To do that, make sure that you're logged in to the general account, so the management account of the organization and you've got the Northern Virginia region selected.

      Now attached to this demo is a one click deployment link to deploy the infrastructure.

      So go ahead and click on that link.

      That's going to open this quick create stack screen and all you need to do is scroll down to the bottom, check this capabilities box and click on create stack.

      Now you're going to need this to be in a create complete state before you continue with this demo.

      So go ahead and pause the video, wait for that stack to move into the create complete status and then you can continue.

      Okay, now that's finished and the stack is in a create complete state.

      You're also going to be running some commands within EC2 instances as part of this demo.

      Also attached to this lesson is a lesson commands document which contains all of those commands and you can use this to copy and paste which will avoid errors.

      So go ahead and open that link in a separate browser window or separate browser tab.

      It should look something like this and we're going to be using this throughout the lesson.

      Now this cloud formation template has created a number of resources, but the three that we're concerned about are the three EC2 instances.

      So instance one, instance two and instance three.

      So the next thing to do is to move across to the EC2 console.

      So click on the services drop down and then either locate EC2 under all services, find it in recently visited services or you can use the search box at the top type EC2 and then open that in a new tab.

      Now the EC2 console is going through a number of changes so don't be alarmed if it looks slightly different or if you see any banners welcoming you to this new version.

      Now if you click on instances running, you'll see a list of the three instances that we're going to be using within this demo lesson.

      We have instance one - az a.

      We have instance two - az a and then instance one - az b.

      So these are three instances, two of which are in availability zone A and one which is in availability zone B.

      Next I want you to scroll down and locate volumes under elastic block store and just click on volumes.

      And what you'll see is three EBS volumes, each of which is eight GIB in size.

      Now these are all currently in use.

      You can see that in the state column and that's because all of these volumes are in use as the boot volumes for those three EC2 instances.

      So on each of these volumes is the operating system running on those EC2 instances.

      Now to give you some experience of working with EBS volumes, we're going to go ahead and create a volume.

      So click on the create volume button.

      The first thing you'll need to do when creating a volume is pick the type and there are a number of different types available.

      We've got GP2 and GP3 which are the general purpose storage types.

      We're going to use GP3 for this demo lesson.

      You could also select one of the provisioned IOPS volumes.

      So this is currently IO1 or IO2.

      And with both of these volume types, you're able to define IOPS separately from the size of the volume.

      So these are volume types that you can use for demanding storage scenarios where you need high-end performance or when you need especially high performance for smaller volume sizes.

      Now IO1 was the first type of provisioned IOPS SSD introduced by AWS and more recently they've introduced IO2 and enhanced it which provides even higher levels of performance.

      In addition to that we do have the non-SSD volume types.

      So SC1 which is cold HDD, ST1 which is throughput optimized HDD and then of course the original magnetic type which is now legacy and AWS don't recommend this for any production usage.

      For this demo lesson we're going to go ahead and select GP3.

      So select that.

      Next you're able to pick a size in GIB for the volume.

      We're going to select a volume size of 10 GIB.

      Now EBS volumes are created within a specific availability zone so you have to select the availability zone when you're creating the volume.

      At this point I want you to go ahead and select US-EAST-1A.

      When creating volume you're also able to specify a snapshot as the basis for that volume.

      So if you want to restore a snapshot into this volume you can select that here.

      At this stage in the demo we're going to be creating a blank EBS volume so we're not going to select anything in this box.

      We're going to be talking about encryption later in this section of the course.

      You are able to specify encryption settings for the volume when you create it but at this point we're not going to encrypt this volume.

      We do want to add a tag so that we can easily identify the volume from all of the others so click on add tag.

      For the key we're going to use name.

      For the value we're going to put EBS test volume.

      So once you've entered both of those go ahead and click on create volume and that will begin the process of creating the volume.

      Just close down any dialogues and then just pay attention to the different states that this volume goes through.

      It begins in a creating state.

      This is where the storage is being provisioned and then made available by the EBS product.

      If we click on refresh you'll see that it changes from creating to available and once it's in an available state this means that we can attach it to EC2 instances.

      And that's what we're going to do so we're going to right click and select attach volume.

      Now you're able to attach this volume to EC2 instances but crucially only those in the same availability zone.

      EBS is an availability zone scoped service and so you can only attach EBS volumes to EC2 instances within that same availability zone.

      So if we select the instance box you'll only see instances in that same availability zone.

      Now at this point go ahead and select instance 1 in availability zone A.

      Once you've selected it you'll see that the device field is populated and this is the device ID that the instance will see for this volume.

      So this is how the volume is going to be exposed to the EC2 instance.

      So if we want to interact with this instance inside the operating system this is the device that we'll use.

      Now different operating systems might see this in slightly different ways.

      So as this warning suggests certain Linux kernels might rename SDF to XVDF.

      So we've got to be aware that when you do attach a volume to an EC2 instance you need to get used to how that's seen inside the operating system.

      How we can identify it and how we can configure it within the operating system for use.

      And I'm going to demonstrate that in the next part of this demo lesson.

      So at this point just go ahead and click on attach and this will attach this volume to the EC2 instance.

      Once that's attached to the instance and you see the state change to in use then just scroll up on the left hand side and select instances.

      We're going to go ahead and connect to instance 1 in availability zone A.

      This is the instance that we just attached that EBS volume to so we want to interact with this instance and see how we can see the EBS volume.

      So right click on this instance and select connect and then you could either connect with an SSH client or use instance connect and to keep things simple we're going to connect from our browser so select the EC2 instance connect option make sure the user's name is set to EC2-user and then click on connect.

      So now we connected to this EC2 instance and it's at this point that we'll start needing the commands that are listed inside the lesson commands document and again this is attached to this lesson.

      So first we need to list all the block devices which are connected to this instance and we're going to use the LSBLK command.

      Now if you're not comfortable with Linux don't worry just take this nice and slowly and understand at a high level all the commands that we're going to run.

      So the first one is LSBLK and this is list block devices.

      So if we run this we'll be able to see a list of all of the block devices connected to this EC2 instance.

      You'll see the root device this is the device that's used to boot the instance it contains the instance operating system you'll see that it's 8 gig in size and then this is the EBS volume that we just attached to this instance.

      You'll see that device ID so XVDF and you'll see that it's 10 gig in size.

      Now what we need to do next is check whether there is a file system on this block device.

      So this block device we've created it with EBS and then we've attached it to this instance.

      Now we know that it's blank but it's always safe to check if there's any file system on a block device.

      So to do that we run this command.

      So we're going to check are there any file systems on this block device.

      So press enter and if you see just data that indicates that there isn't any file system on this device and so we need to create one.

      You can only mount file systems under Linux and so we need to create a file system on this raw block device this EBS volume.

      So to do that we run this command.

      So shoo-doo again is just giving us admin permissions on this instance.

      MKFS is going to make a file system.

      We specify the file system type with hyphen t and then XFS which is a type of file system and then we're telling it to create this file system on this raw block device which is the EBS volume that we just attached.

      So press enter and that will create the file system on this EBS volume.

      We can confirm that by rerunning this previous command and this time instead of data it will tell us that there is now an XFS file system on this block device.

      So now we can see the difference.

      Initially it just told us that there was data, so raw data on this volume and now it's indicating that there is a file system, the file system that we just created.

      Now the way that Linux works is we mount a file system to a mount point which is a directory.

      So we're going to create a directory using this command.

      MKDIR makes a directory and we're going to call the directory forward slash EBS test.

      So this creates it at the top level of the file system.

      This signifies root which is the top level of the file system tree and we're going to make a folder inside here called EBS test.

      So go ahead and enter that command and press enter and that creates that folder and then what we can do is to mount the file system that we just created on this EBS volume into that folder.

      And to do that we use this command, mount.

      So mount takes a device ID, so forward slash dev forward slash xvdf.

      So this is the raw block device containing the file system we just created and it's going to mount it into this folder.

      So type that command and press enter and now we have our EBS volume with our file system mounted into this folder.

      And we can verify that by running a df space hyphen k.

      And this will show us all of the file systems on this instance and the bottom line here is the one that we've just created and mounted.

      At this point I'm just going to clear the screen to make it easier to see and what we're going to do is to move into this folder.

      So cd which is change directory space forward slash EBS test and then press enter and that will move you into that folder.

      Once we're in that folder we're going to create a test file.

      So we're going to use this command so shudu nano which is a text editor and we're going to call the file amazing test file dot txt.

      So type that command in and press enter and then go ahead and type a message.

      It can be anything you just need to recognize it as your own message.

      So I'm going to use cats are amazing and then some exclamation marks.

      Then I'm going to press control o and enter to save that file and then control x to exit again clear the screen to make it easier to see.

      And then I'm going to do an LS space hyphen LA and press enter just to list the contents of this folder.

      So as you can see we've now got this amazing test file dot txt.

      And if we cat the contents of this so cat amazing test file dot txt you'll see the unique message that you just typed in.

      So at this point we've created this file within the folder and remember the folder is now the mount point for the file system that we created on this EBS volume.

      So the next step that I want you to do is to reboot this EC2 instance.

      To do that type sudo space and then reboot and press enter.

      Now this will disconnect you from this session.

      So you can go ahead and close down this tab and go back to the EC2 console.

      Just go ahead and click on instances.

      Okay, so this is the end of part one of this lesson.

      It was getting a little bit on the long side and so I wanted to add a break.

      It's an opportunity just to take a rest or grab a coffee.

      Part two will be continuing immediately from the end of part one.

      So go ahead complete the video and when you're ready join me in part two.

    1. Author response:

      The following is the authors’ response to the original reviews.

      New Experiments

      (1) Activation-dependent dynamics of PKA with the RIα regulatory subunit, adding to the answer to Reviewers 1 and 2. To determine the dynamics of all PKA isoforms, we have added experiments that used PKA-RIα as the regulatory subunit. We found differential translocation between PKA-C (co-expressed with PKA-RIα) and PKA-RIα (Figure 1–figure supplement 3), similar to the results when PKA-RIIα or PKA-RIβ was used.

      (2) PKA-C dynamics elicited by a low concentration of norepinephrine, addressing Reviewer 3’s comment. We have found that PKA-C (co-expressed with RIIα) exhibited similar translocation into dendritic spines in the presence of a 5x lowered concentration (2 μM) of norepinephrine, suggesting that the translocation occurs over a wide range of stimulus strengths (Figure 1-figure supplement 2).

      Reviewer #1 (Public Review):

      Summary:

      This is a short self-contained study with a straightforward and interesting message. The paper focuses on settling whether PKA activation requires dissociation of the catalytic and regulatory subunits. This debate has been ongoing for ~ 30 years, with renewed interest in the question following a publication in Science, 2017 (Smith et al.). Here, Xiong et al demonstrate that fusing the R and C subunits together (in the same way as Smith et al) prevents the proper function of PKA in neurons. This provides further support for the dissociative activation model - it is imperative that researchers have clarity on this topic since it is so fundamental to building accurate models of localised cAMP signalling in all cell types. Furthermore, their experiments highlight that C subunit dissociation into spines is essential for structural LTP, which is an interesting finding in itself. They also show that preventing C subunit dissociation reduces basal AMPA receptor currents to the same extent as knocking down the C subunit. Overall, the paper will interest both cAMP researchers and scientists interested in fundamental mechanisms of synaptic regulation.

      Strengths:

      The experiments are technically challenging and well executed. Good use of control conditions e.g untransfected controls in Figure 4.

      We thank the reviewer for their accurate summarization of the position of the study in the field and for the positive evaluation of our study.

      Weaknesses:

      The novelty is lessened given the same team has shown dissociation of the C subunit into dendritic spines from RIIbeta subunits localised to dendritic shafts before (Tillo et al., 2017). Nevertheless, the experiments with RII-C fusion proteins are novel and an important addition.

      We thank the reviewer for noticing our earlier work. The first part of the current work is indeed an extension of previous work, as we have articulated in the manuscript. However, this extension is important because recent studies suggested that the majority of PKA-RIIβ are axonal localized. The primary PKA subtypes in the soma and dendrite are likely PKA-RIβ or PKA-RIIα. Although it is conceivable that the results from PKA-RIIβ can be extended to the other subunits, given the current debate in the field regarding PKA dissociation (or not), it remains important to conclusively demonstrate that these other regulatory subunit types also support PKA dissociation within intact cells in response to a physiological stimulant. To complete the survey for all PKA-R isoforms, we have now added data for PKA-RIα (New Experiment #1), as they are also expressed in the brain (e.g., https://www.ncbi.nlm.nih.gov/gene/5573). Additionally, as the reviewer points out, our second part is a novel addition to the literature.

      Reviewer #2 (Public Review):

      Summary:

      PKA is a major signaling protein that has been long studied and is vital for synaptic plasticity. Here, the authors examine the mechanism of PKA activity and specifically focus on addressing the question of PKA dissociation as a major mode of its activation in dendritic spines. This would potentially allow us to determine the precise mechanisms of PKA activation and address how it maintains spatial and temporal signaling specificity.

      Strengths:

      The results convincingly show that PKA activity is governed by the subcellular localization in dendrites and spines and is mediated via subunit dissociation. The authors make use of organotypic hippocampal slice cultures, where they use pharmacology, glutamate uncaging, and electrophysiological recordings.

      Overall, the experiments and data presented are well executed. The experiments all show that at least in the case of synaptic activity, the distribution of PKA-C to dendritic spines is necessary and sufficient for PKA-mediated functional and structural plasticity.

      The authors were able to persuasively support their claim that PKA subunit dissociation is necessary for its function and localization in dendritic spines. This conclusion is important to better understand the mechanisms of PKA activity and its role in synaptic plasticity.

      We thank the reviewer for their positive evaluation of our study.

      Weaknesses:

      While the experiments are indeed convincing and well executed, the data presented is similar to previously published work from the Zhong lab (Tillo et al., 2017, Zhong et al 2009). This reduces the novelty of the findings in terms of re-distribution of PKA subunits, which was already established. A few alternative approaches for addressing this question: targeting localization of endogenous PKA, addressing its synaptic distribution, or even impairing within intact neuronal circuits, would highly strengthen their findings. This would allow us to further substantiate the synaptic localization and re-distribution mechanism of PKA as a critical regulator of synaptic structure, function, and plasticity.

      We thank the reviewer for noticing our earlier work. The first part of the current work is indeed an extension of previous work, as we have articulated in the manuscript. However, this extension is important because recent studies suggested that the majority of PKA-RIIβ are axonal localized. The primary PKA subtypes in the soma and dendrite are likely PKA-RIβ or PKA-RIIα. Although it is conceivable that the results from PKA-RIIβ can be extended to the other subunits, given the current debate in the field regarding PKA dissociation (or not), it remains important to conclusively demonstrate that these other regulatory subunit types also support PKA dissociation within intact cells in response to a physiological stimulant. To complete the survey for all PKA-R isoforms, we have now added data for PKA-RIα (New Experiment #1), as they are also expressed in the brain (e.g., https://www.ncbi.nlm.nih.gov/gene/5573). Additionally, as Reviewer 1 points out, our second part is a novel addition to the literature.

      We also thank the reviewer for suggesting the experiments to examine PKA’s synaptic localization and dynamics as a key mechanism underlying synaptic structure and function. We agree that this is a very interesting topic. At the same time, we feel that this mechanistic direction is open ended at this time and beyond what we try to conclude within this manuscript: prevention of PKA dissociation in neurons affects synaptic function. Therefore, we will save the suggested direction for future studies. We hope the reviewer understand.

      Reviewer #3 (Public Review):

      Summary:

      Xiong et al. investigated the debated mechanism of PKA activation using hippocampal CA1 neurons under pharmacological and synaptic stimulations. Examining the two PKA major isoforms in these neurons, they found that a portion of PKA-C dissociates from PKA-R and translocates into dendritic spines following norepinephrine bath application. Additionally, their use of a non-dissociable form of PKC demonstrates its essential role in structural long-term potentiation (LTP) induced by two-photon glutamate uncaging, as well as in maintaining normal synaptic transmission, as verified by electrophysiology. This study presents a valuable finding on the activation-dependent re-distribution of PKA catalytic subunits in CA1 neurons, a process vital for synaptic functionality. The robust evidence provided by the authors makes this work particularly relevant for biologists seeking to understand PKA activation and its downstream effects essential for synaptic plasticity.

      Strengths:

      The study is methodologically robust, particularly in the application of two-photon imaging and electrophysiology. The experiments are well-designed with effective controls and a comprehensive analysis. The credibility of the data is further enhanced by the research team's previous works in related experiments. The conclusions of this paper are mostly well supported by data. The research fills a significant gap in our understanding of PKA activation mechanisms in synaptic functioning, presenting valuable insights backed by empirical evidence.

      We thank the reviewer for their positive evaluation of our study.

      Weaknesses:

      The physiological relevance of the findings regarding PKA dissociation is somewhat weakened by the use of norepinephrine (10 µM) in bath applications, which might not accurately reflect physiological conditions. Furthermore, the study does not address the impact of glutamate uncaging, a well-characterized physiologically relevant stimulation, on the redistribution of PKA catalytic subunits, leaving some questions unanswered.

      We agreed with the Reviewer that testing under physiological conditions is critical especially given the current debate in the literature. That is why we tested PKA dynamics induced by the physiological stimulant, norepinephrine. It has been suggested that, near the release site, local norepinephrine concentrations can be as high as tens of micromolar (Courtney and Ford, 2014). Based on this study, we have chosen a mid-range concentration (10 μM). At the same time, in light of the Reviewer’s suggestion, we have now also tested PKA-RIIα dissociation at a 5x lower concentration of norepinephrine (2 μM; New Experiment #2). The activation and translocation of PKA-C is also readily detectible under this condition to a degree comparable to when 10 μM norepinephrine was used.

      Regarding the suggested glutamate uncaging experiment, it is extremely challenging because of finite signal-to-noise ratios in our experiments. From our past studies, we know that activated PKA-C can diffuse three dimensionally, with a fraction as membrane-associated proteins and the other as cytosolic proteins. Although we have evidence that its membrane affinity allows it to become enriched in dendritic spines, it is not known (and is unlikely) that activated PKA-C is selectively targeted to a particular spine. Glutamate uncaging of a single spine presumably would locally activate a small number of PKA-C. It will be very difficult to trace the 3D diffusion of these small number of molecules in the presence of surrounding resting-state PKA-C molecules. Finally, we hope the reviewer agrees that, regardless of the result of the glutamate uncaging experiment, the above new experiment (New Experiment #2) already indicate that certain physiologically relevant stimuli can drive PKA-C dissociation from PKA-R and translocation to spines, supporting our conclusion.

      Reviewer #2 (Recommendations For The Authors):

      It was a pleasure reading your paper, and the results are well-executed and well-presented.

      My main and only recommendations are two ways to further expand the scope of the findings.

      First, I believe addressing the endogenous localization of PKA-C subunit before and after PKA activation would be highly important to validate these claims. Overexpression of tagged proteins often shows vastly different subcellular distribution than their endogenous counterparts. Recent technological advances with CRISPR/Cas9 gene editing (Suzuki et al Nature 2016 and Gao et al Neuron 2019 for example) which the Zhong lab recently contributed to (Zhong et al 2021 eLife) allow us to tag endogenous proteins and image them in fixed or live neurons. Any experiments targeting endogenous PKA subunits that support dissociation and synaptic localization following activation would be very informative and greatly increase the novelty and impact of their findings.

      We agreed that addressing the endogenous PKA dynamics is important. However, despite recent progress, endogenous labeling using CRISPR-based methods remains challenging and requires extensive optimization. This is especially true for signaling proteins whose endogenous abundance is often low. We have tried to label PKA catalytic subunits and regulatory subunits using both the homologous recombination-based method SLENDR and our own non-homologous end joining-based method CRISPIE. We did not succeed, in part because it is very difficult to see any signal under wide-field fluorescence conditions, which makes it difficult to screen different constructs for optimizing parameters. It is also possible that, at the endogenous abundance, the label is just not bright enough to be seen. Nevertheless, for both PKA type Iβ and type IIα that we studied in this manuscript, we have correlated the measured parameters (specifically, Spine Enrichment Index or SEI) with the overexpression level (Figure 1-figure supplement 1). We found that they are not strongly correlated with the expression level under our conditions. By extrapolating to non-overexpression conditions, our conclusion remains valid.

      To overcome the inability to label endogenous PKA subunits using CRISPR-based methods, we have also attempted a conditional knock-in method call ENABLED that we previously developed to label PKA-Cα. In preliminary results, we found that endogenously label PKA were very dim. However, in a subset of cells that are bright enough to be quantified, the PKA catalytic subunit indeed translocated to dendritic spines upon stimulation (see Additional Fig. 1 in the next page), corroborating our results using overexpression. These results, however, are not ready to be published because characterization of the mouse line takes time and, at this moment, the signal-to-noise ratio remains low. We hope that the reviewer can understand.

      Author response image 1.

      Endogeneous PKA-Cα translocate to dendritic spines upon activation.

      Second, experiments which would advance and validate these findings in vivo would be highly valuable. This could be achieved in a number of ways - one would be overexpression of tagged PKA versions and examining sub-cellular distribution before and after physiological activation in vivo. Another possibility is in vivo perturbation - one would speculate that disruption or tethering of PKA subunits to the dendrite would lead to cell-specific functional and structural impairments. This could be achieved in a similar manner to the in vitro experiments, with a PKA KO and replacement strategy of the tethered C-R plasmid, followed by structural or functional examination of neurons.

      I would like to state that these experiments are not essential in my opinion, but any improvements in one of these directions would greatly improve and extend the impact and findings of this paper.

      We thank the reviewer for the suggestion and the understanding. The suggested in vivo experiments are fascinating. However, in vivo imaging of dendritic spine morphology is already in itself challenging. The difficulty greatly increases when trying to detect partial, likely transient translocation of a signaling protein. It is also very difficult to knock down endogenous PKA while simultaneously expressing the R-C construct in a large number of cells to achieve detectable circuit or behavioral effect (and hope that compensation does not happen over weeks). We hope the reviewer agrees that these experiments would be their own project and go beyond the time and scope of the current study.

      Reviewer #3 (Recommendations For The Authors):

      Please elaborate on the methods used to visualize PKA-RIIα and PKA-RIβ subunits.

      As suggested, we have now included additional details for visualizing PKA-Rs in the text. Specifically, we write (pg. 5): “…, as visualized using expressed PKA-R-mEGFP in separate experiments (Figs. 1A-1C).”.

    1. Overwriting existing notes for object 056ca11c01b47e2bfe1e51178b65c80bbdeef7b0

      It seems that you're able to make notes on commits. Since a commit can be referenced by a tag, or branch, you can make notes on those, too -- kind of.

    1. Reviewer #1 (Public review):

      Summary:

      In their manuscript, Zhou et al. analyze the factors controlling the activation and maintenance of a sustained cell cycle block in response to persistent DNA DSBs. By conditionally depleting components of the DDC using auxin-inducible degrons, the authors verified that some of them are only required for the activation (e.g., Dun1) or the maintenance (e.g., Chk1) of the DSB-dependent cell cycle arrest, while others such as Ddc2, Rad24, Rad9 or Rad53 are required for both processes. Notably, they further show that after a prolonged arrest (>24 h) in a strain carrying two DSBs, the DDC becomes dispensable and the mitotic block is then maintained by SAC proteins such as Mad1, Mad2 or the mitotic exit network (MEN) component Bub2.

      Strengths:

      The manuscript dissects the specific role of different components of the DDC and the SAC during the induction of a cell cycle arrest induced by DNA damage, as well as their contribution for the short-term and long-term maintenance of a DNA DSB-induced mitotic block. Overall, the experiments are well described and properly executed, and the data in the manuscript are clearly presented. The conclusions drawn are generally well supported by the experimental data. Their observations contribute to drawing a clearer picture of the relative contribution of these factors to the maintenance of genome stability in cells exposed to permanent DNA damage.

      Weaknesses:

      The main weakness of the study is that it is fundamentally based on the use of the auxin-inducible degron (AID) strategy to deplete proteins. This widely used method allows an efficient depletion of proteins in the cell. However, the drawback is that a tag is added to the protein, which can affect the functionality of the targeted protein or modify its capacity to interact with others. In fact, three of the proteins that are depleted using the AID systems are shown to be clearly hypomorphic, and hence their capacity to induce a strong checkpoint response might be compromised. A corroboration of at least some of the results using an alternative manner to eliminate the proteins would help to strengthen the conclusions of the manuscript.

    2. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors):

      To hopefully contribute to more strongly support the conclusions drawn by the authors, I am including a series of concerns regarding the manuscript, as well as some suggestions that could be useful to address these issues:

      (1) The main results of this study derive from the use of auxin-inducible degron (AID)-tagged proteins. Despite the great advantages of the AID strategy to conditionally deplete proteins, the AID tag can affect the normal function of a protein. In fact, some of the AID-labeled DDC components generated in this work are shown to be hypomorphic. Hence, the manuscript would have benefited from the additional confirmation of some of the observations using a different way to eliminate the proteins (e.g., temperature-sensitive mutants).

      Most ts mutants are also hypomorphic; hence we don’t see there is much advantage to their use. The addition of the AID to these proteins alone does not interfere with the ability to sustain checkpoint arrest as demonstrated in Figure S1. Instead we found that by overexpressing Rad9-AID we could demonstrate that inactivating Rad9 after 15 h behaved the same way as the inactivation of Ddc2, significantly strengthening our finding that the DDC checkpoint becomes dispensable while the SAC takes over. 

      (2) In cells depleted of Rad53-AID, the deletion of CHK1 stimulates an earlier release from a mitotic arrest induced by two DSBs (Figures 2D and 3C). Likewise, the authors claim that a faster escape from the cell cycle block can also be observed when upstream factors such as Ddc2, Rad9, or Rad24 are depleted in the absence of CHK1 (Figures 2A-C and Figures 3D-F). However, this earlier release from the cell cycle arrest, if at all, is only slightly noticeable in a Rad9-AID background (Figures 2B and 3E). In this sense, it is also worth pointing out that Rad9-AID chk1Δ (Figure 3E) and Rad24-AID chk1Δ (Figure 3F) cells were only evaluated up to 7 h, while in all other instances, cells were followed for 9 h, which hinders a fair assessment of the differences in the release from the cell cycle arrest.

      As noted above, we have now been able to examine Rad9 over the long-time frame.

      (3) Although only 25% of the cells depleted for Dun1 remained in G2/M arrest 7 h following the induction of two DSBs, it is shocking that Rad53 was nonetheless still phosphorylated after the cells had escaped the cell cycle blockage (Figure 4A).

      This persistence of Rad53 phosphorylation is also seen with the inactivation of Mad2, allowing escape in spite of continued Rad53 phosphorylation.

      (4) Generation of Rad9-AID2 and Rad24-AID2 strains did not fully restore the function of these proteins, since most cells had adapted 24 h after induction of two DSBs (Figure S1C). Nonetheless, Rad9-AID2 and Rad24-AID2 are still likely more stable than their AID counterparts, and hence the authors could have instead used the AID2 proteins for the experiments in Figure 2 to better evaluate the role of Rad9 and Rad24 in the maintenance of the DDC-dependent arrest.

      We note again that we have found a way to study Rad9 up to 24 h. 

      (5) Deletion of BFA1 has been shown to promote the escape from a cell cycle arrest triggered by telomere uncapping (Wang et al. 2000, Hu et al. 2001, Valerio-Santiago et al. 2013). Likewise, while cells carrying the cdc5-T238A allele cannot adapt to a checkpoint arrest induced by one irreparable DSB, BFA1 deletion rescues the adaptation defect of this mutant CDC5 allele (Rawal et al., 2016). The authors show how, using AID-degrons of Bfa1 and Bub2, that only Bub2, but not Bfa1, is required to maintain a prolonged cell cycle arrest after the induction of two DSBs. To reinforce this point, and as shown for mad2Δ cells (Figure S6A), the authors could perform a complete time course using both the Bfa1-AID and a bfa1Δ mutant to demonstrate that they do indeed show the same behavior in terms of the adaptation to a two DSB-induced cell cycle arrest.

      We thank the reviewer for noting these other instances where bfa1D promoted an escape from arrest. We tested a 2-DSB bfa1 deletion, data has been added to Figure S9E-F. We did not observe a difference in the percentage of cells escaping arrest between the 2-DSB bfa1 deletion and the 2-DSB BFA1-AID strains.

      (6) Bypass or adaptation of a checkpoint-induced cell cycle arrest in S. cerevisiae often leads to cells entering a new cell cycle without doing cytokinesis and, hence, to the accumulation of rebudded cells. However, the experiments shown in the manuscript only account for G1 or budded cells with either one or two nuclei. Do any of the mutants show cytokinesis problems and subsequent rebudding of the cells? If so, this should have been also noted and quantified in the corresponding assays.

      In the cases we have studied we have not seen instances where the cells re-bud without completing mitosis (at least as assessed by the formation of budded cells with two distinct DAPI staining masses). In the morphological assays we have done, we score the continuation of the cell cycle by the appearance of multiple buds, G1, and small budded cells. In our adaptation assays when cells escaped G2/M arrest they formed microcolonies indicating no short-term deficiency in cell division.

      (7) The location of the DSB relative to the centromere of a chromosome seems to be a factor that determines the capacity of the SAC to sustain a prolonged cell cycle arrest. The authors discuss the possibility that the DSB could somehow affect the structure of the kinetochore. Did they evaluate whether Mad1 or Mad2 were more actively recruited to kinetochores in those strains that more strongly trigger the SAC after induction of the DSBs?

      We have not attempted to follow Mad1/2 recruitment. ChIP-seq could be used to monitor Mad1/2 localization at the 16 centromeres in response to DSBs and the spread of g-H2AX across the centromere. Our previous data showed that g-H2AX could spread across the centromere region and could create a change that would be detected by Mad1/2.  This change does not, however, affect the mitotic behavior of a strain in which the H2A genes have been modified to the possibly phosphomimetic H2A-S129E allele.

      (8) The authors could speculate in the discussion about the reasons that could explain why the DDC is required for the maintenance of checkpoint arrest at early stages but then becomes dispensable for the preservation of a prolonged cell DNA DSB-induced cycle arrest, which is instead sustained at later stages by the SAC.

      Our suggestion is that cells would have adapted, but modification of the centromere region engages SAC.

      Finally, some minor issues are:

      (1) The lines in the graphs that display the results from adaptation assays (e.g., Figures 1B and 1E) or cell and nuclear morphology (e.g., Figures 1D and 1G) are too thick. This makes it sometimes difficult to distinguish the actual percentages of cells in each category, particularly in the experiments monitoring nuclear division.

      Fixed

      (2) While both the adaptation assay and the analysis of nuclear division in Figures 1E and 1G, respectively, show a complete DDC-dependent arrest at 4h, the Western blot in Figure 1F suggests that Rad53 is not phosphorylated at that time point. Do these figures represent independent experiments? Ideally, the analysis of cell budding and nuclear division, which is performed in liquid cultures, and the Western blot displaying Rad53 phosphorylation should correspond to the same experiment.

      Cell budding in liquid cultures and adaptation assays were performed in triplicate with 3 biological replicates and the collective results are shown in each graph showing the percentage of large-budded cells. Western blot samples were collected in each liquid culture experiment. The western blot in 1G is a representative western blot.

      (3) It is somewhat confusing that the blots for the proteins are not displayed in the same order in Figures 2A (Rad53 at the top) and 2B or 2C (Rad53 in the middle).

      Fixed.  We place Rad53 – the relevant protein - at the top.

      Reviewer #2 (Recommendations For The Authors):

      (1) Yeast with the two breaks responds to DNA damage checkpoint (DDC) until sometimes 4-15 h post DNA damage. Since the auxin-induced degradation does not completely deplete all the tagged proteins in cells, the results should be more carefully considered and not to interpret if the checkpoint entry or maintenance depends on each target protein's ability to induce Rad53 phosphorylation. It should be theoretically possible if checkpoint maintenance requires only a modest amount of checkpoint factors especially because the experiments involve the induction of one or two DSBs. The low levels of DDC factors may be insufficient for Rad53 activation but could still be effective for cell cycle arrest. Indeed, the Haber group showed that the mating type switch did not induce Rad53 phosphorylation but still invoked detectable DNA damage response. To test such possibilities, the authors might consider employing yet another marker for DDC such as H2A or Chk1 phosphorylation besides Rad53 autophosphorylation. Alternatively, the authors might check if auxin-induced depletion also disrupts break-induced foci formation for checkpoint maintenance or their enrichment at DNA breaks using ChIP assays at various points post-damage.

      DAPI staining of Ddc2-AID cells show that when IAA is added 4 h after DSB induction (Figure S3A), cells escape G2/M arrest as evidenced by the increase in large-budded cells with 2 DAPI signals, small budded cells, and G1 cells. Overexpression of Ddc2 can sustain the checkpoint past 24 h, but without SAC proteins like Mad2 they will eventually adapt (Figure S6B).

      That Rad9-AID or Rad24-AID in the absence of added auxin (but in the presence of TIR1) is unable to sustain arrest suggests to us that low levels of Rad9 or Rad24 are not sufficient to maintain arrest.  As the reviewer notes, normal MAT switching doesn’t cause Rad53 phosphorylation or arrest, though early damage-induced events such as H2A phosphorylation do occur.  But our point is that Rad9 or Ddc2 is needed to maintain arrest only up to a certain point, after which they become superfluous and a different checkpoint arrest is imposed. At that point apparently a low level of these proteins plays no obvious role.

      (2) It is interesting that DDC no longer responds to the damage signaling after 15 h of DSB-induced prolonged checkpoint arrest after two DNA double-strand breaks. Is this also applicable to other adaptation mutants? The results might improve the broad impact of the current conclusions. It is also possible that the transition from DDC to SPC depends on simply the changes in signaling or in part due to the molecular changes in the status of DNA breaks or its flanking regions. Indeed, the proposed model suggests that the spreading of H2A phosphorylation to centromeric regions induces SAC and thus mitotic arrest. The authors could measure H2A phosphorylation near the centromere using ChIP assays at various intervals post-DNA damage. It is particularly interesting if depletion of Ddc2 at 15 h post DNA damage does not alter the level of H2A phosphorylation at or near centromere.

      Our previous data have suggested that the involvement of the SAC in prolonging DSB-induced arrest involved post-translational modification of centromeric chromatin such as the Mec1- and Tel1-dependent phosphorylation of the histone H2A (Dotiwala). In budding yeast there is also a similar DSB-induced modification of histone H2B (Lee et al.). To ask if there is an intrinsic activation of the SAC if the regions around centromeres were modified by checkpoint kinase phosphorylation, we examined cell cycle progression in strains in which histone H2A or histone H2B was mutated to their putative phosphomimetic forms (H2A-S129E and H2B-T129E).  As shown in Figure S11, there was no effect on the growth rate of these strains, or of the double mutant, suggesting that cells did not experience a delay in entering mitosis because of these modifications. We note that although histone H2A-S129E is recognized by an antibody specific for the phosphorylation of histone H2A-S129, the mutation to S129E may not be fully phosphomimetic. 

      (3) It is puzzling why Rad9-AID or Rad24-AID are proficient for DDC establishment but cannot sustain permanent arrest in the two break cells. It appears Rad53 phosphorylation for DDC is weaker in cells expressing Rad9-AID or Rad24-AID according to Fig.2B and C even though their protein level before IAA treatment is still robust. This might also explain why the results of depleting Rad53 and Rad9 are very different. It also raises concern if the effect of Rad24 depletion on checkpoint maintenance is in part due to the weaker checkpoint establishment. It might be necessary to use the AID2 system to redo Rad24 depletion to exclude such a possibility.

      We believe that the AID mutants are very sensitive to the low level of IAA present in yeast.  The instability of the protein is entirely dependent on the TIR1 SCF factor, so the proteins themselves are not intrinsically defective; they are just subject to degradation.  Overexpressing Rad9 allowed us to evaluate its role at late time points. 

      (4) It is intriguing that the switch from DDC to SAC might take place at around 12 h when yeasts with a single unrepairable break ignore DDC and resume cell cycling (so-called "adaptation"). Since 4h and 15h are far apart and the transition point from DDC to SAC likely takes place between these two points, it will be very helpful to analyze and compare cell cycle exit after 24 h by treating IAA at multiple points between 4-15h.

      When we add IAA to Mad2-AID and Mad1-AID 4 h after DSB induction, cells remain arrested for up to 12 h after DSB induction. At 15 h cells begin to exit checkpoint arrest indicating that the handoff of checkpoint arrest must occur between 12 to 15 h after DSB induction. If we degraded DNA damage checkpoint proteins at any point before Mad2, Mad1, and Bub2 begin to contribute to checkpoint arrest, then arrested cells will likely adapt in a similar manner to when IAA was added 4 h after DSB induction.

      (5) Some of the Western blot quality is poor. For instance, in Figure 6C, Mad1-AID level after IAA addition is not compelling especially because the TIR level (the loading control) is also very low.

      In Figure 6C, while the relative levels of TIR1 are similar in the IAA treated and untreated samples, there is no detectable amount of Mad1-AID in the IAA treated samples indicating that Mad1-AID was successful degraded with the AID system.

      (6) Fig. 8 is complex. It might be helpful to define the different types of arrows in the figure. The legend also has a spelling error, Rad23 should be Rad24.

      We’ve defined what each arrow means in the legend and corrected the spelling error in the figure legend.

      Reviewer #3 (Recommendations For The Authors):

      Major concerns:

      Much of the manuscript states that two unrepairable DSBs lead to a long and severe G2/M arrest. Two main cytological approaches are used to make this statement: bud size and number on plates after micromanipulation (microcolony assay), and cell and nuclear morphology in liquid cultures. While the latter gives a clear pattern that can be assigned to a G2/M block as expected by DDC, i.e. metaphase-like mononucleated cells with large buds, the former can only tell whether cells eventually reach a second S phase (large budded cells on the plate can be in a proper G2/M arrest, but can also be in an anaphase block or even in the ensuing G1). The authors always performed the microcolony assay, but there are several cases where the much more informative budding/DAPI assay is missing. These include Dun1-aid and others, but more importantly chk1D and its combinations with DDC proteins. Incidentally, for the microcolony assay, it is more accurate to label the y-axis of the corresponding graphs (and in the figure legends and main text) with something like "large budded cells"; "G2/M arrested cells" is misleading.

      Figures have been updated to more accurately reflect what we are measuring.

      The results obtained with the Bfa1/Bub2 partner are intriguing. These two proteins form a complex whose canonical function is to prevent exit from mitosis until the spindle is properly aligned, acting in a distinct subpathway within the SAC that blocks MEN rather than anaphase onset. The data presented by the authors suggest that, on the one hand, both SAC subpathways work together to block the cell cycle. However, why does canonical SAC (Mad1/Mad2) inactivation not lead to a transition from G2/M (metaphase-like) arrested cells to anaphase-like arrest maintained by Bfa1-Bub2? Since Bfa1-Bub2 is a target of DDC, is it possible that DDC knockdown also inactivates this checkpoint, allowing adaptation? On the other hand, can the authors provide more data to confirm and strengthen their claim of a Bfa1-independent Bub2 role in prolonged arrest? Perhaps long-term protein localization and PTM changes. Bub2-independent roles for Bfa1 have been reported, but not vice versa, to the best of my knowledge.

      In the mitotic exit network Bfa1/Bub2 prime activation of the pathway by bringing Tem1 to spindle pole bodies. Phosphorylation of Bfa1 causes Tem1 to be released and phosphorylate Cdc5 to trigger exit by MEN. It has been shown that DNA damage, in a cdc13-1 ts mutant, phosphorylates Bfa1 in a Rad53 and Dun1 dependent manner. This phosphorylation of Bfa1 could release Tem1 and prime cells to exit checkpoint arrest when cells pass through anaphase. Looking at Tem1 localization to spindle pole bodies and interactions with Bfa1/Bub2 in response to DNA damage might give insight into why cells don’t experience an anaphase-like arrest when they are released by either deactivation of the DNA damage checkpoint or SAC.

      We have previously shown that a deletion of bub2 in a 1-DSB background shortens DSB-induced checkpoint arrest. Deletion of bfa1 in a 2-DSB background showed ~80-70% of cells stuck in a large-budded state as measured through an adaptation assay tracking the morphology of G1 cells on a YP-Gal plate and DAPI staining. Deletion or degradation of bfa1 might not release cells from arrest because the Mad2/Mad1 prevent cells from transitioning into anaphase. Our DAPI data for Bub2-AID shows an increase in cells with 2 DAPI signals (transition into anaphase) and small budded cells indicating that degradation of Bub2 is releasing cells into anaphase and allowing cells to complete mitosis.

      Further suggestions:

      It would be richer if authors could provide more than one experimental replicate in some panels (e.g., S1A,B; S4A; and S6B).

      S1C confirms that Rad9-AID and Rad24-AID will adapt by 24 h even with the point mutant TIR1(F74G) which has lower basal degradation than TIR1. S4A has been updated with additional experimental replicates. The 48 h timepoint after DSB induction was to show the importance of Mad2 even when Ddc2 is overexpressed.

      Figure 1: Rearrange figure panels when they are first mentioned in the text. For example, it makes more sense to have the plate adaptation assay as panel B for both 1-DSB and 2-DSB strains, budding plus DAPI as panel C, and Rad53 as panel D.

      These figures have been rearranged in the order that they are mentioned in the paper.

      Figure 5: Correct Ph-5-IAA in the Rad53 WBs (it should be 5-Ph-IAA).

      This has been corrected.

      Figure S2: The straight line under the "+IAA" text box is misleading. I think it should also cover the "-2" time point, right? Also, check the figure legend. Information is missing and does not correspond to the figure layout.

      This has been corrected.

      Figure S3: Perhaps "Cell cycle profile as determined by budding and DAPI staining" is a better and more accurate legend title.

      The legend title has been updated to “Cell cycle profile as determined by budding and DAPI staining in Ddc2-AID and Rad53-AID mutants ± IAA 4 h after galactose.”

      Figure S5: Detection of both Rad53 and Ddc2 in the same blot could lead to misinterpretation as hyperphosphorylated Rad53 appears to coincide with Ddc2 migration.

      Figure S5A-B are representative western blots where Rad53 was probed to show activation of the DNA damage checkpoint by Rad53 phosphorylation. When measuring the relative abundance of Ddc2 we did not probe all blots for Rad53.

      Table S1: Include the post-hoc test used for comparisons after ANOVA.

      A Sidak post-hoc test was used in PRISM for the one-way ANOVA test. PRISM listed the Sidak post-hoc test as the recommended test to correct for multiple comparisons. A column has been added to S. Table 1 to show which post-hoc test was used.

      Page 10, line 4: The putative additive effect of chk1 knockout with Dun1 depletion should also be compared to chk1 alone (in Figure 3A).

      We address the additive effect of chk1 knockout with Dun1-AID depletion in a later section on Page 11, line 6. Since we had not explored possible effects from downstream targets of Rad53 for prolonging checkpoint arrest when Rad53 was depleted, we did not mention the effect of the chk1 knockout on Dun1 depletion.

      Page 14, second paragraph, line 4: "Figure 6A-D", is it not?

      Figure S6A is measuring checkpoint arrest in a deletion of mad2 in a 2-DSB strain. Figure 6A-D shows how degradation of Mad2-AID and Mad1-AID after the handoff of arrest causes cells to exit the checkpoint in a Rad53 independent manner.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Review:

      Summary:

      Bursicon is a key hormone regulating cuticle tanning in insects. While the molecular mechanisms of its function are rather well studied--especially in the model insect Drosophila melanogaster, its effects and functions in different tissues are less well understood. Here, the authors show that bursicon and its receptor play a role in regulating aspects of the seasonal polyphenism of Cacopsylla chinensis. They found that low temperature treatment activated the bursicon signaling pathway during the transition from summer form to winter form and affect cuticle pigment and chitin content, and cuticle thickness. In addition, the authors show that miR-6012 targets the bursicon receptor, CcBurs-R, thereby modulating the function of bursicon signaling pathway in the seasonal polyphenism of C. chinensis. This discovery expands our knowledge of the roles of neuropeptide bursicon action in arthropod biology.

      However, the study falls short of its claim that it reveals the molecular mechanisms of a seasonal polyphenism. While cuticle tanning is an important part of the pear psyllid polyphenism, it is not the equivalent of it. First, there are other traits that distinguish between the two morphs, such as ovarian diapause (Oldfield, 1970), and the role of bursicon signaling in regulating these aspects of polyphenism were not measured. Thus, the phenotype in pear psyllids, whereby knockdown bursicon reduces cuticle tanning seems to simply demonstrate the phenotypes of Drosophila mutants for bursicon receptor (Loveall and Deitcher, 2010, BMC Dev Biol) in another species (Fig. 2I, 4H). Second, the study fails to address the threshold nature of cuticular tanning in this species, although it is the threshold response (specifically, to temperature and photoperiod) that distinguishes this trait as a part of a polyphenism. Whereas miR-6012 was found to regulate bursicon expression, there no evidence is provided that this microRNA either responds to or initiates a threshold response to temperature. In principle, miR-6012 could regulate bursicon whether or not it is part of a polyphenism. Thus, the impact of this work would be significantly increased if it could distinguish between seasonal changes of the cuticle and a bona fide reflection of polyphenism.

      Thanks for your valuable suggestion. We concur with the review’s comment that cuticle tanning does not equate to the C. chinensis polyphenism. To better reflect the core focus of our research, we have revised the title to "Neuropeptide Bursicon and its receptor mediated the transition from summer-form to winter-form of Cacopsylla chinensis".

      In response to the reviewer's inquiry regarding the threshold nature of cuticular tanning in C. chinensis, we have included a detailed analysis of the phenotypic changes (including nymph phenotypes, cuticle pigment absorbance, and cuticle thickness) during the transition from summer-form to winter-form in C. chinensis at distinct time intervals (3, 6, 9, 12, 15 days) under different temperature conditions (10°C and 25°C). As shown in Figure S1, nymphs exhibit a light yellow and transparent coloration at 3, 6, and 9 days, while nymphs at 12 and 15 days display shades of yellow-green or blue-yellow under 25°C conditions. At 10°C conditions, the abdomen end turns black at 3, 6, and 9 days. By the 12 days, numerous light black stripes appear on the chest and abdomen of nymphs at 10°C. At 15 days, nymphs exhibit an overall black-brown appearance, featuring dark brown stripes on the left and right sides of each chest and abdominal section. Furthermore, the end of the abdomen and back display a large black-brown coloration at 10°C (Figure S1A). The UV absorbance of the total pigment extraction at a 300 nm wavelength markedly increases following 10°C exposure for 6, 9, 12, and 15 days compared to the 25°C treatment group (Figure S1B). Cuticle thicknesses also increased following 10°C exposure for 6, 9, 12, and 15 days compared to the 25°C treatment group (Figure S1C). The detailed results (L122-143), materials and methods (L647-652), and discussion (L319-322) have been added in our revised manuscript.

      Regarding the response of miR-6012 to temperature, we have already determined its expression at 3, 6, 10 days under different temperatures in the previous Figure 5E. We now included additional time intervals (9, 12, 15 days) in the updated Figure 5E. Our results indicate a significant decrease in the expression levels of miR-6012 after 10°C treatment for 3, 6, 9, 12, 15 days compared to the 25°C treatment group. Detailed information regarding this has been integrated into the Materials and Methods (Line 608-610) of our revised manuscript.

      Strengths:

      This study convincingly identifies homologs of the genes encoding the bursicon subunits and its receptor, showing an alignment with those of another psyllid as well as more distant species. It also demonstrates that the stage- and tissue-specific levels of bursicon follow the expected patterns, as informed by other insect models, thus validating the identity of these genes in this species. They provide strong evidence that the expression of bursicon and its receptor depend on temperature, thereby showing that this trait is regulated through both parts of the signaling mechanism.

      Several parallel measurements of the phenotype were performed to show the effects of this hormone, its receptor, and an upstream regulator (miR-6012), on cuticle deposition and pigmentation (if not polyphenism per se, as claimed). Specifically, chitin staining and TEM of the cuticle qualitatively show difference between controls and knockdowns, and this is supported by some statistical tests of quantitative measurements (although see comments below). Thus, this study provides strong evidence that bursicon and its receptor play an important role in cuticle deposition and pigmentation in this psyllid.

      The study identified four miRNAs which might affect bursicon due to sequence motifs. By manipulating levels of synthetic miRNA agonists, the study successfully identified one of them (miR-6012) to cause a cuticle phenotype. Moreover, this miRNA was localized (by FISH) to the cuticle, body-wide. To our knowledge, this is the first demonstrated function for this miRNA, and this study provides a good example of using a gene of known function as an entry point to discovering others influencing a trait. Thus, this finding reveals another level of regulation of cuticle formation in insects.

      Weaknesses:

      (1) The introduction to this manuscript does not accurately reflect progress in the field of mechanisms underlying polyphenism (e.g., line 60). There are several models for polyphenism that have been used to uncover molecular mechanisms in at least some detail, and this includes seasonal polyphenisms in Hemiptera. Therefore, the justification for this study cannot be predicated on a lack of knowledge, nor is the present study original or unique in this line of research (e.g., as reviewed by Zhang et al. 2019; DOI: 10.1146/annurev-ento-011118-112448). The authors are apparently aware of this, because they even provide other examples (lines 104-108); thus the introduction seems misleading as framed.

      Thanks for your excellent suggestion. We have added the paper of Zhang et al. 2019 which recommended by reviewer (DOI: 10.1146/annurev-ento-011118-112448) in Line 57 of our revised manuscript. The statement has been revised to “However, the specific molecular mechanism underling temperature-dependent polyphenism still require further clarification” in Line 60-61 of our revised manuscript.

      (2) The data in Figure 2H show "percent of transition." However, the images in 2I show insects with tanned cuticle (control) vs. those without (knockdown). Yet, based on the description of the Methods provided, there appears to be no distinction between "percent of transition" and "percent with tanning defects". This an important distinction to make if the authors are going to interpret cuticle defects as a defect in the polyphenism. Furthermore, there is no mention of intermediate phenotypes. The data in 2H are binned as either present or absent, and these are the phenotypes shown in 2I. Was the phenotype really an all-or-nothing response? Instead of binning, which masks any quantitative differences in the tanning phenotypes, the authors should objectively quantify the degree of tanning and plot that. This would show if and to what degree intermediate tanning phenotypes occurred, which would test how bursicon affects the threshold response. This comment also applies to the data in Figures 4G and 6G. Since cuticle tanning is present in more insect than just those with seasonal polyphenism, showing how this responds as a threshold is needed to make claims about polyphenism.

      We appreciate your insightful comments. As shown in Figure 1 of our published paper (Zhang et al., 2013; doi.org/10.7554/eLife.88744.3) and Figure 2C-2I of the current manuscript, the transition from summer-form to winter-form entails not only external cuticular tanning but also alterations in internal cuticular chitin levels and cuticle thickness. While external cuticular tanning serves as a prominent and easily observable indicator of this transition, it is crucial to acknowledge that internal changes also play a significant role and should be taken into consideration. Therefore, we propose that the term "percent of transition" may be more suitable than "percent with tanning defects" to describe this process accurately.

      In order to provide a more visually comprehensive understanding of the phenotypic changes during the transition from summer-form to winter-form, we have included images at different time points (3, 6, 9, 12, 15 days) under different temperature conditions in Figure S1A of our revised manuscript. Specifically, under the 10°C condition, nymphs exhibit abdomen tanning after 6 and 9 days of treatment, while the thorax remains untanned. By days 12 to 15, both the abdomen and thorax of the nymphs show tanning, resulting in the majority of summer-form nymphs transitioning into winter-form, as depicted in Figure 2I for comparison. This observation indicates the presence of a critical threshold for cuticle tanning of C. chinensis following exposure to 10°C. Nymphs that did not undergo the transition to winter-form succumbed to the cold, highlighting the absence of intermediate phenotypes at 12-15 days under the 10°C condition. The UV absorbance of the total pigment extraction at a 300 nm wavelength markedly increases following 10°C exposure for 6, 9, 12, and 15 days compared to the 25°C treatment group (Figure S1B). Additionally, cuticle thickness shows an increase following 10°C exposure for 6, 9, 12, and 15 days compared to the 25°C treatment group (Figure S1C). These results highlight the relationship between the threshold of cuticular tanning and the transition process. The detailed description and information have been added in Results (L122-143), Materials and Methods (L647-652), and Discussion (L319-322) of our manuscript.

      (3) This study also does not test the threshold response of cuticle phenotypes to levels of bursicon, its receptor, or miR-6012. Hormone thresholds are the most widespread and, in most systems where polyphenism has been studied, the defining characteristic of a polyphenism (e.g., Nijhout, 2003, Evol Dev). Quantitative (not binned) measurements of a polyphenism marker (e.g., chitin) should be demonstrated to result as a threshold titer (or in the case of the receptor, expression level) to distinguish defects in polyphenism from those of its component trait.

      Thanks for your valuable feedback. We have supplemented additional data on the phenotypes (Figure S1A), cuticle pigment absorbance (Figure S1B), cuticle thickness (Figure S1C), expression levels of bursicon (Figure 1E and 1F), its receptors (Figure 3G), and miR-6012 (Figure 5E) corresponding to nymphs treated over different time periods (3, 6, 9, 12, 15 days) under both 10°C and 25°C conditions in our revised manuscript.

      While all these identified markers exhibit a strong correlation with the transition from summer-form to winter-form, it is important to note that they are not suitable as definitive thresholds due to the nature of relative gene expression quantification and chitin content assessment, rather than absolute quantitation. Further, given that tanning hormones are neuropeptides present in trace amounts in insects, unlike steroid hormones, determining their titers poses a considerable challenge.

      (4) Cuticle issue:

      (a) Unlike Fig. 6D and F, Figs. 2D and F do not correspond to each other. Especially the lack and reduction of chitin in ds-a+b! By fluorescence microscopy there is hardly any signal, whereas by TEM there is a decent cuticle. Additionally, the dsGFP control cuticle in 2D is cut obliquely with a thick and a thin chitin layer. This is misleading.

      Thanks for your insightful feedback. We have replaced the previous WGA chitin staining images in the dsCcbursα+β treatment of Figure 2D with new representative images aligning with Figure 2F. Furthermore, the presence of both thin and thick chitin layers observed in the dsEGFP treatment of Figure 2D could potentially be ascribed to the chitin content in the insect midgut or fat body as previously discussed (Zhu et al., 2016). It is notable that during the process of cuticle staining, the chitin located in the midgut and fat body of C. chinensis may exhibit green fluorescence, leading to the appearance of a thin chitin layer. A detailed analysis and elucidation of these observations have been added in the discussion section (Lines 347-352) of our revised manuscript.

      Zhu KY, Merzendorfer H, Zhang W, Zhang J, Muthukrishnan S. Biosynthesis, Turnover, and Functions of Chitin in Insects. Annu Rev Entomol. 2016;61:177-196. doi:10.1146/annurev-ento-010715-023933.

      (b) In Figs. 2F and 4F, the endocuticle appears to be missing, a portion of the procuticle that is produced post-molting. As tanning is also occurring post-molting, there seems to be a general problem with cuticle differentiation at this time point. This may be a timing issue. Please clarify.

      Thank you for your suggestion. The insect cuticle typically comprises three distinct layers (endocuticle, exocuticle, and epicuticle), with the thickness of each layer varying among different insect species. Cuticle differentiation is closely linked to the molting cycle of insects (Mrak et al., 2017). In our study, nymphal cuticles exhibited normal differentiation patterns, characterized by a thin epicuticle and comparable widths of the endocuticle and exocuticle following dsEGFP treatment, as illustrated in Figure 2F and 4F. Conversely, nymphs treated with dsCcBurs-α, dsCcBurs-β, and dsCcburs-R displayed impaired development, manifesting only the exocuticle without a discernible endocuticle layer. These findings suggest that bursicon genes and their receptor play a pivotal role in regulating insect cuticle development (Costa et al., 2016). We have added some discussion about these results in Lines 356-367 of our revised manuscript.

      Mrak, P., Bogataj, U., Štrus, J., & Žnidaršič, N. (2017). Cuticle morphogenesis in crustacean embryonic and postembryonic stages. Arthropod structure & development, 46(1), 77–95. https://doi.org/10.1016/j.asd.2016.11.001

      Costa, C. P., Elias-Neto, M., Falcon, T., Dallacqua, R. P., Martins, J. R., & Bitondi, M. (2016). RNAi-mediated functional analysis of Bursicon genes related to adult cuticle formation and tanning in the Honeybee, Apis mellifera. PloS one, 11(12), e0167421. https://doi.org/10.1371/journal.pone.0167421

      (c) To provide background information, it would be useful analyze cuticle formation in the summer and winter morphs of controls separately by light and electron microscopy. More baseline data on these two morphs is needed.

      Thanks for your valuable feedback. To provide more background information about cuticle formation, we supplied the results of nymph phenotypes, cuticle pigment absorbance, and cuticle thickness at distinct time intervals (3, 6, 9, 12, 15 days) under different temperatures of 10°C and 25°C in Figure S1 of our revised manuscript. Hope these results can help better understand the baseline data on these two morphs.

      (d) For the TEM study, it is not clear whether the same part of the insect's thorax is being sectioned each time, or if that matters. There is not an obvious difference in the number of cuticular layers, but only the relative widths of those layers, so it is difficult to know how comparable those images are. This raises two questions that the authors should clarify. First, is it possible that certain parts of the thoracic cuticle, such as those closer to the intersegmental membrane, are naturally thinner than other parts of the body? Second, is the tanning phenotype based on the thickness or on the number of chitin layers, or both? The data shown later in Figure 4I, J convincingly shows that the biosynthesis pathway for chitin is repressed, but any clarification of what this might mean for deposition of chitin would help to understand the phenotypes reported. Also, more details on how the data in Fig. 2G were collected would be helpful. This also goes for the data in Fig. 4 (bursicon receptor knockdowns).

      Thanks for your great comment. The TEM investigation adhered to a standardized protocol was used as previous description (Zhang et al., 2023), Initially, insect heads were uniformly excised and then fixed in 4% paraformaldehyde. Subsequently, a consistent cutting and staining procedure was executed at a uniform distance above the insect's thorax. The dorsal region of the thorax was specifically chosen for subsequent fluorescence imaging or transmission electron microscopy assessments with the specific objective of quantifying cuticle thickness. Regarding the measurement of cuticle thickness, use the built-in measuring ruler on the software to select the top and bottom of the same horizontal line on the cuticle. Measure the cuticle of each nymph at two close locations. Six nymphs were used for each sample. Randomly select 9 values and plot them. The related description has been added in the Materials and Methods (Line 660-668) of our revised manuscript.

      Zhang, S.D., Li, J.Y., Zhang, D.Y., Zhang, Z.X., Meng, S.L., Li, Z., & Liu, X.X. (2023). MiR-252 targeting temperature receptor CcTRPM to mediate the transition from summer-form to winter-form of Cacopsylla chinensis. eLife, 12. https://doi.org/10.7554/eLife.88744

      (5) Tissue issue:

      The timed experiments shown in all figures were done in whole animals. However, we know from Drosophila that Bursicon activity is complex in different tissues. There is, thus, the possibility, that the effects detected on different days in whole animals are misleading because different tissues--especially the brain and the epidermis, may respond differentially to the challenge and mask each other's responses. The animal is small, so the extraction from single tissue may be difficult. However, this important issue needs to be addressed.

      Thanks for your excellent suggestion. We express our heartfelt appreciation to the reviewer for their valuable input regarding the challenges involved in dissecting various tissue sections from the diminutive early instar nymphs of C. chinensis. In light of the metamorphic transition of C. chinensis across developmental stages, this study concentrated on examining the extensive phenotypic alterations. Consequently, intact samples of C. chinensis were specifically chosen for for qPCR analysis. The related descriptions have been added in the Materials and Methods (Line 513, 517, 553, 555, and 613) and Discussion (Line 327-329) of our revised manuscript.

      (6) No specific information is provided regarding the procedure followed for the rescue experiments with burs-α and burs-β (How were they done? Which concentrations were applied? What were the effects?). These important details should appear in the Materials and Methods and the Results sections.

      Thanks for your excellent suggestion. For the rescue experiments, the dsRNA of CcBurs-R and proteins of burs α-α, burs β-β homodimers, or burs α-β heterodimer (200 ng/μL) were fed together. The concentration of heterodimer protein of CcBurs-α+β was 200 ng/μL. The heterodimer protein of CcBurs-α+β fully rescued the effect of RNAi-mediated knockdown on CcBurs-R expression, while α+α or β+β homodimers did not (Figure 3F). Feeding the α+β heterodimer protein fully rescued the defect in the transition percent and morphological phenotype after CcBurs-R knockdown (Figure 4G-4H). We have added the detailed methods of rescued experiments and specific concentrations in the Materials and Methods (Line 561-563), and Results (Line 263) of our revised manuscript.

      (7) Pigmentation

      (a) The protocol used to assess pigmentation needs to be validated. In particular, the following details are needed: Were all pigments extracted? Were pigments modified during extraction? Were the values measured consistent with values obtained, for instance, by light microscopy (which should be done)?

      Thanks for your excellent comment. Our protocol for pigment extracted as detailed in Bombyx mori, the cuticles were pulverized in liquid nitrogen and then dissolved in 30 milliliters of acidified methanol (Futahashi et al., 2012; Osanai-Futahashi et al., 2012). Thus, all cuticle pigments were dissected and treated with acidified methanol. Pigments were not modified during extraction.. The details description have been integrated into the Materials and Methods (Line 630-633) of our revised manuscript.

      Futahashi, R., Kurita, R., Mano, H., & Fukatsu, T. (2012). Redox alters yellow dragonflies into red. Proceedings of the National Academy of Sciences of the United States of America, 109(31), 12626–12631. https://doi.org/10.1073/pnas.1207114109

      Osanai-Futahashi, M., Tatematsu, K. I., Yamamoto, K., Narukawa, J., Uchino, K., Kayukawa, T., Shinoda, T., Banno, Y., Tamura, T., & Sezutsu, H. (2012). Identification of the Bombyx red egg gene reveals involvement of a novel transporter family gene in late steps of the insect ommochrome biosynthesis pathway. The Journal of biological chemistry, 287(21), 17706–17714. https://doi.org/10.1074/jbc.M111.321331

      (b) In addition, pigmentation occurs post-molting; thus, the results could reflect indirect actions of bursicon signaling on pigmentation. The levels of expression of downstream pigmentation genes (ebony, lactase, etc) should be measured and compared in molting summer vs. winter morphs.

      Thanks for your valuable suggestion. Actually, we already studied the function of some downstream pigmentation genes, including ebony, Lactase, Tyrosine hydroxylase, Dopa decarboxylase, and Acetyltransferase. The variations in the expression patterns of these genes are closely tied to the molting dynamics of nymphs undergoing transitions between summer-form and winter-form. These findings will put in another manuscript currently being prepared for submission, thus detailed outcomes are not suitable for inclusion in the current manuscript.

      (8) L236: "while the heterodimer protein of CcBurs α+β could fully rescue the effect of CcBurs-R knockdown on the transition percent (Figure 4G 4H)". This result seems contradictory. If CcBurs-R is the receptor of bursicon, the heterodimer protein of CcBurs α+β should not be able to rescue the effect of CcBurs-R knockdown insects. How can a neuropeptide protein rescue the effect when its receptor is not there! If these results are valid, then the CcBurs-R would not be the (sole) receptor for CcBurs α+β heterodimer. This is a critical issue for this manuscript and needs to be addressed (also in L337 in Discussion).

      Thanks for your insightful suggestion. Following the administration of dsCcBur-R to C. chinensis, the expression of CcBurs-R exhibited a reduction of approximately 66-82% as depicted in Figure 4A, rather than complete suppression. Activation of endogenous CcBurs-R through feeding of the α+β heterodimer protein results in an increase in CcBurs-R expression, with the effectiveness of the rescue effect contingent upon the dosage of the α+β heterodimer protein. Consequently, the capacity of the α+β heterodimer protein to effectively mitigate the impacts of CcBurs-R knockdown on the conversion rate is clearly demonstrated. We have added additional discussion in Line 396-403 of our revised manuscript.

      (9) Fig. 5D needs improvement (the magnification is poor) and further explanation and discussion. mi6012 and CcBurs-R seem to be expressed in complementary tissues--do we see internal tissues also (see problem under point 2)? Again, the magnification is not high enough to understand and appreciate the relationships discussed.

      Thanks for your valuable suggestion. In order to enhance the resolution of the magnified images, we conducted FISH co-localization of miR-6012 and CcBurs-R in 3rd instar nymphs and obtained detailed zoomed-in images. As shown in the magnified view of Figure 5D, miR-6012 and CcBurs-R appear to exhibit complementary expression patterns in tissues. During the FISH assays, epidermis transparency of C. chinensis was achieved via decolorization treatment. Noteworthy observations from Figure 3G and Figure 5E reveal an inverse correlation in the expression profiles of CcBurs-R and miR-6012. Consequently, the FISH results distinctly highlight a significant disparity in the expression levels of CcBurs-R and miR-6012 within the same tissue. We have added related explanation and discussion in Line 291-293 of our revised manuscript.

      (10) The schematic in Fig. 7 is a useful summary, but there is a part of the logic that is unsupported by the data, specifically in terms of environmental influence on cuticle formation (i.e., plasticity). What is the evidence that lower temperatures influence expression of miR-6012? The study measures its expression over life stages, whether with an agonist or not, over a single temperature. Measuring levels of expression under summer form-inducing temperature is necessary to test the dependence of miR-6012 expression on temperature. Otherwise, this result cannot be interpreted as polyphenism control, but rather the control of a specific trait.

      Thanks for your great suggestion. We actually conducted the assessment of miR-6012 expression at specific time intervals (3, 6, 9, 12, 15 days) under different temperatures of 10°C and 25°C. As depicted in Figure 5E, the expression levels of miR-6012 were notably reduced at 10°C compared to 25°C. Additionally, the evaluation of agomir-6012 expression level of C. chinensis under 25°C conditions at various time points (3, 6, 9, 12, 15 days) revealed no significant changes. Hence, we suggest that the impact of miR-6012 on the seasonal morphological transition is influenced upon temperature.

      Recommendations for the authors:

      The authors report a novel role of Bursicon and its receptor in regulating the seasonal polyphenism of Cacopsylla chinensis. They found that low temperature treatment (10°C) activated the Bursicon signaling pathway during the transition from summer-form to winter-form, which influences cuticle pigment content, cuticle chitin content, and cuticle thickness. Moreover, the authors identified miR-6012 and show that it targets CcBurs-R, thereby modulating the function of Bursicon signaling pathway in the seasonal polyphenism of C. chinensis. This discovery expands our knowledge of multiple roles of neuropeptide bursicon action in arthropod biology. However, the m

      anuscript does have several major weaknesses, described under "Public review", which the authors need to address.

      Major issues:

      (1) L152-154 Fig S2E and S2F: Bursicon has been shown to be expressed in the CNS in a specific set of neurons. For example, In the larval CNS of Manduca sexta, bursicon expression is restricted to the subesophageal ganglion (SG), thoracic ganglia, and first abdominal ganglion. Pharate pupae and pharate adults show expression of this heterodimer in all ganglia. In Drosophila larvae, expression of a bursicon heterodimer is confined to abdominal ganglia. The additional neurons in the ventral nerve cord express only burs. In pharate adults, bursicon is produced by neurons in the SG and abdominal ganglia. I am wondering where bursicon subunits are expressed in the C. chinensis CNS? Since the authors have the antibodies, it would be useful to include immunocytochemical staining of bursicon alpha and beta in the CNS. The qPCR results from head or other tissues (Fig S2E and S2F) is not the most informative way to document localization of gene expression. Regarding the qPCR results, they show that the cuticle and the fat body express CcBurs-α and CcBurs-β. Can the authors confirm this unexpected results independently?

      Thanks for your insightful comment. In this study, we did not directly used antibodies targeting bursicon subunits, instead, the bursicon subunits along with a histidine tag were integrated into the expression vector pcDNA3.1 using homologous recombination. The experimental procedures were executed as follows: initially, the histidine tag was fused to the pcDNA3.1-mCherry vector through homologous recombination to generate the recombinant plasmid pcDNA3.1-his-mCherry. Subsequently, the amino acid sequences of the two bursicon subunits were introduced into the pcDNA3.1-his-mCherry vector via homologous recombination to produce the recombinant plasmids pcDNA3.1-CcBurs-α-his-mCherry and pcDNA3.1-CcBurs-β-his-mCherry. Finally, the P2A sequence was incorporated into the vector using reverse PCR to yield the recombinant plasmids pcDNA3.1-CcBurs-α-his-P2A-mCherry and pcDNA3.1-CcBurs-β-his-P2A-mCherry. Consequently, the bursicon subunits, along with the histidine tag, were capable of generating fusion proteins with the histidine tag. Western blot analysis was conducted using antibodies targeting the histidine tag, enabling the detection of histidine expression, which corresponds to the expression of the bursicon subunits. However, they are not suitable to conduct the in vivo immunocytochemical staining of bursicon alpha and beta in the CNS.

      Due to the diminutive size of the C. chinensis nymphs, dissection of the central nervous system (CNS) was unfeasible, precluding specific assessment of bursicon expression in the CNS. Prior literature has documented the expression of bursicon subunits in the epidermis and fat body of C. chinensis. Studies suggest that bursicon subunits not only play a role in the melanization and sclerotization processes of insect epidermis but also have significant roles in insect immunity (An et al., 2012). The presence of bursicon subunits in the epidermis, gut, and fat body of C. chinensis may indicate their crucial roles in the immune functions of these tissues. Further investigation is required to elucidate the specific immune functions they perform, hinting at the potential expression of these bursicon subunits in these two tissues.

      An, S., Dong, S., Wang, Q., Li, S., Gilbert, L. I., Stanley, D., & Song, Q. (2012). Insect neuropeptide bursicon homodimers induce innate immune and stress genes during molting by activating the NF-κB transcription factor Relish. PloS one, 7(3), e34510. https://doi.org/10.1371/journal.pone.0034510

      (2) L222: "CcBurs-R is the Bursicon receptor of C. chinensis". Is this statement supported by affinity binding assay results?

      Thanks for your excellent suggestion. We employed a fluorescence-based assay to quantify calcium ion concentrations and investigate the binding affinities of bursicon heterodimers and homodimers to the bursicon receptor across varying concentrations. Our findings suggest that activation of the receptor by the burs α-β heterodimer leads to significant alterations in intracellular calcium ion levels, whereas stimulation with burs α-α and burs β-β homodimers, in conjunction with Adipokinetic hormone (AKH), maintains consistent intracellular calcium ion levels. Consequently, this research definitively identifies CcBurs-R as the bursicon receptor. For further details, please refer to the Materials and Methods (Lines 493-504), Results (Lines 231-239), and Discussion (Lines 377-384) of our revised manuscript.

      (3) L245 Figure 4I-4J: Since knockdown of bursicon and its receptor cause a decrease pigment accumulation in the cuticle, it would be useful to examine 1-2 rate limiting enzyme-encoding genes in the bursicon regulated cuticle darkening process if possible (as was done for genes involved in cuticle thickening).

      Thanks for your excellent comment. Following the further study, a thorough analysis was conducted to evaluate the impact of bursicon and its receptor on the expression levels of Lactase, Tyrosine hydroxylase, Dopa decarboxylase, Acetyltransferase, and the effects of RNA interference targeting these genes on the seasonal morphological transition. The findings underscored their role in the bursicon-mediated cuticle darkening process. However, as this section is slated for inclusion in an upcoming manuscript intended for submission, it is deemed unsuitable for incorporation into the current manuscript.

      Minor issues:

      (1) L75 "stronger resistance (Ge et al., 2019; Tougeron et al., 2021)". Stronger resistance to what? Stronger resistance to environmental stress or weather condition? Please clarify.

      Thanks for your excellent suggestion. We have changed the statement to “stronger resistance to weather condition” in Line 75 of our revised manuscript.

      (2) L132 Figure 1A and 1B: Bursicon sequence was first identified and functionally characterized in Drosophila melanogaster: is there any reason why Drosophila bursicon sequences were not included in the comparison?

      Thanks for your excellent comment. We have added the sequence of Burs-α and Burs-β of D. melanogaster in the sequence alignment results of Figure 1A and 1B of our revised manuscript.

      (3) Although the authors clearly identify and validate the function for the bursicon genes and its receptor's, there is no mention of whether duplicates of this gene are also present in the pear psyllid. This has been known to happen in otherwise conserved hormone pathways (e.g., insulin receptor in some insects), so a formal check of this should be done.

      Thanks for your excellent comment. As shown in Figure S2A-S2B and 3B, there are two bursicon subunit genes and only one bursicon receptor gene in our selected insect species, for examples Drosophila melanogaster, Diaphorina citri, Bemisia tabaci, Nilaparvata lugens, and Sogatella furcifera. In our transcriptome database of C. chinensis, we also only identified two bursicon subunit genes and only one bursicon receptor gene.

      (4) Line 41: Here, as in the title, "fascinating" is a subjective judgement that does not improve a study's presentation.

      Thanks for your great comment. We have changed "fascinating" to "transformation" in Line 41 and also revised the title of our revised manuscript.

      (5) Line 44: What makes some fields "cutting-edge" and others not?

      Thanks for your excellent suggestion. The expression of "in cutting-edge fields" has been deleted in Line 44 of our revised manuscript.

      (6) Line 97: This is a peculiar choice of reference for the concept of slower development in cold temperatures. The concept of degree-days and growth rates is old and widespread in entomology.

      Thanks for your insightful comment. The reference of Nyamaukondiwa et al., 2011 in Line 95 has been deleted in our revised manuscript.

      (7) Lines 149-150: What justifies the assumption that higher levels of expression mean a more important role? This gene might be just as necessary for development of the summer form, even if expressed at lower levels.

      Thanks for your excellent suggestion. This sentence has been revised to “Increased gene expression levels may potentially contribute to the transition from summer-form to winter-form in C. chinensis.” in Line 168-169 of our revised manuscript.

      (8) The blue arrow in Fig. 7 is confusing.

      Thanks for your excellent suggestion. In Figure 7, the blue arrow represents the down-regulated expression of miR-6012. We have added a description about the blue arrow in Figure 7 of our revised manuscript.

    1. Another reason why it saves time is that here you canimply things instead of having to express them in full,for your Card-System and its Headings need only to beclear to yourself (see p. 67), whereas a complete Essayor Speech must be in Sentences and must be clear toyour readers or hearers as well. In the Cards you canuse all kinds of Abbreviations (p. 70) : these, again,need only be clear to yourself.

      Miles touches on the interplay of knowledge written down on index cards and the knowledge which is kept only in one's mind. Some practitioners in the space from 2013-2024 seem to imply that they're writing almost everything out in far deeper detail than Miles would indicate. In his incarnation, much of the knowledge might be more quickly indicated by a short sentence or heading which the brain can associate to longer explanations.

      This sort of indexing is akin to some of the method potentially seen in Marshall Mathers' zettelkasten.


      I'm creating a tag here for "card index for productivity" to track the idea of productivity in writing which I'm specifically using separately from the tag "card index as productivity system" which is used to describe their use for project tracking systems in systems like GTD, Memindex, etc.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Many thanks to the editors for the reviewing of the revised manuscript.

      We are very grateful to the Reviewers for their time and for the appreciation of the revision.

      We thank the Reviewer 3 for acknowledging the use of sulforhodamine B (SRB) fluorescence as a real-time readout of astrocyte volume dynamics. Experimental data in brain slices were provided to validate this approach.<br /> The incomplete matching of our observation with early reported data in cultured astrocytes (e.g., Solenov et al., AJP-Cell, 2004), might reflect certain of their properties differing from the slice/in vivo counterparts as discussed in the manuscript.<br /> The study (T.R. Murphy et al., Front Cell Neurosci., 2017) showed that AQP4 knockout increased astrocyte swelling extent in response to hypoosmotic solution in brain slices (Fig 9), and discussed '... AQP4 can provide an efficient efflux pathway for water to leave astrocytes.’ Correspondingly, our data suggest that AQP4 mediate astrocyte water efflux in basal conditions.<br /> We have discussed the study (Igarashi et al., NeuroReport 2013); our current data would help to understand the cellular mechanisms underlying the finding of Igarashi et al.


      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Pham and colleagues provide an illuminating investigation of aquaporin-4 water flux in the brain utilizing ex vivo and in vivo techniques. The authors first show in acute brain slices, and in vivo with fiber photometry, SRB-loaded astrocytes swell after inhibition of AQP4 with TGN-020, indicative of tonic water efflux from astrocytes in physiological conditions. Excitingly, they find that TGN-020 increases the ADC in DW-MRI in a region-specific manner, potentially due to AQP4 density. The resolution of the DW-MRI cannot distinguish between intracellular or extracellular compartments, but the data point to an overall accumulation of water in the brain with AQP4 inhibition. These results provide further clarity on water movement through AQP4 in health and disease.

      Overall, the data support the main conclusions of the article, with some room for more detailed treatment of the data to extend the findings.

      Strengths:

      The authors have a thorough investigation of AQP4 inhibition in acute brain slices. The demonstration of tonic water efflux through AQP4 at baseline is novel and important in and of itself. Their further testing of TGN-020 in hyper- and hypo-osmotic solutions shows the expected reduction of swelling/shrinking with AQP4 blockade.

      Their experiment with cortical spreading depression further highlights the importance of water efflux from astrocytes via AQP4 and transient water fluxes as a result of osmotic gradients. Inhibition of AQP4 increases the speed of tissue swelling, pointing to a role in the efflux of water from the brain.

      The use of DW-MRI provides a non-invasive measure of water flux after TGN-020 treatment.

      We thank the reviewer for the insightful comments.

      Weaknesses:

      The authors specifically use GCaMP6 and light sheet microscopy to image their brain sections in order to identify astrocytic microdomains. However, their presentation of the data neglects a more detailed treatment of the calcium signaling. It would be quite interesting to see whether these calcium events are differentially affected by AQP4 inhibition based on their cellular localization (ie. processes vs. soma vs. vascular end feet which all have different AQP4 expressions).

      Following the suggestion, we provide new data on the effect of AQP4 inhibition on spontaneous calcium signals in perivascular astrocyte end-feet. As shown now in Fig.S2, acute application of TGN020 induced Ca2+ oscillations in astrocyte end-feet regions where the GCaMP6 labeling lines the profile of the blood vessel. It is noted that on average, the strength of basal Ca2+ signals in the end-feet is higher than that observed across global astrocyte territories (4.65 ± 0.55 vs. 1.45 ± 0.79, p < 0.01), as does the effect of TGN (8.4 ± 0.62 vs. 6.35 ± 0.97, p < 0.05; Fig S2 vs. Fig 2B). This likely reflects the enrichment of AQP4 in astrocyte end-feet. We describe the data in Fig.S2, and on page 8, line 20 – 23.  

      We now use the transgenic line GLAST-GCaMP6 for cytosolic GCaMP6 expression in astrocytes. Spontaneous calcium signals, reflected by transient fluorescence rises, occur in discrete micro-domains whereas the basal GCaMP6 fluorescence in the soma is weak. In the present condition, it is difficult to unambiguously discriminate astrocyte soma from the highly intermingled processes. 

      The authors show the inhibition of AQP4 with TGN-020 shortens the onset time of the swelling associated with cortical spreading depression in brain slices. However, they do not show quantification for many of the other features of CSD swelling, (ie. the duration of swelling, speed of swelling, recovery from swelling).

      Regarding the features of the CSD swelling, we have performed new analysis to quantify the duration of swelling, speed of swelling and the recovery time from swelling in control condition and in the presence of TGN-020. The new analysis is now summarized in Fig. S5. Blocking AQP4 with TGN-020 increases the swelling speed, prolongs the duration of swelling and slows down the recovery from swelling, confirming our observation that acute inhibition of AQP4 water efflux facilitates astrocyte swelling while restrains shrinking. We describe the result on page 11, line 19-21. 

      Significance:

      AQP4 is a bidirectional water channel that is constitutively open, thus water flux through it is always regulated by local osmotic gradients. Still, characterizing this water flux has been challenging, as the AQP4 channel is incredibly water-selective. The authors here present important data showing that the application of TGN-020 alone causes astrocytic swelling, indicating that there is constant efflux of water from astrocytes via AQP4 in basal conditions. This has been suggested before, as the authors rightfully highlight in their discussion, but the evidence had previously come from electron microscopy data from genetic knockout mice.

      AQP4 expression has been linked with the glymphatic circulation of cerebrospinal fluid through perivascular spaces since its rediscovery in 2012 [1]. Further studies of aging[2], genetic models[3], and physiological circadian variation[4] have revealed it is not simply AQP4 expression but AQP4 polarization to astrocytic vascular endfeet that is imperative for facilitating glymphatic flow. Still, a lingering question in the field is how AQP4 facilitates fluid circulation. This study represents an important step in our understanding of AQP4's function, as the basal efflux of water via AQP4 might promote clearance of interstitial fluid to allow an influx of cerebrospinal fluid into the brain. Beyond glymphatic fluid circulation, clearly, AQP4-dependent volume changes will differentially alter astrocytic calcium signaling and, in turn, neuronal activity.

      (1) Iliff, J.J., et al., A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β. Sci Transl Med, 2012. 4(147): p. 147ra111.

      (2) Kress, B.T., et al., Impairment of paravascular clearance pathways in the aging brain. Ann Neurol, 2014. 76(6): p. 845-61.

      (3) Mestre, H., et al., Aquaporin-4-dependent Glymphatic Solute Transport in the Rodent Brain. eLife, 2018. 7.

      (4) Hablitz, L., et al., Circadian control of brain glymphatic and lymphatic fluid flow. Nature Communications, 2020. 11(1).

      We thank the reviewer in acknowledging the significance of our study and the functional implication in brain glymphatic system. We have now highlighted the mentioned studies as well as the potential implication glymphatic fluid circulation (page 4, line 9-10; page 5, line 1-3; and page 19, line 3-10). 

      Reviewer #2 (Public Review):

      Summary:

      The paper investigates the role of astrocyte-specific aquaporin-4 (AQP4) water channel in mediating water transport within the mouse brain and the impact of the channel on astrocyte and neuron signaling. Throughout various experiments including epifluorescence and light sheet microscopy in mouse brain slices, and fiber photometry or diffusion-weighted MRI in vivo, the researchers observe that acute inhibition of AQP4 leads to intracellular water accumulation and swelling in astrocytes. This swelling alters astrocyte calcium signaling and affects neighboring neuron populations. Furthermore, the study demonstrates that AQP4 regulates astrocyte volume, influencing mainly the dynamics of water efflux in response to osmotic challenges or associated with cortical spreading depolarization. The findings suggest that AQP4-mediated water efflux plays a crucial role in maintaining brain homeostasis, and indicates the main role of AQP4 in this mechanism. However authors highlight that the report sheds light on the mechanisms by which astrocyte aquaporin contributes to the water environment in the brain parenchyma, the mechanism underlying these effects remains unclear and not investigated. The manuscript requires revision.

      Strengths:

      The paper elucidates the role of the astrocytic aquaporin-4 (AQP4) channel in brain water transport, its impact on water homeostasis, and signaling in the brain parenchyma. In its idea, the paper follows a set of complimentary experiments combining various ex vivo and in vivo techniques from microscopy to magnetic resonance imaging. The research is valuable, confirms previous findings, and provides novel insights into the effect of acute blockage of the AQP4 channel using TGN-020.

      We thank the reviewer for the constructive comments.

      Weaknesses:

      Despite the employed interdisciplinary approach, the quality of the manuscript provides doubts regarding the significance of the findings and hinders the novelty claimed by the authors. The paper lacks a comprehensive exploration or mention of the underlying molecular mechanisms driving the observed effects of astrocytic aquaporin-4 (AQP4) channel inhibition on brain water transport and brain signaling dynamics. The scientific background is not very well prepared in the introduction and discussion sections. The important or latest reports from the field are missing or incompletely cited and missconcluded. There are several citations to original works missing, which would clarify certain conclusions. This especially refers to the basis of the glymphatic system concept and recently published reports of similar content. The usage of TGN-020, instead of i.e. available AER-270(271) AQP4 blocker, is not explained. While employing various experimental techniques adds depth to the findings, some reasoning behind the employed techniques - especially regarding MRI - is not clear or seemingly inaccurate. Most of the time the number of subjects examined is lacking or mentioned only roughly within the figure captions, and there are lacking or wrongly applied statistical tests, that limit assessment and reproducibility of the results. In some cases, it seems that two different statistical tests were used for the same or linked type of data, so the results are contradictory even though appear as not likely - based on the figures. Addressing these limitations could strengthen the paper's impact and utility within the field of neuroscience, however, it also seems that supplementary experiments are required to improve the report.

      The current data hint at a tonic water efflux from astrocyte AQP4 in physiological condition, which helps to understand brain water homeostasis and the functional implication for the glymphatic system. The underlying molecular and cellular mechanisms appear multifaceted and functionally interconnected, as discussed (page 14 line 8 –page 15, line 3). We agree that a comprehensive exploration will further advance our understanding.

      The introduction and discussion are now strengthened by incorporating the important advances in glymphatic system while highlighting the relevant studies. 

      The use of TGN-020 was based on its validation by wide range of ex vivo and in vivo studies including the use of heterologous expression system and the AQP4 KO mice. The validation of AER-270(271, the water soluble prodrug) using AQP4 KO mice is reported recently (Giannetto et al., 2024). AER-271 was noted to impact brain water ADC (apparent diffusion coefficient evaluated by diffusion-weighted MRI) in AQP4 KO mice ~75 min after the drug application (Giannetto et al., 2024). This likely reflects that AER270(271) is also an inhibitor for κΒ nuclear factor (NF-κΒ) whose inhibition could reduce CNS water content independent of AQP4 targeting (Salman et al., 2022). In addition, the inhibition efficiency of AER-270(271) seems lower than TGN-020 (Farr et al., 2019; Giannetto et al., 2024; Huber et al., 2009; Salman et al., 2022). We have now supplemented this information in the manuscript (page 7, line 1-6 and page15, line 7-17).

      The description on the DW-MRI is now updated (page 4, line 10-14). 

      We also performed new experiments and data analysis as described in a point-to-point manner below in the section ‘Recommendations For The Authors’.

      Reviewer #3 (Public Review):

      Summary:

      In this manuscript, the authors propose that astrocytic water channel AQP4 represents the dominant pathway for tonic water efflux without which astrocytes undergo cell swelling. The authors measure changes in astrocytic sulforhodamine fluorescence as the proxy for cell volume dynamics. Using this approach, they perform a technically elegant series of ex vivo and in vivo experiments exploring changes in astrocytic volume in response to AQP4 inhibitor TGN-020 and/or neuronal stimulation. The key finding is that TGN-020 produces an apparent swelling of astrocytes and modifies astrocytic cell volume regulation after spreading depolarizations. Additionally, systemic application of TGN-020 produced changes in diffusion-weighted MRI signal, which the authors interpret as cellular swelling. This study is perceived as potentially significant. However, several technical caveats should be strongly considered and perhaps addressed through additional experiments.

      Strengths:

      (1) This is a technically elegant study, in which the authors employed a number of complementary ex vivo and in vivo techniques to explore functional outcomes of aquaporin inhibition. The presented data are potentially highly significant (but see below for caveats and questions related to data interpretation).

      (2) The authors go beyond measuring cell volume homeostasis and probe for the functional significance of AQP4 inhibition by monitoring Ca2+ signaling in neurons and astrocytes (GCaMP6 assay).

      (3) Spreading depolarizations represent a physiologically relevant model of cellular swelling. The authors use ChR2 optogenetics to trigger spreading depolarizations. This is a highly appropriate and much-appreciated approach.

      We thank the reviewer for the effort in evaluating our work.

      Weaknesses:

      (1) The main weakness of this study is that all major conclusions are based on the use of one pharmacological compound. In the opinion of this reviewer, the effects of TGN-020 are not consistent with the current knowledge on water permeability in astrocytes and the relative contribution of AQP4 to this process.

      Specifically: Genetic deletion of AQP4 in astrocytes reduces plasmalemmal water permeability by ~two-three-fold (when measured a 37oC, Solenov et al., AJP-Cell, 2004). This is a significant difference, but it is thought to have limited/no impact on water distribution. Astrocytic volume and the degree of anisosmotic swelling/shrinkage are unchanged because the water permeability of the AQP4null astrocytes remains high. This has been discussed at length in many publications (e.g., MacAulay et al., Neuroscience, 2004; MacAulay, Nat Rev Neurosci, 2021) and is acknowledged by Solenov and Verkman (2004).

      Keeping this limitation in mind, it is important to validate astrocytic cell volume changes using an independent method of cell volume reconstruction (diameter of sulforhodamine-labeled cell bodies? 3D reconstruction of EGFP-tagged cells? Else?)

      Solenov and coll. used the calcein quenching assay and KO mice demonstrating AQP4 as a functional water channel in cultured astrocytes (Solenov et al., 2004). AQP4 deletion reduced both astrocyte water permeability and the absolute amplitude of swelling over comparable time, and also slowed down cell shrinking, which overall parallels our results from acute AQP4 blocking. Yet in Solenovr’s study, the time to swelling plateau was prolonged in AQP4 KO astrocytes, differing from our data from the pharmacological acute blocking. This discrepancy may be due to compensatory mechanisms in chronic AQP4 KO, or reflect the different volume responses in cultured astrocytes from brain slices or in vivo results as suggested previously (Risher et al., 2009). 

      Soma diameter might be an indicator of cell volume change, yet it is challenging with our current fluorescence imaging method that is diffraction-limited and insufficient to clearly resolve the border of the soma in situ. In addition, the lateral diameter of cell bodies may not faithfully reflect the volume changes that can occur in all three dimensions. Rapid 3D imaging of astrocyte volume dynamics with sufficient high Z-axis resolution appears difficult with our present tools. 

      We have now accordingly updated the discussion with relevant literatures being cited (page 17 line 14 – page 18, line 3).

      (2) TGN-020 produces many effects on the brain, with some but not all of the observed phenomena sensitive to the genetic deletion of AQP4. In the context of this work, it is important to note that TGN020 does not completely inhibit AQP4 (70% maximal inhibition in the original oocyte study by Huber et al., Bioorg Med Chem, 2009). Thus, besides not knowing TGN-020 levels inside the brain, even

      "maximal" AQP4 inhibition would not be expected to dramatically affect water permeability in astrocytes.

      This caveat may be addressed through experiments using local delivery of structurally unrelated AQP4 blockers, or, preferably, AQP4 KO mice.

      It is an important point that TGN-020 partially blocks AQP4, implying the actual functional impact of AQP4 per se might be stronger than what we observed. TGN provides a means to acutely probe AQP4 function in situ, still we agree, its limitation needs be acknowledged. We mention this now on page 15, line 7-9 and 14-17.

      We agree that local delivery of an alternative blocker will provide additional information. Meanwhile, local delivery requires the stereotaxic implantation of cannula, which would cause inflammations to surrounding astrocytes (and neurons). The recently introduced AQP4 blocker AER-270(271) has received attention that it influences brain water dynamics (ADC in DW-MRI) in AQP4 KO mice (Giannetto et al., 2024), recalling that AER-270(271) is also an inhibitor for κΒ nuclear factor (NF-κΒ). This pathway can potentially perturb CNS water content and influence brain fluid circulation, in an AQP4independent manner (Salman et al., 2022). The inhibition efficiency on mouse AQP4 of AER-270 (~20%, Farr et al., 2019; Salman et al., 2022) appears lower than TGN-020 (~70%, Huber et al., 2009).

      We chose to use the pharmacological compound to achieve acute blocking of AQP4 thereby avoiding the chronic genetics-caused alterations in brain structural, functional and water homeostasis. Multiple lines of evidence including the recent study (Gomolka et al., 2023), have shown that AQP4 KO mice alters brain water content, extracellular space and cellular structures, which raises concerns to use the transgenic mouse to pinpoint the physiological functions of the AQP4 water channel. 

      We have now mentioned the concerns on AQP4 pharmacology by supplementing additional literatures in the field (page 15, line 8-18). 

      (3) This reviewer thinks that the ADC signal changes in Figure 5 may be unrelated to cellular swelling. Instead, they may be a result of the previously reported TGN-020-induced hyphemia (e.g., H. Igarashi et al., NeuroReport, 2013) and/or changes in water fluxes across pia matter which is highly enriched in AQP4. To amplify this concern, AQP4 KO brains have increased water mobility due to enlarged interstitial spaces, rather than swollen astrocytes (RS Gomolka, eLife, 2023). Overall, the caveats of interpreting DW-MRI signal deserve strong consideration.

      The previous observation show that TGN-020 increases regional cerebral blood flow in wild-type mice but not in AQP4 KO mice (Igarashi et al., 2013). Our current data provide a possible mechanism explanation that TGN-020 blocking of astrocyte AQP4 causes calcium rises that may lead to vasodilation as suggested previously (Cauli and Hamel, 2018). We now add updates to the discussion on page 15, line 3-7.

      We are in line with the reviewer regarding the structural deviations observed with the AQP4 KO mice

      (Gomolka et al., 2023), now mentioned on page 19, line 3-5. Following the Reviewer’s suggestion, we have also updated the interpretation of the DW-MRI signal and point that in addition to being related to the astrocyte swelling, the ADC signal changes may also be caused by indirect mechanisms, such as the transient upregulation of other water-permeable pathways in compensating AQP4 blocking. We now describe this alternative interpretation and the caveats of the DW-MRI signals (page 20, line 1-8). 

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Private recommendations

      My more broad experimental suggestions are in the "weaknesses" section. Some minor points that would improve the manuscript are included below:

      (1) A more detailed explanation for why SRB fluorescence reflects the astrocyte volume changes, whereas typical intracellular GFP does not.

      As an engineered fluorescence protein, the GFP has been used to tag specific type of cells. Meanwhile, as a relatively big protein (MW, 26.9 kDa), the diffusion rate of EGFP is expected to be much less than SRB, a small chemical dye (MW, 558.7 Da). Also, the IP injection of SRB enables geneticsless labeling of brain astrocytes, so to avoid the influence of protein overexpression on astrocyte volume and water transport responses. We have now stated this point in the manuscript (page 13, line 21 – page 14, line 4).

      (2) Figure 1 panel B should have clear labels on the figure and a description in the legend to delineate which part of the panel refers to hyper- or hypo-osmotic treatment.

      We have now updated the figure and the legend.  

      (3) For Figure 2, what is the rationale for analyzing the calcium signaling data between the cell types differently?

      We analyzed calcium micro-domains for astrocytes as their spontaneous signals occur mainly in discrete micro-domains (Shigetomi et al., 2013). While for neurons, we performed global analysis by calculating the mean fluorescence of imaging field of view, because calcium signal changes were only observed at global level rather than in micro-domains. This information is now included (page 24, line1820).

      (4) For Figure 3, the authors mention that TGN-020 likely caused swelling prior to the hypotonic solution administration. Do they have any measurements from these experiments prior to the TGN-020 application to use as a "true baseline" volume?

      The current method detects the relative changes in astrocyte volume (i.e., transmembrane water transport), which nevertheless is blind to the absolute volume value. We have no readout on baseline volumes.  

      (5) For Figures 3 and 4, did the authors see any evidence for regulatory volume decrease? And is this impaired by TGN-020? It is a well-characterized phenomenon that astrocytes will open mechanosensitive channels to extrude ions during hypo-osmotic induced swelling. This process is dependent on AQP4 and calcium signaling [5]

      Mola and coll. provided important results demonstrating the role of AQP4 in astrocyte volume regulation (Mola et al., 2016). In the present study in acute brain slices, when we applied hypotonic solution to induce astrocyte swelling, our protocol did not reveal rapid regulatory volume decrease (e.g., Fig. 3D). When we followed the volume changes of SRB-labeled astrocytes during optogenetically induced CSD, we observed the phase of volume decrease following the transient swelling (Fig. 4F), where the peak amplitude and the degree of recovery were both reduced by inhibiting AQP4 with TGN020. These data imply that regulatory astrocyte volume decrease may occur in specific conditions, which intriguingly has been suggested to be absent in brain slices and in vivo (e.g., Risher et al., 2009). We have not specifically investigated this phenomenon, and now briefly discuss this point on page18 line 6-14.

      (6) Figure 5 box plots do not show all data points, could the authors modify to make these plots show all the animals, or edit the legend to clarify what is plotted?

      We have now updated the plot and the legend. This plot is from all animals (n = 7 per condition).

      (7) pg. 9 line 6, there is a sentence that seems incomplete or otherwise unfinished. "We first followed the evoked water efflux and shrinking induced by hypertonic solution while."

      Fixed (now, page 9 line 17-18). 

      (8)  During the discussion on pg 13 line 11, it may be more clear to describe this as the cotransport of water into the cells with ions/metabolites as reviewed by Macaulay 2021 [6].

      We agree; the text is modified following this suggestion (now page14, line 12-13).  

      (1) Iliff, J.J., et al., A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β. Sci Transl Med, 2012. 4(147): p. 147ra111.

      (2) Kress, B.T., et al., Impairment of paravascular clearance pathways in the aging brain. Ann Neurol, 2014. 76(6): p. 845-61.

      (3) Mestre, H., et al., Aquaporin-4-dependent Glymphatic Solute Transport in the Rodent Brain. eLife, 2018. 7.

      (4) Hablitz, L., et al., Circadian control of brain glymphatic and lymphatic fluid flow. Nature Communications, 2020. 11(1).

      (5) Mola, M., et al., The speed of swelling kinetics modulates cell volume regulation and calcium signaling in astrocytes: A different point of view on the role of aquaporins. Glia, 2016. 64(1).

      (6) MacAulay, N., Molecular mechanisms of brain water transport. Nat Rev Neurosci, 2021. 22(6): p. 326-344.

      We thank the reviewer. These important literatures are now supplemented to the manuscript together with the corresponding revisions.

      Reviewer #2 (Recommendations For The Authors):

      In its concept, the paper is interesting and provides additional value - however, it requires revision.

      Below, I provide the following remarks for the following sections/ pages/lines:

      ABSTRACT/page 2 (remarks here refer to the rest of the manuscript, where these sentences are repeated):

      - It seems that the 'homeostasis' provides not only physical protection, but also determines the diffusion of chemical molecules...' Please correct the sentence as it is grammatically incorrect.

      It is now corrected (page 2, line 1).

      - The term 'tonic water' is not clear. I understand, after reading the paper, that it is about tonicity of the solutes injected into the mouse.

      We use the term ‘tonic’ to indicate that in basal conditions, a constant water efflux occurs through the APQ4 channel.

      - 'tonic aquaporin water efflux maintains volume equilibrium' - I believe it is about maintaining volume and osmotic equilibrium?

      This description is now refined (now page 2, line 10).

      - It is not clear whether the tonic water outflow refers to the cellular level or outflow from the brain parenchyma (i.e., glymphatic efflux)

      It refers to the cellular level. 

      INTRODUCTION/page 3:

      - 'clearance of waste molecules from the brain as described in the glymphatic system' - The original papers describing the phenomena are not cited: Iliff et al. 2012, 2013, Mestre et al. 2018, as well as reviews by Nedergaard et al.

      Indeed. We have now cited these key literatures (now page 4, line 10).

      - 'brain water diffusion is the basis for diffusion-weighted magnetic resonance imaging (DW-MRI)' - The statement is wrong. it is the mobility of the water protons that DWI is based on, but not the diffusion of molecules in the brain. This should be clarified and based on the DW-MRI principle and the original works by Le Bihan from 1986, 1988, or 2015.

      This sentence is now updated (page 4, line10-14).

      - Similarly, I suggest correcting or removing the citations and the sentence part regarding the clinical use of DWI, as it has no value here. Instead, it would be worth mentioning what actually ADC reflects as a computational score, and what were the results from previous studies assessing glymphatic systems using DWI. This is especially important when considering the mislocalization of the AQP4 channel.

      We now states recent studies using DW-MRI to evaluate glymphatic systems (page 4, line16-17).  

      - 'In the brain, AQP4 is predominantly expressed in astrocytes'-please review the citations. I suggest reading the work by Nielsen 1997, Nagelhus 2013, Wolburg 2011, and Li and Wang from 2017. To my best knowledge, in the brain AQP4 is exclusively expressed in astrocytes.

      Thanks for the reviewer. It is described that while enriched in astrocytes, AQP4 is also expressed in ependymal cells lining the ventricles (e.g., (Mayo et al., 2023; Verkman et al., 2006)). ‘predominantly’ is now removed (page 4, line 21).

      - The conclusion: ' Our finding suggests that aquaporin acts as a water export route in astrocytes in physiological conditions, so as to counterbalance the constitutive intracellular water accumulation caused by constant transmitter and ion uptake, as well as the cytoplasmic metabolism processes. This mechanism hence plays a necessary role in maintaining water equilibrium in astrocytes, thereby brain water homeostasis' seems to be slightly beyond the actual findings in the paper. I suggest clarifying according to the described phenomena.

      We have now refined the conclusion sticking to the experimental observations (page 5, line16-18).

      - The introduction lacks important information on existing AQP4 blockers and their effects, pros and cons on why to use TGN-020. Among others, I would refer to recent work by Giannetto et al 2024, as well as previous work of Mestre et al. 2018 and Gomolka et al. 2023.

      We initiated the study by using TGN-020 as an AQP4 blocker because it has been validated by wide range of ex vivo and in vivo studies as documented in the text (page 7, line 1-6). We also update discussions on the recent advances in validating the AQP4 blocker AER-270(271) while citing the relevant studies (page 15, line 7-17).  

      RESULTS:

      - Page 5, lines 19-20: '...transport, we performed fluorescence intensity translated (FIT) imaging.' - this term was never introduced in the methods so it is difficult for the reader to understand it at first sight. -'To this end,' - it is not clear which action refers to 'this'. (is it about previous works or the moment that the brain samples were ready for imaging? Please clarify, as it is only starting to be clear after fully reading the methods.

      We now refine the description give the principle of our imaging method first, then explain the technical steps. To avoid ambiguity, the term ‘To this end’ is removed. The updated text is now on page 6, line 1-3.  

      - From page 6 onwards - all references to Figures lack information to which part of the figure subpanel the information refers (top/middle bottom or left/middle/right).

      We apologize. The complementary indication is now added for figure citations when applicable.  

      - 'whereas water export and astrocyte shrinking upon hyperosmotic manipulation increased astrocyte fluorescence (Figure 1B). Hence, FIT imaging enables real-time recording of astrocyte transmembrane water transport and volume dynamics.' - this part seems to be undescribed or not clear in the methods.

      We have now refined this description (page 6, line 19-20).

      - Page 6, lines 17-22: TGN-020. In addition to the above, I suggest familiarizing also with the following works by Igarashi 2011. doi: 10.1007/s10072-010-0431-1, and by Sun 2022. doi: 10.3389/fimmu.2022.870029.

      These studies are now cited (page 7, line 3-4).

      - Page 7: ' AQP4 is a bidirectional channel facilitating... ' - AQP4 water channel is known as the path of least resistance for water transfer, please see Manley, Nature Medicine, 2000 and Papadopoulos, Faseb J, 2004.

      This sentence is now updated (page 7, line 12-13).

      - ' astrocyte AQP4 by TGN-020 caused a gradual decrease in SRB fluorescence intensity, indicating an intracellular water accumulation' - tissue slice experiment is a very valuable method. However it seems right, the experiment does not comment on the cell swelling that may occur just due to or as a superposition of tissue deterioration and the effect of TGN-020. The AQP4 channel is blocked, and the influx of water into astrocytes should be also blocked. Thus, can swelling be also a part of another mechanism, as it was also observed in the control group? I suggest this should be addressed thoroughly.

      We performed this experiment in acute brain slices to well control the pharmacological environment and gain spatial-temporal information. Post slicing, the brain slices recovered > 1hr prior to recording, so that the slices were in a stable state before TGN-020 application as evidenced by the stable baseline. The constant decrease in the control trace is due to photobleaching which did not change its curve tendency in response to vehicle. TGN-020, in contrast, caused a down-ward change suggesting intracellular water accumulation and swelling. 

      The experiment was performed at basal condition without active water influx; a decrease in SRB fluorescence hints astrocyteintracellular water buildup. This result shows that in basal condition, astrocyte aquaporin mediates a constant (i.e., tonic) water efflux; its blocking causes intracellular water accumulation and swelling. 

      We have accordingly updated the description of this part (page 7, line 15-20).

      - From the Figure 1 legend: Only 4 mice were subjected to the experiment, and only 1 mouse as a control. I suggest expanding the experiment and performing statistics including two-way ANOVA for data in panels B, C, and D, as no results of statistical tests confirm the significance of the findings provided.

      The panel B confirms that cytosolic SRB fluorescence displays increasing tendency upon water efflux and volume shrinking, and vice versa. As for the panel C, the number of mice is now indicated. Also, the downward change in the SRB fluorescence was now respectively calculated for the phases prior and post to TGN (and vehicle) application, and this panel is accordingly updated. TGN-020 induced a declining in astrocyte SRB fluorescence, which is validated by t-test performed in MATLAB. To clarify, we now add cross-link lines to indicate statistical significance between the corresponding groups (Fig 1C, middle). As for panel D, we calculated the SRB fluorescence change (decrease) relative to the photobleaching tendency illustrated by the dotted line. The significance was also validated by t-test performed in MATLAB.  

      - Figure 1: Please correct the figure - pictures in panel A are low quality and do not support the specificity of SRB for astrocytes. Panels B-D are easier to understand if plotted as normal X/Y charts with associated statistical findings. Some drawings are cut or not aligned.

      In GFAP-EGFP transgenic, astrocytes are labeled by EGFP. SRB labeling (red fluorescence) shows colocalization with EGFP-positive astrocytes, meanwhile not all EGFP-positive astrocytes are labeled by SRB. The PDF conversion procedure during the submission may also somehow have compromised image quality. We have tried to update and align the figure panels.  

      - Page 12: ' TGN-020 increased basal water diffusion within multiple regions including the cortex,

      hippocampus and the striatum in a heterogeneous manner (Figure 5C).'

      This sentence is updated now (page 12, line 12 – page13, line 2). It reads ‘The representative images reveal the enough image quality to calculate the ADC, which allow us to examine the effect of TGN-020 on water diffusion rate in multiple regions (Fig. 5C).’

      - The expression of AQP4 within the brain parenchyma is known to be heterogenous. Please familiarize yourself with works by Hubbard 2015, Mestre 2018, and Gomolka 2023. A correlation between ADC score and AQP4 expression ROI-wise would be useful, but it is not substantial to conduct this experiment.

      We thank the reviewer. This point is stressed on page 19, line 12-14.

      DISCUSSION:

      - Most of the issues are commented on above, so I suggest following the changes applied earlier. -Page 16: 'We show by DW-MRI that water transport by astrocyte aquaporin is critical for brain water homeostasis.' This statement is not clear and does not refer to the actual impact of the findings. DWI is allowed only to verify the changes of ADC fter the application of TGN-020. I suggest commenting on the recent report by Giannetto 2024 here.

      This sentence is now refined (page 19, line 1-2), followed by the updates commenting on the recent studies employing DW-MRI to evaluate brain fluid transport, including the work of (Giannetto et al., 2024) (page 19, line 3-10). 

      METHODS:

      - Page 18: no total number of mice included in all experiments is provided, as well as no clearly stated number of mice used in each experiment. Please correct.

      We have now double checked the number of the mice for the data presented and updated the figure legends accordingly (e.g., updates in legends fig1, fig5, etc).

      -  Page 18, line 7: 'Axscience' is not a producer of Isoflurane, but a company offering help with scientific manuscript writing. If this company's help was used, it should be stated in the acknowledgments section. Reference to ISOVET should be moved from line 15 to line 7.

      We apologize. We did not use external writing help, and now have removed the ‘Axcience’. The Isoflurane was under the mark ‘ISOVET’ from ‘Piramal’. This info is now moved up (page 21, line 11). 

      - Page 18, line 9: ' modified artificial cerebrospinal fluid (aCSF)'. Additional information on the reason for the modified aCSF would be useful for the reader.

      In this modified solution, the concentration of depolarizing ions (Na+, Ca2+) was reduced to lower the potential excitotoxicity during the tissue dissection (i.e., injury to the brain) for preparing the brain slices. Extra sucrose was added to balance the solution osmolarity. This solution has been used previously for the dissection and the slicing steps in adult mice (Jiang et al., 2016). We now add this justification in the text and quote the relevant reference (page 21, line14-16). 

      - Page 19, line 6: a reasoning for using Tamoxifen would be helpful for the reader.

      The Glast-CreERT2 is an inducible conditional mouse line that expresses Cre recombinase selectively in astrocytes upon tamoxifen injection. We now add this information in the text (page 22, line 10-11). 

      - Line 8 - 'Sigma'

      Fixed.

      - Line 7/8: It is not clear if ethanol is of 10% solution or if proportions of ethanol+tamoxifen to oil were of 1:9. The reasoning for each performed step is missing.

      We have now clarified the procedure (page 22, line 11-15).

      - Line 10: '/' means 'or'?

      Here, we mean the bigenic mice resulting from the crossing of the heterozygous Cre-dependent GCaMP6f and Glast-CreERT2 mouse lines. We now modify it to ‘Glast-CreERT2::Ai95GCaMP6f//WT’, in consistence with the presentation of other mouse lines in our manuscript (page 22, line 16).

      - Lines 22-23: being in-line with legislation was already stated at the beginning of the Methods so I suggest combining for clearance.

      Done. 

      - Page 21, line 4: it is good to mention which printer was used, but it would be worth mentioning the material the chamber was printed from - was it ABS?

      Yes. We add this info in the text now (page 24, line 5).

      - Line 9 -'PI' requires spelling out.

      It is ‘Physik Instrumente’, now added (page 24, line 10).

      - Line 11-12: What is the reason for background subtraction - clearer delineation of astrocytes/ increasing SNR in post-processing, or because SRB signal was also visible and changing in the background over time? Was the background removed in each frame independently (how many frames)? How long was the time-lapse and was the F0 frame considered as the first frame acquired? The background signal should be also measured and plotted alongside the astrocytic signal, as a reference (Figure 1). This should be clarified so that steps are to be followed easily.

      We sought to follow the temporal changes in SRB fluorescence signal. The acquired fluorescent images contain not only the SRB signals, but also the background signals consisting of for instance the biological tissue autofluorescence, digital camera background noise and the leak light sources from the environments. The value of the background signal was estimated by the mean fluorescence of peripheral cell-free subregions (15 × 15 µm²) and removed from all frames of time-lapse image stack. The traces shown in the figures reflect the full lengths of the time-lapse recordings. F0 was identified as the mean value of the 10 data points immediately preceding the detected fluorescence changes. The text is now updated (page 24 line 21 - page 25 line 5).

      - Line 15: Was astrocyte image delineation performed manually or automatically? Where was the center of the region considered in the reference to the astrocyte image? It would be good to see the regions delineated for reference.

      Astrocytes labeled by SRB were delineated manually with the soma taken as the center of the region of interest. We now exemplify the delineated region in Fig 1A, bottom.

      - Page 22, line 2: 'x4 objective'.

      Added (now, page 25, line 16). 

      - Line 3: 'barrels' - reference to publication or the explanation missing.

      The relevant reference is now added on barrel cortex (Erzurumlu and Gaspar, 2020) (page 25, line 19-20). 

      - Line 19: were the coordinates referred to = bregma?

      Yes. This info is now added (page 26, line 12). 

      - Line 20: was the habituation performed directly at the acquisition date? It is rather difficult to say that it was a habituation, but rather acute imaging. I suggest correcting, that mice were allowed to familiarize themselves with the setup for 30 minutes prior to the imaging start.

      In this context, although it is a very nice idea and experiment, the influence of acute stress in animals familiar with the setup only from the day of acquisition is difficult to avoid. It is a major concern, especially when considering norepinephrine as a master driver of neuronal and vascular activity through the brain, and strong activation of the hypothalamic-adrenal axis in response to acute stress. It is well known, that the response of monoamines is reduced in animals subjected to chronic v.s acute stress, but still larger than that if the stressor is absent.

      Major remark: The animals should, preferably, be imaged at least after 3 days of habituation based on existing knowledge. I suggest exploring the topic of the importance of habituation. It is difficult though, to objectively review these findings without considering stress and associated changes in vascular dynamics.

      Many thanks for the reviewer to help to precise this information. The text is accordingly updated to describe the experiment (now page 26, line 14). 

      - Page 23, line 17: number of animals included in experiments missing.

      The number of animals is added in Methods (page 27, line 12) and indicated in the legend of Figure 5. 

      - Line 18/19: were the respiratory effects observed after injection of saline or TGN-020? Since DWI was performed, the exclusion of perfusive flow on ADC is impossible.

      I suggest an additional experiment in n=3 animals per group, verifying the HR (and if possible BP) response after injection of TGN-020 and saline in mice.

      The respiratory rate has been recorded. We added the averaged respiratory rate before and after injection of TGN-020 or saline (now, Fig. S6; page 13, line 5-6).

      - Line 22: Please, provide the model of the scanner, the model of the cryoprobe, as well as the model of the gradient coil used, otherwise it is difficult to assess or repeat these experiments.

      We have now added the information of MRI system in Methods section (page 27, line17-21).

      - Page 24: line 3/4: although the achieved spatial resolution of DWI was good and slightly lower than desired and achievable due to limitations of the method itself as well as cryoprobe, it is acceptable for EPI in mice.

      Still, there is no direct explanation provided on the reasoning for using surface instead of volumetric coil, as well as on assuming an anisotropic environment (6 diffusion directions) for DWI measurements. This is especially doubtful if such a long echo-time was used alongside lower-thanpossible spatial resolution. Longer echo time would lower the SNR of the depicted signal but also would favor the depiction of signal from slow-moving protons and larger water pools. On the other hand, only 3 b-values were used, which is the minimum for ADC measurements, while a good research protocol could encompass at least 5 to increase the accuracy of ADC estimation and avoid undersampling between 250 and 1800 b-values. What was the reason for choosing this particular set of b-values and not 50, 600, and 2000? Besides, gradient duration time was optimally chosen, however, I have concerns about the decision for such a long gradient separation times.

      If the protocol could have been better optimized, the assessment could have been also performed in respiratory-gated mode, allowing minimization of the effects of one of the glymphatic system driving forces.

      Thus, I suggest commenting on these issues.

      We chose the cryoprobe to increase the signal-to-noise ratio (SNR) in DW-MRI with long echo-time and high b-value. The volume coil has a more homogeneous SNR in the whole brain rather than the cryoprobe, but SNR should be reduced compared with cryoprobe. We confirmed that, even at the ventral part of the brain, the image quality of DW-MRI images was enough to investigate the ADC with cryoprobe (Fig. 5B-C). This is mentioned now in Methods (page 27, line 17-21).

      We performed DW-MRI scanning for 5 min at each time-point using the condition of anisotropic resolution and 3 b-values, to investigate the time-course of ADC change following the injection of TGN020. Because the effect of TGN-020 appears about dozen of minutes post the injection (Igarashi et al., 2011), fast DW-MRI scanning is required. If isotropic DW-MRI with lower echo-time and more direction is used, longer scan time at each time point is required, maybe more than 1h. We agree that three bvalues is minimum to calculate the ADC and more b-values help to increase the accuracy. However, to achieve the temporal resolution so as to better catch the change of water diffusion, we have decided to use the minimum b-values. The previous study also validates the enough accuracy of DW-MRI with three b-values (Ashoor et al., 2019). Furthermore, previous study that used long diffusion time (> 20 ms) and long echo time (40 ms) shows the good mean diffusivity (Aggarwal et al., 2020), supporting that our protocol is enough to investigate the ADC. We have now updated the description (page 28 line 5-9).  The reason why we choose the b = 250 and 1800 s/mm² is that 2000 s/mm² seems too high to get the good quality of image. In the previous study, we have optimized that ADC is measurable with b = 0, 250, and 1800 s/mm² (Debacker et al., 2020). 

      - Page 24, line 7: What was the post-processing applied for images acquired over 70 minutes? Did it consider motion-correction, co-registration, or drift-correction crucial to avoid pitfalls and mismatches in concluding data?

      The motion correction and co-registration were explained in Methods (page 28, line 12-14).

      Also, were these trace-weighted images or magnitude images acquired since DTI software was used for processing - while ADC fitting could be reliably done in Matlab, Python, or other software. Thus, was DSI software considering all 3 b-values or just used 0 and 1800 for the calculation of mean diffusivity for tractography (as ADC). The details should be explained.

      DSIstudio was used with all three b values (b = 0, 250, and 1800 s/mm²) to calculate the ADC. We added the description in Methods (page 28, line 16-18).

      To make sure that the results are not affected by the MR hardware, I suggest performing 3 control measurements in a standard water phantom, and presenting the results alongside the main findings.

      Thanks for this suggestion. We have performed new experiments and now added the control measurement with three phantoms, that is water, undecane, and dodecane. These new data are summarized now in Fig. S7, showing the stability of ADC throughout the 70 min scanning. We have updated the description on Method part (page 28, line 9-11) and on the Results (page 13, line 6-8).  

      - Line 13: were the ROI defined manually or just depicted from previously co-registered Allen Brain atlas?

      The ROIs of the cortex, the hippocampus, and the striatum were depicted with reference to Allen mouse brain atlas (https://scalablebrainatlas.incf.org/mouse/ABA12). This is explained in Methods (page 28, line 14-16).

      - Line 10: why the average from 1st and 2nd ADC was not considered, since it would reduce the influence of noise on the estimation of baseline ADC?

      We are sorry that it was a typo. The baseline was the average between 1st and 2nd ADC. We corrected the description (page 28, line 20).

      STATISTIC:

      Which type of t-test - paired/unpaired/two samples was used and why? Mann-Whitney U-tets are used as a substitution for parametric t-tests when the data are either non-parametric or assuming normal distribution is not possible. In which case Bonferroni's-Holm correction was used? - I couldn't find any mention of any multiple-group analysis followed by multiple comparisons. Each section of the manuscript should have a description of how the quantitative data were treated and in which aim. I suggest carefully correcting all figures accordingly, and following the remarks given to the Figure 1.

      We used unpaired t-test for data obtained from samples of different conditions. Indeed, MannWhitney U-test is used when the data are non-parametric deviating from normal distributions.  Bonferroni-Holm correction was used for multiple comparisons (e.g., Fig. 4D-E).

      Reviewer #3 (Recommendations For The Authors):

      I think that the following statement is insufficient: "The authors commit to share data, documentation, and code used in analysis". My understanding is eLife expects that all key data to be provided in a supplement.

      We thank the reviewer; we follow the publication guidelines of eLife. 

      References

      Aggarwal, M., Smith, M.D., and Calabresi, P.A. (2020). Diffusion-time dependence of diffusional kurtosis in the mouse brain. Magn Reson Med 84, 1564-1578.

      Ashoor, M., Khorshidi, A., and Sarkhosh, L. (2019). Estimation of microvascular capillary physical parameters using MRI assuming a pseudo liquid drop as model of fluid exchange on the cellular level. Rep Pract Oncol Radiother 24, 3-11.

      Cauli, B., and Hamel, E. (2018). Brain Perfusion and Astrocytes. Trends in neurosciences 41, 409-413.

      Debacker, C., Djemai, B., Ciobanu, L., Tsurugizawa, T., and Le Bihan, D. (2020). Diffusion MRI reveals in vivo and non-invasively changes in astrocyte function induced by an aquaporin-4 inhibitor. PLoS One 15, e0229702.

      Erzurumlu, R.S., and Gaspar, P. (2020). How the Barrel Cortex Became a Working Model for Developmental Plasticity: A Historical Perspective. J Neurosci 40, 6460-6473.

      Farr, G.W., Hall, C.H., Farr, S.M., Wade, R., Detzel, J.M., Adams, A.G., Buch, J.M., Beahm, D.L., Flask, C.A., Xu, K., et al. (2019). Functionalized Phenylbenzamides Inhibit Aquaporin-4 Reducing Cerebral Edema and Improving Outcome in Two Models of CNS Injury. Neuroscience 404, 484-498.

      Giannetto, M.J., Gomolka, R.S., Gahn-Martinez, D., Newbold, E.J., Bork, P.A.R., Chang, E., Gresser, M., Thompson, T., Mori, Y., and Nedergaard, M. (2024). Glymphatic fluid transport is suppressed by the aquaporin-4 inhibitor AER-271. Glia.

      Gomolka, R.S., Hablitz, L.M., Mestre, H., Giannetto, M., Du, T., Hauglund, N.L., Xie, L., Peng, W., Martinez, P.M., Nedergaard, M., et al. (2023). Loss of aquaporin-4 results in glymphatic system dysfunction via brain-wide interstitial fluid stagnation. eLife 12.

      Huber, V.J., Tsujita, M., and Nakada, T. (2009). Identification of aquaporin 4 inhibitors using in vitro and in silico methods. Bioorg Med Chem 17, 411-417.

      Igarashi, H., Huber, V.J., Tsujita, M., and Nakada, T. (2011). Pretreatment with a novel aquaporin 4 inhibitor, TGN-020, significantly reduces ischemic cerebral edema. Neurol Sci 32, 113-116.

      Igarashi, H., Tsujita, M., Suzuki, Y., Kwee, I.L., and Nakada, T. (2013). Inhibition of aquaporin-4 significantly increases regional cerebral blood flow. Neuroreport 24, 324-328.

      Jiang, R., Diaz-Castro, B., Looger, L.L., and Khakh, B.S. (2016). Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice. J Neurosci 36, 3453-3470.

      Mayo, F., Gonzalez-Vinceiro, L., Hiraldo-Gonzalez, L., Calle-Castillejo, C., Morales-Alvarez, S., Ramirez-Lorca, R., and Echevarria, M. (2023). Aquaporin-4 Expression Switches from White to Gray Matter Regions during Postnatal Development of the Central Nervous System. Int J Mol Sci 24.

      Mola, M.G., Sparaneo, A., Gargano, C.D., Spray, D.C., Svelto, M., Frigeri, A., Scemes, E., and Nicchia, G.P. (2016). The speed of swelling kinetics modulates cell volume regulation and calcium signaling in astrocytes: A different point of view on the role of aquaporins. Glia 64, 139-154.

      Risher, W.C., Andrew, R.D., and Kirov, S.A. (2009). Real-time passive volume responses of astrocytes to acute osmotic and ischemic stress in cortical slices and in vivo revealed by two-photon microscopy. Glia 57, 207-221.

      Salman, M.M., Kitchen, P., Yool, A.J., and Bill, R.M. (2022). Recent breakthroughs and future directions in drugging aquaporins. Trends Pharmacol Sci 43, 30-42.

      Shigetomi, E., Bushong, E.A., Haustein, M.D., Tong, X., Jackson-Weaver, O., Kracun, S., Xu, J., Sofroniew, M.V., Ellisman, M.H., and Khakh, B.S. (2013). Imaging calcium microdomains within entire astrocyte territories and endfeet with GCaMPs expressed using adeno-associated viruses. J Gen Physiol 141, 633-647.

      Solenov, E., Watanabe, H., Manley, G.T., and Verkman, A.S. (2004). Sevenfold-reduced osmotic water permeability in primary astrocyte cultures from AQP-4-deficient mice, measured by a fluorescence quenching method. Am J Physiol Cell Physiol 286, C426-432.

      Verkman, A.S., Binder, D.K., Bloch, O., Auguste, K., and Papadopoulos, M.C. (2006). Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. Biochim Biophys Acta 1758, 10851093.

    1. The fact that many here are maintainers of Ruby implementations also has a biased effect on new features, as they might represent a burden on them. I'm not saying this is a bad thing, I love the diversity of points of view that this brings! OTOH, it's fair that people that do take time to discuss things here have a bigger influence on the direction that Ruby follows.
    1. Peridata

      for - omni-optionai - omni-contextual - omni-transitional - omni-repurpose

      deep coupling powered by

      coevolutionary easy to refactoraboe extensable

    1. Reviewer #1 (Public review):

      Summary:

      The manuscript by Zhou et al offers new high resolution Cryo-EM structures of two human biotin-dependent enzymes: propionyl-CoA carboxylase (PCC) and methycrotonyl-CoA carboxylase (MCC). While X-ray crystal structures and Cryo-EM structures have previously been reported for bacterial and trypanosomal versions of MCC and for bacterial versions of PCC, this marks one of the first high resolution Cryo-EM structures of the human version of these enzymes. Using the biotin cofactor as an affinity tag, this team purified a group of four different human biotin-dependent carboxylases from cultured human Expi 293F (kidney) cells (PCC, MCC, acetyl-CoA carboxylase (ACC), and pyruvate carboxylase). Following further enrichment by size-exclusion chromatography, they were able to vitrify the sample and pick enough particles of MCC and PCC to separately refine the structures of both enzymes to relatively high average resolutions (the Cryo-EM structure of ACC also appears to have been determined from these same micrographs, though this is the subject of a separate publication). To determine the impact of substrate binding on the structure of these enzymes and to gain insights into substrate selectivity, they also separately incubated with propionyl-CoA and acetyl-CoA and vitrified the samples under active turnover conditions, yielding a set of cryo-EM structures for both MCC and PCC in the presence and absence of substrates and substrate analogues.

      Strengths:

      The manuscript has several strengths. It is clearly written, the figures are clear and the sample preparation methods appear to be well described. This study demonstrates that Cryo-EM is an ideal structural method to investigate the structure of these heterogeneous samples of large biotin-dependent enzymes. As a consequence, many new Cryo-EM structures of biotin-dependent enzymes are emerging, thanks to the natural inclusion of a built-in biotin affinity tag. While the authors report no major differences between the human and bacterial forms of these enzymes, it remains an important finding that they demonstrate how/if the structure of the human enzymes are or are not distinct from the bacterial enzymes. The MCC structures also provide evidence for a transition for BCCP-biotin from an exo-binding site to an endo-binding site in response to acetyl-CoA binding. This contributes to a growing number of biotin-dependent carboxylase structures that reveal BCCP-biotin binding at locations both inside (endo-) and outside (exo-) of the active site.

      Weaknesses:

      There are some minor weaknesses. Notably, there are not a lot of new insights coming from this paper. The structural comparisons between MCC and PCC have already been described in the literature and there were not a lot of significant changes (outside of the exo- to endo- transition) in the presence vs. absence of substrate analogues. There are sections of this manuscript that do not sufficiently clarify what represents a new insight from the current set of structures (there are few of them), vs. what is largely recapitulating what has been seen in previous structures.

      There is not a great deal of depth of analysis in the discussion. For example, no new insights were gained with respect to the factors contributing to substrate selectivity (the factors contributing to selectivity for propionyl-CoA vs. acetyl-CoA in PCC). The authors acknowledge that they are limited in their interpretations as a consequence of the acyl groups being unresolved in all of the structures. They offer a simple, overarching and not particularly insightful explanation that the longer acyl group in propionyl-CoA may mediate stronger hydrophobic interactions that stabilize the alpha carbon of the acyl group at the proper position. The authors did not take the opportunity to describe the specific interactions that may be responsible for the stronger hydrophobic interaction nor do they offer any plausible explanation for how these might account for an astounding difference in the selectivity for propionyl-CoA vs. acetyl-CoA. Essentially, the authors concede that these cryo-EM structures offer no new insights into the structural basis for substrate selectivity in PCC, confirming that these structures do not yet fully capture the proper conformational states.

      Some of these minor deficiencies aside, the overall aim of contributing new cryo-EM structures of the human MCC and PCC has been achieved. While I am not a cryo-EM expert, I see no flaws in the methodology or approach. While the contributions from these structures are somewhat incremental, it is nevertheless important to have these representative examples of the human enzymes and it is noteworthy to see a new example of the exo-binding site in a biotin-dependent enzyme.

    1. eLife Assessment

      This work presents a valuable finding on how the interplay between transcription factors SOX2 and OCT4 establishes the pluripotency network in early mouse embryos. Despite the high quality of the data, the evidence supporting the claims of the authors is currently incomplete and would benefit from more omics analysis such as H3K4me1 and H3K27ac CUT&Tag. The work will be of interest to biologists working on embryonic development.

    1. Reviewer #1 (Public review):

      Hotinger et al. explore the population dynamics of Salmonella enterica serovar Typhimurium in mice using genetically tagged bacteria. In addition to physiological observations, pathology assessments, and CFU measurements, the study emphasizes quantifying host bottleneck sizes that limit Salmonella colonization and dissemination. The authors also investigate the genetic distances between bacterial populations at various infection sites within the host.

      Initially, the study confirms that pretreatment with the antibiotic streptomycin before inoculation via orogastric gavage increases the bacterial burden in the gastrointestinal (GI) tract, leading to more severe symptoms and heightened fecal shedding of bacteria. This pretreatment also significantly reduces between-animal variation in bacterial burden and fecal shedding. The authors then calculate founding population sizes across different organs, discovering a severe bottleneck in the intestine, with founding populations reduced by approximately 10^6-fold compared to the inoculum size. Streptomycin pretreatment increases the founding population size and bacterial replication in the GI tract. Moreover, by calculating genetic distances between populations, the authors demonstrate that, in untreated mice, Salmonella populations within the GI tract are genetically dissimilar, suggesting limited exchange between colonization sites. In contrast, streptomycin pretreatment reduces genetic distances, indicating increased exchange.

      In extraintestinal organs, the bacterial burden is generally not substantially increased by streptomycin pretreatment, with significant differences observed only in the mesenteric lymph nodes and bile. However, the founding population sizes in these organs are increased. By comparing genetic distances between organs, the authors provide evidence that subpopulations colonizing extraintestinal organs diverge early after infection from those in the GI tract. This hypothesis is further tested by measuring bacterial burden and founding population sizes in the liver and GI tract at 5 and 120 hours post-infection. Additionally, they compare orogastric gavage infection with the less injurious method of infection via drinking, finding similar results for CFUs, founding populations, and genetic distances. These results argue against injuries during gavage as a route of direct infection.

      To bypass bottlenecks associated with the GI tract, the authors compare intravenous (IV) and intraperitoneal (IP) routes of infection. They find approximately a 10-fold increase in bacterial burden and founding population size in immune-rich organs with IV/IP routes compared to orogastric gavage in streptomycin-pretreated animals. This difference is interpreted as a result of "extra steps required to reach systemic organs."

      While IP and IV routes yield similar results in immune-rich organs, IP infections lead to higher bacterial burdens in nearby sites, such as the pancreas, adipose tissue, and intraperitoneal wash, as well as somewhat increased founding population sizes. The authors correlate these findings with the presence of white lesions in adipose tissue. Genetic distance comparisons reveal that, apart from the spleen and liver, IP infections lead to genetically distinct populations in infected organs, whereas IV infections generally result in higher genetic similarity.

      Finally, the authors investigate GI tract reseeding, identifying two distinct routes. They observe that the GI tracts of IP/IV-infected mice are colonized either by a clonal or a diversely tagged bacterial population. In clonally reseeded animals, the genetic distance within the GI tract is very low (often zero) compared to the bile population, which is predominantly clonal or pauciclonal. These animals also display pathological signs, such as cloudy/hardened bile and increased bacterial burden, leading the authors to conclude that the GI tract was reseeded by bacteria from the gallbladder bile. In contrast, animals reseeded by more complex bacterial populations show that bile contributes only a minor fraction of the tags. Given the large founding population size in these animals' GI tracts, which is larger than in orogastrically infected animals, the authors suggest a highly permissive second reseeding route, largely independent of bile. They speculate that this route may involve a reversal of known mechanisms that the pathogen uses to escape from the intestine.

      The manuscript presents a substantial body of work that offers a meticulously detailed understanding of the population dynamics of S. Typhimurium in mice. It quantifies the processes shaping the within-host dynamics of this pathogen and provides new insights into its spread, including previously unrecognized dissemination routes. The methodology is appropriate and carefully executed, and the manuscript is well-written, clearly presented, and concise. The authors' conclusions are well-supported by experimental results and thoroughly discussed. This work underscores the power of using highly diverse barcoded pathogens to uncover the within-host population dynamics of infections and will likely inspire further investigations into the molecular mechanisms underlying the bottlenecks and dissemination routes described here.

      Major point:

      Substantial conclusions in the manuscript rely on genetic distance measurements using the Cavalli-Sforza chord distance. However, it is unclear whether these genetic distance measurements are independent of the founding population size. I would anticipate that in populations with larger founding population sizes, where the relative tag frequencies are closer to those in the inoculum, the genetic distances would appear smaller compared to populations with smaller founding sizes independent of their actual relatedness. This potential dependency could have implications for the interpretation of findings, such as those in Figures 2B and 2D, where antibiotic-pretreated animals consistently exhibit higher founding population sizes and smaller genetic distances compared to untreated animals.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors have developed a valuable method based on a fully cell-free system to express a channel protein and integrate it into a membrane vesicle in order to characterize it biophysically. The study presents a useful alternative to study channels that are not amenable to being studied by more traditional methods.

      Strengths:

      The evidence supporting the claims of the authors is solid and convincing. The method will be of interest to researchers working on ionic channels, allowing them to study a wide range of ion channel functions such as those involved in transport, interaction with lipids, or pharmacology.

      Weaknesses:

      The inclusion of a mechanistic interpretation of how the channel protein folds into a protomer or a tetramer to become functional in the membrane would strengthen the study.

      Work from other labs has described key factors which can improve expression and artificial lipid integration of cellfree derived transmembrane proteins (PMIDs: 35520093, 29625253, 26270393) . However, a significant number of additional experiments would be needed to elucidate the exact biophysical properties governing channel assembly of synthetically derived polycystins. We carried out additional biochemical experiments to address these concerns (see new Figure 1— figure supplement 1 D, E). We used fluorescence-detection size-exclusion chromatography (FSEC) with the goal of understanding how much of the CFE-derived protomers are biochemically folding and assembly into functional tetramers upon incorporation into SUVs. When compared to protein recombinant sources from HEK cells, the production of assembled channels is less than 4% when using the CFE+SUV approach, an estimate based on the oligomer peak fluorescence. In the absence of chaperones found in cells, the assembly of synthetically derived protomers into tetramers is likely intrinsic to the chemical properties of the proteins, and the biophysical principles governing helical membrane protein when inserted into the lipid membrane  (PMID:35133709). We have added our interpretation in lines 111-121.

      Reviewer #2 (Public Review):

      It is challenging to study the biophysical properties of organelle channels using conventional electrophysiology. The conventional reconstitution methods require multiple steps and can be contaminated by endogenous ionophores from the host cell lines after purification. To overcome this challenge, in this manuscript, Larmore et al. described a fully synthetic method to assay the functional properties of the TRPP channel family. The TRPP channels are an important organelle ion channel family that natively traffic to primary cilia and ER organelles. The authors utilized cell-free protein expression and reconstitution of the synthetic channel protein into giant unilamellar vesicles (GUV), the single channel properties can be measured using voltage-clamp electrophysiology. Using this innovative method, the authors characterized their membrane integration, orientation, and conductance, comparing the results to those of endogenous channels. The manuscript is well-written and may present broad interest to the ion channel community studying organelle ion channels. Particularly because of the challenges of patching native cilia cells, the functional characterization is highly concentrated in very few labs. This method may provide an alternative approach to investigate other channels resistant to biophysical analysis and pharmacological characterization.

      Thank you for evaluating our manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) It would be useful to explain how the Polycystin protein is folded under the experimental conditions used. The expression data shown in Figure 1 Supplement 1B show different protein concentrations of protomer or tetramer. However, it is not described how each form is identified and distinguished. It is also important to mention in the manuscript that this method is only applicable to membrane channels that do not require chaperons for its folding and expression into the membrane. How is the tetramer mechanistically conformed? In line 184, it is stated that this method can be leveraged for studying the effects of channel subunit composition. Would this method allow the expression of two different subunit proteins in order to produce a heteromeric channel?

      In Figure 1—figure supplement 1B, total fluorescence from the synthesized channel-GFP was measured. Protein concentration was calculated based on the linear regression of the GFP standards. Monomeric protein concentration was reported directly from total fluorescence. Tetrameric protein concentration was calculated by dividing the fluorescence by four, and subsequently calculating the concentration based off the GFP standards. 

      This is a good point. Based on your suggestion, we carried out additional biochemical experiments (see new Figure 1— figure supplement 1 D, E). We used fluorescence-detection size-exclusion chromatography (FSEC) with the goal of understanding how much of the CFE-derived protomers are biochemically folding and assembly into functional tetramers upon incorporation into SUVs. As controls we produced recombinant PKD2-GFP and PKD2L1GFP channels as elution time standards and to compare the relative production of tetrameric channels generated when using the two expression systems. The synthetically derived polycystin channels indeed produced tetramers and protomers, which supports feasibility of using this method to assay their functional properties.  When compared to protein recombinant sources from HEK cells, the production of assembled channels is less than 4% when using the CFE+SUV approach, an estimate based on the oligomer peak fluorescence. We speculate that assembly of synthetically derived protomers into tetramers is likely intrinsic to the chemical properties of the proteins, and the biophysical principles governing helical membrane protein when inserted into the lipid membrane (PMID: 35133709). Although an interesting question, a systematic analysis of these channel-lipid interactions is beyond the scope of this eLife Report but can be addressed in future studies. The limitation of using this method to characterize channels which fold and membrane integrate without the aid of molecular chaperones is now stated in lines 201205. In principle, the CFE-GUV method can be deployed to co-express different subunits to produce heteromeric channels. We have modified the text lines 192-197 to be clearer on this point.

      (2) The type of plasmid (and promoter) required for this methodology should be mentioned.

      Added to the methods (lines 210-211). “PKD2 and PKD2L1 are in pET19b plasmid under T7 promoter.”

      (3) Since this paper is methodological, it would be useful to have some information about the stability of the GUVs containing the synthetic channel. In Methods, it is stated that GUV vesicles are used on the same day (line 207). And in line 193 it says that the reactions (?) are placed at 4{degree sign}C for storage.

      Restated in lines 226-228: GUVs are electroformed and used for electrophysiology the same day. SUVs with channel incorporated are stored at 4°C for 3 days.

      (4) A comment reasoning why the PKD2 protein is more frequently incorporated into the membrane in comparison to PKD2L1 should be included. A brief description of the differences between these two proteins would also be helpful for the reader.

      In terms of overall protein production and oligomeric assembly— more PKD2L1 channels are produced compared to PKD2 (see new Figure 1C, and Figure 1— figure supplement 1 D, E). In lines 149-155 we note single channel openings were frequently observed for the high expressing PKD2L1 channels, but this often resulted in patch instability. As a result, GUV patches with lower expressing PKD2-GFP channel were more stable and thus more successfully recorded from. We have revised the text to be clearer on this point.

      (5) There are no methods for preparing hippocampal neurons or IMCD cells shown in Figure 4 Supplement 1. Instead, the method of mammalian cultures provided corresponds to HEK 293T cells.

      This information has been added to lines 273-284.

      (6) Minor:

      In Figure 2C, please include the actual % of the Cell488+Surface647+Clear lumen vesicles.

      Added

      Line 99, 108: Figures 1B and 1C are swapped. Please correct.

      Corrected in figure and figure legends.

      Line 108: misspelling: effect.

      Done

      Line 109: check sentence: verb is missing.

      Sentence now reads “Minimal changes in fluorescence were detected when a control plasmid (Ctrl) encoding a non- fluorescent protein (dihyrofolate reductase) was used in the reaction.”

      Line 145: recoding. Correct.

      Recoding changed to recordings

      Line 169: "from" is missing (recorded from MCD cilia).

      Added

      Line 169: In Table 1, the PKD2 K+ conductance magnitudes recorded from IMCD cilia were significantly smaller, not larger as stated, than those assayed using CFE-GUV system. Please correct.

      Corrected

      Line 180: "of" is missing (adaptation of CFE derived...).

      Corrected

      Line 182: "to" is missing (generalized to other channels).

      Corrected

      Line 193: "in" 4ºC, correct at.

      Corrected

      Line 197: replace "mole" for "mol".

      Corrected

      Line 207: are used "within the" same day.

      Corrected

      Line 210: c-terminally. C-should be capital letter.

      Corrected

      Line 231: n-terminally. N- should be capital letter.

      Corrected

      Reviewer #2 (Recommendations For The Authors):

      The authors validated their method using PKD2 and PKD2L1 channels, demonstrating the potential of this approach. However, a few points merit further clarification or validation:

      (1) Stability of the protein vesicles for recording. The authors observed membrane instability during voltage transitions. It would be beneficial to discuss potential solutions to enhance stability.

      In lines 197-202, we have added a discussion of potential solutions to enhance stability. CsF in the intracellular saline could be added to stabilize the GUV membranes. CsF is frequently added to stabilize whole cell membranes in HTS planer patch clamp recording. We did not explore this formulation because Cs+ would limit outward polycystin conductance. We also suggest but did not test altering the membrane formulation of GUVs with additional cholesterol to stabilize these recordings.

      (2) Validation. Further discussion on how broadly this method can be applied to other channels would strengthen the manuscript.

      We have included further discussion on this point in lines 190-206. 

      (3) Protein production estimated by a standard GFP absorbance assay. The estimation of protein production using GFP absorption may be affected by improperly folded protein. Additional validation methods could be considered.

      C-terminal GFP fluorescence has been widely used in expression systems to designate proper folding of the target protein upstream of the GFP-tag (PMID: 22848743, PMID: 21805523, PMID: 35520093). Nonetheless we have conducted additional experiments designed to estimate the amount of assembled PKD2 and PKD2L1 channels generated using the CFE method. In the new Figure 1— figure supplement 1 D, E, we carried out fluorescencedetection size-exclusion chromatography and compared channel assembly of recombinant and CFE+SUV derived PKD2-GFP and PKD2L1-GFP. Here, we clearly observed tetrameric and protomeric forms of the channels using the synthetic approach, which supports feasibility of using this method to assay their functional properties (see new Figure 1— figure supplement 1 D, E).  When compared to protein recombinant sources from HEK cells, the production of assembled channels is less than 4% when using the CFE+SUV approach, an estimate based on the oligomer peak fluorescence. 

      (4) Single channels were observed more frequently from PKD2 incorporated GUVs compared to PKD2L1. Does this just randomly happen or is there a reason behind this difference?

      In terms of overall protein production and oligomeric assembly— more PKD2L1 channels are produced compared to PKD2 (Figure 1C, and Figure 1— figure supplement 1 D, E). This is apparent whether the channels are produced recombinantly in cells or when using the cell-free method (Figure 1— figure supplement 1 D, E). In lines 149-155, we note single channel openings were frequently observed but that the high expression of the PKD2L1 often resulted in patch instability. As a result, GUV patches the lower expressing PKD2-GFP channel were more stable and thus more successfully recorded from. As requested, we have included a brief description of the two proteins in lines 76-78. 

      (5) Additional validation or clarification for examining the channel orientation may strengthen the manuscript.

      We have modified the text to make this point clearer. 

      (6) Advantage and limitations. The authors compared the recordings from hippocampal primary cilia membranes, noting differences in conductance magnitudes compared to the GUV method. Further discussing the limitations and advantages of this approach for the biophysical properties of organelle channels would be beneficial.

      We have revised the final paragraph to discuss the limitations of this method.

      (7) Including experiments that demonstrate ligand-induced activation or inhibition to further validate the current using this method would strengthen the manuscript (optional, not required).

      Despite our best attempts, exchange of the external bath to apply inhibitors (Gd3+, La3+) resulted in GUV patch instability. Our plans are to investigate ways to stabilize the high resistance seals to develop pharmacological screening using the CFE+GUV method.

    1. Reviewer #1 (Public review):

      Summary:

      The authors aim to investigate the role of ORMDL3 in regulating Type 1 interferon (IFN) responses and its effect on tumor growth inhibition. The study focuses on the mechanisms involving the RIG-I pathway and USP10-mediated degradation and attempts to establish a link between ORMDL3 expression and the effectiveness of cancer therapy. The authors also explore the broader implications of ORMDL3 in immune signaling, particularly within the context of Type 1 IFN signaling and its therapeutic potential.

      Strengths:

      • The manuscript explores a novel aspect of cancer immunology by examining the relationship between ORMDL3 and Type 1 IFN signaling, potentially offering new therapeutic avenues.<br /> • A variety of experimental approaches are employed, including knockdown models, overexpression assays, and protein interaction analyses, to elucidate the role of ORMDL3 in modulating immune responses.<br /> • The findings suggest a potential mechanism by which ORMDL3 affects the tumor microenvironment and immune responses, which could have significant implications for understanding cancer progression and therapy.

      Weaknesses:

      • The study does not clearly establish the relationship between Type 1 IFN and cancer therapy, and more robust data are needed to support the claim that tumor growth inhibition occurs via Type 1 IFN upregulation following ORMDL3 knockdown.<br /> • There is ambiguity regarding whether ORMDL3 has a positive or negative role in the Type 1 IFN pathway, especially given conflicting findings in the literature that link higher ORMDL3 levels to increased Type 1 IFN expression.<br /> • The use of certain experimental models, such as HEK293T cells (which are not typical Type 1 IFN producers), raises concerns about the validity and generalizability of the results. Further clarity is needed regarding the rationale for using the same tag in overexpression experiments.<br /> • The manuscript contains several inconsistencies and lacks detailed explanations of critical areas, such as the mechanism by which ORMDL3 facilitates USP10 transfer to RIG-I despite no direct interaction between ORMDL3 and RIG-I.

    2. Author response:

      • The study does not clearly establish the relationship between Type 1 IFN and cancer therapy, and more robust data are needed to support the claim that tumor growth inhibition occurs via Type 1 IFN upregulation following ORMDL3 knockdown.

      We thank the reviewer’s concern. In Figure 6 we detected the expression of IFNB1 and ISGs in MC38 and LLC tumor upon ORMDL3 knockdown. At the mean time, we also used IHC to explore the abundance of RIG-I and ORMDL3 in these tumors. In addition, in figure S5 we performed western blots to detect the expression of RIG-I with or without ORMDL3 knockdown. All these results support our hypothesis that that ORMDL3 is a negative regulator of interferon via modulating RIG-I abundance.

      • There is ambiguity regarding whether ORMDL3 has a positive or negative role in the Type 1 IFN pathway, especially given conflicting findings in the literature that link higher ORMDL3 levels to increased Type 1 IFN expression.

      We appreciate the reviewer’s concern. In our system and experiments, we validated that ORMDL3 is a negative regulator of interferon, although there is also literature that links higher ORMDL3 levels to increased type-I IFN response. ORMDL3 has been reported associated with rhinovirus-induced childhood asthma (Nature.  2007;448(7152):470-473; N Engl J Med. 2013 Apr 11;368(15):1398-407), and ORMDL3 level is positively associated with rhinovirus abundance (N Engl J Med. 2013 Apr 11;368(15):1398-407).  There are reports indicating that ORMDL3 supports the replication of rhinovirus (for example, Am J Respir Cell Mol Biol. 2020 Jun;62(6):783-792). This phenomenon is consistent with our findings that higher ORMDL3 expression leads to lower interferon production, which facilitates viral replication. We believe that the different experimental conclusions obtained in these experiments are due to different experiment condition and different stimulation. In our research, we provided comprehensive studies at the molecular, cellular, and animal levels to support the conclusion that ORMDL3 is a negative regulator of type-I interferon.

      • The use of certain experimental models, such as HEK293T cells (which are not typical Type 1 IFN producers), raises concerns about the validity and generalizability of the results. Further clarity is needed regarding the rationale for using the same tag in overexpression experiments.

      We thank the reviewer’s suggestion. Besides HEK293T, in Figure 1C and 1D we also used A549 and BMDM to overexpress ORMDL3 and stimulate them with polyI:C or polyG:C, Our results showed that ORMDL3 especially inhibits RLR signaling. Additionally, in Figure 3H we found that the endogenous RIG-I expression decreased when we overexpressed ORMDL3 in BMDM. Regarding the issue of using different protein tags, we plan to use different tags to validate our results.

      • The manuscript contains several inconsistencies and lacks detailed explanations of critical areas, such as the mechanism by which ORMDL3 facilitates USP10 transfer to RIG-I despite no direct interaction between ORMDL3 and RIG-I.

      There are some ERMC (ER-mitochondria contact) proteins that mediate the interaction between ER and mitochondria. ORMDL3 locates in ER, and it has been reported to be associated with calcium transportation. At the meantime, the calcium transfer between ER and mitochondria plays an important role in protein synthesis. It is possible that some ERMC proteins mediate the interaction between ORMDL3 and MAVS. In addition,  we also validated that ORMDL3 interacts with USP10 (Figure 5B). Although ORMDL3 and RIG-I do not interact directly, we generated a mechanistic model that ORMDL3 and MAVS recruit USP10 and RIG-I to ERMCS respectively, thus USP10 could form a complex with RIG-I (Figure 5C) and regulate the stability of RIG-I upon RNA sensing.

    1. Not that it couldn't be done, but I'll suggest that following the structure/order of a Luhmann-artig zettelkasten may be a bit more limiting or difficult for creating fiction.

      There's a rich history of researching, outlining, and writing with card indexes as part of the creative process. Perhaps looking briefly at some examples particularly focusing on fiction may be helpful? Once you've done this, you can pick and choose the portions and affordances that work best for your preferred way of thinking and working.

      Some quick examples:

      Perhaps querying my digital zettelkasten may be helpful for you? Start with: https://hypothes.is/users/chrisaldrich?q=tag%3A%27card+index+for+writing%27

      Ultimately, you can only spend so much time going down the rabbit hole of how you ought to do this work and taking suggestions or reading about how others have done it. The more difficult but more fruitful portion is to pick a method which seems like it will work for you and experiment with it by actually using or evolving it for yourself. How you start may not necessarily be how you end, but you won't know what's best for you if you don't start. Practice, practice, practice will get you much farther faster.

      reply to u/Atreides_Lion at https://reddit.com/r/Zettelkasten/comments/1ft4r3z/a_very_important_matter_for_me/

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      (1) The overall writing is very difficult to follow and the authors need to work on significant re-writing. 

      Thank you for your comment. We have rewritten the text and asked an immunology expert, who is also a native English speaking editor, to review it.

      (2) The paper in its current form really lacks detail and it is NOT possible for readers to repeat or follow their methods. For example: a) It is not clear whether the authors checked the serum to see if the mice were producing antibodies before they sacrificed them to harvest spleen/blood i.e. using ELISA? b) How long after administration of the second dose were the mice sacrificed? c) What cell types are taken for single B cell sorting? Splenocytes or PBMC?

      Thank you for your comment. We have revised the methodology section thoroughly to ensure that the readers can follow and replicate the method. Our responses to the specific examples raised are as follows:

      a) We did not examine the serum titer after immunization. An increased serum titer, as determined by ELISA, does not always reflect the number of cross-reactive B cells because we expected the serum titer to consist of polyclonal antibodies, which are a mixture of PR8-reactive, H2-reactive, and cross-reactive clones. We thus anticipated that we would not obtain enough cross-reactive B cells after a series of immunizations. After comparing various immunization methods, including different adjuvants and immunization sites, using the readout of the number of cross-reactive B cells, we decided to adopt the immunization protocol presented in this paper.

      b) We sacrificed the mice two weeks after the second immunization (see Supplementary Figure 5).

      c) For this experiment, we used CD43 MACS B cells from the spleen purified with negatively charged beads (see Supplementary Figure 6).

      (3) According to the authors, 77 clones were sorted from the PR8+ and H2+ double positive quadrant. It is surprising that after transfection and re-analyzing of bulk antibody presenting EXPI cells on FACS, only 13 clones (or 8 clones? - unclear) seemed to be truly cross-reactive. If that is the case, the approach is not as efficient as the authors claimed.

      Thank you for your comment. To isolate high affinity antibodies, we gated the high fluorescent intensity population of cross-reactive B cells during Ig-expressing 293 cell sorting, as shown in Fig 2B, while we collected a wide intensity population of cross-reactive cells during splenocyte sorting. The narrow gating reduced the number of clones. We, however, cannot quantify how many clones we lost in the process, but we achieved a cloning efficiency exceeding 75%. To avoid any confusion, we have clarified this point by attaching additional supplementary figures (Supplementary Figures 5 and 6).

      Reviewer #2 (Public Review):

      (4) A His tagged antigen was used for immunization and H1-his was used in all assays. Either the removal of His specific clones needs to be done before selection, or a different tag needs to be used in the subsequent assays.

      Thank you for your comment. As pointed out, the possibility of antibody generation in regions other than HA cannot be ruled out since the immunized antigen and the detection antigen were the same. However, as shown in Table 1, the cross-reactive antibodies obtained in this study exhibited characteristic binding abilities to each of the six types of HA. If these were antibodies recognizing His, they would bind to all six types of HA. This indicates that these cross-reactive antibodies were not His-specific clones.

      We have incorporated information on this potential caveat into the discussion (page 12, lines 4-9).

      (5) This assay doesn't directly test the neutralization of influenza but rather equates viral clearance to competitive inhibition. The results would be strengthened with the demonstration of a functional antibody in vivo with viral clearance.

      Thank you for your constructive comment. While we agree that demonstration of a functional antibody in vivo with viral clearance would strengthen our results, this is clearly out of the scope of our current study and will be subject of future research.

      (6) Limitations of this new technique are as follows: there is a significant loss of cells during FACs, transfection and cloning efficiency are critical to success, and well-based systems limit the number of possible clones (as the author discussed in the conclusions). Early enrichment of the B cells could improve efficiency, such as selection for memory B cells.

      Thank you for your comment. Our cloning efficiency for sorted B cells exceeded 75%. However, we selected high binders of cross-reactive B cells during Ig-expressing 293 functional screening on purpose, as shown in Figure 2B, while we collected all cross-reactive B cells during B cell sorting (see attached Supplementary Figure 5). This functional selection step reduced the number of clones. We clarified this point by attaching additional supplementary figures (Supplementary Figures 5 and 6).

      Our sorted cross-reactive B cells are most likely CD38+ memory B cells, as shown in Supplementary Figure 6.

      Reviewer #1 (Recommendations For The Authors):

      a) It is advised for the authors to provide a flow chart with time stamps to prove the many statements made in the paper. For example, it is stated that "we demonstrated efficient isolation of influenza cross-reactive antibodies with high affinity from mouse germinal B cells over 4 days". It is not clear how this was calculated.

      Thank you for your comment. We have prepared a time-stamped flow chart (Supplementary Figure 5).

      b) The papers cited by the authors are relatively old if not outdated. There are many papers published focusing on efficient isolation of mAbs for SARS-CoV-2 research. For example, the paper by Lima et al (Nat Comm 2022, 13:7733) used a very similar strategy for rapid isolation of cross-reactive mAbs by FACS sorting followed by cloning of paired heavy and light chains from single B cells. The authors need to incorporate citations from the latest publications in this field.

      Thank you for your comment. The paper by Lima et al. (Nat Comm 2022, 13:7733) has been cited in the Discussion as ref 28.

      c) Figure 2 needs much more detail for readers to follow.

      Thank you for your comment. We have revised the legend of Figure 2 accordingly and added additional supplementary figures (Supplementary Figures 5 and 6) to increase clarity.

    1. if (!skip_kasan_poison) { kasan_poison_pages(page, order, init); /* Memory is already initialized if KASAN did it internally. */ if (kasan_has_integrated_init()) init = false; }

      bool skip_kasan_poison = should_skip_kasan_poison(page, fpi_flags);

      bool should_skip_kasan_poison(...) { bool skip_kasan_poison = should_skip_kasan_poison(page, fpi_flags); }

      Skip KASAN memory poisoning is based on the configuration (depending on which kind of KASAN: generic or tag-based)

    1. adding to what clemp wrote. Structure or categorisation is earned imo and emergent from working with my material. Any categorisation, indexing, tagging also is personal imo meaning no external standard as to how things should be organised applies in any way. Structures are personal tools and can be temporary. Which ones do you need and can add to over time while your interacting with your material? That way there’s a ratchet effect, but no need to structure everything as a separate task. I start everything I do with a search in my stuff. I add to the things I find and seem relevant at that time as tags the things I was searching for. If I found a piece about gardening while searching for things about health, I will add that health relation as tag. Or as link to another note. This lengthens the traces of my work with my material, and longer traces I’m more likely to cross. Over time I will see the stuff emerge that is most relevant to me over time. The start for me is when I save something external I always add the following 2 things: the reason I wanted to save it, what made me interested, in my own words (might include some tags). And always a link to something already in my notes that I associate it with. For me the switch in mindset is that there is no intrinsic information contained in anything I keep, all meaning is in my own eyes when I use it later. Any structuring reflects that, and I work form the assumption there are no objective descriptors I must use as categories or tags etc. Rather than organize/structure during note taking, I organize/structure during note using. With my initial remark and internal link as curation to help me on my way.

      my comment, in response to someone getting lost in up front organising of notes, and ending up in a 'mess'. Embrace the mess, lengthen traces to stumble upon, earn structure (they're a personal tool not an outside standard or demand). Organise during note usage rather than during note taking, except for curation when saving something external with a remark (tags sometimes) and an internal link.

  3. docdrop.org docdrop.org
    1. When I ask my students if they have tracking programs at schools they have attended or where they completed their student teaching, many of them routinely answer "no." When I inquire about gifted and talented (GAT or TAG) programs, many of them instinctively begin to describe, in detail, the differentiated curricu-lum, enrichment opportunities, and vastly different experiences each program entails.

      It points out that when students are asked about tracking programs in their schools, many say there aren't any. However, when asked about gifted and talented programs, they can easily describe how different those programs are. This shows that students might not realize how tracking affects their education, even though they notice the differences in opportunities for gifted students. It raises questions about fairness in education and how these experiences shape their views on learning. Why do you think some students don't see tracking as an issue?

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This study provides an incremental advance to the scavenger receptor field by reporting the crystal structures of the domains of SCARF1 that bind modified LDL such as oxidized LDL and acylated LDL. The crystal packing reveals a new interface for the homodimerization of SCARF1. The authors characterize SCARF1 binding to modified LDL using flow cytometry, ELISA, and fluorescent microscopy. They identify a positively charged surface on the structure that they predict will bind the LDLs, and they support this hypothesis with a number of mutant constructs in binding experiments.

      Strengths:

      The authors have crystallized domains of an understudied scavenger receptor and used the structure to identify a putative binding site for modified LDL particles. An especially interesting set of experiments is the SCARF1 and SCARF2 chimeras, where they confer binding of modified LDLs to SCARF2, a related protein that does not bind modified LDLs, and use show that the key residues in SCARF1 are not conserved in SCARF2.

      Weaknesses:

      While the data largely support the conclusions, the figures describing the structure are cursory and do not provide enough detail to interpret the model or quality of the experimental X-ray structure data. Additionally, many of the flow cytometry experiments lack negative controls for non-specific LDL staining and controls for cell surface expression of the SCARF constructs. In several cases, the authors interpret single data points as increased or decreased affinity, but these statements need dose-response analysis to support them. These deficiencies should be readily addressable by the authors in the revision.

      The paper is a straightforward set of experiments that identify the likely binding site of modified LDL on SCARF1 but adds little in the way of explaining or predicting other binding interactions. That a positively charged surface on the protein could mediate binding to LDL particles is not particularly surprising. This paper would be of greater importance if the authors could explain the specificity of the binding of SCARF1 to the various lipoparticles that it does or does not bind. Incorporating these mutants into an assay for the biological role of SCARF1 would be powerful.

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Wang and colleagues provided mechanistic insights into SCARF1 and its interactions with the lipoprotein ligands. The authors reported two crystal structures of the N-terminal fragments of SCARF1 ectodomain (ECD). On the basis of the structural analysis, the authors further investigated the interactions between SCARF1 and modified LDLs using cell-based assays and biochemical experiments. Together with the two structures and supporting data, this work provided new insights into the diverse mechanisms of scavenger receptors and especially the crucial role of SCARF1 in lipid metabolism.

      Strengths:

      The authors started by determining the crystal structures of two fragments of SCARF1 ECD. The superposition of the two high-resolution structures, together with the predicted model by AlphaFold, revealed that the ECD of SCARF1 adopts a long-curved conformation with multiple EGF-like domains arranged in tandem. Non-crystallographic and crystallographic two-fold symmetries were observed in crystals of f1 and f2 respectively, indicating the formation of SCARF1 homodimers. Structural analysis identified critical residues involved in dimerization, which were validated through mutational experiments. In addition, the authors conducted flow cytometry and confocal experiments to characterize cellular interactions of SCARF1 with lipoproteins. The results revealed the vital role of the 133-221aa region in the binding between SCARF1 and modified LDLs. Moreover, four arginine residues were identified as crucial for modified LDL recognition, highlighting the contribution of charge interactions in SCARF1-lipoprotein binding. The lipoprotein binding region is further validated by designing SCARF1/SCARF2 chimeric molecules. Interestingly, the interaction between SCARF1 and modified LDLs could be inhibited by teichoic acid, indicating potential overlap in or sharing of binding sites on SCARF1 ECD.

      The author employed a nice collection of techniques, namely crystallographic, SEC, DLS, flow cytometry, ELISA, and confocal imaging. The experiments are technically sound and the results are clearly written, with a few concerns as outlined below. Overall, this research represents an advancement in the mechanistic investigation of SCARF1 and its interaction with ligands. The role of scavenger receptors is critical in lipid homeostasis, making this work of interest to the eLife readership.

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Wang et. al. described the crystal structures of the N-terminal fragments of Scavenger receptor class F member 1 (SCARF1) ectodomains. SCARF1 recognizes modified LDLs, including acetylated LDL and oxidized LDL, and it plays an important role in both innate and adaptive immune responses. They characterized the dimerization of SCARF1 and the interaction of SCARF1 with modified lipoproteins by mutational and biochemical studies. The authors identified the critical residues for dimerization and demonstrated that SCARF1 may function as homodimers. They further characterized the interaction between SCARF1 and LDLs and identified the lipoprotein ligand recognition sites, the highly positively charged areas. Their data suggested that the teichoic acid inhibitors may interact with SCARF1 in the same areas as LDLs.

      Strengths:

      The crystal structures of SCARF1 were high quality. The authors performed extensive site-specific mutagenesis studies using soluble proteins for ELISA assays and surface-expressed proteins for flow cytometry.

      Weaknesses:

      (1) The schematic drawing of human SCARF1 and SCARF2 in Fig 1A did not show the differences between them. It would be useful to have a sequence alignment showing the polymorphic regions.

      The schematic drawing in Fig.1A is to give a brief idea about the two molecules, the sequence alignment may take too much space in the figure. A careful alignment between SCARF1 and SCARF2 can be found in Ref. 24 (Ishii, et al., J Biol Chem, 2002. 277, 39696-702) an also mentioned in p.4.

      (2) The description of structure determination was confusing. The f1 crystal structure was determined by SAD with Pt derivatives. Why did they need molecular replacement with a native data set? The f2 crystal structure was solved by molecular replacement using the structure of the f1 fragment. Why did they need to use EGF-like fragments predicted by AlphaFold as search models?

      The crystal structure of f1 was first determined by SAD using Pt derivatives, but soaking of Pt reduced the resolution of the crystals, therefore we use this structure as a search model for a native data set that had higher resolution for further refinement. For the structural determination of f2, the molecular replacement using f1 structure was not able to show the initial density of the extra region in f2 (residues 133-209), which was missing in f1. Therefore, the EGF-like domains of SCARF1 modeled by AlphaFold were applied as search models for this region (p.18).

      (3) It's interesting to observe that SCARA1 binds modified LDLs in a Ca2+-independent manner. The authors performed the binding assays between SCARF1 and modified LDLs in the presence of Ca2+ or EDTA on Page 9. However, EDTA is not an efficient Ca2+ chelator. The authors should have performed the binding assays in the presence of EGTA instead.

      The binding assays in the presence of EGTA are included in the revised manuscript (Fig. S7) (p.9), which also suggest that SCARA1 binds OxLDL in a Ca2+-independent manner.

      (4) The authors claimed that SCARF1Δ353-415, the deletion of a C-terminal region of the ectodomain, might change the conformation of the molecule and generate hinderance for the C-terminal regions. Why didn't SCARF1Δ222-353 have a similar effect? Could the deletion change the interaction between SCARF1 and the membrane? Is SCARF1Δ353-415 region hydrophobic?

      The truncation mutants were constructed to roughly locate the binding region of lipoproteins on SCARF1, and the overall results showed that the sites might locate at the region of 133-221. Mutant Δ222-353 may also affect the conformation, but it still had binding with OxLDL like wild type, suggesting the binding sites were retained in this mutant. Mutant Δ353-415 showed a reduction of binding, implying that the binding sites might be retained but binding was affected, we think it might be due to the conformational change that could reduce the binding or accessibility of lipoproteins. Since this region locates closer to the membrane, it’s possible that it may change the interaction with the membrane. In the AF model, Δ353-415 region does not seem to be more hydrophobic than other regions (Fig. S2C).

      (5) What was the point of having Figure 8? Showing the SCARF1 homodimers could form two types of dimers on the membrane surface proposed? The authors didn't have any data to support that.

      Fig. 8 shows a potential model of the SCARF1 dimers on the cell surface by combining the structural information from crystals and AF predictions. The two dimers in the figure are identical but with different viewing angles. The lipoprotein binding sites are also indicated (Fig. 8).

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      The authors need to show examples of the electron density for both structures.

      Electron density examples of the two structures are shown in Fig. S2A.

      Figure 1)

      The figure does not show enough details of the structure. The text mentions hydrogen-bond and disulfide bonds that stabilize the loops, these should be shown.

      Disulfide bonds of the two structures are shown in Fig. 1.

      Figure 2)

      D) The full gel should be shown.

      E) Rather than just relying on changes in gel filtration elution volumes, the authors do the appropriate experiment and measure the hydrodynamic radius of the WT and mutant ectodomains by DLS. However, they need to show plots of the size distribution, not just mean radial values, in order to show if the sample is monodisperse.

      The full gel and plots of DLS are shown in Fig. S3A-B.

      Figure 3)

      I have concerns about the rigor of the experiments in panels A-D. The authors include a non-transfected control but do not appear to have treated non-transfected cells with the lipoproteins to evaluate the specificity of binding. Every cell binding assay (flow  or confocal) must show the data from non-transfected cells treated with each lipoprotein, as each lipoprotein species could have a unique non-specific binding pattern. The authors show these controls in Figure 6, but these controls are necessary in every experiment.

      In Fig. 3A, since several lipoproteins were included in the figure, we use non-transfected cells without lipoprotein treatment as a negative control. The OxLDL or AcLDL treated non-transfected cells were also used as negative controls and shown in Fig. 3B-C. LDL, HDL or OxHDL may have their own non-specific binding patterns, the treatment of LDL, HDL or OxHDL with the transfected cells all gave negative results (Fig. 3A and D).

      Cell-surface of the SCARF1 variants is a major concern. The constructs the authors use are tagged with a GFP on the cytosolic side. However, the Methods to do indicate if they gate on GFP+ transfected cells for analytical flow. Such gating may have been used because the staining experiments in Figures 3 and 4 show uniform cell populations, whereas the staining done with an anti-SCARF1 Ab in S4 shows most of the cells not expressing the protein on the surface. Please clarify.

      Data for the anti-SCARF1 Ab assay is gated for GFP in the revised Fig. S4, and  the non-transfected cells are included as a control.

      The authors must demonstrate cell-surface staining with an epitope tag on the extracellular side and clarify if the analyzed cells are gated for surface expression. The anti-SCARF antibody used in S4 may not recognize the truncated or mutant SCARFs equally. Cell-surface expression in the flow experiments cannot be inferred from confocal experiments because the flow experiments have a larger quantitative range.

      Anti-SCARF1 antibody assay provides an estimation of the surface expression of the proteins. If the epitope of the antibody was mutated or removed in the mutants, most likely it would lose binding activity. Including an epitope tag on the ectodomain could be an option, but if truncation or mutation changes the conformation of the ectodomain, the accessibility of the epitope may also be affected, and addition of an extra sequence or domain, such as an epitope tag, may affect the surface expression of proteins sometimes.

      In several places, the authors infer increased or decreased affinity from mean fluorescent intensity values of a single concentration point without doing appropriate dose-curves. These experiments need to be done or else the mentions of changes in apparent affinities should be removed.

      We add a concentration for the WT interaction with OxLDL (Fig. S6, p.9) and the manuscript is also modified accordingly.

      Figure 7

      The concentration of teichoic acid used to inhibit modified LDL binding should be indicated and a dose-curve analysis should be done comparing teichoic acid to some non-inhibitory bacterial polymer.

      The concentration of teichoic acids used in the inhibition assays is 100 mg/ml (p.21). Unfortunately, we don’t have other bacterial polymers in the lab and not sure about the potential inhibitory effects.

      Reviewer #2 (Recommendations For The Authors):

      Major points:

      (1) The SCARF1 ECD contains three N-linked glycosylation sites (N289, N382, N393). It remains unclear whether these modifications are involved in SCARF1 binding to modified LDLs. Is it possible to design some experiments to investigate the effect of N-glycans on the recognition of modified LDLs? In particular, N382 and N393 are included in 353-415aa and the truncation mutant of SCARF1Δ353-415aa resulted in reduced binding with OxLDL in Fig.3G. Or whether the reduced binding is only due to the potential conformational changes caused by the deletion of the C-terminal region of the ECD?

      A previous study regarding the N-glycans (N289, N382, N393) of SCARF1 (ref.17) has shown that they may affect the proteolytic resistance, ligand-binding affinity and subcellular localization of SCARF1, which is not quite surprising as lipoproteins are large particles, the N-glycans on the surface of SCARF1 could affect accessibility or affinity for lipoproteins. But the exact roles of each glycan could be difficult to clarify as they might also be involved in protein folding and trafficking.

      The reduction of the binding of OxLDL for the mutant SCARF1 Δ353-415aa may be due to the conformational change or the loss of the glycans or both.

      (2) The authors speculated that the dimeric form of SCARF1 may be more efficient in recognizing lipoproteins on the cell surface. Please highlight the critical region/sites for ligand binding in Figure 8 and discuss the structural basis of dimerization improving the binding.

      The binding sites for lipoproteins on SCARF1 are indicated in Fig. 8. According to our data, it might be possible the conformation of the dimeric form of SCARF1 makes it more accessible to the ligands on the cell surface as implied by flow cytometry (p.14-15), but still needs further evidence on this.

      (3) Could the two salt bridges (D61-K71, R76-D98) observed in f1 crystals be found in f2 crystals? They seemed to be a little far from the defined dimeric interface (F82, S88, Y94) and how important are these to SCARF1 dimerization?

      The two salt bridges observed in f1 crystal are not found in f2 crystal (distances are larger than 5.0 Å), suggesting they are not required for dimerization (p. 7-8), but may be helpful in some cases.

      (4) The monomeric mutants (S88A/Y94A, F82A/S88A/Y94A) exhibited opposite affinity trends to OxLDL in ELISA and flow cytometry. The authors proposed steric hinderance of the dimers coated onto the plates as the potential explanation for this observation. However, the method of ELISA stated that OxLDLs, instead of SCARF1 ECD, were coated onto the plates. So what's the underlying reason for the inconsistency in different assays?

      Thanks. ELISA was done by coating OxLDLs on the plates as described in the Methods. But still, a dimeric form of SCARF1 may only bind one OxLDL coated on the plates due to steric hinderance. We correct this on p.12.

      Minor points:

      (1) Figure 2D and Figure S3 - please label the molecular weight marker on the SEC traces to indicate the native size of various purified proteins.

      The elution volume of SEC not only reflects the molecular weight, but it’s also affected by the conformation or shape of protein. The ectodomain of SCARF1 has a long curved conformation, the elution volumes of the monomeric or dimeric forms of SCARF1 do not align well with the standard molecular weight marker and elute much earlier in SEC. We include the standard molecular weight marker in Fig. S3C-D.

      (2) Could the authors provide SEC profiles of f1 and f2 that were used in crystallographic study?

      The SEC profiles of f1 and f2 for crystallization are shown in Fig. S5 (p.6).

      (3) The legend of Figure 3A states that the NC in flow cytometry assay represents the non-transfected cells, but please confirm whether the NC in Fig. 3A-C corresponds to non-transfected cells or no lipoprotein.

      NC in Fig. 3A represents the non-transfected cells, and no lipoproteins were added in this case as several lipoproteins are included in Fig. 3A. The lipoprotein (OxLDL or AcLDL) treated non-transfected cells (NC) were shown in Fig. 3B-C as negative controls.

    1. Reviewer #2 (Public review):

      The manuscript by Yorek et al explores the role of fatty acids, particularly unsaturated fatty acids, in lipid droplet accumulation and lipolysis in tumor-associated macrophages (TAMs). Using flow cytometry, immunofluorescent imaging, and TEM, the authors observed that unsaturated fatty acids, such as linoleic acids (LA), tend to induce lipid droplet accumulation in the ER of macrophages, but not in the lysosomes. This phenomenon led them to examine the key enzymes involved in lipid droplet/TAG biosynthesis, where they found incubation of LA upregulates GPAT/DGAT and C/EBPα. In vitro studies, data from public databases, single-cell RNA sequencing of splenic macrophages, and more show that FABP4 emerges as an important mediator for C/EBPα activation. This is further confirmed by FABP4-knockout macrophages, where lipid accumulation and utilization of unsaturated fatty acids were compromised in macrophages through inhibition of LA-induced lipolysis. Using the co-culture system and immunohistochemical analysis, they found that the high FABP4 expression in TAMs, which are observed in metastatic breast cancer tissue, promotes breast cancer cell migration in vitro.

      This study is important since the impact of tumor microenvironment is crucial for the development of breast cancer. The individual experiments are well-designed and structured. However, the logic connecting to the next step is a bit difficult to follow, especially when combined with incomplete statistical analysis in some figures, making the conclusion less convincing. For instance, the comparison of macrophage FABP4 expression between breast cancer patients with or without metastasis illustrates the importance of FABP4 expression in metastasis, yet there is no examination of the expression of other key enzymes in the lipolysis or lipid biosynthesis pathway nor there is any correlation with parameters that would reflect patients' consumption of fatty acids. Similarly, an in vivo study comparing FABP4 knockout mice with or without unsaturated fatty acids would yield more compelling evidence. The statistical analysis was largely focused on the sets of unsaturated fatty acids when data from both types of fatty acids were present. In some cases, significant changes are observed in the sets of saturated fat, but there is no explanation of why only the data from unsaturated fats are important for investigation.

      Overall, there is solid evidence for the importance of FABP4 expression in TAMs on metastatic breast cancer as well as lipid accumulation by LA in the ER of macrophages. A stronger rationale for the exclusive contribution of unsaturated fatty acids to the utilization of TAMs in breast cancer and a more detailed description and statistical analysis of data will strengthen the findings and resulting claims.

    2. Reviewer #3 (Public review):

      Summary:

      Regulated metabolism has only recently been recognized as a key component of cancer biology, and even more recently recognized as a significant modulator of the tumor microenvironment (TME). TAMs in the TME play a major role in supporting cancer cell survival and growth/spread, as well as generating an immunosuppressive ME to suppress anti-tumor immunity. Specific regulation of lipid metabolism in this context, in particular how lipids are stored and subsequently mobilized for metabolism, is largely unexplored - especially in the immunological components of the TME.

      In this manuscript, the authors build on their previous observations that the fatty acid-binding protein FABP4 plays an important role in macrophage function and that FABP4 expression in tumor associated macrophages (TAM) promotes breast cancer progression. They demonstrate:

      (1) Unlike saturated fatty acids (FA), unsaturated FA promotes lipid droplet (LD) accumulation in murine macrophages. LD is the primary intracellular storage depot for FA.

      (2) Unsaturated FA activates the FABP4-C/EBPalpha axis to upregulate transcription of the enzymes involved in the synthesis of neutral triacylglycerol (TAG) is an essential step in the formation of the neutral lipid core of LD. It should be noted that the authors speculate that UFA-activated FABP4 translocates to the nucleus to activate PPARgamma, which is known to induce C/EBPalpha expression, but do not directly test the involvement of PPARgamma in this axis.

      (3) FABP4 deficiency compromises unsaturated FA-mediated lipid accumulation and utilization in murine macrophages.

      (4) FABP4-mediated lipid metabolism in macrophages (TAMS) contributes to breast cancer metastasis, in in-vitro of tumor migration induced by murine macrophages and in correlative studies from human patient breast cancer biopsies.

      From these studies, the manuscript concludes that FABP4 plays a pivotal role in mediating lipid droplet formation and lipolysis in TAM, which provides lipids to breast cancer cells that contribute to their growth and metastasis.

      These are significant findings, as they provide new insight into the mechanistic regulation of TAM biology via regulation of lipid metabolism, as well as define new biomarkers and potential novel therapeutic targets.

      The findings are strong in the studies that mechanistically define the role of FAB4 in lipid accumulation and utilization in murine macrophages. However, evidence is less compelling regarding TAM biology and human breast cancer in 3 main areas:

      First, while there is clear in vitro evidence that co-cultured murine macrophages genetically deficient in FABP4 (or their conditioned media) do not enhance breast cancer cell motility and invasion, these macrophages are not bonafide TAM - which may have different biology. The use of actual TAM in these experiments would be more compelling. Perhaps more importantly, there is no in vivo data in tumor-bearing mice that macrophage deficiency of FABP4 affects tumor growth or metastasis - which are doable experiments given the availability of the FABP4 KO mice.

      Second, no data is presented that the mechanisms/biology that are elegantly demonstrated in the murine macrophages also occur in human macrophages - which would be foundational to translating these findings into human breast cancer. It seems like straightforward in vitro studies in human monocytes/macrophages could be done to recapitulate the main characteristics seen in the murine macrophages.

      Third, while the data from the human breast cancer specimens is very intriguing, it is difficult to ascertain how accurate IHC is in determining that the CD163+ cells (TAM) are in fact the same cells expressing FABP4 - which is the central premise of these studies. Demonstrating that IHC has the resolution to do this would be important. Additionally, the in vitro characterization of FABP4 expression in human macrophages would also add strength to these findings.

      In summary, the strengths of this manuscript are the significance of metabolic regulation of the immune tumor microenvironment (TME), and the careful mechanistic delineation of FABP4 involvement in mediating lipid droplet formation and lipolysis in murine macrophages. The weaknesses of the work are the lack of direct experimental evidence that human macrophages behave in the same way as murine macrophages, the incomplete characterization of the role of FABP4 expression in TAM in modulating tumor growth in vivo (in murine models), and whether it can be definitively determined that FABP4 is being primarily expressed in the CD163+ macrophages in human breast cancer samples.

      Strengths:

      (1) Regulated metabolism has only recently been recognized as a key component of cancer biology, and even more recently recognized as a significant modulator of the tumor microenvironment (TME). TAMs in the TME play a major role in supporting cancer cell survival and growth/spread, as well as generating an immunosuppressive ME to suppress anti-tumor immunity.

      (2) Regulation of lipid metabolism in this context is largely unexplored, especially in the immunological components of the TME.

      (3) The work builds on the authors' previous work on the role of FABP4 plays an important role in macrophage function including FABP4 expression in TAM promotes breast cancer progression (Hao et al, Cancer Res 2018). This paper identified FABP4-expressing macrophages as being pro-tumorigenic via upregulation of IL-6STAT3 signaling.

      (4) The careful and thorough mechanistic delineation of FABP4 involvement in mediating lipid droplet formation and lipolysis in murine macrophages.

      (5) The intriguing observations that FABP4-mediated lipid metabolism in macrophages contributes to breast cancer metastasis, in in vitro of tumor migration induced by murine macrophages and in correlative studies from human patient breast cancer biopsies that CD163+ cell numbers (putatively TAM) and FABP4 expression was associated with increased metastatic disease and poor overall survival.

      (6) Identification of FABP4 both a prognostic biomarker and a potential therapeutic target to modulate the pro-tumor immune TME.

      Weaknesses:

      (1) While the authors speculate that UFA-activated FABP4 translocates to the nucleus to activate PPARgamma, which is known to induce C/EBPalpha expression, they do not directly test involvement of PPARgamma in this axis.

      (2) While there is clear in vitro evidence that co-cultured murine macrophages genetically deficient in FABP4 (or their conditioned media) do not enhance breast cancer cell motility and invasion, these macrophages are not bonafide TAM - which may have different biology. Use of actual TAM in these experiments would be more compelling. Perhaps more importantly, there is no in vivo data in tumor bearing mice that macrophage-deficiency of FABP4 affects tumor growth or metastasis.

      (3) Related to this, the authors find FABP4 in the media and propose that macrophage secreted FABP4 is mediating the tumor migration - but don't do antibody neutralizing experiments to directly demonstrate this.

      (4) No data is presented that the mechanisms/biology that are elegantly demonstrated in the murine macrophages also occurs in human macrophages - which would be foundational to translating these findings into human breast cancer.

      (5) While the data from the human breast cancer specimens is very intriguing, it is difficult to ascertain how accurate IHC is in determining that the CD163+ cells (TAM) are in fact the same cells expressing FABP4 - which is central premise of these studies. Demonstration that IHC has the resolution to do this would be important. Additionally, the in vitro characterization of FABP4 expression in human macrophages would also add strength to these findings.

    3. Author response:

      Reviewer #1:

      (1) After Figure 1, a single saturated (palmitic acid; PA) and a single unsaturated (linoleic acid; LA) fatty acid are used for the remaining studies, bringing into question whether effects are in fact the result of a difference in saturation vs. other potential differences.

      PA, SA, OA and LA are the most common FA species in humans (Figure 1A in manuscript). Among them, PA predominantly represents saturated FAs while LA is the main unsaturated FAs, respectively. Of note, although both SA and OA were included in our studies, their effects were comparable to those of PA and LA, respectively. Due to space constraints, the data of SA and OA are not presented in the figures.  

      (2) While primary macrophages are used in several mechanistic studies, tumor-associated macrophages (TAMs) are not used. Rather, correlative evidence is provided to connect mechanistic studies in macrophage cell lines and primary macrophages to TAMs.

      The roe of FABP4 in TAMs has been demonstrated in our previous studies using in vivo animal models1. Therefore, we did not include TAM-specific data in the current study.

      (3) CEBPA and FABP4 clearly regulate LA-induced changes in gene expression. However, whether these two key proteins act in parallel or as a pathway is not resolved by presented data.

      Multiple lines of evidence in our studies suggest that FABP4 and CEBPA act as a pathway in LA-induced changes: 1) FABP4-negative macrophages exhibit reduced expression of CEBPA in single cell sequencing data; 2) FABP4 KO macrophages exhibited reduced CEBPA expression; 3) LA-induced CEBPA expression in macrophages was compromised when FABP4 was absent.

      (4) It is very interesting that FABP4 regulates both lipid droplet formation and lipolysis, yet is unclear if the regulation of lipolysis is direct or if the accumulation of lipid droplets - likely plus some other signal(s) - induces upregulation of lipolysis genes.

      Yes, it is likely that tumor cells induce lipolysis signals. Multiple studies have shown that various tumor types stimulate lipolysis to support their growth and progression2-4.  In this process, lipid-loaded macrophages have emerged as a promising therapeutic target in cancer5, 6. Consistent with findings that lipolysis is essential for tumor-promoting M2 alternative macrophage activation7, our data using FABP4 WT and KO macrophages demonstrate that FABP4 plays a critical role in LA-induced lipid accumulation and lipolysis for tumor metastasis. 

      (5) In several places increased expression of genes coding for enzymes with known functions in lipid biology is conflated with an increase in the lipid biology process the enzymes mediate. Additional evidence would be needed to show these processes are in fact increased in a manner dependent on increased enzyme expression.

      We fully agree with the reviewer that increased gene expression does not necessarily equate to increased activity. The key finding of this study is that FABP4 plays a pivotal role in linoleic acid (LA)-mediated lipid accumulation and lipolysis in macrophages that promote tumor metastasis. Numerous lipid metabolism-related genes, including FABP4, CEBPA, GPATs, DGATs, and HSL, are involved in this process. While it was not feasible to verify the activity of all these genes, we confirmed the functional roles of key genes like FABP4 and CEBPA through various functional assays, such as gene silencing, knockout cell lines, lipid droplet formation, and tumor migration assays. Supported by established lipid metabolism pathways, our data provide compelling evidence that FABP4 functions as a crucial lipid messenger, facilitating unsaturated fatty acid-driven lipid accumulation and lipolysis in tumor-associated macrophages (TAMs), thus promoting breast cancer metastasis.   

      Reviewer #2:

      Overall, there is solid evidence for the importance of FABP4 expression in TAMs on metastatic breast cancer as well as lipid accumulation by LA in the ER of macrophages. A stronger rationale for the exclusive contribution of unsaturated fatty acids to the utilization of TAMs in breast cancer and a more detailed description and statistical analysis of data will strengthen the findings and resulting claims.

      We greatly appreciated the positive comments from Reviewer #2. In our study, we evaluated the effects of both saturated and unsaturated fatty acids (FA) on lipid metabolism in macrophages.  Our results showed that unsaturated FAs exhibited a preference for lipid accumulation in macrophages compared to saturated FAs. Further analysis revealed that unsaturated LA, but not saturated PA, induced FABP4 nuclear translocation and CEBPA activation, driving the TAG synthesis pathway. For in vitro experiments, statistical analyses were performed using a two-tailed, unpaired student t-test, two-way ANOVA followed by Bonferroni’s multiple comparison test, with GraphPad Prism 9. For experiments analyzing associations of FABP4, TAMs and other factors in breast cancer patients, the Kruskal-Wallis test was applied to compare differences across levels of categorical predictor variable. Additionally, multiple linear regression models were used to examine the association between the predictor variables and outcomes, with log transformation and Box Cox transformation applied to meet the normality assumptions of the model. It is worth noting that in some experiments, only significant differences were observed in groups treated with unsaturated fatty acids. Non-significant results from groups treated with saturated fatty acids were not included in the figures.

      Reviewer #3

      (1) While the authors speculate that UFA-activated FABP4 translocates to the nucleus to activate PPARgamma, which is known to induce C/EBPalpha expression, they do not directly test involvement of PPARgamma in this axis.

      Yes, LA induced FABP4 nuclear translocation and activation of PPARgamma in macrophages (see Figure below). Since these findings have been reported in multiple other studies 8, 9, we did not include the data in the current manuscript.

      Author response image 1.

      LA induced PPARg expression in macrophages. Bone-marrow derived macrophages were treated with 400μM saturated FA (SFA), unsaturated FA (UFA) or BSA control for 6 hours. PPARg expression was measured by qPCR (***p<0.001).

      (2) While there is clear in vitro evidence that co-cultured murine macrophages genetically deficient in FABP4 (or their conditioned media) do not enhance breast cancer cell motility and invasion, these macrophages are not bonafide TAM - which may have different biology. Use of actual TAM in these experiments would be more compelling. Perhaps more importantly, there is no in vivo data in tumor bearing mice that macrophage-deficiency of FABP4 affects tumor growth or metastasis.

      In our previous studies, we have shown that macrophage-deficiency of FABP4 reduced tumor growth and metastasis in vivo in mouse models1.

      (3) Related to this, the authors find FABP4 in the media and propose that macrophage secreted FABP4 is mediating the tumor migration - but don't do antibody neutralizing experiments to directly demonstrate this.

      Yes, we have recently published a paper of developing anti-FABP4 antibody for treatment of breast cancer in moue models10.

      (4) No data is presented that the mechanisms/biology that are elegantly demonstrated in the murine macrophages also occurs in human macrophages - which would be foundational to translating these findings into human breast cancer.

      Thanks for the excellent suggestions. Since this manuscript primarily focuses on mechanistic studies using mouse models, we plan to apply these findings in our future human studies. 

      (5) While the data from the human breast cancer specimens is very intriguing, it is difficult to ascertain how accurate IHC is in determining that the CD163+ cells (TAM) are in fact the same cells expressing FABP4 - which is central premise of these studies. Demonstration that IHC has the resolution to do this would be important. Additionally, the in vitro characterization of FABP4 expression in human macrophages would also add strength to these findings.

      The expression of FABP4 in CD163+ TAM observed through IHC is consistent with our previous findings, where we confirmed FABP4 expression in CD163+ TAMs using confocal microscopy. Emerging evidence further supports the pro-tumor role of FABP4 expression in human macrophages across various types of obesity-associated cancers11-13. 

      References

      (1) Hao J, Yan F, Zhang Y, Triplett A, Zhang Y, Schultz DA, Sun Y, Zeng J, Silverstein KAT, Zheng Q, Bernlohr DA, Cleary MP, Egilmez NK, Sauter E, Liu S, Suttles J, Li B. Expression of Adipocyte/Macrophage Fatty Acid-Binding Protein in Tumor-Associated Macrophages Promotes Breast Cancer Progression. Cancer Res. 2018;78(9):2343-55. Epub 2018/02/14. doi: 10.1158/0008-5472.CAN-17-2465. PubMed PMID: 29437708; PMCID: PMC5932212.

      (2) Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498-503. Epub 20111030. doi: 10.1038/nm.2492. PubMed PMID: 22037646; PMCID: PMC4157349.

      (3) Wang YY, Attane C, Milhas D, Dirat B, Dauvillier S, Guerard A, Gilhodes J, Lazar I, Alet N, Laurent V, Le Gonidec S, Biard D, Herve C, Bost F, Ren GS, Bono F, Escourrou G, Prentki M, Nieto L, Valet P, Muller C. Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight. 2017;2(4):e87489. Epub 20170223. doi: 10.1172/jci.insight.87489. PubMed PMID: 28239646; PMCID: PMC5313068.

      (4) Balaban S, Shearer RF, Lee LS, van Geldermalsen M, Schreuder M, Shtein HC, Cairns R, Thomas KC, Fazakerley DJ, Grewal T, Holst J, Saunders DN, Hoy AJ. Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration. Cancer Metab. 2017;5:1. Epub 20170113. doi: 10.1186/s40170-016-0163-7. PubMed PMID: 28101337; PMCID: PMC5237166.

      (5) Masetti M, Carriero R, Portale F, Marelli G, Morina N, Pandini M, Iovino M, Partini B, Erreni M, Ponzetta A, Magrini E, Colombo P, Elefante G, Colombo FS, den Haan JMM, Peano C, Cibella J, Termanini A, Kunderfranco P, Brummelman J, Chung MWH, Lazzeri M, Hurle R, Casale P, Lugli E, DePinho RA, Mukhopadhyay S, Gordon S, Di Mitri D. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med. 2022;219(2). Epub 20211217. doi: 10.1084/jem.20210564. PubMed PMID: 34919143; PMCID: PMC8932635.

      (6) Marelli G, Morina N, Portale F, Pandini M, Iovino M, Di Conza G, Ho PC, Di Mitri D. Lipid-loaded macrophages as new therapeutic target in cancer. J Immunother Cancer. 2022;10(7). doi: 10.1136/jitc-2022-004584. PubMed PMID: 35798535; PMCID: PMC9263925.

      (7) Huang SC, Everts B, Ivanova Y, O'Sullivan D, Nascimento M, Smith AM, Beatty W, Love-Gregory L, Lam WY, O'Neill CM, Yan C, Du H, Abumrad NA, Urban JF, Jr., Artyomov MN, Pearce EL, Pearce EJ. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol. 2014;15(9):846-55. Epub 2014/08/05. doi: 10.1038/ni.2956. PubMed PMID: 25086775; PMCID: PMC4139419.

      (8) Gillilan RE, Ayers SD, Noy N. Structural basis for activation of fatty acid-binding protein 4. J Mol Biol. 2007;372(5):1246-60. Epub 2007/09/01. doi: 10.1016/j.jmb.2007.07.040. PubMed PMID: 17761196; PMCID: PMC2032018.

      (9) Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, Rohrer J, Benninghoff AU, Hontecillas R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology. 2004;127(3):777-91. doi: 10.1053/j.gastro.2004.06.049. PubMed PMID: 15362034.

      (10) Hao J, Jin R, Yi Y, Jiang X, Yu J, Xu Z, Schnicker NJ, Chimenti MS, Sugg SL, Li B. Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer. Breast Cancer Res. 2024;26(1):119. Epub 20240725. doi: 10.1186/s13058-024-01873-y. PubMed PMID: 39054536; PMCID: PMC11270797.

      (11) Liu S, Wu D, Fan Z, Yang J, Li Y, Meng Y, Gao C, Zhan H. FABP4 in obesity-associated carcinogenesis: Novel insights into mechanisms and therapeutic implications. Front Mol Biosci. 2022;9:973955. Epub 20220819. doi: 10.3389/fmolb.2022.973955. PubMed PMID: 36060264; PMCID: PMC9438896.

      (12) Miao L, Zhuo Z, Tang J, Huang X, Liu J, Wang HY, Xia H, He J. FABP4 deactivates NF-kappaB-IL1alpha pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression. Clin Transl Med. 2021;11(4):e395. doi: 10.1002/ctm2.395. PubMed PMID: 33931964; PMCID: PMC8087928.

      (13) Yang J, Liu S, Li Y, Fan Z, Meng Y, Zhou B, Zhang G, Zhan H. FABP4 in macrophages facilitates obesity-associated pancreatic cancer progression via the NLRP3/IL-1beta axis. Cancer Lett. 2023;575:216403. Epub 20230921. doi: 10.1016/j.canlet.2023.216403. PubMed PMID: 37741433.

    1. Reviewer #2 (Public review):

      Summary:

      The authors tried to determine how PA28g functions in oral squamous cell carcinoma (OSCC) cells. They hypothesized it may act through metabolic reprogramming in the mitochondria.

      Strengths:

      They found that the genes of PA28g and C1QBP are in an overlapping interaction network after an analysis of a genome database. They also found that the two proteins interact in coimmunoprecipitation and pull-down assays using the lysate from OSCC cells with or without expression of the exogenous genes. They used truncated C1QBP proteins to map the interaction site to the N-terminal 167 residues of C1QBP protein. They observed the levels of the two proteins are positively correlated in the cells. They provided evidence for the colocalization of the two proteins in the mitochondria, the effect on mitochondrial form and function in vitro and in vivo OSCC models, and the correlation of the protein expression with the prognosis of cancer patients.

      Weaknesses:

      Many data sets are shown in figures that cannot be understood without more descriptions, either in the text or the legend, e.g., Figure 1A. Similarly, many abbreviations are not defined.

      Some of the pull-down and coimmunoprecipitation data do not support the conclusion about the PA28g-C1QBP interaction. For example, in Appendix Figure 1B the Flag-C1QBP was detected in the Myc beads pull-down when the protein was expressed in the 293T cells without the Myc-PA28g, suggesting that the pull-down was not due to the interaction of the C1QBP and PA28g proteins. In Appendix Figure 1C, assume the SFB stands for a biotin tag, then the SFB-PA28g should be detected in the cells expressing this protein after pull-down by streptavidin; however, it was not. The Western blot data in Figure 1E and many other figures must be quantified before any conclusions about the levels of proteins can be drawn.

      The immunoprecipitation method is flawed as it is described. The antigen (PA28g or C1QBP) should bind to the respective antibody that in turn should binds to Protein G beads. The resulting immunocomplex should end up in the pellet fraction after centrifugation and be analyzed further by Western blot for coprecipitates. However, the method in the Appendix states that the supernatant was used for the Western blot.

      To conclude that PA28g stabilizes C1QBP through their physical interaction in the cells, one must show whether a protease inhibitor can substitute PA28q and prevent C1QBP degradation, and also show whether a mutation that disrupts the PA28g-C1QBP interaction can reduce the stability of C1QBP. In Figure 1F, all cells expressed Myc-PA28g. Therefore, the conclusion that PA28g prevented C1QBP degradation cannot be reached. Instead, since more Myc-PA28g was detected in the cells expressing Flag-C1QBP compared to the cells not expressing this protein, a conclusion would be that the C1QBP stabilized the PA28g. Figure 1G is a quantification of Western blot data that should be shown.

      The binding site for PA28g in C1QBP was mapped to the N-terminal 167 residues using truncated proteins. One caveat would be that some truncated proteins did not fold correctly in the absence of the sequence that was removed. Thus, the C-terminal region of the C1QBP with residues 168-283 may still bind to the PA29g in the context of full-length protein. In Figure 1I, more Flag-C1QBP 1-167 was pulled down by Myc-PA28g than the full-length protein or the Flag-C1QBP 1-213. Why?

      The interaction site in PA28g for C1QBP was not mapped, which prevents further analysis of the interaction. Also, if the interaction domain can be determined, structural modeling of the complex would be feasible using AlphaFold2 or other programs. Then, it is possible to test point mutations that may disrupt the interaction and if so, the functional effect

  4. Sep 2024
    1. Welcome back and in this lesson I want to cover a few really important topics which will be super useful as you progress your general IT career, but especially so for anyone who is working with traditional or hybrid networking.

      Now I want to start by covering what a VLAN is and why you need them, then talk a little bit about Trump connections and finally cover a more advanced version of VLANs called Q in Q.

      Now I've got a lot to cover so let's just jump in and get started straight away.

      Let's start with what I've talked about in my technical fundamentals lesson so far.

      This is a physical network segment.

      It has a total of eight devices, all connected to a single, layer 2 capable device, a switch.

      Each LAN, as I talked about before, is a shared broadcast domain.

      Any frames which are addressed to all Fs will be broadcast on all ports of the switch and reach all devices.

      Now this might be fine with eight devices but it doesn't scale very well.

      Every additional device creates yet more broadcast traffic.

      Because we're using a switch, each port is a different collision domain and so by using a switch rather than a layer 1 hub we do improve performance.

      Now this local network also has three distinct groups of users.

      We've got the game testers in orange, we've got sales in blue and finance in green.

      Now ideally we want to separate the different groups of devices from one another.

      In larger businesses you might have a requirement for different segments of the network from normal devices, for servers and for other infrastructure.

      Different segments for security systems and CCTV and maybe different ones for IoT devices and IP telephony.

      Now if we only had access to physical networks this would be a challenge.

      Let's have a look at why.

      Let's say that we talk each of the three groups and split them into either different floors or even different buildings.

      On the left finance, in the middle game testers and on the right sales.

      Each of these buildings would then have its own switch and the switches in those buildings would be connected to devices also in those buildings.

      Which for now is all the finance, all the game tester and all the sales teams and machines.

      Now these switches aren't connected and because of that each one is its own broadcast domain.

      This would be how things would look in the real world if we only had access to physical networking.

      And this is fine if different groups don't need to communicate with us so we don't require cross domain communication.

      The issue right now is that none of these switches are connected so the switches have no layer 2 communications between them.

      If we wanted to do cross building or cross domain communications then we could connect the switches.

      But this creates one larger broadcast domain which moves us back to the architecture on the previous screen.

      What's perhaps more of a problem in this entirely physical networking world is what happens if a staff member changes role but not building.

      In this case moving from sales to game tester.

      In this case you need to physically run a new cable from the middle switch to the building on the right.

      If this happens often it doesn't scale very well and that is why some form of virtual local area networking is required.

      And that's why VLANs are invaluable.

      Let's have a look at how we support VLANs using layer 2 as the OSI 7-Line model.

      This is a normal Ethernet frame.

      In the context of this lesson what's important is that it has a source and destination MAC address fields together with a payload.

      Now the payload carries the data.

      The source MAC address is the MAC address of the device which is creating and sending the frame.

      The destination MAC address can contain a specific MAC address which means that it's a unique S-frame to a frame that's destined for one other device.

      Or it can contain all F's which is known as a broadcast.

      And it means that all of the devices on the same layer 2 network will see that frame.

      What a standard frame doesn't offer us is any way to isolate devices into different parts, different networks.

      And that's where a new standard comes in handy which is known as 802.1Q, also known as .1Q. .1Q changes the frame format of the standard Ethernet frame by adding a new field, a 32-bit field in the middle in Scion.

      The maximum size of the frame as a result can be larger to accommodate this new data. 12 bits of this 32-bit field can be used to store values from 0 through to 4095.

      This represents a total of 4096 values.

      This is used for the VLAN ID or VID.

      A 0 in this 12-bit value signifies no VLAN and 1 is generally used to signify the management VLAN.

      The others can be used as desired by the local network admin.

      What this means is that any .1Q frames can be a member of over 4,000 VLANs.

      And this means that you can create separate virtual LANs or VLANs in the same layer 2 physical network.

      A broadcast frame so anything that's destined to all PEPs would only reach all the devices which are in the same VLAN.

      Essentially, it creates over 4,000 different broadcast domains in the same physical network.

      You might have a VLAN for CCTV, a VLAN for servers, a VLAN for game testing, a VLAN for guests and many more.

      Anything that you can think of and can architect can be supported from a networking perspective using VLANs.

      But I want you to imagine even bigger.

      Think about a scenario where you as a business have multiple sites and each site is in a different area of the country.

      Now each site has the same set of VLANs.

      You could connect them using a dedicated wide area network and carry all of those different company specific VLANs and that would be fine.

      But what if you wanted to use a comms provider, a service provider who could provide you with this wide area network capability?

      What if the comms provider also uses VLANs to distinguish between their different clients?

      Well, you might face a situation where you use VLAN 1337 and another client of the comms provider also uses VLAN 1337.

      Now to help with this scenario, another standard comes to the rescue, 802.1AD.

      And this is known as Q in Q, also known as provider bridging or stacked VLANs.

      This adds another space in the frame for another VLAN field.

      So now instead of just the one field for 802.1Q VLANs, now you have two.

      You keep the same customer VLAN field and this is known as the C tag or customer tag.

      But you add another VLAN field called the service tag or the S tag.

      This means that the service provider can use VLANs to isolate their customer traffic while allowing each customer to also use VLANs internally.

      As the customer, you can tag frames with your VLANs and then when those frames move onto the service provider network, they can tag with the VLAN ID which represents you as a customer.

      Once the frame reaches another of your sites over the service provider network, then the S tag is removed and the frame is passed back to you as a standard .1Q frame with your customer VLAN still tagged.

      Q in Q tends to be used for larger, more complex networks and .1Q is used in smaller networks as well as cloud platforms such as AWS.

      For the remainder of this lesson, I'm going to focus on .1Q though if you're taking an advanced networking course of mine, I will be returning to the Q in Q topic in much more detail.

      For now though, let's move on and look visually at how .1Q works.

      This is a cut down version of the previous physical network I talked about, only this time instead of the three groups of devices we have two.

      So on the left we have the finance building and on the right we have game testers.

      Inside these networks we have switches and connected to these switches are two groups of machines.

      These switches have been configured to use 802.1Q and ports have been configured in a very specific way which I'm going to talk about now.

      So what makes .1Q really cool is that I've shown these different device types as separate buildings but they don't have to be.

      Different groupings of devices can operate on the same layer to switch and I'll show you how that works in a second.

      With 802.1Q ports and switches are defined as either access ports or trunk ports and access ports generally has one specific VLAN ID or vid associated with it.

      A trunk conceptually has all VLAN IDs associated with it.

      So let's say that we allocate the finance team devices to VLAN 20 and the game tester devices to VLAN 10.

      We could easily hit any other numbers, remember we have over 4,000 to choose from, but for this example let's keep it simple and keep 10 and 20.

      Now right now these buildings are separate broadcast domains because they have separate switches which are not connected and they have devices within them.

      Two laptops connected to switch number one for the finance team and two laptops connected to switch number two for the game tester team.

      Now I mentioned earlier that we have two types of switch ports in a VLAN cable network.

      The first are access ports and the ports which the orange laptops on the right are connected to are examples of access ports.

      Access ports communicate with devices using standard Ethernet which means no VLAN tags are applied to the frames.

      So in this case the laptop at the top right sends a frame to the switch and let's say that this frame is a broadcast frame.

      When the frame exits an access port it's tagged with a VLAN that the access port is assigned to.

      In this case VLAN 10 which is the orange VLAN.

      Now because this is a broadcast frame the switch now has to decide what to do with the frame and the default behaviour for switches is to forward the broadcast out of all ports except the one that it was received on.

      For switches using VLANs this is slightly different.

      First it forwards to any other access ports on the same VLAN but the tagging will be removed.

      This is important because devices connected to access ports won't always understand 802.1Q so they expect normal untagged frames.

      In addition the switch will fold frames over any trunk ports.

      A trunk port in this context is a port between two switches for example this one between switch two and switch one.

      Now a trunk port is a connection between two dot 1Q capable devices.

      It forwards all frames and it includes the VLAN tagging.

      So in this case the frame will also be forwarded over to switch one tagged as VLAN 10 which is the gain tester VLAN.

      So tagged dot 1Q frames they only get forwarded to other access ports with the same VLAN but they have the tag stripped or they get forwarded across trunk ports with the VLAN tagging intact.

      And this is how broadcast frames work.

      For unicast ones which go to a specific single MAC address well these will be either forwarded to an access port in the same VLAN that the specific device is on or if the switch isn't aware of the MAC address of that device in the same VLAN then it will do a broadcast.

      Now let's say that we have a device on the finance VLAN connected to switch two.

      And let's say that the bottom left laptop sends a broadcast frame on the finance VLAN.

      Can you see what happens to this frame now?

      Well first it will go to any other devices in the same VLAN using access ports meaning the top left laptop and in that case the VLAN tag will be removed.

      It will also be forwarded out of any trunk ports tagged with VLAN 20 so the green finance VLAN.

      It will arrive at switch two with the VLAN tag still there and then it will be forwarded to any access ports on the same VLAN so VLAN 20 on that switch but the VLAN tagging will be removed.

      Using virtual LANs in this way allows you to create multiple virtual LANs or VLANs.

      With this visual you have two different networks.

      The finance network in green so the two laptops on the left and the one at this middle bottom and then you have the gain testing network so VLAN 10 meaning the orange one on the right.

      Both of these are isolated.

      Devices cannot communicate between VLANs which are led to networks without a device operating between them such as a layer 3 router.

      Both of these virtual networks operate over the top of the physical network and it means that now we can configure this network in using virtual configuration software which can be configured on the switches.

      Now VLANs are how certain things within AWS such as public and private vifs on direct connect works so keep this lesson in mind when I'm talking about direct connect.

      A few summary points though that I do want to cover before I finish up with this lesson.

      First VLANs allow you to create separate layer 2 network segments and these provide isolation so traffic is isolated within these VLANs.

      If you don't configure and deploy a router between different VLANs then frames cannot leave that VLAN boundary so they're virtual networks and these are ideal if you want to configure different virtual networks for different customers or if you want to access different networks for example when you're using direct connect to access VPCs.

      VLANs offer separate broadcast domains and this is important.

      They create completely separate virtual network segments so any broadcast frames within a VLAN won't leave that VLAN boundary.

      If you see any mention of 802.1Q then you know that means VLANs.

      If you see any mention of VLANs stacking or provide a bridging or 802.1AD or Q in Q this means nested VLANs.

      So having a customer tag and a service tag allowing you to have VLANs in VLANs and these are really useful if you want to use VLANs on your internal business network and then use a service provider to provide wide area network connectivity who also uses VLANs and if you are doing any networking exams then you will need to understand Q in Q as well as 802.1Q.

      So with that being said that's everything I wanted to cover.

      Go ahead and complete this video and when you're ready I'll look forward to you joining me in the next.

    1. 1) the aggressors outnumbered the target of aggression (“strength in numbers”), (2) equal numbers of aggressors and targets of aggression (“fair fight”), and (3) the targets of aggression outnumbered the aggressor (“outnumbered”). We were able to assign observations to 1 of these 3 categories in 1,704 of the 2,014 instances (852 observations that noted the precise numbers of crows and ravens involved in the interaction, and 852 additional observations that described a flock of crows and a solitary raven involved in the interaction).

      This breakdown of classical aggression tactics I believe helped mitigate the lack of individual-specific behaviors being observed. I also think it highlights the fact that within the crow social circle there are both hierarchies as well as the fascinating (albeit strange) existence of clique-like behavior and tag-teaming to agitate or attack other birds.

    1. Author response:

      We sincerely thank the reviewers for their thoughtful, critical, and constructive comments, which will help us in further exploring the mechanisms by which LDH regulates glycolysis, the tricarboxylic acid cycle, and oxidative phosphorylation future studies. The following is our responses to the reviewers' comments.

      Reviewer #1 (Public Review):

      Summary:

      Zeng et al. have investigated the impact of inhibiting lactate dehydrogenase (LDH) on glycolysis and the tricarboxylic acid cycle. LDH is the terminal enzyme of aerobic glycolysis or fermentation that converts pyruvate and NADH to lactate and NAD+ and is essential for the fermentation pathway as it recycles NAD+ needed by upstream glyceraldehyde-3-phosphate dehydrogenase. As the authors point out in the introduction, multiple published reports have shown that inhibition of LDH in cancer cells typically leads to a switch from fermentative ATP production to respiratory ATP production (i.e., glucose uptake and lactate secretion are decreased, and oxygen consumption is increased). The presumed logic of this metabolic rearrangement is that when glycolytic ATP production is inhibited due to LDH inhibition, the cell switches to producing more ATP using respiration. This observation is similar to the well-established Crabtree and Pasteur effects, where cells switch between fermentation and respiration due to the availability of glucose and oxygen. Unexpectedly, the authors observed that inhibition of LDH led to inhibition of respiration and not activation as previously observed. The authors perform rigorous measurements of glycolysis and TCA cycle activity, demonstrating that under their experimental conditions, respiration is indeed inhibited. Given the large body of work reporting the opposite result, it is difficult to reconcile the reasons for the discrepancy. In this reviewer's opinion, a reason for the discrepancy may be that the authors performed their measurements 6 hours after inhibiting LDH. Six hours is a very long time for assessing the direct impact of a perturbation on metabolic pathway activity, which is regulated on a timescale of seconds to minutes. The observed effects are likely the result of a combination of many downstream responses that happen within 6 hours of inhibiting LDH that causes a large decrease in ATP production, inhibition of cell proliferation, and likely a range of stress responses, including gene expression changes.

      Strengths:

      The regulation of metabolic pathways is incompletely understood, and more research is needed, such as the one conducted here. The authors performed an impressive set of measurements of metabolite levels in response to inhibition of LDH using a combination of rigorous approaches.

      Weaknesses:

      Glycolysis, TCA cycle, and respiration are regulated on a timescale of seconds to minutes. The main weakness of this study is the long drug treatment time of 6 hours, which was chosen for all the experiments. In this reviewer's opinion, if the goal was to investigate the direct impact of LDH inhibition on glycolysis and the TCA cycle, most of the experiments should have been performed immediately after or within minutes of LDH inhibition. After 6 hours of inhibiting LDH and ATP production, cells undergo a whole range of responses, and most of the observed effects are likely indirect due to the many downstream effects of LDH and ATP production inhibition, such as decreased cell proliferation, decreased energy demand, activation of stress response pathways, etc.

      We appreciate the reviewer’s critical comments. The main argument is whether the inhibition of LDH induces a temporal perturbation in glycolysis, the TCA cycle, and OXPHOS, or if it leads to a shift to a new steady state. We argue that this shift represents a transition between two steady states; specifically, GNE-140 treatment drives metabolism from one steady state to another.

      Before conducting the experiment, we performed a time course experiment, measuring glucose consumption and lactate production in cells treated with GNE-140. The results demonstrated a very good linearity, indicating that the glycolytic rate remained constant—thus confirming that glycolysis was at steady state. Given the tight coupling between glycolysis, the TCA cycle, and OXPHOS, we infer that the TCA cycle and OXPHOS were also at steady state. However, this ‘infer’ requires further confirmation.

      Multiple published reports have shown that LDH inhibition in cancer cells causes a shift from fermentative ATP production to respiratory ATP production. This notion persists because it is often compared to the well-established Crabtree and Pasteur effects, where cells toggle between fermentation and respiration based on glucose and oxygen availability. However, in the Pasteur or Crabtree effects, the deprivation of oxygen—the terminal electron acceptor—drives the switch, which is fundamentally different from LDH inhibition.

      Reviewer #2 (Public Review):

      Summary:

      Zeng et al. investigated the role of LDH in determining the metabolic fate of pyruvate in HeLa and 4T1 cells. To do this, three broad perturbations were applied: knockout of two LDH isoforms (LDH-A and LDH-B), titration with a non-competitive LDH inhibitor (GNE-140), and exposure to either normoxic (21% O2) or hypoxic (1% O2) conditions. They show that knockout of either LDH isoform alone, though reducing both protein level and enzyme activity, has virtually no effect on either the incorporation of a stable 13C-label from a 13C6-glucose into any glycolytic or TCA cycle intermediate, nor on the measured intracellular concentrations of any glycolytic intermediate (Figure 2). The only apparent exception to this was the NADH/NAD+ ratio, measured as the ratio of F420/F480 emitted from a fluorescent tag (SoNar).

      The addition of a chemical inhibitor, on the other hand, did lead to changes in glycolytic flux, the concentrations of glycolytic intermediates, and in the NADH/NAD+ ratio (Figure 3). Notably, this was most evident in the LDH-B-knockout, in agreement with the increased sensitivity of LDH-A to GNE-140 (Figure 2). In the LDH-B-knockout, increasing concentrations of GNE-140 increased the NADH/NAD+ ratio, reduced glucose uptake, and lactate production, and led to an accumulation of glycolytic intermediates immediately upstream of GAPDH (GA3P, DHAP, and FBP) and a decrease in the product of GAPDH (3PG). They continue to show that this effect is even stronger in cells exposed to hypoxic conditions (Figure 4). They propose that a shift to thermodynamic unfavourability, initiated by an increased NADH/NAD+ ratio inhibiting GAPDH explains the cascade, calculating ΔG values that become progressively more endergonic at increasing inhibitor concentrations.

      Then - in two separate experiments - the authors track the incorporation of 13C into the intermediates of the TCA cycle from a 13C6-glucose and a 13C5-glutamine. They use the proportion of labelled intermediates as a proxy for how much pyruvate enters the TCA cycle (Figure 5). They conclude that the inhibition of LDH decreases fermentation, but also the TCA cycle and OXPHOS flux - and hence the flux of pyruvate to all of those pathways. Finally, they characterise the production of ATP from respiratory or fermentative routes, the concentration of a number of cofactors (ATP, ADP, AMP, NAD(P)H, NAD(P)+, and GSH/GSSG), the cell count, and cell viability under four conditions: with and without the highest inhibitor concentration, and at norm- and hypoxia. From this, they conclude that the inhibition of LDH inhibits the glycolysis, the TCA cycle, and OXPHOS simultaneously (Figure 7).

      Strengths:

      The authors present an impressively detailed set of measurements under a variety of conditions. It is clear that a huge effort was made to characterise the steady-state properties (metabolite concentrations, fluxes) as well as the partitioning of pyruvate between fermentation as opposed to the TCA cycle and OXPHOS.

      A couple of intermediary conclusions are well supported, with the hypothesis underlying the next measurement clearly following. For instance, the authors refer to literature reports that LDH activity is highly redundant in cancer cells (lines 108 - 144). They prove this point convincingly in Figure 1, showing that both the A- and B-isoforms of LDH can be knocked out without any noticeable changes in specific glucose consumption or lactate production flux, or, for that matter, in the rate at which any of the pathway intermediates are produced. Pyruvate incorporation into the TCA cycle and the oxygen consumption rate are also shown to be unaffected.

      They checked the specificity of the inhibitor and found good agreement between the inhibitory capacity of GNE-140 on the two isoforms of LDH and the glycolytic flux (lines 229 - 243). The authors also provide a logical interpretation of the first couple of consequences following LDH inhibition: an increased NADH/NAD+ ratio leading to the inhibition of GAPDH, causing upstream accumulations and downstream metabolite decreases (lines 348 - 355).

      Weaknesses:

      Despite the inarguable comprehensiveness of the data set, a number of conceptual shortcomings afflict the manuscript. First and foremost, reasoning is often not pursued to a logical conclusion. For instance, the accumulation of intermediates upstream of GAPDH is proffered as an explanation for the decreased flux through glycolysis. However, in Figure 3C it is clear that there is no accumulation of the intermediates upstream of PFK. It is unclear, therefore, how this traffic jam is propagated back to a decrease in glucose uptake. A possible explanation might lie with hexokinase and the decrease in ATP (and constant ADP) demonstrated in Figure 6B, but this link is not made.

      We appreciate the reviewer's critical comment. In Figure 3C, there is no accumulation of F6P or G6P, which are upstream of PFK1. This is because the PFK1-catalyzed reaction sets a significant thermodynamic barrier. Even with treatment using 30 μM GNE-140, the ∆GPFK1 (Gibbs free energy of the PFK1-catalyzed reaction) remains -9.455 kJ/mol (Figure 3D), indicating that the reaction is still far from thermodynamic equilibrium, thereby preventing the accumulation of F6P and G6P.

      We agree with the reviewer that hexokinase inhibition may play a role, this requires further investigation.

      The obvious link between the NADH/NAD+ ratio and pyruvate dehydrogenase (PDH) is also never addressed, a mechanism that might explain how the pyruvate incorporation into the TCA cycle is impaired by the inhibition of LDH (the observation with which they start their discussion, lines 511 - 514).

      We agree with the reviewer’s comment. In this study, we did not explore how the inhibition of LDH affects pyruvate incorporation into the TCA cycle. As this mechanism was not investigated, we have titled the study: "Elucidating the Kinetic and Thermodynamic Insights into the Regulation of Glycolysis by Lactate Dehydrogenase and Its Impact on the Tricarboxylic Acid Cycle and Oxidative Phosphorylation in Cancer Cells."

      It was furthermore puzzling how the ΔG, calculated with intracellular metabolite concentrations (Figures 3 and 4) could be endergonic (positive) for PGAM at all conditions (also normoxic and without inhibitor). This would mean that under the conditions assayed, glycolysis would never flow completely forward. How any lactate or pyruvate is produced from glucose, is then unexplained.

      This issue also concerned me during the study. However, given the high reproducibility of the data, we consider it is true, but requires explanation.

      The PGAM-catalyzed reaction is tightly linked to both upstream and downstream reactions in the glycolytic pathway. In glycolysis, three key reactions catalyzed by HK2, PFK1, and PK are highly exergonic, providing the driving force for the conversion of glucose to pyruvate. The other reactions, including the one catalyzed by PGAM, operate near thermodynamic equilibrium and primarily serve to equilibrate glycolytic intermediates rather than control the overall direction of glycolysis, as previously described by us (J Biol Chem. 2024 Aug 8;300(9):107648).

      The endergonic nature of the PGAM-catalyzed reaction does not prevent it from proceeding in the forward direction. Instead, the directionality of the pathway is dictated by the exergonic reaction of PFK1 upstream, which pushes the flux forward, and by PK downstream, which pulls the flux through the pathway. The combined effects of PFK1 and PK may account for the observed endergonic state of the PGAM reaction.

      However, if the PGAM-catalyzed reaction were isolated from the glycolytic pathway, it would tend toward equilibrium and never surpass it, as there would be no driving force to move the reaction forward.

      Finally, the interpretation of the label incorporation data is rather unconvincing. The authors observe an increasing labelled fraction of TCA cycle intermediates as a function of increasing inhibitor concentration. Strangely, they conclude that less labelled pyruvate enters the TCA cycle while simultaneously less labelled intermediates exit the TCA cycle pool, leading to increased labelling of this pool. The reasoning that they present for this (decreased m2 fraction as a function of DHE-140 concentration) is by no means a consistent or striking feature of their titration data and comes across as rather unconvincing. Yet they treat this anomaly as resolved in the discussion that follows.

      GNE-140 treatment increased the labeling of TCA cycle intermediates by [13C6]glucose but decreased the OXPHOS rate, we consider the conflicting results as an 'anomaly' that warrants further explanation. To address this, we analyzed the labeling pattern of TCA cycle intermediates using both [13C6]glucose and  [13C5]glutamine. Tracing the incorporation of glucose- and glutamine-derived carbons into the TCA cycle suggests that LDH inhibition leads to a reduced flux of glucose-derived acetyl-CoA into the TCA cycle, coupled with a decreased flux of glutamine-derived α-KG, and a reduction in the efflux of intermediates from the cycle. These results align with theoretical predictions. Under any condition, the reactions that distribute TCA cycle intermediates to other pathways must be balanced by those that replenish them. In the GNE-140 treatment group, the entry of glutamine-derived carbon into the TCA cycle was reduced, implying that glucose-derived carbon (as acetyl-CoA) entering the TCA cycle must also be reduced, or vice versa.

      This step-by-step investigation is detailed under the subheading "The Effect of LDHB KO and GNE-140 on the Contribution of Glucose Carbon to the TCA Cycle and OXPHOS" in the Results section in the manuscript.

      In the Discussion, we emphasize that caution should be exercised when interpreting isotope tracing data. In this study, treatment of cells with GNE-140 led to an increase labeling percentage of TCAC intermediates by [13C6]glucose (Figure 5A-E). However, this does not necessarily imply an increase in glucose carbon flux into TCAC; rather, it indicates a reduction in both the flux of glucose carbon into TCAC and the flux of intermediates leaving TCAC. When interpreting the data, multiple factors must be considered, including the carbon-13 labeling pattern of the intermediates (m1, m2, m3, ---) (Figure 5G-K), replenishment of intermediates by glutamine (Figure 5M-V), and mitochondrial oxygen consumption rate (Figure 5W). All these factors should be taken into account to derive a proper interpretation of the data. 

      Reviewer #3 (Public Review):

      Hu et al in their manuscript attempt to interrogate the interplay between glycolysis, TCA activity, and OXPHOS using LDHA/B knockouts as well as LDH-specific inhibitors. Before I discuss the specifics, I have a few issues with the overall manuscript. First of all, based on numerous previous studies it is well established that glycolysis inhibition or forcing pyruvate into the TCA cycle (studies with PDKs inhibitors) leads to upregulation of TCA cycle activity, and OXPHOS, activation of glutaminolysis, etc (in this work authors claim that lowered glycolysis leads to lower levels of TCA activity/OXPHOS). The authors in the current work completely ignore recent studies that suggest that lactate itself is an important signaling metabolite that can modulate metabolism (actual mechanistic insights were recently presented by at least two groups (Thompson, Chouchani labs). In addition, extensive effort was dedicated to understanding the crosstalk between glycolysis/TCA cycle/OXPHOS using metabolic models (Titov, Rabinowitz labs). I have several comments on how experiments were performed. In the Methods section, it is stated that both HeLa and 4T1 cells were grown in RPMI-1640 medium with regular serum - but under these conditions, pyruvate is certainly present in the medium - this can easily complicate/invalidate some findings presented in this manuscript. In LDH enzymatic assays as described with cell homogenates controls were not explained or presented (a lot of enzymes in the homogenate can react with NADH!). One of the major issues I have is that glycolytic intermediates were measured in multiple enzyme-coupled assays. Although one might think it is a good approach to have quantitative numbers for each metabolite, the way it was done is that cell homogenates (potentially with still traces of activity of multiple glycolytic enzymes) were incubated with various combinations of the SAME enzymes and substrates they were supposed to measure as a part of the enzyme-based cycling reaction. I would prefer to see a comparison between numbers obtained in enzyme-based assays with GC-MS/LC-MS experiments (using calibration curves for respective metabolites, of course). Correct measurements of these metabolites are crucial especially when thermodynamic parameters for respective reactions are calculated. Concentrations of multiple graphs (Figure 1g etc.) are in "mM", I do not think that this is correct.

      While the roles of lactate as a signaling metabolite and metabolic models are important areas of research, our work focuses on different aspects.

      It is true that cell homogenates contain many enzymes that use NAD as a hydride acceptor or NADH as a hydride donor. However, in our assay system, the substrates are pyruvate and NADH, meaning only enzymes that catalyze the conversion of pyruvate + NADH to NAD + lactate can utilize NADH. Other enzymes do not interfere with this reaction. Although some enzymes may also catalyze this reaction, their catalytic efficiency is markedly lower than that of LDH, ensuring the validity of this assay.

      Similarly, the assays for glycolytic intermediates are validated by the substrate specificity.

      We have developed an LC-MS methodology for some glycolytic intermediates, but the accuracy of quantification remains unsatisfactory due to inherent limitations of this methodology.

    2. Reviewer #2 (Public Review):

      Summary:

      Zeng et al. investigated the role of LDH in determining the metabolic fate of pyruvate in HeLa and 4T1 cells. To do this, three broad perturbations were applied: knockout of two LDH isoforms (LDH-A and LDH-B), titration with a non-competitive LDH inhibitor (GNE-140), and exposure to either normoxic (21% O2) or hypoxic (1% O2) conditions. They show that knockout of either LDH isoform alone, though reducing both protein level and enzyme activity, has virtually no effect on either the incorporation of a stable 13C-label from a 13C6-glucose into any glycolytic or TCA cycle intermediate, nor on the measured intracellular concentrations of any glycolytic intermediate (Figure 2). The only apparent exception to this was the NADH/NAD+ ratio, measured as the ratio of F420/F480 emitted from a fluorescent tag (SoNar).

      The addition of a chemical inhibitor, on the other hand, did lead to changes in glycolytic flux, the concentrations of glycolytic intermediates, and in the NADH/NAD+ ratio (Figure 3). Notably, this was most evident in the LDH-B-knockout, in agreement with the increased sensitivity of LDH-A to GNE-140 (Figure 2). In the LDH-B-knockout, increasing concentrations of GNE-140 increased the NADH/NAD+ ratio, reduced glucose uptake, and lactate production, and led to an accumulation of glycolytic intermediates immediately upstream of GAPDH (GA3P, DHAP, and FBP) and a decrease in the product of GAPDH (3PG). They continue to show that this effect is even stronger in cells exposed to hypoxic conditions (Figure 4). They propose that a shift to thermodynamic unfavourability, initiated by an increased NADH/NAD+ ratio inhibiting GAPDH explains the cascade, calculating ΔG values that become progressively more endergonic at increasing inhibitor concentrations.

      Then - in two separate experiments - the authors track the incorporation of 13C into the intermediates of the TCA cycle from a 13C6-glucose and a 13C5-glutamine. They use the proportion of labelled intermediates as a proxy for how much pyruvate enters the TCA cycle (Figure 5). They conclude that the inhibition of LDH decreases fermentation, but also the TCA cycle and OXPHOS flux - and hence the flux of pyruvate to all of those pathways. Finally, they characterise the production of ATP from respiratory or fermentative routes, the concentration of a number of cofactors (ATP, ADP, AMP, NAD(P)H, NAD(P)+, and GSH/GSSG), the cell count, and cell viability under four conditions: with and without the highest inhibitor concentration, and at norm- and hypoxia. From this, they conclude that the inhibition of LDH inhibits the glycolysis, the TCA cycle, and OXPHOS simultaneously (Figure 7).

      Strengths:

      The authors present an impressively detailed set of measurements under a variety of conditions. It is clear that a huge effort was made to characterise the steady-state properties (metabolite concentrations, fluxes) as well as the partitioning of pyruvate between fermentation as opposed to the TCA cycle and OXPHOS.

      A couple of intermediary conclusions are well supported, with the hypothesis underlying the next measurement clearly following. For instance, the authors refer to literature reports that LDH activity is highly redundant in cancer cells (lines 108 - 144). They prove this point convincingly in Figure 1, showing that both the A- and B-isoforms of LDH can be knocked out without any noticeable changes in specific glucose consumption or lactate production flux, or, for that matter, in the rate at which any of the pathway intermediates are produced. Pyruvate incorporation into the TCA cycle and the oxygen consumption rate are also shown to be unaffected.

      They checked the specificity of the inhibitor and found good agreement between the inhibitory capacity of GNE-140 on the two isoforms of LDH and the glycolytic flux (lines 229 - 243). The authors also provide a logical interpretation of the first couple of consequences following LDH inhibition: an increased NADH/NAD+ ratio leading to the inhibition of GAPDH, causing upstream accumulations and downstream metabolite decreases (lines 348 - 355).

      Weaknesses:

      Despite the inarguable comprehensiveness of the data set, a number of conceptual shortcomings afflict the manuscript. First and foremost, reasoning is often not pursued to a logical conclusion. For instance, the accumulation of intermediates upstream of GAPDH is proffered as an explanation for the decreased flux through glycolysis. However, in Figure 3C it is clear that there is no accumulation of the intermediates upstream of PFK. It is unclear, therefore, how this traffic jam is propagated back to a decrease in glucose uptake. A possible explanation might lie with hexokinase and the decrease in ATP (and constant ADP) demonstrated in Figure 6B, but this link is not made.

      The obvious link between the NADH/NAD+ ratio and pyruvate dehydrogenase (PDH) is also never addressed, a mechanism that might explain how the pyruvate incorporation into the TCA cycle is impaired by the inhibition of LDH (the observation with which they start their discussion, lines 511 - 514).

      It was furthermore puzzling how the ΔG, calculated with intracellular metabolite concentrations (Figures 3 and 4) could be endergonic (positive) for PGAM at all conditions (also normoxic and without inhibitor). This would mean that under the conditions assayed, glycolysis would never flow completely forward. How any lactate or pyruvate is produced from glucose, is then unexplained.

      Finally, the interpretation of the label incorporation data is rather unconvincing. The authors observe an increasing labelled fraction of TCA cycle intermediates as a function of increasing inhibitor concentration. Strangely, they conclude that less labelled pyruvate enters the TCA cycle while simultaneously less labelled intermediates exit the TCA cycle pool, leading to increased labelling of this pool. The reasoning that they present for this (decreased m2 fraction as a function of DHE-140 concentration) is by no means a consistent or striking feature of their titration data and comes across as rather unconvincing. Yet they treat this anomaly as resolved in the discussion that follows.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer 2:

      In addition, it is still unacceptable for me that the number of ovulated oocytes in mice at 6 months of age is only one third of young mice (10 vs 30; Fig. S1E). The most of published literature show that mice at 12 months of age still have ~10 ovulated oocytes.

      We disagree with the reviewer’s comment, and the concerns raised were not shared by the other reviewers.  We have reported our data with full transparency (each data point is plotted). In the current study, we observed an intermediate phenotype in gamete number (assessed by both ovarian follicle counts and ovulated eggs) when comparing 6 month old mice to 6 week or 10 month old mice; this is as expected. It is well accepted that follicle counts are highly mouse strain dependent.  Although the reviewer mentions that mice at 12 months have ~10 ovulated oocytes, no actual references are provided nor are the mouse strain or other relevant experimental details mentioned.  Therefore, we do not know how these quoted metrics relate to the female FVB mice used in our current study.   As clearly explained and justified in our manuscript, we used mice at 6 months and 10 months to represent a physiologic aging continuum. 

      Moreover, based on the follicle counting method used in the present study (Fig. S1D), there are no antral follicles observed in mice at 6 months and 10 months of age, which is not reasonable.

      This statement is incorrect. Antral follicles were present at 6 and 10 months of age, but due to the scale of the y-axis and the normalization of follicle number/area in Fig. S1D, the values are small.  The absolute number of antral follicles per ovary (counted in every 5th section) was 31.3 ± 3.8 follicles for 6-week old mice, 9.3 ± 2.3 follicles for 6-month old mice, and 5.3 ± 1.8 follicles for 10-month old mice.  Moreover, it is important to note that these ovaries were not collected in a specific stage of the estrous cycle, so the number of antral follicles may not be maximal.  In addition, as described in the Materials and Methods, antral follicles were only counted when the oocyte nucleus was present in a section to avoid double counting.  Therefore, this approach (which was applied consistently across samples) could potentially underestimate the total number.


      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This manuscript by Bomba-Warczak describes a comprehensive evaluation of long-lived proteins in the ovary using transgenerational radioactive labelled 15N pulse-chase in mice. The transgenerational labeling of proteins (and nucleic acids) with 15N allowed the authors to identify regions enriched in long-lived macromolecules at the 6 and 10-month chase time points. The authors also identify the retained proteins in the ovary and oocyte using MS. Key findings include the relative enrichment in long-lived macromolecules in oocytes, pregranulosa cells, CL, stroma, and surprisingly OSE. Gene ontology analysis of these proteins revealed enrichment for nucleosome, myosin complex, mitochondria, and other matrix-type protein functions. Interestingly, compared to other post-mitotic tissues where such analyses have been previously performed such as the brain and heart, they find a higher fractional abundance of labeled proteins related to the mitochondria and myosin respectively.

      Response: We thank the reviewer for this thoughtful summary of our work.  We want to clarify that our pulse-chase strategy relied on a two-generation stable isotope-based metabolic labelling of mice using 15N from spirulina algae (for reference, please see (Fornasiero & Savas, 2023; Hark & Savas, 2021; Savas et al., 2012; Toyama et al., 2013)).  We did not utilize any radioactive isotopes.

      Strengths:

      A major strength of the study is the combined spatial analyses of LLPs using histological sections with MS analysis to identify retained proteins.

      Another major strength is the use of two chase time points allowing assessment of temporal changes in LLPs associated with aging.

      The major claims such as an enrichment of LLPs in pregranulosa cells, GCs of primary follicles, CL, stroma, and OSE are soundly supported by the analyses, and the caveat that nucleic acids might differentially contribute to this signal is well presented.

      The claims that nucleosomes, myosin complex, and mitochondrial proteins are enriched for LLPs are well supported by GO enrichment analysis and well described within the known body of evidence that these proteins are generally long-lived in other tissues.

      Weaknesses:

      Comment 1: One small potential weakness is the lack of a mechanistic explanation of if/why turnover may be accelerating at the 6-10 month interval compared to 1-6.

      Response 1: At the 6-month time point, we detected more long lived proteins than the 10 month time point in both the ovary and the oocyte.  We anticipated this because proteins are degraded over time, and substantially more time has elapsed at the later time point.  Moreover, at the 6–10-month time point, age-related tissue dysfunction is already evident in the ovary.  For example, in 6-9 month old mice, there is already a deterioration of chromosome cohesion in the egg which results in increased interkinetochore distances (Chiang et al., 2010), and by 10 months, there are multinucleated giant cells present in the ovarian stroma which is consistent with chronic inflammation (Briley et al., 2016).  Thus, the observed changes in protein dynamics may be another early feature of aging progression in the ovary.  

      Comment 2: A mild weakness is the open-ended explanation of OSE label retention. This is a very interesting finding, and the claims in the paper are nuanced and perfectly reflect the current understanding of OSE repair. However, if the sections are available and one could look at the spatial distribution of OSE signal across the ovarian surface it would interesting to note if label retention varied by regions such as the CLs or hilum where more/less OSE division may be expected. 

      Response 2: We agree that the enrichment of long-lived molecules in the OSE is interesting. To make interpretable conclusions about the dynamics of long-lived molecules in the OSE, we would need to generate a series of samples at precise stages of the estrous cycle or ideally across a timecourse of ovulation to capture follicular rupture and repair.  These samples do not currently exist and are beyond the scope of this study. However, this idea is an important future direction and it has been added to the discussion (lines 221-223). Furthermore, from a practical standpoint, MIMS imaging is resource and time intensive. Thus, we are not able to readily image entire ovarian sections.  Instead, we focused on structures within the ovary and took select images of follicles, stroma, and OSE.  We, therefore, do not have a comprehensive series of images of the OSE from the entire ovarian section for each mouse analyzed.

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Bomba-Warczak et al. applied multi-isotope imaging mass spectrometry (MIMS) analysis to identify the long-lived proteins in mouse ovaries during reproductive aging, and found some proteins related to cytoskeletal and mitochondrial dynamics persisting for 10 months.

      Response: We thank the reviewer for their summary and feedback.

      Strengths:

      The manuscript provides a useful dataset about protein turnover during ovarian aging in mice.

      Weaknesses:

      Comment 1: The study is pretty descriptive and short of further new findings based on the dataset. In addition, some results such as the numbers of follicles and ovulated oocytes in aged mice are not consistent with the published literature, and the method for follicle counting is not accurate. The conclusions are not fully supported by the presented evidence.

      Response 1: We agree with the reviewer that this study is descriptive. Our goal, as stated, was to use a discovery-based approach to define the long-lived proteome of the ovary and oocyte across a reproductive aging continuum.  As the prominent aging researcher, Dr. James Kirkland, stated: “although ‘descriptive’ is sometimes used as a pejorative term…descriptive or discovery research leading to hypothesis generation has become highly sophisticated and of great relevance to the aging field (Kirkland, 2013).”  We respectfully disagree with the reviewer that our study is short of new findings. In fact, this is the first time that a stable two-generation stable isotope-based metabolic labelling of mice in combination with two different state-of-the-art mass spectrometry methods has been used to identify and localize long lived molecules in the ovary and oocyte along this particular reproductive aging continuum in an unbiased manner.  We have identified proteins groups that were previously not known to be long lived in the ovary and oocyte.  Our hope is that this long-lived proteome will become an important hypothesis-generating resource for the field of reproductive aging.

      The age-dependent decline in number of follicles and eggs ovulated in mice has been well established by our group as well as others (Duncan et al., 2017; Mara et al., 2020).  Thus, we are unclear about the reviewer’s comments that our results are not consistent with the published literature.  The absolute numbers of follicles and eggs ovulated as well as the rate of decline with age are highly strain dependent.  Moreover, mice can have a very small ovarian reserve and still maintain fertility (Kerr et al., 2012).  In our study, we saw a consistent age-dependent decrease in the ovarian reserve (Figure 1 – figure supplement 1 D), the number of oocytes collected from large antral follicles following hyperstimulation with PMSG (used for LC-MS/MS), and the number of eggs collected from the oviduct following hyperstimulation and superovulation with PMSG and hCG (Figure 1 – figure supplement 1 E and F).  In all cases, the decline was greater in 10 month old compared to 6 month old mice demonstrating a relative reproductive aging continuum even at these time points.

      Our research team has significant expertise in follicle classification and counting as evidenced by our publication record (Duncan et al., 2017; Kimler et al., 2018; Perrone et al., 2023; Quan et al., 2020).  We used our established methods which we have further clarified in the manuscript text (lines 395-397).  Follicle counts were performed on every 5th tissue section of serial sectioned ovaries, and 1 ovary from 3 mice per timepoint were counted. Therefore, follicle counts were performed on an average of 48-62 total sections per ovary. The number of follicles was then normalized per total area (mm2) of the tissue section, and the counts were averaged. Figure 1 – figure supplement 1 C and D represents data averaged from all ovarian sections counted per mouse.   It is important to note that the same criteria were applied consistently to all ovaries across the study, and thus regardless of the technique used, the relative number of follicles or oocytes across ages can be compared.

      Reviewer #3 (Public Review):

      Summary:

      In this study, Bomba-Warczak et al focused on reproductive aging, and they presented a map for long-lived proteins that were stable during reproductive lifespan. The authors used MIMS to examine and show distinct molecules in different cell types in the ovary and tissue regions in a 6 month mice group, and they also used proteomic analysis to present different LLPs in ovaries between these two timepoints in 6-month and 10-month mice. The authors also examined the LLPs in oocytes in the 6-months mice group and indicated that these were nuclear, cytoskeleton, and mitochondria proteins.

      Response: We thank the reviewer for their summary and feedback.

      Strengths:

      Overall, this study provided basic information or a 'map' of the pattern of long-lived proteins during aging, which will contribute to the understanding of the defects caused by reproductive aging.

      Weaknesses:

      Comment 1: The 6-month mice were used as an aged model; no validation experiments were performed with proteomics analysis only.  

      Response 1:  We did not select the 6-month time point to be representative of the “aged model” but rather one of two timepoints on the reproductive aging continuum – 6 and 10 months.  In the manuscript (Figure 1 – figure supplement 1) we have demonstrated the relevance of the two timepoints by illustrating a decrease in follicle counts, number of fully grown oocytes collected, and number of eggs ovulated as well as a tendency towards increased stromal fibrosis (highlighted in the main text lines 78-85).  Inclusion of the 6-month timepoint ultimately turned out to be informative and essential as many long-lived proteins were absent by the 10 month timepoint. These results suggest that important shifts in the proteome occur during mid to advanced reproductive age.  The relevance of these timepoints is mentioned in the discussion (lines 247-270).

      Two independent mass spectrometry approaches (MIMS and LC-MS/MS) were used to validate the presence of long-lived macromolecules in the ovary and oocyte. Studies focused on the role of specific long-lived proteins in oocyte and ovarian biology as well as how they change with age in terms of function, turnover, and modification are beyond the scope of the current study but are ongoing.  We have acknowledged these important next steps in the manuscript text (lines 286-288, 311-312).

      It is important to note, that oocytes are biomass limited cells, and their numbers decrease with age.  Thus, we had to select ages where we could still collect enough from the mice available to perform LC-MS/MS. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Comment 1: The writing and figures are beautiful - it would be hard to improve this manuscript.

      Response 1: We greatly appreciate this enthusiastic evaluation of our work.

      Comment 2: In Fig S1E/F it would help to list the N number here. Why are there 2 groups at 6-12 wk?

      Response 2:  We did not have 6 month and 10-month-old mice available at the same time to be able to run the hyperstimulation and superovulation experiment in parallel.  Therefore, we performed independent experiments comparing the number of eggs collected from either 6-month-old or 10 month old mice relative to 6-12 week old controls.  In each trial, eggs were collected from pooled oviducts from between 3-4 mice per age group, and the average total number of eggs per mouse was reported.  Each point on the graph corresponds to the data from an individual trial, and two trials were performed.  This has been clarified in the figure legend (lines 395-397).  Of note, while addressing this reviewer’s comments, we noticed that we were missing Materials and Methods regarding the collection of eggs from the oviduct following hyperstimulation and superovulation with PMSG and hCG.  This information has now been added in Methods Section, lines 477-481.

      Comment 3: The manuscript would benefit from an explanation of why the pups were kept on a 1-month N15 diet after birth, since the oocytes are already labeled before birth, and granulosa at most by day 3-4. Would ZP3 have not been identified otherwise?

      Response 3:   The pups used in this study were obtained from fully labeled female dams that were maintained on an15N diet.  These pups had to be kept with their mothers through weaning.  To limit the pulse period only through birth, the pups would have had to be transferred to unlabeled foster mothers.  However, this would have risked pup loss which would have significantly impacted our ability to conduct the studies given that we only had 19 labeled female pups from three breeding pairs.  We have clarified this in the manuscript text in lines 78-80.  It is hard to know, without doing the experiment, whether we would have detected ZP3 if we only labeled through birth.  The expression of ZP3 in primordial follicles, albeit in human, would suggest that this protein is expressed quite early in development.

      Comment 4: What is happening to the mitochondria at 6-10 months? Does their number change in the oocyte? Is there a change in the rate of fission? Any chance to take a stab at it with these or other age-matched slides?

      Response 4:  The reviewer raises an excellent point.  As mentioned previously in the Discussion (lines 290-301), there are well documented changes in mitochondrial structure and function in the oocyte in mice of advanced reproductive age.  However, there is a paucity of data on the changes that may happen at earlier mid-reproductive age time points.  From the oocyte mitochondrial proteome perspective, our data demonstrate a prominent decline in the persistence of long-lived proteins between 6 and 10 months, and this occurs in the absence of a change in the total pool of mitochondrial proteins (both long and short lived populations) as assessed by spectral counts or protein IDs (figure below).  These data, which we have added into Figure 3 – figure supplement 1 and in the manuscript text (lines 164-170) are suggestive of similar numbers of mitochondria at these two timepoints. It would be informative to do a detailed characterization of oocyte mitochondrial structure and function within this window to see if there is a correlation with this shift in long lived mitochondrial proteins.  Although this analysis is beyond the scope of the current manuscript, it is an important next line of inquiry which we have highlighted in the manuscript text (lines 255-257 and 311-312).

      Reviewer #2 (Recommendations For The Authors):

      Several concerns are raised as shown below.

      Comment 1: In Fig. 2F, it is surprising that ZP3 disappeared in the ovary from mice at the age of 10 months by MIMS analysis, because quite a few oocytes with intact zona pellucida can still be obtained from mice at this age. Notably, ZP would not be renewed once formed.

      Response 1: To clarify, Figure 2F shows LC-MS/MS data and not MIMS data.  As mentioned in the Discussion, the detection of long-lived pools of ZP3 at 6 months cannot be derived from newly synthesized zona pellucidae in growing follicles because they would not have been present during the pulse period.  The only way we could detect ZP3 at 6 months is if it forms a primitive zona scaffold in the primordial follicle or if ZPs from atretic follicles of the first couple of waves of folliculogenesis incorporate into the extracellular matrix of the ovary.  The lack of persistence of ZP3 at 10 months could be due to protein degradation. Should ZP3 indeed form a primitive zona, its loss at 10 months would be predicted to result in poor formation of a bona fide zona pellucida upon follicle growth.  Interestingly, aging has been associated with alterations in zona pellucida structure and function.   These data open novel hypotheses regarding the zona pellucida (e.g. a primitive zona scaffold and part of the extracellular matrix) and will require significant further investigation to test. These points are highlighted in the Discussion lines 227-245.

      Comment 2: To determine whether those proteins that can not be identified by MIMS at the time point of 10 months are degraded or renewed, the authors should randomly select some of them to examine their protein expression levels in the ovary by immunoblotting analysis.

      Response 2: To clarify, proteins were identified by LC-MS/MS and not MIMS which was used to visualize long lived macromolecules.   Each protein will be comprised of old pools (15N containing) and newly synthesized pools (14N containing).  Degradation of the old pool of protein does not mean that there will be a loss of total protein.  Moreover, immunoblotting cannot distinguish old and newly synthesized pools of protein. Where overall peptide counts are listed for each protein identified at both time points.  As peptides derive from proteins, the table provided with the manuscript reflects what immunoblotting would, but on a larger and more precise scale.

      Comment 3: I think those proteins that can be identified by MIMS at the time point of 6 months but not 10 months deserve more analyses as they might be the key molecules that drive ovarian aging.

      Response 3:  This comment conflicts with comment 2 from Reviewer #3 (Recommendations For The Authors).  This underscores that different researchers will prioritize the value and follow up of such rich datasets differently.  We agree that the LLP identified at 6 months are of particular interest to reproductive aging, and we are planning to follow up on these in future studies.

      Comment 4:  Figure 1 – figure supplement 1 C-F, compared with the published literature, the numbers of follicles at different developmental stages and ovulated oocytes at both ages of 6 months and 10 months were dramatically low in this study. For 6-month-old female mice, the reproductive aging just begins, thus these numbers should not be expected to decrease too much. In addition, follicle counting was carried out only in an area of a single section, which is an inaccurate way, because the numbers and types of follicles in various sections differ greatly. Also, the data from a single section could not represent the changes in total follicle counts.

      Response 4: We have addressed these points in response to Comment 1 in the Reviewer #2 Public Review, and corresponding changes in the text have been noted.    

      Comment 5:  The study lacks follow-up verification experiments to validate their MIMS data.

      Response 5: Two independent mass spectrometry approaches (MIMS and LC-MS/MS) were used to validate the presence of long-lived macromolecules in the ovary and oocyte. Studies focused on the role of specific long-lived proteins in oocyte and ovarian biology as well as how they change with age in terms of function, turnover, and modification are beyond the scope of the current study but ongoing.  We have acknowledged these important next steps in the manuscript text (lines 286-288 and 311-312).

      Reviewer #3 (Recommendations For The Authors):

      Comment 1: The authors used the 6-month mice group to represent the aged model, and examined the LLPs from 1 month to 6 months. Indeed, 6-month-old mice start to show age-related changes; however, for the reproductive aging model, the most widely accepted model is that 10-month-old age mice start to show reproductive-related changes and 12-month-old mice (corresponding to 35-40 year-old women) exhibit the representative reproductive aging phenotypes. Therefore, the data may not present the typical situation of LLPs during reproductive aging.

      Response 1: As described in the response to Comment 1 in the Reviewer #3 Public Review, there were clear logistical and technical feasibility reasons why the 6 month and 10-month timepoints were selected for this study.  Importantly, however, these timepoints do represent a reproductive aging continuum as evidenced by age-related changes in multiple parameters.  Furthermore, there were ultimately very few LLPs that remained at 10 months in both the oocyte and ovary, so inclusion of the 6-month time point was an important intermediate.  Whether the LLPs at the 6-month timepoint serve as a protective mechanism in maintaining gamete quality or whether they contribute to decreased quality associated with reproductive aging is an intriguing dichotomy which will require further investigation.  This has been added to the discussion (lines 247-257).

      Comment 2:  Following the point above, the authors examined the ovaries in 6 months and 10 months mice by proteomics, and found that 6 months LLPs were not identical compared with 10 months, while there were Tubb5, Tubb4a/b, Tubb2a/b, Hist2h2 were both expressed at these two time points (Fig 2B), why the authors did not explore these proteins since they expressed from 1 month to 10 months, which are more interesting.

      Response 2:  The objective of this study was to profile the long-lived proteome in the ovary and oocyte as a resource for the field rather than delving into specific LLPs at a mechanistic level.  That being said, we wholeheartedly agree with the reviewer that the proteins that were identified at both 6 month and 10 months are the most robust and long lived and worthy of prioritizing for further study.  Interestingly, Tubb5 and Tubb4a have high homology to primate-specific Tubb8, and Tubb8 mutations in women are associated with meiosis I arrest in oocytes and infertility (Dong et al., 2023; Feng et al., 2016).  Thus, perturbation of these specific proteins by virtue of their long-lived nature may be associated with impaired function and poor reproductive outcomes.  We have highlighted the importance of these LLPs which are present at both timepoints and persist to at least 10 months in the manuscript text (lines 259-270).

      Comment 3:  The authors also need to provide a hypothesis or explanation as to why LLDs from 6 months LLPs were not identical compared with 10 months.

      Response 3:  We agree that LLDs identified at 10 months should be also identified as long-lived at 6 months. This is a common limitation of mass spectrometry-based proteomics where each sample is prepared and run individually, which introduces variability between biological replicates, especially when it comes to low abundant proteins. It is key to note that just because we do not identify a protein, it does not mean the protein is not there – it merely means that we were not able to detect it in this particular experiment, but low levels of the protein may still be there. To compensate for this known and inherent variability, we have applied stringent filtering criteria where we required long-lived peptides to be identified in an independent MS scan (alternative is to identify peptide in either heavy or light scan and use modeling to infer FA value based on m/z shift), which gave us peptides of highest confidence. Ideally, these experiments would be done using TMT (tandem mass tag) approach. However, TMT-based experiments typically require substantial amount of input (80-100ug per sample) which unfortunately is not feasible with oocytes obtained from a limited number of pulse-chased animals.  We have added this explanation to the discussion (lines 265-270).

      Comment 4:  The reviewer thinks that LLPs from 6 months to 10 months may more closely represent the long-lived proteins during reproductive aging.

      Response 4:  We fully agree that understanding the identity of LLPs between the 6 month and 10 month period will be quite informative given that this is a dynamic period when many of LLPs get degraded and thus might be key to the observed decline in reproductive aging. This is a very important point that we hope to explore in future follow-up studies.

      Comment 5: The authors used proteomics for the detection of ovaries and oocytes, however, there are no validation experiments at all. Since proteomics is mainly for screening and prediction, the authors should examine at least some typical proteins to confirm the validity of proteomics. For example, the authors specifically emphasized the finding of ZP3, a protein that is critical for fertilization.

      Response 5:  Thank you, we agree that closer examination of proteins relevant and critical for fertilization is of importance.  However, a detailed analysis of specific proteins fell outside of the scope of this study which aimed at unbiased identification of long-lived macromolecules in ovaries and oocytes. We hope to continue this important work in near future.

      Comment 6: For the oocytes, the authors indicated that cytoskeleton, mitochondria-related proteins were the main LLPs, however, previous studies reported the changes of the expression of many cytoskeleton and mitochondria-related proteins during oocyte aging. How do the authors explain this contrary finding?   

      Response 6:  Our findings are not contrary to the studies reporting changes in protein expression levels during oocyte aging – the two concepts are not mutually exclusive. The average FA value at 6-month chase for oocyte proteins is 41.3 %, which means that while 41.3% of long-lived proteins pool persisted for 6 months, the other 58.7% has in fact been renewed. With the exception of few mitochondrial proteins (Cmkt2 and Apt5l), and myosins (Myl2 and Myh7), which had FA values close to 100% (no turnover), most of the LLPs had a portion of protein pools that were indeed turned over. Moreover, we included new data analysis illustrating that we identify comparable number of mitochondrial proteins between the two time points, indicating that while the long-lived pools are changing over time, the total content remains stable (Figure 3 – figure supplement 1E-G).

      Comment 7:  The authors also should provide in-depth discussion about the findings of the current study for long-lived proteins. In this study, the authors reported the relationship between these "long-lived" proteins with aging, a process with multiple "changes". Do long-lived proteins (which are related to the cytoskeleton and mitochondria) contribute to the aging defects of reproduction? or protect against aging?

      Response 7: This is a very important comment and one that needs further exploration. The fact is – we do not know at this moment whether these proteins are protective or deleterious, and such a statement would be speculative at this stage of research into LLPs in ovaries and oocytes. Future work is needed to address this question in detail.

      Briley, S. M., Jasti, S., McCracken, J. M., Hornick, J. E., Fegley, B., Pritchard, M. T., & Duncan, F. E. (2016). Reproductive age-associated fibrosis in the stroma of the mammalian ovary. Reproduction, 152(3), 245-260. https://doi.org/10.1530/REP-16-0129

      Chiang, T., Duncan, F. E., Schindler, K., Schultz, R. M., & Lampson, M. A. (2010). Evidence that Weakened Centromere Cohesion Is a Leading Cause of Age-Related Aneuploidy in Oocytes. Current Biology, 20(17), 1522-1528. https://doi.org/10.1016/j.cub.2010.06.069

      Dong, J., Jin, L., Bao, S., Chen, B., Zeng, Y., Luo, Y., Du, X., Sang, Q., Wu, T., & Wang, L. (2023). Ectopic expression of human TUBB8 leads to increased aneuploidy in mouse oocytes. Cell Discov, 9(1), 105. https://doi.org/10.1038/s41421-023-00599-z

      Duncan, F. E., Jasti, S., Paulson, A., Kelsh, J. M., Fegley, B., & Gerton, J. L. (2017). Age-associated dysregulation of protein metabolism in the mammalian oocyte. Aging Cell, 16(6), 1381-1393. https://doi.org/10.1111/acel.12676

      Feng, R., Sang, Q., Kuang, Y., Sun, X., Yan, Z., Zhang, S., Shi, J., Tian, G., Luchniak, A., Fukuda, Y., Li, B., Yu, M., Chen, J., Xu, Y., Guo, L., Qu, R., Wang, X., Sun, Z., Liu, M., . . . Wang, L. (2016). Mutations in TUBB8 and Human Oocyte Meiotic Arrest. N Engl J Med, 374(3), 223-232. https://doi.org/10.1056/NEJMoa1510791

      Fornasiero, E. F., & Savas, J. N. (2023). Determining and interpreting protein lifetimes in mammalian tissues. Trends Biochem Sci, 48(2), 106-118. https://doi.org/10.1016/j.tibs.2022.08.011

      Hark, T. J., & Savas, J. N. (2021). Using stable isotope labeling to advance our understanding of Alzheimer's disease etiology and pathology. J Neurochem, 159(2), 318-329. https://doi.org/10.1111/jnc.15298

      Kerr, J. B., Hutt, K. J., Michalak, E. M., Cook, M., Vandenberg, C. J., Liew, S. H., Bouillet, P., Mills, A., Scott, C. L., Findlay, J. K., & Strasser, A. (2012). DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol Cell, 48(3), 343-352. https://doi.org/10.1016/j.molcel.2012.08.017

      Kimler, B. F., Briley, S. M., Johnson, B. W., Armstrong, A. G., Jasti, S., & Duncan, F. E. (2018). Radiation-induced ovarian follicle loss occurs without overt stromal changes. Reproduction, 155(6), 553-562. https://doi.org/10.1530/REP-18-0089

      Kirkland, J. L. (2013). Translating advances from the basic biology of aging into clinical application. Exp Gerontol, 48(1), 1-5. https://doi.org/10.1016/j.exger.2012.11.014

      Mara, J. N., Zhou, L. T., Larmore, M., Johnson, B., Ayiku, R., Amargant, F., Pritchard, M. T., & Duncan, F. E. (2020). Ovulation and ovarian wound healing are impaired with advanced reproductive age. Aging (Albany NY), 12(10), 9686-9713. https://doi.org/10.18632/aging.103237

      Perrone, R., Ashok Kumaar, P. V., Haky, L., Hahn, C., Riley, R., Balough, J., Zaza, G., Soygur, B., Hung, K., Prado, L., Kasler, H. G., Tiwari, R., Matsui, H., Hormazabal, G. V., Heckenbach, I., Scheibye-Knudsen, M., Duncan, F. E., & Verdin, E. (2023). CD38 regulates ovarian function and fecundity via NAD(+) metabolism. iScience, 26(10), 107949. https://doi.org/10.1016/j.isci.2023.107949

      Quan, N., Harris, L. R., Halder, R., Trinidad, C. V., Johnson, B. W., Horton, S., Kimler, B. F., Pritchard, M. T., & Duncan, F. E. (2020). Differential sensitivity of inbred mouse strains to ovarian damage in response to low-dose total body irradiationdagger. Biol Reprod, 102(1), 133-144. https://doi.org/10.1093/biolre/ioz164

      Savas, J. N., Toyama, B. H., Xu, T., Yates, J. R., 3rd, & Hetzer, M. W. (2012). Extremely long-lived nuclear pore proteins in the rat brain. Science, 335(6071), 942. https://doi.org/10.1126/science.1217421

      Toyama, B. H., Savas, J. N., Park, S. K., Harris, M. S., Ingolia, N. T., Yates, J. R., 3rd, & Hetzer, M. W. (2013). Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell, 154(5), 971-982. https://doi.org/10.1016/j.cell.2013.07.037

    1. Reviewer #1 (Public review):

      Summary:

      The manuscript by Jang et al. describes the application of new methods to measure the localization GTP-binding signaling proteins (G proteins) on different membrane structures in a model mammalian cell line (HEK293). G proteins mediate signaling by receptors found at the cell surface (GPCRs), with evidence from the last 15 years suggesting that GPCRs can induce G-protein mediated signaling from different membrane structures within the cell, with variation in signal localization leading to different cellular outcomes. While it has been clearly shown that different GPCRs efficiently traffic to various intracellular compartments, it is less clear whether G proteins traffic in the same manor, and whether GPCR trafficking facilitates "passenger" G protein trafficking. This question was a blind spot in the burgeoning field of GPCR localized signaling in need of careful study, and the results obtained will serve as an important guide post for further work in this field.<br /> The extent to which G proteins localize to different membranes within the cell is the main experimental question tested in this manuscript. This question is pursued by through two distinct methods, both relying on genetic modification of the G-beta subunit with a tag. In one method, G-beta is modified with a small fragment of the fluorescent protein mNG, which combines with the larger mNG fragment to form a fully functional fluorescent protein to facilitate protein trafficking by fluorescent microscopy. This approach was combined with expression of fluorescent proteins directed to various intracellular compartments (different types of endosomes, lysosome, endoplasmic reticulum, golgi, mitochondria) to look for colocalization of G-beta with these markers. These experiments showed compelling evidence that G-beta co-localizes with markers at the plasma membrane and the lysosome, with weak or absent co-localization for other markers. A second method for measuring localization relied on fusing G-beta with a small fragment from a miniature luciferase (HiBit) that combines with a larger luciferase fragment (LgBit) to form an active luciferase enzyme. Localization of G-beta (and luciferase signal) was measured using a method known as bystander BRET, which relies on expression of a fluorescent protein BRET acceptor in different cellular compartments. Results using bystander BRET supported findings from fluorescence microscopy experiments. These methods for tracking G protein localization were also used to probe other questions. The activation of GPCRs from different classes had virtually no impact on the localization of G-beta, suggesting that GPCR activation does not result in shuttling of G proteins through the endosomal pathway with activated receptors.

      In the revised version of this manuscript the authors have performed informative and important new experiments in addition to adding new text to address conceptual questions. These new data and discussions are commendable and address most or all of the weaknesses listed in the initial review.

      Strengths:

      The question probed in this study is quite important and, in my opinion, understudied by the pharmacology community. The results presented here are an important call to be cognizant of the localization of GPCR coupling partners in different cellular compartments. Abundant reports of endosomal GPCR signaling need to consider how the impact of lower G protein abundance on endosomal membranes will affect the signaling responses under study.

      *The work presented is carefully executed, with seemingly high levels of technical rigor. These studies benefit from probing the experimental questions at hand using two different methods of measurement (fluorescent microscopy and bystander BRET). The observation that both methods arrive at the same (or a very similar) answer inspires confidence about the validity of these findings.

      Weaknesses:

      *As noted by the authors, they do not demonstrate that the tagged G-beta is predominantly found within heterotrimeric G protein complexes. In the revised manuscript the authors have added new discussion text on why it is likely that G-beta is mostly found in complexes. This line of reasoning is convincing, although more robust experimental methods for assessing the assembly status of G-beta could be a valuable target for future experimental developments.

    2. Reviewer #3 (Public review):

      Summary:

      This article addresses an important and interesting question concerning intracellular localization and dynamics of endogenous G proteins. The fate and trafficking of G protein-coupled receptors (GPCRs) have been extensively studied but so far little is known about the trafficking routes of their partner G proteins that are known to dissociate from their respective receptors upon activation of the signaling pathway. Authors utilize modern cell biology tools including genome editing and bystander bioluminescence resonance energy transfer (BRET) to probe intracellular localization of G proteins in various membrane compartments in steady state and also upon receptor activation. Data presented in this manuscript shows that while G proteins are mostly present on the plasma membrane, they can be also detected in endosomal compartments, especially in late endosomes and lysosomes. This distribution, according to data presented in this study, seems not to be affected by receptor activation. These findings will have implications in further studies addressing GPCR signaling mechanisms from intracellular compartments.

      Strengths:

      The methods used in this study are adequate for the question asked. Especially use of genome-edited cells (for addition of the tag on one of the G proteins) is a great choice to prevent effects of overexpression. Moreover, use of bystander BRET allowed authors to probe intracellular localization of G proteins in a very high-throughput fashion. By combining imaging and BRET authors convincingly show that G proteins are very low abundant on early endosomes (also ER, mitochondria, and medial Golgi), however seem to accumulate on membranes of late endosomal compartments. Moreover, authors also looked at the dynamics of G protein trafficking by tracking them over multiple time points in different compartments.

      Weaknesses:

      While authors provide a novel dataset, many questions regarding G protein trafficking remain open. For example, it is not entirely clear which pathway is utilized to traffic G proteins from the plasma membrane to intracellular compartments. Additionally, future studies should also include more quantitative details considering G-protein distribution in different compartments as well as more detailed dynamic data on G protein internalization as well as intracellular trafficking kinetics.

    3. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The manuscript by Jang et al. describes the application of new methods to measure the localization of GTP-binding signaling proteins (G proteins) on different membrane structures in a model mammalian cell line (HEK293). G proteins mediate signaling by receptors found at the cell surface (GPCRs), with evidence from the last 15 years suggesting that GPCRs can induce G-protein mediated signaling from different membrane structures within the cell, with variation in signal localization leading to different cellular outcomes. While it has been clearly shown that different GPCRs efficiently traffic to various intracellular compartments, it is less clear whether G proteins traffic in the same manner, and whether GPCR trafficking facilitates "passenger" G protein trafficking. This question was a blind spot in the burgeoning field of GPCR localized signaling in need of careful study, and the results obtained will serve as an important guidepost for further work in this field. The extent to which G proteins localize to different membranes within the cell is the main experimental question tested in this manuscript. This question is pursued through two distinct methods, both relying on genetic modification of the G-beta subunit with a tag. In one method, G-beta is modified with a small fragment of the fluorescent protein mNG, which combines with the larger mNG fragment to form a fully functional fluorescent protein to facilitate protein trafficking by fluorescent microscopy. This approach was combined with the expression of fluorescent proteins directed to various intracellular compartments (different types of endosomes, lysosome, endoplasmic reticulum, Golgi, mitochondria) to look for colocalization of G-beta with these markers. These experiments showed compelling evidence that G-beta co-localizes with markers at the plasma membrane and the lysosome, with weak or absent co-localization for other markers. A second method for measuring localization relied on fusing G-beta with a small fragment from a miniature luciferase (HiBit) that combines with a larger luciferase fragment (LgBit) to form an active luciferase enzyme. Localization of Gbeta (and luciferase signal) was measured using a method known as bystander BRET, which relies on the expression of a fluorescent protein BRET acceptor in different cellular compartments. Results using bystander BRET supported findings from fluorescence microscopy experiments. These methods for tracking G protein localization were also used to probe other questions. The activation of GPCRs from different classes had virtually no impact on the localization of G-beta, suggesting that GPCR activation does not result in the shuttling of G proteins through the endosomal pathway with activated receptors.

      Strengths:

      The question probed in this study is quite important and, in my opinion, understudied by the pharmacology community. The results presented here are an important call to be cognizant of the localization of GPCR coupling partners in different cellular compartments. Abundant reports of endosomal GPCR signaling need to consider how the impact of lower G protein abundance on endosomal membranes will affect the signaling responses under study.

      The work presented is carefully executed, with seemingly high levels of technical rigor. These studies benefit from probing the experimental questions at hand using two different methods of measurement (fluorescent microscopy and bystander BRET). The observation that both methods arrive at the same (or a very similar) answer inspires confidence about the validity of these findings.

      Weaknesses:

      The rationale for fusing G-beta with either mNG2(11) or SmBit could benefit from some expansion. I understand the speculation that using the smallest tag possible may have the smallest impact on protein performance and localization, but plenty of researchers have fused proteins with whole fluorescent proteins to provide conclusions that have been confirmed by other methods. Many studies even use G proteins fused with fluorescent proteins or luciferases. Is there an important advantage to tagging G-beta with small tags? Is there evidence that G proteins with full-size protein tags behave aberrantly? If the studies presented here would not have been possible without these CRISPR-based tagging approaches, it would be helpful to provide more context to make this clearer. Perhaps one factor would be interference from newly synthesized G proteins-fluorescent protein fusions en route to the plasma membrane (in the ER and Golgi).

      There are several advantages to using small peptide tags that we did not fully explain. From a practical standpoint the most important advantage of using the HiBit tag instead of full-length Nanoluc is that it allows us to restrict luminescence output to cells transiently transfected with LgBit. In this way untransfected cells contribute no background signal. Although we did not take advantage of it here, this also applies to fluorescent protein complementation, and will be useful for visualizing proteins in individual cells within tissues. The HiBit tag also allows PAGE analysis by probing membranes with LgBit (as in Fig. 1). We are not aware of evidence that tagging Gb or Gg subunits on the N terminus results in aberrant behavior, while there is some evidence that Ga subunits tagged with full-size protein tags (in some positions) have altered functional properties (PMID: 16371464). We do think that editing endogenous genes is critical, as studies using transient overexpression (usually driven by strong promoters) have sometimes reported accumulation of tagged G proteins in the biosynthetic pathway (e.g., PMID: 17576765), as the reviewer suggests. Ga and Gbg appear to be mutually dependent on each other for appropriate trafficking to the plasma membrane (reviewed in PMID: 23161140), therefore the native (presumably matched) stoichiometry is likely to be critical.

      To clarify this context the revised manuscript includes the following:

      “For bioluminescence experiments we added the HiBit tag (Schwinn et al., 2018) and isolated clonal “HiBit-b1“ cell lines. An advantage of this approach over adding a full-length Nanoluc luciferase is that it requires coexpression of LgBit to produce a complemented luciferase. This limits luminescence to cotransfected cells and thus eliminates background from untransfected cells.”

      “Some studies using overexpressed G protein subunits have suggested that a large pool of G proteins is located on intracellular membranes, including the Golgi apparatus (Chisari et al., 2007; Saini et al., 2007; Tsutsumi et al., 2009), whereas others have indicated a distribution that is dominated by the plasma membrane (Crouthamel et al., 2008; Evanko, Thiyagarajan, & Wedegaertner, 2000; Marrari et al., 2007; Takida & Wedegaertner, 2003). A likely factor contributing to these discrepant results is the stoichiometry of overexpressed subunits, as neither Ga nor Gbg traffic appropriately to the plasma membrane as free subunits (Wedegaertner, 2012). Our gene-editing approach presumably maintains the native subunit stoichiometry, providing a more accurate representation of native G protein distribution.”

      As noted by the authors, they do not demonstrate that the tagged G-beta is predominantly found within heterotrimeric G protein complexes. If there is substantial free G-beta, then many of the conclusions need to be reconsidered. Perhaps a comparison of immunoprecipitated tagged G beta vs immunoprecipitated supernatant, with blotting for other G protein subunits would be informative.

      We do think that HiBit-b1 exists predominantly within heterotrimeric complexes, for several reasons. First, overexpression studies have shown that Gbg requires association with Ga to traffic to the plasma membrane, and that by itself Gbg is retained on the endoplasmic reticulum

      (PMID: 12609996; PMID: 12221133). We find almost no endogenous Gb1 on the endoplasmic reticulum, and a high density on the plasma membrane. Second, we are able to detect large increases in free HiBit-Gbg after G protein activation using free Gbg sensors (e.g. Fig. 1). Third, many proteins that bind to free Gbg are found entirely in the cytosol of HEK 293 cells (e.g. PMID: 10066824), suggesting there is not a large population of free Gbg. We have added discussion of these points to the revised manuscript as follows:

      “Endogenous Ga and Gb subunits are expressed at approximately a 1:1 ratio, and Gb subunits are tightly associated with Gg and inactive Ga subunits (Cho et al., 2022; Gilman, 1987; Krumins & Gilman, 2006). Moreover, proteins that bind to free Gbg dimers are found in the cytosol of unstimulated HEK 293 cells, suggesting at most only a small population of free Gbg in these cells. Therefore, we assume that the large majority of mNG-b1 and HiBit-b1 subunits in unstimulated cells are part of heterotrimers.”

      “Notably, when Gbg dimers are expressed alone they accumulate on the endoplasmic reticulum

      (Michaelson et al., 2002; Takida & Wedegaertner, 2003). That we detect almost no endogenous Gbg on the endoplasmic reticulum supports our conclusion that the large majority of Gbg in unstimulated HEK 293 cells is associated with Ga, although we cannot rule out a small population of free Gbg.”

      We do not entirely understand the suggested experiment, as free Gbg will still be largely associated with the membrane fraction. Notably, we find almost no HiBit-b1 in the supernatant after lysis in hypotonic buffer and preparation of membrane fractions, and the small amount that we do find does not change if Ga is overexpressed.

      Additional context and questions:

      (1) There exists some evidence that certain GPCRs can form enduring complexes with G-betagamma (PubMed: 23297229, 27499021). That would seem to offer a mechanism that would enable receptor-mediated transport of G protein subunits. It would be helpful for the authors to place the findings of this manuscript in the context of these previous findings since they seem somewhat contradictory.

      We agree. In our original submission we noted “It is possible that other receptors will influence G protein distribution using mechanisms not shared by the receptors we studied.” In the revised manuscript we have added:

      “For example, a few receptors are thought to form relatively stable complexes with Gbg, which could provide a mechanism of trafficking to endosomes (Thomsen et al., 2016; Wehbi et al., 2013).”

      (2) There is some evidence that GaS undergoes measurable dissociation from the plasma membrane upon activation (see the mechanism of the assay in PubMed: 35302493). It seems possible that G-alpha (and in particular GaS) might behave differently than the G-beta subunit studied here. This is not entirely clear from the discussion as it now stands.

      Indeed, there is abundant evidence that some Gas translocates away from the plasma membrane upon activation. We referred to translocation of “some Ga subunits” in the introduction, although we did not specify that Gas is by far the most studied example. In a previous study (PMID: 27528603) we found that overexpressed Gas samples many intracellular membranes upon activation and returns to the plasma membrane when activation ceases. This is similar to activation-dependent translocation of free Gbg dimers. Because these translocation mechanisms depend on activation and are reversible they are unlikely to be a major source of inactive heterotrimers for intracellular membranes.

      We did a poor job of making it clear that we intentionally avoided translocation mechanisms that operate only during receptor and G protein stimulation. In the revised manuscript we have added new data showing reversible activation-dependent translocation of endogenous HiBitGb1.

      (3) The authors say "The presence of mNG-b1 on late endosomes suggested that some G proteins may be degraded by lysosomes". The mechanism of lysosomal degradation by proteins on the outside of the lysosome is not clear. It would be helpful for the authors to clarify.

      We agree we didn’t connect the dots here. Our initial idea was that G proteins on the surface of late endosomes might reach the interior of late endosomes and then lysosomes by involution into multivesicular bodies. However, the reviewer correctly points out that much of the G protein associated with lysosomes still appears to be on the cytosolic surface, where it would not be subject to degradation. In fact, since lysosomes can fuse with the plasma membrane under certain circumstances, this could even represent a pathway for recycling G proteins to the plasma membrane.

      We have revised the text to avoid giving the impression that lysosomes degrade G proteins, since we have scant evidence that this occurs. In the revised discussion we point out that we do not know the fate of G proteins located on the surface of lysosomes and speculate that these could be returned to the plasma membrane:

      “We do not know the fate of G proteins located on the surface of lysosomes. Since lysosomes may fuse with the plasma membrane under certain circumstances (Xu & Ren, 2015), it is possible that this represents a route of G protein recycling to the plasma membrane.”

      (4) Although the authors do a good job of assessing G protein dilution in endosomal membranes, it is unclear how this behavior compares to the measurement of other lipidanchored proteins using the same approach. Is the dilution of G proteins what we would expect for any lipid-anchored protein at the inner leaflet of the plasma membrane?

      This is a great question. To begin to address it we have studied a model lipid-anchored protein consisting of mNeongreen2 anchored to the plasma membrane by the C terminus of HRas, which is palmitoylated and prenylated. We find that this protein is also diluted on endocytic vesicles, although to a lesser degree than heterotrimeric G proteins. We have added a section to the results and a new figure supplement describing these results:

      “To test if other peripheral membrane proteins are similarly depleted from endocytic vesicles, we performed analogous experiments by overexpressing mNG bearing the C-terminal membrane anchor of HRas (mNG-HRas ct). We found that mNG-HRas ct was also less abundant on FM464-positive endocytic vesicles than expected based on plasma membrane abundance, although not to the same extent as mNG-b1 (Figure 4 - figure supplement 2); mNG-HRas ct density on FM4-64-positive vesicles was 64 ± 17% (mean ± 95% CI; n=78) of the nearby plasma membrane.”

      Reviewer #2 (Public Review):

      This is an interesting method that addresses the important problem of assessing G protein localization at endogenous levels. The data are generally convincing.

      Specific comments

      Methods:

      The description of the gene editing method is unclear. There are two different CRISPR cell lines made in two different cell backgrounds. The methods should clearly state which CRISPR guides were used on which cell line. It is also not clear why HiBit is included in the mNG-β1 construct. Presumably, this is not critical but it would be helpful to explicitly note. In general, the Methods could be more complete.

      We have added the following to the methods to clarify that the same gRNA was used to produce both cell lines:

      “The human GNB1 gene was targeted at a site corresponding to the N-terminus of the Gb1 protein; the sequence 5’-TGAGTGAGCTTGACCAGTTA-3’ was incorporated into the crRNA, and the same gRNA was used to produce both HiBit-b1 and mNG-b1 cell lines.”

      We have added the following to the methods to clarify why HiBit is included in the mNG-b1 construct:

      “HiBit was included in the repair template for producing mNG-b1 cells to enable screening for edited clones using luminescence.”

      Results:

      The explanation of validation experiments in Figures 1 C and D is incomplete and difficult to follow. The rationale and explanation of the experiments could be expanded. In addition, because this is an interesting method, it would be helpful to know if the endogenous editing affects normal GPCR signaling. For example, the authors could include data showing an Isoinduced cAMP response. This is not critical to the present interpretation but is relevant as a general point regarding the method. Also, it may be relevant to the interpretation of receptor effects on G protein localization.

      We have expanded the rationale and explanation of experiments in Figures 1C and D by adding:

      “For example, we observed agonist-induced BRET between the D2 dopamine receptor and mNG-b1, an interaction that requires association with endogenous Ga subunits (Figure 1C). Similarly, we observed BRET between HiBit-b1 and the free Gbg sensor memGRKct-Venus after activation of receptors that couple Gi/o, Gs, and Gq heterotrimers, indicating that HiBit-b1 associated with endogenous Ga subunits from these three families (Figure 1D).”

      We have done the suggested cAMP experiment and provide the data in a new figure supplement:

      “We also found that cyclic AMP accumulation in response to stimulation of endogenous b adrenergic receptors was similar in edited cell lines and their unedited parent lines (Figure 1 - figure supplement 1).”

      Discussion:

      The conclusion that beta-gamma subunits do not redistribute after GPCR activation seems new and different from previous reports. Is this correct? Can the authors elaborate on how the results compare to previous literature?

      Many previous studies have indeed shown that free Gbg dimers can redistribute after GPCR activation and sample intracellular membranes. Our initial focus was on possible changes in heterotrimer distribution after GPCR activation, but in retrospect we should have directly addressed free Gbg translocation and made the distinction clear. 

      In the revised manuscript we show that during stimulation we observe changes consistent with modest translocation of endogenous Gbg from the plasma membrane and sampling of intracellular compartments. To our knowledge this is the first demonstration of endogenous Gbg translocation.

      We have added:

      “With overexpressed G proteins free Gbg dimers translocate from the plasma membrane and sample intracellular membrane compartments after activation-induced dissociation from Ga subunits. Consistent with this, we observed small decreases in bystander BRET at the plasma membrane and small increases in bystander BRET at intracellular compartments during activation of GPCRs, suggesting that endogenous Gbg subunits undergo similar translocation (Figure 5- figure supplement 1). Notably, these changes occurred at room temperature, suggesting that endocytosis was not involved, and developed over the course of minutes. The latter observation and the small magnitude of agonist-induced changes are both consistent with expression of primarily slowly-translocating endogenous Gg subtypes in HEK 293 cells. Moreover, as shown previously for overexpressed Gbg, the changes we observed with endogenous Gbg were readily reversible (Figure 5- figure supplement 1), suggesting that most heterotrimers reassemble at the plasma membrane after activation ceases.”

      Can the authors note that OpenCell has endogenously tagged Gβ1 and reports more obvious internal localization? Can the authors comment on this point?

      OpenCell has tagged GNB1 and the Leonetti group kindly provided a parent cell line we used to add a slightly different tag. Although their study did not identify any specific intracellular compartments, our impression is that most of the internal structures visible in their images are likely to be lysosomes, as they are large, round and often have a clear lumen. Overall their images and ours are comfortingly similar. We have added:

      “Unsurprisingly, our images are quite similar to those made as part of previous study that labeled Gb1 subunits with mNG2 (Cho et al., 2022).”

      Notably, the Leonetti group has recently reported the subcellular distribution of many untagged proteins using a proteomic approach. They find that Gb1 is enriched on the plasma membrane and lysosomes but is not enriched on endosomes, the Golgi apparatus, endoplasmic reticulum or mitochondria (https://www.biorxiv.org/content/10.1101/2023.12.18.572249v1). We have cited this work in the revised manuscript.

      Is this the first use of CRISPR / HiBit for BRET assay? It would be helpful to know this or cite previous work if not. Also, as this is submitted as a tools piece, the authors might say a little more about the potential application to other questions.

      The only previous study we are aware of utilizing a similar combination of methods is a 2020 report from the group of Dr. Stephen Hill, in which the authors studied binding of fluorescent ligands to HiBit-tagged GPCRs. This work is now cited.

      We have also added the following to our previous brief statement about potential applications:

      “In addition, it may also be possible to use these cells in combination with targeted sensors to study endogenous G protein activation in different subcellular compartments. More broadly, our results show that subcellular localization of endogenous membrane proteins can be studied in living cells by adding a HiBit tag and performing bystander BRET mapping. Applied at large scale this approach would have some advantages over fluorescent protein complementation, most notably the ability to localize endogenous membrane proteins that are expressed at levels that are too low to permit fluorescence microscopy.”

      Reviewer #3 (Public Review):

      Summary:

      This article addresses an important and interesting question concerning intracellular localization and dynamics of endogenous G proteins. The fate and trafficking of G protein-coupled receptors (GPCRs) have been extensively studied but so far little is known about the trafficking routes of their partner G proteins that are known to dissociate from their respective receptors upon activation of the signaling pathway. The authors utilize modern cell biology tools including genome editing and bystander bioluminescence resonance energy transfer (BRET) to probe intracellular localization of G proteins in various membrane compartments in steady state and also upon receptor activation. Data presented in this manuscript shows that while G proteins are mostly present on the plasma membrane, they can be also detected in endosomal compartments, especially in late endosomes and lysosomes. This distribution, according to data presented in this study, seems not to be affected by receptor activation. These findings will have implications in further studies addressing GPCR signaling mechanisms from intracellular compartments.

      Strengths:

      The methods used in this study are adequate for the question asked. Especially, the use of genome-edited cells (for the addition of the tag on one of the G proteins) is a great choice to prevent the effects of overexpression. Moreover, the use of bystander BRET allowed authors to probe the intracellular localization of G proteins in a very high-throughput fashion. By combining imaging and BRET authors convincingly show that G proteins are very low abundant on early endosomes (also ER, mitochondria, and medial Golgi), however seem to accumulate on membranes of late endosomal compartments.

      Weaknesses:

      While the authors provide a novel dataset, many questions regarding G protein trafficking remain open. For example, it is not entirely clear which pathway is utilized to traffic G proteins from the plasma membrane to intracellular compartments. Additionally, future studies should also address the dynamics of G protein trafficking, for example by tracking them over multiple time points.

      We agree, there is much more to do.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      On page 7 the text says "the difference did reach significance (Figure 5D)". It looks like the difference did not reach significance. Please check on this.

      Thank you, this was an unfortunately significant typo.

      Reviewer #3 (Recommendations For The Authors):

      This article addresses an important and interesting question concerning intracellular localization and dynamics of endogenous G proteins. While the posed question is indeed a grand one and the methods used by the authors are novel, I believe that the data presented in this manuscript are still insufficient to support all claims posed by the authors. Below I list my major concerns:

      (1) The authors claim that they provide a "detailed subcellular map of endogenous G protein distribution", however, the map is in my opinion not sufficiently detailed (e.g. trans-Golgi network is not included) and not quantitative enough (e.g. % of proteins present on one compartment vs. the other as authors claim that BRET signals "cannot be directly compared between different compartments"). To strengthen this statement, except for providing more extensive and quantitative data, it would be beneficial to provide such a "map" as an illustration based on the findings presented in this article.

      “Detailed” is certainly a subjective term. While we maintain that our description of endogenous G protein distribution is far more detailed than any previous study, we now simply claim to provide a “subcellular map”. We have added images of TGNP (TGN46; TGOLN2), showing that endogenous G proteins are readily detectable on the structures labeled by this marker. These data are now provided in Figure 3 – figure supplement 7.

      We did not claim that our study was quantitative- we did not try to count G proteins. However, if we use published estimates of total G proteins and surface area for HEK 293 cells we estimate that there are roughly 2,500 G proteins µm-2 on the plasma membrane and 500 G proteins µm-2 on endocytic vesicles. For other intracellular compartments relative density can be approximated by inspecting images, but a truly quantitative estimate would require a surface area standard analogous to FM4-64 for each compartment. The percentage of the total G protein pool on a given compartment is, in our opinion, less important than the density of G proteins on that compartment, as the latter is more likely to affect the efficiency of local signal transduction. Since we do not claim to have accurate G protein density estimates for many intracellular compartments, we prefer to provide several raw images for each compartment rather than a schematized map.

      Bystander BRET values cannot be compared directly across compartments due to differences in expression and energy transfer efficiency of different markers and compartment surface area. This method is well suited for following changes in distribution as a function of time or after perturbations and for sensitive detection of weak colocalization but can only provide approximate “maps” of absolute distribution.

      (2) Probing of the intracellular distribution of these proteins, especially after GPCR activation, includes a single chosen timepoint. I believe that the manuscript would greatly benefit from including some dynamic data on internalization and intracellular trafficking kinetics. What is the turnover of tested G proteins? What is the fraction that is going to recycling compartments and/or lysosomes? Authors could perhaps turn to other methods to be able to dynamically track proteins over time e.g. via photoconversion techniques.

      Because G protein trafficking appears to be largely constitutive there is no easy way for us to assess how long it takes G proteins to transit various intracellular compartments, although we agree this would be interesting. As the reviewer suggests, dynamic data on constitutive trafficking would require methods (such as photoconversion) not currently available to us for endogenous G proteins. Accordingly, we have made no claims regarding the kinetics of G protein trafficking. As for possible redistribution after GPCR activation, in the revised manuscript we have added 5- and 15-minute timepoints after agonist stimulation for our bystander BRET mapping (Figure 5- figure supplement 2). These timepoints were chosen to correspond to persistent signaling mediated by internalized receptors. 

      (3) Exemplary images with cells showing significant colocalization with lysosomal compartments seem to contain more intracellular vesicles visible in the mNG channel than in the case of the other compartment. Is it an effect of the treatment to stain lysosomes? It would be beneficial to compare it with some endogenous marker e.g. LAMP1 without additional treatments.

      The visibility of intracellular vesicles in our lysosome images likely reflects our selection of cells and regions with visible and abundant lysosomes, specifically peripheral regions directly adhered to the coverslip, rather than treatment with lysosomal stains (LV 633 and dextran). As suggested, we now include images of cells expressing LAMP1 as an alternative lysosome marker (Figure 3 - figure supplement 6).

      (4) The authors probe an abundance of G proteins along the constitutive endocytic pathway. However, to prove that G proteins are not de-palmitoylated rather than endocytosed authors should perform control experiments where endocytosis is blocked e.g. pharmacologically or via a knockdown approach. Additionally, various endocytic pathways can be probed.

      We did not claim that depalmitoylation plays no role in delivery of G proteins to internal compartments. In fact, we pointed out that we cannot at present rule out other pathways and delivery mechanisms. Importantly, if some of the G proteins that we detect along the endocytic pathway do arrive there by trafficking through the cytosol this would only strengthen our major conclusion that endocytosis is inefficient.

      Having said this, we have now conducted extensive experiments investigating the role of palmitate cycling in the trafficking of heterotrimeric G proteins and the small G protein H-Ras. Our results suggest that a depalmitoylation-repalmitoylation cycle is not important for the distribution of heterotrimers, but these findings will be the subject of a separate publication focused on this specific question for both large and small G proteins.

      We agree that it will be interesting to probe different endocytic pathways, as suggested using a genetic approach. Our main interest here was in endocytic membranes that were defined functionally (with FM4-64 or internalized receptors) rather than biochemically.

      Minor comments:

      (5) "Imaging" paragraph in the Methods section refers to a non-existent figure called "SI Appendix S9".

      Thank you.

      (6) It is not clear what was used as a "control" in Figure 5E.

      “Control” refers to DPBS vehicle alone. This information is now added to the legend for Figure 5E.

    1. Introduction

      This webpage has multiple images without descriptive alt tags. This creates an accessibility barrier for individuals with visual impairments. Often times, people who are blind rely on assistive technologies such as text-to-speech software to access web content. Without descriptive alt tags, tools cannot provide meaningful context for the images, preventing users from having the full online experience.

      For example, even as someone without visual impairments, I find it challenging to understand the image below without any context. If I find it frustrating, it must be even more difficult for those with physical disabilities. Therefore, it is essential to ensure that every image has a descriptive alt tag of 125 characters or less. This description should be concise yet detailed enough to effectively convey the image’s content.

      ** I was unable to highlight the image, so this was the closest item I could highlight.**

    1. Reviewer #1 (Public Review):

      The study identifies the epigenetic reader SntB as a crucial transcriptional regulator of growth, development, and secondary metabolite synthesis in Aspergillus flavus, although the precise molecular mechanisms remain elusive. Using homologous recombination, researchers constructed sntB gene deletion (ΔsntB), complementary (Com-sntB), and HA tag-fused sntB (sntB-HA) strains. Results indicated that deletion of the sntB gene impaired mycelial growth, conidial production, sclerotia formation, aflatoxin synthesis, and host colonization compared to the wild type (WT). The defects in the ΔsntB strain were reversible in the Com-sntB strain.

      Further experiments involving ChIP-seq and RNA-seq analyses of sntB-HA and WT, as well as ΔsntB and WT strains, highlighted SntB's significant role in the oxidative stress response. Analysis of the catalase-encoding catC gene, which was upregulated in the ΔsntB strain, and a secretory lipase gene, which was downregulated, underpinned the functional disruptions observed. Under oxidative stress induced by menadione sodium bisulfite (MSB), the deletion of sntB reduced catC expression significantly. Additionally, deleting the catC gene curtailed mycelial growth, conidial production, and sclerotia formation, but elevated reactive oxygen species (ROS) levels and aflatoxin production. The ΔcatC strain also showed reduced susceptibility to MSB and decreased aflatoxin production compared to the WT.

      This study outlines a pathway by which SntB regulates fungal morphogenesis, mycotoxin synthesis, and virulence through a sequence of H3K36me3 modification to peroxisomes and lipid hydrolysis, impacting fungal virulence and mycotoxin biosynthesis.

      The authors have achieved the majority of their aims at the beginning of the study, finding target genes, which led to catC mediated regulation of development, growth and aflatoxin metabolism. Overall most parts of the study are solid and clear.

      Comments on revision:

      The authors have thoroughly addressed all the concerns I raised. The current manuscript is robust and effectively presents evidence supporting its claims. The overall quality of the manuscript has significantly improved.

    1. Reviewer #3 (Public review):

      Summary:

      This paper identifies GTSE1 as a potential substrate of cyclin D1-CDK4/6 and shows that GTSE1 correlates with cancer prognosis, probably through an effect on cell proliferation. The main problem is that the phosphorylation analysis relies on the over-expression of cyclin D1. It is unclear if the endogenous cyclin D1 is responsible for any phosphorylation of GTSE1 in vivo, and what, if anything, this moderate amount of GTSE1 phosphorylation does to drive proliferation.

      Strengths:

      There are few bonafide cyclin D1-Cdk4/6 substrates identified to be important in vivo so GTSE1 represents a potentially important finding for the field. Currently, the only cyclin D1 substrates involved in proliferation are the Rb family proteins.

      Weaknesses:

      The main weakness is that it is unclear if the endogenous cyclin D1 is responsible for phosphorylating GTSE1 in the G1 phase. For example, in Figure 2G there doesn't seem to be a higher band in the phos-tag gel in the early time points for the parental cells. This experiment could be redone with the addition of palbociclib to the parental to see if there is a reduction in GTSE1 phosphorylation and an increase in the amount in the G1 phase as predicted by the authors' model.

      The experiments involving palbociclib do not disentangle cell cycle effects. Adding Cdk4 inhibitors will progressively arrest more and more cells in the G1 phase and so there will be a reduction not just in Cdk4 activity but also in Cdk2 and Cdk1 activity. More experiments, like the serum starvation/release in Figure 2G, with synchronized populations of cells would be needed to disentangle the cell cycle effects of palbociclib treatment.

      It is unclear if GTSE1 drives the G1/S transition. Presumably, this is part of the authors' model and should be tested.

      The proliferation assays need to be more quantitative. Figure 4B should be plotted on a log scale so that the slope can be used to infer the proliferation rate of an exponentially increasing population of cells. Figure 4c should be done with more replicates and error analysis since the effects shown in the lower right-hand panel are modest.

    2. Author response:

      Reviewer #1:

      Summary:

      García-Vázquez et al. identify GTSE1 as a novel target of the cyclin D1-CDK4/6 kinases. The authors show that GTSE1 is phosphorylated at four distinct serine residues and that this phosphorylation stabilizes GTSE1 protein levels to promote proliferation.

      Strengths:

      The authors support their Kindings with several previously published results, including databases. In addition, the authors perform a wide range of experiments to support their Kindings.

      Weaknesses:

      I feel that important controls and considerations in the context of the cell cycle are missing. Cyclin D1 overexpression, Palbociclib treatment and apparently also AMBRA1 depletion can lead to major changes in cell cycle distribution, which could strongly inKluence many of the observed effects on the cell cycle protein GTSE1. It is therefore important that the authors assess such changes and normalize their results accordingly.

      We have approached the question of GTSE1 phosphorylation to account for potential cell cycle effects from multiple angles:  

      (i) We conducted in vitro experiments with puriIied, recombinant proteins and shown that GTSE1 is phosphorylated by cyclin D1-CDK4 in a cell-free system (Figure 2A-C). This experiment provides direct evidence of GTSE1 phosphorylation by cyclin D1-CDK4 without the inIluence of any other cell cycle effectors.  

      (ii) We present data using synchronized AMBRA1 KO cells (Figure 2G and Supplementary Figure 3B).  As shown previously (Simoneschi et al., Nature 2021, PMC8875297), AMBRA1 KO cells progress faster in the cell cycle but they are still synchronized as shown, for example by the mitotic phosphorylation of Histone H3. Under these conditions we observed that while phosphorylation of GTSE1 in parental cells peaks at the G2/M transition, AMBRA1 KO cells exhibited sustained phosphorylation of GTSE1 across all cell cycle phases.  This is evident when using Phos-tag gels as in the current top panel of Figure 2G. We now re-run one the biological triplicates of the synchronized cells using higher concentration of Zn+2-Phos-tag reagent and lower voltage to allow better separation.  Under these conditions, GTSE1 phosphorylation is more apparent. In the new version of the paper, we will either show both blots or substitute the old panel with the new one. This experiment provides evidence that high levels of cyclin D1 in AMBRA1 KO cells affect GTSE1 independently of the speciIic points in the cell cycle.  

      (iii) The relative short half-life of GTSE1 (<4 hours) makes its levels sensitive to acute treatments such as Palbococlib or AMBRA1 depletion. The effects of these treatments on GTSE1 levels are measurable within a time frame too short to affect cell cycle progression in a meaningful way. For example, we used cells with fusion of endogenous AMBRA1 to a mini-Auxin Inducible Degron (mAID) at the N-terminus. This system allows for rapid and inducible degradation of AMBRA1 upon addition of auxin, thereby minimizing compensatory cellular rewiring. Again, we observed an increase in GTSE1 levels upon acute ablation of AMBRA1 (i.e., in 8 hours) (Figure 3B), when no signiIicant effects on cell cycle distribution are observed (please see Simoneschi et al., Nature 2021, PMC8875297 and Rona et al., Mol. Cell 2024, PMC10997477). 

      All together, these lines of evidence support our conclusion that GTSE1 is a target of cyclin D1-CDK4, independent of cell cycle effects. In conclusion, as stated in the Discussion section, GTSE1 has been established as a substrate of mitotic cyclins, but we observed that overexpression of cyclin D1-CDK4 induce GTSE1 phosphorylation at any point of the cell cycle. Thus, we propose that GTSE1 is phosphorylated by CDK4 and CDK6 particularly in pathological states, such as cancers displaying overexpression of D-type cyclins beyond the G1 phase. In turn, GTSE1 phosphorylation induces its stabilization, leading to increased levels that, as expected based on the existing literature, contribute to enhanced cell proliferation. So, the cyclin D1-CDK4/6 kinase-dependent phosphorylation of GTSE1 induces its stabilization independently of the cell cycle.  

      Reviewer #2:

      Summary:

      The manuscript by García-Vázquez et al identifies the G2 and S phases expressed protein

      1(GTSE1) as a substrate of the CycD-CDK4/6 complex. CycD-CDK4/6 is a key regulator of the G1/S cell cycle restriction point, which commits cells to enter a new cell cycle. This kinase is also an important therapeutic cancer target by approved drugs including Palbocyclib. Identification of substrates of CycD-CDK4/6 can therefore provide insights into cell cycle regulation and the mechanism of action of cancer therapeutics. A previous study identified GTSE1 as a target of CycB-Cdk1 but this appears to be the first study to address the phosphorylation of the protein by Cdk4/6.

      The authors identified GTSE1 by mining an existing proteomic dataset that is elevated in AMBRA1 knockout cells. The AMBRA1 complex normally targets D cyclins for degradation. From this list, they then identified proteins that contain a CDK4/6 consensus phosphorylation site and were responsive to treatment with Palbocyclib. 

      The authors show CycD-CDK4/6 overexpression induces a shift in GTSE1 on phostag gels that can be reversed by Palbocyclib. In vitro kinase assays also showed phosphorylation by CDK4. The phosphorylation sites were then identified by mutagenizing the predicted sites and phostag got to see which eliminated the shift. 

      The authors go on to show that phosphorylation of GTSE1 affects the steady state level of the protein. Moreover, they show that expression and phosphorylation of GTSE1 confer a growth advantage on tumor cells and correlate with poor prognosis in patients.

      Strengths:

      The biochemical and mutagenesis evidence presented convincingly show that the GTSE1 protein is indeed a target of the CycD-CDK4 kinase. The follow-up experiments begin to show that the phosphorylation state of the protein affects function and has an impact on patient outcomes. 

      Weaknesses:

      It is not clear at which stage in the cell cycle GTSE1 is being phosphorylated and how this is affecting the cell cycle. Considering that the protein is also phosphorylated during mitosis by CycB-Cdk1, it is unclear which phosphorylation events may be regulating the protein.

      In cells that do not overexpress cyclin D1, GTSE1 is phosphorylated at the G2/M transition, consistent with the known cyclin B1-CDK1-mediated phosphorylation of this protein. However, AMBRA1 KO cells exhibited high levels of cyclin D1 throughout the cell cycle and sustained phosphorylation of GTSE1 across all cell cycle points (Figure 2G and Supplementary Figure 3B). Please see also answer to Reviewer #1.  Moreover, we show that, compared to the amino acids phosphorylated by cyclin D1-CDK4, cyclin B1-CDK1 phosphorylates GTSE1 on either additional residues or different sites (Figure 2H). Finally, we show that expression of a phospho-mimicking GTSE1 mutant leads to accelerated growth and an increase in the cell proliferative index (Figure 4C).  However, we have not evaluated how phosphorylation affects the cell cycle distribution.  We will perform FACS analyses and include them in the new version. 

      Reviewer #3:

      Summary:

      This paper identifies GTSE1 as a potential substrate of cyclin D1-CDK4/6 and shows that GTSE1 correlates with cancer prognosis, probably through an effect on cell proliferation. The main problem is that the phosphorylation analysis relies on the over-expression of cyclin D1. It is unclear if the endogenous cyclin D1 is responsible for any phosphorylation of GTSE1 in vivo, and what, if anything, this moderate amount of GTSE1 phosphorylation does to drive proliferation.

      Strengths: 

      There are few bonafide cyclin D1-Cdk4/6 substrates identified to be important in vivo so GTSE1 represents a potentially important finding for the field. Currently, the only cyclin D1 substrates involved in proliferation are the Rb family proteins.

      Weaknesses:

      The main weakness is that it is unclear if the endogenous cyclin D1 is responsible for phosphorylating GTSE1 in the G1 phase. For example, in Figure 2G there doesn't seem to be a higher band in the phos-tag gel in the early time points for the parental cells. This experiment could be redone with the addition of palbociclib to the parental to see if there is a reduction in GTSE1 phosphorylation and an increase in the amount in the G1 phase as predicted by the authors' model. The experiments involving palbociclib do not disentangle cell cycle effects. Adding Cdk4 inhibitors will progressively arrest more and more cells in the G1 phase and so there will be a reduction not just in Cdk4 activity but also in Cdk2 and Cdk1 activity. More experiments, like the serum starvation/release in Figure 2G, with synchronized populations of cells would be needed to disentangle the cell cycle effects of palbociclib treatment.    

      In normal cells, GTSE1 is phosphorylated at the G2/M transition in a cyclin B1-CDK1dependent manner.  During G1, when the levels of cyclin D1 peak, GTSE1 is not phosphorylated. This could be due to a higher affinity between GTSE1 and mitotic cyclins as compared to G1 cyclins or to a higher concentration of mitotic cyclins compared to G1 cyclins.  We show that higher levels of cyclin D1 induce GTSE1 phosphorylation during interphase, but we do not rely only on the overexpression of exogenous cyclin D1. In fact, we observe similar effect when we deplete endogenous AMBRA1, resulting in the stabilization of endogenous cyclin D1.  As mentioned in the Discussion section, we propose that GTSE1 is phosphorylated by CDK4 and CDK6 particularly in pathological states, such as cancers displaying overexpression of D-type cyclins (i.e., the overexpression appears to overcome the lower afIinity of the cyclin D1-GTSE1 complex). In sum, our study suggests that overexpression of cyclin D1, which is often observed in cancers cells beyond the G1 phase, induces phosphorylation of GTSE1 at all points in the cell cycle displaying high levels of cyclin D1.  Please see also response to Reviewer #1.  Concerning the experiments involving palbociclib, we limited confounding effects on the cell cycle by treating cells with palbociclib for only 4-6 hours. Under these conditions, there is simply not enough time for the cells to arrest in G1.

      It is unclear if GTSE1 drives the G1/S transition. Presumably, this is part of the authors' model and should be tested.

      We are not claiming that GTSE1 drives the G1/S transition.  GTSE1 is known to promote cell proliferation, but how it performs this task is not well understood.  Our experiments indicate that, when overexpressed, cyclin D1 promotes GTSE1 phosphorylation and its consequent stabilization.  In agreement with the literature, we show that higher levels of GTSE1 promote cell proliferation.  To measure cell cycle distribution upon expressing various forms of GTSE1, we will now perform FACS analyses and include them in the new version. 

      The proliferation assays need to be more quantitative. Figure 4B should be plotted on a log scale so that the slope can be used to infer the proliferation rate of an exponentially increasing population of cells. Figure 4c should be done with more replicates and error analysis since the effects shown in the lower right-hand panel are modest.

      In Figure 4B, we plotted data in a linear scale as done in the past (Donato et al. Nature Cell Biol. 2017, PMC5376241) to better represent the changes in total cell number overtime.  The experiments in Figure 4C were performed in triplicate. Error analysis was not included for simplicity, given the complexity of the data. We will include the other two sets of experiments in the revised version.  While the effects shown in the lower right-hand panel of Figure 4C are modest, they demonstrate the same trend as those observed in the AMBRA KO cells (Figure 4C and Simoneschi et al., Nature 2021, PMC8875297). It's important to note that this effect is achieved through the stable expression of a single phosphomimicking protein, whereas AMBRA KO cells exhibit changes in numerous cell cycle regulators.

      We appreciate the constructive comments and suggestions made by the reviewers, and we believe that the resulting additions and changes will improve the clarity and message of our study.

    1. The point of GPL licenses is to protect the user of the software, not the developer. If you want "protection" as a developer, use MIT (disclaimer of warranty). GPL "infects" other parts of a system to combat a work-around which was used to violate the software freedom of the user, by firewalling sections of GPL'ed code from the rest of the system. If you don't care about your users' software freedom in the first place, then (L)GPL is the wrong choice.
      • goal: protect user rights/freedoms
      • non-goal: protect developer rights/freedoms
    1. Ma‐Nee Chacaby is a respected Two‐Spirit Elder from northwestern Ontario. Photo: Ruth Kivilahti

      <ALT> tag is available to describe the image on the screen which makes it accessible to people with visual impairments

    1. The judges also ruled on reparations claims, awarding between 200 million to one billion Guinean francs (approximately US$23,000 to $115,000) for the different groups of victims, including those who have suffered physical and psychological trauma.

      what pitfalls come with putting a price tag on trauma / harm? when is the debt paid?

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      We thank both reviewers for their detailed and critical assessment of our work. Below we provide a step-by-step response to your concerns.

      Reviewer #1

      Evidence, reproducibility and clarity

      The manuscript presents data demonstrating the function of BRI1 in removing the H3K27me3 epigenetic marks in genes involved in seed coat development in Arabidopsis. The results support that BRI1 may function here independently of brassinosteroid. The work combines genetics with a large panel of mutant lines, phenotyping by quantitative microscopy and chemical treatment, H3K27me3 profiling by CUT&TAG, and data mining for published gene profiling. The introduction is adequately informative, complete and explaining the state-of-the-art to the readers. The result part may be a bit lengthy (especially the first part) and some parts may be a bit repetitive.

      Thank you for your positive assessment of our work and for the constructive criticism. Below we respond to each of your points.

      Major

      1. Seed size is dependent of multiple factors. And few are explained here, notably the number of seeds per silique, the number of ovule per silique, the position of the silique of the branch (related to the age of the meristem), the total number of produced siliques (fertilised flowers) by the inflorescence meristem and the plant. And maybe if produced by the main and lateral branches. Were the authors consistent in the evaluation of analyzed siliques coming from the same type of branches, same age of the meristem, etc? Especially as some of the analysed mutants are dwarf, which is a sign of different plant fitness compared to WT.

      This is a valid point. We did aim to analyze seeds coming from the main inflorescences of the plants and at similar stages of shoot development. This was harder to achieve in some genotypes, as indeed some BR and JMJ mutants have different plant architectures. However, we did repeat those experiments multiple times and always found consistent differences between the WTs and the mutants. See also our response to your next point and to the first point raised by Reviewer 2, as well as our new Fig. S6.

      1. The seed perimeter measurements in BR mutant seeds (Figure S6) are variable. Are you sue the ovule size does not have any influence? What about presenting the relative size as earlier in the text?

      Yes, this is particularly true for the Col-0 vs dwf5 comparison. The reason for this is that a different growth chamber was used for this experiment (greenhouse vs a climate chamber). We have observed that absolute seed growth phenotypes can change depending on the environmental conditions, which is something we are currently studying. However, importantly, we do not see changes in relative growth of the mutants when compared to the WT, independently of the growth conditions. That is, BR mutants produce consistently smaller seeds than the WT, independently of the conditions in which the plants are grown. To illustrate this point, we now add a new Figure, Fig. S6, where we show four independent biological replicates of assays comparing seed size between WT and det2 or bri1. These replicates were done in different growth chambers.

      Indeed, presenting the data as relative size would solve this issue, but we worried that we would be hiding the "real" values by doing so. However, if the Reviewer and Editor deem it necessary, we could replot the data as relative to WT.

      1. The number of evaluated samples is often {plus minus} n = 30, sometimes less, meaning less than what a silique contains of seeds. Did the authors evaluate the variability and reproductibility of their measurements, e.g, how many siliques per plant, how many plants, how many biological repeats? For example, in Figure S6, the number of measured ovules were as low as 16, which could be the reason why no significant difference in size were observed (low statitical strength). The variation in the Col WT is already visible. Is this variation significant?

      On average we pooled seeds from 6-10 siliques coming from 2-3 different plants of the same genotype. We then took microscopic photos of 60 to 100 random seeds in those pools. Out of those, 30 random photos were used for the measurements. You are right this is an important point. We now added this information to the Methods section.

      Moreover, we did calculate whether the sample size we were using provided enough statistical power. For the differences that we see, of around 50 um in perimeter, 26 samples would have been enough to achieve 80% statistical power, which most studies use as standard. In most of our experiments we used closer to 30 samples, which gives us 95% power.

      Indeed, the left-most panel on Fig S6B is the exception. With that plot we mostly wanted to test if ovules produced by BR mutants were smaller than those of WT plants. That does not seem to be the case, even if the sample size is small. However, if deemed necessary, we can repeat those measurements with a higher sample number.

      1. You indicate (line 149) that REF6 is not expressed in the gametophyte but GFP signal is observed in the cytoplasm for the central cell in Fig 1. The same goes for the expression pattern with the GUS line in Figure S2. (Line 290) One can not exclude expression in the endosperm or embryo with the presented pictures, or in the seed coat in older seeds.

      We interpreted those diffuse signals in the cytoplasm of the gametophyte as background noise, as REF6 should be nuclearly localized. But we could be wrong. We therefore made changes to the text in lines 150-152 to reflect this.

      And you are right that REF6 is expressed in the endosperm and embryo in later stages of development. We mention this in lines 157-159.

      1. Make sure that you do not overstate your result conclusions, or add a reference to some of the statements. For example, line 185, for the choice of 3 DAP time point and the fact that seed coat development is based on cell expansion and interaction with the endosperm. Another example, in line 262, is where it is stated that the jmj mutants are compromised in ovule and pollen development. This was not assessed. You only checked the reduced seed set, not the fitness of the gametophytes. Or in line 337, where you indicate that KLUH is not expressed in all integument layers.

      Thank you for pointing this out. For the claim that seed size at early time points is dictated only by the seed coat and endosperm, and not by the embryo, we added the appropriate reference. For the claim that jmj mutants are compromised in ovule development, this was based on our observations of Fig. S3C. We do see malformed or absent megagametophytes in jmj mutants. For pollen development, you are correct that we did not formally address this. We rephrased the sentence to reflect that. For the statement that KLU is not expressed in all integument cell layers, we added the reference.

      1. Another example of this is in line 289 where you stated "a sporophytic function of JMJs at early stages of seed development, [..] and to a zygotic function at the later stages of seed development". I am not sure on what data do you base this conclusion as in all three categories (endosperm, embryo, seed coat) in Fig 2 and S5, genes are expressed in pre-globular stages. And again in line 475: "seed coat growth genes are expressed independentlyof fertilization". Do you have any evidence, a reference?

      The evidence for a sporophytic JMJ function at early stages of seed development, and zygotic function at later stages, comes from our observations that jmj seed phenotypes are maternal in origin at early stages, but become zygotic later in development. But you are correct that we have to be careful with this interpretation. We now modified that sentence accordingly.

      For the data of Fig 2E and Fig S5, we cannot rule out that some putative REF6 target genes are also expressed even when in the absence of REF6. The expression of those genes is also likely controlled by other factors. The point we wanted to make with those plots is that REF6 may have different target genes in different seed tissues, thus potentially regulating different developmental processes in a tissue-specific manner. We mention this in lines 288-290.

      For your second point, we added the adequate reference.

      1. (around lines 461) I understand that using a 35S promoter is not a good strategy as it would affect many other tissues. Did you consider using a tissue-specific approach as presented in Figure 4?

      We suppose you mean the 35S::ELF6 construct. Yes, this makes sense and we did spend quite some time trying to come up with a good strategy. However, we failed to find a suitable promoter. The issue is that we would need a promoter that is active in all (or most) seed coat layers, but only after fertilization. There are promoters like those of TT genes which are active post-fertilization, but only in one cell layer, and thus likely not useful for our purpose. And there are other promoters, like those of STK or ANT, which are expressed in most integument cell layers, but are also expressed during integument development, and not just after fertilization. So they would have the same issue as the 35S promoter. Unfortunately, so far we have not identified a promoter that would be useful for this kind of experiment, which is why we went with a constitutive promoter, but which is specific to the sporophytic tissues.

      1. You observed that the triple swn clf bri mutant is less dwarf than bri1 mutant and stated in line 483 that it is larger, has more leaves, grow tallerm and flower later and longer. Do you have any qunatitative data? If not, I would state that these observations are qualitative from growing plant aside.

      You are correct that this was based on qualitative assessments, rather than on quantitative data (as it was not the point of the manuscript). We now indicate this in lines 489-490.

      Minor: 1. The title should precise the studies species, here Arabidopsis thaliana. Also the title of one of the part could be rephrased. "in a zygotic manner" sounds strange.

      We modified both title and subtitle, as suggested.

      1. Scale bars are missing in many figures.

      Fixed.

      1. The font size in the graphs is small. The authors may use the empty space of the figures to increase the size of the graphs for clarity. Guidelines could be found here https://tpc.msubmit.net/html/TPC_Detailed_Figure_Guidelines.pdf, as example of good practices.

      You are right. We revised all the figures and increased the font size, especially in the plot labels.

      1. Be consitent in the mutant name, e.g., brz1-D is also presented as brz1-d.

      Fixed.

      1. Figure legend S1: I would not use the word "extremely" while you still have 30% seed set. Extremely would qualifiy for

      We suppose you mean Fig. S3. We corrected the legend.

      1. Figure S8 is missing the WT control for comparison.

      Fixed.

      1. Figure S12, stats are missing

      Fixed.

      1. I would recommend to add a line in the Supplemental tables with the name as this name disappears from the file name during upload. It would help the readers to navigate the data.

      We now made it so the top line is static and is always visible.

      1. Methods: Are all the lines listed used in the study? SR2200 is missing for the method, and please indicate the selection marker for each of the generated lines for open-access of the data if other researchers later use your lines.

      You are right that some references had been left over from a previous document. We now updated the list of lines.

      And indeed, we forgot to mention the use of SR2200. It is now added to the Methods section. We also added the information on the selection markers for the lines we generated.

      1. You have a duplicate for reference Vukašinovíc et al.

      Fixed.

      1. Line 393, remove "s" in embryo and endosperm, in coat (line 674), in size (lines 684, 686

      Fixed.

      1. Line 410, write RPS5A in upper case.

      Fixed throughout the manuscript.

      1. LIne 676, the sentence "...H3K27me3 to be removed from the integuments." I would recomend to be more precise. For example "H3K27mme3 marks to be removed from genes to be expressed in the integuments" or something like that.

      We rephrased this sentence to "We thus hypothesized that BR signaling would be required for JMJ function, allowing for H3K27me3 to be removed from genes necessary for seed coat formation."

      Significance

      The authors provide novel information on the step-wise regulation of seed coat development and its influence on seed size. This is a topic of general interest, beyond the plant model Arabidopsis, especially in the context of reduced seed set caused by (a)biotic stress. The results of this study are valuable to understand seed size regulation in differnet growth context or species. The group previously showed that the auxin phytohormone is necessary after fertilization to initiate seed coat differentiation by inhibiting PRC2. However, as seed coat develops mainly as cell elongation, the epigenetic marks are not diluted by cell division and needs to be actively removed. This study provides insight into this process by identifcation 2 JMJ proteins responsible for removing H3K27me3 marks in the seed coat after fertilization to initiation seed coat development and regulating seed size. BRI1, BES1 and BZR1 are involved in this process, indepently of brassinosteroid, to guide JMJ to their target loci. While the study bring some genetic evidence of this process, molecular insight is still missing. Notably the identification of the target genes and how BRI1 is regulated/activated upon fertilization. Or how auxin and BRI1 co-regulate the process. These questions appear how of scope of this current study.

      Thank you for the assessment. Indeed, the identification of BRI1 downstream genes is out of scope of this work. As you point out earlier in the review, the manuscript is already quite long, and adding such data would make it even more so.

      Reviewer #2

      In this study, Pankaj et al. investigate the role of brassinosteroids and H3K27me3 in seed development, particularly in controlling seed size. They demonstrate that defects in these pathways affect seed size control and suggest that this control occurs in the maternal seed coat. This paper presents novel findings that merit publication and would be of interest to the plant community. However, the data interpretation and presentation could be improved. Additionally, I have a few comments that necessitate further analysis and revision.

      Thank you for the careful and critical assessment of our work. Below we respond to each of the points you raised.

      Major Comments

      1. My main concern is the use of seed size measurement as a proxy for seed coat development. Mature seed size measurements can vary significantly with growth conditions, so it is crucial that the authors present at least three independent experiments (wild type and mutant grown in parallel) in a single box plot to ensure data reliability. Additionally, due to the high number of seeds analyzed, significant changes are often observed, though they are not always reproducible. The authors should standardize their seed measurements, using either seed area or seed perimeter.

      You are right that we do see some variation in seed size between experiments. And, indeed, we suspect this is due to slightly different plant growth conditions, for example when different growth chambers are used. As you suggest, we now show data from four independent biological replicates of seed size comparisons of WT and BR mutants. This is in the new Fig. S6. As you can see, although we do see variations in absolute seed sizes, depending on the growth conditions, there is a consistent difference between WT and mutant seeds across experiments.

      1. It would be beneficial to include data on cell division and cell elongation in the seed coat if the authors aim to extend the seed size phenotype to a seed coat phenotype.

      This is indeed a good point. However, we already showed in a previous publication that seed coat growth is driven by cell elongation and not cell division (https://elifesciences.org/articles/20542). But you are right that this is important to point out. We mention it in lines 66-67.

      1. It is challenging to be fully convinced by the seed coat specificity of the phenotype, as the authors observe variations in total seed set and phenotypic differences in self-crosses and when the mutants are used paternally. Some of the observed phenotypes do not support their hypothesis. In all mutant analyses, the authors should complement their phenotype analysis using seed coat-specific promoters and include heterozygote measurements, as done in some figures.

      We assume you mean the effect of jmj mutations. For BR mutants, we do show data supporting a seed coat effect (Fig. 4). For PRC2 mutants, that has also been previously described (doi.org/10.7554/eLife.20542 and doi.org/10.1073/pnas.1117111108).

      For the JMJ mutants, you are right that we cannot be 100% sure that their effect is purely sporophytic. We now modified the text accordingly to reflect this (see also the response to point 6 of Reviewer 1). We indeed show that REF6 and ELF6 are expressed in the sporophytic tissues of the ovule and that the double mutant has seed coat defects (smaller seed coats and defects in accumulation of proanthocyanidins). And although we can say that those defects are maternal in nature, we can not 100% conclude that they are simply due to the effect of those JMJs in the sporophyte. There may be gametophytic effects that we cannot rule out, even though we do not see either protein expressed in embryo sacs. Thank you for pointing this out.

      Doing a tissue-specific rescue of these phenotypes would be very informative indeed, but also very hard. As we mention in the response to point 7 of Reviewer 1, we do not currently have suitable promoters for this. So we simply cannot run such experiments in a reasonable time frame.

      Overall, we now tried to be more careful in our conclusions and avoid claiming that the effect of JMJs is purely sporophytic. We can make that argument for the BR machinery and for PRC2, but not necessarily for JMJs. You are correct in that assessment.

      1. The authors need to include a fluorescent reporter for ELF6; tissue-specific expression cannot be conclusively determined with the GUS reporter.

      We did obtain an ELF6::GFP line from Caroline Dean's lab (https://www.pnas.org/doi/full/10.1073/pnas.1605733113), but could not see much expression during endosperm or seed coat development. As you can see from that publication, even in embryos and in roots the expression of ELF6:GFP is very blurry. It seems ELF6 is simply expressed at very low levels. We therefore used the GUS reporter, as a more sensitive means to visualize where ELF6 is expressed. You are right that the results are not as precise as that obtained with a fluorescent reporter. However, note that we simply claim that ELF6 is expressed in the integuments and seed coat (line 155). This can be clearly seen in Fig. 1B. The blue product of the β-glucuronidase reaction should be immotile and not travel between tissues (also note that there are no plasmodesmata between endosperm and seed coat). Therefore, we believe that GUS is a suitable reporter to test the seed coat expression of ELF6.

      1. Text editing: In some places, the text is unclear and could benefit from simplification. The authors should replace the term "seed coat formation," as developmentally, integuments are already present before fertilization. The authors are not studying the formation of the seed coat but rather its growth. They should also clarify the term "PRC2 removal." It is unclear whether the authors mean PRC2 lack of expression in the integument, PRC2 eviction from chromatin, or removal of H3K27me3.

      Thank you for noting that. It is very important to us that the text is clear to the reader. If you could indicate where the text is unclear, we are happy to simplify it.

      Regarding the wording, we refer to "seed coat formation" because the seed coat only indeed forms after fertilization. Before fertilization, the sporophytic tissues that cover the megagametophyte are called integuments, and not seed coat. Therefore, we see the seed coat as "forming" from the integuments (i.e., the integuments become seed coat via growth and differentiation).

      With PRC2 removal we indeed mean reduction of expression of PRC2 components. We now make this clear in lines 54-55.

      Minor Comments

      1. L151: Is REF6 expressed in zygotic tissues?

      Reviewer 1 also raised this question. We now added this information to lines 148-150.

      1. Confirm mutant complementation with the different reporter lines.

      All mutant lines that we used have been previously described to be either loss-of-function or hypomorphic mutants. We did not use any mutant line that has not been previously described. We added all references to the corresponding publications in the Methods.

      1. Confirm by qPCR that JMJ13 is indeed not expressed in seeds.

      We tested JMJ13 as a possible factor involved in H3K27me3 removal in the seed coat due to it being described, together with ELF6 and REF6, as one of the three main H3K27 demethylases. But there are, in fact, transcriptomic datasets showing that the expression of JMJ13 is indeed very low or absent in seeds: see RNAseq data in Table S3 in doi.org/10.3389/fpls.2022.998664. Moreover we checked CPMs on published seed scRNAseq datasets (doi.org/10.1038/s41477-021-00922-0) and JMJ13 (AT5G46910) has zero transcript counts in these datasets.

      Because of these two independent instances showing that the expression of JMJ13 is extremely low in seeds (or even totally absent), together with the analysis that we did of the fluorescent reporter line, we believe this is sufficient evidence that this JMJ is specific to the pollen during reproductive development. Note that the reporter that we used is strongly expressed in pollen grains, as had been previously described (doi.org/10.1038/s41556-020-0515-y).

      Even so, if the Reviewer and the Editor deem it necessary that we check JMJ13 expression by qPCR, we can of course do so.

      1. Fig1a and Fig1b: Align the panels in the figure.

      Done.

      1. L183-189: This section is unclear.

      I am sorry that the section is not clear. If you direct us to the points that need to be cleared, we are happy to make changes.

      1. There may be a PDF artifact, but most figures have unattractive misaligned boxes.

      We went through every figure and made slight modifications to avoid such artifacts. We hope they now appear more clear in the new version.

      1. Change the color in Fig 2a.

      Fixed.

      1. The introduction is heavily self-cited. The authors should try to include a broader range of literature.

      It is not clear to us why the Reviewer sees it like that. We only refer to three of our publications in the Introduction. One review manuscript and two research manuscripts. We cite almost 40 manuscripts in the introduction. Therefore, citing three of our works does not seem out of line to us, especially since those manuscripts laid the foundation for this work.

      1. Fig3F: Typo in "microM."

      Fixed.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      The manuscript presents data demonstrating the function of BRI1 in removing the H3K27me3 epigenetic marks in genes involved in seed coat development in Arabidopsis. The results support that BRI1 may function here independently of brassinosteroid. The work combines genetics with a large panel of mutant lines, phenotyping by quantitative microscopy and chemical treatment, H3K27me3 profiling by CUT&TAG, and data mining for published gene profiling. The introduction is adequately informative, complete and explaining the state-of-the-art to the readers. The result part may be a bit lengthy (especially the first part) and some parts may be a bit repetitive.

      Major comments:

      1. Seed size is dependent of multiple factors. And few are explained here, notably the number of seeds per silique, the number of ovule per silique, the position of the silique of the branch (related to the age of the meristem), the total number of produced siliques (fertilised flowers) by the inflorescence meristem and the plant. And maybe if produced by the main and lateral branches. Were the authors consistent in the evaluation of analyzed siliques coming from the same type of branches, same age of the meristem, etc? Especially as some of the analysed mutants are dwarf, which is a sign of different plant fitness compared to WT.

      2. The seed perimeter measurements in BR mutant seeds (Figure S6) are variable. Are you sue the ovule size does not have any influence? What about presenting the relative size as earlier in the text?

      3. The number of evaluated samples is often {plus minus} n = 30, sometimes less, meaning less than what a silique contains of seeds. Did the authors evaluate the variability and reproductibility of their measurements, e.g, how many siliques per plant, how many plants, how many biological repeats? For example, in Figure S6, the number of measured ovules were as low as 16, which could be the reason why no significant difference in size were observed (low statitical strength). The variation in the Col WT is already visible. Is this variation significant?

      4. You indicate (line 149) that REF6 is not expressed in the gametophyte but GFP signal is observed in the cytoplasm for the central cell in Fig 1. The same goes for the expression pattern with the GUS line in Figure S2. (Line 290) One can not exclude expression in the endosperm or embryo with the presented pictures, or in the seed coat in older seeds.

      5. Make sure that you do not overstate your result conclusions, or add a reference to some of the statements. For example, line 185, for the choice of 3 DAP time point and the fact that seed coat development is based on cell expansion and interaction with the endosperm. Another example, in line 262, is where it is stated that the jmj mutants are compromised in ovule and pollen development. This was not assessed. You only checked the reduced seed set, not the fitness of the gametophytes. Or in line 337, where you indicate that KLUH is not expressed in all integument layers.

      6. Another example of this is in line 289 where you stated "a sporophytic function of JMJs at early stages of seed development, [..] and to a zygotic function at the later stages of seed development". I am not sure on what data do you base this conclusion as in all three categories (endosperm, embryo, seed coat) in Fig 2 and S5, genes are expressed in pre-globular stages. And again in line 475: "seed coat growth genes are expressed independentlyof fertilization". Do you have any evidence, a reference?

      7. (around lines 461) I understand that using a 35S promoter is not a good strategy as it would affect many other tissues. Did you consider using a tissue-specific approach as presented in Figure 4?

      8. You observed that the triple swn clf bri mutant is less dwarf than bri1 mutant and stated in line 483 that it is larger, has more leaves, grow tallerm and flower later and longer. Do you have any qunatitative data? If not, I would state that these observations are qualitative from growing plant aside.

      Minor comments:

      1. The title should precise the studies species, here Arabidopsis thaliana. Also the title of one of the part could be rephrased. "in a zygotic manner" sounds strange.

      2. Scale bars are missing in many figures.

      3. The font size in the graphs is small. The authors may use the empty space of the figures to increase the size of the graphs for clarity. Guidelines could be found here https://tpc.msubmit.net/html/TPC_Detailed_Figure_Guidelines.pdf, as example of good practices.

      4. Be consitent in the mutant name, e.g., brz1-D is also presented as brz1-d.

      5. Figure legend S1: I would not use the word "extremely" while you still have 30% seed set. Extremely would qualifiy for <5%, I guess.

      6. Figure S8 is missing the WT control for comparison.

      7. Figure S12, stats are missing

      8. I would recommend to add a line in the Supplemental tables with the name as this name disappears from the file name during upload. It would help the readers to navigate the data.

      9. Methods: Are all the lines listed used in the study? SR2200 is missing for the method, and please indicate the selection marker for each of the generated lines for open-access of the data if other researchers later use your lines.

      10. You have a duplicate for reference Vukašinovíc et al.

      11. Line 393, remove "s" in embryo and endosperm, in coat (line 674), in size (lines 684, 686

      12. Line 410, write RPS5A in upper case.

      13. LIne 676, the sentence "...H3K27me3 to be removed from the integuments." I would recomend to be more precise. For example "H3K27mme3 marks to be removed from genes to be expressed in the integuments" or something like that.

      Cross-commenting:

      I have been comparing our peer-review reports of the manuscript and found much similarity on our assessment:

      1. The seed size assemment and how this relates to seed coat development

      2. The GUS expression of ELF6 is not sufficient for the provided conclusion of the ELF6 expression

      3. The same would be for REP6

      4. Use of tissue-specific (seed coat specific) promoters to confirm the conclusion.

      Significance

      The authors provide novel information on the step-wise regulation of seed coat development and its influence on seed size. This is a topic of general interest, beyond the plant model Arabidopsis, especially in the context of reduced seed set caused by (a)biotic stress. The results of this study are valuable to understand seed size regulation in differnet growth context or species. The group previously showed that the auxin phytohormone is necessary after fertilization to initiate seed coat differentiation by inhibiting PRC2. However, as seed coat develops mainly as cell elongation, the epigenetic marks are not diluted by cell division and needs to be actively removed. This study provides insight into this process by identifcation 2 JMJ proteins responsible for removing H3K27me3 marks in the seed coat after fertilization to initiation seed coat development and regulating seed size. BRI1, BES1 and BZR1 are involved in this process, indepently of brassinosteroid, to guide JMJ to their target loci. While the study bring some genetic evidence of this process, molecular insight is still missing. Notably the identification of the target genes and how BRI1 is regulated/activated upon fertilization. Or how auxin and BRI1 co-regulate the process. These questions appear how of scope of this current study.

      My filed of expertise: hormones, plant reproduction, Arabidopis, oilseed rape, microscopy, transformation

    1. Author response:

      The following is the authors’ response to the current reviews.

      Public Reviews: 

      Reviewer #1 (Public Review):

      In the article by Dearlove et al., the authors present evidence in strong support of nucleotide ubiquitylation by DTX3L, suggesting it is a promiscuous E3 ligase with capacity to ubiquitylate ADP ribose and nucleotides. The authors include data to identify the likely site of attachment and the requirements for nucleotide modification. 

      While this discovery potentially reveals a whole new mechanism by which nucleotide function can be regulated in cells, there are some weaknesses that should be considered. Is there any evidence of nucleotide ubiquitylation occurring cells? It seems possible, but evidence in support of this would strengthen the manuscript. The NMR data could also be strengthened as the binding interface is not reported or mapped onto the structure/model, this seems of considerable interest given that highly related proteins do have the same activity. 

      The paper is for the most part well well-written and is potentially highly significant 

      Comments on revised version: 

      The revised manuscript has addressed many of the concerns raised and clarified a number of points. As a result the manuscript is improved. 

      The primary concern that remains is the absence of biological function for Ub-ssDNA/RNA and the inability to detect it in cells. Despite this the manuscript will be of interest to those in the ubiquitin field and will likely provoke further studies and the development of tools to better assess the cellular relevance. As a result this manuscript is important. 

      We agree with the reviewer’s assessment.

      Minor issue: 

      Figure 1A - the authors have now included the constructs used but it would be more informative if the authors lined up the various constructs under the relevant domains in the full-length protein. 

      Figure 1 will be fixed in the Version of Record.

      Reviewer #2 (Public Review):

      The manuscript by Dearlove et al. entitled "DTX3L ubiquitin ligase ubiquitinates single-stranded nucleic acids" reports a novel activity of a DELTEX E3 ligase family member, DTX3L, which can conjugate ubiquitin to the 3' hydroxyl of single-stranded oligonucleotides via an ester linkage. The findings that unmodified oligonucleotides can act as substrates for direct ubiquitylation and the identification of DTX3 as the enzyme capable of performing such oligonucleotide modification are novel, intriguing, and impactful because they represent a significant expansion of our view of the ubiquitin biology. The authors perform a detailed and diligent biochemical characterization of this novel activity, and key claims made in the article are well supported by experimental data. However, the studies leave room for some healthy skepticism about the physiological significance of the unique activity of DTX3 and DTX3L described by the authors because DTX3/DTX3L can also robustly attach ubiquitin to the ADP ribose moiety of NAD or ADP-ribosylated substrates. The study could be strengthened by a more direct and quantitative comparison between ubiquitylation of unmodified oligonucleotides by DTX3/DTX3L with the ubiquitylation of ADP-ribose, the activity that DTX3 and DTX3L share with the other members of the DELTEX family.

      Comment on revised version:

      In my opinion, reviewers' comments are constructively addressed by the authors in the revised manuscript, which further strengthens the revised submission and makes it an important contribution to the field. Specifically, the authors perform a direct quantitative comparison of two distinct ubiquitylation substrates, unmodified oligonucleotides and fluorescently labeled NADH and report that kcat/Km is 5-fold higher for unmodified oligos compared to NADH. This observation suggests that ubiquitylation of unmodified oligos is not a minor artifactual side reaction in vitro and that unmodified oligonucleotides may very well turn out to be the physiological substrates of the enzyme. However, the true identity of the physiological substrates and the functionally relevant modification site(s) remain to be established in further studies. 

      We agree with the reviewer’s assessment.


      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      In the article by Dearlove et al., the authors present evidence in strong support of nucleotide ubiquitylation by DTX3L, suggesting it is a promiscuous E3 ligase with capacity to ubiquitylate ADP ribose and nucleotides. The authors include data to identify the likely site of attachment and the requirements for nucleotide modification. 

      While this discovery potentially reveals a whole new mechanism by which nucleotide function can be regulated in cells, there are some weaknesses that should be considered. Is there any evidence of nucleotide ubiquitylation occurring cells? It seems possible, but evidence in support of this would strengthen the manuscript. The NMR data could also be strengthened as the binding interface is not reported or mapped onto the structure/model, this seems of considerable interest given that highly related proteins do have the same activity. 

      The paper is for the most part well well-written and is potentially highly significant, but it could be strengthened as follows: 

      (1) The authors start out by showing DTX3L binding to nucleotides and ubiquitylation of ssRNA/DNA. While ubiquitylation is subsequently dissected and ascribed to the RD domains, the binding data is not followed up. Does the RD protein alone bind to the nucleotides? Further analysis of nucleotide binding is also relevant to the Discussion where the role of the KH domains is considered, but the binding properties of these alone have not been analysed. 

      We thank the reviewer for the suggestion. We have tested DTX3L RD for ssDNA binding using NMR (see Figure 4A and Figure S2), which showed that DTX3L RD binds ssDNA. We have now tested the DTX3L KH domains for RNA/ssDNA binding using an FP experiment. However, the FP experiment did not show significant changes upon titrating RNA/ssDNA, suggesting that the KH domains alone are not sufficient to bind RNA/ssDNA. We have opted to put this data in the response-to-review as future investigation will be required to examine whether other regions of DTX3L cooperate with RD to bind RNA/ssDNA. We have revised the Discussion on the KH domains. We now state that “Our findings show the DTX3L DTC domain binds nucleic acids but whether the KHL domains contribute to nucleic acid binding requires further investigation.”

      Author response image 1.

      Fold change of fluorescence polarisation of 6-FAM-labelled ssDNA D4 upon titrating with DTX3L variants. DTX3L KH domain fragments were expressed with a N-terminal His-MBP tag to increase the molecular weight to enhance the signal.

      (2) With regard to the E3 ligase activity, can the authors account for the apparent decreased ubiquitylation activity of the 232-C protein in Figure 1/S1 compared to FL and RD? 

      We found that the 232-C protein batch used in the assay was not pure and have subsequently re-purified the protein. We have repeated the ubiquitination of ssDNA and RNA (Fig. 1H and 1I) and 232-C exhibited similar activity as WT. Furthermore, we performed autoubiquitination (Fig. S1G) and E2~Ub discharge assay (Fig. S1H) to compare the activity. 232-C was slower in autoubiquitination (Fig. S1G), but showed similar activity in the E2~Ub discharge assay as WT. These findings suggest that the RING domain in 232-C is functional and 232-C likely lacks ubiquitination site(s) present in 1-231 region necessary for autoubiquitination.

      (3) Was it possible to positively identify the link between Ub and ssDNA/RNA using mass spectrometry? This would overcome issues associated with labels blocking binding rather than modification. 

      We have tried to use mass spectrometry to detect the linkage between Ub and ssDNA/RNA, but was unable to do so. We suspect that the oxyester linkage might be labile, posing a challenge for mass spectrometry techniques. Similarly, a recent preprint from Ahel lab, which utilises LC-MS, detects the Ub-NMP product rather than the linkage (https://www.biorxiv.org/content/10.1101/2024.04.19.590267v1.full.pdf).

      (4) Furthermore, can a targeted MS approach be used to show that nucleotides are ubiquitylated in cells? 

      This will require future development and improvement of the MS approach, specifically the isolation of labile oxyester-linked products from cells and the optimisation of the MS detection method.

      (5) Do the authors have the assignments (even partial?) for DTX3L RD? In Figure 4 it would be helpful to identify the peaks that correspond to the residues at the proposed binding site. Also do the shifts map to a defined surface or do they suggest an extended site, particularly for the ssDNA.

      We only collected HSQC spectra which was insufficient for assignments. We have performed a competition experiment using ADPr and labelled ssDNA, showing that ADPr competes against the ubiquitination of ssDNA (Figure 4D). We have also provided an additional experiment showing that ssDNA with a blocked 3’-OH can compete against ubiquitination of ADPr (Figure 4E). These data, together with our NMR analysis, further strengthen the evidence that ssDNA and ADPr compete the same binding pocket in DTX3L RD. Understanding how DTX3L RD binds ssDNA/RNA is an ongoing research in the lab.

      (6) Does sequence analysis help explain the specificity of activity for the family of proteins? 

      We have performed sequence alignment and structure comparison of DTX proteins using both RING and DTC domains (Fig. S3). These analyses showed that DTX3 and DTX3L RING domains lack a N-terminal helix and two loop insertions compared to DTX1, DTX2 and DTX4. These additions make DTX1, DTX2 and DTX4 RING domain larger than DTX3L and DTX3. It is not clear how these would influence the orientation of the recruited E2~Ub. Comparison of the DTC domain showed that DTX1, DTX2 and DTX4 contain an Ala-Arg motif, which causes a bulge at one end of DTC pocket. In the absence of Ala-Arg motif, DTC pockets of DTX3 and DTX3L contain an extended groove which might accommodate one or more of the nucleotides 5' to the targeted terminal nucleotide. It seems that both features of RING and DTC domains might attribute to the specificity of DTX3L and DTX3. We have included these comparisons in the discussion and suggested that future structural characterization is necessary to unveil the specificity.

      (7) While including a summary mechanism (Figure 5I) is helpful, the schematic included does not necessarily make it easier for the reader to appreciate the key findings of the manuscript or to account for the specificity of activity observed. While this figure could be modified, it might also be helpful to highlight the range of substrates that DTX3L can modify - nucleotide, ADPr, ADPr on nucleotides etc. 

      We have modified this Figure to include the range of substrates.

      Reviewer #2 (Public Review): 

      Summary: 

      The manuscript by Dearlove et al. entitled "DTX3L ubiquitin ligase ubiquitinates single-stranded nucleic acids" reports a novel activity of a DELTEX E3 ligase family member, DTX3L, which can conjugate ubiquitin to the 3' hydroxyl of single-stranded oligonucleotides via an ester linkage. The findings that unmodified oligonucleotides can act as substrates for direct ubiquitylation and the identification of DTX3 as the enzyme capable of performing such oligonucleotide modification are novel, intriguing, and impactful because they represent a significant expansion of our view of the ubiquitin biology. The authors perform a detailed and diligent biochemical characterization of this novel activity, and key claims made in the article are well supported by experimental data. However, the studies leave room for some healthy skepticism about the physiological significance of the unique activity of DTX3 and DTX3L described by the authors because DTX3/DTX3L can also robustly attach ubiquitin to the ADP ribose moiety of NAD or ADP-ribosylated substrates. The study could be strengthened by a more direct and quantitative comparison between ubiquitylation of unmodified oligonucleotides by DTX3/DTX3L with the ubiquitylation of ADP-ribose, the activity that DTX3 and DTX3L share with the other members of the DELTEX family. 

      Strengths: 

      The manuscript reports a novel and exciting observation that ubiquitin can be directly attached to the 3' hydroxyl of unmodified, single-stranded oligonucleotides by DTX3L. The study builds on the extensive expertise and the impactful previous studies by the Huang laboratory of the DELTEX family of E3 ubiquitin ligases. The authors perform a detailed and diligent biochemical characterization of this novel activity, and all claims made in the article are well supported by experimental data. The manuscript is clearly written and easy to read, which further elevates the overall quality of submitted work. The findings are impactful and will help illuminate multiple avenues for future follow-up investigations that may help establish how this novel biochemical activity observed in vitro may contribute to the biological function of DTX3L. The authors demonstrate that the activity is unique to the DTX3/DTX3L members of the DELTEX family and show that the enzyme requires at least two single-stranded nucleotides at the 3' end of the oligonucleotide substrate and that the adenine nucleotide is preferred in the 3' position. Most notably, the authors describe a chimeric construct containing RING domain of DTX3L fused to the DTC domain DTX2, which displays robust NAD ubiquitylation, but lacks the ability to ubiquitylate unmodified oligonucleotides. This construct will be invaluable in the future cell-based studies of DTX3L biology that may help establish the physiological relevance of 3' ubiquitylation of nucleic acids. 

      Weaknesses: 

      The main weakness of the study is in the lack of direct evidence that the ubiquitylation of unmodified oligonucleotides reported by the authors plays any role in the biological function of DTX3L. The study leaves plenty of room for natural skepticism regarding the physiological relevance of the reported activity, because, akin to other DELTEX family members, DTX3 and DTX3L can also catalyze attachment of ubiquitin to NAD, ADP ribose and ADP-ribosylated substrates. Unfortunately, the study does not offer any quantitative comparison of the two distinct activities of the enzyme, which leaves plenty of room for doubt. One is left wondering, whether ubiquitylation of unmodified oligonucleotides is just a minor and artifactual side activity owing to the high concentration of the oligonucleotide substrates and E2~Ub conjugates present in the in-vitro conditions and the somewhat lower specificity of the DTX3 and DTX3L DTC domains (compared to DTX2 and other DELTEX family members) for ADP ribose over other adenine-containing substrates such as unmodified oligonucleotides, ADP/ATP/dADP/dATP, etc. The intriguing coincidence that DTX3L, which is the only DTX protein capable of ubiquitylating unmodified oligonucleotides, is also the only family member that contains nucleic acid interacting domains in the N-terminus, is suggestive but not compelling. A recently published DTX3L study by a competing laboratory (PMID: 38000390), which is not cited in the manuscript, suggests that ADP-ribose-modified nucleic acids could be the physiologically relevant substrates of DTX3L. That competing hypothesis appears more convincing than ubiquitylation of unmodified oligonucleotides because experiments in that study demonstrate that ubiquitylation of ADP-ribosylated oligos is quite robust in comparison to ubiquitylation of unmodified oligos, which is undetectable. It is possible that the unmodified oligonucleotides in the competing study did not have adenine in the 3' position, which may explain the apparent discrepancy between the two studies. In summary, a quantitative comparison of ubiquitylation of ADP ribose vs. unmodified oligonucleotides could strengthen the study. 

      We thank the reviewer for the constructive feedback. We agree that evidence for the biological function is lacking. While we have tried to detect Ub-ssDNA/RNA from cells, we found that isolating and detecting labile oxyester-linked Ub-ssDNA/RNA products remain challenging due to (1) low levels of Ub-ssDNA/RNA products, (2) the presence of DUBs and nucleases that rapidly remove the products during the experiments, and (3) our lack of a suitable MS approach to detect the product. For these reasons, we feel that discovering the biological function will require future effort and expertise and is beyond the scope of our current manuscript.

      In the manuscript (PMID: 38000390), the authors used PARP10 to catalyse ADP-ribosylation onto 5’-phosphorylated ssDNA/RNA. They used the following sequences which lacks 3’-adenosine, which could explain the lack of ubiquitination.

      E15_5′P_RNA [Phos]GUGGCGCGGAGACUU

      E15_5′P_DNA [Phos]GTGGCGCGGAGACTT

      We have performed the experiment using this sequence to verify this (see Author response image 2 below). We have cited this manuscript but for some reasons, Pubmed has updated its published date from mid 2023 to Jan 2024. We have updated the Endnote in the revised manuscript.

      Author response image 2.

      Fluorescently detected SDS-PAGE gel of in vitro ubiquitination catalysed by DTX3L-RD in the presence ubiquitination components and 6-FAM-labelled ssDNA D4 or D31.

      We agree that it is crucial to compare ubiquitination of oligonucleotides and ADPr by DTX3L to find its preferred substrate. We have challenged oligonucleotide ubiquitination by adding excess ADPr and found that ADPr efficiently competes with oligonucleotide (Figure 4D). We have also performed an experiment showing that ssDNA with a blocked 3’-OH can compete against ubiquitination of ADPr (Figure 4E). These data support that ADPr and ssDNA compete for the same binding site on DTX3L.

      We also performed kinetic analysis of ubiquitination of fluorescently labelled ssDNA (D4) and NAD+ by DTX3L-RD (Fig. 4F and Fig. S2D–G) to assess substrate preferences. Here, we used fluorescent-labelled NAD+ (F-NAD+) in place of ADPr as labelled NAD+ is commercially available. With the known concentration of fluorescently labelled ssDNA and NAD+ as the standard, we could estimate the rate of ubiquitinated product formation across different substrate concentrations. We have included this finding in the main text “DTX3L-RD displayed _k_cat value of 0.0358 ± 0.0034 min-1 and a _K_m value of 6.56 ± 1.80 mM for Ub-D4 formation, whereas the Michaelis-Menten curve did not reach saturation for Ub-F-NAD+ formation (Fig. 4F and fig. S2, D-G). Comparison of the estimated catalytic efficiency (_k_cat/_K_m = 5457  M-1 min-1 for D4 and estimated _k_cat/_K_m = 1190  M-1 min-1 for F-NAD+; Fig. 4F) suggested that DTX3L-RD exhibited 4.5-fold higher catalytic efficiency for D4 than F-NAD+. This difference primarily results from a better _K_m value for D4 compared to F-NAD+. Although DTX3L-RD showed weak _K_m for F-NAD+, it displays a higher rate for converting F-NAD+ to Ub-F-NAD+ at higher substrate concentration (Fig. 4F). Thus, substrate concentration will play a role in determining the preference.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Writing/technical points: 

      (1) The introduction is relatively complex and the last paragraph, which reviews the discoveries on the paper, is long. It may be helpful to highlight the significance and frame the experiments as what they have addressed, rather than detailing each set of experiments completed. 

      We have modified the last paragraph in the introduction to highlight the major discovery of our work.

      (2) Line 24, Abstract. 'Its N-terminal region' is not obvious 

      We have changed “Its N-terminal region” to “the N-terminal region of DTX3L”.

      (3) Line 44 - split sentence to emphasize E3 ligase point? 

      We have modified the sentence as suggested.

      (4) Figures 1B and 1C could be larger - currently they are not very helpful. Also atoms (ADPr?) are shown, but not indicated in the legend or labelled on the panel. 

      We have enlarged Figures 1B and 1C and indicated RNA on the structure.

      (5) The structure of the D2 domain of DTX3L has recently been reported (Vela-Rodriguez et al). It might be helpful to comment on this manuscript. 

      We have now commented on D2 domain in the results section and in the discussion.

      (6) It would be helpful to indicate the DTX3L constructs used in Figure 1a. 

      We have included all DTX3L constructs used in Figure 1a.

      (7) Interpretation of Figure 4A is difficult, the authors may wish to consider other ways to visualize the data. 

      We have now removed the black arrow in Figure 4A as it was confusing. Instead, we drew a black box on the cross-peak where the close-up views are shown in Figures 4B and 4C.

      (8) Figure 4A. Please indicate which binding partner is highlighted by red/black arrows. 

      We have removed black arrow. The red arrows indicate cross-peaks which undergo chemical shift perturbation when DTX3L-RD was titrated with ssDNA or ADPr, highlighting their binding sites on DTX3L-RD overlap.

      (9) Line 284 - please indicate the bulge in Figure S3. 

      We have indicated the bulge on Figure S3.

      (10) Aspects of the discussion are speculative, given that evidence of Ub conjugated to nucleotides in cells is yet to be obtained and the functional consequences of modification are uncertain. 

      We understand that the discussion on the potential roles of ubiquitination of ssNAs is speculative. We have now modified it to: “Based on the known functions of the DTX3L/PARP9 complex and the findings of this study, we propose several hypotheses for future research”, so that readers will understand that these are speculative.

      (11) Line 295 onwards - this paragraph discusses the role of the KH domains in nucleotide binding, but it is not clear that the authors have directly demonstrated that the KH domains bind nucleotides as all constructs used in the binding experiments in Figure 1/S1 include the RING-DTC domains. 

      We found that KH domains alone did not bind ssDNA or RNA. We have modified line 295. This section now reads “Typically, KH domains contain a GXXG motif within the loop between the first and second α helix (22). However, analysis of the sequence of the KHL domains in DTX3L shows these domains lack this motif. Multiple studies have shown that mutation in this motif abolishes binding to nucleic acids (23-26). Our findings show the DTX3L DTC domain binds nucleic acids but whether the KHL domains contribute to nucleic acid binding requires further investigation. Additionally, the structure of the first KHL domain was recently reported and shown to form a tetrameric assembly (20). Our analysis with DTX3L 232-C, which lacks the first KHL domain and RRM, indicate that it can still bind ssDNA and ssRNA. Despite this, a more detailed analysis will be required to determine whether oligomerization plays a role in nucleic acid binding and ubiquitination.”

    1. Reviewer #1 (Public review):

      This study describes a useful antibody-free method to map G-quadruplexes in vertebrate cells. The analysis of the data is solid but it remains primarily descriptive and does not substantially add to existing publications (such as PMID:34792172 for example). Nevertheless, the datasets generated here might constitute a good starting point for more functional studies.

      Comments on revised version:

      It is disappointing to see that the authors decided to brush aside most of the comments made by the three referees, even though these comments were largely consistent with each other. As a result, the revised manuscript is not substantially changed or improved. Legitimate concerns regarding the specificity of the Cut&Tag signals were not addressed and therefore remain. The sensitivity of the HBD-seq signals to a combination of RNase A and RNase H does not demonstrate that HBD-seq specifically reports the presence of RNA:DNA hybrids. The new Figure 9 comparing HepG4-seq to existing datasets does not unequivocally demonstrate the superiority of the Hemin-based strategy to map G4s.

    2. Reviewer #3 (Public review):

      Summary:

      The authors developed and optimized the methods for detecting G4s and R-loops independent of BG4 and S9.6 antibody, and mapped genomic native G4s and R-loops by HepG4-seq and HBD-seq, revealing that co-localized G4s and R-loops participate in regulating transcription and affecting the self-renewal and differentiation capabilities of mESCs.

      Strengths:

      By utilizing the peroxidase activity of G4-hemin complex and combining proximity labeling technology, the authors developed HepG4-seq (high throughput sequencing of hemin-induced proximal labelled G4s) , which can detect the dynamics of G4s in vivo. Meanwhile, the "GST-His6-2xHBD"-mediated CUT&Tag protocol (Wang et al., 2021) was optimized by replacing fusion protein and tag, the optimized HBD-seq avoids the generation of GST fusion protein aggregates and can reflect the genome-wide distribution of R-loops in vivo.

      The authors employed HepG4-seq and HBD-seq to establish comprehensive maps of native co-localized G4s and R-loops in human HEK293 cells and mouse embryonic stem cells (mESCs). The data indicate that co-localized G4s and R-loops are dynamically altered in a cell type-dependent manner and are largely localized at active promoters and enhancers of transcriptional active genes.

      Combined with Dhx9 ChIP-seq and co-localized G4s and R-loops data in wild-type and dhx9KO mESCs, the authors found that the helicase Dhx9, a major regulator of co-localized G4s and R-loops, affects the self-renewal and differentiation capacities of mESCs.

      In conclusion, the authors provide an approach to study the interplay between G4s and R-loops, shedding light on the important roles of co-localized G4s and R-loops in development and disease by regulating the transcription of related genes.

      Weaknesses:

      As we know, there are at least two structure data of S9.6 antibody very recently, and the questions about the specificity of the S9.6 antibody on RNA:DNA hybrids should be finished. The authors referred (Hartono et al., 2018; Konig et al., 2017; Phillips et al., 2013) need to be updated, and the author's bias against S9.6 antibodies needs also to be changed. In contrast to S9.6 CUT&Tag and other inactive ribonucleotide H1-based methods including MapR (inactive ribonucleotide H1-mediated CUT&Run) (Yan et al., 2019)and GST-2xHBD CUT&Tag (Wang et al., 2021), HBD-seq did not perform satisfactorily and its binding specificity was questionable.

      Although HepG4-seq is an effective G4s detection technique, and the authors have also verified its reliability to some extent, given the strong link between ROS homeostasis and G4s formation, hemin's affinity for different types of G4s and their differences in peroxidase activities, whether HepG4-seq reflects the dynamics of G4s in vivo more accurately than existing detection techniques still needs to be more carefully corroborated.

      The authors focus on the interaction of non-B DNA structures G4s and R-loops and their roles in development and disease by regulating the transcription of related genes. Compared to the complex regulatory network of G4s and R-loops, the authors provide limited mechanistic insight into the major regulator of co-localized G4s and R-loops, helicase Dhx9. However, the authors propose that "A degron system-mediated simultaneous and/or stepwise degradation system of multiple regulators will help us elucidate the interplaying effects between G4s and R-loops." is attractive. The main innovations of this article are the proposal of new antibody-independent methods for detecting G4s and the optimization of the GST-2xHBD CUT&Tag (Wang et al., 2021) method for detecting R-loops. Unfortunately, however, the reliability and accuracy of these methods are still debatable, and the reference value of the G4s and R-loops datasets based on these methods is relatively limited.

    3. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This useful study describes an antibody-free method to map G-quadruplexes (G4s) in vertebrate cells. While the method might have potential, the current analysis is primarily descriptive and does not add substantial new insights beyond existing data (e.g., PMID:34792172). While the datasets provided might constitute a good starting point for future functional studies, additional data and analyses would be needed to fully support the major conclusions and, at the same time, clarify the advantage of this method over other methods. Specifically, the strength of the evidence for DHX9 interfering with the ability of mESCs to differentiate by regulating directly the stability of either G4s or R-loops is still incomplete.

      We thank the editors for their helpful comments.

      Given that antibody-based methods have been reported to leave open the possibility of recognizing partially folded G4s and promoting their folding, we have employed the peroxidase activity of the G4-hemin complex to develop a new method for capturing endogenous G4s that significantly reduces the risk of capturing partially folded G4s. We have included a new Fig. 9 and a new section “Comparisons of HepG4-seq and HBD-seq with previous methods” to carefully compare our methods to other methods.

      In the Fig. 7, we applied the Dhx9 CUT&Tag assay to identify the G4s and R-loops directly bound by Dhx9 and further characterized the differential Dhx9-bound G4s and R-loops in the absence of Dhx9. Dhx9 is a versatile helicase capable of directly resolving R-loops and G4s or promoting R-loop formation (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). Furthermore, we showed that depletion of Dhx9 significantly altered the levels of G4s or R-loops around the TSS or gene bodies of several key regulators of mESC and embryonic development, such as Nanog, Lin28a, Bmp4, Wnt8a, Gata2, and Lef1, and also their RNA levels (Fig.7 I). The above evidence is sufficient to support the transcriptional regulation of mESCs cell fate by directly modulating the G4s or R-loops within the key regulators of mESCs.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Non-B DNA structures such as G4s and R-loops have the potential to impact genome stability, gene transcription, and cell differentiation. This study investigates the distribution of G4s and R-loops in human and mouse cells using some interesting technical modifications of existing Tn5-based approaches. This work confirms that the helicase DHX9 could regulate the formation and/or stability of both structures in mouse embryonic stem cells (mESCs). It also provides evidence that the lack of DHX9 in mESCs interferes with their ability to differentiate.

      Strengths:

      HepG4-seq, the new antibody-free strategy to map G4s based on the ability of Hemin to act as a peroxidase when complexed to G4s, is interesting. This study also provides more evidence that the distribution pattern of G4s and R-loops might vary substantially from one cell type to another.

      We appreciate your valuable points.

      Weaknesses:

      This study is essentially descriptive and does not provide conclusive evidence that lack of DHX9 does interfere with the ability of mESCs to differentiate by regulating directly the stability of either G4 or R-loops. In the end, it does not substantially improve our understanding of DHX9's mode of action.

      In this study, we aimed to report new methods for capturing endogenous G4s and R-loops in living cells. Dhx9 has been reported to directly unwind R-loops and G4s or promote R-loop formation (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). To understand the direct Dhx9-bound G4s and R-loops, we performed the Dhx9 CUT&Tag assay and analyzed the co-localization of Dhx9-binding sites and G4s or R-loops. We found that 47,857 co-localized G4s and R-loops are directly bound by Dhx9 in the wild-type mESCs and 4,060 of them display significantly differential signals in absence of Dhx9, suggesting that redundant regulators exist as well. We showed that depletion of Dhx9 significantly altered the RNA levels of several key regulators of mESC and embryonic development, such as Nanog, Lin28a, Bmp4, Wnt8a, Gata2, and Lef1, which coincides with the significantly differential levels of G4s or R-loops around the TSS or gene bodies of these genes (Fig.7). The comprehensive molecular mechanism of Dhx9 action is indeed not the focus of this study. We will work on it in the future studies. Thank you for the comments.

      There is no in-depth comparison of the newly generated data with existing datasets and no rigorous control was presented to test the specificity of the hemin-G4 interaction (a lot of the hemin-dependent signal seems to occur in the cytoplasm, which is unexpected).

      The specificity of hemin-G4-induced peroxidase activity and self-biotinylation has been well demonstrated in previous studies (PMID: 19618960, 22106035, 28973477, 32329781). In the Fig.1A, we compared the hemin-G4-induced biotinylation levels in different conditions. Cells treated with hemin and Bio-An exhibited a robust fluorescence signal, while the absence of either hemin or Bio-An almost completely abolished the biotinylation signals, suggesting a specific and active biotinylation activity. To identify the specific signals, we have included the non-label control and used this control to call confident HepG4 peaks in all HepG4-seq assays.

      The hemin-RNA G4 complex has also been reported to have mimic peroxidase activity and trigger similar self-biotinylation signals as DNA G4s (PMID: 32329781, 31257395, 27422869). Therefore, it is not surprising to observe hemin-dependent signals in the cytoplasm generated by cytoplasmic RNA G4s.

      In the revised version, we have included a new Fig. 9 and a new section “Comparisons of HepG4-seq and HBD-seq with previous methods” to carefully compare our methods to other methods.

      The authors talk about co-occurrence between G4 and R-loops but their data does not actually demonstrate co-occurrence in time. If the same loci could form alternatively either R-loops or G4 and if DHX9 was somehow involved in determining the balance between G4s and R-loops, the authors would probably obtain the same distribution pattern. To manipulate R-loop levels in vivo and test how this affects HEPG4-seq signals would have been helpful.

      Single-molecule fluorescence studies have shown the existence of a positive feedback mechanism of G4 and R-loop formation during transcription (PMID: 32810236, 32636376), suggesting that G4s and Rloops could co-localize at the same molecule. Dhx9 is a versatile helicase capable of directly resolving R-loops and G4s or promoting R-loop formation (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). Although depletion of Dhx9 resulted in 6,171 Dhx9-bound co-localized G4s and R-loops with significantly altered levels of G4s or R-loops, only 276 of them (~4.5%) harbored altered G4s and R-loops, suggesting that the interacting G4s and R-loops are rare in living cells. Nowadays, the genome-wide co-occurrence of two factors are mainly obtained by bioinformatically intersection analysis. We agreed that F We will carefully discuss this point in the revised version. At the same time, we will make efforts to develop a new method to map the co-localized G4 and R-loop in the same molecule in the future study.

      This study relies exclusively on Tn5-based mapping strategies. This is a problem as global changes in DNA accessibility might strongly skew the results. It is unclear at this stage whether the lack of DHX9, BLM, or WRN has an impact on DNA accessibility, which might underlie the differences that were observed. Moreover, Tn5 cleaves DNA at a nearby accessible site, which might be at an unknown distance away from the site of interest. The spatial accuracy of Tn5-based methods is therefore debatable, which is a problem when trying to demonstrate spatial co-occurrence. Alternative mapping methods would have been helpful.

      In this study, we used the recombinant streptavidin monomer and anti-GP41 nanobody fusion protein (mSA-scFv) to specifically recognize hemin-G4-induced biotinylated G4 and then recruit the recombinant GP41-tagged Tn5 protein to these G4s sites. Similarly, the recombinant V5-tagged N-terminal hybrid-binding domain (HBD) of RNase H1 specifically recognizes R-loops and recruit the recombinant protein G-Tn5 (pG-Tn5) with the help of anti-V5 antibody. Therefore, the spatial distance of Tn5 to the target sites is well controlled and very short, and also the recruitment of Tn5 is specifically determined by the existence of G4s in HepG4-seq and R-loops in HBD-seq. In addition, RNase treatment markedly abolished the HBD-seq signals and the non-labeled controls exhibit obviously reduction of HepG4-seq signals, demonstrating that HBD-seq and HepG4-seq were not contamination from tagmentation of asccessible DNA.

      Reviewer #2 (Public Review):

      Summary:

      In this study, Liu et al. explore the interplay between G-quadruplexes (G4s) and R-loops. The authors developed novel techniques, HepG4-seq and HBD-seq, to capture and map these nucleic acid structures genome-wide in human HEK293 cells and mouse embryonic stem cells (mESCs). They identified dynamic, cell-type-specific distributions of co-localized G4s and R-loops, which predominantly localize at active promoters and enhancers of transcriptionally active genes. Furthermore, they assessed the role of helicase Dhx9 in regulating these structures and their impact on gene expression and cellular functions.

      The manuscript provides a detailed catalogue of the genome-wide distribution of G4s and R-loops. However, the conceptual advance and the physiological relevance of the findings are not obvious. Overall, the impact of the work on the field is limited to the utility of the presented methods and datasets.

      Strengths:

      (1) The development and optimization of HepG4-seq and HBD-seq offer novel methods to map native G4s and R-loops.

      (2) The study provides extensive data on the distribution of G4s and R-loops, highlighting their co-localization in human and mouse cells.

      (3) The study consolidates the role of Dhx9 in modulating these structures and explores its impact on mESC self-renewal and differentiation.

      We appreciate your valuable points.

      Weaknesses:

      (1) The specificity of the biotinylation process and potential off-target effects are not addressed. The authors should provide more data to validate the specificity of the G4-hemin.

      The specificity of hemin-G4-induced peroxidase activity and self-biotinylation has been well demonstrated in previous studies (PMID: 19618960, 22106035, 28973477, 32329781). In the Fig.1A, we compared the hemin-G4-induced biotinylation levels in different conditions. Cells treated with hemin and Bio-An exhibited a robust fluorescence signal, while the absence of either hemin or Bio-An almost completely abolished the biotinylation signals, suggesting a specific and active biotinylation activity.

      (2) Other methods exploring a catalytic dead RNAseH or the HBD to pull down R-loops have been described before. The superior quality of the presented methods in comparison to existing ones is not established. A clear comparison with other methods (BG4 CUT&Tag-seq, DRIP-seq, R-CHIP, etc) should be provided.

      Thank you for the suggestions. We have included a new Fig. 9 and a new section “Comparisons of HepG4-seq and HBD-seq with previous methods” to carefully compare our methods to other methods.

      (3) Although the study demonstrates Dhx9's role in regulating co-localized G4s and R-loops, additional functional experiments (e.g., rescue experiments) are needed to confirm these findings.

      Dhx9 has been demonstrate as a versatile helicase capable of directly resolving R-loops and G4s or promoting R-loop formation in previous studies (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). We believe that the current new dataset and previous studies are enough to support the capability of Dhx9 in regulating co-localized G4s and R-loops.

      (4) The manuscript would benefit from a more detailed discussion of the broader implications of co-localized G4s and R-loops.

      Thank you for the suggestions. We have included the discussion in the revised version.

      (5) The manuscript lacks appropriate statistical analyses to support the major conclusions.

      We apologized for this point. Whereas we have applied careful statistical analyses in this study, lacking of some statistical details make people hard to understand some conclusions. We have carefully added details of all statistical analysis.

      (6) The discussion could be expanded to address potential limitations and alternative explanations for the results.

      Thank you for the suggestions. We have included the discussion about this point in the revised version.

      Reviewer #3 (Public Review):

      Summary:

      The authors developed and optimized the methods for detecting G4s and R-loops independent of BG4 and S9.6 antibody, and mapped genomic native G4s and R-loops by HepG4-seq and HBD-seq, revealing that co-localized G4s and R-loops participate in regulating transcription and affecting the self-renewal and differentiation capabilities of mESCs.

      Strengths:

      By utilizing the peroxidase activity of G4-hemin complex and combining proximity labeling technology, the authors developed HepG4-seq (high throughput sequencing of hemin-induced proximal labelled G4s), which can detect the dynamics of G4s in vivo. Meanwhile, the "GST-His6-2xHBD"-mediated CUT&Tag protocol (Wang et al., 2021) was optimized by replacing fusion protein and tag, the optimized HBD-seq avoids the generation of GST fusion protein aggregates and can reflect the genome-wide distribution of R-loops in vivo.

      The authors employed HepG4-seq and HBD-seq to establish comprehensive maps of native co-localized G4s and R-loops in human HEK293 cells and mouse embryonic stem cells (mESCs). The data indicate that co-localized G4s and R-loops are dynamically altered in a cell type-dependent manner and are largely localized at active promoters and enhancers of transcriptionally active genes.

      Combined with Dhx9 ChIP-seq and co-localized G4s and R-loops data in wild-type and dhx9KO mESCs, the authors confirm that the helicase Dhx9 is a direct and major regulator that regulates the formation and resolution of co-localized G4s and R-loops.

      Depletion of Dhx9 impaired the self-renewal and differentiation capacities of mESCs by altering the transcription of co-localized G4s and R-loops-associated genes.

      In conclusion, the authors provide an approach to studying the interplay between G4s and R-loops, shedding light on the important roles of co-localized G4s and R-loops in development and disease by regulating the transcription of related genes.

      We appreciate your valuable points.

      Weaknesses:

      As we know, there are at least two structure data of S9.6 antibody very recently, and the questions about the specificity of the S9.6 antibody on RNA:DNA hybrids should be finished. The authors referred to (Hartono et al., 2018; Konig et al., 2017; Phillips et al., 2013) need to be updated, and the authors' bias against S9.6 antibodies needs also to be changed. However, as the authors had questioned the specificity of the S9.6 antibody, they should compare it in parallel with the data they have and the data generated by the widely used S9.6 antibody.

      Thank you for the updating information about the structure data of S9.6 antibody. We politely disagree the specificity of the S9.6 antibody on RNA:DNA hybrids. The structural studies of S9.6 (PMID: 35347133, 35550870) used only one RNA:DNA hybrid to show the superior specificity of S9.6 on RNA:DNA hybrid than dsRNA and dsDNA. However, Fabian K. et al has reported that the binding affinities of S9.6 on RNA:DNA hybrid exhibits obvious sequence-dependent bias from null to nanomolar range (PMID: 28594954). We have included the comparison between S9.6-derived data and our HBD-seq data in the Fig.9 and the section “Comparisons of HepG4-seq and HBD-seq with previous methods”.

      Although HepG4-seq is an effective G4s detection technique, and the authors have also verified its reliability to some extent, given the strong link between ROS homeostasis and G4s formation, and hemin's affinity for different types of G4s, whether HepG4-seq reflects the dynamics of G4s in vivo more accurately than existing detection techniques still needs to be more carefully corroborated.

      Thank you for pointing out this issue. In the in vitro hemin-G4 induced self-biotinylation assay, parallel G4s exhibit higher peroxidase activities than anti-parallel G4s. Thus, the dynamics of G4 conformation could affect the HepG4-seq signals (PMID: 32329781). In the future, people may need to combine HepG4-seq and BG4s-eq to carefully explain the endogenous G4s. We have discussed this point in the revised version.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Figures 1A&1G. Although no merge images were provided, it seems that the biotin signals are strongly enriched outside the nucleus. This suggests that hemin is not specific for G4s in DNA. Does it mean that Hemin can also recognise G4 on RNAs? How do the authors understand the cytoplasmic signal?

      Hemin indeed could interact with RNA G4 to obtain the peroxidase activity like DNA G4-hemin complex (PMID: 27422869, 32329781, 31257395). The cytoplasmic signals in Figure 1A&1G were derived from RNA G4.

      Figure 1A: The fact that there is no Alexa647 signal without hemin or Bio-An does not actually demonstrate that the signals are specific. These controls do not actually test for the specificity of the G4-Hemin interaction.

      The specificity of hemin-G4-induced peroxidase activity and self-biotinylation has been well demonstrated in previous studies (PMID: 19618960, 22106035, 28973477, 32329781). In this study, we performed the IF to confirm this phenomena.

      Figure 1C: It looks like the HepG4-seq signals are simply an amplification of the noise given by the Tn5 (the non-label ctrl has the same pattern, albeit weaker). It is unclear why this happens but it might happen if somehow hemin increased the probability that the Tn5 is close to chromatin in an unspecific manner (it would cut G-rich, nucleosome-poor, accessible sites in an unspecific manner). To discard this possibility, it would be interesting to investigate directly which loci are biotinylated. For this, the authors could extract and sonicate the genomic DNA and use streptavidin to enrich for biotinylated fragments. Strand-specific DNA sequencing could then be used to map the biotinylated loci.

      In the cell culture medium, there were a certain amount of hemin from serum and a low dosage of biotin from the basal medium DMEM, which could not be avoid. Thus, these contaminated hemin and biotin would generate the background signals observed in the Non-label control samples. The biotinylated sites were specifically recognized by the recombinant Streptavidin monomer which further recruits Tn5 to the biotinylated sites with the help of Moon-tag. Different from the signals in the HEK293 samples, a much more robust HepG4-seq signals were observed in the mESC samples and the signals were also abolished in the non-label control samples. Thus, the relatively small signal-to-noise ratio in the HEK293 samples suggest the week abundance of endogenous G4s in the HEK293 cells. Thus, we politely disagree that hemin increased the non-specific recruitment of Th5. In addition, the CUT&Tag technology has been wildly demonstrated to have a much lower background, high signal-to-noise ratio and high sensitivity. Thus, we also politely disagree to replace the CUT&Tag with the traditional DNA library preparation method.

      Figure 1H: No spike-in was added and the data are not quantitative. The number of replicates is unclear. 70000 extra peaks (10x) after inhibition of BLM or WRN seems enormous. These extra peaks should be better characterised: do they contain G4 motifs? Are they transcribed? etc...; again what kind of controls should be used here, in case the inhibition of BLP and WRN has a global impact on chromatin accessibility?

      To quantitatively compare different samples, we have normalized all samples according their de-duplicated uniquely mapping reads numbers. Given that the inhibitors were dissolved in the DMSO, we used the DMSO as the control. Since the Tn5 were specifically recruited the biotinylated G4 sites through the recombinant Streptavidin monomer protein and the moon tag system, the chromatin accessibility will not affect the Tn5, which were normally observed in the ATAT-seq.

      As suggested, we have analyzed the enriched motifs of the extra peaks induced by BLM or WRN inhibition and showed that the top enriched motifs are also G-rich in the supplementary Fig.1E. In addition, we analyzed the RNA-seq levels of genes-associated with these extra peaks. As shown in the figure below, the majority of these genes are actively transcribed.

      Author response image 1.

      Figure 2: The mutated version of HBD should have been used as a control. As shown clearly in PMID: 37819055, the HBD domain does interact in an unspecific manner with chromatin at low levels. As above, this might be enough to increase the local concentration of the Tn5 close to chromatin in the Cut&Tag approach and to cleave accessible sites close to TSS in an unspecific manner.

      As shown in Fig.2B and Fig.4A, we have included the RNase treatment as the control and showed that the HBD-seq-identified R-loops signals are dramatically attenuated (Fig.2B) or almost completely abolished after the RNase treatment (Fig.4A). These data demonstrate the specificity of HBD-seq.

      Figure 2: What fraction of the HEPG4-seq signal is sensitive to RNase treatment? The authors used a combination of RNase A and RNase H but previous data have shown that the RNase A treatment is sufficient to remove the HBD-seq signal (which means that it is not actually possible on this sole basis to claim or disclaim that the signals do correspond to genuine R-loops). Do the authors have evidence that the RNase H treatment alone does impact their HBD-seq or HEPG4-seq signals?

      As shown in Fig.2B and Fig.4A, the HBD-seq-identified R-loops signals are all dramatically attenuated (Fig.2B) or almost completely abolished after the RNase treatment (Fig.4A). The specificity of HBD on recognizing R-loops has been carefully demonstrated in the previous study (PMID: 33597247). In this study, we used the same two copies of HBD (2xHBD) and replaced the GST tag to EGFP-V5 to reduce the possibility of variable high molecular-weight aggregates caused by GST tag. In addition, RNase H treatment has been shown to fail to completely abolish the CUT&Tag signals since a subset of DNA-RNA hybrids with high GC skew are partially resistant to RNase H (PMID: 32544226, 33597247). In consideration of the high GC skew of co-localized G4s and R-loops, we combined the RNase A and RNase H. We currently did not have the RNaseH alone samples.

      Figure 3A: "RNA-seq analysis revealed that the RNA levels of co-localized G4s and R-loops-associated genes are significantly higher": the differences are not very convincing.

      In the Figure 3A, we have performed the Mann-Whitney test to examine the significance in the revised manuscript. RNA levels of co-localized G4s and R-loops-associated genes are indeed significantly higher than all genes, G4s or R-loops- associated genes with the Mann-Whitney test p < 2.2E-16.

      Figure 3B: the patterns for "G4" and "co-localised G4 and R-loop" are extremely similar, suggesting that nearly all G4s mapped here could also form R-loops. If this is the case, most of the HEPG4-seq signals should be sensitive to exogenous RNase H treatment or to the in vivo over-expression of RNase H1. This should be tested (see above).

      The percentage of co-localized G4 and R-loop in G4 peaks is 80.3% ( 5,459 out of 6,799) in HEK293 cells and 72.0% (68,482 out of 95,128) in mESC cells, respectively. The co-localization does not mean that G4 and R-loop interact with each other. We have showed that only small proportion of co-localized G4s and R-loops displayed differential G4s and R-loops at the same time in the dhx9KO mESCs (Fig. 6D, Supplementary Fig. 3B), suggesting that the majority of co-localized G4s and R-loops do not interact with each other. Thus, we thought that it is not necessary to perform the RNase H test.

      Figure 3C: there is no correlation between the FC of G4 and the FC of RNA; this is not really consistent with the idea that the stabilisation of G4 is the driver rather than a consequence of the transcriptional changes.

      Given that the treatment of WRN or BLM inhibition induced a large mount of G4 accumulation (Fig.1H-I), we examined the transcription effect on genes associated with these accumulated G4s in Fig.3C. We indeed observed the effect of G4 accumulation on transcription of G4-associated genes. Given that G4 stabilization triggers the transcriptional changes, it does not mean that the transcriptional changes should be highly correlated with the increase levels of G4s. To our knowledge, we have not observed this type of connections in the previous studies. 

      l279: the overlap with H3K4me1 is really not convincing.

      For all G4 peaks, the signals of H3K4me1 indeed exhibit a high background around the center of G4 peaks but we still could observe a clear peak in the center.

      Figure 5C: it should be clearly indicated here that the authors compare Cut&Tag and ChIP data. The origin of the ChIP-seq data is also unclear and should be indicated.

      Thank you for the suggestions. We have clarified this point.

      For the ChIP data, we have described the origin of ChIP-seq data in the “Data availability” section as below: “The ChIP-seq data of histone markers and RNAP are openly available in GNomEx database (accession number 44R) (Wamstad et al., 2012).”

      Reviewer #2 (Recommendations For The Authors):

      (1) Figure 1A. An experimental condition lacking H2O2 (-H2O2) should be included.

      We have added this control in Fig.1A

      (2) Does RNAse H affect G4 profiles?

      We have not tested the effect of RNase H on G4 forming. However, we have showed that only small proportion of co-localized G4s and R-loops displayed differential G4s and R-loops at the same time in the dhx9KO mESCs (Fig. 6D, Supplementary Fig. 3B), suggesting that the majority of co-localized G4s and R-loops do not interact with each other. Thus, we thought that it is not necessary to perform the RNase H test on G4. In addition, to treat cells wit RNase H, we have to permeabilize cells first to let RNase H enter the nuclei. If so, we will lose the pictures of endogenous G4s.

      (3) Figure 2G. R-loops are detected upstream of the KPNB1 gene. What is this region? Is it transcribed?

      We are so sorry to make a mistake when we prepared this figure. We have change it to the correct one in Fig. 2G. The R-loop is around the TSS of KPNB1. We also showed the RNA-seq data in this region in Author response image 2 below. This region is indeed transcribed.

      Author response image 2.

      (4) Did BLM and WRN inhibition specifically affect the expression of genes containing colocalized G4s and R-loops? Was the effect seen in other genes as well? Appropriate statistical analyses are needed.

      In the Fig.3, we have shown that the accumulation of co-localized G4 and R-loops induced by the inhibition of BLM or WRN significantly caused the changes of genes (480 in BLM inhibition, 566 in WRN inhibition) containing these structures most of which are localized at the promoter-TSS regions. We indeed detected the effect in other genes as well. There were 918 and 1020 genes with significantly changes (padjust <0.05 & FC >=2 or FC <=0.5) in BLM and WRN inhibition, respectively.

      (5) The claim that "The co-localized G4s and R-loops-mediated transcriptional regulation in HEK293 cells" (title of Figure 3) is not supported by the presented data. A causality link is not established in this study, which only reports correlations between G4s/R-loops and transcription regulation.

      We politely disagree with this point. BLM and WRN are the best characterized DNA G4-resolving helicase ((Fry and Loeb, 1999; Mendoza et al., 2016; Mohaghegh et al., 2001). Here, we used the selective small molecules to specifically inhibit their ATPase activity and observed dramatical induction of G4 accumulation. Notably, the accumulated G4s that trigger the transcriptional changes are mainly located at the promoter-TSS region. If the transcriptional changes trigger the G4 accumulations, we should not observe such a biased distribution and more accumulated G4s should be detected in the gene body.

      (6) The effect of Dhx9 KO on colocalized G4s/R-loops and transcription is not clear. The suggestion that Dhx9 could regulate transcription by modulating G4s, R-loops, and co-localized G4s and R-loops is not supported by the presented data. Additional experiments and statistical analyses are needed to conclude the role of Dhx9 on colocalized G4s/Rloops and transcription.

      Dhx9 has been extensively studied and reported to directly unwind R-loops and G4s or promote R-loop formation (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). Thus, it is not necessary to repeat these assays again. To understand the direct Dhx9-bound G4s and R-loops, we performed the Dhx9 CUT&Tag assay and analyzed the co-localization of Dhx9-binding sites and G4s or R-loops. 47,857 co-localized G4s and R-loops are directly bound by Dhx9 in the wild-type mESCs and 4,060 of them display significantly differential signals in absence of Dhx9, suggesting that redundant regulators exist as well. These data have clearly shown the roles of Dhx9 directly modulating the stabilities of G4s and R-loops. Furthermore, we showed that loss of Dhx9 caused 816 Dhx9 directly bound colocalized G4 and R-loop associated genes significantly differentially expressed, supporting the transcriptional regulation of Dhx9. We performed the differential analysis following the standard pipeline: DESeq2 for RNA-seq and DiffBind for HepG4-seq and HBD-seq. The statistical details have been described in the figure legends.

      (7) The conclusion that Dhx9 regulates the self-renewal and differentiation capacities of mESCs is vague. Additional experiments are needed to elucidate the exact contribution of Dhx9.

      In this study, we aimed to report new methods for capturing endogenous G4s and R-loops in living cells. In this study, we have shown that depletion of Dhx9 significantly attenuated the proliferation of the mESCs and also influenced the capacity of mESCs differentiation into three germline lineages during the EB assay. In addition, we showed that depletion of Dhx9 significantly reduced the protein levels of mESCs pluripotent markers Nanog and Lin28a. The comprehensive molecular mechanism of Dhx9 action is indeed not the focus of this study. We will work on it in the future studies. Thank you for the comments.

      Reviewer #3 (Recommendations For The Authors):

      The study on the involvement of native co-localized G4s and R-loops in transcriptional regulation further enriches the readers' understanding of genomic regulatory networks, and the functional dissection of Dhx9 also lays a good foundation for the study of the dynamic regulatory mechanisms of co-localized G4s and R-loops. Unfortunately, however, the authors lack a strong basis for questioning the widely used BG4 and S9.6 antibodies, and the co-localized G4s and R-loops sequencing data obtained by the developed and optimized method also lack parallel comparison with existing sequencing technologies, which cannot indicate that HepG4-seq and HBD-seq are more reliable and superior than BG4 and S9.6 antibody-based sequencing technologies. There are also some minor errors in the manuscript that need to be corrected.

      Thank you for the constructive comments. We have added a new section (Comparisons of HepG4-seq and HBD-seq with previous methods) and a new figure 9 to parallelly compare our methods to other widely-used methods.

      (1) This work mainly focuses on co-localized G4s and R-loops, but in the introduction section, the interplay between G4s and R-loops is only briefly mentioned. It is suggested that the importance of the interplay of G4s and R-loops for gene regulation should be further expanded to help readers better understand the significance of studying co-localized G4s and R-loops.

      Thank you for the comments. The current studies about the interplay between G4s and R-loops are limited. We have summarized all we could find in the literatures.

      (2) The authors mentioned that "a steady state equilibrium is generally set at low levels in living cells under physiological conditions (Miglietta et al., 2020) and thus the addition of high-affinity antibodies may pull the equilibrium towards folded states", in my understanding this is one of the important reasons why the authors optimized the G4s and R-loops detection assays, I wonder if there is a reliable basis for this statement. If there is, I suggest that the authors can supplement it in the manuscript.

      The main reason we develop the new method is to develop an antibody-free method to label the endogenous G4s in living cells. We ever tried to capture endogenous G4s using the tet-on controlled BG4. Unfortunately, we found that even a short time induction of BG4 in living cells was toxic. The traditional antibody-based methos rely on permeabilizing cells first to let the antibodies enter the nuclei. In this case, it is easy to lost the physiological pictures of endogenous G4s. We will add more discussion about this point. For R-loops, we just further optimized the GST-2xHBD-mediated method to avoid the problem of GST-tag. GST-fusion proteins are prone to form variable high molecular-weight aggregates and these aggregates often undermine the reliability of the fusion proteins.

      (3) Some questions about HepG4-seq:

      Is there a difference in hemin affinity for intramolecular G quadruplexes, interstrand G quadruplexes, and their different topologies? If so, does this bias affect the accuracy of sequencing results based on G4-hemin complexes?

      Thank you for pointing out this issue. In the in vitro hemin-G4 induced self-biotinylation assay, parallel G4s exhibit higher peroxidase activities than anti-parallel G4s (PMID: 32329781). Thus, the dynamics of G4 conformation possibly affect the HepG4-seq signals. In the future, people may need to combine HepG4-seq and BG4s-eq to carefully explain the endogenous G4s. We have discussed this point in the revised version.

      HepG4-seq is based on proximity labeling and peroxidase activity of the G4-hemin complex. The authors tested and confirmed that the addition of hemin and Bio-An in the experiment had no significant influences on sequencing results, but the effect of exogenous H2O2 treatment may also need to be taken into account since ROS can mediate the formation of G4s.

      For HepG4-seq protocol, we only treat cells with H2O2 for one minute. Thus, we thought that the side effect of H2O2 treatment should be limited in such a short time.

      (4) As we know, there have been at least two structure data of the S9.6 antibody very recently, and the questions about the specificity of the S9.6 antibody on RNA:DNA hybrids should be finished. The authors referred to (Hartono et al., 2018; Konig et al., 2017; Phillips et al., 2013) need to be updated, and the author's bias against S9.6 antibodies needs also to be changed. However, as the authors had questioned the specificity of the S9.6 antibody, they should compare in parallel with the data they have and the data generated by the widely used S9.6 antibody.

      Thank you for the updating information about the structure data of S9.6 antibody. We politely disagree the specificity of the S9.6 antibody on RNA:DNA hybrids. The structural studies of S9.6 (PMID: 35347133, 35550870) used only one RNA:DNA hybrid to show the superior specificity of S9.6 on RNA:DNA hybrid than dsRNA and dsDNA. However, Fabian K. et al has reported that the binding affinities of S9.6 on RNA:DNA hybrid exhibits obvious sequence-dependent bias from null to nanomolar range (PMID: 28594954). We have included the comparison between S9.6-derived data and our HBD-seq data in the Fig.9 and the section “Comparisons of HepG4-seq and HBD-seq with previous methods”.

      (5) It is hoped that the results of immunofluorescence experiments can be statistically analyzed.

      We have performed the statistical analysis and included the data in the new figure.

      (6) Some minor errors:

      Line 168, "G4-froming" should be "G4-forming";

      Figure 5E, the color of the "Repressed" average signal at the top of the HepG4-seq heatmap should be blue;

      Figure 7C, the abbreviation "Gloop" should be indicated in the text or in the figure caption.

      Thank you for pointing out these issues. We are sorry for these mistakes. We have corrected them in the revised version.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      The manuscript proposes an alternative method by SDS-PAGE calibration of Halo-Myo10 signals to quantify myosin molecules at specific subcellular locations, in this specific case filopodia, in epifluorescence datasets compared to the more laborious and troublesome single molecule approaches. Based on these preliminary estimates, the authors developed further their analysis and discussed different scenarios regarding myosin 10 working models to explain intracellular diffusion and targeting to filopodia. 

      Strengths: 

      I confirm my previous assessment. Overall, the paper is elegantly written and the data analysis is appropriately presented. Moreover, the novel experimental approach offers advantages to labs with limited access to high-end microscopy setups (super-resolution and/or EM in particular), and the authors proved its applicability to both fixed and live samples. 

      Weaknesses: 

      Myself and the other two reviewers pointed to the same weakness, the use of protein overexpression in U2OS. The authors claim that Myosin10 is not expressed by U2OS, based on Western blot analysis. Does this completely rule out the possibility that what they observed (the polarity of filopodia and the bulge accumulation of Myo10) could be an artefact of overexpression? I am afraid this still remains the main weakness of the paper, despite being properly acknowledged in the Limitations.

      Respectfully, our observations do not capture an “artefact” of overexpression but rather the “response” to overexpression. Our goal in this project was to overexpress Myo10 in a situation where it is the limiting reagent for generating filopodia. As Reviewer 3 notes below, overexpression shows that filopodial tips “can accommodate a surprisingly (shockingly) large number of motors.” This is exactly the point. Reviewer 2 considered our handling of this issue to be a strength of the paper. As far as whether bulges occur in endogenous Myo10 systems, please see our comments to Reviewer 3. 

      I consider all the remaining issues I expressed during the first revision solved. 

      Reviewer #2 (Public Review): 

      Summary: 

      The paper sought to determine the number of myosin 10 molecules per cell and localized to filopodia, where they are known to be involved in formation, transport within, and dynamics of these important actin-based protrusions. The authors used a novel method to determine the number of molecules per cell. First, they expressed HALO tagged Myo10 in U20S cells and generated cell lysates of a certain number of cells and detected Myo10 after SDS-PAGE, with fluorescence and a stained free method. They used a purified HALO tagged standard protein to generate a standard curve which allowed for determining Myo10 concentration in cell lysates and thus an estimate of the number of Myo10 molecules per cell. They also examined the fluorescence intensity in fixed cell images to determine the average fluorescence intensity per Myo10 molecule, which allowed the number of Myo10 molecules per region of the cell to be determined. They found a relatively small fraction of Myo10 (6%) localizes to filopodia. There are hundreds of Myo10 in each filopodia, which suggests some filopodia have more Myo10 than actin binding sites. Thus, there may be crowding of Myo10 at the tips, which could impact transport, the morphology at the tips, and dynamics of the protrusions themselves. Overall, the study forms the basis for a novel technique to estimate the number of molecules per cell and their localization to actin-based structures. The implications are broad also for being able to understand the role of myosins in actin protrusions, which is important for cancer metastasis and wound healing. 

      Strengths: 

      The paper addresses an important fundamental biological question about how many molecular motors are localized to a specific cellular compartment and how that may relate to other aspects of the compartment such as the actin cytoskeleton and the membrane. The paper demonstrates a method of estimating the number of myosin molecules per cell using the fluorescently labeled HALO tag and SDS-PAGE analysis. There are several important conclusions from this work in that it estimates the number of Myo10 molecules localized to different regions of the filopodia and the minimum number required for filopodia formation. The authors also establish a correlation between number of Myo10 molecules filopodia localized and the number of filopodia in the cell. There is only a small % of Myo10 that tip localized relative to the total amount in the cell, suggesting Myo10 have to be activated to enter the filopodia compartment. The localization of Myo10 is log-normal, which suggests a clustering of Myo10 is a feature of this motor. 

      One of the main critiques of the manuscript was that the results were derived from experiments with overexpressed Myo10 and therefore are hard to extrapolate to physiological conditions. The authors counter this critique with the argument that their results provide insight into a system in which Myo10 is a limiting factor for controlling filopodia formation. They demonstrate that U20S cells do not express detectable levels of Myo10 (supplementary Figure 1E) and thus introducing Myo10 expression demonstrates how triggering Myo10 expression impacts filopodia. An example is given how melanoma cells often heavily upregulate Myo10. 

      In addition, the revised manuscript addresses the concerns about the method to quantitate the number of Myo10 molecules per cell and therefore puncta in the cell. The authors have now made a good faith effort to correct for incomplete labeling of the HALO tag (Figure 2A-C, supplementary Figure 2D-E). The authors also address the concerns about variability in transfection efficiency (Figure 1D-E). 

      A very interesting addition to the revised manuscript was the quantitation of the number of Myo10 molecules present during an initiation event when a newly formed filopodia just starts to elongate from the plasma membrane. They conclude that 100s of Myo10 molecules are present during an initiation event. They also examined other live cell imaging events in which growth occurs from a stable filopodia tip and correlated with elongation rates. 

      Weaknesses: 

      The authors acknowledge that a limitation of the study is that all of the experiments were performed with overexpressed Myo10. They address this limitation in the discussion but also provide important comparisons for how their work relates to physiological conditions, such as melanoma cells that only express large amounts of Myo10 when they are metastatic. Also, the speculation about how fascin can outcompete Myo10 should include a mechanism for how the physiological levels of fascin can complete with the overabundance of Myo10 (page 10, lines 401-408). 

      We have expanded the discussion about fascin competing with high concentrations of Myo10 in filopodial tips on pg. 15. The key feature is that fascin binding in a bundle is essentially irreversible, so it wins if any space opens up and it manages to bind before the next Myo10 arrives.

      Reviewer #3 (Public Review): 

      Summary 

      The work represents progress in quantifying the number of Myo10 molecules present in the filopodia tip. It reveals that cells overexpressing fluorescently labeled Myo10 that the tip can accommodate a wide range of Myo10 motors, up to hundreds of molecules per tip. 

      The revised, expanded manuscript addresses all of this reviewer's original comments. The new data, analysis and writing strengthen the paper. Given the importance of filopodia in many cellular/developmental processes and the pivotal, as yet not fully understood role of Myo10 in their formation and extension, this work provides a new look at the nature of the filopodial tip and its ability to accommodate a large number of Myo10 motor proteins through interactions with the actin core and surrounding membrane. 

      Specific comments - 

      (1) One of the comments on the original work was that the analysis here is done using cells ectopically expressing HaloTag-Myo10. The author's response is that cells express a range of Myo10 levels and some metastatic cancer cells, such as breast cancer, have significantly increased levels of Myo10 compared to non-transformed cell lines. It is not really clear how much excess Myo10 is present in those cells compared to what is seen here for ectopic expression in U2OS cells, making a direct correspondence difficult.

      We agree, a direct correspondence is difficult, and is further complicated by other variables (e.g., expression levels of Myo10 activators, cargoes, fascin, or other filopodial components) that may differ among cell lines. Properly sorting this out will require additional work in a few key cellular systems.

      However, there are two points to keep in mind that somewhat mitigate this concern. First, because ectopic expression of Myo10 causes an ~30x increase in the number of filopodia, the activated Myo10 population is divided over that larger filopodial population. Second, the log-normal distribution of Myo10 across filopodia has a long tail, which means that some cells with low levels of Myo10 will concentrate that Myo10 in a few filopodia. 

      In response to comments about the bulbous nature of many filopodia tips the authors point out that similar-looking tips are seen when cells are immunostained for Myo10, citing Berg & Cheney (2002). In looking at those images as well as images from papers examining Myo10 immunostaining in metastatic cancer cells (Arjonen et al, 2014, JCI; Summerbell et al, 2020, Sci Adv) the majority of the filopodia tips appear almost uniformly dot-like or circular. There is not too much evidence of the elongated, bulbous filopodial tips seen here.

      Yes, the tips in Berg and Cheney are circular, but their size varies considerably (just as a balloon is roughly circular, its size varies with the amount of air it contains). Non-bulbous filopodial tips have a theoretical radius of ~100 nm, which is below the diffraction limit. However, many of the filopodial tips are larger than the diffraction limit in Berg and Cheney, Fig. 1a. We cropped and zoomed in the images to show each fully visible filopodial tip

      We attempted to perform a similar analysis of the images in Arjonen and Summerbell. Unfortunately, their images are too small to do so. 

      However, in reconsidering the approach and results, it is the case that the finding here do establish the plasticity of filopodia tips that can accommodate a surprisingly (shockingly) large number of motors. The authors discuss that their results show that targeting molecules to the filopodia tip is a relatively permissive process (lines 262 - 274). That could be an important property that cells might be able to use to their advantage in certain contexts. 

      (2) The method for arriving at the intensity of an individual filopodium puncta (starting on line 532 and provided in the Response), and how this is corrected for transfection efficiency and the cell-to-cell variation in expression level is still not clear to this reviewer. The first part of the description makes sense - the authors obtain total molecules/cell based on the estimation on SDS-PAGE using the signal from bound Halo ligand. It then seems that the total fluorescence intensity of each expressing cell analyzed is measured, then summed to get the average intensity/cell. The 'total pool' is then arrived at by multiplying the number of molecules/cell (from SDS-PAGE) by the total number of cells analyzed. After that, then: 'to get the number of molecules within a Myo10 filopodium, the filopodium intensity was divided by the bioreplicate signal intensity and multiplied by 'total pool.' ' The meaning of this may seem simple or straightforward to the authors, but it's a bit confusing to understand what the 'bioreplicate signal intensity' is and then why it would be multiplied by the 'total pool'. This part is rather puzzling at first read.

      We agree, such information is critical. We have now revised this description with more precise terms and have included a formula on pg. 20.

      Since the approach described here leads the authors to their numerical estimates every effort should be made to have it be readily understood by all readers. A flow chart or diagram might be helpful. 

      We have added a diagram of the calculations to the supplemental material (Figure 1—figure supplement 3). We hope that both changes will make it easier for others to follow our work.

      (3) The distribution of Myo10 punctae around the cell are analyzed (Fig 2E, F) and the authors state that they detect 'periodic stretches of higher Myo10 density along the plasma membrane' (line 123) and also that there is correlation and anti-correlation of molecules and punctae at opposite ends of the cells. 

      In the first case, it is hard to know what the authors really mean by the phrase 'periodic stretches'. It's not easy to see a periodicity in the distribution of the punctae in the many cells shown in Supp Fig 3. Also, the correlation/anti-correlation is not so easily seen in the quantification shown in Fig 2F. Can the authors provide some support or clarification for what they are stating? 

      The periodic pattern that we refer to is most apparent in the middle panels of Fig. 2E, F. These panels show the density of Myo10 puncta. These puncta numbers closely correspond to filopodia counts, with the caveat that some filopodia might have multiple puncta. This periodic density might not be as apparent in the raw data shown in Supp. Fig. 3. We have therefore rewritten this paragraph to clarify our observations (pg. 6).

      (4) The authors are no doubt aware that a paper from the Tyska lab that employs a completely different method of counting molecules arrives at a much lower number of Myo10 molecules at the filopodial tip than is reported here was just posted (Fitz & Tyska, 2024, bioRxiv, DOI: 10.1101/2024.05.14.593924). 

      While it is not absolutely necessary for the authors to provide a detailed discussion of this new work given the timing, they may wish to consider adding a note briefly addressing it. 

      We are aware of this manuscript and that it uses a different approach for calibrating the fluorescence signal in microscopy. However, we are not comfortable commenting on that manuscript at this time, given that it has not yet been peer reviewed with the chance for author revisions.

      Recommendations for the authors: 

      Reviewer #1 (Recommendations For The Authors): 

      The manuscript the authors are now presenting does not comply with the formatting limits of a Short report, but it is instead presented as a full article type. I believe the authors could shorten the Discussion, and meet the criteria for a more appropriate Short Report format. 

      For instance, I continue to believe that the study of truncation variants could sustain the claim that membrane binding represents the driving force that leads to Myo10 accumulation. I understand the authors want to address these mechanisms in a follow-up story, for this reason, I encourage them to shorten the discussion, which seems unnecessarily long for a technique-based manuscript.

      In the first round of review, Reviewer 3 asked us to expand the discussion. Given that, we are happy with where we have landed on the length of the discussion.

      Figure 2, could include some images to facilitate the readers on the different messages of the two rose plots E and F, by picking one of the examples from the supplementary Figure 3 

      We have now added a supplemental figure showing an example cell (Fig. 2 figure supplement 2). But please note that the averaging of ~150 cells (Fig. 2E, F) should be more reliable to show these overall trends.

      Reviewer #2 (Recommendations For The Authors): 

      Also, the speculation about how fascin can outcompete Myo10 should include a mechanism for how the physiological levels of fascin can complete with the overabundance of Myo10 (page 10, lines 401-408). 

      As noted above, we have now clarified this point. 

      Reviewer #3 (Recommendations For The Authors): 

      line 495 - what is GOC? 

      We have now defined this oxygen scavenger system in the main text.

      lines 603/604 - it is stated that 'velocity analysis does not only account for Myo10 punctum that moved away from the starting point of the trajectory.' It's not clear what this really means. 

      The sentence now reads: "For Figure 4 parts G-H, note that velocity analysis includes a few Myo10 puncta that switch direction within a single trajectory (e.g., a retracting punctum that then elongates)."

      References #4 and #14 are the same. 

      Thank you for catching that; it has now been corrected.

      Fig 1C - the plot for signal intensity versus fmol of protein has numbers for the standard and then live and fixed cells. While the R2 value is quite good, it seems a bit odd that the three (?) data points for live cells are all quite small relative to the fixed cells and all bunched together at the left side of the plot. 

      As mentioned in the main text, the time post-transfection has a noticeable effect on the level of Myo10 expression. The three fixed-cell bioreplicates had higher Myo10 expression because they were analyzed 48 hours post-transfection compared to the three live-cell bioreplicates (24 hours). Therefore, the fixed cell data points are larger in value because they represent more molecules, and the live cell data points are on the left side of the plot because they represent fewer molecules.

    1. These tags can lose their meaning in different cultural contexts or on different platforms - the #meta tag might imply something different on Flicker versus its use on Facebook. But machine learning has flattened these differences. Algorithms can now identify similar data across the internet with or without tags or vocabularies.

      At work we have this sprint retrospect task we do every two weeks, everyone says what they think went well or not so well or saying thanks to someone as anons, then we collectively group the same things said by people together is they are the same thing, then we all get 4 votes we use as anon's to signal what we think was most important

    1. In June 2019, we (Bret, Luke, Josh, Paula, Omar, Weiwei) collected all of our Dynamicland-related photos and videos onto a "documentation drive".  The media was organized both by date and by Realtalk project or topic.  We also also made a giant table in Notion of all notable Realtalk projects, with notes and page numbers.  In early 2020, I got media from Toby and Glen, and added the subsequent media from Luke, Josh, and Omar.Last week, I made some Realtalk pages to scan the collection, assign every file an "accession number" of the form DL2018-01-31-debb83.mov(where 2018-01-31 is the date the photo/video was taken, and debb83 is the first six digits of the file's md5), tag the files based on their old directory names and filenames, generate a new directory structure of the form, archived-media/originals/2018/01/DL2018-01-31-debb83.movgenerate thumbnails of the form archived-media/thumbnails/2018/01/DL2018-01-31-debb83.jpgand print out an album.

      Interesante esta mezcla de digital a análogo y las herramientas que en el domino digital continúan usando (drives, Notion, etc). Por supuesto, el grupo está enfocado en la segunda parte y sus innovaciones (Realtak, etc) y no en las innovaciones en la primera (drive, Notion). Dado que nosotros sí nos enfocamos en esta gestión alterna de conocimiento en lo digital, usando infraestructuras de bolsillo, metaherramientas y programación intersticial, cómo esto podría tener una contraparte y puente en análogo, lowtech, similar a Hypertalk in the world

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Chen et al. identified the role of endocardial id2b expression in cardiac contraction and valve formation through pharmaceutical, genetic, electrophysiology, calcium imaging, and echocardiography analyses. CRISPR/Cas9 generated id2b mutants demonstrated defective AV valve formation, excitation-contraction coupling, reduced endocardial cell proliferation in AV valve, retrograde blood flow, and lethal effects.

      Strengths:

      Their methods, data and analyses broadly support their claims.

      Weaknesses:

      The molecular mechanism is somewhat preliminary.

      We thank the reviewer for the constructive comments. To further elucidate the molecular mechanisms underlying the observed phenotypes, we will conduct the following experiments: (1) perform qRT-PCR to analyze the expression of id2a in hearts isolated from tricane-treated embryos and in id2b-deleted embryos; (2) use RNAscope to detect the expression of id2b in developing embryos; (3) validate the interaction between Id2b and Tcf3b in vivo; and (4) conduct CUT&Tag experiments in developing zebrafish embryos to further validate the Tcf3b binding sites upstream of nrg1.

      Reviewer #2 (Public review):

      Summary:

      Biomechanical forces, such as blood flow, are crucial for organ formation, including heart development. This study by Shuo Chen et al. aims to understand how cardiac cells respond to these forces. They used zebrafish as a model organism due to its unique strengths, such as the ability to survive without heartbeats, and conducted transcriptomic analysis on hearts with impaired contractility. They thereby identified id2b as a gene regulated by blood flow and is crucial for proper heart development, in particular, for the regulation of myocardial contractility and valve formation. Using both in situ hybridization and transgenic fish they showed that id2b is specifically expressed in the endocardium, and its expression is affected by both pharmacological and genetic perturbations of contraction. They further generated a null mutant of id2b to show that loss of id2b results in heart malformation and early lethality in zebrafish. Atrioventricular (AV) and excitation-contraction coupling were also impaired in id2b mutants. Mechanistically, they demonstrate that Id2b interacts with the transcription factor Tcf3b to restrict its activity. When id2b is deleted, the repressor activity of Tcf3b is enhanced, leading to suppression of the expression of nrg1 (neuregulin 1), a key factor for heart development. Importantly, injecting tcf3b morpholino into id2b-/- embryos partially restores the reduced heart rate. Moreover, treatment of zebrafish embryos with the Erbb2 inhibitor AG1478 results in decreased heart rate, in line with a model in which Id2b modulates heart development via the Nrg1/Erbb2 axis. The research identifies id2b as a biomechanical signaling-sensitive gene in endocardial cells that mediates communication between the endocardium and myocardium, which is essential for heart morphogenesis and function.

      Strengths:

      The study provides novel insights into the molecular mechanisms by which biomechanical forces influence heart development and highlights the importance of id2b in this process.

      Weaknesses:

      The claims are in general well supported by experimental evidence, but the following aspects may benefit from further investigation:

      (1) In Figure 1C, the heatmap demonstrates the up-regulated and down-regulated genes upon tricane-induced cardiac arrest. Aside from the down-regulation of id2b expression, it was also evident that id2a expression was up-regulated. As a predicted paralog of id2b, it would be interesting to see whether the up-regulation of id2a in response to tricaine treatment was a compensatory response to the down-regulation of id2b expression.

      As suggested by the reviewer, we will perform qRT-PCR to analyze the expression of id2a in hearts isolated from tricane-treated embryos, as well as in id2b-deleted embryos.

      (2) The study mentioned that id2b is tightly regulated by the flow-sensitive primary cilia-klf2 signaling axis; however aside from showing the reduced expression of id2b in klf2a and klf2b mutants, there was no further evidence to solidify the functional link between id2b and klf2. It would therefore be ideal, in the present study, to demonstrate how Klf2, which is a transcriptional regulator, transduces biomechanical stimuli to Id2b.

      We have examined the expression levels of id2b in both klf2a and klf2b mutants. The whole mount in situ results clearly demonstrate a decrease in id2b signal in both mutants. As noted by the reviewer, klf2 is a transcriptional regulator, suggesting that the regulation of id2b may occur at the transcriptional level. However, dissecting the molecular mechanisms underling the crosstalk between klf2 and id2b is beyond the scope of the present study.

      (3) The authors showed the physical interaction between ectopically expressed FLAG-Id2b and HA-Tcf3b in HEK293T cells. Although the constructs being expressed are of zebrafish origin, it would be nice to show in vivo that the two proteins interact.

      We agree with the reviewer and will perform additional experiments to validate the interaction between Id2b and Tcf3b in vivo. Due to the lack of antibodies targeting these proteins, we will overexpress Flag-id2b and HA-Tcf3b in zebrafish embryos and conduct a co-IP analysis.

      Reviewer #3 (Public review):

      Summary:

      How mechanical forces transmitted by blood flow contribute to normal cardiac development remains incompletely understood. Using the unique advantages of the zebrafish model system, Chen et al make the fundamental discovery that endocardial expression of id2b is induced by blood flow and required for normal atrioventricular canal (AVC) valve development and myocardial contractility by regulating calcium dynamics. Mechanistically, the authors suggest that Id2b binds to Tcf3b in endocardial cells, which relieves Tcf3b-mediated transcriptional repression of Neuregulin 1 (NRG1). Nrg1 then induces expression of the L-type calcium channel component LRRC1. This study significantly advances our understanding of flow-mediated valve formation and myocardial function.

      Strengths:

      Strengths of the study are the significance of the question being addressed, use of the zebrafish model, and data quality (mostly very nice imaging). The text is also well-written and easy to understand.

      Weaknesses:

      Weaknesses include a lack of rigor for key experimental approaches, which led to skepticism surrounding the main findings. Specific issues were the use of morpholinos instead of genetic mutants for the bmp ligands, cilia gene ift88, and tcf3b, lack of an explicit model surrounding BMP versus blood flow induced endocardial id2b expression, use of bar graphs without dots, the artificial nature of assessing the physical interaction of Tcf3b and Id2b in transfected HEK293 cells, and artificial nature of examining the function of the tcf3b binding sites upstream of nrg1.

      We thank the reviewer for the constructive assessments. Our specific responses are as follows:

      (1) As all the morpholinos used in this study, including those targeting bmp ligands, the cilia gene ift88, and tcf3b, have been published and validated using genetic mutants in previous studies, we believe these loss-of-function analyses are sufficient to delineate their role in regulating id2b expression or function.

      (2) To assess the role of BMP versus blood flow in regulating endocardial id2b expression, we plan to perform live imaging in the id2b:GFP knockin line prior to the initiation of the heartbeat, with or without of BMP inhibitors.

      (3) We will revise the data presentation and use bar graphs with individual data points.

      (4) We plan to perform additional Co-IP experiment in zebrafish embryos to assess the interaction between Tcf3b and Id2b.

      (5) To further validate the tcf3b binding sites upstream of nrg1, we will conduct CUT&Tag experiments in developing zebrafish embryos.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      UGGTs are involved in the prevention of premature degradation for misfolded glycoproteins, by utilizing UGGT-KO cells and a number of different ERAD substrates. They proposed a concept by which the fate of glycoproteins can be determined by a tug-of-war between UGGTs and EDEMs.

      Strengths:

      The authors provided a wealth of data to indicate that UGGT1 competes with EDEMs, which promotes glycoprotein degradation.

      Weaknesses:

      Less clear, though, is the involvement of UGGT2 in the process. Also, to this reviewer, some data do not necessarily support the conclusion.

      Major criticisms:

      (1) One of the biggest problems I had on reading through this manuscript is that, while the authors appeared to generate UGGTs-KO cells from HCT116 and HeLa cells, it was not clearly indicated which cell line was used for each experiment. I assume that it was HCT116 cells in most cases, but I did not see that it was clearly mentioned. As the expression level of UGGT2 relative to UGGT1 is quite different between the two cell lines, it would be critical to know which cells were used for each experiment.

      Thank you for this comment. We have clarified this point, especially in the figure legends.

      (2) While most of the authors' conclusion is sound, some claims, to this reviewer, were not fully supported by the data. Especially I cannot help being puzzled by the authors' claim about the involvement of UGGT2 in the ERAD process. In most of the cases, KO of UGGT2 does not seem to affect the stability of ERAD substrates (ex. Fig. 1C, 2A, 3D). When the author suggests that UGGT2 is also involved in the ERAD, it is far from convincing (ex. Fig. 2D/E). Especially because now it has been suggested that the main role of UGGT2 may be distinct from UGGT1, playing a role in lipid quality control (Hung, et al., PNAS 2022), it is imperative to provide convincing evidence if the authors want to claim the involvement of UGGT2 in a protein quality control system. In fact, it was not clear at all whether even UGGT1 is also involved in the process in Fig. 2D/E, as the difference, if any, is so subtle. How the authors can be sure that this is significant enough? While the authors claim that the difference is statistically significant (n=3), this may end up with experimental artifacts. To say the least, I would urge the authors to try rescue experiments with UGGT1 or 2, to clarify that the defect in UGGT-DKO cells can be reversed. It may also be interesting to see that the subtle difference the authors observed is indeed N-glycan-dependent by testing a non-glycosylated version of the protein (just like NHK-QQQ mutants in Fig. 2C).

      We appreciate this comment. According to this comment, we reevaluated the importance of UGGT2 for ER-protein quality control. As this reviewer mentioned, KO of UGGT2 does not affect the stability of ATF6a, NHK, rRI332-Flag or EMC1-△PQQ-Flag (Fig. 1E, 2A, and 3DE). Furthermore, we tested whether overexpression of UGGT2 reverses the phenotype of UGGT-DKO regarding the degradation rate of NHK, and we found that it did not affect the degradation rate of NHK, whereas overexpression of UGGT1 restored the degradation rate to that in WT cells.

      Author response image 1.

      Collectively, these facts suggest that the role of UGGT2 in ER protein quality control is rather limited in HCT116 cells. Therefore, we have decided not to mention UGGT2 in the title, and weakened the overall claim that UGGT2 contributes to ER protein quality control. Tissues with high expression of UGGT2 or cultured cells other than HCT116 would be appropriate for revealing the detailed function of UGGT2.

      To this reviewer, it is still possible that the involvement of UGGT1 (or 2, if any) could be totally substrate-dependent, and the substrates used in Fig 2D or E happen not to be dependent to the action of UGGTs. To the reviewer, without the data of Fig. 2D and E the authors provide enough evidence to demonstrate the involvement of UGGT1 in preventing premature degradation of glycoprotein ERAD substrates. I am just afraid that the authors may have overinterpreted the data, as if the UGGTs are involved in stabilization of all glycoproteins destined for ERAD.

      Based on the point this reviewer mentioned, we decided to delete previous Fig. 2D and 2E. There may be more or less efficacy of UGGT1 for preventing early degradation of substrates.

      (3) I am a bit puzzled by the DNJ treatment experiments. First, I do not see the detailed conditions of the DNJ treatment (concentration? Time?). Then, I was a bit surprised to see that there were so little G3M9 glycans formed, and there was about the same amount of G2M9 also formed (Figure 1 Figure supplement 4B-D), despite the fact that glucose trimming of newly syntheized glycoproteins are expected to be completely impaired (unless the authors used DNJ concentration which does not completely impair the trimming of the first Glc). Even considering the involvement of Golgi endo-alpha-mannosidase, a similar amount of G3M9 and G2M9 may suggest that the experimental conditions used for this experiment (i.e. concentration of DNJ, duration of treatment, etc) is not properly optimized.

      We think that our experimental condition of DNJ treatment is appropriate to evaluate the effect of DNJ. Referring to the other papers (Ali and Field, 2000; Karlsson et al., 1993; Lomako et al., 2010; Pearse et al., 2010; Tannous et al., 2015), 0.5 mM DNJ is appropriate. In our previously reported experiment, 16 h treatment with kifunensine mannosidase inhibitor was sufficient for N-glycan composition analysis prior to cell collection (Ninagawa et al., 2014), and we treated cells for a similar time in Figure 1-Figure Supplement 4 and 5 (and Figure 1-Figure Supplement 6). We could see the clear effect of DNJ to inhibit degradation of ATF6a with 2 hours of pretreatment (Fig. 1G). Furthermore, our results are very reasonable and consistent with previous findings that DNJ increased GM9 the most (Cheatham et al., 2023; Gross et al., 1983; Gross et al., 1986; Romero et al., 1985). In addition to DNJ, we used CST for further experiments in new figures (Fig. 1H and Figure 1-Figure supplement 6). DNJ and CST are inhibitors of glucosidase; DNJ is a stronger inhibitor of glucosidase II, while CST is a stronger inhibitor of glucosidase I (Asano, 2000; Saunier et al., 1982; Szumilo et al., 1987; Zeng et al., 1997). An increase in G3M9 and G2M9 was detected using CST (Figure1-Figure Supplement 6). Like DNJ, CST also inhibited ATF6a degradation in UGGT-DKO cells (Fig. 1H). These findings show that our experimental condition using glucosidase inhibitor is appropriate and strongly support our model (Fig. 5). Differences between the effects of DNJ and CST are now described in our manuscript pages 8 to 10.

      Reviewer #2 (Public Review):

      In this study, Ninagawa et al., shed light on UGGT's role in ER quality control of glycoproteins. By utilizing UGGT1/UGGT2 DKO cells, they demonstrate that several model misfolded glycoproteins undergo early degradation. One such substrate is ATF6alpha where its premature degradation hampers the cell's ability to mount an ER stress response.

      While this study convincingly demonstrates early degradation of misfolded glycoproteins in the absence of UGGTs, my major concern is the need for additional experiments to support the "tug of war" model involving UGGTs and EDEMs in influencing the substrate's fate - whether misfolded glycoproteins are pulled into the folding or degradation route. Specifically, it would be valuable to investigate how overexpression of UGGTs and EDEMs in WT cells affects the choice between folding and degradation for misfolded glycoproteins. Considering previous studies indicating that monoglucosylation influences glycoprotein solubility and stability, an essential question is: what is the nature of glycoproteins in UGGTKO/EDEMKO and potentially UGGT/EDEM overexpression cells? Understanding whether these substrates become more soluble/stable when GM9 versus mannose-only translation modification accumulates would provide valuable insights.

      In the new figure 2DE, we conducted overexpression experiments of structure formation factors UGGT1 and/or CNX, and degradation factors EDEMs. While overexpression of structure formation factors (Fig. 2DE) and KO of degradation factors (Ninagawa et al., 2015; Ninagawa et al., 2014) increased stability of substrates, KO of UGGT1 (Fig. 1E, 2A and 3DF) and overexpression of degradation factors (Fig. 2DE) (Hirao et al., 2006; Hosokawa et al., 2001; Mast et al., 2005; Olivari et al., 2005) accelerated degradation of substrates. A comparison of the properties of N-glycan with the normal type and the type without glucoses was already reported (Tannous et al., 2015). The rate of degradation of substrate was unchanged, but efficiency of secretion of substrates was affected.

      The study delves into the physiological role of UGGT, but is limited in scope, focusing solely on the effect of ATF6alpha in UGGT KO cells' stress response. It is crucial for the authors to investigate the broader impact of UGGT KO, including the assessment of basal ER proteotoxicity levels, examination of the general efflux of glycoproteins from ER, and the exploration of the physiological consequences due to UGGT KO. This broader perspective would be valuable for the wider audience. Additionally, the marked increase in ATF4 activity in UGGTKO requires discussion, which the authors currently omit.

      We evaluated the sensitivity of WT and UGGT1-KO cells to ER stress (Figure 4G). KO of UGGT1 increased the sensitivity to ER stress inducer Tg, indicating the importance of UGGT1 for resisting ER stress.

      We add the following description in the manuscript about ATF4 activity in UGGT1-KO: “In addition to this, UGGT1 is necessary for proper functioning of ER resident proteins such as ATF6a (Fig. 4B-F). It is highly possible that ATF6a undergoes structural maintenance by UGGT1, which could be necessary to avoid degradation and maintain proper function, because ATF6a with more rigid in structure tended to remain in UGGT1-KO cells (Fig. 4C). Responses of ERSE and UPRE to ER stress, which require ATF6a, were decreased in UGGT1-KO cells (Fig. 4DE). In contrast, ATF4 reporter activity was increased in UGGT1-KO cells (Fig. 4F), while the basal level of ATF4 in UGGT1-KO cells was comparable with that in WT (Figure 1-Figure supplement 2B). The ATF4 pathway might partially compensate the function of the ERSE and UPRE pathways in UGGT1-KO cells in acute ER stress. This is now described on Page 17 in our manuscript.

      The discussion section is brief and could benefit from being a separate section. It is advisable for the authors to explore and suggest other model systems or disease contexts to test UGGT's role in the future. This expansion would help the broader scientific community appreciate the potential applications and implications of this work beyond its current scope.

      Thank you for making this point. The DISCUSSION part has now been separated in our manuscript. We added some points in the manuscript about other model organisms and diseases in the DISCUSSION as follows: “ Our work focusing on the function of mammalian UGGT1 greatly advances the understanding how ER homeostasis is maintained in higher animals. Considering that Saccharomyces cerevisiae does not have a functional orthologue of UGGT1 (Ninagawa et al., 2020a) and that KO of UGGT1 causes embryonic lethality in mice (Molinari et al., 2005), it would be interesting to know at what point the function of UGGT1 became evolutionarily necessary for life. Related to its importance in animals, it would also be of interest to know what kind of diseases UGGT1 is associated with. Recently, it has been reported that UGGT1 is involved in ER retention of Trop-2 mutant proteins, which are encoded by a causative gene of gelatinous drop-like corneal dystrophy (Tax et al., 2024). Not only this, but since the ER is known to be involved in over 60 diseases (Guerriero and Brodsky, 2012), we must investigate how UGGT1 and other ER molecules are involved in diseases.”

      Reviewer #3 (Public Review):

      This manuscript focuses on defining the importance of UGGT1/2 in the process of protein degradation within the ER. The authors prepared cells lacking UGGT1, UGGT2, or both UGGT1/UGGT2 (DKO) HCT116 cells and then monitored the degradation of specific ERAD substrates. Initially, they focused on the ER stress sensor ATF6 and showed that loss of UGGT1 increased the degradation of this protein. This degradation was stabilized by deletion of ERAD-specific factors (e.g., SEL1L, EDEM) or treatment with mannose inhibitors such as kifunesine, indicating that this is mediated through a process involving increased mannose trimming of the ATF6 N-glycan. This increased degradation of ATF6 impaired the function of this ER stress sensor, as expected, reducing the activation of downstream reporters of ER stress-induced ATF6 activation. The authors extended this analysis to monitor the degradation of other well-established ERAD substrates including A1AT-NHK and CD3d, demonstrating similar increases in the degradation of destabilized, misfolding protein substrates in cells deficient in UGGT. Importantly, they did experiments to suggest that re-overexpression of wild-type, but not catalytically deficient, UGGT rescues the increased degradation observed in UGGT1 knockout cells. Further, they demonstrated the dependence of this sensitivity to UGGT depletion on N-glycans using ERAD substrates that lack any glycans. Ultimately, these results suggest a model whereby depletion of UGGT (especially UGGT1 which is the most expressed in these cells) increases degradation of ERAD substrates through a mechanism involving impaired re-glucosylation and subsequent re-entry into the calnexin/calreticulin folding pathway.

      I must say that I was under the impression that the main conclusions of this paper (i.e., UGGT1 functions to slow the degradation of ERAD substrates by allowing re-entry into the lectin folding pathway) were well-established in the literature. However, I was not able to find papers explicitly demonstrating this point. Because of this, I do think that this manuscript is valuable, as it supports a previously assumed assertion of the role of UGGT in ER quality control. However, there are a number of issues in the manuscript that should be addressed.

      Notably, the focus on well-established, trafficking-deficient ERAD substrates, while a traditional approach to studying these types of processes, limits our understanding of global ER quality control of proteins that are trafficked to downstream secretory environments where proteins can be degraded through multiple mechanisms. For example, in Figure 1-Figure Supplement 2, UGGT1/2 knockout does not seem to increase the degradation of secretion-competent proteins such as A1AT or EPO, instead appearing to stabilize these proteins against degradation. They do show reductions in secretion, but it isn't clear exactly how UGGT loss is impacting ER Quality Control of these more relevant types of ER-targeted secretory proteins.

      We appreciate your comment. It is certainly difficult to assess in detail how UGGT1 functions against secretion-competent proteins, but we think that the folding state of these proteins is improved, which avoids their degradation and increases their secretion. In Figure 1-Figure supplement 2E, there is a clear decrease in secretion of EPO in UGGT1-KO cells, suggesting that UGGT1 also inhibits degradation of such substrates. Note that, as shown in Fig. 3A-C, once a protein forms a solid structure, it is rarely degraded in the ER.

      Lastly, I don't understand the link between UGGT, ATF6 degradation, and ATF6 activation. I understand that the idea is that increased ATF6 degradation afforded by UGGT depletion will impair activation of this ER stress sensor, but if that is the case, how does UGGT2 depletion, which only minimally impacts ATF6 degradation (Fig. 1), impact activation to levels similar to the UGGT1 knockout (Fig 4)? This suggests UGGT1/2 may serve different functions beyond just regulating the degradation of this ER stress sensor. Also, the authors should quantify the impaired ATF6 processing shown in Fig 4B-D across multiple replicates.

      According to this valuable comment, we reevaluated our manuscript. As this reviewer mentioned, involvement of UGGT2 in the activation of ATF6a cannot be explained only by the folding state of ATF6a. Thus, the part about whether UGGT2 is effective in activating ATF6 is outside the scope of this paper. The main focus of this paper is the contribution of UGGT1 to the ER protein quality control mechanism.

      Ultimately, I do think the data support a role for UGGT (especially UGGT1) in regulating the degradation of ERAD substrates, which provides experimental support for a role long-predicted in the field. However, there are a number of ways this manuscript could be strengthened to further support this role, some of which can be done with data they have in hand (e.g., the stats) or additional new experiments.

      In this revision period, to further elucidate the function of UGGT, we did several additional experiments (new figures Fig. 1H, 2DE, 4G and, Figure 1-Figure Supplement 6). We hope that these will bring our papers up to the level you have requested.

      Reviewer #1 (Recommendations For The Authors):

      Minor points:

      (1) Abbreviations: GlcNAc, N-acetylglucosamines -> why plural?

      Corrected.

      (2) Abstract: to this reviewer, it may not be so common to cite references in the abstract.

      We submit this manuscript to eLife as “Research Advances”. In the instructions of eLife for “Research Advances”, there is the description: “A reference to the original eLife article should be included in the abstract, e.g. in the format “Previously we showed that XXXX (author, year). Here we show that YYYY.” We follow this.

      (3) Introduction: "as the site of biosynthesis of approximately one-third of all proteins." Probably this statement needs a citation?

      We added the reference there. You can also confirm this in “The Human Protein Atlas” website. https://www.proteinatlas.org/humanproteome/tissue/secretome

      (4) Figure 1F - the authors claimed that maturation of HA was delayed also in UGGT2 cells, but it was not at all clear to me. Rescue experiments with UGGT2 would be desired.

      We agree with this reviewer, but there was a statistically significant difference in the 80 min UGGT2-KO strain. Previously, it was reported that HA maturation rate was not affected by UGGT2 (Hung et al., 2022). We think that the difference is not large. A rescue experiment of UGGT2 on the degradation of NHK was conducted, and is shown in this response to referees.

      (5) Figure 4A, here also the authors claim that UGGT2 is "slightly" involved in folding of ATF6alpha(P) but it is far from convincing to this reviewer.

      Now we also think that involvement of UGGT2 in ER protein quality control should be examined in the future.

      (6) Page 11, line 7 from the bottom: "peak of activation was shifted from 1 hour to 4 hours after the treatment of Tg in UGGT-KO cells". I found this statement a bit awkward; how can the authors be sure that "the peak" is 4 hours when the longest timing tested is 4 hours (i.e. peak may be even later)?

      Corrected. We deleted the description.

      (7) Page 11, line 4 "a more rigid structure that averts degradation" Can the authors speculate what this "rigid" structure actually means? The reviewer has to wonder what kind of change can occur to this protein with or without UGGT1. Binding proteins? The difference in susceptibility against trypsin appears very subtle anyway (Figure 4 Figure Supplement 1).

      Let us add our thoughts here: Poorly structured ATF6a is immediately routed for degradation in UGGT1-KO cells. As a result, ATF6a with a stable or rigid structure have remained in the UGGT1-KO strain. ATF6a with a metastable state is tended to be degraded without assistance of UGGT1.

      (8) Figure 1 Figure supplement 2; based on the information provided, I calculate the relative ratio of UGGT2/UGGT1 in HCT116 which is 4.5%, and in HeLa 26%. Am I missing something? Also significant figure, at best, should be 2, not 3 (i.e. 30%, not 29.8%).

      Corrected. Thank you for this comment.

      Reviewer #2 (Recommendations For The Authors):

      (1) The effect in Fig. 2B with UGGT1-D1358A add-back is minimal. Testing the inactive and active add-back on other substrates, such as ATF6alpha, which undergoes a more rapid degradation, would provide a more comprehensive assessment.

      To examine the effect of full length and inactive mutant of UGGT1 in UGGT1-KO and UGGT2-KO on the rate of degradation of endogenous ATF6a, we tried to select more than 300 colonies stably expressing full-length Myc-UGGT1/2, UGGT1/2-Flag, and UGGT1/2 (no tag), and their point mutant of them. However, no cell lines expressing nearly as much or more UGGT1/2 than endogenous ones were obtained. The expression level of UGGT1 seemed to be tightly regulated. A low-expressing stable cell line could not recover the phenotype of ATF6a degradation.

      We also tried to measure the degradation rate of exogenously expressed ATF6a. But overexpressed ATF6a is partially transported to the Golgi and cleaved by proteases, which makes it difficult to evaluate only the effect of degradation.

      (2) In reference to this statement on pg. 11:

      "This can be explained by the rigid structure of ATF6(P) lacking structural flexibility to respond to ER stress because the remaining ATF6(P) in UGGT1-KO cells tends to have a more rigid structure that averts degradation, which is supported by its slightly weaker sensitivity to trypsin (Figure 4-figure supplement 1A). "

      The rationale for testing ATF6(P) rigidity via trypsin digestion needs clarification. The authors should provide more background, especially if it relates to previous studies demonstrating UGGT's influence on substrate solubility. If trypsin digestion is indeed addressing this, it should be applied consistently to all tested misfolded glycoproteins, ensuring a comprehensive approach.

      We now provide more background with three references about trypsin digestion. Trypsin digestion allows us to evaluate the structure of proteins originated from the same gene, but it can sometimes be difficult to comparatively evaluate the structure of proteins originated from different genes. For example, antitrypsin is resistant to trypsin by its nature, which does not necessarily mean that antitrypsin forms a more stable structure than other proteins. NHK, a truncated version of antitrypsin, is still resistant to trypsin compared with other substrates.

      (3) Many of the figures described in the manuscript weren't referred to a specific panel. For example, pg. 12 "Fig. 1E and Fig.5," the exact panel for Fig. 5 wasn't referenced.

      Thank you for this comment. Corrected.

      (4) For experiments measuring the composition of glycoproteins in different KO lines, it is necessary to do the experiment more than once for conducting statistical analysis and comparisons. Moreover, the authors did not include raw composition data for these experiments. Statistical analysis should also be done for Fig. 4E-F.

      Our N-glycan composition data (Figure 1-Figure supplement 5 and 6C) is consistent with previous our papers (George et al., 2021; George et al., 2020; Ninagawa et al., 2015; Ninagawa et al., 2014). We did it twice in the previous study and please refer to it regarding statistical analysis (George et al., 2020). We add the raw composition data of N-glycan (Figure 1-Figure supplement 4 and 6B). In Fig. 4D-F, now statistical analysis is included.

      Ali, B.R., and M.C. Field. 2000. Glycopeptide export from mammalian microsomes is independent of calcium and is distinct from oligosaccharide export. Glycobiology. 10:383-391.

      Asano, N. 2000. Glycosidase-Inhibiting Glycomimetic Alkaloids. Biological Activities and Therapeutic Perspectives. Journal of Synthetic Organic Chemistry, Japan. 58:666-675.

      Cheatham, A.M., N.R. Sharma, and P. Satpute-Krishnan. 2023. Competition for calnexin binding regulates secretion and turnover of misfolded GPI-anchored proteins. J Cell Biol. 222.

      George, G., S. Ninagawa, H. Yagi, J.I. Furukawa, N. Hashii, A. Ishii-Watabe, Y. Deng, K. Matsushita, T. Ishikawa, Y.P. Mamahit, Y. Maki, Y. Kajihara, K. Kato, T. Okada, and K. Mori. 2021. Purified EDEM3 or EDEM1 alone produces determinant oligosaccharide structures from M8B in mammalian glycoprotein ERAD. Elife. 10.

      George, G., S. Ninagawa, H. Yagi, T. Saito, T. Ishikawa, T. Sakuma, T. Yamamoto, K. Imami, Y. Ishihama, K. Kato, T. Okada, and K. Mori. 2020. EDEM2 stably disulfide-bonded to TXNDC11 catalyzes the first mannose trimming step in mammalian glycoprotein ERAD. Elife. 9:e53455.

      Gross, V., T. Andus, T.A. Tran-Thi, R.T. Schwarz, K. Decker, and P.C. Heinrich. 1983. 1-deoxynojirimycin impairs oligosaccharide processing of alpha 1-proteinase inhibitor and inhibits its secretion in primary cultures of rat hepatocytes. Journal of Biological Chemistry. 258:12203-12209.

      Gross, V., T.A. Tran-Thi, R.T. Schwarz, A.D. Elbein, K. Decker, and P.C. Heinrich. 1986. Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein. Biochem J. 236:853-860.

      Hirao, K., Y. Natsuka, T. Tamura, I. Wada, D. Morito, S. Natsuka, P. Romero, B. Sleno, L.O. Tremblay, A. Herscovics, K. Nagata, and N. Hosokawa. 2006. EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming. J Biol Chem. 281:9650-9658.

      Hosokawa, N., I. Wada, K. Hasegawa, T. Yorihuzi, L.O. Tremblay, A. Herscovics, and K. Nagata. 2001. A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO reports. 2:415-422.

      Hung, H.H., Y. Nagatsuka, T. Solda, V.K. Kodali, K. Iwabuchi, H. Kamiguchi, K. Kano, I. Matsuo, K. Ikeda, R.J. Kaufman, M. Molinari, P. Greimel, and Y. Hirabayashi. 2022. Selective involvement of UGGT variant: UGGT2 in protecting mouse embryonic fibroblasts from saturated lipid-induced ER stress. Proc Natl Acad Sci U S A. 119:e2214957119.

      Karlsson, G.B., T.D. Butters, R.A. Dwek, and F.M. Platt. 1993. Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120. Journal of Biological Chemistry. 268:570-576.

      Lomako, J., W.M. Lomako, C.A. Carothers Carraway, and K.L. Carraway. 2010. Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF-beta. Journal of cellular physiology. 223:209-214.

      Mast, S.W., K. Diekman, K. Karaveg, A. Davis, R.N. Sifers, and K.W. Moremen. 2005. Human EDEM2, a novel homolog of family 47 glycosidases, is involved in ER-associated degradation of glycoproteins. Glycobiology. 15:421-436.

      Ninagawa, S., T. Okada, Y. Sumitomo, S. Horimoto, T. Sugimoto, T. Ishikawa, S. Takeda, T. Yamamoto, T. Suzuki, Y. Kamiya, K. Kato, and K. Mori. 2015. Forcible destruction of severely misfolded mammalian glycoproteins by the non-glycoprotein ERAD pathway. J Cell Biol. 211:775-784.

      Ninagawa, S., T. Okada, Y. Sumitomo, Y. Kamiya, K. Kato, S. Horimoto, T. Ishikawa, S. Takeda, T. Sakuma, T. Yamamoto, and K. Mori. 2014. EDEM2 initiates mammalian glycoprotein ERAD by catalyzing the first mannose trimming step. J Cell Biol. 206:347-356.

      Olivari, S., C. Galli, H. Alanen, L. Ruddock, and M. Molinari. 2005. A novel stress-induced EDEM variant regulating endoplasmic reticulum-associated glycoprotein degradation. J Biol Chem. 280:2424-2428.

      Pearse, B.R., T. Tamura, J.C. Sunryd, G.A. Grabowski, R.J. Kaufman, and D.N. Hebert. 2010. The role of UDP-Glc:glycoprotein glucosyltransferase 1 in the maturation of an obligate substrate prosaposin. J Cell Biol. 189:829-841.

      Romero, P.A., B. Saunier, and A. Herscovics. 1985. Comparison between 1-deoxynojirimycin and N-methyl-1-deoxynojirimycin as inhibitors of oligosaccharide processing in intestinal epithelial cells. Biochem J. 226:733-740.

      Saunier, B., R.D. Kilker, J.S. Tkacz, A. Quaroni, and A. Herscovics. 1982. Inhibition of N-linked complex oligosaccharide formation by 1-deoxynojirimycin, an inhibitor of processing glucosidases. Journal of Biological Chemistry. 257:14155-14161.

      Szumilo, T., G.P. Kaushal, and A.D. Elbein. 1987. Purification and properties of the glycoprotein processing N-acetylglucosaminyltransferase II from plants. Biochemistry. 26:5498-5505.

      Tannous, A., N. Patel, T. Tamura, and D.N. Hebert. 2015. Reglucosylation by UDP-glucose:glycoprotein glucosyltransferase 1 delays glycoprotein secretion but not degradation. Molecular biology of the cell. 26:390-405.

      Zeng, Y., Y.T. Pan, N. Asano, R.J. Nash, and A.D. Elbein. 1997. Homonojirimycin and N-methyl-homonojirimycin inhibit N-linked oligosaccharide processing. Glycobiology. 7:297-304.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We would like to thank the reviewers and editor for their helpful comments and suggestions. In response, we have revised the manuscript in two main ways:

      (1) To address the comments about rearranging figures and tables, we added a new Figure 3 that summarizes neurotransmitter assignments across all neuron classes. Our rationale for this change is detailed below.

      (2) To address the comment on clarifying neurotransmitter synthesis versus uptake, we analyzed two additional reporter alleles that tag the monoamine uptake transporters for 5-HT and potentially tyramine. These results are now presented in a new Figure 8 and corresponding sections in the manuscript. Related tables have been updated to include this expression data. Two more authors have been added due to their contributions to these experiments.

      For more detailed changes, please see our responses to the specific reviewer's comments as well as the revised manuscript.

      Public Reviews:

      Reviewer #1 (Public Review): 

      Wang and colleagues conducted a study to determine the neurotransmitter identity of all neurons in C. elegans hermaphrodites and males. They used CRISPR technology to introduce fluorescent gene expression reporters into the genomic loci of NT pathway genes. This approach is expected to better reflect in vivo gene expression compared to other methods like promoter- or fosmid-based transgenes, or available scRNA datasets. The study presents several noteworthy findings, including sexual dimorphisms, patterns of NT co-transmission, neuronal classes that likely use NTs without direct synthesis, and potential identification of unconventional NTs (e.g. betaine releasing neurons). The data is well-described and critically discussed, including a comparison with alternative methods. Although many of the observations and proposals have been previously discussed by the Hobert lab, the current study is particularly valuable due to its comprehensiveness. This NT atlas is the most complete and comprehensive of any nervous system that I am aware of, making it an extremely useful tool for the community. 

      Reviewer #2 (Public Review):

      Summary: 

      Together with the known anatomical connectivity of C. elegans, a neurotransmitter atlas paves the way toward a functional connectivity map. This study refines the expression patterns of key genes for neurotransmission by analyzing the expression patterns from CRISPR-knocked-in GFP reporter strains using the color-coded Neuropal strain to identify neurons. Along with data from previous scRNA sequencing and other reporter strains, examining these expression patterns enhances our understanding of neurotransmitter identity for each neuron in hermaphrodites and the male nervous system. Beyond the known neurotransmitters (GABA, Acetylcholine, Glutamate, dopamine, serotonin, tyramine, octopamine), the atlas also identifies neurons likely using betaine and suggests sets of neurons employing new unknown monoaminergic transmission, or using exclusively peptidergic transmission. 

      Strengths: 

      The use of CRISPR reporter alleles and of the Neuropal strain to assign neurotransmitter usage to each neuron is much more rigorous than previous analysis and reveals intriguing differences between scRNA seq, fosmid reporter, and CRISPR knock-in approaches. Among other mechanisms, these differences between approaches could be attributed to 3'UTR regulatory mechanisms for scRNA vs. knockin or titration of rate-limited negative regulatory mechanisms for fosmid vs. knockin. It would be interesting to discuss this and highlight the occurrences of these potential phenomena for future studies.  

      We recognize that readers of this study may be interested in understanding the differences between the three approaches. Therefore, in the Introduction, we addressed the potential risk of overexpression artifacts associated with multicopy transgenes, such as fosmid-based reporters, which can affect rate-limiting negative regulatory mechanisms. Additionally, in the Discussion, we included a section titled 'Comparing approaches and caveats of expression pattern analysis' to further explore these comparative methods and their associated nuances.

      Weaknesses: 

      For GABAergic transmission, one shortcoming arises from the lack of improved expression pattern by a knockin reporter strain for the GABA recapture symporter snf-11. In its absence, it is difficult to make a final conclusion on GABA recapture vs GABA clearance for all neurons expressing the vesicular GABA transporter neurons (unc-47+) but not expressing the GAD/UNC-25 gene e.g. SIA or R2A neurons. At minima, a comparison of the scRNA seq predictions versus the snf-11 fosmid reporter strain expression pattern would help to better judge the proposed role of each neuron in GABA clearance or recycling. 

      The snf-11 fosmid-based reporter data shows very good overlap with scRNA seq predictions (now included in Supp. Table S1). 

      But there are two much stronger reasons why we did not seek to further the analysis of expression of the snf-11 GABA uptaker:

      (1) Due to available anti-GABA staining data, we do know which neurons have the potential to take up GABA (via SNF-11).

      (2) Focusing on SNF-11 function rather than expression, we can ask which neurons lose anti-GABA staining in snf-11 mutants.

      Both of these types of analyses have been done in an earlier study from our lab (Gendrel et al., 2016, PMID 27740909), which, among other things, investigated GABA uptake mechanisms via SNF-11. Apart from analyzing the expression of a fosmid-based snf-11 reporter, we immunostained worms for GABA in both snf-11 mutant and wild type backgrounds (results summarized in Tables 1 and 2 of Gendrel et al.). Of the neurons that typically stain for GABA (Table 1, Gendrel et al.), two neuron classes (ALA and AVF) lost the staining in snf-11 mutants, suggesting that these neurons likely uptake GABA via SNF-11. Importantly, one of the neurons the reviewer mentioned, R2A, stains for GABA in both wild type and snf-11 mutants, indicating that it likely does not uptake GABA via SNF-11. The other neuron mentioned, SIA, does not stain for GABA in wild type (Table 2, Gendrel et al.), hence not a GABA uptake neuron. In cases like SIA and other neurons, where a neuron does not express unc-25 but does express unc-47 reporters (either fosmid or CRISPR reporter alleles), we speculate that UNC-47 transport another neurotransmitter.

      Considering the complexities of different tagging approaches, like T2A-GFP and SL2-GFP cassettes, in capturing post-translational and 3'UTR regulation is important. The current formulation is simplistic. e.g. after SL2 trans-splicing the GFP RNA lacks the 5' regulatory elements, T2A-GFP self-cleavage has its own issues, and the his-44-GFP reporter protein does certainly have a different post-translational life than vesicular transporters or cytoplasmic enzymes. 

      Yes, agreed, these points are mentioned in the Introduction and discussed in "Comparing approaches and caveats of expression pattern analysis" in the Discussion.

      Do all splicing variants of neurotransmitter-related genes translate into functional proteins? The possibility that some neurons express a non-functional splice variant, leading to his-74-GFP reporter expression without functional neurotransmitter-related protein production is not addressed. 

      We thank the reviewer for bringing up this really interesting point, which we had not considered. First and foremost, with the exception of unc-25 (discussed in the next point), for all other genes that produce multiple splice forms, we made sure to append our tag (at 5’ or 3’ end) such that the expression of all splice forms is captured. The reviewer raises the interesting point that in an alternative splicing scenario, some of the cells that express the primary transcript may “switch” to an inactive form. While we cannot exclude this possibility, we have confirmed by sequence analysis in WormBase that in five of the six cases where there is alternative splicing, the alternatively spliced exon lies outside the conserved, functionally relevant (enzymatic or structural) domain. In one case, unc-25, a shorter isoform is produced that does cut into the functionally relevant domain; however, since all unc-25 reporter allele expression cells are also staining positive for GABA, this may not be an issue. 

      Also, one tagged splice variant of unc-25 is expected to fail to produce a GFP reporter, can this cause trouble? 

      Yes, there is indeed a third splice variant of unc-25 with an alternative C-terminus. To address potential expression of this isoform, we CRISPR-engineered another reporter, unc-25(ot1536[unc-25b.1::t2a::gfp::h2b]), in which the inserted t2a::gfp::h2b sequences are fused to the C-terminus of the alternative splice form, but we did not observe any expression of this reporter. Now included in the manuscript.

      Reviewer #3 (Public Review): 

      Summary: 

      In this paper, Wang et al. provide the most comprehensive description and comparison of the expression of the different genes required to synthesize, transport, and recycle the most common neurotransmitters (Glutamate, Acetylcholine, GABA, Serotonin, Dopamine, Octopamine, and Tyramine) used by hermaphrodite and male C. elegans. This paper will be a seminal reference in the field. Building and contrasting observations from previous studies using fosmid, multicopy reporters, and single-cell sequencing, they now describe CRISPR/Cas-9-engineered reporter strains that, in combination with the multicolor pan-neuronal labeling of all C. elegans neurons (NeuroPAL), allows rigorous elucidation of neurotransmitter expression patterns. These novel reporters also illuminate previously unappreciated aspects of neurotransmitter biology in C. elegans, including sexual dimorphism of expression patterns, cotransmission, and the elucidation of cell-specific pathways that might represent new forms of neurotransmission. 

      Strengths: 

      The authors set out to establish neurotransmitter identities in C. elegans males and hermaphrodites via varying techniques, including integration of previous studies, examination of expression patterns, and generation of endogenous CRISPR-labeled alleles. Their study is comprehensive, detailed, and rigorous, and achieves the aims. It is an excellent reference for the field, particularly those interested in biosynthetic pathways of neurotransmission and their distribution in vivo, in neuronal and non-neuronal cells. 

      Weaknesses: 

      No weaknesses were noted. The authors do a great job linking their characterizations with other studies and techniques, giving credence to their findings. As the authors note, there are sexually dimorphic differences across animals and varying expression patterns of enzymes. While it is unlikely there will be huge differences in the reported patterns across individual animals, it is possible that these expression patterns could vary developmentally, or based on physiological or environmental conditions. It is unclear from the study how many animals were imaged for each condition, and if the authors noted changes across individuals during development (could be further acknowledged in the discussion?)  

      We have updated the Methods section to specify the number of animals used for imaging. We agree with the reviewer that documenting the developmental dynamics of neurotransmitter expression would be interesting. However, except for one gene (tph-1, Fig. S2), we did not analyze the expression during different developmental stages for most genes in this study. Following the reviewer's suggestion, we have included this as a potential future direction in "Conclusions" at the end of the revised manuscript.

      Recommendations for the authors:

      After the consultation session, a common suggestion from the reviewers is to bring the tables more upfront, perhaps even in the form of legible main Figures and in alphabetical order of neurons; since we believe that the study will be in the long-term often used for these data; while the Figures with fluorescent expression patterns could be moved to the supplemental information. 

      We appreciate the reviewers' and editor's acknowledgment of the tables' possibly frequent usage by the field. We have considered carefully how to order the data presentation. We prefer to keep most of the fluorescent figures in the main text because they convey important subtleties that we want the reader to be aware of.

      To address the suggestions to bring key data more upfront, we have added an entirely new figure (Figure 3) before the ensuing data figures that summarized expression patterns of the fluorescent reporters. This new figure (A) summarizes the neurotransmitter use for all neuron classes and (B) illustrates this information within worm schematics, showing the position of neurons in the whole worm. This figure serves as a good overview of neurotransmitter assignments but also specifically refers to the more extensive data and supplementary tables with detailed notes. We believe this solution effectively balances the need for comprehensive information and ease of reference.

      Reviewer #1 (Recommendations for The Authors):

      Suggestions: 

      (1) The study contains up to 10 Figures with gene expression patterns; however, I believe the community will use this paper mostly in the future for its summarizing tables. I wonder if it would be more useful to edit the tables and move them to the main figures while most fluorescent reporter images could be moved to the supplementary part. 

      Yes, as mentioned above, we made new summary table & schematic upfront. We do prefer to keep primary data in main figure body. Please see above (Public Review & Response).

      (2) In the section titled 'Neurotransmitter Synthesis versus Uptake', the author's wording could be more careful. The data rather suggests functions for individual neuronal classes, such as clearance neurons or signaling neurons. However, these functions remain hypotheses until further detailed studies are conducted to test them. 

      These are fair points. We have made several improvements: 

      (1) In the referenced section, we added a sentence at the end of the paragraph on betaine to suggest the importance of future functional studies.

      (2) We analyzed reporter allele expression for two additional genes: the known uptake transporter for 5-HT (mod-5, reporter allele vlc47) and the predicted uptake transporter for tyramine (oct-1, reporter allele syb8870). The results from these experiments are presented in the new Figure 8 and discussed in Results and Discussion correspondingly. We also collaborated with Curtis Loer, who conducted anti-5-HT staining in wild type and mod-5 mutant animals (results shown in Figure 12). These experiments have enhanced our understanding of 5-HT uptake mechanisms and potential tyramine uptake mechanisms.

      (3) At the end of the Conclusions, we emphasized the need for future detailed studies to test the functions of neurotransmitter synthesis and uptake.

      (3) Page 21; add to the discussion: neurons could use mainly electrical synapses for communication. Especially for RMG neurons, this might be the case (in addition to neuropeptide communication). 

      “Main usage” is a difficult term to use. If there were neurons that are clearly devoid of any form of synaptic vesicle (small or DCV; note that RMG has plenty of DCVs), but show robust and reproducible electrical synapses, we would agree that such neurons could primarily be a “coupling” neuron. But this call is very hard to make for any C. elegans neuron (RMG included) and hence we prefer to not add further to an already quite long Discussion section.

      (4) Page 23: I believe that multi-copy promoter-based transgenes (despite array suppression mechanisms) could be potentially more sensitive than single-copy insertion of fluorescent reporters. In our lab, we observed this a couple of times. This could be discussed. 

      We discuss this in "Comparing approaches and caveats of expression pattern analysis" in the Discussion.

      We have also added a third possibility (i.e. technical issues related to neuron-ID) in the revised manuscript.   

      Reviewer #2 (Recommendations For The Authors): 

      Comment during consultation session: As for my feedback on the lack of an SNF-11 reporter strain, exercising more caution in their conclusions would suffice for me. Other comments are simple edits/discussion.  

      Please see above.  

      Several neurotransmitter symporters exist in the C. elegans genome, does any express specifically in the "orphan" UNC-47+ neurons? 

      Yes, good point, we considered this possibility, but of the >10 SLC6-family of neurotransmitter reporters, only the classic, de-orphanized ones that we discuss here in the paper show robust scRNA signals (as discussed in the paper) and none of those give clues about the orphan unc-47(+) neurons.

      Based on UNC-47+ expression the article suggests a "Novel inhibitory neurotransmitter". Why would any new neurotransmitter using UNC-47 be necessarily inhibitory? The presence of one potential glycine-gated anion channel and one GPCR in C. elegans genome sounds poor evidence to suggest a sign of glycine or b-alanine transmission. 

      Yes, agreed, it does not need to be inhibitory. Fixed in Results and Discussion. 

      To help readers the expression of the knocked in GFP in neurons should not be reported as binary in table S1 which leads to a feeling of strong discrepancy between scRNA seq and CRISPR GFP, which is not the case.  

      There might be some misunderstanding regarding the coloring in this table. To clarify, the green-filled Excel cells denote the expression of reporters utilized in prior studies, rather than the CRISPR reporter alleles. Expression of the CRISPR alleles is instead indicated on the left side of the neuron names, marked as "CRISPR+" in green font. For signifying absence of expression, we used "no CRISPR" in red font in the first submission. We have now changed it into "CRISPR-" for greater clarity.

      The variable expression of reporter GFP between individuals for the same neuron is intriguing. It is unclear if this is observed only for dim neurons or can be more of an ON/OFF expression. 

      Variability only occurs for dim expression. We have now clarified this point in Discussion, "Comparing approaches and caveats of expression pattern analysis".

      The multiple occurrences of co-transmission, especially in male neurons, are interesting. It will be interesting in the future to establish whether the neurotransmitters are synaptically segregated or coreleased. As the section on sexual dimorphism of neurotransmitter usage does not discuss novel information coming from this study, it is not very necessary. 

      Agreed. We added this perspective to the Discussion, "Co-transmission of multiple neurotransmitters".  

      In the abstract, dopamine is missing in the main known transmitter.  

      Fixed. Thanks for spotting this.

      Reviewer #3 (Recommendations For The Authors): 

      Great article. Minor suggestions to strengthen presentation: 

      Figure 1B is hard to interpret. There could be more intuitive ways of representing the data and the methodologies that support a given expression pattern. Neurons should also be reordered by alphabetical order rather than expression levels to facilitate finding them.  

      We considered alternative ways of presenting this data, but, regrettably, did not come up with a better approach. To clarify, the primary focus of Fig. 1B is to compare expression of previously reported reporters and scRNA data, which was quite literally the initial impetus for our analysis, i.e. we noted strong scRNA signals that had not previously been supported by transgenic reporter data. For a comprehensive version of the table that includes more details on the expression of CRISPR reporter alleles, please refer to Table S1, which we referenced in the figure legend.   

      GFP-only channel images in Figures 3, 4, 5, and 9 sometimes show dim signals that the authors are highlighting as new findings. We recommend using the inverted grayscale version of that channel since the contrast of dim signals is more noticeable to the human eye rather than when the image is colorized. 

      Good point, we implemented these suggestions in the figures the reviewer mentioned, now re-numbered Figures 4, 5, 6, and 12. For Figure 6 (tph-1, bas-1, and cat-1 expression in hermaphrodites), we used a new cat-1 head image to reflect the newly identified ASI and AVL expression that wasn’t readily visible in the original projection used in the earlier version of this manuscript. We also added grayscale images in Figure 13 to reflect dim tbh-1 expression in IL2 neurons more clearly.

      A plan to integrate this new information into WormAtlas. The C. elegans community is characterized by the open sharing of information on platforms that are user-friendly and accessible. Ideally, the new information would not just 'erase' what was observed before but will describe the new observations and will let the community reach their own conclusions since there is no perfect method and even these CRISPR/Cas9 reporter strains are only proxy for gene expression that subject to post-transcriptional regulation since they depend on T2A and SL2 sequences. 

      We completely agree with the reviewer’s suggestion. We will coordinate with WormAtlas on integrating this new information. 

      In the case of neurons that were removed from using a specific neurotransmitter, like PVQ. What do the authors conclude overall, if it does not use glutamate, are there any new hypotheses to what it could be using?

      Since all neurons express multiple neuropeptides, we hypothesize neurons such as PVQ may be primarily peptidergic. This is included in Discussion, "Neurons devoid of canonical neurotransmitter pathway genes may define neuropeptide-only neurons".  

      In Table S5, the I4 neuron is listed as a variable for eat-4 expression but in Table S1 it says that there was no CRISPR expression detected. Which one is correct? 

      Thanks for spotting this. Table S5 is correct, we saw very dim and variable expression of the eat-4 reporter allele in I4. Table S1 is fixed now.

      Additional discussion points that might be important for the community: 

      CRIPSR strains used here should be deposited in the CGC. 

      Yes, all strains generated in this study have already been deposited to CGC. 

      It would be great to have an additional discussion point on how the neural clusters in CenGEN were defined based on the fosmid reporter expression, so in a way using the defining factor as one that was already defined by it might make results confusing. 

      Neural cluster definition in CeNGEN did not rely on isolated data points but on the combination of many expression reagents, each with its own shortcomings, but in combination providing reliable identification. Since one feedback we have gotten from many readers of our manuscript is that it is already very long as is, we prefer not to dilute the discussion further.

      It would be important to discuss the rate of neurotransmitter genes that have variable expression patterns. Are any of those genes used in NeuroPAL to define specific neuronal classes? This is important to describe as NeuroPAL labeling is being used to define neuronal identity. 

      All the reporters used in NeuroPAL are promoter-based, very robust and do not include the full loci of genes, so they are not directly comparable with the CRISPR reporter alleles in this study. However, we recognize that some expression pattern variability could be confusing. We have discussed this more in the section "Comparing approaches and caveats of expression pattern analysis" in the Discussion.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this study, James Lee, Lu Bai, and colleagues use a multifaceted approach to investigate the relationship between transcription factor condensate formation, transcription, and 3D gene clustering of the MET regulon in the model organism S. cerevisiae. This study represents a second clear example of inducible transcriptional condensates in budding yeast, as most evidence for transcriptional condensates arises from studies of mammalian systems. In addition, this study links the genomic location of transcriptional condensates to the potency of transcription of a reporter gene regulated by the master transcription factor contained in the condensate. The strength of evidence supporting these two conclusions is strong. Less strong is evidence supporting the claim that Met4-containing condensates mediate the clustering of genes in the MET regulon.

      Strengths:

      The manuscript is for the most part clearly written, with the overriding model and specific hypothesis being tested clearly explained. Figure legends are particularly well written. An additional strength of the manuscript is that most of the main conclusions are supported by the data. This includes the propensity of Met4 and Met32 to form puncta-like structures under inducing conditions, formation of Met32-containing LLPS-like droplets in vitro (within which Met4 can colocalize), colocalization of Met4-GFP with Met4-target genes under inducing conditions, enhanced transcription of a Met3pr-GFP reporter when targeted within 1.5 - 5 kb of select Met4 target genes, and most impressively, evidence that several MET genes appear to reposition under transcriptionally inducing conditions. The latter is based on a recently reported novel in vivo methylation assay, MTAC, developed by the Bai lab.

      Weaknesses:

      My principal concern is that the authors fail to show convincing evidence for a key conclusion, highlighted in the title, that nuclear condensates per se drive MET gene clustering. Figure 4E demonstrates that Met4 molecules, not condensates per se, are necessary for fostering distant cis and trans interactions between MET6 and three other Met4 targets under -met inducing conditions. In addition, the paper would be strengthened by discussing a recent study conducted in yeast that comes to many of the same conclusions reported here, including the role of inducible TF condensates in driving 3D genome reorganization (Chowdhary et al, Mol. Cell 2022).

      Following the reviewer’s advice, we carried out MTAC with the VP near MET6 in WT Met4 and ΔIDR2.3 strains (results shown below). The conclusions are somewhat ambiguous. For long-distance interactions with MUP1, YKG9, STR3, and MET13, we indeed observe decreased MTAC signals close to background levels in the ΔIDR2.3 strain, which aligns with the model suggesting that Met4 condensation promotes clustering among Met4 targeted genes. However, we also noticed significant decreases in the local MTAC signals (HIS3 and MET6). It is possible that the changes in Met4 condensates alter the chromosomal folding near MET6, thereby affecting the local MTAC signals. Alternatively, LacI-M.CviPI (the methyltransferase) could be induced to a lesser extent in the ΔIDR2.3 strain, leading to a genome-wide decrease in MTAC signals. Due to this ambiguity, we decided not to include the following plot in the main figure.

      Author response image 1.

      We discussed Hsf1 and added the suggested reference on page 13.

      Other concerns:

      (1) A central premise of the study is that the inducible formation of condensates underpins the induction of MET gene transcription and MET gene clustering. Yet, Figure 1 suggests (and the authors acknowledge) that puncta-like Met4-containing structures pre-exist in the nuclei of non-induced cells. Thus, the transcription and gene reorganization observed is due to a relatively modest increase in condensate-like structures. Are we dealing with two different types of Met4 condensates? (For example, different combinations of Met4 with its partners; Mediator- or Pol II-lacking vs. Mediator- or Pol II-containing; etc.?) At the very least, a comment to this effect is necessary.

      Although Met4 can form smaller puncta in the +met condition (Figure 1A), it cannot be recruited to its target genes due to the absence of its sequence-specific binding partners, Met31 and Met32 (these two factors are actively degraded in the +met condition). Consistently, in the +met condition, Met4 shows extremely low genome-wide ChIP signals (Figure 3C). Therefore, these Met4 puncta in +met do not have organize the 3D genome or have gene regulatory functions. This discussion is added on page 12.

      (2) Using an in vitro assay, the authors demonstrate that Met4 colocalizes with Met32 LLPS droplets (Figure 2F). Is the same true in vivo - that is, is Met32 required for Met4 condensation? This could be readily tested using auxin-induced degradation of Met32. Along similar lines, the claim that Met32 is required for MET gene clustering (line 250) requires auxin-induced degradation of this protein.

      As the reviewer pointed out above, cells in the +met condition also show small Met4 puncta. In this condition, Met32 is essentially undetectable (Met31 level is even lower and remains undetectable even in the -met conditions). Therefore, Met4 does not strictly require the presence of Met32 in vivo (may require other factors or modifications). Met4 does not have DNA-binding activity, and therefore it cannot target and organize chromosomes on its own. Although we did not do the Met32 degradation experiment, we measured the 3D genome conformation in +met and showed that there are no detectable interactions among Met4 target genes.

      (3) The authors use a single time point during -met induction (2 h) to evaluate TF clustering, transcription (mRNA abundance), and 3D restructuring. It would be informative to perform a kinetic analysis since such an analysis could reveal whether TF clustering precedes transcriptional induction or MET gene repositioning. Do the latter two phenomena occur concurrently or does one precede the other?

      We appreciate the reviewer’s insightful question. It is indeed intriguing to consider whether TF clustering precedes transcriptional induction and MET gene clustering. However, as mentioned on page 12 of our manuscript, this experiment poses significant challenges. The low intensities of the Met4 and Met32 signals necessitate high excitation for imaging, which also makes them prone to photo-bleaching. Consequently, we have been unable to measure the dynamics of Met4 and Met32 puncta in vivo, let alone co-image them with DNA/RNA. Undertaking this experiment will require considerable effort, which we plan to pursue in the future.

      (4) Based on the MTAC assay, MET13 does not appear to engage in trans interactions with other Met4 targets, whereas MET6 does (Figures 4C and 4E). Does this difference stem from the greater occupancy of Met4 at MET6 vs. MET13, greater association of another Met co-factor with the chromatin of MET6 vs. MET13, or something else?

      We were also surprised by this result, given that MET13 emerged as one of the strongest transcriptional hotspots in our previous screen. It also exhibits one of the highest Met4 ChIP signals and is closely associated with the nuclear pore complex. Our earlier findings indicate that DNA dynamics near the VP significantly influence the MTAC signal; specifically, a VP with constrained motion is less effective at methylating interacting sites (Li et al., 2024). Therefore, it is plausible that MET13 is associated with a large Met4 condensate, which constrains the motion of nearby chromatin and diminishes MTAC efficiency.

      Reviewer #2 (Public Review):

      Summary:

      This manuscript combines live yeast cell imaging and other genomic approaches to study how transcription factor (TF) condensates might help organize and enhance the transcription of the target genes in the methionine starvation response pathway. The authors show that the TFs in this response can form phase-separated condensates through their intrinsically disordered regions (IDRs), and mediate the spatial clustering of the related endogenous genes as well as reporter inserted near the endogenous target loci.

      Strengths:

      This work uses rigorous experimental approaches, such as imaging of endogenously labeled TFs, determining expression and clustering of endogenous target genes, and reporter integration near the endogenous target loci. The importance of TFs is shown by rapid degradation. Single-cell data are combined with genomic sequencing-based assays. Control loci engineered in the same way are usually included. Some of these controls are very helpful in showing the pathway-specific effect of the TF condensates in enhancing transcription.

      Weaknesses:

      Perhaps the biggest weakness of this work is that the role of IDR and phase separation in mediating the target gene clustering is unclear. This is an important question. TF IDRs may have many functions including mediating phase separation and binding to other transcriptional molecules (not limited to proteins and may even include RNAs). The effect of IDR deletion on reduced Fano number in cells could come from reduced binding with other molecules. This should be tested on phase separation of the purified protein after IDR deletion. Also, the authors have not shown IDR deletion affects the clustering of the target genes, so IDR deletion may affect the binding of other molecules (not the general transcription machinery) that are specifically important for target gene transcription. If the self-association of the IDR is the main driving force of the clustering and target gene transcription enhancement, can one replace this IDR with totally unrelated IDRs that have been shown to mediate phase separation in non-transcription systems and still see the gene clustering and transcription enhancement effects? This work has all the setup to test this hypothesis.

      We thank the reviewer for raising this point, and we tried more in vitro and in vivo experiments with Met4 IDR deletions. See the answer to Reviewer 1 for the in vivo 3D mapping experiment.

      We purified Met4-ΔIDR2 with an MBP tag, but its low yield made labeling and conducting thorough experiments challenging. At concentrations above ~10 μM, the protein tends to aggregate, while at lower concentrations, it remains diffusive in solution and does not form condensates. When we mixed purified Met4-ΔIDR2 with Met32, we observed reduced partitioning inside Met32 condensates compared to the full-length Met4. As the reviewer noted, this diminished interaction may contribute to the decreased puncta formation observed in vivo. This result is added to the manuscript on page 11 and supplementary figure 5.

      The Met4 protein was tagged with MBP but Met 32 was not. MBP tag is well known to enhance protein solubility and prevent phase separation. This made the comparison of their in vitro phase behavior very different and led the authors to think that maybe Met32 is the scaffold in the co-condensates. If MBP was necessary to increase yield and solubility during expression and purification, it should be cleaved (a protease cleavage site should be engineered) to allow phase separation in vitro.

      Following the reviewer’s advice, we purified Met4-TEV-MBP so that the MBP can be cleaved off. Unfortunately, concentrated Met4-TEV-MBP needs to be stored at high salt (400mM) to be soluble. When exchanged into a suitable buffer for TEV cleavage (≤200 mM NaCl), nearly all soluble protein aggregates. Attempts to digest the protein in storage buffer results in observable aggregation before significant cleavage (see below).  

      Author response image 2.

      Are ATG36 and LDS2 also supposed to be induced by -met? This should be explained clearly. The signals are high at -met.

      Genomic loci ATG36 and LDS2 were chosen as controls because they are not bound by Met TFs (ChIP-seq tracks) and their expressions are not induced by -met (RNA-seq data). This information is added to the manuscript on page 9. When MET3pr-GFP reporter is inserted into these loci, GFP is induced by -met (because it is driven by the MET3 promoter), but the induction level is less than the same reporter inserted into the transcriptional hotspot like MET13 and MET6 (Figure 6E, also see Du et al., Plos Genetics, 2017).

      ChIP-seq data:

      Author response image 3.

      RNA-seq counts:

      Author response table 1.

      Figure 6B, the Met4-GFP seems to form condensates at all three loci without a very obvious difference, though 6C shows a difference. 6C is from only one picture each. The authors should probably quantify the signals from a large number of randomly selected pictures (cells) and do statistics.

      If we understand this comment correctly, the reviewer is referring to the fact that all three loci in Figure 6B appear to show a peak in GFP intensity. This pattern emerges because these images are averaged among many cells (number of cells analyzed in 6B has been added to the Figure legends). GFP intensities near the center will always be higher because peripheral pixels are more likely to fall outside the nuclei boundaries, where Met4 signals are absent (same as in Figure 3F). Importantly, MET6 locus shows higher intensity near the center in comparison to PUT1 and ATG36, indicating its co-localization with Met4 condensates.

      Reviewer #3 (Public Review):

      Summary:

      In this study, the authors probe the connections between clustering of the Met4/32 transcription factors (TFs), clustering of their regulatory targets, and transcriptional regulation. While there is an increasing number of studies on TF clustering in vitro and in vivo, there is an important need to probe whether clustering plays a functional role in gene expression. Another important question is whether TF clustering leads to the clustering of relevant gene targets in vivo. Here the authors provide several lines of evidence to make a compelling case that Met4/32 and their target genes cluster and that this leads to an increase in transcription of these genes in the induced state. First, they found that, in the induced state, Met4/32 forms co-localized puncta in vivo. This is supported by in vitro studies showing that these TFs can form condensates in vitro with Med32 being the driver of these condensates. They found that two target genes, MET6 and MET13 have a higher probability of being co-localized with Met4 puncta compared with non-target loci. Using a targeted DNA methylation assay, they found that MET13 and MET6 show Met4-dependent long-range interactions with other Met4-regulated loci, consistent with the clustering of at least some target genes under induced conditions. Finally, by inserting a Met4-regulated reporter gene at variable distances from MET6, they provide evidence that insertion near this gene is a modest hotspot for activity.

      Weaknesses:

      (1) Please provide more information on the assay for puncta formation (Figure 1). It's unclear to me from the description provided how this assay was able to quantitate the number of puncta in cells.

      Due to the variation in puncta size and intensity (as illustrated in Figure 1A), counting the number of puncta would be highly subjective with arbitrary cutoffs. Therefore, we chose to calculate the CV and Fano values instead, which are unbiased measures. Proteins that form puncta will exhibit greater pixel-to-pixel variations in GFP intensity, resulting in higher CV and Fano values.

      (2) How does the number of puncta in cells correspond with the number of Met-regulated genes? What are the implications of this calculation?

      As previously mentioned, defining the exact number of Met4 puncta is challenging. The number of puncta does not necessarily have one-to-one correspondence to the number of Met4 target genes. Some puncta may not be associated with chromosomes, while others may interact with multiple genes.

      (3) A control for chromosomal insertion of the Met-regulated reporter was a GAL4 promoter derivative reporter. However, this control promoter seems 5-10 fold more active than the Met-regulated promoter (Figure 6). It's possible that the high activity from the control promoter overcomes some other limiting step such that chromosomal location isn't important. It would be ideal if the authors used a promoter with comparable activity to the Met-reporter as a control.

      We agree with the reviewer that it will be better to use another promoter with comparable activity. Indeed, this was our rationale for selecting the attenuated GAL1 promoter over the WT version; however, it still exhibited substantially higher activity than the MET3pr. Unfortunately, we do not have a promoter from a different pathway that is calibrated to match the activity level of MET3pr. Nonetheless, MET17pr has much higher activity (~3 fold) than MET3pr, and we observed similar degree of stimulus from the hotspot in comparison to the control locus for both promoters (1.5-2-fold increase in GFP expression) (Figure 6E & F). This suggests that the observed effects are more likely to depend on the activation pathway and TF identity rather than the promoter strength.

      (4) It seems like transcription from a very large number of genes is altered in the Met4 IDR mutant (Figure 7F). Why is this and could this variability affect the conclusions from this experiment?

      We agree with the reviewer that ΔIDR 2.3 truncation affects the expression of 2711 (P-adj <0.05) genes (1339 up,1372 down). We suspect that this is due to the decreased expression of Met4 target genes, leading to altered levels of methionine and other sulfur-containing metabolites. Such changes would have a global impact on gene expression. Importantly, despite the similar number of genes that show up vs down regulation in the ΔIDR 2.3 strain, almost all Met4 targets showed decreased expression (Fig 7F). This supports the model where Met4 condensates lead to increased expression in its target genes.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for The Authors):

      (1) The introduction contains multiple miscitations. Rather than gene clustering, most of the studies and reviews cited (e.g., lines 35-39) report interactions between genomic loci (E-E, E-P, and P-P). There are other claims not supported by the papers cited. Moreover, the authors lump together original research papers and reviews within a given group without distinguishing which is which.

      We thank the reviewer for pointing this out. We reorganized the references in the introduction.

      (2) One option to address the concern regarding the lack of evidence that nuclear condensates per se drive MET gene clustering is to test the impact of Met4 ΔIDR2.3 on MTAC signals.

      We carried out the suggested experiment. See answer above (Reviewer #1, Question #1).

      (3) Authors claim that there are significant differences between values depicted in Figures 1B and 3G. Statistical tests are necessary to show this.

      Significance values were calculated in comparison to free GFP using two-tailed Student’s t-test in 1B,1C, and 3G. The corresponding figure legends are updated.

      (4) How are the data in Figures 3F, G, and 6B, C generated? This is unclear from the information provided in the Figure legends and Materials and Methods.

      For each cell, we projected the highest mCherry and GFP intensity at each pixel for all z positions onto a 2D plane (MIP). The MIP images were aligned with the mCherry dot at the center and averaged among all cells. To calculate the GFP intensities like in Figure 3G and 6C, a single line was drawn across the center and the GFP profile was analyzed by ImageJ. We now describe this in the corresponding figure legends, and the Materials and Methods are also updated.

      (5) Typos/ unclear writing: lines 24, 58, 79, 82, 84, 96, 117, 121, 131, 142, 147, 161 (terminus, not "terminal"), 250, 325, 349, 761 (was, not "are"). For several of these: "condense" is not "condensate"; for many others: inappropriate use of "the". Supplementary Figure 1 legend: not "a single nuclei" instead "a single nucleus".

      We thank the reviewer for pointing this out. We tried our best to correct grammatical errors.

      (6) Define GAL1Spr (Figure 6F).

      The GAL1S promoter is an attenuated GAL1 promoter that lacks two out of the four Gal4 binding site. The original paper is now cited in the manuscript on page 10.  

      (7) Figure 7B, C: there appears to be an inconsistency between the image and bar graph value for ΔIDR3.

      The Fano values calculated in 7C are averaged among a population of cells (we added the cell numbers to the legend), while the image in 7B is an example of an individual nucleus. There is some cell-to-cell variability in how the Met4 appears. To be more representative, we chose a different image for ΔIDR3.

      (8) Supplementary Tables: use descriptive titles for file names.

      This is corrected.

      Reviewer #2 (Recommendations For The Authors):

      Minor:

      Figure 4F is not cited in the text, and the color legend seems wrong for targeted and control.

      Figure 4F is now cited in the text. The labels were corrected.

    1. 一个 Docker Registry 中可以包含多个仓库(Repository);每个仓库可以包含多个标签(Tag);每个标签对应一个镜像。 通常,一个仓库会包含同一个软件不同版本的镜像,而标签就常用于对应该软件的各个版本。我们可以通过 <仓库名>:<标签> 的格式来指定具体是这个软件哪个版本的镜像。如果不给出标签,将以 latest 作为默认标签。
    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      1. Point-by-point description of the revisions

      This section is mandatory. *Please insert a point-by-point reply describing the revisions that were already carried out and included in the transferred manuscript. *

      Reviewer #1 (Evidence, reproducibility, and clarity (Required)): This is an interesting manuscript from the Jagannathan laboratory, which addresses the interaction proteome of two satellite DNA-binding proteins, D1 and Prod. To prevent a bias by different antibody affinities they use GFP-fusion proteins of D1 and Prod as baits and purified them using anti GFP nanobodies. They performed the purifications in three different tissues: embryo, ovary and GSC enriched testes. Across all experiments, they identified 500 proteins with surprisingly little overlap among tissues and between the two different baits. Based on the observed interaction of prod and D1 with members of the canonical piRNA pathway the authors hypothesized that both proteins might influence the expression of transposable elements. However, neither by specific RNAi alleles or mutants that lead to a down regulation of D1 and Prod in the gonadal soma nor in the germline did they find an effect on the repression of transposable elements. They also did not detect an effect of a removal of piRNA pathway proteins on satellite DNA clustering, which is mediated by Prod and D1. However, they do observe a mis-localisation of the piRNA biogenesis complex to an expanded satellite DNA in absence of D1, which presumably is the cause of a mis-regulation of transposable elements in the F2 generation.This is an interesting finding linking satellite DNA and transposable element regulation in the germline. However, I find the title profoundly misleading as the link between satellite DNA organization and transgenerational transposon repression in Drosophila has not been identified by multi-tissue proteomics but by a finding of the Brennecke lab that the piRNA biogenesis complex has a tendency to localise to satellite DNA when the localisation to the piRNA locus is impaired. Nevertheless, the investigation of the D1 and Prod interactome is interesting and might reveal insights into the pathways that drive the formation of centromeres in a tissue specific manner.

      We thank the reviewer for the overall positive comments on our manuscript. As noted above, we have performed a substantial number of revision experiments and improved our text. We believe that our revised manuscript demonstrates a clear link between our proteomics data and the transposon repression. We would like to make three main points,

      1. Our proteomics data identified that D1 and Prod co-purified transposon repression proteins in embryos. To test the functional significance of this association, we have used Drosophila genetics to generate flies lacking embryonic D1. In adult ovaries from these flies, we observe a striking elevation in transposon expression and Chk2-dependent gonadal atrophy. Along with the results from the control genotypes (F1 D1 mutant, F2 D1 het), our data clearly indicate that embryogenesis (and potentially early larval development) are a period when D1 establishes heritable TE silencing that can persist throughout development.
      2. Based on the newly acquired RNA-seq and small RNA seq data, we have edited our title to more accurately reflect our data. Specifically, we have substituted the word 'transgenerational' with 'heritable', meaning that the presence of D1 during early development alone is sufficient to heritably repress TEs at later stages of development.
      3. In addition, our RNA seq and small RNA seq experiments demonstrate that D1 makes a negligible contribution to piRNA biogenesis and TE repression in adults, despite the significant mislocalization of the RDC complex. In this regard, our results are substantially different from the recent Kipferl study from the Brennecke lab (Baumgartner et al. 2022).

        Major comments Unfortunately, the proteomic data sets are not very convincing. Not even the corresponding baits are detected in all assays. I wonder whether the extraction procedure really allows the authors to analyze all functionally relevant interactions of Prod and D1. It would be good to see a western blot or an MS analysis of the soluble nuclear extract they use for purification compared to the insoluble chromatin. It may well be that a large portion of Prod or D1 is lost in this early step. I also find the description of the proteomic results hard to follow as the authors mostly list which proteins the find as interactors of Prod and D1 without stating in which tissue or with what bait they could purify them (i.e. p7: Importantly, our hits included known chromocenter-associated or pericentromeric heterochromatin-associated proteins, such as Su(var)3-9[52], ADD1[23,24], HP5[23,24],mei-S332[53], Mes-4[23], Hmr[24,39,54], Lhr[24,39], and members of the chromosome passenger complex, such as borr and Incenp[55]). It would be interesting to at least discuss tissue specific interactions.

      Out of six total AP-MS experiments in this manuscript (D1 x 3, Prod x 2 and Piwi), we observe a strong enrichment of the bait in 5/6 attempts (log2FC between 4-12). In the initial submission, the lack of a third high-quality biological replicate for the D1 testis sample meant that only the p-value (0.07) was not meeting the cutoff. To address this, we have repeated this experiment with an additional biological replicate (Fig. S2A), and our data now clearly show that D1 is significantly enriched in the testis sample.

      As suggested by the reviewer, we have also assessed our lysis conditions (450mM NaCl and benzonase) and the solubilization of our baits post-lysis. In Fig. S1D, we have blotted equivalent fractions of the soluble supernatant and insoluble pellet from GFP-Piwi embryos and show that both GFP-Piwi and D1 are largely solubilized following lysis. In Fig. S1E, we also show that our IP protocol works efficiently.

      GFP-Prod pulldown in embryos is the only instance in which we do not detect the bait by mass spectrometry. Here, one reason could be relatively low expression of GFP-Prod in comparison to GFP-D1 (Fig. S1E), which may lead to technical difficulties in detecting peptides corresponding to Prod. However, we note that Prod IP co-purified proteins such as Bocks that were previously suggested as Prod interactors from high-throughput studies (Giot et al. 2003; Guruharsha et al. 2011). In addition, Prod IP from embryos also co-purified proteins known to associate with chromocenters such as Hcs and Saf-B. Finally, the concordance between D1 and Prod co-purified proteins from embryo lysates (Fig. 2A, C) suggest that the Prod IP from embryos is of reasonable quality.

      We also acknowledge the reviewer's comment that the description of the proteomic data was hard to follow. Therefore, we have revised our text to clearly indicate which bait pulled down which protein in which tissue (lines 148-156). We have also highlighted and discussed bait-specific and tissue-specific interactions in the text (lines 162-173).

      Minor comments The authors may also want to provide a bit more information on the quantitation of the proteomic data such as how many values were derive from the match-between runs function and how many were imputed as this can severely distort the quantification.

      Figure 1: Distribution of data after imputation in embryo (left), ovary (middle) and testis (right) datasets. Imputation is performed with random sampling from the 1% least intense values generated by a normal distribution.

      To ensure the robustness of our data analysis, we considered only those proteins that were consistently identified in all replicates for at least one bait (GFP-D1, GFP-Prod or NLS-GFP). This approach resulted in a relative low number of missing values. However, it is also important to bear in mind that in an AP-MS experiment, the number of missing values is higher, as interactors are not identified in the control pulldown. Importantly, the imputation of missing values during the data analysis did not alter the normal distribution of the dataset (Fig. 1, this document). Detailed information regarding the imputed values is also provided (Table 1, this document). The coding script used for the data analysis is available in the PRIDE submission of the dataset (Table 2, this document). This information has been added to our methods section under data availability.

      Table 1: ____Number of match-between-runs and imputations for embryo, ovary and testis datasets

      Dataset

      #match-between-runs

      %match-between-runs

      %imputation

      Embryo

      5541/27543

      20.11%

      8.36%

      Ovary

      1936/9530

      20.30%

      8.18%

      Testis

      1748/7168

      24.39%

      3.12%

      Table 2: ____Access to the PRIDE submission of the datasets

      Name

      ID PRIDE

      UN reviewer

      PW reviewer

      IP-MS of D1 from Testis tissue

      PXD044026

      reviewer_pxd044026@ebi.ac.uk

      ydswDQVW

      IP-MS of Piwi from Embryo tissue

      PXD043237

      reviewer_pxd043237@ebi.ac.uk

      TMCoDsdx

      IP-MS of Prod and D1 proteins from Ovary tissue

      PXD043236

      reviewer_pxd043236@ebi.ac.uk

      VOHqPmaS

      IP-MS of Prod and D1 proteins from Embryo tissue

      PXD043234

      reviewer_pxd043234@ebi.ac.uk

      L77VXdvA

      **Referee Cross-Commenting** I agree with the two other reviewers that the connection between the interactome and the transgenerational phenotype is unclear. This is also what I meant i my comment that the title is somewhat misleading. A systematic analysis of the D1 and Prod knock down effect on mRNAs and small Rnas would indeed be helpful to better understand the interesting effect.

      As suggested by the reviewer, we have performed RNA seq and small RNA seq in control and D1 mutant ovaries (Fig. 4) to fully understand the contribution of D1 in piRNA biogenesis and TE repression. Briefly, the mislocalization of RDC complex in D1 mutant ovaries does not significantly affect TE-mapping piRNA biogenesis (Fig. 4C, E). In addition, loss of D1 does not substantially alter TE expression in the ovaries (Fig. 4B) or alter the expression of genes involved in TE repression (Fig. 4F). Along with the results presented in Fig. 5 and Fig. 6, our data clearly indicate that embryogenesis (and potentially early larval development) is a critical period during which D1 makes an important contribution to TE repression.

      Reviewer #1 (Significance (Required)): Nevertheless, the investigation of the D1 and Prod interactome is interesting and might reveal insights into the pathways that drive the formation of centromeres in a tissue specific manner. It may be mostly interesting for the Drosophila community but could also be exiting for a broader audience interested in the connection of heterochromatin and its indirect effect on the regulation of transposable elements.

      We thank the reviewer again for the helpful and constructive comments, which have enabled us to significantly improve our study. We are excited by the results from our study, which illuminate unappreciated aspects of transcriptional silencing in constitutive heterochromatin.

      Reviewer #2 (Evidence, reproducibility and clarity (Required)): Chavan et al. set out to enrich our compendium of pericentric heterochromatin-associated proteins - and to learn some new biology along the way. An ambitious AP-Mass baited with two DNA satellite-binding proteins (D1 and Prod), conducted across embryos, ovaries, and testes, yielded hundreds of candidate proteins putatively engaged at chromocenters. These proteins are enriched for a restricted number of biological pathways, including DNA repair and transposon regulation. To investigate the latter in greater depth, the authors examine D1 and prod mutants for transposon activity changes using reporter constructs for multiple elements. These reporter constructs revealed no transposon activation in the adult ovary, where many proteins identified in the mass spec experiments restrict transposons. However, the authors suggest that the D1 mutant ovaries do show disrupted localization of a key member of a transposon restriction pathway (Cuff), and infer that this mislocalization triggers a striking, transposon derepression phenotype in the F2 ovaries.

      The dataset produced by the AP-Mass Spec offers chromosome biologists an unprecedented resource. The PCH is long-ignored chromosomal region that has historically received minimal attention; consequently, the pathways that regulate heterochromatin are understudied. Moreover, attempting to connect genome organization to transposon regulation is a new and fascinating area. I can easily envision this manuscript triggering a flurry of discovery; however, there is quite a lot of work to do before the data can fully support the claims.

      We appreciate the reviewer taking the time to provide thoughtful comments and constructive suggestions to improve the manuscript. We believe that we have addressed all the comments raised to the significant advantage of our paper.

      Major comments 1. The introduction requires quite a radical restructure to better highlight the A) importance of the work and B) limit information whose relevance is not clear early in the manuscript. A. Delineating who makes up heterochromatin is a long-standing problem in chromosome biology. This paper has huge potential to contribute to this field; however, it is not the first. Others are working on this problem in other systems, for example PMID:29272703. Moreover, we have some understanding of the distinct pathways that may impact heterochromatin in different tissues (e.g., piRNA biology in ovaries vs the soma). Also, the mutant phenotypes of prod and D1 are different. Fleshing out these three distinct points could help the reader understand what we know and what we don't know about heterochromatin composition and its special biology. Understanding where we are as a field will offer clear predictions about who the interactors might be that we expect to find. For example, given the dramatically different D1 and prod mutant phenotypes (and allele swap phenotypes), how might the interactors with these proteins differ? What do we know about heterochromatin formation differences in different tissues? And how might these differences impact heterochromatin composition?

      The reviewer brings up a fair point and we have significantly reworked our introduction. We share the reviewer's opinion that improved knowledge of the constitutive heterochromatin proteome will reveal novel biology.

      1. The attempt to offer background on the piRNA pathway and hybrid dysgenesis in the Introduction does not work. As a naïve reader, it was not clear why I was reading about these pathways - it is only explicable once the reader gets to the final third of the Results. Moreover, the reader will not retain this information until the TE results are presented many pages later. I strongly urge the authors to shunt the two TE restriction paragraphs to later in the manuscript. They are currently a major impediment to understanding the power of the experiment - which is to identify new proteins, pathways, and ultimately, biology that are currently obscure because we have so little handle on who makes up heterochromatin.

      We agree with this suggestion. We have introduced the piRNA pathway in the results section (lines 205 - 216), right before this information is needed. We've also removed the details on hybrid dysgenesis, since our new data argues against a maternal effect from the D1 mutant.

      The implications of the failure to rescue female fertility by the tagged versions of both D1 and Prod are not discussed. Consequently, the reader is left uneasy about how to interpret the data.

      We understand this point raised by the reviewer. However, in our proteomics experiments, we have used GFP-D1 and GFP-Prod ovaries from ~1 day old females (line 579, methods). These ovaries are morphologically similar to the wild type (Fig. S1C) and their early germ cell development appears to be intact. Moreover, chromocenter formation in female GSCs is comparable to the wildtype (Fig. 1C-D). These data, along with the rescue of the viability of the Prod mutant (Fig. S1A-B), suggest that the presence of a GFP tag is not compromising D1 or Prod function in the early stages of germline development and is consistent with published and unpublished data from our lab. In addition, D1 and Prod from ovaries co-purify proteins such as Rfc38 (D1), Smn (D1), CG15107 (Prod), which have been identified in previous high-throughput screens (Guruharsha et al. 2011; Tang et al. 2023). For these reasons, we believe that GFP-D1 and GFP-Prod ovaries are a good starting point for the AP-MS experiment. We speculate that the failure to completely rescue female fertility may be due to improper expression levels of GFP-D1 or GFP-Prod flies at later stages of oogenesis, which are not present in ovaries from newly eclosed females and therefore unlikely to affect our proteomic data.

      1. How were the significance cut-offs determined? Is the p-value reported the adjusted p-value? As a non-expert in AP-MS, I was surprised to find that the p-value, at least according to the Methods, was not adjusted based on the number of tests. This is particularly relevant given the large/unwieldy(?) number of proteins that were identified as signficant in this study. Moreover, the D1 hit in Piwi pull down is actually not significant according to their criteria of p We used a standard cutoff of log2FC>1 and p2FC and low p-value) since these are more likely to be bona fide interactors. Third, we have used string-DB for functional analyses where we can place our hits in existing protein-protein interaction networks. Using this approach, we detect that Prod (but not D1) pulls down multiple members of the RPA complex in the embryo (RPA2 and RpA-70, Fig. S2B) while embryonic D1 (but not Prod) pulls down multiple components of the origin recognition complex (Orc1, lat, Orc5, Orc6, Fig. S2C) and the condensin I complex (Cap-G, Cap-D2, barr, Fig. S2D). Altogether, these filtering strategies allow us to eliminate as many false positives as possible while making sure to minimize the loss of true hits through multiple testing correction.

      How do we know if the lack of overlap across tissues is indeed germline- or soma-specialization rather than noise?

      To address this part of the comment, we have amended our text (lines 162-173) as follows,

      'We also observed a substantial overlap between D1- and Prod-associated proteins (yellow points in Fig. 2A, B, Table S1-3), with 61 hits pulled down by both baits (blue arrowheads, Fig. 2C) in embryos and ovaries. This observation is consistent with the fact that both D1 and Prod occupy sub-domains within the larger constitutive heterochromatin domain in nuclei. Surprisingly, only 12 proteins were co-purified by the same bait (D1 or Prod) across different tissues (magenta arrowheads, Fig. 2C, Table S1-3). In addition, only a few proteins such as an uncharacterized DnaJ-like chaperone, CG5504, were associated with both D1 and Prod in embryos and ovaries (Fig. 2D). One interpretation of these results is that the protein composition of chromocenters may be tailored to cell- and tissue-specific functions in Drosophila. However, we also note that the large number of unidentified peptides in AP-MS experiments means that more targeted experiments are required to validate whether certain proteins are indeed tissue-specific interactors of D1 and Prod.'

      To make this inference, conducting some validation would be required. More generally, I was surprised to see no single interactor validated by reciprocal IP-Westerns to validate the Mass-Spec results, though I am admittedly only adjacent to this technique. Note that colocalization, to my mind, does not validate the AP-MS data - in fact, we would a priori predict that piRNA pathway members would co-localize with PCH given the enrichment of piRNA clusters there.

      Here, we would point out that we have conducted multiple validation experiments with a specific focus on the functional significance of the associations between D1/Prod and TE repression proteins in embryos. While the reviewer suggests that piRNA pathway proteins may be expected to enrich at the pericentromeric heterochromatin, this is not always the case. For example, Piwi and Mael are present across the nucleus (pulled down by D1/Prod in embryos) while Cutoff, which is present adjacent to chromocenters in nurse cells, was not observed to interact with either D1 or Prod in the ovary samples.

      Therefore, for Piwi, we performed a reciprocal AP-MS experiment in embryos due to the higher sensitivity of this method (GFP-Piwi AP-MS, Fig. 3B). Excitingly, this experiment revealed that four largely uncharacterized proteins (CG14715, CG10208, Ugt35D1 and Fit) were highly enriched in the D1, Prod and Piwi pulldowns and these proteins will be an interesting cohort for future studies on transposon repression in Drosophila (Fig. 3C).

      Furthermore, we believe that determining the localization of proteins co-purified by D1/Prod is an important and orthogonal validation approach. For Sov, which is implicated in piRNA-dependent heterochromatin formation, we observe foci that are in close proximity to D1- and Prod-containing chromocenters (Fig. 3A).

      As for suggestion to validate by IP-WBs, we would point out that chromocenters exhibit properties associated with phase separated biomolecular condensates. Based on the literature, these condensates tend to associate with other proteins/condensates through low affinity or transient interactions that are rarely preserved in IP-WBs, even if there are strong functional relationships. One example is the association between D1 and Prod, which do not pull each other down in an IP-WB (Jagannathan et al. 2019), even though D1 and Prod foci dynamically associate in the nucleus and mutually regulate each other's ability to cluster satellite DNA repeats (Jagannathan et al. 2019). Similarly, IP-WB using GFP-Piwi embryos did not reveal an interaction with D1 (Fig. S4B). However, our extensive functional validations (Figures 4-6) have revealed a critical role for D1 in heritable TE repression.

      The AlphaFold2 data are very interesting but seem to lack of negative control. Is it possible to incorporate a dataset of proteins that are not predicted to interact physically to elevate the impact of the ones that you have focused on? Moreover, the structural modeling might suggest a competitive interaction between D1 and piRNAs for Piwi. Is this true? And even if not, how does the structural model contribute to your understanding for how D1 engages with the piRNA pathway? The Cuff mislocalization?

      In the revised manuscript, we have generated more structural models using AlphaFold Multimer (AFM) for proteins (log2FC>2, p0.5 and ipTM>0.8), now elaborated in lines 175-177. Despite the extensive disorder in D1 and Prod, we identified 22 proteins, including Piwi, that yield interfaces with ipTM scores >0.5 (Table S4, Table S8). These hits are promising candidates to further understand D1 and Prod function in the future.

      For the predicted model between Prod/D1 and Piwi (Fig. S4A), one conclusion could indeed be competition between D1/Prod and piRNAs for Piwi. Another possibility is that a transient interaction mediated by disordered regions on D1/Prod could recruit Piwi to satellite DNA-embedded TE loci in the pericentromeric heterochromatin. These types of interactions may be especially important in the early embryonic cycles, where repressive histone modifications such as H3K9me2/3 must be deposited at the correct loci for the first time. We suggest that mutating the disordered regions on D1 and Prod to potentially abrogate the interaction with Piwi will be important for future studies.

      The absence of a TE signal in D1 and Prod mutant ovaries would be much more compelling if investigated more agnostically. The observation that not all TE reporter constructs show a striking signal in the F2 embryos makes me wonder if Burdock and gypsy are not regulated by these two proteins but possibly other TEs are. Alternatively, small RNA-seq would more directly address the question of whether D1 and Prod regulate TEs through the piRNA pathway.

      We completely agree with this comment from the reviewer. We have performed RNA seq on D1 heterozygous (control) and D1 mutant ovaries in a chk26006 background. Since Chk2 arrests germ cell development in response to TE de-repression and DNA damage(Ghabrial and Schüpbach 1999; Moon et al. 2018), we reasoned that the chk2 mutant background would prevent developmental arrest of potential TE-expressing germ cells and we observed that both genotypes exhibited similar gonad morphology (Fig. 4A). From our analysis, we do not observe a significant effect on TE expression in the absence of D1, except for the LTR retrotransposon tirant (Fig. 4B). We also do not observe differential expression of TE repression genes (Fig. 4F).

      We have complemented our RNA seq experiment with small RNA profiling from D1 heterozygous (control) and D1 mutant ovaries. Here, overall piRNA production and antisense piRNAs mapping to TEs were largely unperturbed (Fig. 4C-E).

      Overall, our data is consistent with the TE reporter data (Fig. S7) and suggests that zygotic depletion of D1 does not have a prominent role in TE repression. However, we have uncovered that the presence of D1 during embryogenesis is critical for TE repression in adult gonads (Fig. 6, Fig. S9).

      I had trouble understanding the significance of the Cuff mis-localization when D1 is depleted. Given Cuff's role in the piRNA pathway and close association with chromatin, what would the null hypothesis be for Cuff localization when a chromocenter is disrupted? What is the null expectation of % Cuff at chromocenter given that the chromocenter itself expands massively in size (Figure 4D). The relationship between these two factors seems rather indirect and indeed, the absence of Cuff in the AP would suggest this. The biggest surprise is the absence of TE phenotype in the ovary, given the Cuff mutant phenotype - but we can't rule out given the absence of a genome-wide analysis. I think that these data leave the reader unconvinced that the F2 phenotype is causally linked to Cuff mislocalization.

      We apologize that this data was not more clearly represented. In a wild-type context, Cuff is distributed in a punctate manner across the nurse cell nuclei, with the puncta likely representing piRNA clusters (Fig. 5A-B). We find that a small fraction of Cuff (~5%) is present adjacent to the nurse cell chromocenter (inset, Fig. 5A and Fig. 5D). In the absence of D1, the nurse cell chromocenters increase ~3-4 fold in size. However, the null expectation is still that ~5% of total Cuff would be adjacent to the chromocenter, since the piRNA clusters are not expected to expand in size. In reality, we observe ~27% of total Cuff is mislocalized to chromocenters. Our data indicate that the satellite DNA repeats at the larger chromocenters must be more accessible to Cuff in the D1 mutant nurse cells. This observation is corroborated by the significant increase in piRNAs corresponding to the 1.688 satellite DNA repeat family (Fig. 4E).

      The lack of TE expression in the F1 D1 mutant was indeed surprising based on the Cuff mislocalization but as the reviewers pointed out, we only analyzed two TE reporter constructs in the initial submission. In the revised manuscript, we have performed both RNA seq and small RNA seq. Surprisingly, our data reveal that the Cuff mislocalization does not significantly affect piRNA biogenesis (Fig. 4C, D) and piRNAs mapping to TEs. As a result, both TE repression (Fig. 4B) and fertility (Fig. 6D) are largely preserved in the absence of D1 in adult ovaries.

      Finally, we thank the reviewer for their excellent suggestion to incorporate the F2 D1 heterozygote (Fig. S9) in our analysis! This important control has revealed that the maternal effect of the D1 mutant is negligible for gonad development and fertility (Fig. 6B-D). Rather, our data clearly emphasize embryogenesis (or early larval development) as a key period during which D1 can promote heritable TE repression. Essentially, D1 is not required during adulthood for TE repression if it was present in the early stages of development.

      Apologies if I missed this, but Figure 5 shows the F2 D1 mutant ovaries only. Did you look at the TM6 ovaries as well? These ovaries should lack the maternally provisioned D1 (assuming that females are on the right side) but have the zygotic transcription.

      As mentioned above, this was a great suggestion and we've now characterized this important control in the context of germline development and fertility, to the significant advantage of our paper.

      Minor comments 9. Add line numbers for ease of reference

      We apologize for this. Line numbers have been added in the full revision.

      1. The function of satellite DNA itself is still quite controversial - I would recommend being a bit more careful here - the authors could refer instead to genomic regions enriched for satellite DNA are linked to xyz function (see Abstract line 2 and 7, for example.)

      The abstract has been rewritten and does not directly implicate satellite DNA in a specific cellular function. However, we have taken the reviewer's suggestion in the introduction (line 57-58).

      "Genetic conflicts" in the introduction needs more explanation.

      This sentence has been removed from the introduction in the revised manuscript.

      "In contrast" is not quite the right word. Maybe "However" instead (1st line second paragraph of Intro)

      Done. Line 57 of the revised manuscript.

      Results: what is the motivation for using GSC-enriched testis?

      We use GSC-enriched testes for practical reasons. First, they contain a relatively uniform population of mitotically dividing germ cells unlike regular testes which contain a multitude of post-mitotic germ cells such as spermatocytes, spermatids and sperm. Second, GSC-enriched testes are much larger than normal testes and reduced the number of dissections that were needed for each replicate.

      1. Clarify sentence about the 500 proteins in the Results section - it's not clear from context that this is the union of all experiments.

      Done. Lines 145-149 in the revised manuscript.

      The data reported are not the first to suggest that satellite DNA may have special DNA repair requirements. e.g., PMID: 25340780

      We apologize if we gave the impression that we were making a novel claim. Specialized DNA repair requirements at repetitive sequences have indeed been previously hypothesized(Charlesworth et al. 1994) and studied and we have altered the text to better reflect this (lines 193-195). We have cited the study suggested by the reviewer as well as studies from the Chiolo(Chiolo et al. 2011; Ryu et al. 2015; Caridi et al. 2018) and Soutoglou(Mitrentsi et al. 2022) labs, which have also addressed this fascinating question.

      Page 10: indicate-> indicates.

      Done.

      1. Page 14: revise for clarity: "investigate a context whether these interactions could not take place"

      We've incorporated this suggestion in the revised text (lines 383-386).

      1. Might be important to highlight the 500 interactions are both direct and indirect. "Interacting proteins" alone suggests direct interactions only.

      Done. Lines 145-149.

      The effect of the aub mutant on chromocenter foci did not seem modest to me - however, the bar graphs obscure the raw data - consider plotting all the data not just the mean and error?

      Done. This data is now represented by a box-and-whisker plot (Fig. S5), which shows the distribution of the data.

      Reviewer #2 (Significance (Required)):

      The dataset produced by the AP-Mass Spec offers chromosome biologists an unprecedented resource. The PCH is long-ignored chromosomal region that has historically received minimal attention; consequently, the pathways that regulate heterochromatin are understudied. Moreover, attempting to connect genome organization to transposon regulation is a new and fascinating area. I can easily envision this manuscript triggering a flurry of discovery; however, there is quite a lot of work to do before the data can fully support the claims.

      This manuscript represents a significant contribution to the field of chromosome biology.

      We thank the reviewer for the positive evaluation of our manuscript, and we really appreciate the great suggestion for the F2 D1 heterozygote control! Overall, we believe that our manuscript is substantially improved with the addition of RNA seq, small RNA seq and important genetic controls. Moreover, we are excited by the potential of our study to open new doors in the study of pericentromeric heterochromatin.

      Reviewer #3 (Evidence, reproducibility and clarity (Required)): In the manuscript entitled "Multi-tissue proteomics identifies a link between satellite DNA organization and transgenerational transposon repression", the authors used two satellite DNA-binding proteins, D1 and Prod, as baits to identify chromocenter-associated proteins through quantitative mass spectrometry. The proteomic analysis identified ~500 proteins across embryos, ovaries, and testes, including several piRNA pathways proteins. Depletion of D1 or Prod did not directly contribute to transposon repression in ovary. However, in the absence of maternal and zygotic D1, there was a dramatic increase of agametic ovaries and transgenerational transposon de-repression. Although the study provides a wealth of proteomic data, it lacks mechanistic insights into how satellite DNA organization influence the interactions with other proteins and their functional consequences.

      We thank the reviewer for highlighting that this study will be a valuable resource for future studies on the composition and function of pericentromeric heterochromatin. Based on the reviewer's request for more mechanistic knowledge into how satellite DNA organization affects transposon repression, we have performed RNA seq and small RNA seq, added important genetic controls and significantly improved our text. In the revised manuscript, our data clearly demonstrate that embryogenesis (and potentially early larval development) is a critical time period when D1 contributes to heritable TE repression. Flies lacking D1 during embryogenesis exhibit TE expression in germ cells as adults, which is associated with Chk2-dependent gonadal atrophy. We are particularly excited by these data since TE loci are embedded in the satellite DNA-rich pericentromeric heterochromatin and our study demonstrates an important role for a satellite DNA-binding protein in TE repression.

      Major____ comments 1. While the identification of numerous interactions is significant, it would be helpful to acknowledge that lots of these proteins were known to bind DNA or heterochromatin regions. To strengthen the study, I recommend conducting functional validation of the identified interactions, in addition to the predictions made by Alphfold 2.

      We are happy to take this comment on board. In fact, we believe that the large number of DNA-binding and heterochromatin-associated proteins identified in this study are a sign of quality for the proteomic datasets. In the revised manuscript, we have highlighted known heterochromatin proteins co-purified by D1/Prod in lines 148-151 as well as proteins previously suggested to interact with D1/Prod from high-throughput studies in lines 153-156 (Guruharsha et al. 2011; Tang et al. 2023). In this study, we have focused on the previously unknown associations between D1/Prod and TE repression proteins and functionally validated these interactions as presented in Figures 3-6.

      The observation of transgenerational de-repression is intriguing. However, to better support this finding, it would be better to provide a mechanistic explanation based on the data presented.

      We appreciate this comment from the reviewer, which is similar to major comment #6 raised by reviewer #2. To generate mechanistic insight into the underlying cause of gonad atrophy in the F2 D1 mutant, we have performed RNA seq, small RNA seq and analyzed germline development and fertility in the F2 D1 heterozygous control (Fig. S9).

      For the RNA seq, we used D1 heterozygous (control) and D1 mutant ovaries in a chk26006 background. Since Chk2 arrests germ cell development in response to TE de-repression and DNA damage(Ghabrial and Schüpbach 1999; Moon et al. 2018), we reasoned that the chk2 mutant background would prevent developmental arrest of potential TE-expressing germ cells and we observed that both genotypes exhibited similar gonad morphology (Fig. 4A). From our analysis, we do not observe a significant effect on TE expression in the absence of D1, except for the LTR retrotransposon tirant (Fig. 4B). We also do not observe differential expression of TE repression genes (Fig. 4F).

      We have complemented our RNA seq experiment with small RNA profiling from D1 heterozygous (control) and D1 mutant ovaries. Here, overall piRNA production and antisense piRNAs mapping to TEs were largely unperturbed (Fig. 4C-E). Together, these data are consistent with the TE reporter data (Fig. S7) and suggests that zygotic depletion of D1 does not have a prominent role in TE repression.

      However, we have uncovered that the presence of D1 during embryogenesis is critical for TE repression in adult gonads (Fig. 6, Fig. S9). Essentially, either only maternal deposited D1 (F1 D1 mutant) or only zygotically expressed D1 (F2 D1 het) were sufficient to ensure TE repression and fertility. In contrast, a lack of D1 during embryogenesis (F2 D1 mutant) led to elevated TE expression and Chk2-mediated gonadal atrophy.

      Our results also explain why previous studies have not implicated either D1 or Prod in TE repression, since D1 likely persists during embryogenesis when using depletion approaches such as RNAi-mediated knockdown or F1 generation mutants.

      Minor____ comments 3. Given the maternal effect of the D1 mutant, in Figure 4, I suggest analyzing not only nurse cells but also oocytes to gain a more comprehensive understanding.

      We agree with the reviewer that this experiment can be informative. In the F2 D1 mutant ovaries, germ cell development does not proceed to a stage where oocytes are specified, thus limiting microscopy-based approaches. Nevertheless, we have gauged oocyte quality in all the genotypes using a fertility assay (Fig. 6D) since even ovaries that have a wild-type appearance can produce dysfunctional gametes. In this experiment, we observe that fertility is largely intact in the F1 D1 mutant and F2 D1 heterozygote strains, suggesting that it is the presence of D1 during embryogenesis (or early larval development) that is critical for heritable TE repression and proper oocyte development.

      The conclusion that D1 and Prod do not directly contribute to the repression of transposons needs further analysis from RNA-seq data. Alternatively, the wording could be adjusted to indicate that D1 and Prod are not required for specific transposon silencing, such as Burdock and gypsy.

      Agreed. We have performed RNA-seq in D1 heterozygous (control) and D1 mutant ovaries in a chk26006 background (Fig. 4A, B) as described above.

      As D1 mutation affects Cuff nuclear localization, it would be insightful to sequence the piRNA in the ovaries.

      Agreed. We have performed small RNA profiling from D1 heterozygous (control) and D1 mutant ovaries. Despite the significant mislocalization of the RDC complex, overall piRNA production and antisense piRNAs mapping to TEs were largely unaffected (Fig. 4C-E). However, we observed significant changes in piRNAs mapping to complex satellite DNA repeats (Fig. 4D), but these changes were not associated with a maternal effect on germline development or fertility (F2 D1 heterozygote, Fig. 6B-D).

      **Referee Cross-Commenting**

      I appreciate the valuable insights provided by the other two reviewers regarding this manuscript. I concur with their assessment that substantial improvements are needed before considering this manuscript for publication.

      1. The proteomics data has the potential to be a valuable resource for other scientific community. However, I share the concerns raised by reviewer 1 about the current quality of the data sets. Addressing this, it will augment the manuscript with additional data to show the success of the precipitation. Moreover, as reviewer 2 and I suggested, additional co-IP validations of the IP-MS results are needed to enhance the reliability.

      In the revised manuscript, we have performed multiple experiments to address the quality of the MS datasets based on comments raised by reviewer #1. They are as follows,

      Out of six total AP-MS experiments in this manuscript (D1 x 3, Prod x 2 and Piwi), we observe a strong enrichment of the bait in 5/6 attempts (log2FC between 4-12, Fig. 2A, B, Fig. S2A, Table S1-S3, Table S7). In the D1 testis sample from the initial submission, the lack of a third biological replicate meant that only the p-value (0.07) was not meeting the cutoff. To address this, we have repeated this experiment with an additional biological replicate (Fig. S2A), and our data now clearly show that D1 is also significantly enriched in the testis sample.

      As suggested by the reviewer #1, we have assessed our lysis conditions (450mM NaCl and benzonase) and the solubilization of our baits post-lysis. In Fig. S1D, we have blotted equivalent fractions of the soluble supernatant and insoluble pellet from GFP-Piwi embryos and show that both GFP-Piwi and D1 are largely solubilized following lysis. In Fig. S1E, we also show that our IP protocol works efficiently.

      The only instance in which we do not detect the bait by mass spectrometry is for GFP-Prod pulldown in embryos. Here, one reason could be relatively low expression of GFP-Prod in comparison to GFP-D1 (Fig. S1E), which may lead to technical difficulties in detecting peptides corresponding to Prod. However, we note that Prod IP from embryos co-purified proteins such as Bocks that were previously suggested as Prod interactors from high-throughput studies (Giot et al. 2003; Guruharsha et al. 2011). In addition, Prod IP from embryos also co-purified proteins known to associate with chromocenters such as Hcs(Reyes-Carmona et al. 2011) and Saf-B(Huo et al. 2020). Finally, the concordance between D1 and Prod co-purified proteins from embryo lysates (Fig. 2A, C) suggest that the Prod IP from embryos is of reasonable quality.

      As for the IP-WB validations, we would point out that chromocenters exhibit properties associated with phase separated biomolecular condensates. In our experience, these condensates tend to associate with other proteins/condensates through low affinity or transient interactions that are rarely preserved in IP-WBs, even if there are strong functional relationships. One example is the association between D1 and Prod, which do not pull each other down in an IP-WB (Jagannathan et al. 2019), even though D1 and Prod foci dynamically associate in the nucleus and mutually regulate each other's ability to cluster satellite DNA repeats (Jagannathan et al. 2019). Similarly, IP-WB using GFP-Piwi embryos did not reveal an interaction with D1 (Fig. S4B). However, our extensive functional validations (Figures 4-6) have revealed a critical role for D1 in heritable TE repression.

      I agree with reviewer 2 that the present conclusion is not appropriate regarding D1 and Prod do not contribute to transposon silencing. As reviewer 2 and I suggested, the systematical analysis by using both mRNA-seq and small RNA-seq is required to draw the conclusion.

      Agreed. We have performed RNA seq and small RNA seq as elaborated above. Our conclusions on the role of D1 in TE repression are now much stronger.

      1. The transgenerational phenotype is an intriguing aspect of the study. I agree with reviewer 2 that the inclusion of TM6 ovaries would be a nice control. Further, it is hard to connect this phenotype with the interactions identified in this manuscript. It would be appreciated if the author could provide a mechanistic explanation.

      We have significantly improved these aspects of our study in the revised manuscript. Through the analysis of germline development in the F2 D1 heterozygotes as suggested by reviewer #2, in addition to the recommended RNA seq and small RNA seq, we have now identified embryogenesis (and potentially early larval development) as a time period when D1 makes an important contribution to TE repression. Loss of D1 during embryogenesis leads to TE expression in adult germline cells, which is associated with Chk2-dependent gonadal atrophy. Taken together, we have pinpointed the specific contribution of a satellite DNA-binding protein to transposon repression.

      Reviewer #3 (Significance (Required)):

      Although this study successfully identified several interactions, the authors did not fully elucidate how these interactions contribute to the transgenerational silencing of transposons or ovary development.

      We thank the reviewer for the thoughtful comments and overall positive evaluation of our study, especially the proteomic dataset. We are confident that the revised manuscript has improved our mechanistic understanding of the contribution made by a satellite DNA-binding protein in TE repression.

      References

      Baumgartner L, Handler D, Platzer SW, Yu C, Duchek P, Brennecke J. 2022. The Drosophila ZAD zinc finger protein Kipferl guides Rhino to piRNA clusters eds. D. Bourc'his, K. Struhl, and Z. Zhang. eLife 11: e80067.

      Caridi CP, D'Agostino C, Ryu T, Zapotoczny G, Delabaere L, Li X, Khodaverdian VY, Amaral N, Lin E, Rau AR, et al. 2018. Nuclear F-actin and myosins drive relocalization of heterochromatic breaks. Nature 559: 54-60.

      Charlesworth B, Sniegowski P, Stephan W. 1994. The evolutionary dynamics of repetitive DNA in eukaryotes. Nature 371: 215-220.

      Chiolo I, Minoda A, Colmenares SU, Polyzos A, Costes SV, Karpen GH. 2011. Double-strand breaks in heterochromatin move outside of a dynamic HP1a domain to complete recombinational repair. Cell 144: 732-744.

      Ghabrial A, Schüpbach T. 1999. Activation of a meiotic checkpoint regulates translation of Gurken during Drosophila oogenesis. Nat Cell Biol 1: 354-357.

      Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y, Hao YL, Ooi CE, Godwin B, Vitols E, et al. 2003. A protein interaction map of Drosophila melanogaster. Science 302: 1727-1736.

      Guruharsha KG, Rual JF, Zhai B, Mintseris J, Vaidya P, Vaidya N, Beekman C, Wong C, Rhee DY, Cenaj O, et al. 2011. A protein complex network of Drosophila melanogaster. Cell 147: 690-703.

      Huo X, Ji L, Zhang Y, Lv P, Cao X, Wang Q, Yan Z, Dong S, Du D, Zhang F, et al. 2020. The Nuclear Matrix Protein SAFB Cooperates with Major Satellite RNAs to Stabilize Heterochromatin Architecture Partially through Phase Separation. Molecular Cell 77: 368-383.e7.

      Jagannathan M, Cummings R, Yamashita YM. 2019. The modular mechanism of chromocenter formation in Drosophila eds. K. VijayRaghavan and S.A. Gerbi. eLife 8: e43938.

      Mitrentsi I, Lou J, Kerjouan A, Verigos J, Reina-San-Martin B, Hinde E, Soutoglou E. 2022. Heterochromatic repeat clustering imposes a physical barrier on homologous recombination to prevent chromosomal translocations. Molecular Cell 82: 2132-2147.e6.

      Moon S, Cassani M, Lin YA, Wang L, Dou K, Zhang ZZ. 2018. A Robust Transposon-Endogenizing Response from Germline Stem Cells. Dev Cell 47: 660-671 e3.

      Pascovici D, Handler DCL, Wu JX, Haynes PA. 2016. Multiple testing corrections in quantitative proteomics: A useful but blunt tool. PROTEOMICS 16: 2448-2453.

      Reyes-Carmona S, Valadéz-Graham V, Aguilar-Fuentes J, Zurita M, León-Del-Río A. 2011. Trafficking and chromatin dynamics of holocarboxylase synthetase during development of Drosophila melanogaster. Molecular Genetics and Metabolism 103: 240-248.

      Ryu T, Spatola B, Delabaere L, Bowlin K, Hopp H, Kunitake R, Karpen GH, Chiolo I. 2015. Heterochromatic breaks move to the nuclear periphery to continue recombinational repair. Nat Cell Biol 17: 1401-1411.

      Tang H-W, Spirohn K, Hu Y, Hao T, Kovács IA, Gao Y, Binari R, Yang-Zhou D, Wan KH, Bader JS, et al. 2023. Next-generation large-scale binary protein interaction network for Drosophila melanogaster. Nat Commun 14: 2162.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      We thank all reviewers for their constructive criticism and suggestions. We have addressed all the points as detailed below. We also added an experiment that strengthens the connection between replication stress and GSF2 and suggests a role of GSF2 in recovery from the DNA replication checkpoint arrest (Fig. 4g).

      Reviewer #1 (Evidence, reproducibility and clarity)

      Summary

      The manuscript by the Khmelinskii group reports that they have successfully constructed two conditional degron libraries of budding yeast for almost all proteins. For this purpose, the authors employed an improved auxin-inducible degron (AID2). Initially, they constructed yeast libraries by fusing HaloTag to the N- or C-terminus of proteins and found that C-terminal tagging is less likely to affect the location and function of proteins (Fig. 1). Based on this finding, the authors fused mNG-AID*-3Myc or AID*-3Myc (AID-v1 or AID-v2 library, respectively) to more than 5600 proteins and found that 4079 proteins were significantly depleted when cells were treated with 5-Ph-IAA (Fig. 2). A fitness defect was observed for over 60% of essential proteins, indicating the target depletion showed the expected phenotype in many cases (Fig. 3). Finally, the authors screened proteins required for maintaining viability in the presence of MMS, CPT and HU, and identified common proteins involved in DNA repair (such as RAD52 epistasis proteins) and other proteins specific for MMS, CPT or HU resistance (Fig. 4). Furthermore, the authors revealed that an ER membrane protein, Gsf2, is required for HU resistance, which was not found in previous studies with the YKO library because gsf2∆ cells in the YKP library had acquired a suppressor mutation (Fig. 4e).

      Major comments

      1 - In Figure S2a, the authors initially checked the growth of yeast cells expressing OsTIR1(F74G) under the GAL1 promoter, saying that "expression of OsTir1(F74G) from the strong galactose-inducible GAL1 promoter had a negligible impact on yeast fitness (page 3)". To me, the OsTIR1(G74G) expressing cells showed slightly slower growth compared to the control cells. Moreover, the cells expressing it under the very strong GPD promoter showed apparent slow growth, suggesting that OsTIR1(F74G) overexpression caused a side effect. The authors should carefully evaluate the cells with GAL1-OsTIR1(F74G).

      Indeed high levels of OsTir1(F74G) impaired growth, at least in the strain background used in our experiments. Expression from the strongest promoter we tested (GPD) resulted in an obvious fitness defect, whereas conditional expression from the strong GAL1 promoter had a small impact on fitness and expression from the weaker CYC1 and ADH1 promoters did not affect fitness (Fig. S2a). Despite the small fitness impairment, we decided to use the GAL1-OsTIR1(F74G) construct for the AID libraries for two reasons: the conditional nature of this promoter is likely to limit adaptation to expression of OsTir1(F74G) and the high expression levels of OsTir1(F74G) are less likely to limit degradation of AID-tagged proteins. We added this explanation to the Results section.

      As suggested by the reviewer, we quantitatively evaluated the fitness impact of the GAL1-OsTIR1(F74G) construct. Using the colony size data of the AID-v1 library (grown on galactose medium with 1 µM 5-Ph-IAA, Fig. 2c), we compared colony sizes of OsTIR1– and OsTIR1+ strains for non-essential ORFs. As degradation of non-essential proteins is not expected to affect fitness, the difference in colony size between OsTIR1– and OsTIR1+ strains can be attributed to OsTir1 expression. On average, the presence of the OsTIR1 construct reduced colony size by 7% (median fitness of OsTIR1+ strains relative to OsTIR1– strains of 0.93 ± 0.06, n = 4698 non-essential ORFs). We performed the same comparison for strains that did not exhibited OsTIR1-dependent protein degradation. In this set of strains, the presence of the OsTIR1 construct also reduced colony size by 7% (median fitness of OsTIR1+ strains relative to OsTIR1– strains of 0.93 ± 0.05, n = 624 ORFs in the “not affected” group in Fig. 2d). We added this information to Fig. S3a.

      2 - Given the possibility that OsTIR1(F74G) overexpression might cause a growth problem, it is not appropriate to compare OsTIR1+ and OsTIR1- conditions for evaluating growth fitness (Fig. 2). As shown in Fig. S4b, it is more appropriate to compare the +/- 5-Ph-IAA conditions. Additionally, the 5-Ph-IAA concentration used in this study was not clearly mentioned in the method section and figure legends.

      The two approaches, comparison of OsTIR1– and OsTIR1+ strains grown on galactose with 5-Ph-IAA (as was done for the AID-v1 library) and comparison of galactose ± 5-Ph-IAA conditions (as was done for the AID-v2 library), have advantages and disadvantages but should yield similar results. The technical noise (due to spatial effects on the screen plates) is lower for the comparison of OsTIR1– and OsTIR1+ strains, as the two strains for each ORF can be grown next to each other on the same plate (Fig. 2c). Furthermore, corrections of spatial effects are more precise with this layout as the frequency of fitness defects per plate is lower. On the other hand, comparison of galactose ± 5-Ph-IAA conditions implicitly corrects for the fitness impact of the GAL1-OsTIR1(F74G) construct, as the fitness distribution of each condition is normalized to the median of that condition, but this fitness impact of OsTir1 cannot be determine from the screen results.

      We now explicitly corrected the colony size data of the AID-v1 library for the fitness impact of OsTir1 expression (quantified in the previous point) and updated all the analyses and results shown in Fig. 3, Fig. S3b-e and Fig. S4a. The correction was performed using the multiplicative model, whereby the fitness impacts of OsTir1 expression and degradation of the AID-tagged protein are independent. Overall, our observations and conclusions stand unchanged with the corrected data.

      Finally, the 5-Ph-IAA concentration (1 µM) used in all experiments is now indicated in the figure legends and the Methods section.

      3 - The authors found that fitness defects were observed for over 60% of essential proteins (Fig. 3). In other words, depletion of the remaining 40% was not enough to induce growth defects. The authors should discuss how the current AID library can be improved to achieve better target depletion. Previous literature reported various possibilities, such as using a tandem degron tag and combining AID with the Tet promoter system (PMID 25181302, 26081484). Although optional, it would be wonderful if the authors would generate an improved library.

      Following the reviewer’s suggestion, we added the following statement to the discussion:

      “In the future, the libraries could be potentially improved with N-terminal tagging of ORFs that currently exhibit incomplete or no degradation of AID-tagged proteins or using multiple copies of the AID* tag to enhance protein degradation (Kubota et al, 2013; Nishimura & Kanemaki, 2014).”

      Minor comments

      4 - 5-Ph-IAA is not auxin because it does not induce the auxin responses in plants (PMID 29355850). Therefore, the authors should be careful when they refer to 5-Ph-IAA and should not call it auxin.

      We corrected this and now refer to 5-Ph-IAA explicitly throughout the manuscript.

      5 - The availability of the HaloTag and AID libraries should be indicated.

      We added the following statement to the Methods section: “All strains, plasmids and libraries are available upon request.”

      6 - Page 3: "Finally, the extent of AID-dependent degradation varied with protein abundance, in that highly expressed proteins were more likely to be only partially degraded compared to lowly expressed ones (Fig. 2e, Fig. S2e)". Fig. S2e should be Fig. S2d, shouldn't it?

      We corrected this mistake.

      Reviewer #1 (Significance):

      This paper is technically robust and well-conducted. It presents a comprehensive study showcasing the effectiveness of the conditional degron library. The HaloTag libraries will also be useful. The yeast libraries presented in this study will be invaluable for future screenings and studies across all aspects of yeast biology.

      Reviewer #2 (Evidence, reproducibility and clarity):

      In this study, the authors reported the development and characterization of two AID-tagged strain libraries for the model organism S. cerevisiae. The libraries are based on the latest AID technology, AID2. One library contains a fluorescent protein fused to the AID, whereas the other library does not have the fluorescent protein, thus offering better compatibility with imaging-based screens. The authors show that AID-dependent protein degradation can be achieved for most of the library strains, and a growth phenotype was induced for a high fraction of essential genes. Genetic screens for DNA damage-sensitive mutants showcased the applicability of the libraries.

      I only have the following minor comments and suggestions for the authors to consider.

      Point 1, Page 3

      "Optimized tagging of proteins with these N-terminal localization signals likely also contributes to the lack of correlation between differential fitness defects and occurrence of terminal localization signals (Fig. S1f, Table S2)."

      Is this because the genes that cannot tolerate C-terminal addition are already depleted in the C-SWAT library? In the C-SWAT library, a 15-amino-acid linker L3 is added to the C-terminus.

      That is certainly a possibility. During construction of SWAT library, tagging with N-SWAT and C-SWAT acceptor modules failed for 251 and 353 ORFs, respectively (Weill et al. 2018, Meurer et al. 2018). However, these ORFs are not enriched in N- or C-terminal localization signals, respectively (4.6% ORFs with C-terminal signals in C-SWAT library vs 3.3% among failed C-SWAT strains; 12.3% ORFs with N-terminal signals in N-SWAT library vs 2.0% among failed N-SWAT strains).

      The most significant trend in the data is enrichment of ribosomal subunits in both sets of failed strains: 3.9% and 16.3% of the genes mapped to the GO term “ribosome” in the N-SWAT library and the set of failed N-SWAT strains, respectively; 3.6% and 15.9% of the genes in the C-SWAT library and the set of failed C-SWAT strains, respectively. This is consistent with what was reported by Weill et al. for failed N-SWAT strains.

      Point 2, Page 3

      "Expression of OsTir1(F74G) from the strong galactose-inducible GAL1 promoter had a negligible impact on yeast fitness (Fig. S2a)."

      I wonder why the authors chose to use an inducible promoter to express OsTir1(F74G). In other studies, for example Snyder et al. 2019, OsTir1 has been expressed from a constitutive promoter.

      Despite the small fitness impairment, we decided to use the GAL1-OsTIR1(F74G) construct for the AID libraries for two reasons: the conditional nature of this promoter is likely to limit adaptation to expression of OsTir1(F74G) and the high expression levels of OsTir1(F74G) are less likely to limit degradation of AID-tagged proteins. We added this explanation to the Results section.

      Please see our response to reviewer 1, points 1 and 2.

      Point 3, Page 3

      "A similar frequency was previously observed with a set of AID alleles constructed for 758 essential ORFs using the original AID system (Snyder et al, 2019). However, over a third of these alleles exhibited fitness defects even in the absence of auxin, which were further compounded by off-target effects of auxin, highlighting the advantages of the AID2 system."

      Snyder et al. 2019 used a TAP-AID-6FLAG tag. The fitness defect in the absence of auxin may not necessarily be due to the AID part of the tag, as TAP tagging is known to compromise the functions of some genes.

      We corrected our statement as follows:

      “A similar frequency was previously observed with a set of AID alleles constructed for 758 essential ORFs using the original AID system (Snyder et al, 2019). However, over a third of these alleles exhibited fitness defects even in the absence of auxin, which were further compounded by off-target effects of auxin.”

      Point 4, Page 3

      "Interestingly, complete degradation of 33% of essential proteins did not result in a fitness defect. It is possible that in some cases partial degradation results in low protein levels that are below the detection limit of our assay but are sufficient for viability."

      Are these "33% of essential proteins" enriched with genes with low expression levels? I guess genes with low expression levels are more likely to fall below the detection limit even when partially depleted. Are there extreme examples where a highly expressed essential gene does not exhibit a fitness defect when the protein product is no longer detectable?

      We performed the analysis suggest by the reviewer, and observed no difference in pre-degradation protein levels between essential & degraded proteins with and without a fitness defect (now shown in Fig. S3b). This also showed that there are indeed several essential proteins with high pre-degradation proteins levels and without a fitness defects upon degradation to below our detection limit: Pgi1, Nhp2, Smt3, Gus1, Dys1, Sis1, Fas2 and Rpo26 (in the abundance bin 4 in Fig. S2f).

      In addition, we considered the nature of the essential genes in these two groups. Namely, we compared the frequency of core essential genes, which are always required for viability, and conditional essential genes, which vary in essentiality depending on the genetic background or environment (Bosch-Guiteras & van Leeuwen, 2022). Interestingly, the set of essential and degraded proteins without an accompanying fitness defect was enriched in conditional essential genes defined by two independent measures: essentiality across S. cerevisiae natural isolates (Peter et al, 2018) or with bypass suppression interactions in a laboratory strain (van Leeuwen et al, 2020) (Fig. S3c, odds ratio = 1.6, p-value = 0.04 in a Fisher’s exact test and odds ratio = 1.7, p-value = 0.02, respectively). This suggests that conditional essentiality could explain the observed lack of fitness defects upon degradation of some essential proteins.

      We added this analysis to the Results section.

      Reviewer #2 (Significance):

      This study generated highly valuable resources for functional genomic studies.

      Reviewer #3 (Evidence, reproducibility and clarity):

      Summary: In this manuscript, the authors construct and analyze a genome-wide collection of AID-tagged S. cerevisiae strains. The manuscript is clearly written and the analysis appears to be thorough. This collection will be quite useful to the yeast community. There are some issues to address, listed below.

      1. page 1, abstract - "...with protein abundance and tag accessibility as limiting factors." It's not clear what the authors mean by protein abundance as a limiting factor. Are they referring to the protein level pre-depletion? Please clarify.

      That is correct. We clarified this statement as follows:

      “Almost 90% of AID-tagged proteins were degraded in the presence of the auxin analog 5-Ph-IAA, with initial protein abundance and tag accessibility as limiting factors.”

      1. page 1, second paragraph of the Intro, end of the paragraph - There are publications prior to Van Leeuwen et al. 2016 that describe suppressors lurking in the deletion set. Here are two that should be cited: Hughes et al. 2000, DOI: 10.1038/77116 and Teng et al. 2013, DOI: 10.1016/j.molcel.2013.09.026.

      We added the references pointed out by the review.

      1. The goal of this work, stated in the first sentence of results, is to construct genome-wide AID libraries. Yet, to test whether N-terminal or C-terminal tagging is better, the authors used a Halo tag. Those results showed that, for the Halo tag, C-terminal tagging was less likely to impair function. Why weren't these tests done with the same AID tag used to build the libraries in the next section? What is the evidence that the results for a Halo tag will be the same as for an AID tag? While hard to find it documented in publications, there is a lot of anecdotal evidence that the type of tag can make a big difference, as well as its location. While this section will be of interest to those using Halo tags, it's not clear how it relates to the rest of the paper, especially given the careful characterization of the AID library in the next section.

      We chose the Halo tag due its size (33 kDa), similar to many commonly used fluorescent protein tags and to the mNG-AID*-3myc tag in the AID-v1 library, and lack of evidence for a dominant negative effect on the tagged proteins. This is now stated in the Results section.

      We agree that further work is needed to understand how the type of tag, its size and biophysical properties, and the linker between the tag and the protein of interest affect protein localization and function across the proteome. This is now stated in the Results section.

      1. Throughout this manuscript, including the Tables, in cases where the protein is no longer detected, please do not describe this as "complete degradation." Instead, please use "not detectable." This is clearly the case for essential proteins that are no longer detected but that still grow, so it is very likely the case for many or all of the others. If the authors have any understanding of the sensitivity of their fluorescence assay, then that would be helpful to know. For example, they could add a control, taking a known amount of a fluorescent protein and analyzing known dilutions to assay the level of detection.

      We appreciate the reviewer’s suggestion. We decided against “not detectable” instead of “complete degradation” to avoid confusion with proteins that are not detectable pre-degradation. Nevertheless, we replaced “complete degradation” with “degradation” and added the following explanation to the Results section:

      “Out of 5079 proteins detected in OsTIR1– strains, 4455 (~88%) were significantly depleted in OsTIR1+ strains (Fig. 2d, Table S3). 3981 proteins could not be detected specifically in the OsTIR1+ background. Hereafter, we will refer to these proteins as degraded, although it is likely that at least in some cases degradation is not complete but the remainder is below the detection limit of our plate reader assay. Nevertheless, 474 proteins were unequivocally degraded only partially, as they were detectable in the OsTIR1+ background but at reduced levels compared to the OsTIR1– background (Fig. 2d).”

      To estimate the detection limit of the colony fluorescence assay, we correlated the background-corrected mNG intensities in OsTIR1– strains with absolute levels (in molecules per cell) of 1167 proteins determined by Lawless et al. (PMID 26750110). Based on a linear fit, the threshold above which proteins are considered “detected” in our analysis, mNG/bkg(OsTIR1–) > 1.2, corresponds to 200 molecules per cell (95% confidence interval 18 to 2187 molecules per cell). We added this information to the Results section and Fig. S2c.

      This detection limit is in line with our results, where low abundance proteins such as the centromeric histone Cse4/CENP-A (with two Cse4 molecules per centromere adding to 64 molecules per cell, Aravamudhan et al. PMID: 23623551 and several times that amount elsewhere in the cell, Collins et al. PMID: 15530401) can be detected in the colony assay (Table S3).

      1. Fig. S2a and page 3, first full paragraph - The authors wrote that expression of OsTir1(F74G) from the strong GAL1 promoter had a negligible impact on growth. However, the figure shows that there is an obvious effect on growth after 48 hours of incubation, with much smaller colonies. This defect is much less obvious after 72 hours. This difference suggests that the growth effect would have been even more obvious at 24 hours. I think that the text should be modified to indicate this effect.

      We now quantified the fitness impact of the GAL1-OsTIR1(F74G) construct and rephrased this part of the manuscript. In addition, we corrected the AID-v1 library screen results for the fitness impact of the GAL1-OsTIR1(F74G) construct and updated all figures and tables. Please see our response to reviewer 1, points 1 and 2.

      1. One of the main justifications for the construction of the AID library is to allow assays for essential genes. Yet that was not a feature of the screen for DNA damage response factors. Were any essential genes identified in those screens? It would be of great interest to identify lower levels of 5-Ph-IAA that only mildly affect growth of essential genes and then to repeat the screens.

      58 out of the combined 165 potential resistance factors identified in the three screens are essential genes. We added this information to the Results section and essential genes are now indicated in Fig. S5c.

      We now show that chemical-genetic interactions for both essential and non-essential genes can be reproduced in spot tests using the MMS screen as an example (Fig. S5d). We also show that additional essential hits can be identified at lower concentrations of 5-Ph-IAA, which allow determining chemical-genetic interactions for strains that otherwise exhibit no growth in 1 μM 5-Ph-IAA (Fig. S5e). As the screens serve as a demonstration of possible uses of the AID libraries, we consider additional exhaustive screening for DNA damage response factors beyond the scope of this manuscript.

      1. A big advantage of AID depletion over deletions is the ability to look at strains very shortly after loss of the protein of interest. In many cases in the literature, experiments are done after one or two hours after depletion. Yet in this work, there are no data presented on how effective depletion is in the short term versus after a long period of growth (24 hours). It would be a strong addition to the manuscript to include a time course for at least a subset of the proteins to look at the loss of signal over time, either by fluorescence or by Western blots.

      We performed time courses of protein depletion with immunoblotting for 12 strains (4 proteins from the “degraded”, “partially degraded” and “not affected” groups each). The results in Fig. S2e show that “degraded” proteins are depleted to below the detection limit within 60min of 5-Ph-IAA addition, “partially degraded” proteins are depleted less or exhibit a degradation-resistant pool, and the levels of “not affected” proteins remain stable over time, consistent with their classification based on mNG fluorescence in the colony assay. We added this information to the Results section.

      Reviewer #3 (Significance):

      The library will be of use to the yeast community.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      Summary: In this manuscript, the authors construct and analyze a genome-wide collection of AID-tagged S. cerevisiae strains. The manuscript is clearly written and the analysis appears to be thorough. This collection will be quite useful to the yeast community. There are some issues to address, listed below.

      1. page 1, abstract - "...with protein abundance and tag accessibility as limiting factors." It's not clear what the authors mean by protein abundance as a limiting factor. Are they referring to the protein level pre-depletion? Please clarify.
      2. page 1, second paragraph of the Intro, end of the paragraph - There are publications prior to Van Leeuwen et al. 2016 that describe suppressors lurking in the deletion set. Here are two that should be cited: Hughes et al. 2000, DOI: 10.1038/77116 and Teng et al. 2013, DOI: 10.1038/77116 .
      3. The goal of this work, stated in the first sentence of results, is to construct genome-wide AID libraries. Yet, to test whether N-terminal or C-terminal tagging is better, the authors used a Halo tag. Those results showed that, for the Halo tag, C-terminal tagging was less likely to impair function. Why weren't these tests done with the same AID tag used to build the libraries in the next section? What is the evidence that the results for a Halo tag will be the same as for an AID tag? While hard to find it documented in publications, there is a lot of anecdotal evidence that the type of tag can make a big difference, as well as its location. While this section will be of interest to those using Halo tags, it's not clear how it relates to the rest of the paper, especially given the careful characterization of the AID library in the next section.
      4. Throughout this manuscript, including the Tables, in cases where the protein is no longer detected, please do not describe this as "complete degradation." Instead, please use "not detectable." This is clearly the case for essential proteins that are no longer detected but that still grow, so it is very likely the case for many or all of the others. If the authors have any understanding of the sensitivity of their fluorescence assay, then that would be helpful to know. For example, they could add a control, taking a known amount of a fluorescent protein and analyzing known dilutions to assay the level of detection.
      5. Fig. S2a and page 3, first full paragraph - The authors wrote that expression of OsTir1(F74G) from the strong GAL1 promoter had a negligible impact on growth. However, the figure shows that there is an obvious effect on growth after 48 hours of incubation, with much smaller colonies. This defect is much less obvious after 72 hours. This difference suggests that the growth effect would have been even more obvious at 24 hours. I think that the text should be modified to indicate this effect.
      6. One of the main justifications for the construction of the AID library is to allow assays for essential genes. Yet that was not a feature of the screen for DNA damage response factors. Were any essential genes identified in those screens? It would be of great interest to identify lower levels of 5-Ph-IAA that only mildly affect growth of essential genes and then to repeat the screens.
      7. A big advantage of AID depletion over deletions is the ability to look at strains very shortly after loss of the protein of interest. In many cases in the literature, experiments are done after one or two hours after depletion. Yet in this work, there are no data presented on how effective depletion is in the short term versus after a long period of growth (24 hours). It would be a strong addition to the manuscript to include a time course for at least a subset of the proteins to look at the loss of signal over time, either by fluorescence or by Western blots.

      Significance

      The library will be of use to the yeast community.

    3. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      In this study, the authors reported the development and characterization of two AID-tagged strain libraries for the model organism S. cerevisiae. The libraries are based on the latest AID technology, AID2. One library contains a fluorescent protein fused to the AID, whereas the other library does not have the fluorescent protein, thus offering better compatibility with imaging-based screens. The authors show that AID-dependent protein degradation can be achieved for most of the library strains, and a growth phenotype was induced for a high fraction of essential genes. Genetic screens for DNA damage-sensitive mutants showcased the applicability of the libraries.

      I only have the following minor comments and suggestions for the authors to consider.

      Point 1

      Page 3

      "Optimized tagging of proteins with these N-terminal localization signals likely also contributes to the lack of correlation between differential fitness defects and occurrence of terminal localization signals (Fig. S1f, Table S2). " Is this because the genes that cannot tolerate C-terminal addition are already depleted in the C-SWAT library? In the C-SWAT library, a 15-amino-acid linker L3 is added to the C-terminus.

      Point 2

      Page 3

      "Expression of OsTir1(F74G) from the strong galactose-inducible GAL1 promoter had a negligible impact on yeast fitness (Fig. S2a)." I wonder why the authors chose to use an inducible promoter to express OsTir1(F74G). In other studies, for example Snyder et al. 2019, OsTir1 has been expressed from a constitutive promoter.

      Point 3

      Page 3

      "A similar frequency was previously observed with a set of AID alleles constructed for 758 essential ORFs using the original AID system (Snyder et al, 2019). However, over a third of these alleles exhibited fitness defects even in the absence of auxin, which were further compounded by off-target effects of auxin, highlighting the advantages of the AID2 system." Snyder et al. 2019 used a TAP-AID-6FLAG tag. The fitness defect in the absence of auxin may not necessarily be due to the AID part of the tag, as TAP tagging is known to compromise the functions of some genes.

      Point 4

      Page 3

      "Interestingly, complete degradation of 33% of essential proteins did not result in a fitness defect. It is possible that in some cases partial degradation results in low protein levels that are below the detection limit of our assay but are sufficient for viability." Are these "33% of essential proteins" enriched with genes with low expression levels? I guess genes with low expression levels are more likely to fall below the detection limit even when partially depleted. Are there extreme examples where a highly expressed essential gene does not exhibit a fitness defect when the protein product is no longer detectable?

      Significance

      This study generated highly valuable resources for functional genomic studies.

    4. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      Summary

      The manuscript by the Khmelinskii group reports that they have successfully constructed two conditional degron libraries of budding yeast for almost all proteins. For this purpose, the authors employed an improved auxin-inducible degron (AID2). Initially, they constructed yeast libraries by fusing HaloTag to the N- or C-terminus of proteins and found that C-terminal tagging is less likely to affect the location and function of proteins (Fig. 1). Based on this finding, the authors fused mNG-AID-3Myc or AID-3Myc (AID-v1 or AID-v2 library, respectively) to more than 5600 proteins and found that 4079 proteins were significantly depleted when cells were treated with 5-Ph-IAA (Fig. 2). A fitness defect was observed for over 60% of essential proteins, indicating the target depletion showed the expected phenotype in many cases (Fig. 3). Finally, the authors screened proteins required for maintaining viability in the presence of MMS, CPT and HU, and identified common proteins involved in DNA repair (such as RAD52 epistasis proteins) and other proteins specific for MMS, CPT or HU resistance (Fig. 4). Furthermore, the authors revealed that an ER membrane protein, Gsf2, is required for HU resistance, which was not found in previous studies with the YKO library because gsf2∆ cells in the YKP library had aquired a suppressor mutation (Fig. 4e).

      Major comments

      • In Figure S2a, the authors initially checked the growth of yeast cells expressing OsTIR1(F74G) under the GAL1 promoter, saying that "expression of OsTir1(F74G) from the strong galactose-inducible GAL1 promoter had a negligible impact on yeast fitness (page 3)". To me, the OsTIR1(G74G) expressing cells showed slightly slower growth compared to the control cells. Moreover, the cells expressing it under the very strong GPD promoter showed apparent slow growth, suggesting that OstIR1(F74G) overexpression caused a side effect. The authors should carefully evaluate the cells with GAL1-OsTIR1(F74G).
      • Given the possibility that OsTIR1(F74G) overexpression might cause a growth problem, it is not appropriate to compare OsTIR1+ and OsTIR1- conditions for evaluating growth fitness (Fig. 2). As shown in Fig. S4b, it is more appropriate to compare the +/- 5-Ph-IAA conditions. Additionally, the 5-Ph-IAA concentration used in this study was not clearly mentioned in the method section and figure legends.
      • The authors found that fitness defects were observed for over 60% of essential proteins (Fig. 3). In other words, depletion of the remaining 40% was not enough to induce growth defects. The authors should discuss how the current AID library can be improved to achieve better target depletion. Previous literature reported various possibilities, such as using a tandem degron tag and combining AID with the Tet promoter system (PMID 25181302, 26081484). Although optional, it would be wonderful if the authors would generate an improved library.

      Minor comments

      • 5-Ph-IAA is not auxin because it does not induce the auxin responses in plants (PMID 29355850). Therefore, the authors should be careful when they refer to 5-Ph-IAA and should not call it auxin.
      • The availability of the HaloTag and AID libraries should be indicated.
      • Page 3: "Finally, the extent of AID-dependent degradation varied with protein abundance, in that highly expressed proteins were more likely to be only partially degraded compared to lowly expressed ones (Fig. 2e, Fig. S2e)". Fig. S2e should be Fig. S2d, shouldn't it?

      Significance

      This paper is technically robust and well-conducted. It presents a comprehensive study showcasing the effectiveness of the conditional degron library. The HaloTag libraries will also be useful. The yeast libraries presented in this study will be invaluable for future screenings and studies across all aspects of yeast biology.

  5. Aug 2024
    1. The RFID tag then sends out its unique ID number (storedin built-in memory).

      The unique ID stored in the RFID tag is critical for identifying and differentiating between students, ensuring the accuracy of the attendance records.

    Annotators

    1. Author response:

      The following is the authors’ response to the original reviews.

      We would like to thank the reviewers and editor for their helpful comments. We have addressed their concerns as detailed below.

      It would have been nice to have included a bona-fide SIRT2 target as a control throughout the study.

      We agree that including a bona-fide SIRT2 target as a control is important for validating our results. Previous data from our work has shown that SIRT2 demyristoylates ARF6. Thus, we have included a blot in Figure S15 demonstrating that SIRT2 knockdown results in increased myristoylation of ARF6. This serves as a control to confirm the activity and role of SIRT2 in our study.

      Did the authors also consider investigating SIRT1 in their assays? SIRT1 activates ACSS2 while SIRT2 leads to degradation of ACSS2. They should at least discuss these seemingly opposing roles of SIRT1 and SIRT2 in the regulation of ACSS2 and acetate metabolism in more depth particularly as it concerns situations (i.e., diseases, pathologies) where either SIRT1, SIRT2, or both sirtuins, are active. This would enhance the significance of the findings to the broader research community.

      The study by Hallows et al. showed increased SIRT1 deacetylate K661 of ACSS2 and increase its catalytic activity. Subsequently, a follow-up investigation unveiled the role of the circadian clock in modulating intracellular acetyl-CoA levels through SIRT1-catalyzed K661 deacetylation of. Conversely, our research elucidates a contrasting mechanism wherein SIRT2 inhibits ACSS2 by deacetylating K271 under conditions of nutrient stress. The dual regulation of ACSS2 by SIRT1 through the circadian clock and SIRT2 under nutrient stress underscores the intricate and multifaceted nature of regulatory mechanisms involved in lipid metabolism. These findings underscore the versatility of lysine acetylation in modulating cellular metabolic pathways.

      Collectively, these studies contribute to a better understanding of how SIRT1 and SIRT2 regulate ACSS2 activity in various metabolic contexts, thereby enhancing our knowledge of acetate metabolism and its implications in health and disease.

      We have included such discussion of the manuscript.

      In Figure 3, the authors should consider immunoblotting for endogenous ACSS2 throughout the differentiation and lipogenesis study since the total ACSS2 levels is the crucial aspect to affecting acetate-dependent promotion of lipogenesis in adipocytes, and to confirm TM-dependent stabilization of ACSS2 in that assay.

      We have updated Figure 3 to include immunoblotting for endogenous ACSS2 levels. Additionally, we have confirmed the TM-dependent stabilization of ACSS2, which is now shown in Figure S12.

      Do the authors have any data proving the K271 mutants of ACSS2 are still functional? Or that K271 ACSS2 protein is folded correctly?

      To assess the functionality of the mutants, we isolated Flag-tagged wildtype, K271R, and K271Q ACSS2 proteins from SIRT2 knockdown HEK293T cells. Subsequently, we examined acetyl-CoA formation from acetate and CoA using high-performance liquid chromatography (HPLC). Our findings indicate that while the wildtype ACSS2 exhibits slightly higher activity compared to the K271R and K271Q mutants, but all variants remain functional (Figure S13).

      Nearly all experiments are performed in a single cell line. Authors should test whether SIRT2 regulates ACSS2 acetylation in at least 1 or 2 more cell lines. Does SIRT2 regulate ACSS2 acetylation in 3T3-L1 preadipocytes?

      Experiments showing that endogenous ACSS2 levels change in EBSS and nutrient-deprived media were repeated in A549 cells (Figure S5). However, due to the poor transfection efficiency of A549 cells, we were unable to obtain acetylation data. Similarly, conducting acetylation experiments in 3T3-L1 preadipocytes is challenging due to poor transfection efficiency.

      The article does not explicitly address whether the absence of amino acids impacts the acetylation and subsequent degradation of ACSS2 by activating SIRT2. If so, one would expect the level of ACSS2 acetylation or ACSS2 expression under amino acid deprivation to be lower than that under normal conditions, as depicted in Fig. 1C and Fig. S3.

      The experiments shown in Fig. 1C and Fig. S3 were using overexpressed Flag-tagged ACSS2 and we actually adjust the amount of DNA used to have similar Flag-ACSS2 levels.

      To address the comment raised by the reviewer, we added Figure S14, which shows that endogenous ACSS2 acetylation is decreased under amino acid deprivation in SIRT2 control KD cells, indicating that the absence of amino acids impacts ACSS2 acetylation. The decreased expression of ACSS2 under amino acid deprivation is also addressed in Figure S6.

      Several reviewers noted discrepancies between what is occurring to basal levels of ACSS2 vs in SIRT2 KD conditions. Fig. 2H shows higher basal level of acetylated ACSS2 in K271R mutant compared to wildtype (input may be an issue). If Fig. 2H is a critical piece of data, authors are recommended to show this using FLAP-IP & then Ac-K.

      The increased stability of the K271R mutant compared to the wildtype (WT) results in higher protein levels, which results in the different input levels. However, this does not affect the conclusion that K271 is the acetylation site as the quantification result shows that K271R mutant has lower acetylation level and is not regulated by SIRT2 (Figure S16).

      Regarding the basal levels of ACSS2 in control and SIRT2 KD conditions, it was because the experiments in question were using overexpressed Flag-tagged ACSS2 and we actually adjust the amount of DNA used to have similar Flag-ACSS2 levels. To address the concern, we monitored endogenous ACSS2 protein and acetylation levels and the results are shown in Figure S14.

      Also, in Fig 2I there is no difference in basal ubiquitination between WT and K271R mutant. Related, based on model you would expect that overexpression of ACSS2-K271R mutant compared to wildtype would be at higher levels. In many figures authors do not see this (Fig. 2I, 3A, 3B). This needs to be explained.

      This is related to some previous comments. In these experiments, we actually adjusted the DNA used in the transfection to obtain equal protein levels so that we can quantify other things (acetylation or ubiquitination levels). As stated in the manuscript regarding Figures 3A and 3B, "To ensure comparable expression levels at the beginning, we adjusted the amount of transfected DNA for both wild-type and the K271R mutant ACSS2." This approach allowed us to accurately compare the ubiquitination status between the wildtype and K271R mutant ACSS2 variants.

      Data showing role of ACSS2-K271 mutant in lipid accumulation requires clarification. Based on model overexpression of ACSS2-K271 mutant should by itself cause increased lipid accumulation compared to wildtype.

      This is indeed the case and we have added this in the revised manuscript “Consistent with our above observation that ACSS2 K271R mutant is more stable than the WT, expressing the K271R mutant lead to more lipid droplets than expressing the WT ACSS2 (Figure S12).”

      Loading controls are notably absent at certain instances, such as IPs in Fig. 1A, 1C, and the IP in Fig. 2H. Such controls are required to interpret potential changes in acetylation.

      For this experiment, we employed an approach where we overexpressed Flag-tagged wild-type (WT) and mutant forms of ACSS2. We conducted an immunoprecipitation (IP) targeting acetyl-lysine residues to enrich lysine-acetylated proteins, followed by immunoblotting for the Flag tag to specifically detect ACSS2 acetylation levels. To ensure the reliability of our results, we included a Flag blot to confirm equal expression levels of ectopically expressed ACSS2 across our samples before IP. Given the nature of our experimental design and the specific aim of investigating ACSS2 acetylation, we believe that additional loading controls beyond the input Flag blot are not required for the interpretation of our results. The inclusion of the input Flag blot serves as a control for protein expression levels, which is crucial for accurate assessment of ACSS2 acetylation status.

      While CHX treatment is known to inhibit protein synthesis, it appears contradictory that CHX treatment in Fig. 2C seemingly leads to ACSS2 accumulation in SIRT2 knockdown HEK293T cells. This discrepancy requires clarification.

      We conducted quantitative analysis of the immunoblot with replicates to ensure the reliability of our findings. Our analysis indicates that the protein level of ACSS2 remains relatively stable over the time course of CHX treatment. The observed slight increase at the 8-hour time point can be attributed to inherent experimental variability, as evidenced by the presence of large error bars in the graph. We have included a graph in Figure S7 to show that there is no significant change in the level of ACSS2 in the SIRT2 HEK293T cells.

      In Fig. 2F-H, the authors argue that SIRT2 deacetylates ACSS2 to facilitate its ubiquitination and subsequent proteasomal degradation. However, these results are depicted under normal conditions, whereas findings in Fig. 1 suggest that SIRT2 deacetylates ACSS2 exclusively under nutrient stress. An explanation for this inconsistency is warranted.

      These experiments were done in amino acid deprived (EBSS) media. We have corrected this in the manuscript.

      Line 160 authors conclude "amino acid limitation..deacetylates K271"..but this was not directly demonstrated. Authors should add this data or change conclusion.

      Addressed in response to some of the comments above.

      Figures 1A and 1B, acetylation quantification, not clear if it is relative to the Flag tag or actin.

      Acetylation quantification is relative to Flag tag. This is clarified in the figure legend.

      Methods section lacking details & not well referenced (how did authors express wildtype & mutant in 3T3-L1 cells?) 

      ACSS2 wildtype and K271R mutant Flag-tagged expression plasmids were transfected into ACSS2 knockdown 3T3-L1 cells using PEI transfection reagent following the manufacturer’s protocol. The pCMV-Tag4a empty vector was used as the negative control. Differentiation of 3T3L1 cell lines were done according to manufacturer’s protocol (DIF001-1KT, Sigma Aldrich) 24 hours after transfection. This has been included in the methods.

      In Figure 3A, is the actin blot from the same immunoblots above it? Reviewers recommend the authors upload original immunoblot.

      This experiment was repeated, and the blot has been replaced.

    1. Reviewer #2 (Public Review):

      Summary:

      During vertebrate gastrulation, the mesoderm and endoderm arise from a common population of precursor cells and are specified by similar signaling events, raising questions as to how these two germ layers are distinguished. Here, Cheng and colleagues use zebrafish gastrulation as a model for mesoderm and endoderm segregation. By reanalyzing published single-cell sequencing data, they identify a common progenitor population for the anterior endoderm and the mesodermal prechordal plate (PP). They find that expression levels of PP genes Gsc and ripply are among the earliest differences between these populations and that their increased expression suppresses the expression of endoderm markers. Further analysis of chromatin accessibility and Ripply cut-and-tag is consistent with direct repression of endoderm by this PP marker. This study demonstrates the roles of Gsc and Ripply in suppressing anterior endoderm fate, but this role for Gsc was already known and the effect of Ripply is limited to a small population of anterior endoderm. The manuscript also focuses extensively on the function of Nodal in specifying and patterning the mesoderm and endoderm, a role that is already well known and to which the current analysis adds little new insight.

      Strengths:

      Integrated single-cell ATAC- and RNA-seq convincingly demonstrate changes in chromatin accessibility that may underlie the segregation of mesoderm and endoderm lineages, including Gsc and ripply. Identification of Ripply-occupied genomic regions augments this analysis. The genetic mutants for both genes provide strong evidence for their function in anterior mesendoderm development, although these phenotypes are subtle.

      Weaknesses:

      The use of zebrafish embryonic explants for cell fate trajectory analysis (rather than intact embryos) is not justified. In both transcriptomic comparisons between the two fate trajectories of interest and Ripply cut-and-tag analysis, the authors rely too heavily on gene ontology which adds little to our functional understanding. Much of the work is focused on the role of Nodal in the mesoderm/endoderm fate decision, but the results largely confirm previous studies and again provide few new insights. Some experiments were designed to test the relationship between the mesoderm and endoderm lineages and the role of epigenetic regulators therein, but these experiments were not properly controlled and therefore difficult to interpret.

    2. Reviewer #3 (Public Review):

      Summary:

      Cheng, Liu, Dong, et al. demonstrate that anterior endoderm cells can arise from prechordal plate progenitors, which is suggested by pseudo time reanalysis of published scRNAseq data, pseudo time analysis of new scRNAseq data generated from Nodal-stimulated explants, live imaging from sox17:DsRed and Gsc:eGFP transgenics, fluorescent in situ hybridization, and a Cre/Lox system. Early fate mapping studies already suggested that progenitors at the dorsal margin give rise to both of these cell types (Warga) and live imaging from the Heisenberg lab (Sako 2016, Barone 2017) also pretty convincingly showed this. However, the data presented for this point are very nice, and the additional experiments in this manuscript, however, further cement this result. Though better demonstrated by previous work (Alexander 1999, Gritsman 1999, Gritsman 2000, Sako 2016, Rogers 2017, others), the manuscript suggests that high Nodal signaling is required for both cell types, and shows preliminary data that suggests that FGF signaling may also be important in their segregation. The manuscript also presents new single-cell RNAseq data from Nodal-stimulated explants with increased (lft1 KO) or decreased (ndr1 KD) Nodal signaling and multi-omic ATAC+scRNAseq data from wild-type 6 hpf embryos but draws relatively few conclusions from these data. Lastly, the manuscript presents data that SWI/SNF remodelers and Ripply1 may be involved in the anterior endoderm - prechordal plate decision, but these data are less convincing. The SWI/SNF remodeler experiments are unconvincing because the demonstration that these factors are differentially expressed or active between the two cell types is weak. The Ripply1 gain-of-function experiments are unconvincing because they are based on incredibly high overexpression of ripply1 (500 pg or 1000 pg) that generates a phenotype that is not in line with previously demonstrated overexpression studies (with phenotypes from 10-20x lower expression). Similarly, the cut-and-tag data seems low quality and like it doesn't support direct binding of ripply1 to these loci.

      In the end, this study provides new details that are likely important in the cell fate decision between the prechordal plate and anterior endoderm; however, it is unclear how Nodal signaling, FGF signaling, and elements of the gene regulatory network (including Gsc, possibly ripply1, and other factors) interact to make the decision. I suggest that this manuscript is of most interest to Nodal signaling or zebrafish germ layer patterning afficionados. While it provides new datasets and observations, it does not weave these into a convincing story to provide a major advance in our understanding of the specification of these cell types.

      Major issues:

      (1) UMAPs: There are several instances in the manuscript where UMAPs are used incorrectly as support for statements about how transcriptionally similar two populations are. UMAP is a stochastic, non-linear projection for visualization - distances in UMAP cannot be used to determine how transcriptionally similar or dissimilar two groups are. In order to make conclusions about how transcriptionally similar two populations are requires performing calculations either in the gene expression space, or in a linear dimensional reduction space (e.g. PCA, keeping in mind that this will only consider the subset of genes used as input into the PCA). Please correct or remove these instances, which include (but are not limited to):<br /> p.4 107-110<br /> p.4 112<br /> p.8 207-208<br /> p.10 273-275

      (2) Nodal and lefty manipulations: The section "Nodal-Lefty regulatory loop is needed for PP and anterior Endo fate specification" and Figure 3 do not draw any significant conclusions. This section presents a LIANA analysis to determine the signals that might be important between prechordal plate and endoderm, but despite the fact that it suggests that BMP, Nodal, FGF, and Wnt signaling might be important, the manuscript just concludes that Nodal signaling is important. Perhaps this is because the conclusion that Nodal signaling is required for the specification of these cell types has been demonstrated in zebrafish in several other studies with more convincing experiments (Alexander 1999, Gritsman 1999, Gritsman 2000, Rogers 2017, Sako 2016). While FGF has recently been demonstrated to be a key player in the stochastic decision to adopt endodermal fate in lateral endoderm (Economou 2022), the idea that FGF signaling may be a key player in the differentiation of these two cell types has strangely been relegated to the discussion and supplement. Lastly, the manuscript does not make clear the advantage of performing experiments to explore the PP-Endo decision in Nodal-stimulated explants compared to data from intact embryos. What would be learned from this and not from an embryo? Since Nodal signaling stimulates the expression of Wnts and FGFs, these data do not test Nodal signaling independent of the other pathways. It is unclear why this artificial system that has some disadvantages is used since the manuscript does not make clear any advantages that it might have had.

      (3) ripply1 mRNA injection phenotype inconsistent with previous literature: The phenotype presented in this manuscript from overexpressing ripply1 mRNA (Fig S11) is inconsistent with previous observations. This study shows a much more dramatic phenotype, suggesting that the overexpression may be to a non-physiological level that makes it difficult to interpret the gain-of-function experiments. For instance, Kawamura et al 2005 perform this experiment but do not trigger loss of head and eye structures or loss of tail structures. Similarly, Kawamura et al 2008 repeat the experiment, triggering a mildly more dramatic shortening of the tail and complete removal of the notochord, but again no disturbance of head structures as displayed here. These previous studies injected 25 - 100 pg of ripply1 mRNA with dramatic phenotypes, whereas this study uses 500 - 1000 pg. The phenotype is so much more dramatic than previously presented that it suggests that the level of ripply1 overexpression is sufficiently high that it may no longer be regulating only its endogenous targets, making the results drawn from ripply1 overexpression difficult to trust.

      (4) Ripply1 binding to sox17 and sox32 regulatory regions not convincing: The Cut and Tag data presented in Fig 6J-K does not seem to be high quality and does not seem to provide strong support that Ripply 1 binds to the regulatory regions of these genes. The signal-to-noise ratio is very poor, and the 'binding' near sox17 that is identified seems to be even coverage over a 14 kb region, which is not consistent with site-specific recruitment of this factor, and the 'peaks' highlighted with yellow boxes do not appear to be peaks at all. To me, it seems this probably represents either: (1) overtagmentation of these samples or (2) an overexpression artifact from injection of too high concentration of ripply1-HA mRNA. In general, Cut and Tag is only recommended for histone modifications, and Cut and Run would be recommended for transcriptional regulators like these (see Epicypher's literature). Given this and the previous point about Ripply1 overexpression, I am not convinced that Ripply1 regulates endodermal genes. The existing data could be made somewhat more convincing by showing the tracks for other genes as positive and negative controls, given that Ripply1 has known muscle targets (how does its binding look at those targets in comparison) and there should be a number of Nodal target genes that Ripply1 does not bind to that could be used as negative controls. Overall this experiment doesn't seem to be of high enough quality to drive the conclusion that Ripply1 directly binds near sox17 and sox32 and from the data presented in the manuscript looks as if it failed technically.

      (5) "Cooperatively Gsc and ripply1 regulate": I suggest avoiding the term "cooperative," when describing the relationship between Ripply1 and Gsc regulation of PP and anterior endoderm - it evokes the concept of cooperative gene regulation, which implies that these factors interact with each biochemically in order to bind to the DNA. This is not supported by the data in this manuscript, and is especially confusing since Ripply1 is thought to require cooperative binding with a T-box family transcription factor to direct its binding to the DNA.

      (6) SWI/SNF: The differential expression of srcap doesn't seem very remarkable. The dot plots in the supplement S7H don't help - they seem to show no expression at all in the endoderm, which is clearly a distortion of the data, since from the violin plots it's obviously expressed and the dot-size scale only ranges from ~30-38%. Please add to the figure information about fold-change and p-value for the differential expression. Publicly available scRNAseq databases show scrap is expressed throughout the entire early embryo, suggesting that it would be surprising for it to have differential activity in these two cell types and thereby contribute to their separate specification during development. It seems equally possible that this just mildly influences the level of Nodal or FGF signaling, which would create this effect.

      The multiome data seems like a valuable data set for researchers interested in this stage of zebrafish development. However, the presentation of the data doesn't make many conclusions, aside from identifying an element adjacent to ripply1 whose chromatin is open in prechordal plate cells and not endodermal cells and showing that there are a number of loci with differential accessibility between these cell types. That seems fairly expected since both cell types have several differentially expressed transcriptional regulators (for instance, ripply1 has previously been demonstrated in multiple studies to be specific to the prechordal plate during blastula stages). The manuscript implies that SWI/SNF remodeling by Srcap is responsible for the chromatin accessibility differences between these cell types, but that has not actually been tested. It seems more likely that the differences in chromatin accessibility observed are a result of transcription factors binding downstream of Nodal signaling.

      Minor issues:

      Figure 2 E-F: It's not clear which cells from E are quantitated in F. For instance, the dorsal forerunner cells are likely to behave very differently from other endodermal progenitors in this assay. It would be helpful to indicate which cells are analyzed in Fig F with an outline or other indicator of some kind. Or - if both DFCs and endodermal cells are included in F, to perhaps use different colors for their points to help indicate if their fluorescence changes differently.

      Fig 3 J: Should the reference be Dubrulle et al 2015, rather than Julien et al?

      References:<br /> Alexander, J. & Stainier, D. Y. A molecular pathway leading to endoderm formation in zebrafish. Current biology : CB 9, 1147-1157 (1999).<br /> Barone, V. et al. An Effective Feedback Loop between Cell-Cell Contact Duration and Morphogen Signaling Determines Cell Fate. Dev. Cell 43, 198-211.e12 (2017).<br /> Economou, A. D., Guglielmi, L., East, P. & Hill, C. S. Nodal signaling establishes a competency window for stochastic cell fate switching. Dev. Cell 57, 2604-2622.e5 (2022).<br /> Gritsman, K. et al. The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell 97, 121-132 (1999).<br /> Gritsman, K., Talbot, W. S. & Schier, A. F. Nodal signaling patterns the organizer. Development (Cambridge, England) 127, 921-932 (2000).<br /> Kawamura, A. et al. Groucho-associated transcriptional repressor ripply1 is required for proper transition from the presomitic mesoderm to somites. Developmental cell 9, 735-744 (2005).<br /> Kawamura, A., Koshida, S. & Takada, S. Activator-to-repressor conversion of T-box transcription factors by the Ripply family of Groucho/TLE-associated mediators. Molecular and cellular biology 28, 3236-3244 (2008).<br /> Sako, K. et al. Optogenetic Control of Nodal Signaling Reveals a Temporal Pattern of Nodal Signaling Regulating Cell Fate Specification during Gastrulation. Cell Rep. 16, 866-877 (2016).<br /> Rogers, K. W. et al. Nodal patterning without Lefty inhibitory feedback is functional but fragile. eLife 6, e28785 (2017).<br /> Warga, R. M. & Nüsslein-Volhard, C. Origin and development of the zebrafish endoderm. Development 126, 827-838 (1999).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Reviews):

      Summary: 

      The authors use a combination of biochemistry and cryo-EM studies to explore a complex between the cap-binding complex and an RNA binding protein, ALYREF, that coordinates mRNA processing and export.

      Strengths: 

      The biochemistry and structural biology are supported by mutagenesis which tests the model in vitro. The structure provides new insight into how key events in RNA processing and export are likely to be coordinated.

      Weaknesses: 

      The authors provide biochemical studies to confirm the interactions that they identify; however, they do not perform any studies to test these models in cells or explore the consequences of mRNA export from the nucleus. In fact, several of the amino acids that they identified in ALYREF that are critical for the interaction, as determined by their own biochemical studies, are conserved in budding yeast Yra1 (residues E124/E128 are E/Q in budding yeast and residues Y135/V138/P139 are F/S/P), where the impact on poly(A) RNA export from the nucleus could be readily evaluated. The authors could at least mention this point as part of the implications and the need for future studies. No one seems to have yet targeted any of these conserved residues, so this would be a logical extension of the current work.

      We thank the reviewer for the feedback on our work. ALYREF coordinates pre-mRNA processing and export through interactions with a plethora of mRNA biogenesis factors including the DDX39B subunit of the TREX complex, CBC, EJC, and 3’ processing factors. ALYREF mediates the recruitment of the TREX complex on nascent transcripts which depends on its interactions with both CBC and EJC. Our work and studies by others indicate that ALYREF uses overlapping interfaces including both the N-terminal WxHD motif and the RRM domain to bind CBC and EJC. Thus, ALYREF mutants deficient in CBC interaction will also disrupt the ALYREF-EJC interaction and are not ideal for functional studies. In addition, the CBC plays important roles in multiple steps of mRNA metabolism through interactions with a plethora of factors, which often interact competitively with CBC. Identification of separation-of-function mutations on CBC or ALYREF that specifically disrupt their interaction but not other cellular complexes containing CBC or ALYREF would be an important future area to test the model in cells. 

      We appreciate the reviewer’s insightful comments regarding yeast Yra1. Thus far, the physical and functional connection between Yra1 and CBC in yeast has not been demonstrated. There are major differences between yeast Yra1 and human ALYREF. Given the lack of an EJC in S. cerevisiae, it is unclear whether Yra1 acts in a similar manner as human ALYREF. In addition, Yra1 does not contain a WxHD motif in its N-terminal unstructured region, which is involved in CBC and EJC interactions in ALYREF. Characterization of the Yra1-CBC interaction will be an interesting future direction. We now include a discussion about yeast Yra1 in the newly added “Conclusion and perspectives” section. 

      Specific suggestions:

      The authors could put their work in context by speculating how some of the amino acids that they identify as being critical for the interactions they identify could contribute to cancer. For example, they mention mutations of interacting residues in NCBP2 are associated with human cancers, pointing out that NCBP2 R105C amino acid substitution has been reported in colorectal cancer and the NCBP2 I110M mutation has been found in head and neck cancer. Do the authors speculate that these changes would decrease the interaction between NCBP2 and ALYREF and, if so, how would this contribute to cancer? They also mention that a K330N mutation in NCBP1 in human uterine corpus endometrial carcinoma, where Y135 on the α2 helix of mALYREF2 makes a hydrogen bond with K330 of NCBP1. How do they speculate loss of this interaction would contribute to cancer?

      In the revised manuscript, we include a discussion about these CBC mutants found in human cancers in the “Conclusion and perspectives” section. We think some of these CBC mutants, such as NCBP-1 K330N, could reduce interaction with ALYREF. Compromised CBC-ALYREF interaction will affect the recruitment of the TREX complex on nascent transcripts and cause dysregulation of mRNA export. In addition, that could also change the partition of CBC and ALYREF in different cellular complexes and cause perturbation of various steps in mRNA biogenesis that are regulated by CBC and ALYREF. Thus far, it is unclear whether and how loss of the CBC-ALYREF interaction directly contributes to cancer. Our work and that of others provide molecular insights to test in future studies. 

      Reviewer #2 (Public Reviews):

      Summary: 

      In this manuscript, Bradley and his colleagues represented the cryo-EM structure of the nuclear cap-binding complex (CBC) in complex with an mRNA export factor, ALYREF, providing a structural basis for understanding CBC regulating gene expression.

      Strengths: 

      The authors successfully modeled the N-terminal region and the RRM domain of ALYREF (residues 1-183) within the CBC-ALYREF structure, which revealed that both the NCBP1 and NCBP2 subunits of the CBC interact with the RBM domain of ALYREF. Further mutagenesis and pull-down studies provided additional evidence to the observed CBC-ALYREF interface. Additionally, the authors engaged in a comprehensive discussion regarding other cellular complexes containing CBC and/or ALYREF components. They proposed potential models that elucidated coordinated events during mRNA maturation. This study provided good evidence to show how CBC effectively recruits mRNA export factor machinery, enhancing our understanding of CBC regulating gene expression during mRNA transcription, splicing, and export. 

      Weaknesses: 

      No in vivo or in vitro functional data to validate and support the structural observations and the proposed models in this study. Cryo-EM data processing and structural representation need to be strengthened. 

      We appreciate the reviewer’s comments and suggestions. The fact that ALYREF uses highly overlapped binding interfaces for CBC and EJC interactions prevents us from a clear functional dissection of the ALYREF-CBC interaction using in vitro assays or in cells at the current stage. Please also see our response to Reviewer 1. 

      In this revised manuscript, we have reprocessed the cryo-EM data using a different strategy which yields significantly improved maps. We have made improvements to the presentation of the structural work based on the reviewer’s specific comments. 

      Reviewer #3 (Public Reviews):

      Summary: 

      The authors carried out structural and biochemical studies to investigate the multiple functions of CBC and ALYREF in RNA metabolism.

      Strengths: 

      For the structural study part, the authors successfully revealed how NCBP1 and NCBP2 subunits interact with mALYREF (residues 1-155). Their binding interface was then confirmed by biochemical assays (mutagenesis and pull-down assays) presented in this study. 

      Weaknesses: 

      The authors did not provide functional data to support their proposed models. The authors should include more details regarding the workflow of their cryo-EM data processing in the figure. 

      We thank the reviewer for the comments. We completely agree that testing the proposed models in cells would be ideal. However, as we also respond to the other reviewers, functional studies are premature at the current stage because both ALYREF and CBC are components of many cellular complexes that regulate mRNA metabolism. Separation-of-function mutations on CBC or ALYREF first need to be identified in future studies for further investigation. Please also see our response to Reviewer 1. 

      As suggested by the reviewer, we have included more details of the cryo-EM workflow in this revised manuscript. We have also included various validation measures including 3DFSC analyses, map vs model FSC curves, and representative density maps at various protein-protein binding interfaces. 

      Recommendations for the Authors:

      Reviewer #1 (Recommendations for the Authors):

      Major points:

      The authors should take advantage of Figure 1, which shows the domain structures of NCBP1, NCBP2, and ALYREF to indicate for the reader specifically which protein domains are included in the biochemical and structural analyses. In the current version of the manuscript, there is plenty of space to indicate below each domain structure precisely what regions are included.

      In this revised manuscript, we have revised Figure 1A to indicate the protein constructs used in this work. 

      Although it is fine to combine the Results and Discussion, the authors should really offer a concluding paragraph to highlight the novel results from this study and put the results in context.

      We thank the reviewer for the recommendation. We now include a “Conclusion and perspectives” section in this revised manuscript.  

      Minor comments:

      Page 5, last sentence (and others) starts a sentence with the word "Since" when likely "As" which does not imply a time element to the phrase, is the correct word.

      "Since the ALYREF/mALYREF2 interaction with the CBC is conserved and mALYREF2 exhibits better solubility, we focused on mALYREF2 in the cryo-EM investigations."

      Would be more correct as: "As the ALYREF/mALYREF2 interaction with the CBC is conserved and mALYREF2 exhibits better solubility, we focused on mALYREF2 in the cryo-EM investigations."

      We thank the reviewer for the comments. We have made the corrections. 

      The word 'data' is plural so the sentence at the bottom of p.9 that includes the phrase "...in vivo data shows.." should read "..in vivo data show.." 

      Corrected in the revised manuscript.

      Reviewer #2 (Recommendations for the Authors):

      Major points:

      (1) The authors claimed the improved solubility of mouse ALYREF2 (mALYREF2, residues 1-155) compared to the previously employed ALYREF construct. However, human ALYREF has already been purified successfully for pull down assay, indicating soluble human ALYREF obtained, why not use human ALYREF directly? Please clarify. 

      Pull-down studies were performed with GST-tagged ALYREF. For cryo-EM studies, untagged ALYREF is preferred to avoid potential issues that may arise from the expression tag. However, untagged ALYREF is less soluble than GST-tagged ALYREF and is not amenable for structural studies. We have revised the text to clarify this point. 

      (2) The authors confirmed CBC-ALYREF interfaces through mutagenesis and pull-down assays in vitro. However, it would be more informative and interesting to include functional assays in vitro or/and in vivo with mutagenesis. 

      We completely concur with the reviewer that testing the proposed models in vitro and in vivo would be important. However, as we pointed out in our response to public reviews, the highly overlapped binding interfaces on ALYREF for CBC and EJC interactions pose a great challenge for functional studies. Furthermore, both ALYREF and CBC are multifunctional factors and interact with a number of partners. Ideally, separation-of-function mutants that specifically disrupt the CBC-ALYREF interaction but not others need to be identified in future studies in order to perform functional studies. 

      (3) About cryo-EM data processing and structural representation:

      (1) In the description of the cryo-EM data processing, the authors claimed they did heterogeneous refinement, homogenous refinement, and then local refinement. This reviewer is puzzled by this process because the normal procedure should be non-uniform refinement following homogenous refinement. If the authors did not perform non-uniform refinement, they should do it because it would significantly improve the quality and resolution of cryo-EM maps. In addition, the right local refinement should include mask files and only show the density/map of the local region. 

      We thank the reviewer for the suggestions. In response to the reviewer’s comment on the preferred orientation issue (point 5 below), we reprocessed the cryo-EM data and obtained significantly improved cryo-EM maps. In this revised manuscript, the CBC-mALYREF map was refined using homogeneous refinement; the CBC map was refined using homogenous refinement followed by non-uniform refinement. Refinement masks are included in Figure 2-figure supplement1. 

      (2) Further local refinements with signal subtraction should be performed to improve the density and resolution of mALYREF2. 

      We tested local refinement with or without signal subtraction using masks covering mALYREF2 and various regions of CBC. Unfortunately, this approach did not improve the density of mALYREF2. We suspect that the small size of mALYREF2 (77 residues for the RRM domain) and the intrinsic flexibility of CBC are the limiting factors in these attempts. 

      (3) Figures with cryoEM map showing the side chains of the residues on the CBC-mALYREF2 interface should be included to strengthen the claims. Authors could add the map to Figure 3b/c or present it as a supplementary figure.

      We include new supplementary figures (Figure 3-figure supplement 1) to show the electron densities corresponding to the views in Figure 3B and 3C. Residues labeled in Figure 3B and 3C are shown in sticks in these supplementary figures.

      (4) For cryo-EM date processing, the authors have omitted lots of important details. Could the authors elaborate on the data processing with more details in the corresponding Figure and Methods Sections? Only one abi-initial model from the picked good particles was displayed in the figure. Are there any other different conformations of 3D classes for the dataset? In addition, too few classes have been considered in 3D classification, more classes may give a class with better density and resolution.

      We thank the reviewer for the comments. We have reprocessed the cryo-EM data. A major change is to use Topaz for particle picking. We now include more details for data processing in Figure 2-figure supplement 1 and the method section. The cryo-EM sample is relatively uniform. Ab-initio reconstruction and heterogenous refinement yielded only one good class and the other classes are “junk” classes (omitted in the workflow figure). No major conformational changes were observed throughout the multiple rounds of heterogenous refinement for both CBC and CBCmALYREF2. In this revised manuscript, we have been able to obtain significantly improved maps through the new data processing strategy employing Topaz as illustrated in Figure 2-figure supplement 1 to 5.

      (5) Angular distribution plots should be included to show if there is a preferred orientation issue. Based on the presented maps in validation reports, there may exist a preferred orientation issue for the reported two cryo-EM maps. Detailed 3D-Histogram and directional FSC plots for all the cryo-EM maps using 3DFSC web server should be presented to show the overall qualities (https://www.nature.com/articles/nmeth.4347 and https://3dfsc.salk.edu/).

      We thank the reviewer for the recommendations. In response to the reviewer’s comment on the preferred orientation issue, we reprocessed the cryo-EM data. Topaz was used for particle picking instead of template picking. 3DFSC analyses indicate that the new CBC-mALREF2 map has a sphericity of 0.946, which is a significant improvement from the previous map which has a sphericity of 0.815. Consistently, the maps presented in this revised manuscript show significantly improved densities. We now include angular distribution and 3DFSC analyses of the EM maps (Figure 2-figure supplement 2 and 4). 

      (6) Figures of model-to-map FSCs need to be present to demonstrate the quality of the models and the corresponding ones (model resolution when FSC=0.5) should also be included in Table 1. The accuracy of the model is important for structural explanations and description.

      The model-to-map FSCs are now included in Figure 2-figure supplement 3A and 5A. The model resolutions of CBC-mALYREF2 and CBC are estimated to be 3.5 Å and 3.6 Å at an FSC of 0.5. These numbers are now included in Table 1. 

      (7) In addition, figures of local density maps with different regions of the models, showing side chains, are necessary and important to justify the claimed resolutions. 

      We now include density maps overlayed with residue side chains at various regions. For the CBCmALYREF2 map, density maps are shown at the mALYREF2-NCBP1 interfaces (Figure 3-figure supplement 1A and 1B), mALYREF2-NCBP2 interface (Figure 3-figure supplement 1C), NCBP1NCPB2 interface (Figure 2-figure supplement 5B), and the region near m7G (Figure 2-figure supplement 5C). For the CBC map, density maps are shown at the NCBP1-NCPB2 interface (Figure 2-figure supplement 3B) and the region near m7G (Figure 2-figure supplement 3C). 

      Minor points:

      (1) A figure superimposing the models from the CBC-mALYREF2 amp and mALYREF2 alone map is necessary to present that there are no other CBC binding-induced conformational changes in CBC except the claimed by the authors. In addition, a figure showing the density of m7GpppG should be included as well.  

      Overlay of CBC and CBC-mALYREF2 models is now presented in Figure 2-figure supplement 3D. Comparing CBC and CBC-mALYREF2, NCBP1 and NCBP2 have a RMSD of 0.32 Å and 0.30 Å, respectively. The density maps near the M7G cap analog are shown in Figure 2-figure supplement 3C for CBC and Figure 2-figure supplement 5C for CBC-mALYREF2. 

      (2) Authors obtained the two maps from one dataset, so "we first determined" and "we next determined" (page 6) should be replaced with something like "One class of 3D cryo-EM map revealed' and "Another class of 3D cryo-EM map defined". 

      We have revised the text as suggested by the reviewer.  

      (3) In 'Abstract', 'a mRNA export factor' should be 'an mRNA export factor'. 

      Corrected in the revised manuscript.

      (4) In 'Abstract', the final sentence 'Comparison of CBC- ALYREF to other CBC and ALYREF containing cellular complexes provides insights into the coordinated events during mRNA transcription, splicing, and export' doesn't read smoothly, I would suggest revising it to 'Comparing CBC-ALYREF with other cellular complexes containing CBC and/or ALYREF components provides insight into the coordinated events during mRNA transcription, splicing, and export.' 

      We thank the reviewer for the recommendation and have revised accordingly. 

      (5) In paragraph 'CBC-ALYREF and viral hijacking of host mRNA export pathway', line 6, the sentences preceding and following the term 'However' indicate a progressive or parallel relationship, rather than a transitional one. To enhance the coherence, I would suggest replacing 'However' with 'Furthermore' or 'In addition'. 

      Corrected in the revised manuscript.

      (6) In both Figure 5 and Figure 6, the depicted models are proposed and constructed exclusively through the comparison of the CBC-partial ALYREF with other cellular complexes containing components of CBC and/or ALYREF, which need to be confirmed by more studies. To prevent potential confusion and misunderstandings, it is recommended to replace the term 'model' with 'proposed model'. 

      Corrected in the revised manuscript.

      Reviewer #3 (Recommendations for the Authors):

      Major points:

      (1) In the Results and Discussion section, the authors mentioned "Recombinant human ALYREF protein was shown to interact with the CBC in RNase-treated nuclear extracts." However, they used mouse ALYREF for cryo-EM investigations. Can the authors include an explanation for this choice during the revision?  

      In our work, we used a mixture of glutamic acid and arginine to increase the solubility of GSTALYREF. For cryo-EM studies, we use untagged ALYREF to avoid potential issues that may arise from the expression tag. However, untagged ALYREF is less soluble than GST-tagged ALYREF and is not suitable for structural studies in standard buffers. We have made further clarification on this point in this revised manuscript. 

      (2) In the paragraph on "CBC-ALYREF interfaces", the authors stated "For example, E97 forms salt bridges with K330 and K381 of NCBP1. Y135 on the α2 helix of mALYREF2 makes a hydrogen bond with K330 of NCBP1. The importance of this interface between ALYREF and NCBP1 is highlighted by a K330N mutation found in human uterine corpus endometrial carcinoma." I fail to see a strong connection between their structural observations and previous findings regarding the role of a K330N mutation found in human uterine corpus endometrial carcinoma. The authors should add more words to thread these two parts.  

      In response to the reviewer’s comment, we now move the discussion of these CBC mutants to the newly added “Conclusion and perspectives” section. 

      (3) The authors should include side chains of the residues in their figure of Local resolution estimation and FSC curves, especially when they are presenting the binding interface between two components. 

      We have now included density maps that are overlayed with structural models showing side chains of critical residues. These maps include the NCBP1-mALYREF2 interfaces (Figure 3-figure supplement 1A and 1B), NCBP2-mALYREF2 interface (Figure 3-figure supplement 1C), NCBP1NCBP2 interface (Figure 2-figure supplement 3B and 5B), and the m7G cap region (Figure 2figure supplement 3C and 5C). 

      Minor points: 

      (1) Some grammatical mistakes need to be corrected. For example, it is "an mRNA" instead of "a mRNA".  

      Corrected in the revised manuscript.

      (2) The authors can provide more information for the audience to know better about ALYREF when it first appears in the 5th line in the Abstract section. For example, "It promotes mRNA export through direct interaction with ALYREF, a key mRNA export factor, ...". 

      We have revised the sentence based on the reviewer’s comment.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Kelbert et al. presents results on the involvement of the yeast transcription factor Sfp1 in the stabilisation of transcripts whose synthesis it stimulates. Sfp1 is known to affect the synthesis of a number of important cellular transcripts, such as many of those that code for ribosomal proteins. The hypothesis that a transcription factor can remain bound to the nascent transcript and affect its cytoplasmic half-life is attractive. However, the association of Sfp1 with cytoplasmic transcripts remains to be validated, as explained in the following comments:

      A two-hybrid based assay for protein-protein interactions identified Sfp1, a transcription factor known for its effects on ribosomal protein gene expression, as interacting with Rpb4, a subunit of RNA polymerase II. Classical two-hybrid experiments depend on the presence of the tested proteins in the nucleus of yeast cells, suggesting that the observed interaction occurs in the nucleus. Unfortunately, the two-hybrid method cannot determine whether the interaction is direct or mediated by nucleic acids. The revised version of the manuscript now states that the observed interaction could be indirect.

      To understand to which RNA Sfp1 might bind, the authors used an N-terminally tagged fusion protein in a cross-linking and purification experiment. This method identified 264 transcripts for which the CRAC signal was considered positive and which mostly correspond to abundant mRNAs, including 74 ribosomal protein mRNAs or metabolic enzyme-abundant mRNAs such as PGK1. The authors did not provide evidence for the specificity of the observed CRAC signal, in particular what would be the background of a similar experiment performed without UV cross-linking. This is crucial, as Figure S2G shows very localized and sharp peaks for the CRAC signal, often associated with over-amplification of weak signal during sequencing library preparation.

      (1) To rule out possible PCR artifacts, we used a UMI (Unique Molecular Identifier) scan. UMIs are short, random sequences added to each molecule by the 5’ adapter to uniquely tag them. After PCR amplification and alignment to the reference genome, groups of reads with identical UMIs represent only one unique original molecule. Thus, UMIs allow distinguishing between original molecules and PCR duplicates, effectively eliminating the duplicates.

      (2) Looking closely at the peaks using the IGV browser, we noticed that the reads are by no means identical. Each carrying a mutation [probably due to the cross-linking] in a different position and having different length. Note that the reads are highly reproducible in two replicate.

      (3) CRAC+ genes do not all fall into the category of highly transcribed genes.  On the contrary, as depicted in Figure 6A (green dots), it is evident that CRAC+ genes exhibit a diverse range of Rpb3 ChIP and GRO signals. Furthermore, as illustrated in Figure 7A, when comparing CRAC+ to Q1 (the most highly transcribed genes), it becomes evident that the Rpb4/Rpb3 profile of CRAC+ genes is not a result of high transcription levels.

      (4) Only a portion of the RiBi mRNAs binds Sfp1, despite similar expression of all RiBi.

      (5) The CRAC+ genes represent a distinct group with many unique features. Moreover, many CRAC+ genes do not fall into the category of highly transcribed genes.

      (6) The biological significance of the 262 CRAC+ mRNAs was demonstrated by various experiments; all are inconsistent with technical flaws. Some examples are:

      a) Fig. 2a and B show that most reads of CRAC+ mRNA were mapped to specific location – close the pA sites.

      b) Fig. 2C shows that most reads of CRAC+ mRNA were mapped to specific RNA motif.

      c) Most RiBi CRAC+ promoter contain Rap1 binding sites (p= 1.9x10-22), whereas the vast majority of RiBi CRAC- promoters do not contain Rap1 binding site. (Fig. 3C).

      d) Fig. 4A shows that RiBi CRAC+ mRNAs become destabilized due to Sfp1 deletion, whereas RiBi CRAC- mRNAs do not. Fig. 4B shows similar results due to

      e) Fig. 6B shows that the impact of Sfp1 on backtracking is substantially higher for CRAC+ than for CRAC- genes. This is most clearly visible in RiBi genes.

      f) Fig. 7A shows that the Sfp1-dependent changes along the transcription units is substantially more rigorous for CRAC+ than for CRAC-.

      g) Fig. S4B Shows that chromatin binding profile of Sfp1 is different for CRAC+ and CRAC- genes

      In a validation experiment, the presence of several mRNAs in a purified SFP1 fraction was measured at levels that reflect the relative levels of RNA in a total RNA extract. Negative controls showing that abundant mRNAs not found in the CRAC experiment were clearly depleted from the purified fraction with Sfp1 would be crucial to assess the specificity of the observed protein-RNA interactions (to complement Fig. 2D).

      GPP1, a highly expressed genes, is not to be pulled down by Sfp1 (Fig. 2D). GPP1 (alias RHR2) was included in our Table S2 as one of the 264 CRAC+ genes, having a low CRAC value. However, when we inspected GPP1 results using the IGV browser, we realized that the few reads mapped to GPP1 are actually anti-sense to GPP1 (perhaps they belong to the neighboring RPL34B genes, which is convergently transcribed to GPP1) (see Fig. 1 at the bottom of the document). Thus, GPP1 is not a CRAC+ gene and would now serve as a control. See  We changed the text accordingly (see page 11 blue sentences). In light of this observation, we checked other CRAC genes and found that, except for ALG2, they all contain sense reads (some contain both sense and anti-sense reads). ALG2 and GPP1 were removed leaving 262 CRAC+ genes.

      The CRAC-selected mRNAs were enriched for genes whose expression was previously shown to be upregulated upon Sfp1 overexpression (Albert et al., 2019). The presence of unspliced RPL30 pre-mRNA in the Sfp1 purification was interpreted as a sign of co-transcriptional assembly of Sfp1 into mRNA, but in the absence of valid negative controls, this hypothesis would require further experimental validation. Also, whether the fraction of mRNA bound by Sfp1 is nuclear or cytoplasmic is unclear.

      Further experimental validation was provided in some of our figures (e.g., Fig. 5C, Fig. 3B).

      We argue that Sfp1 binds RNA co-transcriptionally and accompanies the mRNA till its demise in the cytoplasm: Co-transcriptional binding is shown in: (I) a drop in the Sfp1 ChIP-exo signal that coincides with the position of Sfp1 binding site in the RNA (Fig. 5C), demonstrating a movement of Sfp1 from chromatin to the transcript, (II) the dependence of Sfp1 RNA-binding on the promoter (Fig. 3B) and binding of intron-containing RNA. Taken together these 3 different experiments demonstrate that Sfp1 binds Pol II transcript co-transcriptionally.  Association of Sfp1 with cytoplasmic mRNAs is shown in the following experiments: (I) Figure 2D shows that Sfp1 pulled down full length RNA, strongly suggesting that these RNA are mature cytoplasmic mRNAs. (II) mRNA encoding ribosomal proteins, which belong to the CRAC+ mRNAs group are degraded by Xrn1 in the cytoplasm (Bresson et al., Mol Cell 2020). The capacity of Sfp1 to regulates this process (Fig. 4A-D) is therefore consistent with cytoplasmic activity of Sfp1. (III) The effect of Sfp1 on deadenylation (Fig. 4D), a cytoplasmic process, is also consistent with cytoplasmic activity of Sfp1. 

      To address the important question of whether co-transcriptional assembly of Spf1 with transcripts could alter their stability, the authors first used a reporter system in which the RPL30 transcription unit is transferred to vectors under different transcriptional contexts, as previously described by the Choder laboratory (Bregman et al. 2011). While RPL30 expressed under an ACT1 promoter was barely detectable, the highest levels of RNA were observed in the context of the native upstream RPL30 sequence when Rap1 binding sites were also present. Sfp1 showed better association with reporter mRNAs containing Rap1 binding sites in the promoter region. Removal of the Rap1 binding sites from the reporter vector also led to a drastic decrease in reporter mRNA levels. Co-purification of reporter RNA with Sfp1 was only observed when Rap1 binding sites were included in the reporter. Negative controls for all the purification experiments might be useful.

      In the swapping experiment, the plasmid lacking RapBS serves as the control for the one with RapBS and vice versa (see Bregman et al., 2011). Remember, that all these contracts give rise to identical RNA. Indeed, RabBS affects both mRNA synthesis and decay, therefore the controls are not ideal. However, see next section.

      More importantly, in Fig. 3B “Input” panel, one can see that the RNA level of “construct F” was higher than the level of “construct E”. Despite this difference, only the RNA encoded by construct E was detected in the IP panel. This clearly shows that the detection of the RNA was not merely a result of its expression level.

      To complement the biochemical data presented in the first part of the manuscript, the authors turned to the deletion or rapid depletion of SFP1 and used labelling experiments to assess changes in the rate of synthesis, abundance and decay of mRNAs under these conditions. An important observation was that in the absence of Sfp1, mRNAs encoding ribosomal protein genes not only had a reduced synthesis rate, but also an increased degradation rate. This important observation needs careful validation,

      Indeed, we do provide validations in Fig. 4C Fig. 4D Fig. S3A and during the revision we included an  additional validation as Fig. S3B. Of note, we strongly suspect that GRO is among the most reliable approaches to determine half-lives (see our response in the first revision letter).

      As genomic run-on experiments were used to measure half-lives, and this particular method was found to give results that correlated poorly with other measures of half-life in yeast (e.g. Chappelboim et al., 2022 for a comparison). As an additional validation, a temperature shift to 42{degree sign}C was used to show that , for specific ribosomal protein mRNA, the degradation was faster, assuming that transcription stops at that temperature. It would be important to cite and discuss the work from the Tollervey laboratory showing that a temperature shift to 42{degree sign}C leads to a strong and specific decrease in ribosomal protein mRNA levels, probably through an accelerated RNA degradation (Bresson et al., Mol Cell 2020, e.g. Fig 5E).

      This was cited. Thank you. 

      Finally, the conclusion that mRNA deadenylation rate is altered in the absence of Sfp1, is difficult to assess from the presented results (Fig. 3D).

      This type of experiment was popular in the past. The results in the literature are similar to ours (in fact, ours are nicer). Please check the papers cited in our MS and a number of papers by Roy Parker.

      The effects of SFP1 on transcription were investigated by chromatin purification with Rpb3, a subunit of RNA polymerase, and the results were compared with synthesis rates determined by genomic run-on experiments. The decrease in polII presence on transcripts in the absence of SFP1 was not accompanied by a marked decrease in transcript output, suggesting an effect of Sfp1 in ensuring robust transcription and avoiding RNA polymerase backtracking. To further investigate the phenotypes associated with the depletion or absence of Sfp1, the authors examined the presence of Rpb4 along transcription units compared to Rpb3. An effect of spf1 deficiency was that this ratio, which decreased from the start of transcription towards the end of transcripts, increased slightly. To what extent this result is important for the main message of the manuscript is unclear.

      Suggestions: a) please clearly indicate in the figures when they correspond to reanalyses of published results.

      This was done.

      b) In table S2, it would be important to mention what the results represent and what statistics were used for the selection of "positive" hits. 

      This was discussed in the text.

      Strengths:

      - Diversity of experimental approaches used.

      - Validation of large-scale results with appropriate reporters.

      Weaknesses:

      - Lack of controls for the CRAC results and lack of negative controls for the co-purification experiments that were used to validate specific mRNA targets potentially bound by Sfp1.

      - Several conclusions are derived from complex correlative analyses that fully depend on the validity of the aforementioned Sfp1-mRNA interactions.

      We hope that our responses to Reviewer 2's thoughtful comments have rulled out concerns regarding the lack of controls.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      Please review the text for spelling errors. While not mandatory, wig or begraph files for the CRAC results would be very useful for the readers.

      Author response image 1.

      A snapshot of IGV GPP1 locus showing that all the reads are anti-sense (pointing at the opposite direction of the gene (the gene arrows [white arrows over blue, at the bottom] are pointing to the right whereas the reads’ orientations are pointing to the left).

    1. Joint Public Review

      The present study explored the principles that allow cells to maintain complex subcellular proteinaceous structures despite the limited lifetimes of the individual protein components. This is particularly critical in the case of neurons, where the size and protein composition of synapses define synaptic strength and encode memory.

      PSD95 is an abundant synapse protein that acts as a scaffold in the recruitment of transmitter receptors and other signaling proteins and is required for memory formation. The authors used super-resolution microscopy to study PSD95 super-complexes isolated from the brains of mice expressing tagged PSD variants (Halo-Tag, mEos, GFP). Their results show compellingly that a large fraction (~25%) of super-complexes contains two PSD95 copies about 13 nm apart, that there is substantial turnover of PSD95 proteins in super-complexes over a period of seven days, and that ~5-20% of the super-complexes contain new and old PSD95 molecules. This percentage is higher in synaptic fractions as compared to total brain lysates, and highest in isocortex samples (~20%). These important findings support the hypothesis put forward by Crick that sequential subunit replacement gives synaptic super-complexes long lifetimes and thus aids in memory maintenance. Overall, this is a very interesting study that provides key insights into how synaptic protein complexes are formed and maintained. On the other hand, the actual role of these PSD95 super-complexes in long-term memory storage remains unknown. Specifically, a direct correlation between PSD95 stability and memory formation remains hypothetical - but the present findings indicate important new directions for studying the mechanisms that control postsynaptic protein organisation and the maintenance of postsynaptic proteinaceous substructures.

      Strengths

      (1) The study employed an appropriate and validated methodology.<br /> (2) Large numbers of PSD95 super-complexes from three different mouse models were imaged and analyzed, providing adequately powered sample sizes.<br /> (3) State-of-the-art super-resolution imaging techniques (PALM and MINFLUX) were used, providing a robust, high-quality, cross-validated analysis of PSD95 protein complexes that is useful for the community.<br /> (4) The result that PSD95 proteins in dimeric complexes are on average 12.7 nm apart is useful and has implications for studies on the nanoscale organization of PSD95 at synapses.<br /> (5) The finding that postsynaptic protein complexes can continue to exist while individual components are being renewed is important for our understanding of synapse maintenance and stability.<br /> (6) The data on the turnover rate of PSD95 in super-complexes from different brain regions provide a first indication of potentially meaningful differences in the lifetime of super-complexes between brain regions.

      Weaknesses

      (1) The manuscript emphasizes the hypothesis that stable super-complexes, maintained through sequential replacement of subunits, might underlie the long-term storage of memory. While an interesting idea, this notion requires considerably more research. The presented experimental data are indeed consistent with this notion, but there is no evidence that these complexes are causally related to memory storage.<br /> (2) Much of the presented work is performed on biochemically isolated protein complexes. The biochemical isolation procedures rely on physical disruption and detergents that are known to alter the composition and structure of complexes in certain cases. Thus, it remains unclear how the protein complexes described in this study relate to PSD95 complexes in intact synapses.<br /> (3) Because not all GFP molecules mature and fold correctly in vitro and the PSD95-mEos mice used were heterozygous, the interpretation of the corresponding quantifications is not straightforward.<br /> (4) It was not tested whether different numbers of PSD95 molecules per super-complex might contribute to different retention times of PSD95, e.g. in synaptic vs. total-forebrain super-complexes.<br /> (5) The conclusion that the population of 'mixed' synapses is higher in the isocortex than in other brain regions is not supported by statistical analysis.<br /> (6) The validity of conclusions regarding PSD95 degradation based on relative changes in the occurrence of SiR-Halo-positive puncta is limited.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public Review):

      Major shortcomings include the unusual normalization strategies used for many experiments and the lack of quantification/statistical analyses for several experiments. Because of these omissions, it is difficult to conclude that the data justify the conclusions. The significance of the data presented is overstated, as many of the experiments presented confirm/support previously published work. The study provides a modest advance in the understanding of the complex issue of SHH membrane extraction.

      Major shortcomings include the unusual normalization strategies used for many experiments and the lack of quantification/statistical analysis for several experiments.

      This statement is not correct for the revised manuscript: The normalization strategies used are clearly described in the manuscript and are not unusual. Each experiment is now statistically analyzed.

      The significance of the data presented is overstated, as many of the experiments presented confirm/support previously published work.

      As reviewer 2 correctly points out, there are many competing models for Hedgehog release. Our study cannot possibly support them all - the reviewer's statement is therefore misleading. In fact, our careful biochemical analysis of the mechanistics of Dispatched- mediated Shh export supports only two of them: The model of proteolytic processing of Shh lipid anchors (shedding) and the model of lipoprotein-mediated Shh transport. In contrast, our study does not support the predominant model of Dispatched-mediated extraction of dual-lipidated Shh and delivery to Scube2, which is currently thought to act as a soluble Shh chaperone. We also do not support Dispatched function in Shh endocytic recycling and cytoneme loading, or any of the other models such as exosome-mediated or micelle Shh transport.

      Reviewer #2 (Public Review):

      A novel and surprising finding of the present study is the differential removal of Shh N- or C- terminal lipid anchors depending on the presence of HDL and/or Disp. In particular, the identification of a non-palmitoylated but cholesterol-modified Shh variant that associates with lipoproteins is potentially important. The authors use RP-HPLC and defined controls to assess the properties of processed forms of Shh, but their precise molecular identity remains to be defined. One caveat is the heavy reliance on overexpression of Shh in a single cell line. The authors detect Shh variants that are released independently of Disp and Scube2 in secretion assays, but these are excluded from interpretation as experimental artifacts. Therefore, it would be important to demonstrate key findings in cells that endogenously secrete Shh.

      We would like to respond as follows:

      The authors use RP-HPLC and defined controls to assess the properties of processed forms of Shh, but their precise molecular identity remains to be defined.

      This is the original reviewers statement regarding our original manuscript submission. We believe that the biochemical and functional data presented in the VOR clearly describe the molecular identity of solubilized Shh: it is monolipidated, lipoprotein-associated, and highly biologically active in two established Shh bioassays.

      One caveat is the heavy reliance on overexpression of Shh in a single cell line.

      As stated by reviewer 1, the strength of our work is the use of a bicistronic SHH-Hhat system to consistently generate doubly lipidated ligand to determine the amount and lipidation status of SHH released into cell culture media. This unique system therefore eliminates the artifacts of protein overexpression. We have also added two other cell lines to our VOR that produce the same results (including Panc1 cells that endogenously produce Shh, Supplementary Figure 1).

      The authors detect Shh variants that are released independently of Disp and Scube2 in secretion assays, but these are excluded from interpretation as experimental artifacts.

      As the reviewer correctly points out, these variants are released independently of Disp and Scube2, both of which are known as essential release factors in vivo. These variants are therefore by definition experimental artifacts. The forms we have included in our analysis are the alternative forms that are clearly dependent on Dispatched and Scube2 for their release - as shown in the first figure in the manuscript, and in pretty much every other figure after that.


      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public Review):

      Key shortcomings include the unusual normalization strategies used for many experiments and the lack of quantification/statistical analyses for several experiments.

      In the updated version of the paper, we have addressed all of this reviewer's criticisms. Most importantly, we have performed several additional experiments to address the concern that unusual normalization strategies were used in our paper and that quantification and statistical analyses were lacking for several experiments. We have now analyzed the full set of release conditions for Shh and engineered proteins from Disp-expressing n.t. control cells and Disp-/- cells both in the presence and absence of Scube2 (Figure 1A'-D', Figure 2E added to the paper, Figure 3B'-D', Figure 5C and Figure S2F-H). Previously, we had only quantified protein release from n.t. controls and Disp-/- cells in the presence but not in the absence of Scube2 under serum-depleted conditions. Quantifications of serum-free protein release and Shh release under conditions ranging from 0.05% FCS to 10% FCS were completely missing from the earlier versions of the manuscript, but have now been added to our paper. In addition, we have reanalyzed all of the data sets in the above figures, as well as Figures 2C and S1B, to address the issue of "unusual normalization strategies": unlike previous assays in which the highest amount of protein detected in the media was set to 100% and all other proteins in that experiment were expressed relative to that value, we now directly compare the relative amounts of cellular and corresponding solubilized proteins as a method to quantify release without the need for data normalization (Figs. 1A'-D', 2C,E, 3B'-D', E, 5C, Fig. S1B, S2F-H).

      We have also repeated the qPCR analyses in C3H10T1/2 cells and now show that the same Shh/C25AShh activities can be observed when using another Shh responsive cell line, NIH3T3 cells (Fig. 4B, 6B, fig. S5B).

      We would like to point out that if the criticism refers to the presentation of our RP-HPLC and SEC data, the normalization of the strongest eluted protein signal to 100% for all proteins tested is necessary to put their behavior in a clearer relationship. This is because only the relative positions of protein elution, and not their amounts, are important in these experiments.

      The significance of the data provided is overstated because many of the presented experiments confirm/support previously published work.

      To mitigate the first reviewer's comment that the significance of the data presented is overstated, we now clearly distinguish between our novel results and the known aspect of Hh release on lipoproteins throughout our paper. We now clearly describe what is new and important in our paper: First, contrary to the general perception in the field, Disp and Scube2 are not sufficient to solubilize Shh, casting doubt on the currently accepted model that Scube2 accepts dual-lipidated Shh from Disp and transports it to the receptor Ptch. Second, lipoproteins shift dual Shh processing to N-terminal peptide processing only to generate different soluble Hh forms with different activities (as shown in Figure 4C). Third, and again contrary to popular belief, this new release mode does not inactivate Shh, as we now show in two established cellular assays for Hh biofunction (Figures 4A-C, 5B'', 6B and S5C-G). Fourth, and most importantly, we show that spatiotemporally controlled, Disp-, Scube2- and HDL-mediated Shh release absolutely requires dual lipidation of the membrane-associated Shh precursor prior to its release. This finding (as shown in Figures 1 and S2) changes the interpretation of previously published in vivo data that have long been interpreted as evidence for the requirement of dual Shh lipidation for full receptor binding and activation.

      The study provides a modest advance in our understanding of the complex issue of Shh membrane extraction.

      Although we agree that our results integrate our novel observations into previously established concepts of Hh release and trafficking, we also hope that our data cast well-founded doubt on the current view that the issue of Hh release and trafficking is largely resolved by the model of Disp-mediated Shh hand-over to Scube2 and then to Ptch, which requires interactions with both Shh lipids. Our data show that this is clearly not the case in the presence of lipoproteins. Thus, the significance of our data is that models of Shh lipid-regulated signaling to Ptch obtained using the dual-lipidated Shh precursor prior to its Disp- and Scube2-mediated conversion into a delipidated or monolipidated, HDL-associated soluble ligand are likely to describe a non-physiological interaction. Instead, our work describes a highly bioactive soluble ligand with only one lipid still attached, which has not been described before in the literature. The in vivo endpoint analyses presented in Fig. S8 suggest that this new protein variant is likely to play an important role during development.

      Reviewer #2 (Public Review):

      The precise molecular identity (of the released Shh) remains to be defined.

      We would like to respond that the direct comparison of soluble proteins and their well-defined double-lipidated precursors side-by-side in the same experiment, as shown in our paper, determines all relevant molecular changes in the Shh release process. Most importantly, we show by SDS-PAGE and RP-HPLC that HDL restricts Shh processing to the N-terminus and that the absence of HDL results in double processing of Shh during its release. We also show by SEC that the C-terminus binds the protein to HDL. In addition, the fly experiments confirm the requirement for N-terminal Hh processing, but not for processing of the C-terminal peptide, and suggest that the N-terminal Cardin-Weintraub sequence replaced by the functionally blocking tag represents the physiological cleavage site.

      It would be important to demonstrate key findings in cells that secrete Shh endogenously.

      We now confirm the key findings of our study in Panc1 cells that endogenously produce and secrete Shh: As shown in Fig. S1D, we find that soluble proteins are processed but retain the C-cholesterol, which we now directly confirm by RP-HPLC (Fig. S4F-H). The in vivo analyses shown in Fig. S8 suggest that the key finding - that N-terminal but not C-terminal Hh shedding is required for release - can be supported, at least in the fly: here, Hh variants impaired in their ability to be processed N-terminally strongly repress the endogenous protein, whereas the same protein impaired in its ability to be processed C-terminally does not.

      The authors detect Shh variants that are expressed independently of Disp and Scube2 in secretion assays, but are excluded from interpretation as experimental artifacts.

      We agree with the reviewer's criticism that the amounts of Shh released independently of Disp and Scube2 in secretion assays were not quantified and analyzed statistically to justify their proposed status as not physiologically relevant. We now show that these forms are indeed secretion artifacts (Fig. 3E and Fig. S2F-H show quantification of the lower electrophoretic mobility protein fraction (i.e., the "top" band representing the double-lipidated soluble protein fraction)) because this fraction is released independently of Disp and Scube2.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Reply to Reviewers

      We would like to thank all the reviewers for their thorough reading and helpful comments. Below, please find our point-by-point response. The reviewer comments received through ReviewCommons have not been altered except for formatting.

      Reviewer #1 (Evidence, reproducibility and clarity (Required)):

      The authors extended the existing recombination-induced tag exchange (RITE) technology to show that they can image a subset of NPCs, improving signal-to-noise ratios for live cell imaging in yeast, and to track the stability or dynamics of specific nuclear pore proteins across multiple cell divisions. Further, the authors use this technology to show that the nuclear basket proteins Mlp1, Mlp2 and Pml39 are stably associated with "old NPCs" through multiple cell cycles. The authors show that the presence of Mlp1 in these "old NPCs" correlates with exclusion of Mlp1-positive NPCs from the nucleolar territory. A surprising result is that basket-less NPCs can be excluded from the non-nucleolar region, an observation that correlates with the presence of Nup2 on the NPC regardless of maturation state of the NPC. In support of the proposal that retention of NPCs via Mlp1 and Nup2 in non-nucleolar regions, simulation data is presented to suggest that basket-less NPCs diffuse faster in the plane of the nuclear envelope.

      However, there are some points that do need addressing:

      Major Points 1. Taking into account that the Nup2 result in Figure 4B forms the basis for one half of the proposed model in Figure 6 regarding the exclusion of NPCs from the nucleolar region of the NE, there is a relatively small amount of data in support of this finding and this proposed model. For example, the only data for Nup2 in the manuscript is a column chart in Figure 4B with no supporting fluorescence microscopy examples for any Nup2 deletion. Further, the Nup60 deletion mutant will have zero basket-containing NPCs, whereas the Nup2 deletion will be a mixture of basket-containing and basket-less NPCs. The only support for the localization of basket-containing NPCs in the Nup2 deletion mutant is through a reference "Since Mlp1-positive NPCs remain excluded from the nucleolar territory in nup2Δ cells (Galy et al., 2004), the homogenous distribution observed in this mutant must be caused predominantly by the redistribution of Mlp-negative NPCs into the nucleolar territory."

      As suggested by the reviewer, we have added fluorescence microscopy examples for the Nup2 deletion to new Figure 4D. In addition, we have added data on Nup1 as suggested by reviewer 3. Since we observed a significant effect on nucleolar NPC density also upon depletion of Nup1 (new Figure 4A), we have overall revised the text and model to now reflect the shared role of Nup1 and Nup2.

      We have also localized Mlp1-GFP in a nup2Δ background as well as in the Nup60ΔC background where Nup2 can no longer bind to the NPC. In both strains, Mlp1-containing NPCs remain excluded from the nucleolus as now shown in the new Figure 4E. Although we also observed partial Mlp1 mislocalization to a nuclear focus in the nup2Δ strain, such mislocalization was only minimal in the strain with the Nup2-binding domain in Nup60 deleted (nup60ΔC), supporting our conclusion that Nup2 contributes to nucleolar exclusion of NPCs independent of Mlp1. Similarly, Mlp1-positive NPCs remained excluded from the nucleolar territory in cells depleted of Nup1 (new Figure 4B).

      1. The authors could consider utilizing this opportunity to discuss their technological innovations in the context of the prior work of Onischenko et al., 2020. This work is referenced for the statement "RITE can be used to distinguish between old and new NPCs" Page 2, Line 43. However, it is not referenced for the statement "We constructed a RITE-cassette that allows the switch from a GFP-labelled protein to a new protein that is not fluorescently labelled (RITE(GFP-to-dark))" despite Onischenko et al., 2020 having already constructed a RITE-cassette for the GFP-to-dark transition. The authors could consider taking this opportunity to instead focus on their innovative approach to apply this technology to decrease the number of fluorescently-tagged NPCs by dilution across multiple cell divisions and to interpret this finding as a measure of the stability of nuclear pore proteins within the broader NPC.

      We apologize for this imprecise citation. We have modified the text to indicate that our RITE cassette was previously used in two publications. It now reads: "We used a RITE-cassette that allows the switch from a GFP-labelled protein to a new protein that is not fluorescently labelled (RITE(GFP-to-dark)) (Onischenko et al., 2020, Kralt et al., 2022)." Together with additional changes to the text throughout, we hope that our new manuscript version more clearly highlights the innovation of our approach relative to previous use cases.

      1. The authors could also consider taking this opportunity to discuss their results in the context of the Saccharomyces cerevisiae nuclear pore complex structures published e.g. in Kim et al., 2018, Akey et al., 2022, Akey et al., 2023 in which the arrangement of proteins in the nuclear basket is presented, and also work from the Kohler lab (Mészáros et al., 2015) on how the basket proteins are anchored to the NPC. There is additional literature that also might help provide some perspective to the findings in the current manuscript, such as the observation that a lesser amount of Mlp2 to Mlp1 observed is consistent with prior work (e.g. Kim et al., 2018) and that intranuclear Mlp1 foci are also formed after Mlp1 overexpression (Strambio-de-Castillia et al., 1999).

      Following the reviewer's suggestion, we extended our discussion of basket Nup stoichiometry and organization in the discussion section including most of the citations mentioned as well as the recent articles on the nuclear basket structure and organization (Stankunas & Köhler 2024 1038/s41556-024-01484-x, Singh et al. 2024 10.1016/j.cell.2024.07.020)

      Minor Points 1. What is the "lag time" of the doRITE switching? Do the authors believe that it is comparable to the approximate 1-hour timeframe following beta-estradiol induction as shown previously in Chen et al. Nucleic Acids Research, Volume 28, Issue 24, 15 December 2000, Page e108, https://doi.org/10.1093/nar/28.24.e108

      We thank the reviewer for suggesting we analyze the kinetics of RITE switching. We carried out quantitative real-time PCR on genomic DNA and found that the half-time of switching is below 20 min. The majority of the population is switched after 1 hour, similar to the results in Chen et al. This data is now included in Supplemental Figure 1A.

      1. The authors could consider a brief explanation of radial position (um) for the benefit of the reader, in Figures 1E (right panel) and 2B (right panel), perhaps using a diagram to make it easier to understand the X-axis (um).

      To address this, we have now included a diagram and refer to it in the figure legend and the text.

      1. In Figure 1G, would the authors consider changing the vertical axis title and the figure legend wording from "mean number of NPCs per cell" to "mean labeled NPC # per cell" to reflect that what is being characterized are the remaining GFP-bearing NPCs over time?

      Thank you for spotting this inaccuracy. We have changed the label to "mean # of labeled NPCs per cell".

      1. In Figure 2C, the magenta-labeled protein in the micrographs is not described in the figure or the legend.

      A description has been added in figure and legend.

      1. In Figure S2A, there is an arrow indicating a Nup159 focus, but this is not described in the figure legend, as is done in Figure 2C.

      A description has been added to the legend.

      1. In Figure S3C, the figure legend does not match the figure. Was this supposed to be designed like Figure 3C and is missing part of the figure? Or is the legend a typographical error?

      We apologize for this error and thank the reviewer for spotting it. The legend has been corrected (now Figure S4B).

      1. In Figure S4B, the spontaneously recombined RITE (GFP-to-dark) Nup133-V5 appears in the western blot as equally abundant to pre-recombined Nup133-V5-GFP. In the figure legend, this is explained as cells grown in synthetic media without selection to eliminate cells that have lost their resistance marker from the population. In Cheng et al. Nucleic Acids Res. 2000 Dec 15; 28(24): e108, Cre-EBD was not active in the absence of B-estradiol, despite galactose-induced Cre-EBD overexpression. Would the authors be able to comment further on the Cre-Lox RITE system in the manuscript?

      We note that also in the cited publication, cells are grown in the presence of selection to select (as stated in this publication) "against pre-excision events that occur because of low but measurable basal expression of the recombinase". Although the authors report that spontaneous recombination is reduced with the b-estradiol inducible system (compared to pGAL expression control of the recombinase only), they show negligible spontaneous recombination only within a two-hour time window. Indeed, we also observe low levels of uninduced recombination on a short timeframe, but occasional events can become significant in longer incubation times (e.g. overnight growth) in the absence of selection. It should be noted that in our system, Cre expression is continuously high (TDH3-promoter) and not controlled by an inducible GAL promoter. We have added the information about the promoter controlling Cre-expression in the methods section.

      1. In Figure 6, the authors may want to consider inverting the flow of the cartoon model to start from the wild type condition and apply the deletion mutations at each step to "arrive" at the mutant conditions, rather than starting with mutant conditions and "adding back" proteins.

      Following the suggestions of this reviewer as well as reviewer 3, we have modified our model to smore clearly represent the contributions of the different basket components.

      Reviewer #1 (Significance (Required)):

      Recent work has drawn attention to the fact that not all NPCs are structurally or functionally the same, even within a single cell. In this light, the work here from Zsok et al. is an important demonstration of the kind of methodologies that can shed light on the stability and functions of different subpopulations of NPCs. Altogether, these data are used to support an interesting and topical model for Nup2 and nuclear-basket driven retention of NPCs in non-nucleolar regions of the nuclear envelope.

      We thank the reviewer for this positive assessment of our work.

      Reviewer #2 (Evidence, reproducibility and clarity (Required)):

      In this study, Zsok et al. develop innovative methods to examine the dynamics of individual nuclear pore complexes (NPCs) at the nuclear envelope of budding yeast. The underlying premise is that with the emergence of biochemically distinct NPCs that co-exist in the same cell, there is a need to develop tools to functionally isolate and study them. For example, there is a pool of NPCs that lack the nuclear basket over the nucleolus. Although the nature of this exclusion has been investigated in the past, the authors take advantage of a modification of recombination induced tag exchange (RITE), the slow turnover of scaffold nups, the closed mitosis of budding yeast, and extensive high quality time lapse microscopy to ultimately monitor the dynamics of individual NPCs over the nucleolus. By leveraging genetic knockout approaches and auxin-induced degradation with sophisticated quantitative and rigorous analyses, the authors conclude that there may be two mechanisms dependent on nuclear basket proteins that impact nucleolar exclusion. They also incorporate some computational simulations to help support their conclusions. Overall, the data are of the highest quality and are rigorously quantified, the manuscript is well written, accessible, and scholarly - the conclusions are thus on solid footing.

      We thank the reviewer for this assessment.

      Reviewer #2 (Significance (Required)):

      I have no concerns about the data or the conclusions in this manuscript. However, the significance is not overly clear as there is no major conceptual advance put forward, nor is there any new function suggested for the NPCs over nucleoli. As NPCs are immobile in metazoans, the significance may also be limited to a specialized audience.

      We respectfully disagree with this assessment. First, our work demonstrates the use of a novel approach in the application of RITE that can be useful for other researchers in the field of NPC biology and beyond. For example, doRITE could be applied to study the properties of aged NPCs, an area of considerable interest due to links between the NPC and age-related neurodegenerative diseases.

      Second, we characterize the interaction between conserved nuclear components, the NPC, the nucleolus and chromatin. While the specific architecture of the nucleus varies between species, many of these interactions are conserved. For example, Nup2's homologue Nup50 also interacts with chromatin in other systems, including mammalian cells, and thus may contribute to regulating the interplay between the nuclear basket and adjoining chromatin. This adds to our understanding of the multiple pathways and interactions that contribute to nuclear organization. Therefore, although the depletion of NPCs from the nucleolar territory in budding yeast may not be of direct importance, understanding the relationships between NPCs and their environment provide insight about nuclear organization throughout different eukaryotic lineages.

      In the revised manuscript, we attempt to better highlight and discuss these aspects.

      Reviewer #3 (Evidence, reproducibility and clarity (Required)):

      The manuscript of Zsok et al. describes the role of nuclear basket proteins in the distribution and mobility of nuclear pore complexes in budding yeast. In particular, the authors showed that the doRITE approach can be used for the analysis of stable and dynamically associated NUPs. Moreover, it can distinguish individual NUPs and follow the inheritance of individual NPCs from mother to daughter cells. The author's findings highlight that Mlp1, Mlp2, and Pml39 are stably associated with the nuclear pore; deletion of Mlp1-Mlp2 and Nup60 leads to the higher NPC density in the nucleolar territory; and NPCs exhibit increased mobility in the absence of the nuclear basket components.

      The manuscript contains most figures supporting the data, and data supports the conclusions. However, authors need to include better explanations for figures in the text and figure legends. Lack of detailed explanation can pose challenges for non-experts. In addition, the authors jump over figures and shuffle them through the manuscript, which disrupts the flow and coherence of the manuscript.

      We thank the reviewer for pointing this out. In response to the detailed comments given below, we have moved some figures and added more explicit explanations to the text to improve the flow and make it easier to follow. In addition, we have modified the figure legends throughout the manuscript to make them more accessible to the reader.

      Major comments: - The nuclear basket contains Nup1, Nup2, Nup60, Mlp1, and Mlp2 in yeast. Nup60 works as a seed for Mlp1/Mlp2 and Nup2 recruitment and plays a key role in the assembly of nuclear pore basket scaffold (PMID: 35148185). Logically, the authors focused primarily on Nup60 in the current manuscript. However, NUP153 has another ortholog of yeast - Nup1, which has not been studied in this work. I recommend adjusting the title of the manuscript to: Nup60 and Mlp1/Mlp2 regulate the distribution and mobility of nuclear pore complexes in budding yeast. I also suggest discussing why work on Nup1 was not included/performed in the manuscript.

      We thank the reviewer for suggesting we should test the role of Nup1. Although we had originally not considered it, since we were focusing on the interactors of Mlp1/2, we found that indeed Nup1 also contributes to nucleolar exclusion. We have therefore changed the title to "Nuclear basket proteins regulate the distribution and mobility of nuclear pore complexes in budding yeast".

      • Figure 2B: I suggest choosing a more representative image for Pml39. It looks not like a stable component but rather dynamic as NUP60 or Gle1 based on figure showed in Figure 2B.

      We thank the reviewer for pointing out this poor choice of panel. We selected a panel for the 14h timepoint that more clearly shows that individual foci can still be seen for Pml39 after this time. Due to its lower copy number, the foci are dimmer for Pml39 than the other stable Nups. Nevertheless, at both the 11 and 14 h timepoint, clear dots can be detected for Pml39, while e.g. Nup116 in the same figure exhibits a more distributed signal and the signal for Nup60 and Gle1 is no longer visible.

      • Depletion of AID-tagged proteins needs to be supported by Western blot analysis with protein-specific antibodies, and PCR results should be included in supplementary data to demonstrate the homozygosity of the strains.

      The correct genomic tagging of the depleted proteins by AID was confirmed by PCR. We include this PCR analysis for the reviewer below. Since we are working with haploid yeast cells, all strains only carry a single copy of the genes. Unfortunately, we do not have protein-specific antibodies against the depleted proteins. However, other phenotypes support the successful depletion of the protein: Mlp1-mislocalization upon Nup60 depletion, reduced transcript production in Pol II depletion (characterized previously: PMID: 31753862, PMID: 36220102), growth defect upon Nup1 depletion.

      • Figure 5B: Snapshots of images from the movie are required. There are no images, only quantifications.

      We have replaced the supplemental movie with a movie showing the detection by Trackmate as well as overlaid tracks. As requested, a snapshot of this movie was inserted in figure 5B. We have also moved the example tracks from the supplement to the main figure. Furthermore, we will deposit the tracking dataset in the ETH Research Collection to make it available to the community.

      Description of figure legends is more technical than supporting/explaining the figure. For example, below my suggestions for Figure 1D. Please, consider more detailed explanation for other figures. (D) Left: Schematic of the RITE cassette. NUP of interest is tagged with V5 tag and eGFP fluorescent protein where LoxP sites flank eGFP. Before the beta-estradiol-induced recombination, the old NPCs are marked with eGFP signal, whereas new NPCs lack an eGFP signal after the recombination. ORF: open reading frame; V5: V5-tag; loxP: loxP recombination site; eGFP: enhanced green fluorescent protein. Right: doRITE assay schematic of stable or dynamic Nup behavior over cell divisions in yeast after the recombination.

      We have modified the figure legends throughout the manuscript to make them more explanatory and helpful for the reader.

      In addition, I recommend highlighting the result in the title of the figures. Please, re-consider titles for Figure S3.

      We have split this figure to better group related results. The new figures S4 and S5 are entitled: " A RITE(dark-to-GFP) cassette to visualize newly assembled NPC. " and "Mlp1 truncations localize predominantly to non-nucleolar NPCs."

      Minor: P.1 Line 31. Extra period symbol before the "(Figure 1A)".

      Fixed

      P.2 Line 10. Inconsistent writing of PML39 and MLP1. Both genes are capitalized. The same for P.4 Line 16. In some cases all letters are capitalized in other only the first one.

      We are following the official yeast gene nomenclature by spelling gene names in italicized capitals and protein names with only the first letter capitalized. We are sorry that this can be confusing for readers more familiar with other model systems.

      P.2 Line 18-22. The sentence is too long and hard to read. I recommend splitting it into two sentences.

      We agree and have fixed this.

      P.2-3 Line 46-47. The sentence is unclear. Suggestion: We expected that successive cell divisions would dilute the signal of labelled and stably associated with the NPC nucleoporins. By contrast, ...

      We have modified the sentence to read: "When tagging a Nup that stably associates with the NPC, we expected that successive cell divisions would dilute labelled NPCs by inheritance to both mother and daughter cells leading to a low density of labelled NPCs. By contrast,..."

      P.4 Line 17-21. Please, consider adding extra information and clarifying lines 19-21. For example, in Line 19 Figure 2B you can add that the reader needs to compare row 1 and row 4.

      Thank you, we have fixed this as suggested.

      P. 5 Line 15. When a number begins a sentence, that number should always be spelled out. You can pe-phrase the sentence to avoid it. Also, I recommend adding an explanation/hypothesis of why new NPCs are less frequently detected in nucleolar territory.

      We have formatted the text. Interestingly, new NPCs are more frequently detected in the nucleolar territory than old NPCs. We have reformulated this section to make it clearer, also in response to the next comment.

      P.5 Line 17-22. I recommend re-phrasing these two sentences. Logically, it is clear that Mlp1/Mlp2 loss mimics "old NPCs" to look more like "new NPCs", and for that reason, they are more frequently included in the nucleolar territory, but it is not clear when you read these two sentences from the first time.

      We have reformulated this section to make it clearer.

      P6. Line 16. No figure supporting data on graph (Figure 3B).

      We have added fluorescent images of the nup2Δ strain to the figure (new Figure 4D).

      P.7 Line 10-13. The sentence is unclear.

      We have shortened the sentence and moved part of the content to the discussion in the next paragraph.

      P.13,14 etc. If 0h timepoint has been used for normalization, why is it present on the graph?

      The 0h timepoint is shown for comparison and to illustrate the standard deviation in the data.

      P.15. Line 32-33. There is no image here. Potentially wrong description of the figure.

      Thank you for spotting this. This was fixed (new Figure S4B).

      Figures: - Inconsistent labeling of figures. For example, Fig.1, Fig.1S, Figure 2 etc.

      Thank you, this has been corrected.

      • Inconsistent labeling of figures. For example, Fig.1 G "mean number of NPCs per cell" - no capitalization of the first letter. Fig.1S "Fraction in population" is capitalized. In general, titles of axis should be capitalized.

      Thank you for spotting this. This was fixed.

      Suggestions for Figure 1D and Figure 6 are attached as a separate file.

      We thank the reviewer for their suggestions to improve these figures. We have taken their recommendation and revised the figures accordingly (see also response to reviewer 1, minor point 8).

      Reviewer #3 (Significance (Required)):

      Zsok et al. used the recombination-induced tag exchange (RITE) approach, which is an interesting and powerful method to follow individual NUPs over time with respect to their localization and abundance. This approach has been used before in PMID: 36515990 to distinguish pre-existing and newly synthesized Nup2 populations and has been extended to other basket NUPs in this work. Using this method, the authors support the earlier data on basket nucleoporins and highlight new insights on how basket nucleoporins regulate NPCs distribution and mobility. Overall, the manuscript provides new details on the stability of nucleoporins in yeast and how these data align with the mass spectrometry and FRAP data performed earlier in other studies. The limitation of this study is the absence of data on Nup1. It was unclear why these data were not present. Additional data can be included on the dynamics of Pml39, for example, using the FRAP method. The dynamic of Pml39 at the pore was shown only using the doRITE method.

      As suggested, we have tested the role of Nup1 (see above).

      Unfortunately, we are not able to provide orthologous data for the dynamics of Pml39. As we discuss in the manuscript, FRAP is not suitable for the analysis of the dynamics of most nucleoporins in yeast due to the high lateral mobility of NPCs in the nuclear envelope and has previously generated misleading results for Mlp1. Furthermore, the low expression levels of Pml39 will make it difficult to obtain reliable FRAP curves for this protein. We therefore do not think that adding FRAP experiments with Pml39 will provide valuable insight.

      However, in addition to the Pml39 doRITE result itself, our observation that the Pml39-dependent pool of Mlp1 exhibits stable association with the NPC supports the interpretation of Pml39 as a stable protein as well.

      In general, this study represents a unique research study of basic research on nuclear pore proteins that will be of general interest to the nuclear transport field.

      Field of expertise: nuclear-cytoplasmic transport, nuclear pore, inducible protein degradation. I do not have sufficient expertise in ExTrack.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      The manuscript of Zsok et al. describes the role of nuclear basket proteins in the distribution and mobility of nuclear pore complexes in budding yeast. In particular, the authors showed that the doRITE approach can be used for the analysis of stable and dynamically associated NUPs. Moreover, it can distinguish individual NUPs and follow the inheritance of individual NPCs from mother to daughter cells. The author's findings highlight that Mlp1, Mlp2, and Pml39 are stably associated with the nuclear pore; deletion of Mlp1-Mlp2 and Nup60 leads to the higher NPC density in the nucleolar territory; and NPCs exhibit increased mobility in the absence of the nuclear basket components.

      The manuscript contains most figures supporting the data, and data supports the conclusions. However, authors need to include better explanations for figures in the text and figure legends. Lack of detailed explanation can pose challenges for non-experts. In addition, the authors jump over figures and shuffle them through the manuscript, which disrupts the flow and coherence of the manuscript.

      Major comments:

      • The nuclear basket contains Nup1, Nup2, Nup60, Mlp1, and Mlp2 in yeast. Nup60 works as a seed for Mlp1/Mlp2 and Nup2 recruitment and plays a key role in the assembly of nuclear pore basket scaffold (PMID: 35148185). Logically, the authors focused primarily on Nup60 in the current manuscript. However, NUP153 has another ortholog of yeast - Nup1, which has not been studied in this work. I recommend adjusting the title of the manuscript to: Nup60 and Mlp1/Mlp2 regulate the distribution and mobility of nuclear pore complexes in budding yeast. I also suggest discussing why work on Nup1 was not included/performed in the manuscript.
      • Figure 2B: I suggest choosing a more representative image for Pml39. It looks not like a stable component but rather dynamic as NUP60 or Gle1 based on figure showed in Figure 2B.
      • Depletion of AID-tagged proteins needs to be supported by Western blot analysis with protein-specific antibodies, and PCR results should be included in supplementary data to demonstrate the homozygosity of the strains.
      • Figure 5B: Snapshots of images from the movie are required. There are no images, only quantifications.
      • Description of figure legends is more technical than supporting/explaining the figure. For example, below my suggestions for Figure 1D. Please, consider more detailed explanation for other figures. (D) Left: Schematic of the RITE cassette. NUP of interest is tagged with V5 tag and eGFP fluorescent protein where LoxP sites flank eGFP. Before the beta-estradiol-induced recombination, the old NPCs are marked with eGFP signal, whereas new NPCs lack an eGFP signal after the recombination. ORF: open reading frame; V5: V5-tag; loxP: loxP recombination site; eGFP: enhanced green fluorescent protein. Right: doRITE assay schematic of stable or dynamic Nup behavior over cell divisions in yeast after the recombination.

      In addition, I recommend highlighting the result in the title of the figures. Please, re-consider titles for Figure S3.

      Minor:

      P.1 Line 31. Extra period symbol before the "(Figure 1A)".

      P.2 Line 10. Inconsistent writing of PML39 and MLP1. Both genes are capitalized. The same for P.4 Line 16. In some cases all letters are capitalized in other only the first one.

      P.2 Line 18-22. The sentence is too long and hard to read. I recommend splitting it into two sentences.

      P.2-3 Line 46-47. The sentence is unclear. Suggestion: We expected that successive cell divisions would dilute the signal of labelled and stably associated with the NPC nucleoporins. By contrast, ...

      P.4 Line 17-21. Please, consider adding extra information and clarifying lines 19-21. For example, in Line 19 Figure 2B you can add that the reader needs to compare row 1 and row 4.

      P. 5 Line 15. When a number begins a sentence, that number should always be spelled out. You can pe-phrase the sentence to avoid it. Also, I recommend adding an explanation/hypothesis of why new NPCs are less frequently detected in nucleolar territory.

      P.5 Line 17-22. I recommend re-phrasing these two sentences. Logically, it is clear that Mlp1/Mlp2 loss mimics "old NPCs" to look more like "new NPCs", and for that reason, they are more frequently included in the nucleolar territory, but it is not clear when you read these two sentences from the first time.

      P6. Line 16. No figure supporting data on graph (Figure 3B).

      P.7 Line 10-13. The sentence is unclear.

      P.13,14 etc. If 0h timepoint has been used for normalization, why is it present on the graph?

      P.15. Line 32-33. There is no image here. Potentially wrong description of the figure.

      Figures:

      • Inconsistent labeling of figures. For example, Fig.1, Fig.1S, Figure 2 etc.
      • Inconsistent labeling of figures. For example, Fig.1 G "mean number of NPCs per cell" - no capitalization of the first letter. Fig.1S "Fraction in population" is capitalized. In general, titles of axis should be capitalized.

      Suggestions for Figure 1D and Figure 6 are attached as a separate file.

      Significance

      Zsok et al. used the recombination-induced tag exchange (RITE) approach, which is an interesting and powerful method to follow individual NUPs over time with respect to their localization and abundance. This approach has been used before in PMID: 36515990 to distinguish pre-existing and newly synthesized Nup2 populations and has been extended to other basket NUPs in this work. Using this method, the authors support the earlier data on basket nucleoporins and highlight new insights on how basket nucleoporins regulate NPCs distribution and mobility. Overall, the manuscript provides new details on the stability of nucleoporins in yeast and how these data align with the mass spectrometry and FRAP data performed earlier in other studies. The limitation of this study is the absence of data on Nup1. It was unclear why these data were not present. Additional data can be included on the dynamics of Pml39, for example, using the FRAP method. The dynamic of Pml39 at the pore was shown only using the doRITE method.

      In general, this study represents a unique research study of basic research on nuclear pore proteins that will be of general interest to the nuclear transport field.

      Field of expertise: nuclear-cytoplasmic transport, nuclear pore, inducible protein degradation. I do not have sufficient expertise in ExTrack.

    3. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      In this study, Zsok et al. develop innovative methods to examine the dynamics of individual nuclear pore complexes (NPCs) at the nuclear envelope of budding yeast. The underlying premise is that with the emergence of biochemically distinct NPCs that co-exist in the same cell, there is a need to develop tools to functionally isolate and study them. For example, there is a pool of NPCs that lack the nuclear basket over the nucleolus. Although the nature of this exclusion has been investigated in the past, the authors take advantage of a modification of recombination induced tag exchange (RITE), the slow turnover of scaffold nups, the closed mitosis of budding yeast, and extensive high quality time lapse microscopy to ultimately monitor the dynamics of individual NPCs over the nucleolus. By leveraging genetic knockout approaches and auxin-induced degradation with sophisticated quantitative and rigorous analyses, the authors conclude that there may be two mechanisms dependent on nuclear basket proteins that impact nucleolar exclusion. They also incorporate some computational simulations to help support their conclusions. Overall, the data are of the highest quality and are rigorously quantified, the manuscript is well written, accessible, and scholarly - the conclusions are thus on solid footing.

      Significance

      I have no concerns about the data or the conclusions in this manuscript. However, the significance is not overly clear as there is no major conceptual advance put forward, nor is there any new function suggested for the NPCs over nucleoli. As NPCs are immobile in metazoans, the significance may also be limited to a specialized audience.

    4. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      The authors extended the existing recombination-induced tag exchange (RITE) technology to show that they can image a subset of NPCs, improving signal-to-noise ratios for live cell imaging in yeast, and to track the stability or dynamics of specific nuclear pore proteins across multiple cell divisions. Further, the authors use this technology to show that the nuclear basket proteins Mlp1, Mlp2 and Pml39 are stably associated with "old NPCs" through multiple cell cycles. The authors show that the presence of Mlp1 in these "old NPCs" correlates with exclusion of Mlp1-positive NPCs from the nucleolar territory. A surprising result is that basket-less NPCs can be excluded from the non-nucleolar region, an observation that correlates with the presence of Nup2 on the NPC regardless of maturation state of the NPC. In support of the proposal that retention of NPCs via Mlp1 and Nup2 in non-nucleolar regions, simulation data is presented to suggest that basket-less NPCs diffuse faster in the plane of the nuclear envelope.

      However, there are some points that do need addressing:

      Major Points

      1. Taking into account that the Nup2 result in Figure 4B forms the basis for one half of the proposed model in Figure 6 regarding the exclusion of NPCs from the nucleolar region of the NE, there is a relatively small amount of data in support of this finding and this proposed model. For example, the only data for Nup2 in the manuscript is a column chart in Figure 4B with no supporting fluorescence microscopy examples for any Nup2 deletion. Further, the Nup60 deletion mutant will have zero basket-containing NPCs, whereas the Nup2 deletion will be a mixture of basket-containing and basket-less NPCs. The only support for the localization of basket-containing NPCs in the Nup2 deletion mutant is through a reference "Since Mlp1-positive NPCs remain excluded from the nucleolar territory in nup2Δ cells (Galy et al., 2004), the homogenous distribution observed in this mutant must be caused predominantly by the redistribution of Mlp-negative NPCs into the nucleolar territory."
      2. The authors could consider utilizing this opportunity to discuss their technological innovations in the context of the prior work of Onischenko et al., 2020. This work is referenced for the statement "RITE can be used to distinguish between old and new NPCs" Page 2, Line 43. However, it is not referenced for the statement "We constructed a RITE-cassette that allows the switch from a GFP-labelled protein to a new protein that is not fluorescently labelled (RITE(GFP-to-dark))" despite Onischenko et al., 2020 having already constructed a RITE-cassette for the GFP-to-dark transition. The authors could consider taking this opportunity to instead focus on their innovative approach to apply this technology to decrease the number of fluorescently-tagged NPCs by dilution across multiple cell divisions and to interpret this finding as a measure of the stability of nuclear pore proteins within the broader NPC.
      3. The authors could also consider taking this opportunity to discuss their results in the context of the Saccharomyces cerevisiae nuclear pore complex structures published e.g. in Kim et al., 2018, Akey et al., 2022, Akey et al., 2023 in which the arrangement of proteins in the nuclear basket is presented, and also work from the Kohler lab (Mészáros et al., 2015) on how the basket proteins are anchored to the NPC. There is additional literature that also might help provide some perspective to the findings in the current manuscript, such as the observation that a lesser amount of Mlp2 to Mlp1 observed is consistent with prior work (e.g. Kim et al., 2018) and that intranuclear Mlp1 foci are also formed after Mlp1 overexpression (Strambio-de-Castillia et al., 1999).

      Minor Points

      1. What is the "lag time" of the doRITE switching? Do the authors believe that it is comparable to the approximate 1-hour timeframe following beta-estradiol induction as shown previously in Chen et al. Nucleic Acids Research, Volume 28, Issue 24, 15 December 2000, Page e108, https://doi.org/10.1093/nar/28.24.e108
      2. The authors could consider a brief explanation of radial position (um) for the benefit of the reader, in Figures 1E (right panel) and 2B (right panel), perhaps using a diagram to make it easier to understand the X-axis (um).
      3. In Figure 1G, would the authors consider changing the vertical axis title and the figure legend wording from "mean number of NPCs per cell" to "mean labeled NPC # per cell" to reflect that what is being characterized are the remaining GFP-bearing NPCs over time?
      4. In Figure 2C, the magenta-labeled protein in the micrographs is not described in the figure or the legend.
      5. In Figure S2A, there is an arrow indicating a Nup159 focus, but this is not described in the figure legend, as is done in Figure 2C.
      6. In Figure S3C, the figure legend does not match the figure. Was this supposed to be designed like Figure 3C and is missing part of the figure? Or is the legend a typographical error?
      7. In Figure S4B, the spontaneously recombined RITE (GFP-to-dark) Nup133-V5 appears in the western blot as equally abundant to pre-recombined Nup133-V5-GFP. In the figure legend, this is explained as cells grown in synthetic media without selection to eliminate cells that have lost their resistance marker from the population. In Cheng et al. Nucleic Acids Res. 2000 Dec 15; 28(24): e108, Cre-EBD was not active in the absence of B-estradiol, despite galactose-induced Cre-EBD overexpression. Would the authors be able to comment further on the Cre-Lox RITE system in the manuscript?
      8. In Figure 6, the authors may want to consider inverting the flow of the cartoon model to start from the wild type condition and apply the deletion mutations at each step to "arrive" at the mutant conditions, rather than starting with mutant conditions and "adding back" proteins.

      Significance

      Recent work has drawn attention to the fact that not all NPCs are structurally or functionally the same, even within a single cell. In this light, the work here from Zsok et al. is an important demonstration of the kind of methodologies that can shed light on the stability and functions of different subpopulations of NPCs. Altogether, these data are used to support an interesting and topical model for Nup2 and nuclear-basket driven retention of NPCs in non-nucleolar regions of the nuclear envelope.

    1. Welcome back, this is part two of this lesson.

      We're going to continue immediately from the end of part one.

      So let's get started.

      Now let's talk about the first of the Glacier Storage Classes, S3 Glacier Instant Retrieval.

      If I had to summarize this storage class, it's like S3 standard in frequent access, except it offers cheaper storage, more expensive retrieval costs, and longer minimums.

      Standard IA is designed for when you need data instantly, but not very often, say once a month.

      Glacier Instant Retrieval extends this, so data where you still want instant retrieval, but where you might only access it say once every quarter.

      In line with this, it has a minimum storage duration charge of 90 days versus the 30 days of standard in frequent access.

      This class is the next step along the path of access frequency, as the access frequency of objects decrease, you can move them gradually from standard, then to standard in frequent access, and then to Glacier Instant Retrieval.

      The important thing to remember about this specific S3 Glacier class is that you still have instant access to your data.

      There's no retrieval process required, you can still use it like S3 standard and S3 standard in frequent access.

      It's just that it costs you more if you need to access the data, but less if you don't.

      Now let's move on to the next type of S3 Glacier Storage Class.

      And the next one I want to talk about is S3 Glacier Flexible Retrieval, and this storage class was formally known as S3 Glacier.

      The name was changed when the previously discussed Instant Retrieval class was added to the lineup of storage classes available within S3.

      So Glacier Flexible Retrieval has the same three availability zone architecture as S3 standard and S3 standard in frequent access.

      It has the same durability characteristics of 11-9s, and at the time of creating this lesson, S3 Glacier Flexible Retrieval has a storage cost which is about one-sixth of the cost of S3 standard.

      So it's really cost effective, but there are some serious trade-offs which you have to accept in order to make use of it.

      For the exam, it's these trade-offs which you need to be fully aware of.

      Conceptually, I want you to think of objects stored with the Glacier Flexible Retrieval class as cold objects.

      They aren't warm, they aren't ready for use, and this will form a good knowledge anchor for the exam.

      Now because they're cold, they aren't immediately available, they can't be made public.

      Well, you can see these objects within an S3 bucket, they're now just a pointer to that object.

      To get access to them, you need to perform a retrieval process.

      That's a specific operation, a job which needs to be run to gain access to the objects.

      Now you pay for this retrieval process.

      When you retrieve objects from S3 Glacier Flexible Retrieval, they're stored in the S3 standard in frequent access storage class on a temporary basis.

      You access them and then they're removed.

      You can retrieve them permanently by changing the class back to one of the S3 ones, but this is a different process.

      Now retrieval jobs come in three different types.

      We have expedited, which generally results in data being available within one to five minutes, and this is the most expensive.

      We've got standard where data is usually accessible in three to five hours, and then a low cost bulk option where data is available in between five and 12 hours.

      So the faster the job type, the more expensive.

      Now this means that S3 Glacier Flexible Retrieval has a first byte latency of minutes or hours, and that's really important to know for the exam.

      So while it's really cheap, you have to be able to tolerate, you can't make the objects public anymore, either in the bucket or using static website hosting, and two, when you do access the objects, it's not an immediate process.

      So you can see the object metadata in the bucket, but the data itself is in chilled storage, and you need to retrieve that data in order to access it.

      Now S3 Glacier Flexible Retrieval has some other limits, so a 40 kb minimum available size and a 90 day minimum available duration.

      For the exam, Glacier Flexible Retrieval is for situations where you need to store archival data where frequent or real-time access isn't needed.

      For example, yearly access, and you're OK with minutes to hours for retrieval operations.

      So it's one of the cheapest forms of storage in S3, as long as you can tolerate the characteristics of the storage class, but it's not the cheapest form of storage.

      That honor goes to S3 Glacier Deep Archive.

      Now S3 Glacier Deep Archive is much cheaper than the storage class we were just discussing.

      In exchange for that, there are even more restrictions which you need to be able to tolerate.

      Conceptually, where S3 Glacier Flexible Retrieval, which data in a chilled state, Glacier Deep Archive is data in a frozen state.

      Objects have minimum, so 40 kb minimum available size and 180 day minimum available duration.

      Like Glacier Flexible Retrieval, objects cannot be made publicly accessible.

      Access to the data requires a retrieval job.

      Just like Glacier Flexible Retrieval, the jobs temporarily restore to S3 standard and frequent access, but those retrieval jobs take longer.

      Standard is 12 hours and bulk is up to 48 hours, so this is much longer than Glacier Flexible Retrieval, and that's the compromise that you agree to.

      The storage is a lot cheaper in exchange for much longer restore times.

      Glacier Deep Archive should be used for data which is archival, which rarely, if ever, needs to be accessed, and where hours or days is tolerable for the retrieval process.

      So it's not really suited to primary system backups because of this restore time.

      It's more suited for secondary long-term archival backups or data which comes under legal or regulatory requirements in terms of retention length.

      Now this being said, there's one final type of storage class which I want to cover, and that's intelligent tearing.

      Now intelligent tearing is different from all the other storage classes which I've talked about.

      It's actually the storage class which contains five different storage tiers.

      With intelligent tearing, when you move objects into this class, there are a range of ways that an object can be stored.

      It can be stored within a frequent access tier or an infrequent access tier, or for objects which are accessed even less frequently, there's an archive instant access, archive access, or deep archived set of tiers.

      You can think of the frequent access tier like S3 standard and the infrequent access tier like S3 standard infrequent access, and the archive tiers are the same price of performance as S3, Glacier, instant retrieval, and flexible retrieval.

      And the deep archive tier is the same price of performance as Glacier Deep Archive.

      Now unlike the other S3 storage classes, you don't have to worry about moving objects between tiers.

      With intelligent tearing, the intelligent tearing system does this for you.

      Let's say that we have an object, say a picture of whiskers which is initially kind of popular and then not popular, and then it goes super viral.

      Well if you store this object using the intelligent tearing storage class, it would monitor the usage of the object.

      When the object is in regular use, it would stay within the frequent access tier and would have the same costs as S3 standard.

      If the object isn't accessed for 30 days, then it would be moved automatically into the infrequent tier where it would stay while being stored at a lower rate.

      Now at this stage you could also add configuration, so based on a bucket, prefix or object tag, any objects which are accessed less frequently can be moved into the three archive tiers.

      Now there's a 90 day minimum for archive instant access, and this is fully automatic.

      Think of this as a cheaper version of infrequent access for objects which are accessed even less frequently.

      Crucially this tier, so archive instant access, still gives you access to the data automatically as and when you need it, just like infrequent access.

      In addition to this, there are two more entirely optional tiers, archive access and deep archive.

      And these can be configured so that objects move into them when they haven't been accessed for 98 to 270 days for archive access, or 180 through to 730 days for deep archive.

      Now these are entirely optional, and it's worth mentioning that when objects are moved into these tiers, getting them back isn't immediate.

      There's a retrieval time to bring them back, so only use these tiers when your application can tolerate asynchronous access patterns.

      So archive instant access requires no application or system changes, it's just another tier for less frequently accessed objects with a lower cost.

      Archive access and deep archive changes things, your applications must support these tiers because retrieving objects requires specific API calls.

      Now if objects do stay in infrequent access or archive instant access, when the objects become super viral in access, these will be moved back to frequent access automatically with no retrieval charges.

      Intelligent tiering has a monitoring and automation cost per 1000 objects instead of the retrieval cost.

      So essentially the system manages the movement of data between these tiers automatically without any penalty for this management fee.

      The cost of the tiers are the same as the base S3 tiers, standard and infrequent access, there's just the management fee on top.

      So it's more flexible than S3 standard and S3 infrequent access, but it's more expensive because of the management fee.

      Now intelligent tiering is designed for long-lived data where the usage is...

      [Sounds of S3 storage] Changing or unknown, if the usage is static either frequently accessed or infrequently accessed, then you're better using the direct S3 storage class, either standard or infrequent access.

      Intelligent tiering is only good if you have data where the pattern changes or you don't know it.

      Now with that being said, that's all of the S3 storage classes which I want to cover.

      That's at least enough technical information and context which you'll need for the exam and to get started in the real world.

      So go ahead and complete the video and when you're ready, I look forward to you joining me in the next.

    1. Welcome back and in this video I want to talk about S3 bucket keys which are a way to help S3 scale and reduce costs when using KMS encryption.

      Let's jump in and take a look.

      So let's look at a pretty typical architecture.

      We have S3 in the middle, we have KMS on the right and inside we have a KMS key, the default S3 service key for this region which is named AWS/S3.

      Then on the left we have a user Bob who's looking to upload some objects to this S3 bucket using KMS encryption.

      Within S3 when you use KMS each object which is put into a bucket uses a unique data encryption key or DEK.

      So let's have a look at how that works.

      So when Bob begins his first PUT operation when the object is arriving in the bucket a call is made to KMS which uses the KMS key to generate a data encryption key unique to this object.

      The object is encrypted and then the object and the unique data encryption key are stored side by side on S3.

      Each object stored on S3 uses a unique data encryption key which is a single call to KMS to generate that data encryption key.

      This means that for every single object that Bob uploads it needs a single unique call to KMS to generate a data encryption key to return that data encryption key to S3, use that key to encrypt the object and then store the two side by side.

      On screen we have three individual PUTs.

      But imagine if this was 30 or 300 or 300,000 every second.

      This presents us with a serious problem.

      KMS has a cost.

      It means that using SSE-KMS carries an ever increasing cost which goes up based on the number of objects that you put into an S3 bucket.

      And perhaps more of a problem is that there are throttling issues.

      The generated data encryption key operation can only be run either 5,500, 10,000 or 50,000 times per second and this is shared across regions.

      Now this exact number depends on which regions you use but this effectively places a limit on how often a single KMS key can be used to generate data encryption keys which limits the amount of PUTs that you can do to S3 every second.

      And this is where bucket keys improve the situation.

      So let's look at how.

      So with bucket keys the architecture changes a little.

      We have the same basic architecture but instead of the KMS key being used to generate each individual data encryption key, instead it's used to generate a time limited bucket key and conceptually this is given to the bucket.

      This is then used for a period of time to generate any data encryption keys within the bucket for individual object encryption operations.

      And this essentially offloads the work from KMS to S3.

      It reduces the number of KMS API calls so reduces the cost and increases scalability.

      Now it's worth noting that this is not retroactive.

      It only affects objects and the object encryption process after it's enabled on a bucket.

      So this is a great way that you can continue to use KMS for encryption with S3 but offload some of the intensive processing from KMS onto S3 reducing costs and improving scalability.

      Now there are some things that you do need to keep in mind when you're using S3 bucket keys.

      First, after you enable an S3 bucket key, if you're using CloudTrail to look at KMS logs, then those logs are going to show the bucket ARN instead of your object ARN.

      Now additionally, because you're offloading a lot of the work from KMS to S3, you're going to see fewer CloudTrail events for KMS in those logs.

      So that's logically offloading the work from KMS to S3 and instead of KMS keys being used to encrypt individual objects, they're used to generate the bucket key.

      And so you're going to see the bucket in the logs not the object.

      So keep that in mind.

      Book keys also work with same region replication and cross region replication.

      There are some nuances you need to keep in mind generally when S3 replicates an encrypted object.

      It generally preserves the encryption settings of that encrypted object.

      So the encrypted object in the destination bucket generally uses the same settings as the encrypted object in the source bucket.

      Now if you're replicating a plain text object, so something that's not encrypted and you're replicating that through to a destination bucket which uses default encryption or an S3 bucket key, then S3 encrypts that object on its way through to the destination with the destination bucket's configuration.

      And it's worth noting that this can result in e-tag changes between the source and the destination.

      Now make sure that I include a link attached to this video which details all of these nuanced features when you're using S3 bucket keys together with same or cross region replication.

      It's beyond the scope of this video, but it might be useful for the exam and the real world to be aware of these nuanced features and requirements as you're using the product.

      Now with that being said, that is everything that I wanted to cover in this video.

      So go ahead and complete the video and when you're ready, I'll look forward to you joining me in the next.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Reviewer #1

      Evidence, reproducibility and clarity

      Sanial et al. carefully analyze the use of in-gel fluorescence as an alternative to immunoblotting. The authors show that simple modifications of common protein extraction protocols can preserve (to varying extents) fluorescent proteins in their native, fluorescent states. This can be exploited in different applications for in-gel fluorescence quantification, bypassing immunoblotting. The experimental results are clear, showcasing the ease and linearity of in-gel fluorescence quantification.

      In my opinion, the trick of this approach is also potentially its main drawback, the partial denaturation conditions. I think the manuscript could be strengthened with more extensive benchmarking of the approach and further discussion of potential caveats as detailed below.

      Major points:

      1. Protein abundance in the original GFP library (and in other FP-tagged libraries constructed in the meanwhile) have been quantified using fluorescence (flow cytometry, microscopy, colony fluorescence) (Ho et al. 2018 10.1016/j.cels.2017.12.004, Weill et al. 2018 10.1038/s41592-018-0044-9, Meurer et al. 2018 10.1038/s41592-018-0045-8). This provides an opportunity to significantly strengthen the manuscript (where most of the test have been done using two abundant cytosolic proteins Bmh1 and Hxk1) if the authors could apply their approach to a representative fraction of the yeast proteome (sampling from such libraries FP-tagged proteins that differ in abundance, localization, membrane vs cytosolic/nuclear, subunits of large stable complexes vs proteins not part of complexes, etc.) and compare their quantification with previous relative abundance estimates. This information would also help future users in case protein-specific issues are identified.

      Indeed, Hxk1 and Bmh1 are quite strongly expressed (41,000 and 65,000 copies/cell, according to SGD, ____www.yeastgenome.org____). In the course of our experiments we were able to detect proteins with a much lower expression level (eg. Reg1, 4000 copies/cell). We have selected a number of proteins based on their expression level as detailed in SGD, ranging from 700 to 75000, and plan to detect the signal by IGF and compare it with published data on absolute protein quantifications for ecah protein. However, this will take a bit of time as each gene must be tagged with EGFP – we cannot use the GFP-S65T from the GFP collection which is poorly amenable to IGF because of its sensitivity to denaturation, as we show in our manuscript.

      The authors discuss several drawbacks, including the change in apparent molecular weight compared to denatured proteins; differential recognition of folded vs denatured proteins by antibodies.

      Other potentials drawbacks should be discussed. For instance, the need of additional steps post-fluorescence imaging for signal normalization against a loading control; the need of antibodies and immunoblotting to decide on the best denaturing temperature for a specific protein or FP tag; complexity of the native protein extraction protocol compared for example to alkaline lysis followed by TCA precipitation (Knop et al. 1999 PMID: 10407276).

      • Regarding the the need of additional steps post-fluorescence imaging for signal normalization against a loading control – this doesn’t take extra time for people using gels with protein stain included in the gel (eg. Stain-Free from BioRad). There are other possibilities of total protein fluorescent labeling that will be discussed. We will provide an example of this application.
      • On the need of antibodies and immunoblotting to decide on the best denaturing temperature for a specific protein or FP tag – we believe that the system could be set up for a protein of interest for which antibodies are available (as we did for Bmh1 or Hxk1), and once this is done, there is no need to do these controls anymore. We will mention this in the manuscript.
      • On the complexity of the native protein extraction protocol compared for example to alkaline lysis followed by TCA precipitation – indeed the protocol is a bit more time-consuming compared to the mentioned method, and we will mention this in the text. However, please note that people studying mammalian cells, for instance, often use this native protocol for total extracts so this is mostly a yeast-model issue. Yet, we will add this comment. Moreover, although the denatured fraction is FP- and temperature-dependent, even under the milder 30{degree sign}C conditions there is a detectable denatured fraction (Fig.s3b). This would seem to preclude the use of this approach for absolute protein quantification.

      True, but it depends a lot on the FP used. For instance, sfGFP is not denatured and could potentially be used for absolute quantification. We will comment in the text.

      Finally, any evidence that the denatured fraction would depend on the protein tagged with the FP?

      We will use several proteins used for point 1 but fused to the most sensitive FP, GFP-S65T, and do a western blot using anti-GFP antibodies to estimate the variation in native vs. denatured forms of the protein.

      Minor points: 1. In the experiments designed to test the linearity and sensitivity of the approach, an alternative approach that would not result in dilution of cell extract is to mix wild type cell extract (no GFP fusion) with extract of the GPF-tagged strain in different ratios.

      Yes, this was an alternative but it seemed that dilution was easier to control than mixing two extracts.

      Define all acronyms at first appearance. For example, DTT and LDS on page 4.

      Thank you, we will address all acronyms in the text.

      Fig.4D: the colors chosen to represent EGFP and sfGFP data make them hard to tell apart. The same comment to Fig.S6.

      Agreed, we will change the figures accordingly.

      As the temperature steps are not uniform in Figures 4 and 5, it would be more informative to indicate the exact temperate above each lane (in addition/instead of the ramp cartoon).

      Agreed, we will change the figures accordingly.

      Regarding linearity, that HRP-based quantification is not linear is expected. A fairer comparison would be to use fluorescently labeled secondary antibodies. It is also puzzling that detection with signal amplification (HRP) is less sensitive than direct quantification of the fluorescence signal from the FP tag.

      We will do a sensitivity tets (dilutions) to compare IGF with HRP-based and fluorescent-based antibody-mediated detection.

      I appreciate the workflow Figure 10. But in my opinion it is trying to show too much (protocol, troubleshooting, calls to figure panels). Perhaps it could be made clearer by separating the protocol steps/settings from the optimization/troubleshooting tips.

      Thank you, we will work on this to make the workflow clearer.

      Some of the discussion of different fluorescent proteins, and expression levels of tagged proteins, could be confounded by the different linkers used in the tagging constructs.

      Thank you for this remark. Indeed, there are various linkers on these constructs and we don’t know to which extent they contribute to the effect on protein expression level. We will comment his in the text.

      Significance

      Could be a generally useful and simple approach for in-gel quantification using fluorescent protein tags.

      __ ____Thank you for your comments and overall assesment.__


      Reviewer #2

      Evidence, reproducibility and clarity

      The present manuscript "Direct observation of fluorescent proteins in gels: a rapid cost-efficient, and quantitative alternative to immunoblotting" describes a method how to visualize bands of fluorescent protein fusions onto a common SDS-PAGE without antibody staining. It is based on ability of GFP-like fluorescent proteins (FPs) to retain their fluorescence under conditions of SDS-PAGE if step of extensive heating (boiling) of protein sample is omitted. This property of FPs is not novel; it was known for more than 20 years (for example, see Fig. 2 in Yanushevich et al. FEBS Lett. 2002 Jan 30, 511:11-4; Supporting Fig. 7 in Campbell et al. Proc Natl Acad Sci USA. 2002 Jun 11, 99:7877-82). However, the authors did perform a very accurate and robust study to quantitatively assess the behavior of several FP fusion protein in SDS-PAGE. A thorough analysis of different conditions for a variety of FPs and target proteins was done; detailed protocols were developed. A surprisingly high sensitivity of FP detection (even superior to that of standard Western blotting) was demonstrated. Considering the simplicity of the proposed approach, it appears to be the method of choice for those working with FP fusion proteins.

      Thank you for this comment. Indeed we do not claim to discover that FP remain fluorescent in mild denaturing conditions, as presented in the text. We did our best to include original publications showing precedent for this and we missed Yanushevich et al. FEBS Lett. 2002 that we will add. However the Campbell paper is cited, precisely for the Supplementary figure 7 that the reviewer mentions.

      I have only minor, discretionary comments:

      1. It is known that under conditions of SDS-PAGE without heating, FPs retain not only fluorescence but also their oligomeric state. The same can be true for proteins of interest (POIs). If so, even for monomeric FPs, the POI-FP band can potentially migrate much slower than expected because of oligomerization of the POI.

      __Thank you for this suggestion. Our data in the manuscript already show that Bmh1 and Bmh2, which are tighlty associated 14-3-3 proteins, no longer intereact in these mild denaturation conditions. In the set of proteins that we will use to answer to Reviewer #1 (point 1), we will include proteins in large complexes to assess whether this can happen. __

      It might be useful to briefly discuss a possibility to use other types of fluorescent proteins (namely, Flavin-binding FPs, bacteriophytochrome-based FPs, bilirubin-binding FP UnaG) in the same way as proposed here. In particular, biliverdin-binding near-infrared FPs (IFP, iRFP, etc.) can be detected even after fully denaturing SDS-PAGE by zinc-induced orange fluorescence of proteins carrying covalently attached bilin chromophore (Berkelman TR, Lagarias JC. Visualization of bilin-linked peptides and proteins in polyacrylamide gels. Anal Biochem. 1986, 156, 194-201; Stepanenko OV, Kuznetsova IM, Turoverov KK, Stepanenko OV. Impact of Double Covalent Binding of BV in NIR FPs on Their Spectral and Physicochemical Properties. Int J Mol Sci. 2022, 23, 7347).

      __Agreed. ____We will extend the discussion to other fluorescent approaches to visualize proteins in gels and compare them. __


      Significance

      A simple method of specific visualization of fluorescent protein fusion bands on SDS-PAGE is proposed.

      Thank you for your comments and overall assesment.

      Reviewer #3

      Evidence, reproducibility and clarity

      In this paper, Sanial et al present in-gel fluorescence detection (IGF), a method that allows the direct detection of fluorescent proteins from SDS-PAGE gels with minimal adaptation of existing protocols. The authors test a range of fluorescent proteins routinely used, especially when working with yeast, and describe their behavior in IGF. They identify heat-induced denaturation of fluorescent proteins as the main component influencing their assay and systematically test this on a selection of fluorescent proteins. Next, they compare the detection limit and the linearity of the signal between IGF and chemiluminescence, showing that IGF is not only comparable but also superior to chemiluminescence. This is particularly significant given that chemiluminescence can suffer from issues such as a limited dynamic range and limitations in accurately quantifying very low or high-abundance proteins. The authors further demonstrate the utility of IGF in co-immunoprecipitation experiments and test whether the mild denaturing conditions are compatible with proteins from other organisms. Overall, the study is well-presented and is an asset to the scientific community. I have one major and some minor comments that, in my opinion, would improve this already informative paper: Major comment 1. In all cases where there is signal quantification the authors should perform replicates to account for variability of the signal (in Fig 6, S6 and S7).

      __Agreed, we will perform triplicates for the indicated experiments. __

      Minor comments 1. The study mainly focuses on soluble protein. While the authors have tested one plasma membrane protein, the study would benefit from including more membrane proteins from different environments (e.g., cell wall, nuclear envelope, mitochondrial). This would help determine if incubation at higher temperatures is necessary to properly solubilize these proteins, in which case the experiment would need adaptation.

      Thank you for this suggestion. __In the set of proteins that we will use to answer to Reviewer #1 (point 1), we will include proteins from various subcellular locations. __

      The authors show that when fluorescent proteins are partially denatured, their migration behavior changes. One cannot exclude that in some cases, the tagged proteins themselves might also be partially resistant to denaturing at the low temperatures used for IGF. This would lead to more than one fluorescent bands. In such cases one should be careful with interpretation, especially in the context of PTMs or isoforms. Could the authors briefly discuss this?

      Thank you for this comment. __We will discuss this in the text. __

      Based on Fig 4D and 5D, some fluorescent proteins seem to have a higher signal variability between replicates than others. It would be helpful to add this information next to the behavior of the proteins in different temperatures so it would be easier to choose the fluorescent protein for specific experiments.

      __Indeed, there are variations between experiments, but it is not clear whether this inherent to the FP considered or the experiment. We will look back at the data and modify the text accordingly if pertinent. __

      The sensitivity experiment (Figure 6) is convincing and important for IP conditions, where the total protein concentration of the sample is radically decreased. Could the authors additionally test if very low abundant proteins can be detected (without any dilution of the total protein content), and compare this to chemiluminescence? This could be done either by tagging some very low abundant proteins (for example a few hundred copies per cell) or diluting the lysate in wild-type lysate to artificially reduce their concentration while maintaining the overall protein load the same.

      __We have planned an experiment in which low abundant proteins will be tagged in response to reviewer 1 (point 1) which should address this point. __

      It would be useful to address the detection of very high molecular weight proteins - or proteins that are problematic in terms of transfer during western blotting.

      Again, in the experiment planned in ____response to reviewer 1 (point 1), proteins or various MW as well as membrane proteins will be studied, which should address this point. __ __

      Significance

      The authors already discuss the strengths and limitations of their approach. The main strength of IGF is that it does not require transfer of the proteins to a membrane and also does not rely on antibody binding and (potential) chemical reactions. In addition to the fact that this is time, cost, equipment, waste and expertise effective, the sensitivity and signal linearity of IGF seems to not only compare but outperforme western blotting. There are two main limitations. First, IGF relies on the resilience to denaturing of the chosen fluorescent protein that depends, according to the authors, at least on the temperature and overall protein concentration and pH. Second, IGF relied on tagging proteins with fluorescent proteins which might affect the stability or even function of the tagged protein. As the authors mention, these factors do not diminish the value of IGF, they highlight the need for appropriate controls.

      A potential development of the technique (not at the present study) could be the compatibility of IGF with different self-labelling proteins (Halo, Snap) and fluorescent dyes.

      We have conducted experiments in which we show the applicability of IGF in combination to SNAP-tagging, that we could show if needed.

      I think IGF will benefit a rather broad range of scientists. As already mentioned by the authors, there are different applications of IGF. From checking of clones when creating strains, to comparison of protein levels in different conditions and coIP experiments.

      Thank you for your comments and overall assesment.

      Cross reviews. Reviewer 1: I agree with the assessment by Reviewer #2. Considering the comment about potential oligomerization of a protein of interest, I stand by my point about testing the method with more proteins of interest. How extensive this testing should be or whether additional discussion of possible issues would suffice is a matter of opinion. It is clear from the manuscript in it's current form that the method works and that it has caveats.

      We believed that the experiments we have planned will clarify these points.

      Reviewer 2: In general, I agree with the points raised by Reviewer #1. However, in my opinion, there is already a large body of reliable experimental results in the manuscript that are worth publishing without a new round of extensive experiments.

      Reviewer 1: Fair enough, I don't insist on the experiments in my point 1.

      We think that this is an important point that will likely be a common question for readers so we will still do our best to provide data for this point.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #1

      Evidence, reproducibility and clarity

      Sanial et al. carefully analyze the use of in-gel fluorescence as an alternative to immunoblotting. The authors show that simple modifications of common protein extraction protocols can preserve (to varying extents) fluorescent proteins in their native, fluorescent states. This can be exploited in different applications for in-gel fluorescence quantification, bypassing immunoblotting. The experimental results are clear, showcasing the ease and linearity of in-gel fluorescence quantification.

      In my opinion, the trick of this approach is also potentially its main drawback, the partial denaturation conditions. I think the manuscript could be strengthened with more extensive benchmarking of the approach and further discussion of potential caveats as detailed below.

      Major points:

      1. Protein abundance in the original GFP library (and in other FP-tagged libraries constructed in the meanwhile) have been quantified using fluorescence (flow cytometry, microscopy, colony fluorescence) (Ho et al. 2018 10.1016/j.cels.2017.12.004, Weill et al. 2018 10.1038/s41592-018-0044-9, Meurer et al. 2018 10.1038/s41592-018-0045-8). This provides an opportunity to significantly strengthen the manuscript (where most of the test have been done using two abundant cytosolic proteins Bmh1 and Hxk1) if the authors could apply their approach to a representative fraction of the yeast proteome (sampling from such libraries FP-tagged proteins that differ in abundance, localization, membrane vs cytosolic/nuclear, subunits of large stable complexes vs proteins not part of complexes, etc.) and compare their quantification with previous relative abundance estimates. This information would also help future users in case protein-specific issues are identified.
      2. The authors discuss several drawbacks, including the change in apparent molecular weight compared to denatured proteins; differential recognition of folded vs denatured proteins by antibodies.

      Other potentials drawbacks should be discussed. For instance, the need of additional steps post-fluorescence imaging for signal normalization against a loading control; the need of antibodies and immunoblotting to decide on the best denaturing temperature for a specific protein or FP tag; complexity of the native protein extraction protocol compared for example to alkaline lysis followed by TCA precipitation (Knop et al. 1999 PMID: 10407276).

      Moreover, although the denatured fraction is FP- and temperature-dependent, even under the milder 30{degree sign}C conditions there is a detectable denatured fraction (Fig.s3b). This would seem to preclude the use of this approach for absolute protein quantification.

      Finally, any evidence that the denatured fraction would depend on the protein tagged with the FP?

      Minor points:

      1. In the experiments designed to test the linearity and sensitivity of the approach, an alternative approach that would not result in dilution of cell extract is to mix wild type cell extract (no GFP fusion) with extract of the GPF-tagged strain in different ratios.
      2. Define all acronyms at first appearance. For example, DTT and LDS on page 4.
      3. Fig.4D: the colors chosen to represent EGFP and sfGFP data make them hard to tell apart. The same comment to Fig.S6.
      4. As the temperature steps are not uniform in Figures 4 and 5, it would be more informative to indicate the exact temperate above each lane (in addition/instead of the ramp cartoon).
      5. Regarding linearity, that HRP-based quantification is not linear is expected. A fairer comparison would be to use fluorescently labeled secondary antibodies. It is also puzzling that detection with signal amplification (HRP) is less sensitive than direct quantification of the fluorescence signal from the FP tag.
      6. I appreciate the workflow Figure 10. But in my opinion it is trying to show too much (protocol, troubleshooting, calls to figure panels). Perhaps it could be made clearer by separating the protocol steps/settings from the optimization/troubleshooting tips.
      7. Some of the discussion of different fluorescent proteins, and expression levels of tagged proteins, could be confounded by the different linkers used in the tagging constructs.

      Referee Cross-commenting

      This session contains comments from all reviewers.

      Reviewer 1: I agree with the assessment by Reviewer #2. Considering the comment about potential oligomerization of a protein of interest, I stand by my point about testing the method with more proteins of interest. How extensive this testing should be or whether additional discussion of possible issues would suffice is a matter of opinion. It is clear from the manuscript in it's current form that the method works and that it has caveats.

      Reviewer 2: In general, I agree with the points raised by Reviewer #1. However, in my opinion, there is already a large body of reliable experimental results in the manuscript that are worth publishing without a new round of extensive experiments.

      Reviewer 1: Fair enough, I don't insist on the experiments in my point 1.

      Significance

      Could be a generally useful and simple approach for in-gel quantification using fluorescent protein tags.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      Manuscript number:

      RC-2024-02569

      Corresponding author(s): Mary O'Riordan, Teresa O'Meara

      1. General Statements

      We thank the reviewers for their positive feedback, highlighting the significance and novelty of our work, especially regarding the novel functions of IRE1a in regulating phagosome biology during infection. We also appreciate some overarching themes that were focused on by multiple reviewers, including the role of XBP1S protein and RIDD activity, which we have addressed here. We have also added additional data, made adjustments to data presentation, and added clarifying language to address concerns from Reviewer 3. We appreciate these constructive suggestions and include our planned experiments to address reviewer concerns here. Our specific responses to the reviewer comments are below.

      Specific figures used in the response to reviewers are in the attached file as they cannot be pasted here.

      2. Description of the planned revisions

      Reviewer 1:

      1) The demonstration of protein misfolding independent IRE1 activation should also be demonstrated using molecules such as TUDCA or 4PBA that should be innocuous regarding the splicing of XBP1s. It would also be interesting to evaluate the activation of the other arms of the UPR in particular through the phosphorylation of eIF2a, expression of ATF4 and cleavage of ATF6.

      We appreciate the suggestion to strengthen our data regarding protein misfolding-independent activation of IRE1 more robust. We note that canonical UPR transcriptional targets are not induced during C. albicans infection (Fig. 2G,H), suggesting that IRE1 is activated in the absence of a standard unfolded protein response. However, we agree that we can use additional chemical chaperones to assay this. To address this point, we will perform the suggested experiments in the presence or absence of TUDCA with C. albicans, LPS, thapsigargin, and tunicamycin. As 4PBA has been shown to inhibit protein synthesis, rather than promoting protein folding or preventing aggregation (PMC9741500), we will avoid using this compound for these assays.

      We will also perform western blots for ATF6 cleavage and eIF2a phosphorylation, although we note that eIF2a can be phosphorylated by multiple kinases and can be triggered by nutrient deprivation or changes in intracellular calcium, both of which occur during C. albicans infection (glucose: PMC6709535; calcium: data within this manuscript).

      3) The authors use thioflavin to evaluate the extent of protein misfolding. This type of stain can lead to artefactual results and in general it is rather safer to test several stainers (see for instance the work presented in PMC10720158)

      We thank the reviewer for this suggestion. We have previously tried Proteostat staining as an additional method to measure protein misfolding, but we found that it bound strongly to the C. albicans cell wall, which would result in a strong false positive signal that is not indicative of host protein misfolding (see below). Congo Red, an additional dye used in the listed reference, is also known to bind to C. albicans and perturbs cell wall synthesis (PMC266468), therefore we have avoided these dyes.

      However, to address this point, we will perform experiments utilizing poly-ubiquitin blotting, as in the suggested reference, as an orthogonal readout of protein misfolding during C. albicans infection or treatment with LPS, depleted zymosan, and thapsigargin.

      __Figure legend: Proteostat staining with _C. albicans_ infection. __Macrophages were infected with C. albicans, and subsequently stained with Proteostat to measure protein misfolding. Proteostat bound and displayed strong fluorescence on the C. albicans cell wall.

      6) The whole study relies on the use of IRE1deltaR to impair IRE1 signaling. The authors should validate their hypothesis with an orthogonal approach, for instance with IRE1 pharmacological inhibitors (eg MKC8866 or KIRA8).

      We consider the use of genetic perturbation of IRE1 to be a strength of this manuscript, as IRE1 inhibitors have been shown to cause off-target effects (KIRA8: PMC9600248). However, to address this point, we will attempt to replicate important phenotypes, including the effect of IRE1 on calcium flux and phagolysosome fusion, using MKC8866 and KIRA8 as representative inhibitors.

      3. Description of the revisions that have already been incorporated in the transferred manuscript

      __Reviewer 1: __

      5) The authors focus on the IRE1/XBP1s signaling arm of the UPR but do not explore RIDD activity which has been linked to several infection mechanisms and lysosomal integrity (in particular by regulating the expression of BLOS1 - see PMC9119680 and PMC6446841). The authors should definitely evaluate how RIDD is activated (or not) in their experimental systems.

      We thank the reviewer for this suggestion, as we have considered potential effects of RIDD when analyzing our RNA-seq data, and are aware of the potential links between IRE1, BLOS1 (encoded by Bloc1s1) expression, and lysosome perturbations. We now add additional figures to our supplemental data (Fig. S3C-D; also shown below) showing that established RIDD targets, including Bloc1s1 are not depleted during C. albicans infection, and also not increased in IRE1 null macrophages. We add the following text to describe these findings (lines 322-326): "Additionally, we did not observe depletion of published RIDD targets (14, 65, 66) during C. albicans infection in WT macrophages (Fig. S3C; Table S2), nor increased expression of RIDD targets in IRE1ΔR macrophages, compared to IRE1 WT macrophages (Fig. S3D; Table S1.1), suggesting minimal RIDD activity during C. albicans infection." We also note that experiments with LysoSensor (Fig. 3E) suggested lysosome biogenesis is not impaired in IRE1 null macrophages. Therefore, we expect RIDD activity has negligible effects on our reported phenotypes.

      Reviewer #1 (Significance (Required)):

      The manuscript is interesting and highlights novel aspects towards the interaction between macrophages and a pathogen, candida albicans, involving the likely selective activation of IRE1. The data are novel and experimentally sound. Several controls are however missing.

      The strengths of the study are associated with the novelty of the findings, with the links that could potentially derive from this study to connect ER biology, UPR signaling and phagosome maturation

      The main weaknesses are associated i) with the fact that the authors did not evaluate RIDD activity which has already been linked with pathogen infection and with lysosome integrity, ii) with methodological aspects, in particular regarding the demonstration of the IRE1 activation independent on protein misfolding and the sole use of a genetic variant of IRE1 to test their hypotheses

      We thank Reviewer 1 for their constructive feedback and for noting the novelty of our findings. We believe that the data we have added regarding RIDD activity and our planned experiments to address additional concerns will add additional evidence to support our findings.

      Reviewer 2:

      1. A point that should be addressed with more detail is the correlation of fungal killing with Ca2+ fluxes and Ire1α activity, given the well-known data regarding the strong ability of the axis dectin/SYK/phospholipase Cγ to induce Ca2+ transients, a response not shared by LPS signaling, and the sequential activation of mitochondrial Ca2+ uniporter (MCU), which is a critical element of fungal killing associated with the citrate-pyruvate shuttle as a NADPH source (Seegren et al., Cell Rep. 33: 108411, 2020). Incidentally, this paper is referred in ref. 46 as a preprint, although it was accessible in Cell Reports in 2020.

      This is an excellent suggestion; we have added this topic to our discussion (lines 605-608) and have corrected the citation.

      The assay of the expression of V-ATPase complex, mitochondrial calcium uniporter, and mitochondrial uptake 1 and 2 could shed light on the dependence of fungal killing on Ire1α function.

      Thank you for this suggestion - below, we plot the transcripts comprising the V-ATPase, as well as Mcu, Micu1, and Micu2. We note that these transcripts are not perturbed in IRE1 null macrophages, suggesting that the basic functions of the V-ATPase complex and mitochondrial calcium uptake are intact in IRE1 null macrophages.

      These data are in agreement with our LysoSensor assay (Fig. 3E), which suggested that lysosome biogenesis is not impaired in IRE1 null macrophages.

      While we cannot rule out a defect in mitochondrial calcium flux from our RNA-seq data, we have added discussion around this topic to our discussion, as mentioned above.

      Expression of V-ATPase subunits and mitochondrial calcium uptake genes in C. albicans-infected IRE1 null macrophages vs C. albicans-infected IRE1 WT macrophages.

      Fig. 1A should be explained with more detail to disclose the products of PstI digestion.

      Thank you for the suggestion. We have added this information to the Figure 1 legend, "RT-PCR-amplified Xbp1 cDNA was treated with PstI, which recognizes a cleavage site within the 26 base pair intron that is removed by IRE1α activity, resulting in cleavage of the unspliced isoform, specifically."

      The anti-XBP1 antibody used to construct the blots in Fig.S1A recognizes epitopes not disclosed by the manufacturers, but they have to pertain to the N-terminal peptide sequence shared by sXBP1 and uXBP1. Showing full lanes encompassing both protein isoforms would allow a better appraisal of protein expression. In connection to point 4, the use of an antibody reactive to the epitopes expressed in sXBP1 in cell lysates or, preferentially in nuclear fractions, could be most valuable to rule out the dependence of the effect of Ire1α on the trans-activating function of sXBP1.

      We have un-cropped these westerns and now show spliced and unspliced XBP1 products on a single image in Fig. S1A.

      On page 23, the mention to Fig. 5A should be changed to Fig. 5B.

      We have fixed this mis-labeling, thank you for calling this to our attention.

      Line 209. I understand gene synthesis refers to gene expression.

      We have clarified this in the text, thank you for the suggestion.

      Line 394. What is the reason to study the cytokine-signature of Candida in LPS-primed cells?

      Thank you for the question; we have added the following text (lines 413-414) to clarify that LPS is used for inflammasome priming:

      "Therefore, we tested secretion of IL-1β, TNF, and IL-6 from WT and IRE1ΔR macrophages after LPS treatment to transcriptionally prime the NLRP3 inflammasome components, followed by C. albicans infection (Fig. 5D-F)."

      Numerous studies have shown that C. albicans can trigger macrophage pyroptosis, resulting in production of pro-inflammatory cytokines like IL-1b, which can also be influenced by phagosome rupture (PMC3910967). However, this requires inflammasome transcriptional priming, and LPS is commonly used to prime macrophages for inflammasome activation in vitro. Therefore, we perform a short pre-treatment with LPS for NLRP3 inflammasome priming to subsequently measure its activation following C. albicans infection, using secreted cytokines as a readout. We also note that macrophages in vivo may not be naive and are often M1-polarized by the microbial or cytokine environment, thus inflammasome priming is likely common during in vivo infection.

      Reviewer #2 (Significance (Required)):

      This study focuses on an aspect not usually addressed in papers devoted to the UPR.

      If more data are shown as suggested, the paper could be of interest for a wider audience

      We thank the reviewer for their positive feedback about the novelty of our work and agree that the suggested experiments will bolster our data and story.


      Reviewer 3:

      Fig. 2:

      Panel A-B: same question as for Fig. 1. The variation in TG DMSO-induced splicing is huge. The effects of the treatments with CHX or Act D are smaller than the variation between experiments with TG DMSO alone. As long as that variation is not controlled for, it is impossible to draw any conclusion from the inhibitors. In this regard, it is very difficult to interpret data if they are not done in one and the same experiment.

      The variability in thapsigargin fold change over mock likely represents differences in basal Xbp1 expression. We consistently see complete Xbp1 splicing in response to thapsigargin treatment (see Fig. 1A). Additionally, we note that thapsigargin treatment is used only as a positive control, not as a physiologically relevant treatment, as it results in unmitigated ER stress that triggers cell death (PMC6986015).

      We have removed the following sentence, "Translation inhibition using cycloheximide was sufficient to alleviate Xbp1 splicing specifically in response to thapsigargin, likely by reducing the nascent protein folding burden (Fig. 2B)," since our data are plotted on separate graphs, matched to their respective controls, for appropriate comparisons.

      4. Description of analyses that authors prefer not to carry out


      Reviewer 1:

      2) Since the IRE1/XBP1 arm of the UPR is also involved in lipid biosynthesis which might be required for phagosome maturation, the authors should perform XBP1s rescues in IRE1 deficient cells to ensure that their observation is XBP1s dependent or IRE1 dependent.

      As we do not see XBP1S protein induced in wild-type macrophages at any timepoint during our C. albicans infection scheme (Fig. S1A-B), we interpret our results as being XBP1S-independent. If we were to add back XBP1S with constitutive expression, we would be overexpressing the protein relative to C. albicans infected wild-type macrophages (in which we do not see measurable XBP1S expression). Therefore, we believe these experiments would not address a physiologically-relevant scenario.

      4) The authors should evaluate in what compartment IRE1 is activated upon CA infection, does that happen in the ER or in the ER fraction fused to phagosomes?

      This is an interesting question for future exploration. In order to answer this question with existing tools, we would need to perform biochemical fractionation of infected cells to isolate an ER-phagosome contact site fraction, followed by phos-tag gel analysis of IRE1 activation in the ER fraction, compared to the ER-phagosome contact site fraction. However, a biochemical fractionation protocol to distinguish the ER fraction from ER-phagosome contact sites has not yet been developed, to our knowledge, and we believe it is outside the scope of this study to develop such a technique.

      We have added additional text regarding this intriguing question to our discussion (lines 549-553).

      Reviewer 2:


      Infection at a MOI 1 of C. albicans is a ratio of infecting agent/susceptible targets not very high for a non-soluble stimulus with limited diffusion in the culture medium. Although I recognize the difficulty of quantitating adhered cell, the mention to 80% confluence makes it more difficult the appraisal of the actual MOI. The delayed time-course of Xbp splicing under these conditions can be explained by the time required for in vitro proliferation, Candida damage, and diffusion of fungal patterns. A study with viable Candida at MOI 5 in human monocyte-derived dendritic cells, which show a robust capacity for non-opsonic phagocytosis associated with C-type lectin receptors only showed initial hypha formation after 2 hours (Rodriguez et al., J. Biol. Chem. 289, P22942-22957, 2014). Consistent with the requirement of a time lag for infecting agent to attain levels of expression consistent with a net response, 16 hours have been considered an appropriate time-course to assay sXBP1 expression following SARS-CoV2 infection (Fernandez et al., Biochim Biophys Acta Mol Basis Dis. 1870(5):167193, 2024). I wonder if a higher MOI could show a similar kinetics.

      We use lower MOI in part due to the size and ability of C. albicans to undergo extensive hyphal growth if its numbers greatly exceed the number of host cells. From our microscopy data, we can see that C. albicans spreads well throughout the culture plate (see Fig. 3A, Fig. 4A). We and others have observed considerable death of macrophage cultures after 12 hours with Candida infection, even at low MOI (PMC6709535), therefore we avoid later timepoints in these assays and all other in vitro assays in our manuscript.

      As all of our in vitro experiments are performed within an 8 hour window of infection, whether XBP1S is induced at later timepoints by C. albicans or depleted zymosan would not alter the conclusions of the rest of our results.

      sXBP1 can be present in nuclear fractions in resting cells, which suggests the involvement of post-translational modifications for the display of transcriptional activity.

      As we do not see induction of XBP1S in our lysates after C. albicans infection, it is unlikely that post-translational modification is influencing its function, although we agree post-translational modification is a likely regulatory control over XBP1S during the unfolded protein response.

      The independence of sXBP1 transcriptional activity from canonical UPR associated with misfolded protein stress is well known from the seminal paper by Martinon et al., (ref.6). Moreover, the expression of CHOP, the final effector of the PERK route, encoded by DDIT3 gene, has been found to be blunted by Candida (Rodriguez et al., J. Biol. Chem. 289, P22942-22957,2014). This is additional evidence for the recruitment of sXBP1 transcriptional activity in the absence of canonical UPR.

      As mentioned, we found that XBP1S protein is not induced during C. albicans infection at any timepoint in our experiments (Fig. S1A-B). Importantly, the work referenced by the reviewer uses RAW267.7 cells, which (as mentioned by the authors) constitutively express CHOP as a result of Abel leukemia virus infection. Based on this specific overexpression, we believe this phenotype is not comparable to our bone marrow-derived macrophages.

      Reviewer 3:

      Fig. 1:

      Panel 1C: please remove outlier in 4h timepoint. This implies that the experiment needs to be redone to reduce variation

      We have performed an outlier test on these data, which revealed that this data point is not a statistical outlier, therefore we do not feel that its removal is appropriate (see below).

      Panel 1E-H: how is the splicing efficiency determined and normalized? How to explain the big differences in splicing efficiency of Xbp1 upon LPS stimulation (appr. 4 to 6 times in E, G and H versus 30-fold in panel F). Where does this difference come from?

      Panel H, outlier needs to be removed.

      We do occasionally see differences in magnitude of Xbp1 splicing in different cell lines or experiments, especially with controls, which may be caused by differences in the basal level of Xbp1 expression, especially as Xbp1 levels have been shown to be affected by circadian rhythm in certain cell types (PMCID: PMC11214543; PMCID: PMC6959563).

      In panel H, an outlier test reveals that these are not statistical outliers, therefore we feel their removal is inappropriate as we do not wish to mask biological variation. Moreover, this graph includes two cell lines (open and closed circles), showing that our data are robust across multiple independent cell lines and are an appropriate measure of experimental replicates.

      Fig. 2:

      Panel A-B: same question as for Fig. 1. The variation in TG DMSO-induced splicing is huge. The effects of the treatments with CHX or Act D are smaller than the variation between experiments with TG DMSO alone. As long as that variation is not controlled for, it is impossible to draw any conclusion from the inhibitors. In this regard, it is very difficult to interpret data if they are not done in one and the same experiment.

      The variability in thapsigargin fold change over mock likely represents differences in basal Xbp1 expression. We consistently see complete Xbp1 splicing in response to thapsigargin treatment (see Fig. 1A). Additionally, we note that thapsigargin treatment is used only as a positive control, not as a physiologically relevant treatment, as it results in unmitigated ER stress that triggers cell death (PMC6986015).

      We have removed the following sentence, "Translation inhibition using cycloheximide was sufficient to alleviate Xbp1 splicing specifically in response to thapsigargin, likely by reducing the nascent protein folding burden (Fig. 2B), since our data are plotted on separate graphs, matched to their respective controls, for appropriate comparisons.

      Below, we plot all data together with replicate matching, although our major interpretation of these data is that C. albicans infection can trigger Xbp1 splicing with or without new gene expression, and not about the impact of the inhibitors on the control treatment thapsigargin.

      Please provide a scheme of how the experiment was performed, at what time were the inhibitors provided, at what time point the inducers? What are matched mock samples. Which mock samples were chosen since they differ from one experiment to the next? Please plot all the data for one and the same experiment in one graph so that the reader can easily compare the results of DMSO, DMSO + inducer, DMSO + inducer + inhibitor. Indicate whether the points in the graph are technical or experimental repetitions.

      -How to explain the increase in XBP1 splicing in combination with ActD? Was this due to differences in Gapdh expression? Where did the authors control for cell death? Please provide the data.

      Below is a scheme of the experimental treatments. We have now clarified in the figure legend that inhibitors (ActD and CHX) are added at the same time as experimental treatments (Mock, Ca, TG). All data included in the original submission are biological replicates, as stated in the figure legend. We have now re-written the figure legend to clearly indicate that these are biological replicates.

      All data are normalized such that the effects of the drugs are directly compared (for example, the fold change over Mock for Candida is matched to its drug treatment; Mock DMSO vs Ca DMSO and Mock ActD vs Ca ActD, or Mock CHX vs Ca CHX). Actinomycin D does inhibit new transcription, although IRE1 can cleave existing Xbp1 transcript. We now show conditions normalized to DMSO Mock in Supplemental Figure 2, which allows visualization of the effects of ActD and CHX on Xbp1-S abundance in comparison to control DMSO treatment, while also seeing the relative changes in Xbp1 splicing caused by C. albicans or thapsigargin treatment (see below).

      -Is RT-qPCR a reliable readout when actinomycinD is used? How can new genes be transcribed.

      We interpret RT-qPCR data as a readout of transcript abundance, rather than transcription. Therefore, we are not measuring new gene expression here, but whether the existing Xbp1 transcript can be cleaved by IRE1. Based on the technique, we can still measure changes in Xbp1-S abundance.

      Panel D: where is TG at 4h and 6h?

      We do not include thapsigargin at later timepoints to avoid autofluorescence from excessive cell death. We include thapsigargin as a positive control at the early 2h timepoint, but note that LPS is sufficient to increase thioflavin T intensity at the 8h timepoint.

      Panel G, why was Ddit3 included here as this is not a typical IRE1 dependent gene (rather PERK dependent). What about IRE1 specific genes such as Sec61 or Sec24a?

      We have added additional text (lines 235-240; "Finally, we measured induction of UPR-responsive genes by RT-qPCR in response to C. albicans infection, LPS and depleted zymosan treatment, or thapsigargin treatment, to further test whether IRE1α activation occurs without canonical UPR induction (Fig. 2G-H). C. albicans infection and depleted zymosan treatment did not lead to induction of UPR-responsive genes (Ddit3, Grp78, Grp94, and total Xbp1) at 4 or 6 hours.") to clarify that the purpose of this figure is to add evidence that IRE1 activation is independent of the canonical UPR response (indicating that IRE1 is likely specifically activated independently of the other UPR branches) during C. albicans infection. Therefore, the transcripts measured are canonical UPR-responsive transcripts, rather than IRE1/XBP1S targets (although some are overlapping).

      Below are RNA-seq data comparing Sec61a1, Sec61a2, and Sec24a in IRE1 null macrophages, compared to IRE1 WT macrophages. While there is less expression of Sec61a1 in IRE1 null macrophages, Sec61a2 and Sec24a are largely unaffected. These data support our finding that XBP1S protein is not induced during C. albicans infection.

      Did the authors also check for RIDD activity?

      As mentioned above in response to Reviewer 1, we now add additional figures to our supplemental data (Fig. SX; also shown below) showing that established RIDD targets are not depleted during C. albicans infection in WT macrophages, and also not increased in IRE1 null macrophages. Therefore, we expect RIDD activity has negligible effects on our reported phenotypes.

      Fig. 3:

      Panel C and D look convincing. Lamp1 is a well-known RIDD target gene (see Osorio et al., Nat Imm, 2014). Did the authors check Lamp1 expression in presence and absence of IRE1 and could RIDD explain their phenotype?

      As shown above, Lamp1 transcript expression is not strongly perturbed in IRE1 null macrophages. If RIDD activity were depleting Lamp1 transcript abundance, we would expect to see increased Lamp1 expression in IRE1 null macrophages. We also note that our experiments using LysoSensor (Fig. 3E) suggested that lysosome biogenesis is not impaired, but more specifically, lysosome recruitment to the phagosome is impaired in IRE1 null macrophages.

      Fig. 4, but especially Fig 5 and Fig 6 suffer from very bad imaging quality. Both Fig 5A and Fig 6A are completely uninterpretable. The SRB staining is all over the cells and it is totally unclear how the authors interpret this as phagosomal leakage or not. Fig. 6A is even worse and appears nothing but vague background. It is difficult to understand how the authors make graphs based on these types of images and dare to draw any conclusions.

      In Figure 4, we observe some photobleaching from frequent image acquisition, which is necessary to capture calcium flux dynamics. Image brightness across the timecourse is adjusted in the same way such that we do not attempt to hide the effects of photobleaching. However, our analyses account for photobleaching over time, and the phagosomal calcium flux is clear and quantifiable. `

      In Figure 5, the sulforhodamine B pulse-chase assay involves loading of the endosomal system with SRB, thus the cells are expected to ingest a considerable amount of SRB and it will distribute throughout the endosomal network. However, as endosomes fuse, we also observe fusion with the C. albicans-containing phagosome and SRB will surround C. albicans hyphae. Our analysis pipeline first segments C. albicans hyphae (see below) and measures SRB signal in proximity to the phagosome. Thus, we measure loss of phagosome-associated SRB over time, as C. albicans ruptures the phagosome, in hundreds of macrophages. This is a standard assay that has been previously used for this purpose (PMID: 33022213; PMID: 30131363).

      For Figure 6, we have added additional wide-field images that we believe will clarify how these images can be readily quantified (Fig. 6A, shown below). The purpose of the previous Fig. 6A (now Fig. 6B) is to demonstrate single cell examples of live and dead C. albicans using the dual-fluorescence assay, although we quantify much wider fields for sufficient numbers. We hope the amended figures provide additional clarity.

      Fig. 7 is again an example where differences in expression are mainly due to one or a few complete outliers, and it is hard to understand why the authors did not repeat these experiments to reduce the problems in variation to get proper data sets before submission.

      After performing outlier tests, we have found a total of 4 data points that are statistical outliers from all of the panels in Figure 7. These included the highest data point in each genotype in the female IL-1Ra levels (Fig. 7A, second graph), the highest data point among the male IRE1 fl/fl mice IL-1Ra levels (Fig. 7B, second graph), and the highest data point among the male TNF levels in IRE1 fl/fl + LysM-Cre mice (Fig. 7B, third graph). We have removed these data points in our updated graphs and changed the text to only point out differences in serum TNF and IL-6 levels. Moreover, our interpretation includes that serum cytokine levels are not different in male mice. However, no other data points are statistical outliers, therefore we believe their removal is inappropriate.

      While the paper started nicely and showed an interesting hypothesis (Fig. 3), the remaining part of the paper was of very poor quality and was not ready for submission.

      We thank the reviewer for the constructive feedback and believe that the addition of data and clarifications we have added will demonstrate that our data are of sufficient quality to support our conclusions.

    1. Nina Paley’s Sita Sings The Blues, released online a little over two months ago, has been generating great press and even greater viewership, closing in on 70,000 downloads at archive.org alone. For the non-inundated, there is great background information on the film at Paley’s website. We recently had the opportunity to talk with Paley about the film – we touched on the film’s aesthetics and plot points, but perhaps most interesting to those in the CC community is Paley’s decision to utilize our copyleft license, Attribution-ShareAlike, and her thoughts on free licensing and the open source movement in general. Read on to learn more about the licensing trials and tribulations associated with the film’s release, how CC has played a role, and Paley’s opinions on the Free Culture movement as a whole. RamSitaGods, Nina Paley | CC BY-SA One of the major stories surrounding Sita Sings The Blues been your use of songs by musician Annette Hanshaw and the back-and-forth dialogue you have had with the copyright owners as a result. Can you explain why you used these songs? The songs themselves inspired the film. There would be no film without those songs. Until I heard them, the Ramayana was just another ancient Indian epic to me. I was feebly connecting this ancient epic to my own experiences in 2002. But the Hanshaw songs were a revelation: Sita’s story has been told a million times not just in India, not just through the Ramayana, but also through American Blues. Hers is a story so primal, so basic to human experience, it has been told by people who never heard of the Ramayana. The Hanshaw songs deal with exactly the same themes as the epic; but they emerged completely independent of it. Their sound is distinctively 1920’s American, and therein lies their power: the listener/viewer knows I didn’t make them up. They are authentic. They are historical evidence supporting the film’s central point: the story of the Ramayana transcends time, place and culture. What is this story? Sita is a goddess/princess/woman utterly devoted to her husband Rama, the god/prince/man. Sita’s story moves from total enmeshment and romantic joy (Here We Are, What Wouldn’t I Do For That Man) to hopeful longing separation (Daddy Won’t You Please Come Home) to reunion (Who’s That Knockin’ At My Door) to romantic rejection (Mean to Me) to reconciliation (If You Want the Rainbow) to further rejection (Moanin’ Low, Am I Blue) to hopeless longing (Lover Come Back to Me,) back to love – this time self-love (I’ve Got a Feelin’ I’m Fallin’). Sita’s role is to suffer, especially through loving a man who rejects her. Women especially connect emotionally to her story and these emotions are clearly expressed in songs. As Nabaneeta Dev Sen writes in “Lady sings the Blues: When Women retell the Ramayana”: But there are always alternative ways of using a myth. If patriarchy has used the Sita myth to silence women, the village women have picked up the Sita myth to give themselves a voice. They have found a suitable mask in the myth of Sita, a persona through which they can express themselves, speak of their day-to-day problems, and critique patriarchy in their own fashion. Sen is talking about the songs of Indian village women, but she could just as easily been talking about American Blues. That is the point of Sita Sings the Blues: we all struggle with this story, which connects humans through time, space and culture, whether we’re aware of it or not. Just as the Ramayana has mostly been written down and controlled by men, the songs in Sita Sings the Blues were mostly written by men; but sung by a woman – Hanshaw – they pack an emotional wallop and express a woman’s voice. The synchronicity of the Hanshaw songs and Sita’s story is uncanny. This impresses audiences and allows the film’s point to be made: the story of the Ramayana transcends time, place and culture. Because the songs feature an authentic voice from the 1920’s, they demonstrate that this story emerged organically in history. New songs composed by the director, while they could be entertaining, could not make that point. They would be a mere contrivance, whereas the authentic, historical songs give weight to the film’s thesis. They are in fact the basis of the film’s thesis, irrefutable evidence that certain stories – like the story of Sita and Rama – are inherent to human experience. Upon reading the above, Karl Fogel added: Using something that already exists demonstrates that the universality of your theme is external to yourself. Whereas causing something new to exist wouldn’t achieve the same effect. Instead, it would be circular: it would demonstrate that the artist has the ability to make more of what she’s already making. So rather than being connective or expanding, it would be narcissistic (just in a descriptive sense, not necessarily a pejorative one). There has to be a reason so many composers, even non-Catholic ones like Bach, set the Latin Mass to music instead of making up their own words. (Hmm, now imagine if those words had been monopoly-restricted… 🙂 ). What has your experience been in trying to get permission it use Hanshaw’s music in the film, and the current state of affairs? Because distributors were going bankrupt right and left in 2008, it was no longer possible to sell an indie film to a distributor for big money and then “have them take care of” the licenses. Since in February of 2008, when the film premiered in Berlin, I was not yet a Free Culture convert, I thought I needed a conventional distributor. So it fell on me to clear the rights. I had to pay intermediaries to contact the license holders, since they don’t speak to mere riff raff like me; they’re too busy, and under no obligation to do so. Even before that, I needed legal help to research who owned the rights in the first place, since there’s no central copyright registry any more, and rights are traded like baseball cards between corporations. Luckily, I was aided by the student attorneys of the Glushko-Samuelson Intellectual Property Law Clinic of American University. Anyway, in 2008 a lawyer charged me $7,000 to get this response from the licensors: an estimate of $15,000 to $26,000 per song, AFTER I’d paid a $500 per song Festival License. (Festival Licenses last one whole year and require a promise to not make any money showing the film. So a festival license isn’t enough to get the “week-long commercial run” required for Academy Award qualification. Now that “Sita”‘s been broadcast, she will never qualify for an Academy nomination; if I’d really wanted one, I would have had to delayed the release of the film for another year. But I digress.). Even though we made it explicitly clear the entire budget for the film was under $200,000, the licensors came back with the “bargain” estimate of about $220,000. It was simply not possible for me to acquire that kind of money. So legally, my only option was to not show the film or commit civil disobedience. I hired another intermediary, a “rights clearance house” which is less expensive than a lawyer, and they negotiated the “step deal” I eventually signed. This brought the price tag of the licenses down to $50,000, but with many restrictions. If more than 5,000 DVDs (or downloads) are sold, I must pay the licensors more. I wrote about this at length on my website. I borrowed $50,000 to pay these licenses for several reasons. First, to reduce my liability. I may still be sued for releasing the film freely online – after all, the licensors may interpret free sharing as “selling” for zero dollars – but I’ll only be sued for breach of contract, not copyright infringement. Copyright infringement carries much harsher penalties, including possible jail time. I also wanted to make free sharing of “Sita” as legal, and therefore legitimate, as possible. Sharing shouldn’t be the exclusive purview of lawbreakers. Sharing should – and can – be wholesome fun for the whole family. I paid up to indemnify the audience, because the audience is Sita’s main distributor. So it’s now legal to copy and share Sita Sings the Blues. The files went up on Archive.org in early March 2009 and have spread far and wide since. Having paid off the licensors, I could have chosen conventional distribution. But I chose a CC BY-SA license to allow the film to reach a much wider audience; to prohibit the copyrighting – “locking up” – of my art; to give back to the greater culture which gave to me; to exploit the power of the audience to promote and distribute more efficiently than a conventional distributor; and to educate about the dangers of copy restrictions, and the beauty and benefits of sharing. As a result of the trouble you’ve had in regards to Annete Hanshaw’s music, you have turned into a self-proclaimed Free Culture activist. Was this shift gradual? What has that experience in particular informed your views on copyright, fair use, and the public domain? Annette Hanshaw was immensely popular in the late 1920’s. Now almost no one’s heard of her. Why? Because of copy-restrictions. I met many talented filmmakers on my “festival circuit.” Most had conventional distribution deals, but it’s very hard to see any of their films, which had small, brief theatrical runs, and then were never heard from again. Why? Copy-restrictions. I’m an artist. I need money to live, but even more importantly I need my art to reach people. A $10,000 advance in return for having my work locked up for 10 years is a devil’s bargain. More than anything, I wanted people to see my film – now and in years to come. My turning point in choosing a CC license happened in October of 2008. “Sita” had just opened the San Francisco Animation Festival, and I’d disclosed to the audience we’d all just done something illegal. It’s always great to share the film on a big screen in a theater with an audience, and this one was particularly enthusiastic. The next morning I woke up realizing that a free release online wouldn’t in any way prevent theatrical screenings. Why had I never considered that before? Because the film industry insists people won’t go to theaters if they can see a film online. But that’s not true of me, nor many cinephiles. When I lived in San Francisco my favorite movie outings were to classic films at the Catsro: 2001, Nights of Cabiria, Modern Times, Mommy Dearest. These are all available on home video, but I went to the Castro for the big screen and the dark room and the shared experience. If enough people watched and liked “Sita” online, there’d be demand for it in cinemas. And so far that’s proving true. In particular, how have you viewed CC licenses in this whole process? What was your motivation to release Sita Sings the Blues under a CC BY-SA license? Why did you choose that license and not another CC license? What are the obstacles and benefits you’ve seen in using CC licenses? I want my film to reach the widest audience. It costs money to run a theater; it costs money to manufacture DVDs; it costs money to make and distribute 35mm film prints. It’s essential I allow people to make money distributing Sita these ways and others; otherwise, no one will do it. So I eschewed the “non commercial” license. Share Alike would “protect” the work from ever being locked up. It’s better than Public Domain; works are routinely removed from the Public Domain via privatized derivatives (just try making your own Pinocchio). I didn’t want some corporation locking up a play or TV show based on Sita. They are certainly welcome to make derivative works, and make money from them; in fact I encourage this. But they may not sue or punish anyone for sharing those works. I looked to the Free Software movement as a model. The CC BY-SA license most closely resembles the GNU GPL, which is the foundation of Free Software. People make plenty of money in Free Software; there’s no reason they can’t do the same in Free Culture, except for those pernicious “non commercial” licenses. A Share Alike license eliminates the corporate abuse everyone’s so afraid of, while it encourages entrepreneurship and innovation. Everyone wins, especially the artist! What else would you like our reader’s to know? Any plans for the future? I’d love you all to read my essay Understanding Free Content and of course watch the film! I’m currently busy making “containers” like DVDs and T shirts available now at our e-store. QuestionCopyright is my main partner in releasing Sita; we’re trying to prove a model in which freedom and revenue work together. We know other filmmakers are watching what happens to Sita, and we’d like to show that yes, you can make money without impinging on everyone else’s freedom. I’m also negotiating with theatrical distributors in France and Switzerland, as well as a couple book publishers. I’m negotiating not “rights” to the film, which belong to everyone already, but rather my Endorsement and assistance. To understand how this works, please read about the Creator Endorsed Mark. Once I have the Sita Sings the Blues Merchandise Empire started, I hope to work on short musical cartoons about free speech – you can hear one of the songs here. There’s more where that came from. Really, I have more ideas than I have time to implement them – a happy yet vexing problem. I also hope to have all my old Nina’s Adventures and Fluff syndicated comic strips scanned and uploaded at high resolution onto archive.org under a CC BY-SA license. The University of Illinois Library is currently seeking funding to move ahead on this project – interested individuals should contact Betsy Kruger. Lastly, I’m still looking for money, although the Sita Sings the Blues Merchandise Empire should be generating some in a few months. Still, I plan to apply for grants and fellowships. Any foundations with too much money burning a hole in your accounts, please get in touch.

      In this text, it dives into how Ramayana as a text is so universal that any set of tunes or music can match it. For example, this text looks into how the music from Annette Hanshaw from the 1920's are able to blend into the Indian epic showing its versatility. One challenge that readers might resonate to is the copyright issues that Paley faced in order to have permission to use Hanshaw's music since there were many legal problems and a bunch of fees. Because of this struggle, it highlights why it can be difficult to use certain words in conjunction with other pieces which might explain why we might not see the types of works that we would like. Even looking at the copyright license that Paley chose for her own film, she chose the one that would allow her to reach a larger group of people because her goal is not to make money but to appreciate art for what it is and to share that with other people. The copyright restrictions that are discussed in this text can be eye-opening for a lot of readers as they can see why creativity might be hindered in a lot of fields and this can help explain why. In this text, the concepts of culture and national identity are closely related to the idea of self. This can be seen in Ramayana as its themes are universal and the ability for it to mesh well with the American Blues songs is proof of that. Not to mention, this is an example that serves to show that cultures can blend together in which a person's self can be a multitude of different aspects reflecting in how modern nation-building does not just rely on one perspective or facet, but it can have many different facets allowing that identity to be fluid as a result. The Indians relating to Ramayana may see themselves as "us" because they resonate to that Indian epic while "them" represents those who know more about the American Blues or western culture in general. With this being said, this contrast in cultures being able to blend and mesh well together show how there is shared human experiences across cultures. There is no sense of otherness in Paley's work because she is able to show how the themes in Ramayana are universal and can be applied to all time periods and all locations. Even though the argument is that Ramayana is universal and can blend with any music types, the choice of American Blues is compelling by Paley and this intention was because she may have wanted to see how English lyrics can mesh with Sanskrit language as a challenge and this weird combination can prove that it would work with all music types as a result. Because of this contrast, it speaks to the power of linguistic authenticity as it is able to prove the themes behind the film and put them into action. The difficulty that Paley faced with copyright laws help explain why people cannot be as creative as they want and why free sharing should exist. As a result, Paley allows her work to be easily more accessed which can be seen in her creative commons license and shows that she backs up the same claim from her own film as well. It shows why artists and all people should move away from exclusive ownership and should embrace a more collaborative model in which all people can contribute and take inspirations from each other in positive ways. CC BY Ajey Sasimugunthan (contact)

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This is an interesting study investigating the mechanisms underlying membrane targeting of the NLRP3 inflammasome and reporting a key role for the palmitoylation-depalmitoylation cycle of cys130 in NRLP3. The authors identify ZDHHC3 and APT2 as the specific ZDHHC and APT/ABHD enzymes that are responsible for the s-acylation and de-acylation of NLRP3, respectively. They show that the levels of ZDHHC3 and APT2, both localized at the Golgi, control the level of palmitoylation of NLRP3. The S-acylation-mediated membrane targeting of NLRP3 cooperates with polybasic domain (PBD)-mediated PI4P-binding to target NLRP3 to the TGN under steady-state conditions and to the disassembled TGN induced by the NLRP3 activator nigericin.

      However, the study has several weaknesses in its current form as outlined below.

      (1) The novelty of the findings concerning cys130 palmitoylation in NLRP3 is unfortunately compromised by recent reports on the acylation of different cysteines in NLRP3 (PMID: 38092000), including palmitoylation of the very same cys130 in NLRP3 (Yu et al https://doi.org/10.1101/2023.11.07.566005), which was shown to be relevant for NLRP3 activation in cell and animal models. What remains novel and intriguing is the finding that NLRP3 activators induce an imbalance in the acylation-deacylation cycle by segregating NLRP3 in late Golgi/endosomes from de-acylating enzymes confined in the Golgi. The interesting hypothesis put forward by the authors is that the increased palmitoylation of cys130 would finally contribute to the activation of NLRP3. However, the authors should clarify the trafficking pathway of acylated-NLRP3. This pathway should, in principle, coincide with that of TGN46 which constitutively recycles from the TGN to the plasma membrane and is trapped in endosomes upon treatment with nigericin. 

      We think the data presented in our manuscript are consistent with the majority of S-acylated NLRP3 remaining on the Golgi via S-acylation in both untreated and nigericin treated cells. We have performed an experiment with BrefeldinA (BFA), a fungal metabolite that disassembles the Golgi without causing dissolution of early endosomes, that further supports the conclusion that NLRP3 predominantly resides on Golgi membranes pre and post activation. Treatment of cells with BFA prevents recruitment of NLRP3 to the Golgi in untreated cells and blocks the accumulation of NLRP3 on the structures seen in the perinuclear area after nigericin treatment (see new Supplementary Figure 4A-D). We do see some overlap of NLRP3 signal with TGN46 in the perinuclear area after nigericin treatment (see new Supplementary Figure 2E), however this likely represents TGN46 at the Golgi rather than endosomes given that the NLRP3 signal in this area is BFA sensitive.  As with 2-BP and GFP-NLRP3C130S, GFP-NLRP3 spots also form in BFA / nigericin co-treated cells but not with untagged NLRP3. These spots also do not show any co-localisation with EEA1, suggesting that under these conditions, endosomes don’t appear to represent a secondary site of NLRP3 recruitment in the absence of an intact Golgi. However, we cannot completely rule out that some NLRP3 may recruited to endosomes at some point during its activation.

      (2) To affect the S-acylation, the authors used 16 hrs treatment with 2-bromopalmitate (2BP). In Figure 1f, it is quite clear that NLRP3 in 2-BP treated cells completely redistributed in spots dispersed throughout the cells upon nigericin treatment. What is the Golgi like in those cells? In other words, does 2-BP alter/affect Golgi morphology? What about PI4P levels after 2-BP treatment? These are important missing pieces of data since both the localization of many proteins and the activity of one key PI4K in the Golgi (i.e. PI4KIIalpha) are regulated by palmitoylation.

      We thank the reviewer for highlighting this point and agree that it is possible the observed loss of NLRP3 from the Golgi might be due to an adverse effect of 2-BP on Golgi morphology or PI4P levels. We have tested the effect of 2-BP on the Golgi markers GM130, p230 and TGN46. 2BP has marginal effects on Golgi morphology with cis, trans and TGN markers all present at similar levels to untreated control cells (Supplementary Figure 2B-D). We also tested the effect of 2-BP on PI4P levels using mCherry-P4M, a PI4P biosensor. Surprisingly, as noted by the reviewer, despite recruitment of PI4K2A being dependent on S-acylation, PI4P was still present on the Golgi after 2-BP treatment, suggesting that a reduction in Golgi PI4P levels does not underly loss of NLRP3 from the Golgi (Supplementary Figure 2A). The pool of PI4P still present on the Golgi following 2-BP treatment is likely generated by other PI4K enzymes that localise to the Golgi independently of S-acylation, such as PI4KIIIB. We have included this data in our manuscript as part of a new Supplementary Figure 2. 

      (3) The authors argue that the spots observed with NLRP-GFP result from non-specific effects mediated by the addition of the GFP tag to the NLRP3 protein. However, puncta are visible upon nigericin treatment, as a hallmark of endosomal activation. How do the authors reconcile these data? Along the same lines, the NLRP3-C130S mutant behaves similarly to wt NLRP3 upon 2-BP treatment (Figure 1h). Are those NLRP3-C130S puncta positive for endosomal markers? Are they still positive for TGN46? Are they positive for PI4P?

      This is a fair point given the literature showing overlap of NLRP3 puncta formed in response to nigericin with endosomal markers and the similarity of the structures we see in terms of size and distribution to endosomes after 2BP + nigericin treatment. We have tested whether these puncta overlap with EEA1, TGN46 or PI4P (Supplementary Figure 2A, E-G). The vast majority of spots formed by GFP-NLRP3 co-treated with 2-BP and nigericin do not co-localise with EEA1, TGN46 or PI4P. This is consistent with these spots potentially being an artifact, although it has recently been shown that human NLRP3 unable to bind to the Golgi can still respond to nigericin (Mateo-Tórtola et al., 2023). These puncta might represent a conformational change cytosolic NLRP3 undergoes in response to stimulation, although our results suggest that this doesn’t appear to happen on endosomes.

      (4) The authors expressed the minimal NLRP3 region to identify the domain required for NLRP3 Golgi localization. These experiments were performed in control cells. It might be informative to perform the same experiments upon nigericin treatment to investigate the ability of NLRP3 to recognize activating signals. It has been reported that PI4P increases on Golgi and endosomes upon NG treatment. Hence, all the differences between the domains may be lost or preserved. In parallel, also the timing of such recruitment upon nigericin treatment (early or late event) may be informative for the dynamics of the process and of the contribution of the single protein domains.

      This is an interesting point which we thank the reviewer for highlighting. However, we think that each domain on its own is not capable of responding to nigericin as shown by the effect of mutations in helix115-125 or the PB region in the full-length NLRP3 protein. NLRP3HF, which still contains a functional PB region, isn’t capable of responding to nigericin in the same way as wild type NLRP3 (Supplementary Figure 6C-D). Similarly, mutations in the PB region of full length NLRP3 that leave helix115-125 intact show that helix115-125 is not sufficient to allow enhanced recruitment of NLRP3 to Golgi membranes after nigericin treatment (Supplementary Figure 9A). We speculate that helix115-125, the PB region and the LRR domain all need to be present to provide maximum affinity of NLRP3 for the Golgi prior to encounter with and S-acylation by ZDHHC3/7. Mutation or loss of any one of the PB region, helix115-125 or the LRR lowers NLRP3 membrane affinity, which is reflected by reduced levels of NLRP3 captured on the Golgi by S-acylation at steady state and in response to nigericin. 

      (5) As noted above for the chemical inhibitors (1) the authors should check the impact of altering the balance between acyl transferase and de-acylases on the Golgi organization and PI4P levels. What is the effect of overexpressing PATs on Golgi functions?

      We have checked the effect of APT2 overexpression on Golgi morphology and can show that it has no noticeable effect, ruling out an impact of APT on Golgi integrity as the reason for loss of NLRP3 from the Golgi in the presence of overexpressed APT2. We have included these images as Supplementary Figure 11H-J. 

      It is plausible that the effects of ZDHHC3 or ZDHHC7 on enhanced recruitment of NLRP3 to the Golgi may be via an effect on PI4P levels since, as mentioned above, both enzymes are involved in recruitment of PI4K2A to the Golgi and have previously been shown to enhance levels of PI4K2A and PI4P on the Golgi when overexpressed (Kutchukian et al., 2021). However, NLRP3 mutants with most of the charge removed from the PB region, which are presumably unable to interact with PI4P or other negatively charged lipids, are still capable of being recruited to the Golgi by excess ZDHHC3. This would suggest that the effect of overexpressed ZDHHC3 on NLRP3 is largely independent of changes in PI4P levels on the Golgi and instead driven by helix115-125 and S-acylation at Cys-130. The latter point is supported by the observation that NLRP3HF and NLRP3Cys130 are insensitive to ZDHHC3 overexpression.

      At the levels of HA-ZDHHC3 used in our experiments with NLRP3 (200ng pEF-Bos-HAZDHHC3 / c.a. 180,000 cells) we don’t see any adverse effect on Golgi morphology (Author response image 1), although it has been noted previously by others that higher levels of ZDHHC3 can have an impact on TGN46 (Ernst et al., 2018). ZDHHC3 overexpression surprisingly has no adverse effects on Golgi function and in fact enhances secretion from the Golgi (Ernst et al., 2018).  

      Author response image 1.

      Overexpression of HA-ZDHHC3 does not impact Golgi morphology. A) Representative confocal micrographs of HeLaM cells transfected with 200 ng HA-ZDHHC3 fixed and stained with antibodies to STX5 or TGN46. Scale bars = 10 µm. 

      Reviewer #2 (Public Review):

      Summary:

      This paper examines the recruitment of the inflammasome seeding pattern recognition receptor NLRP3 to the Golgi. Previously, electrostatic interactions between the polybasic region of NLRP3 and negatively charged lipids were implicated in membrane association. The current study reports that reversible S-acylation of the conserved Cys-130 residue, in conjunction with upstream hydrophobic residues plus the polybasic region, act together to promote Golgi localization of NLRP3, although additional parts of the protein are needed for full Golgi localization. Treatment with the bacterial ionophore nigericin inhibits membrane traffic and prevents Golgi-associated thioesterases from removing the acyl chain, causing NLRP3 to become immobilized at the Golgi. This mechanism is put forth as an explanation for how NLRP3 is activated in response to nigericin.

      Strengths:

      The experiments are generally well presented. It seems likely that Cys-130 does indeed play a previously unappreciated role in the membrane association of NLRP3.

      Weaknesses:

      The interpretations about the effects of nigericin are less convincing. Specific comments follow.

      (1) The experiments of Figure 4 bring into question whether Cys-130 is S-acylated. For Cys130, S-acylation was seen only upon expression of a severely truncated piece of the protein in conjunction with overexpression of ZDHHC3. How do the authors reconcile this result with the rest of the story?

      Providing direct evidence of S-acylation at Cys-130 in the full-length protein proved difficult. We attempted to detect S-acylation of this residue by mass spectrometry. However, the presence of the PB region and multiple lysines / arginines directly after Cys-130 made this approach technically challenging and we were unable to convincingly detect S-acylation at Cys-130 by M/S. However, Cys-130 is clearly important for membrane recruitment as its mutation abolishes the localisation of NLRP3 to the Golgi. It is feasible that it is the hydrophobic nature of the cysteine residue itself which supports localisation to the Golgi, rather than S-acylation of Cys-130. A similar role for cysteine residues present in SNAP-25 has been reported (Greaves et al., 2009). However, the rest of our data are consistent with Cys-130 in NLRP3 being S-acylated. We also refer to another recently published study which provides additional biochemical evidence that mutation of Cys-130 impacts the overall levels of NLRP3 S-acylation (Yu et al., 2024). 

      (2) Nigericin seems to cause fragmentation and vesiculation of the Golgi. That effect complicates the interpretations. For example, the FRAP experiment of Figure 5 is problematic because the authors neglected to show that the FRAP recovery kinetics of nonacylated resident Golgi proteins are unaffected by nigericin. Similarly, the colocalization analysis in Figure 6 is less than persuasive when considering that nigericin significantly alters Golgi structure and could indirectly affect colocalization. 

      We agree that it is likely that the behaviour of other Golgi resident proteins are altered by nigericin. This is in line with a recent proteomics study showing that nigericin alters the amount of Golgi resident proteins associated with the Golgi (Hollingsworth et al., 2024) and other work demonstrating that changes in organelle pH can influence the membrane on / off rates of Rab GTPases (Maxson et al., 2023). However, Golgi levels of other peripheral membrane proteins

      that associate with the Golgi through S-acylation, such as N-Ras, appear unaltered (Author response image 2.), indicating a degree of selectivity in the proteins affected. Our main point here is that NLRP3 is amongst those proteins whose behaviour on the Golgi is sensitive to nigericin and that this change in behaviour may be important to the NLRP3 activation process, although this requires further investigation and will form the basis of future studies. 

      The reduction in co-localisation between NLRP3 and APT2, due to alterations in Golgi organisation and trafficking, was the point we were trying to make with this figure, and we apologise if this was not clear. We think that the changes in Golgi structure and function caused by nigericin potentially affect the ability of APT2 to encounter NLRP3 and de-acylate it. We have added a new paragraph to the results section to hopefully explain this more clearly. We recognise that our results supporting this hypothesis are at present limited and we have toned down the language used in the results section to reflect the nature of these findings..  

      Author response image 2.

      S-acylated peripheral membrane proteins show differential sensitivity to nigericin. A) Representative confocal micrographs of HeLaM cells coexpressing GFP-NRas and an untagged NLRP3 construct. Cells were left untreated or treated with 10 µM nigericin for 1 hour prior to fixation. Scale bars = 10 µm. B) Quantification of GFP-NRas or NLRP3 signal in the perinuclear region of cells treated with or without nigericin

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      (1) Does overnight 2-BP treatment potentially have indirect effects that could prevent NLRP3 recruitment? It would be useful here to show some sort of control confirming that the cells are not broadly perturbed.

      Please see our response to point (2) raised by reviewer #1 which is along similar lines. 

      (2) In Figure 5, "Veh" presumably is short for "Vehicle". This term should be defined in the legend.

      We have now corrected this.

      References

      Ernst, A.M., S.A. Syed, O. Zaki, F. Bottanelli, H. Zheng, M. Hacke, Z. Xi, F. Rivera-Molina, M. Graham, A.A. Rebane, P. Bjorkholm, D. Baddeley, D. Toomre, F. Pincet, and J.E. Rothman. 2018. SPalmitoylation Sorts Membrane Cargo for Anterograde Transport in the Golgi. Dev Cell. 47:479-493 e477.

      Greaves, J., G.R. Prescott, Y. Fukata, M. Fukata, C. Salaun, and L.H. Chamberlain. 2009. The hydrophobic cysteine-rich domain of SNAP25 couples with downstream residues to mediate membrane interactions and recognition by DHHC palmitoyl transferases. Mol Biol Cell. 20:1845-1854.

      Hollingsworth, L.R., P. Veeraraghavan, J.A. Paulo, J.W. Harper, and I. Rauch. 2024. Spatiotemporal proteomic profiling of cellular responses to NLRP3 agonists. bioRxiv.

      Kutchukian, C., O. Vivas, M. Casas, J.G. Jones, S.A. Tiscione, S. Simo, D.S. Ory, R.E. Dixon, and E.J. Dickson. 2021. NPC1 regulates the distribution of phosphatidylinositol 4-kinases at Golgi and lysosomal membranes. EMBO J. 40:e105990.

      Mateo-Tórtola, M., I.V. Hochheiser, J. Grga, J.S. Mueller, M. Geyer, A.N.R. Weber, and A. TapiaAbellán. 2023. Non-decameric NLRP3 forms an MTOC-independent inflammasome. bioRxiv:2023.2007.2007.548075.

      Maxson, M.E., K.K. Huynh, and S. Grinstein. 2023. Endocytosis is regulated through the pHdependent phosphorylation of Rab GTPases by Parkinson’s kinase LRRK2. bioRxiv:2023.2002.2015.528749.

      Yu, T., D. Hou, J. Zhao, X. Lu, W.K. Greentree, Q. Zhao, M. Yang, D.G. Conde, M.E. Linder, and H. Lin. 2024. NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation. Cell Rep. 43:114070.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this manuscript, the authors investigate the contributions of the long noncoding RNA snhg3 in liver metabolism and MAFLD. The authors conclude that liver-specific loss or overexpression of Snhg3 impacts hepatic lipid content and obesity through epigenetic mechanisms. More specifically, the authors invoke that the nuclear activity of Snhg3 aggravates hepatic steatosis by altering the balance of activating and repressive chromatin marks at the Pparg gene locus. This regulatory circuit is dependent on a transcriptional regulator SND1.

      Strengths:

      The authors developed a tissue-specific lncRNA knockout and KI models. This effort is certainly appreciated as few lncRNA knockouts have been generated in the context of metabolism. Furthermore, lncRNA effects can be compensated in a whole organism or show subtle effects in acute versus chronic perturbation, rendering the focus on in vivo function important and highly relevant. In addition, Snhg3 was identified through a screening strategy and as a general rule the authors the authors attempt to follow unbiased approaches to decipher the mechanisms of Snhg3.

      Weaknesses:

      Despite efforts at generating a liver-specific knockout, the phenotypic characterization is not focused on the key readouts. Notably missing are rigorous lipid flux studies and targeted gene expression/protein measurement that would underpin why the loss of Snhg3 protects from lipid accumulation. Along those lines, claims linking the Snhg3 to MAFLD would be better supported with careful interrogation of markers of fibrosis and advanced liver disease. In other areas, significance is limited since the presented data is either not clear or rigorous enough. Finally, there is an important conceptual limitation to the work since PPARG is not established to play a major role in the liver.

      We thank the reviewer for the detailed comment. In this study, hepatocyte-specific Snhg3 deficiency decreased body and liver weight and alleviated hepatic steatosis in DIO mice, whereas overexpression induced the opposite effect (Figure 2 and 3). Furthermore, we investigated the hepatic differentially expressed genes (DEGs) between the DIO Snhg3-HKI and control WT mice using RNA-Seq and revealed that Snhg3 exerts a global effect on the expression of genes involved in fatty acid metabolism using GSEA (Figure 4B). We validated the expression of some DEGs involved in fatty acid metabolism by RT-qPCR. The results showed that the hepatic expression levels of some genes involved in fatty acid metabolism, including Cd36, Cidea/c and Scd1/2 were upregulated in Snhg3-HKO mice and were downregulated in Snhg3-HKI mice compared to the controls (Figure 4C), respectively. Please check them in the first paragraph in p8.

      As a transcription regulator of Cd36 and Cidea/c, it is well known that PPARγ plays major adipogenic and lipogenic roles in adipose tissue. Although the expression of PPARγ in the liver is very low under healthy conditions, induced expression of PPARγ in both hepatocytes and non-parenchymal cells (Kupffer cells, immune cells, and HSCs) in the liver has a crucial role in the pathophysiology of MASLD (Lee et al., 2023b, Chen et al., 2023, Gross et al., 2017). The activation of PPARγ in the liver induces the adipogenic program to store fatty acids in lipid droplets as observed in adipocytes (Lee et al., 2018). Moreover, the inactivation of liver PPARγ abolished rosiglitazone-induced an increase in hepatic TG and improved hepatic steatosis in lipoatrophic AZIP mice (Gavrilova et al., 2003). Furthermore, there is a strong correlation between the onset of hepatic steatosis and hepatocyte-specific PPARγ expression. Clinical trials have also indicated that increased insulin resistance and hepatic PPARγ expressions were associated with NASH scores in some obese patients (Lee et al., 2023a, Mukherjee et al., 2022). Even though PPARγ’s primary function is in adipose tissue, patients with MASLD have much higher hepatic expression levels of PPARγ, reflecting the fact that PPARγ plays different roles in different tissues and cell types (Mukherjee et al., 2022). As these studies mentioned above, our result also hinted at the importance of PPARγ in the pathophysiology of MASLD. Snhg3 deficiency or overexpression respectively induced the decrease or increase in hepatic PPARγ. Moreover, administration of PPARγ antagonist T0070907 mitigated the hepatic Cd36 and Cidea/c increase and improved Snhg3-induced hepatic steatosis. However,  conflicting findings suggest that the expression of hepatic PPARγ is not increased as steatosis develops in humans and in clinical studies and that PPARγ agonists administration didn’t aggravate liver steatosis (Gross et al., 2017). Thus, understanding how the hepatic PPARγ expression is regulated may provide a new avenue to prevent and treat the MASLD (Lee et al., 2018). We also discussed it in revised manuscript, please refer the first paragraph in the section of Discussion in p13.

      Hepatotoxicity accelerates the development of progressive inflammation, oxidative stress and fibrosis (Roehlen et al., 2020). Chronic liver injury including MASLD can progress to liver fibrosis with the formation of a fibrous scar. Injured hepatocytes can secrete fibrogenic factors or exosomes containing miRNAs that activate HSCs, the major source of the fibrous scar in liver fibrosis (Kisseleva and Brenner, 2021). Apart from promoting lipogenesis, PPARγ has also a crucial function in improving inflammation and fibrosis (Chen et al., 2023). In this study, no hepatic fibrosis phenotype was seen in Snhg3-HKO and Snhg3-HKI mice (figures supplement 1D and 2D). Moreover, deficiency and overexpression of Snhg3 respectively decreased and increased the expression of profibrotic genes, such as collagen type I alpha 1/2 (Col1a1 and Col1a2), but had no effects on the pro-inflammatory factors, including transforming growth factor β1 (Tgfβ1), tumor necrosis factor α (Tnfα), interleukin 6 and 1β (Il6 and Il1β) (figures supplement 3A and B). Inflammation is an absolute requirement for fibrosis because factors from injured hepatocytes alone are not sufficient to directly activate HSCs and lead to fibrosis (Kisseleva and Brenner, 2021). Additionally, previous studies indicated that exposure to HFD for more 24 weeks causes less severe fibrosis (Alshawsh et al., 2022). In future, the effect of Snhg3 on hepatic fibrosis in mice need to be elucidated by prolonged high-fat feeding or by adopting methionine- and choline deficient diet (MCD) feeding. Please check them in the second paragraph in the section of Discussion in p13.

      References

      ALSHAWSH, M. A., ALSALAHI, A., ALSHEHADE, S. A., SAGHIR, S. A. M., AHMEDA, A. F., AL ZARZOUR, R. H. & MAHMOUD, A. M. 2022. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. Molecules, 27. DIO:10.3390/molecules27030858, PMID:35164140

      CHEN, H., TAN, H., WAN, J., ZENG, Y., WANG, J., WANG, H. & LU, X. 2023. PPAR-gamma signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets. Pharmacol Ther, 245, 108391. DIO:10.1016/j.pharmthera.2023.108391, PMID:36963510

      GAVRILOVA, O., HALUZIK, M., MATSUSUE, K., CUTSON, J. J., JOHNSON, L., DIETZ, K. R., NICOL, C. J., VINSON, C., GONZALEZ, F. J. & REITMAN, M. L. 2003. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem, 278, 34268-76. DIO:10.1074/jbc.M300043200, PMID:12805374

      GROSS, B., PAWLAK, M., LEFEBVRE, P. & STAELS, B. 2017. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol, 13, 36-49. DIO:10.1038/nrendo.2016.135, PMID:27636730

      KISSELEVA, T. & BRENNER, D. 2021. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol, 18, 151-166. DIO:10.1038/s41575-020-00372-7, PMID:33128017

      LEE, S. M., MURATALLA, J., KARIMI, S., DIAZ-RUIZ, A., FRUTOS, M. D., GUZMAN, G., RAMOS-MOLINA, B. & CORDOBA-CHACON, J. 2023a. Hepatocyte PPARgamma contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice. Cell Mol Life Sci, 80, 39. DIO:10.1007/s00018-022-04629-z, PMID:36629912

      LEE, S. M., MURATALLA, J., SIERRA-CRUZ, M. & CORDOBA-CHACON, J. 2023b. Role of hepatic peroxisome proliferator-activated receptor gamma in non-alcoholic fatty liver disease. J Endocrinol, 257. DIO:10.1530/JOE-22-0155, PMID:36688873

      LEE, Y. K., PARK, J. E., LEE, M. & HARDWICK, J. P. 2018. Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2. Liver Res, 2, 209-215. DIO:10.1016/j.livres.2018.12.001, PMID:31245168

      MUKHERJEE, A. G., WANJARI, U. R., GOPALAKRISHNAN, A. V., KATTURAJAN, R., KANNAMPUZHA, S., MURALI, R., NAMACHIVAYAM, A., GANESAN, R., RENU, K., DEY, A., VELLINGIRI, B. & PRINCE, S. E. 2022. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells, 11. DIO:10.3390/cells11243959, PMID:36552725

      ROEHLEN, N., CROUCHET, E. & BAUMERT, T. F. 2020. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9. DIO:10.3390/cells9040875, PMID:32260126

      Reviewer #2 (Public Review):

      Through RNA analysis, Xie et al found LncRNA Snhg3 was one of the most down-regulated Snhgs by a high-fat diet (HFD) in mouse liver. Consequently, the authors sought to examine the mechanism through which Snhg3 is involved in the progression of metabolic dysfunction-associated fatty liver diseases (MASLD) in HFD-induced obese (DIO) mice. Interestingly, liver-specific Snhg3 knockout was reduced, while Snhg3 over-expression potentiated fatty liver in mice on an HFD. Using the RNA pull-down approach, the authors identified SND1 as a potential Sngh3 interacting protein. SND1 is a component of the RNA-induced silencing complex (RISC). The authors found that Sngh3 increased SND1 ubiquitination to enhance SND1 protein stability, which then reduced the level of repressive chromatin H3K27me3 on PPARg promoter. The upregulation of PPARg, a lipogenic transcription factor, thus contributed to hepatic fat accumulation.

      The authors propose a signaling cascade that explains how LncRNA sngh3 may promote hepatic steatosis. Multiple molecular approaches have been employed to identify molecular targets of the proposed mechanism, which is a strength of the study. There are, however, several potential issues to consider before jumping to a conclusion.

      (1) First of all, it's important to ensure the robustness and rigor of each study. The manuscript was not carefully put together. The image qualities for several figures were poor, making it difficult for the readers to evaluate the results with confidence. The biological replicates and numbers of experimental repeats for cell-based assays were not described. When possible, the entire immunoblot imaging used for quantification should be presented (rather than showing n=1 representative). There were multiple mislabels in figure panels or figure legends (e.g., Figure 2I, Figure 2K, and Figure 3K). The b-actin immunoblot image was reused in Figure 4J, Figure 5G, and Figure 7B with different exposure times. These might be from the same cohort of mice. If the immunoblots were run at different times, the loading control should be included on the same blot as well.

      We thank the reviewer for the detailed comment. We have provided the clear figures in revised manuscript, please check them.

      The biological replicates and numbers of experimental repeats for cell-based assays had been updated and please check them in the manuscript.

      The entire immunoblot imaging used for quantification had been provided in the primary data. Please check them.

      The original Figure 2I, Figure 2K, Figure 3K have been revised and replaced with new Figure 2F, Figure 2H, Figure 3H, and their corresponding figure legends has also been corrected in revised manuscript.

      The protein levels of CD36, PPARγ and β-ACTIN were examined at the same time and we had revised the manuscript, please check them in revised Figure 7B and 7C.

      (2) The authors can do a better job in explaining the logic for how they came up with the potential function of each component of the signaling cascade. Snhg3 is down-regulated by HFD. However, the evidence presented indicates its involvement in promoting steatosis. In Figure 1C, one would expect PPARg expression to be up-regulated (when Sngh3 was down-regulated). If so, the physiological observation conflicts with the proposed mechanism. In addition, SND1 is known to regulate RNA/miRNA processing. How do the authors rule out this potential mechanism? How about the hosting snoRNA, Snord17? Does it involve the progression of NASLD?

      We thank the reviewer for the detailed comment. Our results showed that the expression of Snhg3 was decreased in DIO mice which led us to speculate that the downregulation of Snhg3 in DIO mice might be a stress protective reaction to high nutritional state, but the specific details need to be clarified. This is probably similar to fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15), whose endogenous expression and circulating levels are elevated in obese humans and mice despite their beneficial effects on obesity and related metabolic complications (Keipert and Ost, 2021). Although FGF21 can be induced by oxidative stress and be activated in obese mice and in NASH patients, elevated FGF21 paradoxically protects against oxidative stress and reduces hepatic steatosis (Tillman and Rolph, 2020).  We had added the content the section of Discussion, please check it in the second paragraph in p12.

      SND1 has multiple roles through associating with different types of RNA molecules, including mRNA, miRNA, circRNA, dsRNA and lncRNA. SND1 could bind negative-sense SARS-CoV-2 RNA and promoted viral RNA synthesis, and to promote viral RNA synthesis (Schmidt et al., 2023). SND1 is also involved in hypoxia by negatively regulating hypoxia‐related miRNAs (Saarikettu et al., 2023). Furthermore, a recent study revealed that lncRNA SNAI3-AS1 can competitively bind to SND1 and perturb the m6A-dependent recognition of Nrf2 mRNA 3'UTR by SND1, thereby reducing the mRNA stability of Nrf2 (Zheng et al., 2023). Huang et al. also reported that circMETTL9 can directly bind to and increase the expression of SND1 in astrocytes, leading to enhanced neuroinflammation (Huang et al., 2023). However, whether there is an independent-histone methylation role of SND1/lncRNA-Snhg3 involved in lipid metabolism in the liver needs to be further investigated. We also discussed the limitation in the manuscript and please refer the section of Discussion in the third paragraph in p17.

      Snhg3 serves as host gene for producing intronic U17 snoRNAs, the H/ACA snoRNA. A previous study found that cholesterol trafficking phenotype was not due to reduced Snhg3 expression, but rather to haploinsufficiency of U17 snoRNA. Upregulation of hypoxia-upregulated mitochondrial movement regulator (HUMMR) in U17 snoRNA-deficient cells promoted the formation of ER-mitochondrial contacts, resulting in decreasing cholesterol esterification and facilitating cholesterol trafficking to mitochondria (Jinn et al., 2015). Additionally, disruption of U17 snoRNA caused resistance to lipid-induced cell death and general oxidative stress in cultured cells. Furthermore, knockdown of U17 snoRNA in vivo protected against hepatic steatosis and lipid-induced oxidative stress and inflammation (Sletten et al., 2021). We determined the expression of hepatic U17 snoRNA and its effect on SND1 and PPARγ. The results showed that the expression of U17 snoRNA decreased in the liver of DIO Snhg3-HKO mice and unchanged in the liver of DIO Snhg3-HKI mice, but overexpression of U17 snoRNA had no effect on the expression of SND1 and PPARγ (figure supplement 5A-C), indicating that Sngh3 induced hepatic steatosis was independent on U17 snoRNA. We also discussed it in revised manuscript, please refer the section of Discussion in p15.

      References

      HUANG, C., SUN, L., XIAO, C., YOU, W., SUN, L., WANG, S., ZHANG, Z. & LIU, S. 2023. Circular RNA METTL9 contributes to neuroinflammation following traumatic brain injury by complexing with astrocytic SND1. J Neuroinflammation, 20, 39. DIO:10.1186/s12974-023-02716-x, PMID:36803376

      JINN, S., BRANDIS, K. A., REN, A., CHACKO, A., DUDLEY-RUCKER, N., GALE, S. E., SIDHU, R., FUJIWARA, H., JIANG, H., OLSEN, B. N., SCHAFFER, J. E. & ORY, D. S. 2015. snoRNA U17 regulates cellular cholesterol trafficking. Cell Metab, 21, 855-67. DIO:10.1016/j.cmet.2015.04.010, PMID:25980348

      KEIPERT, S. & OST, M. 2021. Stress-induced FGF21 and GDF15 in obesity and obesity resistance. Trends Endocrinol Metab, 32, 904-915. DIO:10.1016/j.tem.2021.08.008, PMID:34526227

      SAARIKETTU, J., LEHMUSVAARA, S., PESU, M., JUNTTILA, I., PARTANEN, J., SIPILA, P., POUTANEN, M., YANG, J., HAIKARAINEN, T. & SILVENNOINEN, O. 2023. The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. FASEB Bioadv, 5, 183-198. DIO:10.1096/fba.2022-00115, PMID:37151849

      SCHMIDT, N., GANSKIH, S., WEI, Y., GABEL, A., ZIELINSKI, S., KESHISHIAN, H., LAREAU, C. A., ZIMMERMANN, L., MAKROCZYOVA, J., PEARCE, C., KREY, K., HENNIG, T., STEGMAIER, S., MOYON, L., HORLACHER, M., WERNER, S., AYDIN, J., OLGUIN-NAVA, M., POTABATTULA, R., KIBE, A., DOLKEN, L., SMYTH, R. P., CALISKAN, N., MARSICO, A., KREMPL, C., BODEM, J., PICHLMAIR, A., CARR, S. A., CHLANDA, P., ERHARD, F. & MUNSCHAUER, M. 2023. SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. Cell, 186, 4834-4850 e23. DIO:10.1016/j.cell.2023.09.002, PMID:37794589

      SLETTEN, A. C., DAVIDSON, J. W., YAGABASAN, B., MOORES, S., SCHWAIGER-HABER, M., FUJIWARA, H., GALE, S., JIANG, X., SIDHU, R., GELMAN, S. J., ZHAO, S., PATTI, G. J., ORY, D. S. & SCHAFFER, J. E. 2021. Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis. Nat Commun, 12, 5214. DIO:10.1038/s41467-021-25457-y, PMID:34471131

      TILLMAN, E. J. & ROLPH, T. 2020. FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases. Front Endocrinol (Lausanne), 11, 601290. DIO:10.3389/fendo.2020.601290, PMID:33381084

      ZHENG, J., ZHANG, Q., ZHAO, Z., QIU, Y., ZHOU, Y., WU, Z., JIANG, C., WANG, X. & JIANG, X. 2023. Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m(6)A-dependent recognition of Nrf2 mRNA mediated by SND1. J Exp Clin Cancer Res, 42, 127. DIO:10.1186/s13046-023-02684-3, PMID:37202791

      (3) The role of PPARg in fatty liver diseases might be a rodent-specific phenomenon. PPARg agonist treatment in humans may actually reduce ectopic fat deposition by increasing fat storage in adipose tissues. The relevance of the findings to human diseases should be discussed.

      We thank the reviewer for the detailed comment. As a transcription regulator of Cd36 and Cidea/c, it is well known that PPARγ plays major adipogenic and lipogenic roles in adipose tissue. Although the expression of PPARγ in the liver is very low under healthy conditions, induced expression of PPARγ in both hepatocytes and non-parenchymal cells (Kupffer cells, immune cells, and hepatic stellate cells (HSCs)) in the liver has a crucial role in the pathophysiology of MASLD (Lee et al., 2023b, Chen et al., 2023, Gross et al., 2017). The activation of PPARγ in the liver induces the adipogenic program to store fatty acids in lipid droplets as observed in adipocytes (Lee et al., 2018). Moreover, the inactivation of liver PPARγ abolished rosiglitazone-induced an increase in hepatic TG and improved hepatic steatosis in lipoatrophic AZIP mice (Gavrilova et al., 2003). Apart from promoting lipogenesis, PPARγ has also a crucial function in improving inflammation and fibrosis (Chen et al., 2023). Furthermore, there is a strong correlation between the onset of hepatic steatosis and hepatocyte-specific PPARγ expression. Clinical trials have also indicated that increased insulin resistance and hepatic PPARγ expressions were associated with NASH scores in some obese patients (Lee et al., 2023a, Mukherjee et al., 2022). Even though PPARγ’s primary function is in adipose tissue, patients with MASLD have much higher hepatic expression levels of PPARγ, reflecting the fact that PPARγ plays different roles in different tissues and cell types (Mukherjee et al., 2022). As these studies mentioned above, our result also hinted at the importance of PPARγ in the pathophysiology of MASLD. Snhg3 deficiency or overexpression respectively induced the decrease or increase in hepatic PPARγ. Moreover, administration of PPARγ antagonist T0070907 mitigated the hepatic Cd36 and Cidea/c increase and improved Snhg3-induced hepatic steatosis. However,  conflicting findings suggest that the expression of hepatic PPARγ is not increased as steatosis develops in humans and in clinical studies and that PPARγ agonists administration didn’t aggravate liver steatosis (Gross et al., 2017). Thus, understanding how the hepatic PPARγ expression is regulated may provide a new avenue to prevent and treat the MASLD (Lee et al., 2018). We also discussed it in revised manuscript, please refer the first paragraph in the section of Discussion in p13.

      References

      CHEN, H., TAN, H., WAN, J., ZENG, Y., WANG, J., WANG, H. & LU, X. 2023. PPAR-gamma signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets. Pharmacol Ther, 245, 108391. DIO:10.1016/j.pharmthera.2023.108391, PMID:36963510

      GAVRILOVA, O., HALUZIK, M., MATSUSUE, K., CUTSON, J. J., JOHNSON, L., DIETZ, K. R., NICOL, C. J., VINSON, C., GONZALEZ, F. J. & REITMAN, M. L. 2003. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem, 278, 34268-76. DIO:10.1074/jbc.M300043200, PMID:12805374

      GROSS, B., PAWLAK, M., LEFEBVRE, P. & STAELS, B. 2017. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol, 13, 36-49. DIO:10.1038/nrendo.2016.135, PMID:27636730

      LEE, S. M., MURATALLA, J., KARIMI, S., DIAZ-RUIZ, A., FRUTOS, M. D., GUZMAN, G., RAMOS-MOLINA, B. & CORDOBA-CHACON, J. 2023a. Hepatocyte PPARgamma contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice. Cell Mol Life Sci, 80, 39. DIO:10.1007/s00018-022-04629-z, PMID:36629912

      LEE, S. M., MURATALLA, J., SIERRA-CRUZ, M. & CORDOBA-CHACON, J. 2023b. Role of hepatic peroxisome proliferator-activated receptor gamma in non-alcoholic fatty liver disease. J Endocrinol, 257. DIO:10.1530/JOE-22-0155, PMID:36688873

      LEE, Y. K., PARK, J. E., LEE, M. & HARDWICK, J. P. 2018. Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2. Liver Res, 2, 209-215. DIO:10.1016/j.livres.2018.12.001, PMID:31245168

      MUKHERJEE, A. G., WANJARI, U. R., GOPALAKRISHNAN, A. V., KATTURAJAN, R., KANNAMPUZHA, S., MURALI, R., NAMACHIVAYAM, A., GANESAN, R., RENU, K., DEY, A., VELLINGIRI, B. & PRINCE, S. E. 2022. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells, 11. DIO:10.3390/cells11243959, PMID:36552725

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      As a general strategy for the revision, I would advise the authors to focus on strengthening the analysis of the liver with the two most important figures being Figure 2 and Figure 3. The mechanism as it stands is problematic which reduces the impact of the animal studies despite substantial efforts from the authors. Consider removing or toning down some of the studies focused on mechanisms in the nucleus, including changing the title.

      We thank the reviewer for the detailed comment. In this study, hepatocyte-specific Snhg3 deficiency decreased body and liver weight, alleviated hepatic steatosis and promoted hepatic fatty acid metabolism in DIO mice, whereas overexpression induced the opposite effect. The hepatic differentially expressed genes (DEGs) between the DIO Snhg3-HKI and control WT mice using RNA-Seq and revealed that Snhg3 exerts a global effect on the expression of genes involved in fatty acid metabolism using GSEA (Figure 4B). RT-qPCR analysis confirmed that the hepatic expression levels of some genes involved in fatty acid metabolism, including Cd36, Cidea/c and Scd1/2, were upregulated in Snhg3-HKO mice and were downregulated in Snhg3-HKI mice compared to the controls (Figure 4C). Moreover, deficiency and overexpression of Snhg3 respectively decreased and increased the expression of profibrotic genes, such as Col1a1 and Col1a2, but had no effects on the pro-inflammatory factors, including Tgfβ1, Tnfα, Il6 and Il1β (figure supplement 3A and B). The results indicated that Snhg3 involved in hepatic steatosis through regulating fatty acid metabolism. Furthermore, PPARγ was selected to study its role in Snhg3-induced hepatic steatosis by integrated analyzing the data from CUT&Tag-Seq, ATAC-Seq and RNA-Seq. Finally, inhibition of PPARγ with T0070907 alleviated Snhg3 induced Cd36 and Cidea/c increases and improved Snhg3-aggravated hepatic steatosis. In summary, we confirmed that SND1/H3K27me3/PPARγ is partially responsible for Sngh3-inuced hepatic steatosis. As the reviewer suggested, we replaced the title with “LncRNA-Snhg3 Aggravates Hepatic Steatosis via PPARγ Signaling”.

      (1) How is steatosis changing in the liver? Is this due to a change in fatty acid uptake, lipogenesis/synthesis, beta-oxidation, trig secretion, etc..? The analysis in Figures 2 and 3 is mostly focused on metabolic chamber studies which seem distracting, particularly in the absence of a mechanism and given a liver-specific perturbation. The authors should use a combination of targeted gene expression, protein blots, and lipid flux measurements to provide better insights here. The histology in Figure 2H suggests a very dramatic effect but does match with lipid measurements in 2I.

      We thank the reviewer for the detailed comment. The pathogenesis of MASLD has not been entirely elucidated. Multifarious factors such as genetic and epigenetic factors, nutritional factors, insulin resistance, lipotoxicity, microbiome, fibrogenesis and hormones secreted from the adipose tissue, are recognized to be involved in the development and progression of MASLD (Buzzetti et al., 2016, Lee et al., 2017, Rada et al., 2020, Sakurai et al., 2021, Friedman et al., 2018). In this study, we investigated the hepatic differentially expressed genes (DEGs) between the DIO Snhg3-HKI and control WT mice using RNA-Seq and revealed that Snhg3 exerts a global effect on the expression of genes involved in fatty acid metabolism using GSEA (Figure 4B). We validated the expression of some DEGs involved in fatty acid metabolism by RT-qPCR. The results showed that the hepatic expression levels of some genes involved in fatty acid metabolism, including Cd36, Cidea/c and Scd1/2 were upregulated in Snhg3-HKO mice and were downregulated in Snhg3-HKI mice compared to the controls (Figure 4C), respectively. Additionally, we re-analyzed the metabolic chamber data using CalR and the results showed that there were no obvious differences in heat production, total oxygen consumption, carbon dioxide production or RER between DIO Snhg3-HKO or DIO Snhg3-HKI and the corresponding control mice (figure supplement 1C and 2C). Unfortunately, we did not detect lipid flux due to limited experimental conditions. However, in summary, our results indicated that Snhg3 is involved in hepatic steatosis by regulating fatty acid metabolism. Please check them in the first paragraph in p8.

      Additionally, we determined the hepatic TC levels in other batch of DIO Snhg3-HKO and control mice and found there was no difference in hepatic TC (as below) between DIO Snhg3-HKO and control mice fed HFD 18 weeks. Perhaps the apparent difference in TC requires a prolonged high-fat diet feeding time.

      Author response image 1.

      Hepatic TC contents of in DIO Snhg3-Flox and Snhg3-HKO mice.

      References

      BUZZETTI, E., PINZANI, M. & TSOCHATZIS, E. A. 2016. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism, 65, 1038-48. DIO:10.1016/j.metabol.2015.12.012, PMID:26823198

      FRIEDMAN, S. L., NEUSCHWANDER-TETRI, B. A., RINELLA, M. & SANYAL, A. J. 2018. Mechanisms of NAFLD development and therapeutic strategies. Nat Med, 24, 908-922. DIO:10.1038/s41591-018-0104-9, PMID:29967350

      LEE, J., KIM, Y., FRISO, S. & CHOI, S. W. 2017. Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med, 54, 78-88. DIO:10.1016/j.mam.2016.11.008, PMID:27889327

      RADA, P., GONZALEZ-RODRIGUEZ, A., GARCIA-MONZON, C. & VALVERDE, A. M. 2020. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis, 11, 802. DIO:10.1038/s41419-020-03003-w, PMID:32978374

      SAKURAI, Y., KUBOTA, N., YAMAUCHI, T. & KADOWAKI, T. 2021. Role of Insulin Resistance in MAFLD. Int J Mol Sci, 22. DIO:10.3390/ijms22084156, PMID:33923817

      (2) Throughout the manuscript the authors make claims about liver disease models, but this is not well supported since markers of advanced liver disease are not examined. The authors should stain and show expression for fibrosis and inflammation.

      We thank the reviewer for the detailed comment. Metabolic dysfunction-associated fatty liver disease (MASLD) is characterized by excess liver fat in the absence of significant alcohol consumption. It can progress from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis and eventually to chronic progressive diseases such as cirrhosis, end-stage liver failure, and hepatocellular carcinoma (Loomba et al., 2021). As the reviewer suggested, we detected the effect of Snhg3 on liver fibrosis and inflammation. The results showed no hepatic fibrosis phenotype was seen in Snhg3-HKO and Snhg3-HKI mice (figures supplement 1D and 2D). Moreover, deficiency and overexpression of Snhg3 respectively decreased and increased the expression of profibrotic genes, such as collagen type I alpha 1/2 (Col1a1 and Col1a2), but had no effects on the pro-inflammatory factors including Tgf-β, Tnf-α, Il-6 and Il-1β (figure supplement 3A and 3B). Inflammation is an absolute requirement for fibrosis because factors from injured hepatocytes alone are not sufficient to directly activate HSCs and lead to fibrosis (Kisseleva and Brenner, 2021). Additionally, previous studies indicated that exposure to HFD for more 24 weeks causes less severe fibrosis (Alshawsh et al., 2022). In future, the effect of Snhg3 on hepatic fibrosis in mice need to be elucidated by prolonged high-fat feeding or by adopting methionine- and choline deficient diet (MCD) feeding. Please check them in the second paragraph in the section of Discussion in p13.

      References

      ALSHAWSH, M. A., ALSALAHI, A., ALSHEHADE, S. A., SAGHIR, S. A. M., AHMEDA, A. F., AL ZARZOUR, R. H. & MAHMOUD, A. M. 2022. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. Molecules, 27. DIO:10.3390/molecules27030858, PMID:35164140

      KISSELEVA, T. & BRENNER, D. 2021. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol, 18, 151-166. DIO:10.1038/s41575-020-00372-7, PMID:33128017

      LOOMBA, R., FRIEDMAN, S. L. & SHULMAN, G. I. 2021. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell, 184, 2537-2564. DIO:10.1016/j.cell.2021.04.015, PMID:33989548

      (3) Publicly available datasets show that PPARG protein is not expressed in the liver (Science 2015 347(6220):1260419, PMID: 25613900). Are the authors sure this is not an effect on another PPAR isoform like alpha? ChIP and RNA-seq pathway readouts do not distinguish between different isoforms.

      We thank the reviewer for the detailed comment. As a transcription regulator of Cd36 and Cidea/c, it is well known that PPARγ plays major adipogenic and lipogenic roles in adipose tissue. Although the expression of PPARγ in the liver is very low under healthy conditions, induced expression of PPARγ in both hepatocytes and non-parenchymal cells (Kupffer cells, immune cells, and hepatic stellate cells (HSCs)) in the liver has a crucial role in the pathophysiology of MASLD (Lee et al., 2023b, Chen et al., 2023, Gross et al., 2017). The activation of PPARγ in the liver induces the adipogenic program to store fatty acids in lipid droplets as observed in adipocytes (Lee et al., 2018). Moreover, the inactivation of liver PPARγ abolished rosiglitazone-induced an increase in hepatic TG and improved hepatic steatosis in lipoatrophic AZIP mice (Gavrilova et al., 2003). Apart from promoting lipogenesis, PPARγ has also a crucial function in improving inflammation and fibrosis (Chen et al., 2023). Furthermore, there is a strong correlation between the onset of hepatic steatosis and hepatocyte-specific PPARγ expression. Clinical trials have also indicated that increased insulin resistance and hepatic PPARγ expressions were associated with NASH scores in some obese patients (Lee et al., 2023a, Mukherjee et al., 2022). Even though PPARγ’s primary function is in adipose tissue, patients with MASLD have much higher hepatic expression levels of PPARγ, reflecting the fact that PPARγ plays different roles in different tissues and cell types (Mukherjee et al., 2022). As these studies mentioned above, our result also hinted at the importance of PPARγ in the pathophysiology of MASLD. Snhg3 deficiency or overexpression respectively induced the decrease or increase in hepatic PPARγ. Moreover, administration of PPARγ antagonist T0070907 mitigated the hepatic Cd36 and Cidea/c increase and improved Snhg3-induced hepatic steatosis. However,  conflicting findings suggest that the expression of hepatic PPARγ is not increased as steatosis develops in humans and in clinical studies and that PPARγ agonists administration didn’t aggravate liver steatosis (Gross et al., 2017). Thus, understanding how the hepatic PPARγ expression is regulated may provide a new avenue to prevent and treat the MASLD (Lee et al., 2018). We also discussed it in revised manuscript, please refer the first paragraph in the section of Discussion in p13 in revised manuscript.

      PPARα, most highly expressed in the liver, transcriptionally regulates lipid catabolism by regulating the expression of genes mediating triglyceride hydrolysis, fatty acid transport, and β-oxidation. Activators of PPARα decrease plasma triglycerides by inhibiting its synthesis and accelerating its hydrolysis (Chen et al., 2023). Mice with deletion of the Pparα gene exhibited more hepatic steatosis under HFD induction. As the reviewer suggested, we investigated the effect of Snhg3 on Pparα expression.  The result showed that both deficiency of Snhg3 or overexpression of Snhg3 doesn’t affect the mRNA level of Pparα as showing below, indicating that Snhg3-induced lipid accumulation independent on PPARα. Additionally, the exon, upstream 2k, 5’-UTR and intron regions of Pparγ, not Pparα, were enriched with the H3K27me3 mark (fold_enrichment = 4.15697) in the liver of DIO Snhg3-HKO mice using the CUT&Tag assay (table supplement 8), which was further confirmed by ChIP (Figure 6F and G). Therefore, we choose PPARγ to study its role in Sngh3-induced hepatic steatosis by integrated analyzing the data from CUT&Tag-Seq, ATAC-Seq and RNA-Seq.

      Author response image 2.

      The mRNA levels of hepatic Pparα expression in DIO Snhg3-HKO mice and Snhg3-HKI mice compared to the controls.

      References

      CHEN, H., TAN, H., WAN, J., ZENG, Y., WANG, J., WANG, H. & LU, X. 2023. PPAR-gamma signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets. Pharmacol Ther, 245, 108391. DIO:10.1016/j.pharmthera.2023.108391, PMID:36963510

      GAVRILOVA, O., HALUZIK, M., MATSUSUE, K., CUTSON, J. J., JOHNSON, L., DIETZ, K. R., NICOL, C. J., VINSON, C., GONZALEZ, F. J. & REITMAN, M. L. 2003. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem, 278, 34268-76. DIO:10.1074/jbc.M300043200, PMID:12805374

      GROSS, B., PAWLAK, M., LEFEBVRE, P. & STAELS, B. 2017. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol, 13, 36-49. DIO:10.1038/nrendo.2016.135, PMID:27636730

      LEE, S. M., MURATALLA, J., KARIMI, S., DIAZ-RUIZ, A., FRUTOS, M. D., GUZMAN, G., RAMOS-MOLINA, B. & CORDOBA-CHACON, J. 2023a. Hepatocyte PPARgamma contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice. Cell Mol Life Sci, 80, 39. DIO:10.1007/s00018-022-04629-z, PMID:36629912

      LEE, S. M., MURATALLA, J., SIERRA-CRUZ, M. & CORDOBA-CHACON, J. 2023b. Role of hepatic peroxisome proliferator-activated receptor gamma in non-alcoholic fatty liver disease. J Endocrinol, 257. DIO:10.1530/JOE-22-0155, PMID:36688873

      LEE, Y. K., PARK, J. E., LEE, M. & HARDWICK, J. P. 2018. Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2. Liver Res, 2, 209-215. DIO:10.1016/j.livres.2018.12.001, PMID:31245168

      MUKHERJEE, A. G., WANJARI, U. R., GOPALAKRISHNAN, A. V., KATTURAJAN, R., KANNAMPUZHA, S., MURALI, R., NAMACHIVAYAM, A., GANESAN, R., RENU, K., DEY, A., VELLINGIRI, B. & PRINCE, S. E. 2022. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells, 11. DIO:10.3390/cells11243959, PMID:36552725

      (4) Previous work suggests that SNHG3 regulates its neighboring gene MED18 which is an important regulator of global transcription. Could some of the observed effects be due to changes in MED18 or other neighboring genes?

      We thank the reviewer for the detailed comment. Previous work suggested that human SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation (Xuan and Wang, 2019). Here, we studied the effect of mouse Snhg3 on Med18 and the result showed that Snhg3 had no effect on the mRNA levels of Med18 (as below). Additionally, we also tested the effect of mouse Snhg3 on its neighboring gene, regulator of chromosome condensation 1 (Rcc1). Although deficiency of Snhg3 inhibited the mRNA level of Rcc1, overexpression of Snhg3 doesn’t affect the mRNA level of Rcc1 as showing below. RCC1, the only known guanine nucleotide exchange factor in the nucleus for Ran, a nuclear Ras-like G protein, directly participates in cellular processes such as nuclear envelope formation, nucleocytoplasmic transport, and spindle formation (Ren et al., 2020). RCC1 also regulates chromatin condensation in the late S and early M phases of the cell cycle. Many studies have found that RCC1 plays an important role in tumors. Furthermore, whether Rcc1 mediates the alleviated effect on MASLD of Snhg3 needs to be further investigated.

      Author response image 3.

      The mRNA levels of hepatic Rcc1 and Med18 expression in DIO Snhg3-HKO mice and Snhg3-HKI mice compared to the controls.

      References

      REN, X., JIANG, K. & ZHANG, F. 2020. The Multifaceted Roles of RCC1 in Tumorigenesis. Front Mol Biosci, 7, 225. DIO:10.3389/fmolb.2020.00225, PMID:33102517

      XUAN, Y. & WANG, Y. 2019. Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation. Cell Death Dis, 10, 694. DIO:10.1038/s41419-019-1940-3, PMID:31534128

      (5) The claim that Snhg3 regulates SND1 protein stability seems subtle. There is data inconsistency between different panels regarding this regulation including Figure 5I, Figure 6A, and Figure 7E. In addition, is ubiquitination happening in the nucleus where Snhg3 is expressed?

      We thank the reviewer for the detailed comment. The effect of Snhg3-induced SND1 expression had been confirmed by western blotting, please check them in Figure 5I, Figure 6A, Figure 7E and corresponding primary data. Additionally, Snhg3-induced SND1 protein stability seemed subtle, indicating there may be other mechanism by which Snhg3 promotes SND1, such as riboregulation. We had added it in the section of Discussion, please check it in the second paragraph in p16.

      Additionally, we did not detect the sites where SND1 is modified by ubiquitination. Our results showed that Snhg3 was more localized in the nucleus (Figure 1D) and Snhg3 also promoted the nuclear localization of SND1 (Figure 5O). We had revised the diagram of Snhg3 action in Figure 8G. Please check them in revised manuscript.

      (6) The authors show that the loss of Snhg3 changes the global H3K27me3 level. Few enzymes modify H3K27me3 levels. Did the authors check for an interaction between EZH2, Jmjd3, UTX, and Snhg3/SND1?

      We thank the reviewer for the detailed comment. It is crucial to ascertain whether SND1 itself functions as a new demethylase or if it influences other demethylases, such as Jmjd3, enhancer of zeste homolog 2 (EZH2), and ubiquitously transcribed tetratricopeptide repeat on chromosome X (UTX). The precise mechanism by which SND1 regulates H3K27me3 is still unclear and hence requires further investigation. We had added the limitations in the section of Discussion and please check it in the third paragraph in p17.

      (7) Can the authors speculate if the findings related to Snhg3/SND1 extend to humans?

      We thank the reviewer for the detailed comment. Since the sequence of Snhg3 is not conserved between mice and humans, the findings in this manuscript may not be applicable to humans, but the detail need to be further exploited.

      (8) As a general rule the figures are too small or difficult to read with limited details in the figure legends which limits evaluation. For example, Figure 1B and almost all of 4 cannot read labels. Figure 2, cannot see the snapshots show of mice or livers. What figure is supporting the claim that snhg3KI are more 'hyper-accessible'? Can the authors clarify what Figure 4H is referring to?

      We thank the reviewer for the detailed comment. We have provided high quality figures in our revised manuscript.

      The ‘hyper-accessible’ state in the liver of Snhg3-HKI mice was inferred by the differentially accessible regions (DARs), that is, we discovered 4305 DARs were more accessible in Snhg3-HKI mice and only 2505 DARs were more accessible in control mice and please refer table supplement 3).

      The result of Figure 4H about heatmap for Cd36 was from hepatic RNA-seq of DIO Snhg3-HKI and control WT mice. For avoiding ambiguity, we have removed it.

      (9) Authors stated that upon Snhg3 knock out, more genes are upregulated(1028) than downregulated(365). This description does not match Figure 4A. It seems in Figure 4A there are equal numbers of up and downregulated genes.

      We thank the reviewer for the detailed question. We apologized for this mistake and have corrected it.

      (10) Provide a schematic of the knockout and KI strategy in the supplement.

      We thank the reviewer for the detailed comment. We had included the knockout and KI strategy in figure supplement 1A and B, and 2A.

      Reviewer #2 (Recommendations For The Authors):

      (1) Metabolic cage data need to be reanalyzed with CalR (particularly when the body weights are significantly different).

      We thank the reviewer for the detailed comment. We reanalyzed the metabolic cage data using CalR (Mina et al., 2018). The results showed that there were no obvious differences in heat production, total oxygen consumption, carbon dioxide production and the respiratory exchange ratio between DIO Snhg3-HKO and control mice. Similar to DIO Snhg3-HKO mice, there was also no differences in heat production, total oxygen consumption, carbon dioxide production, and RER between DIO Snhg3-HKI mice and WT mice. Please check them in figure supplement 1C and 2C, and Mouse Calorimetry in Materials and Methods.

      Reference

      MINA, A. I., LECLAIR, R. A., LECLAIR, K. B., COHEN, D. E., LANTIER, L. & BANKS, A. S. 2018. CalR: A Web-Based Analysis Tool for Indirect Calorimetry Experiments. Cell Metab, 28, 656-666 e1. DIO:10.1016/j.cmet.2018.06.019, PMID:30017358

      (2) ITT in Figure 2F should also be presented as % of the initial glucose level, which would reveal that there is no difference between WT and KO.

      We thank the reviewer for the detailed comment. We repeated ITT experiment and include the new data in revised manuscript, please check it in Figure 2C.

      (3) The fasting glucose results are inconsistent between ITT and GTT. Is there any difference in fasting glucose?

      We thank the reviewer for the questions. The difference between GTT and ITT was caused owing to different fasting time, that is, mice were fasted for 6 h in ITT and were fasted for 16 h in GTT. It seems that Snhg3 doesn’t affect short- and longer-time fasting glucose levels and please refer Figures 2C and 3C.

    1. Author response:

      Reviewer #1 (Public Review):

      In this paper, Tompary & Davachi present work looking at how memories become integrated over time in the brain, and relating those mechanisms to responses on a priming task as a behavioral measure of memory linkage. They find that remotely but not recently formed memories are behaviorally linked and that this is associated with a change in the neural representation in mPFC. They also find that the same behavioral outcomes are associated with the increased coupling of the posterior hippocampus with category-sensitive parts of the neocortex (LOC) during a post-learning rest period-again only for remotely learned information. There was also correspondence in rest connectivity (posterior hippocampus-LOC) and representational change (mPFC) such that for remote memories specifically, the initial post-learning connectivity enhancement during rest related to longer-term mPFC representational change.

      This work has many strengths. The topic of this paper is very interesting, and the data provide a really nice package in terms of providing a mechanistic account of how memories become integrated over a delay. The paper is also exceptionally well-written and a pleasure to read. There are two studies, including one large behavioral study, and the findings replicate in the smaller fMRI sample. I do however have two fairly substantive concerns about the analytic approach, where more data will be required before we can know whether the interpretations are an appropriate reflection of the findings. These and other concerns are described below.

      Thank you for the positive comments! We are proud of this work, and we feel that the paper is greatly strengthened by the revisions we made in response to your feedback. Please see below for specific changes that we’ve made.

      1) One major concern relates to the lack of a pre-encoding baseline scan prior to recent learning.

      a) First, I think it would be helpful if the authors could clarify why there was no pre-learning rest scan dedicated to the recent condition. Was this simply a feasibility consideration, or were there theoretical reasons why this would be less "clean"? Including this information in the paper would be helpful for context. Apologies if I missed this detail in the paper.

      This is a great point and something that we struggled with when developing this experiment. We considered several factors when deciding whether to include a pre-learning baseline on day two. First, the day 2 scan session was longer than that of day 1 because it included the recognition priming and explicit memory tasks, and the addition of a baseline scan would have made the length of the session longer than a typical scan session – about 2 hours in the scanner in total – and we were concerned that participant engagement would be difficult to sustain across a longer session. Second, we anticipated that the pre-learning scan would not have been a ‘clean’ measure of baseline processing, but rather would include signal related to post-learning processing of the day 1 sequences, as multi-variate reactivation of learned stimuli have been observed in rest scans collected 24-hours after learning (Schlichting & Preston, 2014). We have added these considerations to the Discussion (page 39, lines 1047-1070).

      b) Second, I was hoping the authors could speak to what they think is reflected in the post-encoding "recent" scan. Is it possible that these data could also reflect the processing of the remote memories? I think, though am not positive, that the authors may be alluding to this in the penultimate paragraph of the discussion (p. 33) when noting the LOC-mPFC connectivity findings. Could there be the reinstatement of the old memories due to being back in the same experimental context and so forth? I wonder the extent to which the authors think the data from this scan can be reflected as strictly reflecting recent memories, particularly given it is relative to the pre-encoding baseline from before the remote memories, as well (and therefore in theory could reflect both the remote + recent). (I should also acknowledge that, if it is the case that the authors think there might be some remote memory processing during the recent learning session in general, a pre-learning rest scan might not have been "clean" either, in that it could have reflected some processing of the remote memories-i.e., perhaps a clean pre-learning scan for the recent learning session related to point 1a is simply not possible.)

      We propose that theoretically, the post-learning recent scan could indeed reflect mixture of remote and recent sequences. This is one of the drawbacks of splitting encoding into two sessions rather than combining encoding into one session and splitting retrieval into an immediate and delayed session; any rest scans that are collected on Day 2 may have signal that relates to processing of the Day 1 remote sequences, which is why we decided against the pre-learning baseline for Day 2, as you had noted.

      You are correct that we alluded to in our original submission when discussing the LOC-mPFC coupling result, and we have taken steps to discuss this more explicitly. In Brief, we find greater LOC-mPFC connectivity only after recent learning relative to the pre-learning baseline, and cortical-cortical connectivity could be indicative of processing memories that already have undergone some consolidation (Takashima et al., 2009; Smith et al., 2010). From another vantage point, the mPFC representation of Day 1 learning may have led to increased connectivity with LOC on Day 2 due to Day 1 learning beginning to resemble consolidated prior knowledge (van Kesteren et al., 2010). While this effect is consistent with prior literature and theory, it's unclear why we would find evidence of processing of the remote memories and not the recent memories. Furthermore, the change in LOC-mPFC connectivity in this scan did not correlate with memory behaviors from either learning session, which could be because signal from this scan reflects a mix of processing of the two different learning sessions. With these ideas in mind, we have fleshed out the discussion of the post-encoding ‘recent’ scan in the Discussion (page 38-39, lines 1039-1044).

      c) Third, I am thinking about how both of the above issues might relate to the authors' findings, and would love to see more added to the paper to address this point. Specifically, I assume there are fluctuations in baseline connectivity profile across days within a person, such that the pre-learning connectivity on day 1 might be different from on day 2. Given that, and the lack of a pre-learning connectivity measure on day 2, it would logically follow that the measure of connectivity change from pre- to post-learning is going to be cleaner for the remote memories. In other words, could the lack of connectivity change observed for the recent scan simply be due to the lack of a within-day baseline? Given that otherwise, the post-learning rest should be the same in that it is an immediate reflection of how connectivity changes as a function of learning (depending on whether the authors think that the "recent" scan is actually reflecting "recent + remote"), it seems odd that they both don't show the same corresponding increase in connectivity-which makes me think it may be a baseline difference. I am not sure if this is what the authors are implying when they talk about how day 1 is most similar to prior investigation on p. 20, but if so it might be helpful to state that directly.

      We agree that it is puzzling that we don’t see that hippocampal-LOC connectivity does not also increase after recent learning, equivalently to what we see after remote learning. However, the fact that there is an increase from baseline rest to post-recent rest in mPFC – LOC connectivity suggests that it’s not an issue with baseline, but rather that the post-recent learning scan is reflecting processing of the remote memories (although as a caveat, there is no relationship with priming).

      On what is now page 23, we were referring to the notion that the Day 1 procedure (baseline rest, learning, post-learning rest) is the most straightforward replication of past work that finds a relationship between hippocampal-cortical coupling and later memory. In contrast, the Day 2 learning and rest scan are less ‘clean’ of a replication in that they are taking place in the shadow of Day 1 learning. We have clarified this in the Results (page 23, lines 597-598).

      d) Fourth and very related to my point 1c, I wonder if the lack of correlations for the recent scan with behavior is interpretable, or if it might just be that this is a noisy measure due to imperfect baseline correction. Do the authors have any data or logic they might be able to provide that could speak to these points? One thing that comes to mind is seeing whether the raw post-learning connectivity values (separately for both recent and remote) show the same pattern as the different scores. However, the authors may come up with other clever ways to address this point. If not, it might be worth acknowledging this interpretive challenge in the Discussion.

      We thought of three different approaches that could help us to understand whether the lack of correlations in between coupling and behavior in the recent scan was due to noise. First, we correlated recognition priming with raw hippocampal-LOC coupling separately for pre- and post-learning scans, as in Author response image 1:

      Author response image 1.

      Note that the post-learning chart depicts the relationship between post-remote coupling and remote priming and between post-recent coupling and recent priming (middle). Essentially, post-recent learning coupling did not relate to priming of recently learned sequences (middle; green) while there remains a trend for a relationship between post-remote coupling and priming for remotely learned sequences (middle; blue). However, the significant relationship between coupling and priming that we reported in the paper (right, blue) is driven both by the initial negative relationship that is observed in the pre-learning scan and the positive relationship in the post-remote learning scan. This highlights the importance of using a change score, as there may be spurious initial relationships between connectivity profiles and to-be-learned information that would then mask any learning- and consolidation-related changes.

      We also reasoned that if comparisons between the post-recent learning scan and the baseline scan are noisier than between the post-remote learning and baseline scan, there may be differences in the variance of the change scores across participants, such that changes in coupling from baseline to post-recent rest may be more variable than coupling from baseline to post-remote rest. We conducted F-tests to compare the variance of the change in these two hippocampal-LO correlations and found no reliable difference (ratio of difference: F(22, 22) = 0.811, p = .63).

      Finally, we explored whether hippocampal-LOC coupling is more stable across participants if compared across two rest scans within the same imaging session (baseline and post-remote) versus across two scans across two separate sessions (baseline and post-recent). Interestingly, coupling was not reliably correlated across scans in either case (baseline/post-remote: r = 0.03, p = 0.89 Baseline/post-recent: r = 0.07, p = .74).

      Finally, we evaluated whether hippocampal-LOC coupling was correlated across different rest scans (see Author response image 2). We reasoned that if such coupling was more correlated across baseline and post-remote scans relative to baseline and post-recent scans, that would indicate a within-session stability of participants’ connectivity profiles. At the same time, less correlation of coupling across baseline and post-recent scans would be an indication of a noisier change measure as the measure would additionally include a change in individuals’ connectivity profile over time. We found that there was no difference in the correlation of hipp-LO coupling is across sessions, and the correlation was not reliably significant for either session (baseline/post-remote: r = 0.03, p = 0.89; baseline/post-recent: r = 0.07, p = .74; difference: Steiger’s t = 0.12, p = 0.9).

      Author response image 2.

      We have included the raw correlations with priming (page 25, lines 654-661, Supplemental Figure 6) as well as text describing the comparison of variances (page 25, lines 642-653). We did not add the comparison of hippocampal-LOC coupling across scans to the current manuscript, as an evaluation of stability of such coupling in the context of learning and reactivation seems out of scope of the current focus of the experiment, but we find this result to be worthy of follow-up in future work.

      In summary, further analysis of our data did not reveal any indication that a comparison of rest connectivity across scan sessions inserted noise into the change score between baseline and post-recent learning scans. However, these analyses cannot fully rule that possibility out, and the current analyses do not provide concrete evidence that the post-recent learning scan comprises signals that are a mixture of processing of recent and remote sequences. We discuss these drawbacks in the Discussion (page 39, lines 1047-1070).

      2) My second major concern is how the authors have operationalized integration and differentiation. The pattern similarity analysis uses an overall correspondence between the neural similarity and a predicted model as the main metric. In the predicted model, C items that are indirectly associated are more similar to one another than they are C items that are entirely unrelated. The authors are then looking at a change in correspondence (correlation) between the neural data and that prediction model from pre- to post-learning. However, a change in the degree of correspondence with the predicted matrix could be driven by either the unrelated items becoming less similar or the related ones becoming more similar (or both!). Since the interpretation in the paper focuses on change to indirectly related C items, it would be important to report those values directly. For instance, as evidence of differentiation, it would be important to show that there is a greater decrease in similarity for indirectly associated C items than it is for unrelated C items (or even a smaller increase) from pre to post, or that C items that are indirectly related are less similar than are unrelated C items post but not pre-learning. Performing this analysis would confirm that the pattern of results matches the authors' interpretation. This would also impact the interpretation of the subsequent analyses that involve the neural integration measures (e.g., correlation analyses like those on p. 16, which may or may not be driven by increased similarity among overlapping C pairs). I should add that given the specificity to the remote learning in mPFC versus recent in LOC and anterior hippocampus, it is clearly the case that something interesting is going on. However, I think we need more data to understand fully what that "something" is.

      We recognize the importance of understanding whether model fits (and changes to them) are driven by similarity of overlapping pairs or non-overlapping pairs. We have modified all figures that visualize model fits to the neural integration model to separately show fits for pre- and post-learning (Figure 3 for mPFC, Supp. Figure 5 for LOC, Supp. Figure 9 for AB similarity in anterior hippocampus & LOC). We have additionally added supplemental figures to show the complete breakdown of similarity each region in a 2 (pre/post) x 2 (overlapping/non-overlapping sequence) x 2 (recent/remote) chart. We decided against including only these latter charts rather than the model fits since the model fits strike a good balance between information and readability. We have also modified text in various sections to focus on these new results.

      In brief, the decrease in model fit for mPFC for the remote sequences was driven primarily by a decrease in similarity for the overlapping C items and not the non-overlapping ones (Supplementary Figure 3, page 18, lines 468-472).

      Interestingly, in LOC, all C items grew more similar after learning, regardless of their overlap or learning session, but the increase in model fit for C items in the recent condition was driven by a larger increase in similarity for overlapping pairs relative to non-overlapping ones (Supp. Figure 5, page 21, lines 533-536).

      We also visualized AB similarity in the anterior hippocampus and LOC in a similar fashion (Supplementary Figure 9).

      We have also edited the Methods sections with updated details of these analyses (page 52, lines 1392-1397). We think that including these results considerably strengthen our claims and we are pleased to have them included.

      3) The priming task occurred before the post-learning exposure phase and could have impacted the representations. More consideration of this in the paper would be useful. Most critically, since the priming task involves seeing the related C items back-to-back, it would be important to consider whether this experience could have conceivably impacted the neural integration indices. I believe it never would have been the case that unrelated C items were presented sequentially during the priming task, i.e., that related C items always appeared together in this task. I think again the specificity of the remote condition is key and perhaps the authors can leverage this to support their interpretation. Can the authors consider this possibility in the Discussion?

      It's true that only C items from the same sequence were presented back-to-back during the priming task, and that this presentation may interfere with observations from the post-learning exposure scan that followed it. We agree that it is worth considering this caveat and have added language in the Discussion (page 40, lines 1071-1086). When designing the study, we reasoned that it was more important for the behavioral priming task to come before the exposure scans, as all items were shown only once in that task, whereas they were shown 4-5 times in a random order in the post-learning exposure phase. Because of this difference in presentation times, and because behavioral priming findings tend to be very sensitive, we concluded that it was more important to protect the priming task from the exposure scan instead of the reverse.

      We reasoned, however, that the additional presentation of the C items in the recognition priming task would not substantially override the sequence learning, as C items were each presented 16 times in their sequence (ABC1 and ABC2 16 times each). Furthermore, as this reviewer suggests, the order of C items during recognition was the same for recent and remote conditions, so the fact that we find a selective change in neural representation for the remote condition and don’t also see that change for the recent condition is additional assurance that the recognition priming order did not substantially impact the representations.

      4) For the priming task, based on the Figure 2A caption it seems as though every sequence contributes to both the control and primed conditions, but (I believe) this means that the control transition always happens first (and they are always back-to-back). Is this a concern? If RTs are changing over time (getting faster), it would be helpful to know whether the priming effects hold after controlling for trial numbers. I do not think this is a big issue because if it were, you would not expect to see the specificity of the remotely learned information. However, it would be helpful to know given the order of these conditions has to be fixed in their design.

      This is a correct understanding of the trial orders in the recognition priming task. We chose to involve the baseline items in the control condition to boost power – this way, priming of each sequence could be tested, while only presenting each item once in this task, as repetition in the recognition phase would have further facilitated response times and potentially masked any priming effects. We agree that accounting for trial order would be useful here, so we ran a mixed-effects linear model to examine responses times both as a function of trial number and of priming condition (primed/control). While there is indeed a large effect of trial number such that participants got faster over time, the priming effect originally observed in the remote condition still holds at the same time. We now report this analysis in the Results section (page 14, lines 337-349 for Expt 1 and pages 14-15, lines 360-362 for Expt 2).

      5) The authors should be cautious about the general conclusion that memories with overlapping temporal regularities become neurally integrated - given their findings in MPFC are more consistent with overall differentiation (though as noted above, I think we need more data on this to know for sure what is going on).

      We realize this conclusion was overly simplistic and, in several places, have revised the general conclusions to be more specific about the nuanced similarity findings.

      6) It would be worth stating a few more details and perhaps providing additional logic or justification in the main text about the pre- and post-exposure phases were set up and why. How many times each object was presented pre and post, and how the sequencing was determined (were any constraints put in place e.g., such that C1 and C2 did not appear close in time?). What was the cover task (I think this is important to the interpretation & so belongs in the main paper)? Were there considerations involving the fact that this is a different sequence of the same objects the participants would later be learning - e.g., interference, etc.?

      These details can be found in the Methods section (pages 50-51, lines 1337-1353) and we’ve added a new summary of that section in the Results (page 17, lines 424- 425 and 432-435). In brief, a visual hash tag appeared on a small subset of images and participants pressed a button when this occurred, and C1 and C2 objects were presented in separate scans (as were A and B objects) to minimize inflated neural similarity due to temporal proximity.

      Reviewer #2 (Public Review):

      The manuscript by Tompary & Davachi presents results from two experiments, one behavior only and one fMRI plus behavior. They examine the important question of how to separate object memories (C1 and C2) that are never experienced together in time and become linked by shared predictive cues in a sequence (A followed by B followed by one of the C items). The authors developed an implicit priming task that provides a novel behavioral metric for such integration. They find significant C1-C2 priming for sequences that were learned 24h prior to the test, but not for recently learned sequences, suggesting that associative links between the two originally separate memories emerge over an extended period of consolidation. The fMRI study relates this behavioral integration effect to two neural metrics: pattern similarity changes in the medial prefrontal cortex (mPFC) as a measure of neural integration, and changes in hippocampal-LOC connectivity as a measure of post-learning consolidation. While fMRI patterns in mPFC overall show differentiation rather than integration (i.e., C1-C2 representational distances become larger), the authors find a robust correlation such that increasing pattern similarity in mPFC relates to stronger integration in the priming test, and this relationship is again specific to remote memories. Moreover, connectivity between the posterior hippocampus and LOC during post-learning rest is positively related to the behavioral integration effect as well as the mPFC neural similarity index, again specifically for remote memories. Overall, this is a coherent set of findings with interesting theoretical implications for consolidation theories, which will be of broad interest to the memory, learning, and predictive coding communities.

      Strengths:

      1) The implicit associative priming task designed for this study provides a promising new tool for assessing the formation of mnemonic links that influence behavior without explicit retrieval demands. The authors find an interesting dissociation between this implicit measure of memory integration and more commonly used explicit inference measures: a priming effect on the implicit task only evolved after a 24h consolidation period, while the ability to explicitly link the two critical object memories is present immediately after learning. While speculative at this point, these two measures thus appear to tap into neocortical and hippocampal learning processes, respectively, and this potential dissociation will be of interest to future studies investigating time-dependent integration processes in memory.

      2) The experimental task is well designed for isolating pre- vs post-learning changes in neural similarity and connectivity, including important controls of baseline neural similarity and connectivity.

      3) The main claim of a consolidation-dependent effect is supported by a coherent set of findings that relate behavioral integration to neural changes. The specificity of the effects on remote memories makes the results particularly interesting and compelling.

      4) The authors are transparent about unexpected results, for example, the finding that overall similarity in mPFC is consistent with a differentiation rather than an integration model.

      Thank you for the positive comments!

      Weaknesses:

      1) The sequence learning and recognition priming tasks are cleverly designed to isolate the effects of interest while controlling for potential order effects. However, due to the complex nature of the task, it is difficult for the reader to infer all the transition probabilities between item types and how they may influence the behavioral priming results. For example, baseline items (BL) are interspersed between repeated sequences during learning, and thus presumably can only occur before an A item or after a C item. This seems to create non-random predictive relationships such that C is often followed by BL, and BL by A items. If this relationship is reversed during the recognition priming task, where the sequence is always BL-C1-C2, this violation of expectations might slow down reaction times and deflate the baseline measure. It would be helpful if the manuscript explicitly reported transition probabilities for each relevant item type in the priming task relative to the sequence learning task and discussed how a match vs mismatch may influence the observed priming effects.

      We have added a table of transition probabilities across the learning, recognition priming, and exposure scans (now Table 1, page 48). We have also included some additional description of the change in transition probabilities across different tasks in the Methods section. Specifically, if participants are indeed learning item types and rules about their order, then both the control and the primed conditions would violate that order. Since C1 and C2 items never appeared together, viewing C1 would give rise to an expectation of seeing a BL item, which would also be violated. This suggests that our priming effects are driven by sequence-specific relationships rather than learning of the probabilities of different item types. We’ve added this consideration to the Methods section (page 45, lines 1212-1221).

      Another critical point to consider (and that the transition probabilities do not reflect) is that during learning, while C is followed either by A or BL, they are followed by different A or BL items. In contrast, a given A is always followed by the same B object, which is always followed by one of two C objects. While the order of item types is semi-predictable, the order of objects (specific items) themselves are not. This can be seen in the response times during learning, such that response times for A and BL items are always slower than for B and C items. We have explained this nuance in the figure text for Table 1.

      2) The choice of what regions of interest to include in the different sets of analyses could be better motivated. For example, even though briefly discussed in the intro, it remains unclear why the posterior but not the anterior hippocampus is of interest for the connectivity analyses, and why the main target is LOC, not mPFC, given past results including from this group (Tompary & Davachi, 2017). Moreover, for readers not familiar with this literature, it would help if references were provided to suggest that a predictable > unpredictable contrast is well suited for functionally defining mPFC, as done in the present study.

      We have clarified our reasoning for each of these choices throughout the manuscript and believe that our logic is now much more transparent. For an expanded reasoning of why we were motivated to look at posterior and not anterior hippocampus, see pages 6-7, lines 135-159, and our response to R2. In brief, past research focusing on post-encoding connectivity with the hippocampus suggests that posterior aspect is more likely to couple with category-selective cortex after learning neutral, non-rewarded objects much like the stimuli used in the present study.

      We also clarify our reasoning for LOC over mPFC. While theoretically, mPFC is thought to be a candidate region for coupling with the hippocampus during consolidation, the bulk of empirical work to date has revealed post-encoding connectivity between the hippocampus and category-selective cortex in the ventral and occipital lobes (page 6, lines 123-134).

      As for the use of the predictable > unpredictable contrast for functionally defining cortical regions, we reasoned that cortical regions that were sensitive to the temporal regularities generated by the sequences may be further involved in their offline consolidation and long-term storage (Danker & Anderson, 2010; Davachi & Danker, 2013; McClelland et al., 1995). We have added this justification to the Methods section (page 18, lines 454-460).

      3) Relatedly, multiple comparison corrections should be applied in the fMRI integration and connectivity analyses whenever the same contrast is performed on multiple regions in an exploratory manner.

      We now correct for multiple comparisons using Bonferroni correction, and this correction depends on the number of regions in which each analysis is conducted. Please see page 55, lines 1483-1490, in the Methods section for details of each analysis.

      Reviewer #3 (Public Review):

      The authors of this manuscript sought to illuminate a link between a behavioral measure of integration and neural markers of cortical integration associated with systems consolidation (post-encoding connectivity, change in representational neural overlap). To that aim, participants incidentally encoded sequences of objects in the fMRI scanner. Unbeknownst to participants, the first two objects of the presented ABC triplet sequences overlapped for a given pair of sequences. This allowed the authors to probe the integration of unique C objects that were never directly presented in the same sequence, but which shared the same preceding A and B objects. They encoded one set of objects on Day 1 (remote condition), another set of objects 24 hours later (recent condition) and tested implicit and explicit memory for the learned sequences on Day 2. They additionally collected baseline and post-encoding resting-state scans. As their measure of behavioral integration, the authors examined reaction time during an Old/New judgement task for C objects depending on if they were preceded by a C object from an overlapping sequence (primed condition) versus a baseline object. They found faster reaction times for the primed objects compared to the control condition for remote but not recently learned objects, suggesting that the C objects from overlapping sequences became integrated over time. They then examined pattern similarity in a priori ROIs as a measure of neural integration and found that participants showing evidence of integration of C objects from overlapping sequences in the medial prefrontal cortex for remotely learned objects also showed a stronger implicit priming effect between those C objects over time. When they examined the change in connectivity between their ROIs after encoding, they also found that connectivity between the posterior hippocampus and lateral occipital cortex correlated with larger priming effects for remotely learned objects, and that lateral occipital connectivity with the medial prefrontal cortex was related to neural integration of remote objects from overlapping sequences.

      The authors aim to provide evidence of a relationship between behavioral and neural measures of integration with consolidation is interesting, important, and difficult to achieve given the longitudinal nature of studies required to answer this question. Strengths of this study include a creative behavioral task, and solid modelling approaches for fMRI data with careful control for several known confounds such as bold activation on pattern analysis results, motion, and physiological noise. The authors replicate their behavioral observations across two separate experiments, one of which included a large sample size, and found similar results that speak to the reliability of the observed behavioral phenomenon. In addition, they document several correlations between neural measures and task performance, lending functional significance to their neural findings.

      Thank you for this positive assessment of our study!

      However, this study is not without notable weaknesses that limit the strength of the manuscript. The authors report a behavioral priming effect suggestive of integration of remote but not recent memories, leading to the interpretation that the priming effect emerges with consolidation. However, they did not observe a reliable interaction between the priming condition and learning session (recent/remote) on reaction times, meaning that the priming effect for remote memories was not reliably greater than that observed for recent. In addition, the emergence of a priming effect for remote memories does not appear to be due to faster reaction times for primed targets over time (the condition of interest), but rather, slower reaction times for control items in the remote condition compared to recent. These issues limit the strength of the claim that the priming effect observed is due to C items of interest being integrated in a consolidation-dependent manner.

      We acknowledge that the lack of a day by condition interaction in the behavioral priming effect should discussed and now discuss this data in a more nuanced manner. While it’s true that the priming effect emerges due to a slowing of the control items over time, this slowing is consistent with classic time-dependent effects demonstrating slower response times for more delayed memories. The fact that the response times in the primed condition does not show this slowing can be interpreted as a protection against this slowing that would otherwise occur. Please see page 29, lines 758-766, for this added discussion.

      Similarly, the interactions between neural variables of interest and learning session needed to strongly show a significant consolidation-related effect in the brain were sometimes tenuous. There was no reliable difference in neural representational pattern analysis fit to a model of neural integration between the short and long delays in the medial prefrontal cortex or lateral occipital cortex, nor was the posterior hippocampus-lateral occipital cortex post-encoding connectivity correlation with subsequent priming significantly different for recent and remote memories. While the relationship between integration model fit in the medial prefrontal cortex and subsequent priming (which was significantly different from that occurring for recent memories) was one of the stronger findings of the paper in favor of a consolidation-related effect on behavior, is it possible that lack of a behavioral priming effect for recent memories due to possible issues with the control condition could mask a correlation between neural and behavioral integration in the recent memory condition?

      While we acknowledge that lack of a statistically reliable interaction between neural measures and behavioral priming in many cases, we are heartened by the reliable difference in the relationship between mPFC similarity and priming over time, which was our main planned prediction. In addition to adding caveats in the discussion about the neural measures and behavioral findings in the recent condition (see our response to R1.1 and R1.4 for more details), we have added language throughout the manuscript noting the need to interpret these data with caution.

      These limitations are especially notable when one considers that priming does not classically require a period of prolonged consolidation to occur, and prominent models of systems consolidation rather pertain to explicit memory. While the authors have provided evidence that neural integration in the medial prefrontal cortex, as well as post-encoding coupling between the lateral occipital cortex and posterior hippocampus, are related to faster reaction times for primed objects of overlapping sequences compared to their control condition, more work is needed to verify that the observed findings indeed reflect consolidation dependent integration as proposed.

      We agree that more work is needed to provide converging evidence for these novel findings. However, we wish to counter the notion that systems consolidation models are relevant only for explicit memories. Although models of systems consolidation often mention transformations from episodic to semantic memory, the critical mechanisms that define the models involve changes in the neural ensembles of a memory that is initially laid down in the hippocampus and is taught to cortex over time. This transformation of neural traces is not specific to explicit/declarative forms of memory. For example, implicit statistical learning initially depends on intact hippocampal function (Schapiro et al., 2014) and improves over consolidation (Durrant et al., 2011, 2013; Kóbor et al., 2017).

      Second, while there are many classical findings of priming during or immediately after learning, there are several instances of priming used to measure consolidation-related changes to newly learned information. For instance, priming has been used as a measure of lexical integration, demonstrating that new word learning benefits from a night of sleep (Wang et al., 2017; Gaskell et al., 2019) or a 1-week delay (Tamminen & Gaskell, 2013). The issue is not whether priming can occur immediately, it is whether priming increases with a delay.

      Finally, it is helpful to think about models of memory systems that divide memory representations not by their explicit/implicit nature, but along other important dimensions such as their neural bases, their flexibility vs rigidity, and their capacity for rapid vs slow learning (Henke, 2010). Considering this evidence, we suggest that systems consolidation models are most useful when considering how transformations in the underlying neural memory representation affects its behavioral expression, rather than focusing on the extent that the memory representation is explicit or implicit.

      With all this said, we have added text to the discussion reminding the reader that there was no statistically significant difference in priming as a function of the delay (page 29, lines 764 - 766). However, we are encouraged by the fact that the relationship between priming and mPFC neural similarity was significantly stronger for remotely learned objects relative to recently learned ones, as this is directly in line with systems consolidation theories.

      References

      Abolghasem, Z., Teng, T. H.-T., Nexha, E., Zhu, C., Jean, C. S., Castrillon, M., Che, E., Di Nallo, E. V., & Schlichting, M. L. (2023). Learning strategy differentially impacts memory connections in children and adults. Developmental Science, 26(4), e13371. https://doi.org/10.1111/desc.13371

      Dobbins, I. G., Schnyer, D. M., Verfaellie, M., & Schacter, D. L. (2004). Cortical activity reductions during repetition priming can result from rapid response learning. Nature, 428(6980), 316–319. https://doi.org/10.1038/nature02400

      Durrant, S. J., Cairney, S. A., & Lewis, P. A. (2013). Overnight consolidation aids the transfer of statistical knowledge from the medial temporal lobe to the striatum. Cerebral Cortex, 23(10), 2467–2478. https://doi.org/10.1093/cercor/bhs244

      Durrant, S. J., Taylor, C., Cairney, S., & Lewis, P. A. (2011). Sleep-dependent consolidation of statistical learning. Neuropsychologia, 49(5), 1322–1331. https://doi.org/10.1016/j.neuropsychologia.2011.02.015

      Gaskell, M. G., Cairney, S. A., & Rodd, J. M. (2019). Contextual priming of word meanings is stabilized over sleep. Cognition, 182, 109–126. https://doi.org/10.1016/j.cognition.2018.09.007

      Henke, K. (2010). A model for memory systems based on processing modes rather than consciousness. Nature Reviews Neuroscience, 11(7), 523–532. https://doi.org/10.1038/nrn2850

      Kóbor, A., Janacsek, K., Takács, Á., & Nemeth, D. (2017). Statistical learning leads to persistent memory: Evidence for one-year consolidation. Scientific Reports, 7(1), 760. https://doi.org/10.1038/s41598-017-00807-3

      Kuhl, B. A., & Chun, M. M. (2014). Successful remembering elicits event-specific activity patterns in lateral parietal cortex. The Journal of Neuroscience, 34(23), 8051–8060. https://doi.org/10.1523/JNEUROSCI.4328-13.2014

      Richter, F. R., Chanales, A. J. H., & Kuhl, B. A. (2016). Predicting the integration of overlapping memories by decoding mnemonic processing states during learning. NeuroImage, 124, Part A, 323–335. https://doi.org/10.1016/j.neuroimage.2015.08.051

      Schapiro, A. C., Gregory, E., Landau, B., McCloskey, M., & Turk-Browne, N. B. (2014). The necessity of the medial-temporal lobe for statistical learning. Journal of Cognitive Neuroscience, 1–12. https://doi.org/10.1162/jocn_a_00578

      Schlichting, M. L., & Preston, A. R. (2014). Memory reactivation during rest supports upcoming learning of related content. Proceedings of the National Academy of Sciences, 111(44), 15845–15850. https://doi.org/10.1073/pnas.1404396111

      Smith, J. F., Alexander, G. E., Chen, K., Husain, F. T., Kim, J., Pajor, N., & Horwitz, B. (2010). Imaging systems level consolidation of novel associate memories: A longitudinal neuroimaging study. NeuroImage, 50(2), 826–836. https://doi.org/10.1016/j.neuroimage.2009.11.053

      Takashima, A., Nieuwenhuis, I. L. C., Jensen, O., Talamini, L. M., Rijpkema, M., & Fernández, G. (2009). Shift from hippocampal to neocortical centered retrieval network with consolidation. The Journal of Neuroscience, 29(32), 10087–10093. https://doi.org/10.1523/JNEUROSCI.0799-09.2009

      Tamminen, J., & Gaskell, M. G. (2013). Novel word integration in the mental lexicon: Evidence from unmasked and masked semantic priming. The Quarterly Journal of Experimental Psychology, 66(5), 1001–1025. https://doi.org/10.1080/17470218.2012.724694

      van Kesteren, M. T. R. van, Fernández, G., Norris, D. G., & Hermans, E. J. (2010). Persistent schema-dependent hippocampal-neocortical connectivity during memory encoding and postencoding rest in humans. Proceedings of the National Academy of Sciences, 107(16), 7550–7555. https://doi.org/10.1073/pnas.0914892107

      Wang, H.-C., Savage, G., Gaskell, M. G., Paulin, T., Robidoux, S., & Castles, A. (2017). Bedding down new words: Sleep promotes the emergence of lexical competition in visual word recognition. Psychonomic Bulletin & Review, 24(4), 1186–1193. https://doi.org/10.3758/s13423-016-1182-7

    1. Author response:

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      In Drosophila melanogaster, expression of Sex-lethal (Sxl) protein determines sexual identity and drives female development. Functional Sxl protein is absent from males where splicing includes a termination codon-containing "poison" exon. Early during development, in the soma of female individuals, Sxl expression is initiated by an X chromosome counting mechanism that activates the Sxl establishment promoter (SxlPE) to produce an initial amount of Sxl protein. This then suppresses the inclusion of the "poison" exon, directing the constructive splicing of Sxl transcripts emerging from the Sxl maintenance promotor (SxlPM) which is activated at a later stage during development irrespective of sex. This autoregulatory loop maintains Sxl expression and commits to female development. 

      Sxl also determines the sexual identity of the germline. Here Sxl expression generally follows the same principles as in somatic tissues, but the way expression is initiated differs from the soma. This regulation has so far remained elusive. 

      In the presented manuscript, Goyal et al. show that activation of Sxl expression in the germline depends on additional regulatory DNA sequences, or sequences different from the ones driving initial Sxl expression in the soma. They further demonstrate that sisterless A (sisA), a transcription factor that is required for activation of Sxl expression in the soma, is also necessary, but not sufficient, to initiate the expression of functional Sxl protein in female germ cells. sisA expression precedes Sxl induction in the germline and its ablation by RNAi results in impaired expression of Sxl, formation of ovarian tumors, and germline loss, phenocopying the loss of Sxl. Intriguingly, this phenotype can be rescued by the forced expression of Sxl, demonstrating that the primary function of sisA in the germline is the induction of Sxl expression. 

      Strengths: 

      The clever design of probes (for RNA FISH) and reporters allowed the authors to dissect Sxl expression from different promoters to get novel insight into sex-specific gene regulation in the germline. All experiments are carefully controlled. Since Sxl regulation differs between the soma and the germline, somatic tissues provide elegant internal controls in many experiments, ensuring e.g. functionality of the reporters. Similarly, animals carrying newly generated alleles (e.g. genomic tagging of the Sxl locus) are fertile and viable, demonstrating that the genetic manipulation does not interfere with protein function. The conclusions drawn from the experimental data are sound and advance our understanding of how Sxl expression is induced in the female germline. 

      Weaknesses: 

      The assays employed by the authors provide valuable information on when Sxl promoters become active. However, since no information on the stability of the gene products (i.e. RNA and protein) is available, it remains unclear when the SxlPE promoter is switched off in the germline (conceptually it only needs to be active for a short time period to initiate production of functional Sxl protein). As correctly stated by the authors, the persisting signals observed in the germline might therefore not reflect the continuous activity of the SxlPE promoter. 

      Mapping of regulatory elements and their function: SxlPE with 1.5 kb of flanking upstream sequence is sufficient to recapitulate early Sxl expression in the soma. The authors now provide evidence that beyond that, additional DNA sequences flanking the SxlPE promoter are required for germline expression. However, a more precise mapping was not performed. Also, due to technical limitations, the authors could not precisely map the sisA binding sites. Since this protein is also involved in the somatic induction of Sxl, its binding sites likely reside in the region 1.5kb upstream of the SxlPE promoter, which has been reported to be sufficient for somatic regulation. The regulatory role of the sequences beyond SxlPE-1.5kb therefore remains unaddressed and it remains to be investigated which trans-acting factor(s) exert(s) its/their function(s) via this region. 

      We agree that a more precise mapping of the essential elements within the 10.2 kb reporter is an important direction in which to proceed. Unfortunately, this is out of the scope of the current manuscript given current lab personnel. In regard to the 1.5 kb promoter that activates SxlPE in the soma, we do not feel that the Sisa binding sites are necessarily in this region. It is important to note that, while the 1.5 kb promoter is sufficient for female-specific expression in the soma, it may not contain all of the regulatory elements that normally regulate PE from the endogenous locus. Activation of PE in the soma is thought to be regulated by a combination of positive-acting factors (SisA, SisB, etc.) and repressive factors (e.g. Dpn) that set a threshold for PE activation. Much more work would need to be done to determine whether all of these factors bind to the 1.5 kb promoter, or whether additional sequences are also involved to control the proper timing and robustness of normal Sxl PE activation in the soma.

      The central question of how Sxl expression is initiated and controlled in the germline still remains unanswered. Since sisA is zygotically expressed in both the male and the female germline (Figure 4D), it is unlikely the factor that restricts Sxl expression to the female germline. 

      X chromosome “counting” elements like SisA are always expressed in both males and females, but it is thought that the 2X does of them in females activates PE, while the 1X does in males does not. Thus, we do expect SisA to be expressed in both males and females as we observed.

      How does weak expression of Sxl in male tissues or expression above background after knockdown of sisA reconcile with the model that an autoregulatory feedback loop enforces constant and clonally inheritable Sxl expression once Sxl is induced? Is the current model for Sxl expression too simple or are we missing additional factors that modulate Sxl expression (such as e.g. Sister of Sex-lethal)? While I do not expect the authors to answer these questions, I would expect them to appropriately address these intriguing aspects in the discussion. 

      It is difficult to know what is “background” and what is actual weak Sxl expression in males. We agree that, if it is real, then why it doesn’t activate autoregulation of the Sxl PM transcript is mysterious. And yes, the current model for female-specific expression of Sxl in the soma may well be incomplete. Sxl PM transcript is present in the testis based on community RNA-seq data and our own analysis of male vs. female bam-mutant gonads (PMID 31329582), but it is at lower levels. Whether the lower level in the testis is due to tissue differences or sex-specific regulation of RNA levels is unknown. Our observations that the HA-tagged Sxl Early protein remains present in somatic cells in L1 larvae, and that GFP expression from the 10.2 kb Sxl PE-GFP can be detected in the soma until L2 could either be due to perdurance of the protein products, or continued sex-specific expression of PE long after the time that it was thought to shut off. This is also long after dosage compensation should have equalized the expression of X chromosome gene expression, meaning that X chromosomes can no longer be “counted” by factors like SisA and SisB. Thus, sex-specific expression of PE at this time would require another mechanism besides the current model (such as feedback regulation of Sxl PE transcription from downstream factors).

      Reviewer #2 (Public Review): 

      Summary: 

      The authors wanted to determine whether cis-acting factors of Sxl - two different Sxl promoters in somatic cells - regulate Sxl in a similar way in germ cells. They also wanted to determine whether trans-acting factors known to regulate Sxl in the soma also regulate Sxl in the germline. 

      Regarding the cis-acting factors, they examine the Sxl "establishment promoter" (SxlPE) that is activated in female somatic cells by the presence of two X chromosomes. Slightly later in development, dosage compensation equalizes X chromosome expression in males and females and so X chromosomes can no longer be counted. The second Sxl promoter is the "maintenance promoter," (SxlPM), which is activated in both sexes. The mRNA produced from the maintenance promoter has to be alternatively splicing from early Sxl protein generated earlier in development by the PE. This leads to an autoregulatory loop that maintains Sxl expression in female somatic cells. The authors used fluorescent in situ hybridization (FISH) with oligopaints to determine the temporal activation of the PE or PM promoters. They find that - unlike the soma - the PE does not precede the PM and instead is activated contemporaneously or later than the PM - this is confusing with the later results (see below). Next, they generated transcriptional reporter constructs containing large segments of the Sxl locus, the 1.5 kb used in somatic studies, a 5.2 kb reporter, and a 10.2 kb. Interestingly the 1.5 kb reporter that was reported to recapitulate Sxl expression in soma and germline was not observed by the authors. The 5.2 kb reporter was observed in female somatic cells but not in germ cells. Only when they include an additional 5 kb downstream of the 5.2 kb reporter (here the 10.2 kb reporter) they did see expression in germ cells but this occurred at the L1 stages. Their data indicate that Sxl activity in the germ requires different cis-regulation than the soma and that the PE is activated later in germ cells than in somatic cells. The authors next use gene editing to insert epitope tags in two distinct strains in the hopes of creating an early Sxl and a later Sxl protein derived from the PE and PM, respectively. The HA-tagged protein from the PE was seen in somatic cells but never in the germline, possibly due to very low expression. The FLAG-tagged late Sxl protein is observed in L2 germ cells. Because the early HA-Sxl protein is not perceptible in germ cells, it is not possible to conclude its role in the germline. However, because late FLAG-Sxl was only observed in L2 germ cells and the PE was detected in L1, this leaves open the possibility that PE produces early HA-Sxl (which currently cannot be detected), which then alternatively splices the transcript from the PM. In other words, the soma and germline could have a similar temporal relationship between the two Sxl promoters. While I agree with the authors about this conclusion, the earlier work with the oligopaints leads to the conclusion that SE is active after PM. This is confusing. 

      The temporal relationship between Sxl PE and Sxl PM in the germline is indeed confusing. One source of confusion comes from whether one is discussing Sxl protein production or promoter activity. As the reviewer nicely summarizes, our transcription analysis with oligopaints indicates that, unlike in the soma, Sxl PE is NOT on in the germline prior to PM. Our other data indicate that PE is instead likely only active well after transcription from PM has begun. However, this still means that the temporal order of the EARLY and LATE Sxl proteins can be the same as the soma. Even if PM is active well before PE in the germline, the PE transcript cannot produce any functional protein in the absence of being alternatively spliced by the Sxl protein (Sxl autoregulation). Thus, even if PM is active before PE in the germline, we would not expect to observe any LATE Sxl protein until the PE promoter comes on, and produces a pulse of EARLY Sxl protein. The fact that we observe LATE Sxl protein at L2 is consistent with our observation that the 10.2 kb Sxl PE reporter is active at L1. We will attempt to explain all of this better in a revised manuscript.

      Next, the authors wanted to turn their attention to the trans-acting factors that regulate Sxl in the soma, including Sisterless A (SisA), SisB, Runt, and the JAK/STAT ligand Unpaired. Using germline RNAi, the authors found that only knockdown of SisA causes ovarian tumors, similar to the loss of Sxl, suggesting that SisA regulates Sxl (ie the PE) in both the soma and the germline. They generated a SisA null allele using CRISPR/Cas9 and these animals had ovarian tumors and germ cell-less ovaries. FISH revealed that sisA is activated in primordial germ cells in stages 3-6 before the activation of Sxl. They used CRISPR-Cas9 to generate an endogenously-tagged SisA and found that tagged SisA was expressed in stage 3-6 PCGs, which is consistent with activating PE in the germline. They showed that sisA is upstream of Sxl as germline depletion of sisA led to a significant decrease in expression from the 10.2 kb PE reporter and in SXL protein. The authors could rescue the ovarian tumors and loss of Sxl protein upon germline depletion of sisA by supplying Sxl from another protein (the otu promoter). These data indicate that sisA is necessary for Sxl activation in the germline. However, ectopic sisA in germ cells in the testis did not lead to ectopic Sxl, suggesting that sisA is not sufficient to activate Sxl in the germline. 

      Strengths: 

      (1) The genetic and genomic approaches in this study are top-notch and they have generated reagents that will be very useful for the field. 

      (2) Excellent use of powerful approaches (oligo paint, reporter constructs, CRISPR-Cas9 alleles). 

      (3) The combination of state of art approaches and quantification of phenotypes allows the authors to make important conclusions. 

      Weaknesses: 

      (1) Confusion in line 127 (this indicates that SxlPE is not activated before SxlPM in the germline) about PE not being activated before the PM in the germline when later figures show that PE is activated in L1 and late Sxl protein is seen in L2. It would be helpful to the readers if the authors edited the text to avoid this confusion. Perhaps more explanation of the results at specific points would be helpful. 

      We agree--see response above.

      Reviewer #3 (Public Review): 

      Summary: 

      The mechanisms governing the initial female-specific activation of Sex-lethal (Sxl) in the soma, the subsequent maintenance of female-specific expression and the various functions of Sxl in somatic sex determination and dosage compensation are well documented. While Sxl is also expressed in the female germline where it plays a critical role during oogenesis, the pathway that is responsible for turning Sxl on in germ cells has been a long-standing mystery. This manuscript from Goyal et al describes studies aimed at elucidating the mechanism(s) for the sex-specific activation of the Sex-lethal (Sxl) gene in the female germline of Drosophila. 

      In the soma, the Sxl establishment promoter, Sxl-Pe, is regulated in pre-cellular blastoderm embryos in somatic cells by several X-linked transcription factors (sis-a, sis-b, sis-c and runt). At this stage of development, the expression of these transcription factors is proportional to gene dose, 2x females and 1x in males. The cumulative two-fold difference in the expression of these transcription factors is sufficient to turn Sxl-Pe on in female embryos. Transcripts from the Sxl-Pe promoter encode an "early" version of the female Sxl protein, and they function to activate a splicing positive autoregulatory loop by promoting the female-specific splicing of the initial pre-mRNAs derived from the Sxl maintenance promoter, Sxl-Pm (which is located upstream of Sxl-Pm). These female Sxl-Pm mRNAs encode a Sxl protein with a different N-terminus from the Sxl-Pe mRNAs, and they function to maintain female-specific splicing in the soma during the remainder of development. 

      In this manuscript, the authors are trying to understand how the Sxl-Pm positive autoregulatory loop is established in germ cells. If Sxl-Pe is used and its activation precedes Sxl-Pm as is true in the soma, they should be able to detect Sxl-Pe transcripts in germ cells before Sxl-Pm transcripts appear. To test this possibility, they generated RNA FISH probes complementary to the Sxl-Pe first exon (which is part of an intron sequence in the Sxl-Pm transcript) and to a "common sequence" that labels both Sxl-Pe and Sxl-Pm transcripts. Transcripts labeled by both probes were detected in germ cells beginning at stage 5 (and reaching a peak at stage 10), so either the Sxl-Pm and Sxl-Pe promoters turn on simultaneously, or Sxl-Pe is not active. 

      They next switched to Sxl-Pe reporters. The first Sxl-Pe:gfp reporter they used has a 1.5 kb upstream region which in other studies was found to be sufficient to drive sex-specific expression in the soma of blastoderm embryos. Also like the endogenous Sxl gene it is not expressed in germ cells at this early stage. In 2011, Hashiyama et al reported that this 1.5 kb promoter fragment was able to drive gfp expression in Vasa-positive germ cells later in development in stage 9/10 embryos. However, because of the high background of gfp in the nearby soma, their result wasn't especially convincing. Though they don't show the data, Goyal et al indicated that unlike Hashiyama et al they were unable to detect gfp expressed from this reporter in germ cells. Goyal et al extended the upstream sequences in the reporter to 5 kb, but they were still unable to detect germline expression of gfp. 

      Goyal et al then generated a more complicated reporter which extends 5 kb upstream of the Sxl-Pe start site and 5 kb downstream-ending at or near 4th exon of the Sxl-Pm transcript (the Sxl-Pe10 kb reporter). (The authors were not explicit as to whether the 5 kb downstream sequence extended beyond the 4th exon splice junction-in which case splicing could potentially occur with an upstream exon(s)-or terminated prior to the splice junction as seems to be indicated in their diagram.) With this reporter, they were able to detect sex-specific gfp expression in the germline beginning in L1 (first instar larva). With the caveat that gfp detection might be delayed compared to the onset of reporter activation, these findings indicated that the sequences in the reporter are able to drive sex-specific transcription in the germline at least as early as L1. 

      The authors next tagged the N-terminal end of the Sxl-Pe protein with HA (using Crispr/Cas9) and the N-terminal end of Sxl-Pm protein with Flag. They report that the HA-Sxl-Pe protein is first detected in the soma at stage 9 of embryogenesis. Somatic HA-Sxl-Pe protein persists into L1, but is no longer detected in L2. However, while somatic HA-Sxl-Pe protein is detected, they were unable to detect HA-Sxl-Pe protein in germ cells. In the case of FLAG-Sxl-Pm, it could first be detected in L2 germ cells indicating that at this juncture the Sxl-positive autoregulatory loop has been activated. This contrasts with Sxl-Pm transcripts which are observed in a few germ cells at stage 5 of embryogenesis, and in most germ cells by stage 10. The authors propose (based on the expression pattern of the Sxl-Pe10kb reporter and the appearance of Flag-Sxl-Pm protein) that Sxl-Pe comes on in germ cells in L1, and that the Sxl-Pe protein activates the female splicing of Sxl-Pm transcripts, giving detectable Flag-Sxl-Pm proteins beginning in L2. 

      To investigate the signals that activate Sxl-Pe in germ cells, the authors tested four of the X-linked genes (sis-a, sis-b, sis-c, and runt) that function to activate Sxl-Pe in the soma in early embryos. RNAi knockdown of sis-b, sis-c, and runt had no apparent effect on oogenesis. In contrast, knockdown of sis-a resulted in tumorous ovaries, a phenotype associated with Sxl mutations. (Three different RNAi transgenes were tested-two gave this phenotype, the third did not.) Sxl-Pe10kb reporter activity in L1 female germ cells is also dependent on sis-A. 

      Several approaches were used to confirm a role for sis-a in a) oogenesis and b) the activation of the Sxl-Pm autoregulatory loop. They showed that sis-a germline clones (using tissue-specific Crispr/Cas9 editing) resulted in the tumorous ovary phenotype and reduced the expression of Sxl protein in these ovaries. They found that sis-a transcripts and GFP-tagged Sis-A protein are present in germ cells. Finally, they showed tumorous ovary phenotype induced by germline RNAi knockdown of sis-a can be partially rescued by expressing Sxl in the germ cells. 

      Critique: 

      While this manuscript addresses a longstanding puzzle - the mechanism activating the Sxl autoregulatory loop in female germ cells-and likely identified an important germline transcriptional activator of Sxl, sis-a, the data that they've generated doesn't make a compelling story. At every step, there are puzzle pieces that don't fit the narrative. In addition, some of their findings are inconsistent with many previous studies. 

      We respect and appreciate this reviewer for the detailed comments. However, we feel that the claim that our work doesn’t “make a compelling story” and that many “pieces…don’t fit the narrative” is incorrect. The main issue that this reviewer raises is that we do not know if Sxl “early” transcription in the germline initiates from the Pe promoter. This is true, which we fully acknowledge, but the detail of whether “germline early” transcription of Sxl initiates from Pe or from other, as yet undefined, germline promoter does not affect the main conclusions of the paper. These conclusions are that a) regulation of Sxl in the germline is fundamentally different from in the soma and 2) despite point (1), sisA acts as an activator of Sxl in both the soma and the germline. Neither of these main points is disputed by this reviewer.

      (1) The authors used RNA FISH to time the expression of Sxl-Pe and Sxl-Pm transcripts in germ cells. Transcripts complementary to Sxl-Pe and Sxl-Pm were detected at the same time in embryos beginning at stage 5. This is not a definitive experiment as it could mean a) that Sxl-Pe and Sxl-Pm turn on at the same time, b) that Sxl-Pe comes on after Sxl-Pm (as suggested by the Sxl-Pe10kb reporter) or c) Sxl-Pe never comes on. 

      When designing this experiment, we wanted to test whether the “soma model” of Pe activation before Pm was also true in the germ cells. Our data clearly demonstrate that transcripts beginning downstream of Pe are not expressed prior to transcripts beginning downstream of Pm. Thus, we can state that the “soma model” of Pe first and then Pm does not occur in the germline, which is very interesting. However, we cannot make any other conclusions about Pe in the germline from these data, as the reviewer indicates.

      (2) Hashiyama et al reported that they detected gfp expression in stage 9/10 germ cells from a 1.5 kb Sxl-Pe-gfp. As noted above, this result wasn't entirely convincing and thus it isn't surprising that Goyal et al were unable to reproduce it. Extending the upstream sequences to just before the 1st exon of Sxl-Pm transcripts also didn't give gfp expression in germ cells. Only when they added 5 kb downstream did they detect gfp expression. However, from this result, it isn't possible to conclude that the Sxl-Pe promoter is actually driving gfp expression in L1 germ cells. Instead, the Sxl promoter active in the germ line could be anywhere in their 10 kb reporter. 

      We agree that we have not determined the transcriptional start sites for Sxl in the germline and it is possible that the 10.2 kb reporter uses a different promoter than Pe, as long as that transcript can also be spliced into exon 4 where the GFP tag has been placed. The three types of experiments conducted—FISH to regions of the nascent transcripts, tagged versions of the different predicted ORFs, and promoter-GFP constructs—are extensive, but all have different limitations. Indeed, it would be challenging to determine the transcription start sites in the germline, as it would require obtaining enough L1 larvae to be able to dissociate the animals, or isolated gonads, into single cells in order to FACS purify the germ cells for RACE or long-read sequencing (I’m not sure that L1 larval single-nucleus seq would be enough for calling start sites). Otherwise, there would be no way to determine if expected or unexpected transcripts came from the soma or the germline. We can consider these experiments in the future.

      Fortunately, the main conclusions from this paper do not require knowing whether the germline uses Pe or some other “germline early” promoter that can produce Sxl protein in the absence of autoregulation by existing Sxl protein. The observations that a nascent transcript including the region downstream of Pm is observed in embryonic germ cells, but that the tagged LATE protein is not observed until L2, suggest that the transcript produced in early germ cells cannot produce a functional protein. This is consistent with the need for Sxl autoregulation of the Pm transcript in the germline as in the soma, as was previously thought. This is further supported by the observations that activity of the 10.2 kb reporter is only observed in L1 germ cells, and that the LATE Sxl protein is only observed in germ cells after this point. Thus, we can conclude that either Pe, or another “germline early” promoter, acts to produce female-specific Sxl protein to initiate autoregulation of Sxl splicing and protein production in the germline. We feel that this is a significant advance for the field, and we will make it more clear in the text that the initial expression of Sxl in the germline may not be from the Pe promoter.

      Other conclusions of the manuscript are unaffected by the start site for “germline early” Sxl transcription, including that the germline activates Sxl protein expression much later than the soma, which calls into question previous work indicating an early role for Sxl in the germline. Also unaffected is our conclusion that different enhancer sequences are required for activation of Sxl expression in the germline than in the soma, consistent with previous work demonstrating that the genetics of Sxl activation in the germline are different than in the soma. Lastly, our conclusions that sisA acts upstream of Sxl, and is required for Sxl germline expression, either directly or indirectly, are also unaffected by the nature of the Sxl “germline early” start site.

      (3) At least one experiment suggests that Sxl-Pe never comes on in germ cells. The authors tagged the N-terminus of the Sxl-Pe protein with HA and the N-terminus of the Sxl-Pm protein with Flag. Though they could detect HA-Sxl-Pe protein in the soma, they didn't detect it in germ cells. On the other hand, the Flag-Sxl-Pm protein was detected in L2 germ cells (but not earlier). These results would more or less fit with those obtained for the 10 kb reporter and would support the following model: Prior to L1, Sxl-Pm transcripts are expressed and spliced in the male pattern in both male and female germ cells. During L1, Sxl protein expressed via a mechanism that depends upon a 10 kb region spanning Sxl-Pe (but not on Sxl-Pe) is produced and by L2 there are sufficient amounts of this protein to switch the splicing of Sxl-Pm transcripts from a male to a female pattern-generating Flag-tagged Sxl-Pm protein. 

      As described above, it is indeed possible that another promoter besides Pe is active as the “germline early” promoter. We will make this more clear in a revised version, but the major conclusions of the manuscript are unaffected.

      (4) The 10kb reporter is sex-specific, but not germline-specific. The levels of gfp in female L1 somatic cells are equal to if not greater than those in L1 female germ cells. That the Sxl-Pe10kb reporter is active in the soma complicates the conclusion that it represents a germ line-specific promoter. Germline activity is, however, sensitive to sis-A knockdowns which is plus. Presumably, somatic expression of the reporter wouldn't be sensitive to a (late) sis-A knockdown- but this wasn't shown. 

      We are confused by this comment because we do not conclude that the Pe is a germline-specific promoter. Pe is known to be expressed in the soma, from considerable previous work cited by this reviewer, and the simplest model is that Pe is used in both the soma and the germline, as reflected by our 10.2 kb reporter. It is actually quite interesting how late this promoter seems active in the soma, contrary to current dogma, but we did not study somatic activation of Sxl in this work.

      (5) Their results with the HA-Sxl-Pe protein don't fit with many previous studies-assuming that the authors have explained their results properly. They report that HA-Sxl-Pe protein is first detected in the soma at stage 9 of embryogenesis and that it then persists till L2. However, previous studies have shown that Sxl-Pe transcripts and then Sxl-Pe proteins are first detected in ~NC11-NC12 embryos. In RNase protection experiments, the Sxl-Pe exon is observed in 2-4 hr embryos, but not detected in 5-8 hr, 14-12 hr, L1, L2, L3, or pupae. Northerns give pretty much the same picture. Western blots also show that Sxl-Pe proteins are first detectable around the blastoderm stage. So it is not at all clear why HA-Sxl-Pe proteins are first observed at stage 9 which, of course, is well after the time that the Sxl-Pm autoregulatory loop is established. 

      Given the obvious problems with the initial timing of somatic expression described here, it is hard to know what to make of the fact that HA-tagged Sxl-Pe proteins aren't observed in germ cells. 

      As for the presence of HA-Sxl-Pe proteins later than expected: While RNase protection/Northern experiments showed that Sxl-Pe mRNAs are expressed in 2-4 hr embryos and disappear thereafter, one could argue from the published Western experiments that the Sxl-PE proteins expressed at the blastoderm stage persist at least until the end embryogenesis, though perhaps at somewhat lower levels than at earlier points in development. So the fact that Goyal et al were able to detect HA-Sxl-Pe proteins in stage 9 embryos and later on in L1 larva probably isn't completely unexpected. What is unexpected is that the HA-Sxl-Pe proteins weren't present earlier. 

      We thank the reviewer for this detailed analysis. Since we were not focused on somatic expression of Sxl in this work, it is possible that stage 9 was the earliest stage we observed in our experiments, rather than the earliest stage in which it is ever observed. We will repeat these experiments to verify when the HA-tagged early Sxl protein is first observed. However, these comments have no bearing on our conclusions about Sxl expression in the germline, which is the focus of this manuscript.

      (6) The authors use RNAi and germline clones to demonstrate that sis-A is required for proper oogenesis: when sis-A activity is compromised in germ cells, i) tumorous ovary phenotypes are observed and ii) there is a reduction in the expression of Sxl-Pm protein. They are also able to rescue the phenotypic effects of sis-a knockdown by expressing a Sxl-Pm protein. While the experiments indicating sis-a is important for normal oogenesis and that at least one of its functions is to ensure that sufficient Sxl is present in the germline stem cells seem convincing, other findings would make the reader wonder whether Sis-A is actually functioning (directly) to activate Sxl transcription from promoter X. 

      It is true that we do not know the binding specificity for SisA, which is why we have made no claims about the directness of SisA regulation of Sxl. This does not change our conclusions that sisA is upstream of Sxl activation, since loss of sisA function has a similar phenotype to loss of Sxl, loss of sisA blocks Sxl protein expression, and expression of Sxl rescues the sisA mutant phenotype.

      The authors show that sis-a mRNAs and proteins are expressed in stage 3-5 germ cells (PGCs). This is not unexpected as the X-linked transcription factors that turn Sxl-Pe on are expressed prior to nuclear migration, so their protein products should be present in early PGCs. The available evidence suggests that their transcription is shut down in PGCs by the factors responsible for transcriptional quiescence (e.g., nos and pgc) in which case transcripts might be detected in only one or two PGC-which fits with their images. However, it is hard to believe that expression of Sis-A protein in pre-blastoderm embryos is relevant to the observed activation of the Sxl-Pm autoregulatory loop hours later in L2 larva. 

      It is also not clear how the very low level of gfp-Sis-A seen in only a small subset of migrating germ cells in stage 10 embryos (Figure S6) would be responsible for activating the Sxl-Pe10kb reporter in L1. It seems likely that the small amount of protein seen in stage 10 embryos is left over from the pre-cellular blastoderm stage. In this case, it would not be surprising to discover that the residual protein is present in both female and male stage 10 germ cells. This would raise further doubts about the relevance of the gfp-Sis-A at these early stages. 

      In fact, given the evidence presented implicating sis-a in activating Sxl, (the germline activation of the Sxl-Pe10kb reporter, the RNAi knockdowns, and the germ cell-specific sis-a clones) it is clear that the sis-A RNAs and proteins seen in pre-cellular blastoderm PGCs aren't relevant. The germline clone experiment (and also the RNAi knockdowns) indicates that sis-A must be transcribed in germ cells after Cas9 editing has taken place. Presumably, this would be after transcription is reactivated in the germline (~stage 10) and after the formation of the embryonic gonad (stage 14) so that the somatic gonadal cells can signal to the germ cells. With respect to the reporter, the relevant time frame for showing that sis-A is present in germ cells would be even later in L1. 

      The reviewer is correct in wondering how early sisA transcription can affect late Sxl activation, and we are clear about this conundrum in our manuscript. However, they are incorrect about the early sisA expression. Our experiments examining nascent sisA transcripts indicate that sisA is zygotically expressed in the formed germ cells rather than being leftover from expression in early nuclei. The fact that only a portion of germ cells express sisA at any time may well be due to a timing issue, where not all germ cells express sisA at the same time. They are also incorrect about the timing of Cas9 editing in the germline—the guide RNAs are expressed from a general promoter that is active both maternally and in the early embryo, and the Cas9 RNA from the nos promoter is deposited in the germ plasm where it is translated long before cellularization, meaning that sisA CRISPR knockout can begin at the earliest stages of germ cell formation or before.

      (7) As noted above, the data in this manuscript do not support the idea that Sxl-Pe proteins activate the Sxl-Pm female splicing in the germline. Flybase indicates that there is at least one other Sxl promoter that could potentially generate a transcript that includes the male exon but still could encode a Sxl protein. This promoter "Sxl-Px" is located downstream of Sxl-Pm and from its position it could have been included in the authors' 10 kb reporter. The reported splicing pattern of the endogenous transcript skips exon2, and instead links an exon just downstream of Sxl-Px to the male exon. The male exon is then spliced to exon4. If the translation doesn't start and end at one of the small upstream orfs in the exons close to Sxl-Px and the male exon, a translation could begin with an AUG codon in exon4 that is in frame with the Sxl protein coding sequence. This would produce a Sxl protein that lacks aa sequences from N-terminus, but still retains some function. 

      Another possible explanation for how gfp is expressed from the 10 kb reporter is that the transcript includes the "z" exon described by Cline et al., 2010.

      As discussed above, the exact location of the start site for the Sxl transcript in the germline remains to be determined, but does not affect the main conclusions of the paper.

    1. What typwriter-related project(s) are you working on this weekend?

      Maybe you're:

      Let us know what you're doing in the comments...

      Posted at https://old.reddit.com/r/typewriters/comments/1euount/what_typwriterrelated_projects_are_you_working_on/

    1. NPC; chromatin organization; cross-linking mass spectrometry; cryo-electron tomography; cryo-focused-ion-beam milling; in-cell structural biology; integrative modeling; mRNA transport; nuclear basket; nuclear pore complex; subtomogram analysis.

      denem 123

    1. Welcome back, and in this demo lesson, I want to give you some experience working with Service Control Policies (SCPs).

      At this point, you've created the AWS account structure which you'll be using for the remainder of the course. You've set up an AWS organization, with the general account that created it becoming the management account. Additionally, you've invited the production AWS account into the organization and created the development account within it.

      In this demo lesson, I want to show you how you can use SCPs to restrict what identities within an AWS account can do. This is a feature of AWS Organizations.

      Before we dive in, let's tidy up the AWS organization. Make sure you're logged into the general account, the management account of the organization, and then navigate to the organization's console. You can either type that into the 'Find Services' box or select it from 'Recently Used Services.'

      As discussed in previous lessons, AWS Organizations allows you to organize accounts with a hierarchical structure. Currently, there's only the root container of the organization. To create a hierarchical structure, we need to add some organizational units. We will create a development organizational unit and a production organizational unit.

      Select the root container at the top of the organizational structure. Click on "Actions" and then "Create New." For the production organizational unit, name it 'prod.' Scroll down and click on "Create Organizational Unit." Next, do the same for the development unit: select 'Route,' click on "Actions," and then "Create New." Under 'Name,' type 'dev,' scroll down, and click on "Create Organizational Unit."

      Now, we need to move our AWS accounts into these relevant organizational units. Currently, the Development, Production, and General accounts are all contained in the root container, which is the topmost point of our hierarchical structure.

      To move the accounts, select the Production AWS account, click on "Actions," and then "Move." In the dialogue that appears, select the Production Organizational Unit and click "Move." Repeat this process for the Development AWS account: select the Development AWS account, click "Actions," then "Move," and select the 'dev' OU before clicking "Move."

      Now, we've successfully moved the two AWS accounts into their respective organizational units. If you select each organizational unit in turn, you can see that 'prod' contains the production AWS account, and 'dev' contains the development AWS account. This simple hierarchical structure is now in place.

      To prepare for the demo part of this lesson where we look at SCPs, move back to the AWS console. Click on AWS, then the account dropdown, and switch roles into the production AWS account by selecting 'Prod' from 'Role History.'

      Once you're in the production account, create an S3 bucket. Type S3 into the 'Find Services' box or find it in 'Recently Used Services' and navigate to the S3 console. Click on "Create Bucket." For the bucket name, call it 'CatPics' followed by a random number—S3 bucket names must be globally unique. I’ll use 1, lots of 3s, and then 7. Ensure you select the US East 1 region for the bucket. Scroll down and click "Create Bucket."

      After creating the bucket, go inside it and upload some files. Click on "Add Files," then download the cat picture linked to this lesson to your local machine. Upload this cat picture to the S3 bucket by selecting it and clicking "Open," then "Upload" to complete the process.

      Once the upload finishes, you can view the picture of Samson. Click on it to see Samson looking pretty sleepy. This demonstrates that you can currently access the Samson.jpg object while operating within the production AWS account.

      The key point here is that you’ve assumed an IAM role. By switching roles into the production account, you’ve assumed the role called "organization account access role," which has the administrator access managed policy attached.

      Now, we’ll demonstrate how this can be restricted using SCPs. Move back to the main AWS console. Click on the account dropdown and switch back to the general AWS account. Navigate to AWS Organizations, then Policies. Currently, most options are disabled, including Service Control Policies, Tag Policies, AI Services, Opt-out Policies, and Backup Policies.

      Click on Service Control Policies and then "Enable" to activate this functionality. This action adds the "Full AWS Access" policy to the entire organization, which imposes no restrictions, so all AWS accounts maintain full access to all AWS services.

      To create our own service control policy, download the file named DenyS3.json linked to this lesson and open it in a code editor. This SCP contains two statements. The first statement is an allow statement with an effect of allow, action as star (wildcard), and resource as star (wildcard). This replicates the full AWS access SCP applied by default. The second statement is a deny statement that denies any S3 actions on any AWS resource. This explicit deny overrides the explicit allow for S3 actions, resulting in access to all AWS services except S3.

      Copy the content of the DenyS3.json file into your clipboard. Move back to the AWS console, go to the policy section, and select Service Control Policies. Click "Create Policy," delete the existing JSON in the policy box, and paste the copied content. Name this policy "Allow all except S3" and create it.

      Now, go to AWS Accounts on the left menu, select the prod OU, and click on the Policies tab. Attach the new policy "Allow all except S3" by clicking "Attach" in the applied policies box. We will also detach the full AWS access policy directly attached. Check the box next to full AWS access, click "Detach," and confirm by clicking "Detach Policy."

      Now, the only service control policy directly attached to production is "Allow all except S3," which allows access to all AWS products and services except S3.

      To verify, go back to the main AWS console and switch roles into the production AWS account. Go to the S3 console and you should receive a permissions error, indicating that you don't have access to list buckets. This is because the SCP attached to the production account explicitly denies S3 access. Access to other services remains unaffected, so you can still interact with EC2.

      If we switch back to the general account, reattach the full AWS access policy, and detach "Allow all except S3," the production account will regain access to S3. By following the same process, you’ll be able to access the S3 bucket and view the object once again.

      This illustrates how SCPs can be used to restrict access for identities within an AWS account, in this case, the production AWS account.

      To clean up, delete the bucket. Select the catpics bucket, click "Empty," type "permanently delete," and select "Empty." Once that's done, you can delete the bucket by selecting it, clicking "Delete," confirming the bucket name, and then clicking "Delete Bucket."

      You’ve now demonstrated full control over S3, evidenced by successfully deleting the bucket. This concludes the demo lesson. You’ve created and applied an SCP that restricts S3 access, observed its effects, and cleaned up. We’ll discuss more about boundaries and restrictions in future lessons. For now, complete this video, and I'll look forward to seeing you in the next lesson.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      We thank the reviewers for going through our manuscript and providing valuable feedback. We are grateful to all 3 reviewers for describing our findings as important and valuable, well-designed and robust, and of value to the Parkinson's and Crohn's disease communities studying LRRK2. Below we detail a point-by-point response to the reviewers.

      __Reviewer #1 (Evidence, reproducibility and clarity (Required)): __

      The paper by Dikovskaya and collaborators investigated the activitiy and expression of LRRK2 in different subtypes of splenic and intestinal immune cells, taking advantage of a novel GFP-Lrrk2 knockin mouse. Interestingly, they found that T-cell-released IL-4 stimulates Lrrk2 expression in B cells. I have a few comments and suggestions for the authors. 1) Figure 1C. LRRK2 KO cells display residual Rab10 phosphorylation. Do the authors have any idea of which kinase other than LRRK2 could be involved in this phosphorylation?

      As far as we are aware no other kinase is known to phosphorylate Rab10 at T73 in vivo. In vitro, recombinant Rab10 can be phosphorylated by MST3 at this site (Knebel A. et al, protocols.io https://dx.doi.org/10.17504/protocols.io.bvjxn4pn), but its relevance in vivo or in cells has not been shown. It is possible that the residual band recognised by anti-pT73 Rab10 ab in splenocytes is unspecific background, as it is mainly seen in LRRK2 KO spleen cells and not in other tissues. But to be certain that our assay assesses LRRK2-dependent Rab10 phosphorylation, we have always compared with the MLi-2 control.

      2) Since there are no good antibodies for IF/IHC as pointed by the authors, the GFP-Lrrk2 mouse gives the opportunity to check endogenous LRRK2 localization, i.e. in cells untreated or treated with IL-4 or other cytokines. Also, does endogenous GFP-LRRK2 accumulate into filaments/puncta upon MLi2 inhibition? The relocalization into filaments of inhibited LRRK2 has been observed in overexpression but not under endogenous expression. This analysis would be interesting also in light of the observed side effect of type-I inhibitors.

      We thank the reviewer for this suggestion. We will attempt a super-resolution microscopy using Airyscan with isolated B-cells treated with cytokine and/or LRRK2 inhibitor to address this question.

      3) Figure 5. The authors need to label more clearly the graphs referring to wt mice versus GFP-Lrrk2 KI mice.

      We have now labelled the panels referring to the WT mice only with "WT mice", to distinguish them from the other panels that incorporate data from both EGFP-Lrrk2 mice and their WT littermates used as a background.

      They should also replace GFP-LRRK2 with GFP-Lrrk2 since they edited the endogenous murine gene.

      Thank you, we have corrected it, and also the other mouse genotypes.

      4) In the material and methods MLi-2 administration in mice is indicated at 60 mg/kg for 2 hr whereas in suppl. figure 5 the indicated dose is 30 mg/kg. Please correct with the actual dose used.

      Thank you, we have corrected the mistake.

      5) The discovery of IL-4 as a Lrrk2 activator in B cells is a very interesting and novel finding. The authors could take advantage of the GFP tag to investigate LRRK2 interactome upon IL-4 stimulation (optional). Also, is the signaling downstream of IL-4 attenuated in Lrrk2 KO cells?

      We thank the reviewer for these interesting suggestions. The role of LRRK2 in IL-4 activated B-cells is currently under active research in the lab.

      Reviewer #1 (Significance (Required)):

      The manuscript is well designed and organized, and the experimental approaches are robust. These results are significant for the field as they add additional layers in the complex regulation and regulatory roles of LRRK2 in immunity, with implication for inflammatory disorders and Parkinson's disease.

      We thank the reviewer for their positive comments and for recognising our efforts to provide some clarity to a complex field.

      __Reviewer #2 (Evidence, reproducibility and clarity (Required)): __

      The authors present a flow cytometry methodology to assess LRRK2 expression and pathway markers in mouse models and explore LRRK2 in splenic and intestinal immune cells. This is a highly valuable study given the emerging understanding that LRRK2 pathway activity in peripheral tissues may be of crucial importance to Parkinson's disease and Crohn's disease. P8 : the authors state that their results indicate 'that the effects of LRRK2-R1441C mutation and inflammation on LRRK2 activity represent two different parallel pathways'. This seems like an overinterpretation as pathway suggests the presence of additional partners in the pathway while R1441C is a LRRK2 intrinsic modification. The results can equally be explained by synergistic effects between both activation mechanisms (mutant and inflammation).

      We agree with the reviewer, and have added this into the text. The sentence now reads "suggesting that the LRRK2-R1441C mutation and inflammation have different impacts on LRRK2 activity, either in parallel or in synergy."

      Methods and experiment descriptions in results : the authors appear to use the terms anti-CD3 stimulation and CD3 stimulation interchangeably, although it is not always clear in the text that these are synonymous. This should be clarified.

      We thank reviewer for pointing out this error on our part. We have made the necessary changes to always refer to the stimulation as anti-CD3.

      One major observation in this paper is that LRRK2 is not detected in gut epithelial cells as previously has been reported. It would be useful to comment on any differences between the presented protocol and the previous reports, in particular relating to the antigen retrieval step. In order to reinforce the finding, it would be useful to include in situ hybridization data that could further strengthen the observations of which cellular subtypes express LRRK2 and which do not. Indeed, while the KO control shows that there is an unacceptable high non-specific staining, it does not prove absence of expression. Also, can any conclusions be made about expression of LRRK2 in neural cells of the gut? This important information on LRRK2 detection in gut should be mentioned in the abstract and highlighted in the discussion.

      We thank the reviewer for pointing this out. In fact, we think the observation that LRRK2 is not detected in epithelial cells is so important that we have a separate manuscript exploring this point. Please see 1. Tasegian, A. et al.https://doi.org/10.1101/2024.03.07.582590 (2024). In this manuscript we have explored the expression of LRRK2 in human and murine intestinal epithelial cells using qPCR. Although we do not have in situ hybridization data, we believe that using both the EGFP-LRRK2 and the pRab10 flow cytometry, as well as qPCR and proteomics on selected cell types, corroborates our findings on the cell types that express LRRK2. We did not analyse LRRK2 expression in the neural cells of the gut, as the focus was on the immune cells, however we hope that others will use the tools developed here to explore this further.

      The authors mention in the discussion that they 'show for the first time that eosinophils also express active LRRK2 at levels comparable to B-cells and DCs.' The relevance of this finding should be further developed. Why is this important?

      We thank the reviewer for this point. We don't know how LRRK2 is important in these cells. However, as the role of LRRK2 in eosinophils and neutrophils has not yet been explored and both cell types play important roles in IBD, we think it is important to point out. We have now added a sentence to the discussion highlighting the importance of eosinophils in IBD. "Since eosinophils have recently been implicated as key player in intestinal defense and colitis(Gurtner et al, 2022), it will be interesting to evaluate LRRK2 functions in these cells."

      In the isolation of lamina propria cells, what efforts were made to characterize the degree of purification of the lamina propria cells compared to cells of other gut wall layers such as epithelium, muscularis mucosa, or deeper layers? Please specify.

      Isolation of lamina propria cells is a very well-established process (LeFrancois and Lycke, 'Isolation of Mouse Small Intestinal Intraepithelial Lymphocytes, Peyer's Patch, and Lamina Propria Cells.' Curr. Protocols in Immunology 2001), where we extensively wash off the epithelial layer before digesting the tissue for the LP. After the digestion the muscle and wall of the gut are still intact, so we do not get any contamination with other deeper layers. The subsets of cells we find in the LP are in line with isolations from other labs.

      Minor comments Figure 5G, for the graphs indicating LRRK2 activity and LRRK2 phosphorylation, the specific measures should be specified in the graph titles to avoid any ambiguity (pT73-Rab10, pS935-LRRK2).

      We have added the specifications to the new version of the figure.

      Suppl figure 1 : please specify the figure label and abbreviation AF568 in the legend. Suppl figure 2 : please specify the figure label and abbreviation anti-rb in the legend

      Thank you, we added the abbreviations to the legends. The Figure labels for both figures have been already included at the top of figure legends.

      Reviewer #2 (Significance (Required)):

      The authors present a flow cytometry methodology to assess LRRK2 expression and pathway markers in mouse models and explore LRRK2 in splenic and intestinal immune cells. This is a highly valuable study given the emerging understanding that LRRK2 pathway activity in peripheral tissues may be of crucial importance to Parkinson's disease and Crohn's disease.

      We thank the reviewer for recognising the value of this study.

      Reviewer #3

      Evidence, reproducibility and clarity

      The paper describes a set of experiments to analyse LRRK2 activity in tissues and despite it has very important findings and technical developments is largely descriptive. It does look like a collection of experiments more than a defined hypothesis and experiments to address that.

      We thank the reviewer for recognising the importance of our findings and the technical developments. We agree that the paper's focus is to describe where LRRK2 is expressed in immune cells, and in which cells is it active or activated after inflammation in a hypothesis-free unbiased manner. We believe this is important data to share as a resource for the wider LRRK2 community and we will submit the manuscript as a Resource.

      The flow cytometry assay of the first part is a great technical challenge and represents the establishment of a potentially very useful tool for the field. It would have been important to test other organs, either as controls or for example because of their relevance e.g. lungs. This first part is disconnected from the second part below.

      We thank the reviewer for pointing out that the pRab10 assay would be useful to apply to other organs too. Since we are interested in the role of LRRK2 in IBD, we had focused on applying the pRab10 assay on intestinal tissue, with spleens also analysed as major lymphoid organ and a source of immune cells that can translocate to the gut in inflammation. We hope that the publication of this method would allow other researchers to analyse other tissues in the future.

      The authors generated a new mouse KI mouse expressing EGFP-LRRK2 and show data the levels of LRRK2 expression are reduced in tissues at different degrees and established a flow cytometry assay to measure LRRK2 expression by monitoring the GFP signal. Interestingly they found that expression does not correlate with activity (as measured by phospho-Rabs). I suggest taking this part out as it breaks the flow of the paper. If data using this mouse is included, then microscopy should be included to complement the flow cytometry data. I understand the mice were used later with the anti-CD3 treatment, but it is very confusing that some experiments are done with EGFP-LRRK2 mice and others not. It does look in general like the mice do not behave as wild types and this is an important caveat. Without microscopy of the tissues or even cells (Figure 4) is hard to conclude much about these experiments.

      We thank the reviewer for this point and would like to explain. It is true that in Suppl Figure 5, we show reduction of LRRK2 signal in the EGFP-Lrrk2-KI mice. However, based on immunoblotting, a significant reduction in EGFP-LRRK2 expression levels was seen only in the brain, but not in the tissues we analysed, that is the spleen and the intestine. Further, we have shown clearly using proteomics (Fig. 3D and 5E), that the GFP signal in immune cells correlates very well with the WT LRRK2 expression. Therefore, we think that the GFP signal in these mice reflects WT LRRK2 expression pattern. Further, despite the limitations of reduced kinase activity that we thoroughly describe, we think this model is very useful since no antibodies work to stain for LRRK2 in mice. We therefore respectfully disagree with this reviewer that the EGFP-LRRK2 data should be taken out, as it has proven to be an invaluable tool to measure and track changes in endogenous LRRK2 expression. Moreover, we think the fact that LRRK2 expression does not correlate with levels of activity, that is, LRRK2 is more active in some immune cells than in others, is a very important finding that evidences the cell-specific regulation of LRRK2 activity beyond its expression level.

      We tried but failed to visualize the EGFP-LRRK2 signal using fluorescence microscopy in the tissue. This is most likely due to the low expression of LRRK2 (proteomics data suggests that even neutrophils express less than 9000 copies), confounded further by the high background autofluorescence in tissues, especially in the gut. We now explain the lack of tissue images from the EGFP-LRRK2 mice in the text. However, we can visualize the EGFP-LRRK2 in B cells, and we will provide these images in a revised version of the manuscript.

      We have also added the following paragraph to the discussion:

      "We complemented the pRab10 assay with the development of the EGFP-Lrrk2-KI reporter mouse. Although the reporter was initially designed as a fluorescent tracker for imaging LRRK2 localisation in cells and tissues, the low expression of LRRK2, combined with high and variable autofluorescence in tissues precluded its use for microscopy. Even in neutrophils, which express highest level of LRRK2 among immune cells, there are less than 9000 copies of LRRK2 per cell (Sollberger et al, 2024), making it difficult to identify localization. However, the EGFP signal was sufficient for flow cytometry-based measurements, where background autofluorescence of each cell type was taken into account and subtracted."

      Then the authors show that LRRK2 expression and activity is different in different cell types and depends on inflammation. The anti-CD3 strategy to induce inflammation is very different from physiological inflammation such as sepsis and LPS stimulation, so experiments with other stimuli could be important here to contribute to the message of inflammatory trigger of LRRK2 activation and decoupling of cell type.

      We thank the reviewer for this suggestion. We used the anti-CD3 model as it also causes intestinal inflammation, and mimics T-cell cytokine storms that happens in many diseases. However, for the revisions we will also test another model of inflammation as suggested, such as LPS stimulation, to measure how inflammation affects LRRK2 expression and activity.

      The IL-4 data is intriguing but too preliminary. The lack of strong effect of IFN-gamma is expected as the promoter of LRRK2 in mice and humans is different and human cells responds much better with regards to LRRK2 expression after IFN-gamma stimulation.

      We are confused by what the reviewer means by saying the IL-4 data is preliminary. We have shown by flow cytometry, immunoblotting, qPCR and proteomics that IL-4 induced LRRK2 expression in B-cells. So we are uncertain as to how else this can be shown. As to the effect of IFNγ on LRRK2 expression, it may indeed be that human cells respond better than murine cells. Importantly, the IL-4 ability to induce LRRK2 in B-cells is a novel and important finding, regardless of the effects of IFNγ.

      Reviewer #3 (Significance (Required))

      The paper describes a set of experiments to analyse LRRK2 activity in tissues and despite it has very important findings and technical developments is largely descriptive. It does look like a collection of experiments more than a defined hypothesis and experiments to address that.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #2

      Evidence, reproducibility and clarity

      The paper by Dikovskaya and collaborators investigated the activitiy and expression of LRRK2 in different subtypes of splenic and intestinal immune cells, taking advantage of a novel GFP-Lrrk2 knockin mouse. Interestingly, they found that T-cell-released IL-4 stimulates Lrrk2 expression in B cells.

      I have a few comments and suggestions for the authors.

      1. Figure 1C. LRRK2 KO cells display residual Rab10 phosphorylation. Do the authors have any idea of which kinase other than LRRK2 could be involved in this phosphorylation?
      2. Since there are no good antibodies for IF/IHC as pointed by the authors, the GFP-Lrrk2 mouse gives the opportunity to check endogenous LRRK2 localization, i.e. in cells untreated or treated with IL-4 or other cytokines. Also, does endogenous GFP-LRRK2 accumulate into filaments/puncta upon MLi2 inhibition? The relocalizaiton into filaments of inhibited LRRK2 has been observed in overexpression but not under endogenous expression. This analysis would be interesting also in light of the observed side effect of type-I inhibitors.
      3. Figure 5. The authors need to label more clearly the graphs referring to wt mice versus GFP-Lrrk2 KI mice. They should also replace GFP-LRRK2 with GFP-Lrrk2 since they edited the endogenous murine gene.
      4. In the material and methods MLi-2 administration in mice is indicated at 60 mg/kg for 2 hr whereas in suppl. figure 5 the indicated dose is 30 mg/kg. Please correct with the actual dose used.
      5. The discovery of IL-4 as a Lrrk2 activator in B cells is a very interesting and novel finding. The authors could take advantage of the GFP tag to investigate LRRK2 interactome upon IL-4 stimulation (optional). Also, is the signaling downstream of IL-4 attenuated in Lrrk2 KO cells?

      Significance

      The manuscript is well designed and organized, and the experimental approaches are robust. These results are significant for the field as they add additional layers in the complex regulation and regulatory roles of LRRK2 in immunity, with implication for inflammatory disorders and Parkinson's disease.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      The authors used structural and biophysical methods to provide insight into Parkin regulation. The breadth of data supporting their findings was impressive and generally well-orchestrated. Still, the impact of their results builds on recent structural studies and the stated impact is based on these prior works.

      Strengths:

      (1) After reading through the paper, the major findings are:

      - RING2 and pUbl compete for binding to RING0.

      - Parkin can dimerize.

      - ACT plays an important role in enzyme kinetics.

      (2) The use of molecular scissors in their construct represents a creative approach to examining inter-domain interactions.

      (3) From my assessment, the experiments are well-conceived and executed.

      We thank the reviewer for their positive remark and extremely helpful suggestions.

      Weaknesses:

      The manuscript, as written, is NOT for a general audience. Admittedly, I am not an expert on Parkin structure and function, but I had to do a lot of homework to try to understand the underlying rationale and impact. This reflects, I think, that the work generally represents an incremental advance on recent structural findings.

      To this point, it is hard to understand the impact of this work without more information highlighting the novelty. There are several structures of Parkin in various auto-inhibited states, and it was hard to delineate how this is different.

      For the sake of the general audience, we have included all the details of Parkin structures and conformations seen (Extended Fig. 1). The structures in the present study are to validate the biophysical/biochemical experiments, highlighting key findings. For example, we solved the phospho-Parkin (complex with pUb) structure after treatment with 3C protease (Fig. 2C), which washes off the pUbl-linker, as shown in Fig 2B. The structure of the pUbl-linker depleted phospho-Parkin-pUb complex showed that RING2 returned to the closed state (Fig. 2C), which is confirmation of the SEC assay in Fig. 2B. Similarly, the structure of the pUbl-linker depleted phospho-Parkin R163D/K211N-pUb complex (Fig. 3C), was done to validate the SEC data showing displacement of pUbl-linker is independent of pUbl interaction with the basic patch on RING0 (Fig. 3B). In addition, the latter structure also revealed a new donor ubiquitin binding pocket in the linker (connecting REP and RING2) region of Parkin (Fig. 9). Similarly, trans-complex structure of phospho-Parkin (Fig. 4D) was done to validate the biophysical data (Fig. 4A-C, Fig. 5A-D) showing trans-complex between phospho-Parkin and native Parkin. The latter also confirmed that the trans-complex was mediated by interactions between pUbl and the basic patch on RING0 (Fig. 4D). Furthermore, we noticed that the ACT region was disordered in the trans-complex between phospho-Parkin (1-140 + 141-382 + pUb) (Fig. 8A) which had ACT from the trans molecule, indicating ACT might be present in the cis molecule. The latter was validated from the structure of trans-complex between phospho-Parkin with cis ACT (1-76 + 77-382 + pUb) (Fig. 8C), showing the ordered ACT region. The structural finding was further validated by biochemical assays (Fig. 8 D-F, Extended Data Fig. 9C-E).

      The structure of TEV-treated R0RBR (TEV) (Extended Data Fig. 4C) was done to ensure that the inclusion of TEV and treatment with TEV protease did not perturb Parkin folding, an important control for our biophysical experiments.

      As noted, I appreciated the use of protease sites in the fusion protein construct. It is unclear how the loop region might affect the protein structure and function. The authors worked to demonstrate that this did not introduce artifacts, but the biological context is missing.

      We thank the reviewer for appreciating the use of protease sites in the fusion protein construct.  Protease sites were used to overcome the competing mode of binding that makes interactions very transient and beyond the detection limit of methods such as ITC or SEC. While these interactions are quite transient in nature, they could still be useful for the activation of various Parkin isoforms that lack either the Ubl domain or RING2 domain (Extended Data Fig. 6, Fig. 10). Also, our Parkin localization assays also suggest an important role of these interactions in the recruitment of Parkin molecules to the damaged mitochondria (Fig. 6).

      While it is likely that the binding is competitive between the Ubl and RING2 domains, the data is not quantitative. Is it known whether the folding of the distinct domains is independent? Or are there interactions that alter folding? It seems plausible that conformational rearrangements may invoke an orientation of domains that would be incompatible. The biological context for the importance of this interaction was not clear to me.

      This is a great point. In the revised manuscript, we have included quantitative data between phospho-Parkin and untethered ∆Ubl-Parkin (TEV) (Fig. 5B) showing similar interactions using phospho-Parkin K211N and untethered ∆Ubl-Parkin (TEV) (Fig. 4B). Folding of Ubl domain or various combinations of RING domains lacking Ubl seems okay. Also, folding of the RING2 domain on its own appears to be fine. However, human Parkin lacking the RING2 domain seems to have some folding issues, majorly due to exposure of hydrophobic pocket on RING0, also suggested by previous efforts (Gladkova et al.ref. 24, Sauve et al. ref. 29).  The latter could be overcome by co-expression of RING2 lacking Parkin construct with PINK1 (Sauve et al. ref. 29) as phospho-Ubl binds on the same hydrophobic pocket on RING0 where RING2 binds. A drastic reduction in the melting temperature of phospho-Parkin (Gladkova et al.ref. 24), very likely due to exposure of hydrophobic surface between RING0 and RING2, correlates with the folding issues of RING0 exposed human Parkin constructs.

      From the biological context, the competing nature between phospho-Ubl and RING2 domains could block the non-specific interaction of phosphorylated-ubiquitin-like proteins (phospho-Ub or phospho-NEDD8) with RING0 (Lenka et al. ref. 33), during Parkin activation. 

      (5) What is the rationale for mutating Lys211 to Asn? Were other mutations tried? Glu? Ala? Just missing the rationale. I think this may have been identified previously in the field, but not clear what this mutation represents biologically.

      Lys211Asn is a Parkinson’s disease mutation; therefore, we decided to use the same mutation for biophysical studies.  

      I was confused about how the phospho-proteins were generated. After looking through the methods, there appear to be phosphorylation experiments, but it is unclear what the efficiency was for each protein (i.e. what % gets modified). In the text, the authors refer to phospho-Parkin (T270R, C431A), but not clear how these mutations might influence this process. I gather that these are catalytically inactive, but it is unclear to me how this is catalyzing the ubiquitination in the assay.

      This is an excellent question. Because different phosphorylation statuses would affect the analysis, we ensured complete phosphorylation status using Phos-Tag SDS-PAGE, as shown below.

      Author response image 1.

      Our biophysical experiments in Fig. 5C show that trans complex formation is mediated by interactions between the basic patch (comprising K161, R163, K211) on RING0 and phospho-Ubl domain in trans. These interactions result in the displacement of RING2 (Fig. 5C). Parkin activation is mediated by displacement of RING2 and exposure of catalytic C431 on RING2. While phospho-Parkin T270R/C431A is catalytically dead, the phospho-Ubl domain of phospho-Parkin T270R/C431would bind to the basic patch on RING0 of WT-Parkin resulting in activation of WT-Parkin as shown in Fig. 5E. A schematic figure is shown below to explain the same.

      Author response image 2.

      (7) The authors note that "ACT can be complemented in trans; however, it is more efficient in cis", but it is unclear whether both would be important or if the favored interaction is dominant in a biological context.

      First, this is an excellent question about the biological context of ACT and needs further exploration. While due to the flexible nature of ACT, it can be complemented both in cis and trans, we can only speculate cis interactions between ACT and RING0 could be more relevant from the biological context as during protein synthesis and folding, ACT would be translated before RING2, and thus ACT would occupy the small hydrophobic patch on RING0 in cis. Unpublished data shows the replacement of the ACT region by Biogen compounds to activate Parkin (https://doi.org/10.21203/rs.3.rs-4119143/v1). The latter finding further suggests the flexibility in this region.        

      (8) The authors repeatedly note that this study could aid in the development of small-molecule regulators against Parkin to treat PD, but this is a long way off. And it is not clear from their manuscript how this would be achieved. As stated, this is conjecture.

      As suggested by this reviewer, we have removed this point in the revised manuscript.

      Reviewer #2 (Public Review):

      This manuscript uses biochemistry and X-ray crystallography to further probe the molecular mechanism of Parkin regulation and activation. Using a construct that incorporates cleavage sites between different Parkin domains to increase the local concentration of specific domains (i.e., molecular scissors), the authors suggest that competitive binding between the p-Ubl and RING2 domains for the RING0 domain regulates Parkin activity. Further, they demonstrate that this competition can occur in trans, with a p-Ubl domain of one Parkin molecule binding the RING0 domain of a second monomer, thus activating the catalytic RING1 domain. In addition, they suggest that the ACT domain can similarly bind and activate Parkin in trans, albeit at a lower efficiency than that observed for p-Ubl. The authors also suggest from crystal structure analysis and some biochemical experiments that the linker region between RING2 and repressor elements interacts with the donor ubiquitin to enhance Parkin activity.<br /> Ultimately this manuscript challenges previous work suggesting that the p-Ubl domain does not bind to the Parkin core in the mechanism of Parkin activation. The use of the 'molecular scissors' approach to probe these effects is an interesting approach to probe this type of competitive binding. However, there are issues with the experimental approach manuscript that detract from the overall quality and potential impact of the work.

      We thank the reviewer for their positive remark and constructive suggestions.

      The competitive binding between p-Ubl and RING2 domains for the Parkin core could have been better defined using biophysical and biochemical approaches that explicitly define the relative affinities that dictate these interactions. A better understanding of these affinities could provide more insight into the relative bindings of these domains, especially as it relates to the in trans interactions.

      This is an excellent point regarding the relative affinities of pUbl and RING2 for the Parkin core (lacking Ubl and RING2). While we could purify p-Ubl, we failed to purify human Parkin (lacking RING2 and phospho-Ubl). The latter folding issues were likely due to the exposure of a highly hydrophobic surface on RING0 (as shown below) in the absence of pUbl and RING2 in the R0RB construct. Also, RING2 with an exposed hydrophobic surface would be prone to folding issues, which is not suitable for affinity measurements. A drastic reduction in the melting temperature of phospho-Parkin (Gladkova et al.ref. 24) also highlights the importance of a hydrophobic surface between RING0 and RING2 on Parkin folding/stability. A separate study would be required to try these Parkin constructs from different species and ensure proper folding before using them for affinity measurements.

      Author response image 3.

      I also have concerns about the results of using molecular scissors to 'increase local concentrations' and allow for binding to be observed. These experiments are done primarily using proteolytic cleavage of different domains followed by size exclusion chromatography. ITC experiments suggest that the binding constants for these interactions are in the µM range, although these experiments are problematic as the authors indicate in the text that protein precipitation was observed during these experiments. This type of binding could easily be measured in other assays. My issue relates to the ability of a protein complex (comprising the core and cleaved domains) with a Kd of 1 µM to be maintained in an SEC experiment. The off-rates for these complexes must be exceeding slow, which doesn't really correspond to the low µM binding constants discussed in the text. How do the authors explain this? What is driving the Koff to levels sufficiently slow to prevent dissociation by SEC? Considering that the authors are challenging previous work describing the lack of binding between the p-Ubl domain and the core, these issues should be better resolved in this current manuscript. Further, it's important to have a more detailed understanding of relative affinities when considering the functional implications of this competition in the context of full-length Parkin. Similar comments could be made about the ACT experiments described in the text.

      This is a great point. In the revised manuscript, we repeated ITC measurements in a different buffer system, which gave nice ITC data. In the revised manuscript, we have also performed ITC measurements using native phospho-Parkin. Phospho-Parkin and untethered ∆Ubl-Parkin (TEV) (Fig. 5B) show similar affinities as seen between phospho-Parkin K211N and untethered ∆Ubl-Parkin (TEV) (Fig. 4B). However, Kd values were consistent in the range of 1.0 ± 0.4 µM which could not address the reviewer’s point regarding slow off-rate. The crystal structure of the trans-complex of phospho-Parkin shows several hydrophobic and ionic interactions between p-Ubl and Parkin core, suggesting a strong interaction and, thus, justifying the co-elution on SEC. Additionally, ITC measurements between E2-Ub and P-Parkin-pUb show similar affinity (Kd = 0.9 ± 0.2 µM) (Kumar et al., 2015, EMBO J.), and yet they co-elute on SEC (Kumar et al., 2015, EMBO J.).

      Ultimately, this work does suggest additional insights into the mechanism of Parkin activation that could contribute to the field. There is a lot of information included in this manuscript, giving it breadth, albeit at the cost of depth for the study of specific interactions. Further, I felt that the authors oversold some of their data in the text, and I'd recommend being a bit more careful when claiming an experiment 'confirms' a specific model. In many cases, there are other models that could explain similar results. For example, in Figure 1C, the authors state that their crystal structure 'confirms' that "RING2 is transiently displaced from the RING0 domain and returns to its original position after washing off the p-Ubl linker". However, it isn't clear to me that RING2 ever dissociated when prepared this way. While there are issues with the work that I feel should be further addressed with additional experiments, there are interesting mechanistic details suggested by this work that could improve our understanding of Parkin activation. However, the full impact of this work won't be fully appreciated until there is a more thorough understanding of the regulation and competitive binding between p-Ubl and RIGN2 to RORB both in cis and in trans.

      We thank the reviewer for their positive comment. In the revised manuscript, we have included the reviewer’s suggestion. The conformational changes in phospho-Parkin were established from the SEC assay (Fig. 2A and Fig. 2B), which show displacement/association of phospho-Ubl or RING2 after treatment of phospho-Parkin with 3C and TEV, respectively. For crystallization, we first phosphorylated Parkin, where RING2 is displaced due to phospho-Ubl (as shown in SEC), followed by treatment with 3C protease, which led to pUbl wash-off. The Parkin core separated from phospho-Ubl on SEC was used for crystallization and structure determination in Fig. 2C, where RING2 returned to the RING0 pocket, which confirms SEC data (Fig. 2B).

      Reviewer #3 (Public Review):

      Summary:

      In their manuscript "Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans", Lenka et al present data that could suggest an "in trans" model of Parkin ubiquitination activity. Parkin is an intensely studied E3 ligase implicated in mitophagy, whereby missense mutations to the PARK2 gene are known to cause autosomal recessive juvenile parkinsonism. From a mechanistic point of view, Parkin is extremely complex. Its activity is tightly controlled by several modes of auto-inhibition that must be released by queues of mitochondrial damage. While the general overview of Parkin activation has been mapped out in recent years, several details have remained murky. In particular, whether Parkin dimerizes as part of its feed-forward signaling mechanism, and whether said dimerization can facilitate ligase activation, has remained unclear. Here, Lenka et al. use various truncation mutants of Parkin in an attempt to understand the likelihood of dimerization (in support of an "in trans" model for catalysis).

      Strengths:

      The results are bolstered by several distinct approaches including analytical SEC with cleavable Parkin constructs, ITC interaction studies, ubiquitination assays, protein crystallography, and cellular localization studies.

      We thank the reviewer for their positive remark.

      Weaknesses:

      As presented, however, the storyline is very confusing to follow and several lines of experimentation felt like distractions from the primary message. Furthermore, many experiments could only indirectly support the author's conclusions, and therefore the final picture of what new features can be firmly added to the model of Parkin activation and function is unclear.

      We thank the reviewer for their constructive criticism, which has helped us to improve the quality of this manuscript.

      Major concerns:

      (1) This manuscript solves numerous crystal structures of various Parkin components to help support their idea of in trans transfer. The way these structures are presented more resemble models and it is unclear from the figures that these are new complexes solved in this work, and what new insights can be gleaned from them.

      The structures in the present study are to validate the biophysical/biochemical experiments highlighting key findings. For example, we solved the phospho-Parkin (complex with pUb) structure after treatment with 3C protease (Fig. 2C), which washes off the pUbl-linker, as shown in Fig. 2B. The structure of pUbl-linker depleted phospho-Parkin-pUb complex showed that RING2 returned to the closed state (Fig. 2C), which is confirmation of the SEC assay in Fig. 2B. Similarly, the structure of the pUbl-linker depleted phospho-Parkin R163D/K211N-pUb complex (Fig. 3C), was done to validate the SEC data showing displacement of pUbl-linker is independent of pUbl interaction with the basic patch on RING0 (Fig. 3B). In addition, the latter structure also revealed a new donor ubiquitin binding pocket in the linker (connecting REP and RING2) region of Parkin (Fig. 9). Similarly, trans-complex structure of phospho-Parkin (Fig. 4D) was done to validate the biophysical data (Fig. 4A-C, Fig. 5A-D) showing trans-complex between phospho-Parkin and native Parkin. The latter also confirmed that the trans-complex was mediated by interactions between pUbl and the basic patch on RING0 (Fig. 4D). Furthermore, we noticed that the ACT region was disordered in the trans-complex between phospho-Parkin (1-140 + 141-382 + pUb) (Fig. 8A) which had ACT from the trans molecule, indicating ACT might be present in the cis molecule. The latter was validated from the structure of trans-complex between phospho-Parkin with cis ACT (1-76 + 77-382 + pUb) (Fig. 8C), showing the ordered ACT region. The structural finding was further validated by biochemical assays (Fig. 8 D-F, Extended Data Fig. 9C-E).

      The structure of TEV-treated R0RBR (TEV) (Extended Data Fig. 4C) was done to ensure that the inclusion of TEV and treatment with TEV protease did not perturb Parkin folding, an important control for our biophysical experiments.

      (2) There are no experiments that definitively show the in trans activation of Parkin. The binding experiments and size exclusion chromatography are a good start, but the way these experiments are performed, they'd be better suited as support for a stronger experiment showing Parkin dimerization. In addition, the rationale for an in trans activation model is not convincingly explained until the concept of Parkin isoforms is introduced in the Discussion. The authors should consider expanding this concept into other parts of the manuscript.

      We thank the reviewer for appreciating the Parkin dimerization. Our biophysical data in Fig. 5C shows that Parkin dimerization is mediated by interactions between phospho-Ubl and RING0 in trans, leading to the displacement of RING2. However, Parkin K211N (on RING0) mutation perturbs interaction with phospho-Parkin and leads to loss of Parkin dimerization and loss of RING2 displacement (Fig. 5C). The interaction between pUbl and K211 pocket on RING0 leads to the displacement of RING2 resulting in Parkin activation as catalytic residue C431 on RING2 is exposed for catalysis. The biophysical experiment is further confirmed by a biochemical experiment where the addition of catalytically in-active phospho-Parkin T270R/C431A activates autoinhibited WT-Parkin in trans using the mechanism as discussed (a schematic representation also shown in Author response image 2).

      We thank this reviewer regarding Parkin isoforms. In the revised manuscript, we have included Parkin isoforms in the results section, too.

      (2a) For the in trans activation experiment using wt Parkin and pParkin (T270R/C431A) (Figure 3D), there needs to be a large excess of pParkin to stimulate the catalytic activity of wt Parkin. This experiment has low cellular relevance as these point mutations are unlikely to occur together to create this nonfunctional pParkin protein. In the case of pParkin activating wt Parkin (regardless of artificial point mutations inserted to study specifically the in trans activation), if there needs to be much more pParkin around to fully activate wt Parkin, isn't it just more likely that the pParkin would activate in cis?

      To test phospho-Parkin as an activator of Parkin in trans, we wanted to use the catalytically inactive version of phospho-Parkin to avoid the background activity of p-Parkin. While it is true that a large excess of pParkin (T270R/C431A) is required to activate WT-Parkin in the in vitro set-up, it is not very surprising as in WT-Parkin, the unphosphorylated Ubl domain would block the E2 binding site on RING1. Also, due to interactions between pParkin (T270R/C431A) molecules, the net concentration of pParkin (T270R/C431A) as an activator would be much lower. However, the Ubl blocking E2 binding site on RING1 won’t be an issue between phospho-Parkin molecules or between Parkin isoforms (lacking Ubl domain or RING2).

      (2ai) Another underlying issue with this experiment is that the authors do not consider the possibility that the increased activity observed is a result of increased "substrate" for auto-ubiquitination, as opposed to any role in catalytic activation. Have the authors considered looking at Miro as a substrate in order to control for this?

      This is quite an interesting point. However, this will be only possible if Parkin is ubiquitinated in trans, as auto-ubiquitination is possible with active Parkin and not with catalytically dead (phospho-Parkin T270R, C431A) or autoinhibited (WT-Parkin). Also, in the previous version of the manuscript, where we used only phospho-Ubl as an activator of Parkin in trans, we tested Miro1 ubiquitination and auto-ubiquitination, and the results were the same (Author response image 4).

      Author response image 4.

      (2b) The authors mention a "higher net concentration" of the "fused domains" with RING0, and use this to justify artificially cleaving the Ubl or RING2 domains from the Parkin core. This fact should be moot. In cells, it is expected there will only be a 1:1 ratio of the Parkin core with the Ubl or RING2 domains. To date, there is no evidence suggesting multiple pUbls or multiple RING2s can bind the RING0 binding site. In fact, the authors here even show that either the RING2 or pUbl needs to be displaced to permit the binding of the other domain. That being said, there would be no "higher net concentration" because there would always be the same molar equivalents of Ubl, RING2, and the Parkin core.

      We apologize for the confusion. “Higher net concentration” is with respect to fused domains versus the domain provided in trans. Due to the competing nature of the interactions between pUbl/RING2 and RING0, the interactions are too transient and beyond the detection limit of the biophysical techniques. While the domains are fused (for example, RING0-RING2 in the same polypeptide) in a polypeptide, their effective concentrations are much higher than those (for example, pUbl) provided in trans; thus, biophysical methods fail to detect the interaction. Treatment with protease solves the above issue due to the higher net concentration of the fused domain, and trans interactions can be measured using biophysical techniques. However, the nature of these interactions and conformational changes is very transient, which is also suggested by the data. Therefore, Parkin molecules will never remain associated; rather, Parkin will transiently interact and activate Parkin molecules in trans.

      (2c) A larger issue remaining in terms of Parkin activation is the lack of clarity surrounding the role of the linker (77-140); particularly whether its primary role is to tether the Ubl to the cis Parkin molecule versus a role in permitting distal interactions to a trans molecule. The way the authors have conducted the experiments presented in Figure 2 limits the possible interactions that the activated pUbl could have by (a) ablating the binding site in the cis molecule with the K211N mutation; (b) further blocking the binding site in the cis molecule by keeping the RING2 domain intact. These restrictions to the cis parkin molecule effectively force the pUbl to bind in trans. A competition experiment to demonstrate the likelihood of cis or trans activation in direct comparison with each other would provide stronger evidence for trans activation.

      This is an excellent point. In the revised manuscript, we have performed experiments using native phospho-Parkin (Revised Figure 5), and the results are consistent with those in Figure 2 ( Revised Figure 4), where we used the K211N mutation.

      (3) A major limitation of this study is that the authors interpret structural flexibility from experiments that do not report directly on flexibility. The analytical SEC experiments report on binding affinity and more specifically off-rates. By removing the interdomain linkages, the accompanying on-rate would be drastically impacted, and thus the observations are disconnected from a native scenario. Likewise, observations from protein crystallography can be consistent with flexibility, but certainly should not be directly interpreted in this manner. Rigorous determination of linker and/or domain flexibility would require alternative methods that measure this directly.

      We also agree with the reviewer that these methods do not directly capture structural flexibility. Also, rigorous determination of linker flexibility would require alternative methods that measure this directly. However, due to the complex nature of interactions and technical limitations, breaking the interdomain linkages was the best possible way to capture interactions in trans. Interestingly, all previous methods that report cis interactions between pUbl and RING0 also used a similar approach (Gladkova et al.ref. 24, Sauve et al. ref. 29).  

      (4) The analysis of the ACT element comes across as incomplete. The authors make a point of a competing interaction with Lys48 of the Ubl domain, but the significance of this is unclear. It is possible that this observation could be an overinterpretation of the crystal structures. Additionally, the rationale for why the ACT element should or shouldn't contribute to in trans activation of different Parkin constructs is not clear. Lastly, the conclusion that this work explains the evolutionary nature of this element in chordates is highly overstated.

      We agree with the reviewer that the significance of Lys48 is unclear. We have presented this just as one of the observations from the crystal structure. As the reviewer suggested, we have removed the sentence about the evolutionary nature of this element from the revised manuscript.

      (5) The analysis of the REP linker element also seems incomplete. The authors identify contacts to a neighboring pUb molecule in their crystal structure, but the connection between this interface (which could be a crystallization artifact) and their biochemical activity data is not straightforward. The analysis of flexibility within this region using crystallographic and AlphaFold modeling observations is very indirect. The authors also draw parallels with linker regions in other RBR ligases that are involved in recognizing the E2-loaded Ub. Firstly, it is not clear from the text or figures whether the "conserved" hydrophobic within the linker region is involved in these alternative Ub interfaces. And secondly, the authors appear to jump to the conclusion that the Parkin linker region also binds an E2-loaded Ub, even though their original observation from the crystal structure seems inconsistent with this. The entire analysis feels very preliminary and also comes across as tangential to the primary storyline of in trans Parkin activation.

      We agree with the reviewer that crystal structure data and biochemical data are not directly linked. In the revised manuscript, we have also highlighted the conserved hydrophobic in the linker region at the ubiquitin interface (Fig. 9C and Extended Data Fig. 11A), which was somehow missed in the original manuscript. We want to add that a very similar analysis and supporting experiments identified donor ubiquitin-binding sites on the IBR and helix connecting RING1-IBR (Kumar et al., Nature Str. and Mol. Biol., 2017), which several other groups later confirmed. In the mentioned study, the Ubl domain of Parkin from the symmetry mate Parkin molecule was identified as a mimic of “donor ubiquitin” on IBR and helix connecting RING1-IBR.

      In the present study, a neighboring pUb molecule in the crystal structure is identified as a donor ubiquitin mimic (Fig. 9C) by supporting biophysical/biochemical experiments. First, we show that mutation of I411A in the REP linker of Parkin perturbs Parkin interaction with E2~Ub (donor) (Fig. 9F). Another supporting experiment was performed using a Ubiquitin-VS probe assay, which is independent of E2. Assays using Ubiquitin-VS show that I411A mutation in the REP-RING2 linker perturbs Parkin charging with Ubiquitin-VS (Extended Data Fig. 11 B). Furthermore, the biophysical data showing loss of Parkin interaction with donor ubiquitin is further supported by ubiquitination assays. Mutations in the REP-RING2 linker perturb the Parkin activity (Fig. 9E), confirming biophysical data. This is further confirmed by mutations (L71A or L73A) on ubiquitin (Extended Data Fig. 11C), resulting in loss of Parkin activity. The above experiments nicely establish the role of the REP-RING2 linker in interaction with donor ubiquitin, which is consistent with other RBRs (Extended Data Fig. 11A).

      While we agree with the reviewer that this appears tangential to the primary storyline in trans-Parkin activation, we decided to include this data because it could be of interest to the field.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) For clarity, a schematic of the domain architecture of Parkin would be helpful at the outset in the main figures. This will help with the introduction to better understand the protein organization. This is lost in the Extended Figure in my opinion.

      We thank the reviewer for suggesting this, which we have included in Figure 1 of the revised manuscript.

      (2) Related to the competition between the Ubl and RING2 domains, can competition be shown through another method? SPR, ITC, etc? ITC was used in other experiments, but only in the context of mutations (Lys211Asn)? Can this be done with WT sequence?

      This is an excellent suggestion. In the revised Figure 5, we have performed ITC experiment using WT Parkin, and the results are consistent with what we observed using Lys211Asn Parkin.

      (3) The authors also note that "the AlphaFold model shows a helical structure in the linker region of Parkin (Extended Data Figure 10C), further confirming the flexible nature of this region"... but the secondary structure would not be inherently flexible. This is confusing.

      The flexibility is in terms of the conformation of this linker region observed under the open or closed state of Parkin. In the revised manuscript, we have explained this point more clearly.

      (4) The manuscript needs extensive revision to improve its readability. Minor grammatical mistakes were prevalent throughout.

      We thank the reviewer for pointing out this and we have corrected these in the revised manuscript.

      (5) The confocal images are nice, but inset panels may help highlight the regions of interest (ROIs).

      This is corrected in the revised manuscript.

      (6) Trans is misspelled ("tans") towards the end of the second paragraph on page 16.

      This is corrected in the revised manuscript.

      (7) The schematics are helpful, but some of the lettering in Figure 2 is very small.

      This is corrected in the revised manuscript.

      Reviewer #3 (Recommendations For The Authors):

      (1) A significant portion of the results section refers to the supplement, making the overall readability very difficult.

      We accept this issue as a lot of relevant data could not be added to the main figures and thus ended up in the supplement.  In the revised manuscript, we have moved some of the supplementary figures to the main figures.

      (2) Interpretation of the experiments utilizing many different Parkin constructs and cleavage scenarios (particularly the SEC and crystallography experiments) is extremely difficult. The work would benefit from a layout of the Parkin model system, highlighting cleavage sites, key domain terminology, and mutations used in the study, presented together and early on in the manuscript. Using this to identify a simpler system of referencing Parkin constructs would also be a large improvement.

      This is a great suggestion. We have included these points in the revised manuscript, which has improved the readability.

      (3) Lines 81-83; the authors say they "demonstrate the conformational changes in Parkin during the activation process", but fail to show any actual conformational changes. Further, much of what is demonstrated in this work (in terms of crystal structures) corroborates existing literature. The authors should use caution not to overstate their original conclusions in light of the large body of work in this area.

      We thank the reviewer for pointing out this. We have corrected the above statement in the revised manuscript to indicate that we meant it in the context of trans conformational changes.

      (4) Line 446 and 434; there is a discrepancy about which amino acid is present at residue 409. Is this a K408 typo? The authors also present mutational work on K416, but this residue is not shown in the structure panel.

      We thank the reviewer for pointing out this. In the revised manuscript, we have corrected these typos.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1:

      This research used cell-based signaling assay and Gaussian-accelerated molecular dynamics (GaMD) to study peptide-mediated signaling activation of Polycystin-1 (PC1), which is responsible for the majority of autosomal dominant polycystic kidney disease (ADPKD) cases. Synthetic peptides of various lengths derived from the N-terminal portion of the PC1 C-terminal fragment (CTF) were applied to HEK293T cells transfected with stalkless mouse CTF expression construct. It was shown that peptides including the first 7, 9, and 17 residues of the N-terminal portion could activate signaling to the NFAT reporter. To further understand the underlying mechanism, docking and peptide-GaMD simulations of peptides composed of the first 9, 17, and 21 residues from the N-terminal portion of the human PC1 CTF were performed. These simulations revealed the correlation between peptide-CTF binding and PC1 CTF activation characterized by the close contact (salt bridge interaction) between residues R3848 and E4078. Finally, a Potts statistical model was inferred from diverged PC1 homologs to identify strong/conserved interacting pairs within PC1 CTF, some of which are highly relevant to the findings from the peptide GaMD simulations. The peptide binding pockets identified in the GaMD simulations may serve as novel targets for the design of therapeutic approaches for treating ADPKD.

      We greatly appreciate the reviewer’s encouraging and positive comments. The reviewer’ specific comments are addressed pointwise below and changes to the text will be highlighted in yellow in the revised manuscript.

      (1) The GaMD simulations all include exogenous peptides, thus lacking a control where no such peptide is present (and only stalkless CTF). An earlier study (PNAS 2022 Vol. 119 No. 19 e2113786119) covered this already, but it should be mentioned here that there was no observation of close/activation for the stalkless CTF.

      We appreciate the reviewer’s concern about the lack of a control where no exogenous peptide is present. As suggested by the reviewer, we are adding more details about the study on the stalkless CTF as a control in the Introduction of the revised manuscript. 

      (2) Although 5 independent trajectories were generated for each peptide, the authors did not provide sufficient details regarding the convergence of the simulation. This leaves some uncertainties in their results. Given that the binding poses changed relative to the starting docked poses for all three peptides, it is possible that some other binding pockets and/or poses were not explored.

      We appreciate the reviewer’s comment regarding the convergence of the simulation results. This is clarified in the revised manuscript as: 

      “We have calculated free energy profiles of individual simulations for each system, including the p9, p17, and p21, as shown below (Figs. S5, S6 and S8). For the p9 peptide, the “Bound” lowenergy state was consistently identified in the 2D free energy profile of each individual simulation (Fig. S5). For the p17 peptide, Pep-GaMD simulations were able to refine the peptide conformation from the "Unbound” to the "Intermediate” and “Bound” states in Sim1 and Sim5, while the peptide reached only the "Intermediate” state in the other three simulations (Fig. S6). For the p21 peptide, Pep-GaMD was able to refine the peptide docking conformation to the

      "Bound” state in all the five individual simulations (Fig. S8).”

      “It is important to note that the free energy profiles calculated from GaMD simulations of PC1 CTF were not fully converged since certain variations were observed among the individual simulations. Nevertheless, these calculations allowed us to identify representative low-energy binding conformations of the peptides.”

      (3) The free energy profiles (Figures 2 to 4) based on the selected coordinates provide important information regarding binding and CTF conformational change. However, it is a coarsegrained representation and complementary analysis such as RDFs, and/or contact maps between the peptide and CTF residues might be helpful to understand the details of their interactions. These details are currently only available in the text. 

      Following the reviewer's suggestion, we have now included a set of protein contact maps showing contacts between the peptides and the TOP domain for each peptide in the representative "Bound” state in revised Supplementary Information (Fig. S4). The contact maps serve to visualize the list of contacts mentioned in the main text. This will be clarified in the revised manuscript.

      (4) The use of a stalkless CTF is necessary for studying the functions of the exogenous peptides. However, the biological relevance of the stalkless CTF to ADPKD was not clearly explained, if any.

      We appreciate the reviewer’s comment. As correctly assessed by the reviewer, the stalkless CTF is not a biological form of PC1 observed in ADPKD, but rather was used as the simplest or least complex system in which the activities and binding of exogenous peptides could be studied. However, in ADPKD, there are numerous missense mutations reported within the GPCR autoproteolysis-inducing (GAIN) domain that have been shown to prevent or inhibit cleavage at the GPCR-coupled proteolysis site (GPS). Loss of PC1 GPS cleavage, which is known to cause ADPKD, would retain or sequester the stalk tethered agonist within the interior of the GAIN domain, which would presumably interfere with interactions between stalk tethered agonist residues and the remainder of the CTF. Furthermore, there are 10 single nucleotide polymorphisms reported within the stalk sequence (ADPKD Variant Database; https://pkdb.mayo.edu/welcome), most of which we have found to significantly reduce CTF-mediated activation of the NFAT reporter (Magenheimer BS, et al., Constitutive signaling by the C-terminal fragment of polycystin1 is mediated by a tethered peptide agonist; bioRxiv 2021.08.05.455255). In particular, the ADPKD-associated G3052R stalk mutation that was analyzed along with the stalkless CTF by GaMD simulations (Pawnikar et al, PNAS, 2022) has the same reduction in activity as the stalkless CTF in the cellular signaling reporter assays and the same loss of closed conformation interactions in GaMD analyses. As such, we believe the stalkless CTF has biological relevance from the aspect that it mimics the deficiency in signaling activation observed for PC1 CTF stalk mutants. This is clarified in the revised manuscript in the Introduction, page 5, “constructs encoding a stalkless PC1 CTF (a nonbiological mutant of PC1 with deletion of the first 21 N-terminal residues of CTF) and three ADPKD-associated…”) and near the beginning of the Discussion, page 16, where the biological relevance of studying the stalkless CTF is explained

      (5) The authors might want to clarify if a stalkless CTF is commonly seen in ADPKD, or if it is just a construct used for this study.

      The stalkless CTF is not a biological form of PC1, but rather a construct used for this study. This was clarified in the revised manuscript (see response above).

      (6) (Pages 7-8) "...we generated expression constructs of mouse (m) PC1 consisting of the CD5 signal peptide sequence fused in frame with the stalk sequence of mCTF ...". What is the CD5 signal peptide sequence here? What is its use?

      The CD5 signal peptide sequence is “MPMGSLQPLATLYLLGMLVASVLG” from the T cell surface glycoprotein, CD5. Since the N-terminus of PC1 CTF is derived from a posttranslational, autocatalytic, endoproteolytic cleavage event, this isoform is already membraneembedded and therefore lacks its endogenous signal peptide. The CD5 signal peptide coding sequence is added to the PC1 CTF expression constructs in order to ensure translation and insertion of the encoded protein at the endoplasmic reticulum. Additional details were added to the Experimental Procedures, page 2 of Supporting Information.

      (7) (Page 8) "All peptides were appended with a C-terminal, 7-residue hydrophilic sequence (GGKKKKK) to increase solubility". How did the authors make sure that this sequence has no influence on the signaling? 

      To determine the possible effect of the hydrophilic GGKKKKK sequence on signaling, we had a ‘solubility tag’ peptide (LGGKKKKK) synthesized and purified by GenScript. It was necessary to add an N-terminal Leu residue to the 7-residue hydrophilic tag sequence in order for the highly hydrophilic peptide to be recovered. Effect of treatment with the solubility tag peptide on activation of the NFAT reporter was assessed for both empty vector- and ∆stalkCTF-transfected cells in 3 separate signaling experiments (see figure below). Each experiment also included a negative control treatment (no peptide/culture medium only addition) and a positive control treatment (stalk peptide p17). The p17 peptide we had available was derived from the stalk sequence of human PC1 that differs from the mouse PC1 sequence at residues 15 and 17, which are two poorly conserved positions within the stalk sequence (see Reviewer 2, Response 3). In the first experiment with the solubility tag and human p17 peptides (B in figure below), we inadvertently used the empty expression vector and ∆stalkCTF expression construct from mouse PC1. After realizing our error, we then performed 2 additional signaling experiments (C and D in figure below) with the ‘correct’ human ∆stalkCTF expression construct and empty vector. In the revised manuscript, we have provided the results from each of the 3 experiments as Fig. S2 (below).

      (8) (Page 9) "Using a computational model of the ΔStalk PC1 CTF developed previously". The authors might want to expand here a little to give a short review about the structure preparation.

      We appreciate the reviewer’s suggestion regarding the addition of details for structure preparation for Stalkless CTF. We have added these details in section “Docking and Pep-GaMD simulations of peptide agonist binding to stalkless PC1 CTF” on Page 10 in the revised manuscript:  “The cryo-EM structure of human PC1-PC2 complex (PDB: 6A70) was used to build the computational model for WT PC1 CTF. As the protein had several missing regions including the Stalk and several loops, homology modeling of the missing regions was done using I-TASSER web server. Using the WT PC1 CTF model, computational model for ΔStalk was generated by deleting the first 21 residues (3049-3069) of the WT PC1 and using the structure for stalkless CTF, we successfully docked the p9, p17 and p21 stalk peptides with HPEPDOCK.  The peptides all bound to the TOP domain and the interface between the TOP domain and extracellular loop 1 (ECL1) of CTF.”

      (9) How was "contact" defined when counting the number of contacts used in the 2D PMFs (Figures 2-4). Response: We appreciate the reviewer’s comment regarding the definition of the number of contacts used in the 2D PMFs. This has been clarified in the revised manuscript as: “The number of contacts is calculated between any atom pairs within 4 Å distance of the peptide and extracellular domains of PC1 protein.”

      (10) How was the ranking of GaMD clusters done? It looks from Figure 3A that the "intermediate" state is more favorable compared to the "bound" state, but it was claimed in the text the "bound" state was ranked 1st. 

      Thanks to the reviewer for this comment. It has been clarified in the revised

      Supplementary Information: “Three independent Pep-GaMD simulations were combined to perform structural clustering using the hierarchical agglomerative clustering algorithm in CPPTRAJ. A 3 Å RMSD cutoff was used for each peptide system. PyReweighting was then applied to calculate the original free energy values of each peptide structural cluster with a cutoff of 500 frames. The structural clusters were finally ranked according to the reweighted free energy values.” And in the revised main text: “It is important to note that the free energy profiles calculated from GaMD simulations of PC1 CTF were not fully converged since certain variations were observed among the individual simulations. The free energy values of 2D PMF minima shown in Figure 3A could differ from those in the 1D PMF minima of peptide structural clusters, especially with the usage of distinct reaction coordinates. Nevertheless, these calculations allowed us to identify representative low-energy binding conformations of the peptides.”

      (11) When mentioning residue pair distances, such as in the sentence "The distance between the TOP domain residue R3848 and PL residue E4078 was 3.8 Å (Fig. 4D)" on page 12, it should be clarified if these distances are average distance, or a statistical error can be given.

      We appreciate the reviewer’s comment regarding the TOP Domain and PL distance between residues R3848-E4078. This has been clarified on page 14 in the revised manuscript as:

      “The distance between the TOP domain residue R3848 and PL residue E4078 was 3.8 Å. The distance was extracted from the top-ranked structural cluster of the p21 bound to the ΔStalk CTF, corresponding to the “Closed/Active” low-energy conformational state. (Fig. 4E)”.

      (12) More analysis of the GaMD can be performed. For example, the authors observed a single "bound" state for p21, but there must be some flexibility in the peptide and the protein itself. The authors might want to consider adding some plots illustrating the flexibility of the peptide residues (for example, a RMSD plot). Contact maps can also be added to visualize the results currently discussed in the text. 

      We thank the reviewer for their constructive suggestions. To characterize flexibility of the peptide and protein in the revised manuscript, we have added plots of the TOP-PL interaction distance between residues R3848-E4078 in PC1, the radius of gyration (Rg) of p21 and root-mean square deviation (RMSD) of p21 relative to the starting HPEPDOCK conformation of the peptide in the new Fig. S7. The peptide-protein contact map has also been added in the new Fig. S4.

      (13) (Page 7) In the sentence `...sampled the "Closed/Active" low-energy state relative to the large number of Stalk-TOP contacts`, I suggest using "related to" instead of "relative to"

      We thank the reviewer for the comment, and we have replaced "relative to" to “related to” in the following sentence `...sampled the "Closed/Active" low-energy state relative to the large number of Stalk-TOP contacts`

      (14) (Page 7) In the sentence `Our previous study utilized expression constructs of human PC1 CTF, however, in order to prepare for ...`, "PC1 CTF, however," -> "PC1 CTF. However,"

      We thank the reviewer for the comment, and we have replaced "PC1 CTF, however," to "PC1 CTF. However," in the following sentence `Our previous study utilized expression constructs of human PC1 CTF, however, in order to prepare for ...`.

      Reviewer 2:

      The autosomal dominant polycystic kidney disease (ADPKD) is a major form of polycystic kidney disease (PKD). To provide better treatment and avoid side effects associated with currently available options, the authors investigated an interesting GPCR, polycystin-1 (PC1), as a potential therapeutic target. In vitro and in silico studies were combined to identify peptide agonists for PC1 and to elucidate their roles in PC1 signaling. Overall, regarding the significance of the findings, this work described valuable peptide agonists for PC1 and the combined in vitro and in silico approach can be useful to study a complex system like PC1. However, the strength of the evidence is incomplete, as more experiments are needed as controls to validate the computational observations. The work appears premature.

      We greatly appreciate the reviewer’s encouraging and positive comments. The reviewer’ specific comments are addressed pointwise below and changes to the text will be highlighted in yellow in the revised manuscript.

      (1) The therapeutic potential of PC1 peptide agonists is unclear in the introduction. For example, while the FDA-approved drug Jynarque was mentioned, the text was misleading as it sounded like Jynarque targeted PC1. In fact, it targets another GPCR, the vasopressin receptor 2 (V2). A clear comparison of targeting PC1 over V2 pathways and their therapeutic relevance can help the readers better understand the importance of this work. Importantly, a clear background on the relationship between PC1 agonism and treatments for ADPKD is necessary.

      We understand the confusion that was caused by the brevity of our introductory paragraph and will clarify the differences in therapeutic targeting between Jynarque and our PC1 stalk-derived peptides in the revised manuscript. We will also expound on the rationale for targeting PC1 agonism as a therapeutic approach for ADPKD versus Jynarque. For example: It is known that ADPKD disease severity is dependent on the functional levels of PC1. Jynarque is a small molecule antagonist of the arginine vasopressin receptor 2, V2R, whose signaling, and production of cAMP has been shown to be increased in ADPKD. As this drug targets one of the downstream aberrant pathways, it is only capable of slowing disease progression and has numerous undesirable side effects. We reasoned that a therapeutic agent capable of stimulating and thus augmenting PC1 signaling function would be a safer, cyst initiation-proximal treatment capable of preventing cyst formation with few side effects.

      (2) PC1 is a complex membrane protein, and most figures focus on the peptide-binding site. For general readers (or readers that did not read the previous PNAS publication), it is hard to imagine the overall structure and understand where the key interactions (e.g., R3848-E4078) are in the protein and how peptide binding affects locally and globally. I suggest enhancing the illustrations.

      We thank the reviewer for the constructive comment on adding more illustrations for the PC1 protein to understand the overall structure and the location of the key interaction R3848E4078. We have included these suggestions and modified the main figures in the revised manuscript.  

      (3) The authors used the mouse construct for the cellular assays and the peptide designs in preparation for future in vivo assays. This is helpful in understanding biology, but the relevance of drug discovery is weakened. Related to Point 1, the therapeutic potential of PC1 peptide agonist is largely missing.

      The therapeutic potential of a PC1 peptide agonist is addressed in response #1 above. As mentioned in the manuscript and recognized by the reviewer, the cellular signaling assays were performed with the mouse PC1 CTF expression construct and with peptides based on the mouse PC1 stalk sequence for future, pre-clinical studies, while the peptide binding studies were performed with the human PC1 stalk sequence. We feel the relevance for drug discovery is not significantly weakened for a number of reasons: 1) as shown in Fig. 1A, the stalk sequence is highly conserved between mouse and human PC1, specifically there are only 2 residue differences present within peptides p17 and p21. One of the differences is a ‘semi-conservative’ Gln-Arg substitution at peptide residue 15, while the second difference is a conservative Ile-Val substitution at peptide residue 17; 2) we have found that an Arg to Cys mutation within the mouse PC1 CTF stalk has the same effect on signaling as the corresponding human Gln to Cys ADPKD-associated mutation which was analyzed in Pawnikar et al., 2022; and 3) both peptide residues 15 and 17 represent highly variable positions within the PC1 stalk as shown in the sequence logo (below) of the stalk sequence from 16 vertebrate species; and 4) while addressing the potential effect of the hydrophilic solubility tag on stalk peptide-mediated rescue of CTF∆stalk signaling (see Reviewer 1 comments, point #7), we utilized the ‘human’ version of p17 as a positive control and tested its activation with both mouse and human CTF∆stalk expression constructs and found that human p17 peptide was also capable of stimulating the mouse CTF∆stalk protein (Fig. S2).

      Author response image 1.

      (4) More control experiments are needed. For example, a 7-residue hydrophilic sequence (GGKKKKK) is attached to the peptide design to increase solubility. This 7-residue peptide should be tested for PC1 activation as a control. Second, there is no justification for why the peptide design must begin with residue T3041. Can other segments of the stalk also be agonists?

      As mentioned above for Reviewer 1, the hydrophilic peptide has been synthesized and tested for activation of signaling by the stalkless CTF in the revised manuscript as Fig. S2. The design of peptides that begin with residue T3041 of mouse PC1 CTF is modeled on numerous similar studies for the family of adhesion GPCRs. Optimization of the binding and activity of the PC1 peptide agonist will be investigated in future studies and could include such parameters as whether the peptide must include the first residue and whether subsegments of the stalk are also agonists, however, we feel these questions are beyond the scope of this initial report.

      (5) There are some major concerns about the simulations: The GaMD simulations showed different binding sites of p-21, p-17, and p-9, and the results report the simulated conformations as "active conformational states". However, these are only computational findings without structural biology or mutagenesis data to validate. Further, neither docking nor the simulation data can explain the peptide SAR. Finally, it will be interesting if the authors can use docking or GaMD and explain why some peptide designs (like P11-P15) are less active (as control simulations).

      The reviewer brings up an important observation regarding differences in binding sites between peptides p9, p17 and p21. We will include discussion of this observation and our interpretations to the revised manuscript. While the present study is focused on identification of initial peptides that are able to activate the PC1 CTF, we shall include further mutation experiments and simulations, peptide SAR and optimization of the lead peptides in future studies. This has been clarified in the revised manuscript.

      (6) Additional experiments for the controls and for validating the simulations. Additional simulations to explain the SAR.

      We appreciate the reviewer’s comment for additional experiments for the controls and additional simulations to explain the SAR. For future studies, we shall include further mutation experiments and simulations, peptide SAR and optimization of the lead peptides.

      (7) What is the selectivity of the peptides between PC1 and PC2?

      We have not tested the selectivity of the peptides for PC1 versus PC2 primarily because transfection of PC2 does not activate the NFAT reporter. However, it is possible that co-transfection of PC2 with the PC1 CTF could alter stalk peptide binding. This will be important to consider in future studies.

      Reviewer 3:

      The authors demonstrate the activation of Polycystin-1 (PC1), a G-protein coupled receptor, using small peptides derived from its original agonist, the stalk TA protein. In the experimental part of the study, the authors performed cellular assays to check the peptide-induced reactivation of a mutant form of PC1 which does not contain the stalk agonist. The experimental data is supported by computational studies using state-of-the-art Gaussian accelerated Molecular Dynamics (GaMD) and bioinformatics analysis based on sequence covariance. The computer simulations revealed the mechanistic details of the binding of the said peptides with the mutant PC1 protein and discovered different bound, unbound, and intermediate conformations depending on the peptide size and sequence. The use of reliable and well-established molecular simulation algorithms and the physiological relevance of this protein autosomal dominant polycystic kidney disease (ADPKD) make this work particularly valuable.

      We greatly appreciate the reviewer’s encouraging and positive comments. The reviewer’ specific comments are addressed pointwise below and changes to the text will be highlighted in yellow in the revised manuscript.

      (1) No control has been used for the computational (GaMD) study as the authors only report the free energy surface for 3 highly agonistic peptides but for none of the other peptides that did not induce an agonistic effect. Therefore, in the current version, the reliability of the computational results is not foolproof.

      We appreciate the reviewer’s concern about the lack of control with the other peptides that did not induce an agonistic effect. To address the reviewer’s concern, we have included more details on the study of the stalkless CTF and the solubility tag peptide (Fig. S2) as controls in the revised manuscript.

      (2) All discussions about the residue level interactions focused only on geometric aspects (distance, angle, etc) but not the thermodynamic aspect (e.g. residue-wise interaction energy). Considering they perform a biased simulation; the lack of interaction energy analysis only provides a qualitative picture of the mechanism.

      As mentioned by the reviewer, we have added MM/PBSA analysis results in the revised manuscript and SI.

      Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) analysis was performed to calculate the binding free energies of peptides p9, p17 and p21 to PC1 CTF. The analysis was performed using the trajectory in which the peptide was bound to the receptor. In MM/PBSA, the binding free energy of the ligand (L) to the receptor (R) to form the complex (RL) is calculated as:

      where GRL is the Gibbs free energy of the complex RL, GR is the Gibbs free energy of the molecule R in its unbound state and GL is the Gibbs free energy of the molecule L in its unbound state, respectively. 

      𝛥𝐺𝑏𝑖𝑛𝑑 can be divided into contributions of different interactions as:

      in which

      where ΔEMM , ΔGsol , 𝞓H and −TΔS are the changes in the gas-phase molecular mechanics (MM) energy, solvation free energy, enthalpy and conformational entropy upon ligand binding, respectively. ΔEMM includes the changes in the internal energies ΔEint (bond, angle and dihedral energies), electrostatic energies ΔEelec , and the van der Waals energies ΔEvdW. ΔGsol is the sum of the electrostatic solvation energy ΔGPB/GB (polar contribution) and the nonpolar contribution ΔGSA between the solute and the continuum solvent. The polar contribution is calculated using either the Poisson Boltzmann (PB) or Generalized Born (GB) model, while the nonpolar energy is usually estimated using the solvent-accessible surface area (SASA) where 𝞬 is surface tension coefficient and b is the constant offset. The change in conformational entropy −TΔS is usually calculated by normal-mode analysis on a set of conformational snapshots taken from MD simulations. However, due to the large computational cost, changes in the conformational entropy are usually neglected as we were concerned more on relative binding free energies of the similar peptide ligands.

      MM/PBSA analysis was performed using the gmx_MMPBSA software with the following command line:

      gmx_MMPBSA -O -i mmpbsa.in -cs com.tpr -ci index.ndx -cg 1 13 -ct com_traj.xtc -cp topol.top -o FINAL_RESULTS_MMPBSA.dat -eo FINAL_RESULTS_MMPBSA.csv Input file for running MM/PBSA analysis:

      &general

      sys_name="Prot-Pep-CHARMM",

      startframe=1, endframe=200, # In gmx_MMPBSA v1.5.0 we have added a new PB radii set named charmm_radii. 

      # This radii set should be used only with systems prepared with CHARMM force fields. 

      # Uncomment the line below to use charmm_radii set

      # PBRadii=7,

      /

      &pb

      # radiopt=0 is recommended which means using radii from the prmtop file for both the PB calculation and for the NP

      # calculation

      istrng=0.15, fillratio=4.0, radiopt=0

      The relative rank of the overall peptide binding free energies (Table S1) was consistent with the experimental signaling data, i.e., p21>p9>p17, for which p21 showed the largest binding free energy value of binding (-40.29±6.94 kcal/mol).

      (3) It is not mentioned clearly whether the reader should interpret the free energy landscapes quantitatively or qualitatively. Considering no error analysis or convergence plots are reported for the GaMD free energy surfaces, it may be assumed the results are qualitative. The readers should consider this caveat and not try to quantitatively reproduce these free energy landscapes with other comparable techniques.

      We appreciate the reviewer’s comment whether the free energy landscapes should be interpreted quantitatively or qualitatively. The presented free energy landscapes could be considered semi-quantitative since the simulations are not fully converged. This will be clarified in the revised manuscript as: “It is important to note that the free energy profiles calculated from GaMD simulations of PC1 CTF were not fully converged since certain variations were observed among the individual simulations. Nevertheless, these calculations allowed us to identify representative low-energy binding conformations of the peptides.”

      (4) Energy decomposition analysis similar to the following paper (https://pubs.acs.org/doi/10.1021/bi201856m) should be provided to understand the residue level enthalpic contribution in the peptide-protein interaction.

      As mentioned by the reviewer, we have performed residue-wise interaction energy analysis and included the analysis results in the revised manuscript and SI.

      Residue-wise interaction energy analysis was performed on peptides p9, p17 and p21 using the trajectory in which the peptide was bound to the PC1 CTF using the gmx_MMPBSA software with the following command line:

      gmx_MMPBSA -O -i mmpbsa.in -cs com.tpr -ct com_traj.xtc -ci index.ndx -cg 3 4 -cp topol.top -o FINAL_RESULTS_MMPBSA.dat -eo FINAL_RESULTS_MMPBSA.csv -do FINAL_DECOMP_MMPBSA.dat -deo FINAL_DECOMP_MMPBSA.csv

      Input file for running residue-wise energy decomposition analysis:

      &general

      sys_name="Decomposition", startframe=1, endframe=200,

      # forcefields="leaprc.protein.ff14SB"

      /

      &gb

      igb=5, saltcon=0.150,

      /

      # make sure to include at least one residue from both the receptor #and peptide in the print_res mask of the &decomp section.

      # this requirement is automatically fulfilled when using the within keyword.

      # http://archive.ambermd.org/201308/0075.html

      &decomp

      idecomp=2, dec_verbose=3, print_res="A/854-862 A/1-853”,

      /

      Residue-wise energy decomposition analysis allowed us to identify key residues that contributed the most to the peptide binding energies. These included residues T1 and V9 in p9 (Table S2), residues T1, R15 and V17 in p17 (Table S3), and residues P10, P11, P19 and P21 in p21 and residue W3726 in the PC1 CTF (Table S4). The energetic contributions of these residues apparently correlated to the sequence coevolution predicted from the Potts model.

      (5) To showcase the reliability of the computational approach, the authors should perform the MD simulation studies with one peptide that did not show any significant agonistic effect in the experiment. This will work as a control for the computational protocol and will demonstrate the utility of the pep-GaMD simulation in this work.

      We appreciate the reviewer’s concern about the lack of control with the other peptides that did not induce an agonistic effect. It is difficult for us to add more MD simulations on the other peptides, due to student leave after PhD graduation. But to address the reviewer’s concern, we have included more details on the study of the stalkless CTF as a control in the revised manuscript.

      (6) To assess the accuracy of the computational results the authors should mention (either in the main text or SI) whether the reported free energy surfaces were the average of the five simulations or computed from one simulation. In the latter case, free energy surfaces computed from the other four simulations should be provided in the SI. In addition, how many binding unbinding events have been observed in each simulation should be mentioned.

      We appreciate the reviewer’s comment regarding convergence of the simulation free energy surfaces. In response to Reviewer 1, we have calculated free energy profiles of individual simulations for each system, including the p9, p17, and p21 (Figs. S5, S6 and S8). 

      “We have calculated free energy profiles of individual simulations for each system, including the p9, p17, and p21 (Figs. S5, S6 and S8). For the p9 peptide, the “Bound” low-energy state was consistently identified in the 2D free energy profile of each individual simulation (Fig. S5). For the p17 peptide, Pep-GaMD simulations were able to refine the peptide conformation from the "Unbound” to the "Intermediate” and “Bound” states in Sim1 and Sim5, while the peptide reached only the "Intermediate” state in the other three simulations (Fig. S6). For the p21 peptide, PepGaMD was able to refine the peptide docking conformation to the "Bound” state in all the five individual simulations (Fig. S8).”

      “It is important to note that the free energy profiles calculated from GaMD simulations of PC1 CTF were not fully converged since certain variations were observed among the individual simulations. Nevertheless, these calculations allowed us to identify representative low-energy binding conformations of the peptides.”

    1. Reviewer #2 (Public Review):

      Choi et al. describe a new approach for enabling input-specific CRISPR-based genome editing in cultured cells. While CRISPR-Cas9 is a broadly applied system across all of biology, one limitation is the difficulty in inducing genome editing based on cellular events. A prior study, from the same group, developed ENGRAM - which relies on activity-dependent transcription of a prime editing guide RNA, which records a specific cellular event as a given edit in a target DNA "tape". However, this approach is limited to the detection of induced transcription and does not enable the detection of broader molecular events including protein-protein interactions or exposure to small molecules. As an alternative, this study envisioned engineering the reconstitution of a split prime editing guide RNA (pegRNA) in a protein-protein interaction (PPI)-dependent manner. This would enable location- and content-specific genome editing in a controlled setting.

      The authors explored three different design possibilities for engineering a PPI-dependent split pegRNA. First, they tried splitting pegRNA into a functional sgRNA and corresponding prime editing transRNA, incorporating reverse-complementary dimerization sequences on each guide half. This approach, however, resulted in low editing efficiency across 7 different designs with various complementary annealing template lengths (<2% efficiency). They also tried inserting a self-splicing ribozyme within the pegRNA, which produces a functional pegRNA post-transcriptionally. The incorporation of a split-ribozyme, dependent on a PPI, could have been used to reconstitute the split pegRNA in an event-controlled manner. However again, only modest levels of editing were observed with the self-splicing ribozyme design (<2%). Finally, they tried splitting the pegRNA at the repeat:anti-repeat junction that was used to join the original dual-guide system comprised of a crRNA and tracrRNA, into a single-guide RNA. They incorporated the prime editing features into the tracrRNA half, to create petracrRNA. Dimerization was initially induced by different complementary RNA annealing sequences. Using this design, they were able to induce an editing efficiency of ~28% (compared to 37% efficiency using a positive control epegRNA guide).

      Having identified a suitable split pegRNA system, they next sought to induce the reconstitution of the two halves in a PPI-dependent manner. They replaced the complementary RNA annealing sequences with two different RNA aptamers (MS2 and BoxB). MS2 detects the MCP protein, while BoxB detects the LambdaN protein. Close proximity between MCP and LambdaN would thus bring together the two split pegRNA halves, creating a functional pegRNA that would enable prime editing at a specific target site. They demonstrated that they could induce MCP-BoxB proximity by fusing them to different dimerizing protein partners: 1) constitutive epitope-nanobody/antibody pairs such as scFv/GCN4 or NbALFA/ALFA-Tag; 2) split-GFP; or 3) chemically-induced protein pairs such as FKBP/FRB or ABI/PYL. For all of these approaches, they could achieve between ~20-60% normalized editing efficiency (relative to positive control editing levels with epegRNA). Additional mutation of the linkers between the RNA and aptamers could increase editing efficiency but also increase non-specific background editing even in the absence of an induced PPI.

      Additional applications of this overall strategy included incorporating the design with different DNA base editors, with the most promising examples shown with the base editors CBE4max and ABE8. It should be noted that these specific examples used a non-physiological LambdaN-MCP direct fusion protein as the "bait" that induced reconstitution of the two halves of the guideRNA, rather than relying on a true induced PPI. They also demonstrated that the recently reported RADARS strategy could be incorporated into their system. In this example, they used an ADAR-guide-RNA to drive the expression of a LambdaN-PCP fusion protein in the presence of a specific target RNA molecule, IL6. This induced LambdaN-PCP protein could then reconstitute the split peg-RNAs to drive prime editing. To enable this last application, they replaced the MS2 aptamer in their pegRNA with the PP7 aptamer that binds the PCP protein (this was to avoid crosstalk with RADARS, which also uses MS2/MCP interaction). Using this strategy, they observed a normalized editing efficiency of around 12% (but observed non-specific editing of around 8% in the absence of the target RNA).

      Strengths:

      The strengths of this paper include an interesting concept for engineering guide RNAs to enable activity-dependent genome editing in living cells in the future, based on discreet protein-protein interactions (either constitutively, spatially, or chemically induced). Important groundwork is laid down to engineer and improve these guide RNAs in the future (especially the work describing altering the linkers in Supplementary Figure 3 - which provides a path forward).

      Weaknesses:

      In its current state, the editing efficiency appears too low to be applied in physiological settings. Much of the latter work in the paper relies on a LambdaN-MCP direction fusion protein, rather than two interacting protein pairs. Further characterizations in the future, especially varying the transfection amounts/durations/etc of the various components of the system, would be beneficial to improve the system. It will also be important to demonstrate editing at additional sites; to characterize how long the PPI must be active to enable efficient prime editing; and how reversible the reconstitution of the split pegRNA is.

    1. Note: This response was posted by the corresponding author to Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      We would first like to thank the reviewers for their careful reading and thoughtful feedback.

      We have substantially revised the manuscript and included additional experimental evidence on O-GlcNAc and OGT/OGA protein levels in the placenta of embryos bearing the OGT-Y851A hypomorphic mutation.

      Overall, we believe our improved manuscript provides compelling evidence that the glycosyltransferase activity of OGT, and thus the O-GlcNAc modification itself, plays a sexually dimorphic function in placental development and the developmental repression of retrotransposons in the developing embryo.

      We have addressed each of the reviewers' comments below. The original comments (C) are in italic, our responses (R) in Roman font.

      Reviewer #1

      Evidence, reproducibility and clarity

      C1: Formichetti at el. developed mice with OGT catalytic dead mutations and then studied their function during early embryogenesis. Not surprisingly, dramatic reduction in OGT activity failed to produce embryos; however, mild reduction in OGT did produce animals. The authors then use the T931 animals that have a mild reduction in activity to further characterize the function in the early embryo. Not surprisingly, male mice showed changes in gene expression, implantation sub-lethality, and an uptick in loss of retrotransposon silencing. The authors also show that an even milder reduction in OGT activity (Y851A) effects male placenta function and chromatin remodeling. Finally, the authors make a less stable OGT transgene within the mouse and again found embryogenesis issues in the males and alterations in numerous gene families including mTOR signaling and p53 function. All in all, this is an interesting study that track functions of OGT in early embryonic development. The studies are well-controlled and rigorous.

      R1: We thank the reviewer for their clear understanding and their appreciation of the rigor and impact of this work.

      Significance

      C2: This is a good study and novel. Not only is it of interest to reproductive biologist, but it echos themes found in O-GlcNAc biology.

      R1: We are pleased that the reviewer underlined the novelty of the study and its impact across fields.

      Reviewer #2

      Evidence, reproducibility and clarity

      Comments to authors

      C3: To investigate the function of OGT at specific developmental stages, the authors perturbed OGT's function in vivo by creating a murine allelic series featuring four single amino acid substitutions that variably reduced OGT's catalytic activity. The goal was to identify the direct effect of O-GlcNAcylation, using a sophisticated collection of genetic mutants to evaluate in vivo the role of this modification at early stages of development. Overall, the severity of embryonic lethality correlated with the extent of catalytic impairment of OGT, demonstrating that the O-GlcNAc modification is essential for early development.The study represents a substantial advance in our understanding of OGT and O-GlcNAcylation in mammalian development. The creation of novel murine models and inducible systems is an important contribution, providing powerful tools for future research in this field. The insights into the role of OGT's catalytic activity and its involvement in epigenetic regulation during embryonic development are noteworthy, opening new avenues for research.

      R3: We thank the reviewer for their insightful comments. We are grateful for the supporting statements. Please find below detailed response to all your comments.

      However, there are a few considerations and concerns:

      Major:

      C4: 1. An assumption of the study is that different mutations cause different levels of O-GlcNAcylation rather than alterations in substrate specificity. It might be important to test, at least in cultured cells, that the different mutations do not change the preference of OGT to modify certain proteins rather than others, which can provide alternative explanations for their findings.

      R4: Thanks for asking this question, it helped us to better explain the rationale behind the choice of the Ogt amino-acid substitutions.

      This is a critical point that we carefully considered in the design of the single amino-acid substitutions. Two lines of evidence support that the precise mutations created impact the catalytic rate without modifying the substrate specificity:

      First, as explained in the text, the choice of the single amino-acid substitutions was driven by previous structural and enzymology knowledge. The impact of the four point mutations selected on OGT protein stability and on the Michaelis-Menten kinetic values had previously been determined experimentally (Fig. 1A legend and Martinez-Fleites, C. et al. Nature Structure Molecular Biology 2008; https://doi.org/10.1038/nsmb.1443).

      There is a second important rationale that we added in the revised manuscript: the four point mutations selected are all located in the catalytic domain (specifically, H568A in the N-Cat domain and Y851A, T931A and Q849A in the C-Cat domain), while the substrate recognition is operated via two other domains namely the intervening domain (Int-D) https://doi.org/10.1038/s41589-023-01422-2) and the tetratricopeptide Repeat (TPR) superhelix (10.1021/jacs.7b13546; https://doi.org/10.1073/pnas.2303690120). Therefore, for both these reasons, it is extremely unlikely that these mutations could influence the substrate specificity.

      C5.1: 2. In Fig 1D and 1H, the thresholds to define a gene or TE as differentially expressed are not strong. According to the figure legends, "any" change in terms of log2Fc was considered as DE and colored. I think the figures should illustrate better that the changes are subtle, by for example adding a dotted line (at least) in the value 0.5 of the y-axis. These subtle transcriptional changes should be reflected better in certain paragraphs where the expression of TEs are presented/and discussed as a hallmark of the absence of O-GlcNAcylation in the OGT-mutants. The same happens with Suppl Fig 3C (changes are very minor). {. Applying a stronger threshold, among the upregulated genes, only Xist will be significantly overexpressed. If a gentle threshold needs to be applied to this data, authors should at least justify the reasons behind doing so. Same for Fig2D.

      R5.1: The reviewer means Figure 2D for MA plot of gene expression and Figure 2H for retrotransposons expression. These figures now include a dash line to indicate Log2FC = 0.5 (as all MA plots).

      The text is explicit on the subtle changes in transcription, it reads "with 2/3 of the genes downregulated and 90% of the significant changes below 1 log__2__FC"; "most of the Ogt__T931del/Y embryos showed a low magnitude upregulation of retrotransposons".

      The revised text states "Notably, most of the OgtT931__del/Y embryos showed a low magnitude (log2FC < 1) upregulation of retrotransposons".

      We expand on this topic in the next response (R5.2) noting that changes in gene expression upon O-GlcNAc perturbation in different systems were previously characterized as subtle and widespread. We suggest that this phenotype may arise from the scarcely understood pleiotropic function of O-GlcNAc in fine-tuning gene expression; this phenotype could have a biological significance.

      C5.2: If a gentle threshold needs to be applied to this data, authors should at least justify the reasons behind doing so. Same for Fig2D.

      R5.2: Previous studies in different systems reported that O-GlcNAc perturbation causes a widespread change in gene expression of low magnitude (https://doi.org/10.1101/2024.01.22.576677, https://www.pnas.org/doi/10.1073/pnas.2218332120). We use the same thresholds as a recent functional Ogt study in ES cells to call differentially expressed genes, specifically: p<0.05 (Wald test), any FC (Li et al. PNAS 2023, https://www.pnas.org/doi/10.1073/pnas.2218332120). The p value threshold is standard; the absence of FC threshold is dictated by the insufficient knowledge of the significance of the low magnitude changes observed across many transcripts.

      C6: 3. In Figure 2B, the T931del allele was recovered in the blastocyst population with a very high frequency, even higher than the male WT group (T931del: 10; WT: 3). This observation suggests that the T931del allele did not significantly affect blastocyst survival. Further clarification or additional experiments might be necessary to understand the implications of this finding on early developmental stages.

      R6: This is only a hint as the numbers of blastocysts recovered were too small to perform statistics on Mendelian distribution. Thus, more experiments are needed to perform these statistical tests. These experiments are onerous because the low frequency of germline transmission is incompatible with maintaining this mutation by breeding heterozygous animals. Because of this, a new mouse line needs to be created by CRISPR-HDR targeting in the zygote in order to compute statistics on Mandelian ratios. Importantly, this question - does T931del affect blastocyst survival? - is peripheral, and the results of these experiments would not affect our conclusions in any way.

      C7: 4. Similarly, in Figure 2G, there is an apparent higher expression of TE expression in the T931A/Y embryos group than in the T931del/Y group, which combined with the higher frequency of blastocyst generated in this latest group it may indicate a deeper molecular consequence after the deletion of the T931. A comparison of the transcriptome between these two cell lines help to address this possibility. Also, the authors should compare the O-GlcNAc levels of WT, T931A, and T931del mutant blastocysts by immunostaining, similar to what was done in Figure S5F.

      R7: We agree that a direct comparison between the two mutations of the T931 residue would be interesting; however, this comment is very difficult to address experimentally for the reasons outlined below:

      Firstly, it is not possible to perform a statistical comparison of the transcriptome T931A/Y VS. T931del/Y with the data generated because the number of hemizygous T931A/Y (n=2) is too small. Hence, it cannot be ruled out that the seemingly milder retrotransposon reactivation in one of the T931A/Y embryos could have occurred by chance.

      Secondly, considering the low magnitude effect on gene expression changes upon O-GlcNAc genetic perturbation, to statistically assess the penetrance of the molecular phenotype and perform the differential expression analysis, numerous (>>3) hemizygous blastocysts of each genotype would be needed. Because females heterozygous for the T931 mutations transmit the mutant allele at very low frequency, these experiments require numerous de novo CRISPR injection sessions.

      Thirdly, for the immunostaining of O-GlcNAc to be semi-quantitative, a large number of hemizygous blastocysts for each genotype would be required (note that in Figure S5F, 29 morulae per condition were imaged), thus requiring numerous CRISPR injection experiments as discussed above. Moreover, O-GlcNAc changes could be subtler than what expected based on the strong reduction of OGT activity, since as a compensatory mechanism Ogt expression is upregulated in the Ogt__T931A/del blastocysts (Fig. S2D), making a quantification even more challenging despite a high number of stained embryos.

      In sum, these in vivo experiments are difficult and require sacrificing many animals (about 20 females per CRISPR injection experiment). Because the results would bring refinement to the study but would not change our conclusions, we suggest that the cost/benefit is too high.

      C8: 5. In Boulard et al. 2019 O-GlcNAcylation was shown to be sufficient to modulate expression of DNA methylation-dependent TEs. It would be interesting to know (or at least discuss) if the changes in TE expression observed in OGT-mutant embryos in this study involve changes in DNA methylation. Ideally, some DNA methylation measurement optimized for low input numbers of cells would be useful.

      R8: Thank you for making the link with our previous study. In the PNAS paper, we report that targeted removal of O-GlcNAc at proteins bound to specific TEs (e.g. IAPez) causes their full-blown reactivation without detectable changes in DNA methylation, thus suggesting a role of the O-GlcNAc modification for the silencing of methylated TEs downstream or independent of DNA methylation. We agree that it would be informative to quantify DNA methylation in the T931-mutant blastocysts to test if the in vitro result is the same in vivo, but this would require performing onerous microinjection sessions as explained above.

      C9: 6. The data related with the OGT-degron system in MEs seem disconnected with the rest of the manuscript. While the developmental models (blastocyst, etc) elegantly assess the contribution of O-GlcNAcylation to the control of cell survival and gene expression through the use of different OGT mutants, the degron system is a system of graded depletion that unfortunately was only possible to be used in MEFs (instead of embryos). Thus, the results obtained with the degron system in MEFs are difficult to intersect with the data from the use of OGT-mutants in embryos. Even though there are obvious interesting questions that one may want to know about this OGT degron MEF system, none of them would demonstrate a direct role for O-GlcNAcylation in cellular function, the major point addressed in the developmental system. Using the degron system in embryonic stem cells might have provided a more parallel comparison. The authors should discuss this point in more detail and either use ESC instead of MEFs or provide a stronger justification for the use of MEFs over ESC.

      R9: We thank the reviewer for their clear understanding of the system. The choice of primary MEF as an in vitro model was imposed by technical limitations we encountered during the study. We fully agree that ES cells is the model of choice for preimplantation embryos; thus we initially derived ES cells and obtained only one male clone bearing the AID degron system. Upon auxin addition to the culture media, OGT's level remained unchanged in ES cells. Thus, the ES cells model was not usable. To test the AID degron in a different cell type, we then derived MEFs and showed its effectiveness (Figures 4C and S4C-E), which also allowed to collect functional data on OGT's cellular function (Figures 4D-F). We took the comment on board and clarified the rationale of studying MEFs in the revised manuscript. We agree that it remains to be verified that the OGT-dependent pathways uncovered in MEFs are relevant in the preimplantation embryo. Despite this caveat, we feel the mouse model for endogenous OGT-degron, as well as the negative results in vivo and conclusions in MEFs should be shared with the community, which could take advantage of our results to refine the system.

      Minor:C10: 7. In Fig 2C the color and shape codes are confusing to understand - there are some colors/shapes that are not represented in the PCA plot. The same in Fig 3H, where in the PCA plot there are pink triangles that do not match with the code legends.

      R10: We apologize for the confusion with the legends of Figures 2C and 3H, that we have made unambiguous in the revised version (as well as Figures S2B,C and S3C).

      C11: 8. In the figure legends of Figures 2D, 2E, 2F, and 2H, the notation should be corrected from "OgtT931A/Y" to "OgtT931del/Y".

      R11: This has been corrected; many thanks for bringing it to our attention.

      Significance

      C12: To investigate the function of OGT at specific developmental stages, the authors perturbed OGT's function in vivo by creating a murine allelic series featuring four single amino acid substitutions that variably reduced OGT's catalytic activity. The goal was to identify the direct effect of O-GlcNAcylation, using a sophisticated collection of genetic mutants to evaluate in vivo the role of this modification at early stages of development. Overall, the severity of embryonic lethality correlated with the extent of catalytic impairment of OGT, demonstrating that the O-GlcNAc modification is essential for early development.

      R12: We thank the reviewer for their clear understanding of our work and their appreciation of the biological importance of the findings.

      Reviewer #3

      Evidence, reproducibility and clarity

      C13: This is a conceptually interesting paper that attempts to leverage the knowledge of OGT catalysis to begin to dissect OGT function. The evidence is presented I a straightforward fashion and is in general well documented. The breeding strategies are well informed and the paper draws heavily on previous work carried out in the mouse.

      R13: We greatly appreciate the overall supporting review. However, we fail to understand what they mean with "the paper draws heavily on previous work carried out in the mouse". This comment may stem from a misunderstanding because this work is not based on any previously published study. Specifically, neither the seven murine alleles presented and analyzed nor the single embryo-transcriptomic data sets on which our conclusions are based have been published elsewhere.

      To put this work into context, before our study there were two seminal studies published two decades ago that reported the essential role of Ogt for mouse development, but no molecular profiling was performed (10.1073/pnas.100471497, 10.1128/mcb.24.4.1680-1690.2004). The two Ogt loss-of-function alleles studied in these papers were deemed as not suitable for interrogating molecular phenotypes because they caused cell death that confounds molecular profiling and embryonic lethality at implantation, thus preventing study of the sexually-dimorphic role of Ogt placenta. To overcome this long-standing problem, we created new seven murine alleles, which allowed us to tease apart molecular phenotypes at key stages of mouse embryonic development, focusing on the blastocyst and the placenta.

      Significance

      C14: The paper describes tools which will help dissect the many potential roles of O-GlcNAc addition in early development. As it stands, this is a descriptive manuscript that will lead to hypothesis generation and testing and this should not be undervalued. The biological reagents produced and characterized will be of general interest to the field. Most of the findings presented represented a verification of existing ideas in the field but this is not meant as a criticism since part of the motivation for the approach was to generate a reproducible system for analyzing the biological phenomena.

      R14: We thank the reviewer for their appreciation of the importance of experimentally testing ideas shared in the field without direct evidence.

      However, we must respectfully disagree with the qualification of "descriptive manuscript". This qualification may stem from the particularly difficult challenge to accessing the molecular details on how the O-GlcNAc modification exerts the biological functions we report. We are fully cognizant of the limitations of the study that we discussed in the discussion section and in R20.2. However, we feel that the adjective "descriptive" is not a fair qualification because we provide numerous novel functional evidence. Specifically, we introduce two novel orthogonal in vivo perturbations for endogenous Ogt that allowed us to interrogate for the first time its function in the developing mouse embryo. These perturbations allow us to draw causative conclusions (not descriptive) on the essential role of the O-GlcNAc modification itself for preimplantation development, its sexually-dimorphic role in the placenta and its requirement in vivo for the stable repression of retrotransposons.

      C15: There are perhaps some bioinformatic shortcuts taken that may need to be corrected upon thorough review. These do not lessen the overall impact of the contribution.

      R15: All the code written for the bioinformatic analyses performed in this study is publicly available: https://github.com/boulardlab/Ogt_mouse_models_Formichetti2024. The reviewer needs to specify which bioinformatic analysis they suggest could be improved.

      Reviewer #4 (Evidence, reproducibility and clarity (Required)):

      Summary

      C16: O-GlcNAcylation is the fundamental post-translational modification of numerous nuclear and cytosolic proteins. OGT is the sole enzyme catalyzing O-GlcNAc addition onto the proteins. The essentiality of OGT for early development and cellular viability has been established by using OGT-KO mice and cell lines. However, it remains to be elucidated whether the catalytic activity of OGT is required for the early development, and if the catalytic activity of OGT is required what are the functions of OGT or O-GlcNAcylation in early development due to a lack of appropriate mouse models. To overcome the technical difficulty of manipulating the levels of O-GlcNAcylation in early embryos, Formichetti et al. created the series of four mouse models (OgtY851A, OgtT931A, OgtQ849N, and OgtH568A) with different OGT activity by introducing single amino acid substitution in the catalytic domain. By analyzing the inheritance of the hypomorphic OGT alleles and the lethality of mouse embryos, they discovered OGT activity is a critical factor for early development. Subsequently, RNA-seq analyses with two mouse models showing the maternal inheritance of the hypomorphic OGT alleles indicated that sever hypo-OGT activity altered transcription and silencing of retrotransposon in preimplantation development while mild reduction of OGT's activity affected placental development in a sexually dimorphic manner rather than preimplantation development. Furthermore, to study the function of OGT at specific developmental stages, they developed a mouse model bearing endogenously AID-tagged OGT for acute degradation of OGT. Although the degron system wasn't efficient in preimplantation embryos, they discovered quick transcriptional changes upon OGT deletion in MEFs. The quality of the manuscript is good because the question to be solved was appropriately set, the approach was well designed, and their findings were interesting, although their writing was sometimes hard to understand as I raised in my following comments. Nevertheless, there are several points to be fixed before being published.

      R16: We thank the reviewer for their clear understanding of our work and their appreciation of the biological importance of the findings. Your comprehensive review of the manuscript and the questions you raised were extremely helpful in improving the manuscript and fully addressing its limitations. Below, we respond to comments in full, have revised the manuscript to improve clarity and have included novel results.

      Major Comments

      C17: 1. Although the authors showed in vitro activity of each mutant of OGT used in this manuscript by referencing the previous literature, they never showed the levels of global O-GlcNAcylation (and OGT itself) in their established mouse embryos. Although it could be impossible to determine O-GlcNAc levels in OgtQ849N and OgtH568A embryos because of the lack of germline transmission and founder line, respectively, they could do that in OgtY851A and OgtT931A embryos. Given that Y851A and T931A mutants had similar VMAX/KM with different VMAX, it is possible that their activity is comparable or Y851A has even lower activity in vivo depending on the concentration of UDP-GlcNAc in embryos. Therefore, it is critical to assess whether in vivo OGT activity is correlated with that in vitro as expected to conclude that severity of sub-Mendelian inheritance is proportional to the reduction of activity of OGT in vivo. Moreover, since the authors developed the elegant system to deplete OGT, the activity of Q849N and H568A mutant OGT can be examined at least in cells by expressing them in MEFs with OGT-degron system. Thus, I propose determination of global O-GlcNAc levels compensated by OGT levels by western blotting in OgtY851A, and OgtT931A embryos or MEFs with the OGT degron system re-expressing the individual four mutant OGTs. If the protein amount is insufficient for western blotting in the embryos because of the sizes of the earlier stages of embryos, I believe the author could address this by utilizing immunofluorescence as shown in Figure S5.

      R17: We fully agree that this is an important point that requires revision. The only mutation for which the level of O-GlcNAc and OGT can be assessed by western blot in vivo is Y851A, the other mutations resulting in embryonic lethality before the blastocyst stage.

      We have included in the revised manuscript western blot analyses of protein expression for OGT, OGA and O-GlcNAc levels in the placenta of the OgtY851A mutants (new Figures 3C,D). The new data show that OGT is upregulated at the protein level in homozygous females, in good agreement with our transcriptomic analysis. Furthermore, O-GlcNAc levels were slightly reduced in homozygous and hemizygous placentae thus showing the impact of the point mutation on global O-GlcNAc levels in the placentae. Moreover, the analysis of OGA protein level unexpectedly revealed the enrichment of a previously uncharacterized OGA fast migrating isoform in hemizygous and homozygous placentae.

      We agree that it would be informative to compare O-GlcNAc levels in OgtT931A versus OgtY851A embryos. A comparison implies performing the experiment at the same developmental stage, which has to be the blastocyst stage or prior because T931A/Y embryos die around implantation. The blastocyst being made of approximately 140 cells, it would require to pool many single blastocysts to obtain the necessary protein input for western blot. We are not aware of another study performing western blot with pooled blastocysts. An additional great challenge for this experiment is the necessity to genotype and sex the blastocysts before pooling. Thus, the feasibility of this experiment is uncertain.

      As an alternative, the reviewer suggests measuring O-GlcNAc levels in the degron MEFs after introduction of OGT transgenes bearing the mutation studied. This experiment would not be conclusive because of residual O-GlcNAc after OGT degradation (Figure S4E). Furthermore, the O-GlcNAc proteome is dynamic during development (as shown in the developing brain by Liu et al. https://doi.org/10.1371/journal.pone.0043724), therefore the MEFs results would have limited value to explain our results in the early embryo.

      In sum, available technologies to quantify O-GlcNAc (e.g. western bot, mass spectrometry) are inadequate for low input samples as the early embryo. However, our series of hypomorphic alleles backed up with in vitro enzymology measurements brings indirect evidence to this question. Specifically, the qualitative correlation between the measured OGT activity in vitro and the developmental phenotype indicates that the resulting relative levels of O-GlcNAc are consistent with in vitro measurements.

      C18.1 : 2. I didn't understand why the authors couldn't find any founder lines of the OgtH568A mutant. Was that because mosaic mice with OgtH568A mutation are lethal?

      R18.1: To answer to this question, it is important to recall two key features of the biological system:

      1) The mutation H568A was reported to disrupt the glycosyltransferase activity completely (10.1038/nsmb.1443). Hence, OGT-H588A is catalytic dead.

      2) We performed the CRISPR-HDR targeting in the 1-cell embryo.

      Based on these premises, the absence of F0 with the OgtH568A mutation (0/31) suggests that introducing this mutation causes embryonic lethality in both males and females. This hypothesis is consistent with the previously reported lethality around implementation of Ogt-null alleles (10.1128/mcb.24.4.1680-1690.2004). It is possible that the sgRNA is very efficient and results in homozygous mutations in all female zygotes injected (as we have not obtained heterozygous females bearing these mutations). High efficiency of the targeted mutagenesis in the zygote results in mutants where all or the majority of cells bear the mutation (no or low mosaicism). The high number of microinjections performed (416 embryos over the 3 injection sessions) allows us to make these claims.

      C18.2 : Also, I believe there was no explanation why the OgtQ849N allele showed no maternal inheritance. Was that because Q849N possesses enough activity for sustaining mosaic embryos, but not oocytes? The authors should better explain these points in the manuscript text.

      R18.2: Thanks for this comment, we agree that this maternal effect phenotype demands further explanation.

      The phenotype observed suggests two possibilities: either that the oocyte cannot maturate or that the cleavage-stage embryo cannot develop with the resulting lower levels of O-GlcNAc. The cleavage-stage embryo does not transcribe a catalytically active OGT before the 8-cell stage and thus relies on the OGT protein inherited from the oocyte until this stage (https://doi.org/10.1101/2024.01.22.576677).

      Thank you for this comment, we added this interpretation of the result in the text:<br /> "The lack of maternal transmission of the Q849N allele from seemingly mosaic founder females is likely explained by the reliance of the cleavage stage embryo onto the oocyte payload of OGT and O-GlcNAc modified proteins. Specifically, Ogt's exons encoding for the catalytic domains are not detectable before the 8-cell stage, while OGT full-length protein is present and thus maternally inherited (Formichetti et al, 2024)."

      C19: 3. The authors serendipitously found a T931del-allele in the "WT" allele of the OgtT931A line, and suggested that T931del had milder activity loss, although the lethality of embryos was greatly mitigated. Nevertheless, transcriptome analyses in male blastocysts revealed that 120 genes' expression was changed in T931del/Y males. This raised the question about which mutant OGT has higher activity, Y851A or T931del. I think comparing the activity of Y851A and T931del mutants in MEFs with OGT-degron system is important to confirm the proportional relationship between activity and phenotypic severity.

      R19: We agree that it is a limitation that the effect of the T931del mutation on OGT activity has not been biochemically characterized. However, the important point here is that our assessment of phenotypic severity based on maternal inheritance of the mutant allele and embryonic lethality is based on the point mutations for which the catalytic activity has been determined, namely Y851A, T931A, Q849N and H568A, but not T931del.

      We studied the serendipitously discovered T931del mutation to obtain transcriptional insights in the blastocyst. Because the deleted residue T931 is key for the binding to the donor substrate, we can reasonably assume that this mutation affects the catalytic activity, albeit to an undetermined level.

      Hence, our conclusions regarding the requirement of O-GlcNAcylation for development are unaffected by the lack of biochemical knowledge on T931del.

      C20.1: 4. Regarding transcriptomes of T931del/Y, the authors found the upregulation of proteasomal activity and stress granules along with the downregulation of amino acid metabolism, mitochondrial respiration, and so on. To validate the results, the authors should perform qPCR on several up- or down-regulated genes.

      R20.1 : We agree that, in principle, qPCR validation is suitable. However, this validation experiment is particularly expensive in this case because of the requirement of numerous CRISPR zygote pronuclear injection sessions.

      The conclusions of the RNA-seq analysis are strongly supported by a high number of biological replicates (n=10). This high number of biological replicates was essential to obtain sufficient statistical power to quantify with a high level of confidence transcriptional changes of low magnitudes (below 2-fold change, see R5.1 and R5.2).

      Therefore, the qPCR validation experiment would require to repeat the CRISPR zygote pronuclear injection sessions with the same high number of animals. This represents a major investment in experimental work and the sacrificing of about 40 animals. Importantly, the RNA-seq results presented are authoritative because of a high number of biological replicates and high number of sequencing reads per sample. Thus, we argue that qPCR validation is not essential and thus the high cost of this experiment is difficult to justify.

      C20.2: In addition, according to Figure S2E, the authors pointed out that at least for genes upregulated in OgtT931A embryos, the changes were not explained by a developmentally delayed transcriptome, suggesting that upregulation of these genes was the cause of developmental delay. Therefore, I strongly encourage them to discuss in the manuscript text how up-regulated genes could contribute to developmental delay.

      R20.2: Throughout the manuscript, we have been cautious to avoid establishing causal relationships between the differentially expressed genes uncovered and the developmental phenotypes (e.g. delayed development). There are two main obstacles which we believe prevent us from establishing causality with the data available. Firstly, it is not possible to disentangle differentially expressed genes and developmental delay (in other words, we have no way to tell which is the cause and which is the consequence). Secondly, O-GlcNAc modifies over 5000 proteins and the developing embryo is a particularly dynamic system; thus we cannot know whether the differentially expressed promoters are direct targets of O-GlcNAc modified proteins (or alternatively secondary effect of another molecular alteration, for example of the proteome). We discuss this limitation of the study in the discussion section.

      C21: 5. Regarding the transcriptome in OgtY851A mice, Y851A/Y male mice had huge transcriptomic differences, while Y851A/Y851A female mice barely had any. Although it seems to agree with the number of Ogt alleles, I wonder whether other X-linked genes expressed higher in female placenta as shown in Figure 3C could attenuate the effects of decreased OGT activity. I don't think this possibility can be excluded, unless the authors further decrease OGT activity in Y851A/Y851A female placenta and obtain the similar results as for male placenta. Or if they compared the levels of global O-GlcNAcylation between Y851A/Y and Y851A/Y851A mouse placentas and discovered they had similar levels of O-GlcNAcylation, then the authors could conclude that the number of Ogt alleles was not the reason of sexual-dimorphism. The authors should determine the levels of O-GlcNAcylation in Y851A/Y and Y851A/Y851A mouse placentas and/or at least discuss the above possibilities in the manuscript text.

      R21: Thank you for the thoughtful feedback. We agree that the most likely explanation for the higher sensitivity of males placenta as compared to females to OGT reduced activity is the difference in Ogt copy number, especially because Ogt escapes X-chromosome inactivation in the placenta (new Figure S3A).

      Western blot quantification of global O-GlcNAc levels was now performed (new Figures 3C,D). We measured similar level of O-GlcNAc in Y851A/Y and Y851A/Y851A placentas (lowered than WT males in both cases), but we cannot exclude that the WB does not have the dynamic range required to detect a subtle difference. In fact, female homozygous were expected to have an intermediate level between WT males and hemizygous males, and the difference between the two male genotypes (also considering sample-to-sample variability) is already small when quantified from the blot (new Figure 3D). It is possible that a X-linked modifier attenuates the impact of hypo-O_GlcNAcylation in female mutant placenta in the case of identical O-GlcNAc levels in homozygous females and hemizygous males. Thank you for the idea that we included in the revised manuscript:

      "Of note, the lower sensitivity of the homozygous females' transcriptome to Ogt disruption (Fig. 3F,I and S3B) seems difficult to reconcile with their lower O-GlcNAc level comparable (lower) O-GlcNAc level to the hemizygous males (Fig. 3C). It is possible that the western blot technique is not sensitive enough to detect subtle differences in O-GlcNAcylation. An alternative hypothesis, if O-GlcNAc levels were truly identical between Y851A/Y and Y851A/Y851A, could be the existence of a modifier in female that could be a XCI-escapee."

      C22: 6. In terms of the transcriptome in OgtY851A mice, similar to comment 4, the authors should confirm their transcriptomics data shown as Figure 3D by qPCR. In addition, the authors should describe the potential mechanisms by which the differentiation of precursor cells of LaTPs and JZPs were disrupted. Were master regulators of the differentiation known to be O-GlcNAcylated and loss of O-GlcNAcylation perturbed the function?

      R22: As for the whole embryo discussed in R20.2, we also interpret cautiously the gene expression phenotype observed in the placenta. Specifically, we state in the manuscript that it could either be caused by an impact of lower O-GlcNAcylation on placental differentiation or by a general delay in placentation or in the development of the embryo as a whole. The hypothesis of a general delay (of the whole embryo and/or of placental formation specifically) is supported by the downregulation of essentially all markers of more differentiated cell types and the upregulation of the precursor marker. We favor this hypothesis because it is consistent with what observed with the T931 mutants and also with the enzymatic removal of O-GlcNAc in the zygote (Formichetti et al., 2024 BioRxiv). Because of the thousands of O-GlcNAcylated proteins present in the cell, it is impossible to know which is the responsible molecular mechanism, which could even start at much earlier stages.

      Minor Comments

      C23: 1. Regarding DFP461-463 mutant, I couldn't understand the point of this figure because the results had no difference, and the meaning of the mutation was quite different from the others. Thus, the figure was awkward and a little confusing to me. If the authors still want to include the figures, I would suggest that they should reorganize the position of the figure (maybe after figure 3 is better to show you had tried to investigate the effects of nuclear localization of OGT on the changes of transcriptomes) and add some results. Since WT OGT seems to be localized mainly in the cytosol at steady state (Figure S1B and S1C), the effect of mutation on its nuclear localization should not be obvious. Therefore, it is difficult to conclude the mutation had no effect on the nuclear localization unless the ratio of nuclear and cytosol localization is quantified. Also, I wonder whether the O-GlcNAc levels of nuclear and cytosolic proteins in the mutant cells were comparable to those in WT cells. If this is the case, the results would also support the authors' conclusion.

      R23: We took the comments on board and made it clearer that the rationale for the DFP461-463 mutant was an attempt to separate OGT's nuclear and cytosolic functions. We fully agree that these results are peripheral, and thus we presented these results in Supplementary Figure 1 (not in the main figure).

      The biochemical evidence presented in Fig S1C shows that the genetic substitution of DFP to AAA on endogenous OGT has no detectable impact on its nuclear localization in primary MEFs. This result is far more authoritative than the evidence provided by Seo et al. 2016 (doi: 10.1038/srep34614), which is based on the overexpression of OGT transgenes in HeLa cells. Importantly, Seo et al. 2016 did not assess the impact of their mutations on endogenous OGT.

      We believe that the negative results we obtained with the DFP461-463 mouse model shall be extremely valuable for the field. Firstly, science can move forward only if both negative and positive results are shared. In this specific case, we found that mutation of endogenous OGT in MEFs yielded to a different result than previously reported overexpression of the same mutant construct in HeLa cells. Secondly, we want to make the Ogt-NLS- mouse model available for further investigations.

      C24: 2. Since OGT or O-GlcNAcylation regulates chromatin status, the authors analyzed the gene expression profiles of retrotransposons in T931del/Y or T931A/Y mice. Is it possible to investigate if the release of gene silencing is also seen in non-retrotransposon genes? I assumed retrotransposons might be a well-established system to analyze gene silencing status, however, if the authors could find similar effects on genes other than retrotransposons, that would be highly valuable.

      R24: This is an interesting idea. This notion refers to the activation of promoters that are normally epigenetically repressed (e.g. silent despite the presence of all trans-active factors required for their expression). Epigenetically repressed promoters include retrotransposons, imprinted genes and germline specific genes that are normally expressed in germ cells and maintained in a repressed state in somatic cells (10.1038/s41580-019-0159-6). Testing of mono-allelic expression of imprinted genes required F1-hybrid. Thus, we assessed whether well-studied germline specific genes could be realized from silencing in T931del/Y or T931A/Y blastocyst and found no evidence for it (see dot plot below). The unbiased transcriptomic analysis presented in the manuscript shows that the product of upregulated genes are enriched in mRNA processing (Figure 2E), but these genes are not normally epigenetically repressed. Thus, contrary to retrotransposons, the role of O-GlcNAc at cellular gene promoters appears not to be linked to epigenetic silencing. This could be explained by the many different protein substrates for O-GlcNAc.

      C25: 3. OgtY851A mice with milder OGT activity loss didn't exhibit impaired preimplantation development, but did display postimplantation development such as placental development, suggesting that O-GlcNAcylation of proteins required for preimplantation and postimplantation development relies on different degrees of OGT activity. I wonder whether global O-GlcNAc levels in embryos in preimplantation and postimplantation developmental stages are different or not. This might include both the pattern of blotting and intensities. The results would give the authors an explanation why the dependency on OGT activity was different in two developmental stages. Can the authors provide data? If not, then the authors should at least describe hypotheses in the manuscript to address these questions.

      R25: We recently reported that the subcellular patterns of O-GlcNAc are highly dynamic during preimplantation development (Formichetti et al. 2024, BioRxiv). The most striking O-GlcNAc remodeling we observed is the enrichment of nuclear O-GlcNAc as compared to cytoplasmic O-GlcNAc that is concomitant to embryonic genome activation (Formichetti et al. 2024, BioRxiv). We quantified the ratio of the nuclear/cytoplasmic signal by immunofluorescence, but absolute quantification is not possible with this method. Due to the limited number of cells of the preimplantation embryo, this analysis cannot be performed by western blot. Hence, there is no appropriate method to quantitatively compare O-GlcNAc levels between preimplantation and postimplantation embryos.

      C26: 4. The authors' AID-degron system elegantly worked in MEFs but was inefficient in preimplantation embryos. I wonder if this was because of the high expression of the shorter isoform of OGT detected as OGTp78 in the author's western blot. Is it possible to examine this possibility in the embryos? Either way, the authors should describe a potential explanation for why the efficiency in the embryos was low. In addition, the authors should describe why they inserted the AID tag only into the longest OGT isoform.

      R26: This is a good point. The smallest isoform OGTp78 bears the catalytic domain and thus can partially compensate for the degradation of OGTp110. Note that the level of OGTp78 is low and does not increase upon OGTp110 degradation; thus a compensation can only be partial (Figures S4A and S4D). Alternative hypotheses for the ineffectiveness of the degron system in ex vivo grown embryos include: i) the expression level of OsTIR that may be too low in the early embryo (Rosa26 promoter not being activated at EGA), ii) a possible steric hindrance of the N-ter AID tag in these cells, iii) the lower concentration of Auxin imposed by toxicity on the embryo is likely suboptimal. Testing these possibilities is very difficult in preimplantation embryos.

      It is unclear how the OGTp78 isoform is produced; it was hypothesized to originate from an alternative transcription start site (https://doi.org/10.1007/s00335-001-2108-9). We initially attempted to target both isoforms by inserting the AID tag at the C-terminus, but we were unsuccessful in producing this mouse model. It is possible that the C-terminus that is near the catalytic site cannot tolerate the AID knock-in.

      C27: 5. In Figure S1C, is the band detected right below OGTp78 in nuclei fractions non-specific or do both bands correspond to OGTp78 ?

      R27: To answer this question, a knockout control would be needed. OGTp78 being not targeted by our AID-degron, we cannot test the specificity of these bands using our perturbation tool kit.

      C28: 6. Figure 1D top row third column: hemizgous -> hemizygous

      R28: Many thanks; the embarrassing typo has been corrected.

      C29: 7. Figure 1D second row third column: hemyzygous -> hemizygous

      R29: Thanks for bringing this other typo to our attention, it is now corrected.

      Reviewer #4 (Significance (Required)):

      General assessment: strengths and limitations

      C30: Strength: This manuscript elegantly revealed the requirement of OGT in mammalian development by taking advantage knock-in mouse models with different OGT activity. In addition, the manuscript provided the interesting and important transcriptomics data in both pre- and post-implantation embryos of OGT mutant mice. These data sets could explain detailed mechanisms how OGT or O-GlcNAcylation regulates mammalian development in the future. Furthermore, development of AID-tagged OGT system would be a useful tool for other researchers studying OGT function.

      Limitation: Although they found interesting changes in terms transcriptomes in developing mice with different OGT activity, they lack the data showing how these changes caused the observed phenotypes. In other words, there are less mechanistic insights behind the developmental problems seen in mice with different OGT activity.

      In addition, although I agree the question about whether OGT activity itself is crucial for the early development of mammals has not been completely solved for a long time, I assume people thought OGT activity is actually important for the mammalian development thorough the observation of OGT-linked congenital disorders of glycosylation.

      Therefore, I would say the novelty of the manuscript is a little less impactful. Furthermore, although AID-tagged OGT system revealed fundamental questions regarding the transcriptional changes upon acute depletion of OGT in cellular levels, the system was inefficient in mouse embryos. So, they showed nothing about developmental-stage specific requirements of OGT.

      Advance: The manuscript can fill a current gap regarding requirement of OGT in mammalian development. Also, the manuscript developed a series of mutant mice with different OGT activity and an AID-tagged OGT mouse line. These mice provide technical advances.

      Audience: The manuscript will be interested in researchers in specific fields such as glycobiology, developmental biology, and clinical fields.

      Describe your expertise: Biochemistry, Glycobiology, Cell biology

      R30: We are thankful for the constructive and supportive review.

      We fully agree with the limitations of the study and discussed them in the manuscript. Our in vivo approach revealed the most phenotypically relevant transcriptional phenotypes resulting from OGT catalytic impairment during embryonic development. We make the mouse models created for this study available to the community to facilitate follow-up studies aiming at exploring the underlying molecular details.

      As pointed out in the comments, the requirement of OGT glycosyltransferase activity for mammalian development was widely assumed by the field, but this belief was without direct experimental evidence. This study provides the first in vivo evidence for this important conclusion.

      Conclusion: The reviewers' comments were tremendously useful to improving the clarity of the manuscript and adding important new in vivo evidence. We note that none of the reviewers provided any reason to doubt our important conclusions:

      • The demonstration that the enzymatic activity of Ogt, thus the O-GlcNAc modification itself, is essential for preimplantation development.
      • The finding that a mild reduction of OGT's activity is sufficient to perturb the silencing of multiple families of retrotransposons in the growing embryo.
      • The indication, from transcriptomes of hypo-O-GlcNAcylated embryos, of a developmental retardation upon a mild O-GlcNAc perturbation.

      • The discovery that OGT's rapid depletion in vitro downregulates basal cellular function, including translation. This result provides mechanistic support to the embryonic growth delay resulting from decreasing O-GlcNAc in vivo.

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #4

      Evidence, reproducibility and clarity

      Summary

      O-GlcNAcylation is the fundamental post-translational modification of numerous nuclear and cytosolic proteins. OGT is the sole enzyme catalyzing O-GlcNAc addition onto the proteins. The essentiality of OGT for early development and cellular viability has been established by using OGT-KO mice and cell lines. However, it remains to be elucidated whether the catalytic activity of OGT is required for the early development, and if the catalytic activity of OGT is required what are the functions of OGT or O-GlcNAcylation in early development due to a lack of appropriate mouse models. To overcome the technical difficulty of manipulating the levels of O-GlcNAcylation in early embryos, Formichetti et al. created the series of four mouse models (OgtY851A, OgtT931A, OgtQ849N, and OgtH568A) with different OGT activity by introducing single amino acid substitution in the catalytic domain. By analyzing the inheritance of the hypomorphic OGT alleles and the lethality of mouse embryos, they discovered OGT activity is a critical factor for early development. Subsequently, RNA-seq analyses with two mouse models showing the maternal inheritance of the hypomorphic OGT alleles indicated that sever hypo-OGT activity altered transcription and silencing of retrotransposon in preimplantation development while mild reduction of OGT's activity affected placental development in a sexually dimorphic manner rather than preimplantation development. Furthermore, to study the function of OGT at specific developmental stages, they developed a mouse model bearing endogenously AID-tagged OGT for acute degradation of OGT. Although the degron system wasn't efficient in preimplantation embryos, they discovered quick transcriptional changes upon OGT deletion in MEFs. The quality of the manuscript is good because the question to be solved was appropriately set, the approach was well designed, and their findings were interesting, although their writing was sometimes hard to understand as I raised in my following comments. Nevertheless, there are several points to be fixed before being published.

      Major Comments

      1. Although the authors showed in vitro activity of each mutant of OGT used in this manuscript by referencing the previous literature, they never showed the levels of global O-GlcNAcylation (and OGT itself) in their established mouse embryos. Although it could be impossible to determine O-GlcNAc levels in OgtQ849N and OgtH568A embryos because of the lack of germline transmission and founder line, respectively, they could do that in OgtY851A and OgtT931A embryos. Given that Y851A and T931A mutants had similar VMAX/KM with different VMAX, it is possible that their activity is comparable or Y851A has even lower activity in vivo depending on the concentration of UDP-GlcNAc in embryos. Therefore, it is critical to assess whether in vivo OGT activity is correlated with that in vitro as expected to conclude that severity of sub-Mendelian inheritance is proportional to the reduction of activity of OGT in vivo. Moreover, since the authors developed the elegant system to deplete OGT, the activity of Q849N and H568A mutant OGT can be examined at least in cells by expressing them in MEFs with OGT-degron system. Thus, I propose determination of global O-GlcNAc levels compensated by OGT levels by western blotting in OgtY851A, and OgtT931A embryos or MEFs with the OGT degron system re-expressing the individual four mutant OGTs. If the protein amount is insufficient for western blotting in the embryos because of the sizes of the earlier stages of embryos, I believe the author could address this by utilizing immunofluorescence as shown in Figure S5.
      2. I didn't understand why the authors couldn't find any founder lines of the OgtH568A mutant. Was that because mosaic mice with OgtH568A mutation are lethal? Also, I believe there was no explanation why the OgtQ849N allele showed no maternal inheritance. Was that because Q849N possesses enough activity for sustaining mosaic embryos, but not oocytes? The authors should better explain these points in the manuscript text.
      3. The authors serendipitously found a T931del-allele in the "WT" allele of the OgtT931A line, and suggested that T931del had milder activity loss, although the lethality of embryos was greatly mitigated. Nevertheless, transcriptome analyses in male blastocysts revealed that 120 genes' expression was changed in T931del/Y males. This raised the question about which mutant OGT has higher activity, Y851A or T931del. I think comparing the activity of Y851A and T931del mutants in MEFs with OGT-degron system is important to confirm the proportional relationship between activity and phenotypic severity.
      4. Regarding transcriptomes of T931del/Y, the authors found the upregulation of proteasomal activity and stress granules along with the downregulation of amino acid metabolism, mitochondrial respiration, and so on. To validate the results, the authors should perform qPCR on several up- or down-regulated genes. In addition, according to Figure S2E, the authors pointed out that at least for genes upregulated in OgtT931A embryos, the changes were not explained by a developmentally delayed transcriptome, suggesting that upregulation of these genes was the cause of developmental delay. Therefore, I strongly encourage them to discuss in the manuscript text how up-regulated genes could contribute to developmental delay.
      5. Regarding the transcriptome in OgtY851A mice, Y851A/Y male mice had huge transcriptomic differences, while Y851A/Y851A female mice barely had any. Although it seems to agree with the number of Ogt alleles, I wonder whether other X-linked genes expressed higher in female placenta as shown in Figure 3C could attenuate the effects of decreased OGT activity. I don't think this possibility can be excluded, unless the authors further decrease OGT activity in Y851A/Y851A female placenta and obtain the similar results as for male placenta. Or if they compared the levels of global O-GlcNAcylation between Y851A/Y and Y851A/Y851A mouse placentas and discovered they had similar levels of O-GlcNAcylation, then the authors could conclude that the number of Ogt alleles was not the reason of sexual-dimorphism. The authors should determine the levels of O-GlcNAcylation in Y851A/Y and Y851A/Y851A mouse placentas and/or at least discuss the above possibilities in the manuscript text.
      6. In terms of the transcriptome in OgtY851A mice, similar to comment 4, the authors should confirm their transcriptomics data shown as Figure 3D by qPCR. In addition, the authors should describe the potential mechanisms by which the differentiation of precursor cells of LaTPs and JZPs were disrupted. Were master regulators of the differentiation known to be O-GlcNAcylated and loss of O-GlcNAcylation perturbed the function?

      Minor Comments

      1. Regarding DFP461-463 mutant, I couldn't understand the point of this figure because the results had no difference, and the meaning of the mutation was quite different from the others. Thus, the figure was awkward and a little confusing to me. If the authors still want to include the figures, I would suggest that they should reorganize the position of the figure (maybe after figure 3 is better to show you had tried to investigate the effects of nuclear localization of OGT on the changes of transcriptomes) and add some results. Since WT OGT seems to be localized mainly in the cytosol at steady state (Figure S1B and S1C), the effect of mutation on its nuclear localization should not be obvious. Therefore, it is difficult to conclude the mutation had no effect on the nuclear localization unless the ratio of nuclear and cytosol localization is quantified. Also, I wonder whether the O-GlcNAc levels of nuclear and cytosolic proteins in the mutant cells were comparable to those in WT cells. If this is the case, the results would also support the authors' conclusion.
      2. Since OGT or O-GlcNAcylation regulates chromatin status, the authors analyzed the gene expression profiles of retrotransposons in T931del/Y or T931A/Y mice. Is it possible to investigate if the release of gene silencing is also seen in non-retrotransposon genes? I assumed retrotransposons might be a well-established system to analyze gene silencing status, however, if the authors could find similar effects on genes other than retrotransposons, that would be highly valuable.
      3. OgtY851A mice with milder OGT activity loss didn't exhibit impaired preimplantation development, but did display postimplantation development such as placental development, suggesting that O-GlcNAcylation of proteins required for preimplantation and postimplantation development relies on different degrees of OGT activity. I wonder whether global O-GlcNAc levels in embryos in preimplantation and postimplantation developmental stages are different or not. This might include both the pattern of blotting and intensities. The results would give the authors an explanation why the dependency on OGT activity was different in two developmental stages. Can the authors provide data? If not, then the authors should at least describe hypotheses in the manuscript to address these questions.
      4. The authors' AID-degron system elegantly worked in MEFs but was inefficient in preimplantation embryos. I wonder if this was because of the high expression of the shorter isoform of OGT detected as OGTp78 in the author's western blot. Is it possible to examine this possibility in the embryos? Either way, the authors should describe a potential explanation for why the efficiency in the embryos was low. In addition, the authors should describe why they inserted the AID tag only into the longest OGT isoform.
      5. In Figure S1C, is the band detected right below OGTp78 in nuclei fractions non-specific or do both bands correspond to OGTp78 ?
      6. Figure 1D top row third column: hemizgous -> hemizygous
      7. Figure 1D second row third column: hemyzygous -> hemizygous

      Significance

      General assessment: strengths and limitations

      Strength: This manuscript elegantly revealed the requirement of OGT in mammalian development by taking advantage knock-in mouse models with different OGT activity. In addition, the manuscript provided the interesting and important transcriptomics data in both pre- and post-implantation embryos of OGT mutant mice. These data sets could explain detailed mechanisms how OGT or O-GlcNAcylation regulates mammalian development in the future. Furthermore, development of AID-tagged OGT system would be a useful tool for other researchers studying OGT function.

      Limitation: Although they found interesting changes in terms transcriptomes in developing mice with different OGT activity, they lack the data showing how these changes caused the observed phenotypes. In other words, there are less mechanistic insights behind the developmental problems seen in mice with different OGT activity. In addition, although I agree the question about whether OGT activity itself is crucial for the early development of mammals has not been completely solved for a long time, I assume people thought OGT activity is actually important for the mammalian development thorough the observation of OGT-linked congenital disorders of glycosylation. Therefore, I would say the novelty of the manuscript is a little less impactful. Furthermore, although AID-tagged OGT system revealed fundamental questions regarding the transcriptional changes upon acute depletion of OGT in cellular levels, the system was inefficient in mouse embryos. So, they showed nothing about developmental-stage specific requirements of OGT.

      Advance: The manuscript can fill a current gap regarding requirement of OGT in mammalian development. Also, the manuscript developed a series of mutant mice with different OGT activity and an AID-tagged OGT mouse line. These mice provide technical advances.

      Audience: The manuscript will be interested in researchers in specific fields such as glycobiology, developmental biology, and clinical fields.

      Describe your expertise: Biochemistry, Glycobiology, Cell biology

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1:

      (1) Peptides were synthesized with fluorescein isothiocyanate (FITC) and Tat tag, and then PEGylated with methoxy PEG Succinimidyl Succinate.

      I have two concerns about the peptide design. First, FTIC was intended "for monitoring" (line 129), but was never used in the manuscript. Second, PEGylation targets the two lysine sidechains on the Tat, which would alter its penetration property.

      (1) We conducted an analysis of the cellular trafficking of FITC-tagged peptides following their permeabilization into cells.

      Author response image 1.

      However, we did not include it in the main text because it is a basic result.

      (2) As can be seen in the figure above, after pegylation and permeabilization, the cells were stained with FITC. It appears that this does not affect the ability to penetrate into the cells.

      (2) "Superdex 200 increase 10/300 GL column" (line 437) was used to isolate mono/di PEGylated PDZ and separate them from the residual PEG and PDZ peptide. "m-PEG-succinimidyl succinate with an average molecular weight of 5000 Da" (lines 133 and 134).

      To my knowledge, the Superdex 200 increase 10/300 GL column is not suitable and is unlikely to produce traces shown in Figure 1B.

      As Superdex 200 increase 10/300 GL featrues a fractionation range of 10,000 to 600,000 Da, we used it to fractionate PEGylated products including DiPEGylated PDZ (approx. 15 kDa) and MonoPEGylated PDZ (approx. 10 kDa) from residuals (PDZ and PEG), demonstrating successful isolation of PEGylated products (Figure 1C). Considering the molecular weights of PDZ and PEG are approximately 4.1 kDa and and 5.0 kDa, respectively, the late eluting peaks from SEC were likely to represent a mixed absorbance of PDZ and PEG at 215 nm.

      However, as the reviewer pointed out, it could be unreasonable to annotate peaks representing PDZ and PEG, respectively, from mixed absorbance detected in a region (11-12 min) beyond the fractionation range.

      In our revised manuscript, therefore, multiple peaks in the late eluting volume (11-12 min) were labeled as 'Residuals' all together. As a reference, the revised figure 1B includes a chromatogram of pure PDZ-WT under the same analytic condition.

      Therefore, we changed Fig.1B to new results.

      (3) "the in vivo survival effect of LPS and PDZ co-administration was examined in mice. The pretreatment with WT PDZ peptide significantly increased survival and rescued compared to LPS only; these effects were not observed with the mut PDZ peptide (Figure 2a)." (lines 159-160).

      Fig 2a is the weight curve only. The data is missing in the manuscript.

      We added the survived curve into Fig. 2A.

      (4) Table 1, peptide treatment on ALT and AST appears minor.

      In mice treated with LPS, levels of ALT and AGT in the blood are elevated, but these levels decrease upon treatment with WT PDZ. However, the use of mut PDZ does not result in significant changes. Figure 3A shows inflammatory cells within the central vein, yet no substantial hepatotoxicity is observed during the 5-day treatment with LPS. Normally, the ranges of ALT and AGT in C57BL6 mice are 16 ~ 200 U/L and 46 ~ 221 U/L, respectively, according to UCLA Diagnostic Labs. Therefore, the values in all experiments fall within these normal ranges. In summary, a 5-day treatment with LPS induces inflammation in the liver but is too short a duration to induce hepatotoxicity, resulting in lower values.

      (5) MitoTraker Green FM shouldn't produce red images in Figure 6.

      We changed new results (GREEN one) into Figs 6A and B.

      (6) Figure 5. Comparison of mRNA expression in PDZ-treated BEAS-2B cells. Needs a clearer and more detailed description both in the main text and figure legend. The current version is very hard to read.

      We changed Fig. 5A to new one to understand much easier and added more detailed results and figure legend.

      Results Section in Figure 5:

      we performed RNA sequencing analysis. The results of RNA-seq analysis showed the expression pattern of 24,424 genes according to each comparison combination, of which the results showed the similarity of 51 genes overlapping in 4 gene categories and the similarity between each comparison combination (Figure 5a). As a result, compared to the control group, it was confirmed that LPS alone, WT PDZ+LPS, and mut PDZ+LPS were all upregulated above the average value in each gene, and when LPS treatment alone was compared with WT PDZ+LPS, it was confirmed that they were averaged or downregulated. When comparing LPS treatment alone and mut PDZ+LPS, it was confirmed that about half of the genes were upregulated. Regarding the similarity between comparison combinations, the comparison combination with LPS…

      Figure 5 Legend Section:

      Figure 5. Comparison of mRNA expression in PDZ-treated BEAS-2B cells.

      BEAS-2B cells were treated with wild-type PDZ or mutant PDZ peptide for 24 h and then incubated with LPS for 2 h, after which RNA sequencing analysis was performed. (a) The heat map shows the general regulation pattern of about 51 inflammation-related genes that are differentially expressed when WT PDZ and mut PDZ are treated with LPS, an inflammatory substance. All samples are RED = upregulated and BLUE = downregulated relative to the gene average. Each row represents a gene, and the columns represent the values of the control group treated only with LPS and the WT PDZ and mut PDZ groups with LPS. This was used by converting each log value into a fold change value. All genes were adjusted to have the same mean and standard deviation, the unit of change is the standard deviation from the mean, and the color value range of each row is the same. (b) Significant genes were selected using Gene category chat (Fold change value of 2.00 and normalized data (log2) value of 4.00). The above pie chart shows the distribution of four gene categories when comparing LPS versus control, WT PDZ+LPS/LPS, and mut PDZ+LPS/LPS. The bar graph below shows RED=upregulated, GREEN=downregulated for each gene category, and shows the number of upregulated and downregulated genes in each gene category. (c) The protein-protein interaction network constructed by the STRING database differentially displays commonly occurring genes by comparing WT PDZ+LPS/LPS, mut PDZ+LPS/LPS, and LPS. These nodes represent proteins associated with inflammation, and these connecting lines denote interactions between two proteins. Different line thicknesses indicate types of evidence used in predicting the associations.

      Reviewer #2:

      (1) In this paper, the authors demonstrated the anti-inflammatory effect of PDZ peptide by inhibition of NF-kB signaling. Are there any results on the PDZ peptide-binding proteins (directly or indirectly) that can regulate LPS-induced inflammatory signaling pathway? Elucidation of the PDZ peptide-its binding partner protein and regulatory mechanisms will strengthen the author's hypothesis about the anti-inflammatory effects of PDZ peptide.

      As mentioned in the Discussion section, we believe it is crucial to identify proteins that directly interact with PDZ and regulate it. This direct interaction can modulate intracellular signaling pathways, so we plan to express GST-PDZ and induce binding with cellular lysates, then characterize it using the LC-Mass/Mass method. We intend to further research these findings and submit them for publication.

      (2) The authors presented interesting insights into the therapeutic role of the PDZ motif peptide of ZO-1. PDZ domains are protein-protein interaction modules found in a variety of species. It has been thought that many cellular and biological functions, especially those involving signal transduction complexes, are affected by PDZ-mediated interactions. What is the rationale for selecting the core sequence that regulates inflammation among the PDZ motifs of ZO-1 shown in Figure 1A?

      The rationale for selecting the core sequence that regulates inflammation among the PDZ motifs of ZO-1, as shown in Figure 1A, is grounded in the specific roles these motifs play in signal transduction pathways that are crucial for inflammatory processes. PDZ domains are recognized for their ability to function as scaffolding proteins that organize signal transduction complexes, crucial for modulating cellular and biological functions. The chosen core sequence is particularly important because it is conserved across ZO-1, ZO-2, and ZO-3, indicating a fundamental role in maintaining cellular integrity and signaling pathways. This conservation suggests that the sequence’s involvement in inflammatory regulation is not only significant in ZO-1 but also reflects a broader biological function across the ZO family.

      (3) In Figure 3, the authors showed the representative images of IHC, please add the quantification analysis of Iba1 expression and PAS-positive cells using Image J or other software. To help understand the figure, an indication is needed to distinguish specifically stained cells (for example, a dotted line or an arrow).

      We added the semi-quantitative results into Figs. 3d,e,f.

      Result section: The specific physiological mechanism by which WT PDZ peptide decreases LPS-induced systemic inflammation in mice and the signal molecules involved remain unclear. These were confirmed by a semi-quantitative analysis of Iba-1 immunoreactivity and PAS staining in liver, kidney, and lung,respectively (Figures 4d, e, and f). To examine whether WT PDZ peptide can alter LPS-induced tissue damage in the kidney, cell toxicity assay was performed (Figure 3g). LPS induced cell damage in the kidney, however, WT PDZ peptide could significantly alleviate the toxicity, but mut PDZ peptide could not. Because cytotoxicity caused by LPS is frequently due to ROS production in the kidney (Su et al., 2023; Qiongyue et al., 2022), ROS production in the mitochondria was investigated in renal mitochondria cells harvested from kidney tissue (Figure 3h)......

      Figure legend section: Indicated scale bars were 20 μm. (d,e,f) Semi-quantitative analysis of each are positive for Iba-1 in liver and kidney, and positive cells of PAS in lung, respectively. (g) After the kidneys were harvested, tissue lysates were used for MTT assay. (h) After.....

      (4) In Figure 6G, H, the authors confirmed the change in expression of the M2 markers by PDZ peptide using the mouse monocyte cell line Raw264.7. It would be good to add an experiment on changes in M1 and M2 markers caused by PDZ peptides in human monocyte cells (for example, THP-1).

      We thank you for your comments. To determine whether PDZ peptide regulates M1/M2 polarization in human monocytes, we examined changes in M1 and M2 gene expression in THP-1 cells. As a result, wild-type PDZ significantly suppressed the expression of M1 marker genes (hlL-1β, hIL-6, hIL-8, hTNF-ɑ), while increasing the expression of M2 marker genes (hlL-4, hIL-10, hMRC-1). However, mutant PDZ did not affect M1/M2 polarization. These results suggest that PDZ peptide can suppress inflammation by regulating M1/M2 polarization of human monocyte cells. These results are for the reviewer's reference only and will not be included in the main content.

      Author response image 2.

      Minor point:

      The use of language is appropriate, with good writing skills. Nevertheless, a thorough proofread would eliminate small mistakes such as:

      • line 254, " mut PDZ+LPS/LPS (45.75%) " → " mut PDZ+LPS/LPS (47.75%) "

      • line 296, " Figure 6f " → " Figure 6h "

      We changed these points into the manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      In this work, Odenwald and colleagues show that mutant biotin ligases used to perform proximity-dependent biotin identification (TurboID) can be used to amplify signal in fluorescence microscopy and to label phase-separated compartments that are refractory to many immunofluorescence approaches. Using the parasite Trypanosoma brucei, they show that fluorescent methods such as expansion microscopy and CLEM, which require bright signals for optimal detection, benefit from the elevated signal provided by TurboID fusion proteins when coupled with labeled streptavidin. Moreover, they show that phase-separated compartments, where many antibody epitopes are occluded due to limited diffusion and potential sequestration, are labeled reliably with biotin deposited by a TurboID fusion protein that localizes within the compartment. They show successful labeling of the nucleolus, likely phase-separated portions of the nuclear pore, and stress granules. Lastly, they use a panel of nuclear pore-TurboID fusion proteins to map the regions of the T. brucei nuclear pore that appear to be phase-separated by comparing antibody labeling of the protein, which is susceptible to blocking, to the degree of biotin deposition detected by streptavidin, which is not. 

      Strengths: 

      Overall, this study shows that TurboID labelling and fluorescent streptavidin can be used to boost signal compared to conventional immunofluorescence in a manner similar to tyramide amplification, but without having to use antibodies. TurboID could prove to be a viable general strategy for labeling phase-separated structures in cells, and perhaps as a means of identifying these structures, which could also be useful. 

      Weaknesses: 

      However, I think that this work would benefit from additional controls to address if the improved detection that is being observed is due to the increased affinity and smaller size of streptavidin/biotin compared to IgGs, or if it has to do with the increased amount of binding epitope (biotin) being deposited compared to the number of available antibody epitopes. I also think that using the biotinylation signal produced by the TurboID fusion to track the location of the fusion protein and/or binding partners in cells comes with significant caveats that are not well addressed here, mostly due to the inability to discern which proteins are contributing to the observed biotin signal. 

      To dissect the contributions of the TurboID fusion to elevating signal, anti-biotin antibodies could be used to determine if the abundance of the biotin being deposited by the TurboID is what is increasing detection, or if streptavidin is essential for this.

      We agree with the reviewer, that it would be very interesting to distinguish whether the increase in signal comes from the multiple biotinylation sites or from streptavidin being a very good binder, or perhaps from both. However, this question is very hard to answer, as antibodies differ massively in their affinity to the antigen which is further dependent on the respective IF-conditions, and are therefore not directly comparible. Even if anti-biotin gives a better signal then anti-HA, this can be either caused by the increase in antigen-number (more biotin than HA-tag) or by the higher binding affinity, or by a combination of both, thus hard to distinguish. Nevertheless, we have tested monoclonal mouse anti-biotin targeting the (non-phase-separated) NUP158. We found the signal from the biotin-antibody to be much weaker than from anti-HA, indicating that, at least this particular biotin antibody, is not a very good binder in IF. 

      Alternatively, HaloTag or CLIP tagging could be used to see if diffusion of a small molecule tag other than biotin can overcome the labeling issue in phase-separated compartments. There are Halo-biotin substrates available that would allow the conjugation of 1 biotin per fusion protein, which would allow the authors to dissect the relative contributions of the high affinity of streptavidin from the increased amount of biotin that the TurboID introduces. 

      This is a very good idea, as in this case, the signals are both from streptavidin and are directly comparable. We expressed NUP158 with HaloTag and added PEG-biotin as a Halo ligand. However, PEG-biotin is poorly cell-permeable, and is in general only used on lysates. In trypanosomes, cell permeability is particular restricted, and even Halo-ligands that are considered highly cell-penetrant give only a weak signal. Even after over-night incubation, we could not get any signal with PEG-biotin. Our control, the TMR-ligand 647, gave a weak nuclear pore staining, confirming the correct expression and function of the HaloTag-NUP158.

      The idea of using the biotin signal from the TurboID fusion as a means to track the changing localization of the fusion protein or the location of interacting partners is an attractive idea, but the lack of certainty about what proteins are carrying the biotin signal makes it very difficult to make clear statements. For example, in the case of TurboID-PABP2, the appearance of a biotin signal at the cell posterior is proposed to be ALPH1, part of the mRNA decapping complex. However, because we are tracking biotin localization and biotin is being deposited on a variety of proteins, it is not formally possible to say that the posterior signal is ALPH1 or any other part of the decapping complex. For example, the posterior labeling could represent a localization of PABP2 that is not seen without the additional signal intensity provided by the TurboID fusion. There are also many cytoskeletal components present at the cell posterior that could be being biotinylated, not just the decapping complex. Similar arguments can be made for the localization data pertaining to MLP2 and NUP65/75. I would argue that the TurboID labeling allows you to enhance signal on structures, such as the NUPs, and effectively label compartments, but you lack the capacity to know precisely which proteins are being labeled.  

      We fully agree with the reviewer, that tracking proteins by streptavidin imaging alone is problematic, because it cannot distinguish, which protein is biotinylated. We therefore used words like “likely”  in the description of the data. However, we still think, it is a valid method, as long as it is confirmed by an orthogonal method. We have added this paragraph to the end of this chapter:

      “Importantly, tracking of proteins by streptavidin imaging requires orthogonal controls, as the imaging alone does not provide information about the nature of the biotinylated proteins. These can be proximity ligation assay, mass spectrometry or specific tagging visualisation of protein suspects by fluorescent tags. Once these orthogonal controls are established for a specific tracking, streptavidin imaging is an easy and cheap and highly versatile method to monitor protein interactions in a specific setting.”

      Reviewer #2 (Public Review): 

      Summary: 

      The authors noticed that there was an enhanced ability to detect nuclear pore proteins in trypanosomes using a streptavidin-biotin-based detection approach in comparison to conventional antibody-based detection, and this seemed particularly acute for phase-separated proteins. They explored this in detail for both standard imaging but also expansion microscopy and CLEM, testing resolution, signal strength, and sensitivity. An additional innovative approach exploits the proximity element of biotin labelling to identify where interacting proteins have been as well as where they are. 

      Strengths: 

      The data is high quality and convincing and will have obvious application, not just in the trypanosome field but also more broadly where proteins are tricky to detect or inaccessible due to phase separation (or some other steric limitations). It will be of wide utility and value in many cell biological studies and is timely due to the focus of interest on phase separation, CLEM, and expansion microscopy. 

      Thank you! We are glad you liked it.

      Reviewer #3 (Public Review): 

      Summary: 

      The authors aimed to investigate the effectiveness of streptavidin imaging as an alternative to traditional antibody labeling for visualizing proteins within cellular contexts. They sought to address challenges associated with antibody accessibility and inconsistent localization by comparing the performance of streptavidin imaging with a TurboID-HA tandem tag across various protein localization scenarios, including phase-separated regions. They aimed to assess the reliability, signal enhancement, and potential advantages of streptavidin imaging over antibody labeling techniques. 

      Overall, the study provides a convincing argument for the utility of streptavidin imaging in cellular protein visualization. By demonstrating the effectiveness of streptavidin imaging as an alternative to antibody labeling, the study offers a promising solution to issues of accessibility and localization variability. Furthermore, while streptavidin imaging shows significant advantages in signal enhancement and preservation of protein interactions, the authors must consider potential limitations and variations in its application. Factors such as the fact that tagging may sometimes impact protein function, background noise, non-specific binding, and the potential for off-target effects may impact the reliability and interpretation of results. Thus, careful validation and optimization of streptavidin imaging protocols are crucial to ensure reproducibility and accuracy across different experimental setups. 

      Strengths: 

      - Streptavidin imaging utilizes multiple biotinylation sites on both the target protein and adjacent proteins, resulting in a substantial signal boost. This enhancement is particularly beneficial for several applications with diluted antigens, such as expansion microscopy or correlative light and electron microscopy. 

      - This biotinylation process enables the identification and characterization of interacting proteins, allowing for a comprehensive understanding of protein-protein interactions within cellular contexts. 

      Weaknesses: 

      - One of the key advantages of antibodies is that they label native, endogenous proteins, i.e. without introducing any genetic modifications or exogenously expressed proteins. This is a major difference from the approach in this manuscript, and it is surprising that this limitation is not really mentioned, let alone expanded upon, anywhere in the manuscript. Tagging proteins often impacts their function (if not their localization), and this is also not discussed.

      - Given that BioID proximity labeling encompasses not only the protein of interest but also its entire interacting partner history, ensuring accurate localization of the protein of interest poses a challenge. 

      - The title of the publication suggests that this imaging technique is widely applicable. However, the authors did not show the ability to track the localization of several distinct proteins on the same sample, which could be an additional factor demonstrating the outperformance of streptavidin imaging compared with antibody labeling. Similarly, the work focuses only on small 2D samples. It would have been interesting to be able to compare this with 3D samples (e.g. cells encapsulated in an extracellular matrix) or to tissues.  

      Recommendations for the authors:

      To enhance the assessment from 'incomplete' to 'solid', the reviewers recommend that the following major issues be addressed: 

      Major issues: 

      (1) Anti-biotin antibodies in combination with TurboID labeling should be used to compare the signal/labelling penetrance to streptavidin results. That would show if elevated biotin deposition matters, or if it is really the smaller size, more fluors, and higher affinity of streptavidin that's making the difference. 

      We agree with the reviewer, that it would be very interesting to distinguish whether the increase in signal comes from the multiple biotinylation sites or from streptavidin being a very good binder, or perhaps from both, and whether the size matters (IgG versus streptavidin). However, this question is very hard to answer, as antibodies differ massively in their affinity to the antigen. Thus, even if antibiotin would give a better signal then anti-HA, this could be either caused by the increase in antigen-number (more biotin than HA-tag) or by the better binding affinity, or by a combination, and it would not allow to truly answer the question. We have now tested anti-biotin antibodies, also in repsonse to reviewer 1, and got a much poorer signal in comparison to anti-HA or streptavidin.

      Please note that we made another attempt using nanobodies to target phase-separated proteins, to see, whether size matters (Fig. 2I). The nanobody did not stain Mex67 at the nuclear pores, but gave a weak nucelolar signal for NOG1, which may suggest that the nanobody can slightly better penetrate than IgG, but it does not rule out that the nanobody simply binds with higher affinity. Reviewer 1 has suggested to use the Halo Tag with PEG-biotin: this would indeed allow to directly compare the streptavidin signal caused by the TurboID with a single biotin added by the Halo tag. Unfortunately, the PEG-biotin does not  penetrate trypanosome cells. In conclusion, we are not aware of a method that would allow to establish why streptavidin but not IgGs can penetrate to phase separated areas. We therefore prefer to not overinterpret our data, but stick to what is supported by the data: “the inability to label phase-separated areas is not restricted to anti-HA but applies to other antibodies”.

      (3) Figure 4 A-B. The validity of claiming the correct localization demonstrated by streptavidin imaging comes into question, especially when endogenous fluorescence, via the fusion protein, remains undetectable (as indicated by the yellow arrow at apex). 

      In this figure, the streptavidin imaging does NOT show the correct localisation of the bait protein, but it does show proteins from historic interactions that have a distinct localisation to the bait. We had therefore introduced this chapter with the paragraph below, to make sure, the reader is aware of the limitations (which we also see as an opportunity, if properly controlled):

      “We found that in most cases, streptavidin labelling faithfully reflects the steady state localisation of a bait protein, e.g., the localisation resembles those observed with immunofluorescence or direct fluorescence imaging of GFP-fusion proteins. For certain bait proteins, this is not the case, for example, if the bait protein or its interactors have a dynamic localisation to distinct compartments, or if interactions are highly transient. It is thus essential to control streptavidin-based de novo localisation data by either antibody labelling (if possible) or by direct fluorescence of fusion-proteins for each new bait protein.”

      In particular, on lines 450-460, there's a fundamental issue with the argument put forward here. It is not possible to formally know that the posterior labeling is ALPH1 vs. another part of the decapping complex that was associated with PABP2-Turbo, or if the higher detection capacity of the Turbo-biotin label is uncovering a novel localization of the PABP2. While it is likely that it is ALPH1, it is not possible to rule out other possibilities with this approach. These issues should be discussed here and more generally the possibility of off-target labeling with this approach should be addressed in the discussion. 

      We fully agree with the reviewer, that tracking proteins by streptavidin imaging alone is problematic, because it cannot distinguish, which protein is biotinylated. We therefore used words like “likely”  in the description of the data. However, we still think, it is a valid method, as long as it is back-uped by an orthogonal method. We have added this paragraph to the end of this chapter:

      “Importantly, tracking of proteins by streptavidin imaging requires orthogonal controls, as the imaging alone does not provide information about the nature of the biotinylated proteins. These can be proximity ligation assay, mass spectrometry or specific tagging visualisation of protein suspects by fluorescent tags. Once these orthogonal controls are established for a specific tracking, streptavidin imaging is an easy and cheap and highly versatile method to monitor protein interactions in a specific setting.”

      (4) More discussion and acknowledgment of the general limitations in using tagged proteins are needed to balance the manuscript, especially if the hope is to draw a comparison with antibody labeling, which works on endogenous proteins (not requiring a tag). For example: (a) tagging proteins requires genetic/molecular work ahead of time to engineer the constructs and/or cells if trying to tag endogenous proteins; (b) tagged proteins should technically be validated in rescue experiments to confirm the tag doesn't disrupt function in the cell/tissue/context of interest; and (c) exogenous tagged proteins compete with endogenous untagged proteins, which can complicate the interpretation of data.  

      We have added this paragraph to the first paragraph of the discussion part:

      “Like many methods that are frequently used in cell- and molecular biology, streptavidin imaging is based on the expression of a genetically engineered fusion protein: it is essential to validate both, function and localisation of the TurboID-HA tagged protein by orthogonal methods. If the fusion protein is non-functional or mis-localised, tagging at the other end may help, but if not, this protein cannot be imaged by streptavidin imaging. Likewise, target organisms not amenable to genetic manipulation, or those with restricted genetic tools,  are not or less suitable for this method.”

      Also, we like to point out that for non-mainstream organisms like trypanosomes, antibodies are not commercially available and often genetic manipulation is more time-efficient and cheaper than the production of antiserum against the target protein.

      Also, the introduction would ideally be more general in scope and introduce the pros and cons of antibody labeling vs biotin/streptavidin, which are mentioned briefly in the discussion. The fact that the biotin-streptavidin interaction is ~100-fold higher affinity than an IgG binding to its epitope is likely playing a key role in the results here. The difference in size between IgG and streptavidin, the likelihood that the tetrameric streptavidin carries more fluors than a IgG secondary, and the fact that biotin can likely diffuse into phase-separated environments should be clearly stated. The current introduction segues from a previous paper that a more general audience may not be familiar with. 

      We have now included this paragraph to the introduction:

      “It remains unclear, why streptavidin was able to stain biotinylated proteins within these antibody inaccessible regions, but possible reasons are: (i) tetrameric streptavidin is smaller and more compact than IgGs (60 kDa versus a tandem of two IgGs, each with 150 kDa) (ii) the interaction between streptavidin and biotin is ~100 fold stronger than a typical interaction between antibody and antigen and (iii) streptavidin contains four fluorophores, in contrast to only one per secondary IgG.”

      Minor issues: 

      The copy numbers of the HA and Ty1 epitope tags vary depending on the construct being used. For example, Ty1 is found as a single copy tag in the TurboID tag, but on the mNeonGreen tag there are 6 copies of the epitope. It makes it hard to know if differences in detection are due to variations in copies of the epitope tags. Line 372-374: can the authors explain why they chose to use nanobodies in this case? It would be great to show the innate mNeonGreen signal in 2K to compare to the Ty1 labeling. The presence of 6 copies of the Ty1 epitope could be essential to the labeling seen here.

      We agree with the reviewer, that these data are a bit confusing. We have now removed Figure 3K, as it is the only construct with 6 Ty1 instead of one, and it does not add to the conclusions. (the mNeonsignal is entirely in the nucleolus, as shown by Tryptag). We have also added an explanation why we used nanobodies (“The absence of a nanobody signal rules out that its simply the size of IgGs that prevents the staining of Mex67 at the nuclear pores, as nanobodies are smaller than (tetrameric) streptavidin”). However, as stated above, we prefer not to overinterpret the data, as signals from different antibodies/nanobodies – antigen combinations are not comparable. Important to us was to stress that the absence of signal in phase-separated areas is NOT restricted to the anti-HA antibody, which is clearly supported by the data.

      What is the innate streptavidin background labeling look like in cells that are not carrying a TurboID fusion, from the native proteins that are biotinylated? That should be discussed. 

      We have now included the controls without the TurboID fusions for trypanosomes and HeLa cells: “Wild type cells of both Trypanosomes and human showed only a very low streptavidin signal, indicating that the signal from naturally biotinylated proteins is neglectable (Figure S8 in supplementary material).”

      Line 328-331: This is likely to be dependent on whether or not the protein moves to different localizations within the cell. 

      True, we agree, and we have added this paragraph:

      “The one exception are very motile proteins that produce a “biotinylation trail” distinct to the steady state localisation; these exceptions, and how they can be exploited to understand protein interactions, are discussed in chapter 4 below. “

      Line 304-305: Does biotin supplementation not matter at all? 

      No, we never saw any increase in biotinylation when we added extra biotin to trypanosomes. The 0.8 µM biotin concentration in the medium were sufficient.

      Line 326-327: Was the addition of biotin checked for enhancement in the case of the mammalian NUP98? I would argue that there is a significant number of puncta in Figure 1D that are either green or magenta, not both. The amount of extranuclear puncta in the HA channel is also difficult to explain. Biotin supplementation to 500 µM was used in mammalian TurboID experiments in the original Nature Biotech paper- perhaps nanomolar levels are too low. 

      We now tested HeLa cells with 500 µM Biotin and saw an increase in signal, but also in background; due to the increased background  we conclude that low biotin concentrations are more suitable . We have also repeated the experiment using 4HA tags instead of 1HA, and we found a minor improvement in the antibody signal for NUP88 (while the phase separated NUP54 was still not detectable). We have replaced the images in Figure 1D  (NUP88) and also in Figure 2F (NUP54) with improved images and using 4HA tags. However, we like to note that single nuclear pore resolution is beyond what can be expected of light microscopy.

      Line 371: In 2I, I see a signal that looks like the nucleus, similar to the Ty1 labeling in 2G, so I don't think it's accurate to say that that Mex67 was "undetectable". Does the serum work for blotting? 

      Thank you, yes, “undetectable” was not the correct phrase here. Mex67 localises to the nuclear pores, to the nuceoplasm and to the nucleolus (GFP-tagging or streptavidin). Antibodies, either to the tag or to the endogenous proteins, fail to detect Mex67 at the nuclear pores and also don’t show any particular enrichment in the nucleolus. They do, however, detect Mex67 in the (not-phase-separated) area of the nucleoplasm. We have changed the text to make this clearer. The Mex67 antiserum works well on a western blot (see for example: Pozzi, B., Naguleswaran, A., Florini, F., Rezaei, Z. & Roditi, I. The RNA export factor TbMex67 connects transcription and RNA export in Trypanosoma brucei and sets boundaries for RNA polymerase I. Nucleic Acids Res. 51, 5177–5192 (2023))

      Line 477: "lacked" should be "lagged".

      Thank you, corrected.

      Line 468-481: My previous argument holds here - how do you know that the difference in detection here is just a matter of much higher affinity/quantity of binding partner for the avidin?

      See answer to the second point of (3), above.

      483-491: Same issue - without certainty about what the biotin is on, this argument is difficult to make. 

      See answer to the second point of (3), above.

      Line 530: "bone-fine" should be "bonafide"

      Thank you, corrected.

      Line 602: biotin/streptavidin labeling has been used for expansion microscopy previously (Sun, Nature Biotech 2021; PMID: 33288959). 

      Thank you, we had overlooked this! We have now included this reference and describe the differences to our approach clearer in the discussion part:

      “Fluorescent streptavidin has been previously used in expansion microscopy to detect biotin residues in target proteins produced by click chemistry (Sun et al., 2021). However, to the best of our knowledge, this is the first report that employs fluorescent streptavidin as a signal enhancer in expansion microscopy and CLEM, by combining it with multiple biotinylation sites added by a biotin ligase. Importantly, for both CLEM and expansion, streptavidin imaging is the only alternative approach to immunofluorescence, as denaturing conditions associated with these methods rule out direct imaging of fluorescent tags.”

    1. For the first time, there was someone else with him: A squat white woman with a plastic name-tag and the kind of squarish perm you can only get in Southern beauty salons with faded glamor-shots in the windows. The boy trailed behind her looking thin and pressed, like a flower crushed between dictionary pages. I wondered how badly you had to fuck up to get assigned a school counselor after hours, until I read her name-tag: Department of Community-Based Services, Division of Protection and Permanency, Child Caseworker (II).Oh. A foster kid.

      I like this part a lot because it gives the reader a new perspective of this character that is in the narrator's life. We also get to see how she comes to realize the deeper part of his life.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This article by Navratna et al. reports the first structure of human HGSNAT in an acetyl-CoA-bound state. Through careful structural analysis, the authors propose potential reasons why certain human mutations lead to lysosomal storage disorders and outline a catalytic mechanism. The structural data are of good quality, and the manuscript is clearly written. This study represents an important step toward understanding the mechanism of HGSNAT and is valuable to the field. I have the following suggestions:

      (1) The authors should characterize whether the purified protein is active. Otherwise, how does one know if the detergent used maintains the protein in a biologically relevant state? The authors should at least attempt to do so. If these prove to be challenging, at the very least, the authors should try a cell-based assay to demonstrate that the GFP tag does not interfere with the function.

      We have addressed these concerns in the revised version and mentioned these efforts in our previous response letter. We’re briefly mentioning them here again. We attempted measuring HGSNAT catalyzed reaction by monitoring the decrease in acetyl-CoA in the presence of D-glucosamine (acetyl group acceptor) using a coupled enzyme acetyl-CoA assay kit from SIGMA (MAK039) that converts acetyl-CoA to a fluorescent product measurable at Ex/Em of 535/587 nm. We noticed a decrease in the level of acetyl-CoA (gray) upon the addition of HGSNAT (red) (Rebuttal figure 1).

      Author response image 1.

      Acetyl-CoA levels in absence and presence of HGSNAT purified in digitonin. Decrease in the levels of 10 M acetyl-CoA was measured in presence of 10 M D-glucosamine and 30 nM HGSNAT at pH 7.5.

      While optimizing the assay, Xu et al. (2024, Nat Struct Mol Biol) published structural and biochemical characterization of HGSNAT, showing that detergent-purified HGSNAT is active. In addition, we have shown by cryo-EM that GFP-tagged HGSNAT that we purified in detergent was already bound to the endogenous substrate ACO, an observation that has been observed by Xu et al., as well. Finally, we performed LC-MS on GFP-tagged HGSNAT purified in detergent to detect bound ACO, which could be further removed by dialysis. These results have been included in Figure S9. The endogenous binding of ACO to HGSNAT in detergent suggests that neither the tag nor detergent are detrimental to the function.

      (2) In Figure 5, the authors present a detailed schematic of the catalytic cycle, which I find to be too speculative. There is no evidence to suggest that this enzyme undergoes isomerization, similar to a transporter, between open-to-lumen and open-to-cytosol states. Could it not simply involve some movements of side chains to complete the acetyl transfer?

      We have already changed this figure in our latest submission. Perhaps the changes made were not obvious while reviewing. We agreed with this reviewer that the enzyme could likely achieve catalysis by simple side chain movements without undergoing extensive isomerization steps, as depicted in Figure 5. In the absence of data supporting large movements during the acetyl transfer reaction, old Figure 5 appeared speculative. Hence, we have edited Figure 5 in the revised version of the manuscript based on the observations we made in this study, and different states shown in the figure do not show any conformational changes and only depict acetyl transfer.

      Reviewer #2 (Public Review):

      Summary:

      This work describes the structure of Heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT), a lysosomal membrane protein that catalyzes the acetylation reaction of the terminal alpha-D-glucosamine group required for degradation of heparan sulfate (HS). HS degradation takes place during the degradation of the extracellular matrix, a process required for restructuring tissue architecture, regulation of cellular function and differentiation. During this process, HS is degraded into monosaccharides and free sulfate in lysosomes.

      HGSNAT catalyzes the transfer of the acetyl group from acetyl-CoA to the terminal non-reducing amino group of alpha-D-glucosamine. The molecular mechanism by which this process occur has not been described so far. One of the main reasons to study the mechanism of HGSNAT is that multiple mutations spanning the entire sequence of the protein, such as, nonsense mutations, splice-site variants, and missense mutations lead to dysfunction that causes abnormal accumulation of HS within the lysosomes. This accumulation is a cause of mucopolysaccharidosis IIIC (MPS IIIC), an autosomal recessive neurodegenerative lysosomal storage disorder, for which there are no approved drugs or treatment strategies.

      This paper provides a 3.26A structure of HGSNAT, determined by single-particle cryo-EM. The structure reveals that HGSNAT is a dimer in detergent micelles, and a density assigned to acetyl-CoA. The authors speculate about the molecular mechanism of the acetylation reaction, map the mutations known to cause MPS IIIC on the structure and speculate about the nature of the HGSNAT disfunction caused by such mutations.

      Strengths:

      The paper describes a structure of HGSNAT a member of the transmembrane acyl transferase (TmAT) superfamily. The high-resolution of a HGSNAT bound to acetyl-CoA is important for our understanding of HGSNAT mechanism. The density map is of high-quality, except for the luminal domain. The location of the acetyl-CoA allows speculation about the mechanistic role of multiple residues surrounding this molecule. The authors thoroughly describe the architecture of HGSNAT and map the mutations leading to MPS IIIC.

      Reviewer #3 (Public Review):

      Summary:

      Navratna et al. have solved the first structure of a transmembrane N-acetyltransferase (TNAT), resolving the architecture of human heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT) in the acetyl-CoA bound state using single particle cryo-electron microscopy (cryoEM). They show that the protein is a dimer, and define the architecture of the alpha- and beta-GSNAT fragments, as well as convincingly characterizing the binding site of acetyl-CoA.

      Strengths:

      This is the first structure of any member of the transmembrane acyl transferase superfamily, and as such it provides important insights into the architecture and acetyl-CoA binding site of this class of enzymes.

      The structural data is of a high quality, with an isotropic cryoEM density map at 3.3Å facilitating building of a high-confidence atomic model. Importantly, the density for the acetyl-CoA ligand is particularly well-defined, as are the contacting residues within the transmembrane domain.

      The structure of HSGNAT presented here will undoubtedly lay the groundwork for future structural and functional characterization of the reaction cycle of this class of enzymes.

      Weaknesses:

      While the structural data for the state presented in this work is very convincing, and clearly defines the binding site of acetyl-CoA, to get a complete picture of the enzymatic mechanism of this family, additional structures of other states will be required.

      A weakness of the study is the lack of functional validation. The enzymatic activity of the enzyme characterized was not measured, and the enzyme lacks native proteolytic processing, so it is a little unclear whether the structure represents an active enzyme.

      Recommendations for the authors:

      Reviewer #3 (Recommendations For The Authors):

      In the response to reviewers, the authors mention revised coordinates, but the revised coordinates provided to this reviewer do not reflect the stated changes (I assume a technical error somewhere)

      Perhaps, the old coordinates in the deposition system were resubmitted with the revised draft. Nevertheless, we have made the changes suggested by this reviewer to structure in the previous round and have released the new coordinates (PDB ID: 8TU9).

      Is there any evidence for the interprotomer disulfide except for the map? e.g. if it is a disulfide-linked dimer, one should see a shift in mobility on non-reducing vs reducing SDS-PAGE. Without this, the evidence from the map is not conclusive - while the symmetry-related cysteines are nearby to one another, based on the map I could argue that they could just as well be modeled with the cys sidechains reduced and pointing away from one another.

      In addition to building the density based on cryo-EM maps, we have performed FSEC-based thermal melt analysis of the Ala mutation of C334 that is involved in disulfide at the dimer interface. C334A is still expressed as a dimer, suggesting that C334A is not the only residue stabilizing the dimer. Upon heating the detergent-solubilized protein, we noticed that the FSEC peak for C334A shows a monomeric HGSNAT (Figure 4-Figure supplement 1 in main manuscript). We hypothesize that in the absence of C334 disulfide, the extensive hydrophobic side-chain interaction network displayed in Figure 2C is responsible for maintaining the integrity of the dimer. Heating disturbs these non-disulfide interactions, thereby rendering the protein monomer. We have also performed PAGE analysis as suggested by this reviewer and noticed that reducing conditions result in a monomeric protein band (Rebuttal figure 2). While we were revising this manuscript, two other groups published structures of HGSNAT (Xu et al., 2024, Nat. Struct Mol Biol, and Zhao et al., 2024, Nat. Comm). These groups have also identified this disulfide at the dimer interface in their HGSNAT structures. Zhao et al. showed that this disulfide is not crucial for dimerization and also suggested that it can break depending on the conformation of HGSNAT. Our FSEC results agree with this observation.

      Author response image 2.

      Comparison of purified HGSNAT on native and reducing SDS-PAGE. The arrows on both the gels indicate N-GFP-HGSNAT. The two bands on the SDS PAGE are, perhaps, two differentially glycosylated forms of HGSNAT.


      The following is the authors’ response to the original reviews.

      (1) The authors should characterize whether the purified protein is active. Otherwise, how does one know if the detergent used maintains the protein in a biologically relevant state? The authors should at least attempt to do so. If these prove to be challenging, at the very least, the authors should try a cell-based assay to demonstrate that the GFP tag does not interfere with the function. The authors would need to establish an in vitro assay using purified protein and assess the level of Acetyl-CoA in the reaction (there are commercial kits and a long list of literature showing how to measure this). They could also follow the HS acetylation reaction by e.g. HPLC-MS or NMR (among other methods).

      The cryo-EM sample was prepared without the exogenous addition of ligand, as noted in the manuscript. However, we see that acetyl-CoA was intrinsically bound to the protein, indicating the ability of GFP-tagged HGSNAT protein to bind the ligand. Upon dialysis, we see release of acetyl-CoA from the protein, which we have confirmed by LC-MS analysis (Fig S9). We purified the protein at a pH optimal for acetyl-CoA binding, as suggested by Bame, K. J. and Rome, L. H. (1985) and Meikle, P. J. et al., (1995). Because we see acetyl-CoA in a structure obtained using a GFP fusion, we argue that GFP does not interfere with protein stability and ability to bind to the co-substrate. As demonstrated by existing literature HGSNAT catalyzed reaction is compartmentalized spatially and conditionally. The binding of acetyl-CoA happens towards the cytosol and is optimal at pH 7-0.8.0, while the transfer of the acetyl group to heparan sulfate occurs towards the luminal side and is optimal at pH 5.0-6.0. We attempted measuring HGSNAT catalyzed reaction by monitoring decrease in acetyl-CoA in presence of D-glucosamine (acetyl group acceptor) using a coupled enzyme acetyl-CoA assay kit from SIGMA (MAK039) that converts acetyl-CoA to a fluorescent product measurable at Ex/Em of 535/587 nm. We noticed a decrease in the level of acetyl-CoA in the presence of HGSNAT-ACO complex (blue) and apo HGSNAT (red); the difference compared to the ACO standard (gray) was not significant. While optimizing the assay, Xu et al. (2024, Nat Struct Mol Biol) published structural and biochemical characterization of HGSNAT, showing that detergent-purified HGSNAT is active.

      Author response image 3.

      Acetyl-CoA levels in absence and presence of HGSNAT purified in digitonin. Decrease in the levels of 10 mM acetyl-CoA was measured in presence of 10 mM D-glucosamine and 30 nM HGSNAT at pH 7.5.

      (2) In Figure 5, the authors present a detailed schematic of the catalytic cycle, which I find to be too speculative. There is no evidence to suggest that this enzyme undergoes isomerization, similar to a transporter, between open-to-lumen and open-to-cytosol states. Could it not simply involve some movements of side chains to complete the acetyl transfer? The speculative nature of this assumption needs to be clearly acknowledged throughout the manuscript and discussed in more detail. The authors could use HDX-MS or introduce cysteine residues in the hypothetical inward- and outward-facing cavities and test accessibility by incubating the purified protein with maleimides or other agents reacting with free cysteine.

      We thank the reviewers for this insightful critique. Yes, the enzyme could likely achieve catalysis by simple side chain movements without undergoing extensive isomerization steps, as depicted in Figure 5. We also agree with the reviewer that HDX-MS could be the best way to monitor the substrate-induced conformational dynamics within HGSNAT experimentally. In the absence of data supporting large movements during the acetyl transfer reaction, figure 5 is speculative. We have now edited Figure 5 in the revised version of the manuscript based on the observations we made in this study.

      (3) The acetyl-CoA-bound state is described as the open-to-lumen state. Indeed, from Figure 1C, the lumen opening appears much larger than the cytosol opening. Is there any small tunnel that connects the substrate site to the cytosol? In other words, is this state accessible to both the lumen and the cytosol, albeit with a larger opening toward the lumen? This question arises because, in Figure S5, the tunnel calculated by MOLE seems to also connect to the cytosol.

      Yes, it is likely that the ACOS is accessible via lumen and cytosol to varying degrees, as evidenced by MOLE prediction. However, binding of the bulky nucleoside head group of acetyl-CoA at ACOS blocks the cytosolic entrance in the confirmation discussed in this manuscript. MOLE prediction was performed on a structure devoid of acetyl-CoA, and it is possible that the protein doesn’t essentially undergo isomerization between open-to-lumen and open-to-cytosol confirmations during acetyl transfer. Likely, ACOS is always accessible from both the lumen and cytosol, but depending on the substrates or products bound, the accessibility could be limited to either the lysosomal lumen or cytosol. We have rewritten all the statements mentioning an open-to-lumen confirmation to reflect this argument.

      (4) The authors state, "Interestingly, in most of the detergent conditions we tested, HGSNAT was predominantly dimeric (Fig S1C-H)," and also mention, "In all the detergents we tested, HGSNAT eluted as a dimer, a testament to the extensive side-chain interaction network." The dimerization is said to be mediated by a disulfide bond. I would be surprised if the detergents the authors tested could break a disulfide bond. Therefore, can this observation truly serve as a testament to an "extensive" side-chain interaction network?

      We agree with the reviewer that detergents are unlikely to break a disulfide bond. To address this comment, we generated a C334A mutant of HGSNAT and extracted it from cells in 1% digitonin. It is still expressed as a dimer (Fig S8E). However, upon heating the detergent solubilized protein, we noticed that the FSEC peak for C334A shows a monomeric HGSNAT (Fig S8I and S8K). We hypothesize that in the absence of C334 disulfide, the extensive hydrophobic side-chain interaction network displayed in Figure 2C is responsible for maintaining the integrity of the dimer. Heating disturbs these non-disulfide interactions, thereby rendering the protein monomer.

      (5) Apart from the cryo-EM structure, the article does not provide any other experimental evidence to support or explain a molecular mechanism. Due to the complete absence of functional assays, mutagenesis analysis, or other structures such as a ternary complex or an acetylated enzyme intermediate, the mechanistic model depicted in Figure 5 should be taken with caution. This uncertainty needs to be clearly described in the manuscript text. Performing additional mutagenesis experiments to test key hypotheses, or further discussing relevant data from the literature, would strengthen the manuscript.

      We agree with the reviewer on the lack of supporting evidence for the mechanistic models proposed in Fig 5. They were made based on previously reported biochemical characterization of HGSNAT by Rome & Crain (1981), Rome et al. (1983), Miekle et al. (1995), and Fan et al. (2011). However, we agree with the reviewer that this schematic is not experimentally proven and is speculative at best. We have edited Figure 5 in the revised version of the manuscript. In addition, we have also performed mutagenesis analysis to study the stability of mutants (Fig S8) and performed LC-MS analysis to identify endogenously bound acetyl-CoA (Fig S9) to strengthen parts of the manuscript. We have discussed our findings in the results and modified the discussion according to these suggestions.

      (6) It is discussed that H269 is an essential residue that participates in the acetylation reaction, possibly becoming acetylated during the process. However, there is no solid experimental evidence, e.g. mutagenesis analysis or structural analysis, in this or previous articles, that demonstrates this to be the case. Providing more information, ideally involving additional experimental work, would strengthen this aspect of the mechanism that is proposed. This would require establishing an in vitro assay, as described in 1).

      H269, as a crucial catalytic residue, was suggested by monitoring the effect of chemical modifications of amino acids on acetylation of HGSNAT membranes by Bame, K. J. and Rome, L. H. (1986). We generated N258I and H269A mutants of HGSNAT and analyzed their stability. We noticed a greater destabilization in N258I compared to H269A (Fig S8). We believe this is because of the loss of ability to bind acetyl-CoA, as the TMs around a catalytic core of the protein in our cryo-EM structure were stabilized by interactions with acetyl-CoA. Recently, Xu et al. (2024, Nat Struct Mol Biol) suggested that they do not observe acetylated histidine in their structure. However, our structure and that reported by Xu et al. (2024) are obtained at cytosolic pH. Perhaps, acetylation of H269 occurs at acidic lysosomal pH. Extensive structural and catalytic investigation of HGSNAT at low pH is required to rule out H269 acetylation as a step in the HGSNAT catalyzed reaction.

      (7) In the discussion part, the authors mention previous studies in which it was postulated that the catalytic reaction can be described by a random order mechanistic model or a Ping Pong Bi Bi model. However, the authors leave open the question of which of these mechanisms best describes the acetylation reaction. The structure presented here does not provide evidence that could support one mechanism or the other. The authors could explore if an in vitro experimental measurement of protein activity would provide any information in this regard.

      We agree with the reviewer that a more detailed kinetic analysis is necessary to define the bisubstrate reaction mechanism of HGSNAT. All the existing structural data on two isoforms of HGSNAT is obtained at basic pH. As a result, the existing structures do not unambiguously demonstrate the bisusbtrate mechanism of HGSNAT. We believe low pH structural characterization and a detailed kinetic and structural characterization of HGSNAT in membrane mimetics like nanodiscs could provide more insights into the mechanism. However, these studies are a future undertaking and are not a part of this manuscript.

      (8) Although the authors map the mutations leading to MPS IIIC on the structure and use FoldX software to predict the impact of these mutations on folding and fold stability, there is no experimental evidence to support FoldX's predictions. It would be ideal if an additional test for these predictions were included in the manuscript. The authors could follow the unfolding of purified mutants by SEC, FSEC, or changes in intrinsic fluorescence to assess protein stability.

      As suggested here, we prepared HGSNAT MPSIIIC variants and tested their expression and stability (please see Fig S8). These results have been included in the revised version of the manuscript.

      (9) Some sidechains that have quite strong sidechain density are missing atoms. I would be particularly careful with omitting sidechains that pack in the hydrophobic core, as this can tend to artificially reduce the clash score. Check F81, L62, P91 and V87, for example.

      We have revisited the modeling of these regions and deposited new coordinates.

      (10) W316 seems to have the wrong rotamer.

      This has been corrected in the new coordinate file that has been released.

      (11) N134 and N433 seem to have extra density. Are these known glycosylation sites?

      As per Hrebicek M. et al., 2006 and Feldhammer M. et al., 2009, there are five predicted glycosylation sites: N66, N114, N134, N433, and N602. However, we see evidence for NAG density at N114, N134, and N433. These have now been modeled in the structure.

      (12) At the C-terminal residue (Ile-635), the very C-terminal carboxylate is modeled pointing to a hydrophobic environment. It seems more likely to me that the Ile sidechain is packing here, with the C-terminal carboxylate facing the solvent.

      Thank you for pointing this out. We have edited the orientation of the Ile sidechain accordingly.

      Presentation and wording of results/methods:

      - Figure S3 legend "At places with missing density, the side chains were trimmed to C- alpha" - this is incorrect, I think the authors mean C-beta.

      We have corrected this error in the revised version of the manuscript.

      - Figure S3 legend - the authors refer to a gray mesh, where a transparent surface is displayed.

      Thanks for pointing this error out. We have corrected this in the revised version.

      - Some colloquial/vague wording in the main text (a lot of sentences starting with "Interestingly, ...". Making the wording more specific would help the reader I think.

      We have edited out ‘interestingly’ from the document and have re-written parts of the manuscript, per reviewers’ suggestion, for brevity.

      - Figure S2 legend, "throughout the processing workflow the resolution of luminal domain was used as a guidepost" - it is not entirely clear to me what this means in this context, perhaps revise the wording?

      We have rephrased this line in the revised draft of the manuscript.

      - Figure S2 and methods, Local refinements of LD and TMD are mentioned, but not indicated on the processing workflow.

      We have included a new Fig S2 & edited the legend, including these changes, per the reviewers’ suggestions.

    2. Reviewer #1 (Public Review):

      This article by Navratna et al. reports the first structure of human HGSNAT in an acetyl-CoA-bound state. Through careful structural analysis, the authors propose potential reasons why certain human mutations lead to lysosomal storage disorders and outline a catalytic mechanism. The structural data are of good quality, and the manuscript is clearly written. This study represents an important step toward understanding the mechanism of HGSNAT and is valuable to the field. I have the following suggestions:

      (1) The authors should characterize whether the purified protein is active. Otherwise, how does one know if the detergent used maintains the protein in a biologically relevant state? The authors should at least attempt to do so. If these prove to be challenging, at the very least, the authors should try a cell-based assay to demonstrate that the GFP tag does not interfere with the function.

      (2) In Figure 5, the authors present a detailed schematic of the catalytic cycle, which I find to be too speculative. There is no evidence to suggest that this enzyme undergoes isomerization, similar to a transporter, between open-to-lumen and open-to-cytosol states. Could it not simply involve some movements of side chains to complete the acetyl transfer?

    1. The recombinant Pap31 antigen was prepared as described previously.

      "Primers for rPap31 were designed according to the ATCC strain 35685 (KC583) sequence determined by L. Hendrix. The sequence has just been submitted to GenBank (accession number DQ207957) (forward primer: gcagcatatgttatgatcccgcaagaaata; reverse primer: ctaaaggcacaaccacaacgcattcttaag). The rPap31 gene segment was amplified using the genomic DNA of a local strain HOSP 800–09 as the template. PCR product was inserted between the NdeI and EcoRI sites of the expression vector pET24a (pET24a-pap31). The rPap31 protein was expressed in E. coli BL21 (DE3) after induction with 1 mM IPTG. The Pap31 gene segment in pET24a was recloned by GenWay Biotech Incorporated (San Diego, CA) to attach a T7 tag to the N-terminus of the rPap31 gene insert. The rPap31 was expressed as an inclusion body, which was washed and solubilized with 8 M urea in the presence of 1% Triton X-100 and 2 mM DTT in 50 mM Tris HCl, pH 8.0. The polypeptide was refolded by dialysis against 0.1 mM EDTA/12% glycerol in 50 mM Tris-HCl, pH 8.0, at 4°C. The refolded protein was further purified using the T7-tag affinity column in the presence of 2 M urea."

      https://nyaspubs.onlinelibrary.wiley.com/doi/10.1196/annals.1355.045

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In the manuscript entitled "Rtf1 HMD domain facilitates global histone H2B monoubiquitination and regulates morphogenesis and virulence in the meningitis-causing pathogen Cryptococcus neoformans" by Jiang et al., the authors employ a combination of molecular genetics and biochemical approaches, along with phenotypic evaluations and animal models, to identify the conserved subunit of the Paf1 complex (Paf1C), Rtf1, and functionally characterize its critical roles in mediating H2B monoubiquitination (H2Bub1) and the consequent regulation of gene expression, fungal development, and virulence traits in C. deneoformans or C. neoformans. Specially, the authors found that the histone modification domain (HMD) of Rtf1 is sufficient to promote H2B monoubiquitination (H2Bub1) and the expression of genes related to fungal mating and filamentation, and restores the fungal morphogenesis and pathogenicity defects caused by RTF1 deletion.

      Strengths:

      The manuscript is well-written and presents the findings in a clear manner. The findings are interesting and contribute to a better understanding of Rtf1-mediated epigenetic regulation of fungal morphogenesis and pathogenicity in a major human fungal pathogen, and potentially in other fungal species, as well.

      Weaknesses:

      A major limitation of this study is the absence of genome-wide information on Rtf1-mediated H2B monoubiquitination (H2Bub1), as well as a lack of detail regarding the function of the Plus3 domain. Although overexpression of HMD in the rtf1Δ mutant restored global H2Bub1 levels, it did not rescue certain critical biological functions, such as growth at 39 °C and melanin production (Figure 4C-D). This suggests that the precise positioning of H2Bub1 is essential for Rtf1's function. A comprehensive epigenetic landscape of H2Bub1 in the presence of HMD or full-length Rtf1 would elucidate potential mechanisms and shed light on the function of the Plus3 domain.

      We thank the reviewer (and other reviewers) for this excellent suggestion. We have planned to carry out CUT&Tag assay to gain a comprehensive epigenetic landscape of H2Bub1 in the presence of HMD or full-length Rtf1 under conditions, where overexpression of HMD failed to rescue the phenotypes in the _rtf1_Δ mutant, such as growth at 39 °C.

      Reviewer #2 (Public Review):

      Summary:

      The authors set out to determine the role of Rtf1 in Cryptococcal biology, and demonstrate that Rtf1 acts independently of the Paf1 complex to exert regulation of Histone H2B monoubiquitylation (H2Bub1). The biological impact of the loss of H2Bub1 was observed in defects in morphogenesis, reduced production of virulence factors, and reduced pathogenic potential in animal models of cryptococcal infection.

      Strengths:

      The molecular data is quite compelling, demonstrating that the Rtf1-depednent functions require only this histone modifying domain of Rtf1, and are dependent on nuclear localization. A specific point mutation in a residue conserved with the Rtf1 protein in the model yeast demonstrates the conservation of that residue in H2Bub1 modification. Interestingly, whereas expression of the HMD alone suppressed the virulence defect of the rtf1 deletion mutant, it did not suppress defects in virulence factor production.

      Weaknesses:

      The authors use two different species of Cryptococcus to investigate the biological effect of Rtf1 deletion. The work on morphogenesis utilized C. deneoformans, which is well-known to be a robust mating strain. The virulence work was performed in the C. neoformans H99 background, which is a highly pathogenic isolate. The study would be more complete if each of these processes were assessed in the other strain to understand if these biological effects are conserved across the two species of Cryptococcus. H99 is not as robust in morphogenesis, but reproducible results assessing mating and filamentation in this strain have been performed. Similarly, C. deneoformans does produce capsule and melanin.

      This is a fair point raised by the reviewer, and we are going to test whether these biological effects are conserved across the two species. We will access effects of RTF1 deletion on bisexual mating hyphal formation in C. neoformans H99 background and capsule and melanin productions in C. deneoformans XL280 background.

      There are some concerns with the conclusions related to capsule induction. The images reported in Figure B are purported to be grown under capsule-inducing conditions, yet the H99 panel is not representative of the induced capsule for this strain. Given the lack of a baseline of induction, it is difficult to determine if any of the strains may be defective in capsule induction. Quantification of a population of cells with replicates will also help to visualize the capsular diversity in each strain population.

      We thank the reviewer for raising this concern. We are going to confirm the conclusions related to capsule induction under multiple capsule-inducing conditions, including Dulbecco’s Modified Eagle’s Medium (DMEM), Littman’s medium, and 10% fetal bovine serum (FBS) agar medium [1].

      The authors demonstrate that for specific mating-related genes, the expression of the HMD recapitulated the wild-type expression pattern. The RNA-seq experiments were performed under mating conditions, suggesting specificity under this condition. The authors raise the point in the discussion that there may be differences in Rtf1 deposition on chromatin in H99, and under conditions of pathogenesis. The data that overexpression of HMD restores H2Bub1 by western is quite compelling, but does not address at which promoters H2Bub1 is modulating expression under pathogenesis conditions, and when full-length Rtf1 is present vs. only the HMD.

      We thank the reviewer for raising these concerns. As mentioned in the response to Reviewer 1, our CUT&Tag assay will provide evidence to address these questions.

      Reviewer #3 (Public Review):

      Summary:

      In this very comprehensive study, the authors examine the effects of deletion and mutation of the Paf1C protein Rtf1 gene on chromatin structure, filamentation, and virulence in Cryptococcus.

      Strengths:

      The experiments are well presented and the interpretation of the data is convincing.

      Weaknesses:

      Yet, one can be frustrated by the lack of experiments that attempt to directly correlate the change in chromatin structure with the expression of a particular gene and the observed phenotype. For example, the authors observed a strong defect in the expression of ZNF2, a known regulator of filamentation, mating, and virulence, in the rtf1 mutant. Can this defect explain the observed phenotypes associated with the RTF1 mutation? Is the observed defect in melanin production associated with altered expression of laccase genes and altered chromatin structure at this locus?

      We completely agree with the reviewer, and as mentioned in our response to Reviewer 1 and 2, we are going to conduct CUT&Tag assay to investigate the genetic relationship between Rtf1-mediated H2Bub1 and the expression of particular genes.

      (1) Jang, E.-H., et al., Unraveling Capsule Biosynthesis and Signaling Networks in Cryptococcus neoformans. Microbiology Spectrum, 2022. 10(6): p. e02866-22.

    1. Reviewer #2 (Public Review):

      Summary:

      This manuscript by Wei et al studies the role of ZFP36L1, an RNA-binding protein, in promoting PD-L1 expression in gastric cancer (GC). They used human gastric cancer tissues from six patients and performed H3K27ac CUT&Tag to unbiasedly identify SE specific for the infiltrative type. They identified an SE driving the expression of ZFP36L1 and immune evasion through upregulation of PD-L1. Mechanistically, they show that SPI1 binds to ZFP36L1-SE and ZFP36L1 in turn regulates PD-L1 expression through modulation of the 3'UTR of HDAC3. This mechanism of PD-L1 regulation in gastric cancer is novel, and ZFP36L1 has not been previously implicated in GC progression. However, the data presented are largely correlations and no direct proof is presented that the identified SE regulates ZFP36L1 expression. Furthermore, the effect of ZFP36L1 manipulation elicited a modest effect on PDL1 expression. In fact, several cell lines (XGC1, MNK45) express abundant ZFP36L1 but no PD-L1, suggesting the ZFP36L1 per se is not a key stimulant of PD-L1 expression as IFNg is. Thus, the central conclusions are not supported by the data.

      Strengths:

      Use of human GC specimens to identify SE regulating PD-L1 expression and immune evasion.

      Weaknesses:

      Major comments:

      (1) The difference in H3K27ac over the ZFP36L1 locus and SE between the expanding and infiltrative GC is marginal (Figure 2G). Although the authors establish that ZFP36L1 is upregulated in GC, particularly in the infiltrative subtype, no direct proof is provided that the identified SE is the source of this observation. CRISPR-Cas9 should be employed to delete the identified SE to prove that it is causatively linked to the expression of ZFP36L1.

      (2) In Figure 3C the impact of shZFP36L1 on PD-L1 expression is marginal and it is observed in the context of IFNg stimulation. Moreover, in XGC-1 cell line the shZFP36L1 failed to knock down protein expression thus the small decrease in PD-L1 level is likely independent of ZFP36L1. The same is the case in Figure 3D where forced expression of ZFP36L1 does not upregulate the expression of PDL1 and even in the context of IFNg stimulation the effect is marginal.

      (3) In Figure 4, it is unclear why ELF1 and E2F1 that bind ZFP36L1-SE do not upregulate its expression and only SPI1 does. In Figure 4D the impact of SPI overexpression on ZFP36L1 in MKN45 cells is marginal. Likewise, the forced expression of SPI did not upregulate PD-L1 which contradicts the model. Only in the context of IFNg PD-L1 is expressed suggesting that whatever role, if any, ZFP36L1-SPI1 axis plays is secondary.

      (4) The data presented in Figure 6 are not convincing. First, there is no difference in the tumor growth (Figure 6E). IHC in Figure 6I for CD8a is misleading. Can the authors provide insets to point CD8a cells? This figure also needs quantification and review from a pathologist.

    1. Reviewer #1 (Public Review):

      The manuscript by Li et al. investigates the metabolism-independent role of nuclear IDH1 in chromatin state reprogramming during erythropoiesis. The authors describe accumulation and redistribution of histone H3K79me3, and downregulation of SIRT1, as a cause for dyserythropoiesis observed due to IDH1 deficiency. The authors studied the consequences of IDH1 knockdown, and targeted knockout of nuclear IDH1, in normal human erythroid cells derived from hematopoietic stem and progenitor cells and HUDEP2 cells respectively. They further correlate some of the observations such as nuclear localization of IDH1 and aberrant localization of histone modifications in MDS and AML patient samples harboring IDH1 mutations. These observations are intriguing from a mechanistic perspective and they hold therapeutic significance, however there are major concerns that make the inferences presented in the manuscript less convincing.

      (1) The authors show the presence of nuclear IDH1 both by cell fractionation and IF, and employ an efficient strategy to knock out nuclear IDH1 (knockout IDH1/ Sg-IDH1 and rescue with the NES tagged IDH1/ Sg-NES-IDH1 that does not enter the nucleus) in HUDEP2 cells. However, some important controls are missing.<br /> A) In Figure 3C, for IDH1 staining, Sg-IDH1 knockout control is missing.<br /> B) Wild-type IDH1 rescue control (ie., IDH1 without NES tag) is missing to gauge the maximum rescue that is possible with this system.

      (2) Considering the nuclear knockout of IDH1 (Sg-NES-IDH1 referenced in the previous point) is a key experimental system that the authors have employed to delineate non-metabolic functions of IDH1 in human erythropoiesis, some critical experiments are lacking to make convincing inferences.<br /> A) The authors rely on IF to show the nuclear deletion of Sg-NES-IDH1 HUDEP2 cells. As mentioned earlier since a knockout control is missing in IF experiments, a cellular fractionation experiment (similar to what is shown in Figure 2F) is required to convincingly show the nuclear deletion in these cells.<br /> B) Since the authors attribute nuclear localization to a lack of metabolic/enzymatic functions, it is important to show the status of ROS and alpha-KG in the Sg-NES-IDH1 in comparison to control, wild type rescue, and knockout HUDEP2 cells. The authors observe an increase of ROS and a decrease of alpha-KG upon IDH1 knockdown. If nuclear IDH1 is not involved in metabolic functions, is there only a minimal or no impact of the nuclear knockout of IDH1 on ROS and alpha-KG, in comparison to complete knockout? These studies are lacking.<br /> C) Authors show that later stages of terminal differentiation are impacted in IDH1 knockdown human erythroid cells. They also report abnormal nuclear morphology, an increase in euchromatin, and enucleation defects. However, the authors only report abnormal nuclear morphology in Sg-NES-IDH1 cells, as evaluated by cytospins. It is important to show the status of the other phenotypes (progression through terminal differentiation, euchromatin %, and enucleation) similar to the quantitations in the IDH1 knockdown cells.

      (3) The authors report abnormal nuclear phenotype in IDH1 deficient erythroid cells. It is not clear what parameters are used here to define and quantify abnormal nuclei. Based on the cytospins (eg., Figure 1A, 3D) many multinucleated cells are seen in both shIDH1 and Sg-NES-IDH1 erythroid cells, compared to control cells. Importantly, this phenotype and enucleation defects are not rescued by the administration of alpha-KG (Figures 1E, F). The authors study these nuclei with electron microscopy and report increased euchromatin in Figure 4B. However, there is no discussion or quantification of polyploidy/multinucleation in the IDH1 deficient cells, despite their increased presence in the cytospins.

      A) PI staining followed by cell cycle FACS will be helpful in gauging the extent of polyploidy in IDH1 deficient cells and could add to the discussions of the defects related to abnormal nuclei.<br /> B) For electron microscopy quantification in Figures 4B and C, how the quantification was done and the labelling of the y-axis (% of euchromatin and heterochromatin) in Figure 4 C is not clear and is confusingly presented. The details on how the quantification was done and a clear label (y-axis in Figure 4C) for the quantification are needed.<br /> C) As mentioned earlier, what parameters were used to define and quantify abnormal nuclei (e.g. Figure 1A) needs to be discussed clearly. The red arrows in Figure 1A all point to bi/multinucleated cells. If this is the case, this needs to be made clear.

      (4) The authors mention that their previous study (reference #22) showed that ROS scavengers did not rescue dyseythropoiesis in shIDH1 cells. However, in this referenced study they did report that vitamin C, a ROS scavenger, partially rescued enucleation in IDH1 deficient cells and completely suppressed abnormal nuclei in both control and IDH1 deficient cells, in addition to restoring redox homeostasis by scavenging reactive oxygen species in shIDH1 erythroid cells. In the current study, the authors used ROS scavengers GSH and NAC in shIDH1 erythroid cells and showed that they do not rescue abnormal nuclei phenotype and enucleation defects. The differences between the results in their previous study with vitamin C vs GSH and NAC in the context of IDH1 deficiency need to be discussed.

      (5) The authors describe an increase in euchromatin as the consequential abnormal nuclei phenotype in shIDH1 erythroid cells. However, in their RNA-seq, they observe an almost equal number of genes that are up and down-regulated in shIDH1 cells compared to control cells. If possible, an RNA-Seq in nuclear knockout Sg-NES-IDH1 erythroid cells in comparison with knockout and wild-type cells will be helpful to tease out whether a specific absence of IDH1 in the nucleus (ie., lack of metabolic functions of IDH) impacts gene expression differently.

      (6) In Figure 8, the authors show data related to SIRT1's role in mediating non-metabolic, chromatin-associated functions of IDH1.<br /> A) The authors show that SIRT1 inhibition leads to a rescue of enucleation and abnormal nuclei. However, whether this rescues the progression through the late stages of terminal differentiation and the euchromatin/heterochromatin ratio is not clear.<br /> B) In addition, since the authors attribute a role of SIRT1 in mediating non-metabolic chromatin-associated functions of IDH1, documenting ROS levels and alpha-KG is important, to compare with what they showed for shIDH1 cells.

      (7) In Figure 4 and Supplemental Figure 8, the authors show the accumulation and altered cellular localization of H3K79me3, H3K9me3, and H3K27me2, and the lack of accumulation of other three histone modifications they tested (H3K4me3, H3K35me4, and H3K36me2) in shIDH1 cells. They also show the accumulation and altered localization of the specific histone marks in Sg-NES-IDH1 HUDEP2 cells.<br /> A) To aid better comparison of these histone modifications, it will be helpful to show the cell fractionation data of the three histone modifications that did not accumulate (H3K4me3, H3K35me4, and H3K36me2), similar to what was shown in Figure 4E for H3K79me3, H3K9me3, and H3K27me2).<br /> B) Further, the cell fractionation and staining for histone marks is done in human primary erythroid cells on day15 of terminal differentiation, and these studies revealed that H3K79me3, H3K9me3, and H3K27me2 were retained in the nucleus in shIDH1 cells unlike a cellular localization observed in control cells. The authors cite reference #40 in relation to the cellular localization of histones - in this study, it was shown that the cellular export of histone to cytosol happens during later stages of terminal differentiation. In the current manuscript, the authors observe nuclear IDH1 throughout erythropoiesis and have shown this at both early and late time points of differentiation (between day7 to day15 of differentiation in primary erythroid cells, between day0 to day8 in HUDEP2 cells) in Figure 2. To help correlate the dynamics of localization and to discuss the mechanism for the retention of histone marks in the nucleus in IDH1 deficient cells, it will be helpful to show the cellular location of histone marks using cell fractionations for both early and late time points in terminal erythroid differentiation, similar to what they showed for IDH1 localization studies.<br /> C) Among the three histone marks that are dysregulated in IDH1 deficient cells (H3K79me3, H3K9me3, and H3K27me2), the authors show via ChIP-seq (Fig5) that H3K79me3 is the critical factor. However, the ChIP-seq data shown here lacks many details and this makes it hard to interpret the data. For example, in Figure 5A, they do not mention which samples the data shown correspond to (are these differential peaks in shIDH1 compared to shLuc cells?). There is also no mention of how many replicates were used for the ChIP seq studies.

    1. Top 10 frameworks de Node.js O JavaScript fugiu de vez do navegador e nós escolhemos 10 frameworks que você deve usar quando se trata de Node.js.

      310724 232004 qua. BEMIG-MG-IPT. Aloj. AlfreDom<br /> o LIDO

  6. Jul 2024
    1. Background As biological data increases, we need additional infrastructure to share it and promote interoperability. While major effort has been put into sharing data, relatively less emphasis is placed on sharing metadata. Yet, sharing metadata is also important, and in some ways has a wider scope than sharing data itself.Results Here, we present PEPhub, an approach to improve sharing and interoperability of biological metadata. PEPhub provides an API, natural language search, and user-friendly web-based sharing and editing of sample metadata tables. We used PEPhub to process more than 100,000 published biological research projects and index them with fast semantic natural language search. PEPhub thus provides a fast and user-friendly way to finding existing biological research data, or to share new data.

      This work has been peer reviewed in GigaScience (see paper), which carries out open, named peer-review. These reviews are published under a CC-BY 4.0 license and were as follows:

      Reviewer name: Weiwen Wang (original submission)

      This manuscript by LeRoy et al. introduces PEPhub, a database aimed at enhancing the sharing and interoperability of biological metadata using the PEP framework. One of the key highlights of this manuscript is the visualization of the PEP framework, which improves the adoption of the PEP framework, facilitating the reuse of metadata. Additionally, PEPhub integrates data from GEO, making it convenient for users to access and utilize. Furthermore, PEPhub offers metadata validation, allowing users to quickly compare their PEP with other PEPhub schemas. Another notable feature is the natural language search, which further enhances the user experience. Overall, PEPhub provides a comprehensive solution that promotes efficient metadata sharing, while leveraging the impact of the PEP framework in organizing large-scale biological research projects.While this manuscript was interesting to read, I have several concerns regarding its "semantic" search system and the interaction of PEPHub.1.

      The authors mentioned their use of a tool called "pepembed" to embed PEP descriptions into vectors. However, I was unable to locate the tool on GitHub, and there is limited information in the Method section regarding this. Could the authors provide additional details regarding the process of embedding vectors?2. The authors implemented semantic search as an advantage of PEPhub. However, they did not evaluate the effectiveness of their natural language search engine, such as assessing accuracy, recall rate, or F1 score. It would be beneficial for the authors to perform an evaluation of their natural language search engine and provide metrics to demonstrate its performance. This would enhance the credibility and reliability of their claims regarding the advantages of natural language search in PEPhub.3. It would be more beneficial to include the metadata in the search system rather than solely relying on the project description. For instance, when I searched for SRX17165287 (https://pephub.databio.org/geo/gse211736?tag=default), no results were returned.4. When creating a new PEP, it appears that I can submit two samples with identical values. According to the PEP framework guidelines, it is mentioned that "Typically, samples should have unique values in the sample table index column". Therefore, the authors should enhance their metadata validation system to enforce this uniqueness constraint. Additionally, if I enter two identical values in the sample field and then attempt to add a SUBSAMPLE, an error occurs. However, when I modify one of the samples, I am able to save it successfully.5. The error messages should provide more specific guidance. Currently, when attempting to save metadata with an incorrect format, all error messages are displayed as: "Unknown error occurred: Unknown".6.

      PEPhub should consider providing user guidelines or examples on how to fill in subsample metadata and any relevant rules associated with it.7. In the Validation module, what are the rules for validation? Does it only check for the required column names in the schema, or does it also validate the content of the metadata, such as whether the metadata is in the correct format (e.g., int or string)? Additionally, it would be beneficial to provide an option to download the relevant schema and clearly specify the required column names in the schema. This would enable users to better organize their PEP to comply with the schema format and ensure that their metadata is accurately validated.8. This version of PEPHub primarily focuses on metadata. Have the authors considered any plans to expand this database to include data/pipeline management within the PEP framework? It would be valuable for the authors to discuss their future plans for PEPHub in this manuscript.Some minor concerns:1. When searching for content within a specific namespace, it would be beneficial for the pagination bar at the bottom of the webpage to display the number of pages. Now there are only Previous/Next buttons.2. As a web service, it is better to show the supporting browsers, such as Google Chrome (version xxx and above), Firefox (version xxx and above). I failed to open PEPHub website using an old version of Chrome.

    1. security of the data transmission by encrypting the data

      Understand how identity/tokens are established/rotated/stored.

      1. Are tokens short spanned by default?
      2. What is the blast radius of the token compromise?
      3. How are tokens/cred stored locally?
      4. What is the revocation logic that it is dependent on?
    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      Fita-Torró et al. study the toxic effects of the intermediary lipid degradation product trans-2-hexadecenal (t-2-hex) on yeast mitochondria and suggest a mechanism by which Hfd1 safeguards Tom40 from lipidation by t-2-hex and its consequences, such as mitochondrial protein import inhibition, cellular proteostasis deregulation, and stress-responses. 

      The authors aimed to dissect a mechanism for t-2-hex' apoptotic consequences in yeast and they suggest it is via lipidation of Tom40 but really under the tested conditions everything seems lipidated. Thus, it is unclear whether Tom40 is the crucial causal target. They also do not provide much biochemical experiments to investigate this phenomenon further functionally. Tom40 is one possible and perhaps, given the cellular consequences, a reasonable candidate but not validated beyond in vitro lipidation by exogenous t-2-hex. 

      In the revised version of our manuscript, we have now included extensive new experimentation, which shows that protein import at the TOM complex is a physiologically important target of the pro-apoptotic lipid t-2-hex and that enzymes such as the Hfd1 dehydrogenase sensitively regulate this inhibition. In vitro chemoproteomic experiments have now been performed at more physiological t-2hex concentrations of 10µM, which is lower than published data in human cell models. Consistently, several TOM and TIM subunits are enriched in these in vitro lipidation studies (new Fig. 8B). Tom40 lipidation alone is not sufficient to explain t2-hex toxicity, as a cysteine-free version of Tom40 does not confer tolerance to the apoptotic lipid (new Fig. 8D). Importantly however, the loss of function of nonessential accessory Tom subunits 70 or 20 confers t-2-hex tolerance (new Fig. 8D) indicating that pre-protein import at the TOM complex is a physiological target of t2-hex most likely dependent on lipidation of more Tom subunits than just the essential Tom40 pore. Moreover, we now show that mitochondrial protein import is inhibited by the lipid at low physiological doses of 10µM and that this inhibition is modulated by the gene dose of the t-2-hex degrading Hfd1 enzyme (new Fig. 5G).

      Strengths: 

      The effects of lipids and their metabolic intermediates on protein function are understudied thus the authors' research contributing to elucidating direct effects of a single lipid is appreciated. It is particularly unknown by which mechanism t-2hex causes cell death in yeast. The authors elegantly use modulation of the levels of enzyme Hfd1 that endogenously catabolizes t-2-hex as an approach to studying t2-hex stress. Understanding the cause and consequences of this stress is relevant for understanding fundamental regulation mechanisms, and also to human health since the human homolog of Hfd1, ALDH3A2, is mutated in Sjögren-Larsson Syndrome. The application of a variety of global transcriptomic, functional genomic, and chemoproteomic approaches to study t-2-hex stress targets in the yeast model is laudable. 

      Weaknesses: 

      -  The extent of the contribution of Tom40 lipidation to the general t-2-hex stress phenotype is unclear. Is Tom40 lipidation alone enough to cause the phenotype? An alteration of the cysteine residue in question could help answer this key question. 

      Deletion of all four cysteine residues in Tom40 is not sufficient to confer resistance to t-2-hex stress. This result had been included in the original manuscript, but was somehow hidden in the Discussion. The revised manuscript now includes t-2hex tolerance assays for the Tom40 cysteine free mutant in new Figure 8. As a result, cysteine lipidation of Tom40 alone is not sufficient to confer t-2-hex toxicity. This implies most likely other lipidation targets within the TOM and TIM complexes, as indicated by our in vitro lipidation studies. We therefore included the non-essential adaptor proteins Tom70 and Tom20 of the TOM complex and tested the tolerance of the respective deletion mutants in t-2-hex tolerance assays. As shown in new Figure 8, the absence of Tom70 and Tom20 function significantly increases tolerance to t-2hex and the tom20 mutant accumulates less Aim17 pre-protein upon t-2-he stress, indicating that the TOM complex is a physiologically important target of the proapoptotic lipid, which acts most likely via lipidation of more subunits than the Tom40 import channel.

      -  It is unclear whether the exogenously applied amounts of t-2-hex (concentrations chosen between 25-200 uM) are physiologically relevant in yeast cells. For comparison, Chipuk et al. (2012) used at most 1 uM on mitochondria of human cells, while Jarugumilli et al. (2018) considered 25 uM a 'lower dose' on human cells. Since the authors saw responses below 10 uM (Fig. 3B) and at the lowest selected concentration of 25 uM (Fig. 8), why were no lower, likely more specific, concentrations applied for the global transcriptomic and chemoproteomic experiments? Key experiments have to be repeated with the lower concentrations. 

      We have now performed several experiments with lower t-2-hex concentrations. A new chemoproteomic study with 10µM t-2-hex-alkyne has been conducted and the new results added to the supplementary information, combining 10µM and 100µM in vitro lipidation studies (Suppl. Table 6). Many subunits of the TOM and TIM complexes consistently are enriched significantly in both chemoproteomic experiments. These new data are summarized in revised Figure 8. Additionally we have performed in vivo pre-protein assays with lower t-2-hex concentrations. As shown in new Figure 5, Aim17 mitochondrial import is already inhibited by t-2-hex doses as low as 10µM in a wild type strain, and that this inhibition is enhanced in a hfd1 mutant and alleviated in a Hfd1 overexpressor. It is important to note that a dose of 10µM of external t-2-hex addition is significantly lower than doses applied to human cell cultures such as in Jarugumilli et al. (2018). It proves that mitochondrial protein import is a sensitive and physiologically relevant t2-hex target in our yeast models and that t-2-hex detoxification by enzymes such as the Hfd1 dehydrogenase sensitively regulates this specific inhibition.

      -  The amount of t-2-hex applied is especially important to consider in light of over 1300 proteins lipidated to an extent equal to or greater than Tom40 (Supp. Table 6). This chemoproteomic experiment (Fig. 8B, Supp. Table 6) is also weakened by the inclusion of only 2 replicates, thus precluding assessment of statistical significance. The selection of targets in Fig. 8B as "among the best hits" is neither immediately comprehensible nor further explained and represents at best cherrypicking. Further evidence based on statistical significance or validation by other means should be provided.

      We performed the chemoproteomic screens as described by Jarugumilli et al. (2018) with 2 replicates of mock treated versus 2 replicates of t-2-hex-alkyne treated cell extracts.  A new chemoproteomic study with 10µM t-2-hex-alkyne has been conducted and the new results added to the supplementary information combining 10µM and 100µM in vitro lipidation studies (Suppl. Table 6). Differential enrichment analysis of the proteomic data was performed with the amica software (Didusch et al., 2022). Proteins were ranked according to their log2 fold induction comparing lipid- and mock-treated samples with a threshold of ≥1.5, and the adjusted p-value was calculated. Several TOM and TIM subunits were consistently identified as differentially enriched proteins, which is summarized in new Figure 8B.

      - The authors unfortunately also underuse the possible contribution of mass spectrometry technology to in addition determine the extent and localization of lipidation on a global scale (especially relevant since Cohen et al. (2020) suggest site-specific mechanisms). 

      We agree that site-specific modifications of t-2-hex will be most likely important in the inhibition or other type of regulation of specific target proteins. Our collective data show that in the case of the inhibition of mitochondrial protein import, several lipidation events on TOM and TIM are involved. Dissection of individual cysteine lipidations on those subunits will be interesting, but we feel that this is out of the scope of the present work.

      - The general novelty of studying t-2-hex stress is lowered in light of existing literature in humans (see e. g. Chipuk et al., 2012; Cohen et al., 2020; Jarugumilli et al., 2018), and in yeast by the same authors (Manzanares-Estreder et al., 2017) and as the authors comment themselves, a significant part of the manuscript may represent rather a confirmation of the already described consequences of t-2-hex stress 

      We do not agree and we have not commented that our present study is a mere confirmation of t-2-hex stress previously applied in yeast and human models. In humans, t-2-hex has been identified as an efficient pro-apoptotic lipid, which causes mitochondrial dysfunction via direct lipidation of Bax, however the studies of Jarugumilli et al. (2018) revealed that many other direct t-2-hex targets exist, which remained uninvestigated to date. This work continues our previous studies (Manzanares-Estreder et al., 2017), where we show that t-2-hex is a universal proapoptotic lipid applicable in yeast models and contributes important novel findings, such as the massive transcriptional response resembling proteostatic defects caused by t-2-hex, mitochondrial protein import as a physiologically important and direct target of t-2-hex, the function of detoxifying enzymes such as Hfd1 in modulating lipid-mediated inhibition of mitochondrial protein import and general proteostasis. Additionally, we provide transcriptomic, chemoproteomic and functional genomic data to the scientific community, which will be a rich source for future studies on yet undiscovered pro-apoptotic mechanisms employed by t-2-hex. 

      Reviewer #2 (Public Review): 

      This study elucidates the toxic effects of the lipid aldehyde trans-2-hexadecenal (t-2-hex). The authors show convincingly that t-2-hex induces a strong transcriptional response, leads to proteotoxic stress, and causes the accumulation of mitochondrial precursor proteins in the cytosol. 

      The data shown are of high quality and well controlled. The genetic screen for mutants that are hyper-and hypo-sensitive to t-2-hex is elegant and interesting, even if the mechanistic insights from the screen are rather limited. The last part of the study is less convincing. The authors show evidence that t-2-hex affects subunits of the TOM complex. However, they do not formally demonstrate that the lipidation of a TOM subunit is responsible for the toxic effect of t-2-hex. A t-2-hexresistant TOM mutant was not identified. Moreover, it is not clear whether the concentrations of t-2-hex in this study are physiological. This is, however, a critical aspect. The literature is full of studies claiming the toxic effects of compounds such as H2O2; even if such studies are technically sound, they are misleading if nonphysiological concentrations of such compounds were used. 

      Nevertheless, this is an interesting study of high quality. A few specific aspects should be addressed.

      We have now performed t-2-hex toxicity assays using several mutants in Tom subunits, the cysteine free mutant of the essential Tom40 core channel and deletion mutants in the accessory subunits Tom70 and Tom20 (new Figure 8). As a result, cysteine lipidation of Tom40 alone is not sufficient to confer t-2-hex toxicity. This implies most likely other lipidation targets within the TOM and TIM complexes, as indicated by our in vitro lipidation studies. Indeed, as shown in new Figure 8, the absence of Tom70 and Tom20 function significantly increases tolerance to t-2-hex indicating that the TOM complex is a physiologically important target of the proapoptotic lipid, which acts most likely via lipidation of more subunits than the Tom40 import channel.

      We have now performed several experiments with lower t-2-hex concentrations. A new chemoproteomic study with 10µM t-2-hex-alkyne has been conducted and the new results added to the supplementary information combining 10µM and 100µM in vitro lipidation studies (Suppl. Table 6). Many subunits of the TOM and TIM complexes consistently are enriched significantly in both chemoproteomic experiments. These new data are summarized in revised Figure 8.

      Additionally we have performed in vivo pre-protein assays with lower t-2-hex concentrations. As shown in new Figure 5, Aim17 mitochondrial import is already inhibited by t-2-hex doses as low as 10µM in a wild type strain, and that this inhibition is enhanced in a hfd1 mutant and alleviated in a Hfd1 overexpressor. It is important to note that a dose of 10µM of external t-2-hex addition is significantly lower than doses applied to human cell cultures such as in Jarugumilli et al. (2018). It proves that mitochondrial protein import is a sensitive and physiologically relevant t2-hex target in our yeast models and that t-2-hex detoxification by enzymes such as the Hfd1 dehydrogenase sensitively regulates this specific inhibition.

      Reviewer #3 (Public Review): 

      Summary: The authors investigate the effect of the lipid aldehyde trans-2hexadecenal (t-2-hex) in yeast using multiple omic analyses that show that a large range of cellular functions across all compartments are affected, e.g. transcriptomic changes affect 1/3 of all genes. The authors provide additional analyses, from which they built a model that mitochondrial protein import caused by modification of Tom40 is blocked. 

      Strengths: Global analyses (transcriptomic and functional genomics approach) to obtain an unbiased overview of changes upon t-2-hex treatment. 

      Weaknesses: It is not clear why the authors decided to focus on mitochondria, as only 30 genes assigned to the GO term "mitochondria" are increasing, and also the follow-up analyses using SATAY is not showing a predominance for mitochondrial proteins (only 4 genes are identified as hits). The provided additional experimental data do not support the main claims as neither protein import is investigated nor is there experimental evidence that lipidation of Tom40 occurs in vivo and impacts on protein translocation. 

      30 mitochondrial gene functions are very strongly (>10 fold) up-regulated by t-2-hex. However, when genes up-regulated (>2 log2FC) or down-regulated (<-2 log2FC) by t-2-hex were selected and subjected to GO category enrichment analysis, we found that “Mitochondrial organization” was the most numerous GO group activated by t-2-hex, while it was “Ribosomal subunit biogenesis” for t-2-hex repression (new data in Suppl. Tables 1 and 2). 

      In the revised version of our manuscript, we have now included extensive new experimentation, which shows that protein import at the TOM complex is a physiologically important target of the pro-apoptotic lipid t-2-hex and that enzymes such as the Hfd1 dehydrogenase sensitively regulate this inhibition. In vitro chemoproteomic experiments have now been performed at more physiological t-2hex concentrations of 10µM, which is lower than published data in human cell models. Consistently, several TOM and TIM subunits are enriched in these in vitro lipidation studies (new Fig. 8B). Tom40 lipidation alone is not sufficient to explain t2-hex toxicity, as a cysteine-free version of Tom40 does not confer tolerance to the apoptotic lipid (new Fig. 8D). Importantly however, the loss of function of nonessential accessory Tom subunits 70 or 20 confers t-2-hex tolerance (new Fig. 8D) indicating that pre-protein import at the TOM complex is a physiological target of t2-hex most likely dependent on lipidation of more Tom subunits than just the essential Tom40 pore. Moreover, we now show that mitochondrial protein import is inhibited by the lipid at low physiological doses of 10µM and that this inhibition is modulated by the gene dose of the t-2-hex degrading Hfd1 enzyme (new Fig. 5G).

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Private recommendations for the authors 

      - On the existing data from Supp. Table 6, the authors may include a global assessment of whether or not the protein included a cysteine (the likely site for lipidation). 

      Although free cysteines in target proteins are the most frequent sites of modification by LDEs such as t-2-hex, other amino acids such as lysines or histidines can be lipidated by these lipid derivatives. Therefore we would like to exclude this information from our chemoproteomic data.

      - What determines whether a gene is labeled in Fig. 6B other than fold change? Why is MAC1 with the highest FC not shown? 

      We analyzed the potential anti-apoptotic SATAY hits with a log2 < -0.75 according to expected detoxification pathways (heat shock response, pleiotropic drug response), to their function in the ER (the intracellular site where t-2-hex is generated) or in mitochondria (the major t-2-hex target identified so far). This is now better described in the text. As for the potential pro-apoptotic SATAY hits, we analyzed gene functions with a log2 > 1.5 and marked the predominant groups “Cytosolic ribosome and translation” and “Amino acid metabolism”. In any case, the interested reader has all SATAY data available in supplemental tables 4 and 5 to find alternative gene functions with a potential role in cellular adaptation to t-2-hex.

      - Supplementary Table numbering should be double-checked.

      Ok, numbering has been double-checked.

      Reviewer #2 (Recommendations For The Authors): 

      Major points 

      (1) Identification of the t-2-hex target. Neither Tom70, Tom20 nor the cysteine in Tom40 is essential. If one of these components is critical for the t-2-hex-mediated toxicity, mutants should be t-2-hex-resistant. This is a straight-forward, simple, and critical experiment. 

      We have now performed t-2-hex toxicity assays in the cysteine free Tom40 mutant, and tom20 and tom70 deletion mutants. As shown in new Figure 8, cysteine lipidation of Tom40 alone is not sufficient to confer t-2-hex toxicity. However, the absence of Tom70 and Tom20 function significantly increases tolerance to t-2-hex indicating that the TOM complex is a physiologically important target of the proapoptotic lipid, which acts most likely via lipidation of more subunits than the Tom40 import channel.

      (2) The authors claim that t-2-hex blocks the TOM complex. Since in vitro import assays with yeast mitochondria are a well established and simple technique, the authors should isolate mitochondria from their cells and perform import experiments. It is expected that those mitochondria show reduced import rates, however, swelling of these mitochondria to mitoplasts should suppress the import defect. 

      We agree that our study does not investigate a direct effect of t-2-hex on the import capacity of purified mitochondria. However, we determine the in vivo accumulation of several mitochondrial precursor proteins, which is widely used to assay for the efficiency of mitochondrial protein import, for example the recent hallmark paper discovering the mitoCPR protein import surveillance pathway exclusively uses epitope-tagged mitochondrial precursors to determine the regulation of mitochondrial protein import (Weidberg and Amon, Science 2018 360(6385)). Additionally, our new results that mutants in accessory TOM subunits 20 and 70 are hyperresistant to t-2-hex (Figure 8D) and that deletion of TOM20 decreases the t-2-hex induced pre-protein accumulation (Suppl. Figure 1) identify the TOM complex and hence protein import at the outer mitochondrial membrane as a physiologically important t-2-hex target.

      (3) The first part of the study is very strong. The last figure is also of good quality, however, it is not clear whether the effects on TOM subunits are really causal for the observed t-2-hex effect on gene expression. The authors might cure this by improved data or by avoiding bold statements such as: 'Hfd1 associates with the Tom70 subunit of the TOM complex and t-2-hex covalently lipidates the central Tom40 channel, which altogether indicates that transport of mitochondrial precursor proteins through the outer mitochondrial membrane is directly inhibited by the pro-apoptotic lipid and thus represents a hotspot for pro- and anti-apoptotic signaling.' (Abstract). 

      We now show that several TOM and TIM subunits are lipidated in vitro by physiological low t-2-hex concentrations, that loss of function of accessory subunits Tom20 or Tom70 rescues t-2-hex toxicity (new Figure 8) and that the gene dose of Hfd1 determines the degree of mitoprotein import block (new Figure 5). These data identify the TOM complex as a physiologically important target of the pro-apoptotic lipid. The Abstract has been modified accordingly.

      (4) If the t-2-hex levels are in a physiological range, one would expect that overexpression of Hfd1 prevents the t-2-hex-induced import arrest.

      We have now confirmed that overexpression of Hfd1 indeed prevents inhibition of mitochondrial protein import by t-2-hex. As shown in new Figure 5, Aim17 mitochondrial import is already inhibited by t-2-hex doses as low as 10µM in a wild type strain, and that this inhibition is enhanced in a hfd1 mutant and alleviated in a Hfd1 overexpressor.

      (5) The authors claim that Fmp52 is a t-2-hex-detoxifying enzyme, but do not show evidence. They should rewrite this sentence and be more cautious, or they should show that increased Fmp52 levels indeed deplete t-2-hex from mitochondria.  

      We show that loss of Fmp52 function leads to a strong t-2-hex sensitivity. Fmp52 belongs to the NAD-binding short-chain dehydrogenase/reductase (SDR) family and localizes to highly purified mitochondrial outer membranes (Zahedi et al, 2006). These are the indications that suggest that Fmp52 participates in the enzymatic detoxification of t-2-hex in addition to Hfd1. The Results section has been modified accordingly.

      Minor points: 

      (6) Aim17 was recently identified as a characteristic constituent of cytosolic protein aggregates named MitoStores (Krämer et al., 2023, EMBO J). The authors might test whether the cytosolic Aim17 protein colocalizes with the Hsp104-GFP granules that accumulate upon t-2-hex exposure as shown in Fig. 4A. 

      We agree that determining the fate of unimported mitochondrial precursors upon t-2-hex stress would be interesting. We have made some attempts to co-visualize Aim17-dsRed and Hsp104-GFP upon t-2-hex treatment, but we still have some technical issues. While we clearly see that Aim17 accumulates in cytoplasmic foci upon prolonged t-2-hex exposure, we are not able to determine colocalization with Hsp104, in great part because t-2-hex causes mitochondrial fragmentation, which leads to the appearance of Aim17-stained foci in the cytosol independently of protein aggregates. While so far we are not able to localize Aim17 unambiguously in Hsp104 containing aggregates (mitoStores) upon lipid stress, we would like to move the manuscript farther without those experiments.

      (7) In Fig. 1A, the figures of the different lines are difficult to distinguish. Lines of one color with different intensities would be better suited. 

      We have been working before with dose-response profiles generated by the destabilized luciferase system and found that the color-coded representation of the plots is the most effective way to represent the data, see for example Fita-Torró et al. Mol Ecol. 2023 32(13):3557-3574, Pascual-Ahuir et al. BBA 2019 1862(4):457-471, Rienzo et al., Mol Cell Biol. 2015 35(21):3669-83, and several other publications. Therefore we want to keep the format of the Figure.

      (8) A title page should be added to each of the supplemental data files with short descriptions of the information that is provided in the columns of the tables.  Response: Explanatory title pages have been now added to the supplemental data files.

      Reviewer #3 (Recommendations For The Authors): 

      Figure 5A: The authors aim to assess protein import, however, their experimental set-up is not suited and does not allow conclusions about protein translocation into mitochondria. The authors monitor protein steady state levels, which does not reflect import capacity. For this e.g. pulse-chase experiments coupled to coIP or in organello import assays with radiolabeled substrate proteins would be required. In addition, the authors lack a non-treated control to show that no precursor accumulates in the absence of CCCP and t-2-hex. At the moment, the conclusion of blocked import cannot be made, as there are many other explanations for the observed steady state levels, e.g. the TAP tag interfered with the import competence of the precursor or t-2-hex could impact on MPP function (in particular as Figure 8B shows that also intra-mitochondrial proteins undergo modification by t-2-hex). 

      We agree that our study does not investigate a direct effect of t-2-hex on the import capacity of purified mitochondria. However, we determine the in vivo accumulation of several mitochondrial precursor proteins, which is widely used to assay for the efficiency of mitochondrial protein import, for example the recent hallmark paper discovering the mitoCPR protein import surveillance pathway exclusively uses epitope-tagged mitochondrial precursors to determine the regulation of mitochondrial protein import (Weidberg and Amon, Science 2018 360(6385)). Figure 5 contains several non-treated control experiments, which show that no (or less in the case of Ilv6) precursors of Tap-tagged Aim17, Cox5a, Ilv6, or Sdh4 accumulate in the absence of CCCP or t-2-hex. This is shown in Figure 5A for untreated cells or in Figure 5B and new Figure 5G for solvent (DMSO) treated cells. This demonstrates that the Tap-tag does not interfere with the import of the respective precursors. Additionally, our new results that mutants in accessory TOM subunits 20 and 70 are hyperresistant to t-2-hex (Figure 8D) identify the TOM complex and hence protein import at the outer mitochondrial membrane as a physiologically important t-2-hex target.

      Figure 8: The conclusion that Tom40 is directly lipidated comes from an in vitro assay, with the conclusion that Tom40 is the main target, because it is the only Tom protein with a cysteine (Tom70 as not being part of the Tom core is excluded, however, lack of Tom70 function would also have detrimental consequences for mitochondrial protein import). However, there is no experiment showing a modification of Tom40 and a consequence for protein import. The proposed model is therefore very far-fetched and several aspects are speculation but not supported by experimental data. To propose such a model, the author needs to show experimental evidence, e.g. by generating a yeast strain in which the cysteine i Tom40 are replaced by e.g. Serine residues, and then assess if protein import (e.g. pulse-chase assays) are not affected anymore upon addition of t-2-hex. 

      Deletion of all four cysteine residues in Tom40 is not sufficient to confer resistance to t-2-hex stress. This result had been included in the original manuscript, but was somehow hidden in the Discussion. The revised manuscript now includes t-2hex tolerance assays for the Tom40 cysteine free mutant in new Figure 8D. As a result, cysteine lipidation of Tom40 alone is not sufficient to confer t-2-hex toxicity. This implies most likely other lipidation targets within the TOM and TIM complexes, as indicated by our in vitro lipidation studies. We therefore included the non-essential adaptor proteins Tom70 and Tom20 of the TOM complex and tested the tolerance of the respective deletion mutants in t-2-hex tolerance assays. As shown in new Figure 8D, the absence of Tom70 and Tom20 function significantly increases tolerance to t2-hex indicating that the TOM complex is a physiologically important target of the pro-apoptotic lipid, which acts most likely via lipidation of more subunits than the Tom40 import channel.

      Figure 8A: The pulldown experiments lack positive (other Tom subunits) and negative controls and were performed with (large) tags on all proteins, which can easily result in false positive interactions. The conclusion that Hfd1 interacts with Tom70 and Tom22 cannot be made. Also, the conclusion if an interaction is robust or not cannot be made as the pull-down lacks control fractions, it is also not clear how much of the eluate was loaded. Finally, Hfd1-HA was not expressed from its endogenous promoter, likely resulting in over-expression, which again strongly hampers conclusions about bona fide interaction partners. 

      We agree that our pulldown studies are done in an artificial context, such as Hfd1 overexpression needed for sufficient protein level for detection or use of Tapfusion proteins. However, the conclusion that Tom70 is a potential interactor of Hfd1 can be made based on the following observations: Hfd1-HA is preferentially pulled down from total protein extracts containing Tom70-Tap, but not from extracts containing no Tap-protein and significantly less from extracts containing Tom22-Tap, another TOM associated subunit. The pulldown assay has been repeated now several times and the efficiency of Hfd1 pulldown has been quantified and statistically analyzed with respect to the quantity of purified Tom protein, which is shown in modified Figure 8A. 

      Figure 4A and C: Depletion of proteasomal activity results in larger aggregates in Figure 4A. However, the addition of t-2-hex blocks proteasomal activity (Figure 4C). How can proteasome inhibition result in bigger aggregates if the proteasomal activity is lost upon t-2-hex addition?

      The negative effect of t-2-hex on proteasomal activity is most likely an indirect effect caused by protein aggregation (Bence et al., Science 2001 292-1552) and occurs in wild type and rpn4 mutant cells with reduced proteasomal activity (Fig. 4C). t-2-hex causes cytosolic protein aggregation in wild type cells, which is aggravated (more and larger protein aggregates) in rpn4 mutants because of their lower levels of active proteasome (Fig. 4A). The observed protein aggregates will further diminish proteasomal activity, which is confirmed in Fig. 4C. 

      Figure 1B: The authors use a reporter to determine HFD1 expression that consists of the promoter region of HFD1 fused to luciferase. These fusion constructs have been shown to often not reflect the bona fide expression levels of genes (Yoneda et al., J Cell Sci 2004). qPCR analysis of transcript levels should be included to support the induction of HFD1. 

      We agree that the live cell luciferase reporters used here are not suitable for the determination of absolute mRNA levels. However, the aim of these reporter experiments is to quantify the inducibility of different genes (HFD1, GRE2) dependent on increasing stress doses. These dose response profiles cannot be obtained by qPCR analysis, while the destabilized reporters are an excellent tool for this, which have been used to accurately describe numerous dynamic stress responses (for example: Dolz-Edo et al. 2013 MCB 33:2228-40, Rienzo et al. 2015 MCB 35:3669-83, PascualAhuir et al. 2019 BBA 862:457-471). Additionally, the induction of HFD1 mRNA levels by salt (NaCl) and oxidative (menadione) stress determined by qPCR has been published before (Manzanares-Estreder et al. 2017 Oxid Med Cell Longevity 2017:2708345).

      The authors conclude from Figure 1 that entry into apoptotic cell death is modulated by efficient t-2-hex detoxification. However, this is based on growth curves and no analysis of apoptotic cell death is performed. The data show that the addition of hexadecenal results in a growth arrest, that is overcome likely upon degradation of t-2-hex (depending on the amount of Hfd1). 

      We agree that our experiments measure growth inhibition and not specifically apoptotic cell death. The text has been changed accordingly.  

      Figure 4A: Microscopy images show between 1-2 yeast cells. Either more cells need to be shown or quantifications of the aggregates are required. In addition, it is not clear if the control received the same DMSO concentration as the treated cells and also the time point for the control is not specified. 

      We have now quantified the number of aggregates across cell populations in new Figure 4A in DMSO, t-2-hex and t-2-hex-H2 treated wt and rpn4 mutants. These data show specific aggregate induction by t-2-hex and not by DMSO or the saturated t-2-hex-H2 control, which is aggravated in rpn4 mutants and avoided by CHX pretreatment.

      Figure 5: Western blots in figure 5A, B, D, E and F lack a loading control. Without this, conclusions about increases in protein abundance cannot be made.  Response: We have now included additional panels with the loading controls for the Western blots in new figure 5, except figure 5B, where the appearance or not of the pre-protein can be compared to the amount of mature protein in the same blot.

      Figure 2B: Complex II assembly factors SDH5,6,9 are described here as ETC complexes. As the proteins are not part of the mature complex II, the heading should be modified into ETC complexes and ETC assembly.

      Figure 2B has been revised and the classification of ETC proteins changed accordingly.

    1. Author response:

      The following is the response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Nitta et al, in their manuscript titled, "Drosophila model to clarify the pathological significance of OPA1 in autosomal dominant optic atrophy." The novelty of this paper lies in its use of human (hOPA1) to try to rescue the phenotype of an OPA1 +/- Drosophilia DOA model (dOPA). The authors then use this model to investigate the differences between dominant-negative and haploinsufficient OPA1 variants. The value of this paper lies in the study of DN/HI variants rather than the establishment of the drosophila model per se as this has existed for some time and does have some significant disadvantages compared to existing models, particularly in the extra-ocular phenotype which is common with some OPA1 variants but not in humans. I judge the findings of this paper to be valuable with regards to significance and solid with regards to the strength of the evidence.

      Suggestions for improvements:

      (1) Stylistically the results section appears to have significant discussion/conclusion/inferences in section with reference to existing literature. I feel that this information would be better placed in the separate discussion section. E.g. lines 149-154.

      We appreciate the reviewer’s suggestion to relocate the discussion, conclusions, and inferences, particularly those that reference existing literature, to a separate discussion section. For lines 149–154, we placed them in the discussion section (lines 343–347) as follows. “Our established fly model is the first simple organism to allow observation of degeneration of the retinal axons. The mitochondria in the axons showed fragmentation of mitochondria. Former studies have observed mitochondrial fragmentation in S2 cells (McQuibban et al., 2006), muscle tissue (Deng et al., 2008), segmental nerves (Trevisan et al., 2018), and ommatidia (Yarosh et al., 2008) due to the LOF of dOPA1.”

      For lines 178–181, we also placed them in the discussion section (lines 347–351) as follows. “Our study presents compelling evidence that dOPA1 knockdown instigates neuronal degeneration, characterized by a sequential deterioration at the axonal terminals and extending to the cell bodies. This degenerative pattern, commencing from the distal axons and progressing proximally towards the cell soma, aligns with the paradigm of 'dying-back' neuropathy, a phenomenon extensively documented in various neurodegenerative disorders (Wang et al., 2012). ”

      For lines 213–217, 218–220, and 222–223, we also placed them in the discussion section (lines 363– 391) as follows. “To elucidate the pathophysiological implications of mutations in the OPA1 gene, we engineered and expressed several human OPA1 variants, including the 2708-2711del mutation, associated with DOA, and the I382M mutation, located in the GTPase domain and linked to DOA. We also investigated the D438V and R445H mutations in the GTPase domain and correlated with the more severe DOA plus phenotype. The 2708-2711del mutation exhibited limited detectability via HA-tag probing. Still, it was undetectable with a myc tag, likely due to a frameshift event leading to the mutation's characteristic truncated protein product, as delineated in prior studies (Zanna et al., 2008). Contrastingly, the I382M, D438V, and R445H mutations demonstrated expression levels comparable to the WT hOPA1. However, the expression of these mutants in retinal axons did not restore the dOPA1 deficiency to the same extent as the WT hOPA1, as evidenced in Figure 5E. This finding indicates a functional impairment imparted by these mutations, aligning with established understanding (Zanna et al., 2008). Notably, while the 2708-2711del and I382M mutations exhibited limited functional rescue, the D438V and R445H mutations did not show significant rescue activity. This differential rescue efficiency suggests that the former mutations, particularly the I382M, categorized as a hypomorph (Del Dotto et al., 2018), may retain partial functional capacity, indicative of a LOF effect but with residual activity. The I382M missense mutation within the GTPase domain of OPA1 has been described as a mild hypomorph or a disease modifier. Intriguingly, this mutation alone does not induce significant clinical outcomes, as evidenced by multiple studies (Schaaf et al., 2011; Bonneau et al., 2014; Bonifert et al., 2014; Carelli et al., 2015). A significant reduction in protein levels has been observed in fibroblasts originating from patients harboring the I382M mutation. However, mitochondrial volume remains unaffected, and the fusion activity of mitochondria is only minimally influenced (Kane et al., 2017; Del Dotto et al., 2018). This observation is consistent with findings reported by de la Barca et al. in Human Molecular Genetics 2020, where a targeted metabolomics approach classified I382M as a mild hypomorph. In our current study, the I382M mutation preserves more OPA1 function compared to DN mutations, as depicted in Figures 5E and F. Considering the results from our Drosophila model and previous research, we hypothesize that the I382M mutation may constitute a mild hypomorphic variant. This might explain its failure to manifest a phenotype on its own, yet its contribution to increased severity when it occurs in compound heterozygosity.

      (2) I do think further investigation as to why a reduction of mitochondria was noticed in the knockdown. There are conflicting reports on this in the literature. My own experience of this is fairly uniform mitochondrial number in WT vs OPA1 variant lines but with an increased level of mitophagy presumably reflecting a greater turnover. There are a number of ways to quantify mitochondrial load e.g. mtDNA quantification, protein quantification for tom20/hsp60 or equivalent. I feel the reliance on ICC here is not enough to draw conclusions. Furthermore, mitophagy markers could be checked at the same time either at the transcript or protein level. I feel this is important as it helps validate the drosophila model as we already have a lot of experimental data about the number and function of mitochondria in OPA+/- human/mammalian cells.

      We thank the reviewer for the insightful comments and suggestions regarding our study on the impact of mitochondrial reduction in a knockdown model. We concur with the reviewer’s observation that our initial results did not definitively demonstrate a decrease in the number of mitochondria in retinal axons. Furthermore, we measured mitochondrial quantity by conducting western blotting using antiCOXII and found no reduction in mitochondrial content with the knockdown of dOPA1 (Figure S4A and B). Consequently, we have revised our manuscript to remove the statement “suggesting a decreased number of mitochondria in retinal axons. However, whether this decrease is due to degradation resulting from a decline in mitochondrial quality or axonal transport failure remains unclear.” Instead, we have refocused our conclusion to reflect our electron microscopy findings, which indicate reduced mitochondrial size and structural abnormalities. The reviewer’s observation of consistent mitochondrial numbers in WT versus mutant variant lines and elevated mitophagy levels prompted us to evaluate mitochondrial turnover as a significant factor in our study. Regarding verifying mitophagy markers, we incorporated the mito-QC marker in our experimental design. In our experiments, mito-QC was expressed in the retinal axons of Drosophila to assess mitophagy activity upon dOPA1 knockdown. We observed a notable increase in mCherry positive but GFP negative puncta signals one week after eclosion, indicating the activation of mitophagy (Figure 2D–H). This outcome strongly suggests that dOPA1 knockdown enhances mitophagy in our Drosophila model. The application of mito-QC as a quantitative marker for mitophagy, validated in previous studies, offers a robust approach to analyzing this process. Our findings elucidate the role of dOPA1 in mitochondrial dynamics and its implications for neuronal health. These results have been incorporated into Figure 2, with the corresponding text updated as follows (lines 159–167): “Given that an increase in mitophagy activity has been reported in mouse RGCs and nematode ADOA models (Zaninello et al., 2022; Zaninello et al., 2020), the mitoQC marker, an established indicator of mitophagy activity, was expressed in the photoreceptors of Drosophila. The mito-QC reporter consists of a tandem mCherry-GFP tag that localizes to the outer membrane of mitochondria (Lee et al., 2018). This construct allows the measurement of mitophagy by detecting an increase in the red-only mCherry signal when the GFP is degraded after mitochondria are transported to lysosomes. Post dOPA1 knockdown, we observed a significant elevation in mCherry positive and GFP negative puncta signals at one week, demonstrating an activation of mitophagy as a consequence of dOPA1 knockdown (Figure 2D–H).”  

      (3) Could the authors comment on the failure of the dOPA1 rescue to return their biomarker, axonal number to control levels. In Figure 4D is there significance between the control and rescue. Presumably so as there is between the mutant and rescue and the difference looks less.

      As the reviewer correctly pointed out, there is a significant difference between the control and rescue groups, which we have now included in the figure. Additionally, we have incorporated the following comments in the discussion section (lines 329–342) regarding this significant difference: “In our study, expressing dOPA1 in the retinal axons of dOPA1 mutants resulted in significant rescue, but it did not return to control levels. There are three possible explanations for this result. The first concerns gene expression levels. The Gal4-line used for the rescue experiments may not replicate the expression levels or timing of endogenous dOPA1. Considering that the optimal functionality of dOPA1 may be contingent upon specific gene expression levels, attaining a wild-type-like state necessitates the precise regulation of these expression levels. The second is a nonautonomous issue. Although dOPA1 gene expression was induced in the retinal axons for the rescue experiments, many retinal axons were homozygous mutants, while other cell types were heterozygous for the dOPA1 mutation. If there is a non-autonomous effect of dOPA1 in cells other than retinal axons, it might not be possible to restore the wild-type-like state fully. The third potential issue is that only one isoform of dOPA1 was expressed. In mouse OPA1, to completely restore mitochondrial network shape, an appropriate balance of at least two different isoforms, lOPA1 and s-OPA1, is required (Del Dotto et al., 2017). This requirement implies that multiple isoforms of dOPA1 are essential for the dynamic activities of mitochondria.”

      (4) The authors have chosen an interesting if complicated missense variant to study, namely the I382M with several studies showing this is insufficient to cause disease in isolation and appears in high frequency on gnomAD but appears to worsen the phenotype when it appears as a compound het. I think this is worth discussing in the context of the results, particularly with regard to the ability for this variant to partially rescue the dOPA1 model as shown in Figure 5.

      As the reviewer pointed out, the I382M mutation is known to act as a disease modifier. However, in our system, as suggested by Figure 5, I382M appears to retain more activity than DN mutations. Considering previous studies, we propose that I382M represents a mild hypomorph. Consequently, while I382M alone may not exhibit a phenotype, it could exacerbate severity in a compound heterozygous state. We have incorporated this perspective in our revised discussion (lines 375-391).

      “Notably, while the 2708-2711del and I382M mutations exhibited limited functional rescue, the D438V and R445H mutations did not show significant rescue activity. This differential rescue efficiency suggests that the former mutations, particularly the I382M, categorized as a hypomorph (Del Dotto et al., 2018), may retain partial functional capacity, indicative of a LOF effect but with residual activity. The I382M missense mutation within the GTPase domain of OPA1 has been described as a mild hypomorph or a disease modifier. Intriguingly, this mutation alone does no induce significant clinical outcomes, as evidenced by multiple studies (Schaaf et al., 2011; Bonneau et al., 2014; Bonifert et al., 2014; Carelli et al., 2015). A significant reduction in protein levels has been observed in fibroblasts originating from patients harboring the I382M mutation. However, mitochondrial volume remains unaffected, and the fusion activity of mitochondria is only minimally influenced (Kane et al., 2017; Del Dotto et al., 2018). This observation is consistent with findings reported by de la Barca et al. in Human Molecular Genetics 2020, where a targeted metabolomics approach classified I382M as a mild hypomorph. In our current study, the I382M mutation preserves more OPA1 function compared to DN mutations, as depicted in Figures 5E and F. Considering the results from our Drosophila model and previous research, we hypothesize that the I382M mutation may constitute a mild hypomorphic variant. This might explain its failure to manifest a phenotype on its own, yet its contribution to increased severity when it occurs in compound heterozygosity.”

      (5) I feel the main limitation of this paper is the reliance on axonal number as a biomarker for OPA1 function and ultimately rescue. I have concerns because a) this is not a well validated biomarker within the context of OPA1 variants b) we have little understanding of how this is affected by over/under expression and c) if it is a threshold effect e.g. once OPA1 levels reach <x% pathology develops but develops normally when opa1 expression is >x%. I think this is particularly relevant when the authors are using this model to make conclusions on dominant negativity/HI with the authors proposing that if expression of a hOPA1 transcript does not increase opa1 expression in a dOPA1 KO then this means that the variant is DN. The authors have used other biomarkers in parts of this manuscript e.g. ROS measurement and mito trafficking but I feel this would benefit from something else particularly in the latter experiments demonstrated in figure 5 and 6.

      The reviewer raised concerns regarding the adequacy of axonal count as a validated biomarker in the context of OPA1 mutants. In response, we corroborated its validity using markers such as MitoSOX, Atg8, and COXII. Experiments employing MitoSOX revealed that the augmented ROS signals resulting from dOPA1 knockdown were mitigated by expressing human OPA1. Conversely, the mutant variants 2708-2711del, D438V, and R445H did not ameliorate these effects, paralleling the phenotype of axonal degeneration observed. These findings are documented in Figure 5F, and we have incorporated the following text into section lines 248–254 of the results:

      “Furthermore, we assessed the potential for rescuing ROS signals. Similar to its effect on axonal degeneration, wild-type hOPA1 effectively mitigated the phenotype, whereas the 2708-2711del, D438V, and R445H mutants did not (Figure 5F). Importantly, the I382M variant also reduced ROS levels comparably to the wild type. These findings demonstrate that both axonal degeneration and the increase in ROS caused by dOPA1 downregulation can be effectively counteracted by hOPA1. Although I382M retains partial functionality, it acts as a relatively weak hypomorph in this experimental setup.”

      Moreover, utilizing mito-QC, we observed elevated mitophagy in our Drosophila model, with these results now included in Figure 2D–H. Given the complexity of the genetics involved and the challenges in establishing lines, autophagy activity was quantified by comparing the ratio of Atg8-1 to Atg8-2 via Western blot analysis. However, no significant alterations were detected across any of the genotypes. Additionally, mitochondrial protein levels derived from COXII confirmed consistent mitochondrial quantities, showing no considerable variance following knockdown. These insights affirm that retinal axon degeneration and mitophagy activation are present in the Drosophila DOA model, although the Western blot analysis revealed no significant changes in autophagy activation. Such findings necessitate caution as this model may not fully replicate the molecular pathology of the corresponding human disease. These Western blot findings are presented in Figure S4, with the following addition made to section lines 255–263 of the results:

      “We also conducted Western blot analyses using anti-COXII and anti-Atg8a antibodies to assess changes in mitochondrial quantity and autophagy activity following the knockdown of dOPA1. Mitochondrial protein levels, indicated by COXII quantification, were evaluated to verify mitochondrial content, and the ratio of Atg8a-1 to Atg8a-2 was used to measure autophagy activation. For these experiments, Tub-Gal4 was employed to systemically knockdown dOPA1. Considering the lethality of a whole-body dOPA1 knockdown, Tub-Gal80TS was utilized to repress the knockdown until eclosion by maintaining the flies at 20°C. After eclosion, we increased the temperature to 29°C for two weeks to induce the knockdown or expression of hOPA1 variants. The results revealed no significant differences across the genotypes tested (Figure S4A–D).”

      In assessing the effects of dominant negative mutations, measurements including ROS levels, the ratio of Atg8-1 to Atg8-2, and the quantity of COXII protein were conducted, yet no significant differences were observed (Figure S6). This limitation of the fly model is mentioned in the results, noting the observation of the axonal degeneration phenotype but not alterations in ROS signaling, autophagy activity, or mitochondrial quantity as follows (line 287–290):

      “We investigated the impacts of dominant negative mutations on mitochondrial oxidation levels, mitochondrial quantity, and autophagy activation levels; however, none of these parameters showed statistical significance (Figure S6).”

      The reviewer also inquired about the effects of overexpressing and underexpressing OPA1 on axonal count and whether these effects are subject to a threshold. In response, we expressed both wild-type and variant forms of human OPA1 in Drosophila in vivo and assessed their protein levels using Western blot analysis. The results showed no significant differences in expression levels between the wild-type and variant forms in the OPA1 overexpression experiments, suggesting the absence of a variation threshold effect. These findings have been newly documented as quantitative data in Figure 5C. Furthermore, we have included a statement in the results section for Figure 6A, clarifying that overexpression of hOPA1 exhibited no discernible impact, as detailed on lines 274–276.

      “The results presented in Figure 5C indicate that there are no significant differences in the expression levels among the variants, suggesting that variations in expression levels do not influence the outcomes.”

      (6) Could the authors clarify what exons in Figure 5 are included in their transcript. My understanding is transcript NM_015560.3 contains exon 4,4b but not 5b. According to Song 2007 this transcript produces invariably s-OPA1 as it contains the exon 4b cleavage site. If this is true, this is a critical limitation in this study and in my opinion significantly undermines the likelihood of the proposed explanation of the findings presented in Figure 6. The primarily functional location of OPA1 is at the IMM and l-OPA1 is the primary opa1 isoform probably only that localizes here as the additional AA act as a IMM anchor. Given this is where GTPase likely oligomerizes the expression of s-OPA1 only is unlikely to interact anyway with native protein. I am not aware of any evidence s-OPA1 is involved in oligomerization. Therefore I don't think this method and specifically expression of a hOPA1 transcript which only makes s-OPA1 to be a reliable indicator of dominant negativity/interference with WT protein function. This could be checked by blotting UAS-hOPA1 protein with a OPA1 antibody specific to human OPA1 only and not to dOPA1. There are several available on the market and if the authors see only s-OPA1 then it confirms they are not expressing l-OPA1 with their hOPA1 construct.

      As suggested by the reviewer, we performed a Western blot using a human OPA1 antibody to determine if the expressed hOPA1 was producing the l-OPA1 isoform, as shown in band 2 of Figure 5D. The results confirmed the presence of both l-OPA1 and what appears to be s-OPA1 in bands 2 and 4, respectively. These findings are documented in the updated Figure 5D, with a detailed description provided in the manuscript at lines 224-226. Additionally, the NM_015560.3 refers to isoform 1, which includes only exons 4 and 5, excluding exons 4b and 5b. This isoform can express both l-OPA1 and s-OPA1 (refer to Figure 1 in Song et al., J Cell Biol. 2007). We have updated the schematic diagram in the figure to include these exons. The formation of s-OPA1 through cleavage occurs at the OMA1 target site located in exon 5 and the Yme1L target site in exon 5b of OPA1. Isoform 1 of OPA1 is prone to cleavage by OMA1, but a homologous gene for OMA1 does not exist in Drosophila. Although a homologous gene for Yme1L is present in Drosophila, exon 5b is missing in isoform 1 of OPA1, leaving the origin of the smaller band resembling s-OPA1 unclear at this point.

      Reviewer #2 (Public Review):

      The data presented support and extend some previously published data using Drosophila as a model to unravel the cellular and genetic basis of human Autosomal dominant optic atrophy (DOA). In human, mutations in OPA1, a mitochondrial dynamin like GTPase (amongst others), are the most common cause for DOA. By using a Drosophila loss-of-function mutations, RNAi- mediated knockdown and overexpression, the authors could recapitulate some aspects of the disease phenotype, which could be rescued by the wild-type version of the human gene. Their assays allowed them to distinguish between mutations causing human DOA, affecting the optic system and supposed to be loss-of-function mutations, and those mutations supposed to act as dominant negative, resulting in DOA plus, in which other tissues/organs are affected as well. Based on the lack of information in the Materials and Methods section and in several figure legends, it was not in all cases possible to follow the conclusions of the authors.

      We appreciate the reviewer's constructive feedback and the emphasis on enhancing clarity in our manuscript. We recognize the concerns raised about the lack of detailed information in the Materials and Methods section and several figure legends, which may have obscured our conclusions. In response, we have appended the detailed genotypes of the Drosophila strains used in each experiment to a supplementary table. Additionally, we realized that the description of 'immunohistochemistry and imaging' was too brief, previously referenced simply as “immunohistochemistry was performed as described previously (Sugie et al., 2017).” We have now expanded this section to include comprehensive methodological details. Furthermore, we have revised the figure legends to provide clearer and more thorough descriptions.

      Similarly, how the knowledge gained could help to "inform early treatment decisions in patients with mutations in hOPA1" (line 38) cannot be followed.

      To address the reviewer's comments, we have refined our explanation of the clinical relevance of our findings as follows. We believe this revision succinctly articulates the practical application of our research, directly responding to the reviewer’s concerns about linking the study's outcomes to treatment decisions for patients with hOPA1 mutations. By underscoring the model’s value in differential diagnosis and its influence on initiating treatment strategies, we have clarified this connection explicitly, within the constraints of the abstract’s word limit. The revised sentence now reads: "This fly model aids in distinguishing DOA from DOA plus and guides initial hOPA1 mutation treatment strategies."

      Reviewer #3 (Public Review):

      Nitta et al. establish a fly model of autosomal dominant optic atrophy, of which hundreds of different OPA1 mutations are the cause with wide phenotypic variance. It has long been hypothesized that missense OPA1 mutations affecting the GTPase domain, which are associated with more severe optic atrophy and extra-ophthalmic neurologic conditions such as sensorineural hearing loss (DOA plus), impart their effects through a dominant negative mechanism, but no clear direct evidence for this exists particularly in an animal model. The authors execute a well-designed study to establish their model, demonstrating a clear mitochondrial phenotype with multiple clinical analogs including optic atrophy measured as axonal degeneration. They then show that hOPA1 mitigates optic atrophy with the same efficacy as dOPA1, setting up the utility of their model to test disease-causing hOPA1 variants. Finally, they leverage this model to provide the first direct evidence for a dominant negative mechanism for 2 mutations causing DOA plus by expressing these variants in the background of a full hOPA1 complement.

      Strengths of the paper include well-motivated objectives and hypotheses, overall solid design and execution, and a generally clear and thorough interpretation of their results. The results technically support their primary conclusions with caveats. The first is that both dOPA1 and hOPA1 fail to fully restore optic axonal integrity, yet the authors fail to acknowledge that this only constitutes a partial rescue, nor do they discuss how this fact might influence our interpretation of their subsequent results.

      As the reviewer rightly points out, neither dOPA1 nor hOPA1 achieve a complete recovery. Therefore, we acknowledge that this represents only a partial rescue and have added the following explanations regarding this partial rescue in the results and discussion sections.

      Result:

      Significantly —> partially (lines 207 and 228) Discussion (lines 329–342):

      In our study, expressing dOPA1 in the retinal axons of dOPA1 mutants resulted in significant rescue, but it did not return to control levels. There are three possible explanations for this result. The first concerns gene expression levels. The Gal4-line used for the rescue experiments may not replicate the expression levels or timing of endogenous dOPA1. Considering that the optimal functionality of dOPA1 may be contingent upon specific gene expression levels, attaining a wild-type-like state necessitates the precise regulation of these expression levels. The second is a non-autonomous issue. Although dOPA1 gene expression was induced in the retinal axons for the rescue experiments, many retinal axons were homozygous mutants, while other cell types were heterozygous for the dOPA1 mutation. If there is a non-autonomous effect of dOPA1 in cells other than retinal axons, it might not be possible to restore the wild-type-like state fully. The third potential issue is that only one isoform of dOPA1 was expressed. In mouse OPA1, to completely restore mitochondrial network shape, an appropriate balance of at least two different isoforms, l-OPA1 and s-OPA1, is required (Del Dotto et al., 2017). This requirement implies that multiple isoforms of dOPA1 are essential for the dynamic activities of mitochondria.

      The second caveat is that their effect sizes are small. Statistically, the results indeed support a dominant negative effect of DOA plus-associated variants, yet the data show a marginal impact on axonal degeneration for these variants. The authors might have considered exploring the impact of these variants on other mitochondrial outcome measures they established earlier on. They might also consider providing some functional context for this marginal difference in axonal optic nerve degeneration.

      In response to the reviewer’s comment regarding the modest effect sizes observed, we acknowledge that the magnitude of the reported changes is indeed small. To explore the impact of these variants on additional mitochondrial outcomes as suggested, we employed markers such as MitoSOX, Atg8, and COXII for validation. However, we could not detect any significant effects of the DOA plus-associated variants using these methods. We apologize for the redundancy, but to address Reviewer #1's fifth question, we present experimental results showing that while the increased ROS signals observed upon dOPA1 knockdown were rescued by expressing human OPA1, the mutant variants 2708-2711del, D438V, and R445H did not ameliorate this effect. This outcome mirrors the axonal degeneration phenotype and is documented in Figure 5F. The following text has been added to the results section lines 248–254:

      “Furthermore, we assessed the potential for rescuing ROS signals. Similar to its effect on axonal degeneration, wild-type hOPA1 effectively mitigated the phenotype, whereas the 2708-2711del, D438V, and R445H mutants did not (Figure 5F). Importantly, the I382M variant also reduced ROS levels comparably to the wild type. These findings demonstrate that both axonal degeneration and the increase in ROS caused by dOPA1 downregulation can be effectively counteracted by hOPA1. Although I382M retains partial functionality, it acts as a relatively weak hypomorph in this experimental setup.”

      Moreover, utilizing mito-QC, we observed elevated mitophagy in our Drosophila model, with these results now included in Figure 2D–H. Given the complexity of the genetics involved and the challenges in establishing lines, autophagy activity was quantified by comparing the ratio of Atg8-1 to Atg8-2 via Western blot analysis. However, no significant alterations were detected across any of the genotypes. Additionally, mitochondrial protein levels derived from COXII confirmed consistent mitochondrial quantities, showing no considerable variance following knockdown. These insights affirm that retinal axon degeneration and mitophagy activation are present in the Drosophila DOA model, although the Western blot analysis revealed no significant changes in autophagy activation. Such findings necessitate caution as this model may not fully replicate the molecular pathology of the corresponding human disease. These Western blot findings are presented in Figure S4, with the following addition made to section lines 255–263 of the results:

      “We also conducted Western blot analyses using anti-COXII and anti-Atg8a antibodies to assess changes in mitochondrial quantity and autophagy activity following the knockdown of dOPA1. Mitochondrial protein levels, indicated by COXII quantification, were evaluated to verify mitochondrial content, and the ratio of Atg8a-1 to Atg8a-2 was used to measure autophagy activation. For these experiments, Tub-Gal4 was employed to systemically knockdown dOPA1. Considering the lethality of a whole-body dOPA1 knockdown, Tub-Gal80TS was utilized to repress the knockdown until eclosion by maintaining the flies at 20°C. After eclosion, we increased the temperature to 29°C for two weeks to induce the knockdown or expression of hOPA1 variants. The results revealed no significant differences across the genotypes tested (Figure S4A–D).”

      In assessing the effects of dominant negative mutations, measurements including ROS levels, the ratio of Atg8-1 to Atg8-2, and the quantity of COXII protein were conducted, yet no significant differences were observed (Figure S6). This limitation of the fly model is mentioned in the results, noting the observation of the axonal degeneration phenotype but not alterations in ROS signaling, autophagy activity, or mitochondrial quantity as follows (line 287–290):

      “We investigated the impacts of dominant negative mutations on mitochondrial oxidation levels, mitochondrial quantity, and autophagy activation levels; however, none of these parameters showed statistical significance (Figure S6).”

      Despite these caveats, the authors provide the first animal model of DOA that also allows for rapid assessment and mechanistic testing of suspected OPA1 variants. The impact of this work in providing the first direct evidence of a dominant negative mechanism is under-stated considering how important this question is in development of genetic treatments for DOA. The authors discuss important points regarding the potential utility of this model in clinical science. Comments on the potential use of this model to investigate variants of unknown significance in clinical diagnosis requires further discussion of whether there is indeed precedent for this in other genetic conditions (since the model is nevertheless so evolutionarily removed from humans).

      As suggested by the reviewer, we have expanded the discussion in our study to emphasize in greater detail the significance of the fruit fly model and the MeDUsA software we have developed, elaborating on the model's potential applications in clinical science and its precedents in other genetic disorders. Our text is as follows (lines 299–318):

      “We have previously utilized MeDUsA to quantify axonal degeneration, applying this methodology extensively to various neurological disorders. The robust adaptability of this experimental system is demonstrated by its application in exploring a wide spectrum of genetic mutations associated with neurological conditions, highlighting its broad utility in neurogenetic research. We identified a novel de novo variant in Spliceosome Associated Factor 1, Recruiter of U4/U6.U5 Tri-SnRNP (SART1). The patient, born at 37 weeks with a birth weight of 2934g, exhibited significant developmental delays, including an inability to support head movement at 7 months, reliance on tube feeding, unresponsiveness to visual stimuli, and development of infantile spasms with hypsarrhythmia, as evidenced by EEG findings. Profound hearing loss and brain atrophy were confirmed through MRI imaging. To assess the functional impact of this novel human gene variant, we engineered transgenic Drosophila lines expressing both wild type and mutant SART1 under the control of a UAS promoter.

      Our MeDUsA analysis suggested that the variant may confer a gain-of-toxic-function (Nitta et al.,  2023). Moreover, we identified heterozygous loss-of-function mutations in DHX9 as potentially causative for a newly characterized neurodevelopmental disorder. We further investigated the pathogenic potential of a novel heterozygous de novo missense mutation in DHX9 in a patient presenting with short stature, intellectual disability, and myocardial compaction. Our findings indicated a loss of function in the G414R and R1052Q variants of DHX9 (Yamada et al., 2023). This experimental framework has been instrumental in elucidating the impact of gene mutations, enhancing our ability to diagnose how novel variants influence gene function.”

      Recommendations for the Authors:

      Reviewer #1 (Recommendations For The Authors):

      Overall I enjoyed reading this paper. It is well presented and represents a significant amount of well executed study. I feel it further characterizes a poorly understood model of OPA1 variants and one which displays significant differences with the human phenotype. However I feel the use of this model with the author's experiments are not enough to validate this model/experiment as a screening tool for dominant negativity. I have therefore suggested the above experiments as a way to both further validate the mitochondrial dysfunction in this model and to ensure that the expressed transcript is able affect oligomerization as this is a pre-requisite to the authors conclusions.

      We assessed the extent to which our model reflects mitochondrial dysfunction using COXII, Atg8, and MitoSOX markers. Unfortunately, neither COXII levels nor the ratio of Atg8a-1 to Atg8a-2 showed significant variations across genotypes that would clarify the impact of dominant negative mutations. Nonetheless, MitoSOX and mito-QC results revealed that mitochondrial ROS levels and mitophagy are increased in Drosophila following intrinsic knockdown of dOPA1. These findings are documented in Figures 2, 5, and S6.

      Regarding oligomer formation, the specifics remain elusive in this study. However, the expression of dOPA1K273A, identified as a dominant negative variant in Drosophila, significantly disrupted retinal axon organization, as detailed in Figure S7. From these observations, we hypothesize that oligomerization of wild-type and dominant negative forms in Drosophila results in axonal degeneration. Conversely, co-expression of Drosophila wild-type with human dominant negative forms does not induce degeneration, suggesting that they likely do not interact.

      Reviewer #2 (Recommendations For The Authors):

      Materials and Methods:

      The authors used GMR-Gal4 to express OPA1-RNAi. I) GMR is expressed in most cells in the developing eye behind the morphogenetic furrow. So the defects observed can be due to knock- down in support cells rather than in photoreceptor cells.

      We have added the following sentences in the result (lines 194–196)."The GMR-Gal4 driver does not exclusively target Gal4 expression to photoreceptor cells. Consequently, the observed retinal axonal degeneration could potentially be secondary to abnormalities in support cells external to the photoreceptors.”

      OPA1-RNAi: how complete is the knock-down? Have the authors tested more than one RNAi line?

      We conducted experiments with an additional RNAi line, and similarly observed degeneration in the retinal axons (Figure S2 A and B; lines 178–179).

      The loss-of-function allele, induced by a P-element insertion, gives several eye phenotypes when heterozygous (Yarosh et al., 2008). Does RNAi expression lead to the same phenotypes?

      A previous report indicated that the compound eyes of homozygous mutations of dOPA1 displayed a glossy eye phenotype (Yarosh et al., 2008). Upon knocking down dOPA1 using the GMR-Gal4 driver, we also observed a glossy eye-like rough eye phenotype in the compound eyes. These findings have been added to Figure S3 and lines 192–194.

      There is no description on the way the somatic clones were generated. How were mutant cells in clones distinguished from wild-type cells (e. g. in Fig. 4).

      In the Methods section, we described the procedure for generating clones and their genotypes as follows (lines 502–505): "The dOPA1 clone analysis was performed by inducing flippase expression in the eyes using either ey-Gal4 with UAS-flp or ey3.5-flp, followed by recombination at the chromosomal location FRT42D to generate a mosaic of cells homozygous for dOPA1s3475." Furthermore, we have created a table detailing these genotypes. In these experiments, it was not possible to differentiate between the clone and WT cells. Accordingly, we have noted in the Results section (lines 201–203): "Note that the mutant clone analysis was conducted in a context where mutant and heterozygous cells coexist as a mosaic, and it was not possible to distinguish between them.”

      Why were flies kept at 29{degree sign}C? this is rather unusual.

      Increased temperature was demonstrated to induce elevated expression of GAL4 (Kramer and Staveley, Genet. Mol. Res., 2003), which in turn led to an enhanced expression of the target genes. Therefore, experiments involving knockdown assays or Western blotting to detect human OPA1 protein were exclusively conducted at 29°C. However, all other experiments were performed at 25°C, as described in the methods sections: “Flies were maintained at 25°C on standard fly food. For knockdown experiments (Figures 1C–E, 1F–H, 2A–H, 3B–K, 5F, S1, S2 A and B, and S6A), flies were kept at 29°C in darkness.” Furthermore, “We regulated protein expression temporally across the whole body using the Tub-Gal4 and Tub-GAL80TS system. Flies harboring each hOPA1 variant were maintained at a permissive temperature of 20°C, and upon emergence, females were transferred to a restrictive temperature of 29°C for subsequent experiments.”

      Legends:

      It would be helpful to have a description of the genotypes of the flies used in the different experiments. This could also be included as a table.

      We have created a table detailing the genotypes. Additionally, in the legend, we have included a note to consult the supplementary table for genotypes.

      Results:

      Line 141: It is not clear what they mean by "degradation", is it axonal degeneration? And if so, what is the argument for this here?

      In the manuscript, we addressed the potential for mitochondrial degradation; however, recognizing that the expression was ambiguous, the following sentence has been omitted: "Nevertheless, the degradation resulting from mitochondrial fragmentation may have decreased the mitochondrial signal.”

      Fig. 2: Axons of which photoreceptors are shown?

      We have added "a set of the R7/8 retinal axons" to the legend of Figure 2.

      Line 167: The authors write that axonal degeneration is more severe after seven days than after eclosion. Is this effect light-dependent? The same question concerns the disappearance of the rhabdomere (Fig. 3G–J).

      We conducted the experiments in darkness, ensuring that the observed degeneration is not light- dependent. This condition has been added to the methods section to clarify the experimental conditions.

      Line 178/179: Based on what results do they conclude that there is degeneration of the "terminals" of the axons?

      Quantification via MeDUsA has enabled us to count the number of axonal terminals, and a noted decrease has led us to conclude axonal terminal degeneration. We have published two papers on these findings. We have added the following description to the results section to clarify how we defined degeneration (lines 174–176): "We have assessed the extent of their reduction from the total axonal terminal count, thereby determining the degree of axonal terminal degeneration (Richard JNS 2022; Nitta HMG 2023).

      Line 189: They write: ".. we observed dOPA1 mutant axons...". How did they distinguish es mutant from the controls?

      Fig. 5 and Fig. 6: How did they distinguish genetically mutant cells from genetically control cells in the somatic clones?

      Mutant clone analysis was conducted in a context where mutant and heterozygous cells coexist as a mosaic, and it was not possible to distinguish between them. Accordingly, this point has been added to lines 201–203, “Note that the mutant clone analysis was conducted in a context where mutant and heterozygous cells coexist as a mosaic, and it was not possible to distinguish between them.” and the text in the results section has been modified as follows:

      (Before “To determine if dOPA1 is responsible for axon neurodegeneration, we observed the dOPA1 mutant axons by expressing full- length versions of dOPA1 in the photoreceptors at one day after eclosion and found that dOPA1 expression significantly rescued the axonal degeneration” —>

      (After “To determine if dOPA1 is responsible for axon neurodegeneration, we quantify the number of the axons in the dOPA1 eye clone fly with the expression of dOPA1 at one day after eclosion and found that dOPA1 expression partially rescued the axonal degeneration”

      Line 225/226: It is not clear to me how their approach "can quantitatively measure the degree of LOF".

      To address the reviewer's question and clarify how our approach quantitatively measures the degree of loss of function (LOF), we revised the statement (lines 238–247):

      "Our methodology distinctively facilitates the quantitative evaluation of LOF severity by comparing the rescue capabilities of various mutations. Notably, the 2708-2711del and I382M mutations demonstrated only partial rescue, indicative of a hypomorphic effect with residual activity. In contrast, the D438V and R445H mutations failed to show significant rescue, suggesting a more profound LOF. The correlation between the partial rescue by the 2708-2711del and I382M mutations and their classification as hypomorphic is significant. Moreover, the observed differences in rescue efficacy correspond to the clinical severities associated with these mutations, namely in DOA and DOA plus disorders. Thus, our results substantiate the model’s ability to quantitatively discriminate among mutations based on their impact on protein functionality, providing an insightful measure of LOF magnitude.”

      Discussion:

      Line 251, 252 and line 358: What is "the optic nerve" in the adult Drosophila?

      In humans, the axons of retinal ganglion cells (RGCs) are referred to as the optic nerve, and we posit that the retinal axons in flies are similar to this structure. In the introduction section, where it is described that the visual systems of flies and humans bear resemblance, we have appended the following definition (lines 107–108): “In this study, we defined the retinal axons of Drosophila as analogous to the human optic nerve.”

      Line 344: These bands appear only upon overexpression of the hOPA1 constructs, so this part of the is very speculative.

      Confirmation was achieved using anti-hOPA1, demonstrating that myc is not nonspecific. These results have been added to Figure 5D. Furthermore, the phrase “The upper band was expected as” has been revised to “From a size perspective, the upper band was inferred to represent the full-length hOPA1 including the mitochondria import sequence (MIS).” (lines 464–465)

      I was missing a discussion about the increase of ROS upon loss/reduction of dOPA1 observed by others and described here. Is there an increase of ROS upon expression of any of the constructs used?

      We demonstrated that not only axonal degeneration but also ROS can be suppressed by expressing human OPA1 in the genetic background of dOPA1 knockdown. Additionally, rescue was not possible with any variants except for I382M. Furthermore, we assessed whether there were changes in ROS in the evaluation of dominant negatives, but no significant differences were observed in this experimental system. These findings have been added to the discussion section as follows (lines 318–328). “Our research established that dOPA1 knockdown precipitates axonal degeneration and elevates ROS signals in retinal axons. Expression of human OPA1 within this context effectively mitigated both phenomena; it partially reversed axonal degeneration and nearly completely normalized ROS levels. These results imply that factors other than increased ROS may drive the axonal degeneration observed post-knockdown. Furthermore, while differences between the impacts of DN mutations and loss-of- function mutations were evident in axonal degeneration, they were less apparent when using ROS as a biomarker. The extensive use of transgenes in our experiments might have mitigated the knockdown effects. In a systemic dOPA1 knockdown, assessments of mitochondrial quantity and autophagy activity revealed no significant changes, suggesting that the cellular consequences of reduced OPA1 expression might vary across different cell types.”

      Reviewer #3 (Recommendations For The Authors):

      Consider being more explicit regarding literature that has or has failed to test a direct dominant negative effect by expressing a variant in question in the background of a full OPA1 complement. My understanding is that this is the first direct evidence of this widely held hypothesis. This lends to the main claim promoting the utility of fly as a model in general. The authors might also outline this in the introduction as a knowledge gap they fill through this study.

      In the introduction, we have incorporated a passage that highlights precedents capable of distinguishing between LOF and DN effects, and we note the absence of models capable of dissecting these distinctions within an in vivo organism. This study aims to address this gap, proposing a model that elucidates the differential impacts of LOF and DN within the context of a living model organism, thereby contributing to a deeper understanding of their roles in disease pathology. We added the following sentences in the introduction (lines 71–80).

      “In the quest to differentiate between LOF and DN effects within the context of genetic mutations, precedents exist in simpler systems such as yeast and human fibroblasts. These models have provided valuable insights into the conserved functions of OPA1 across species, as evidenced by studies in yeast models (Del Dotto et al., 2018) and fibroblasts derived from patients harboring OPA1 mutations (Kane et al., 2017). However, the ability to distinguish between LOF and DN effects in an in vivo model organism, particularly at the structural level of retinal axon degeneration, has remained elusive. This gap underscores the necessity for a more complex model that not only facilitates molecular analysis but also enables the examination of structural changes in axons and mitochondria, akin to those observed in the actual disease state.”

      The authors should clarify the language used in the abstract and introduction on the effect of hOPA1 DOA and DOA plus on the dOPA1- phenotype. Currently written as "none of the previously reports mutations known to cause DOA or DOA plus were rescued, their functions seems to be impaired." but presumably the authors mean that these variants failed to rescue to the dOPA1 deficient phenotype.

      We thank the reviewer for the constructive feedback. We acknowledge the need for clarity in our description of the effects of hOPA1 DOA and DOA plus mutations on the dOPA1- phenotype in both the abstract and the introduction. The current phrasing, "none of the previously reported mutations known to cause DOA or DOA plus were rescued, their functions seem to be impaired," may indeed be confusing. To address your concern, we have revised this statement to more accurately reflect our findings: "Previously reported mutations failed to rescue the dOPA1 deficiency phenotype." For Abstract site, we have changed as following. "we could not rescue any previously reported mutations known to cause either DOA or DOA plus.”→ “mutations previously identified did not ameliorate the dOPA1 deficiency phenotype.”

      DOA plus is associated with a multiple sclerosis-like illness; as written it suggests that the pathogenesis of sporadic multiple sclerosis and that associated with DOA plus share and underlying pathogenic mechanism. Please use the qualifier "-like illness." 

      We have added the term “multiple sclerosis-like illness” wherever “multiple sclerosis” is mentioned.

    1. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      Summary:

      Parkin, a E3 ubiquitin ligase, is involved in the clearance of damaged mitochondrial via mitophagy. Upon mitochondrial damage, the activated Parkin ubiquitinates many mitochondrial substrates, leading to the recruitment of mitophagy effectors. However, the mechanism of substrate recognition by Parkin is still not known.

      In this manuscript, Koszela et al. utilized diverse biochemical assays and biophysical approaches, combined with AlphaFold prediction, to identify a conserved region in the flexible linker between the Ubl and RING0 domains of Parkin that recognizes mitochondrial GTPase Miro1 via a stretch of hydrophobic residues and is critical for its ubiquitination activity on Miro1. This manuscript reveals the mechanisms by which Parkin recognizes and ubiquitinates substrate Miro1, providing a biochemical explanation for the presence of Parkin at the mitochondrial membrane prior to activation by mitochondrial damage. This study also provides insights into mitochondrial homeostasis and may facilitate new therapeutic approaches for Parkinson's disease.

      Major Comments:

      • The authors should expand the background introduction to include the biological function of Miro1, the domain architecture of Miro1 and more context of Miro1 K572 ubiquitination in mitophagy.
      • Figure 1B is confusing. Due to the presence of various bands, it is hard to assign specific bands in each lane. In addition, there are various unlabeled bands that makes things unclear. The authors should include loading controls to clearly discern pParkin, Ube1, Ube2L3, and all substrates.
      • In Figure 1B, it was not possible to identify the ubiquitination bands of E2 enzyme UBE2L3 and the E1 enzyme UBE1. Please indicate these bands on the gel.
      • Since ubiquitinated Miro1 and Mfn1 are similar in molecular weight (Fig. 1b), the authors should show a western blot against the Miro1 and Mfn1 tag as done in the supplementary information, At least for the competition assays involving both Miro1 and Mfn1.
      • The conclusion that Miro1 is pParkin's preferred substrate is not convincing. In the competition assay used to show substrate preference, Miro1 is at a five-fold higher concentration than the other substrates and 25-fold higher than FANCI/D2. This would ultimately drive pParkin's interaction with Miro1. This is further highlighted by the fact that it adding Mfn1 in excess has a similar effect. The competition assay should be done at equimolar concentrations of Miro1 and substrate. More convincing would be a competition assay where substrate ubiquitination is quantified at several different concentrations of Miro1.
      • In Figure 1F, it is unclear what is defined as "high" or "low" ubiquitination levels statistically. Some of the changes in ubiquitination levels are extremely subtle (ex. mitoNEET and FancI/D2 in the presence and absence of Miro1 and Mfn1). In some cases, I find it extremely difficult to tell if there is any change in the ubiquitination levels when comparing lanes containing excess of different substrates. I would like to see band quantifications of this experiment in triplicate to support the conclusions drawn from the competition assay.
      • The authors used both unmodified and phosphorylated Parkin for the crosslinking experiments and observe no difference in the intensity of the bands. However, this is not sufficient to draw any conclusion about the affinity between phosphorylated Parkin and Miro1 (which was done in lines 341-343). The authors should comment on why they did not test pParkin binding with Miro1, especially given the statement:

      "In our assays in the absence of pUb, pParkin must interact with its substrates without the action of pUb, likely through 158 transient, low affinity interactions" - The reference to Parkin115-124 as a "Substrate Targeting Region (STR)" is misleading. This would imply that this motif in Parkin is responsible for general substrate recognition when there is no direct evidence of this. In Figure 5F, the authors create a synthetic peptide based off the STR sequence. Although this sequence was effective in inhibiting the ubiquitination of Miro1, it was ineffective against Mfn1. This would indicate that Mfn1 relies on a completely different set of interactions for ubiquitination by Parkin. I suggest that the authors tone down the language in describing this region and rename this region (perhaps "Miro1 Targeting Region (MTR)"?). - The authors appear to confuse plDDT and PAE scores in Figure 5B. The PAE describes the expected positional error of each residue in the model. The plot should be colored in terms of Expected Position Error (Ångstrom), not plDDT scores.

      Minor Comments:

      • Figure 1A would benefit from a schematic showing the domain architecture. If the goal is to appreciate the length of the linker, then showing the actual amino acid length would be beneficial.
      • In Supplementary Figure 2D, the authors performed the MST experiment with His6-Smt3-tagged Parkin. The group had previously shown that the presence of the tag artificially interferes with autoubiquitination, potentially by forming intramolecular interactions. The SEC, Native Page, and ITC data of untagged Parkin with Miro1 provide sufficient evidence that the interaction between the two are weak. The authors should consider removing the MST data, since they are not congruent with the other experiments.
      • The ITC data in Supplementary Figure 2C look promising. It would be nice if the authors could try to quantify the Kd of their STR peptides to Miro1
      • Are STR peptides 1 and/or 2 unable to inhibit ubiquitination of other Parkin substrates besides Mfn1? Do these other substrates utilize the STR for recognition? AlphaFold modeling may provide some insight on Parkin recognition of other substrates.
      • The authors shold consider using AlphaFold3 to model the interaction of pParkin with Miro1 compares to unmodified Parkin.
      • Please label the protein names in Figure 4A for a better presentation.
      • Page 2, line 37. "...by a 65-residue flexible region (linker) to a unique to Parkin RING0 domain..." should be "...by a 65-residue flexible region (linker) to a unique Parkin RING0 domain...". The second "to" should be omitted.
      • Page 3, Line 48: "fulfill", not "fulfil"
      • Page 5, line 110. In sentence, "...phosphorylation at Ser65 of Parkin...", it is better to explicitly state that this phosphorylation happens on the Parkin Ubl domain.
      • Page 7, line151. Figure 1F should be Figure 1G.
      • Page 11, line 241. In sentence "...Miro1 residues R263, R265 and D228...", do the authors mean R261 and not R265?

      Significance

      Parkin is an E3 ubiquitin ligase that is activated to ubiquitinate diverse substrates on the mitochondrial membrane in response to mitochondrial damage, thereby recruiting mitophagy effectors. This study reveals the mechanisms by which Parkin recognizes and ubiquitinates Miro1, providing insights into mitochondrial homeostasis and facilitating new therapeutic approaches for Parkinson's disease.

      Readers with a background in protein ubiquitination and mitochondrial homeostasis might be interested in this study. My expertise includes protein ubiquitination and structural biology. However, I do not have sufficient expertise to evaluate the NMR experiments in this manuscript.

    1. Reviewer #2 (Public Review):

      The authors addressed the question of how mitochondrial proteins that are dually localized or only to a minor fraction localized to mitochondria can be visualized on the whole genome scale. For this, they used an established and previously published method called BiG split-GFP, in which GFP strands 1-10 are encoded in the mitochondrial DNA and fused the GFP11 strand C-terminally to the yeast ORFs using the C-SWAT library. The generated library was imaged under different growth and stress conditions and yielded positive mitochondrial localization for approximately 400 proteins. The strength of this method is the detection of proteins that are dually localized with only a minor fraction within mitochondria, which so far has hampered their visualization due to strong fluorescent signals from other cellular localizations. The weakness of this method is that due to the localization of the GFP1-10 in the mitochondrial matrix, only matrix proteins and IM proteins with their C-termini facing the matrix can be detected. Also, proteins that are assembled into multimeric complexes (which will be the case for probably a high number of matrix and inner membrane-localized proteins) resulting in the C-terminal GFP11 being buried are likely not detected as positive hits in this approach. Taking these limitations into consideration, the authors provide a new library that can help in the identification of eclipsed protein distribution within mitochondria, thus further increasing our knowledge of the complete mitochondrial proteome. The approach of global tagging of the yeast genome is the logical consequence after the successful establishment of the BiG split-GFP for mitochondria. The authors also propose that their approach can be applied to investigate the topology of inner membrane proteins, however, for this, the inherent issue remains that it cannot be excluded that even the small GFP11 tag can impact on protein biogenesis and topology. Thus, the approach will not overcome the need to assess protein topology analysis via biochemical approaches on endogenous untagged proteins.

    2. Reviewer #3 (Public Review):

      Summary:

      Here, Bykov et al move the bi-genomic split-GFP system they previously established to the genome-wide level in order to obtain a more comprehensive list of mitochondrial matrix and inner membrane proteins. In this very elegant split-GFP system, the longer GFP fragment, GFP1-10, is encoded in the mitochondrial genome and the shorter one, GFP11, is C-terminally attached to every protein encoded in the genome of yeast Saccharomyces cerevisiae. GFP fluorescence can therefore only be reconstituted if the C-terminus of the protein is present in the mitochondrial matrix, either as part of a soluble protein, a peripheral membrane protein, or an integral inner membrane protein. The system, combined with high-throughput fluorescence microscopy of yeast cells grown under six different conditions, enabled the authors to visualize ca. 400 mitochondrial proteins, 50 of which were not visualised before and 8 of which were not shown to be mitochondrial before. The system appears to be particularly well suited for analysis of dually localized proteins and could potentially be used to study sorting pathways of mitochondrial inner membrane proteins.

      Strengths:

      Many fluorescence-based genome-wide screens were previously performed in yeast and were central to revealing the subcellular location of a large fraction of yeast proteome. Nonetheless, these screens also showed that tagging with full-length fluorescent proteins (FP) can affect both the function and targeting of proteins. The strength of the system used in the current manuscript is that the shorter tag is beneficial for the detection of a number of proteins whose targeting and/or function is affected by tagging with full-length FPs.

      Furthermore, the system used here can nicely detect mitochondrial pools of dually localized proteins. It is especially useful when these pools are minor and their signals are therefore easily masked by the strong signals coming from the major, nonmitochondrial pools of the proteins.

      Weaknesses:

      My only concern is that the biological significance of the screen performed appears limited. The dataset obtained is largely in agreement with several previous proteomic screens but it is, unfortunately, not more comprehensive than them, rather the opposite. For proteins that were identified inside mitochondria for the first time here or were identified in an unexpected location within the organelle, it remains unclear whether these localizations represent some minor, missorted pools of proteins or are indeed functionally important fractions and/or productive translocation intermediates. The authors also allude to several potential applications of the system but do little to explore any of these directions.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      The study reports on a previously unrecognized function of ATG6 in plant immunity. The work is valuable because it proposes a direct interaction between ATG6 and a well-studied salicylic acid receptor protein, NPR1, which may interest researchers investigating plant immunity regulation. While the data presented are compelling, more information regarding the specificity of ATG6's role would improve the overall impact of the study, especially with an eye towards consistency with prior work.

      We also genuinely thank the editor and reviewers for the constructive and helpful suggestions and comments. These comments have greatly improved the quality and thoroughness of our manuscript. We have carefully studied these comments and have made the appropriate changes as far as possible. Additionally, some minor errors were also corrected during the revision process. New text is shown in blue in the revised manuscript. Our responses to the reviewer's comments are provided below each respective comment.

      Public Reviews:

      Reviewer #1 (Public Review):<br /> Summary:<br /> The authors showed that autophagy-related genes are involved in plant immunity by regulating the protein level of the salicylic acid receptor, NPR1.<br /> Strengths:<br /> The experiments are carefully designed and the data is convincing. The authors did a good job of understanding the relationship between ATG6 and NRP1.

      Thank you very much for recognizing our research.

      Weaknesses:<br /> - The authors can do a few additional experiments to test the role of ATG6 in plant immunity.<br /> I recommend the authors to test the interaction between ATGs and other NPR1 homologs (such as NPR2).

      Thanks to your valuable feedback, it was discovered that the Arabidopsis NPRs family comprises six members: NPR1, NPR2, NPR3, NPR4, NPR5/PETIOLE 1 (BOP1), and NPR6/BOP2. NPR3/4 function in tandem as negative regulators to modulate SA signaling and plant immune responses (Ding et al., 2018). Similar to NPR1, NPR2 acts as a positive regulator of SA signaling (Castello et al., 2018). NPR5/BOP1 and NPR6/BOP2 primarily participate in the regulation of plant growth and development (McKim et al., 2008). This study specifically investigates the correlation between ATG6 and NPRs in plant resistance to pathogenic bacteria. Consequently, we experimentally confirmed the interaction between ATG6 and NPR1, NPR3, and NPR4 (Fig. 1 and Fig. S1 in the revised manuscript). It would be intriguing to further explore the interactions between ATG6 and other NPRs in the context of regulating plant growth and development in future research endeavors.

      -The concentration of SA used in the experiment (0.5-1 mM) seems pretty high. Does a lower concentration of SA induce ATG6 accumulation in the nucleus?

      Thank you for pointing this out. The NPR1 protein is known to be unstable and prone to degradation through the 26S proteasome pathway (Spoel et al., 2009; Saleh et al., 2015). Consequently, to investigate the function of NPR1, many scientists and research groups typically employ higher concentrations of SA (e.g., 0.5 mM, 1 mM, or even 5 mM) to elucidate its role (Spoel et al., 2009; Fu et al., 2012; Lee et al., 2015; Saleh et al., 2015; Skelly et al., 2019; Zavaliev et al., 2020; Chen et al., 2021a). In our study, we observed an interaction between ATG6 and NPR1. To enhance the detection of the NPR1 protein, we standardized the SA concentration (Arabidopsis was treated with 0.5 mM SA; Tobacco was treated with 1 mM SA) used in our experiments. Subsequently, we analyzed the nuclear accumulation ATG6 or NPR1 using a relatively high SA concentration (Arabidopsis was treated with 0.5 mM SA; Tobacco was treated with 1 mM SA), consistent with concentrations used in previous studies (Spoel et al., 2009; Lee et al., 2015; Saleh et al., 2015; Skelly et al., 2019; Zavaliev et al., 2020; Chen et al., 2021a).

      -Does the silencing of ATG6 affect the cell death (or HR) triggered by AvrRPS4?

      Thank you for pointing this out. In this study, we examined changes in Pst DC3000/avrRps4-induced cell death in Col, amiRNAATG6 # 1, amiRNAATG6 # 2, npr1, NPR1-GFP, ATG6-mCherry and ATG6-mCherry × NPR1-GFP plants. The results of Taipan blue staining showed that Pst DC3000/avrRps4-induced cell death in npr1, amiRNAATG6 # 1 and amiRNAATG6 # 2 was significantly higher compared to Col (Fig. S15 in the revised manuscript). Conversely, Pst DC3000/avrRps4-induced cell death in ATG6-mCherry, NPR1-GFP and ATG6-mCherry × NPR1-GFP was significantly lower compared to Col. Notably, Pst DC3000/avrRps4-induced cell death in ATG6-mCherry × NPR1-GFP was significantly lower compared ATG6-mCherry and NPR1-GFP (Fig. S15 in the revised manuscript). These results suggest that ATG6 and NPR1 cooperatively inhibit Pst DC3000/avrRps4-induced cell dead. The relevant description can be found in lines 394-404 of the revised manuscript.

      -SA and NPR1 are also required for immunity and are activated by other NLRs (such as RPS2 and RPM1). Is ATG6 also involved in immunity activated by these NLRs?

      Thank you for your valuable comments. The most notable event in the NLR-mediated ETI immune response is the induction of hypersensitive response-programmed cell death (HR-PCD) (Jones and Dangl, 2006; Yuan et al., 2021). SA plays a dual role in the ETI response. On one hand, the accumulation of SA during the R gene-mediated ETI defense response is directly linked to the onset of HR-PCD (Nawrath and Metraux, 1999). SA and NPR1 can enhance the ETI response by regulating the expression of downstream target genes (Falk et al., 1999; Feys et al., 2001; Ding et al., 2018; Liu et al., 2020). On the other hand, the activation of SA signaling can have a negative regulatory effect on HR-PCD during the ETI response. High levels of SA have been shown to significantly inhibit HR-PCD triggered by the avrRpt2 effector (Rate and Greenberg, 2001; Devadas and Raina, 2002; Jurkowski et al., 2004). Rate et al. discovered that the inhibition of HR-PCD by SA relies on NPR1 (Rate and Greenberg, 2001).

      Arabidopsis AtATG6 or its homologs in other species (such as NbBECLIN1, TaATG6s, etc.) have been identified as positive regulators in plant immunity, playing a crucial role in inhibiting cell death and preventing invasion by pathogenic microorganisms (Liu et al., 2005; Patel and Dinesh-Kumar, 2008; Yue et al., 2015). Patel et al. demonstrated that, akin to autophagy-deficient mutants previously documented, AtATG6 antisense (AtATG6-AS) plants treated with Pst DC3000/avrRpm1 exhibited diffuse cell death, indicating the necessity of ATG6 in restricting cell death (Patel and Dinesh-Kumar, 2008). In tobacco, deficiencies in BECLIN 1 result in the onset of diffuse HR-PCD, underscoring the essential role of BECLIN 1 in limiting HR-PCD (Liu et al., 2005). Despite the genetic evidence supporting the critical function of ATG6 in plant immunity, the precise molecular mechanisms through which ATG6 impedes the invasion of pathogenic microorganisms remain elusive.

      In our study, we uncovered that ATG6 interacts with NPR1 to hinder pathogen invasion and inhibit the initiation of cell death. In animals, members of the NLR family have been observed to interact with the autophagy-related protein LC3 to inhibit the survival of pathogen (Zhang et al., 2019). Similar mechanisms may exist in plants. However, it remains to be explored whether NLR directly induces the activation of ATG6 through interaction or the relationship between NPR1-ATG6 interactions and NLR-mediated plant immunity, necessitating further investigation.

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Zhang et al. explores the effect of autophagy regulator ATG6 on NPR1-mediated immunity. The authors propose that ATG6 directly interacts with NPR1 in the nucleus to increase its stability and promote NPR1-dependent immune gene expression and pathogen resistance. This novel role of ATG6 is proposed to be independent of its role in autophagy in the cytoplasm. The authors demonstrate through biochemical analysis that ATG6 interacts with NPR1 in yeast and very weakly in vitro. They further demonstrate using overexpression transgenic plants that in the presence of ATG6-mcherry the stability of NPR1-GFP and its nuclear pool is increased.

      However, the overall conclusions of the study are not well supported experimentally. The significance of the findings is low because of their mostly correlational nature, and lack of consistency with earlier reports on the same protein.

      Thank you for your valuable and constructive suggestions. In this article, we unveil a novel relationship in which ATG6 positively regulates NPR1 in plant immunity (Fig. 8 in the revised manuscript). ATG6 interacts with NPR1 to synergistically enhance plant resistance by regulating NPR1 protein levels, stability, nuclear accumulation, and formation of SINCs-like condensates. This may be of interest to researchers studying the regulation of plant immunity. While there may be minor flaws in our current study, the significance of these findings cannot be overstated, as they have the potential to redirect scientific attention towards uncovering novel functions for autophagy genes.

      Based on the integrity and quality of the data as well as the depth of analysis, it is not yet clear if ATG6 is a specific regulator of NPR1 or if it is affecting NPR1's stability indirectly, through inducing an elevation of SA levels in plants. As such, the current study demonstrates a correlation between overexpression of ATG6, SA accumulation, and NPR1 stability, however, whether and how these components work together is not yet demonstrated.

      Thanks to your valuable feedback. Although as the reviewer said there may be some flaws in our data from the current results, scientific research is an ongoing process and I am confident that future studies will be even better. From the results given to us at the moment at least this study reports a previously undiscovered function of ATG6 in plant immunity. We propose a direct interaction between ATG6 and a well-studied salicylic acid receptor protein, NPR1. We unveil a novel relationship in which ATG6 positively regulates NPR1 in plant immunity (Fig. 8 in the revised manuscript). ATG6 interacts with NPR1 to synergistically enhance plant resistance by regulating NPR1 protein levels, stability, nuclear accumulation, and formation of SINCs-like condensates. This may be of interest to researchers studying the regulation of plant immunity.

      Based on the provided biochemical data, it is not yet clear if the ATG6 functions specifically through NPR1 or through its paralogs NPR3 and NPR4, which are negative regulators of immunity. It is quite possible that interaction with NPR1 (or any NPR) is not the major regulatory step in the activity of ATG6 in plant immunity. The effect of ATG6 on NPR1 could well be indirect, through a change in the SA level and redox environment of the cell during the immune response. Both SA level and redox state of the cell were reported to induce accumulation of NPR1 in the nucleus and increase in stability.

      Thanks to your valuable feedback. In this study, we validated the interaction between ATG6 and NPR1 through various approaches and identified the key regions mediating their interaction. Our findings indicate that ATG6 interacts with NPR1 to synergistically enhance plant resistance by regulating NPR1 protein levels, stability, nuclear accumulation, and the formation of SINC-like condensates. These results clearly demonstrate the involvement of ATG6 in the regulation of NPR1.Furthermore, we also found that ATG6 interacts with NPR3/4 (Fig. S1 in the revised manuscript). This is particularly relevant given that NPR3 and NPR4 have been shown to act as adaptors for the ubiquitin E3 ligase Cullin 3 (CUL3) to regulate the degradation of NPR1. Therefore, whether ATG6 regulates NPR1 through its interactions with NPR3/4 is an intriguing question worth exploring in future studies. We appreciate the reviewer's concerns and are committed to addressing them in our future research to further elucidate the complex regulatory mechanisms involving ATG6, NPR1, and other key players in plant immunity.

      Another major issue is the poor quality of the subcellular analyses. In contradiction to previous studies, ATG6 in this study is not localized to autophagosome puncta, which suggests that the soluble localization pattern presented here does not reflect the true localization of ATG6. Even if the authors propose a novel, non-canonical nuclear localization for ATG6, they still should have detected the canonical autophagy-like localization of this protein.

      Thanks to your valuable feedback. We conducted predictions at NLS Mapper (https://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi) and identified two bipartite NLSs in ATG6, with the sequences "MRKEEIPDKSRTIPIDPNLPKWVCQNCHHS" and "DPNLPKWVCQNCHHS LTIVGVDSYAGKFFNDP". To further elucidate the nuclear localization of ATG6, we introduced Agrobacterium tumefaciens carrying ATG6-GFP into nls-mCherry tobacco leaves through transient transformation. Subsequently, we observed the localization of ATG6-GFP, along with the canonical autophagy-like patterns. Our findings revealed fluorescence signals of ATG6-GFP in both the cytoplasm and nuclei (Figure 2b). The nuclear-localized ATG6-GFP overlapping with the nuclear-localized marker, nls-mCherry (indicated by white arrows). Additionally, we observed punctate patterns indicative of canonical autophagy-like localization of ATG6-GFP fluorescence signals (indicated by red circles). Based on these results, we are more confident about the authenticity of ATG6's nuclear localization. The revised manuscript includes clearer images to support our observations.

      Recommendations for the Authors:

      Reviewer #2 (Recommendations For The Authors):

      The duration and concentration of SA treatments are quite variable between experiments which makes comparisons difficult.

      Thank you for pointing this out. The NPR1 protein is known to be unstable and prone to degradation through the 26S proteasome pathway (Spoel et al., 2009; Saleh et al., 2015). Consequently, to investigate the function of NPR1, many scientists and research groups typically employ higher concentrations of SA (e.g., 0.5 mM, 1 mM, or even 5 mM) to elucidate its role (Spoel et al., 2009; Fu et al., 2012; Lee et al., 2015; Saleh et al., 2015; Skelly et al., 2019; Zavaliev et al., 2020; Chen et al., 2021a). In our study, we observed an interaction between ATG6 and NPR1. To enhance the detection of the NPR1 protein, we standardized the SA concentration used in our experiments. In this study, for the treatment of Arabidopsis, we followed the protocols outlined in Saleh et al. and Spoel et al., utilizing 0.5 mM SA (Spoel et al., 2009; Saleh et al., 2015). For tobacco treatment, we adopted the methodology described in the study by Zavaliev et al., administering 1 mM SA (Zavaliev et al., 2020).

      The methods section does not explain some of the essential experimental conditions and reagents used in the study.

      Thank you for pointing this out. Due to word limitations we have placed the detailed experimental methods and reagents in Supplemental Data 1. In Supplemental Data 1, we provide a comprehensive overview of the experimental flow and conditions employed in our study.

      Lines 62-63: the C-terminal domain of all NPRs has a name (already defined as SA-binding domain (SBD)). Also, it would be worth referring to the structure of NPR1 (Kumar et al 2022, Nat) as the source of information about its domains.

      Thank you for pointing this out, we have changed this description in the revised manuscript (lines 62-63).

      Lines 66-69: NPR1 doesn't form monomers. A recent study showed that the basic functional unit of NPR1 is a dimer (Kumar et al 2022, Nat).

      Thank you for pointing this out. In the revised manuscript (line 67) " monomers " has been changed to “dimer”.

      Lines 89-95 and elsewhere: the term "invasion" has a very specific meaning and it doesn't necessarily refer to disease. A pathogen can invade the plant but cause no disease (e.g. ETI). Most plant genetic immune mechanisms act after pathogen invasion, not before it. Those cited works reported the disease resistance, not the invasion resistance.

      Thank you for pointing this out. We've changed the incorrect description in the revised manuscript (line 91).

      Lines 113-119: the truncation at the aa328 includes half of the ANK domain (repeats 1 and 2), not just BTB. The C-terminal truncation variant contains the other half (repeats 3 and 4) of the ANK domain, not the entire ANK domain. It also contains the SBD, not just the NLS. So, this kind of analysis cannot determine the role of ANK domain in the interaction, nor it can conclusively determine if the interaction is through SBD. The interaction should be tested with the SBD domain only in order to make this conclusion.

      Thank you for pointing this out, we have removed the inappropriate description and made the appropriate changes in the revised manuscript (lines 114 and 115).

      In Figure S1, the equally strong interaction of atg6 is found for NPR3/NPR4. Does that mean that atg6 functions also through these other NPRs? What's the significance of these data compared to NPR1-ATG6 interaction? This is especially important, because both NPR3 and NPR4 are predominantly nuclear proteins, and they are unlikely to significantly overlap with autophagy components in the cytoplasm.

      NPR1 and its paralogues NPR3/NPR4, which frequently interact with other proteins to regulate plant immune responses (Backer et al., 2019; Chen et al., 2019). To identify ATGs that interact with NPRs, we performed yeast two-hybrid (Y2H) screens using NPRs as bait. Interestingly, ATG6 interacted with NPR1, NPR3 and NPR4, respectively, and different concentrations of SA treatment did not significantly affect their interaction (Fig. S1a). NPR1 is an important positive regulator of the plant immune response (Chen et al., 2021b). In Arabidopsis and N. benthamian, ATG6 or its homologues was reported to act as a positive regulator to enhance plant disease resistance to P. syringae pv. tomato (Pst) DC3000 and Pst DC3000/avrRpm1 bacteria (Patel and Dinesh-Kumar, 2008), N. benthamiana mosaic virus (TMV) (Liu et al., 2005). Therefore, in this study we focused on investigating the biological significance of the interaction between ATG6 and NPR1. Whether the interaction between ATG6 and NPR3/4 also has an effect on plant immunity is a question that remains to be explored in future studies.

      In Figure 1c and elsewhere: why not use the anti-mCherry antibody to detect atg6-mcherry? Are we seeing the correct protein band of atg6-mcherry? Also, it is not clear what antibodies they used throughout the study: the sources and specificities of antibodies are not provided.

      Thank you for pointing this out. We initially synthesized the ATG6 antibody (anti-ATG6, 1:200, peptide, C-KEKKKIEEEERK, Abmart) in order to detect the endogenous ATG6 protein, and we also tested the specificity and potency of the ATG6 antibody (results are shown in Fig. S17). Additionally, in order to determine the location of the ATG6-mCherry bands, we also detected ATG6-mCherry in ATG6-mCherry Arabidopsis using the ATG6 antibody, and we also used Col as a control (results are shown in Fig. S4). These results show that our synthesized ATG6 antibody can effectively and clearly immunize to both ATG6 and ATG6-mCherry. Therefore, in this study, we used the ATG6 antibody to analyze both ATG6-mCherry and endogenous ATG6. Detailed antibody information is presented in Supplementary Data 1, table S4

      In Figures 1d, 2a, and 2b, the subcellular localization pattern of atg6 contradicts what was published before (Fujiki et al 2007, Plant Phys; Liu et al 2018, FPlS; Xu et al 2017, Autophagy; Li et al 2018, Nat. Comm.). As an autophagy protein, atg6 was shown to localize to cytoplasmic puncta (autophagosomes), like atg8. No nuclear localization was found in those studies. The lack of puncta and the strong nuclear accumulation are signs that the localization of atg6 reported here has to be interpreted with caution. With the data provided, I am not convinced yet that we are looking at the correct ATG6 subcellular localization. Even if the authors propose a novel, non-canonical localization for atg6, they still should have detected the canonical autophagy-like localization of this protein.

      Thanks to your valuable feedback. To further elucidate the nuclear localization of ATG6, we introduced Agrobacterium tumefaciens carrying ATG6-GFP into nls-mCherry tobacco leaves through transient transformation. Subsequently, we observed the localization of ATG6-GFP, along with the canonical autophagy-like patterns. Our findings revealed fluorescence signals of ATG6-GFP in both the cytoplasm and nuclei (Figure 2b). The nuclear-localized ATG6-GFP overlapping with the nuclear-localized marker, nls-mCherry (indicated by white arrows). Additionally, we observed punctate patterns indicative of canonical autophagy-like localization of ATG6-GFP fluorescence signals (indicated by red circles). Based on these results, we are more confident about the authenticity of ATG6's nuclear localization. The revised manuscript includes clearer images to support our observations.

      It would make more sense to include the BiFC data (fig. S2) in the main figure, instead of the co-localization (fig. 1d) which cannot serve as evidence for interaction.

      Thank you for the feedback. We accept your suggestion. In Fig.1, we have replaced the co-localization image with a BiFC (Bimolecular Fluorescence Complementation) image to better illustrate the interaction.

      In Figure S2, the bifc signals have to be quantified to qualify as evidence for interaction. also, a subcellular marker has to be used (e.g. nuclear mcherry). From the current poor-quality images, one cannot determine where in the cell the presumed interaction takes place, nucleus or cytoplasm, or both. Also, no puncta are seen in these images.

      Thank you for pointing this out. Despite the lack of clarity in the images we provided, our BiFC results unequivocally demonstrate the interaction between ATG6 and NPR1 in both the cytoplasm and nucleus. Notably, as the reviewer pointed out, punctate signals were not observed in our images. This lack of punctate signals is consistent with previous studies (Figure 2) that have also shown BiFC results between autophagy-associated proteins ATG8s and their interacting partners. For instance, Fig 1G (Marshall et al. 2019, Cell), Fig 2F (Marshall et al. 2019, Cell), Fig 4B (Macharia et al. 2019, BMC Plant Biology), and Fig 3 (Zhou et al. 2018, Autophagy) all did not exhibit punctate signals, aligning closely with our findings.

      In Figure S3a, the nuclear localization is shown for stomata. It is known that stomata are especially strong expressors of the transgenes, and localization there could be an artefact of overaccumulation of the fusion protein. Also, why do they present the localization of atg6-gfp, if the analysis and the cross were made with atg6-mcherry?

      Thank you for pointing this out. In our previous experiments, we observed the localization of ATG6 in the nucleus of Arabidopsis thaliana plants overexpressing ATG6-GFP (Fig. S3a). To clearly visualize the location of the nucleus, we used the cytosolic DAPI dye, which readily stained the nuclei of the stomatal guard cells. This allowed us to easily identify the nuclear regions for our observations. Additionally, in Fig. 2a and Fig.S3b, we detected the fluorescence signal of ATG6-mCherry within the nucleus, further confirming the nuclear localization of ATG6. Moreover, the nuclear and cytoplasmic fractions were separated. Under SA treatment, ATG6-mCherry and ATG6-GFP were detected in the cytoplasmic and nuclear fractions in N. benthamiana (Fig. 2c and d). Similarly, ATG6 was also detected in the nuclear fraction of UBQ10::ATG6-GFP and UBQ10::ATG6-mCherry overexpressing plants (Fig. 2e and f).

      In Figure S3b, the images are low resolution and of poor quality. Why atg6-mcherry is expressed in a single cell if these are transgenic plants? The nuclear co-localization with npr1-gfp has to be shown more clearly with high res. images and also be quantified, because the expression of atg6-mcherry is not as uniform as npr1-gfp.

      Thank you for pointing this out. Contrary to the reviewer's assertion, the ATG6-mCherry fluorescence signal depicted in Figure S3b was not exclusive to a single cell. In fact, this fluorescence was also evident in other cells, albeit with relatively weaker intensity. This disparity in fluorescence intensity may be attributed to the irregularities in leaf structure at the time of image capture using the microscope. To bolster our conclusion, we further examined the fluorescence signals in the cells of the root elongation zone in ATG6-mCherry x NPR1-GFP, as depicted in the figure below. Our observations revealed that the fluorescence signals of ATG6-mCherry exhibited uniform distribution, with detection in both the cytoplasm and nucleus. We have replaced the original unclear image with a high-quality image.

      Lines 138-143: In fig. S3d, it would make more sense to show the WB on the hybrid npr1-gfp/atg6-mcherry plants with both anti-gfp and anti-mcherry antibodies to detect the free mcherry/gfp. Since the analysis of the level of free FP is done, then why didn't they test the free mcherry levels in Figure S4a? This would be more important than testing the free GFP in ATG6-GFP plants, because the imaging of atg6-mcherry was done in the hybrid plants (fig. S3b).

      Thank you for pointing this out. We initially synthesized the ATG6 antibody (anti-ATG6, 1:200, peptide, C-KEKKKIEEEERK, Abmart) in order to detect the endogenous ATG6 protein, and we also tested the specificity and potency of the ATG6 antibody (results are shown in Fig. S17). Additionally, in order to determine the location of the ATG6-mCherry bands, we also detected ATG6-mCherry in ATG6-mCherry Arabidopsis using the ATG6 antibody, and we also used Col as a control (results are shown in Fig. S4). These results show that our synthesized ATG6 antibody can effectively and clearly immunize to both ATG6 and ATG6-mCherry. Therefore, in this study, we used the ATG6 antibody to analyze both ATG6-mCherry and endogenous ATG6. Detailed antibody information is presented in Supplementary Data 1, table S4. In the previous experiments, we procured the mCherry antibody (mCherry-Tag Monoclonal Antibody(6B3), BD-PM2113, China) to immunolabel ATG6-mCherry. However, we encountered challenges with the potency of this mCherry antibody, and considering our budget constraints, as well as the availability of our self-synthesized ATG6 antibody, we chose not to pursue the purchase of another antibody from a different company for the continuation of the Western Blot experiment.

      In Figure 2c, there's no atg6-mcherry detected at time 0, in either cytoplasm or nucleus, yet the microscope images in panel a show strong accumulation in both compartments.

      Thank you for pointing this out. Previous studies ATG6 can also be degraded via the 26s proteasome pathway (Qi et al., 2017). We speculate that this phenomenon might be attributed to the rapid turnover of ATG6 at time 0.

      Lines 156-160: this statement is unsupported by the data. In fig. S5, the bands for native atg6 in the nuclear fraction are extremely weak, and they do not show the reverse pattern of change along the time points compared to the cytoplasmic fraction, which would indicate that the nuclear fraction is complementary to the cytoplasmic pool of the protein. The result more likely suggests that the majority of the ATG6 is in the cytoplasm, and that the weak bands detected in the nucleus are either background signal, or a contamination from the cytoplasmic pool. At this low protein level or poor immuno-detection the background signal is inevitable due to overexposure. Even though the actin marker is not detected in the nuclear fraction, it doesn't necessarily mean that there's no contamination from the cytoplasm in the nuclear fraction. The actin is just too abundant and can be detected at lower exposure.

      Thank you for pointing this out. In Fig. S5, we detected the subcellular localization of endogenous ATG6, although the image quality was somewhat low. Nevertheless, the cytosolic and nuclear localization of ATG6 could be clearly observed. In addition to this, we also verified the cytosolic and nuclear localization of ATG6 in Arabidopsis using confocal fluorescence microscopy and nucleoplasmic separation experiments. Actin and H3 were used as cytoplasmic and nucleus internal reference, respectively. (Fig. 2e and f). Furthermore, we observed the cytosolic and nuclear localization of ATG6 when we expressed ATG6-GFP or ATG6-mCherry in tobacco leaves through cis-transfection experiments (Fig. 2a-d). These results are consistent with the prediction of the subcellular location of ATG6 in the Arabidopsis subcellular database (https://suba.live/) (Fig. S3c). The reviewer's feedback has been valuable in helping us present these findings more clearly. We acknowledge the limitations in the image quality for the endogenous ATG6 localization, but we believe the combination of multiple experimental approaches, including the use of fluorescent protein fusions, provides robust evidence for the cytosolic localization of ATG6 in plant cells. Moving forward, we will continue to investigate the significance of ATG6's subcellular distribution and its potential dual roles in both the nucleus and the cytosol, particularly in the context of its interaction with the key immune regulator NPR1. We appreciate the reviewer's constructive comments, as they will help us strengthen the presentation and interpretation of our findings.

      In Figure 3a the images are of too low resolution to see the co-localization. The focal planes of the top and bottom panels are quite different: the top is focused on stomata, the bottom - on pavement cells. So, the number of the NPR1-GFP nuclei between these two focal planes is dramatically different. Also, it looks like the atg6-mcherry in these plants are predominantly in the cytoplasm, not the nucleus as the authors claim. A higher resolution and higher quality of images are required to determine this.

      Thank you for pointing this out. To ensure the clarity and accuracy of our confocal images, we have supplied a clearer image as supplementary evidence. The Bright images distinctly show that both sets of images are in the same plane of focus. Furthermore, in the figure (third one in the fourth column), the nucleus localization of ATG6-mCherry is clearly visible, and that ATG6-mCherry is co-localized with NPR1-GFP in the nucleus, as indicated by the white arrow.

      In Figure 3b, it is not indicated what exactly was measured and in what condition, mock or SA. If these are numbers of nuclei, then it should be indicated what size of the area was sampled, not just "section", and both mock and SA should be included in the measurements. Also, how many independent images have been sampled? what does the error bar represent? What does "normal" mean? Shouldn't this be a mock treatment?

      Thank you for pointing out this. The term "Normal" in this context refers to mock treatment, and we have revised the description for clarity. In Figure 3b, the graph illustrates the count of nuclear localizations of NPR1-GFP in ATG6-mCherry × NPR1-GFP and NPR1-GFP Arabidopsis plants following SA treatment. Statistical data were obtained from three independent experiments, each comprising five individual images, resulting in a total of 15 images analyzed for this comparison. Detailed descriptions were also added to the revised manuscript (Lines 568-570, 800-804).

      Lines 167-168: the proposed increase of NPR1-GFP in the nucleus could be simply due to a higher accumulation of SA in the hybrid plants, not because of the direct interaction of atg6.

      Thank you for pointing out this. Our results confirmed that ATG6 overexpression significantly increased nuclear accumulation of NPR1 (Fig. 3). Notably, the ratio (nucleus NPR1/total NPR1) in ATG6-mCherry × NPR1-GFP was not significantly different from that in NPR1-GFP, and there is a similar phenomenon in N. benthamiana (Fig. 3c-f). These results suggested that the increased nuclear accumulation of NPR1 by ATG6 might result from higher levels and more stable NPR1, rather than the enhanced nuclear translocation of NPR1 facilitated by ATG6. Furthermore, we found that under SA treatment, the protein levels of NPR1 were significantly higher in the ATG6-mCherry × NPR1-GFP line compared to the NPR1-GFP line (Fig. 5a). Notably, even in the absence of differences in SA levels between the two lines, we observed that ATG6 could delay the degradation of NPR1 under normal conditions (Fig. 6). These findings suggest that ATG6 employs both SA-dependent and SA-independent mechanisms to maintain the stability of the key immune regulator NPR1. In summary, we therefore suggest that the increased nuclear accumulation in NPR1 cells is a dual effect of SA and ATG6.

      Lines 202-204: "Increased nuclear accumulation" implies increased translocation. However, they found that the ratio of NPR1-GFP does not change (Figure 3), so the reason for higher nuclear accumulation is not translocation, but abundance.

      Thank you for pointing out this. Our results confirmed that ATG6 overexpression significantly increased nuclear accumulation of NPR1 (Fig. 3). ATG6 also increases NPR1 protein levels and improves NPR1 stability (Fig. 5 and 6). Therefore, we consider that the increased nuclear accumulation of NPR1 in ATG6-mCherry x NPR1-GFP plants might result from higher levels and more stable NPR1 rather than the enhanced nuclear translocation of NPR1 facilitated by ATG6. To verify this possibility, we determined the ratio of NPR1-GFP in the nuclear localization versus total NPR1-GFP. Notably, the ratio (nucleus NPR1/total NPR1) in ATG6-mCherry × NPR1-GFP was not significantly different from that in NPR1-GFP, and there is a similar phenomenon in N. benthamiana (Fig. 3c-f). These results suggested that the increased nuclear accumulation of NPR1 by ATG6 might result from higher levels and more stable NPR1, rather than the enhanced nuclear translocation of NPR1 facilitated by ATG6. Further we analyzed whether ATG6 affects NPR1 protein levels and protein stability. Our results show that ATG6 increases NPR1 protein levels under SA treatment and ATG6 maintains the protein stability of NPR1 (Fig. 5 and 6). These results suggested that the increased nuclear accumulation of NPR1 by ATG6 result from higher levels and more stable NPR1. The corresponding description is shown in revised manuscript (lines 338~352).

      Lines 204-205: the co-localization in Figure 1d cannot be interpreted as interaction.

      Thank you for the feedback. We have replaced the co-localization image with a BiFC (Bimolecular Fluorescence Complementation) image to better illustrate the interaction in Fig 1d.

      What age of plants were used for the analysis in Figures 4 and S7? The age of the plant might significantly affect the free SA levels under control conditions.

      Thank you for the feedback. In Figures 4 and S7, 3-week-old plants were used to determine salicylic acid (SA) levels and the expression of target genes. Figures 4 and S7 figure notes provide detailed descriptions (lines 818-819).

      In Figure 5a they treat with SA, but the analysis in Figure S10 is done with the pathogen, so how can these data be correlated?

      Thank you for pointing out this. Previous studies have demonstrated that pathogen infestation rapidly increases the salicylic acid (SA) content in plants, and the elevated SA then activates plant immune responses. Therefore, both pathogen treatment and direct SA treatment can activate SA-dependent plant immune responses. The NPR1 protein is known for its instability. In Figure 5a, we utilized a 0.5 mM SA treatment to assess the changes in NPR1 protein levels, as the impact of SA treatment is more immediate and pronounced.

      Lines 241-242: In Figure 5b, it is not clear why there's no detection of NPR1-GFP and atg6-mcherry at time 0?? The levels of proteins in the transient assay are sufficiently high for detection by WB.

      Thank you for pointing this out. The NPR1 protein is known to be unstable and prone to degradation through the 26S proteasome pathway (Spoel et al., 2009; Saleh et al., 2015). In addition, previous studies ATG6 can also be degraded via the 26s proteasome pathway (Qi et al., 2017). We speculate that this phenomenon might be attributed to the rapid turnover of NPR1 and ATG6 at time 0.

      In Figures 5c-d, the quality of these images is very poor, and they do not clearly show the signs. What structure was exactly measured in these images? There are so many fluorescent bodies there, that it is not clear what are we looking at. Also, it is not clear why they did not show the mcherry channel? It would be important to see if the bodies in SA-treated plants show co-localization with atg6-mcherry autophagosomes (if these exist at all).

      Thank you for pointing this out. Interestingly, similar to previous reports (Zavaliev et al., 2020), SA promoted the translocation of NPR1 into the nucleus, but still a significant amount of NPR1 was present in the cytoplasm (Fig. 3c and e). Previous studies have shown that SA increased NPR1 protein levels and facilitated the formation of SINCs in the cytoplasm, which are known to promote cell survival (Zavaliev et al., 2020). We therefore observed the fluorescence signal of SINCs-like condensates in the cytoplasm of tobacco leaves. After 1mM SA treatment, more SINCs-like condensates fluorescence were observed in N. benthamiana co-transformed with ATG6-mCherry + NPR1-GFP compared to mCherry + NPR1-GFP (Fig. 5c-d and Supplemental movie 1-2). We have a clearer demonstration in the supplemental video movie 1-2. Additionally, we observed that SINCs-like condensates signaling partial co-localized with certain ATG6-mCherry autophagosomes fluorescence signals.

      Lines 245-247: so, is it atg6 or SA that increases the NPR1 levels? If this is due to SA, then the whole study doesn't have novelty, because we already know from previous works that SA increases the stability of npr1.

      Thank you for pointing this out. Indeed, previous studies have shown that salicylic acid (SA) increases NPR1 levels and protein stability (Spoel et al., 2009; Saleh et al., 2015). In our experiments, we found that under SA treatment, the protein levels of NPR1 were significantly higher in the ATG6-mCherry × NPR1-GFP line compared to the NPR1-GFP line (Fig. 5a). Additionally, free SA levels were also significantly elevated in the ATG6-mCherry × NPR1-GFP line under pathogen challenge (Pst DC3000/avrRps4), but not under normal conditions (Fig. 4a). Furthermore, even in the absence of differences in SA levels between the two lines, we observed that ATG6 could delay the degradation of NPR1 under normal conditions (Fig. 6). These findings represent one of our new discoveries. These findings suggest that ATG6 employs both SA-dependent and SA-independent mechanisms to maintain the stability of the key immune regulator NPR1.

      Lines 313-316: npr1 and atg6 can function independently from each other, so the term "jointly" is misleading. Based on the overall data provided in this manuscript it cannot be concluded that the two proteins work in one complex to control plant immunity.

      Thank you for pointing this out. In the revised manuscript "jointly" has been changed to “cooperatively”.

      Lines 369-374: this speculation is beyond the main hypothesis claiming that atg6 functions through npr1. If atg6 can activate the transcription alone, then what is the significance of its activation of npr1? How can one distinguish between the two?

      Thank you for pointing this out. Transcription activation by transcription factors typically requires at least two conserved structural domains: a transcription activation domain and a DNA-binding domain. However, ATG6 does not possess these two typical conserved structural domains found in canonical transcription factors. Given this structural context, it is unlikely that ATG6 would be able to directly activate transcription on its own. The lack of the canonical transcription factor domains in ATG6 suggests that it may not be able to function as a direct transcriptional activator. Previous studies have shown that acidic activation domains (AADs) in transcriptional activators (such as Gal4, Gcn4 and VP16) play important roles in activating downstream target genes. Acidic amino acids and hydrophobic residues are the key structural elements of AAD (Pennica et al., 1984; Cress and Triezenberg, 1991; Van Hoy et al., 1993). Chen et al. found that EDS1 contains two ADD domains and confirmed that EDS1 is a transcriptional activator with AAD (Chen et al., 2021a). Here, we also have similar results that ATG6 overexpression significantly enhanced the expression of PR1 and PR5 (Fig. 4b-c and S9), and that the ADD domain containing acidic and hydrophobic amino acids is also found in ATG6 (148-295 AA) (Fig. S14). We speculate that ATG6 might act as a transcriptional coactivator to activate PRs expression synergistically with NPR1.

      Lines 389-400: the cell death due to AvrRPS4 in Col-0 ecotype is extremely weak as there's no complete receptor complex for this effector. So, one has to use a very high dose to induce cell death in Col-0, certainly higher than the one used for bacterial growth. The authors used the same dose in both assays, so it is likely that what we see as "cell death" is not an effector-triggered response, but rather symptom-associated for the virulent pathogen.

      Thank you for pointing this out. Indeed, as the reviewer pointed out, most cell death assays use higher concentrations of Pst DC3000/avrRps4 or Pst DC3000/avrRpt2, but they typically treat Arabidopsis for a relatively short period, usually less than 1 day(Hofius et al., 2009; Zavaliev et al., 2020). In this study, although we used relatively low Pst DC3000/avrRps4 (0.001) injections, we detected cell death under a relatively long period of Pst DC3000/avrRps4 infestation (3 days). Pst DC3000/avrRps4-infested plants multiply significantly in host cells, and therefore we assumed that the propagated pathogens after 3 days of incubation would be sufficient to induce intense cell death. Consequently, we chose this concentration of Pst DC3000/avrRps4 for the experiment.

      Lines 407-416: why do you expect "delay of degradation" with autophagy inhibitor? Shouldn't it be the opposite? In Figure S14, if we compare the bands between 120min and 120min+ConA+WM, the effect of autophagy inhibitors is actually quite strong (0.47 vs 0.22), with about 50% more degradation of NPR1 in their presence. So, the conclusion that the degradation of NPR1 is autophagy-independent is wrong according to this result.

      Thank you for pointing this out. We have revised the inaccurate description, as outlined in the revised manuscript (lines 413-425).

      References

      Backer R, Naidoo S, van den Berg N. 2019. The NONEXPRESSOR OF PATHOGENESIS-RELATED GENES 1 (NPR1) and Related Family: Mechanistic Insights in Plant Disease Resistance. Front Plant Sci 10, 102.

      Castello MJ, Medina-Puche L, Lamilla J, et al. 2018. NPR1 paralogs of Arabidopsis and their role in salicylic acid perception. PLoS One 13, e0209835.

      Chen H, Li M, Qi G, et al. 2021a. Two interacting transcriptional coactivators cooperatively control plant immune responses. Sci Adv 7, eabl7173.

      Chen J, Mohan R, Zhang Y, et al. 2019. NPR1 Promotes Its Own and Target Gene Expression in Plant Defense by Recruiting CDK8. Plant Physiol 181, 289-304.

      Chen J, Zhang J, Kong M, et al. 2021b. More stories to tell: NONEXPRESSOR OF PATHOGENESIS-RELATED GENES1, a salicylic acid receptor. Plant Cell Environ.

      Cress WD, Triezenberg SJ. 1991. Critical structural elements of the VP16 transcriptional activation domain. Science 251, 87-90.

      Devadas SK, Raina R. 2002. Preexisting systemic acquired resistance suppresses hypersensitive response-associated cell death in Arabidopsis hrl1 mutant. Plant Physiol 128, 1234-1244.

      Ding Y, Sun T, Ao K, et al. 2018. Opposite Roles of Salicylic Acid Receptors NPR1 and NPR3/NPR4 in Transcriptional Regulation of Plant Immunity. Cell 173, 1454-1467 e1415.

      Falk A, Feys BJ, Frost LN, et al. 1999. EDS1, an essential component of R gene-mediated disease resistance in Arabidopsis has homology to eukaryotic lipases. Proc Natl Acad Sci U S A 96, 3292-3297.

      Feys BJ, Moisan LJ, Newman MA, et al. 2001. Direct interaction between the Arabidopsis disease resistance signaling proteins, EDS1 and PAD4. EMBO J 20, 5400-5411.

      Fu ZQ, Yan S, Saleh A, et al. 2012. NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants. Nature 486, 228-232.

      Hofius D, Schultz-Larsen T, Joensen J, et al. 2009. Autophagic components contribute to hypersensitive cell death in Arabidopsis. Cell 137, 773-783.

      Jones JD, Dangl JL. 2006. The plant immune system. Nature 444, 323-329.

      Jurkowski GI, Smith RK, Jr., Yu IC, et al. 2004. Arabidopsis DND2, a second cyclic nucleotide-gated ion channel gene for which mutation causes the "defense, no death" phenotype. Mol Plant Microbe Interact 17, 511-520.

      Lee HJ, Park YJ, Seo PJ, et al. 2015. Systemic Immunity Requires SnRK2.8-Mediated Nuclear Import of NPR1 in Arabidopsis. Plant Cell 27, 3425-3438.

      Liu Y, Schiff M, Czymmek K, et al. 2005. Autophagy regulates programmed cell death during the plant innate immune response. Cell 121, 567-577.

      Liu Y, Sun T, Sun Y, et al. 2020. Diverse Roles of the Salicylic Acid Receptors NPR1 and NPR3/NPR4 in Plant Immunity. Plant Cell 32, 4002-4016.

      McKim SM, Stenvik GE, Butenko MA, et al. 2008. The BLADE-ON-PETIOLE genes are essential for abscission zone formation in Arabidopsis. Development 135, 1537-1546.

      Nawrath C, Metraux JP. 1999. Salicylic acid induction-deficient mutants of Arabidopsis express PR-2 and PR-5 and accumulate high levels of camalexin after pathogen inoculation. Plant Cell 11, 1393-1404.

      Patel S, Dinesh-Kumar SP. 2008. Arabidopsis ATG6 is required to limit the pathogen-associated cell death response. Autophagy 4, 20-27.

      Pennica D, Goeddel DV, Hayflick JS, et al. 1984. The amino acid sequence of murine p53 determined from a c-DNA clone. Virology 134, 477-482.

      Qi H, Xia FN, Xie LJ, et al. 2017. TRAF Family Proteins Regulate Autophagy Dynamics by Modulating AUTOPHAGY PROTEIN6 Stability in Arabidopsis. Plant Cell 29, 890-911.

      Rate DN, Greenberg JT. 2001. The Arabidopsis aberrant growth and death2 mutant shows resistance to Pseudomonas syringae and reveals a role for NPR1 in suppressing hypersensitive cell death. Plant J 27, 203-211.

      Saleh A, Withers J, Mohan R, et al. 2015. Posttranslational Modifications of the Master Transcriptional Regulator NPR1 Enable Dynamic but Tight Control of Plant Immune Responses. Cell Host Microbe 18, 169-182.

      Skelly MJ, Furniss JJ, Grey H, et al. 2019. Dynamic ubiquitination determines transcriptional activity of the plant immune coactivator NPR1. Elife 8.

      Spoel SH, Mou Z, Tada Y, et al. 2009. Proteasome-mediated turnover of the transcription coactivator NPR1 plays dual roles in regulating plant immunity. Cell 137, 860-872.

      Van Hoy M, Leuther KK, Kodadek T, et al. 1993. The acidic activation domains of the GCN4 and GAL4 proteins are not alpha helical but form beta sheets. Cell 72, 587-594.

      Yuan M, Ngou BPM, Ding P, et al. 2021. PTI-ETI crosstalk: an integrative view of plant immunity. Curr Opin Plant Biol 62, 102030.

      Yue J, Sun H, Zhang W, et al. 2015. Wheat homologs of yeast ATG6 function in autophagy and are implicated in powdery mildew immunity. BMC Plant Biol 15, 95.

      Zavaliev R, Mohan R, Chen T, et al. 2020. Formation of NPR1 Condensates Promotes Cell Survival during the Plant Immune Response. Cell 182, 1093-1108 e1018.

    1. Irgendwann kam der Punkt, Ausgangssperre, 3G Regel, Spielplatze abgesperrt, Schulen komplett geschlossen, da gingen die Eingriffe einfach im Verhältnis zur Realität einfach zu weit. uuh ein normie... die "eingriffe" gingen seit tag 1 zu weit, weil der ganze covid hoax von anfang an eine controlled demolition war wie 9/11. wer das nicht von anfang an durchschaut hat, der sollte bei "großen" themen wie politik nicht mitreden dürfen, also kein wahlrecht haben. kein wahlrecht für vollidioten. aber nee, ihr spastis wollt ja "demokratie" haben, und mit euerer dummheit alle anderen mit runter in die hölle ziehen...

      quote:

      Hello, You have been banned from participating in r/DePi for 7 days because your comment violates this community's rules. You won't be able to post or comment, but you can still view and subscribe to it.

      Note from the moderators:

      Für Verschwörungstheorien gibt es bessere Orte als diesen.

      If you have a question regarding your ban, you can contact the moderator team by replying to this message.

      Reminder from the Reddit staff: If you use another account to circumvent this subreddit ban, that will be considered a violation of the Content Policy and can result in your account being suspended from the site as a whole.

    1. Author response:

      Reviewer #1 (Public Review):  

      Weaknesses:  

      The weakness of this study lies in the fact that many of the genomic datasets originated from novel methods that were not validated with orthogonal approaches, such as DNA-FISH. Therefore, the detailed correlations described in this work are based on methodologies whose efficacy is not clearly established. Specifically, the authors utilized two modified protocols of TSA-seq for the detection of NADs (MKI67IP TSA-seq) and LADs (LMNB1-TSA-seq). Although these methods have been described in a bioRxiv manuscript by Kumar et al., they have not yet been published. Moreover, and surprisingly, Kumar et al., work is not cited in the current manuscript, despite its use of all TSA-seq data for NADs and LADs across the four cell lines. Moreover, Kumar et al. did not provide any DNA-FISH validation for their methods. Therefore, the interesting correlations described in this work are not based on robust technologies.    

      An attempt to validate the data was made for SON-TSA-seq of human foreskin fibroblasts (HFF) using multiplexed FISH data from IMR90 fibroblasts (from the lung) by the Zhuang lab (Su et al., 2020). However, the comparability of these datasets is questionable. It might have been more reasonable for the authors to conduct their analyses in IMR90 cells, thereby allowing them to utilize MERFISH data for validating the TSA-seq method and also for mapping NADs and LADs. 

      We disagree with the statement that the TSA-seq approach and data has not been validated by orthogonal approaches and with the conclusion that the TSA-seq approach is not robust as summarized here and detailed below in “Specific Comments”.  TSA-seq is robust because it is based only on the original immunostaining specificity provided by the primary and secondary antibodies plus the diffusion properties of the tyramide-free radical. TSA-seq has been extensively validated by microscopy and by the orthogonal genomic measurements provided by LMNB1 DamID and NAD-seq.  This includes: a) the initial validation by FISH of both nuclear speckle (to an accuracy of ~50 nm) and nuclear lamina TSA-seq  and the cross-validation of nuclear lamina TSA-seq with lamin B1 DamID in a first publication (Chen et al, JCB 2018, doi: 10.1083/jcb.201807108); b) the further validation of SON TSA-seq by FISH in a second publication ((Zhang et al, Genome Research 2021, doi:10.1101/gr.266239.120); c) the cross-validation of nucleolar TSA-seq using NAD-seq and the validation by light microscopy of the predictions of differences in the relative distributions of centromeres, nuclear speckles, and nucleoli made from nuclear speckle, nucleolar, and pericentric heterochromatin TSA-seq in the Kumar et al, bioRxiv preprint (which is in a last revision stage involving additional formatting for the journal requirements) doi:https://doi.org/10.1101/2023.10.29.564613; d) the extensive validation of nuclear speckle, LMNB1, and nucleolar TSA-seq generated in HFF human fibroblasts using published light microscopy distance measurements of hundreds of probes generated by multiplexed immuno-FISH MERFISH data (Su et al, Cell 2020, https://doi.org/10.1016/j.cell.2020.07.032), as we described for nucleolar TSA-seq in the Kumar et al, bioRxiv preprint and to some extent for LMNB1 and SON TSA-seq in the current manuscript version (see Specific Comments with attached Author response image 2).

      Reviewer 1 raised concerns regarding this FISH validation given that the HFF TSA-seq and DamID data was compared to IMR90 MERFISH measurements.  The Su et al, Cell 2020 MERFISH paper came out well after the 4D Nucleome Consortium settled on HFF as one of the two main “Tier 1” cell lines.  We reasoned that the nuclear genome organization in a second fibroblast cell line would be sufficiently similar to justify using IMR90 FISH data as a proxy for our analysis of our HFF data. Indeed, there is a high correlation between the HFF TSA-seq and distances measured by MERFISH to nuclear lamina, nucleoli, and nuclear speckles (Author response image 1).  Comparing HFF SON-TSA-seq data with published IMR90 SON TSA-seq data (Alexander et al, Mol Cell 2021, doi.org/10.1016/j.molcel.2021.03.006), the HFF SON TSA-seq versus MERFISH scatterplot is very similar to the IMR90 SON TSA-seq versus MERFISH scatterplot.  We acknowledge the validation provided by the IMR90 MERFISH is limited by the degree to which genome organization relative to nuclear locales is similar in IMR90 and HFF fibroblasts. However, the correlation between measured microscopic distances from nuclear lamina, nucleoli, and nuclear speckles and TSA-seq scores is already quite high. We anticipate the conclusions drawn from such comparisons are solid and will only become that much stronger with future comparisons within the same cell line.

      Author response image 1.

      Scatterplots showing the correlation between TSA-seq and MERFISH microscopic distances. Top: IMR90 SON TSA-seq (from Alexander et al, Mol Cell 2021) (left) and HFF SON TSA-seq (right) (x-axis) versus distance to nuclear speckles (y-axis). Bottom: HFF Lamin B1 TSA-seq (x-axis) versus distance to nuclear lamina (y-axis) (left) and HFF MKI67IP (nucleolar) TSA-seq (x-axis) versus distance to nucleolus (y-axis) (right).

      In our revision, we will add justification of the use of IMR90 fibroblasts as a proxy for HFF fibroblasts through comparison of available data sets. 

      Reviewer #2 (Public Review):  

      Weaknesses:  

      The experiments are largely descriptive, and it is difficult to draw many cause-and-effect relationships. Similarly, the paper would be very much strengthened if the authors provided additional summary statements and interpretation of their results (especially for those not as familiar with 3D genome organization). The study would benefit from a clear and specific hypothesis.

      We acknowledge that this study was hypothesis-generating rather than hypothesis-testing in its goal. This research was funded through the NIH 4D-Nucleome Consortium, which had as its initial goal the development, benchmarking, and validation of new genomic technologies.  Our Center focused on the mapping of the genome relative to different nuclear locales and the correlation of this intranuclear positioning of the genome with functions- specifically gene expression and DNA replication timing. By its very nature, this project has taken a discovery-driven versus hypothesis-driven scientific approach.  Our question fundamentally was whether we could gain new insights into nuclear genome organization through the integration of genomic and microscopic measurements of chromosome positioning relative to multiple different nuclear compartments/bodies and their correlation with functional assays such as RNA-seq and Repli-seq.

      Indeed, as described in this manuscript, this study resulted in multiple new insights into nuclear genome organization as summarized in our last main figure.  We believe our work and conclusions will be of general interest to scientists working in the fields of 3D genome organization and nuclear cell biology.  We anticipate that each of these new insights will prompt future hypothesis-driven science focused on specific questions and the testing of cause-and-effect relationships. 

      Given the extensive scope of this manuscript, we were limited in the extent that we could describe and summarize the background, data, analysis, and significance for every new insight. In our editing to reach the eLife recommended word count, we removed some of the explanations and summaries that we had originally included. 

      As suggested by Reviewer 2, in our revision we will add back additional summary and interpretation statements to help readers unfamiliar with 3D genome organization.

      Specific Comments in response to Reviewer 1:

      (1)  We disagree with the comment that TSA-seq has not been cross-validated by other orthogonal genomic methods.  In the first TSA-seq paper (Chen et al, JCB 2018, doi: 10.1083/jcb.201807108), we showed a good correlation between the identification of iLADs and LADs by nuclear lamin and nuclear speckle TSA-seq and the orthogonal genomic method of lamin B1 DamID, which is reproduced using our new TSA-seq 2.0 protocol in this manuscript.  Similarly, in the Kumar et al, bioRxiv preprint (doi:https://doi.org/10.1101/2023.10.29.564613), we showed a general agreement between the identification of NADs by nucleolar TSA-seq and the orthogonal genomic method of NAD-seq.  (We expect this preprint to be in press soon; it is now undergoing a last revision involving only reformatting for journal requirements.) Additionally, we also showed a high correlation between Hi-C compartments and subcompartments and TSA-seq in the Chen et al, JCB 2018 paper. Specifically, there is an excellent correlation between the A1 Hi-C subcompartment and Speckle Associated Domains as detected by nuclear speckle TSA-seq.  Additionally, the A2 Hi-C subcompartment correlated well with iLAD regions with intermediate nuclear speckle TSA-seq scores, and the B2 and B3 Hi-C subcompartments with LADs detected by both LMNB TSA-seq and LMNB1 DamID.  More generally, Hi-C A and B compartment identity correlated well with predictions of iLADs versus LADs from nuclear speckle and nuclear lamina TSA-seq.

      (2)  In the Chen et al, JCB 2018 paper we also qualitatively and quantitatively validated TSA-seq using FISH.  Qualitatively, we showed that both nuclear speckle and nuclear lamin TSA-seq correlated well with distances to nuclear speckles versus the nuclear lamina, respectively, measured by immuno-FISH.

      Quantitatively, we showed that SON TSA-seq could be used to estimate the microscopic mean distance to nuclear speckles with mean and median residuals of ~50 nm.  First, we used light microscopy to show that the spreading of tyramide-biotin signal from a point-source of TSA staining fits well with the exponential decay predicted theoretically by reaction-diffusion equations assuming a steady rate of tyramide-biotin free radical generation by the HRP enzyme and a constant probability throughout the nucleus of free-radical quenching (through reaction with protein tyrosine residues and nucleic acids).  Second, we used the exponential decay constant measured by light microscopy together with FISH measurements of mean speckle distance for several genomic regions to fit an exponential function and to predict distance to nuclear speckles genome-wide directly from SON TSA-seq sequencing reads.  Third, we used this approach to test the predictions against a new set of FISH measurements, demonstrating an accuracy of these predictions of ~50 nm.

      (3)  The importance of the quantitative validation by immuno-FISH of using TSA-seq to estimate mean distance to nuclear speckles is that it demonstrates the robustness of the TSA-seq approach.  Specifically, it shows how the TSA-seq signal is predicted to depend only on the specificity of the primary and secondary antibody staining and the diffusion properties of the tyramide-biotin free radicals produced by the HRP peroxidase.  This is fundamentally different from the significant dependence on antibodies and choice of marker proteins for molecular proximity assays such as DamID, ChIP-seq, and Cut and Run/Tag which depend on molecular proximity for labeling and/or pulldown of DNA.

      This robustness leads to specific predictions.  First, it predicts similar TSA-seq signals will be produced using antibodies against different marker proteins against the same nuclear compartment.  This is because the exponential decay constant (distance at which the signal drops by one half) for the spreading of the TSA is in the range of several hundred nm, as measured by light microscopy for several TSA staining conditions.  Indeed, we showed in the Chen et al, JCB 2018 paper that antibodies against two different nuclear speckle proteins produced very similar TSA-seq signals while antibodies against LMNB versus LMNA also produced very similar TSA-seq signals.  Similarly, we showed in the Kumar et al preprint that antibodies against four different nucleolar proteins showed similar TSA-seq signals, with the highest correlation coefficients for the TSA-seq signals produced by the antibodies against two GC nucleolar marker proteins and the TSA-seq signals produced by the antibodies against two FC/DFC nucleolar marker proteins.

      Author response image 2.

      Comparison of TSA-seq data from different cell lines versus IMR90 MERFISH.  The observed correlation between SON (nuclear speckle) TSA-seq versus MERFISH is nearly as high for TSA-seq data from HFF as it is for TSA-seq data from the IMR90 cell line (Alexander et al, Mol Cell 2021) in which the MERFISH was performed. The correlations for SON, LMNB1 (nuclear lamina) and MKI67IP (nucleolus) versus MERFISH are highest for HFF TSA-seq data as compared to TSA-seq data from other cell lines (H1, K562, HCT116).  Comparison of measured distances to nuclear locale (y-axis) versus TSA-seq scores (x-axis) from different cell lines labeled in red. Left to right: SON, LMNB1, and MKI67IP.  Top to bottom: SON TSA-seq versus MERFISH for two TSA-seq replicates; TSA-seq from HFF, H1, K562, and HCT116 versus MERFISH.

      Second, it predicts that the quantitative relationship between TSA-seq signal and mean distance from a nuclear compartment will depend on the convolution of the predicted exponential decay of spreading of the TSA signal produced by a point source with the more complicated staining distribution of nuclear compartments such as the nuclear lamina or nucleoli.  We successfully used this concept to explain the differences emerging between LMNB1 DamID and TSA-seq signals for flat nuclei and to recognize the polarized distribution of different LADs over the nuclear periphery.

      (4)  After our genomic data production and during our data analysis, a valuable resource from the Zhuang lab was published, using MERFISH to visualize hundreds of genomic loci in IMR90 cells. We acknowledge that the much more extensive validation of TSA-seq by the multiplexed immuno-FISH MERFISH data is dependent on the degree to which the nuclear genome organization is similar between IMR90 and HFF fibroblasts.  However, the correlation between distances to nuclear speckles, nucleoli, and the nuclear lamina measured in IMR90 fibroblasts and the nuclear speckle, nucleolar, and nuclear lamina TSA-seq measured in HFF fibroblasts is already striking (See Author response image 1).  With regard to SON TSA-seq, the MERFISH versus HFF TSA-seq correlation is close to what we observe using published IMR90 SON TSA-seq data (correlation coefficients of 0.89 (IMR90 TSA-seq) versus 0.86 (HFF TSA-seq).  Moreover, this correlation is highest using TSA-seq data from HFF cells as compared to the three other cell lines. (see Author response image 2).  We believe these correlations can be considered a lower bound on the actual correlations between the FISH distances and TSA-seq that we would have observed if we had performed both assays on the same cell line. 

      (5)  Currently, we still require tens of millions of cells to perform each TSA-seq assay.  This requires significant expansion of cells and a resulting increase in passage numbers of the IMR90 cells before we can perform the TSA-seq. During this expansion we observe a noticeable slowing of the IMR90 cell growth as expected for secondary cell lines as we approach the Hayflick limit.  We still do not know to what degree nuclear organization relative to nuclear locales may change as a function of cell cycle composition (ie percentage of cycling versus quiescent cells) and cell age.  Thus, even if we performed TSA-seq on IMR90 cells we would be comparing MERFISH from lower passages with a higher percentage of actively proliferating cells with TSA-seq from higher passages with a higher percentage of quiescent cells. 

      We are currently working on a new TSA-seq protocol that will work with thousands of cells.  We believe it is better investment of time and resources to wait until this new protocol is optimized before we repeat TSA-seq in IMR90 cells for a better comparison with multiplexed FISH data. 

      Specific Comments in response to Reviewer 2:

      (1)  As we acknowledge in our Response summary, we were limited in the degree to which we could actually follow-up our findings with experiments designed to test specific hypotheses generated by our data.  However, we do want to point out that our comparison of wild-type K562 cells with the LMNA/LBR double knockout was designed to test the long-standing model that nuclear lamina association of genomic loci contributes to gene silencing.  This experiment was motivated by our surprising result that gene expression differences between cell lines correlated strongly with differences in positioning relative to nuclear speckles rather than the nuclear lamina.  Despite documenting in these double knockout cells a decreased nuclear lamina association of most LADs, and an increased nuclear lamina association of the “p-w-v” fiLADs identified in this manuscript, we saw no significant change in gene expression in any of these regions as compared to wild-type K562 cells.  Meanwhile, distances to nuclear speckles as measured by TSA-seq remained nearly constant.

      We would argue that this represents a specific example in which new insights generated by our genomics comparison of cell lines led to a clear and specific hypothesis and the experimental testing of this hypothesis.

      In response to Reviewer 2, we are modifying the text to make this clearer and to explicitly describe how we were testing the hypothesis that distance to nuclear lamina is correlated with but not causally linked to gene expression and how to test this hypothesis we used a DKO of LMNA and LBR to change distances relative to the nuclear lamina and to test the effect on gene expression.

    1. Reviewer #2 (Public Review):

      Summary:

      In this study, Liu et al. explore the interplay between G-quadruplexes (G4s) and R-loops. The authors developed novel techniques, HepG4-seq and HBD-seq, to capture and map these nucleic acid structures genome-wide in human HEK293 cells and mouse embryonic stem cells (mESCs). They identified dynamic, cell-type-specific distributions of co-localized G4s and R-loops, which predominantly localize at active promoters and enhancers of transcriptionally active genes. Furthermore, they assessed the role of helicase Dhx9 in regulating these structures and their impact on gene expression and cellular functions.

      The manuscript provides a detailed catalogue of the genome-wide distribution of G4s and R-loops. However, the conceptual advance and the physiological relevance of the findings are not obvious. Overall, the impact of the work on the field is limited to the utility of the presented methods and datasets.

      Strengths:

      (1) The development and optimization of HepG4-seq and HBD-seq offer novel methods to map native G4s and R-loops.

      (2) The study provides extensive data on the distribution of G4s and R-loops, highlighting their co-localization in human and mouse cells.

      (3) The study consolidates the role of Dhx9 in modulating these structures and explores its impact on mESC self-renewal and differentiation.

      Weaknesses:

      (1) The specificity of the biotinylation process and potential off-target effects are not addressed. The authors should provide more data to validate the specificity of the G4-hemin.

      (2) Other methods exploring a catalytic dead RNAseH or the HBD to pull down R-loops have been described before. The superior quality of the presented methods in comparison to existing ones is not established. A clear comparison with other methods (BG4 CUT&Tag-seq, DRIP-seq, R-CHIP, etc) should be provided.

      (3) Although the study demonstrates Dhx9's role in regulating co-localized G4s and R-loops, additional functional experiments (e.g., rescue experiments) are needed to confirm these findings.

      (4) The manuscript would benefit from a more detailed discussion of the broader implications of co-localized G4s and R-loops.

      (5) The manuscript lacks appropriate statistical analyses to support the major conclusions.

      (6) The discussion could be expanded to address potential limitations and alternative explanations for the results.

    2. Reviewer #3 (Public Review):

      Summary:

      The authors developed and optimized the methods for detecting G4s and R-loops independent of BG4 and S9.6 antibody, and mapped genomic native G4s and R-loops by HepG4-seq and HBD-seq, revealing that co-localized G4s and R-loops participate in regulating transcription and affecting the self-renewal and differentiation capabilities of mESCs.

      Strengths:

      By utilizing the peroxidase activity of G4-hemin complex and combining proximity labeling technology, the authors developed HepG4-seq (high throughput sequencing of hemin-induced proximal labelled G4s) , which can detect the dynamics of G4s in vivo. Meanwhile, the "GST-His6-2xHBD"-mediated CUT&Tag protocol (Wang et al., 2021) was optimized by replacing fusion protein and tag, the optimized HBD-seq avoids the generation of GST fusion protein aggregates and can reflect the genome-wide distribution of R-loops in vivo.

      The authors employed HepG4-seq and HBD-seq to establish comprehensive maps of native co-localized G4s and R-loops in human HEK293 cells and mouse embryonic stem cells (mESCs). The data indicate that co-localized G4s and R-loops are dynamically altered in a cell type-dependent manner and are largely localized at active promoters and enhancers of transcriptionally active genes.

      Combined with Dhx9 ChIP-seq and co-localized G4s and R-loops data in wild-type and dhx9KO mESCs, the authors confirm that the helicase Dhx9 is a direct and major regulator that regulates the formation and resolution of co-localized G4s and R-loops.

      Depletion of Dhx9 impaired the self-renewal and differentiation capacities of mESCs by altering the transcription of co-localized G4s and R-loops-associated genes.

      In conclusion, the authors provide an approach to studying the interplay between G4s and R-loops, shedding light on the important roles of co-localized G4s and R-loops in development and disease by regulating the transcription of related genes.

      Weaknesses:

      As we know, there are at least two structure data of S9.6 antibody very recently, and the questions about the specificity of the S9.6 antibody on RNA:DNA hybrids should be finished. The authors referred to (Hartono et al., 2018; Konig et al., 2017; Phillips et al., 2013) need to be updated, and the authors' bias against S9.6 antibodies needs also to be changed. However, as the authors had questioned the specificity of the S9.6 antibody, they should compare it in parallel with the data they have and the data generated by the widely used S9.6 antibody.

      Although HepG4-seq is an effective G4s detection technique, and the authors have also verified its reliability to some extent, given the strong link between ROS homeostasis and G4s formation, and hemin's affinity for different types of G4s, whether HepG4-seq reflects the dynamics of G4s in vivo more accurately than existing detection techniques still needs to be more carefully corroborated.

    3. Author response:

      eLife assessment

      This useful study describes an antibody-free method to map G-quadruplexes (G4s) in vertebrate cells. While the method might have potential, the current analysis is primarily descriptive and does not add substantial new insights beyond existing data (e.g., PMID:34792172). While the datasets provided might constitute a good starting point for future functional studies, additional data and analyses would be needed to fully support the major conclusions and, at the same time, clarify the advantage of this method over other methods. Specifically, the strength of the evidence for DHX9 interfering with the ability of mESCs to differentiate by regulating directly the stability of either G4s or R-loops is still incomplete.

      We thank the editors for their helpful comments.

      Given that antibody-based methods have been reported to leave open the possibility of recognizing partially folded G4s and promoting their folding, we have employed the peroxidase activity of the G4-hemin complex to develop a new method for capturing endogenous G4s that significantly reduces the risk of capturing partially folded G4s. We will be happy to clarify the advantage of our method.

      In the Fig. 7, we applied the Dhx9 CUT&Tag assay to identify the G4s and R-loops directly bound by Dhx9 and further characterized the differential Dhx9-bound G4s and R-loops in the absence of Dhx9. Dhx9 is a versatile helicase capable of directly resolving R-loops and G4s or promoting R-loop formation (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). Furthermore, we showed that depletion of Dhx9 significantly altered the levels of G4s or R-loops around the TSS or gene bodies of several key regulators of mESC and embryonic development, such as Nanog, Lin28a, Bmp4, Wnt8a, Gata2, and Lef1, and also their RNA levels (Fig.7 I). The above evidence is sufficient to support the transcriptional regulation of mESCs cell fate by directly modulating the G4s or R-loops within the key regulators of mESCs.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Non-B DNA structures such as G4s and R-loops have the potential to impact genome stability, gene transcription, and cell differentiation. This study investigates the distribution of G4s and R-loops in human and mouse cells using some interesting technical modifications of existing Tn5-based approaches. This work confirms that the helicase DHX9 could regulate the formation and/or stability of both structures in mouse embryonic stem cells (mESCs). It also provides evidence that the lack of DHX9 in mESCs interferes with their ability to differentiate.

      Strengths:

      HepG4-seq, the new antibody-free strategy to map G4s based on the ability of Hemin to act as a peroxidase when complexed to G4s, is interesting. This study also provides more evidence that the distribution pattern of G4s and R-loops might vary substantially from one cell type to another.

      We appreciate your valuable points.

      Weaknesses:

      This study is essentially descriptive and does not provide conclusive evidence that lack of DHX9 does interfere with the ability of mESCs to differentiate by regulating directly the stability of either G4 or R-loops. In the end, it does not substantially improve our understanding of DHX9's mode of action.

      In this study, we aimed to report new methods for capturing endogenous G4s and R-loops in living cells. Dhx9 has been reported to directly unwind R-loops and G4s or promote R-loop formation (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). To understand the direct Dhx9-bound G4s and R-loops, we performed the Dhx9 CUT&Tag assay and analyzed the co-localization of Dhx9-binding sites and G4s or R-loops. We found that 47,857 co-localized G4s and R-loops are directly bound by Dhx9 in the wild-type mESCs and 4,060 of them display significantly differential signals in absence of Dhx9, suggesting that redundant regulators exist as well. We showed that depletion of Dhx9 significantly altered the RNA levels of several key regulators of mESC and embryonic development, such as Nanog, Lin28a, Bmp4, Wnt8a, Gata2, and Lef1, which coincides with the significantly differential levels of G4s or R-loops around the TSS or gene bodies of these genes (Fig.7). The comprehensive molecular mechanism of Dhx9 action is indeed not the focus of this study. We will work on it in the future studies. Thank you for the comments.

      There is no in-depth comparison of the newly generated data with existing datasets and no rigorous control was presented to test the specificity of the hemin-G4 interaction (a lot of the hemin-dependent signal seems to occur in the cytoplasm, which is unexpected).

      The specificity of hemin-G4-induced peroxidase activity and self-biotinylation has been well demonstrated in previous studies (PMID: 19618960, 22106035, 28973477, 32329781). In the Fig.1A, we compared the hemin-G4-induced biotinylation levels in different conditions. Cells treated with hemin and Bio-An exhibited a robust fluorescence signal, while the absence of either hemin or Bio-An almost completely abolished the biotinylation signals, suggesting a specific and active biotinylation activity. To identify the specific signals, we have included the non-label control and used this control to call confident HepG4 peaks in all HepG4-seq assays.

      The hemin-RNA G4 complex has also been reported to have mimic peroxidase activity and trigger similar self-biotinylation signals as DNA G4s (PMID: 32329781, 31257395, 27422869). Therefore, it is not surprising to observe hemin-dependent signals in the cytoplasm generated by cytoplasmic RNA G4s.

      In the revised version, we will include careful comparison between our data and previous datasets.

      The authors talk about co-occurrence between G4 and R-loops but their data does not actually demonstrate co-occurrence in time. If the same loci could form alternatively either R-loops or G4 and if DHX9 was somehow involved in determining the balance between G4s and R-loops, the authors would probably obtain the same distribution pattern. To manipulate R-loop levels in vivo and test how this affects HEPG4-seq signals would have been helpful.

      Single-molecule fluorescence studies have shown the existence of a positive feedback mechanism of G4 and R-loop formation during transcription (PMID: 32810236, 32636376), suggesting that G4s and Rloops could co-localize at the same molecule. Dhx9 is a versatile helicase capable of directly resolving R-loops and G4s or promoting R-loop formation (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). Although depletion of Dhx9 resulted in 6,171 Dhx9-bound co-localized G4s and R-loops with significantly altered levels of G4s or R-loops, only 276 of them (~4.5%) harbored altered G4s and R-loops, suggesting that the interacting G4s and R-loops are rare in living cells. Nowadays, the genome-wide co-occurrence of two factors are mainly obtained by bioinformatically intersection analysis. We agreed that the heterogenous distribution between cells will give false positive co-occurrence patterns. We will carefully discuss this point in the revised version. At the same time, we will make efforts to develop a new method to map the co-localized G4 and R-loop in the same molecule in the future study.

      This study relies exclusively on Tn5-based mapping strategies. This is a problem as global changes in DNA accessibility might strongly skew the results. It is unclear at this stage whether the lack of DHX9, BLM, or WRN has an impact on DNA accessibility, which might underlie the differences that were observed. Moreover, Tn5 cleaves DNA at a nearby accessible site, which might be at an unknown distance away from the site of interest. The spatial accuracy of Tn5-based methods is therefore debatable, which is a problem when trying to demonstrate spatial co-occurrence. Alternative mapping methods would have been helpful.

      In this study, we used the recombinant streptavidin monomer and anti-GP41 nanobody fusion protein (mSA-scFv) to specifically recognize hemin-G4-induced biotinylated G4 and then recruit the recombinant GP41-tagged Tn5 protein to these G4s sites. Similarly, the recombinant V5-tagged N-terminal hybrid-binding domain (HBD) of RNase H1 specifically recognizes R-loops and recruit the recombinant protein G-Tn5 (pG-Tn5) with the help of anti-V5 antibody. Therefore, the spatial distance of Tn5 to the target sites is well controlled and very short, and also the recruitment of Tn5 is specifically determined by the existence of G4s in HepG4-seq and R-loops in HBD-seq.

      Reviewer #2 (Public Review):

      Summary:

      In this study, Liu et al. explore the interplay between G-quadruplexes (G4s) and R-loops. The authors developed novel techniques, HepG4-seq and HBD-seq, to capture and map these nucleic acid structures genome-wide in human HEK293 cells and mouse embryonic stem cells (mESCs). They identified dynamic, cell-type-specific distributions of co-localized G4s and R-loops, which predominantly localize at active promoters and enhancers of transcriptionally active genes. Furthermore, they assessed the role of helicase Dhx9 in regulating these structures and their impact on gene expression and cellular functions.

      The manuscript provides a detailed catalogue of the genome-wide distribution of G4s and R-loops. However, the conceptual advance and the physiological relevance of the findings are not obvious. Overall, the impact of the work on the field is limited to the utility of the presented methods and datasets.

      Strengths:

      (1) The development and optimization of HepG4-seq and HBD-seq offer novel methods to map native G4s and R-loops.

      (2) The study provides extensive data on the distribution of G4s and R-loops, highlighting their co-localization in human and mouse cells.

      (3) The study consolidates the role of Dhx9 in modulating these structures and explores its impact on mESC self-renewal and differentiation.

      We appreciate your valuable points.

      Weaknesses:

      (1) The specificity of the biotinylation process and potential off-target effects are not addressed. The authors should provide more data to validate the specificity of the G4-hemin.

      The specificity of hemin-G4-induced peroxidase activity and self-biotinylation has been well demonstrated in previous studies (PMID: 19618960, 22106035, 28973477, 32329781). In the Fig.1A, we compared the hemin-G4-induced biotinylation levels in different conditions. Cells treated with hemin and Bio-An exhibited a robust fluorescence signal, while the absence of either hemin or Bio-An almost completely abolished the biotinylation signals, suggesting a specific and active biotinylation activity.

      (2) Other methods exploring a catalytic dead RNAseH or the HBD to pull down R-loops have been described before. The superior quality of the presented methods in comparison to existing ones is not established. A clear comparison with other methods (BG4 CUT&Tag-seq, DRIP-seq, R-CHIP, etc) should be provided.

      Thank you for the suggestions. We will include the comparisons in the revised version.

      (3) Although the study demonstrates Dhx9's role in regulating co-localized G4s and R-loops, additional functional experiments (e.g., rescue experiments) are needed to confirm these findings.

      Dhx9 has been demonstrate as a versatile helicase capable of directly resolving R-loops and G4s or promoting R-loop formation in previous studies (PMID: 21561811, 30341290, 29742442, 32541651, 35905379, 34316718). We believe that the current new dataset and previous studies are enough to support the capability of Dhx9 in regulating co-localized G4s and R-loops.

      (4) The manuscript would benefit from a more detailed discussion of the broader implications of co-localized G4s and R-loops.

      Thank you for the suggestions. We will include a more detailed discussion in the revised version.

      (5) The manuscript lacks appropriate statistical analyses to support the major conclusions.

      We apologized for this point. Whereas we have applied careful statistical analyses in this study, lacking of some statistical details make people hard to understand some conclusions. We will carefully add details of all statistical analysis.

      (6) The discussion could be expanded to address potential limitations and alternative explanations for the results.

      Thank you for the suggestions. We will include a more detailed discussion about this point in the revised version.

      Reviewer #3 (Public Review):

      Summary:

      The authors developed and optimized the methods for detecting G4s and R-loops independent of BG4 and S9.6 antibody, and mapped genomic native G4s and R-loops by HepG4-seq and HBD-seq, revealing that co-localized G4s and R-loops participate in regulating transcription and affecting the self-renewal and differentiation capabilities of mESCs.

      Strengths:

      By utilizing the peroxidase activity of G4-hemin complex and combining proximity labeling technology, the authors developed HepG4-seq (high throughput sequencing of hemin-induced proximal labelled G4s), which can detect the dynamics of G4s in vivo. Meanwhile, the "GST-His6-2xHBD"-mediated CUT&Tag protocol (Wang et al., 2021) was optimized by replacing fusion protein and tag, the optimized HBD-seq avoids the generation of GST fusion protein aggregates and can reflect the genome-wide distribution of R-loops in vivo.

      The authors employed HepG4-seq and HBD-seq to establish comprehensive maps of native co-localized G4s and R-loops in human HEK293 cells and mouse embryonic stem cells (mESCs). The data indicate that co-localized G4s and R-loops are dynamically altered in a cell type-dependent manner and are largely localized at active promoters and enhancers of transcriptionally active genes.

      Combined with Dhx9 ChIP-seq and co-localized G4s and R-loops data in wild-type and dhx9KO mESCs, the authors confirm that the helicase Dhx9 is a direct and major regulator that regulates the formation and resolution of co-localized G4s and R-loops.

      Depletion of Dhx9 impaired the self-renewal and differentiation capacities of mESCs by altering the transcription of co-localized G4s and R-loops-associated genes.

      In conclusion, the authors provide an approach to studying the interplay between G4s and R-loops, shedding light on the important roles of co-localized G4s and R-loops in development and disease by regulating the transcription of related genes.

      We appreciate your valuable points.

      Weaknesses:

      As we know, there are at least two structure data of S9.6 antibody very recently, and the questions about the specificity of the S9.6 antibody on RNA:DNA hybrids should be finished. The authors referred to (Hartono et al., 2018; Konig et al., 2017; Phillips et al., 2013) need to be updated, and the authors' bias against S9.6 antibodies needs also to be changed. However, as the authors had questioned the specificity of the S9.6 antibody, they should compare it in parallel with the data they have and the data generated by the widely used S9.6 antibody.

      Thank you for the updating information about the structure data of S9.6 antibody. We politely disagree the specificity of the S9.6 antibody on RNA:DNA hybrids. The structural studies of S9.6 (PMID: 35347133, 35550870) used only one RNA:DNA hybrid to show the superior specificity of S9.6 on RNA:DNA hybrid than dsRNA and dsDNA. However, Fabian K. et al has reported that the binding affinities of S9.6 on RNA:DNA hybrid exhibits obvious sequence-dependent bias from null to nanomolar range (PMID: 28594954). We will include the comparison between S9.6-derived data and our HBD-seq data in the revised version.

      Although HepG4-seq is an effective G4s detection technique, and the authors have also verified its reliability to some extent, given the strong link between ROS homeostasis and G4s formation, and hemin's affinity for different types of G4s, whether HepG4-seq reflects the dynamics of G4s in vivo more accurately than existing detection techniques still needs to be more carefully corroborated.

      Thank you for pointing out this issue. In the in vitro hemin-G4 induced self-biotinylation assay, parallel G4s exhibit higher peroxidase activities than anti-parallel G4s. Thus, the dynamics of G4 conformation could affect the HepG4-seq signals (PMID: 32329781). In the future, people may need to combine HepG4-seq and BG4s-eq to carefully explain the endogenous G4s. We will carefully discuss this point in the revised version.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      This paper by Beath et. al. identifies a potential regulatory role for proteins involved in cytoplasmic streaming and maintaining the grouping of paternal organelles: holding sperm contents in the fertilized embryos away from the oocyte meiotic spindle so that they don't get ejected into the polar body during meiotic chromosome segregation. The authors show that by time-lapse video, paternal mitochondria (used as a readout for sperm and its genome) is excluded from yolk granules and maternal mitochondria, even when moving long distances by cytoplasmic streaming. To understand how this exclusion is accomplished, they first show that it is independent of both internal packing and the engulfment of the paternal chromosomes by maternal endoplasmic reticulum creating an impermeable barrier. They then test whether the control of cytoplasmic steaming affects this exclusion by knocking down two microtubule motors, Katanin and kinesis I. They find that the ER ring, which is used as a proxy for paternal chromosomes, undergoes extensive displacement with these treatments during anaphase I and interacts with the meiotic spindle, supporting their hypothesis that the exclusion of paternal chromosomes is regulated by cytoplasmic streaming. Next, they test whether a regulator of maternal ER organization, ATX-2, disrupts sperm organization so that they can combine the double depletion of ATX-2 and KLP-7, presumably because klp-7 RNAi (unlike mei-1 RNAi) does not affect polar body extrusion and they can report on what happens to paternal chromosomes. They find that the knockdown of both ATX-2 and KLP-7 produces a higher incidence of what appears to be the capture of paternal chromosomes by the meiotic spindle (5/24 vs 1/25). However, this capture event appears to halt the cell cycle, preventing the authors from directly observing whether this would result in the paternal chromosomes being ejected into the polar body. 

      Strengths: 

      This is a useful, descriptive paper that highlights a potential challenge for embryos during fertilization: when fertilization results in the resumption of meiotic divisions, how are the paternal and maternal genomes kept apart so that the maternal genome can undergo chromosome segregation and polar body extrusion without endangering the paternal genome? In general, the experiments are well-executed and analyzed. In particular, the authors' use of multiple ways to knock down ATX-2 shows rigor. 

      Weaknesses: 

      The paper makes a case that this regulation may be important but the authors should do some additional work to make this case more convincing and accessible for those outside the field. In particular, some of the figures could include greater detail to support their conclusions, they could explain the rationale for some experiments better and they could perform some additional control experiments with their double depletion experiments to better support their interpretations. Also, the authors' inability to assess the functional biological consequences of the capture of the sperm genome by the oocyte spindle should be discussed, particularly in light of the cell cycle arrest that they observe. 

      These general comments are addressed in the more specific critiques below.

      Reviewer #2 (Public Review): 

      Summary 

      In this manuscript, Beath et al. use primarily C. elegans zygotes to test the overarching hypothesis that cytoplasmic mechanisms exit to prevent interaction between paternal chromosomes and the meiotic spindle, which are present in a shared zygotic cytoplasm after fertilization. Previous work, much of which by this group, had characterized cytoplasmic streaming in the zygote and the behavior of paternal components shortly after fertilization, primarily the clustering of paternal mitochondria and membranous organelles around the paternal chromosomes. This work set out to identify the molecular mechanisms responsible for that clustering and test the specific hypothesis that the "paternal cloud" helps prevent the association of paternal chromosomes with the meiotic spindle. 

      Strengths 

      This work is a collection of technical achievements. The data are primarily 3- and 4-channel time-lapse images of zygotes shortly after fertilization, which were performed inside intact animals. There are many instances in which the experiments show extreme technical skill, such as tracking the paternal chromosomes over large displacements throughout the volume of the embryo. The authors employ a wide variety of fluorescent reporters to provide a remarkably clear picture of what is going on in the zygote. These reagents and the novel characterization of these stages that they provide will be widely beneficial to the community. 

      The data provide direct visualization of what had previously been a mostly hypothetical structure, the "paternal cloud," using simultaneous labeling of paternal DNA and mitochondria in combination with a variety of maternal proteins including maternal mitochondria, yolk granules, tubulin, and plasma membrane. Together, these images provided convincing evidence of the existence of this specified cytoplasmic domain. They go on to show that the knockdown of the ataxin-2 homolog ALX-2, a protein previously shown to affect ER dynamics, disrupted the paternal cloud, identifying a role for ER organization in this structure. 

      The authors then used the system to test the functional consequences of perturbing the cytoplasmic organization. Consistent with the paternal cloud being a stable structure, it stayed intact during large movements the authors generated using previously published knockdowns (of mei-1/katanin and kinesin-13/kpl-7) that increased cytoplasmic streaming. They used this data to document instances in which the paternal chromosomes were likely to have been attached to the spindle. They concluded with direct evidence of spindle fibers connecting to the paternal chromatin upon knockdown of ATX-2 in combination with increased cytoplasmic streaming, providing strong, direct support for their overarching hypothesis. 

      Weaknesses 

      While the data is convincing, the narrative of the paper could be streamlined to highlight the novelty of the experiments and better articulate the aims. For example, the cloud of paternal mitochondria and membranous organelles was previously shown, but Figures 1-2 largely reiterate that observation. The innovation seems to be that the combination of ER, yolk, and maternal mitochondrial markers makes the existence of a specified domain more concrete. There are also some instances where more description is needed to make the conclusions from the images clear. 

      These general comments are addressed in the more specific critiques below.

      The manuscript intersperses what read like basic characterizations of fluorescent markers that, as written, can distract from the main story. The authors characterized the dynamics of ER organization throughout the substages of meiosis and the permeability of the envelope of ER that surrounds the paternal chromatin, but it could be more clearly established how the ability to visualize these structures allowed them to address their aims.

      We have added the following after the initial description of ER morphology changes: (ER morphology was used to determine cell-cycle stages during live imaging reported below in Fig. 6.)

      More background on what was previously known about ER organization in M-phase and the role of ataxin proteins specifically may help provide more continuity. 

      We have added references to transitions to ER sheets during mitotic M-phase in HeLa cells and Xenopus extracts.

      Reviewer #3 (Public Review): 

      Summary: 

      This study by Beath et al. investigated the mechanisms by which sperm DNA is excluded from the meiotic spindle after fertilization. Time-lapse imaging revealed that sperm DNA is surrounded by paternal mitochondria and maternal ER that is permeable to proteins. By increasing cytoplasmic streaming using kinesin-13 or katanin RNAi, the authors demonstrated that limiting cytoplasmic streaming in the embryo is an important step that prevents the capture of sperm DNA by the oocyte meiotic spindle. Further experiments showed that the Ataxin-2 protein is required to hold paternal mitochondria together and close to the sperm DNA. Finally, double depletion of kinesin-13 and Ataxin-2 suggested an increased risk of meiotic spindle capture of sperm DNA. 

      Overall, this is an interesting finding that could provide a new understanding of how meiotic spindle capture of sperm DNA and its accidental expulsion into the polar body is prevented. However, some conceptual gaps need to be addressed and further experiments and improved data analyses would strengthen the paper. 

      - It would be helpful if the authors could discuss in good detail how they think maternal ER surrounds the sperm DNA

      We have added 2 references to papers about nuclear envelope re-assembly from Shirin Bahmanyar’s lab and suggest the ER envelope is a halted intermediate in nuclear envelope reassembly.

      and why is it not disrupted following Ataxin disruption. 

      We have been attempting to disrupt ER structures in the meiotic embryo for the last 5 years by depleting profilin, BiP, atlastin, ATX-2 and by optogenetically packing ER into a ball in the middle of the oocyte.  None of these treatments prevent envelopment of the sperm DNA by maternal ER.  None of these treatments remove ER from the spindle envelope and none remove ER from the plasma membrane.  These treatments mostly result in “large aggregates” of ER that we have not examined by EM.  Wild speculation: any disruption of the ER strong enough to prevent ER envelopment around chromatin would be sterile because the M to S transition in the mitotic zone of the germline would be blocked.  Rapid depletion of ATX-2 to the extent shown by rigorous data in this manuscript does not prevent ER envelopment around chromatin.  We chose not to speculate about the reasons for this because we do not know why.

      - Since important phenotypes revealed in RNAi experiments (e.g. kinesin-13 and ataxin-2 double depletion) are not very robust, the authors should consider toning down their conclusions and revising some of their section headings. I appreciate that they are upfront about some limitations, but they do nonetheless make strong concluding sentences. 

      We have changed the discussion of the klp-7 atx-2 double depletion to: “The capture of the sperm DNA by the meiotic spindle in ATX-2 KLP-7 double depleted embryos suggests that the integrity of the exclusion zone around the sperm DNA might insulate the sperm DNA from spindle microtubules.  However, a much larger number of klp-7(RNAi) singly depleted and atx-2(degron) singly depleted time-lapse sequences are needed to rigorously support this idea. “

      - The discussion section could be improved further to present the authors' findings in the larger context of current knowledge in the field. 

      We have expanded the discussion as suggested.

      - The authors previously demonstrated that F-actin prevents meiotic spindle capture of sperm DNA in this system. However, the current manuscript does not discuss how the katanin, kinesin-13 and Ataxin-2 mechanisms could work together with previously established functions of F-actin in this process. 

      We have added pfn-1(RNAi) to the discussion section.

      - How can the authors exclude off-target effects in their RNAi depletion experiments? Can kinesin-13, katanin, and Ataxin phenotypes be rescued for instance? 

      For ataxin-2 phenotypes, two completely independent controls for off target effects are shown.  GFP(RNAi) on a strain with and endogenous ATX-2::GFP tag vs GFP(RNAi) on a strain with no tag on the ATX-2.  ATX-2::AID with or without auxin.  For kinesin-13 and katanin, we did not do a rigorous control for off-target effects of RNAi.  However, the effects of these depletions on cytoplasmic microtubules have been previously reported by others

      - How are the authors able to determine if the paternal genome was actually captured by the spindle? Does lack of movement definitively suggest capture without using a spindle marker? 

      mKate::tubulin labels the spindle in each capture event.  This can be seen in Video S3. for mei-1(RNAi) and Figure 9 for atx-2 klp-7 double depletions.

      (1) Major issues: 

      The images provided are not convincing that mitochondria are entirely excluded from the regions with yolk granules from the images provided. Please provide insets of magnified images of the paternal mitochondria in Figure 1E to more clearly show the exclusion even when paternal mitochondria are streaming. Providing grayscale images, individual z-sections and/or some quantification of this data might also be more convincing to this reviewer. 

      We have modified Fig. 1 by adding single wavelength magnified insets to more clearly show that paternal mitochondria are in a “black hole” in the maternal yolk granules during  cytoplasmic streaming.

      Figure 2 -This figure can be retitled to highlight that the paternal organelle cloud is impermeable to mitochondria and conserved. 

      The legend has been re-titled as suggested.

      Figure 3B, An image of the DNA within the ring of maternal ER especially since the maternal ER ring is used as a proxy for the paternal chromosomes in later figures would strengthen the authors' claims.

      We have added a panel showing DAPI-stained DNA in the center of the ER ring and paternal mitochondria cloud. 

      Why is the faster time scale imaging significant? I think this could be more clearly set up in the paper. Perhaps rapid imaging of maternal mito-labeled kca-1(RNAi) embryos would better show the difference in time scale, with the expectation that the paternal cloud forms and persists while the ER invades. 

      We are not sure what the reviewer means.  5 sec time intervals were used throughout the paper.  We are also not sure how kca-1(RNAi) would help.  Movement of the entire oocyte into and out of the spermatheca is what limits the ability to keep a fusing sperm in focus.  kca-1(RNAi) would prevent cytoplasmic streaming but not ovulation movements.

      Figure 4 - The question about the permeability of the ER envelope seems to come out of nowhere as written. It isn't clear how it contributes to the larger story about preventing sperm incorporation in the spindle.

      This section of the results is introduced with: “If the maternal ER envelope around sperm DNA was sealed and impermeable during meiosis, this could both prevent the sperm DNA from inducing ectopic spindle assembly and prevent the sperm DNA from interacting with meiotic spindle microtubules.” 

      The data in Figure 4 would probably not be expected to be in this paper based on the paper title. Maybe the title needs something about ER dynamics? "eg. ATX-2 but not an ER envelope" isolates the paternal chromatin? 

      In Figure 5, it seems that RNAi of klp-7 and Mei-1 had slightly different effects on short-axis displacement of the ER envelope (klp-7 affecting it more dramatically than mei-1) and slightly different effects on interaction with the meiotic spindle (capture vs streaming past the spindle). The authors mention in their discussion that the difference in the interaction with the meiotic spindle might reflect the effects that loss of Mei-1 may have on the spindle but could it also be a consequence of the differences in cytoplasmic streaming observed?

      With our current data, the only statistically significant difference between cytoplasmic streaming of the sperm contents in mei-1(RNAi) vs klp-7(RNAi) is that excessive streaming persists longer into metaphase II in klp-7(RNAi).  We have added a sentence describing this difference to the results.  If differences in streaming were the cause of different capture frequencies, then klp-7(RNAi) would cause more capture events than mei-1(RNAi) but the opposite was observed.  We have avoided too much discussion here because the frequency of capture events is too low to demonstrate statistically significant differences between mei-1(RNAi), klp-7(RNAi), and atx-2(degron) + klp-7(RNAi) without a very large increase in the number of time-lapse sequences.  

      Also, the authors should find a way to represent this interaction with the meiotic spindle in a quantitative or table form to allow the reader to observe some of the patterns they report more easily.

      We have added a table to Fig. 9 that summarizes capture data.

      Finally, can the authors report when they observe the closest association with the meiotic spindle: Does it correlate with the period of greatest displacement (AI) or are they unlinked? 

      The low frequency of capture events makes it difficult to test this rigorously.

      Figure 6- 'Endogenously tagged ATX-2 was observed throughout oocytes and meiotic embryos without partial co-localization with ER.' How can the authors exclude co-localization with ER? 

      We have changed the wording to: “Endogenously tagged ATX-2 was observed throughout oocytes and meiotic embryos (Fig. 6A; Fig. S2).  ATX-2 did not uniquely  co-localize with ER (Fig. S2).“

      The rationale for why the authors think that the integrity of sperm organelles is important to keep the genomes apart is not clear to this reviewer and needs to be explained better. Moving the discussion of the displacement experiments in Figure S3 from the end of the results section to the ATX-2 knockdown section would help accomplish this. 

      We have added the sentence: “The frequency of sperm capture by the meiotic spindle (Fig. 9D) was significantly higher than wild-type controls in klp-7(RNAi) atx-2(AID) double depleted embryos (p=0.011 Fisher’s exact test).   Although the number of single mutant embryos analyzed was too low to demonstrate a significant difference between single and double mutant embryos,  these results qualitatively support the hypothesis that limiting cytoplasmic streaming and maintaining the integrity of the ball of paternal mitochondria are both important for preventing capture events between the meiotic spindle and sperm DNA.”

      It looks like, in the double knockdown of ATX-2 and KLP-7, the spread of paternal mitochondria is less affected than when only ATX-2 is depleted. What effect does this result have on the observation that the incidence of sperm capture appears to increase in the double depletion? What does displacement of the ER ring look like in the double depletion? Is it additive, consistent with their interpretation that both limiting cytoplasmic streaming and maintaining the integrity of the ball of paternal mitochondria is required to keep the genomes separate? 

      We cannot show a significant difference between single a double knockdowns without increasing n by alot.  We did not analyze ER ring displacement in the double mutant.

      Is the increased incidence of capture in the double-depleted embryos significant? 

      We have added the sentence: “The frequency of sperm capture by the meiotic spindle (Fig. 9D) was significantly higher than wild-type controls in klp-7(RNAi) atx-2(AID) double depleted embryos (p=0.011 Fisher’s exact test).   Although the number of single mutant embryos analyzed was too low to demonstrate a significant difference between single and double mutant embryos,  these results qualitatively support the hypothesis that limiting cytoplasmic streaming and maintaining the integrity of the ball of paternal mitochondria are both important for preventing capture events between the meiotic spindle and sperm DNA.”

      What do the authors make of the cell cycle arrest observed when paternal chromosomes are captured? Is there an argument to be made that this arrest supports the idea that preventing this capture is actively regulated and therefore functionally important? 

      We chose not to discuss the mechanism of this arrest because considerably more work would be required to prove that it is not caused by a combination of imaging conditions and genotype.  The low frequency of these capture + arrest events would make it very difficult to show that the arrest does not occur after depleting a checkpoint protein.

      (2) Minor concerns: 

      Top of page 4: "streaming because depletion tubulin stops cytoplasmic streaming (7)" should be "streaming because depletion of tubulin stops cytoplasmic streaming (7)" 

      The ”of” has been inserted.

      Page 6: "This result indicated that the volume of paternal mitochondria excludes maternal mitochondria and yolk granules but not maternal ER." The authors have only shown this for maternal mitochondria, not yolk granules. 

      We have deleted the mention of yolk granules here.

      Page 7: "These results suggest that all maternal membranes are initially excluded from the sperm at fusion." Should be "These results show that maternal ER are initially excluded from the sperm at fusion. Since maternal mitochondria and yolk granules are excluded later, this suggests that all maternal membranes are initially excluded from the sperm at fusion." 

      We have changed this sentence as suggested.

      It's not clear why the authors show other types of movement that might be quantified when cytoplasmic streaming is affected in Figure 5A and only quantify long-axis and short-axis displacement. 

      We have deleted the other types of movement from the schematic.  Although these parameters were quantified, we did not include this data in the results so it would be confusing for the reader to have them in the schematic.

      Bottom of page 7: Mention that the GFP::BAF-1 was maternally provided. 

      We have added “Maternally provided..”

      Missing an Arrow on Figure 1A 9:20. 

      We removed the text citation to an arrow in Fig. 1A because we moved most of the description of the ER ring to Fig. 3 to address other reviewer suggestions.

      Supplemental videos should be labeled appropriately to indicate what structures are labeled. It is currently difficult to understand what is being shown. 

      (3) Issues with the Discussion section: 

      "The simplest explanation is that cytoplasm does not mix during the 45 min from GVBD to pronucleus formation due to the high viscosity of cytoplasm." - Citation page 12. 

      We have changed the sentence to: “The simplest hypothesis is that maternal and paternal cytoplasm might not mix during the 45 min from GVBD to pronucleus formation due to the high viscosity of cytoplasm.” 

      "The higher frequency of capture of the sperm DNA by the meiotic spindle in ATX-2 KLP-7 double depleted embryos compared with either single depletion suggests that the integrity of the exclusion zone around the sperm DNA may insulate the sperm DNA from spindle microtubule" - Pages 12-13 reference the figures. 

      This sentence has been rewritten in response to other comments but the new sentence now references revised Fig. 9.

      "ATX-2 is required to maintain the integrity of the ball of paternal mitochondria around the sperm DNA, but the mechanism is unknown." - Page 13 reference figure. 

      A reference to Figs 7 and 8 has been inserted.

      " In control embryos, the sperm contents rarely came near the meiotic spindle in agreement with a previous study that found that male and female pronuclei rarely form next to each other (6). Streaming of the sperm contents was most commonly restricted to a jostling motion with little net displacement, circular streaming in the short axis of the embryo, or long axis streaming in which the sperm turned away from the spindle before the halfway point of the embryo. Depletion of MEI-1 or KLP-7 resulted in longer excursions of the sperm contents in the long axis of the embryo toward the spindle but frequent capture of the sperm by the spindle was only observed in mei-1(RNAi)." - Page 13, the corresponding figures need to be referenced for these sentences. 

      We have inserted figure references.

      "In capture events observed after double depletion of ATX-2 and KLP-7, a bundle of microtubules was discernible extending from the spindle into the ER envelope surrounding the sperm DNA. Such bundles were not observed in mei-1(RNAi) capture events, likely because of the previously reported low density of microtubules in mei-1(RNAi) spindles (36, 37)." - Pages 13-14 references figures here. 

      We have inserted figure references.

      "The higher frequency of capture of the sperm DNA by the meiotic spindle in ATX-2 KLP-7 double depleted embryos compared with either single depletion suggests that the integrity of the exclusion zone around the sperm DNA may insulate the sperm DNA from spindle microtubules." - This should be toned down since this phenotype is not robust. 

      We have changed this to: “The capture of the sperm DNA by the meiotic spindle in ATX-2 KLP-7 double depleted embryos suggests that the integrity of the exclusion zone around the sperm DNA might insulate the sperm DNA from spindle microtubules.  However, a much larger number of klp-7(RNAi) singly depleted and atx-2(degron) singly depleted time-lapse sequences are needed to rigorously support this idea. “

      ATX-2 depletion alters ER morphology but does not impact the maternal ER envelope - could the authors provide a potential explanation for this? 

      In the discussion, we cite papers showing that ATX-2 depletion affects many different cellular processes so the effect we see on paternal mitochondria might have nothing to do with the ER ring.   We have been attempting to disrupt ER structures in the meiotic embryo for the last 5 years by depleting profilin, BiP, atlastin, ATX-2 and by optogenetically packing ER into a ball in the middle of the oocyte.  None of these treatments prevent envelopment of the sperm DNA by maternal ER.  None of these treatments remove ER from the spindle envelope and none remove ER from the plasma membrane.  These treatments mostly result in “large aggregates” of ER that we have not examined by EM.  Wild speculation: any disruption of the ER strong enough to prevent ER envelopment around chromatin would be sterile because the M to S transition in the mitotic zone of the germline would be blocked.  Rapid depletion of ATX-2 to the extent shown by rigorous data in this manuscript does not prevent ER envelopment around chromatin.  We chose not to speculate about the reasons for this because we do not know why.

      It would be good to have representative images of what the altered spindle looks like in MEI-1-depleted oocytes. 

      The structure of MEI-1-depleted spindles has been described in the cited references.

      "Depletion of MEI-1 or KLP-7 resulted in longer excursions of the sperm contents in the long axis of the embryo toward the spindle but frequent capture of the sperm by the spindle was only observed in mei-1(RNAi)" - It is intriguing that this does not happen in the double depletion experiments of kinesin-13 and ATX-2. The authors should perhaps discuss this. 

      This does happen in KLP-7 ATX-2 double depleted embryos as shown in Fig. 9.

      (4) Missing citations: 

      "This analysis was restricted to embryos from anaphase I through anaphase II because our streaming data and that of Kimura 2020 indicate that the sperm contents have not moved significantly before anaphase I." - This needs an appropriate citation. Page 10. 

      We have inserted citations here.

      " The simplest explanation is that cytoplasm does not mix during the 45 min from GVBD to pronucleus formation due to the high viscosity of cytoplasm." - Citation page 12. Not referencing figures in the discussion. 

      We have changed the sentence to: “The simplest hypothesis is that maternal and paternal cytoplasm might not mix during the 45 min from GVBD to pronucleus formation due to the high viscosity of cytoplasm.” 

      "The higher frequency of capture of the sperm DNA by the meiotic spindle in ATX-2 KLP-7 double depleted embryos compared with either single depletion suggests that the integrity of the exclusion zone around the sperm DNA may insulate the sperm DNA from spindle microtubule" - Pages 12-13 reference the figures. 

      A reference to the revised Fig. 9 has been inserted in the revised version of this sentence.

      "ATX-2 is required to maintain the integrity of the ball of paternal mitochondria around the sperm DNA, but the mechanism is unknown." 

      References to Figs. 7 and 8 have been inserted.

      Page 13 reference figure 

      " In control embryos, the sperm contents rarely came near the meiotic spindle in agreement with a previous study that found that male and female pronuclei rarely form next to each other (6). Streaming of the sperm contents was most commonly restricted to a jostling motion with little net displacement, circular streaming in the short axis of the embryo, or long axis streaming in which the sperm turned away from the spindle before the halfway point of the embryo. Depletion of MEI-1 or KLP-7 resulted in longer excursions of the sperm contents in the long axis of the embryo toward the spindle but frequent capture of the sperm by the spindle was only observed in mei-1(RNAi)." Page 13, the corresponding figures need to be referenced for these sentences. 

      We have inserted citations here.

      "In capture events observed after double depletion of ATX-2 and KLP-7, a bundle of microtubules was discernible extending from the spindle into the ER envelope surrounding the sperm DNA. Such bundles were not observed in mei-1(RNAi) capture events, likely because of the previously reported low density of microtubules in mei-1(RNAi) spindles (36, 37)." Pages 13-14 references figures here. 

      We have inserted citations here.

      (5) Referencing wrong figures in the text: 

      Figure 5 - In the figure legend there is a 5C but there is no 5C panel in the figure. 

      A C has been inserted in Fig. 5.

      Figure 6A - "Dark holes were observed suggesting exclusion from the lumens of larger membranous organelles (Fig. 6A; Fig. S2)." Page 10. 

      6A has been changed to 6C.

      Figure 6A is showing background autofluorescence in WT oocytes so I am not certain why it is cited here. 

      The Figure citation has been corrected to 6B, C.

      Figure 8 - I could not find the supplemental data file with the individual mitochondria distance measurements. 

      We are including the Excel file with the revised submission.

      The last sentence of the first paragraph should be re-worded to be more concise ". In C. elegans, the nucleus is positioned away from the site of future fertilization so that the meiosis I spindle assembles at the opposite end of the ellipsoid zygote from the site of fertilization (2-4). " 

      Every word of this sentence is important.

      Last sentence second paragraph typo "These microtubules are thought to drive meiotic cytoplasmic streaming because depletion tubulin stops cytoplasmic streaming (7) and depletion of the microtubule-severing protein katanin by RNAi results in an increased mass of cortical microtubules and an increase in cytoplasmic streaming (8)." Pages 3-4. 

      “of” has been inserted.

      (6) Typos in the introduction should be corrected: 

      Ataxin or kinesin-13 are not mentioned in the introduction but these are a big focus of the paper. 

      Gong et al 2024 written instead of number citation (page 5), no citation in References.

      This has been corrected. 

      Supplemental videos should be labeled appropriately to indicate what structures are labeled. It is currently difficult to understand what is being shown.

    1. nisation des outils de configuration du CAP4000 Transition vers une nouvelle application web Auteur Joshua JOURDAM Date de publication 17 juillet 2024 Résumé au dos ou au début du mémoire synthèse carte de visite anglais / français ~15 lignes 3 à 5 mot clés Le renouvellement constant des technologies dans l’industrie est un phénomène de plus en plus marquant de nos jours. Les entreprises qui souhaitent rester compétitives sur le marché doivent s’adapter à ces changements et innover en permanence. Dans ce contexte, le présent projet a pour objectif de développer une nouvelle solution pour répondre aux besoins actuels des industriels. Le projet s’inscrit dans la conception et la réalisation d’une plateforme web permettant de faciliter la gestion des opérations de maintenance et de suivi des équipements SDEL Contrôle Commande. Mots clés Calculateur, Développement WEB, API REST, Authentification Table des matières 1 Environnement et Contexte 1.1 Entreprise, service et position 1.1.1 Vinci 1.1.2 Vinci Energies 1.1.3 Hiérarchie et Fonctionnement de l’Entreprise 1.1.4 SDEL Contrôle Commande 1.1.5 Le service Recherche et Développement 1.2 Contexte du projet 2 Problématique 3 Buts et Objectifs 3.1 Objectifs Stratégiques et Opérationnels 3.1.1 Sélectionner un Cadre de Développement Optimal 3.1.2 Préparer la Transition Technologique 3.1.3 Développer la Nouvelle Application Web 3.1.4 Objectif 4 : Développer les Compétences en Gestion de Projet et Techniques 4 Démarche 4.1 Démarche générale 4.2 Méthodologie, techniques et technologies 4.3 Analyse des risques 4.4 Acteurs 4.5 Lotissements 4.6 Planning prévisionnel 4.7 Planning effectif 4.7.1 Jalons 4.7.2 Livrables 4.8 Budget 5 Résultats 5.1 Evaluation des technologies du marché 5.2 Transition 5.2.1 OpenAPI 5.2.2 Authentification 5.2.3 POC supervision stage 5.3 Développement 5.3.1 Spécification de l’application 5.3.2 Fonctionnement de la solution 5.3.3 Architecture/Workspace (expliquer comment fonctionne un monorepo) 5.3.4 Bibliothèques (zod, react-hook-form, react-query, react-router, orval, react-testing-library, vitest) 5.3.5 Gestion des erreurs et des chargements 5.3.6 Authentification et autorisation 5.3.7 Application 5.3.8 Modules 5.3.9 Tests 5.3.10 Performances 5.3.11 Application 6 Conclusion 6.1 Bilan 7 Annexes 7.1 Références 7.2 Grille des compétences Acronymes HSP PRP REST API SDELCC JWT HTTP HTTPS HMAC WBS CSR SPA Remerciements Ce projet s’intègre dans le cadre de mon apprentissage au sein de l’entreprise SDEL Contrôle Commande. SDEL Contrôle Commande appartient à la filiale Energies du groupe VINCI. Grâce à son expertise technique, SDEL Contrôle commande propose son accompagnement auprès des gestionnaires de réseaux de transport et de distribution d’énergie. J’ai intégré l’entreprise en tant qu’apprenti ingénieur en informatique. J’ai été affecté au service Recherche et Développement, sous la responsabilité de Monsieur Sébastien BARRE, responsable du développement logiciel. Le service Recherche et Développement est en charge de la conception et du développement de calculateurs utilisés principalement dans le domaine de l’énergie notamment dans les postes de transformation du réseau électrique français. Il est également en charge de la maintenance des produits existants. Cette maintenance peut s’effectuer sur de longues périodes, de l’ordre de 20 ans. Le projet s’inscrit dans une dynamique globale qui vise à moderniser les logiciels et les outils que nos équipements embarquent. Cette modernisation à pour objectif de proposer des outils plus ergonomiques et de répondre à des contraintes de cybersécurité plus strictes. Le projet à pour objectif de développer une nouvelle application d’administration et de configuration des automates SDEL. IL se déroule sur la dernière année de ma formation d’ingénieur en apprentissage sur la période de Juin 2023 à août 2024. Ce rapport est découpé en 3 parties : Environnement et contexte : Dans un premier temps, je présenterai le contexte de mon entreprise, puis mon poste et mes rôles au sein de celle-ci. Je présenterai également le contexte, la problématique spécifique ainsi que les buts et objectif du projet. Mise en œuvre et analyse des résultats : Dans cette partie, j’aborderai la méthodologie de travail choisie et les outils utilisés pour assurer son bon déroulement. Je présenterai ensuite les résultats obtenus en évoquant les écarts avec les objectif établis. Bilan et perspectives : Enfin, je ferai un bilan et j’évoquerai les perspectives d’évolution du projet. Je présenterai également les compétences acquises et les apports de ce projet dans mon parcours de formation. Pour finir, je présenterai mes perspectives futures pour ma carrière professionnelle. 1 Environnement et Contexte développer contexte entreprise, Vinci et hiérarchie (energies, omexom), nos marchés (où) ce qu’il faut retenir de chaque chapitre (bullet list) 1.1 Entreprise, service et position 1.1.1 Vinci image/svg+xml Figure 1: Logo VINCI Vinci est une entreprise multinationale française spécialisée dans la construction et les concessions. Fondée en 1899 sous le nom de Société Générale d’Entreprises (SGE), elle est devenue Vinci en 2000. Vinci est l’une des plus grandes entreprises de construction et de concessions dans le monde, avec des activités diversifiées dans le domaine de la construction, des infrastructures, des services énergétiques et de la gestion des infrastructures. Secteurs d’activité : Construction : Vinci Construction est spécialisée dans le bâtiment, les travaux publics, le génie civil, les fondations et les infrastructures de transport. Concessions : Vinci Autoroutes et Vinci Airports gèrent des réseaux autoroutiers et des aéroports dans plusieurs pays. Énergie : Vinci Energies intervient dans les domaines des infrastructures d’énergie, des industries, des technologies de l’information, et de la transition énergétique. Immobilier : Vinci Immobilier est active dans le développement immobilier résidentiel, tertiaire et commercial. #mermaid-1{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#ccc;}#mermaid-1 .error-icon{fill:#a44141;}#mermaid-1 .error-text{fill:#ddd;stroke:#ddd;}#mermaid-1 .edge-thickness-normal{stroke-width:2px;}#mermaid-1 .edge-thickness-thick{stroke-width:3.5px;}#mermaid-1 .edge-pattern-solid{stroke-dasharray:0;}#mermaid-1 .edge-pattern-dashed{stroke-dasharray:3;}#mermaid-1 .edge-pattern-dotted{stroke-dasharray:2;}#mermaid-1 .marker{fill:lightgrey;stroke:lightgrey;}#mermaid-1 .marker.cross{stroke:lightgrey;}#mermaid-1 svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#mermaid-1 .edge{stroke-width:3;}#mermaid-1 .section--1 rect,#mermaid-1 .section--1 path,#mermaid-1 .section--1 circle,#mermaid-1 .section--1 polygon,#mermaid-1 .section--1 path{fill:#1f2020;}#mermaid-1 .section--1 text{fill:lightgrey;}#mermaid-1 .node-icon--1{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge--1{stroke:#1f2020;}#mermaid-1 .edge-depth--1{stroke-width:17;}#mermaid-1 .section--1 line{stroke:#e0dfdf;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-0 rect,#mermaid-1 .section-0 path,#mermaid-1 .section-0 circle,#mermaid-1 .section-0 polygon,#mermaid-1 .section-0 path{fill:#0b0000;}#mermaid-1 .section-0 text{fill:lightgrey;}#mermaid-1 .node-icon-0{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-0{stroke:#0b0000;}#mermaid-1 .edge-depth-0{stroke-width:14;}#mermaid-1 .section-0 line{stroke:#f4ffff;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-1 rect,#mermaid-1 .section-1 path,#mermaid-1 .section-1 circle,#mermaid-1 .section-1 polygon,#mermaid-1 .section-1 path{fill:#4d1037;}#mermaid-1 .section-1 text{fill:lightgrey;}#mermaid-1 .node-icon-1{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-1{stroke:#4d1037;}#mermaid-1 .edge-depth-1{stroke-width:11;}#mermaid-1 .section-1 line{stroke:#b2efc8;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-2 rect,#mermaid-1 .section-2 path,#mermaid-1 .section-2 circle,#mermaid-1 .section-2 polygon,#mermaid-1 .section-2 path{fill:#3f5258;}#mermaid-1 .section-2 text{fill:lightgrey;}#mermaid-1 .node-icon-2{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-2{stroke:#3f5258;}#mermaid-1 .edge-depth-2{stroke-width:8;}#mermaid-1 .section-2 line{stroke:#c0ada7;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-3 rect,#mermaid-1 .section-3 path,#mermaid-1 .section-3 circle,#mermaid-1 .section-3 polygon,#mermaid-1 .section-3 path{fill:#4f2f1b;}#mermaid-1 .section-3 text{fill:lightgrey;}#mermaid-1 .node-icon-3{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-3{stroke:#4f2f1b;}#mermaid-1 .edge-depth-3{stroke-width:5;}#mermaid-1 .section-3 line{stroke:#b0d0e4;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-4 rect,#mermaid-1 .section-4 path,#mermaid-1 .section-4 circle,#mermaid-1 .section-4 polygon,#mermaid-1 .section-4 path{fill:#6e0a0a;}#mermaid-1 .section-4 text{fill:lightgrey;}#mermaid-1 .node-icon-4{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-4{stroke:#6e0a0a;}#mermaid-1 .edge-depth-4{stroke-width:2;}#mermaid-1 .section-4 line{stroke:#91f5f5;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-5 rect,#mermaid-1 .section-5 path,#mermaid-1 .section-5 circle,#mermaid-1 .section-5 polygon,#mermaid-1 .section-5 path{fill:#3b0048;}#mermaid-1 .section-5 text{fill:lightgrey;}#mermaid-1 .node-icon-5{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-5{stroke:#3b0048;}#mermaid-1 .edge-depth-5{stroke-width:-1;}#mermaid-1 .section-5 line{stroke:#c4ffb7;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-6 rect,#mermaid-1 .section-6 path,#mermaid-1 .section-6 circle,#mermaid-1 .section-6 polygon,#mermaid-1 .section-6 path{fill:#995a01;}#mermaid-1 .section-6 text{fill:lightgrey;}#mermaid-1 .node-icon-6{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-6{stroke:#995a01;}#mermaid-1 .edge-depth-6{stroke-width:-4;}#mermaid-1 .section-6 line{stroke:#66a5fe;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-7 rect,#mermaid-1 .section-7 path,#mermaid-1 .section-7 circle,#mermaid-1 .section-7 polygon,#mermaid-1 .section-7 path{fill:#154706;}#mermaid-1 .section-7 text{fill:lightgrey;}#mermaid-1 .node-icon-7{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-7{stroke:#154706;}#mermaid-1 .edge-depth-7{stroke-width:-7;}#mermaid-1 .section-7 line{stroke:#eab8f9;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-8 rect,#mermaid-1 .section-8 path,#mermaid-1 .section-8 circle,#mermaid-1 .section-8 polygon,#mermaid-1 .section-8 path{fill:#161722;}#mermaid-1 .section-8 text{fill:lightgrey;}#mermaid-1 .node-icon-8{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-8{stroke:#161722;}#mermaid-1 .edge-depth-8{stroke-width:-10;}#mermaid-1 .section-8 line{stroke:#e9e8dd;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-9 rect,#mermaid-1 .section-9 path,#mermaid-1 .section-9 circle,#mermaid-1 .section-9 polygon,#mermaid-1 .section-9 path{fill:#00296f;}#mermaid-1 .section-9 text{fill:lightgrey;}#mermaid-1 .node-icon-9{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-9{stroke:#00296f;}#mermaid-1 .edge-depth-9{stroke-width:-13;}#mermaid-1 .section-9 line{stroke:#ffd690;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-10 rect,#mermaid-1 .section-10 path,#mermaid-1 .section-10 circle,#mermaid-1 .section-10 polygon,#mermaid-1 .section-10 path{fill:#01629c;}#mermaid-1 .section-10 text{fill:lightgrey;}#mermaid-1 .node-icon-10{font-size:40px;color:lightgrey;}#mermaid-1 .section-edge-10{stroke:#01629c;}#mermaid-1 .edge-depth-10{stroke-width:-16;}#mermaid-1 .section-10 line{stroke:#fe9d63;stroke-width:3;}#mermaid-1 .disabled,#mermaid-1 .disabled circle,#mermaid-1 .disabled text{fill:lightgray;}#mermaid-1 .disabled text{fill:#efefef;}#mermaid-1 .section-root rect,#mermaid-1 .section-root path,#mermaid-1 .section-root circle,#mermaid-1 .section-root polygon{fill:hsl(180, 1.5873015873%, 48.3529411765%);}#mermaid-1 .section-root text{fill:#2c2c2c;}#mermaid-1 .icon-container{height:100%;display:flex;justify-content:center;align-items:center;}#mermaid-1 .edge{fill:none;}#mermaid-1 .mindmap-node-label{dy:1em;alignment-baseline:middle;text-anchor:middle;dominant-baseline:middle;text-align:center;}#mermaid-1 :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}VINCIVinci EnergiesVinci ConstructionVinci AutoroutesVinci AirportsVinci Immobilier 1.1.2 Vinci Energies Vinci Energies, une filiale de Vinci, est spécialisée dans les services énergétiques et les technologies de l’information. Elle propose des solutions dans les domaines de l’énergie, des technologies de l’information, et des télécommunications. Ses principales activités incluent : Infrastructure Énergie : Gestion des réseaux électriques et des infrastructures de distribution d’énergie. Industrie : Optimisation des processus industriels et amélioration de l’efficacité énergétique. TIC (Technologies de l’Information et de la Communication) : Solutions pour les systèmes d’information et les télécommunications. Transition Énergétique et Environnementale : Développement de solutions pour une énergie plus durable et respectueuse de l’environnement. Vinci Energies, une division du groupe VINCI, regroupe plusieurs marques spécialisées dans divers domaines des services énergétiques et des technologies de l’information. Les cinq principales marques de Vinci Energies sont : Actemium : Spécialisée dans les solutions et les services pour les processus industriels, couvrant l’ensemble du cycle de vie des installations industrielles. Axians : Focalisée sur les technologies de l’information et de la communication (TIC), offrant des solutions pour les infrastructures IT, la cybersécurité, le cloud, les réseaux et la collaboration. Cegelec : Fournit des services et des solutions en ingénierie électrique et maintenance pour les infrastructures et les bâtiments. Omexom : Se concentre sur les infrastructures énergétiques, notamment les réseaux de transport et de distribution d’électricité, les énergies renouvelables et les systèmes de stockage d’énergie. VINCI Facilities : Offre des services de gestion et de maintenance des bâtiments, incluant des solutions de facility management intégrées pour optimiser les performances des installations. 1.1.3 Hiérarchie et Fonctionnement de l’Entreprise 1.1.3.1 Organisation Vinci est organisée en plusieurs divisions opérationnelles, chacune ayant une structure hiérarchique propre. La hiérarchie de Vinci et de ses filiales, comme Vinci Energies, est généralement structurée de la manière suivante : Conseil d’Administration : Organe suprême de la société, responsable de la stratégie globale et de la surveillance de la direction exécutive. Direction Générale : Composée du Président-Directeur Général (PDG) et d’autres membres de la direction exécutive, responsables de la mise en œuvre de la stratégie et de la gestion quotidienne de l’entreprise. Directeurs de Divisions/Branches : Chacun responsable d’une branche spécifique (par exemple, Vinci Construction, Vinci Energies). Directeurs de Filières/Entités : Supervisent des sous-divisions ou entités spécifiques au sein de chaque branche, telles que des régions géographiques ou des domaines spécialisés. Chefs de Projet et Managers Opérationnels : Responsables de la gestion quotidienne des projets et des équipes sur le terrain. Équipes Opérationnelles : Constituent les employés qui travaillent directement sur les projets, incluant ingénieurs, techniciens, ouvriers, et autres professionnels spécialisés. 1.1.3.2 Fonctionnement Décentralisation : Vinci privilégie une approche décentralisée, permettant à ses différentes divisions et filiales de bénéficier d’une grande autonomie. Cela favorise la réactivité et l’adaptabilité aux marchés locaux. Innovation : L’entreprise met l’accent sur l’innovation technologique et l’efficacité énergétique, soutenant les projets de recherche et développement pour anticiper les besoins futurs. Responsabilité Sociétale et Environnementale : Vinci est engagée dans une démarche de développement durable, visant à réduire son empreinte écologique et à améliorer ses performances environnementales. En résumé, Vinci est une entreprise diversifiée avec une structure hiérarchique bien définie, soutenant une approche décentralisée et innovante pour répondre aux besoins de ses marchés dans le domaine de la construction, des concessions, et des services énergétiques. 1.1.4 SDEL Contrôle Commande Figure 2: Entrée principale de SDEL Contrôle Commande SDEL Contrôle Commande appartient à la filiale Energies du groupe VINCI. Elle est composée de plusieurs marques, comme Omexom, Actemium et Axians. Chaque marque est spécialisée dans un domaine d’activité précis. Ainsi VINCI Energies offre une gamme complète de services et de solutions dans le domaine de l’énergie. SDEL Contrôle Commande est une entreprise mono-site basée à Saint-Aignan-Grandlieu. Au sein du réseau Omexom, SDEL Contrôle Commande intervient dans la gestion de projets clé en main, la conception, l’ingénierie, l’intégration, l’installation, la configuration, les essais, la mise en service et la maintenance de systèmes de contrôle commande de postes électriques et d’automatismes. Figure 3: Tranches SDEL Composée de plus de 300 salariés, elle bénéficie de plus de 50 années d’expérience dans le contrôle commande. Ainsi, grâce à son expertise technique, SDEL Contrôle commande propose son accompagnement auprès des gestionnaires de réseaux de transport et de distribution d’énergie. Nos clients majeurs sont RTE et Enedis. Nous proposons une offre sur mesure de produits à destination des postes du réseau électrique français. Nous fournissons également des systèmes de contrôle commande à Thales pour le pilotage de batteries marines et à la RATP pour la supervision du système de ventilation du métro parisien. RTE Enedis Thales RATP EDF Nos principaux concurrents sont Actia Telecom, SCLE, Eiffage Energie. Ils proposent une gamme de produits similaire sur le marché de la distribution et du transport de l’énergie. Quelques entreprises du groupe VINCI sont également en compétition directe avec SDEL Contrôle Commande sur certains appels d’offre. #fig-market-mermaid{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#ccc;}#fig-market-mermaid .error-icon{fill:#a44141;}#fig-market-mermaid .error-text{fill:#ddd;stroke:#ddd;}#fig-market-mermaid .edge-thickness-normal{stroke-width:2px;}#fig-market-mermaid .edge-thickness-thick{stroke-width:3.5px;}#fig-market-mermaid .edge-pattern-solid{stroke-dasharray:0;}#fig-market-mermaid .edge-pattern-dashed{stroke-dasharray:3;}#fig-market-mermaid .edge-pattern-dotted{stroke-dasharray:2;}#fig-market-mermaid .marker{fill:lightgrey;stroke:lightgrey;}#fig-market-mermaid .marker.cross{stroke:lightgrey;}#fig-market-mermaid svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#fig-market-mermaid .pieCircle{stroke:black;stroke-width:2px;opacity:0.7;}#fig-market-mermaid .pieOuterCircle{stroke:black;stroke-width:2px;fill:none;}#fig-market-mermaid .pieTitleText{text-anchor:middle;font-size:25px;fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%);font-family:"trebuchet ms",verdana,arial,sans-serif;}#fig-market-mermaid .slice{font-family:"trebuchet ms",verdana,arial,sans-serif;fill:#ccc;font-size:17px;}#fig-market-mermaid .legend text{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%);font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:17px;}#fig-market-mermaid :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}85%10%4%1%EnergieDéfenseTransportAutres industries Figure 4: Répartition des marchés de SDEL Contrôle Commande #fig-organisation-mermaid{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#ccc;}#fig-organisation-mermaid .error-icon{fill:#a44141;}#fig-organisation-mermaid .error-text{fill:#ddd;stroke:#ddd;}#fig-organisation-mermaid .edge-thickness-normal{stroke-width:2px;}#fig-organisation-mermaid .edge-thickness-thick{stroke-width:3.5px;}#fig-organisation-mermaid .edge-pattern-solid{stroke-dasharray:0;}#fig-organisation-mermaid .edge-pattern-dashed{stroke-dasharray:3;}#fig-organisation-mermaid .edge-pattern-dotted{stroke-dasharray:2;}#fig-organisation-mermaid .marker{fill:lightgrey;stroke:lightgrey;}#fig-organisation-mermaid .marker.cross{stroke:lightgrey;}#fig-organisation-mermaid svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#fig-organisation-mermaid .edge{stroke-width:3;}#fig-organisation-mermaid .section--1 rect,#fig-organisation-mermaid .section--1 path,#fig-organisation-mermaid .section--1 circle,#fig-organisation-mermaid .section--1 polygon,#fig-organisation-mermaid .section--1 path{fill:#1f2020;}#fig-organisation-mermaid .section--1 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon--1{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge--1{stroke:#1f2020;}#fig-organisation-mermaid .edge-depth--1{stroke-width:17;}#fig-organisation-mermaid .section--1 line{stroke:#e0dfdf;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-0 rect,#fig-organisation-mermaid .section-0 path,#fig-organisation-mermaid .section-0 circle,#fig-organisation-mermaid .section-0 polygon,#fig-organisation-mermaid .section-0 path{fill:#0b0000;}#fig-organisation-mermaid .section-0 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-0{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-0{stroke:#0b0000;}#fig-organisation-mermaid .edge-depth-0{stroke-width:14;}#fig-organisation-mermaid .section-0 line{stroke:#f4ffff;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-1 rect,#fig-organisation-mermaid .section-1 path,#fig-organisation-mermaid .section-1 circle,#fig-organisation-mermaid .section-1 polygon,#fig-organisation-mermaid .section-1 path{fill:#4d1037;}#fig-organisation-mermaid .section-1 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-1{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-1{stroke:#4d1037;}#fig-organisation-mermaid .edge-depth-1{stroke-width:11;}#fig-organisation-mermaid .section-1 line{stroke:#b2efc8;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-2 rect,#fig-organisation-mermaid .section-2 path,#fig-organisation-mermaid .section-2 circle,#fig-organisation-mermaid .section-2 polygon,#fig-organisation-mermaid .section-2 path{fill:#3f5258;}#fig-organisation-mermaid .section-2 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-2{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-2{stroke:#3f5258;}#fig-organisation-mermaid .edge-depth-2{stroke-width:8;}#fig-organisation-mermaid .section-2 line{stroke:#c0ada7;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-3 rect,#fig-organisation-mermaid .section-3 path,#fig-organisation-mermaid .section-3 circle,#fig-organisation-mermaid .section-3 polygon,#fig-organisation-mermaid .section-3 path{fill:#4f2f1b;}#fig-organisation-mermaid .section-3 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-3{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-3{stroke:#4f2f1b;}#fig-organisation-mermaid .edge-depth-3{stroke-width:5;}#fig-organisation-mermaid .section-3 line{stroke:#b0d0e4;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-4 rect,#fig-organisation-mermaid .section-4 path,#fig-organisation-mermaid .section-4 circle,#fig-organisation-mermaid .section-4 polygon,#fig-organisation-mermaid .section-4 path{fill:#6e0a0a;}#fig-organisation-mermaid .section-4 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-4{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-4{stroke:#6e0a0a;}#fig-organisation-mermaid .edge-depth-4{stroke-width:2;}#fig-organisation-mermaid .section-4 line{stroke:#91f5f5;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-5 rect,#fig-organisation-mermaid .section-5 path,#fig-organisation-mermaid .section-5 circle,#fig-organisation-mermaid .section-5 polygon,#fig-organisation-mermaid .section-5 path{fill:#3b0048;}#fig-organisation-mermaid .section-5 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-5{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-5{stroke:#3b0048;}#fig-organisation-mermaid .edge-depth-5{stroke-width:-1;}#fig-organisation-mermaid .section-5 line{stroke:#c4ffb7;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-6 rect,#fig-organisation-mermaid .section-6 path,#fig-organisation-mermaid .section-6 circle,#fig-organisation-mermaid .section-6 polygon,#fig-organisation-mermaid .section-6 path{fill:#995a01;}#fig-organisation-mermaid .section-6 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-6{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-6{stroke:#995a01;}#fig-organisation-mermaid .edge-depth-6{stroke-width:-4;}#fig-organisation-mermaid .section-6 line{stroke:#66a5fe;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-7 rect,#fig-organisation-mermaid .section-7 path,#fig-organisation-mermaid .section-7 circle,#fig-organisation-mermaid .section-7 polygon,#fig-organisation-mermaid .section-7 path{fill:#154706;}#fig-organisation-mermaid .section-7 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-7{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-7{stroke:#154706;}#fig-organisation-mermaid .edge-depth-7{stroke-width:-7;}#fig-organisation-mermaid .section-7 line{stroke:#eab8f9;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-8 rect,#fig-organisation-mermaid .section-8 path,#fig-organisation-mermaid .section-8 circle,#fig-organisation-mermaid .section-8 polygon,#fig-organisation-mermaid .section-8 path{fill:#161722;}#fig-organisation-mermaid .section-8 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-8{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-8{stroke:#161722;}#fig-organisation-mermaid .edge-depth-8{stroke-width:-10;}#fig-organisation-mermaid .section-8 line{stroke:#e9e8dd;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-9 rect,#fig-organisation-mermaid .section-9 path,#fig-organisation-mermaid .section-9 circle,#fig-organisation-mermaid .section-9 polygon,#fig-organisation-mermaid .section-9 path{fill:#00296f;}#fig-organisation-mermaid .section-9 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-9{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-9{stroke:#00296f;}#fig-organisation-mermaid .edge-depth-9{stroke-width:-13;}#fig-organisation-mermaid .section-9 line{stroke:#ffd690;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-10 rect,#fig-organisation-mermaid .section-10 path,#fig-organisation-mermaid .section-10 circle,#fig-organisation-mermaid .section-10 polygon,#fig-organisation-mermaid .section-10 path{fill:#01629c;}#fig-organisation-mermaid .section-10 text{fill:lightgrey;}#fig-organisation-mermaid .node-icon-10{font-size:40px;color:lightgrey;}#fig-organisation-mermaid .section-edge-10{stroke:#01629c;}#fig-organisation-mermaid .edge-depth-10{stroke-width:-16;}#fig-organisation-mermaid .section-10 line{stroke:#fe9d63;stroke-width:3;}#fig-organisation-mermaid .disabled,#fig-organisation-mermaid .disabled circle,#fig-organisation-mermaid .disabled text{fill:lightgray;}#fig-organisation-mermaid .disabled text{fill:#efefef;}#fig-organisation-mermaid .section-root rect,#fig-organisation-mermaid .section-root path,#fig-organisation-mermaid .section-root circle,#fig-organisation-mermaid .section-root polygon{fill:hsl(180, 1.5873015873%, 48.3529411765%);}#fig-organisation-mermaid .section-root text{fill:#2c2c2c;}#fig-organisation-mermaid .icon-container{height:100%;display:flex;justify-content:center;align-items:center;}#fig-organisation-mermaid .edge{fill:none;}#fig-organisation-mermaid .mindmap-node-label{dy:1em;alignment-baseline:middle;text-anchor:middle;dominant-baseline:middle;text-align:center;}#fig-organisation-mermaid :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}SDEL Contrôle CommandeRecherche etDéveloppementIngénierieInnovationGestion affairesStratégie IndustrielleBureau d 'étudesIntégrationLogistiqueChaîne achatsApprovisionnementEssaisMise en serviceTravauxInterventions Figure 5: Les services de SDEL Contrôle Commande 1.1.5 Le service Recherche et Développement SDEL Contrôle Commande propose des solutions techniques adaptées aux besoins de ses clients grâce à ses services Recherche et Développement, Ingénierie et Innovation. En plus de notre connaissance approfondie des différents constructeurs, notre expertise dans le domaine d’application nous permet de répondre aux besoins en ingénierie, dimensionnement, configuration et déploiement d’équipements de protection et de contrôle pour les réseaux électriques de transport et de distribution d’énergie. Le service Recherche et Développement est composé de 16 personnes. Il est spécialisé dans la conception de calculateurs et d’équipements utilisés dans les réseaux de distribution électriques. #fig-software-team-mermaid{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#ccc;}#fig-software-team-mermaid .error-icon{fill:#a44141;}#fig-software-team-mermaid .error-text{fill:#ddd;stroke:#ddd;}#fig-software-team-mermaid .edge-thickness-normal{stroke-width:2px;}#fig-software-team-mermaid .edge-thickness-thick{stroke-width:3.5px;}#fig-software-team-mermaid .edge-pattern-solid{stroke-dasharray:0;}#fig-software-team-mermaid .edge-pattern-dashed{stroke-dasharray:3;}#fig-software-team-mermaid .edge-pattern-dotted{stroke-dasharray:2;}#fig-software-team-mermaid .marker{fill:lightgrey;stroke:lightgrey;}#fig-software-team-mermaid .marker.cross{stroke:lightgrey;}#fig-software-team-mermaid svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#fig-software-team-mermaid .edge{stroke-width:3;}#fig-software-team-mermaid .section--1 rect,#fig-software-team-mermaid .section--1 path,#fig-software-team-mermaid .section--1 circle,#fig-software-team-mermaid .section--1 polygon,#fig-software-team-mermaid .section--1 path{fill:#1f2020;}#fig-software-team-mermaid .section--1 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon--1{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge--1{stroke:#1f2020;}#fig-software-team-mermaid .edge-depth--1{stroke-width:17;}#fig-software-team-mermaid .section--1 line{stroke:#e0dfdf;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-0 rect,#fig-software-team-mermaid .section-0 path,#fig-software-team-mermaid .section-0 circle,#fig-software-team-mermaid .section-0 polygon,#fig-software-team-mermaid .section-0 path{fill:#0b0000;}#fig-software-team-mermaid .section-0 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-0{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-0{stroke:#0b0000;}#fig-software-team-mermaid .edge-depth-0{stroke-width:14;}#fig-software-team-mermaid .section-0 line{stroke:#f4ffff;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-1 rect,#fig-software-team-mermaid .section-1 path,#fig-software-team-mermaid .section-1 circle,#fig-software-team-mermaid .section-1 polygon,#fig-software-team-mermaid .section-1 path{fill:#4d1037;}#fig-software-team-mermaid .section-1 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-1{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-1{stroke:#4d1037;}#fig-software-team-mermaid .edge-depth-1{stroke-width:11;}#fig-software-team-mermaid .section-1 line{stroke:#b2efc8;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-2 rect,#fig-software-team-mermaid .section-2 path,#fig-software-team-mermaid .section-2 circle,#fig-software-team-mermaid .section-2 polygon,#fig-software-team-mermaid .section-2 path{fill:#3f5258;}#fig-software-team-mermaid .section-2 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-2{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-2{stroke:#3f5258;}#fig-software-team-mermaid .edge-depth-2{stroke-width:8;}#fig-software-team-mermaid .section-2 line{stroke:#c0ada7;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-3 rect,#fig-software-team-mermaid .section-3 path,#fig-software-team-mermaid .section-3 circle,#fig-software-team-mermaid .section-3 polygon,#fig-software-team-mermaid .section-3 path{fill:#4f2f1b;}#fig-software-team-mermaid .section-3 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-3{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-3{stroke:#4f2f1b;}#fig-software-team-mermaid .edge-depth-3{stroke-width:5;}#fig-software-team-mermaid .section-3 line{stroke:#b0d0e4;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-4 rect,#fig-software-team-mermaid .section-4 path,#fig-software-team-mermaid .section-4 circle,#fig-software-team-mermaid .section-4 polygon,#fig-software-team-mermaid .section-4 path{fill:#6e0a0a;}#fig-software-team-mermaid .section-4 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-4{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-4{stroke:#6e0a0a;}#fig-software-team-mermaid .edge-depth-4{stroke-width:2;}#fig-software-team-mermaid .section-4 line{stroke:#91f5f5;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-5 rect,#fig-software-team-mermaid .section-5 path,#fig-software-team-mermaid .section-5 circle,#fig-software-team-mermaid .section-5 polygon,#fig-software-team-mermaid .section-5 path{fill:#3b0048;}#fig-software-team-mermaid .section-5 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-5{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-5{stroke:#3b0048;}#fig-software-team-mermaid .edge-depth-5{stroke-width:-1;}#fig-software-team-mermaid .section-5 line{stroke:#c4ffb7;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-6 rect,#fig-software-team-mermaid .section-6 path,#fig-software-team-mermaid .section-6 circle,#fig-software-team-mermaid .section-6 polygon,#fig-software-team-mermaid .section-6 path{fill:#995a01;}#fig-software-team-mermaid .section-6 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-6{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-6{stroke:#995a01;}#fig-software-team-mermaid .edge-depth-6{stroke-width:-4;}#fig-software-team-mermaid .section-6 line{stroke:#66a5fe;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-7 rect,#fig-software-team-mermaid .section-7 path,#fig-software-team-mermaid .section-7 circle,#fig-software-team-mermaid .section-7 polygon,#fig-software-team-mermaid .section-7 path{fill:#154706;}#fig-software-team-mermaid .section-7 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-7{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-7{stroke:#154706;}#fig-software-team-mermaid .edge-depth-7{stroke-width:-7;}#fig-software-team-mermaid .section-7 line{stroke:#eab8f9;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-8 rect,#fig-software-team-mermaid .section-8 path,#fig-software-team-mermaid .section-8 circle,#fig-software-team-mermaid .section-8 polygon,#fig-software-team-mermaid .section-8 path{fill:#161722;}#fig-software-team-mermaid .section-8 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-8{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-8{stroke:#161722;}#fig-software-team-mermaid .edge-depth-8{stroke-width:-10;}#fig-software-team-mermaid .section-8 line{stroke:#e9e8dd;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-9 rect,#fig-software-team-mermaid .section-9 path,#fig-software-team-mermaid .section-9 circle,#fig-software-team-mermaid .section-9 polygon,#fig-software-team-mermaid .section-9 path{fill:#00296f;}#fig-software-team-mermaid .section-9 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-9{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-9{stroke:#00296f;}#fig-software-team-mermaid .edge-depth-9{stroke-width:-13;}#fig-software-team-mermaid .section-9 line{stroke:#ffd690;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-10 rect,#fig-software-team-mermaid .section-10 path,#fig-software-team-mermaid .section-10 circle,#fig-software-team-mermaid .section-10 polygon,#fig-software-team-mermaid .section-10 path{fill:#01629c;}#fig-software-team-mermaid .section-10 text{fill:lightgrey;}#fig-software-team-mermaid .node-icon-10{font-size:40px;color:lightgrey;}#fig-software-team-mermaid .section-edge-10{stroke:#01629c;}#fig-software-team-mermaid .edge-depth-10{stroke-width:-16;}#fig-software-team-mermaid .section-10 line{stroke:#fe9d63;stroke-width:3;}#fig-software-team-mermaid .disabled,#fig-software-team-mermaid .disabled circle,#fig-software-team-mermaid .disabled text{fill:lightgray;}#fig-software-team-mermaid .disabled text{fill:#efefef;}#fig-software-team-mermaid .section-root rect,#fig-software-team-mermaid .section-root path,#fig-software-team-mermaid .section-root circle,#fig-software-team-mermaid .section-root polygon{fill:hsl(180, 1.5873015873%, 48.3529411765%);}#fig-software-team-mermaid .section-root text{fill:#2c2c2c;}#fig-software-team-mermaid .icon-container{height:100%;display:flex;justify-content:center;align-items:center;}#fig-software-team-mermaid .edge{fill:none;}#fig-software-team-mermaid .mindmap-node-label{dy:1em;alignment-baseline:middle;text-anchor:middle;dominant-baseline:middle;text-align:center;}#fig-software-team-mermaid :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}BARRE SebastienChef de groupeIngénieurBAUDOUIN Jean LouisIHMTechnicienJANNIERE SylvainCAP4000 /IHMIngénieurCECILLON LucasCAP4000 /CybersécuritéApprentiDUPONT DavidIHMIngénieurHELARD FlorentCAP4000IngénieurMINIER BertrandYocto /CAP4000IngénieurJOURDAM JoshuaYocto /IHMApprenti Figure 6: Organigramme équipe logiciel Monsieur Sébastien BARRE, est responsable du développement logiciel dans le service Recherche et Développement. L’équipe logiciel travaille les applicatifs et le système d’exploitation des équipements que nous développons. Ces matériels sont destinés à être commercialisés via l’intégration dans les produits et services fournis par SDEL contrôle commande. Par exemple lors de la vente d’armoires de contrôle commande ou lors de l’installation d’un poste électrique. Figure 7: DigiBOX, calculateur SDELCC dédié aux applications des postes électriques Applications : Système de supervision de poste Passerelle de téléconduite Synoptique de poste local Consignateur d’état Concrètement -> embarqué, linux, yocto En tant qu’apprenti j’ai pour rôle de contribuer au développement de nos logiciels. Je suis aussi mobilisé pour tester et étudier l’intégration de nouvelles technologies sur les produits. Mon travail comprends l’étude, l’analyse de données, la création de prototypes, la mise en place de tests et l’assistance aux techniciens et aux ingénieurs dans leur travail. Je suis également amené à rédiger de la documentation et la communiquer les résultats de mes travaux. J’ai l’occasion de travailler sur des projets concrets et de développer mes compétences dans le domaine de l’informatique embarquée principalement. Avec ma montée en compétences au fur et à mesure de ma formation, je suis maintenant amené à travailler sur des projets plus complexes et à diriger le présent projet. 1.2 Contexte du projet Le CAP4000 est une base logicielle modulaire qui est utilisée par tous les équipements développés par le service Recherche et Développement. C’est une application qui fonctionne en permanence. Elle gère les principales fonctionnalités de nos produits en s’interfaçant avec différents composants tels que : Système d’exploitation (réseau, alimentation, processus …) Périphériques (affichage, cartes d’extensions, clé usb, …) Moteur d’automatisme Panneau frontal (leds, boutons, …) Nos équipements sont hautement configurables. Pour simplifier l’utilisation par nos client, l’administration des équipements doit pouvoir être effectuée à distance. Ces tâches sont réalisées grâce à aux outils de configuration historiques qui sont inclus dans une application de bureau windows. Figure 8: Utilitaire de configuration Depuis 2020 l’équipe logiciel travaille sur le remplacement de cette application. L’objectif est de moderniser nos outils pour simplifier et intégrer des contraintes de cybersécurité plus strictes dans les processus de gestion et de maintenance des équipements. Pour moderniser les principes d’accès aux ressources d’un calculateur, une API de type REST à été implémentée dans le logiciel CAP4000. L’objectif est de mettre à disposition un système de dialogue fiable et sécurisé avec un équipement dans le but de créer des outils basés sur les technologies Web pour les produits SDELCC. API (Interface de Programmation d’Application) Les API pour Application Programming Interface permettent à 2 ordinateur de communiquer entre eux. Imaginez cela comme l’utilisation d’un site web, mais au lieu de cliquer sur des boutons, vous écrivez du code pour demander explicitement des données à un serveur. Une API dite RESTful, suit un ensemble de règles et contraintes imposées par l’architecture REST (REpresentational State Transfer). Une API REST fonctionne sur le protocole HTTP (Hypertext Transfer Protocol). Elle mets à disposition des ressources (données) accessible par des URL uniques. Une requête permet d’accéder aux ressources. Chaque requête (GET, POST, PATCH, DELETE) respecte le principe CRUD (Create, Read, Update, Delete) et suit un format spécifique : méthode, URL, en-têtes (métadonnées) et corps (données). Un client effectue une requête sur le serveur via une URL, le serveur exécute du code (généralement accède à une base de données), formate les données dans une réponse avec un code d’état (indiquant le succès, une erreur client ou serveur). Les API REST sont stateless, ce qui signifie que chaque interaction est indépendante des précédentes, rendant les applications prévisibles et fiables. Les API de type REST sont devenues le standard de facto pour le développement d’API web depuis le début des années 2000. #fig-rest-api-flow-mermaid{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#ccc;}#fig-rest-api-flow-mermaid .error-icon{fill:#a44141;}#fig-rest-api-flow-mermaid .error-text{fill:#ddd;stroke:#ddd;}#fig-rest-api-flow-mermaid .edge-thickness-normal{stroke-width:2px;}#fig-rest-api-flow-mermaid .edge-thickness-thick{stroke-width:3.5px;}#fig-rest-api-flow-mermaid .edge-pattern-solid{stroke-dasharray:0;}#fig-rest-api-flow-mermaid .edge-pattern-dashed{stroke-dasharray:3;}#fig-rest-api-flow-mermaid .edge-pattern-dotted{stroke-dasharray:2;}#fig-rest-api-flow-mermaid .marker{fill:lightgrey;stroke:lightgrey;}#fig-rest-api-flow-mermaid .marker.cross{stroke:lightgrey;}#fig-rest-api-flow-mermaid svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#fig-rest-api-flow-mermaid .label{font-family:"trebuchet ms",verdana,arial,sans-serif;color:#ccc;}#fig-rest-api-flow-mermaid .cluster-label text{fill:#F9FFFE;}#fig-rest-api-flow-mermaid .cluster-label span,#fig-rest-api-flow-mermaid p{color:#F9FFFE;}#fig-rest-api-flow-mermaid .label text,#fig-rest-api-flow-mermaid span,#fig-rest-api-flow-mermaid p{fill:#ccc;color:#ccc;}#fig-rest-api-flow-mermaid .node rect,#fig-rest-api-flow-mermaid .node circle,#fig-rest-api-flow-mermaid .node ellipse,#fig-rest-api-flow-mermaid .node polygon,#fig-rest-api-flow-mermaid .node path{fill:#1f2020;stroke:#81B1DB;stroke-width:1px;}#fig-rest-api-flow-mermaid .flowchart-label text{text-anchor:middle;}#fig-rest-api-flow-mermaid .node .label{text-align:center;}#fig-rest-api-flow-mermaid .node.clickable{cursor:pointer;}#fig-rest-api-flow-mermaid .arrowheadPath{fill:lightgrey;}#fig-rest-api-flow-mermaid .edgePath .path{stroke:lightgrey;stroke-width:2.0px;}#fig-rest-api-flow-mermaid .flowchart-link{stroke:lightgrey;fill:none;}#fig-rest-api-flow-mermaid .edgeLabel{background-color:hsl(0, 0%, 34.4117647059%);text-align:center;}#fig-rest-api-flow-mermaid .edgeLabel rect{opacity:0.5;background-color:hsl(0, 0%, 34.4117647059%);fill:hsl(0, 0%, 34.4117647059%);}#fig-rest-api-flow-mermaid .cluster rect{fill:hsl(180, 1.5873015873%, 28.3529411765%);stroke:rgba(255, 255, 255, 0.25);stroke-width:1px;}#fig-rest-api-flow-mermaid .cluster text{fill:#F9FFFE;}#fig-rest-api-flow-mermaid .cluster span,#fig-rest-api-flow-mermaid p{color:#F9FFFE;}#fig-rest-api-flow-mermaid div.mermaidTooltip{position:absolute;text-align:center;max-width:200px;padding:2px;font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:12px;background:hsl(20, 1.5873015873%, 12.3529411765%);border:1px solid rgba(255, 255, 255, 0.25);border-radius:2px;pointer-events:none;z-index:100;}#fig-rest-api-flow-mermaid .flowchartTitleText{text-anchor:middle;font-size:18px;fill:#ccc;}#fig-rest-api-flow-mermaid :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}OdrinateurÉquipementNavigateurCAP4000VisiteRequêteGET/POST/PUT/DELETERéponseJSONLit et écritExecuteApplication webAPIrestModule XBase de donnéesProcéduresUtilisateur Figure 9: Principe d’utilisation de l’API REST du CAP4000 Cette API à pour principal objectif de permettre la configuration et la gestion des équipements à distance. Elle permet de récupérer des informations sur l’état de l’équipement et de ses composants. Elle permet également la modification la configuration de l’équipement et le déclenchement de procédures comme le redémarrage. Par exemple, il est possible de récupérer la version du logiciel installé sur l’équipement en exécutant la requête HTTP GET suivante : http://<ip-equipement>/api/v1/identification. identification { "CAP4000": { "IndiceValidation": 0, "Nom": "DigiBOX", "VersionCorrectif": 1, "VersionMajeure": 6, "VersionMineure": 0, "VersionProtocole": 2 }, "OS": { "Nom": "digibox-debug-os", "VersionCorrectif": 5, "VersionMajeure": 0, "VersionMineure": 4 }, "Produit": { "Nom": "digibox-debug", "VersionCorrectif": 1, "VersionMajeure": 2, "VersionMineure": 0 } } Une expérimentation d’application à été développée. Cette application est disponible pour deux plateformes : Windows et Web. Elle dialogue avec l’API REST du CAP4000. L’application a été développée avec le framework Qt. C’est un framework que nous utilisons déjà sur d’autres projets. Il a donc été choisi afin de capitaliser sur l’expertise du service. L’application est découpée en modules qui représentent une fonctionnalité dans l’interface (debug, configuration réseau, import de configuration, …). Qt (prononcé “cute”) Qt est un framework de développement d’applications multi-plateformes basé sur le language C++. Il permet de créer des logiciels avec une interface utilisateur graphique. Les applications peuvent être exécutées sur différents systèmes d’exploitation tels que Windows, macOS, Linux, etc., mais aussi dans un navigateur sans nécessiter de modifications majeures du code source. Pour fonctionner dans un navigateur, une application Qt doit être compilée au format WebAssembly. WebAssembly est un format binaire qui permet d’exécuter du code bas niveau de manière portable et sécurisée dans les navigateurs web modernes. Il est conçu pour compléter les langages de programmation traditionnels utilisés sur le web, tels que JavaScript, en offrant des performances plus élevées pour les applications web. Cette application expérimentale est destinée à être utilisée en interne par les collaborateurs de SDEL Contrôle Commande ainsi que certains clients qui souhaitent l’évaluer. Figure 10: Interface web du produit DigiBox (menu principal) On retrouve des fonctionnalités comme : Configuration des interfaces réseau Gestion des certificats État des cartes entrées/sorties Affichage des informations de débogage Gestion de l’alimentation Import de configuration … L’application gère les utilisateurs du système d’exploitation et les rôles du CAP4000. Ainsi, il est possible de restreindre l’accès à certaines fonctionnalités. Par exemple, un utilisateur avec le rôle “observateur” ne pourra pas accéder à la configuration réseau de l’équipement. L’architecture du cette solution peut être représentée par la pile technologique suivante : Table 1: Pile technologique Frontend API Backend Qt API REST CAP4000 Pile technologique D’abord c’est quoi ? Une pile technologique peut être découpée en trois catégories : Frontend La couche frontend inclus les outils requis pour construire une interface homme machine pour les utilisateurs finaux. Elle peut être développée pour fonctionner dans un navigateur internet ou sur un système d’exploitation (windows, linux, macos, android, ios, …). Backend La couche backend inclus un runtime (environnement d’exécution) serveur généralement accompagné d’une base de données. Elle permet de gérer les données et la logique métier de l’application (gestion des utilisateurs, des droits, fonctionnalités …). API La couche APIs permet de connecter le frontend et le backend (REST, GraphQL). Elle gère aussi l’intégration avec des services tiers (paiement, gestion des identités, messagerie, …) L’application web est accessible localement en accédant à un équipement via son adresse ip depuis un navigateur internet. Elle est compatible avec les navigateurs modernes (Chrome, Firefox, Edge, Safari, …). L’application est donc distribuée directement dans le système d’exploitation d’un équipement et ne nécessite aucune installation sur les postes de travail de nos clients. Chaque type d’équipement dispose de sa propre version de l’application intégrant plus ou moins de fonctionnalités. Dans la suite du rapport, nous allons présenter les différentes étapes de la réalisation de ce projet. Nous commencerons par présenter la problématique et les objectifs du projet. Nous détaillerons ensuite la méthodologie utilisée pour réaliser le projet. Enfin, nous présenterons les résultats obtenus et les perspectives pour la suite du projet. Parler des licenses libres / open sources https://www.diatem.net/les-licences-open-source/ 2 Problématique Aujourd’hui, nous souhaitons intégrer l’application web sur l’ensemble des produits que nous commercialisons. En informatique, les logiciels sont distribués sous plusieurs types de licenses. Les licenses open-sources permettent aux développeurs de les utiliser, de les modifier et de les redistribuer en suivant certaines règles. Il existe beaucoup de licences open-sources et chacune dispose de ses propres règles d’utilisation. Il est important de prendre en compte ces conditions avant de commercialiser un produit qui intègre un composant open-source. Le framework Qt est la propriété de The Qt Company. Il est distribué sous plusieurs licenses. Jusqu’ici nous avons utilisé la version open-source de ce logiciel pour commercialiser nos produits. Cependant cette version ne permet pas de distribuer une application au format WebAssembly sans également distribuer le code source de celle-ci. La direction de VINCI ne souhaite pas publier les sources de ses applications. Nous avons également écarté la possibilité de payer des licenses commerciales. La commercialisation des produits intégrant de l’application web sous sa forme actuelle n’est donc pas envisageable. Le présent projet vise à développer une nouvelle application en se basant sur une autre technologie. Nous souhaitons une interface graphique web reposant sur le dialogue avec un calculateur via l’API REST. Nous souhaitons utiliser un framework open source et entièrement gratuit, adapté aux besoins de l’embarqué. Ce projet permettra également d’explorer et monter en compétences sur les technologies web ainsi que consolider notre solution en utilisant des technologies pérennes qui autorisent la diffusion de nos applications sous licence propriétaire. Problématique Comment choisir judicieusement un framework open source pour le développement d’une nouvelle application web intégrée à l’ensemble de la gamme de produits, tout en respectant les contraintes de confidentialité imposées par la direction de l’entreprise et en garantissant la possibilité de diffuser les applications sous licence propriétaire ? Ce projet aura un impact sur les utilisateurs de l’application Qt. Comme cette application était encore en phase expérimentale, seuls les développeurs du service recherche et développement et les intervenants internes divers (test, bureau d’études, etc …) seront impactés. Nos client qui profitent déjà de l’application seront limités à l’utilisation sur la plateforme Windows uniquement. Lorsque la prochaine application sera développée, ils pourront bénéficier d’une mise à niveau vers la nouvelle version système de leur produit. L’application Qt continuera à être développée par Jean-Louis Baudoin. Un autre groupe de travail a réussi à reproduire le fonctionnement de l’application web en explorant des solutions alternatives au WebAssembly. Cela est rendu possible en installant l’application de bureau directement sur les calculateurs et partageant l’environnement de bureau grace aux technologies de type VNC. Cette solution, rapide à mettre en place, restera cependant temporaire en raison de ses faible performances et sera à terme définitivement remplacée définitivement lorsque la future application sera publiée. 3 Buts et Objectifs Choisir un framework Établir une liste de minimum 10 critères permettant la comparaison des frameworks Évaluer et tester au moins trois frameworks alternatifs en fonction la liste de critères Réaliser un prototype (POC) fonctionnel comprenant un menu ainsi que 3 modules Préparer la transition Mettre à niveau la spécification de l’API pour répondre au standard OpenAPI 3 Modifier la méthode d’authentification des requêtes pour simplifier l’implémentation de l’API dans la nouvelle application Changer le système d’authentification afin de garantir la sécurité de l’API Effectuer une semaine d’auto-formation sur le framework choisi Établir une liste ordonnée de modules à porter, à créer ou à supprimer comprenant au minimum les modules existants Développer la nouvelle application web Développer au moins 20 modules Atteindre des performances au moins équivalentes (dégradation maximale de 5%) à l’application actuelle Acquérir les compétences d’un ingénieur débutant Mettre en place une démarche de gestion de projet permettant d’atteindre les buts et objectifs fixés Fournir l’ensemble des livrables demandés par l’ESEO Avoir une note supérieure à 14 aux 3 évaluations PING Bien sûr, voici une proposition de structure alternative pour les objectifs, avec des formulations plus étoffées et professionnelles : 3.1 Objectifs Stratégiques et Opérationnels 3.1.1 Sélectionner un Cadre de Développement Optimal Identifier et choisir un framework adapté aux besoins spécifiques du projet. Élaborer une Liste de Critères de Sélection : Objectif : Développer une liste détaillée d’au moins 10 critères pertinents pour la comparaison des frameworks. Délai : 2 semaines. Description : Inclure des critères tels que la performance, la scalabilité, la facilité d’intégration, le support communautaire, la documentation, et la sécurité. Évaluer et Tester des Frameworks Alternatifs : Objectif : Évaluer au moins trois frameworks alternatifs en fonction de la liste de critères établie. Délai : 4 semaines. Description : Effectuer des tests pratiques pour chaque framework afin de vérifier leur conformité aux critères et documenter les résultats. Développer un Prototype Fonctionnel : Objectif : Réaliser un Proof of Concept (POC) comprenant un menu principal et trois modules fonctionnels. Délai : 6 semaines. Description : Utiliser le framework sélectionné pour développer un prototype démontrant les capacités du framework à répondre aux exigences du projet. 3.1.2 Préparer la Transition Technologique Assurer une transition fluide et sécurisée vers le nouveau framework. Mettre à Niveau la Spécification de l’API : Objectif : Conformer la spécification de l’API au standard OpenAPI 3. Délai : 2 semaines. Description : Revoir et modifier la spécification actuelle pour garantir la compatibilité et les bonnes pratiques. Modifier le Système d’Authentification : Objectif : Mettre en place un système d’authentification robuste pour garantir la sécurité de l’API. Délai : 3 semaines. Description : Intégrer des méthodes modernes d’authentification (par exemple, OAuth2) pour renforcer la sécurité et simplifier l’implémentation. Former l’Équipe sur le Nouveau Framework : Objectif : Effectuer une semaine d’auto-formation pour l’ensemble de l’équipe sur le framework sélectionné. Délai : 1 semaine. Description : Utiliser des ressources en ligne et des formations internes pour acquérir les compétences nécessaires. Établir une Liste de Modules à Migrer : Objectif : Créer une liste ordonnée des modules existants à porter, créer ou supprimer. Délai : 2 semaines. Description : Prioriser les modules en fonction de leur importance et de leur complexité, en incluant une évaluation des efforts requis pour chaque module. Minimum viable product : Liste modules 3.1.3 Développer la Nouvelle Application Web Concevoir et déployer une nouvelle application web performante et fonctionnelle. Développer les Modules Nécessaires : Objectif : Concevoir et développer au moins 20 modules fonctionnels pour la nouvelle application. Délai : 3 mois. Description : Chaque module doit être testé et validé selon les critères de qualité et de performance. Optimiser les Performances de l’Application : Objectif : Assurer que les performances de la nouvelle application ne se dégradent pas de plus de 5% par rapport à l’application actuelle. Délai : 1 mois. Description : Effectuer des tests de performance réguliers et optimiser le code et l’infrastructure en conséquence. 3.1.4 Objectif 4 : Développer les Compétences en Gestion de Projet et Techniques But : Acquérir et démontrer les compétences nécessaires pour réussir dans le cadre du projet. Mettre en Place une Démarche de Gestion de Projet : Objectif : Développer une approche structurée de gestion de projet pour atteindre les objectifs fixés. Délai : 1 semaine. Description : Utiliser des outils de gestion de projet (comme Jira ou Trello) pour suivre les tâches, les progrès et les délais. Fournir les Livrables Requis : Objectif : Produire et livrer tous les livrables exigés par l’ESEO. Délai : Selon les échéances établies. Description : Assurer la qualité et la complétude de tous les documents et livrables. Obtenir des Notes Élevées aux Évaluations PING : Objectif : Obtenir une note supérieure à 14/20 aux trois évaluations PING. Délai : Prochaine session d’évaluations. Description : Préparer et réviser les matières évaluées pour garantir une performance optimale. 4 Démarche Comment fonctionne le service R&D de base outils de gestion de projet Redmine Fiche de développement Notes Outils - Gestion de projet - Gestion de version - Environnement de développement - Produits de développement - Langages de programmation 4.1 Démarche générale La démarché générale du projet est définie par le présent document. Ce document défini les buts et objectif attendus. Il établis également un plan d’action pour les atteindre. Il mets en place un processus de communication pour garantir la circulation de l’information. Enfin, il identifie les risques et problèmes potentiels qui pourraient survenir et établi des solutions pour y faire face. 4.2 Méthodologie, techniques et technologies Le développement logiciel suit plusieurs étapes essentielles pour assurer la création et le bon fonctionnement d’un logiciel. Analyse des besoins : Identifier et définir les besoins des utilisateurs et les objectifs du logiciel. Les exigences fonctionnelles et non fonctionnelles sont spécifiées, ainsi que les contraintes du projet. Conception : Créer une architecture logicielle en se basant sur l’analyse des besoins. Cela implique la création de diagrammes, de schémas et de modèles qui servent de guide pour la réalisation du logiciel. Tests : Vérifier la qualité et la conformité du logiciel. Des tests unitaires, d’intégration et de validation sont réalisés pour détecter et corriger les éventuelles erreurs et bugs. Intégration : Assembler les différentes parties du logiciel en un ensemble fonctionnel et cohérent. Cela inclut l’ajout de fonctionnalités supplémentaires et l’optimisation des performances. Déploiement : Rendre le logiciel disponible aux utilisateurs finaux. Cela peut impliquer l’installation sur des serveurs, la distribution de fichiers d’installation ou la mise à disposition sur des plateformes en ligne. Maintenance : Maintenir le logiciel en état de fonctionnement. Les erreurs sont corrigées, des mises à jour sont effectuées, des nouvelles fonctionnalités peuvent être ajoutées et des améliorations sont apportées pour répondre aux besoins changeants des utilisateurs. Dans le cadre de ce projet, une approche de gestion de projet agile sera utilisée. Cette approche permettra une meilleure gestion des changements et des imprévus, tout en limitant l’effet tunnel. Méthodologie agile La méthodologie agile est une approche de gestion de projet qui se caractérise par sa flexibilité, sa collaboration continue avec les parties prenantes et sa capacité à s’adapter aux changements tout au long du cycle de développement. Les méthodologies agiles mettent l’accent sur la livraison itérative et incrémentale du produit, favorisant des cycles de développement courts et des retours fréquents des utilisateurs. L’agilité est souvent utilisée dans le développement logiciel, mais elle peut également être appliquée à d’autres domaines. Pour plus d’informations sur les méthodologies agiles, voir https://www.atlassian.com/fr/agile. La phase de développement sera découpée en sprints. Chaque période entreprise (2 à 4 semaines) intégrera un unique sprint. Cette segmentation permettra d’effectuer des contrôles réguliers de l’avancement et favorisera un dialogue continu. Sprint Un sprint en développement agile est un cycle de travail itératif et incrémental qui permet à une équipe de développer et de livrer des fonctionnalités de manière régulière, tout en restant flexible et adaptative aux changements et aux retours client. Un sprint intègre généralement les étapes suivantes : Planification des tâches en début du sprint Développement et test continu Revues et rétrospectives en fin de sprint Livraison logicielle potentielle Le projet utilisera un backlog pour recueillir, organiser et hiérarchiser l’ensemble des travaux à réaliser dans le cadre du projet. Chaque fonctionnalité à développer sera spécifiée en une user story et ajoutée comme ticket dans le backlog. Une user story est une technique de description des besoins du client du point de vue de ce dernier. L’objectif de chaque user story est de décrire une fonctionnalité du logiciel de manière simple et compréhensible, tout en se concentrant sur la valeur apportée à l’utilisateur final. Chaque user story pourra dépendre de plusieurs tâches de développements, qui seront rattachés à ce ticket. Au début de chaque sprint, le backlog devra être complété en ajoutant les tâches à traiter pour les trois semaines à venir. Si nécessaire, une modélisation de la fonctionnalité à implémenter pourra être réalisée pour répondre aux spécifications établies précédemment. Chaque sprint devra intégrer la spécification, le développement, les tests et la documentation d’une ou plusieurs user story. Un réunion sera effectué à la fin de chaque sprint afin de suivre l’état d’avancement et d’exercer un esprit critique. Le but de ces réunions sera de replacer les tickets qui n’ont pas pu être traités et d’effectuer un bilan de ce qui à marché et ce qui n’a pas fonctionné pour mieux organiser les sprints futurs. Ces réunions seront basés sur un unique document de suivi, qui sera mis à jour durant chaque sprint. L’utilisation d’UML sera privilégiée pour la modélisation des différents aspects du projet, tels que les cas d’utilisation, les diagrammes de classes, les diagrammes de séquence, etc. Cela permettra de décrire plus précisément les besoins du projet et de mieux visualiser les différentes parties impliquées. 4.3 Analyse des risques Table 2: SWOT (Strengths Weaknesses Opportunities Threats) Atouts Handicapes Interne Forces Maintenir la confidentialité du code source Economies de coûts à long terme Étendre et renforcer les compétences techniques de l’équipe de développement Faiblesses Coûteux en termes de temps et de ressources Peut ne pas répondre aux besoins Difficultés à apprendre un nouveau framework Externe Opportunités Nouvelles opportunités de développement pour l’entreprise Élargir son champ d’expertise Bénéficier de l’expertise de la communauté open source Menaces Coûts de licence prohibitifs ou des restrictions d’utilisation Difficulté à trouver une alternative qui soit compatible avec la cible embarquée Retards dans le développement en raison de l’apprentissage d’un nouveau framework Manque de compétences sur le nouveau framework et les technologies associées Établir un calendrier pour l’apprentissage et la mise en œuvre du nouveau framework Offrir une formation à l’équipe de développement pour aider à l’apprentissage du nouveau framework Mobiliser des ressources supplémentaires pour maintenir les délais Communauté du framework limitée Effectuer une recherche sur les communautés de développeurs pour identifier les frameworks les plus populaires Évaluer la taille de la communauté et la fréquence des mises à jour Évaluer la qualité de la documentation et des exemples Manque de ressources Augmenter l’équipe de développement pour combler les manques Étendre les délais du projet Réduire les fonctionnalités à développer Incompatibilité avec la cible embarquée Examiner les exigences de la cible embarquée et les spécifications de l’alternative Effectuer des tests de compatibilité pour vérifier si l’alternative répond aux exigences de la cible embarquée Résistance au changement Communiquer sur les avantages du nouveau framework choisi Mettre en place une formation pour les développeurs qui ne connaissent pas le nouveau framework Difficulté à trouver une alternative viable Effectuer une analyse des besoins pour identifier les caractéristiques essentielles que l’alternative doit posséder Effectuer une recherche sur les coûts des licences pour les différentes alternatives Quadrant chart risk analysis 4.4 Acteurs Table 3: Acteurs Acteur Rôle Description Joshua Jourdam Chef de projet, Développeur Fourni le livrable du projet. Conduit et pilote le projet. Anime les différentes réunions. Principal développeur. Sébastien Barré Sponsor du projet, Client Responsable global du projet et est un soutien pour le chef de projet. Prend les décisions importantes et arbitre entre deux choix, notamment en situation de crise. Détermine les attendus du projet et les exigences liées. Validera la conformité du livrable à ses attentes et exigences. Opérateurs, testeurs, développeurs Utilisateurs finaux Personnes qui vont utiliser le produit ou le service au quotidien. Exprime leur soutien ou leur mécontentement vis à vis du projet. Jean-Louis Baudoin Utilisateur clé Référent métier, développeur de l’application Qt. Sera le principal interlocuteur pour collecter des informations sur l’application actuelle. David Dupond Utilisateur clé Référent licenses, pourra valider la license d’utilisation du nouvel outil. Lucas Cecillon Utilisateur clé Référent cybersécurité, pourra être consulté sur les problématiques de sécurité de l’application et de l’API. Stagiaires Support Peuvent intervenir en renfort sur le projet, notamment lors des périodes estivales. 4.5 Lotissements %%| label: fig-work-breakdown-structure %%| fig-cap: WBS (Work Breakdown Structure) %%| file: ./graphics/wbs.mmd 4.6 Planning prévisionnel #fig-forecast-schedule-mermaid{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#ccc;}#fig-forecast-schedule-mermaid .error-icon{fill:#a44141;}#fig-forecast-schedule-mermaid .error-text{fill:#ddd;stroke:#ddd;}#fig-forecast-schedule-mermaid .edge-thickness-normal{stroke-width:2px;}#fig-forecast-schedule-mermaid .edge-thickness-thick{stroke-width:3.5px;}#fig-forecast-schedule-mermaid .edge-pattern-solid{stroke-dasharray:0;}#fig-forecast-schedule-mermaid .edge-pattern-dashed{stroke-dasharray:3;}#fig-forecast-schedule-mermaid .edge-pattern-dotted{stroke-dasharray:2;}#fig-forecast-schedule-mermaid .marker{fill:lightgrey;stroke:lightgrey;}#fig-forecast-schedule-mermaid .marker.cross{stroke:lightgrey;}#fig-forecast-schedule-mermaid svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#fig-forecast-schedule-mermaid .mermaid-main-font{font-family:"trebuchet ms",verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-forecast-schedule-mermaid .exclude-range{fill:hsl(52.9411764706, 28.813559322%, 48.431372549%);}#fig-forecast-schedule-mermaid .section{stroke:none;opacity:0.2;}#fig-forecast-schedule-mermaid .section0{fill:hsl(52.9411764706, 28.813559322%, 58.431372549%);}#fig-forecast-schedule-mermaid .section2{fill:#EAE8D9;}#fig-forecast-schedule-mermaid .section1,#fig-forecast-schedule-mermaid .section3{fill:#333;opacity:0.2;}#fig-forecast-schedule-mermaid .sectionTitle0{fill:#F9FFFE;}#fig-forecast-schedule-mermaid .sectionTitle1{fill:#F9FFFE;}#fig-forecast-schedule-mermaid .sectionTitle2{fill:#F9FFFE;}#fig-forecast-schedule-mermaid .sectionTitle3{fill:#F9FFFE;}#fig-forecast-schedule-mermaid .sectionTitle{text-anchor:start;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-forecast-schedule-mermaid .grid .tick{stroke:lightgrey;opacity:0.8;shape-rendering:crispEdges;}#fig-forecast-schedule-mermaid .grid .tick text{font-family:"trebuchet ms",verdana,arial,sans-serif;fill:#ccc;}#fig-forecast-schedule-mermaid .grid path{stroke-width:0;}#fig-forecast-schedule-mermaid .today{fill:none;stroke:#DB5757;stroke-width:2px;}#fig-forecast-schedule-mermaid .task{stroke-width:2;}#fig-forecast-schedule-mermaid .taskText{text-anchor:middle;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-forecast-schedule-mermaid .taskTextOutsideRight{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%);text-anchor:start;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-forecast-schedule-mermaid .taskTextOutsideLeft{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%);text-anchor:end;}#fig-forecast-schedule-mermaid .task.clickable{cursor:pointer;}#fig-forecast-schedule-mermaid .taskText.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#fig-forecast-schedule-mermaid .taskTextOutsideLeft.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#fig-forecast-schedule-mermaid .taskTextOutsideRight.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#fig-forecast-schedule-mermaid .taskText0,#fig-forecast-schedule-mermaid .taskText1,#fig-forecast-schedule-mermaid .taskText2,#fig-forecast-schedule-mermaid .taskText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%);}#fig-forecast-schedule-mermaid .task0,#fig-forecast-schedule-mermaid .task1,#fig-forecast-schedule-mermaid .task2,#fig-forecast-schedule-mermaid .task3{fill:hsl(180, 1.5873015873%, 35.3529411765%);stroke:#ffffff;}#fig-forecast-schedule-mermaid .taskTextOutside0,#fig-forecast-schedule-mermaid .taskTextOutside2{fill:lightgrey;}#fig-forecast-schedule-mermaid .taskTextOutside1,#fig-forecast-schedule-mermaid .taskTextOutside3{fill:lightgrey;}#fig-forecast-schedule-mermaid .active0,#fig-forecast-schedule-mermaid .active1,#fig-forecast-schedule-mermaid .active2,#fig-forecast-schedule-mermaid .active3{fill:#81B1DB;stroke:#ffffff;}#fig-forecast-schedule-mermaid .activeText0,#fig-forecast-schedule-mermaid .activeText1,#fig-forecast-schedule-mermaid .activeText2,#fig-forecast-schedule-mermaid .activeText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%)!important;}#fig-forecast-schedule-mermaid .done0,#fig-forecast-schedule-mermaid .done1,#fig-forecast-schedule-mermaid .done2,#fig-forecast-schedule-mermaid .done3{stroke:grey;fill:lightgrey;stroke-width:2;}#fig-forecast-schedule-mermaid .doneText0,#fig-forecast-schedule-mermaid .doneText1,#fig-forecast-schedule-mermaid .doneText2,#fig-forecast-schedule-mermaid .doneText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%)!important;}#fig-forecast-schedule-mermaid .crit0,#fig-forecast-schedule-mermaid .crit1,#fig-forecast-schedule-mermaid .crit2,#fig-forecast-schedule-mermaid .crit3{stroke:#E83737;fill:#E83737;stroke-width:2;}#fig-forecast-schedule-mermaid .activeCrit0,#fig-forecast-schedule-mermaid .activeCrit1,#fig-forecast-schedule-mermaid .activeCrit2,#fig-forecast-schedule-mermaid .activeCrit3{stroke:#E83737;fill:#81B1DB;stroke-width:2;}#fig-forecast-schedule-mermaid .doneCrit0,#fig-forecast-schedule-mermaid .doneCrit1,#fig-forecast-schedule-mermaid .doneCrit2,#fig-forecast-schedule-mermaid .doneCrit3{stroke:#E83737;fill:lightgrey;stroke-width:2;cursor:pointer;shape-rendering:crispEdges;}#fig-forecast-schedule-mermaid .milestone{transform:rotate(45deg) scale(0.8,0.8);}#fig-forecast-schedule-mermaid .milestoneText{font-style:italic;}#fig-forecast-schedule-mermaid .doneCritText0,#fig-forecast-schedule-mermaid .doneCritText1,#fig-forecast-schedule-mermaid .doneCritText2,#fig-forecast-schedule-mermaid .doneCritText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%)!important;}#fig-forecast-schedule-mermaid .activeCritText0,#fig-forecast-schedule-mermaid .activeCritText1,#fig-forecast-schedule-mermaid .activeCritText2,#fig-forecast-schedule-mermaid .activeCritText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%)!important;}#fig-forecast-schedule-mermaid .titleText{text-anchor:middle;font-size:18px;fill:#ccc;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-forecast-schedule-mermaid :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;} 01/06 01/07 01/08 01/09 01/10 01/11 01/12 01/01 01/02 01/03 01/04 01/05 01/06 01/07 01/08 01/09Réunion de lancement Collecte informations Rapport avant projet Réunion premier choix OpenAPI Soutenance avant projet Authentification FormationPOC Réunion de validation Feuille de route Sprints Rapport intermédiaire Soutenance intermédiaire Réunion de clôture Rapport final Soutenance final EvaluationPréparationDéveloppementEseo Figure 11: Diagramme de GANTT prévisionnel 4.7 Planning effectif #fig-actual-schedule-mermaid{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#ccc;}#fig-actual-schedule-mermaid .error-icon{fill:#a44141;}#fig-actual-schedule-mermaid .error-text{fill:#ddd;stroke:#ddd;}#fig-actual-schedule-mermaid .edge-thickness-normal{stroke-width:2px;}#fig-actual-schedule-mermaid .edge-thickness-thick{stroke-width:3.5px;}#fig-actual-schedule-mermaid .edge-pattern-solid{stroke-dasharray:0;}#fig-actual-schedule-mermaid .edge-pattern-dashed{stroke-dasharray:3;}#fig-actual-schedule-mermaid .edge-pattern-dotted{stroke-dasharray:2;}#fig-actual-schedule-mermaid .marker{fill:lightgrey;stroke:lightgrey;}#fig-actual-schedule-mermaid .marker.cross{stroke:lightgrey;}#fig-actual-schedule-mermaid svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#fig-actual-schedule-mermaid .mermaid-main-font{font-family:"trebuchet ms",verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-actual-schedule-mermaid .exclude-range{fill:hsl(52.9411764706, 28.813559322%, 48.431372549%);}#fig-actual-schedule-mermaid .section{stroke:none;opacity:0.2;}#fig-actual-schedule-mermaid .section0{fill:hsl(52.9411764706, 28.813559322%, 58.431372549%);}#fig-actual-schedule-mermaid .section2{fill:#EAE8D9;}#fig-actual-schedule-mermaid .section1,#fig-actual-schedule-mermaid .section3{fill:#333;opacity:0.2;}#fig-actual-schedule-mermaid .sectionTitle0{fill:#F9FFFE;}#fig-actual-schedule-mermaid .sectionTitle1{fill:#F9FFFE;}#fig-actual-schedule-mermaid .sectionTitle2{fill:#F9FFFE;}#fig-actual-schedule-mermaid .sectionTitle3{fill:#F9FFFE;}#fig-actual-schedule-mermaid .sectionTitle{text-anchor:start;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-actual-schedule-mermaid .grid .tick{stroke:lightgrey;opacity:0.8;shape-rendering:crispEdges;}#fig-actual-schedule-mermaid .grid .tick text{font-family:"trebuchet ms",verdana,arial,sans-serif;fill:#ccc;}#fig-actual-schedule-mermaid .grid path{stroke-width:0;}#fig-actual-schedule-mermaid .today{fill:none;stroke:#DB5757;stroke-width:2px;}#fig-actual-schedule-mermaid .task{stroke-width:2;}#fig-actual-schedule-mermaid .taskText{text-anchor:middle;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-actual-schedule-mermaid .taskTextOutsideRight{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%);text-anchor:start;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-actual-schedule-mermaid .taskTextOutsideLeft{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%);text-anchor:end;}#fig-actual-schedule-mermaid .task.clickable{cursor:pointer;}#fig-actual-schedule-mermaid .taskText.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#fig-actual-schedule-mermaid .taskTextOutsideLeft.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#fig-actual-schedule-mermaid .taskTextOutsideRight.clickable{cursor:pointer;fill:#003163!important;font-weight:bold;}#fig-actual-schedule-mermaid .taskText0,#fig-actual-schedule-mermaid .taskText1,#fig-actual-schedule-mermaid .taskText2,#fig-actual-schedule-mermaid .taskText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%);}#fig-actual-schedule-mermaid .task0,#fig-actual-schedule-mermaid .task1,#fig-actual-schedule-mermaid .task2,#fig-actual-schedule-mermaid .task3{fill:hsl(180, 1.5873015873%, 35.3529411765%);stroke:#ffffff;}#fig-actual-schedule-mermaid .taskTextOutside0,#fig-actual-schedule-mermaid .taskTextOutside2{fill:lightgrey;}#fig-actual-schedule-mermaid .taskTextOutside1,#fig-actual-schedule-mermaid .taskTextOutside3{fill:lightgrey;}#fig-actual-schedule-mermaid .active0,#fig-actual-schedule-mermaid .active1,#fig-actual-schedule-mermaid .active2,#fig-actual-schedule-mermaid .active3{fill:#81B1DB;stroke:#ffffff;}#fig-actual-schedule-mermaid .activeText0,#fig-actual-schedule-mermaid .activeText1,#fig-actual-schedule-mermaid .activeText2,#fig-actual-schedule-mermaid .activeText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%)!important;}#fig-actual-schedule-mermaid .done0,#fig-actual-schedule-mermaid .done1,#fig-actual-schedule-mermaid .done2,#fig-actual-schedule-mermaid .done3{stroke:grey;fill:lightgrey;stroke-width:2;}#fig-actual-schedule-mermaid .doneText0,#fig-actual-schedule-mermaid .doneText1,#fig-actual-schedule-mermaid .doneText2,#fig-actual-schedule-mermaid .doneText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%)!important;}#fig-actual-schedule-mermaid .crit0,#fig-actual-schedule-mermaid .crit1,#fig-actual-schedule-mermaid .crit2,#fig-actual-schedule-mermaid .crit3{stroke:#E83737;fill:#E83737;stroke-width:2;}#fig-actual-schedule-mermaid .activeCrit0,#fig-actual-schedule-mermaid .activeCrit1,#fig-actual-schedule-mermaid .activeCrit2,#fig-actual-schedule-mermaid .activeCrit3{stroke:#E83737;fill:#81B1DB;stroke-width:2;}#fig-actual-schedule-mermaid .doneCrit0,#fig-actual-schedule-mermaid .doneCrit1,#fig-actual-schedule-mermaid .doneCrit2,#fig-actual-schedule-mermaid .doneCrit3{stroke:#E83737;fill:lightgrey;stroke-width:2;cursor:pointer;shape-rendering:crispEdges;}#fig-actual-schedule-mermaid .milestone{transform:rotate(45deg) scale(0.8,0.8);}#fig-actual-schedule-mermaid .milestoneText{font-style:italic;}#fig-actual-schedule-mermaid .doneCritText0,#fig-actual-schedule-mermaid .doneCritText1,#fig-actual-schedule-mermaid .doneCritText2,#fig-actual-schedule-mermaid .doneCritText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%)!important;}#fig-actual-schedule-mermaid .activeCritText0,#fig-actual-schedule-mermaid .activeCritText1,#fig-actual-schedule-mermaid .activeCritText2,#fig-actual-schedule-mermaid .activeCritText3{fill:hsl(28.5714285714, 17.3553719008%, 86.2745098039%)!important;}#fig-actual-schedule-mermaid .titleText{text-anchor:middle;font-size:18px;fill:#ccc;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#fig-actual-schedule-mermaid :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;} 01/06 01/07 01/08 01/09 01/10 01/11 01/12 01/01 01/02 01/03 01/04 01/05 01/06 01/07 01/08 01/09Réunion de lancement Recherche technologies Rapport avant projet Soutenance avant projet POC Spécification API Spécification fonctionelle Présentation des frameworks Présentation application React / Choix définitif Création du projet Sprint 1 Point authentification Authentification Point stratégie de tests Validation specification API Fiche de développement V1 Test déploiement sur cible Sprint 2 Sprint 3 Soutenance intermédiaire Sprint 4 Formation React Introduction plateforme de développementSprint 5 Rapport final Soutenance finale EvaluationPréparationDéveloppementEseo Figure 12: Diagramme de GANTT effectif 4.7.1 Jalons Réunion de lancement : Cadre le projet, enjeux, objectifs, finalité, jalons projet, risques identifiés, calendrier projet, … Réunion premier choix : Choix du framework pour commencer le POC Réunion de validation : Validation définitive du choix du framework, planification des étapes de développement Réunion en début de sprint : Tri, organisation, revue des tâches à réaliser Réunion de fin de sprint: Bilan, présentation des tâches réalisés, revue des spécification, replanification des tâches non réalisées, … Réunion de clôture : Fin du projet, assure une transition pour la maintenance et l’exploitation du projet 4.7.2 Livrables Document de comparaison des frameworks avec une évaluation quantitative de chaque critère, basée sur une analyse détaillée. Document de spécification, détaillant les fonctionnalités, les exigences système, les ressources requises et les performances attendues. Prototype (POC) fonctionnel de l’interface web, respectant toutes les spécifications documentées. Feuille de route pour la mise en place du framework, détaillant les étapes à suivre pour la pour le développement des fonctionnalités, les ressources requises et les délais. Documentation développeur qui comprends un guide de démarrage et les bonnes pratiques de développement. Documentation utilisateur qui comprends un guide d’utilisation et les bonnes pratiques d’utilisation. Rapports et soutenances de projet. 4.8 Budget La durée du projet PING est estimée à 500 heures minimum. Ce projet devrait nécessiter plus de ressources. Le temps total nécessaire à la réalisation du projet est difficilement quantifiable pour le moment. Étant donné que le projet est cadré pour une seule personne, le coût peut être calculé en utilisant le tarif horaire du salaire brut annuel moyen d’un ingénieur débutant. Cela représente environ 10 000 €. Des coûts d’intervention de développement externes supplémentaires ponctuels peuvent s’ajouter, mais ils sont plus difficiles à chiffrer. La mobilisation de certains membres de l’équipe logiciel lors des réunions peut également être prise en compte. 5 Résultats 5.1 Evaluation des technologies du marché La première phase du projet visait à trouver une technologie alternative au framework Qt pour développer des application pour la plateforme web. Pour cela, j’ai établi une liste de critères permettant d’évaluer chaque solution. Besoins développement Besoins fonctionnels Langage de programmation Communauté et support Proximité avec l’existant Date de sortie Documentation Évolutivité Licence Outils Patron de conception Plateformes Popularité Possibles freins J’ai identifié l’ensemble des technologies qui permettent de développer des application pour la plateforme Web. Ces technologies peuvent être regroupées en 2 catégories, natif et multi-plateforme. La première catégorie comprends l’ensemble des frameworks basés sur le langage JavaScript. La seconde réuni quand à elle des solutions plus diverses qui ce basent sur différent langages comme le C#, le Dart ou le C++. Ces technologies peuvent permettre de cibler plusieurs plateformes (web, bureau, mobile) avec une base de code unique. Ce premier découpage m’a amener à tester 5 solutions. Natif : React Vue Angular Multi-plateforme : Flutter Uno platform J’ai établi une procédure de test unique. L’objectif était de comprendre le fonctionnement basique et l’architecture des frameworks ainsi que les langages sur lesquels ils sont basés. Le test consistait à réaliser une page affichant des données reçues par l’API REST et un formulaire permettant de modifier le nom d’hôte de l’équipement. A partir de cette petite étude, j’ai conclu que les frameworks multi-plateformes sont des solution moins adaptés à notre besoin. Elle sont plus complexes et n’ont pas une intégration complète avec le fonctionnalités d’un navigateur web. Les solutions natives semblaient plus simples à utiliser. La prochaine étape consistait à réaliser un POC plus complet qui intègre les fonctionnalités de certains modules de l’application Qt. J’ai opté pour l’utilisation de React, le framework les plus largement utilisé. J’ai supervisé activement la période de stage de Romain LeDivenah, qui a pris en charge la réalisation de ce POC. Malgré mon statut de débutant, j’ai pu guider Romain dans la prise en main de React. Au cours du mois de supervision, l’objectif était de développer un prototype fonctionnel, répondant aux critères définis, comprenant un menu ainsi que trois modules distincts. 5.2 Transition 5.2.1 OpenAPI La spécification de l’API est définie dans un document word qui évolue au fur et à mesure de l’ajout de fonctionnalités. Cette documentation peut être améliorée. Il existe des outils spécialisés respectant les standards de l’industrie. Ils permettent de générer la documentation, la modélisation et du code a partir d’un fichier de description. J’ai souhaité intégrer la migration vers une spécification de notre API REST basée sur la norme OpenAPI 3 pour avoir a disposition une spécification qui suis des règles appliquées au marché actuel. Il existe de nombreux outil qui utilisent cette norme que je voulais également intégrer. Le stage de Romain LeDivenah m’a permis de travailler sur d’autres aspects en parallèle comme la spécification de l’api, et l’intégration d’outils. J’ai rédigé la spécification de l’API REST en suivant la norme OpenAPI 3.0.0. J’ai également mis en place l’outil Swagger UI pour mettre à disposition une documentation interactive de l’API à partir de cette spécification. J’ai aussi utilisé OpenAPI Generator pour générer un SDK client en JavaScript. Cet étape permettra de simplifier l’utilisation de l’API REST dans l’application à développer. Enfin le dernier outil que j’ai déployé est Spotlight Prism. C’est un serveur simulé HTTP open source qui permet d’émuler le comportement de notre API à partir d’un jeu d’exemple qui peut être défini dans la spécification. Cet outil permet de tester l’API sans avoir d’équipement à disposition ou de développer la partie graphique avant ou en parallèle de l’intégration d’une nouvelle fonctionnalité dans le CAP4000. Exemple de documentation générée avec Swagger UI 5.2.2 Authentification L’authentification de l’API est basée sur un secret partagé. Cette solution pouvait être utilisé avec l’application Qt car celle-ci était compilée en un format binaire. Cela présente cependant des problématiques majeures, particulièrement dans le contexte du langage JavaScript. Étant un langage interprété, le code source JavaScript est généralement envoyé au client, exposant ainsi le secret partagé au sein du code. Cette exposition représente une menace sérieuse pour la sécurité de l’API, car un utilisateur malveillant pourrait potentiellement accéder au code source, récupérer le secret partagé et compromettre l’authentification. L’utilisation du protocole HTTP (non sécurisé) pour communiquer avec l’API représente un risque supplémentaire. En effet, les données envoyées sur le réseau ne sont pas chiffrées, ce qui permet à un attaquant d’intercepter les requêtes et d’obtenir le secret partagé. La vulnérabilité de cette approche souligne la nécessité de stratégies plus sécurisées, telles que l’utilisation de méthodes d’authentification basées sur des jetons et l’utilisation du protocole HTTPS pour communiquer avec l’API. Lucas CECILLON, référent cybersécurité, a pu travailler sur cette partie en spécifiant et en implémentant un nouveau mécanisme d’authentification basé sur l’utilisation d’un jeton JWT et l’utilisation du protocole HTTPS. Ce mécanisme à également introduit d’autres problématiques comme la gestion des certificats utilisés pour chiffrer la connexion HTTPS sur un équipement. Le protocole HTTP est utilisé pour communiquer avec l’API REST. L’authentification est basée sur un secret partagé. Ce secret est stocké dans le code source de l’application Qt. L’authentification est effectuée avec plusieurs sécurités : Signature des requêtes avec un HMAC (basé sur le secret partagé) Timestamp pour éviter les attaques de rejeu Contrairement à l’IHM Web en QT utilisant WebAssembly (projet compilé puis exécuté directement par le navigateur), React envoie les sources au navigateur (JS, HTML, CSS) pour y être exécutées. Le secret est donc facilement interceptable et visible par n’importe qui. Par conséquent, il est essentiel de mettre en place une gestion plus sécurisée de la session utilisateur. Plusieurs solutions ont été envisagées pour sécuriser l’authentification : - JWT - Bearer - Session Cookie - Basic La solution mise en place s’axe autour de trois points : Utilisation du protocole HTTPS pour sécuriser les échanges Utilisation de JWT (JSON Web Token) pour l’authentification Gestion des certificats pour chiffrer les communications Suivant les recommandations de l’anssi 5.2.2.1 Mesures de protection SSL CSRF CSP CORS Protection des cookies HSTS XSS Rafraîchissement du token Cryptographie Rejeux 5.2.2.2 HTTPS Selon l’étude [DR01] réalisée, il est essentiel d’établir une communication entre le client et l’API en utilisant le protocole HTTPS (HTTP sécurisé avec TLS). Cela signifie que chaque appel à l’API doit obligatoirement être effectué via le port HTTPS. Par exemple : https://192.168.0.1:3001/api/v3/test. De la même manière, il est impératif que l’utilisateur ne puisse accéder à l’application Web qu’en utilisant le protocole HTTPS. Aucun accès en HTTP ne pourra être fait. Tout cela nécessite une gestion appropriée des certificats sur le calculateur afin de prévenir d’éventuels problèmes d’accès en cas de certificats corrompus ou expirés. 5.2.2.3 JWT Dorénavant, l’authentification des requêtes sera basée sur l’utilisation de jetons d’accès. Ces jetons seront générés par l’API et renvoyés une fois l’authentification effectuée. Par la suite, pour chaque requête jusqu’à la déconnexion du client, le jeton devra être inclus dans la demande envoyée à l’API. Avant de traiter une demande, l’API vérifiera systématiquement le contenu et l’intégrité du jeton de la manière suivante : • Est-il valide ? ◦ SHA256(header + « . » + payload) == signature  • Est-il expiré ? ◦ Valeur « exp » • L’utilisateur a-t-il le droit d’effectuer cette requête ? ◦ Valeur « role » Selon l’étude [DR01] réalisée, l’API doit renvoyer le token dans un cookie sécurisé. Voici les paramètres à appliquer au cookie : • name : name (nom du cookie) • value : value (valeur du token) • domain : domain (nom de domaine du site, ou ip) • path : « / » (chemin du cookie) • sameSite : strict (politique de cloisonnement) • httpOnly : true (inaccessible côté client) • session : true (cookie de session) • secure : true (portée limitée aux canaux sécurisés) L’API doit spécifier le domaine du cookie en fonction de l’adresse IP à partir de laquelle elle a été sollicitée. 5.2.2.4 Certificats La mise en place d’une nouvelle version de l’IHM et d’API qui communiquent exclusivement via HTTPS soulève des questions concernant le gestion des certificats sur le calculateur. En effet, si l’utilisateur de l’IHM parvient à déposer sur le calculateur un couple de clé-privée/certificat corrompus, alors le serveur web ne sera pas joignable en HTTPS. Cela empechera toute configuration par le client, ce qui n’est pas souhaitable. Pour éviter cette situation, il est essentiel de mettre en œuvre une solution de gestion de la configuration TLS robuste, reposant sur trois piliers principaux : la génération automatique de certificats auto-signés de secours, la sécurisation de l’import des certificats et de leur utilisation. Flowchart fallback certificats 5.2.3 POC supervision stage 5.3 Développement 5.3.1 Spécification de l’application Figure 13: Redmine IHM Web CAP4000 Figure 14: User story : configuration des interfaces réseaux L’application Qt n’a pas de spécification propre. J’ai utilisé le logiciel Redmine pour créer un backlog de l’ensemble des fonctionnalités à développer. J’ai également utilisé ce logiciel pour créer des user stories qui décrivent les fonctionnalités à développer. Ces user stories sont utilisées pour définir les critères d’acceptation des fonctionnalités. Elles sont également utilisées pour suivre l’avancement du développement. Evolution spécification Avant / Après Comparaison Utilité Changements 5.3.2 Fonctionnement de la solution On garde le meme principe voir schema contexte Fonctionnement de React TODO 5.3.3 Architecture/Workspace (expliquer comment fonctionne un monorepo) CI/CD (commitlint, semantic versioning, changelog) Développement (branches, pull request) Comparaison SVN Git -> gitlab J’ai créé l’environnement du projet dans un “monorepo”. C’est un référentiel unique qui permet de contenir plusieurs projet. J’ai choisi cette approche car nous souhaitons développer une application par produit. Comme l’application Qt, le code sera découpé en modules qui pourront être intégrés ou non dans l’application d’un produit. J’ai également mis en place une démarche qualité du code et des méthodologies de développement. L’application adopte la norme semantic versioning pour gérer les versions des projets. J’ai préparé un changelog pour répertorier toutes le évolution de l’application. J’ai finalement intégré l’outil commitlint pour vérifier que les messages de commit suivent une convention de rédaction. Le projet est versionné avec l’outil de gestion de configuration Subversion. Le projet suivra une méthodologie de développement en branches. Chaque fonctionnalité sera développée dans une branche dédiée. Une fois la fonctionnalité terminée, la branche sera fusionnée dans la branche principale. Cette approche permet de travailler sur plusieurs fonctionnalités en parallèle et de garder une branche principale stable. #mermaid-8{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;fill:#ccc;}#mermaid-8 .error-icon{fill:#a44141;}#mermaid-8 .error-text{fill:#ddd;stroke:#ddd;}#mermaid-8 .edge-thickness-normal{stroke-width:2px;}#mermaid-8 .edge-thickness-thick{stroke-width:3.5px;}#mermaid-8 .edge-pattern-solid{stroke-dasharray:0;}#mermaid-8 .edge-pattern-dashed{stroke-dasharray:3;}#mermaid-8 .edge-pattern-dotted{stroke-dasharray:2;}#mermaid-8 .marker{fill:lightgrey;stroke:lightgrey;}#mermaid-8 .marker.cross{stroke:lightgrey;}#mermaid-8 svg{font-family:"trebuchet ms",verdana,arial,sans-serif;font-size:16px;}#mermaid-8 .commit-id,#mermaid-8 .commit-msg,#mermaid-8 .branch-label{fill:lightgrey;color:lightgrey;font-family:'trebuchet ms',verdana,arial,sans-serif;font-family:var(--mermaid-font-family);}#mermaid-8 .branch-label0{fill:#2c2c2c;}#mermaid-8 .commit0{stroke:hsl(180, 1.5873015873%, 48.3529411765%);fill:hsl(180, 1.5873015873%, 48.3529411765%);}#mermaid-8 .commit-highlight0{stroke:rgb(133.6571428571, 129.7428571428, 129.7428571428);fill:rgb(133.6571428571, 129.7428571428, 129.7428571428);}#mermaid-8 .label0{fill:hsl(180, 1.5873015873%, 48.3529411765%);}#mermaid-8 .arrow0{stroke:hsl(180, 1.5873015873%, 48.3529411765%);}#mermaid-8 .branch-label1{fill:lightgrey;}#mermaid-8 .commit1{stroke:hsl(321.6393442623, 65.5913978495%, 38.2352941176%);fill:hsl(321.6393442623, 65.5913978495%, 38.2352941176%);}#mermaid-8 .commit-highlight1{stroke:rgb(93.5483870969, 221.4516129033, 139.677419355);fill:rgb(93.5483870969, 221.4516129033, 139.677419355);}#mermaid-8 .label1{fill:hsl(321.6393442623, 65.5913978495%, 38.2352941176%);}#mermaid-8 .arrow1{stroke:hsl(321.6393442623, 65.5913978495%, 38.2352941176%);}#mermaid-8 .branch-label2{fill:lightgrey;}#mermaid-8 .commit2{stroke:hsl(194.4, 16.5562913907%, 49.6078431373%);fill:hsl(194.4, 16.5562913907%, 49.6078431373%);}#mermaid-8 .commit-highlight2{stroke:rgb(149.4437086091, 117.6092715231, 107.5562913906);fill:rgb(149.4437086091, 117.6092715231, 107.5562913906);}#mermaid-8 .label2{fill:hsl(194.4, 16.5562913907%, 49.6078431373%);}#mermaid-8 .arrow2{stroke:hsl(194.4, 16.5562913907%, 49.6078431373%);}#mermaid-8 .branch-label3{fill:#2c2c2c;}#mermaid-8 .commit3{stroke:hsl(23.0769230769, 49.0566037736%, 40.7843137255%);fill:hsl(23.0769230769, 49.0566037736%, 40.7843137255%);}#mermaid-8 .commit-highlight3{stroke:rgb(99.9811320754, 162.7735849057, 202.0188679245);fill:rgb(99.9811320754, 162.7735849057, 202.0188679245);}#mermaid-8 .label3{fill:hsl(23.0769230769, 49.0566037736%, 40.7843137255%);}#mermaid-8 .arrow3{stroke:hsl(23.0769230769, 49.0566037736%, 40.7843137255%);}#mermaid-8 .branch-label4{fill:lightgrey;}#mermaid-8 .commit4{stroke:hsl(0, 83.3333333333%, 43.5294117647%);fill:hsl(0, 83.3333333333%, 43.5294117647%);}#mermaid-8 .commit-highlight4{stroke:rgb(51.5000000001, 236.5, 236.5);fill:rgb(51.5000000001, 236.5, 236.5);}#mermaid-8 .label4{fill:hsl(0, 83.3333333333%, 43.5294117647%);}#mermaid-8 .arrow4{stroke:hsl(0, 83.3333333333%, 43.5294117647%);}#mermaid-8 .branch-label5{fill:lightgrey;}#mermaid-8 .commit5{stroke:hsl(289.1666666667, 100%, 24.1176470588%);fill:hsl(289.1666666667, 100%, 24.1176470588%);}#mermaid-8 .commit-highlight5{stroke:rgb(154.2083333334, 255, 132.0000000001);fill:rgb(154.2083333334, 255, 132.0000000001);}#mermaid-8 .label5{fill:hsl(289.1666666667, 100%, 24.1176470588%);}#mermaid-8 .arrow5{stroke:hsl(289.1666666667, 100%, 24.1176470588%);}#mermaid-8 .branch-label6{fill:lightgrey;}#mermaid-8 .commit6{stroke:hsl(35.1315789474, 98.7012987013%, 40.1960784314%);fill:hsl(35.1315789474, 98.7012987013%, 40.1960784314%);}#mermaid-8 .commit-highlight6{stroke:rgb(51.331168831, 135.1948051946, 253.6688311688);fill:rgb(51.331168831, 135.1948051946, 253.6688311688);}#mermaid-8 .label6{fill:hsl(35.1315789474, 98.7012987013%, 40.1960784314%);}#mermaid-8 .arrow6{stroke:hsl(35.1315789474, 98.7012987013%, 40.1960784314%);}#mermaid-8 .branch-label7{fill:lightgrey;}#mermaid-8 .commit7{stroke:hsl(106.1538461538, 84.4155844156%, 35.0980392157%);fill:hsl(106.1538461538, 84.4155844156%, 35.0980392157%);}#mermaid-8 .commit-highlight7{stroke:rgb(206.1818181817, 89.948051948, 241.051948052);fill:rgb(206.1818181817, 89.948051948, 241.051948052);}#mermaid-8 .label7{fill:hsl(106.1538461538, 84.4155844156%, 35.0980392157%);}#mermaid-8 .arrow7{stroke:hsl(106.1538461538, 84.4155844156%, 35.0980392157%);}#mermaid-8 .branch{stroke-width:1;stroke:lightgrey;stroke-dasharray:2;}#mermaid-8 .commit-label{font-size:10px;fill:rgb(183.8476190475, 181.5523809523, 181.5523809523);}#mermaid-8 .commit-label-bkg{font-size:10px;fill:hsl(180, 1.5873015873%, 28.3529411765%);opacity:0.5;}#mermaid-8 .tag-label{font-size:10px;fill:#e0dfdf;}#mermaid-8 .tag-label-bkg{fill:#1f2020;stroke:#cccccc;}#mermaid-8 .tag-hole{fill:#ccc;}#mermaid-8 .commit-merge{stroke:#1f2020;fill:#1f2020;}#mermaid-8 .commit-reverse{stroke:#1f2020;fill:#1f2020;stroke-width:3;}#mermaid-8 .commit-highlight-inner{stroke:#1f2020;fill:#1f2020;}#mermaid-8 .arrow{stroke-width:8;stroke-linecap:round;fill:none;}#mermaid-8 .gitTitleText{text-anchor:middle;font-size:18px;fill:#ccc;}#mermaid-8 :root{--mermaid-font-family:"trebuchet ms",verdana,arial,sans-serif;}mainfea-networkfix-log0-14645aa1-6fbbbf7V0.12-dfad1603-a9e8c90V0.25-dda00826-f304b18 5.3.4 Bibliothèques (zod, react-hook-form, react-query, react-router, orval, react-testing-library, vitest) 5.3.4.1 Routing Définition Modules Gestion “plug-in” multi-app 5.3.5 Gestion des erreurs et des chargements 5.3.6 Authentification et autorisation Utilisateurs et rôles principes Note Existant HTTP / Headers auth Problème Solutions HTTPS/JWT choix reauthentification flow dashboard lucas 5.3.6.1 RBAC 5.3.7 Application Primitives/Core Routing Navigation Layout Page d’accueil QtReact Empty Previous Next 5.3.8 Modules J’ai étudié l’application Qt pour comprendre son fonctionnement et son architecture. J’ai ensuite identifié les modules qui la composent et les fonctionnalités qu’ils offrent. J’ai regroupé certains modules qui partagent des fonctionnalités similaires. J’ai ensuite créé une liste permettant de prioriser les modules en fonction de leur importance. Cette liste est présentée dans le tableau ci-dessous. Table 4: Ordre de priorité des modules Priorité Module Qt Module React 0 IDENTIFICATION Shell REDEMARRAGE CALCULATEUR Shell DECONNEXION Shell 1 ETHERNET ADRESSES IP Réseau NODES CARTES ETAT DES CARTES Cartes ETAT DES E/S DATE/HEURE ETAT SYNCHRO Date et heure MODE SYNCHRO FUSEAU HORAIRE DATE / HEURE JOURNAL JOURNAL Journal RAZ DU JOURNAL 2 CONFIGURATION IMPORT CONFIGURATION Configuration EXPORT CONFIGURATION MOTS DE PASSE Utilisateurs CERT. EQUIPEMENT Certificats CERTIFICATS CA Autorités de certification 3 LISTE MNEMOS Mnémoniques SYS LOG SYSLOG SNMP SNMP 4 SERVEUR IEC 60870 IEC 61850 CLIENT IEC 61850 SERVEUR MODBUS MODBUS MAITRE MODBUS MODBUS ESCLAVE MQTT MQTT 5 FICHIER Fichier IMPRIMANTES Imprimantes DEBOGAGE Débogage 5.3.8.1 Réseau QtReact Previous Next Previous Next Le premier module sur lequel j’ai travaillé est le module réseau. Ce module permet de configurer les adresses IP des interfaces réseau de l’équipement. Il permet également de configurer les nœuds du réseau. Les nœuds sont des équipements distants qui peuvent être connectés à l’équipement principal. Ce module est essentiel pour la configuration de l’équipement et pour assurer la communication avec les autres équipements du réseau. HSR et PRP TODO : Expliquer HSR et PRP https://fr.belden.com/solutions/high-availability-seamless-redundancy 5.3.8.2 Journal QtReact Previous Next Previous Next 5.3.8.3 Date et heure QtReact Previous Next Previous Next 5.3.8.4 Cartes QtReact Previous Next Previous Next 5.3.8.5 Configuration QtReact Previous Next Previous Next 5.3.8.6 Utilisateurs QtReact Previous Next 5.3.8.7 Certificats QtReact Previous Next 5.3.8.8 Autorités de certification QtReact Empty Previous Next 5.3.8.9 Mnémoniques QtReact Previous Next 5.3.9 Tests 5.3.10 Performances Les performance des deux applications ont été évaluée avec l’outil lighthouse de chrome. C’est un outil automatisé open source permettant de mesurer la qualité des pages Web. Les rapports générés par cet outil permettent d’identifier les problèmes de performance, d’accessibilité et de compatibilité. Rapport application Qt Rapport application React Également, l’outil ne calcule pas correctement les temps de chargement initiaux au démarrage des application WebAssembly (Qt). Le temps de chargement de l’application Qt est d’environ 15 secondes tandis que le temps de chargement de l’application react est quasiment instantané (autour de 1 seconde). Finalement l’outil ne rends pas compte de l’expérience utilisateur. L’application React est plus fluide et plus réactive. L’intégration d’une couche de cache limite aussi le rechargement des données. L’interface de l’application Qt est plus simple mais ne permets pas de naviguer rapidement entre les pages. 5.3.11 Application 5.3.11.1 Sprint 1 Autoformation Développement de l’application Shell et layout Module réseau Recherche d’une suite de tests Intégration avec des bibliothèques pertinentes Routage et navigation : react-router Cache client : react-query 5.3.11.2 Sprint 2 Développement de l’application Module journal Module date et heure Module cartes Refactorisation des modules développés modules 1 à 4 Délégation de la gestion des formulaire Validation des données : zod Gestion des formulaires : react-hook-form Mise en place de la gestion multi-application Mise en place des principes d’authentification et d’autorisation avec la gestion multi-utilisateur Mise en place des tests de composants avec cypress Conformité Non régression 5.3.11.3 Sprint 3 Écriture des tests des modules 1 à 4 Test de déploiement sur cible avec un nouveau serveur web Problématiques liées au développement d’ihm Layout Front/back Authentification Echange de données Technologies Evolution rapide Cest quoi react ? fonctionnement => une seule responsabilité => affichage ecosystème très large, nécessité d’adopter d’autres bibliothèques pour étoffer les fonctionnalités et garantir la qualité du code 6 Conclusion En conclusion, le projet entamé en juin 2023, a permis de développer une application de configuration des automates SDEL plus ergonomique et sécurisée. Les nouvelles fonctionnalités et interfaces ont été conçues en collaboration avec les utilisateurs finaux. Les retours positifs attestent de l’efficacité de cette approche centrée utilisateur. Cette nouvelle application vient étoffer notre offre de services et renforce notre positionnement sur le marché de l’énergie qui nécessite l’intégration de contraintes de cybersécurité de plus en plus importantes au fils des années. La vigilance demeure de mise, et une gestion proactive post-implémentation est recommandée pour assurer une adaptation continue aux évolutions technologiques et aux nouvelles menaces. Ce projet constitue ainsi un jalon important dans notre trajectoire vers l’innovation et la pérennité de nos systèmes. Aujourd’hui, l’application est utilisée quotidiennement par les opérateurs de maintenance de nos clients et les équipes de test en interne. D’un point de vue personnel, ce projet vient clôturer ma formation d’ingénieur. Il marque un terme à mes études et m’a permis de mettre en pratique les connaissances acquises durant ces trois années d’apprentissage. Sur le plan technique et scientifique, le projet m’a permis de consolider mes compétences en informatique. J’ai pu découvrir de nouvelles technologies et approfondir mes connaissances en développement WEB. En termes de montée en compétences, j’ai constaté une nette amélioration de ma compréhension des applications WEB ainsi que les contraintes appliqués au domaine de l’embarqué et des réseaux privés. Du point de vue économique, le chiffrage du projet et la mise en place d’un feuille de route ont constitué une expérience pratique sur le fonctionnement et la nécessité des ces processus en entreprise. Cela m’a sensibilisé aux implications financières des choix effectués en tant que responsable et aiguillé ma vision vers une approche plus stratégique et pragmatique. Sur le plan organisationnel, la gestion du projet m’a confronté à certains défis en termes de coordination, de planification et de suivi des tâches. J’ai pu mettre en pratique les méthodes agiles apprises en cours. J’ai également pu progresser en autonomie. Au début parfois trop distant et au fur et à mesure de l’avancement du projet, j’ai amélioré la transmission d’informations vers les différentes parties du projet. Ces compétences organisationnelles acquises seront indéniablement bénéfiques dans ma future carrière professionnelle. Quant à mon projet professionnel, cette expérience a confirmé ma passion pour le développement logiciel et a éclairé les prochaines étapes de ma carrière. Mon objectif est de m’orienter vers le développement logiciel, en particulier dans le domaine WEB et fullstack. Pour finir, cette expérience a été formatrice et enrichissante à bien des égards. Elle a façonné mon identité professionnelle et renforcé ma détermination à exceller dans le domaine de l’informatique. Je suis prêt à relever de nouveaux défis et à contribuer de manière significative à des projets futurs. 6.1 Bilan Le projet a débuté par la mise en place de l’environnement de travail et l’apprentissage autonome des technologies, avec peu de références internes dans l’entreprise. Environ 600 à 700 heures ont été consacrées au projet, avec une moitié du projet déjà réalisée. La plupart des objectifs des premières phases du projet ont été atteints. L’authentification reste à valider lors du prochain sprint. Des refactorisations ont été nécessaires au fur et à mesure de l’apprentissage. Le projet a donc atteint des jalons significatifs, mais le chemin vers la finalisation nécessite encore des efforts substantiels. Il reste encore environ 600 heures de travail pour finir le développement des modules restant. 7 Annexes 7.1 Références 7.2 Grille des compétences 7.3 Acknowledgments I am grateful for the insightful comments offered by the anonymous peer reviewers at Books & Texts. The generosity and expertise of one and all have improved this study in innumerable ways and saved me from many errors; those that inevitably remain are entirely my own responsibility

      pas fou

    Annotators

    1. Reviewer #2 (Public Review):

      Summary:

      Hiramatsu et al. investigated how cognate neurotransmitter receptors with antagonizing downstream effects localize within neurons when co-expressed. They focus on mapping the localization of the dopaminergic Dop1R1 and Dop2R receptors, which correspond to the mammalian D1- and D2-like dopamine receptors, which have opposing effects on intracellular cAMP levels, in neurons of the Drosophila mushroom body (MB). To visualize specific receptors in single neuron types within the crowded MB neuropil, the authors use existing dopamine receptor alleles tagged with 7 copies of split GFP to target reconstitution of GFP tags only in the neurons of interest as a read-out of receptor localization. The authors show that both Dop1R1 and Dop2R, with differing degrees, are enriched in axonal compartments of both the Kenyon Cells cholinergic presynaptic inputs and in different dopamine neurons (DANs), which project axons to the MB. Co-localization studies of dopamine receptors with the presynaptic marker Brp suggest that Dop1R1 and, to a larger extent Dop2R, localize in the proximity of release sites. This localization pattern in DANs suggests that Dop1R1 and Dop2R work in dual-feedback regulation as autoreceptors. Finally, they provide evidence that the balance of Dop1R1 and Dop2R in the axons of two different DAN populations is differentially modulated by starvation and that this regulation plays a role in regulating appetitive behaviors.

      Strengths:

      The authors use reconstitution of GFP fluorescence of split GFP tags knocked into the endogenous locus at the C-terminus of the dopamine receptors as a readout of dopamine receptor localization. This elegant approach preserves the endogenous transcriptional and post-transcriptional regulation of the receptor, which is essential for studies of protein localization.

      The study focuses on mapping the localization of dopamine receptors in neurons of the mushroom body. This is an excellent choice of system to address the question posed in this study, as the neurons are well-studied, and their connections are carefully reconstructed in the mushroom body connectome. Furthermore, the role of this circuit in different behaviors and associative memory permits the linking of patterns of receptor localization to circuit function and resulting behavior. Because of these features, the authors can provide evidence that two antagonizing dopamine receptors can act as autoreceptors within the axonal compartment of MB innervating DANs. The differential regulation of the balance of the two receptors under starvation in two distinct DAN innervations provides evidence of the role that regulation of this balance can play in circuit function and behavioral output.

      Weaknesses:

      The approach of using endogenously tagged alleles to study localization is a strength of this study, but the authors do not provide sufficient evidence that the insertion of 7 copies of split GFP to the C terminus of the dopamine receptors does not interfere with the endogenous localization pattern or function. Both sets of tagged alleles (1X Venus and 7X split GFP tagged) were previously reported (Kondo et al., 2020), but only the 1X Venus tagged alleles were further functionally validated in assays of olfactory appetitive memory. Despite the smaller size of the 7X split-GFP array tag knocked into the same location as the 1X venus tag, the reconstitution of 7 copies of GFP at the C terminus of the dopamine receptor, might substantially increase the molecular bulk at this site, potentially impeding the function of the receptor more significantly than the smaller, single Venus tag. The data presented by Kondo et al. 2020, is insufficient to conclude that the two alleles are equivalent.

      The authors' conclusion that the receptors localize to presynaptic sites is weak. The analysis of the colocalization of the active zone marker Brp whole-brain staining with dopamine receptors labeled in specific neurons is insufficient to conclude that the receptors are localized at presynaptic sites. Given the highly crowded neuropil environment, the data cannot differentiate between the receptor localization postsynaptic to a dopamine release site or at a presynaptic site within the same neuron. The known distribution of presynaptic sites within the neurons analyzed in the study provides evidence that the receptors are enriched in axonal compartments, but co-labeling of presynaptic sites and receptors in the same neuron or super-resolution methods are needed to provide evidence of receptor localization at active zones. The data presented in Figures 5K-5L provides compelling evidence that the receptors localize to neuronal varicosities in DANs where the receptors could play a role as autoreceptors.

      Given the highly crowded environment of the mushroom body neuropil, the analysis of dopamine receptor localization in Kenyon cells is not conclusive. The data is sufficient to conclude that the receptors are preferentially localizing to the axonal compartment of Kenyon cells, but co-localization with brain-wide Brp active zone immunostaining is not sufficient to determine if the receptor localizes juxtaposed to dopaminergic release sites, in proximity of release sites in Kenyon cells, or both.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This study defines a fundamental aspect of protein kinase signalling in the protist parasite Toxoplasma gondii that is required for acute and chronic infections. The authors provide compelling evidence for the role of SPARK/SPARKEL kinases in regulating cAMP/cGMP signalling, although evidence linking the loss of these kinases to changes in the phosphoproteome is incomplete. Overall, this study will be of great interest to those who study Toxoplasma and related apicomplexan parasites.

      We thank the reviewers for their thoughtful and positive evaluation of our work. Below, we have addressed all of the public reviews and recommendations for the authors in point-by-point responses. Additionally, we include with this resubmission RT-qPCR data where we observe no significant change in transcript levels for the relevant AGC kinases, supporting the hypothesis that SPARK/SPARKEL–regulation is post-translational.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Herneisen et al characterise the Toxoplasma PDK1 orthologue SPARK and an associated protein SPARKEL in controlling important fate decisions in Toxoplasma. Over recent years this group and others have characterised the role of cAMP and cGMP signalling in negatively and positively regulating egress, motility, and invasion, respectively. This manuscript furthers this work by showing that SPARK and SPARKEL likely act upstream, or at least control the levels of the cAMP and cGMP-dependent kinases PKA and PKG, respectively, thus controlling the transition of intracellular replicating parasites into extracellular motile forms (and back again).

      The authors use quantitative (phospho)proteomic techniques to elegantly demonstrate the upstream role of SPARK in controlling cAMP and cGMP pathways. They use sophisticated analysis techniques (at least for parasitology) to show the functional association between cGMP and cAMP signalling pathways. They therefore begin to unify our understanding of the complicated signalling pathways used by Toxoplasma to control key regulatory processes that control the activation and suppression of motility. The authors then use molecular and cellular assays on a range of generated transgenic lines to back up their observations made by quantitative proteomics that are clear in their design and approach.

      The authors then extend their work by showing that SPARK/SPARKEL also control PKAc3 function. PKAc3 has previously been shown to negatively regulate differentiation into bradyzoite forms and this work backs up and extends this finding to show that SPARK also controls this. The authors conclude that SPARK could act as a central node of regulation of the asexual stage, keeping parasites in their lytic cell growth and preventing differentiation. Whether this is true is beyond the scope of this paper and will have to be determined at a later date.

      Strengths:

      This is an exceptional body of work. It is elegantly performed, with state-of-the-art proteomic methodologies carefully being applied to Toxoplasma. Observations from the proteomic datasets are masterfully backed up with validation using quantitative molecular and cellular biology assays.

      The paper is carefully and concisely written and is not overreaching in its conclusions. This work and its analysis set a new benchmark for the use of proteomics and molecular genetics in apicomplexan parasites.

      Weaknesses:

      This reviewer did not identify any weaknesses.

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Herneisen et al. examines the Toxoplasma SPARK kinase orthologous to mammalian PDK1 kinase. The extracellular signals trigger cascades of the second messengers and play a central role in the apicomplexan parasites' survival. In Toxoplasma, these cascades regulate active replication of the tachyzoites, which manifests as acute toxoplasmosis, or the development into drug-resilient bradyzoites characteristic of the chronic stage of the disease. This study focuses on the poorly understood signaling mechanisms acting upstream of such second messenger kinases as PKA and PKG. The authors showed that similar to PDK1, Toxoplasma SPARK appears to regulate several AGC kinases.

      Strengths:

      The study demonstrated a strong association of the SPARK kinase with an elongin-like SPARKEL factor and an uncharacterized AGC kinase. Using a set of standard assays, the authors determined the SPARK/SPARKEL role in parasite egress and invasion. Finally, the study presented evidence of the SPARK/SPARKEL involvement in the bradyzoite differentiation.

      Weaknesses:

      Although the study can potentially uncover essential sensing mechanisms operating in Toxoplasma, the evidence of the SPARK/SPARKEL mechanisms is weak. Specifically, due to incomplete data analysis, the SPARK/SPARKEL-dependent phosphoregulation of AGC kinases cannot be evaluated. The manuscript requires better organization and lacks guidance on the described experiments. Although the study is built on advanced genetics, at times, it is unnecessarily complicated, raising doubts rather than benefiting the study.

      The evidence for the SPARK/SPARKEL interaction is demonstrated through diverse experimental approaches that are internally consistent. Five separate mass spectrometry experiments, with replicates and appropriate controls, with tags on either SPARK or SPARKEL, showed that SPARK and SPARKEL form a strong interaction (Figure 1A, 1D, 1E; Figure 1—figure supplement 1). Global mass spectrometry experiments assessing the impact of  SPARK or SPARKEL depletion showed similar features (a reduction in PKG and PKA abundance and up-regulation of bradyzoite-associated proteins; Figure 3C–D). The phenotypes associated with SPARK and SPARKEL depletion phenocopy one another in all cell biological assays we tested (Figure 2A, 2D and PMID: 35484233; Figure 2E–J; Figure 4E–F; Figure 6A–B). Measuring the abundance of SPARK and SPARKEL in unenriched samples was challenging, but immunoblotting and proteomics suggest that depletion of one factor leads to down-regulation of the other (Figure 2B, 2C; Figure 3—figure supplement 1), which explains the genetic and cell biological phenocopying described above. We note that “further biochemical studies are required to discern the regulatory interactions between SPARK and SPARKEL” (first submission lines 590-591) and are beyond the scope of this work.

      The evidence for SPARK/SPARKEL regulation of AGC kinase activity is demonstrated through diverse experimental approaches that are also internally consistent. PKA C1 and PKG abundance levels decrease in parasites depleted of SPARK/SPARKEL, as measured by mass spectrometry (Figure 3A and 3C) and cell-based assays for PKA C1/R (Figure 4D–F). Comparisons of the global SPARK-, PKA R-, PKG-, and PKA C3-depleted phosphoproteomes suggest that PKA and PKG activity is reduced upon SPARK depletion whereas the activity of an unrelated factor (PP1) is unaffected (Figure 4G–H, Figure 4—figure supplement 1, Figure 5D–E, Figure 7I–J). Parasites depleted of SPARK are hypersensitized to a PKG inhibitor (Figure 5B–C). SPARK, PKA, and PKG are proximal in cellulo (Figure 3I) and SPARK co-purifies with PKA C3 (Figure 7A). The kinetic-phase phenotypes associated with SPARK and SPARKEL depletion (PMID: 32379047, Figure 2A, 2D–2J) are consistent with reduced PKG activity (PMID: 28465425) and only develop after PKG has been depleted as shown by proteomics experiments (Figure 2E-J and Figure 3C). Other studies have shown that the effects of reduced PKG activity are dominant to reduced PKA C1 activity (PMID: 29030485). The replicative-phase phenotypes associated with SPARK and SPARKEL depletion are consistent with reduced PKA C3 activity (PMID: 27247232 and herein). Mechanistically, PKG and PKA C1 activity must be lower in SPARK-depleted parasites because the abundances of these kinases are lower (Figure 3A, 3C). The mechanism of regulation may be more complex in the case of PKA C3, as SPARK depletion did not cause a reduction in PKA C3 abundance as measured by cellular assays (Figure 7B–F), but PKA C3 activity decreased (Figure 7I–K). We concede that multiple mechanisms may lead to the reduction in PKA C1 and PKG abundances, such as decreased activation loop phosphorylation and autophosphorylation at other stabilizing sites or enhanced ubiquitin ligase activity leading to active degradation of the kinases; we have moved speculation regarding such mechanisms to the Discussion.

      Although the reviewer commented that the manuscript “requires better organization” in the public review, no specific recommendations were provided to the authors. Therefore, we did not change the organization of the manuscript. We added an additional paragraph to the Discussion to reiterate key findings: “A prior study identified SPARK as a regulator of parasite invasion and egress following 24 hours of kinase depletion (Smith et al., 2022). Unexpectedly, we observed that three hours of SPARK or SPARKEL depletion were insufficient to impact T. gondii motility or calcium-dependent signaling, indicating that the phenotypes associated with SPARK and SPARKEL depletion develop over time. Quantitative proteomics revealed that PKA and PKG abundances began to decrease after more than three hours of SPARK depletion. Proximity labeling experiments also suggested that SPARK, PKA, and PKG are spatially associated within the parasite cell. We propose a model in which SPARK down-regulation coincides with reduced PKG and PKA activity due to diminished protein levels.” This work built upon genetic and proteomic approaches recently described by our group, which we cited in the text and extensive methods section. We added additional experimental detail where noted in the reviewer’s recommendations to the authors.

      The study utilizes advanced genetics because biochemical tools for eukaryotic parasites are limited. For example, no antibodies for T. gondii SPARK, PKA subunits, or PKG exist; to say nothing of phosphosite-specific antibodies, which are common in the mammalian cell signaling field. Therefore, to measure the relationship between SPARK, SPARKEL, and PKA subunits, we had to generate strains in which multiple proteins were tagged with epitopes for downstream analysis. The genetic experiments included appropriate controls and were internally consistent with results obtained using orthogonal approaches, such as mass spectrometry.

      Reviewer #3 (Public Review):

      Summary:

      This paper focuses on the roles of a toxoplasma protein (SPARKEL) with homology to an elongin C and the kinase SPARK that it interacts with. They demonstrate that the two proteins regulate the abundance of PKA and PKG, and that depletion of SPARKEL reduces invasion and egress (previously shown with SPARK), and that their loss also triggers spontaneous bradyzoite differentiation. The data are overall very convincing and will be of high interest to those who study Toxoplasma and related apicomplexan parasites.

      Strengths:

      The study is very well executed with appropriate controls. The manuscript is also very well and clearly written. Overall, the work clearly demonstrates that SPARK/SPARKEL regulate invasion and egress and that their loss triggers differentiation.

      Weaknesses:

      (1) The authors fail to discriminate between SPARK/SPARKEL acting as negative regulators of differentiation as a result of an active role in regulating stage-specific transcription/translation or as a consequence of a stress response activated when either is depleted

      We demonstrate a novel function for SPARK and SPARKEL as negative regulators of differentiation. The pathways leading to differentiation are being actively studied. Up-regulation of a positive transcriptional regulator of chronic differentiation, BFD1, is sufficient to trigger differentiation in vitro in the absence of other stressful growth conditions (PMID: 31955846). SPARK or SPARKEL depletion results in up-regulation of proteins that are up-regulated upon BFD1 overexpression. Whether BFD1 overexpression or SPARK and SPARKEL depletion triggers cellular stress pathways is beyond the scope of the current work, which focused instead on the immediate effect of these pathways on AGC kinases. Study of the effect of the various kinases on the parasite phosphoproteome shows that the putative targets of PKA C3 are specifically downregulated upon SPARK knockdown, indicating PKA C3 activity is indeed decreased in the latter condition.

      (2) The function of SPARKEL has not been addressed. In mammalian cells, Elongin C is part of an E3 ubiquitin ligase complex that regulates transcription and other processes. From what I can tell from the proteomic data, homologs of the Elongin B/C complex were not identified. This is an important issue as the authors find that PKG and PKA protein levels are reduced in the knockdown strains

      Our experiments suggest that SPARK and SPARKEL form a complex, and down-regulation of one complex member leads to down-regulation of the other. Thus in all tested assays, knockdown of SPARK and SPARKEL phenocopy one another. Further biochemical and structural work will be required to determine the mechanism by which SPARKEL regulates SPARK.

      Nearly all studies of the function of elongin C have been conducted in mammalian cells. Proteins with elongin C domains may serve alternative and unexplored functions in unicellular eukaryotes. We searched for the presence of Elongin A/B and known Elongin C complex members in the T. gondii genome and were unable to identify orthologs, explaining why these proteins were not identified in mass spectrometry experiments. Please see our response in Recommendations for the Authors, Reviewer 3 point 2.

      Beyond the concerns raised by the review team, we have identified and corrected the following errors or omissions in the first submission of the manuscript:

      - Line 176 of the first submission referred to a “peptide sequence match (PSM)”, which we have changed to “peptide-spectrum match”.

      - We recolored and relabeled the lines in Figure 5A so that it is easier to match a specific peptide with a specific line; and also corrected a mislabeling.

      - Figure 7B SPARK panel was incorrectly centered. The raw files can be viewed in Figure 7—source data 2.

      - Figure 7—figure supplement 1D was missing an x-axis label.

      - Line 1172 referred to “Supplementary File X”, which we corrected to “Supplementary File 3”.

      - We have updated references to preprints that have since been published, including PMID: 38093015, 37933960, 37966241, and 37610220.

      Editors comments:

      The proteomics data reported in this study underpin the major findings and are very comprehensive. As noted in the reviews, it is strongly recommended that the authors normalize the levels of detected phosphopeptides against the levels of the parent protein in the different mutant lines in order to identify changes in protein phosphorylation that are linked to protein kinase activity rather than protein degradation. A focus on changes that occur at early time points following protein knock-down may also help to identify the main targets of each kinase.

      Please see our response to Reviewer 2 Recommendations for the Authors, points 1 and 2.

      Reviewer #1 (Recommendations For The Authors):

      During my reading, I only found one small mistake. In Figure 7F, the x-axis is missing the word 'PKA'.

      We have updated the x-axis to read “SPARK-AID/PKA C3-mNG (h. + IAA)”.

      All information, code, and reagents are clearly explained.

      Reviewer #2 (Recommendations For The Authors):

      How the phosphoproteome was analyzed needs to be clarified. The normalization step, computing the ratio of the phosphopeptide to the protein (peptide) intensity, appears omitted. It is the most critical step of the analysis. The minor shifts between protein and phosphosite intensity seem negligible, as seen in Figure 4 AB. The significant changes can only be deduced by calculating this ratio. In the current state, the presented results are inconclusive. The manuscript contains overreaching and often unsupported statements because the data has not been appropriately filtered. Related to this topic, it is advisable to use well-accepted terminology and complete words when describing proteome and phosphoproteome. The interexchange of a "peptide" and a "phosphopeptide" in the text confuses and misleads.

      To clarify the phosphoproteome analysis:

      We cite a previous description of the phosphoproteomics sample preparation workflow (lines 1124-1125 of the first submission for example). Our quantitative phosphoproteomics experiments comprise two datasets generated from the same multiplexed samples. The samples were split at the point of phosphopeptide enrichment. Ninety-five percent of the samples were subjected to phosphopeptide enrichment (titanium dioxide followed by nickel affinity chromatography; “enriched samples”). Five percent of the samples were reserved as a reference for the non-enriched proteome (“non-enriched samples”). To clarify this point, we have added the sentences “Approximately 95% of the proteomics sample was used for phosphopeptide enrichment” and “The remaining 5% of the sample was not subjected to the phosphopeptide enrichment protocol” to the Methods sections, after describing the multiplexing steps.

      The samples were fractionated separately and run separately on an LC-MS system, which is described in the Methods section, for example lines 1130-1149 of the first submission. Raw files of the phosphopeptide-enriched and unenriched samples were analyzed separately, which is described in the Methods section, for example lines 1151-1158 of the first submission. To clarify this point, we have added the sentence “Raw files of the phosphopeptide-enriched and unenriched samples were analyzed separately” to the Methods sections. Many of the search parameters and descriptions of normalization and protein abundances were described in lines 1085-1093 of the first submission in reference to the 24h SPARK depletion proteome. We added this information to the description of the SPARK depletion time course phosphoproteome data analysis: “The allowed mass tolerance for precursor and fragment ions was 10 ppm and 0.02 Da, respectively. False discovery was assessed using Percolator with a concatenated target/decoy strategy using a strict FDR of 0.01, relaxed FDR of 0.05, and maximum Delta CN of 0.05. Only unique peptide quantification values were used. Co-isolation and signal-to-noise thresholds were set to 50% and 10, respectively. Normalization was performed according to total peptide amount. In the case of the unenriched samples, protein abundances were calculated from summation of non-phosphopeptide abundances.”

      We hope that this clarifies how the unenriched sample protein-level abundances were calculated. When we discuss “protein abundance”, we are referencing the unenriched sample summed non-phosphopeptide abundance. Our phosphoproteome analysis was based only on phosphopeptides, as our phosphopeptide enrichment resulted in 99% efficiency, and peptides lacking phosphorylation sites were filtered out before subsequent analyses. We used “peptide” and “phosphopeptide” interchangeably because the only peptide-level analysis performed was based on phosphopeptide abundances. We have changed any mention of “peptide” to “phosphopeptide” in the main text. 

      “The normalization step, computing the ratio of the phosphopeptide to the protein (peptide) intensity, appears omitted. It is the most critical step of the analysis.”:

      Unlike common differential gene expression analysis pipelines, proteomics analysis pipelines are not settled. Many analyses do not perform peptide-to-parent-protein corrections; some normalize phosphopeptide abundances to parent protein abundances calculated from summing non-phosphopeptides or a combination of phosphopeptide and non-phosphopeptides on an ad hoc basis; some calculate global normalization factors based on regressions of protein and phosphopeptide abundances or other pairwise comparisons. A caveat of protein normalization of phosphopeptides is that it over-corrects cases in which protein abundance and phosphorylation are interdependent, as is the case for auto-phosphorylation and some activation loop phosphorylations (PMID: 37394063). We used the approach that retained the greatest complexity of the data, which is to not normalize abundances across different mass spectrometry experiments and discard information that was not in the overlap. We have updated Supplementary File 3.3 to include protein-level quantification values (from Supplementary File 3.2) if measured.

      We clarified that the phosphopeptide abundances and protein-level abundances were derived from different datasets that were each internally normalized (globally centered by total peptide amount). Protein-level abundances were summed from non-phosphopeptide abundances. The calculated log2 changes are based on the globally centered data within each dataset. We analyzed the kinetic profiles of changing phosphopeptide abundances relative to a control using approaches similar to those described for several recent temporally resolved T. gondii phosphoproteomes (e.g. PMID: 37933960, 35976251, 36265000, 29141230) and as described in the Methods. The approach does not first correct for unenriched-sample parent protein abundance—in some applications, unenriched samples are not collected at all; instead, phosphopeptide ratios are median-normalized to non-phosphopeptide ratios (quantified due to inefficient phosphopeptide enrichment) and are individually tested against the null distribution of non-phosphopeptide ratios (e.g. PMID: 36265000, 29141230). We did not use this approach because our phosphopeptide enrichment was 99% efficient (18518 phosphopeptides of 18758 peptides with quantification values). In several cases using our approach, parent protein abundance is not quantified in the unenriched proteome dataset, but phosphopeptides are reliably quantified in the enriched proteome dataset. We note that phosphopeptide abundance changes can be difficult to interpret in such cases, e.g. in the first submission lines 178-186 and 193-194. We have added similar text to the results noting that in the case of PKA and PKG, both unenriched parent protein and enriched phosphopeptide abundances decreased (see below). We have also moved speculation about whether SPARK phosphorylates the activation loop of PKA and PKG, or whether the down-regulation of PKA and PKG arises from indirect effects, to the Discussion.

      We have moved comparisons of protein and phosphopeptide abundances from the Results to the Discussion. We added the following sentences to the result section Clustering of phosphopeptide kinetics identifies seven response signatures: “Because non-phosphopeptide and phosphopeptide abundances were quantified in different mass spectrometry experiments, it is challenging to compare the rates of phosphopeptide and parent protein abundance changes, especially when phosphorylation status and protein stability are interconnected. In general, both PKA C1, PKA R, and PKG protein and phosphosite abundances decreased following SPARK depletion (Figure 3—figure supplement 1), as discussed further below. We also observed down-regulation of phosphosite and protein abundances of a MIF4G domain protein.” Figure 3—figure supplement 1E is a new panel that shows PKA C1, PKA R, and PKG phosphopeptide and parent protein abundances along with global changes in phosphopeptide and parent protein abundances in the cases which both were quantified. We changed lines 278-282 in the first submission to “The SPARK depletion time course phosphoproteome showed a reduction in the abundance of PKA C1 T190 and T341, which are located in the activation loop and C-terminal tail, respectively (Figure 4A). Several phosphosites residing in the N terminus of PKA R (e.g. S17, S27, and S94) also decreased following SPARK depletion (Figure 4B).” We changed lines 313-315 in the first submission to “The SPARK depletion time course phosphoproteome showed a reduction in the abundance of several phosphosites residing in the N terminus of PKG as well as T838, which corresponds to the activation loop (Figure 5A). By contrast, S105 did not greatly decrease, and S40 abundance slightly increased.”

      The description of experiments should be more detailed. For example, the 3, 8, and 24 h treatments were used reversely; thus, they should be emphasized as time points before natural egress. Consequently, it seems that 3h treatment should be prioritized, given the SPARK/SPARKEL role in egress/invasion. Unexpectedly, the study draws more attention to a 24-hour treatment. If the AID-SPARK/SPARKEL is eliminated within 1h, parasites undoubtedly accumulate numerous secondary defects during a prolonged 23h deprivation. Since the SPARK pathway activates kinase/phosphatase cascades, the 24h data is likely overwhelmed with the consequences of the long-term complex degradation, making it a poor source of the putative SPARK substrates. Likewise, the downregulation of PKA observed in the 8 hours after SPARK depletion may be an indirect effect of the SPARK degradation. The direct effects and immediate substrates should be detectable within 2-3h of auxin treatment of the nearly egressing cultures.

      The first submission described how parasites were harvested at 32 hours post-infection with 0, 3, 8, or 24 hours of IAA treatment (lines 157-160, 1097-1110, and Figure 3B). To reiterate this experimental detail, we have added “harvested 32 hours post-infection” to the sentence “...quantitative proteomics with tandem mass tag multiplexing that included samples with 0, 3, 8, and 24 hours of SPARK or SPARKEL depletion” and similarly in the figure legend. The time points are unrelated to natural egress because the experiment was terminated at 32 hours post-infection, which is earlier than the window typically used to study natural egress under these conditions (40-48 hours post-infection). We chose to terminate the experiment before natural egress to better localize phosphopeptide changes related to SPARK depletion. The phosphoproteome undergoes dramatic reorganization during egress due to the activity of myriad kinases and phosphatases (see PMID: 35976251, 37933960, and 36265000), which would have likely complicated the signal.

      A pivotal result motivating time-course experiments and analysis was that SPARK/SPARKEL's role in egress and invasion emerges only after an extended depletion period (Figure 2E–J, first submission lines 126-145). The 24h depletion was used in the experimental system that first identified SPARK as a regulator of egress, which motivated our initial experiments, as stated in the first submission lines 126-144 and 149-151. We draw attention to the observation that SPARK and SPARKEL phenotypes develop over time in the first submission, lines 137-145. The role for SPARK/SPARKEL in egress/invasion does not manifest at 3h depletion; it manifests at 24h depletion. To ensure that this point is not overlooked by the reader, we have created a new heading in the Results section (SPARK and SPARKEL depletion phenotypes develop over time) for the paragraph that was previously lines 137-145. The remainder of the manuscript integrates data from proteomic, genetic, and cell-based assays across temporal dimensions to build a working model of how the phenotypes associated with SPARK depletion develop over time.

      Underpinning this comment is an assumption that phosphopeptides that decrease the most rapidly following a kinase’s depletion are direct substrates, whereas phosphopeptides that decrease with slower kinetics are not. This is not always the case. Consider a kinase that phosphorylates sites on substrate A and substrate B. The site on substrate A is also the target of a phosphatase, whereas the site on substrate B is recalcitrant to phosphatase activity. If the kinase were inhibited, then the site on substrate A would be actively dephosphorylated. As measured by a phosphoproteomics experiment, the abundance of the substrate A phosphopeptide would drop rapidly due to the inactivity of the kinase and activity of the phosphatase. In the text, we called such sites “constitutively regulated” or dynamic—they are actively dephosphorylated and phosphorylated within a short timeframe. The phosphosite on substrate B is comparatively static; once it is phosphorylated by the kinase, it is unaffected by subsequent inhibition of the kinase. Only newly synthesized substrate B molecules would be affected by kinase inhibition. As measured by a phosphoproteomics experiment, the abundance of the substrate B phosphopeptide would drop more gradually after kinase inhibition, as the unphosphorylated peptide is found only on newly synthesized proteins that were not previously exposed to kinase activity. An example of the scenario described for substrate A would be that of yeast Cdk1 T14/Y15, which is phosphorylated by Wee1 and dephosphorylated by Cdc25 (e.g. PMID: 7880537). An example of the scenario described for substrate B would be that of the human PKA C activation loop T197, which is phosphorylated by PDK1 and is phosphatase-resistant under physiological conditions (e.g. PMID: 22493239, 15533936).

      Both substrate A and B may be “direct” and functionally relevant targets of the kinase. Categorizing substrates as “immediate” is comparatively less informative in this context (although it may be relevant when studying fast, synchronized processes with high temporal resolution, such as induced Plasmodium spp. gametocyte activation or stimulation of T. gondii secretion). Furthermore, our earlier experiments had shown that the role for SPARK/SPARKEL in motility manifests after 3h depletion and is complete by 24h depletion. By this logic, we were most interested in the candidates showing differences at these time points. We conducted proximity labeling experiments to identify the overlap of proteins that exhibited SPARK-dependent decreases in the global proteomics and were also proximal to SPARK in space (first submission Figure 3I and lines 260-275), thus revealing a prioritized list of candidates, which included PKG and PKA. When technically feasible, we included a temporal dimension to follow-up experiments, rather than relying on a 24h terminal comparison (e.g. Figure 4E–H, Figure 5D–E, Figure 7D–F, Figure 7I–K; all first submission).

      Fig2 (B and C). What antibodies had been used to detect tagged proteins? There is a concern regarding the use of multiple tags attached to the same protein to the point that it doubles the size of the studied protein. The switch of the mobility of the SPARK and SPARKEL on the WB due to a change in MW adds to the confusion. Furthermore, the study did not use all the fused epitopes (e.g., HA). At the same time, the same V5 tag was used to detect two factors in the same parasite. Although the controls are provided, it does not eliminate the possibility that the second band on the WB results from one protein degradation rather than the presence of two individual proteins. Different tags should be used to confirm the co-expression of two proteins. Panel E is missing the X-axis label.

      Figure 2B was incorrectly labeled; the labels corresponding to SPARK and SPARKEL were switched. We corrected this error in the revised figures. The antibodies used were mouse monoclonal anti-V5 as described in the key resources table of the first submission. We added “V5” to Figure 2A and 2B. Regarding the effect of the tagging payload attached to the proteins, we have included in all assays a control relative to a parental strain (TIR1) without a tagging payload, and additionally included internal controls within tagged strains to calculate dependency of a phenotype on IAA treatment. The western blots in Figure 2B and 2C are from two different strains and experiments. The strains and experiments are described in the first submission main text (lines 113-124), the figure legend (lines 1847-1850), the key resources table, and the methods (lines 650-664, 872-891). A description of the SPARK-AID/SPARKEL-mNG strain was included in the key resources table but omitted in the methods. We therefore added the following section to the Methods:

      “SPARKEL-V5-mNG-Ty/SPARK-V5-mAID-HA/RHΔku80Δhxgprt/TIR1

      The HiT vector cutting unit gBlock for SPARKEL (P1) was cloned into the pALH193 HiT empty vector. The vector was linearized with BsaI and co-transfected with the pSS014 Cas9 expression plasmid into SPARK-V5-mAID-HA/RHΔku80Δhxgprt/TIR1 parasites. Clones were selected with 1 µM pyrimethamine and isolated via limiting dilution to generate the SPARKEL-V5-mNG-Ty/SPARK-V5-mAID-HA/RHΔku80Δhxgprt/TIR1 strain. Clones were verified by PCR amplification and sequencing of the junction between the 3′ end of SPARKEL (5’-GGGAGGCCACAACGGCGC-3’) and 5′ end of the protein tag (5’-gggggtcggtcatgttacgt-3’).”

      To clarify the expected MW of each species, we have added the following text to the Methods:

      “The expected molecular weight of SPARKEL-V5-HaloTag-mAID-Ty is 66 kDa, from the 42.7 kDa tagging payload and 23.3 kDa protein sequence. The expected molecular weight of SPARK-V5-mCherry-HA is 89.7 kDa, from the 31.9 kDa tagging payload and 57.8 kDa protein sequence. The expected molecular weight of SPARK-V5-mAID-HA is 71.3 kDa, from the 13.5 kDa tagging payload and 57.8 kDa protein sequence. The expected molecular weight of SPARKEL-V5-mNG-Ty is 55.2 kDa, from the 31.9 kDa tagging payload and 23.3 kDa protein sequence.”

      SPARK and SPARKEL are lowly expressed, which may have been compounded by basal degradation due to the AID tag (see for example Figure 3—figure supplement 1D of the first submission). We attempted several immunoblot conditions and antibodies, and only the V5 antibody proved effective in recognizing these proteins above the limit of detection. For this reason, we included an additional single-tagged control in each immunoblot experiment. Uncropped images of the blots are included in the first submission as Figure 2—figure supplement 1D and E and as Figure 2 source data. We added the following statement to the results section of the text:

      “However, SPARK and SPARKEL abundances are low and approach the limit of detection. We could only detect each protein by the V5 epitope. Although our experiments included single-tagged controls, we cannot formally eliminate the possibility that SPARK-AID yields degradation products that run at the expected molecular weight of SPARKEL. More sensitive methods, such as targeted mass spectrometry, may be required to measure the absolute abundance and stoichiometries of SPARK and SPARKEL.”

      We added “h +IAA” to the x-axis of panel 2E.

      Fig. 3. There is plentiful proteomic data on the factor-depleted parasites. Can it be used to confirm the co-degradation of the SPARK/SPARKEL complex components? This figure mainly includes quality control data that can be moved to Supplement. Did you detect SPARKEL in the TurboID experiment described in panel I? The plot shows only an AGC kinase.

      SPARK and SPARKEL are lowly expressed, and we often do not detect SPARK or SPARKEL peptides with quantification values in complex samples (such as global depletion proteomes and phosphoproteomes; IPs and streptavidin pull-downs are comparatively less complex, with IPs being the least complex samples). We discussed this caveat in the first submission lines 178-186. To additionally clarify this point, we have added “We were unable to measure SPARK or SPARKEL abundances in this proteome” earlier in the text.

      We consider the figure panels relevant to the discussion in the text.

      SPARKEL was not quantified in the SPARK-TurboID experiment (Supplementary File 2). We have added “SPARKEL was not quantified in this experiment” to the text. “Not quantified” is a different outcome from “quantified but not enriched”. The interaction between SPARK and SPARKEL is supported by five other independent interaction experiments in which SPARKEL was quantified (Figure 1A, 1D, 1E; and Figure 1—figure supplement 1). The added insight from the SPARK proximity labeling experiments comes from integration with the global proteomics, which suggests that AGC kinases are in proximity to SPARK and exhibit SPARK-dependent stability and hence activity. The logic of the proximity labeling experiment is described in lines 258-275 of the first submission.

      Fig. 6G is missing deltaBDF1 control for unbiased evaluation of the SPARK KD effect.

      The logic of this experiment was to evaluate whether excess differentiation caused by SPARK and PKA C3 depletion (Figure 6A and 6B) was dependent on the BFD1 circuit. The ∆bfd1 phenotype is well-established under these experimental conditions: parasites lacking BFD1 do not differentiate under spontaneous or alkaline conditions (e.g. PMID: 31955846, 37081202, 37770433). Parasites lacking BFD1 do not differentiate when SPARK and PKA C3 are depleted, suggesting that differentiation caused by SPARK or PKA C3 depletion occurs through the BFD1 circuit. If differentiation caused by SPARK or PKA C3 depletion did not depend on the BFD1 circuit, we might have observed differentiation in the SPARK- and PKA C3-AID/∆bfd1 mutants.

      To clarify this point, we have changed the first sentences of the last paragraph in the results section Depletion of SPARK, SPARKEL, or PKA C3 promotes chronic differentiation: “To assess whether excess differentiation caused by SPARK and PKA C3 depletion is dependent on a previously characterized transcriptional regulator of differentiation, BFD1 (Waldman et al., 2020), we knocked out the BFD1 CDS with a sortable dTomato cassette in the SPARK- and PKA C3-AID strains (Figure 6–figure supplement 1). The resulting SPARK- and PKA C3-AID/∆bfd1 mutants failed to undergo differentiation as measured by cyst wall staining (Figure 6G–H), suggesting that differentiation caused by depletion of these kinases depends on the BFD1 circuit.”

      Lines 239-242. The logic behind the categories of "constitutively regulated sites" and "newly synthesized proteins dependent on SPARK activation" is odd. The former (3h treatment) represents the SPARK-specific events (even though it should be shortened to 1-2h), while an 8h treatment is already contaminated with secondary effects. Since Toxoplasma divides asynchronously, the "newly synthesized" proteins will be present at the time. Also, the protein phosphorylation does not always lead to substrate activation; it can be repressive, too.

      We describe the logic in response to a comment above (substrate A vs. substrate B). It is correct that T. gondii divides asynchronously, with a cell cycle of approximately 8 hours, and 60% of parasites in G1 at a given time (PMID: 11420103). The proteomics experiments measure peptide and protein abundances at a population level. Newly synthesized proteins will be present at all time points; but the proportion of proteins synthesized after SPARK depletion relative to proteins synthesized before SPARK depletion will increase over time.

      We moved lines 238-243 from the first submission to the Discussion.

      It is accurate that phosphorylation does not always lead to substrate activation; it can also be repressive or not change substrate behavior. However, in the case of protein kinases, activation loop phosphorylation is highly correlated with activation (e.g. PMID: 15350212, 31521607).

      Line 250-252: Because the SPARK degradation did not affect intracellular replication, SPARK is unlikely to affect cell cycle-specific phosphorylation.

      To parallel the prior sentences describing different SPARK-dependent down-regulated clusters, we truncated this sentence to “The final cluster of depleted phosphopeptides, Cluster 4, only exhibits down-regulation at 8h of IAA treatment.”

      SPARKEL depletion did not significantly affect intracellular replication under the time frames investigated here (approximately 25 hours post-invasion; Figure 2D). A prior study reported that SPARK depletion did not affect intracellular replication measured on a similar timescale (PMID: 35484233).

      The opening sentence of the Discussion: Typically, we refer to the newly discovered proteins as the orthologs of the previously discovered counterparts and not the vice versa. Thus, calling Toxoplasma SPARK the ortholog of mammalian PDK1 would be more appropriate.

      We changed the opening sentence of the Discussion to “SPARK is an ortholog of PDK1, which is considered a key regulator of AGC kinases”.

      Reviewer #3 (Recommendations For The Authors):

      (1) Authors should show alignment of SPARKEL with Elongin C. Are key residues conserved?

      We have added an alignment of the SKP1/BTB/POZ domains of Homo sapiens elongin C, S. cerevisiae elongin C, and T. gondii SPARKEL as Figure 1—figure supplement 1B. This panel highlights elongin B interface, cullin binding sites, and target protein binding sites based on the human elongin C annotation. As discussed below, these interfaces may not be functionally conserved in T. gondii. Ultimately, future mechanistic and structural studies beyond the scope of the current work will be required to determine how SPARK and SPARKEL physically interact. The Discussion states, “further biochemical studies are required to discern the regulatory interactions between SPARK and SPARKEL” (lines 590-591).

      (2) The failure to identify other Elongin B/C complex members should be addressed by direct IP analysis.

      Indeed, elongin C has traditionally been characterized as a component of multisubunit complexes comprising Elongin A/B/C or Elongin BC/cullin/SOCS that regulate transcription or function as ubiquitin ligases, respectively (for a review, PMID: 22649776). We see two major issues when attempting to generalize these results to apicomplexan parasites. First, nearly all studies of the function of elongin C have been conducted in a single eukaryotic supergroup (the opisthokonts, including yeast and metazoans). The majority of eukaryotic diversity exists in other supergroups, including the SAR supergroup to which apicomplexans such as T. gondii belong (PMID: 31606140). Proteins with elongin C domains may serve alternative and unexplored functions in non-opisthokont unicellular eukaryotes. Second (in support of the first), we were unable to find orthologs of many of the opisthokont complex members in T. gondii, as systematically described below.

      By BLAST, the most similar protein to SPARKEL in S. cerevisiae is ELC1 (YPL046C), with a BLAST E = 0.003. The next most similar protein was SCF ubiquitin ligase subunit SKP1 (YDR328C) with an E value of 0.62. ELC1 is 99 amino acids. The Elongin C (IPR039948) and SKP1/BTB/POZ superfamily domains (IPR011333) span most of this sequence. SPARKEL is 216 amino acids; the Elongin C and  SKP1/BTB/POZ superfamily domains occupy the C-terminal half of the protein. The N-terminal domain of SPARKEL may be important for its function; however, future work is required to address this hypothesis.

      Elongin B: Elongin B is not found universally amongst even opisthokonts; fungi and choanoflagellates lack obvious orthologs. The most similar T. gondii protein to human Elongin B (Q15370) by BLAST is TGME49_223125 (E = 0.017), an apicoplast ubiquitin-like protein PUBL (PMID: 28655825, 33053376). TGME49_223125 has a C-terminal ubiquitin-like domain (IPR000626) but no ELOB domain (IPR039049); indeed, no T. gondii protein has an ELOB domain that can be identified by sequence searching. Given the lack of similarity between EloB and TGME49_223125, as well as this protein’s possible red algal endosymbiont origin, we consider it an unlikely ortholog of EloB and topologically unlikely to  interact with the SPARK/SPARKEL complex. We did not detect TGME49_223125 in SPARK or SPARKEL IPs (Supplementary File 1).

      Elongin A: T. gondii appears to lack a human elongin A ortholog (Q14241) on the basis of sequence similarity. The most similar T. gondii protein to yeast Elongin A (O59671) by BLAST is TGME49_299230 (E = 0.022). Yeast EloA is 263 amino acids. TGME49_299230 is 1101 amino acids and does not have an EloA domain (IPR010684), suggesting it is not a true EloA ortholog.

      Suppressor of cytokine signaling (SOCS): T. gondii appears to lack human SOCS1 or SOCS2 orthologs (O15524 and O14508) on the basis of sequence similarity. We were unable to identify T. gondii proteins with SOCS domains (PF07525, SM00253, SM00969, and SSF158235).

      Von Hippel-Lindau tumor suppressor (VHL): T. gondii appears to lack a human VHL ortholog (P40337) on the basis of sequence similarity.  We were unable to identify T. gondii proteins with VHL domains (IPR024048, IPR024053, PF01847, and SSF49468).

      Cul-2/5: Cullins appeared early in the eukaryotic radiation (PMID: 21554755), and thus T. gondii possesses several. Since the ELC complex has been best characterized with human cullin-2 (Q13617) and cullin-5 (Q93034), we searched for orthologs of these proteins and identified TGME49_289310, TGME49_289310, and TGME49_316660. TGME49_289310 functionally resembles cullin-1 of the SCF complex (PMID: 31348812). None of these proteins were enriched in the SPARK or SPARKEL IPs (Supplementary Table 1).

      Rbx1: We searched for human Rbx1 orthologs (P62877) and identified TGME49_213690, which functionally resembles Rbx1 of the SCF complex (PMID: 31348812); as well as several other RING proteins (TGME49_267520, TGME49_277740, TGME49_261990, and TGME49_232160) that were not found in the SPARK or SPARKEL IPs (Supplementary File 1).

      Rbx2: We searched for human Rbx2 orthologs (Q9UBF6) and identified several RING proteins (TGME49_285190, TGME49_254700, TGME49_292340, TGME49_226740, TGME49_244610, and TGME49_304460) that were not found in the SPARK or SPARKEL IPs (Supplementary File 1). No T. gondii protein has an Rbx2 domain (cd16466) that can be identified by sequence searching.

      In conclusion, we conducted “direct IP analysis” (Figure 1A, 1D; Figure 1-supplement 1A) of the SPARK and SPARKEL complex in the first submission of the manuscript. The observation that SPARK and SPARKEL form strong interactions was validated in cellulo via proximity labeling (Figure 1E; Figure 1-supplement 1B) in the first submission of the manuscript. These results are described together in the results section SPARK complexes with an elongin-like protein, SPARKEL (lines 75-110, first submission of manuscript). The failure to identify an interaction between SPARKEL and Elongin B/C complex members in T. gondii may be due to the observation that Elongin B and several ELC complex members do not exist in most eukaryotes, including T. gondii. We added the sentences “The function of proteins with Elongin C-like domains has not been widely investigated in unicellular eukaryotes” to the Results and “However, the SPARK and SPARKEL IPs and proximity experiments failed to identify obvious components of ubiquitin ligase complexes” to the Discussion.

      (3) PKA and PKG half-lives should be measured as well as their transcript abundances.

      The finding that PKA C1 and PKG protein abundances decreased upon SPARK/SPARKEL depletion was internally consistent across experiments. This down-regulation may be due to transcriptional, translational, or post-translational mechanisms. We measured PKG and PKA C1 transcript abundances in SPARK-AID and TIR1 parasites after 24 hours of IAA treatment using RT-qPCR. We did not detect significant differences in transcript levels of the queried kinases. These findings suggest that SPARK depletion leads to PKG and PKA down-regulation through post-transcriptional mechanisms. Translational control is normally enacted globally, for example through regulation of eukaryotic translation factors (PMID: 15459663). The rapid and specific down-regulation of PKG and PKA C1 would suggest that the kinase abundance levels are regulated by non-global translational mechanisms (e.g. mRNA-specific) or rather post-translational mechanisms.

      Substantial additional work is required to determine protein half-lives in eukaryotic parasites. In our discussion of possible mechanisms and models, we were agnostic as to the cause of reduced PKG and PKA abundances upon SPARK depletion. We note in the discussion, “The cause for reduction of PKA C1 and PKG levels requires further study” (lines 541-542).

    1. Joint Public Review:

      Ewing sarcoma is an aggressive pediatric cancer driven by the EWS-FLI oncogene. Ewing sarcoma cells are addicted to this chimeric transcription factor, which represents a strong therapeutic vulnerability. Unfortunately, targeting EWS-FLI has proven to be very difficult and better understanding how this chimeric transcription factor works is critical to achieving this goal. Towards this perspective, the group had previously identified a DBD-𝛼4 helix (DBD) in FLI that appears to be necessary to mediate EWS-FLI transcriptomic activity. Here, the authors used multi-omic approaches, including CUT&tag, RNAseq, and MicroC to investigate the impact of this DBD domain. Importantly, these experiments were performed in the A673 Ewing sarcoma model where endogenous EWS-FLI was silenced, and EWS-FLI-DBD proficient or deficient isoforms were re-expressed (isogenic context). The authors found that the DBD domain is key to mediate EWS-FLI cis activity (at msat) and to generate the formation of specific TADs. Furthermore, cells expressing DBD deficient EWS-FLI display very poor colony forming capacity, highlighting that targeting this domain may lead to therapeutic perspectives.

      This new version of the study comprises as requested new data from an additional cell line. The new data has strengthened the manuscript. Nevertheless, some of the arguments of the authors pertaining to the limitations of immunoblots to assess stability of the DBD constructs or the poor reproducibility of the Micro C data remain problematic. While the effort to repeat MicroC in a different cell line is appreciated, the data are as heterogeneous as those in A673 and no real conclusion can be drawn. The authors should tone down their conclusions. If DBD has a strong effect on chromatin organization, it should be reproducible and detectable. The transcriptomic and cut and tag data are more consistent and provide robust evidence for their findings at these levels.

      Concerning the issue of stability of the DBD and DBD+ constructs, a simple protein half-life assay (e.g. cycloheximide chase assay) could rule out any bias here and satisfactorily address the issue.

      Suggestions:

      The Reviewing Editor and a referee have considered the revised version and the responses of the referees. While the additional data included in the new version has consolidated many conclusions of the study, the MicroC data in the new cell line are also heterogeneous and as the authors argue, this may be an inherent limitation of the technique. In this situation, the best would be for the authors to avoid drawing robust conclusions from this data and to acknowledge its current limitations.

      The referee and Reviewing Editor also felt that the arguments of the authors concerning a lack of firm conclusions on the stability of EWS-FLI1 under +/-DBD conditions could be better addressed. We would urge the authors to perform a cycloheximide chase type assay to assess protein half-life. These types of experiments are relatively simple to perform and should address this issue in a satisfactory manner.

    2. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      Ewing sarcoma is an aggressive pediatric cancer driven by the EWS-FLI oncogene. Ewing sarcoma cells are addicted to this chimeric transcription factor, which represents a strong therapeutic vulnerability. Unfortunately, targeting EWS-FLI has proven to be very difficult, and a better understanding of how this chimeric transcription factor works is critical to achieving this goal. Towards this perspective, the group had previously identified a DBD-𝛼𝛼4 helix (DBD) in FLI that appears to be necessary to mediate EWS-FLI transcriptomic activity. Here, the authors used multi-omic approaches, including CUT&tag, RNAseq, and MicroC to investigate the impact of this DBD domain. Importantly, these experiments were performed in the A673 Ewing sarcoma model where endogenous EWS-FLI was silenced, and EWS-FLI-DBD proficient or deficient isoforms were re-expressed (isogenic context). They found that the DBD domain is key to mediating EWS-FLI cis activity (at msat) and to generating the formation of specific TADs. Furthermore, cells expressing DBD-deficient EWS-FLI display very poor colony-forming capacity, highlighting that targeting this domain may lead to therapeutic perspectives.

      We thank Reviewer 1 for their strong summary of Ewing sarcoma background and accurate description of our experimental approaches and findings.

      Strengths:

      The group has strong expertise in Ewing sarcoma genetics and epigenetics and also in using and analyzing this model (Theisen et al., 2019; Boone et al., 2021; Showpnil et al., 2022).

      We thank the reviewer.  

      They aim at better understanding how EWS-FLI mediated its oncogenic activity, which is critical to eventually identifying novel therapies against this aggressive cancer.

      We are happy to see that our overall aim was also appreciated by Reviewer 1.

      They use the most recent state-of-the-art omics methods to investigate transcriptome, epigenetics, and genome conformation methods. In particular, Micro-C enables achieving up to 1kb resolved 3D chromatin structures, making it possible to investigate a large number of TADs and sub-TADs structures where EWS-FLI1 mediates its oncogenic activity.

      We thank Reviewer 1 for their acknowledgement of our approaches and the resolution achieved with our Micro-C experiments.  

      They performed all their experiments in an Ewing sarcoma genetic background (A673 cells) which circumvents bias from previously reported approaches when working in non-orthologous cell models using similar approaches.

      We agree with the reviewer about the importance of using model systems that accurately capture features of the disease being studied. As we have added an additional cell line in the revision we should note that this second model also represents a Ewing sarcoma genetic background while representing tumors expressing another oncogenic fusion found in this disease. 

      Weaknesses:

      The main weakness comes from the poor reproducibility of Micro-C data . Indeed, it appears that the distances/clustering observed between replicates are typically similar or even larger than between biological conditions. For instance, in Figure 1B, I do not see any clustering when considering DBD1, DBD2, DBD+1, DBD+2.

      Lanes 80-83: "KD replicates clustered together with DBD replicate 1 on both axes and with DBD replicate 2 on the y-axis. DBD+ replicates, on the other hand, clustered away from both KD and DBD replicates. These observations suggest that the global chromatin structure of DBD replicates is more similar to KD than DBD+ replicates."

      When replacing DBD replicate 1 with DBD replicate 2, their statement would not be true anymore.

      Additional replicates to clarify this aspect seem absolutely necessary since those data are paving the way for the entire manuscript.

      These are valid concerns and we thank the reviewers for highlighting this limitation of poor clustering of Micro-C replicates on MDS plot. We account for this variability between different replicates when identifying differentially interacting regions. By using an adjusted p-value < 0.05, we aim to ensure that repeating the experiments we will discover the same differentially interacting regions with a false discovery rate of 5%.

      We also would like to note that the replicates cluster much closely on PCA plot of RNA-seq data (Supplementary Figure 1C) and as well as on PCA plot of H3K27ac CUT&Tag data (Figure 4A). Notably, the RNA-seq result has now reproduced when performed with different sets of hands across multiple studies (Boone, et. al., 2021 and this report), as well as in a second cell line (as reported in this manuscript revision). These observations suggest that the cells of these replicates are functionally similar to each other at a population level. Chromatin organization detected by Micro-C is a highly heterogenous within cells of a population (Misteli, et. al., 2020). Moreover, despite increased resolution with Micro-C over Hi-C, the conventional sequencing depth that Micro-C is performed at makes resolving finer scale 3D interactions, particularly between enhancers and promoters, challenging (Goel, et. al., 2023). Thus biologically relevant interactions driving EWSR1::ETS transcriptional regulation through de novo enhancers may have relatively weak signal in Micro-C. Both the strength of the signal and the heterogeneous chromatin state present in bulk samples could affect the average signal leading to poor clustering replicates (Hafner and Boettiger, 2022). 

      Importantly, rather than add an additional replicate of a single cell line, we repeated our study in an additional cell line, TTC466, and largely reproduced our high-level findings for transcription, enhancer formation, and 3D chromatin. Specific limitations of the TTC466 study are addressed in the Discussion section (392-420). The reproduction of weak/moderate clustering in the MDS plot in both A673 and TTC466 cell lines suggests the α4 helix of EWSR1::ETS fusions are important for reshaping 3D chromatin. However, higher resolution analyses focused on specific EWSR1::ETS-bound loci are likely an important area of future study required to fully understand the role of the α4 helix in chromatin regulation in Ewing sarcoma.

      Similarly:

      - In Figure 1C, how would the result look when comparing DBD2/KD2/DBD+2? Same when comparing DBD 1 with KD1 and DBD+1. Would the difference go in the same direction?

      This is a great point. We added distance decay plots of individual replicates in Supplementary Figure 2 and added discussion of these results in lines 88-89 of the text.

      - Figure 1D-E. How would these plots look like when comparing each replicate to each other's? How much difference would be observed when comparing, for instance, DBD1/DBD2 ? or DBD1/DBD+1?

      Unfortunately, separate replicates are required to conduct Differentially Interacting Region analysis as it determines statistically significant interactions. Therefore, we are unable to plot these analyses with individual replicates. 

      - Figure 2: again, how would these analyses look like when performing the analysis with only DBD1/DBD+1/KD1 or DBD2/DBD+2/KD?

      This is a good suggestion. It is possible to do such analysis. However, we will lose resolution as such that we may not accurately detect TADs, especially smaller TADs. Therefore, we decided to combine the biological replicates.   

      Another major question is the stability of EWS-FLI DBD vs EWS-FLI DBD+ proteins. In the WB, FLAG intensities seem also higher (2/3 replicates) in DBD+ condition compared to the DBD condition (Figure S1B).

      This is a valid concern with shRNA knock-down/rescue system and we regularly validate new constructs to ensure that they have similar expression levels as rescue with the wildtype fusion before proceeding to more exhaustive experimental workups. We would note that while we have not tested for differences in protein stability, for these constructs we largely see similar expression levels across multiple experiments, multiple cell lines, and multiple sets of hands. There may be some variations in expression level from experiment to experiment, but western blotting is a semiquantitative assay and it is also not possible to rule out that slight differences in band intensity may be a result of error in gel loading. For this reason, alongside western blotting for construct expression, we also validate construct function using RNA-seq and colony formation assays (as reported in this manuscript) and these show good agreement across biological replicates.  

      Indeed, it seems that they have more FLAG (i.e., EWS-FLI) peaks in the DBD+ condition compared to the DBD condition (Figure 2B). 

      We appreciate the comment since the legend of Figure 2B led to a misunderstanding. Figure 2B depicts the number of TADs detected in DBD and DBD+ conditions (height of the bar graphs) and the proportion of those TADs overlapped with FLAG, CTCF, both or neither peaks on y-axis. The number of FLAG peaks is actually lower in DBD+ as compared to DBD as shown in Figure 5A-B.  We clarified our Figure 2 legend to accurately describe the various proportions (color coded section) of TADs bound by DBD/DBD+ FLAG and CTCF.

      Would it be possible that DBD+ is just more expressed or more stable than DBD? The higher stability of the re-expressed DBD+ could also partially explain their results independently of the 3D conformational change. In other words, can they exclude that DBD+ and DBD binding are not related to their respective protein stability or their global re-expression levels?

      It is possible that DBD+ protein is overexpressed or more stable than DBD. With our current set of data, we cannot conclusively exclude if binding by DBD and DBD+ are not related to their expression level or stability. We would note, as above, that western blots, RNA-seq, and agar assays have largely reproduced across experiments, hands, and cell lines and that western blot is an imperfect assay for assessing protein stability.

      Surprisingly, WB FLI bands in DBD+ conditions are systematically (3/3 replicates) fainter than in DBD conditions (Figure S1B). How do the authors explain these opposite results between FLI and FALG in the WB?

      This is an excellent observation that highlights one of the intricacies of studying EWSR1::FLI1 in our KD/rescue system. Often the limiting factor for an experiment is whether or not the KD condition maintains KD through a second viral transduction for rescue and selection. We have observed over many years of working with this system that rescue conditions which are fully functional (i.e. wildtype EWSR1::FLI1, DBD+, etc.) tend to maintain better KD of endogenous EWSR1::FLI1. Constructs that don’t rescue EWSR1::FLI1 function sometimes maintain KD to a lesser degree, though frequently to a functional degree (i.e. cells are not transformed and EWSR1::FLI1 transcriptional regulation is not rescued). We suspect this observation, also raised by Reviewer 1 is resulted from a potential selection of cells with more endogenous EWSR1::FLI1 escaping KD in in DBD conditions due to selective pressures during expansion in tissue culture.

      We should note that the antibody used for detecting FLI recognizes residues that are deleted in

      DBD and DBD+ constructs, such that the FLI1 blot in Supplementary Figure 1B does not detect either construct. It only detects endogenous EWSR1::FLI1 and the 3X-FLAG-EWSR1::FLI1 construct in the middle lane that runs at a slightly higher molecular weight. The FLAG antibody is the only antibody that detects all three rescue constructs.    

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Bayanjargal et al. entitled "The DBD-alpha4 helix of EWS::FLI is required for GGAA microsatellite binding that underlies genome regulation in Ewing sarcoma" reports on the critical role of a small alpha helix in the DNA binding domain (DBD) of the FLI1 portion of EWS::FLI1 that is critical for binding to repetitive stretches of GGAA-motifs, i.e. GGAA microsatellites, which serve as potent neoenhancers in Ewing sarcoma.

      We thank Reviewer 2 for their succinct and accurate summary of our manuscript. 

      Strengths:

      The paper is generally well-written, and easy to follow and the data presented are of high quality, welldescribed and underpin the conclusions of the authors. The report sheds new light on how EWS::FLI1 mechanistically binds to and activates GGAA microsatellite enhancers, which is of importance to the field.

      We appreciate the reviewer’s assessment of our work. 

      Weaknesses:

      While there are no major weaknesses in this paper, there are a few minor issues that the authors may wish to address before publication:

      (1) While the official protein symbol for the gene EWSR1 is indeed EWS, the protein symbol for the gene FLI1 is identical, i.e. FLI1. The authors nominate the fusion oncoprotein EWS::FLI1 (even in the title) but it appears more adequate to use EWS::FLI1.

      We appreciate the reviewer for bringing this to our attention. Indeed, the most recent guideline for fusion proteins nomenclature is to use the full gene symbols separated by double colons. Therefore, the accurate nomenclature is EWSR1::FLI1. We replaced instances of EWS::FLI with EWSR1::FLI1 and have used the EWSR1::ERG nomenclature in our revised manuscript.  

      (2) The used cell lines should be spelled according to their official nomenclature (e.g. A-673 instead of A673).

      Corrected, thanks!

      (3) It appears as if the vast majority of results were generated in a single Ewing sarcoma cell line (A-673) which is an atypical Ewing sarcoma cell line harboring an activating BRAF mutation and may be genomically quite unstable as compared to other Ewing sarcoma cell lines (Kasan et al. 2023 preprint at bioRxiv https://www.biorxiv.org/content/10.1101/2023.11.20.567802v1). Hence, it may be supportive for the paper to recapitulate/cross-validate a few key results in other Ewing sarcoma cell lines, e.g. by using EWS::ERG-positive cell lines. Perhaps the authors could make use of available published data.

      We thank Reviewer 2 for this helpful comment. We replicated the experiments in TTC-466 cells containing EWSR1::ERG fusion and found that as for A-673 cells the DBD-α4 helix is important for transcriptional, enhancer, and 3D chromatin regulation (Supplementary Figures 9-18).  

      (4) Figure 6 and Supplementary Figure 5 are very interesting but focus on two selected target genes of the fusion (FCGRT and CCND1). It would be interesting to see whether these findings also extend to common EWS::ETS transcriptional signatures that have been reported. The authors could explore their data and map established consensus EWS::ETS signatures to investigate which other hubs might be affected at relevant target genes.

      We expanded our analysis to other genes demonstrated to be regulated by EWSR1::FLI1 nucleated transcriptional hubs (Chong, et. al., 2018) and included NKX2-2 and GSTM4 gene regions in

      Supplementary Figure 7-8 in A-673 cells. We also investigated the same gene regions of FCGRT, CCND1, NKX2-2, GSTM4 in TTC466 cells and report them in Supplementary Figures 14-17. For the purpose brevity, we decided to include the above examples. We may need to develop different tools to conduct further analysis to understand the gene regulatory networks driven by DBD and DBD+ in relation to hub formation. Although it is a great suggestion to map such network, this may be outside the scope of this manuscript. We thank the reviewer for bringing such a good point to our attention.  

      (5) Table 1 is a bit hard to read. In my opinion, it is not necessary to display P-values with up to 8 decimal positions. The gene symbols should be displayed in italic font.

      Suggestions are adapted, thanks!

      Reviewing Editor (Recommendations For The Authors):

      We would draw the authors' attention to the following issues that would best benefit from additional revision.

      As indicated by Referee 1, an important issue concerns the apparent poor reproducibility of Micro-C data. In Figure 1B, the clustering of the DBD1, DBD2, DBD+1, and DBD+2 is poor.

      It appears that the distances/clustering observed between replicates are typically similar or even larger than between biological conditions. Lines 80-83: "KD replicates clustered together with DBD replicate 1 on both axes and with DBD replicate 2 on the y-axis. DBD+ replicates, on the other hand, clustered away from both KD and DBD replicates. If one replaced DBD replicate 1 with DBD replicate 2, this statement would no longer be true. The referees believe that it is important to fully account for these potential discrepancies. Most of the study is based on analyses of these data sets, so if there are issues with them it has repercussions on the entire study. We note however that in Figure 4A the clustering of the H3K27ac data is much more convincing. The referees also feel that it is important to show immunoblots of the expression of DBD and DBD+ levels in the experiments performed here. While this was previously shown in the Boone et al publication in 2021, it could be illustrated again here.

      We thank the editors for concisely summarizing the main weaknesses of the paper and underscoring the importance of the Micro-C data in the rest of the paper. While the Editors note tighter clustering of the H3K27ac (Figure 4A), we would like to note that the replicates cluster much closely on PCA plot of RNA-seq data (Supplementary Figure 1C). Notably, the RNA-seq result has now reproduced when performed with different sets of hands across multiple studies (Boone, et. al., 2021 and this report), as well as in a second cell line (as reported in this manuscript revision). Though not as tight, the H3K27ac CUT&Tag also reproduces in TTC466 cells. Thus, we interpret these findings to indicate that our replicates are functionally similar to each other. As discussed above in the response to Reviewer 1 in more detail, there are several factors that could affect how these functional similarities are represented in Micro-C data. Micro-C is ultimately a readout of the chromatin organization in a heterogeneous population of cells (Misteli et al., 2020). Additionally, sequencing depth limitations in conventional Micro-C experiments limit the ability to faithfully assess the enhancer-promoter interactions that may be relevant for our model system (Goel, et. al., 2023). Thus, both the strength of the biologically relevant signal and the heterogeneous chromatin state present in bulk samples could affect the average signal and lead to poorly clustering replicates (Hafner and Boettiger, 2022). 

      To address these important concerns about rigor and reproducibility of the analyses, we repeated our study in an additional cell line, TTC466, and largely reproduced our high-level findings for transcription, enhancer formation, and 3D chromatin. These additional studies were not without their own limitations and these are addressed in the Discussion section (392-420). The reproduction of weak/moderate clustering in the MDS plot in both A673 and TTC466 cell lines suggests the α4 helix of EWSR1::ETS fusions are important for reshaping 3D chromatin. However, additional genomic analyses geared toward higher resolution at specific EWSR1::ETS-bound loci are likely an important area of future study required to fully understand the role of the α4 helix in chromatin regulation in Ewing sarcoma. Live cell imaging, as performed by Chong, et. al., 2018 and additional biochemical techniques may also be informative and are beyond the scope of this report.

      With regards to concerns about construct expression, we have included immunoblots of the rescue constructs in both cell lines (Supplementary Figure 1B and 9A) and discussed Reviewer 1’s specific concerns in detail above.  

      The referees also raise the issue of using an additional cell line to make a more general message. Although it would perhaps be asking too much to repeat the MicroC experiments, consolidation of the observations could be performed by focusing on specific loci such as FCGRT and CCND1 that were analyzed in this study. Could the authors use 4C-type experiments to reproduce the conclusions in an additional cell line? It would also be pertinent to consolidate the findings at these loci by 4C-type approaches even in the cell line used here. For the moment, all conclusions are based on the same set of data and a single technical approach.

      We repeated the experiments in TTC466 cells and analyzed the data using same cut-offs used in A-673 cells. This allows us to compare between the two cell lines. We hope this new set of experiments and analyses address the reviewers’ concerns.  

      Reviewer #1 (Recommendations For The Authors):

      All the data are performed in A673 cells. Knowing the transcriptomic and epigenetic heterogeneity of Ewing sarcoma cells, some of the experiments supporting their findings should be replicated in at least another Ewing sarcoma model.

      Per our discussion above, we have replicated our experiments in an additional cell line model of Ewing sarcoma. Importantly, the TTC466 cell line used expresses the EWSR1::ERG fusion found in 10-15% of Ewing sarcoma cases.  

      Supplementary Figure 2B. Proportion of TAD boundaries bound by FLAG (i.e., EWS-FLI1) and CTCF. The number/proportion of FLAG (i.e., EWS-FLI) peaks observed at CTCF peak/TAD boundaries seems unexpectedly high. How do they explain this result since EWS-FLI peaks are rather intra-TAD to mediate their enhancer function?

      In our previous study, we showed that EWSR1::FLI1 binding can be detected at boundaries of TADs (Showpnil, et. al., 2022). We think therefore it is likely that EWSR1::FLI1 binding is able to mediate enhancer function both inside TADs as well as at the borders of TADs and may, in some cases, function as an insulator between TADs.  

      For the >50kb loop analysis, what was the low-range threshold? Up to 15-20 kp, contact frequency interactions may be caused by PFA crosslink (did they use a 5kb threshold ?). Were those excluded from that analysis?

      We acknowledge that we did not use a lower threshold to exclude those short-range loop interactions. In our previous study, we observed that EWSR1::FLI1 binding reduces long-range interactions in favor of short-range interactions (Showpnil, et. al., 2022) and wanted to be able to capture short-range loops in our analysis.  

      In Figure 2D, they observed that within TADs containing FLAG peaks at GGAA microsatellites, the intensity of the DBD+ FLAG peaks was higher compared to DBD FLAG peaks. How would this analysis look when considering the ETS FLAG peaks (i.e., EWS-FLI rather repressive peaks)? Could they compare TAD with GGAA msat vs TAD with ETS peaks?

      We agree that this is an interesting observation. In our prior analyses we found no discernible relationship between EWSR1::FLI1 binding and changes in 3D chromatin associated with repression (Showpnil, et. al., Nucleic Acids Research, 2022). In contrast, EWSR1::FLI1-bound superenhancers had greater H3K27ac deposition when overlapping both a bound GGAA repeat and a non-microsatellite site. While there have been several additional reports about the relevance of EWSR1::FLI1 binding at nonmicrosatellite peaks, motifs at these loci have not yet been rigorously defined as GGAA repeats were by Johnson, et. al. in PLoS One, 2017. Each ETS factor binds different motifs containing the core 5’-GGAA-3’ with varying affinities depending on the flanking residues. There may be >100-fold difference in sequence-specific binding affinity for “high” vs. “low” affinity motifs. Better defining the types of ETS motifs bound by EWSR1::FLI1 and the functional changes associated with them thus represents an interesting area of future study.

      Figure 1F: What is the biological meaning of these results (29.7, 39.5, and 54Mbp)? These distances are typically the size of a chromosome arm and clearly beyond classical chromatin loop/TAD structures in which EWS-FLI mediates its cis-activity.

      We agree with referee here. This panel is now removed in our revised manuscript.  

      How do DBD, KD, and DBD+ conditions compare with WT parental cells in the omics data? (Figures 1B, 4A). Do DBD+ conditions overlap with WT conditions? It would be nice to have these analyses also for Micro-C and Cut&Tag data. To be acknowledged here, the transcriptome data showing this aspect in Figure S1C are very convincing.

      This is a fair point. We were not able to obtain similar sequencing depth of wtEF Micro-C libraries to that of KD, DBD and DBD+ due to disproportional use of wtEF libraries in troubleshooting. Therefore, we decided to exclude wtEF condition from these analysis. 

      EWS-FLI cis-regulation at CCND1 also occurs through a much closer EWS-FLI peak (~-20kb msat upstream of CCND1 TSS) which was not taken into consideration. EWS-FLI peak intensity in both DBD and DBD+ at this msta seems similar. How would this fit into their model?

      The referee is correct. The closest peak upstream of CCND1 TSS is about ~19kb away. We highlighted this peak with the dashed boxes near the CCND1 TSS (Supplementary Figure 6). Peak intensity of DBD+ FLAG is slightly higher compared to DBD. Nonetheless, we acknowledge that the difference is small. We suspect that the DBD-α4 helix is affecting binding dynamics at GGAA repeats, but these genomics approaches are not well suited to detect small, but significant, changes in binding affinity or dynamics. In this case a more biochemical approach may be needed. Even though, both protein can still bind the same microsatellites, it is possible that they might differ in their stability of binding or in the recruitment of additional proteins. These possibilities are discussed in the Discussion section (444-463).  

      For the Micro-C, they sequenced only 7 to 8 million reads per condition. This coverage seems particularly low, especially for their analyses using 1-5kb bins. How does this compare with other published Micro-C data? Can this explain the variability observed between replicates?

      We apologize for the inconsistent verbiage of sequencing coverage that may have caused confusion. 7 to 8 million reads were used for shallow sequencing and QC analysis. Once a sample passed QC, we then sequenced 300 million reads per sample. 300M is now changed to 300 million to prevent a misunderstanding at line 598.  

      They mention:

      "In our recent studies of EWS::FLI, we found a small alpha helix in the DNA binding domain DBD-𝛼𝛼4, to

      be required for transcription and regulation by the fusion protein (Boone et al., 2021). Interestingly, this study did not find any change in chromatin accessibility (ATAC-Seq) and genome localization of EWS::FLI constructs (CUT&RUN) when DBD-𝛼𝛼4 helix was deleted leaving the mechanistic basis for the requirement of DBD-𝛼𝛼4 in transcription regulation unclear. "

      And

      "To assay the enhancer landscape, we collected H3K27ac CUT&Tag data from KD, DBD, and DBD+ cells. Principal component analysis of H3K27ac localization shows that the DBD replicates were clustered closer to the KD replicates while being in between the KD and the DBD+ replicates (Figure 4A), suggesting that DBD-𝛼𝛼4 helix is required to reshape the enhancer landscape."

      But now H3K27ac CUT&Tag show strong differences which were not observed in ATAC seq. How to explain this discrepancy?

      Though both H3K27ac and ATAC signal are associated with enhancers and promoters in euchromatin, they are not exactly measurements of the same thing. H3K4me2 is a mark more closely associated with ATAC signal than H3K27ac (Henikoff, et. al., 2020). Nonetheless, there are clear differences between the prior publication (Boone, et. al., 2021) and this work with regards to similar ATAC signal for each replicate and differences in H3K27ac. We suspect this may be related to a tighter association between H3K27ac and EWSR1::FLI1-mediated genome regulation and ATAC. Notably, there were very few differentially accessible regions between EWSR1::FLI1-depleted cells and conditions with EWSR1::FLI1 expression (either endogenous or wildtype rescue) using the A673 KD/Rescue system in Boone, et. al., 2021. In contrast, other A673 KD-rescue studies have reported differences in H3K27ac in EWSR1::FLI1 expressing conditions relative to EWSR1::FLI1-depleted conditions (Theisen, et. al., 2021). .  

      The authors mention:

      "Our study thus uncovered a surprising role for FLI DBD in the process of hub formation which is usually attributed to the EWS low complexity domain."

      Not sure this can be claimed, hubs are composed of many other factors that are not investigated here. Furthermore, promoter enhancer hubs/loops often include combined ETS and mSat chains to generate transcriptional hubs which have not been considered here. None of these points were discussed here.

      We replaced “uncovered” with “suggest” in our revised manuscript at line 476.  

      What are the barcode patterns in Supp 5, are those frequently observed in their Micro-C data, likely mapping artifacts, do they have any impact on their analyses?

      The barcode patterns in now Supplementary Figure 6 are blind spots in the hg19 genome assembly. Since they are few in numbers, we don’t expect these blind spots to impact our analysis.

    1. Reviewer #1 (Public Review):

      Summary:

      This research article by Nath et al. from the Lee Lab addresses how lipolysis under starvation is achieved by a transient receptor potential channel, TRPγ, in the neuroendocrine neurons to help animals survive prolonged starvation. Through a series of genetic analyses, the authors identify that TRPγ mutations specifically lead to a failure in lipolytic processes under starvation, thereby reducing animals' starvation resistance. The conclusion was confirmed through total triacylglycerol levels in the animals and lipid droplet staining in the fat bodies. This study highlights the importance of transient receptor potential (TRP) channels in the fly brain to modulate energy homeostasis and combat metabolic stress. While the data is compelling and the message is easy to follow, several aspects require further clarification to improve the interpretation of the research and its visibility in the field.

      Strengths:

      This study identifies the biological meaning of TRPγ in promoting lipolysis during starvation, advancing our knowledge about TRP channels and the neural mechanisms to combat metabolic stress. Furthermore, this study demonstrates the potential of the TRP channel as a target to develop new therapeutic strategies for human metabolic disorders by showing that metformin and AMPK pathways are involved in its function in lipid metabolisms during starvation in Drosophila.

      Weaknesses:

      Some key results that might strengthen their conclusions were left out for discussion or careful explanation (see below). If the authors could improve the writing to address their findings and connect their findings with conclusions, the research would be much more appreciated and have a higher impact in the field.

      Here, I listed the major issues and suggestions for the authors to improve their manuscript:

      (1) Are the increased lipid droplet size and the upregulated total TAG level measured in the starved or sated mutant in Figure 1? This information might be crucial for readers to understand the physiological function of TRP in lipid metabolism. In other words, clarifying whether the upregulated lipid storage is observed only in the starved trp mutant will advance our knowledge of TRPγ. If the increase of total TAG level is only observed in the starved animals, TRP in the Dh44 neurons might serve as a sensor for the starvation state required to promote lipolysis in starvation conditions. On the other hand, if the total TAG level increases in both starved and sated animals, activation of Dh44 through TRPγ might be involved in the lipid metabolism process after food ingestion.

      (2) It is unclear how AMPK activation in Dh44 neurons reduces the total triacylglycerol (TAG) levels in the animals (Figure 3G). As AMPK is activated in response to metabolic stress, the result in Figure 3G might suggest that Dh44 neurons sense metabolic stress through AMPK activation to promote lipolysis in other tissues. Do Dh44 neurons become more active during starvation? Is activation of Dh44 neurons sufficient to activate AMPK in the Dh44 neurons without starvation? Is activation of AMPK in the Dh44 neurons required for Dh44 release and lipolysis during starvation? These answers would provide more insights into the conclusion in Lines 192-193.

      (3) It is unclear how the lipolytic gene brummer is further downregulated in the trpγ mutant during starvation while brummer is upregulated in the control group (Figure 6A). This result implies that the trpγ mutant was able to sense the starvation state but responded abnormally by inhibiting the lipolytic process rather than promoting lipolysis, which makes it more susceptible to starvation (Figure 3B).

      (4) There is an inconsistency of total TAG levels and the lipid droplet size observed in the Dh44 mutant but not in the Dh44-R2 mutant (Figures 7A and 7F). This inconsistency raises a possibility that the signaling pathway from Dh44 release to its receptor Dh44-R2 only accounts for part of the lipid metabolic process under starvation. Adding discussion to address this inconsistency may be helpful for readers to appreciate the finding.

    2. Reviewer #2 (Public Review):

      Summary:

      In this paper, the function of trpγ in lipid metabolism was investigated. The authors found that lipid accumulation levels were increased in trpγ mutants and remained high during starvation; the increased TAG levels in trpγ mutants were restored by the expression of active AMPK in DH44 neurons and oral administration of the anti-diabetic drug metformin. Furthermore, oral administration of lipase, TAG, and free fatty acids effectively restored the survival of trpγ mutants under starvation conditions. These results indicate that TRPv plays an important role in the maintenance of systemic lipid levels through the proper expression of lipase. Furthermore, authors have shown that this function is mediated by DH44R2. This study provides an interesting finding in that the neuropeptide DH44 released from the brain regulates lipid metabolism through a brain-gut axis, acting on the receptor DH44R2 presumably expressed in gut cells.

      Strengths:

      Using Drosophila genetics, careful analysis of which cells express trpγ regulates lipid metabolism is performed in this study. The study supports its conclusions from various angles, including not only TAG levels, but also fat droplet staining and survival rate under starved conditions, and oral administration of substances involved in lipid metabolism.

      Weaknesses:

      Lipid metabolism in the gut of DH44R2-expressing cells should be investigated for a better understanding of the mechanism. Fat accumulation in the gut is not mechanistically linked with fat accumulation in the fat body. The function of lipase in the gut (esp. R2 region) should be addressed, e.g. by manipulating gut-lipases such as magro or Lip3 in the gut in the contest of trpγ mutant. Also, it is not clarified which cell types in the gut DH44R2 is expressed. The study also mentioned only in the text that bmm expression in the gut cannot restore lipid droplet enlargement in the fat body, but this result might be presented as a figure.

    3. Reviewer #3 (Public Review):

      In this manuscript, the authors demonstrated the significance of the TRPγ channel in regulating internal TAG levels. They found high TAG levels in TRPγ mutant, which was ascribed to a deficit in the lipolysis process due to the downregulation of brummer (bmm). It was notable that the expression of TRPγ in DH44+ PI neurons, but not dILP2+ neurons, in the brain restored the internal TAG levels and that the knockdown of TRPγ in DH44+ PI neurons resulted in an increase in TAG levels. These results suggested a non-cell autonomous effect of Dh44+PI neurons. Additionally, the expression of the TRPγ channel in Dh44 R2-expressing cells restored the internal TAG levels. The authors, however, did not provide an explanation of how TRPγ might function in both presynaptic and postsynaptic cells in the non-cell autonomous manner to regulate the TAG storage. The authors further determined the effect of TRPγ mutation on the size of lipid droplets (LD) and the lifespan and found that TRPγ mutation caused an increase in the size of LD and a decrease in the lifespan, which were reverted by feeding lipase and metformin. These were creative endeavors, I thought. The finding that DH44+ PI neurons have non-cell autonomous functions in regulating bodily metabolism (mainly sugar/lipid) in addition to directing sugar nutrient sensing and consumption is likely correct, but the paper has many loose ends. I would like to see a revision that includes more experiments to tighten up the findings and appropriate interpretations of the results.

      (1) The authors need to provide interpretations or speculations as to how DH44+ PI neurons have non-cell autonomous functions in regulating the internal TAG stores, and how both presynaptic DH44 neurons and postsynaptic DH44 R2 neurons require TRPγ for lipid homeostasis.

      (2) The expression of TRPγ solely in DH44 R2 neurons of TRPγ mutant flies restored the TAG phenotype, suggesting an important function mediated by TRPγ in DH44 R2 neurons. However, the authors did not document the endogenous expression of TRPγ in the DH44R2+ gut cells. This needs to be shown.

      (3) While Dh44 mutant flies displayed normal internal TAG levels, Dh44R2 mutant flies exhibited elevated TAG levels (Figure 7A). This suggested that the lipolysis phenotype could be facilitated by a neuropeptide other than Dh44. Alternatively, a Dh44 neuropeptide-independent pathway could mediate the lipolysis. In either case, an additional result is needed to substantiate either one of the hypotheses.

      (4) While the authors observed an increased area of fat body lipid droplets (LD) in Dh44 mutant flies (Figure 7F), they did not specify the particular region of the fat body chosen for measuring the LD area.

      (5) The LD area only accounts for TAG levels in the fat body, whereas TAG can be found in many other body parts, including the R2 area as demonstrated in Figure 5A-D using Nile red staining. As such, measuring the total internal TAG levels would provide a more accurate representation of TAG levels than the average fat body LD area.

      (6) In Figure 5F-I, the authors should perform the similar experiment with Dh44, Dh44R1, and Dh44R2 mutant flies.

      (7) The representative image in Figure 6B does not correspond to the GFP quantification results shown in Figure 6C. In trpr1;bmm::GFP flies, the GFP signal appears stronger in starved conditions than in satiated conditions.

      (8) In Figure 6H-I, fat body-specific expression of bmm reversed the increased LD area in TRPγ mutants. The authors also showed that Dh44+PI neuron-specific expression of bmm yielded a similar result. The authors need to provide an interpretation as to how bmm acts in the fat body or DH44 neurons to regulate this.

      (9) The authors should explain why the DH44 R1 mutant did not represent similar results as the wild type.

      (10) It would be good to have a schematic that represents the working model proposed in this manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The main goal of the authors was to study the testis-specific role of the protein FBXO24 in the formation and function of the ribonucleoprotein granules (membraneless electron-dense structures rich in RNAs and proteins).

      We appreciate the summary comment of reviewer #1.

      Strengths:

      The wide variety of methods used to support their conclusions (including transgenic models)

      We appreciate the positive comment of reviewer #1.

      Weaknesses:

      The lack of specific antibodies against FBXO24. Some of the experiments showing a specific phenotype are descriptive and lack of logical explanation about the possible mechanism (i.e. AR or the tail structure).

      Because we could not obtain specific antibodies against FBXO24, we generated Fbxo24-FLAG transgenic mice, which can be used to show the interaction between FBXO24 and IPO5. For the mechanism of impaired acrosome reaction, we added some results and discussion as written in the response to the question (1) of reviewer #1 (public review). For the mechanism of abnormal flagellar structure, we added new results and fixed the manuscript as written in the response to the major comments of reviewer #3 (recommendations for the authors).

      Questions:

      The paper is excellent and employs a wide variety of methods to substantiate the conclusions. I have very few questions to ask:

      (1) KO mice cannot undergo acrosome reaction (AR) even spontaneously. How do you account for this, given that no visible defects were observed in the acrosome?

      One possibility is that Fbxo24 KO spermatozoa cannot undergo capacitation; however, it is difficult to analyze the capacitation status such as tyrosine phosphorylation because most Fbxo24 KO spermatozoa are not alive (Figure S3A). Other possibility is that AR-related proteins are affected in Fbxo24 KO spermatozoa. Therefore, we analyzed the amounts of AR-related proteins with mass spectrometry (Figure S3C). Although previous studies indicate that the assembly of the SNARE complex is a key event prior to AR [Hutt et al., 2005 (PMID: 15774481); Katafuchi et al., 2000 (PMID: 11066067); Schulz et al., 1997 (PMID: 9356173); Tomes et al., 2002 (PMID: 11884041)], no clear differences were detected for SNARE proteins (Figure S3C and D). PLCD4 that is important for AR [Fukami et al., 2001 (PMID: 11340203)) was also detected in Fbxo24 KO spermatozoa (Figure S3C). Although we could not find differences in the amounts of AR-related proteins, it is still possible that FER1L5, another AR-related protein [Morohoshi et al., 2023 (PMID: 36696506)] not detected in the mass spectrometry analyses, or AR-related proteins not yet identified are affected in Fbxo24 KO spermatozoa. We added these results and discussion (line 160-166 and 305-312).

      (2) KO sperm are unable to migrate in the female tract, and, more intriguingly, they do not pass through the utero-tubal junction (UTJ). The levels of ADAM3 are normal, suggesting that the phenotype is influenced by other factors. The authors should investigate the levels of Ly6K since mice also exhibit the same phenotype but with normal levels of ADAM3.

      We detected LY6K in Fbxo24 KO spermatozoa with immunoblotting, but no difference was found.

      We added the results (Figure S3E and line 172–175).

      (3) In Figure 4A, the authors assert that "RBGS Tg mice revealed that mitochondria were abnormally segmented in Fbxo24 KO spermatozoa." I am unable to discern this from the picture shown in that panel. Could you please provide a more detailed explanation or display the information more explicitly?

      We are sorry for the ambiguous explanation on the morphology of sperm mitochondria sheath. Fbxo24 KO cauda epidydimal spermatozoa shows disorganized mitochondria sheath rather than “segmented”. We fixed the sentence (line 190-192) and added white arrowheads that indicate the disorganized regions (Figure 4A).

      Reviewer #2 (Public Review):

      Summary:

      The manuscript by Kaneda et al "FBXO24 ensures male fertility by preventing abnormal accumulation of membraneless granules in sperm flagella" is a significant paper on the role of FBXO24 in murine male germ cell development and sperm ultrastructure and function. The body of experimental evidence that the authors present is extraordinarily strong in both breadth and depth. The authors investigate the protein's functions in male germ cells and sperm using a wide variety of approaches but focusing predominantly on their novel mouse model featuring deletion of the Fbxo24 gene and its product. Using this mouse, and a cross of it with another model that expresses reporters in the head and midpiece, they logically build from one experiment to the next. Together, their data show that this protein is involved in the regulation of membraneless electron-dense structures; loss of FBXO24 led to an accumulation of these materials and defects in the sperm flagellum and fertilizing ability. Interestingly, the authors found that several of the best-known components of electron-dense ribonucleoprotein granules that are found in the intermitochondrial cement and chromatoid body were not disrupted in the Fbxo24 knockout, suggesting that the electron-dense material and these structures are not all the same, and the biology is more complicated than some might have thought. They found evidence for the most changes in IPO5 and KPNB1, and biochemical evidence that FBXO24 and IPO5 could interact.

      We appreciate the summary comment of reviewer #2.

      Strengths:

      The authors are to be commended for the thoroughness of their experimental approaches and the extent to which they investigated impacts on sperm function and potential biochemical mechanisms. Very briefly, they start by showing that the Fbxo24 message is present in spermatids and that the protein can interact with SKP1, in a way that is dependent on its F-box domain. This points toward a potential function in protein degradation. To test this, they next made the knockout mouse, validated it, and found the males to be sterile, although capable of plugging a female. Looking at the sperm, they identified a number of ultrastructural and morphological abnormalities, which they looked at in high resolution using TEM. They also cross their model with RBGS mice so that they have reporters in both the acrosome and mitochondria. The authors test a variety of sperm functions, including motility parameters, ability to fertilize by IVF, cumulus-free IVF, zona-free-IVF, and ICSI. They found that ICSI could rescue the knockout but not other assisted reproductive technologies. Defects in male fertility likely resulted from motility disruption and failure to get through the utero-tubal junction but defects in acrosome exocytosis also were noted. The authors performed thorough investigations including both targeted and unbiased approaches such as mass spectrometry. These enabled them to show that although the loss of the FBXO24 protein led to more RNA and elevated levels of some proteins, it did not change others that were previously identified in the electron-dense RNP material.

      The manuscript will be highly significant in the field because the exact functions of the electron-dense RNP materials have remained somewhat elusive for decades. Much progress has been made in the past 15 years but this work shows that the situation is more complex than previously recognized. The results show critical impacts of protein degradation in the differentiation process that enables sperm to change from non-descript round cells into highly polarized and compartmentalized mature sperm, with an equally highly compartmentalized flagellum. This manuscript also sets a high bar for the field in terms of how thorough it is, which reveals wide-ranging impacts on processes such as mitochondrial compaction and arrangement in the midpiece, the correct building of the major cytoskeletal elements in the flagellum, etc.

      We appreciate the positive comment of reviewer #2.

      Weaknesses:

      There are no real weaknesses in the manuscript that result from anything in the control of the authors. They attempted to rescue the knockout by expressing a FLAG-tagged Fbxo24 transgene, but that did not rescue the phenotype, either because of inappropriate levels/timing/location of expression, or because of interference by the tag. They also could not make anti-FBXO24 that worked for coimmunoprecipitation experiments, so relied on the FLAG epitope, an approach that successfully showed co-IP with IPO5 and SKP1.

      We could not rescue the phenotype with Fbxo24-FLAG transgene, but different Fbxo24 mutant mice show the same phenotypes (Figure S6G). Further, another group showed that Fbxo24 KO mice exhibited abnormal mitochondrial coiling [Li et al., 2024 (PMID: 38470475)], confirming that

      FBXO24 is involved in the mitochondrial sheath formation.

      Reviewer #3 (Public Review):

      Summary:

      In this manuscript, the authors found that FBXO24, a testis-enriched F-box protein, is indispensable for male fertility. Fbxo24 KO mice exhibited malformed sperm flagellar and compromised sperm motility.

      We appreciate the summary comment of reviewer #3.

      Strengths:

      The phenotype of Fbxo24 KO spermatozoa was well analyzed.

      We appreciate the positive comment of reviewer #3.

      Weaknesses:

      The authors observed numerous membraneless electron-dense granules in the Fbxo24 KO spermatozoa. They also showed abnormal accumulation of two importins, IPO5 and KPNB1, in the Fbxo24 KO spermatozoa. However, the data presented in the manuscript do not support the conclusion that FBXO24 ensures male fertility by preventing the abnormal accumulation of membraneless granules in sperm flagella, as indicated in the manuscript title.

      Fbxo24 KO mice showed abnormal accumulation of membraneless granules in sperm flagella and male infertility, suggesting that FBXO24 is involved in these processes, but there are no results that show the direct relationship as reviewer #3 mentioned. Therefore, we fixed the title.

      Recommendations For The Authors:

      Reviewer #2 (Recommendations For The Authors):

      On page 4, lines 152-154, the authors introduce the RBGS mouse model and use it in their experiments.

      However, they left out an obvious but helpful sentence that tells the reader that they crossed the Fbxo24-null mouse with the RBGS. As one continues reading it is clear, but best to avoid even slight confusion.

      We revised the explanation in the result section (line 150-153).

      Reviewer #3 (Recommendations For The Authors):

      In this manuscript, the authors found that FBXO24, a testis-enriched F-box protein, is indispensable for male fertility. Fbxo24 KO mice exhibited malformed sperm flagellar and compromised sperm motility. The phenotype of Fbxo24 KO spermatozoa was well analyzed.

      The authors observed numerous membraneless electron-dense granules in the Fbxo24 KO spermatozoa. They also showed abnormal accumulation of two importins, IPO5 and KPNB1, in the Fbxo24 KO spermatozoa. However, the data presented in the manuscript do not support the conclusion that FBXO24 ensures male fertility by preventing the abnormal accumulation of membraneless granules in sperm flagella, as indicated in the manuscript title.

      Fbxo24 KO mice showed abnormal accumulation of membraneless granules in sperm flagella and male infertility, suggesting that FBXO24 is involved in these processes, but there are no results that show the direct relationship as reviewer #3 mentioned. Therefore, we fixed the title.

      Major comments:

      In the title, abstract, introduction, and some sections such as lines 275-276, the authors conclude that FBXO24 prevents the accumulation of importins and RNP granules during spermiogenesis. However, the provided data do not substantiate this claim. To provide conclusive evidence to support the current title, the authors need to present evidence supporting: 1) direct degradation of IPO5 and KPNB1 by FBXO24; 2) the direct requirement of IPO5 for the formation of the membraneless granules, and 3) infertility resulting from the presence of membraneless granules, rather than other issues such as abnormal ODF and AX.

      (1) direct degradation of IPO5 and KPNB1 by FBXO24.

      To examine if IPO5 can be degraded by FBXO24, we performed a ubiquitination assay using HEK293T cells. Ubiquitination of IPO5 was upregulated in the presence of WT FBXO24 but not with the mutant ΔF-box FBXO24, suggesting that IPO5 can be ubiquitinated by FBXO24. We did not examine the ubiquitination of KPNB1 because we failed to construct a plasmid vector expressing mouse KPNB1. We think that KPNB1 is not the substrate because we did not detect the interaction between FBXO24 and KPNB1 (Figure 5E). We added the results of the ubiquitination assay (Figure

      5F and line 261-265) and mentioned it in the abstract (line 35).

      (2) the direct requirement of IPO5 for the formation of the membraneless granules.

      (3) infertility resulting from the presence of membraneless granules, rather than other issues such as abnormal ODF and AX.

      We revealed that IPO5 aggregate under stress condition in COS7 cells (Figure 6C and D); however, we did not examine whether IPO5 is required for the formation of the membraneless granules. We consider that protein degradation systems such as PROTAC or Trim-Away to knockdown IPO5 at the protein level in Fbxo24 KO mice could be a good way to see if the membraneless granules are diminished and male fertility is rescued. However, it takes time to apply the degradation systems in vivo. Therefore, we would like to leave this rescue experiment for future studies. We fixed the title and  abstract (line 37-38), and removed the last sentence of the introduction.

      Also, the other group reported the analyses of Fbxo24 KO mice [Li et al., 2024 (PMID: 38470475)] right after we submitted our manuscript to the eLife. They reported not only disorganized flagellar structures but also abnormal head morphology, which may lead to male infertility. The differences from our study may be due to different mouse genetic backgrounds. We mentioned it in the discussion section (line 348-353).

      Minor comments:

      (1) The authors claimed a significant increase in the total amount of RNAs in Fbxo24 KO spermatozoa (lines 259-261), suggesting that the ...contain RNAs. More direct evidence supporting this claim should be provided.

      We show that the amounts of IPO5 and KBNB1 increased in Fbxo24 KO spermatozoa (Figure 5A and B), both of which could be incorporated into RNP granules in COS7 cells (Figure 6C and D), supporting the idea that membraneless electron-dense structures may be RNP granules. However, because we did not show direct evidence that electron-dense structures contain RNAs, we removed the sentences (line 259-261 of the 1st submission manuscript). 

      (2) The author should provide an explanation for the absence of a FLAG band in the input Tg in Figure 5D and the larger size of the IPO5 band in the FLAG-IP group compared to the input. Similar observations are also noted in Figure 5E.

      The FLAG band is weak because the protein amount is low. When we increase the contrast, we can see the FLAG band. We added an image with high contrast (Figure 5D). Sometimes, proteins run differently with SDS-PAGE after immunoprecipitation, likely due to varying protein composition in the sample. We explained it in the figure legend (line 868-869).

      (3) In Line 526, clarify the procedure for sperm purification, and determine the potential for contamination from somatic cells.

      We did not perform sperm purification, but when we observed spermatozoa obtained from cauda epididymis, we rarely observed either somatic cells or immature spermatogenic cells. We added  pictures in Figure S7. Further, we added detailed explanation about how to collect spermatozoa from the epididymis (line 549-550).

      (4) Define the Y-axis in Figure 2E, F, and G.

      We have revised the figures.

    1. Note: This response was posted by the corresponding author to Review Commons. The content has not been altered except for formatting.

      Learn more at Review Commons


      Reply to the reviewers

      We thank the reviewers for their positive and constructive criticism. We answer their points one by one below.

      Reviewer #1

      1.) In the baf-1 G12T mutants the authors find reduced levels of lamin in hypodermal nuclei. It would be good to also examine the dynamics of lamin in the second tissue that was subjected to DamID (intestinal cells).

      We provide a complete analysis of GFP::LMN-1 and EMR-1::mCh in control and baf-1(G12T) day 1 adults in intestine and hypodermis and at 20°C and 25°C. These data demonstrate that GFP::LMN-1 expression is reduced in baf-1(G12T) mutants in both tissue and at both temperatures. In contrast, for EMR-1::mCh a significant reduction was only observed in hypodermal nuclei at 20°C.

      The effects on GFP::LMN-1 and EMR-1::mCh in the hypodermis 20°C were reported in Figure 2E-F in the original version of our manuscript. We have moved these data to the new Supplementary Figure S5 and represent instead the data obtained for hypodermis at 25°C in Figure 2E-F for consistency with the data represented in Figure 2A-D. Data on intestine for both markers and both temperatures are also included in the new Supplementary Figure S5.

      We have modified the text as follows:

      “To test the impact of baf-1(G12T) on LMN-1, EMR-1, and BAF-1 localization in vivo, we quantified these factors at the NE of hypodermal and intestinal cells. We observed a significantly lower median GFP::LMN-1 signal at the NE in baf-1(G12T) mutants in both tissues at 20°C and 25°C (Figure ____2E; Supplementary Figure S____5A-C). In contrast, accumulation of EMR-1 at the NE was unaffected by the baf-1(G12T) mutation in both tissues at 25°C and reduced in the hypodermis at 20°C (Figure ____2F; Supplementary Figure S____5D-F). In human NGPS cells, emerin was observed to be delocalized to the ER (Janssen et al., 2022; Puente et al., 2011), but we detected no increase in cytoplasmic EMR-1::mCh signal in the mutant, indicating that this NGPS phenotype is not present in the C. elegans model. In agreement with these microscopy data, analysis of whole-worm mRNA levels by quantitative RT-PCR also revealed a significant reduction in lmn-1 expression whereas emr-1 was unaffected (Supplementary Figure S4E-F).”

      2.) The authors make a statement that EMR-1 expression was reduced in the baf-1 G12T mutant, but do not comment on LMN-1 expression. Can a statement on this be made by RT PCR?

      Our gene expression analysis by RAPID determined a significant reduction in emr-1 expression in the intestine of baf-1(G12T) mutants, using a fold change of 2 as threshold. In contrast, expression of emr-1 in hypodermis as well as baf-1 and lmn-1 expression in both tissues were not significantly different between wild type and baf-1(G12T) mutants in our RAPID data.

      We performed qRT-PCR on bulk mRNA to compare the expression of baf-1, emr-1 and lmn-1 in control versus baf-1(G12T) mutants. No differences were detected for baf-1 and emr-1 (new Supplementary Figure S4E-F). Considering that the qRT-PCR is on bulk mRNA, the emr-1 result is compatible with the RAPID data that suggest deregulation of emr-1 only in intestine and unaffected expression in the hypodermis. For baf-1 there is agreement between qRT-PCR and RAPID data from both tissues (no difference in the mutant). For lmn-1, the qRT-PCR analysis suggests a modest reduction (23%; not reaching the threshold applied in the RAPID analysis) in baf-1(G12T) mutants, which is concordant with the reduction observed in GFP::LMN-1 intensity in hypodermis and intestine by confocal microscopy (e.g. 14% reduction in median GFP::LMN-1 intensity in hypodermis at 25C; Figure 2E).

      The discordance between RAPID and live imaging for emr-1/EMR-1::mCh (a reduction in the intestine or the hypodermis according to RAPID or live imaging, respectively) is not surprising. Although mRNA and protein levels in general correlate well, often, variation in transcription can only explain We have added these two sentences to the manuscript:

      “In agreement with these microscopy data, analysis of whole-worm mRNA levels by quantitative RT-PCR also revealed a significant reduction in lmn-1 expression whereas emr-1 was unaffected (Supplementary Figure S4E-F).”

      “As described above, the amount of endogenously tagged EMR-1::mCh at the NE of intestinal cells was normal in baf-1(G12T) mutants (Supplementary Figure S5F), suggesting a cellular capacity to buffer the downregulation of emr-1 transcription (Vogel & Marcotte, 2012).”

      3.) The authors find few alterations in gene regulation of the loci which have different occupancy WT BAF-1 versus BAF-1 G12T. It was surprising to see the DamID and RNA polymerase DamID experiments be done with worms grown at 20°C, because the more penetrant phenotypes at the organismal level were observed at 25°C. Could this be the reason for the little change of chromatin occupancy of BAF-1 and BAF-1 G12T or few changes in gene expression? Would it make sense to examine the expression of some selected BAF-1 bound loci by single molecule Fish at 25°C and compare expression wt versus baf-1 G12T?

      We performed the DamID experiments at 20°C to avoid potential artifacts and/or toxicity by higher expression levels of Dam fusion proteins (Greil, Moorman, & van Steensel, 2006; Schuster et al., 2010). We note that altered UV and tert-butyl hydroperoxide was observed at 20°C, indicating that the baf-1(G12T) allele affects physiology at several temperatures. The original version of our manuscript described the expression of fluorescently tagged LMN-1 and EMR-1 in the hypodermis at 20°C (Figure 2E-F). As described above, in the revised version, we report the expression in the intestine at 20°C and in both tissues at 25°C. For GFP::LMN-1, a similar reduction in the baf-1(G12T) mutant was observed at the two temperatures in both tissues, whereas for EMR-1::mCh a reduction was only seen in the hypodermis at 20°C. Taken together, we conclude that 20°C is a suitable temperature for the DamID experiments.

      We appreciate the suggestion to study expression of genes bound by BAF-1 by smFISH. However, we anticipate that because the hypodermis is composed mostly of large syncytia covering the round body of the animal, smFISH would be difficult to quantify. Regarding loci with different occupancy of WT BAF-1 versus BAF-1(G12T), the emr-1 locus was bound in the intestine by Dam::BAF-1 but not by Dam::BAF-1(G12T) (Figure 6B). As mentioned above, we observed that emr-1 expression was reduced in intestine of baf-1(G12T) mutants, suggesting that BAF-1 binding has a positive effect of transcription of this locus.

      4.) The finding that BAF-1 nuclear envelope localization remains unchanged in the mutant stems from detection of the inserted GFP epitope. Given that the tag has an influence on the BAF-1 G12 12T mutant viability, this statement should be phrased with more care. The tag could influence the turnover of the protein for example. Maybe Western blots comparing the signal of WT BAF-1 worms and BAF-1 G12T mutant worms would be instructive to compare the levels of the protein (at 20oC and at 25oC, day 1 adults and day 8 adults).

      We performed Western blot experiments to address this. As controls, we included strains expressing equal amounts of GFP::BAF-1 and GFP::BAF-1(G12T) strains (Figure 3E and Supplementary Figure 7 in original manuscript reported equal expression of the two proteins). Surprisingly, the polyclonal anti-BAF-1 serum raised against recombinant, full-length wild type BAF-1 (Gorjanacz et al., 2007) has significantly lower affinity for mutant GFP::BAF-1(G12T) than for GFP::BAF-1, which precludes the evaluation of untagged proteins:


      Figure 1. [png file provided to reviewers - not possible to include here for technical reasons] Western blot analyses with anti-BAF-1 serum (Gorjanacz et al, 2007). (A) Embryonic extracts. A band of the expected size is observed in wildtype embryos (*), but not in baf-1(G12T) embryos. (B) Extracts from young adults. A faint band of the expected size is observed in wildtype embryos (* in lane 1; longer exposure is shown below), whereas a more prominent band is present corresponding to endogenously tagged GFP::BAF-1 (** in lane 2). The intensity of the potential GFP::BAF-1(G12T) is reduced by >80% (lane 4; >90% reduction was observed in a second experiment).

      We point out in the revised manuscript that the conclusion on equal BAF-1 and BAF-1(G12T) expression was based on endogenously tagged proteins: “Quantifying the intensity at the NE or in the nucleoplasm of hypodermal cells did not demonstrate any difference between endogenously GFP-tagged wild-type and mutant BAF-1 (Figure 3E). A small reduction in cytoplasmic signal was observed for BAF-1(G12T), however, no difference was detected in the ratio between nucleoplasmic/cytoplasmic signal (Figure 3E). Quantitative RT-PCR analysis of whole-worm RNA samples also indicated that baf-1 and baf-1(G12T) are expressed at identical levels (Supplementary Figure S4E-F).”

      5.) Line 105: typo: remove "s"

      Corrected.

      6.) Line 154: A conclusion is missing for the fog-2 experiment.

      We have modified the text as follows: “To test this possibility, we incubated baf-1(G12T) males with fog-2(q71) feminized worms that only produce oocytes and counted daily offspring. At 25°C, the fog-2(q71) allele prevents spermatogenesis specifically in XX hermaphrodites whereas X0 males are unaffected (Schedl & Kimble, 1988). We observed a reduction in brood size of approximately one third when sperm came from baf-1(G12T) males (Supplementary Figure S2B, C). Thus, we concluded that the baf-1(G12T) mutation has a negative impact on spermatogenesis. The male/female ratio in the progeny was ~1, suggesting that meiotic segregation of chromosomes was normal in baf-1(G12T) males.”

      7). Would it make sense to discuss a possible influence of altered lamin binding to the nuclear envelope in the mutant in the context of the gene expression results?

      We agree that this point is relevant, and we have added the following text to the Discussion: “At current, we can only speculate about how the NGPS mutation might affect gene expression. Proteomics analyses indicate that BAF interacts with several histones and transcription factors (Montes de Oca, Shoemaker, Gucek, Cole, & Wilson, 2009), and the differences between BAF-1 and BAF-1(G12T)’s chromatin binding profiles reported here might be accompanied by changes in the association of chromatin factors at the deregulated loci. A particularly interesting candidate is GCL-1/germ cell-less 1, a repressive factor involved in spermatogenesis (Holaska, Lee, Kowalski, & Wilson, 2003). Moreover, it is plausible that the diminished recruitment of LMN-1 to the NE in baf-1(G12T) mutants modifies its interaction with the genome and with chromatin factors.”

      8). In a nutshell, the authors have established a convincing accessible model system for studying aging, ready for consecutive testing interventions to reduce the pace of premature aging.

      We appreciate and share the opinion of the reviewer.

      Reviewer #2

      1). The value of this work is two-fold: First, it is a very robust characterization of NGPS worms. Second, this will be a very useful model for the study of NGPS. Overall, the study is well-designed, technically strong, and the results are carefully and thoughtfully interpreted, which is nicely exemplified by the discussion of the relatively small number of genes which are differentially bound by BAF1 and are also differentially expressed and the authors do a good job of not overinterpreting the data, but simply state them. The results are convincing and informative.

      We thank the reviewer for her/his positive evaluation.

      My only minor point that may make this paper marginally better is that it would be nice to have a paragraph in the Discussing elaborating on the potential and the limitations of using the worm model to understand human NGPS, for example, humans have multiple lamin proteins etc.

      We agree with the reviewer and have added the following text to the Discussion: “We note that the simplicity of invertebrates also implies certain limitations. For instance, while both human and C. elegans genomes contain a single BAF gene, humans, but not C. elegans, express multiple lamin isoforms in tissue-specific ratios that regulate chromatin organization and nuclear mechanics (Swift et al., 2013). Thus, C. elegans is not suitable to explore potential differences in how wild type and NGPS BAF interacts differently with the various lamin isoforms.”

      Reviewer #3

      1). Overall, this manuscript strongly supports the major conclusion that this C. elegans line is a powerful model for human NGPS that complements a previously reported Drosophila model. Equally importantly, from the viewpoint of fundamental discovery, this manuscript also reports major advances in understanding how BAF influences gene expression at the molecular level.

      We thank the reviewer for her/his positive evaluation.

      2). DamID-Baf-1 access to chromatin was unaffected by the G12T mutation (Fig. S7), but they successfully identified subsets of genes 'occupied' by baf-1 in specific cell types, some of which were significantly affected in opposite ways by the NGPS mutation (Fig. 4, Fig. 5). However, these important new results are described too briefly, and discussion is inadequate. E.g., in hypodermal cells, the baf-1 G12T mutation dysregulated genes encoding proteins in five categories (ribosomal, proton transport, cuticle components, cell surface, lysine acetylation), by downregulating genes in three categories (ribosomal, proton transport, histone acetylation) and upregulating three other categories (cuticle components, cell surface, apical region). In intestinal cells, the mutation dysregulated genes in 8 categories (ribosomal, response to X-ray, proton transport, proteasome binding, mitochondrial protein import, endopeptidase activity, carboxy-lyase activity, ATP generation), by downregulating genes in 5 categories (ribosomal, proton transport, peptidase activity, NAD binding, metal cluster binding) and upregulating 3 categories (ribosomal, response to external stimulation, histone acetylation). Opposite results for "ribosomal genes" is confusing. Examples of genes in each affected category are shown in Fig. 6. To fully interpret this data, and address apparently-conflicting results, further analysis is needed to determine if any affected groups of genes have shared regulators. For example, Fig 5E shows "ribosomal protein genes" are both up- and down-regulated by the mutation. The authors should consider: (a) WHICH ribosomal genes are in each category, and (b) does either group of genes have known regulators that might be differentially affected by the baf-1 mutation? Similar consideration of other sets of differentially-affected genes might provide novel insight into specific chromatin-regulatory proteins (e.g., potential baf-1 partners; see next paragraph) affected by the NGPS mutation.

      At first it may seem confusing that some ribosomal genes are downregulated while others are upregulated. However, the baf-1(G12T) mutant represents a disease situation and not a process of natural selection where one might expect “meaningful” groups of up- and down-regulated genes. We have looked closer at the individual deregulated ribosomal genes and found genes encoding structural components of large ribosomal subunits that are either upregulated (rpl-10, rpl-29, rpl-36) or downregulated (rpl-1, rpl-3, rpl-30) in the intestine. Although these opposite behaviors might seem confusing, we propose that they reflect deregulation of ribosome biosynthesis, which is in concordance with the observations in NGPS fibroblasts (Breusegem et al., 2022). We agree that it will be important to investigate how the NGPS mutation induces these oppositely directed effects on gene expression. We found a significant higher association of the 13 deregulated ribosomal genes to BAF-1(G12) than to BAF-1 in the intestine, but we believe it goes beyond the scope of this manuscript to focus on the underlying mechanisms.

      3). The current manuscript is too strictly focused on establishing C. elegans as a model for NGPS, and neglects the novel discoveries. The authors did not consider or discuss HOW a baf-1 mutation might cause such complex gene expression outcomes- given that baf-1 binds dsDNA nonspecifically. One plausible molecular explanation is that the NGPS mutation might affect baf-1 interactions with: (a) transcription factors (Requiem, RBBP4, DDB1) or chromatin-regulators (PARP1; UV-regulated interactions with DDB2 and CUL4A) identified as BAF-associated in a proteomic study (Montes de Oca et al., 2009), or (b) histone modifiers such as SET/I2PP2A (blocks H3 dephosphorylation) or H3K9 methyltransferase 'G9a' (Montes de Oca et al., 2011), or (c) other regulators that control affected genes identified in this manuscript.

      We agree that this point is very relevant, but at this point we do not have experimental support for any of these possibilities. As indicated in the response to Reviewer #2, we have added the following text to the Discussion: “At current, we can only speculate about how the NGPS mutation might affect gene expression. Proteomics analyses indicate that BAF interacts with several histones and transcription factors (Montes de Oca et al., 2009), and the differences between BAF-1 and BAF-1(G12T)’s chromatin binding profiles reported here might be accompanied by changes in the association of chromatin factors at the deregulated loci. A particularly interesting candidate is GCL-1/germ cell-less 1, a repressive factor involved in spermatogenesis (Holaska et al., 2003). Moreover, it is plausible that the diminished recruitment of LMN-1 to the NE in baf-1(G12T) mutants modifies its interaction with the genome and with chromatin factors.”

      4). Figures 1, 2, 4, 5: the graphs in Fig 1A,B,D-F and Fig 2B,D and the colorscales in Fig 4F and Fig 5E are uninterpretable when printed in black-and-white. Please fix Figs 1 and 2 using black/light-gray/white/stippled for bar graphs, and black/light-gray/solid/dotted/dashed for line graphs. Fig 2B can be fixed by direct-labeling of class numbers within each bar (instead of 'color-coding' separately).

      We thank the reviewer for this suggestion. We have modified the figures to enable better visualization when printed in BW.

      5). Revise abstract lines 40-42 ("suggesting a direct relationship between BAF-1 binding [to what?] and gene expression") to reflect the deeper analysis.

      We have rephrased this sentence, so it now reads: “Most genes deregulated by the baf-1(G12T) mutation were characterized by a change in BAF-1 association, suggesting a direct relation between association of a gene to BAF-1 and its expression.” However, we prefer to not extend into speculations in the abstract because of lack of experimental evidence.

      6). Lines 132-155 (Figure 1): The impact on sperm production suggests the NGPS mutation might affect association with Germ cell-less (GCL), a transcription repressor that competes with BAF for binding to emerin in mammalian cells (Holaska et al., 2003 JBC).

      This is indeed an interesting possibility and we have incorporated it into to Discussion (see answer to point 3 above).

      7). Lines 151-154: Did not understand the fog-2 'feminized worm' experiments. Please briefly explain for non-worm experts.

      Please see our response to Reviewer #1’s point 6.

      8). Line 190: Clarify that nuclear shapes were categorized manually by single-blind observer.

      We have amended the text: “Nuclei were manually classified by single-blind observer based on their morphology as previously described (Perez-Jimenez, Rodriguez-Palero, Rodenas, Askjaer, & Munoz, 2014), except that we introduced a fourth class to describe the most irregular nuclei (see Materials and Methods).”

      9). Line 237-252: Abnormal chromosome segregation and postmitotic nuclear assembly in all gfp::baf-1(G12T) embryos is fully consistent (not 'presumably causative'; line 251) with the embryonic loss-of-function phenotype for baf-1 (Margalit et al., 2005, PNAS) and is consistent with mutational disruption of binding to lamin (Liu J et al., 2000, MBC) and/or LEM-domain proteins (Liu J, Lee KK et al., 2003, PNAS).

      We thank the reviewer for pointing this out. We have added the following sentence: “These phenotypes are consistent with the effects of embryonic depletion of BAF-1 or LMN-1 (Liu et al., 2000; Margalit, Segura-Totten, Gruenbaum, & Wilson, 2005).”

      10). Lines 530-533: Baf-1 localization (mobility) in intestinal cells is known to change profoundly in response to heat shock, caloric restriction or food deprivation (Bar et al., 2014, MBC). It would be worthwhile testing, in future, whether the NGPS mutation affects baf-1 localization in response to these stresses.

      We appreciate this suggestion, and we agree with the reviewer that it would be important to test this in future studies.

      Other changes:

      Missing column in Table S3 added.

      Mistake if column heading in Table S4 corrected.

      Breusegem, S. Y., Houghton, J., Romero-Bueno, R., Fragoso-Luna, A., Kentistou, K. A., Ong, K. K., . . . Larrieu, D. (2022). A multiparametric anti-aging CRISPR screen uncovers a role for BAF in protein translation. bioRxiv. doi:10.1101/2022.10.07.509469

      Gorjanacz, M., Klerkx, E. P., Galy, V., Santarella, R., Lopez-Iglesias, C., Askjaer, P., & Mattaj, I. W. (2007). Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly. Embo J, 26(1), 132-143. doi:10.1038/sj.emboj.7601470

      Greil, F., Moorman, C., & van Steensel, B. (2006). DamID: mapping of in vivo protein-genome interactions using tethered DNA adenine methyltransferase. Methods Enzymol, 410, 342-359. doi:10.1016/S0076-6879(06)10016-6

      Holaska, J. M., Lee, K. K., Kowalski, A. K., & Wilson, K. L. (2003). Transcriptional repressor germ cell-less (GCL) and barrier to autointegration factor (BAF) compete for binding to emerin in vitro. J Biol Chem, 278(9), 6969-6975.

      Janssen, A., Marcelot, A., Breusegem, S., Legrand, P., Zinn-Justin, S., & Larrieu, D. (2022). The BAF A12T mutation disrupts lamin A/C interaction, impairing robust repair of nuclear envelope ruptures in Nestor-Guillermo progeria syndrome cells. Nucleic Acids Res. doi:10.1093/nar/gkac726

      Liu, J., Rolef Ben-Shahar, T., Riemer, D., Treinin, M., Spann, P., Weber, K., . . . Gruenbaum, Y. (2000). Essential roles for Caenorhabditis elegans lamin gene in nuclear organization, cell cycle progression, and spatial organization of nuclear pore complexes. Mol Biol Cell, 11(11), 3937-3947.

      Margalit, A., Segura-Totten, M., Gruenbaum, Y., & Wilson, K. L. (2005). Barrier-to-autointegration factor is required to segregate and enclose chromosomes within the nuclear envelope and assemble the nuclear lamina. Proc Natl Acad Sci U S A, 102(9), 3290-3295. doi:10.1073/pnas.0408364102

      Montes de Oca, R., Shoemaker, C. J., Gucek, M., Cole, R. N., & Wilson, K. L. (2009). Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners. PLoS ONE, 4(9), e7050. doi:10.1371/journal.pone.0007050

      Perez-Jimenez, M. M., Rodriguez-Palero, M. J., Rodenas, E., Askjaer, P., & Munoz, M. J. (2014). Age-dependent changes of nuclear morphology are uncoupled from longevity in Caenorhabditis elegans IGF/insulin receptor daf-2 mutants. Biogerontology, 15(3), 279-288. doi:10.1007/s10522-014-9497-0

      Puente, X. S., Quesada, V., Osorio, F. G., Cabanillas, R., Cadinanos, J., Fraile, J. M., . . . Lopez-Otin, C. (2011). Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am J Hum Genet, 88(5), 650-656. doi:10.1016/j.ajhg.2011.04.010

      Schedl, T., & Kimble, J. (1988). fog-2, a germ-line-specific sex determination gene required for hermaphrodite spermatogenesis in Caenorhabditis elegans. Genetics, 119(1), 43-61. doi:10.1093/genetics/119.1.43

      Schuster, E., McElwee, J. J., Tullet, J. M., Doonan, R., Matthijssens, F., Reece-Hoyes, J. S., . . . Gems, D. (2010). DamID in C. elegans reveals longevity-associated targets of DAF-16/FoxO. Mol Syst Biol, 6, 399. doi:10.1038/msb.2010.54

      Swift, J., Ivanovska, I. L., Buxboim, A., Harada, T., Dingal, P. C., Pinter, J., . . . Discher, D. E. (2013). Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science, 341(6149), 1240104. doi:10.1126/science.1240104

      Vogel, C., & Marcotte, E. M. (2012). Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet, 13(4), 227-232. doi:10.1038/nrg3185

    2. Note: This preprint has been reviewed by subject experts for Review Commons. Content has not been altered except for formatting.

      Learn more at Review Commons


      Referee #3

      Evidence, reproducibility and clarity

      The mechanisms of rare human progeria syndromes caused by mutations in nuclear lamina proteins (lamins or BANF1) are still poorly understood, mainly because these proteins are complicated: they interact and are structurally essential for mitosis and nuclear assembly; hence, disrupting either protein can (and often does) disrupt the other. Lamins and BANF1 also have multiple interwoven roles with other partners involved in 3D genome organization, chromatin regulation, and tissue-specific gene regulation during interphase. To focus on Nestor-Guillermo progeria syndrome (NGPS), caused by the homozygous A12T missense mutation in human BANF1, the authors inserted the corresponding G12T mutation in C. elegans baf-1. They tested potential phenotypes at multiple levels (molecular, transcriptional, cellular and organismal) extensively and rigorously, and did careful controls to determine whether BAF, a tiny (89-aa) protein, was disrupted by fusion to proteins such as GFP or TurboID. Animals carrying the G12T mutation exhibited reduced lifespan (Fig. 1, S1), lower responses to UV irradiation and heat-stress (Fig 7B, 7C), and revealed unexpected germline-specific defects in male worms (Fig. S2, S3), and altered gene expression in two tissues affected by human HGPS (Figs. 4 and 5). Overall, this manuscript strongly supports the major conclusion that this C. elegans line is a powerful model for human NGPS that complements a previously reported Drosophila model.

      Equally importantly, from the viewpoint of fundamental discovery, this manuscript also reports major advances in understanding how BAF influences gene expression at the molecular level. Through careful attention to controls, and experimental design, the authors overcome many complications that make BAF difficult to study: its essential roles in mitosis and early embryogenesis, the 'tag'-sensitivity of endogenous BAF, and the absolute necessity to study BAF in native cell types. The authors carefully compared the impacts of tagging either baf-1 or lamin, and compared wildtype versus G12T-mutated baf-1 interactions with lamin and emerin (Fig. S5, S6, S8, S9; videos S1 and S2). DamID-Baf-1 access to chromatin was unaffected by the G12T mutation (Fig. S7), but they successfully identified subsets of genes 'occupied' by baf-1 in specific cell types, some of which were significantly affected in opposite ways by the NGPS mutation (Fig. 4, Fig. 5). However, these important new results are described too briefly, and discussion is inadequate. E.g., in hypodermal cells, the baf-1 G12T mutation dysregulated genes encoding proteins in five categories (ribosomal, proton transport, cuticle components, cell surface, lysine acetylation), by downregulating genes in three categories (ribosomal, proton transport, histone acetylation) and upregulating three other categories (cuticle components, cell surface, apical region). In intestinal cells, the mutation dysregulated genes in 8 categories (ribosomal, response to X-ray, proton transport, proteasome binding, mitochondrial protein import, endopeptidase activity, carboxy-lyase activity, ATP generation), by downregulating genes in 5 categories (ribosomal, proton transport, peptidase activity, NAD binding, metal cluster binding) and upregulating 3 categories (ribosomal, response to external stimulation, histone acetylation). Opposite results for "ribosomal genes" is confusing. Examples of genes in each affected category are shown in Fig. 6. To fully interpret this data, and address apparently-conflicting results, further analysis is needed to determine if any affected groups of genes have shared regulators. For example, Fig 5E shows "ribosomal protein genes" are both up- and down-regulated by the mutation. The authors should consider: (a) WHICH ribosomal genes are in each category, and (b) does either group of genes have known regulators that might be differentially affected by the baf-1 mutation? Similar consideration of other sets of differentially-affected genes might provide novel insight into specific chromatin-regulatory proteins (e.g., potential baf-1 partners; see next paragraph) affected by the NGPS mutation.

      The current manuscript is too strictly focused on establishing C. elegans as a model for NGPS, and neglects the novel discoveries. The authors did not consider or discuss HOW a baf-1 mutation might cause such complex gene expression outcomes- given that baf-1 binds dsDNA nonspecifically. One plausible molecular explanation is that the NGPS mutation might affect baf-1 interactions with: (a) transcription factors (Requiem, RBBP4, DDB1) or chromatin-regulators (PARP1; UV-regulated interactions with DDB2 and CUL4A) identified as BAF-associated in a proteomic study (Montes de Oca et al., 2009), or (b) histone modifiers such as SET/I2PP2A (blocks H3 dephosphorylation) or H3K9 methyltransferase 'G9a' (Montes de Oca et al., 2011), or (c) other regulators that control affected genes identified in this manuscript.

      Other clarifications and revisions to improve the manuscript:

      Figures 1, 2, 4, 5: the graphs in Fig 1A,B,D-F and Fig 2B,D and the colorscales in Fig 4F and Fig 5E are uninterpretable when printed in black-and-white. Please fix Figs 1 and 2 using black/light-gray/white/stippled for bar graphs, and black/light-gray/solid/dotted/dashed for line graphs. Fig 2B can be fixed by direct-labeling of class numbers within each bar (instead of 'color-coding' separately).

      Revise abstract lines 40-42 ("suggesting a direct relationship between BAF-1 binding [to what?] and gene expression") to reflect the deeper analysis.

      Lines 132-155 (Figure 1): The impact on sperm production suggests the NGPS mutation might affect association with Germ cell-less (GCL), a transcription repressor that competes with BAF for binding to emerin in mammalian cells (Holaska et al., 2003 JBC). Lines 151-154: Did not understand the fog-2 'feminized worm' experiments. Please briefly explain for non-worm experts.

      Line 190: Clarify that nuclear shapes were categorized manually by single-blind observer.

      Line 237-252: Abnormal chromosome segregation and postmitotic nuclear assembly in all gfp::baf-1(G12T) embryos is fully consistent (not 'presumably causative'; line 251) with the embryonic loss-of-function phenotype for baf-1 (Margalit et al., 2005, PNAS) and is consistent with mutational disruption of binding to lamin (Liu J et al., 2000, MBC) and/or LEM-domain proteins (Liu J, Lee KK et al., 2003, PNAS).

      Line 424: Agree that this new C. elegans model is important and strongly complements the Drosophila NGPS model.

      Lines 463-464: Agree that future suppressor analysis in this C. elegans model will be powerfully informative.

      Lines 530-533: Baf-1 localization (mobility) in intestinal cells is known to change profoundly in response to heat shock, caloric restriction or food deprivation (Bar et al., 2014, MBC). It would be worthwhile testing, in future, whether the NGPS mutation affects baf-1 localization in response to these stresses.

      Referees cross-commenting

      I agree with the comments from both other reviewers.

      Significance

      Overall, this manuscript strongly supports the major conclusion that this C. elegans line is a powerful model for human NGPS that complements a previously reported Drosophila model.